PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kim, JH; Hagiwara, T				Kim, Jung Hoon; Hagiwara, Tomomichi			L-infinity-induced norm analysis of sampled-data systems via piecewise constant and linear approximations	AUTOMATICA			English	Article						Sampled-data control; L-1 optimal control; L-infinity-induced norm; Operator approximation; Numerical methods	CONTINUOUS-TIME SYSTEMS; H(INFINITY) DESIGN; GENERAL FRAMEWORK; CONTROLLERS; OPERATOR; H(2)	This paper deals with the L-1 analysis of linear sampled-data systems, by which we mean the computation of the L-infinity-induced norm of linear sampled-data systems. Two computation methods based on piecewise constant and piecewise linear approximations are provided through fast-lifting, by which the sampling interval [0, h) is divided into M subintervals with an equal width. Even though the central part of the method with the former approximation essentially coincides with a conventional method via fast-sample/fast-hold (FSFH) approximation after all, we show that both methods successfully lead to the upper and lower bounds of the L-infinity-induced norm, whose gap converges to 0 at the rate of 1/M in the former approximation and 1/M-2 in the latter extended approximation. Such achievements are in sharp contrast with an existing result on the former (i.e., FSFH) approximation, which only shows the convergence rate of the error in the resulting estimate of the L-infinity-induced norm, without providing any readily computable upper and lower bounds. A numerical example is given to illustrate the effectiveness of these methods. (C) 2014 Elsevier Ltd. All rights reserved.	[Kim, Jung Hoon; Hagiwara, Tomomichi] Kyoto Univ, Dept Elect Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kim, JH (reprint author), Kyoto Univ, Dept Elect Engn, Nishikyo Ku, Kyoto 6158510, Japan.	kim@jaguar.kuee.kyoto-u.ac.jp; hagiwara@kuee.kyoto-u.ac.jp					Anderson B. D. O., 1992, IEEE T AUTOMATIC CON, V37, P214; HAGIWARA T, 1995, IEEE T AUTOMAT CONTR, V40, P1411, DOI 10.1109/9.402221; KABAMBA PT, 1993, IEEE T AUTOMAT CONTR, V38, P1337, DOI 10.1109/9.237646; BAMIEH B, 1992, SYST CONTROL LETT, V19, P1, DOI 10.1016/0167-6911(92)90033-O; BAMIEH BA, 1992, IEEE T AUTOMAT CONTR, V37, P418, DOI 10.1109/9.126576; Mirkin L, 1999, SIAM J CONTROL OPTIM, V38, P175, DOI 10.1137/S0363012997329603; BAMIEH B, 1993, IEEE T AUTOMAT CONTR, V38, P717; Dahleh M. A., 1986, Proceedings of the 25th IEEE Conference on Decision and Control (Cat. No.86CH2344-0); DAHLEH MA, 1987, IEEE T AUTOMAT CONTR, V32, P314, DOI 10.1109/TAC.1987.1104603; DAHLEH MA, 1987, IEEE T AUTOMAT CONTR, V32, P889, DOI 10.1109/TAC.1987.1104455; Dahleh M.A., 1986, P AM CONTR C SEATTL, P1964; Dullerud GE, 1999, SYST CONTROL LETT, V37, P87, DOI 10.1016/S0167-6911(99)00009-2; DULLERUD GE, 1992, IEEE T AUTOMAT CONTR, V37, P436, DOI 10.1109/9.126577; Hagiwara T, 2008, EUR J CONTROL, V14, P286, DOI 10.3166/EJC.14.286-296; Khammash M, 2000, IEEE T AUTOMAT CONTR, V45, P180, DOI 10.1109/9.839942; Kim JH, 2014, SYST CONTROL LETT, V67, P1, DOI 10.1016/j.sysconle.2014.01.009; Mirkin L, 1999, SIAM J CONTROL OPTIM, V38, P197, DOI 10.1137/S0363012997329615; OHTA Y, 1992, IEEE T AUTOMAT CONTR, V37, P1683, DOI 10.1109/9.173139; SIVASHANKAR N, 1992, AUTOMATICA, V28, P1267, DOI 10.1016/0005-1098(92)90072-N; TADMOR G, 1992, INT J CONTROL, V56, P99, DOI 10.1080/00207179208934306; TOIVONEN HT, 1992, AUTOMATICA, V28, P45, DOI 10.1016/0005-1098(92)90006-2; VIDYASAGAR M, 1986, IEEE T AUTOMAT CONTR, V31, P527, DOI 10.1109/TAC.1986.1104315; YAMAMOTO Y, 1994, IEEE T AUTOMAT CONTR, V39, P703, DOI 10.1109/9.286247	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	JAN	2015	51						223	232		10.1016/j.automatica.2014.10.102		10	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AZ1RL	WOS:000348015500026		
J	Okubo, M; Murayama, N; Miura, J; Chiba, Y; Yamazaki, H				Okubo, Maho; Murayama, Norie; Miura, Jun; Chiba, Yasuji; Yamazaki, Hiroshi			Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients	BIOCHEMICAL PHARMACOLOGY			English	Article						CYP2D6; CY3A5; Genetic polymorphisms; Mirtazapine; Plasma concentration	DRUG-INTERACTIONS; NEWER ANTIPSYCHOTICS; IN-VITRO; PHARMACOKINETICS; RISPERIDONE; BIOTRANSFORMATION; PHARMACOGENETICS; SCHIZOPHRENIA; ENANTIOMERS; POPULATION	A personalized treatment approach should be considered with the second-generation psychiatric drug mirtazapine because of high frequencies of side effects, including characteristic drowsiness. Plasma concentrations of mirtazapine in patients are influenced by many factors, including polymorphic cytochrome P450 enzymes contributing to its transformation to 8-hydroxymirtazapine and N-demethylmirtazapine. The aim of this study was to investigate the determinant factors for individual variations of metabolic clearance of mirtazapine using in vitro and in vivo methods. In vitro analyses using liver microsomes from individual humans in correlation assays and recombinantly expressed P450 enzymes revealed that CYP2D6 was the major contributor to mirtazapine 8-hydroxylation with high affinity, and that CYP3A5 catalyzed N-demethylation in a similar high-capacity manner to that of CYP3A4. CYP1A2 was a minor contributor to mirtazapine 8-hydroxylation. Metabolic clearance of mirtazapine determined in substrate depletion assays and mirtazapine 8-hydroxylation activities in individual liver microsomes were significantly lower in CYP2D6 intermediate metabolizers (IM) and poor metabolizers (PM) than in extensive metabolizers (EM) (p < 0.05). Trough plasma concentration/dose ratios of mirtazapine from 14 patients were significantly higher in the CYP2D6 IM/PM group than in the EM group and were also higher in the CYP3A5 poor-expressors group than in the expressors group (p < 0.05). Mirtazapine clearance in pooled human liver microsomes was inhibited by quinidine (a CYP2D6 inhibitor), ketoconazole (a CYP3A inhibitor), and in combination with risperidone and duloxetine, possible coadministered medicines. These results suggested that mirtazapine metabolic clearance could be variously influenced by the CYP2D6 and CYP3A5 genotypes and coadministered drugs in clinical patients. (C) 2014 Elsevier Inc. All rights reserved.	[Okubo, Maho; Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan; [Miura, Jun] Muroran Inst Technol, Muroran, Hokkaido 0508585, Japan; [Chiba, Yasuji] Sanai Hosp, Noboribetsu 0590463, Japan	Yamazaki, H (reprint author), Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Makiko Shimizu, Shoko Morita, Asami Mori, and Momoko Narita for their technical assistance and David Smallbones for his English language advice. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adler G, 2009, PHARMACOL REP, V61, P947; Anderson DT, 1999, J ANAL TOXICOL, V23, P544; Spina E, 2008, CLIN THER, V30, P1206, DOI 10.1016/j.clinthera.2008.07.009; Spina E, 2007, BASIC CLIN PHARMACOL, V100, P4, DOI 10.1111/j.1742-7843.2007.00017.x; Timmer CJ, 1996, HUM PSYCHOPHARM CLIN, V11, P497, DOI 10.1002/(SICI)1099-1077(199611)11:6<497::AID-HUP820>3.3.CO;2-A; Onishi Y, 2013, CLIN DRUG INVEST, V33, P597, DOI 10.1007/s40261-013-0104-y; Kelder J, 1997, J PHARM PHARMACOL, V49, P403; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Stormer E, 2000, DRUG METAB DISPOS, V28, P1168; Timmer CJ, 2000, CLIN PHARMACOKINET, V38, P461, DOI 10.2165/00003088-200038060-00001; Delbressine LPC, 1998, CLIN DRUG INVEST, V15, P45, DOI 10.2165/00044011-199815010-00006; Sirot EJ, 2012, J CLIN PSYCHOPHARM, V32, P622, DOI 10.1097/JCP.0b013e3182664d98; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lind AB, 2009, CLIN PHARMACOKINET, V48, P63, DOI 10.2165/0003088-200948010-00005; Fukuen S, 2002, PHARMACOGENETICS, V12, P331, DOI 10.1097/00008571-200206000-00009; Zoccali R, 2003, PHARMACOL RES, V48, P411, DOI 10.1016/S1043-6618(03)00178-6; Dodd S, 2001, HUM PSYCHOPHARM CLIN, V16, P541, DOI 10.1002/hup.328; Brockmoller J, 2007, CLIN PHARMACOL THER, V81, P699, DOI 10.1038/sj.clpt.6100116; Carter NJ, 2009, CNS DRUGS, V23, P523, DOI 10.2165/00023210-200923060-00006; Cartwright AL, 2013, ANN PHARMACOTHER, V47, P350, DOI 10.1345/aph.1R333; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; Fukuda T, 1999, BRIT J CLIN PHARMACO, V47, P450, DOI 10.1046/j.1365-2125.1999.00913.x; Grasmader K, 2004, EUR J CLIN PHARMACOL, V60, P473, DOI 10.1007/s00228-004-0737-0; Koch H, 2012, AFR J PSYCHIATRY, V15, P160, DOI [http://dx.doi.org/10.4314/ajpsy.v15i3.19, 10.4314/ajpsy.v15i3.19]; Lenderts Susan, 2009, Psychiatry (Edgmont), V6, P15; Loonen AJM, 1999, EUR NEUROPSYCHOPHARM, V10, P51, DOI 10.1016/S0924-977X(99)00054-1; Moore KA, 1999, J ANAL TOXICOL, V23, P541; Nakagawa A, 2007, J CLIN PSYCHIAT, V68, P908; Okubo M, 2012, CLIN CHIM ACTA, V413, P1675, DOI 10.1016/j.cca.2012.05.013; Quasim M, 1999, Int J Psychiatry Clin Pract, V3, P17, DOI 10.3109/13651509909024754; Rajpurohit Naveen, 2014, S D Med, V67, P137; Ruwe FJL, 2001, HUM PSYCHOPHARM CLIN, V16, P449, DOI 10.1002/hup.318.abs; Stormer E, 2000, J PHARMACOL EXP THER, V295, P793; Yoshio T, 2012, HUM PSYCHOPHARM CLIN, V27, P70, DOI 10.1002/hup.1272	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	JAN 1	2015	93	1					104	109		10.1016/j.bcp.2014.11.011		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ5MG	WOS:000348264400011		
J	Kubo, A; Yamamoto-Kawai, M; Kanda, J				Kubo, A.; Yamamoto-Kawai, M.; Kanda, J.			Seasonal variations in concentration and lability of dissolved organic carbon in Tokyo Bay	BIOGEOSCIENCES			English	Article							SOUTHEASTERN UNITED-STATES; NORTH-ATLANTIC OCEAN; RIVER WATER; MATTER; DOC; PHYTOPLANKTON; CONSUMPTION; ECOSYSTEMS; SEAWATER; ESTUARY	Concentrations of recalcitrant and bioavailable dissolved organic carbon (DOC) and their seasonal variations were investigated at three stations in Tokyo Bay, Japan, and in two freshwater sources flowing into the bay. On average, recalcitrant DOC (RDOC), as a remnant of DOC after 150 days of bottle incubation, accounted for 78% of the total DOC in Shibaura sewage treatment plant (STP) effluent, 67% in the upper Arakawa River water, 66% in the lower Arakawa River water, and 78% in surface bay water. Bioavailable DOC (BDOC) concentrations, defined as DOC minus RDOC, were lower than RDOC at all stations. In freshwater environments, RDOC concentrations were almost constant throughout the year. In the bay, RDOC was higher during spring and summer than in autumn and winter because of freshwater input and biological production. The relative concentration of RDOC in the bay derived from phytoplankton, terrestrial, and open-oceanic waters was estimated to be 8-10, 21-32, and 59-69 %, respectively, based on multiple regression analysis of RDOC, salinity, and chl a. In addition, comparison with previous data from 1972 revealed that concentrations of RDOC and BDOC have decreased by 33 and 74% at freshwater sites and 39 and 76% in Tokyo Bay, while the ratio of RDOC to DOC has increased. The change in DOC concentration and composition was probably due to increased amounts of STP effluent entering the system. Tokyo Bay exported mostly RDOC to the open ocean because of the remineralization of BDOC.	[Kubo, A.; Kanda, J.] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan; [Yamamoto-Kawai, M.] Tokyo Univ Marine Sci & Technol, Ctr Adv Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Kubo, A (reprint author), Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	kuboatsushi0412@gmail.com	Yamamoto-Kawai, Michiyo/F-7611-2013		Ministry of Education, Culture, Sports, Science and Technology, Japan [24510009]; Canon Foundation grant	We thank Chinatsu Oouchida, as well as other scientists, officers, and crew members on board the R/V Seiyo-maru for their help in sampling. This work was supported by a Grant-in-Aid for Scientific Research (C) (24510009) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a Canon Foundation grant. The authors are grateful to the anonymous reviewers and the associate editor Silvio Pantoja, who provided valuable comments on the manuscript.	Aitkenhead-Peterson J.A., 2003, AQUATIC ECOSYSTEMS I, P25, DOI 10.1016/B978-012256371-3/50003-2; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; MEYERSSCHULTE KJ, 1986, NATURE, V321, P61, DOI 10.1038/321061a0; Hansell DA, 2009, OCEANOGRAPHY, V22, P202; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Amon RMW, 1996, GEOCHIM COSMOCHIM AC, V60, P1783, DOI 10.1016/0016-7037(96)00055-5; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Lonborg C, 2009, MAR CHEM, V113, P219, DOI 10.1016/j.marchem.2009.02.003; Obernosterer I, 2004, LIMNOL OCEANOGR, V49, P117; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; Dai MH, 2012, CURR OPIN ENV SUST, V4, P170, DOI 10.1016/j.cosust.2012.03.003; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; Maki K, 2010, LIMNOLOGY, V11, P143, DOI 10.1007/s10201-009-0299-z; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307; Bauer JE, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P7; Kragh T, 2009, BIOGEOCHEMISTRY, V96, P177, DOI 10.1007/s10533-009-9357-1; Chin WC, 1998, NATURE, V391, P568; OGURA N, 1975, MAR BIOL, V31, P101, DOI 10.1007/BF00391622; Hernes PJ, 2006, MAR CHEM, V100, P66, DOI 10.1016/j.marchem.2005.11.003; TAKADA H, 1992, ESTUAR COAST SHELF S, V35, P141, DOI 10.1016/S0272-7714(05)80109-X; Raymond PA, 2000, AQUAT MICROB ECOL, V22, P1, DOI 10.3354/ame022001; Avery GB, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001964; Bauer JE, 2002, DEEP-SEA RES PT II, V49, P4387, DOI 10.1016/S0967-0645(02)00123-6; Bouman HA, 2010, ESTUAR COAST SHELF S, V87, P63, DOI 10.1016/j.ecss.2009.12.014; Bureau of Sewerage, 2013, MAN PLAN 2013; Carlson C.A., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; Cauwet G., 2002, BIOGEOCHEMISTRY MARI, P579, DOI DOI 10.1016/B978-012323841-2/50014-2; Hansell D. A., 2013, ANNU REV MAR SCI, V5, P31; Japan Sewage Works Association, 2010, SEW STAT; KADLEC R. H., 2008, TREATMENT WETLANDS; Kerner M, 2003, NATURE, V422, P150, DOI 10.1038/nature01469; Lonborg C, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004353; Meybeck M, 1993, INTERACTIONS C N P S, P163; MULHOLLAND PJ, 1981, LIMNOL OCEANOGR, V26, P790; Nakamura T, 2011, J JPN ASS HYDROL SCI, V41, P79, DOI 10.4145/jahs.41.79; National Institute for Land and Infrastructure Management, 2004, INF PORT ENV; Nellemann C., 2008, RAPID RESPONSE ASSES; Nihei Y., 2007, J JSCE, V54, P1226; Nihei Y., 2007, J JSCE, V54, P1221; Ogawa H., 1990, CHIKYUKAGAKU, V24, P27; OGAWA H, 1992, NATURE, V356, P696, DOI 10.1038/356696a0; Okada T., 2007, J HYDRAUL COASTAL EN, V63, P67; Redfield A. C., 1963, SEA, V2, P26; Servais P, 1999, WATER RES, V33, P3521, DOI 10.1016/S0043-1354(99)00056-1; Servais P, 1995, ANN LIMNOL-INT J LIM, V31, P75, DOI 10.1051/limn/1995005; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Tanaka Y, 2011, J OCEANOGR, V67, P427, DOI 10.1007/s10872-011-0046-z; TRANVIK LJ, 1987, APPL ENVIRON MICROB, V53, P482; Yamaguchi Y., 1979, B COAST OCEANOGR, V16, P106; YAMAGUCHI Y, 1991, MAR POLLUT BULL, V23, P723, DOI 10.1016/0025-326X(91)90768-N; Yamashita Y, 2011, ECOSYSTEMS, V14, P1110, DOI 10.1007/s10021-011-9469-z; Yanagi Tetsuo, 1993, Journal of Oceanography, V49, P249, DOI 10.1007/BF02269563	58	1	1	COPERNICUS GESELLSCHAFT MBH	GOTTINGEN	BAHNHOFSALLEE 1E, GOTTINGEN, 37081, GERMANY	1726-4170	1726-4189		BIOGEOSCIENCES	Biogeosciences		2015	12	1					269	279		10.5194/bg-12-269-2015		11	Ecology; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Geology	AZ0UR	WOS:000347960800017		
J	Hara, A; Hamasaki, K; Yoshida, K; Yusa, Y				Hara, Akiko; Hamasaki, Kenji; Yoshida, Kazuhiro; Yusa, Yoichi			Canal type affects invasiveness of the apple snail Pomacea canaliculata through its effects on animal species richness and waterweed invasion	BIOLOGICAL INVASIONS			English	Article						Biotic resistance; Exotic species; Freshwater; Gastropoda; Human impact; Invasional meltdown	BIOTIC RESISTANCE; BIOLOGICAL INVASIONS; IRRIGATION PRACTICES; CENTRAL JAPAN; RICE FIELDS; RAIN-FOREST; HONG-KONG; AMPULLARIIDAE; GASTROPODA; DIVERSITY	Loss of complex natural microhabitats due to human activity is a major cause of decreased biodiversity but its effects on biological invasion are not well understood. The effects of physical environmental factors, especially the type of agricultural canals, on the invasive freshwater snail Pomacea canaliculata were studied at 33 sites in the Chikugogawa River basin, Kyushu, Japan. Differences among sites in the local fauna and vegetation were also monitored. Structural equation modeling with a model selection procedure revealed that canals with a concrete lining had more snails. The effect was indirect in that the concrete lining reduced animal species richness and increased the invasive waterweed Egeria densa, which may serve as a refuge, protecting the snails from predation. A tethering experiment conducted simultaneously indicated high predation pressure on the snails: over 20% of the tethered snails were lost within a day. Thus, human impacts may increase biological invasion by reducing biotic resistance and increasing the risk of invasional meltdown.	[Hara, Akiko; Hamasaki, Kenji; Yusa, Yoichi] Nara Womens Univ, Fac Sci, Kitauoyanishi, Nara 6308506, Japan	Yusa, Y (reprint author), Nara Womens Univ, Fac Sci, Kitauoyanishi, Nara 6308506, Japan.	yusa@cc.nara-wu.ac.jp					Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; BALTZ DM, 1993, ECOL APPL, V3, P246, DOI 10.2307/1941827; Green PT, 2004, BIOL INVASIONS, V6, P1, DOI 10.1023/B:BINV.0000010144.12808.cb; Kimbro DL, 2013, ECOL LETT, V16, P821, DOI 10.1111/ele.12106; Harvey BC, 2004, ECOLOGY, V85, P127, DOI 10.1890/03-3018; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Urban MC, 2006, DIVERS DISTRIB, V12, P337, DOI 10.1111/j.1366-9516.2005.00226.x; Kwong KL, 2008, MALACOLOGIA, V50, P293, DOI 10.4002/0076-2997-50.1.293; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Wong PK, 2010, FRESHWATER BIOL, V55, P2023, DOI 10.1111/j.1365-2427.2010.02458.x; Lane SJ, 1998, BIOL CONSERV, V83, P221, DOI 10.1016/S0006-3207(97)00054-2; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Yamanishi Y, 2012, BIOL INVASIONS, V14, P1343, DOI 10.1007/s10530-011-0158-9; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Byers JE, 2002, OECOLOGIA, V130, P146, DOI 10.1007/s004420100777; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Fujioka M, 1997, ECOL RES, V12, P101, DOI 10.1007/BF02523615; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Yusa Y, 2006, BIOL INVASIONS, V8, P137, DOI 10.1007/s10530-004-1790-4; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Cowie Robert H., 2002, P145, DOI 10.1079/9780851993201.0145; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; ELTON C.S., 1958, ECOLOGY INVASION ANI; Fang L, 2010, FRESHWATER BIOL, V55, P1191, DOI 10.1111/j.1365-2427.2009.02343.x; Hidaka K, 2007, T RURAL PLAN, V26, P233; Hoyle R. H., 1995, STRUCTURAL EQUATION, P1; Hu L., 1995, STRUCTURAL EQUATION, P76; Ito K, 2002, APPL ENTOMOL ZOOL, V37, P655, DOI 10.1303/aez.2002.655; Joshi R. C., 2006, GLOBAL ADV ECOLOGY M; Kubo K, 2012, JPN J CONSERV ECOL, V17, P165; LAKE PS, 1991, OIKOS, V62, P25, DOI 10.2307/3545442; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Martin PR, 2001, MALACOLOGIA, V43, P13; Pugesek B. H., 2003, STRUCTURAL EQUATION; Sato M, 2010, BIOL INVASIONS, V12, P3677, DOI 10.1007/s10530-010-9762-3; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Yusa Yoichi, 2006, P345	42	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-3547	1573-1464		BIOL INVASIONS	Biol. Invasions	JAN	2015	17	1					63	71		10.1007/s10530-014-0703-4		9	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	AY4CW	WOS:000347526800010		
J	Lo, WL; Lin, CM; Yeh, YS; Su, YK; Tseng, YY; Yang, ST; Lin, JW				Lo, Wei-Lun; Lin, Chien-Min; Yeh, Yi-Shian; Su, Yu-kai; Tseng, Yuan-Yun; Yang, Shun-Tai; Lin, Jai-Wei			Comparing Miniopen and Minimally Invasive Transforaminal Interbody Fusion in Single-Level Lumbar Degeneration	BIOMED RESEARCH INTERNATIONAL			English	Article							ISTHMIC SPONDYLOLISTHESIS; POSTEROLATERAL FUSION; CLINICAL-OUTCOMES; FOLLOW-UP; POSTERIOR; INSTRUMENTATION; COMPLICATIONS; FIXATION; ADULTS; SPINE	Degenerative diseases of the lumbar spine, which are common among elderly people, cause back pain and radicular symptoms and lead to a poor quality of life. Lumbar spinal fusion is a standardized and widely accepted surgical procedure used for treating degenerative lumbar diseases; however, the classical posterior approach used in this procedure is recognized to cause vascular and neurologic damage of the lumbar muscles. Various studies have suggested that using the minimally invasive transforaminal interbody fusion (TLIF) technique provides long-term clinical outcomes comparable to those of open TLIF approaches in selected patients. In this study, we compared the perioperative and short-term advantages of miniopen, MI, and open TLIF. Compared with open TLIF, MI-TLIF and miniopen TLIF were associated with less blood loss, shorter hospital stays, and longer operative times; however, following the use of these procedures, no difference in quality of life was measured at 6 months or 1 year. Whether miniopen TLIF or MI-TLIF can replace traditional TLIF as the surgery of choice for treating degenerative lumbar deformity remains unclear, and additional studies are required for validating the safety and efficiency of these procedures.	[Lo, Wei-Lun; Lin, Chien-Min; Yeh, Yi-Shian; Su, Yu-kai; Tseng, Yuan-Yun; Yang, Shun-Tai; Lin, Jai-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei City, Taiwan; [Lo, Wei-Lun] Minist Hlth & Welfare, Keelung Hosp, Keelung, Taiwan; [Lo, Wei-Lun; Lin, Chien-Min; Yeh, Yi-Shian; Su, Yu-kai; Tseng, Yuan-Yun; Yang, Shun-Tai; Lin, Jai-Wei] Taipei Med Univ, Taipei, Taiwan; [Lin, Chien-Min] Univ Fukui, Fac Med Sci, Fukui 910, Japan	Lin, CM (reprint author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei City, Taiwan.	12317@s.tmu.edu.tw					Mannion RJ, 2012, J SPINAL DISORD TECH, V25, P47, DOI 10.1097/BSD.0b013e31820baa1e; Wang JA, 2010, EUR SPINE J, V19, P1780, DOI 10.1007/s00586-010-1404-z; Deguchi M, 1998, J SPINAL DISORD, V11, P459; Schizas C, 2009, INT ORTHOP, V33, P1683, DOI 10.1007/s00264-008-0687-8; Zdeblick TA, 2000, SPINE, V25, P2682, DOI 10.1097/00007632-200010150-00023; LIN PM, 1985, CLIN ORTHOP RELAT R, P90; Kim NH, 1999, SPINE, V24, P812, DOI 10.1097/00007632-199904150-00014; Tsutsumimoto T, 2009, SPINE, V34, P1923, DOI 10.1097/BRS.0b013e3181a9d28e; Lau D, 2011, J CLIN NEUROSCI, V18, P624, DOI 10.1016/j.jocn.2010.09.004; FERNYHOUGH JC, 1992, SPINE, V17, P1474; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Humphreys SC, 2001, SPINE, V26, P567; Christensen FB, 2002, SPINE, V27, P2674, DOI 10.1097/00007632-200212010-00006; Isaacs RE, 2005, J NEUROSURG-SPINE, V3, P98, DOI 10.3171/spi.2005.3.2.0098; Rajaraman V, 1999, J NEUROSURG, V91, P60, DOI 10.3171/spi.1999.91.1.0060; Scheufler KM, 2007, NEUROSURGERY, V60, P203, DOI 10.1227/01.NEU.0000255388.03088.B7; Saraph V, 2004, EUR SPINE J, V13, P425, DOI 10.1007/s00586-004-0722-4; EVANS JH, 1985, CLIN ORTHOP RELAT R, P38; Dhall SS, 2008, J NEUROSURG-SPINE, V9, P560, DOI 10.3171/SPI.2008.9.08142; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; Yan DL, 2008, EUR SPINE J, V17, P1311, DOI 10.1007/s00586-008-0739-1; Lee JC, 2012, SPINE, V37, P1548, DOI 10.1097/BRS.0b013e318252d44b; CLOWARD RB, 1953, J NEUROSURG, V10, P154, DOI 10.3171/jns.1953.10.2.0154; Dong Y. L., 2008, J NEUROSURG-SPINE, V9, P137; Fan SW, 2010, SPINE, V35, P1615, DOI 10.1097/BRS.0b013e3181c70fe3; Gertzbein SD, 1996, SPINE, V21, P1918, DOI 10.1097/00007632-199608150-00018; GOEL VK, 1993, SPINE, V18, P1531; Habib A., 2010, SURG NEUROLOGY INT, V1; Harms J. G., 1998, J ORTHOPAEDICS TRAUM, V6, P88; Kim KT, 2006, SPINE, V31, P1351, DOI 10.1097/01.brs.0000218635.14571.55; Lawton CD, 2011, J NEUROSURG SCI, V55, P259; Lin P M, 1977, Neurosurgery, V1, P118, DOI 10.1097/00006123-197709000-00006; Peng Chan Wearn Benedict, 2009, Spine (Phila Pa 1976), V34, P1385, DOI 10.1097/BRS.0b013e3181a4e3be; STONECIPHER T, 1989, SPINE, V14, P468, DOI 10.1097/00007632-198904000-00026; TAILLARD WF, 1976, CLIN ORTHOP RELAT R, P30; Villavicencio Alan T, 2010, Surg Neurol Int, V1, P12, DOI 10.4103/2152-7806.63905; Wetzel FT, 1999, SPINE, V24, P1138, DOI 10.1097/00007632-199906010-00014	37	1	1	HINDAWI PUBLISHING CORPORATION	NEW YORK	410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015									168384	10.1155/2015/168384		5	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AZ5XT	WOS:000348292600001		
J	Rouached, H; Pal, S; Rachmilevitch, S; Libault, M; Tran, LSP				Rouached, Hatem; Pal, Sikander; Rachmilevitch, Shimon; Libault, Marc; Lam-Son Phan Tran			Plants Coping Abiotic and Biotic Stresses: A Tale of Diligent Management	BIOMED RESEARCH INTERNATIONAL			English	Editorial Material									[Rouached, Hatem] Univ Montpellier 2, CNRS, INRA, Unit Mixte Rech, F-34060 Montpellier, France; [Pal, Sikander] Univ Jammu, Dept Bot, Jammu 180006, Jammu & Kashmir, India; [Rachmilevitch, Shimon] BGU, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Libault, Marc] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Lam-Son Phan Tran] RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Rouached, H (reprint author), Univ Montpellier 2, CNRS, INRA, Unit Mixte Rech, Pl Viala, F-34060 Montpellier, France.	hatem.rouached@supagro.inra.fr; tran@psc.riken.jp	Tran, Lam-Son/A-1346-2009	Tran, Lam-Son/0000-0001-9883-9768				0	0	0	HINDAWI PUBLISHING CORPORATION	NEW YORK	410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015									754754	10.1155/2015/754754		2	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AZ5ZC	WOS:000348296100001		
J	Sulieman, S; Ha, CV; Esfahani, MN; Watanabe, Y; Nishiyama, R; Pham, CTB; Nguyen, DV; Tran, LSP				Sulieman, Saad; Chien Van Ha; Esfahani, Maryam Nasr; Watanabe, Yasuko; Nishiyama, Rie; Chung Thi Bao Pham; Dong Van Nguyen; Lam-Son Phan Tran			DT2008: A Promising New Genetic Resource for Improved Drought Tolerance in Soybean When Solely Dependent on Symbiotic N-2 Fixation	BIOMED RESEARCH INTERNATIONAL			English	Article							NITROGEN-FIXATION; AGRICULTURAL SYSTEMS; MEDICAGO-TRUNCATULA; STRESS; INHIBITION; RESPONSES; SEQUENCE; NODULES	Water deficit is one of the major constraints for soybean production in Vietnam. The soybean breeding research efforts conducted at the Agriculture Genetics Institute (AGI) of Vietnam resulted in the development of promising soybean genotypes, suitable for the drought-stressed areas in Vietnam and other countries. Such a variety, namely, DT2008, was recommended by AGI and widely used throughout the country. The aim of this work was to assess the growth of shoots, roots, and nodules of DT2008 versus Williams 82 (W82) in response to drought and subsequent rehydration in symbiotic association as a means to provide genetic resources for genomic research. Better shoot, root, and nodule growth and development were observed in the cultivar DT2008 under sufficient, water deficit, and recovery conditions. Our results represent a good foundation for further comparison of DT2008 and W82 at molecular levels using high throughput omic technologies, which will provide huge amounts of data, enabling us to understand the genetic network involved in regulation of soybean responses to water deficit and increasing the chances of developing drought-tolerant cultivars.	[Sulieman, Saad; Chien Van Ha; Esfahani, Maryam Nasr; Watanabe, Yasuko; Nishiyama, Rie; Lam-Son Phan Tran] RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan; [Sulieman, Saad] Univ Khartoum, Fac Agr, Dept Agron, Shambat 13314, Khartoum North, Sudan; [Chien Van Ha; Dong Van Nguyen] Vietnamese Acad Agr Sci, Agr Genet Inst, Natl Key Lab Plant Cell Biotechnol, Hanoi 100000, Vietnam; [Esfahani, Maryam Nasr] Lorestan Univ, Dept Biol, Khorramabad 6815144316, Iran; [Chung Thi Bao Pham] Vietnamese Acad Agr Sci, Agr Genet Inst, Dept Mutat & Heterosis Breeding, Hanoi 100000, Vietnam	Tran, LSP (reprint author), RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tran@psc.riken.jp	Tran, Lam-Son/A-1346-2009	Tran, Lam-Son/0000-0001-9883-9768	Japan Society for the Promotion of Science (JSPS); RIKEN, Japan; Vietnam Ministry of Science and Technology [03/2012/HD-DTDL]	The authors are grateful to P. M. Gresshoff (University of Queensland, Australia) for providing the Bradyrhizobium strain (USDA110). Saad Sulieman was supported by a postdoc fellowship from the Japan Society for the Promotion of Science (JSPS), and Chien Van Ha is supported by a Ph.D. fellowship from "International Program Associate" of RIKEN, Japan. This work was also supported in part by a grant (Project code 03/2012/HD-DTDL) from the Vietnam Ministry of Science and Technology to the Research Group of Dong Van Nguyen.	Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serraj R, 1999, J EXP BOT, V50, P143, DOI 10.1093/jexbot/50.331.143; Blum A, 1996, PLANT GROWTH REGUL, V20, P135, DOI 10.1007/BF00024010; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; King CA, 2005, PLANT PHYSIOL, V137, P1389, DOI 10.1104/pp.104.056317; Peoples MB, 2009, SYMBIOSIS, V48, P1; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Gordon AJ, 1997, PLANT PHYSIOL, V114, P937; Gil-Quintana E, 2013, J EXP BOT, V64, P281, DOI 10.1093/jxb/ers334; Sinclair TR, 2007, FIELD CROP RES, V101, P68, DOI 10.1016/j.fcr.2006.09.010; Larrainzar E, 2014, PLANT CELL ENVIRON, V37, P2051, DOI 10.1111/pce.12285; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; DELVES AC, 1986, PLANT PHYSIOL, V82, P588, DOI 10.1104/pp.82.2.588; Goldsmith P. D., 2008, SOYBEANS CHEM PRODUC, P117; Ha C. V., 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/759657, DOI 10.1155/2013/759657]; Sarker A., 2005, GENETIC RESOURCES CR, V52, P89, DOI DOI 10.1007/S10722-005-0289-X; Somasegaran P., 1994, HDB RHIZOBIA, P47; Streeter JG, 2003, PLANT CELL ENVIRON, V26, P1199, DOI 10.1046/j.1365-3040.2003.01041.x; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Thao NP, 2013, INT J MOL SCI, V14, P23828, DOI 10.3390/ijms141223828; Thu NBA, 2014, BIOMED RES INT, DOI 10.1155/2014/809736; USDA GAIN, 2013, VM3018 USDA GAIN; Vinh M. Q., 2009, Induced plant mutations in the genomics era. Proceedings of an International Joint FAO/IAEA Symposium, 2008, P341; Vinh M. Q., 2010, J VIETNAMESE AGR SCI, V6, P46, DOI DOI 10.1007/S10142-010-0178-Z; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189	29	2	2	HINDAWI PUBLISHING CORPORATION	NEW YORK	410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015									687213	10.1155/2015/687213		7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AZ5YT	WOS:000348295200001		
J	Yoshidome, S; Arimura, H; Nakamura, K; Shioyama, Y; Atsumi, K; Nakamura, Y; Yoshikawa, H; Nishikawa, K; Hirata, H				Yoshidome, Satoshi; Arimura, Hidetaka; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Atsumi, Kazushige; Nakamura, Yasuhiko; Yoshikawa, Hideki; Nishikawa, Kei; Hirata, Hideki			Feasibility Study of Automated Framework for Estimating Lung Tumor Locations for Target-Based Patient Positioning in Stereotactic Body Radiotherapy	BIOMED RESEARCH INTERNATIONAL			English	Article							CONE-BEAM CT; RADIATION-THERAPY; IMAGE-GUIDANCE; COMPUTED-TOMOGRAPHY; ACCURACY; IMMOBILIZATION; UNCERTAINTIES; RADIOSURGERY; PROBABILITY; HISTOGRAMS	Objective. To investigate the feasibility of an automated framework for estimating the lung tumor locations for tumor-based patient positioning with megavolt-cone-beam computed tomography (MV-CBCT) during stereotactic body radiotherapy (SBRT). Methods. A lung screening phantomand ten lung cancer cases with solid lung tumors, who were treated with SBRT, were employed to this study. The locations of tumors in MV-CBCT images were estimated using a tumor-template matching technique between a tumor template and the MV-CBCT. Tumor templates were produced by cropping the gross tumor volume (GTV) regions, which were enhanced by a Sobel filter or a blob structure enhancement (BSE) filter. Reference tumor locations (grand truth) were determined based on a consensus between a radiation oncologist and a medical physicist. Results. According to the results of the phantom study, the average Euclidean distances of the location errors in the original, Sobel-filtered, and BSE-filtered images were 2.0 +/- 4.1 mm, 12.8 +/- 9.4 mm, and 0.4 +/- 0.5 mm, respectively. For clinical cases, these were 3.4 +/- 7.1 mm, 7.2 +/- 11.6 mm, and 1.6 +/- 1.2 mm, respectively. Conclusion. The feasibility study suggests that our proposed framework based on the BSE filter may be a useful tool for tumor-based patient positioning in SBRT.	[Yoshidome, Satoshi; Nishikawa, Kei] Kyushu Univ, Dept Clin Radiol, Beppu Hosp, Beppu, Oita 8740838, Japan; [Yoshidome, Satoshi] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Arimura, Hidetaka; Hirata, Hideki] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Nakamura, Katsumasa; Shioyama, Yoshiyuki] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Atsumi, Kazushige] Kyushu Univ, Dept Radiol, Beppu Hosp, Beppu, Oita 8740838, Japan; [Nakamura, Yasuhiko; Yoshikawa, Hideki] Kyushu Univ Hosp, Div Radiol, Dept Med Technol, Higashi Ku, Fukuoka 8128582, Japan	Arimura, H (reprint author), Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	arimurah@med.kyushu-u.ac.jp			JSPS KAKENHI [26670301]	The authors would like to express their appreciation to all of the members of the Arimura Laboratory who provided them with their precious comments and advice and who made great contributions to this study. This research was partially supported by the JSPS KAKENHI Grant no. 26670301 (Grant-in-Aid for Challenging Exploratory Research).	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Nagata Y, 2002, INT J RADIAT ONCOL, V52, P1041, DOI 10.1016/S0360-3016(01)02731-6; Shirato H, 2004, SEMIN RADIAT ONCOL, V14, P10, DOI 10.1053/j.semradonc.2003.10.008; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Fuss M, 2007, MED DOSIM, V32, P102, DOI 10.1016/j.meddos.2007.01.007; Boda-Heggemann J, 2011, STRAHLENTHER ONKOL, V187, P284, DOI 10.1007/s00066-011-2236-4; Takahashi W, 2013, INT J RADIAT ONCOL, V86, P426, DOI 10.1016/j.ijrobp.2013.02.019; Li WN, 2012, INT J RADIAT ONCOL, V84, P520, DOI 10.1016/j.ijrobp.2011.12.039; Negoro Y, 2001, INT J RADIAT ONCOL, V50, P889, DOI 10.1016/S0360-3016(01)01516-4; Guckenberger M, 2009, RADIOTHER ONCOL, V91, P288, DOI 10.1016/j.radonc.2008.08.010; Guckenberger M, 2007, RADIOTHER ONCOL, V83, P57, DOI 10.1016/j.radonc.2007.01.012; Guckenberger M, 2006, ACTA ONCOL, V45, P897, DOI 10.1080/02841860600904839; Bissonnette JP, 2009, INT J RADIAT ONCOL, V73, P927, DOI 10.1016/j.ijrobp.2008.08.059; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; Stroom JC, 1999, INT J RADIAT ONCOL, V43, P905, DOI 10.1016/S0360-3016(98)00468-4; Arimura H, 2002, MED PHYS, V29, P1556, DOI 10.1118/1.1487426; Ding GX, 2013, RADIOTHER ONCOL, V108, P91, DOI 10.1016/j.radonc.2013.05.034; Fung W. W. K., 2011, J RADIOTHERAPY PRACT, V10, P121, DOI 10.1017/S1460396910000270; Hoyer M, 2008, RADIOTHER ONCOL, V87, P1, DOI 10.1016/j.radonc.2008.03.004; Lim DH, 2010, ACTA ONCOL, V49, P219, DOI 10.3109/02841860903302897; Masi L, 2008, ACTA ONCOL, V47, P1422, DOI 10.1080/02841860802251534; Nakagawa K, 2000, INT J RADIAT ONCOL, V48, P449, DOI 10.1016/S0360-3016(00)00617-9; Nuyttens JJ, 2012, EXPERT REV MED DEVIC, V9, P465, DOI [10.1586/erd.12.35, 10.1586/ERD.12.35]; Richmond ND, 2012, BRIT J RADIOL, V85, P819, DOI 10.1259/bjr/54341099; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Takayama K, 2005, INT J RADIAT ONCOL, V61, P1565, DOI 10.1016/j.ijrobp.2004.12.066; Wulf J, 2003, RADIOTHER ONCOL, V66, P141, DOI 10.1016/S0167-8140(02)00372-9; Zhou JN, 2010, MED DOSIM, V35, P12, DOI 10.1016/j.meddos.2008.12.003	28	0	0	HINDAWI PUBLISHING CORPORATION	NEW YORK	410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015									653974	10.1155/2015/653974		9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AZ5YP	WOS:000348294800001		
J	Sato, M; Inada, E; Saitoh, I; Matsumoto, Y; Ohtsuka, M; Miura, H; Nakamura, S; Sakurai, T; Watanabe, S				Sato, Masahiro; Inada, Emi; Saitoh, Issei; Matsumoto, Yuko; Ohtsuka, Masato; Miura, Hiromi; Nakamura, Shingo; Sakurai, Takayuki; Watanabe, Satoshi			A combination of targeted toxin technology and the piggyBac-mediated gene transfer system enables efficient isolation of stable transfectants in nonhuman mammalian cells	BIOTECHNOLOGY JOURNAL			English	Article						Endo--galactosidase C gene; PiggyBac; Porcine embryonic fibroblasts; Targeted toxin; Transposase	PORCINE EMBRYONIC FIBROBLASTS; BETA-GALACTOSIDASE C; TRANSGENE EXPRESSION; BACULOVIRUS GENOME; PRECISE EXCISION; TRANSPOSON IFP2; IN-VIVO; XENOTRANSPLANTATION; LINES; GENERATION	Isolation of cells harboring exogenous DNA is typically achieved by the introduction of plasmids, but its efficiency remains still low. In this study, we developed a novel strategy to obtain stable transfectants efficiently. Porcine embryonic fibroblasts were transfected with two plasmids: (i) pTransIEnd, which comprises the ubiquitous promoter, the piggyBac (PB) transposase gene, an internal ribosomal entry site, the Clostridium perfringens-derived endo--galactosidase C (EndoGalC) gene, and a poly(A) tail and (ii) a PB-based plasmid, termed pT-EGFP, which contains enhanced green fluorescent protein (EGFP) expression unit flanked by PB acceptor sites. The PB transposase can accelerate the chromosomal integration of transposon vectors. EndoGalC expression results in removal of a cell surface -Gal epitope, which is specifically recognized by Bandeiraea simplicifolia isolectin-B-4 (IB4). Four days after transfection, cells were treated with IB4SAP (IB4 conjugated to saporin, which eliminates any -Gal epitope-expressing cells) for a short period, followed by standard culture for approximately 10 days. Several colonies emerged, most of which were positive for EGFP expression and lacked TransIEnd. These results indicated that the proposed approach is useful and efficient for obtaining stable transfectants without the use of drug-resistance genes, and offers a novel route for gene manipulation in cultured nonhuman mammalian cells.	[Sato, Masahiro] Kagoshima Univ, Sect Gene Express Regulat, Frontier Sci Res Ctr, Kagoshima 8908544, Japan; [Inada, Emi; Matsumoto, Yuko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 8908544, Japan; [Saitoh, Issei] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Pediat Dent,Course Oral Life Sci, Niigata, Japan; [Ohtsuka, Masato; Miura, Hiromi] Tokai Univ, Sch Med, Div Basic Mol Sci & Mol Med, Kanagawa 2591100, Japan; [Nakamura, Shingo] Natl Def Med Coll, Res Inst, Div Biomed Engn, Tokorozawa, Saitama 359, Japan; [Sakurai, Takayuki] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Res, Nagano, Japan; [Watanabe, Satoshi] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Div Anim Sci, Ibaraki, Japan	Sato, M (reprint author), Kagoshima Univ, Sect Gene Express Regulat, Frontier Sci Res Ctr, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	masasato@ms.kagoshima-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [24580411]	This study was partly supported by a grant (no. 24580411) from the Ministry of Education, Science, Sports, and Culture, Japan.	Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; NIWA H, 1991, GENE, V108, P193; Yazaki S, 2009, XENOTRANSPLANTATION, V16, P511, DOI 10.1111/j.1399-3089.2009.00549.x; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Sato M, 2012, REPROD DOMEST ANIM, V47, P759, DOI 10.1111/j.1439-0531.2011.01964.x; Kim SJ, 2011, J VET MED SCI, V73, P1453; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Sato Masahiro, 2013, Biology (Basel), V2, P341, DOI 10.3390/biology2010341; Matasci M, 2011, BIOTECHNOL BIOENG, V108, P2141, DOI 10.1002/bit.23167; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; VAUGHAN HA, 1994, TRANSPLANTATION, V58, P879, DOI 10.1097/00007890-199410270-00003; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/nmeth.1332, 10.1038/NMETH.1332]; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Akasaka E, 2010, XENOTRANSPLANTATION, V17, P81, DOI 10.1111/j.1399-3089.2010.00568.x; Galili U, 2004, CANCER IMMUNOL IMMUN, V53, P935, DOI 10.1007/s00262-004-0524-x; Nakayama A, 2007, CLONING STEM CELLS, V9, P523, DOI 10.1089/clo.2007.0021; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Bai DP, 2012, BIOSCI BIOTECH BIOCH, V76, P933, DOI 10.1271/bbb.110939; Bauser CA, 1999, INSECT MOL BIOL, V8, P223, DOI 10.1046/j.1365-2583.1999.820223.x; Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; Clark KJ, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-42; COOPER DKC, 1994, IMMUNOL REV, V141, P31, DOI 10.1111/j.1600-065X.1994.tb00871.x; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Himaki T, 2010, J REPROD DEVELOP, V56, P630, DOI 10.1262/jrd.09-227A; Miura H, 2013, ANAL BIOCHEM, V437, P29, DOI 10.1016/j.ab.2013.02.003; Ogawa H, 2000, J BIOL CHEM, V275, P19368, DOI 10.1074/jbc.M001888200; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Thibault ST, 1999, INSECT MOL BIOL, V8, P119, DOI 10.1046/j.1365-2583.1999.810119.x	36	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	JAN	2015	10	1			SI		143	153		10.1002/biot.201400283		11	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AZ2IT	WOS:000348058200017		
J	Minamihata, K; Goto, M; Kamiya, N				Minamihata, Kosuke; Goto, Masahiro; Kamiya, Noriho			Site-specific conjugation of an antibody-binding protein catalyzed by horseradish peroxidase creates a multivalent protein conjugate with high affinity to IgG	BIOTECHNOLOGY JOURNAL			English	Article						Antibody binding protein; Conjugation; Horseradish peroxidase; IgG cross-linking; Tyrosine coupling reaction		Cross-linking proteins offers an approach to enhance the distinct function of proteins due to the multivalent effect. In this study, we demonstrated the preparation of a multivalent antibody-binding protein possessing high affinity to IgG by conjugating a number of antibody-binding proteins using the horseradish peroxidase (HRP)-mediated protein conjugation method. By introducing a peptide tag containing a tyrosine (Y-tag) to the C-terminus of the model protein, a chimera protein of protein G and protein A (pG(2)pA), the Tyr residue in the Y-tag was efficiently recognized by HRP and cross-linked with each other to yield a pG(2)pA conjugate, composed of mainly two to three units of pG(2)pA. The cross-linking occurred site specifically at the Tyr residue in the Y-tag and introduction of the Y-tag showed no effect on the function of pG(2)pA. The affinity of the Y-tagged pG(2)pA conjugate against IgG clearly increased because of the multivalent effect, demonstrating the benefit of this protein cross-linking reaction, which yields functional protein oligomers. Such multivalent protein conjugates created by this reaction should have potential to be used in ELISA and Western blotting applications in which highly sensitive detection of target molecules is desired.	[Minamihata, Kosuke] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Tokyo, Japan; [Goto, Masahiro; Kamiya, Noriho] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Kyushu, Japan; [Goto, Masahiro; Kamiya, Noriho] Kyushu Univ, Ctr Future Chem, Kyushu, Japan	Kamiya, N (reprint author), 744 Motooka, Fukuoka 8190395, Japan.	nori_kamiya@mail.cstm.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25289297]; JSPS for Young Scientists	We would like to acknowledge Prof. Teruyuki Nagamune for his useful comments on our research and technical support to conduct experiments. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 25289297). K.M. was supported by Research Fellowships of the JSPS for Young Scientists.	Minamihata K, 2011, BIOCONJUGATE CHEM, V22, P74, DOI 10.1021/bc1003982; Kamiya N, 2003, BIOCONJUGATE CHEM, V14, P351, DOI 10.1021/bc025610y; Bieniarz C, 1996, BIOCONJUGATE CHEM, V7, P88, DOI 10.1021/bc950080+; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038; Minamihata K, 2011, BIOCONJUGATE CHEM, V22, P2332, DOI 10.1021/bc200420v; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; Kim CH, 2012, J AM CHEM SOC, V134, P9918, DOI 10.1021/ja303904e; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Tiefenbrunn TK, 2010, BIOPOLYMERS, V94, P95, DOI 10.1002/bip.21337; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gulich S, 2002, PROTEIN ENG, V15, P835, DOI 10.1093/protein/15.10.835; Lee JM, 2007, ANAL CHEM, V79, P2680, DOI 10.1021/ac0619231; Lewandowski AT, 2006, BIOTECHNOL BIOENG, V93, P1207, DOI 10.1002/bit.20840; Niide T., LANGMUIR, V29, P15596; Rollett A, 2013, RSC ADV, V3, P1460, DOI 10.1039/c2ra22560c	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	JAN	2015	10	1			SI		222	226		10.1002/biot.201400512		5	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AZ2IT	WOS:000348058200025		
J	Hamasaki, H; Yanai, H; Kakei, M; Noda, M; Ezaki, O				Hamasaki, Hidetaka; Yanai, Hidekatsu; Kakei, Masafumi; Noda, Mitsuhiko; Ezaki, Osamu			The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study	BMJ OPEN			English	Article							LEFT-VENTRICULAR HYPERTROPHY; DOUBLY LABELED WATER; ADIPOSE-TISSUE; HEART-FAILURE; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; CARDIOVASCULAR EVENTS; ENERGY-EXPENDITURE; METABOLIC SYNDROME; RISK-FACTORS	Objectives: In spite of accumulating evidences suggesting an inverse association between insulin resistance and plasma B-type natriuretic peptide (BNP) levels, the effect of daily physical activity on plasma BNP in individuals with glucose intolerance remains unknown. We investigated the association of physical activity level (PAL) with plasma BNP in patients with impaired fasting glucose, impaired glucose tolerance and type 2 diabetes. Design: Cross-sectional study. Setting: Outpatients visiting the National Center for Global Health and Medicine Kohnodai Hospital. Participants: A total of 60 patients with glucose intolerance who did not take any hypoglycaemic agents, cholesterol-lowering agents and antihypertensive agents were recruited. Patients who were diagnosed as having heart failure and renal impairment, engaged in sports-like exercise and resistance training were excluded. Primary outcome measures: PAL was objectively measured by a triaxial accelerometer. The association between PAL and plasma BNP levels was assessed by multiple regression analysis. Results: PAL was positively correlated with plasma BNP levels (r=0.296, p=0.021). PAL was still significantly correlated with plasma BNP levels after adjustment for age (beta=0.290, p=0.014), and adjustment for age and body mass index (beta=0.282, p=0.018). Plasma BNP levels were inversely correlated with serum insulin levels (r=-0.350, p=0.006) and homeostasis model assessment-estimated insulin resistance (HOMA-IR; r=-0.363, p=0.004). Serum insulin levels (mean +/- SD, 8.1 +/- 6.4 mu U/mL) and HOMA-IR (2.4 +/- 1.9) in the high-BNP group were significantly lower than those (11.2 +/- 7.4 mu U/mL and 3.7 +/- 3.0, respectively) in the low-BNP group. Conclusions: Our findings propose the possibility that plasma BNP may be increased by daily physical activity and BNP is associated with insulin resistance.	[Hamasaki, Hidetaka; Yanai, Hidekatsu] Kohnodai Hosp, Dept Internal Med, Natl Ctr Global Hlth & Med, Chiba, Japan; [Hamasaki, Hidetaka; Kakei, Masafumi] Jichi Med Univ, Sch Med, Dept Gen Med 1, Div Complementary Med,Saitama Med Ctr, Saitama, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Tokyo, Japan; [Ezaki, Osamu] Showa Womens Univ, Fac Human Life & Environm Sci, Dept Human Hlth & Design, Tokyo, Japan	Yanai, H (reprint author), Kohnodai Hosp, Dept Internal Med, Natl Ctr Global Hlth & Med, Chiba, Japan.	dyanai@hospk.ncgm.go.jp		Hamasaki, Hidetaka/0000-0002-0124-597X	National Center for Global Health and Medicine [25-203]	This study was supported by a grant from the National Center for Global Health and Medicine (25-203).	Alehagen U, 2005, INT J CARDIOL, V100, P125, DOI 10.1016/j.ijcard.2004.10.006; American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1301/nr.2004.jul.S82-S97; Mongia SK, 2008, CLIN CHIM ACTA, V391, P102, DOI [10.1016/j.cca.2008.01.026, 10.1016/j.cea.2008.01.026]; McCord J, 2004, ARCH INTERN MED, V164, P2247, DOI 10.1001/archinte.164.20.2247; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Ohkawara K, 2011, BRIT J NUTR, V105, P1681, DOI 10.1017/S0007114510005441; Moro C, 2007, DIABETOLOGIA, V50, P1038, DOI 10.1007/s00125-007-0614-3; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Engeli S, 2012, J CLIN INVEST, V122, P4675, DOI 10.1172/JCI64526; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Leenders NY, 2006, MED SCI SPORT EXER, V38, P2165, DOI 10.1249/01.mss.0000235883.94357.95; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1061/CIRCULATIONHA.105.555573; Gardner DG, 2007, HYPERTENSION, V49, P419, DOI 10.1161/01.HYP.0000258532.07418.fa; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Koizumi M, 2012, HEART VESSELS, V27, P287, DOI 10.1007/s00380-011-0143-3; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; [Anonymous], 1985, WHO TECH REP SER, V724, P1; Kroon MH, 2012, DIABETES CARE, V35, P2510, DOI 10.2337/dc11-1959; Mehra MR, 2004, J AM COLL CARDIOL, V43, P1590, DOI 10.1016/j.jacc.2003.10.066; Polak J, 2011, J AM COLL CARDIOL, V58, P1119, DOI 10.1016/j.jacc.2011.05.042; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Dessi-Fulgheri P, 1997, J HYPERTENS, V15, P1695, DOI 10.1097/00004872-199715120-00074; Barletta G, 1998, INT J CARDIOL, V65, P217, DOI 10.1016/S0167-5273(98)00129-6; Chainani-Wu N, 2010, AM J CARDIOL, V105, P1570, DOI 10.1016/j.amjcard.2010.01.016; Costello-Boerrigter LC, 2009, J AM COLL CARDIOL, V53, P2078, DOI 10.1016/j.jacc.2009.02.037; Ganpule AA, 2007, EUR J CLIN NUTR, V61, P1256, DOI 10.1038/sj.ejcn.1602645; Midorikawa T, 2007, OBESITY, V15, P3031, DOI 10.1038/oby.2007.361; Neeland IJ, 2013, J AM COLL CARDIOL, V62, P752, DOI 10.1016/j.jacc.2013.03.038; Nielsen HB, 2001, REGUL PEPTIDES, V99, P203, DOI 10.1016/S0167-0115(01)00255-5; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Olsen MH, 2004, J HYPERTENS, V22, P1597, DOI 10.1097/01.hjh.0000125451.28861.2a; Schirmer H, 1999, EUR HEART J, V20, P755, DOI 10.1053/euhj.1998.1396; Tekes S, 2007, J HUM HYPERTENS, V21, P546, DOI 10.1038/sj.jhh.1002194	42	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e006276	10.1136/bmjopen-2014-006276		7	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800007		
J	Imai, T; Matsuda, K; Takeda, N; Uno, A; Kitahara, T; Horii, A; Nishiike, S; Inohara, H				Imai, Takao; Matsuda, Kazunori; Takeda, Noriaki; Uno, Atsuhiko; Kitahara, Tadashi; Horii, Arata; Nishiike, Suetaka; Inohara, Hidenori			Light cupula: the pathophysiological basis of persistent geotropic positional nystagmus	BMJ OPEN			English	Article							EYE-MOVEMENT; LOCALIZING SIGNS; 3 DIMENSIONS; CANALOLITHIASIS; CUPULOLITHIASIS; VELOCITY; VERTIGO; PLANE	Objective: To clarify the pathophysiological basis of persistent geotropic positional nystagmus (PGN) in patients with the horizontal canal type of benign paroxysmal positional vertigo (H-BPPV), the time constant (TC) of nystagmus and the relationship between its slow phase eye velocity (SPV) and the angle of head rotation in supine were defined. Methods: Geotropic or apogeotropic positional nystagmus was recorded by video-oculography and analysed three-dimensionally. Results: Geotropic positional nystagmuses in patients with H-BPPV were classified as transient geotropic positional nystagmus with a TC of <= 35 s or PGN with a TC of >35 s. Alternatively, the TC of persistent apogeotropic positional nystagmus (AN) in patients with H-BPPV was >35 s. The direction of the SPV of patients with PGN was opposite to that of patients with AN at each head position across the range of neutral head positions. The relationship between the SPV of patients with PGN and the angle of head rotation was linearly symmetrical against that of patients with AN with respect to a line drawn on the neutral head position. Conclusions: Since its TC was >35 s, it is suggested that PGN is induced by cupula deviation in response to gravity at each head position. It is also suggested that the direction of cupula deviation in patients with PGN is opposite to that of patients with AN across the neutral head positional range with no nystagmus where the long axis of cupula is in alignment with the axis of gravity. Since the pathophysiological basis of AN is considered a heavy cupula, it is suggested that PGN is conversely induced by a light cupula.	[Imai, Takao; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Matsuda, Kazunori; Takeda, Noriaki] Univ Tokushima, Sch Med, Dept Otolaryngol, Tokushima 770, Japan; [Uno, Atsuhiko] Osaka Gen Med Ctr, Dept Otolaryngol, Osaka, Japan; [Kitahara, Tadashi] Nara Med Univ, Dept Otolaryngol, Nara, Japan; [Horii, Arata] Osaka Natl Hosp, Dept Otolaryngol, Osaka, Japan; [Nishiike, Suetaka] Osaka Rosai Hosp, Dept Otolaryngol, Osaka, Japan	Imai, T (reprint author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan.	timai@ent.med.osaka-u.ac.jp			JSPS KAKENHI [24592546]	This study was supported by JSPS KAKENHI Grant Number 24592546.	Imai T, 2008, ACTA OTO-LARYNGOL, V128, P22, DOI 10.1080/00016480701283752; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; Imai T, 2005, AURIS NASUS LARYNX, V32, P3, DOI 10.1016/j.anl.2004.11.009; Imai T, 1999, ACTA OTO-LARYNGOL, V119, P24; Nuti D, 1996, J VESTIBUL RES-EQUIL, V6, P173; Raphan T, 1998, J NEUROPHYSIOL, V79, P2653; Bergenius J, 2006, ACTA OTO-LARYNGOL, V126, P698, DOI 10.1080/00016480500475609; Bisdorff AR, 2001, NEUROLOGY, V57, P1085; ARZI M, 1989, IEEE T BIO-MED ENG, V36, P954, DOI 10.1109/10.35304; Brandt T, 1999, VERTIGO ITS MULTISEN, P251; Ichijo H, 2012, EUR ARCH OTO-RHINO-L, V269, P747, DOI 10.1007/s00405-011-1700-1; Imai T, 2013, ACTA OTO-LARYNGOL, V133, P594, DOI 10.3109/00016489.2012.763180; Kim CH, 2014, LARYNGOSCOPE, V124, pE15, DOI 10.1002/lary.24048; Naoi K, 2003, IEICE T INF SYST, VE86D, P2452; Parnes LS, CMAJ; SCHNABOLK C, 1994, J NEUROPHYSIOL, V71, P623	16	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e006607	10.1136/bmjopen-2014-006607		7	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800008		
J	Katayama, K; Misawa, S; Sato, Y; Sobue, G; Yabe, I; Watanabe, O; Nishizawa, M; Kusunoki, S; Kikuchi, S; Nakashima, I; Ikeda, S; Kohara, N; Kanda, T; Kira, J; Hanaoka, H; Kuwabara, S				Katayama, Kanako; Misawa, Sonoko; Sato, Yasunori; Sobue, Gen; Yabe, Ichiro; Watanabe, Osamu; Nishizawa, Masatoyo; Kusunoki, Susumu; Kikuchi, Seiji; Nakashima, Ichiro; Ikeda, Shu-ichi; Kohara, Nobuo; Kanda, Takashi; Kira, Jun-ichi; Hanaoka, Hideki; Kuwabara, Satoshi		J-POST Trial Study Investigators	Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial	BMJ OPEN			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELL TRANSPLANTATION; VASCULAR-PERMEABILITY FACTOR; SERUM VEGF LEVELS; OF-THE-LITERATURE; HEALTH SURVEY; SF-36	Introduction: Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS) syndrome is a fatal systemic disorder associated with plasma cell dyscrasia and the overproduction of the vascular endothelial growth factor (VEGF). Recently, the prognosis of POEMS was substantially improved by introduction of therapeutic intervention for myeloma. However, no randomised clinical trial has been performed because of the rarity and severity of the disease. Methods and analysis: The Japanese POEMS syndrome with Thalidomide (J-POST) Trial is a phase II/III multicentre, double-blinded, randomised, controlled trial that aims to evaluate the efficacy and safety of a 24-week treatment with thalidomide in POEMS syndrome, with an additional 48-week open-label safety study. Adults with POEMS syndrome who have no indication for transplantation are assessed for eligibility at 12 tertiary neurology centres in Japan. Patients who satisfy the eligibility criteria are randomised (1:1) to receive thalidomide (100-300 mg daily) plus dexamethasone (12 mg/m(2) on days 1-4 of a 28-day cycle) or placebo plus dexamethasone. Both treatments were administered for 24 weeks (six cycles; randomised comparative study period). Patients who complete the randomised study period or show subacute deterioration during the randomised period participate in the subsequent 48-week open-label safety study (long-term safety period). The primary end point of the study is the reduction rate of serum VEGF levels at 24 weeks. Ethics and dissemination: The protocol was approved by the Institutional Review Board of each hospital. The trial was notified and registered at the Pharmaceutical and Medical Devices Agency, Japan (No. 22-1716). The J-POST Trial is currently ongoing and is due to finish in August 2015. The findings of this trial will be disseminated through peer-reviewed publications and conference presentations and will also be disseminated to participants.	[Katayama, Kanako; Sato, Yasunori; Hanaoka, Hideki] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Misawa, Sonoko; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan; [Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yabe, Ichiro] Hokkaido Univ, Dept Neurol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Watanabe, Osamu] Kagoshima Univ, Dept Neurol & Geriatr, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Kusunoki, Susumu] Kinki Univ, Dept Neurol, Fac Med, Osaka, Japan; [Kikuchi, Seiji] Natl Hosp Org, Dept Neurol, Hokkaido Med Ctr, Sapporo, Hokkaido, Japan; [Nakashima, Ichiro] Tohoku Univ, Dept Neurol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Kohara, Nobuo] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan; [Kira, Jun-ichi] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol, Fukuoka 812, Japan	Misawa, S (reprint author), Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Japan.	sonoko.m@mb.infoweb.ne.jp			Japan Medical Association, Center for Clinical Trial (JMACCT) under the 'Large Scale Clinical Trial Network Project' by the Ministry of Health, Labor and Welfare (MHLW)	This work was supported by the Japan Medical Association, Center for Clinical Trial (JMACCT) under the 'Large Scale Clinical Trial Network Project' by the Ministry of Health, Labor and Welfare (MHLW).	Dispenzieri A, 2004, BLOOD, V104, P3400, DOI 10.1182/blood-2004-05-2046; SOUBRIER MJ, 1994, AM J MED, V97, P543, DOI 10.1016/0002-9343(94)90350-6; Li J, 2011, BLOOD, V117, P6445, DOI 10.1182/blood-2010-12-328112; D'Souza A, 2011, BLOOD, V118, P4663, DOI 10.1182/blood-2011-06-362392; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; BARDWICK PA, 1980, MEDICINE, V59, P311; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Dispenzieri A, 2007, BLOOD, V110, P1075, DOI 10.1182/blood-2007-03-082354; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Watanabe O, 1998, MUSCLE NERVE, V21, P1390, DOI 10.1002/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1; Kim SY, 2006, ANN HEMATOL, V85, P545, DOI 10.1007/s00277-006-0119-z; Nobile-Orazio E, 2009, NEUROLOGY, V72, P1024, DOI 10.1212/01.wnl.0000344569.13496.ff; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Kuwabara S, 2008, NEUROLOGY, V71, P1691, DOI 10.1212/01.wnl.0000323811.42080.a4; Kuwabara S, 2006, NEUROLOGY, V66, P105, DOI 10.1212/01.wnl.0000188757.38495.23; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Sinisalo M, 2004, AM J HEMATOL, V76, P66, DOI 10.1002/ajh.20051; Arimura K, 2007, CURRENT TOPICS NEURO, P241; Brown S, 2005, STAT MED, V24, P3715, DOI 10.1002/sim.2391; Isose S, 2011, J NEUROL NEUROSUR PS, V82, P678, DOI 10.1136/jnnp.2010.205369; Kuwabara S, 2012, COCHRANE DB SYST REV, V6; Kuwabara S, 1997, J NEUROL NEUROSUR PS, V63, P385, DOI 10.1136/jnnp.63.3.385; Misawa S, 2013, CLIN EXP NEUROIMMUNO, V4, P318; NAKANISHI T, 1984, NEUROLOGY, V34, P712	26	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e007330	10.1136/bmjopen-2014-007330		8	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800043		
J	Komasawa, N; Nishihara, I; Tatsumi, S; Minami, T				Komasawa, Nobuyasu; Nishihara, Isao; Tatsumi, Shinichi; Minami, Toshiaki			Does prewarming the i-gel supraglottic airway device fit the larynx better compared to keeping it at room temperature for non-paralysed, sedated patients: a randomised controlled trial	BMJ OPEN			English	Article							ANESTHETIZED PATIENTS; DIFFICULT AIRWAY; MASK AIRWAY; VENTILATION; RESUSCITATION; GUIDELINES	Objective: This study aimed to test the hypothesis that the i-gel supraglottic airway device would fit the larynx and provide better sealing pressure if prewarmed to 42 degrees C relative to the device kept at room temperature in non-paralysed, sedated patients. Methods: A total of 74 adult patients were assigned to the warm (i-gel prewarmed to 42 degrees C; W group; 37 patients) or the control (i-gel kept at room temperature; C group; 37 patients) groups. Anaesthesia was induced with propofol and fentanyl. The i-gel was prewarmed to 42 degrees C for 30 min before insertion in the W group, but kept at room temperature (approximately 23 degrees C) for the C group. The number of attempts made until successful insertion and sealing pressure were compared between the two groups. Results: Insertion was successful with one attempt in 35 cases each for the W and C groups. Two attempts were needed in two cases for the W group and one case for the C group. There was one failed attempt in the C group, but none in the W group. None of the differences between the two groups were significant (p= 0.51). Sealing pressure was slightly, but not significantly, higher in the W group than in the C group (W group 22.6 +/- 6.1 cm H2O; C group 20.7 +/- 6.1 cm H2O; p= 0.15). Conclusions: Prewarming of the i-gel to 42 degrees C did not increase the success rate of insertion, nor did it significantly increase sealing pressure in anaesthetised, non-paralysed patients. Our data suggest that we can keep the i-gel at room temperature for emergency airway management for non-paralysed, sedated patients.	[Komasawa, Nobuyasu; Tatsumi, Shinichi; Minami, Toshiaki] Osaka Med Coll, Dept Anaesthesiol, Takatsuki, Osaka 569, Japan; [Nishihara, Isao] Hokusetsu Gen Hosp, Dept Anaesthesiol, Takatsuki, Osaka 569, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anaesthesiol, Takatsuki, Osaka 569, Japan.	ane078@poh.osaka-med.ac.jp					Levitan RM, 2005, ANAESTHESIA, V60, P1022, DOI 10.1111/j.1365-2044.2005.04258.x; Kohama H, 2011, J ANESTH, V25, P98, DOI 10.1007/s00540-010-1054-7; Nishiyama T, 2012, AM J EMERG MED, V30, P1756, DOI 10.1016/j.ajem.2012.02.009; Gabbott DA, 2007, RESUSCITATION, V73, P161, DOI 10.1016/j.resuscitation.2006.10.026; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Ikeda A, 2012, ANESTHESIOLOGY, V117, P487, DOI 10.1097/ALN.0b013e3182668670; Komasawa N, 2012, RESUSCITATION, V83, P365, DOI 10.1016/j.resuscitation.2011.08.025; Keller C, 1999, BRIT J ANAESTH, V83, P480; Janakiraman C, 2009, ANAESTHESIA, V64, P674, DOI 10.1111/j.1365-2044.2009.05898.x; Combes X, 2004, ANESTHESIOLOGY, V100, P1146, DOI 10.1097/00000542-200405000-00016; Komasawa N, 2010, J ANESTH, V24, P582, DOI 10.1007/s00540-010-0950-1; [Anonymous], 2002, ANESTHESIOLOGY, V96, P1004; Theiler LG, 2009, ANESTHESIOLOGY, V111, P55, DOI 10.1097/ALN.0b013e3181a4c6b9; Komasawa N, 2014, J CLIN ANESTH, V26, P663, DOI 10.1016/j.jclinane.2014.08.009; Russo SG, 2012, BRIT J ANAESTH, V109, P996, DOI 10.1093/bja/aes314	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e006653	10.1136/bmjopen-2014-006653		4	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800002		
J	Kubota, K; Kamijima, Y; Sato, T; Ooba, N; Koide, D; Iizuka, H; Nakagawa, H				Kubota, Kiyoshi; Kamijima, Yukari; Sato, Tsugumichi; Ooba, Nobuhiro; Koide, Daisuke; Iizuka, Hajime; Nakagawa, Hidemi			Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database	BMJ OPEN			English	Article							PREVALENCE; DISEASE; TAIWAN; RISK	Objective: The primary objective was to estimate the national prevalence of psoriasis and palmoplantar pustulosis (PPP) in Japan. Secondary objectives were to determine (1) whether psoriasis and PPP disease activity varies by season, and (2) whether disease severity is associated with concurrent diabetes mellitus, hyperlipidaemia and hypertension. Settings: Patients with a psoriasis or PPP diagnosis code between April 2010 and March 2011 were identified using a Japanese national database. Participants: 565 903 patients with psoriasis or PPP were identified. No patient was excluded. Primary and secondary outcome measures: National prevalence was calculated using census data. We estimated the difference in the proportion of patients who used healthcare services, as a proxy for disease activity, between the hot and cold seasons and the difference in the standardised prevalence of comorbidities between severe and mild disease. The measures were estimated separately for the two broad disease categories of psoriasis and PPP but not in all patients as planned because the two disease categories had major differences. Results: The national prevalence of psoriasis and PPP was 0.34% (95% CI 0.34% to 0.34%) and 0.12% (0.12% to 0.12%), respectively. The difference in the proportion of patients who used healthcare services in the hot compared to the cold season was -0.3% (-0.5% to -0.1%) for psoriasis and 10.0% (9.8% to 10.3%) for PPP. The difference in the standardised prevalence between severe and mild psoriasis was 3.1% (2.7% to 3.4%), 3.2% (2.8% to 3.6%) and 5.1% (4.7% to 5.6%) for concurrent diabetes mellitus, hyperlipidaemia and hypertension, respectively. No significant difference in the prevalence of comorbidity was observed for PPP. Conclusions: The national prevalence, seasonal variation in disease activity and prevalence of comorbidities in Japanese patients with psoriasis and PPP estimated in this descriptive study may be used as basic information for future studies.	[Kubota, Kiyoshi; Kamijima, Yukari; Sato, Tsugumichi; Ooba, Nobuhiro] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan; [Kubota, Kiyoshi; Kamijima, Yukari] NPO Drug Safety Res Unit Japan, Tokyo, Japan; [Sato, Tsugumichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba, Japan; [Ooba, Nobuhiro] Nihon Univ, Sch Pharm, Dept Clin Pharm, Chiba, Japan; [Koide, Daisuke] Univ Tokyo, Grad Sch Med, Dept Clin Epidemiol & Syst, Tokyo, Japan; [Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan; [Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Kubota, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo, Japan.	kubotape-tky@umin.net		Kubota, Kiyoshi/0000-0001-6092-8685	Janssen Pharmaceutical K.K.	The current study was supported by research funds provided by Janssen Pharmaceutical K.K. which was not involved in the design or conduct of the research, or the analysis, interpretation and publication of the results.	Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741; Azfar RS, 2012, ARCH DERMATOL, V148, P995, DOI 10.1001/archdermatol.2012.1401; Asumalahti K, 2003, J INVEST DERMATOL, V120, P627, DOI 10.1046/j.1523-1747.2003.12094.x; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Kremers HM, 2007, J AM ACAD DERMATOL, V57, P347, DOI 10.1016/j.jaad.2007.02.007; Ma C, 2013, BRIT J DERMATOL, V168, P486, DOI 10.1111/bjd.12101; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Barber HW, 1930, BRIT J DERMATOL, V42, P500, DOI 10.1111/j.1365-2133.1930.tb09380.x; Brunasso AMG, 2013, BRIT J DERMATOL, V168, P1243, DOI 10.1111/bjd.12223; Chang YT, 2009, ACTA DERM-VENEREOL, V89, P262, DOI 10.2340/00015555-0642; de Waal AC, 2011, J DERMATOL TREAT, V22, P102, DOI 10.3109/09546631003636817; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Griffiths CE, 2007, BRIT J DERMATOL, V168, P1243; Hancox JG, 2004, INT J DERMATOL, V43, P6, DOI 10.1111/j.1365-4632.2004.01828.x; Ministry of Health Labour and Welfare, 2011, CURR STAT EL SUBM HL; Takahashi H, 2011, J DERMATOL, V38, P1125, DOI 10.1111/j.1346-8138.2010.01145.x	22	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e006450	10.1136/bmjopen-2014-006450		9	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800016		
J	Ogawa, K; Tanaka, T; Nagoshi, T; Sekiyama, H; Arase, S; Minai, K; Ogawa, T; Yoshimura, M				Ogawa, Kazuo; Tanaka, Toshikazu; Nagoshi, Tomohisa; Sekiyama, Hiroshi; Arase, Satoshi; Minai, Kosuke; Ogawa, Takayuki; Yoshimura, Michihiro			Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study	BMJ OPEN			English	Article							MALONDIALDEHYDE-MODIFIED LDL; CORONARY HEART-DISEASE; OXIDE SYNTHASE GENE; CIGARETTE-SMOKING; HEALTH-PROFESSIONALS; RISK-FACTORS; HUMAN SERUM; SPASM; ASSOCIATION; MACROPHAGES	Objectives: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlation with MDA-LDL level in high-risk patients requiring catheter intervention. Setting: Secondary care (cardiology), single-centre study. Participants: 600 patients who were admitted to our hospital and underwent cardiac catheterisation. Primary and secondary outcome measures: Blood samples were obtained to measure lipid profiles and MDA-LDL level. Results: With regard to smoking status, MDA-LDL level was significantly higher in ex-smokers/current smokers compared with non-smokers. Of note, there was no improvement of MDA-LDL level even in patients who had quit smoking. Multiple regression analysis showed that MDA-LDL level was positively correlated with LDL-cholesterol (LDL-C) level, Brinkman index and male gender. The correlation between smoking status and either MDA-LDL or LDL-C level was investigated in two groups: namely, patients with and patients without statin treatment. In the non-statin group, MDA-LDL level and MDA-LDL/LDL-C ratio were significantly higher in ex-smokers/current smokers compared with non-smokers, while no significant correlation was observed between smoking status and LDL-C level. In contrast, in the statin group, there were no significant correlations between smoking status and any of the cholesterol parameters. Conclusions: We found that MDA-LDL level was affected by multiple factors, such as smoking status, LDL-C level and male gender. The present findings give additional evidence that smoking should be prohibited from a MDA-LDL standpoint. Furthermore, statin therapy might have a beneficial effect on the reduction of MDA-LDL level.	[Ogawa, Kazuo; Tanaka, Toshikazu; Nagoshi, Tomohisa; Sekiyama, Hiroshi; Arase, Satoshi; Minai, Kosuke; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan	Ogawa, K (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	oga-n@jikei.ac.jp					Nakayama M, 1999, CIRCULATION, V99, P2864; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; Kondo A, 2001, CLIN CHEM, V47, P893; HOLBROOK JH, 1984, CIRCULATION, V70, P1114; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; Tanaga K, 2002, ARTERIOSCL THROM VAS, V22, P662, DOI 10.1161/01.ATV.0000012351.63938.84; HARATS D, 1989, ATHEROSCLEROSIS, V79, P245, DOI 10.1016/0021-9150(89)90130-5; ANDERSON KM, 1991, CIRCULATION, V83, P356; Kitano S, 2004, ANAL CHIM ACTA, V509, P229, DOI 10.1016/j.aca.2003.12.040; Shigematsu S, 2007, CIRC J, V71, P1697, DOI 10.1253/circj.71.1697; Tsimikas S, 2004, CIRCULATION, V109, P3164, DOI 10.1161/01.CIR.0000130844.01174.55; CARALIS DG, 1992, CIRCULATION, V85, P905; GOTTO AM, 1986, AM J MED, V80, P48, DOI 10.1016/0002-9343(86)90160-9; Kondo Akira, 2003, J Atheroscler Thromb, V10, P72; Kondo Akira, 2002, J Atheroscler Thromb, V9, P280; Matsuda M, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-77; Sekiyama H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-4; STEIN Y, 1993, ANN NY ACAD SCI, V686, P66, DOI 10.1111/j.1749-6632.1993.tb39155.x; SUGIISHI M, 1993, CIRCULATION, V87, P76; Takaoka K, 2000, INT J CARDIOL, V72, P121, DOI 10.1016/S0167-5273(99)00172-2; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Yagi H, 2010, J CARDIOL, V55, P345, DOI 10.1016/j.jjcc.2009.12.010; YOKODE M, 1988, P NATL ACAD SCI USA, V85, P2344, DOI 10.1073/pnas.85.7.2344; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e005455	10.1136/bmjopen-2014-005455		8	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800003		
J	Tateyama, M; Fujihara, K; Misu, T; Arai, A; Kaneta, T; Aoki, M				Tateyama, Maki; Fujihara, Kazuo; Misu, Tatsuro; Arai, Akira; Kaneta, Tomohiro; Aoki, Masashi			Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation	BMJ OPEN			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTERSTITIAL LUNG-DISEASE; LARGE-VESSEL VASCULITIS; MANAGEMENT; DIAGNOSIS; MYOSITIS; MYOPATHIES	Objectives: [F-18] Fluorodeoxyglucose positron emission tomography (FDG PET), a standard tool for evaluating malignancies, can also detect inflammatory lesions. However, its usefulness in evaluating muscle lesions in polymyositis and dermatomyositis syndromes (PM/DM) has not been established. Methods: 33 patients with PM/DM who had undergone FDG PET were retrospectively analysed. FDG uptake was visually evaluated (visually identified FDG uptake, vFDG) in 16 regions of the body using mediastinum blood vessels as a positivity criterion. We also calculated the maximum standardised uptake value (SUVmax) in all four limbs of the patients with PM/DM as well as in 22 patients with amyotrophic lateral sclerosis (ALS) with similar disabilities. In 24 patients with PM/DM, MRI and FDG PET findings were compared. Results: vFDG was observed in multiple muscle lesions with varying distributions in two-thirds of the patients with PM/DM, with most lesions being symmetrical. The number of vFDG-positive regions strongly correlated with the mean SUVmax in all four limbs (p<0.0001). Histological grades of biopsied muscles correlated with both the mean SUVmax and number of vFDG-positive regions. Serum creatine kinase levels were higher in patients with more than two vFDG-positive regions than in those with two or less regions (p<0.05). While the inflamed muscles showed diffused, patchy or marginal signal abnormalities on MRI, FDG uptake was most prominent inside the muscles. Compared with ALS, the mean SUVmax was significantly higher in the patients with PM/DM (p<0.0001) and showed a striking correlation in the bilateral muscles, reflecting symmetrical muscle involvement in PM/DM. Conclusions: The visual assessment of FDG uptake as well as calculation of SUV enabled us to comprehensively evaluate skeletal muscle. This method can improve clinical practices and provide insights into pathomechanisms of PM/DM.	[Tateyama, Maki; Fujihara, Kazuo; Misu, Tatsuro; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Tateyama, Maki] Iwate Natl Hosp, Dept Neurol, Miyako, Iwate, Japan; [Arai, Akira; Kaneta, Tomohiro] Tohoku Univ, Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan	Tateyama, M (reprint author), Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan.	mtateyama@iwate-h.com			JSPS KAKENHI (Japan) [25461265]	This study was supported by JSPS KAKENHI Grant Number 25461265 (Japan).	Fuchs M, 2012, EUR J NUCL MED MOL I, V39, P344, DOI 10.1007/s00259-011-1967-x; Yamashita H, 2012, MOD RHEUMATOL, V22, P705, DOI 10.1007/s10165-011-0581-x; Yao L, 2012, AM J ROENTGENOL, V198, pW475, DOI 10.2214/AJR.11.7113; Machado P, 2013, CURR OPIN RHEUMATOL, V25, P763, DOI 10.1097/01.bor.0000434671.77891.9a; Morita Y, 2012, INTERNAL MED, V51, P1613, DOI 10.2169/internalmedicine.51.6813; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; Sobic-Saranovic DP, 2013, CLIN NUCL MED, V38, P516, DOI 10.1097/RLU.0b013e31828731f5; Studynkova JT, 2007, RHEUMATOLOGY, V46, P1174, DOI 10.1093/rheumatology/kem088; Selva-O'Callaghan A, 2010, AM J MED, V123, P558, DOI 10.1016/j.amjmed.2009.11.012; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Tanaka S, 2013, RHEUMATOLOGY, V52, P1271, DOI 10.1093/rheumatology/ket112; Lazarou IN, 2013, J RHEUMATOL, V40, P550, DOI 10.3899/jrheum.120682; Pipitone N, 2012, CLIN EXP RHEUMATOL, V30, P570; Degardin A, 2010, SKELETAL RADIOL, V39, P1219, DOI 10.1007/s00256-010-0930-4; Engel AG, 2004, MYOLOGY, P1321; Hak AE, 2011, NETH J MED, V69, P410; Hoogendijk JE, 2003, NEUROMUSC DISORD; Jackson Ryan S, 2006, J Nucl Med Technol, V34, P29; Kubota K, 2011, ANN NY ACAD SCI, V1228, P29, DOI 10.1111/j.1749-6632.2011.06031.x; Maeda MH, 2012, BRAIN, V135, P1767, DOI 10.1093/brain/aws106; Owada T, 2012, J RHEUMATOL, V39, P1659, DOI 10.3899/jrheum.111597; Tanaka K, 2007, CLIN RHEUMATOL, V26, P1917, DOI 10.1007/s10067-007-0698-7; Tansley S, 2014, CLIN REV ALLERG IMMU, V47, P264, DOI 10.1007/s12016-013-8387-6	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	1							e006763	10.1136/bmjopen-2014-006763		9	Medicine, General & Internal	General & Internal Medicine	AZ4DH	WOS:000348171800042		
J	Yoshida, K; Yamazaki, H; Takenaka, T; Kotsuma, T; Miyake, S; Ueda, MM; Yoshida, M; Masui, K; Yoshioka, Y; Uesugi, Y; Shimbo, T; Yoshikawa, N; Yoshioka, H; Aramoto, K; Narumi, Y; Yamada, S; Tatsumi, K; Tanaka, E				Yoshida, Ken; Yamazaki, Hideya; Takenaka, Tadashi; Kotsuma, Tadayuki; Miyake, Shunsuke; Ueda, Mari Mikami; Yoshida, Mineo; Masui, Koji; Yoshioka, Yasuo; Uesugi, Yasuo; Shimbo, Taiju; Yoshikawa, Nobuhiko; Yoshioka, Hiroto; Aramoto, Kazumasa; Narumi, Yoshifumi; Yamada, Shigetoshi; Tatsumi, Keiji; Tanaka, Eiichi			Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer	BRACHYTHERAPY			English	Article						Interstitial brachytherapy; Uterine cervical cancer; Image-based brachytherapy; Dose-volume histogram	INTRACAVITARY BRACHYTHERAPY; WORKING GROUP; PDR BRACHYTHERAPY; CARCINOMA; RECOMMENDATIONS; PARAMETERS; OPTIMIZATION; MALIGNANCIES; OUTCOMES; IMPACT	PURPOSE: To investigate the effectiveness of our novel MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer. METHODS AND MATERIALS: Between June 2005 and June 2009, 29 previously untreated patients with cervical cancer were enrolled (2 T2b, 2 T3a, 19 T3b, and 6 T4 tumors). We implanted MRI-compatible plastic catheters using our unique ambulatory technique. The total treatment doses were 30-36 Gy (6 Gy per fraction) combined with external beam radiotherapy. RESULTS: The median D-90 (high-risk clinical target volume), D-2 (cc) (bladder), and D-2 (cc) (rectum) per fraction were 6.9, 5, and 4.6 Gy, respectively. The 3-year local control rates were 100%, 95%, and 83% for T2, T3, and T4 tumors, respectively. Grade 3 or 4 late complications occurred in 4 patients. CONCLUSIONS: Our preliminary evaluation of image-based high-dose-rate interstitial brachytherapy showed favorable local treatment results with an acceptable complication rate. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Yoshida, Ken; Uesugi, Yasuo; Shimbo, Taiju; Yoshikawa, Nobuhiko; Yoshioka, Hiroto; Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan; [Yamazaki, Hideya; Masui, Koji] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Takenaka, Tadashi; Miyake, Shunsuke; Ueda, Mari Mikami; Aramoto, Kazumasa] Osaka Natl Hosp, Natl Hosp Org, Dept Radiol, Osaka, Japan; [Kotsuma, Tadayuki; Yoshida, Mineo; Tanaka, Eiichi] Osaka Natl Hosp, Natl Hosp Org, Dept Radiat Oncol, Osaka, Japan; [Yoshioka, Yasuo] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan; [Yamada, Shigetoshi; Tatsumi, Keiji] Osaka Natl Hosp, Natl Hosp Org, Dept Obstet & Gynecol, Osaka, Japan	Yoshida, K (reprint author), Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	yoshidaisbt@gmail.com		Uesugi, Yasuo/0000-0002-0671-5387	JSPS [25461931]	This work was supported by JSPS grant-in-aid for Scientific Research (KAKENHI) (C) grant number 25461931.	Beriwal S, 2006, BRACHYTHERAPY, V5, P218, DOI 10.1016/j.brachy.2006.09.002; Toita T, 2012, GYNECOL ONCOL, V126, P211, DOI 10.1016/j.ygyno.2012.04.036; Haie-Meder C, 2005, RADIOTHER ONCOL, V74, P235, DOI 10.1016/j.radonc.2004.12.015; Potter R, 2011, RADIOTHER ONCOL, V100, P116, DOI 10.1016/j.radonc.2011.07.012; ARAI T, 1992, CANCER, V69, P175, DOI 10.1002/1097-0142(19920101)69:1<175::AID-CNCR2820690129>3.0.CO;2-B; Nag S, 2004, INT J RADIAT ONCOL, V60, P1160, DOI 10.1016/j.ijrobp.2004.04.032; Nag S, 2000, INT J RADIAT ONCOL, V48, P201, DOI 10.1016/S0360-3016(00)00497-1; Kannan N, 2012, BRACHYTHERAPY, V11, P408, DOI 10.1016/j.brachy.2012.02.007; Syed AMN, 2002, INT J RADIAT ONCOL, V54, P67, DOI 10.1016/S0360-3016(02)02900-0; Potter R, 2007, RADIOTHER ONCOL, V83, P148, DOI 10.1016/j.radonc.2007.04.012; Kirisits C, 2006, INT J RADIAT ONCOL, V65, P624, DOI 10.1016/j.ijrobp.2006.01.036; Lindegaard JC, 2008, INT J RADIAT ONCOL, V71, P756, DOI 10.1016/j.ijrobp.2007.10.032; Georg P, 2011, INT J RADIAT ONCOL, V79, P356, DOI 10.1016/j.ijrobp.2009.11.002; Gupta AK, 1999, INT J RADIAT ONCOL, V43, P1055, DOI 10.1016/S0360-3016(98)00522-7; Potter R, 2006, RADIOTHER ONCOL, V78, P67, DOI 10.1016/j.radonc.2005.11.014; Dimopoulos JCA, 2009, INT J RADIAT ONCOL, V75, P56, DOI 10.1016/j.ijrobp.2008.10.033; Yoshida K, 2010, INT J RADIAT ONCOL, V77, P765, DOI 10.1016/j.ijrobp.2009.05.027; Nag S, 1998, GYNECOL ONCOL, V70, P27, DOI 10.1006/gyno.1998.5032; Charra-Brunaud C, 2012, RADIOTHER ONCOL, V103, P305, DOI 10.1016/j.radonc.2012.04.007; Demanes DJ, 1999, INT J RADIAT ONCOL, V45, P105, DOI 10.1016/S0360-3016(99)00124-8; Jurgenliemk-Schulz IM, 2009, RADIOTHER ONCOL, V93, P322, DOI 10.1016/j.radonc.2009.08.014; Kuipers T, 2001, RADIOTHER ONCOL, V58, P25, DOI 10.1016/S0167-8140(00)00320-0; Lee Jl, 2012, INT J RADIAT ONCOL, V84, P1192; Mikami M, 2011, BRACHYTHERAPY, V10, P318, DOI 10.1016/j.brachy.2010.11.006; Pinn-Bingham M, 2013, INT J RADIAT ONCOL, V85, P714, DOI 10.1016/j.ijrobp.2012.05.033; Popowski Y, 2000, INT J RADIAT ONCOL, V47, P759, DOI 10.1016/S0360-3016(00)00488-0; Recio FO, 1998, INT J RADIAT ONCOL, V40, P411, DOI 10.1016/S0360-3016(97)00738-4; Thibault I, 2012, BRACHYTHERAPY, V11, P181, DOI 10.1016/j.brachy.2011.06.005; Viswanathan AN, BRACHYTHERAPY, V12, P240; Yoshida K, 2000, J RADIAT RES, V53, P154; Yoshida Ken, 2006, Radiat Med, V24, P595, DOI 10.1007/s11604-007-0058-1; Yoshida K, 2002, J JPN SOC THER RADIO, V14, P253; Zwahlen D, 2009, INT J RADIAT ONCOL, V74, P1157, DOI 10.1016/j.ijrobp.2008.09.010	33	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	JAN-FEB	2015	14	1					1	8		10.1016/j.brachy.2014.07.006		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	AZ1QN	WOS:000348013200001		
J	Mesci, P; Zaidi, S; Lobsiger, CS; Millecamps, S; Escartin, C; Seilhean, D; Sato, H; Mallat, M; Boillee, S				Mesci, Pinar; Zaidi, Sakina; Lobsiger, Christian S.; Millecamps, Stephanie; Escartin, Carole; Seilhean, Danielle; Sato, Hideyo; Mallat, Michel; Boillee, Severine			System x(C)(-) is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice	BRAIN			English	Article						ALS; neuroinflammation; excitotoxicity; motoneuron; xCT	MOTOR-NEURON DEGENERATION; CYSTINE/GLUTAMATE EXCHANGE TRANSPORTER; MOUSE PERITONEAL-MACROPHAGES; DISEASE PROGRESSION; EXTEND SURVIVAL; GLIAL-CELLS; ALS MICE; GLUTAMATE; MODEL; BRAIN	Amyotrophic lateral sclerosis is the most common adult-onset motor neuron disease and evidence from mice expressing amyotrophic lateral sclerosis-causing SOD1 mutations suggest that neurodegeneration is a non-cell autonomous process where microglial cells influence disease progression. However, microglial-derived neurotoxic factors still remain largely unidentified in amyotrophic lateral sclerosis. With excitotoxicity being a major mechanism proposed to cause motor neuron death in amyotrophic lateral sclerosis, our hypothesis was that excessive glutamate release by activated microglia through their system x C (a cystine/glutamate antiporter with the specific subunit xCT/Slc7a11) could contribute to neurodegeneration. Here we show that xCT expression is enriched in microglia compared to total mouse spinal cord and absent from motor neurons. Activated microglia induced xCT expression and during disease, xCT levels were increased in both spinal cord and isolated microglia from mutant SOD1 amyotrophic lateral sclerosis mice. Expression of xCT was also detectable in spinal cord post-mortem tissues of patients with amyotrophic lateral sclerosis and correlated with increased inflammation. Genetic deletion of xCT in mice demonstrated that activated microglia released glutamate mainly through system xC. Interestingly, xCT deletion also led to decreased production of specific microglial pro-inflammatory/neurotoxic factors including nitric oxide, TNFa and IL6, whereas expression of anti-inflammatory/ neuroprotective markers such as Ym1/Chil3 were increased, indicating that xCT regulates microglial functions. In amyotrophic lateral sclerosis mice, xCT deletion surprisingly led to earlier symptom onset but, importantly, this was followed by a significantly slowed progressive disease phase, which resulted in more surviving motor neurons. These results are consistent with a deleterious contribution of microglial-derived glutamate during symptomatic disease. Therefore, we show that system x C participates in microglial reactivity and modulates amyotrophic lateral sclerosis motor neuron degeneration, revealing system xC inactivation, as a potential approach to slow amyotrophic lateral sclerosis disease progression after onset of clinical symptoms.	[Mesci, Pinar; Zaidi, Sakina; Lobsiger, Christian S.; Millecamps, Stephanie; Seilhean, Danielle; Mallat, Michel; Boillee, Severine] Univ Paris 06, Univ Paris 04, Inst Cerveau & Moelle Epiniere, INSERM,U1127,CNRS,UMR 7225,UMR S 1127,ICM, F-75013 Paris, France; [Escartin, Carole] CEA, DSV, I2BM, MIRCen, Fontenay Aux Roses, France; [Escartin, Carole] CNRS, URA2210, Fontenay Aux Roses, France; [Sato, Hideyo] Yamagata Univ, Fac Agr, Dept Food & Appl Life Sci, Tsuruoka, Yamagata, Japan	Boillee, S (reprint author), Univ Paris 06, Univ Paris 04, Hop La Pitie Salpetriere, INSERM,U1127,CNRS,UMR 7225,ICM Brain & Spinal Cor, 47 Blvd Hop, F-75013 Paris, France.	severine.boillee@upmc.fr	Escartin, Carole/A-1952-2010	Escartin, Carole/0000-0003-3613-4118	Thierry Latran Foundation; Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone; NRJ-Institut de France and European FP7 International Reintegration Marie Curie Grant; French ministry of research; Fondation pour la Recherche Medicale	This work was supported by the Thierry Latran Foundation, the Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone, NRJ-Institut de France and European FP7 International Reintegration Marie Curie Grant. P.M. was supported by fellowships from the French ministry of research and the Fondation pour la Recherche Medicale.	Allen JW, 2002, NEUROTOXICOLOGY, V23, P755, DOI 10.1016/S0161-813X(01)00076-6; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Albano R, 2013, EXP NEUROL, V250, P69, DOI 10.1016/j.expneurol.2013.09.008; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Sato H, 2002, J NEUROSCI, V22, P8028; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.ndb.2003.12.012; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Domercq M, 2007, J IMMUNOL, V178, P6549; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Massie A, 2008, NEUROREPORT, V19, P1589, DOI 10.1097/WNR.0b013e328312181c; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; WATANABE H, 1987, J EXP MED, V165, P628, DOI 10.1084/jem.165.3.628; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Gochenauer GE, 2001, J NEUROCHEM, V78, P276, DOI 10.1046/j.1471-4159.2001.00385.x; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Milanese M, 2011, J NEUROCHEM, V116, P1028, DOI 10.1111/j.1471-4159.2010.07155.x; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Beutler HO, 1985, METHOD ENZYMAT AN, P369; Corcia P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052941; De Groot CJA, 2000, BRAIN RES PROTOC, V5, P85, DOI 10.1016/S1385-299X(99)00059-8; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Lerman BJ, 2012, BRAIN BEHAV, V2, P563, DOI 10.1002/brb3.75; Markowitz AJ, 2007, CELLSCIENCE, V4, P111; PIANI D, 1994, J IMMUNOL, V152, P3578; Pow DV, 2001, GLIA, V34, P27, DOI 10.1002/glia.1037; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	71	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN 1	2015	138		1				53	68		10.1093/brain/awu312		16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ4KM	WOS:000348189800016		
J	Hirose, T				Hirose, Takanori			Preface to special issue	BRAIN TUMOR PATHOLOGY			English	Editorial Material									[Hirose, Takanori] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Kobe, Hyogo, Japan	Hirose, T (reprint author), Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan.	thirose@hp.pref.hyogo.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					1	2		10.1007/s10014-014-0209-x		2	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500001		
J	Kato, Y				Kato, Yukinari			Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas	BRAIN TUMOR PATHOLOGY			English	Review						Isocitrate dehydrogenase 1; Isocitrate dehydrogenase 2; Monoclonal antibody; Mutations; Multi-specific mAb	ISOCITRATE DEHYDROGENASE 1; ACUTE MYELOID-LEUKEMIA; CODON 132 MUTATION; LOW-GRADE GLIOMAS; IDH2 MUTATIONS; MAFFUCCI SYNDROME; D-2-HYDROXYGLUTARIC ACIDURIA; PROGNOSTIC BIOMARKER; OLLIER DISEASE; DIFFUSE GLIOMA	Mutations of isocitrate dehydrogenase 1/2 (IDH1/2) have been reported in gliomas and other types of tumors, such as acute myeloid leukemias, cartilaginous tumors, intrahepatic cholangiocarcinomas, osteosarcomas, and giant cell tumors of bone. In gliomas, IDH mutations uniformly occur in the functionally critical arginine 132 residue (R132) of IDH1 and arginine 172 residue (R172) of IDH2. IDH1 and IDH2 catalyze the oxidative carboxylation of isocitrate to alpha-ketoglutarate (alpha-KG) in the cytosol and mitochondria, respectively. In contrast, mutated IDH1/2 proteins possess a neomorphic enzymatic function that changes alpha-KG into the oncometabolite, R(-)-2-hydroxyglutarate, resulting in genomic hypermethylation, histone methylation, genetic instability, and malignant transformation. To date, several monoclonal antibodies (mAbs) specific for IDH1/2 mutations such as anti-IDH1-R132H mAbs (clone H09, clone IMab-1, and clone HMab-1) or an anti-IDH1-R132S mAb (clone SMab-1) have been established. Furthermore, one of multi-specific mAbs, MsMab-1, recognizes IDH1 mutants (R132H, R132S, R132G) and IDH2 mutants (R172S, R172G), which are observed in gliomas. Another mAb, MsMab-2, recognizes IDH1-R132L and IDH2-R172M. These IDH1/2 mutation-specific mAbs are useful for the immunohistochemical determination of IDH1/2 mutation-bearing gliomas.	Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kato, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yukinari-k@bea.hi-ho.ne.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan	We thank Mika Kato Kaneko, Satoshi Ogasawara, Yuta Tsujimoto, Hiroharu Oki, Xing Liu, Takuro Nakamura, and Noriko Saidoh (Tohoku University) for their helpful suggestion and excellent technical assistance. We also thank Mitsutoshi Nakada and Hemragul Sabit (Kanazawa University) for their immunohistochemical data. This work was supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; by the Regional Innovation Strategy Support Program from MEXT of Japan; and by a Grant-in-Aid for Scientific Research (C) from MEXT of Japan.	Agarwal S, 2011, PATHOLOGY, V43, P327, DOI 10.1097/PAT.0b013e3283463f97; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Kosmider O, 2010, LEUKEMIA, V24, P1094, DOI 10.1038/leu.2010.52; Kaneko MK, 2011, BIOCHEM BIOPH RES CO, V406, P608, DOI 10.1016/j.bbrc.2011.02.102; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Nguyen DN, 2013, BRAIN PATHOL, V23, P237, DOI 10.1111/j.1750-3639.2012.00630.x; Ishizawa K, 2012, CLIN NEUROPATHOL, V31, P67, DOI 10.5414/NP300402; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Joseph NM, 2013, MODERN PATHOL, V26, P315, DOI 10.1038/modpathol.2012.173; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Kato Y, 2013, BIOCHEM BIOPH RES CO, V433, P374, DOI 10.1016/j.bbrc.2013.02.106; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Haberler C, 2014, CLIN NEUROPATHOL, V33, P108, DOI 10.5414/NP300758; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Takano S, 2012, J NEURO-ONCOL, V108, P361, DOI 10.1007/s11060-012-0837-0; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Sellner L, 2010, EUR J HAEMATOL, V85, P457, DOI 10.1111/j.1600-0609.2010.01505.x; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Ogasawara Satoshi, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P377, DOI 10.1089/mab.2013.0050; Capper D, 2011, ACTA NEUROPATHOL, V121, P241, DOI 10.1007/s00401-010-0770-2; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Mellai M, 2011, J NEURO-ONCOL, V105, P345, DOI 10.1007/s11060-011-0596-3; Capper D, 2010, AM J SURG PATHOL, V34, P1199, DOI 10.1097/PAS.0b013e3181e7740d; Moriya K, 2014, CANCER SCI, V105, P359, DOI 10.1111/cas.12337; Motomura K, 2012, CANCER SCI, V103, P1871, DOI 10.1111/j.1349-7006.2012.02377.x; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Arai M, 2012, BRAIN TUMOR PATHOL, V29, P201, DOI 10.1007/s10014-012-0085-1; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Liu X, 2013, CANCER MED-US, V2, P803, DOI 10.1002/cam4.149; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Preusser M, 2011, J NEUROPATH EXP NEUR, V70, P715, DOI 10.1097/NEN.0b013e31822713f0; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Kaneko MK, 2013, BIOCHEM BIOPH RES CO, V432, P40, DOI 10.1016/j.bbrc.2013.01.088; Kaneko Mika Kato, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P224, DOI 10.1089/mab.2013.0006; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Frenel JS, 2013, J NEURO-ONCOL, V114, P85, DOI 10.1007/s11060-013-1152-0; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Mukasa A, 2012, CANCER SCI, V103, P587, DOI 10.1111/j.1349-7006.2011.02175.x; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Thota B, 2012, AM J CLIN PATHOL, V138, P177, DOI 10.1309/AJCPZOIY3WY4KIKE; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Camelo-Piragua S, 2011, J NEUROPATH EXP NEUR, V70, P110, DOI 10.1097/NEN.0b013e31820565f9; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Arita H, 2014, BRAIN TUMOR PATHOL, DOI [10.1007/s10014-014-0197-x, DOI 10.1007/S10014-014-0197-X]; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Birner P, 2011, FOLIA NEUROPATHOL, V49, P88; Camelo-Piragua S, 2010, ACTA NEUROPATHOL, V119, P509, DOI 10.1007/s00401-009-0632-y; Cho HJ, 2014, BRAIN TUMOR PATHOL, DOI [10.1007/s10014-10014-10187-z, DOI 10.1007/S10014-10014-10187-Z]; Desestret V, 2011, J NEURO-ONCOL, V105, P219, DOI 10.1007/s11060-011-0587-4; Kaneko MK, 2013, TOHOKU J EXP MED, V230, P103, DOI 10.1620/tjem.230.103; Kaneko MK, 2014, CANCER SCI, V105, P744, DOI 10.1111/cas.12413; Kato Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05924; Kurian KM, 2013, NEUROPATH APPL NEURO, V39, P27; Kwon MJ, 2012, BRAIN PATHOL, V22, P307, DOI 10.1111/j.1750-3639.2011.00532.x; Lewandowska M, 2014, MOL DIAGN THER, V18, P45, DOI 10.1007/s40291-013-0050-7; Okita Y, 2012, INT J ONCOL, V41, P1325, DOI 10.3892/ijo.2012.1564; Sabit H, 2014, BRAIN TUMOR PATHOL, DOI [10.1007/s10014-10013-10172-y, DOI 10.1007/S10014-10013-10172-Y]; Sipayya V, 2012, J CANCER RES THER, V8, P598, DOI 10.4103/0973-1482.106567; Stockhammer F, 2012, SEIZURE-EUR J EPILEP, V21, P194, DOI 10.1016/j.seizure.2011.12.007; Stoczynsica-Fidelus E, 2014, ANTICANCER RES, V34, P2859; Zhang CB, 2014, J CANCER RES CLIN, V140, P45, DOI 10.1007/s00432-013-1519-9	86	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					3	11		10.1007/s10014-014-0202-4		9	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500002		
J	Tanino, M; Sasajima, T; Nanjo, H; Akesaka, S; Kagaya, M; Kimura, T; Ishida, Y; Oda, M; Takahashi, M; Sugawara, T; Yoshioka, T; Nishihara, H; Akagami, Y; Goto, A; Minamiya, Y; Tanaka, S				Tanino, Mishie; Sasajima, Toshio; Nanjo, Hiroshi; Akesaka, Shiori; Kagaya, Masami; Kimura, Taichi; Ishida, Yusuke; Oda, Masaya; Takahashi, Masataka; Sugawara, Taku; Yoshioka, Toshiaki; Nishihara, Hiroshi; Akagami, Yoichi; Goto, Akiteru; Minamiya, Yoshihiro; Tanaka, Shinya		R-IHC Study Grp	Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors	BRAIN TUMOR PATHOLOGY			English	Article						Rapid immunohistochemistry (R-IHC); Glioma; Central nervous system-lymphoma (CNS-lymphoma)	MICROWAVE IRRADIATION; STAINING METHOD; NEUROPATHOLOGY; ANTIBODY; GLIOMA	Rapid immunohistochemistry (R-IHC) can contribute to the intraoperative diagnosis of central nervous system (CNS) tumors. We have recently developed a new IHC method based on an alternating current electric field to facilitate the antigen-antibody reaction. To ensure the requirement of R-IHC for intraoperative diagnosis, 183 cases of CNS tumors were reviewed regarding the accuracy rate of diagnosis without R-IHC. The diagnostic accuracy was 90.7 % (168/183 cases) in which definitive diagnoses were not provided in 17 cases because of the failure of glioma grading and differential diagnosis of lymphoma and glioma. To establish the clinicopathological application, R-IHC for frozen specimens was compared with standard IHC for permanent specimens. 33 gliomas were analyzed, and the Ki-67/MIB-1 indices of frozen specimens by R-IHC were consistent with the grade and statistically correlated with those of permanent specimens. Thus, R-IHC provided supportive information to determine the grade of glioma. For discrimination between glioma and lymphoma, R-IHC was able to provide clear results of CD20 and Ki-67/MIB-1 in four frozen specimens of CNS lymphoma as well as standard IHC. We conclude that the R-IHC for frozen specimens can provide important information for intraoperative diagnosis of CNS tumors.	[Tanino, Mishie; Akesaka, Shiori; Kimura, Taichi; Ishida, Yusuke; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Sasajima, Toshio; Oda, Masaya; Takahashi, Masataka; Sugawara, Taku] Akita Univ, Grad Sch Med, Dept Neurosurg, Akita 0108543, Japan; [Nanjo, Hiroshi; Yoshioka, Toshiaki; Goto, Akiteru] Akita Univ, Grad Sch Med, Div Clin Pathol, Akita 0108543, Japan; [Kagaya, Masami; Akagami, Yoichi] Akita Ind Technol Ctr, Akita 0101623, Japan; [Nishihara, Hiroshi; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Translat Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Minamiya, Yoshihiro] Akita Univ, Grad Sch Med, Dept Thorac Surg, Akita 0108543, Japan	Tanaka, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	tanaka@med.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590406, 23390311]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI Grant Number 24590406) to M.T. and (KAKENHI Grant Number 23390311) to Y.M.	Hatta H, 2006, PATHOL RES PRACT, V202, P439, DOI 10.1016/j.prp.2006.02.003; Plesec TP, 2007, ARCH PATHOL LAB MED, V131, P1532; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Faehndrich J, 2011, CLIN NEURORADIOL, V21, P123, DOI 10.1007/s00062-011-0073-6; Monig SP, 2006, ONCOL REP, V16, P1143; Hatta H, 2010, J HISTOCHEM CYTOCHEM, V58, P421, DOI 10.1369/jhc.2010.955096; Richter T, 1999, J CLIN PATHOL, V52, P461; Haapasalo J, 2005, J CLIN PATHOL, V58, P263, DOI 10.1136/jcp.2004.018606; Toda H, 2011, ACTA HISTOCHEM CYTOC, V44, P133, DOI 10.1267/ahc.11006; Nihashi T, 2013, AM J NEURORADIOL, V34, P944, DOI 10.3174/ajnr.A3324; Firlik KS, 1999, J NEUROSURG, V91, P454, DOI 10.3171/jns.1999.91.3.0454; ICHIHARA T, 1989, J SURG ONCOL, V42, P209, DOI 10.1002/jso.2930420316; Kammerer U, 2001, J HISTOCHEM CYTOCHEM, V49, P623; Louis DN, 2007, WHO CLASSIFICATION T; Uematsu Y, 2007, BRAIN TUMOR PATHOL, V24, P47, DOI 10.1007/s10014-007-0219-z; Uzuka T, 2011, BRAIN TUMOR PATHOL, V28, P239, DOI 10.1007/s10014-011-0026-4	16	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					12	19		10.1007/s10014-014-0188-y		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500003		
J	Tanino, M; Sasajima, T; Nanjo, H; Akesaka, S; Kagaya, M; Kimura, T; Ishida, Y; Oda, M; Takahashi, M; Sugawara, T; Yoshioka, T; Nishihara, H; Akagami, Y; Goto, A; Minamiya, Y; Tanaka, S				Tanino, Mishie; Sasajima, Toshio; Nanjo, Hiroshi; Akesaka, Shiori; Kagaya, Masami; Kimura, Taichi; Ishida, Yusuke; Oda, Masaya; Takahashi, Masataka; Sugawara, Taku; Yoshioka, Toshiaki; Nishihara, Hiroshi; Akagami, Yoichi; Goto, Akiteru; Minamiya, Yoshihiro; Tanaka, Shinya		R-IHC Study Grp	Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors (vol 32, pg 12, 2015)	BRAIN TUMOR PATHOLOGY			English	Correction									[Tanino, Mishie; Akesaka, Shiori; Kimura, Taichi; Ishida, Yusuke; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Sasajima, Toshio; Oda, Masaya; Takahashi, Masataka; Sugawara, Taku] Akita Univ, Dept Neurosurg, Grad Sch Med, Akita 0108543, Japan; [Nanjo, Hiroshi; Yoshioka, Toshiaki; Goto, Akiteru] Akita Univ, Div Clin Pathol, Grad Sch Med, Akita 0108543, Japan; [Kagaya, Masami; Akagami, Yoichi] Akita Ind Technol Ctr, Akita 0101623, Japan; [Nishihara, Hiroshi; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Translat Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Minamiya, Yoshihiro] Akita Univ, Dept Thorac Surg, Grad Sch Med, Akita 0108543, Japan	Tanaka, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	tanaka@med.hokudai.ac.jp					Tanino M, 2015, BRAIN TUMOR PATHOL, V32, P12, DOI 10.1007/s10014-014-0188-y	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					20	21		10.1007/s10014-014-0194-0		2	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500004		
J	Arita, H; Narita, Y; Matsushita, Y; Fukushima, S; Yoshida, A; Takami, H; Miyakita, Y; Ohno, M; Shibui, S; Ichimura, K				Arita, Hideyuki; Narita, Yoshitaka; Matsushita, Yuko; Fukushima, Shintaro; Yoshida, Akihiko; Takami, Hirokazu; Miyakita, Yasuji; Ohno, Makoto; Shibui, Soichiro; Ichimura, Koichi			Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; IDH1; IDH2; Pyrosequencing; Mutation detection	CODON 132 MUTATION; IDH2 MUTATIONS; BRAIN-TUMORS; IMMUNOHISTOCHEMISTRY; ASTROCYTOMAS; METHYLATION	Assessment of the mutational status of the isocitrate dehydrogenase 1/2 (IDH1/2) gene has become an integral part of the standard diagnostic procedure and, therefore, needs to be accurate. This may, however, be compromised by various factors including the method of analysis and a low tumor cell content. We have developed a rapid, sensitive and robust assay to detect all types of mutation in either IDH1 or IDH2 using pyrosequencing. The efficacy of detecting mutation was evaluated using a panel of control plasmids representing all the different types of IDH1/2 mutation and a set of 160 tumor specimens. The sensitivity of the assays was examined by a serial dilution analysis performed on samples containing various ratios of wild-type and mutant alleles. The pyrosequencing assay detected as little as 5 % of mutant alleles for most mutation types, while conventional Sanger sequencing required the presence of at least 20 % of mutant alleles for identifying mutations. The pyrosequencing assay detected IDH1/2 mutations in three samples which were missed by Sanger sequencing due to their low tumor cell contents. Our assay is particularly useful for the analysis of a large number of specimens as in a retrospective clinical study for example.	[Arita, Hideyuki; Narita, Yoshitaka; Matsushita, Yuko; Miyakita, Yasuji; Ohno, Makoto; Shibui, Soichiro] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo, Japan; [Arita, Hideyuki; Fukushima, Shintaro; Takami, Hirokazu; Ichimura, Koichi] Natl Canc Ctr, Res Inst, Div Brain Tumor Translat Res, Chuo Ku, Tokyo 1040045, Japan; [Yoshida, Akihiko] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; [Takami, Hirokazu] Univ Tokyo, Dept Neurosurg, Bunkyo Ku, Tokyo 1130033, Japan	Ichimura, K (reprint author), Natl Canc Ctr, Res Inst, Div Brain Tumor Translat Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kichimur@ncc.go.jp			JSPS KAKENHI [24659650, 25462283]; National Cancer Center Research and Development Fund [23-A-50]	The authors thank Dr. Sylvia Kocialkowski for critical reading of the manuscript. This work was supported by JSPS KAKENHI Grant Numbers 24659650 (H. A.), 25462283 (K. I.) and by the National Cancer Center Research and Development Fund 23-A-50 (K. I.).	Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Fukushima S, 2013, NEUROPATHOLOGY, V33, P576, DOI 10.1111/neup.12022; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Lee D, 2013, BRAIN PATHOL, V23, P285, DOI 10.1111/bpa.12000; Malley DS, 2011, ACTA NEUROPATHOL, V121, P651, DOI 10.1007/s00401-011-0803-5; Horbinski C, 2013, ACTA NEUROPATHOL, V125, P621, DOI 10.1007/s00401-013-1106-9; Thon N, 2012, CANCER-AM CANCER SOC, V118, P452, DOI 10.1002/cncr.26298; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Mascelli S, 2012, J NEURO-ONCOL, V109, P477, DOI 10.1007/s11060-012-0925-1; Kaneko MK, 2013, BIOCHEM BIOPH RES CO, V432, P40, DOI 10.1016/j.bbrc.2013.01.088; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Kato Y, 2013, BIOCHEM BIOPH RES CO, V432, P564, DOI 10.1016/j.bbrc.2013.02.049; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; MORIMURA T, 1990, ACTA NEUROPATHOL, V80, P287; Choi J, 2013, PATHOL RES PRACT, V209, P284, DOI 10.1016/j.prp.2013.02.010; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Cykowski MD, 2012, DIAGN MOL PATHOL, V21, P214, DOI 10.1097/PDM.0b013e31825d802b; Felsberg J, 2010, ACTA NEUROPATHOL, V119, P501, DOI 10.1007/s00401-010-0647-4; Ronaghi M., 1998, SCIENCE, V281, P365; Setty P, 2010, J MOL DIAGN, V12, P750, DOI 10.2353/jmoldx.2010.090237; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339	31	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					22	30		10.1007/s10014-014-0186-0		9	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500005		
J	Takahashi, H; Inoue, A; Kawabe, Y; Hosokawa, Y; Iwata, S; Sugimoto, K; Yano, H; Yamashita, D; Harada, H; Kohno, S; Ohue, S; Ohnishi, T; Tanaka, J				Takahashi, Hisaaki; Inoue, Akihiro; Kawabe, Yuya; Hosokawa, Yuki; Iwata, Shinji; Sugimoto, Kana; Yano, Hajime; Yamashita, Daisuke; Harada, Hironobu; Kohno, Shohei; Ohue, Shiro; Ohnishi, Takanori; Tanaka, Junya			Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma	BRAIN TUMOR PATHOLOGY			English	Article						Glioblastoma; Oct-3/4; Angiogenesis; VEGF; HIF1; AKT	ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; STEM-LIKE CELLS; CANCER-CELLS; GENE-EXPRESSION; LUNG-CANCER; HYPOXIA; GLIOMA; IDENTIFICATION; MECHANISMS	Accumulating evidence shows that the expression level of Oct-3/4, a self-renewal regulator in stem cells, is positively correlated with the progression of various solid tumors. However, little is known regarding the influence of Oct-3/4 in the tumor angiogenesis of glioblastomas. In the present study, we subcutaneously transplanted Oct-3/4-overexpressing human glioblastoma U251 (U251/EGFP-Oct-3/4) cells into the right thighs of nude mice to evaluate the roles of Oct-3/4 in the tumor angiogenesis. Both tumor size and the number of large vessels growing in the tumor were markedly increased. In an in vitro model of angiogenesis, the conditioned media from U251/EGFP-Oct-3/4 cells significantly accelerated capillary-like tube formation compared with that of U251/EGFP cells. In comparison with U251/EGFP cells, U251/EGFP-Oct-3/4 cells had markedly elevated the expression of vascular endothelial growth factor mRNA under the control of hypoxia-inducible factor (HIF) 1 alpha. In U251/EGFP-Oct-3/4 cells, enhanced protein expression and nuclear translocation of HIF1 alpha were observed. Furthermore, we demonstrated that the involvement of AKT, an oncogenic signaling molecule, in the Oct-3/4 induced upregulation of HIF1 alpha protein. Our findings suggest that Oct-3/4-expressing glioblastoma cells have the ability to adapt to low-oxygen environments within tumor masses by promoting tumor angiogenesis through AKT-HIF1 pathway.	[Takahashi, Hisaaki; Kawabe, Yuya; Hosokawa, Yuki; Iwata, Shinji; Yano, Hajime; Tanaka, Junya] Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan; [Inoue, Akihiro; Yamashita, Daisuke; Harada, Hironobu; Kohno, Shohei; Ohue, Shiro; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime 7910295, Japan; [Sugimoto, Kana] Osaka Univ, Grad Sch Med, Dept Legal Med, Suita, Osaka 5650871, Japan	Takahashi, H (reprint author), Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido 0788510, Japan.	hisaaki@asahikawa-med.ac.jp		inoue, akihiro/0000-0002-7438-2369	Ministry of Education, Culture, Sports, Science and Technology of Japan [23592129]	We thank Dr. M. E. Choudhury for helpful comments on the manuscript. This research was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Program for Scientific Research (C) No. 23592129 to H. T.).	Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Zundel W, 2000, GENE DEV, V14, P391; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Mazure NM, 1997, BLOOD, V90, P3322; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Inoue A, 2010, INT J ONCOL, V37, P1121, DOI 10.3892/ijo_00000764; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Karni R, 2002, J BIOL CHEM, V277, P42919, DOI 10.1074/jbc.M206141200; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Chang CC, 2008, CANCER RES, V68, P6281, DOI 10.1158/0008-5472.CAN-08-0094; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Kobayashi K, 2012, J CELL BIOCHEM, V113, P508, DOI 10.1002/jcb.23374; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Du Z, 2009, GLIA, V57, P724; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jovcevska I, 2013, MOL CLIN ONCOL, V1, P935, DOI DOI 10.3892/MCO.2013.172; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Takahashi H, 2007, NEUROSCI LETT, V417, P250, DOI 10.1016/j.neulet.2007.02.075	37	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					31	40		10.1007/s10014-014-0203-3		10	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500006		
J	Sugita, Y; Terasaki, M; Nakashima, S; Ohshima, K; Morioka, M; Abe, H				Sugita, Yasuo; Terasaki, Mizuhiko; Nakashima, Shinji; Ohshima, Koichi; Morioka, Motohiro; Abe, Hideyuki			The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor	BRAIN TUMOR PATHOLOGY			English	Article						Primary central nervous system lymphoma; CXCL12; CXCL13; Endothelin B receptor; Immune escape	PROSTATE-CANCER; CELL LYMPHOMAS; IMMUNE THERAPY; EXPRESSION; CXCL12; SURVIVAL; CXCR4; LINES	Chemokines are peptides that function as chemoattractant cytokines in cell activation, differentiation and trafficking. Endothelin B receptor (ETBR) is a receptor for endothelin, which is known to function as a vasoconstrictor. In the present study, to clarify the immune escape mechanism of primary central nervous system lymphomas (PCNSLs), the expression of ETBR and of subsets of chemokines (CXCL12, 13) in 24 PCNSLs was investigated. CXCL12 was expressed by lymphoma cells in different resident brain cell populations in 22/24 cases. CXCL13 expression was identified in tumor cells in 19/24 cases, but was only expressed by tumor cells and by proliferating vascular endothelial cells. In addition, tumor-infiltrated lymphocytes (TILs) accumulated in areas with expression of chemokines, particularly of CXCL13. ETBR expression was detected in 12/24 cases. Positive ETBR cases were associated with a paucity of TILs, particularly of cytotoxic T cells, whereas negative ETBR cases were associated with an abundance of TILs. The combined data indicate that CXCL12 and CXCL13 up-regulation may be differently linked to the development of PCNSLs and to the accumulation of TILs. In addition, ETBR expression by lymphoma and endothelial cells may mediate trafficking of TILs, which may explain the immune escape processes of PCNSLs.	[Sugita, Yasuo; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Terasaki, Mizuhiko; Nakashima, Shinji; Morioka, Motohiro] Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan; [Abe, Hideyuki] Kurume Univ, Sch Med, Dept Surg Pathol, Kurume, Fukuoka 8300011, Japan	Sugita, Y (reprint author), Kurume Univ, Sch Med, Dept Pathol, Asahimachi 67, Kurume, Fukuoka 8300011, Japan.	sugita_yasuo@med.kurume-u.ac.jp			JSPS KAKENHI [24500427]	This work was supported by JSPS KAKENHI Grant Number 24500427.	Ahmed SI, 2000, AM J RESP CELL MOL, V22, P422; Anguelova E, 2005, MOL BRAIN RES, V137, P77, DOI 10.1016/j.molbrainres.2005.02.015; Kucia M, 2004, J MOL HISTOL, V35, P233; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Nelson JB, 1996, CANCER RES, V56, P663; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Ponzoni M, 2007, BRIT J HAEMATOL, V138, P316, DOI 10.1111/j.1365-2141.2007.06661.x; KUSUHARA M, 1990, CANCER RES, V50, P3257; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Venetz D, 2010, INT J CANCER, V127, P2300, DOI 10.1002/ijc.25236; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Brunn A, 2007, ACTA NEUROPATHOL, V114, P271, DOI 10.1007/s00401-007-0258-x; Smith J, 2003, DEVELOPMENT, V130, P1, DOI 10.1242/dev.00209; Komatani H, 2009, INT J ONCOL, V34, P665, DOI 10.3892/ijo_00000192; Barbieri F, 2010, J ONCOL, V61, P4961; Deckert M, 2007, PATHOLOGY GENETICS T, P188; Fischer L, 2007, CLIN CANCER RES, V15, P5968; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jahnke K, 2005, BLOOD, V106, P384, DOI 10.1182/blood-2005-01-0324; Kiyasu J, 2012, PATHOL INT, V62, P77, DOI 10.1111/j.1440-1827.2011.02754.x; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Paolillo M, 2006, J NEURO-ONCOL, V79, P1, DOI 10.1007/s11060-005-9111-z; Rosano L, 2001, CANCER RES, V61, P8340; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Smith JR, 2007, AM J CLIN PATHOL, V127, P633, DOI 10.1309/NUQHJ79BHWYD9TAF; Sugita Y, 2007, J NEURO-ONCOL, V82, P249, DOI 10.1007/s11060-006-9281-3; Sugita Y, 2004, PATHOL INT, V54, P659, DOI 10.1111/j.1440-1827.2004.01677.x; Teicher BA, 2007, CLIN CANCER RES, V16, P2927	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					41	48		10.1007/s10014-014-0206-0		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500007		
J	Karki, P; Yonezawa, H; Bohara, M; Oyoshi, T; Hirano, H; Moinuddin, FM; Hiraki, T; Yoshioka, T; Arita, K				Karki, Prasanna; Yonezawa, Hajime; Bohara, Manoj; Oyoshi, Tatsuki; Hirano, Hirofumi; Moinuddin, F. M.; Hiraki, Tsubasa; Yoshioka, Takako; Arita, Kazunori			Third ventricular atypical meningioma which recurred with further malignant progression	BRAIN TUMOR PATHOLOGY			English	Article						Anaplastic meningioma; Atypical meningioma; Papillary pattern; Third ventricle	INTRAVENTRICULAR MENINGIOMAS; 3RD-VENTRICLE; SERIES	Meningiomas in the third ventricle are rare, with only very few cases reported in the literature. We report a case of primary third ventricular anaplastic meningioma in a 49-year-old man who presented with progressive weakness of the left limbs and headache. Magnetic resonance imaging revealed a tumor which seemed to arise from the right thalamus and extending into third ventricle. The tumor was heterogeneously enhanced with gadolinium. It was totally removed by right transventricular-subchoroidal approach. The lesion was intraoperatively found to be whitish hard and embedded in right thalamus, but had attachment to choroid plexus near foramen Monroi with narrow interface. The histological diagnosis was atypical meningioma, WHO Grade II. Lesion recurred 20 months later and was resected via the same approach, which turned out to be papillary meningioma, WHO Grade III. The patient had second recurrence 23 months after second surgery which was operated and the final diagnosis was anaplastic meningioma (WHO Grade III). Literature review showed meningioma of the third ventricle is quite exceptional and more than half of the cases were aggressive subtypes (Grade II or III).	[Karki, Prasanna; Yonezawa, Hajime; Bohara, Manoj; Oyoshi, Tatsuki; Hirano, Hirofumi; Moinuddin, F. M.; Arita, Kazunori] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, Kagoshima 8908544, Japan; [Hiraki, Tsubasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 8908544, Japan; [Yoshioka, Takako] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Kagoshima 8908544, Japan	Hirano, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	hirahira@m2.kufm.kagoshima-u.ac.jp					Song KS, 2008, J NEUROSURG-PEDIATR, V2, P269, DOI 10.3171/PED.2008.2.10.269; Nakamura M, 2003, SURG NEUROL, V59, P491, DOI 10.1016/S0090-3019(03)00082-X; Wajima D, 2011, NEUROL MED-CHIR, V51, P75, DOI 10.2176/nmc.51.75; STRENGER SW, 1987, NEUROSURGERY, V20, P465; Odegaard KM, 2013, NEUROSURG REV, V36, P57, DOI 10.1007/s10143-012-0410-5; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; JAASKELAINEN J, 1986, SURG NEUROL, V25, P233, DOI 10.1016/0090-3019(86)90233-8; Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210; RUSSELL T, 1986, NEUROSURGERY, V19, P1028; Arai H, 1998, Brain Tumor Pathol, V15, P37, DOI 10.1007/BF02482099; Bhatoe Harjinder S, 2006, Neurosurg Focus, V20, pE9, DOI 10.3171/foc.2006.20.3.10; Commins Deborah L, 2007, Neurosurg Focus, V23, pE3, DOI 10.3171/FOC-07/10/E3; Cushing H, 1938, MENINGIOMAS THEIR CL, P139; HUANG PP, 1993, NEUROSURGERY, V33, P312; JELLINGER K, 1975, J NEUROL, V208, P279, DOI 10.1007/BF00312803; PANDYA P, 1990, British Journal of Neurosurgery, V4, P129, DOI 10.3109/02688699008992712; Perry A, 2007, WHO CLASSIFICATION T, P164	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					56	60		10.1007/s10014-014-0183-3		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500009		
J	Kawaji, H; Miyatake, SI; Shinmura, K; Kawabata, S; Tokuyama, T; Namba, H				Kawaji, Hiroshi; Miyatake, Shin-Ichi; Shinmura, Kazuya; Kawabata, Shinji; Tokuyama, Tsutomu; Namba, Hiroki			Effect of boron neutron capture therapy for recurrent anaplastic meningioma: an autopsy case report	BRAIN TUMOR PATHOLOGY			English	Article						Anaplastic meningioma; Autopsy; Boron neutron capture therapy; Bevacizumab; Radiation necrosis	MALIGNANT GLIOMAS; PSEUDOPROGRESSION; APOPTOSIS; CELLS; BNCT	A 70-year-old woman died of systemic metastasis from anaplastic meningioma and underwent autopsy. The patient underwent twice total removal of the right sphenoid ridge meningioma 2 years ago. The tumor recurred 3 times, and then stereotactic radiotherapy was employed. Boron neutron capture therapy (BNCT) was performed for the fourth local recurrence and an additional new lesion. Proliferative activity of the newly developed meningioma, which had been treated with BNCT only, was significantly lower than that of untreated metastatic liver tumor, as well as that of the meningioma specimen obtained at the second surgery. Our pathological findings demonstrated, for the first time, the therapeutic effect of BNCT on anaplastic meningioma at an early stage (2.5 months).	[Kawaji, Hiroshi; Tokuyama, Tsutomu; Namba, Hiroki] Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Miyatake, Shin-Ichi; Kawabata, Shinji] Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka 5698686, Japan; [Shinmura, Kazuya] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Namba, H (reprint author), Hamamatsu Univ Sch Med, Dept Neurosurg, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	hnamba@hama-med.ac.jp	Shinmura, Kazuya /K-8940-2012	Shinmura, Kazuya /0000-0003-4963-746X			Alexandru D, 2011, CANCER-AM CANCER SOC, V117, P4506, DOI 10.1002/cncr.26065; Lou E, 2012, J NEURO-ONCOL, V109, P63, DOI 10.1007/s11060-012-0861-0; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; Miyatake SI, 2005, J NEUROSURG, V103, P1000, DOI 10.3171/jns.2005.103.6.1000; Puchner MJA, 2010, ANN ONCOL, V21, P2445, DOI 10.1093/annonc/mdq634; Hanft S, 2010, J NEURO-ONCOL, V99, P433, DOI 10.1007/s11060-010-0348-9; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Aziz T, 2000, J NEUROPATH EXP NEUR, V59, P62; Enam SA, 1996, ACTA NEUROCHIR, V138, P1172; Kageji T, 2004, J NEURO-ONCOL, V68, P25, DOI 10.1023/B:NEON.0000024725.31515.22; Kawabata S, 2013, J NEUROSURG, V119, P837, DOI 10.3171/2013.5.JNS122204; Miyatake SI, 2013, NEURO-ONCOLOGY, V15, P650, DOI 10.1093/neuonc/not020; Miyatake SI, 2009, NEURO-ONCOLOGY, V11, P430, DOI 10.1215/15228517-2008-107; Nakagawa N, 2007, BRAIN TUMOR PATHOL, V24, P7, DOI 10.1007/s10014-007-0214-4; Nayak L, 2012, J NEUROONCOL, V109, P87; Stenstam BH, 2007, ACTA NEUROL SCAND, V115, P243, DOI 10.1111/j.1600-0404.2006.00776.x; Sun T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-195; Wang P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-661	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	JAN	2015	32	1					61	65		10.1007/s10014-014-0189-x		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	AZ4QW	WOS:000348208500010		
J	Hayashi, N; Niikura, N; Masuda, N; Takashima, S; Nakamura, R; Watanabe, K; Kanbayashi, C; Ishida, M; Hozumi, Y; Tsuneizumi, M; Kondo, N; Naito, Y; Honda, Y; Matsui, A; Fujisawa, T; Oshitanai, R; Yasojima, H; Yamauchi, H; Saji, S; Iwata, H				Hayashi, Naoki; Niikura, Naoki; Masuda, Norikazu; Takashima, Seiki; Nakamura, Rikiya; Watanabe, Ken-ichi; Kanbayashi, Chizuko; Ishida, Mayumi; Hozumi, Yasuo; Tsuneizumi, Michiko; Kondo, Naoto; Naito, Yoichi; Honda, Yayoi; Matsui, Akira; Fujisawa, Tomomi; Oshitanai, Risa; Yasojima, Hiroyuki; Yamauchi, Hideko; Saji, Shigehira; Iwata, Hiroji			Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; HER2; Brain metastases; Retrospective analysis; HER2-targeting agent	LAPATINIB PLUS CAPECITABINE; ADJUVANT TRASTUZUMAB; PHASE-II; THERAPY; SURVIVAL; TRIAL; RISK; HER2	The clinical course and prognostic factors of HER2-positive breast cancer patients with brain metastases are not well known because of the relatively small population. The aim of this study was to determine prognostic factors associated with HER2-positive patients who develop brain metastases. This retrospective study assessed the largest dataset to date of 432 HER2-positive patients who were diagnosed with brain metastases from 24 institutions of the Japan Clinical Oncology Group, Breast Cancer Study Group. The median age of the 432 patients was 54 years (range, 20-86 years). Of the patients, 162 patients (37.5 %) had ER-positive/HER2-positive (ER+HER2+) breast cancer, and 270 (62.5 %) had ER-negative/HER2-positive (ER-HER2+) breast cancer. The median brain metastasis-free survival period from primary breast cancer was 33.5 months in both groups. The median survival after developing brain metastasis was 16.5 and 11.5 months in the ER+HER2+ and ER-HER2+ groups, respectively, (p = 0.117). Patients with > 3 brain metastases had significantly shorter overall survival in both ER+HER2+ (p < 0.001) and ER-HER2+ (p = 0.018) groups. Treatment with trastuzumab before developing brain metastases was not associated with survival duration after developing brain metastases (p = 0.571). However, patients treated with both trastuzumab and lapatinib after developing metastasis had significantly longer survival than patients treated with trastuzumab alone, lapatinib alone, or no HER2-targeting agent (p < 0.001). For HER2-positive patients with brain metastases, regardless of the use of trastuzumab before developing brain metastasis, treatment with both trastuzumab and lapatinib might improve survival.	[Hayashi, Naoki; Yamauchi, Hideko] St Lukes Int Hosp, Dept Breast Surg Oncol, Tokyo, Japan; [Niikura, Naoki; Oshitanai, Risa] Tokai Univ, Sch Med, Dept Breast Surg, Isehara, Kanagawa 2591193, Japan; [Niikura, Naoki; Oshitanai, Risa] Tokai Univ, Sch Med, Dept Endocrine Surg, Isehara, Kanagawa 2591193, Japan; [Niikura, Naoki; Saji, Shigehira] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Kyoto, Japan; [Masuda, Norikazu; Yasojima, Hiroyuki] Natl Hosp Org, Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Takashima, Seiki] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Toon, Ehime, Japan; [Nakamura, Rikiya] Chiba Canc Ctr Hosp, Dept Breast Surg, Chiba, Japan; [Watanabe, Ken-ichi] Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan; [Kanbayashi, Chizuko] Niigata Canc Ctr Hosp, Dept Breast Oncol, Niigata, Japan; [Ishida, Mayumi] Kyushu Natl Canc Ctr, Dept Breast Oncol, Fukuoka, Japan; [Hozumi, Yasuo] Jichi Med Univ, Dept Breast Oncol, Shimotsuke, Tochigi, Japan; [Tsuneizumi, Michiko] Shizuoka Prefectural Gen Hosp, Dept Breast Surg, Shizuoka, Japan; [Kondo, Naoto; Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Naito, Yoichi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Dept Expt Therapeut, Tokyo 104, Japan; [Naito, Yoichi] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, Chiba, Japan; [Honda, Yayoi] Tokyo Metropolitan Canc, Div Breast Surg, Tokyo, Japan; [Honda, Yayoi] Komagome Hosp, Ctr Infect Dis, Tokyo, Japan; [Matsui, Akira] Natl Hosp Org, Tokyo Med Ctr, Dept Surg, Tokyo, Japan; [Fujisawa, Tomomi] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Gunma, Japan	Niikura, N (reprint author), Tokai Univ, Sch Med, Dept Breast Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	niikura@is.icc.u-tokai.ac.jp			National Cancer Center Research and Development Fund [23-A-17]; Health and Labour Sciences Research Expenses for Commision Fund for Applied Research for Innovative Treatment of Cancer [H26-applied-general-046]	We would like to thank the following people for providing us with the data of patients with brain metastases: Yasuyuki Sato, Nagoya Medical Center; Yoshimasa Kosaka, Kitasato University School of Medicine; Tsutomu Iwasa, Kinki University School of Medicine; Hiroyasu Yamashiro, Kure Medical Center/Chugoku Cancer Center; Tadahiko Shien; Okayama University Hospital; Kazuya Miyoshi, NHO Fukuyama Medical Center; Anan Keisei, Kitakyushu Municipal Medical Center, Department of Surgery; Hitoshi Arioka, Yokohama Rosai Hospital; and Maeda Shigeto, National Nagasaki Medical Center. This study was supported by the National Cancer Center Research and Development Fund (23-A-17) and the Health and Labour Sciences Research Expenses for Commision Fund for Applied Research for Innovative Treatment of Cancer (H26-applied-general-046).	Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Mehta AI, 2013, CANCER TREAT REV, V39, P261, DOI 10.1016/j.ctrv.2012.05.006; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Swain SM, 2014, ANN ONCOL, V25, P1116, DOI 10.1093/annonc/mdu133; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Metro G, 2011, ANN ONCOL, V22, P625, DOI 10.1093/annonc/mdq434; Yap YS, 2012, BRIT J CANCER, V107, P1075, DOI 10.1038/bjc.2012.346; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Tomasello G, 2010, CRIT REV ONCOL HEMAT, V75, P110, DOI 10.1016/j.critrevonc.2009.11.003; Bachelot T, 2013, LANCET ONCOL, V14, P64, DOI 10.1016/S1470-2045(12)70432-1; Tamura K, 2013, J NUCL MED, V54, P1869, DOI 10.2967/jnumed.112.118612; Olson EM, 2013, ANN ONCOL, V24, P1526, DOI 10.1093/annonc/mdt036; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Lin NU, 2009, CLIN CANCER RES, V15, P1452, DOI 10.1158/1078-0432.CCR-08-1080; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Pestalozzi BC, 2013, LANCET ONCOL, V14, P244, DOI 10.1016/S1470-2045(13)70017-2; Musolino A, 2011, CANCER-AM CANCER SOC, V117, P1837, DOI 10.1002/cncr.25771; Sutherland S, 2010, BRIT J CANCER, V102, P995, DOI 10.1038/sj.bjc.6605586; DISTEFANO A, 1979, CANCER, V44, P1913, DOI 10.1002/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D; Duchnowska R, 2012, ONCOLOGIST, V17, P26, DOI 10.1634/theoncologist.2011-0212; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Hayashi N, 2013, BREAST CANCER RES TR, V137, P523, DOI 10.1007/s10549-012-2336-6; Iwata H, 2013, INT J CLIN ONCOL, V18, P621, DOI 10.1007/s10147-012-0444-2; Krop IE, 2015, ANN ONCOL, V26, P113, DOI 10.1093/annonc/mdu486; Pivot X, 2012, ESMO 2012 ANN M LBA1; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; The World Health Organization, 1983, NEOPLASMA, V30, P113; Wildiers H, 2013, EUR CANC C 2013; Yin WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021030	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	JAN	2015	149	1					277	284		10.1007/s10549-014-3237-7		8	Oncology	Oncology	AZ4IB	WOS:000348183700030		
J	Miyake, T; Yamamoto, T; Hirai, Y; Otsuka, M; Hamada, T; Tsuji, K; Morizane, S; Suzuki, D; Aoyama, Y; Iwatsuki, K				Miyake, T.; Yamamoto, T.; Hirai, Y.; Otsuka, M.; Hamada, T.; Tsuji, K.; Morizane, S.; Suzuki, D.; Aoyama, Y.; Iwatsuki, K.			Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites	BRITISH JOURNAL OF DERMATOLOGY			English	Article							DELTA-T-CELLS; TRANSCRIPTS; INFECTIONS; EXPRESSION; DISORDERS; LYMPHOMA; DISEASE; BZLF1	BackgroundEpstein-Barr virus (EBV)-associated T/natural-killer lymphoproliferative disorders form a group of diseases that includes classical and systemic hydroa vacciniforme (HV) and hypersensitivity to mosquito bites (HMB). Patients with systemic HV (sHV) and HMB often have a poor prognosis, although little is known about the prognostic factors. ObjectivesTo elucidate the prognostic factors of HV and HMB. MethodsWe studied clinicopathological manifestations, routine laboratory findings, anti-EBV titres, EBV DNA load and EBV-encoded gene expression, including expression of BZLF1, in 50 patients with classical HV (cHV), sHV, HMB only and HMB with HV (HMB+HV), and further analysed 30 patients who were available for follow-up. ResultsThe median age of disease onset was 5years (range 1-74). A follow-up study indicated that fatal outcomes were observed in three of eight patients with sHV, two of six patients with HMB only, and two of five patients with HMB+HV. The main causes of death were complications from haematopoietic stem-cell transplantation and multiorgan failure. There were no fatalities among the 11 patients with cHV. Univariate analysis revealed two poor prognostic indicators: (i) onset age >9years and (ii) the expression of an EBV-encoded immediate-early gene transcript, BZLF1 mRNA, in the skin lesions (P<0001 and P=0003, respectively). ConclusionsNo prognostic correlation was observed in EBV-infected lymphocyte subsets, anti-EBV antibody titres or EBV DNA load. Late onset and EBV reactivation are both related to more severe phenotypes of the disease, and thus may predict a poor prognosis.	[Miyake, T.; Yamamoto, T.; Hirai, Y.; Otsuka, M.; Hamada, T.; Tsuji, K.; Morizane, S.; Suzuki, D.; Aoyama, Y.; Iwatsuki, K.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, Okayama 7008558, Japan; [Yamamoto, T.] Kawasaki Med Univ, Dept Dermatol, Okayama, Japan	Iwatsuki, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	keijiiwa@cc.okayama-u.ac.jp					WEISS LM, 1991, AM J PATHOL, V139, P1259; FLEMINGTON EK, 1991, J VIROL, V65, P7073; Magana M, 1998, J AM ACAD DERMATOL, V38, P574, DOI 10.1016/S0190-9622(98)70120-3; Hirai Y, 2012, J INVEST DERMATOL, V132, P1401, DOI 10.1038/jid.2011.461; Asada H, 2005, J INVEST DERMATOL, V125, P956, DOI 10.1111/j.0022-202X.2005.23915.x; Cho KH, 2004, BRIT J DERMATOL, V151, P372, DOI 10.1111/j.1365-2133.2004.06038.x; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Iwatsuki K, 2006, ARCH DERMATOL, V142, P587, DOI 10.1001/archderm.142.5.587; Fu Z, 2000, J VIROL, V74, P6675, DOI 10.1128/JVI.74.14.6675-6679.2000; Iwatsuki K, 2004, ACTA MED OKAYAMA, V58, P169; Morizane S, 2005, BRIT J DERMATOL, V153, P981, DOI 10.1111/j.1365-2133.2005.06849.x; Quintanilla-Martinez L, 2008, WHO CLASSIFICATION T, P278; Rodriguez-Pinilla SM, 2010, AM J SURG PATHOL, V34, P1773, DOI 10.1097/PAS.0b013e3181fbb4fd; Tanaka C, 2012, BRIT J DERMATOL, V166, P216, DOI 10.1111/j.1365-2133.2011.10512.x; Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751; Yamamoto T, 2012, J MED MICROBIOL, V61, P1445, DOI 10.1099/jmm.0.044727-0; Yamamoto T, 2007, J MICROBIOL METH, V68, P403, DOI 10.1016/j.mimet.2006.09.025	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					56	63		10.1111/bjd.13411		8	Dermatology	Dermatology	AY7FK	WOS:000347726500012		
J	Takeichi, T; Liu, L; Fong, K; Ozoemena, L; McMillan, JR; Salam, A; Campbell, P; Akiyama, M; Mellerio, JE; McLean, WHI; Simpson, MA; McGrath, JA				Takeichi, T.; Liu, L.; Fong, K.; Ozoemena, L.; McMillan, J. R.; Salam, A.; Campbell, P.; Akiyama, M.; Mellerio, J. E.; McLean, W. H. I.; Simpson, M. A.; McGrath, J. A.			Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory	BRITISH JOURNAL OF DERMATOLOGY			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; KINDLER-SYNDROME; COL7A1 MUTATIONS; VII COLLAGEN; SKIN; VARIANTS; RECOMMENDATIONS; DISORDERS; STANDARDS; DISEASES	BackgroundSubtypes of inherited epidermolysis bullosa (EB) vary significantly in their clinical presentation and prognosis. Establishing an accurate diagnosis is important for genetic counselling and patient management. Current approaches in EB diagnostics involve skin biopsy for immunohistochemistry and transmission electron microscopy, and Sanger sequencing of candidate genes. Although informative in most cases, this approach can be expensive and laborious and may fail to identify pathogenic mutations in similar to 15% of cases. ObjectivesNext-generation DNA sequencing (NGS) technologies offer a fast and efficient complementary diagnostic strategy, but the value of NGS in EB diagnostics has yet to be explored. The aim of this study was to undertake whole-exome sequencing (WES) in nine cases of EB in which established diagnostic methods failed to make a genetic diagnosis. MethodsWhole-exome capture was performed using genomic DNA from each case of EB, followed by massively parallel sequencing. Resulting reads were mapped to the human genome reference hg19. Potentially pathogenic mutations were subsequently confirmed by Sanger sequencing. ResultsAnalysis of WES data disclosed biallelic pathogenic mutations in each case, with all mutations occurring in known EB genes (LAMB3, PLEC, FERMT1 and COL7A1). This study demonstrates that NGS can improve diagnostic sensitivity in EB compared with current laboratory practice. ConclusionsWith appropriate diagnostic platforms and bioinformatics support, WES is likely to increase mutation detection in cases of EB and improve EB diagnostic services, although skin biopsy remains an important diagnostic investigation in current clinical practice.	[Takeichi, T.; Fong, K.; Salam, A.; Campbell, P.; Mellerio, J. E.; McGrath, J. A.] Kings Coll London Guys Campus, St Johns Inst Dermatol, London, England; [Takeichi, T.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Liu, L.; Ozoemena, L.; McMillan, J. R.] St Thomas Hosp, Viapath, London, England; [Campbell, P.] Hull York Med Sch, York, N Yorkshire, England; [Mellerio, J. E.] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, London, England; [McLean, W. H. I.; McGrath, J. A.] Univ Dundee, Dundee, Scotland; [Simpson, M. A.] Kings Coll London Guys Campus, Dept Med & Mol Genet, London, England	McGrath, JA (reprint author), Kings Coll London Guys Campus, St Johns Inst Dermatol, London, England.	john.mcgrath@kcl.ac.uk	McGrath, John/D-6824-2012; Mellerio, Jemima/G-3681-2012	McGrath, John/0000-0002-3708-9964; 			Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Takeichi T, 2013, EXP DERMATOL, V22, P825, DOI 10.1111/exd.12276; Varki R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039685; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Eady RAJ, 2010, DERMATOL CLIN, V28, P211, DOI 10.1016/j.det.2009.12.001; Christiano AM, 1997, HUM MUTAT, V10, P408, DOI 10.1002/(SICI)1098-1004(1997)10:5<408::AID-HUMU12>3.3.CO;2-B; Kern JS, 2009, BRIT J DERMATOL, V161, P1089, DOI 10.1111/j.1365-2133.2009.09333.x; McGrath JA, 2012, AM J HUM GENET, V91, P1115, DOI 10.1016/j.ajhg.2012.10.012; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Maddalena A, 2005, GENET MED, V7, P571, DOI 10.1097/01.GIM.0000182738.95726.ca; Mellerio JE, 1997, J INVEST DERMATOL, V109, P246, DOI 10.1111/1523-1747.ep12319792; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; Cho R, 2012, J INVEST DERMATOL, V132, pE26; Dang NN, 2008, EXP DERMATOL, V17, P553, DOI 10.1111/j.1600-0625.2008.00723.x; Fassihi H, 2005, J DERMATOL SCI, V39, P183, DOI 10.1016/j.jdermsci.2005.05.007; Groves RW, 2010, J INVEST DERMATOL, V130, P1551, DOI 10.1038/jid.2010.19; HEAGERTY AHM, 1986, LANCET, V1, P860; HINTNER H, 1981, J INVEST DERMATOL, V76, P113, DOI 10.1111/1523-1747.ep12525447; Liu L, 2006, J DERMATOL SCI, V44, P48, DOI 10.1016/j.jdermsci.2006.05.009; Salam A, 2014, MATRIX BIOL, V33, P35, DOI 10.1016/j.matbio.2013.06.004; Salam A, 2014, ANN MED, V46, P49, DOI 10.3109/07853890.2013.866441; Techanukul T, 2011, ACTA DERM-VENEREOL, V91, P267, DOI 10.2340/00015555-1063; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					94	100		10.1111/bjd.13190		7	Dermatology	Dermatology	AY7FK	WOS:000347726500017		
J	Tani, N; Kimura, Y; Koga, H; Kawakami, T; Ohata, C; Ishii, N; Hashimoto, T				Tani, N.; Kimura, Y.; Koga, H.; Kawakami, T.; Ohata, C.; Ishii, N.; Hashimoto, T.			Clinical and immunological profiles of 25 patients with pemphigoid gestationis	BRITISH JOURNAL OF DERMATOLOGY			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ANTI-BMZ ANTIBODIES; HERPES-GESTATIONIS; LAMINA-LUCIDA; EXTRACELLULAR DOMAIN; TERMINAL DOMAINS; AUTOANTIBODIES; IMMUNOFLUORESCENCE; NC16A; BP180	BackgroundSystematic study of pemphigoid gestationis (PG) has not been performed owing to its rarity. ObjectivesTo perform clinical and immunological analyses of 25 patients with PG. MethodsIn addition to clinical and histopathological assessments, we performed immunofluorescence (IF), immunoblotting (IB) and enzyme-linked immunosorbent assays (ELISAs). ResultsPG developed preferentially during the second or third trimester of pregnancy, with a mean age at onset of 305years. Histopathology showed subepidermal blisters less frequently. Direct IF showed C3 deposition in the basement membrane zone (BMZ) in all patients, with rare reactivity with keratinocyte cell surfaces. Ninety-two per cent of patients showed circulating IgG anti-BMZ autoantibodies during indirect IF of either normal or 1molL(-1) NaCl-split skin. Complement IF revealed linear C3 reactivity with the BMZ of normal skin in 68% of patients, and all patients had C3 reactivity on the epidermal side of 1molL(-1) NaCl-split skin. IB and ELISA of the NC16a domain of BP180 recombinant protein was positive in 96% and 92% of patients, respectively, while only four patients had a positive ELISA for BP230. In IB tests, 28% of patients reacted with the C-terminal domain of BP180 and 20% reacted with leucocyte adhesion deficiency-1 protein. Multigravidae developed PG during a significantly (P<001) earlier stage (211weeks) of pregnancy than primigravidae (313weeks). ConclusionsIB and ELISA of the NC16a domain of BP180 were shown to be sensitive and diagnostic methods in PG. Patients with PG rarely reacted with BP230, suggesting a different pathogenesis between PG and bullous pemphigoid. Multigravidae developed PG skin lesions significantly earlier in pregnancy than primigravidae.	[Tani, N.; Kimura, Y.; Koga, H.; Kawakami, T.; Ohata, C.; Ishii, N.; Hashimoto, T.] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; [Tani, N.; Kimura, Y.; Koga, H.; Kawakami, T.; Ohata, C.; Ishii, N.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp	Ohata, Chika/F-3277-2015	Ohata, Chika/0000-0001-8341-7300			Castro LA, 2006, J AM ACAD DERMATOL, V55, P823, DOI 10.1016/j.jaad.2006.07.015; Sitaru C, 2004, OBSTET GYNECOL, V103, P757, DOI 10.1097/01.AOG.0000115506.76104.ad; GAMMON WR, 1984, J INVEST DERMATOL, V82, P139, DOI 10.1111/1523-1747.ep12259692; Semkova K, 2009, EUR J OBSTET GYN R B, V145, P138, DOI 10.1016/j.ejogrb.2009.05.012; Aoyama Y, 2007, ARCH DERMATOL, V143, P1168, DOI 10.1001/archderm.143.9.1168; Bedane C, 1997, J INVEST DERMATOL, V108, P901, DOI 10.1111/1523-1747.ep12292701; Borrego L, 1999, CLIN EXP DERMATOL, V24, P213; Cobo MF, 2009, CLINICS, V64, P1043, DOI 10.1590/S1807-59322009001100002; DisZenzo G, 2011, J INVEST DERMATOL, V131, P2271; Hashimoto T, 1996, Exp Dermatol, V5, P96, DOI 10.1111/j.1600-0625.1996.tb00101.x; Hashimoto T, 2011, J INVEST DERMATOL, V131, P2175, DOI 10.1038/jid.2011.276; HODGE L, 1978, CLIN EXP DERMATOL, V3, P61, DOI 10.1111/j.1365-2230.1978.tb01461.x; Ishiko A, 1998, J INVEST DERMATOL, V111, P93, DOI 10.1046/j.1523-1747.1998.00231.x; Jones SAV, 1997, BRIT J DERMATOL, V136, P245, DOI 10.1111/j.1365-2133.1997.tb14906.x; KELLY SE, 1988, BRIT J DERMATOL, V118, P605, DOI 10.1111/j.1365-2133.1988.tb02560.x; KELLY SE, 1989, BRIT J DERMATOL, V120, P735, DOI 10.1111/j.1365-2133.1989.tb01371.x; KELLY SE, 1990, BRIT J DERMATOL, V122, P445, DOI 10.1111/j.1365-2133.1990.tb14720.x; KIRTSCHIG G, 1994, BRIT J DERMATOL, V131, P108, DOI 10.1111/j.1365-2133.1994.tb08466.x; KOLODNY RC, 1969, AM J OBSTET GYNECOL, V104, P39; Lee JB, 2003, J DERMATOL SCI, V32, P59, DOI 10.1016/S0923-1811(03)00035-5; Marker M, 2011, J DTSCH DERMATOL GES, V9, P27, DOI 10.1111/j.1610-0387.2010.07500.x; Matsumura K, 1996, ARCH DERMATOL RES, V288, P507, DOI 10.1007/BF02505245; MORRISON LH, 1988, J CLIN INVEST, V81, P2023, DOI 10.1172/JCI113554; Murakami H, 1996, J DERMATOL SCI, V13, P112, DOI 10.1016/S0923-1811(96)00509-9; Nakatani C, 1998, BRIT J DERMATOL, V139, P365; Oyama N, 2003, BRIT J DERMATOL, V148, P939, DOI 10.1046/j.1365-2133.2003.05316.x; RUSSELL B, 1957, BRIT J DERMATOL, V69, P339, DOI 10.1111/j.1365-2133.1957.tb13770.x; SHORNICK JK, 1992, J AM ACAD DERMATOL, V26, P63, DOI 10.1016/0190-9622(92)70008-4; SUGI T, 1989, J CLIN INVEST, V84, P1050, DOI 10.1172/JCI114266; WOODLEY D, 1983, J INVEST DERMATOL, V81, P149, DOI 10.1111/1523-1747.ep12543517; Zone JJ, 1998, J INVEST DERMATOL, V110, P207, DOI 10.1046/j.1523-1747.1998.00129.x	31	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					120	129		10.1111/bjd.13374		10	Dermatology	Dermatology	AY7FK	WOS:000347726500020		
J	Furue, M; Onozuka, D; Takeuchi, S; Murota, H; Sugaya, M; Masuda, K; Hiragun, T; Kaneko, S; Saeki, H; Shintani, Y; Tsunemi, Y; Abe, S; Kobayashi, M; Kitami, Y; Tanioka, M; Imafuku, S; Abe, M; Inomata, N; Morisky, DE; Katoh, N				Furue, M.; Onozuka, D.; Takeuchi, S.; Murota, H.; Sugaya, M.; Masuda, K.; Hiragun, T.; Kaneko, S.; Saeki, H.; Shintani, Y.; Tsunemi, Y.; Abe, S.; Kobayashi, M.; Kitami, Y.; Tanioka, M.; Imafuku, S.; Abe, M.; Inomata, N.; Morisky, D. E.; Katoh, N.			Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							ACNE THERAPY; NONADHERENCE; PSORIASIS		[Furue, M.] Kyushu Univ, Dept Dermatol, Higashi Ku, Fukuoka 8128582, Japan; [Onozuka, D.] Kyushu Univ, Dept Hlth Serv Management & Policy, Higashi Ku, Fukuoka 8128582, Japan; [Takeuchi, S.] Hamanomachi Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Dermatol, Fukuoka, Japan; [Murota, H.] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Sugaya, M.] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan; [Masuda, K.; Katoh, N.] Kyoto Prefectural Univ Med, Dept Dermatol, Kyoto, Japan; [Hiragun, T.] Hiroshima Univ, Dept Dermatol, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Kaneko, S.] Shimane Univ, Dept Dermatol, Fac Med, Matsue, Shimane, Japan; [Saeki, H.] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan; [Shintani, Y.] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan; [Tsunemi, Y.] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Abe, S.] Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan; [Kobayashi, M.] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan; [Kitami, Y.] Showa Univ, Sch Med, Dept Dermatol, Tokyo 142, Japan; [Tanioka, M.] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Imafuku, S.] Fukuoka Univ, Fac Med, Dept Dermatol, Fukuoka 81401, Japan; [Abe, M.] Sapporo Skin Clin, Sapporo, Hokkaido, Japan; [Inomata, N.] Yokohama City Univ, Dept Environm Immunodermatol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Morisky, D. E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188			Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Aubert-Wastiaux H, 2011, BRIT J DERMATOL, V165, P808, DOI 10.1111/j.1365-2133.2011.10449.x; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Brown KK, 2006, J AM ACAD DERMATOL, V55, P607, DOI 10.1016/j.jaad.2005.12.021; Conlon NP, 2014, EUR J DERMATOL, V24, P385, DOI 10.1684/ejd.2014.2323; Reynolds K, 2014, QUAL LIFE RES, V23, P2109, DOI 10.1007/s11136-014-0662-3; Snyder S, 2014, AM J CLIN DERMATOL, V15, P87, DOI 10.1007/s40257-014-0063-y; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037//0021-9010.78.1.98; Dreno B, 2010, INT J DERMATOL, V49, P448, DOI 10.1111/j.1365-4632.2010.04416.x; Torrelo A, 2013, Actas Dermosifiliogr, V104, P409, DOI 10.1016/j.adengl.2013.04.004; Zschocke I, 2014, J EUR ACAD DERMATOL, V28, P4, DOI 10.1111/jdv.12445	12	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					272	275		10.1111/bjd.13377		4	Dermatology	Dermatology	AY7FK	WOS:000347726500042		
J	Ishii, N; Furumura, M; Hamada, T; Mori, O; Ohzono, A; Ueda, A; Karashima, T; Nakama, T; Tsuruta, D; Takedatsu, H; Fujita, H; Hashimoto, T				Ishii, N.; Furumura, M.; Hamada, T.; Mori, O.; Ohzono, A.; Ueda, A.; Karashima, T.; Nakama, T.; Tsuruta, D.; Takedatsu, H.; Fujita, H.; Hashimoto, T.			Oesophageal involvement in epidermolysis bullosa acquisita	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							VII COLLAGEN; DISEASE		[Ishii, N.; Furumura, M.; Hamada, T.; Mori, O.; Ohzono, A.; Ueda, A.; Karashima, T.; Nakama, T.; Hashimoto, T.] Kurume Univ, Dept Dermatol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Ishii, N.; Furumura, M.; Hamada, T.; Mori, O.; Ohzono, A.; Ueda, A.; Karashima, T.; Nakama, T.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan; [Tsuruta, D.] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 558, Japan; [Takedatsu, H.] Kurume Univ, Dept Internal Med, Sch Med, Kurume, Fukuoka 8300011, Japan; [Fujita, H.] Kurume Univ, Dept Surg, Sch Med, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Dept Dermatol, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp					Galloro G, 2005, DIGEST LIVER DIS, V37, P195, DOI 10.1016/j.dld.2004.10.005; Ludwig RJ, 2011, J INVEST DERMATOL, V131, P167, DOI 10.1038/jid.2010.248; Reddy H, 2013, CLIN EXP DERMATOL, V38, P225, DOI 10.1111/ced.12114; Kinoshita Y, 2011, J GASTROENTEROL, V46, P1092, DOI 10.1007/s00535-011-0429-3; Delgado L, 2011, CLIN EXP DERMATOL, V36, P12, DOI 10.1111/j.1365-2230.2010.03845.x; Ishii N, 2011, J PATHOL, V224, P234, DOI 10.1002/path.2857; MIYAGAWA S, 1992, BRIT J DERMATOL, V127, P172, DOI 10.1111/j.1365-2133.1992.tb08052.x; Taniuchi K, 1997, J AM ACAD DERMATOL, V36, P320, DOI 10.1016/S0190-9622(97)80408-2; WETZELS RHW, 1991, AM J PATHOL, V139, P451; Woodley DT, 2007, CLIN REV ALLERG IMMU, V33, P78, DOI 10.1007/s12016-007-0027-6	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					288	290		10.1111/bjd.13224		3	Dermatology	Dermatology	AY7FK	WOS:000347726500048		
J	Espana, A; Gimenez-Azcarate, A; Ishii, N; Idoate, MA; Panizo, C; Hashimoto, T				Espana, A.; Gimenez-Azcarate, A.; Ishii, N.; Idoate, M. A.; Panizo, C.; Hashimoto, T.			Antidesmocollin 1 autoantibody negative subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							BORTEZOMIB; REGIMEN		[Espana, A.; Gimenez-Azcarate, A.] Univ Navarra Clin, Sch Med, Dept Dermatol, Pamplona 31080, Spain; [Idoate, M. A.] Univ Navarra Clin, Sch Med, Dept Pathol, Pamplona 31080, Spain; [Panizo, C.] Univ Navarra Clin, Sch Med, Dept Haematol, Pamplona 31080, Spain; [Ishii, N.; Hashimoto, T.] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Ishii, N.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Espana, A (reprint author), Univ Navarra Clin, Sch Med, Dept Dermatol, POB 4209, Pamplona 31080, Spain.	aespana@unav.es					Adam Z, 2010, WIEN KLIN WOCHENSCHR, V122, P311, DOI 10.1007/s00508-010-1361-x; Taintor AR, 2007, J AM ACAD DERMATOL, V56, pS73, DOI 10.1016/j.jaad.2006.11.023; Tsuruta D, 2011, CLIN DERMATOL, V29, P437, DOI 10.1016/j.clindermatol.2011.01.014; Goldin LR, 2009, INT J CANCER, V124, P1497, DOI 10.1002/ijc.24141; Xu RC, 2013, EUR J DERMATOL, V23, P795, DOI 10.1684/ejd.2013.2177; Asahina A, 2013, BRIT J DERMATOL, V168, P213; BERNARD P, 1990, ANN DERMATOL VENER, V117, P890; Sung JY, 2012, J DERMATOL, V39, P881, DOI 10.1111/j.1346-8138.2012.01556.x; Szturz P, 2011, CL LYMPH MYELOM LEUK, V11, P517, DOI 10.1016/j.clml.2011.06.014; TAKATA M, 1994, DERMATOLOGY, V189, P111	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	JAN	2015	172	1					296	298		10.1111/bjd.13233		3	Dermatology	Dermatology	AY7FK	WOS:000347726500052		
J	Tominaga, Y; Akabayashi, S; Kitahara, T; Arinami, Y				Tominaga, Yoshihide; Akabayashi, Shin-ichi; Kitahara, Takuya; Arinami, Yuki			Air flow around isolated gable-roof buildings with different roof pitches: Wind tunnel experiments and CFD simulations	BUILDING AND ENVIRONMENT			English	Article						Gable roof; Roof pitch; Computational fluid dynamics (CFD); Wind tunnel experiment; Steady RANS	KAPPA-EPSILON-MODEL; TURBULENCE MODELS; STREET CANYONS; BOUNDARY-LAYER; BLUFF-BODY; PRESSURE; DISPERSION; PATTERNS; SHAPE; ENVIRONMENT	The air flow around isolated gable-roof buildings with different roof pitches was investigated by wind tunnel experiments and computational fluid dynamics (CFD) simulations based on a steady Reynoldsaveraged Navier Stokes equations (RANS) model. Firstly, wind tunnel experiments on the air flow around building models with three different pitches, specifically, 3:10, 5:10, and 7.5:10, were conducted to create a measurement database of the time-averaged velocity, turbulent kinetic energy, and pressure coefficient around the building. Next, sensitivity analyses for the grid resolutions and turbulence models of the CFD simulations were performed for the 5:10 roof pitch model. The performance of the CFD simulation with the selected grid resolution and turbulence model was examined and validated by comparing the results of the simulation with the measured data for all the roof pitches. Generally, for the streamwise velocity, the simulation results were found to be in good agreement with the measured values, with an average deviation of less than 15%. For points behind the building, however, the prediction accuracy showed as much as 30% deviation. This discrepancy was closely related to the fact that the transient fluctuations caused by vortex shedding around the building are not reproduced by the steady-RANS simulations used in this study. Finally, the effect of the roof pitch on the flow field around the building was investigated using the CFD simulations. We clarified that the difference in the flow fields of the 3:10 and 5:10 roof pitches is large, relative to the difference between the 5:10 and 7.5:10 pitches. (C) 2014 Elsevier Ltd. All rights reserved.	[Tominaga, Yoshihide; Kitahara, Takuya] Niigata Inst Technol, Dept Architecture & Bldg Engn, Fujihashi, Kashiwazaki 1719, Japan; [Akabayashi, Shin-ichi; Arinami, Yuki] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 8050, Japan	Tominaga, Y (reprint author), Niigata Inst Technol, Dept Architecture & Bldg Engn, Fujihashi, Kashiwazaki 1719, Japan.	tominaga@abe.niit.ac.jp	Tominaga, Yoshihide/P-4104-2014	Tominaga, Yoshihide/0000-0002-4329-0787	 [25420616]	The authors express their gratitude for the financial support of the Grants-in-Aid for Scientific Research in Japan (No. 25420616). The authors also thank Mr. Naoki Suda, undergraduate student of Niigata Institute of Technology, for his invaluable assistance with the experiments related to this study.	Briggen PM, 2009, BUILD ENVIRON, V44, P1675, DOI 10.1016/j.buildenv.2008.11.003; Tsuchiya M, 1997, J WIND ENG IND AEROD, V67-8, P169, DOI 10.1016/S0167-6105(97)00071-8; Kindangen J, 1997, BUILD ENVIRON, V32, P1, DOI 10.1016/S0360-1323(96)00021-2; SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T; Blocken B, 2007, ATMOS ENVIRON, V41, P238, DOI 10.1016/j.atmosenv.2006.08.019; Blocken B, 2012, ENVIRON MODELL SOFTW, V33, P1, DOI 10.1016/j.envsoft.2012.02.001; Takano Y, 2013, J WIND ENG IND AEROD, V123, P107, DOI 10.1016/j.jweia.2013.10.006; Montazeri H, 2013, BUILD ENVIRON, V60, P137, DOI 10.1016/j.buildenv.2012.11.012; Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P1749, DOI 10.1016/j.jweia.2008.02.058; MURAKAMI S, 1993, J WIND ENG IND AEROD, V46-7, P21, DOI 10.1016/0167-6105(93)90112-2; Yoshie R, 2007, J WIND ENG IND AEROD, V95, P1551, DOI 10.1016/j.jweia.2007.02.023; van Hooff T, 2011, BUILD ENVIRON, V46, P22, DOI 10.1016/j.buildenv.2010.06.013; Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P389, DOI 10.1016/j.jweia.2008.01.004; YAKHOT V, 1992, PHYS FLUIDS A-FLUID, V4, P1510, DOI 10.1063/1.858424; Kastner-Klein P, 1999, ATMOS ENVIRON, V33, P3973, DOI 10.1016/S1352-2310(99)00139-9; Kastner-Klein P, 2004, METEOROL ATMOS PHYS, V87, P121, DOI 10.1007/S00703-003-0065-4; Huang YD, 2009, BUILD ENVIRON, V44, P2335, DOI 10.1016/j.buildenv.2009.03.024; Tominaga Y, 2011, BUILD ENVIRON, V46, P899, DOI 10.1016/j.buildenv.2010.10.020; Ntinas GK, 2014, EUR J MECH B-FLUID, V43, P216, DOI 10.1016/j.euromechflu.2013.09.004; Rodi W, 1997, J WIND ENG IND AEROD, V71, P55; Blocken B, 2012, ENVIRON MODELL SOFTW, V30, P15, DOI 10.1016/j.envsoft.2011.11.009; Cebeci T., 1977, MOMENTUM TRANSFER BO; Franke J., 2007, BEST PRACTICE GUIDEL; Guirguis NM, 2007, DESALINATION, V209, P190, DOI 10.1016/j.desal.2007.04.028; KANDA M, 1993, J WIND ENG IND AEROD, V50, P173, DOI 10.1016/0167-6105(93)90072-V; Karava P, 2011, APPL THERM ENG, V31, P1950, DOI 10.1016/j.applthermaleng.2011.02.042; Kobayashi T, 2013, BUILD ENVIRON, V63, P20, DOI 10.1016/j.buildenv.2013.01.018; Launder B. E., 1972, MATH MODELS TURBULEN; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, DOI 10.1016/0045-7825(74)90029-2; LEE BE, 1984, BUILD ENVIRON, V19, P235, DOI 10.1016/0360-1323(84)90004-0; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Mirzaei P, 2013, PROG PHOTOVOLT RES A; MURAKAMI S, 1988, J WIND ENG IND AEROD, V31, P283, DOI 10.1016/0167-6105(88)90009-8; Oliveira PJ, 2000, J WIND ENG IND AEROD, V86, P203, DOI 10.1016/S0167-6105(00)00011-8; Rafailidis S, 1997, BOUND-LAY METEOROL, V85, P255, DOI 10.1023/A:1000426316328; RICHARDSON GM, 1991, J WIND ENG IND AEROD, V38, P249, DOI 10.1016/0167-6105(91)90045-X; Shklyar A, 2004, J WIND ENG IND AEROD, V92, P1039, DOI 10.1016/j.jweia.2004.05.008; Stathopoulos T, 2001, WIND STRUCT, V4, P119; TAYLOR DA, 1980, CAN J CIVIL ENG, V7, P1; Thiis TK, 1999, COLD REG SCI TECHNOL, V30, P175, DOI 10.1016/S0165-232X(99)00021-X	40	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-1323	1873-684X		BUILD ENVIRON	Build. Environ.	JAN	2015	84						204	213		10.1016/j.buildenv.2014.11.012		10	Construction & Building Technology; Engineering, Environmental; Engineering, Civil	Construction & Building Technology; Engineering	AZ9UG	WOS:000348559900021		
J	Nagata, C; Konishi, K; Tamura, T; Wada, K; Tsuji, M; Hayashi, M; Takeda, N; Yasuda, K				Nagata, Chisato; Konishi, Kie; Tamura, Takashi; Wada, Keiko; Tsuji, Michiko; Hayashi, Makoto; Takeda, Noriyuki; Yasuda, Keigo			Associations of Acrylamide Intake with Circulating Levels of Sex Hormones and Prolactin in Premenopausal Japanese Women	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							BREAST-CANCER; POSTMENOPAUSAL WOMEN; OVARIAN CANCERS; SWEDISH WOMEN; RISK; ENDOMETRIAL; COHORT; RATS; NUTRITION; EXPOSURE	Background: It has been hypothesized that alteration of hormone systems is involved in the carcinogenesis of acrylamide. The aim of the present study was to examine the cross-sectional associations between dietary acrylamide intake and sex hormone levels in premenopausal Japanese women. Methods: Study subjects were 393 women who had regular menstrual cycles less than 40 days long. Acrylamide intake was assessed with a food-frequency questionnaire and was based on acrylamide concentration reported from analyses of Japanese foods. We measured the plasma concentrations of estradiol, testosterone, dehydroepiandrosterone sulfate, sex hormone-binding globulin, follicle-stimulating hormone, luteinizing hormone, and prolactin. Results: After controlling for age, the phase of the menstrual cycle, and other covariates, acrylamide intake was statistically significantly inversely associated with total and free estradiol levels and statistically significantly positively associated with follicle-stimulating hormone level. Total and free estradiol levels were 18.2% and 19.3% lower, respectively, in women in the highest quartile of acrylamide intake than in those in the lowest quartile of intake. Follicle-stimulating hormone levels were 23.5% higher in women in the highest quartile of acrylamide intake than in those in the lowest quartile of intake. Conclusion: The data suggest that acrylamide intake may alter estradiol and follicle-stimulating hormone levels. Impact: High estradiol levels have been associated with an increased risk of breast cancer. Although the results need confirmation, they highlight the need to investigate the relationships among dietary acrylamide, sex hormones, and breast cancer risk. (C) 2014 AACR.	[Nagata, Chisato; Konishi, Kie; Tamura, Takashi; Wada, Keiko; Tsuji, Michiko] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu 5011194, Japan; [Tsuji, Michiko] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan; [Hayashi, Makoto; Yasuda, Keigo] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan; [Takeda, Noriyuki] Asahi Univ, Murakami Mem Hosp, Dept Endocrinol & Metab, Gifu, Japan	Nagata, C (reprint author), Gifu Univ, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	chisato@gifu-u.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan	This study was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to C. Nagata).	SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Wei QW, 2014, REPROD TOXICOL, V46, P121, DOI 10.1016/j.reprotox.2014.03.007; Nagata C, 2009, BRIT J NUTR, V101, P1427, DOI 10.1017/S0007114508083566; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Rinaldi S, 2006, CANCER CAUSE CONTROL, V17, P1033, DOI 10.1007/s10552-006-0041-7; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Nagata C, 2011, CANCER CAUSE CONTROL, V22, P581, DOI 10.1007/s10552-011-9731-x; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; Tsuji M, 2012, CANCER CAUSE CONTROL, V23, P683, DOI 10.1007/s10552-012-9935-8; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; Burley VJ, 2010, BRIT J CANCER, V103, P1749, DOI 10.1038/sj.bjc.6605956; Camacho L, 2012, TOXICOL LETT, V211, P135, DOI 10.1016/j.toxlet.2012.03.007; Cramer DW, 1983, JNCI-J NATL CANCER I, V71, P712; Hogervorst JG, 2013, CANCER EPIDEM BIOMAR, V22, P2024, DOI 10.1158/1055-9965.EPI-13-0509; Hogervorst JG, 2007, CANCER EPIDEM BIOMAR, V16, P2304, DOI 10.1158/1055-9965.EPI-07-0581; International Agency for Research on Cancer (IARC), 1994, MON EV CARC RISK HUM; Ishihara K, 2009, J COOKERY SCI JPN, V42, P32; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Larsson SC, 2009, CANCER EPIDEM BIOMAR, V18, P994, DOI 10.1158/1055-9965.EPI-08-0868; Lipworth L, 2012, EUR J CANCER PREV, V21, P375, DOI 10.1097/CEJ.0b013e3283529b64; Mannaa F, 2006, J APPL TOXICOL, V26, P198, DOI 10.1002/jat.1128; Matsuoka A, 2009, KASSUISYU KASSUI WOM, V52, P63; Matsuoka A, 2008, KASSUI WOMENS COLL, V51, P97; Mucci LA, 2005, JAMA-J AM MED ASSOC, V293, P1326, DOI 10.1001/jama.293.11.1326; Mukai N, 2004, NATL RES I BREWING, V176, P121; Olesen PT, 2008, INT J CANCER, V122, P2094, DOI 10.1002/ijc.23359; Ono H, 2003, FOOD ADDIT CONTAM, V20, P215, DOI 10.1080/0265203021000060887; Sasaki S, 1999, J Epidemiol, V9, P190; Shimizu H, 1999, JPN J CLIN ONCOL, V29, P38, DOI 10.1093/jjco/29.1.38; Takatsuki S, 2004, J FOOD HYG SOC JPN, V45, P44; Totani Nagao, 2007, J Oleo Sci, V56, P103; Tsutsumiuchi K, 2007, ANN REPORT RES I BIO, V7, P7; UPHOUSE LL, 1982, NEUROTOXICOLOGY, V3, P121; U.S. Food and Drug Administration, 2006 EXP ASS ACR; WHO, 2006, 64 WHO; Willett W, 1990, NUTR EPIDEMIOLOGY, P245; Wilson KM, 2010, CANCER EPIDEM BIOMAR, V19, P2503, DOI 10.1158/1055-9965.EPI-10-0391; Wilson KM, 2009, AM J EPIDEMIOL, V169, P951; Yokoyama R, 2011, B SHIZUOKA I ENV HYG, V54, P55; Yokoyama R, 2012, B SHIZUOKA I ENV HYG, V55, P55; Yoshida M, 2011, J JPN SOC FOOD SCI, V58, P525	42	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	JAN	2015	24	1					249	254		10.1158/1055-9965.EPI-14-0935		6	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	AZ1YG	WOS:000348030700029		
J	Ando, K; Oki, E; Saeki, H; Yan, Z; Tsuda, Y; Hidaka, G; Kasagi, Y; Otsu, H; Kawano, H; Kitao, H; Morita, M; Maehara, Y				Ando, Koji; Oki, Eiji; Saeki, Hiroshi; Yan, Zhao; Tsuda, Yasuo; Hidaka, Gen; Kasagi, Yuta; Otsu, Hajime; Kawano, Hiroyuki; Kitao, Hiroyuki; Morita, Masaru; Maehara, Yoshihiko			Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer	CANCER MEDICINE			English	Article						Gastric cancer; immunohistochemistry; mutation analysis; p53; staining pattern	HELICOBACTER-PYLORI INFECTION; EPITHELIAL-CELLS; GENE-MUTATIONS; LUNG-CANCER; CARCINOMA; PROTEIN; TP53; OVEREXPRESSION; METAANALYSIS; SUPPRESSOR	Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53. However, there are some discrepancies between the result of immunohistochemistry staining and mutation analysis. This study attempted to find a new definition of p53 staining by its staining pattern. Immunohistochemistry staining of p53 and TP53 gene mutation analysis were performed in 148 gastric cancer patients. Also SNP-CGH array analysis was conducted to four cases. Positive staining of p53 was observed in 88 (59.5%) tumors. Tumors with positive p53 staining showed malignant features compared to negative tumors. Mutation of TP53 gene was observed in 29 (19.6%) tumors with higher age and differentiated type. In positive p53 tumors, two types could be distinguished; aberrant type and scattered type. With comparison to TP53 gene mutation analysis, all the scattered type had wild-type TP53 gene (P = 0.0003). SNP-CGH array showed that scattered-type tumors had no change in the structure of chromosome 17. P53-scattered-type staining tumors may reflect a functionally active nonmutated TP53 gene. In interpretation of p53 immunohistochemistry staining, distinguishing p53-positive tumors by their staining pattern may be important in gastric cancer.	[Ando, Koji; Oki, Eiji; Saeki, Hiroshi; Yan, Zhao; Tsuda, Yasuo; Hidaka, Gen; Kasagi, Yuta; Otsu, Hajime; Kawano, Hiroyuki; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kitao, Hiroyuki] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Oki, E (reprint author), Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okieiji@surg2.med.kyushu-u.ac.jp					Ando K., 2013, GASTRIC CANCER, V17, P255; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Goncalves AR, 2011, PATHOL ONCOL RES, V17, P349, DOI 10.1007/s12253-010-9333-z; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Kirsch DG, 1998, J CLIN ONCOL, V16, P3158; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Umehara S, 2003, ONCOGENE, V22, P8337, DOI 10.1038/sj.onc.1207028; Egashira A, 2007, CANCER SCI, V98, P1152, DOI 10.1111/j.1349-7006.2007.00524.x; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; HALL PA, 1994, J PATHOL, V172, P1, DOI 10.1002/path.1711720103; Mitsudomi T, 2000, CLIN CANCER RES, V6, P4055; BAAS IO, 1994, J PATHOL, V172, P5, DOI 10.1002/path.1711720104; BURNS JS, 1992, MOL CARCINOGEN, V6, P129, DOI 10.1002/mc.2940060208; Calzolari A, 1997, AM J CLIN PATHOL, V107, P7; Elledge R. M., 1994, CANC RES; HURLIMANN J, 1994, MODERN PATHOL, V7, P423; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KAKEJI Y, 1993, BRIT J CANCER, V67, P589, DOI 10.1038/bjc.1993.108; Kaserer K, 2000, J PATHOL, V190, P450; Kato S., 2003, P NATL ACAD SCI US; LEHMAN TA, 1991, CANCER RES, V51, P4090; Matysiak-Budnik T, 2006, EUR J CANCER, V42, P708, DOI 10.1016/j.ejca.2006.01.020; Murakami K, 1999, SCAND J GASTROENTERO, V34, P474, DOI 10.1080/003655299750026191; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Oki E, 2009, DIGESTION, V79, P33, DOI 10.1159/000167864; Oki E, 2005, CANCER LETT, V227, P33, DOI 10.1016/j.canlet.2004.12.006; Rodrigues N. R., 1990, P NATL ACAD SCI USA; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Wei Jinxiong, 2008, Gastroenterology, V134, P1412, DOI 10.1053/j.gastro.2008.01.072; Zha Y, 2012, HEPATO-GASTROENTEROL, V59, P1327, DOI 10.5754/hge12204	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JAN	2015	4	1					75	83		10.1002/cam4.346		9	Oncology	Oncology	AZ4YH	WOS:000348226600009		
J	Ema, A; Waraya, M; Yamashita, K; Kokubo, K; Kobayashi, H; Hoshi, K; Shinkai, Y; Kawamata, H; Nakamura, K; Nishimiya, H; Katada, N; Watanabe, M				Ema, Akira; Waraya, Mina; Yamashita, Keishi; Kokubo, Kenichi; Kobayashi, Hirosuke; Hoshi, Keika; Shinkai, Yoshiko; Kawamata, Hiroshi; Nakamura, Kazunori; Nishimiya, Hiroshi; Katada, Natsuya; Watanabe, Masahiko			Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer	CANCER MEDICINE			English	Article						EGFR; gastric cancer; metastatic lymph node density; S-1 chemotherapy	SQUAMOUS-CELL CARCINOMA; INDEPENDENT PROGNOSTIC-FACTORS; TUMOR-SUPPRESSIVE ACTIVITY; GENE COPY NUMBER; PHASE-II TRIAL; GASTROESOPHAGEAL JUNCTION; COLORECTAL-CANCER; LUNG-CANCER; EXTENDED LYMPHADENECTOMY; ADJUVANT CHEMOTHERAPY	Metastatic lymph node density (ND) has been reproducibly proven to be a prognostic factor in gastric cancer. The molecular mechanisms that underlie this aggressiveness are underexplored. Here, we aimed to identify molecules associated with this unique phenotype. Tumor specimens from patients with stage III gastric cancer with high or low ND (n = 4 for both) were compared at the mRNA level using Affymetrix microarray (harboring 54,675 genes). The expression data were prioritized, and genes that correlated with ND were selected. Ultimately, the EGFR was validated as such a candidate molecule in patients with primary advanced gastric cancer who underwent standard treatment (n = 167). Expression data of the microarray were prioritized based on gene expression ratio and frequency of gene expression. The first priority genes to be selected were genes that are known to be amplified in cancer, which included NKX2.1, CHST9, CTNND2, SLC25A27, FGFR2, EGFR, and PTGER1. Of these genes, the EGFR gene was of particular interest. EGFR expression in primary gastric cancer was examined using immunohistochemistry (IHC). The Student's t-test elucidated a significant difference in EGFR expression between IHC 2+/3+ and IHC 1+ according to ND (P = 0.0035). The Chi-square test also indicated a significant difference between high and low levels of EGFR immunohistochemical staining (IHC2+/3+ and IHC1+, respectively) and ND status (P = 0.0023). According to the least squares method, as ND increased, the risk that EGFR staining levels changed from IHC 1+ to IHC 2+ also increased. In this study, we determined that high EGFR expression may underlie the aggressive mechanism of advanced gastric cancer with high ND.	[Ema, Akira; Waraya, Mina; Yamashita, Keishi; Kawamata, Hiroshi; Nakamura, Kazunori; Nishimiya, Hiroshi; Katada, Natsuya; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Kokubo, Kenichi; Kobayashi, Hirosuke] Kitasato Univ, Sch Allied Hlth Sci, Dept Med Engn & Technol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Hoshi, Keika; Shinkai, Yoshiko] Kitasato Univ, Sch Med, Dept Prevent Med, Kitasato Clin Res Ctr,Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Watanabe, M (reprint author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	gekaw@med.kitasato-u.ac.jp					Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Park SR, 2010, CANCER CHEMOTH PHARM, V65, P579, DOI 10.1007/s00280-009-1067-9; Espin F, 2012, EJSO-EUR J SURG ONC, V38, P497, DOI 10.1016/j.ejso.2012.01.012; Wainberg ZA, 2011, BRIT J CANCER, V105, P760, DOI 10.1038/bjc.2011.280; Ema A, 2014, GASTRIC CANCER, V17, P67, DOI 10.1007/s10120-013-0253-y; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Ooki A, 2007, WORLD J SURG, V31, P2184, DOI 10.1007/s00268-007-9198-9; Sasako M, 2007, DIGEST SURG, V24, P101, DOI 10.1159/000101896; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Vergara-Lluri ME, 2012, MODERN PATHOL, V25, P1326, DOI 10.1038/modpathol.2012.93; HIRONO Y, 1995, ONCOLOGY, V52, P182; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dragovich T, 2006, J CLIN ONCOL, V24, P4922, DOI 10.1200/JCO.2006.07.1316; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Yamashita K, 2008, MOL CANCER RES, V6, P31, DOI 10.1158/1541-7786.MCR-07-0213; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Yamashita K, 2007, ANTICANCER RES, V27, P4381; Bogoevski D., 2008, ANN SURG; Chen Y, 2007, INT J CANCER, V121, P1021, DOI 10.1002/ijc.22753; Deng JY, 2012, ANN SURG, V256, pE35, DOI 10.1097/SLA.0b013e3182769545; Foundation for Promotion of Cancer Research, 2011, CANC STAT JAP 2010; Fukuda K, 2012, INT J ONCOL, V40, P975, DOI 10.3892/ijo.2011.1279; Hirao T, 1999, CANCER GENE THER, V6, P423, DOI 10.1038/sj.cgt.7700058; Huang FY, 2006, GYNECOL ONCOL, V103, P219, DOI 10.1016/j.ygyno.2006.02.028; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Nagatsuma AK, 2014, GASTRIC CANC; Ooki A, 2008, ANTICANCER RES, V28, P2875; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Wang T, 2009, ONCOGENE, V28, P555, DOI 10.1038/onc.2008.399; Yamashita K., 2008, LYMPH NODE METASTASI; Zhao XS, 2010, CANCER GENET CYTOGEN, V203, P176, DOI 10.1016/j.cancergencyto.2010.07.132	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JAN	2015	4	1					90	100		10.1002/cam4.311		11	Oncology	Oncology	AZ4YH	WOS:000348226600011		
J	Narimatsu, T; Matsuura, K; Nakada, C; Tsukamoto, Y; Hijiya, N; Kai, T; Inoue, T; Uchida, T; Nomura, T; Sato, F; Seto, M; Takeuchi, I; Mimata, H; Moriyama, M				Narimatsu, Takahiro; Matsuura, Keiko; Nakada, Chisato; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Kai, Tomoki; Inoue, Toru; Uchida, Tomohisa; Nomura, Takeo; Sato, Fuminori; Seto, Masao; Takeuchi, Ichiro; Mimata, Hiromitsu; Moriyama, Masatsugu			Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma	CANCER MEDICINE			English	Article						9p; array CGH; kidney cancer; metastasis; NDUFB6	COMPARATIVE GENOMIC HYBRIDIZATION; COMPLEX I; CHROMOSOME 9P; ALLELIC LOSS; EXPRESSION; IDENTIFICATION; DISEASE; PROTEIN; CANCER	This study was conducted to clarify the genomic profiles of metastatic clear cell renal cell carcinomas (ccRCCs) and identify the genes responsible for development of metastasis. We analyzed the genomic profiles of 20 cases of primary ccRCC and their corresponding metastases using array-based comparative genomic hybridization, and identified 32 chromosomal regions in which gene copy number alterations were detected more frequently in metastases than in the primary tumors. Among these 32 regions, 9p24.1-p13.3 loss was the most statistically significant alteration. Furthermore, we found that patients with 9p24.1-p13.3 loss in primary tumors exhibited significantly lower rates of recurrence- free and cancer-specific survival, suggesting that 9p loss in the primary tumor is a potential biomarker predicting early recurrence of metastasis. Interestingly, the genomic profiles of primary tumors with 9p loss resembled those of their corresponding metastases, though 9p loss was accumulated in the metastases derived from the primary tumors without 9p loss. Comparison of the mRNA expression levels revealed that 2 of 58 genes located at 9p24.1-p13.3 were downregulated due to gene copy number loss in ccRCCs. An overexpression study of these two genes in ccRCC cell lines revealed that downregulation of NDUFB6 due to loss at 9p24.1-p13.3 may confer a growth advantage on metastatic ccRCC cells. These results were confirmed by analyzing the data of 405 cases of ccRCC obtained from The Cancer Genome Atlas (TCGA). On the basis of our present data, we propose that NDUFB6 is a possible tumor suppressor of metastatic ccRCCs.	[Narimatsu, Takahiro; Matsuura, Keiko; Nakada, Chisato; Tsukamoto, Yoshiyuki; Hijiya, Naoki; Kai, Tomoki; Uchida, Tomohisa; Moriyama, Masatsugu] Oita Univ, Dept Mol Pathol, Fac Med, Yufu City, Oita 8795593, Japan; [Narimatsu, Takahiro; Kai, Tomoki; Inoue, Toru; Nomura, Takeo; Sato, Fuminori; Mimata, Hiromitsu] Oita Univ, Dept Urol, Fac Med, Yufu City, Oita 8795593, Japan; [Seto, Masao] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan	Matsuura, K (reprint author), Oita Univ, Dept Mol Pathol, Fac Med, Yufu City, Oita 8795593, Japan.	matsuura@oita-u.ac.jp; mmoriyam@oita-u.ac.jp			Japanese Ministry of Education, Culture, Sports Science and Technology [24590416]	This work was supported in part by Grants-in-Aid for Scientific Research (to M. M.; no. 24590416) from the Japanese Ministry of Education, Culture, Sports Science and Technology.	Schraml P, 2001, AM J PATHOL, V158, P593, DOI 10.1016/S0002-9440(10)64001-1; Bissig H, 1999, AM J PATHOL, V155, P267, DOI 10.1016/S0002-9440(10)65120-6; Inoue T, 2012, CANCER SCI, V103, P569, DOI 10.1111/j.1349-7006.2011.02176.x; Albracht SPJ, 2011, J BIOENERG BIOMEMBR, V43, P541, DOI 10.1007/s10863-011-9381-4; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Junker K, 2004, EUR UROL, V45, P320, DOI 10.1016/j.eururo.2003.11.017; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Ghosh A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1051, DOI 10.1134/S0006297911090100; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Dieteren CEJ, 2011, BBA-BIOENERGETICS, V1807, P1624, DOI 10.1016/j.bbabio.2011.09.013; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Ikuerowo SO, 2007, EUR UROL, V51, P732, DOI 10.1016/j.eururo.2006.08.010; Junker K, 2000, INT J ONCOL, V17, P903; Junker K, 2003, ONCOL REP, V10, P1035; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Loublier S, 2011, BIOCHEM BIOPH RES CO, V414, P367, DOI 10.1016/j.bbrc.2011.09.078; Matsuura K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-523; Moch H, 1996, CANCER RES, V56, P27; Sanjmyatav J, 2011, J UROLOGY, V186, P2078, DOI 10.1016/j.juro.2011.06.050; Schraml P, 2000, J PATHOL, V190, P457, DOI 10.1002/(SICI)1096-9896(200003)190:4<457::AID-PATH551>3.0.CO;2-C; Shomori K, 2007, MODERN PATHOL, V20, P199, DOI 10.1038/modpathol.3800730; Tanaka T, 1999, ONCOGENE, V18, P3793, DOI 10.1038/sj.onc.1202707; Yoshimoto T, 2007, J PATHOL, V213, P392, DOI 10.1002/path.2239	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JAN	2015	4	1					112	124		10.1002/cam4.351		13	Oncology	Oncology	AZ4YH	WOS:000348226600014		
J	Fukagawa, A; Ishii, H; Miyazawa, K; Saitoh, M				Fukagawa, Akihiko; Ishii, Hiroki; Miyazawa, Keiji; Saitoh, Masao			delta EF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells	CANCER MEDICINE			English	Article						Cancer cells; DNA methylation; E-cadherin; EMT; delta EF1	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; BINDING; MARKERS; COMPLEX; LINES	Abnormal DNA methylation at the C-5 position of cytosine (5mC) of CpG dinucleotides is a well-known epigenetic feature of cancer. Levels of E-cadherin, which is regularly expressed in epithelial tissues, are frequently reduced in epithelial tumors due to transcriptional repression, sometimes accompanied by hypermethylation of the promoter region. delta EF1 family proteins (delta EF1/ZEB1 and SIP1/ZEB2), key regulators of the epithelial-mesenchymal transition (EMT), suppress E-cadherin expression at the transcriptional level. We recently showed that levels of mRNAs encoding delta EF1 proteins are regulated reciprocally with E-cadherin level in breast cancer cells. Here, we examined the mechanism underlying downregulation of E-cadherin expression in three basal-type breast cancer cells in which the E-cadherin promoter region is hypermethylated (Hs578T) or moderately methylated (BT549 and MDA-MB-231). Regardless of methylation status, treatment with 5-aza-2'-deoxycytidine (5-aza), which inhibits DNA methyltransferases, had no effect on E-cadherin expression. Knockdown of delta EF1 and SIP1 resulted in recovery of E-cadherin expression in cells lacking hypermethylation, whereas combined treatment with 5-aza synergistically restored E-cadherin expression, especially when the E-cadherin promoter was hypermethylated. Moreover, delta EF1 interacted with DNA methyltransferase 1 (DNMT1) through the Smad-binding domain. Sustained knockdown of delta EF1 family proteins reduced the number of 5mC sites in the E-cadherin promoter region, suggesting that these proteins maintain 5mC through interaction with DNMT1 in breast cancer cells. Thus, delta EF1 family proteins appear to repress expression of E-cadherin during cancer progression, both directly at the transcriptional level and indirectly at the epigenetic level.	[Fukagawa, Akihiko; Ishii, Hiroki; Miyazawa, Keiji; Saitoh, Masao] Univ Yamanashi, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; [Fukagawa, Akihiko] Univ Yamanashi, Res Training Program Undergrad, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan	Saitoh, M (reprint author), Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	msaitoh-ind@umin.ac.jp			JSPS KAKENHI [24390419]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by JSPS KAKENHI Grant Number 24390419, JSPS Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling", and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan.	Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Singh V, 2013, CURR CANCER DRUG TAR, V13, P379; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Tatematsu K, 2000, GENES CELLS, V5, P677, DOI 10.1046/j.1365-2443.2000.00359.x; Li DQ, 2012, CANCER RES, V72, P387, DOI 10.1158/0008-5472.CAN-11-2345; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Espada J, 2011, NUCLEIC ACIDS RES, V39, P9194, DOI 10.1093/nar/gkr658; Ringnér Markus, 2013, Methods Mol Biol, V973, P279, DOI 10.1007/978-1-62703-281-0_18; Yiwei L., 2014, CURR PHARM DESIGN, V20, P1698	19	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	JAN	2015	4	1					125	135		10.1002/cam4.347		11	Oncology	Oncology	AZ4YH	WOS:000348226600015		
J	Tada, M; Uruga, T; Iwasawa, Y				Tada, Mizuki; Uruga, Tomoya; Iwasawa, Yasuhiro			Key Factors Affecting the Performance and Durability of Cathode Electrocatalysts in Polymer Electrolyte Fuel Cells Characterized by In Situ Real Time and Spatially Resolved XAFS Techniques	CATALYSIS LETTERS			English	Article						Time-resolved XAFS; Spatially resolved XAFS; Laminography-XAFS; Nano-XAFS; In situ	OXYGEN REDUCTION REACTION; ABSORPTION FINE-STRUCTURE; EXCHANGE MEMBRANE; PT/C CATHODE; PLATINUM NANOPARTICLES; CATALYST DEGRADATION; BIMETALLIC SURFACES; WATER TRANSPORT; LIQUID WATER; CO	The account article treats with the characterizations of the structural and electronic transformations of Pt/C, Pt3Co/C, and Pt3Ni/C cathode electrocatalysts in polymer electrolyte fuel cells (PEFCs) involving Pt charging/discharging, Pt-O bond formation/breaking, and Pt-Pt bond breaking/reformation in cathode potential-jump processes and the rate constants of those transformations in the surface reaction sequences on the cathode electrocatalysts by in situ time-resolved X-ray absorption fine structure (XAFS) method. Spatially heterogeneous issue and mechanism for the Pt oxidation and degradation of Pt/C cathode electrocatalyst layers in PEFCs under the operating conditions, which should be uncovered for development of next-generation PEFCs, were also characterized by a scanning nano-XAFS mapping method and a laminography-XAFS method, respectively for 2D and 3D visualizations of Pt chemical species in Pt/C cathode electrocatalyst layers. These XAFS techniques provided new insights into critical issues affecting the performance and property of practical PEFCs under the operating conditions.	[Tada, Mizuki] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Uruga, Tomoya] Spring 8, JASRI, Sayo, Hyogo 6795198, Japan; [Uruga, Tomoya; Iwasawa, Yasuhiro] Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan	Tada, M (reprint author), Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	mtada@chem.nagoya-u.ac.jp; iwasawa@pc.uec.ac.jp					Heggen M, 2012, J PHYS CHEM C, V116, P19073, DOI 10.1021/jp306426a; Mayrhofer KJJ, 2008, J POWER SOURCES, V185, P734, DOI 10.1016/j.jpowsour.2008.08.003; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Yamamoto T, 2007, ANGEW CHEM INT EDIT, V46, P9253, DOI 10.1002/anie.200703085; Sinha PK, 2007, J MATER CHEM, V17, P3089, DOI 10.1039/b703485g; Matanovic I, 2011, J PHYS CHEM C, V115, P10640, DOI 10.1021/jp111930w; Carlton CE, 2012, J PHYS CHEM LETT, V3, P161, DOI 10.1021/jz2016022; Singh J, 2010, CHEM SOC REV, V39, P4754, DOI 10.1039/c0cs00054j; Kitchin JR, 2004, J CHEM PHYS, V120, P10240, DOI 10.1063/1.1737365; Burlatsky SF, 2011, J ELECTROCHEM SOC, V158, pB322, DOI 10.1149/1.3532956; Kramer D, 2005, ELECTROCHIM ACTA, V50, P2603, DOI 10.1016/j.electacta.2004.11.005; Healy J, 2005, FUEL CELLS, V5, P302, DOI 10.1002/fuce.200400050; Arlt T, 2013, J POWER SOURCES, V221, P210, DOI 10.1016/j.jpowsour.2012.08.038; Callejas-Tovar R, 2008, SURF SCI, V602, P3531, DOI 10.1016/j.susc.2008.09.023; Suzuki A, 2003, ANGEW CHEM INT EDIT, V42, P4795, DOI 10.1002/anie.200352318; Markovic NM, 2001, FUEL CELLS, V1, P105, DOI 10.1002/1615-6854(200107)1:2<105::AID-FUCE105>3.0.CO;2-9; Koh S, 2007, ELECTROCHIM ACTA, V52, P2765, DOI 10.1016/j.electacta.2006.08.039; Xu Y, 2004, J AM CHEM SOC, V126, P4717, DOI 10.1021/ja031701+; Helfen L, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3596566; Mun BS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126662; Ishiguro N, 2012, ACS CATAL, V2, P1319, DOI 10.1021/cs300228p; ASAKURA K, 1990, J AM CHEM SOC, V112, P3242, DOI 10.1021/ja00164a072; Chen S, 2009, J PHYS CHEM C, V113, P1109, DOI 10.1021/jp807143e; Bi W, 2007, ELECTROCHEM SOLID ST, V10, pB101, DOI 10.1149/1.2712796; Friebel D, 2011, PHYS CHEM CHEM PHYS, V13, P262, DOI 10.1039/c0cp01434f; Paulus UA, 2002, J PHYS CHEM B, V106, P4181, DOI 10.1021/jp013442l; Ishiguro N, 2013, PHYS CHEM CHEM PHYS, V15, P18827, DOI 10.1039/c3cp52578c; Uemura Y, 2011, J PHYS CHEM C, V115, P5823, DOI 10.1021/jp111286b; Xin HL, 2012, NANO LETT, V12, P490, DOI 10.1021/nl203975u; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Perez-Alonso FJ, 2011, J POWER SOURCES, V196, P6085, DOI 10.1016/j.jpowsour.2011.03.064; Ishiguro N, 2014, J PHYS CHEM C, V118, P15874, DOI 10.1021/jp504738p; Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476; Yu Y, 2012, J POWER SOURCES, V205, P10, DOI 10.1016/j.jpowsour.2012.01.059; Christensen ST, 2009, SMALL, V5, P750, DOI 10.1002/smll.200801920; Tada M, 2007, ANGEW CHEM INT EDIT, V46, P4310, DOI 10.1002/anie.200604732; Suzuki A, 2004, J PHYS CHEM B, V108, P5609, DOI 10.1021/jp030854g; Fluckiger R, 2011, ELECTROCHIM ACTA, V56, P2254, DOI 10.1016/j.electacta.2010.12.016; Menning CA, 2006, J PHYS CHEM B, V110, P15471, DOI 10.1021/jp061697z; Inukai J, 2008, ANGEW CHEM INT EDIT, V47, P2792, DOI 10.1002/anie.200705516; Stamenkovic V, 2006, ANGEW CHEM INT EDIT, V45, P2897, DOI 10.1002/anie.200504386; Perez-Alonso FJ, 2012, ANGEW CHEM INT EDIT, V51, P4641, DOI 10.1002/anie.201200586; Nagasawa K, 2014, PHYS CHEM CHEM PHYS, V16, P10075, DOI 10.1039/c3cp54457e; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Owejan JP, 2007, INT J HYDROGEN ENERG, V32, P4489, DOI 10.1016/j.ijhydene.2007.05.044; Weckhuysen BM, 2003, PHYS CHEM CHEM PHYS, V5, P4351, DOI 10.1039/b309650p; Lamy C, 2004, ELECTROCHIM ACTA, V49, P3901, DOI 10.1016/j.electacta.2004.01.078; MUKERJEE S, 1993, J ELECTROANAL CHEM, V357, P201, DOI 10.1016/0022-0728(93)80380-Z; Choi KS, 2012, FUEL CELLS, V12, P908, DOI 10.1002/fuce.201200035; Manke I, 2010, FUEL CELLS, V10, P26, DOI 10.1002/fuce.200800123; Nesselberger M, 2011, J AM CHEM SOC, V133, P17428, DOI 10.1021/ja207016u; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Nagamatsu S, 2013, J PHYS CHEM C, V117, P13094, DOI 10.1021/jp402438e; Sasabe T, 2011, ELECTROCHEM COMMUN, V13, P638, DOI 10.1016/j.elecom.2011.03.033; Zhang JX, 2007, J ELECTROCHEM SOC, V154, pB1006, DOI 10.1149/1.2764240; Tada M, 2010, PHYS CHEM CHEM PHYS, V12, P5701, DOI 10.1039/c000843p; Uemura Y, 2011, PHYS CHEM CHEM PHYS, V13, P15833, DOI 10.1039/c1cp20994a; Russell AE, 2004, CHEM REV, V104, P4613, DOI 10.1021/cr020708r; Yu YC, 2012, NANO LETT, V12, P4417, DOI 10.1021/nl203920s; Feindel KW, 2004, J AM CHEM SOC, V126, P11436, DOI 10.1021/ja0461116; Harasse S, 2011, OPT EXPRESS, V19, P16560, DOI 10.1364/OE.19.016560; Helfen L, 2005, APPL PHYS LETT, V86, P1; Houchins Cassidy, 2012, Membranes (Basel), V2, P855, DOI 10.3390/membranes2040855; Ishiguro N, 2014, CHEMPHYSCHEM, V15, P1563, DOI 10.1002/cphc.201400090; IWASAWA Y, 1985, Z PHYS CHEM NEUE FOL, V144, P105; Iwasawa Y., 1996, XRAY ABSORPTION FINE; Iwasawa Y, 2003, J CATAL, V216, P165, DOI 10.1016/S0021-9517(02)00138-0; Kityakarn S, 2014, TOP CATAL, V57, P903, DOI 10.1007/s11244-014-0250-3; Manke I, 2007, APPL PHYS LETT, V90, P1; Promfret MB, 2007, ANAL CHEM, V79, P2367; Rice C, 2000, J PHYS CHEM B, V104, P5803, DOI 10.1021/jp0007179; Saida T., 2012, ANGEW CHEM, V124, P10457; Sekizawa O, 2013, J PHYS C SER, V430; Tada M, 2011, PHYS CHEM CHEM PHYS, V13, P14910, DOI 10.1039/c1cp20895k; Takao S, 2014, ANGEW CHEM INT EDIT, V53, P14110, DOI 10.1002/anie.201408845; Tsuji T, 2013, J PHYS C SER, V430; Yamaguchi A, 2000, CATAL LETT, V68, P139, DOI 10.1023/A:1019020528353; Yamaguchi A, 2001, CATAL LETT, V71, P203, DOI 10.1023/A:1009015523732; Yu P, 2005, J POWER SOURCES, V144, P11, DOI 10.1016/j.jpowsour.2004.11.067	80	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	JAN	2015	145	1					58	70		10.1007/s10562-014-1428-9		13	Chemistry, Physical	Chemistry	AY7BT	WOS:000347717000006		
J	Ma, D; Kamer, P; Perez-Ramirez, J; Tanaka, T				Ma, Ding; Kamer, Paul; Perez-Ramirez, Javier; Tanaka, Tsunehiro			Catalysis Science & Technology - five years in 2015	CATALYSIS SCIENCE & TECHNOLOGY			English	Editorial Material									[Ma, Ding] Peking Univ, Beijing, Peoples R China; [Kamer, Paul] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland; [Perez-Ramirez, Javier] Swiss Fed Inst Technol, Zurich, Switzerland; [Tanaka, Tsunehiro] Kyoto Univ, Kyoto 6068501, Japan	Ma, D (reprint author), Peking Univ, Beijing, Peoples R China.							0	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					21	23		10.1039/c4cy90064b		3	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200001		
J	Navlani-Garcia, M; Martis, M; Lozano-Castello, D; Cazorla-Amoros, D; Mori, K; Yamashita, H				Navlani-Garcia, M.; Martis, M.; Lozano-Castello, D.; Cazorla-Amoros, D.; Mori, K.; Yamashita, H.			Investigation of Pd nanoparticles supported on zeolites for hydrogen production from formic acid dehydrogenation	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							ION-EXCHANGED ZEOLITES; PREFERENTIAL OXIDATION; EFFICIENT CATALYST; SURFACE-AREA; STORAGE; DECOMPOSITION; ADSORPTION; BETA; GAS; CO	Catalysts based on palladium nanoparticles supported on different zeolites (BETA, ZSM-5 and Y) were prepared and their catalytic performance in formic acid dehydrogenation was studied. The effects of the zeolite structure and porous texture on the catalytic activity were investigated by comparing the behaviour of these samples. The results revealed that the samples based on BETA zeolite are promising catalysts for this application.	[Navlani-Garcia, M.; Lozano-Castello, D.; Cazorla-Amoros, D.] Univ Alicante, Dept Quim Inorgan, E-03080 Alicante, Spain; [Navlani-Garcia, M.; Lozano-Castello, D.; Cazorla-Amoros, D.] Univ Alicante, Inst Univ Mat, E-03080 Alicante, Spain; [Martis, M.; Mori, K.; Yamashita, H.] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Mori, K.; Yamashita, H.] Kyoto Univ, ESICB, Kyoto 6158520, Japan	Navlani-Garcia, M (reprint author), Univ Alicante, Dept Quim Inorgan, Ap 99, E-03080 Alicante, Spain.	d.lozano@ua.es; yamashita@mat.eng.osaka-u.ac.ps	Cazorla-Amoros, Diego/A-3967-2008; 	Cazorla-Amoros, Diego/0000-0001-5745-4271	Ministerio de Economia y Competitividad; GV; FEDER [CTQ2012/31762, PROMETEOII/2014/010]; University of Alicante; Japan Society for the Promotion of Science (JSPS)	The authors would like to acknowledge the Ministerio de Economia y Competitividad, GV and FEDER (CTQ2012/31762 and PROMETEOII/2014/010) for the financial support. Miriam Navlani-Garcia thanks the University of Alicante for the PhD studentship. Martin Martis thanks the Japan Society for the Promotion of Science (JSPS) for the fellowship.	NEWSAM JM, 1988, P ROY SOC LOND A MAT, V420, P375, DOI 10.1098/rspa.1988.0131; Weir MG, 2010, LANGMUIR, V26, P1137, DOI 10.1021/la902233h; Mendez JAO, 2014, APPL CATAL B-ENVIRON, V147, P439, DOI 10.1016/j.apcatb.2013.09.029; Adak L, 2009, J ORG CHEM, V74, P3982, DOI 10.1021/jo9003037; Mori K, 2013, ACS CATAL, V3, P1114, DOI 10.1021/cs400148n; Corma A, 2008, CHEM MATER, V20, P3218, DOI [10.1021/cm8002244, 10.1021/cmS002244]; Bordiga S, 1997, J CHEM SOC FARADAY T, V93, P3893, DOI 10.1039/a703262e; Rowsell JLC, 2005, ANGEW CHEM INT EDIT, V44, P4670, DOI 10.1002/anie.200462786; Niembro S, 2008, ORG LETT, V10, P3215, DOI 10.1021/ol801091u; Jorda-Beneyto M, 2007, CARBON, V45, P293, DOI 10.1016/j.carbon.2006.09.022; Budd PM, 2007, PHYS CHEM CHEM PHYS, V9, P1802, DOI 10.1039/b618053a; Cuevas F, 2012, PHYS CHEM CHEM PHYS, V14, P1200, DOI 10.1039/c1cp23030a; Uberman PM, 2012, J MOL CATAL A-CHEM, V363, P245, DOI 10.1016/j.molcata.2012.06.016; Lu P, 1999, J PHYS CHEM B, V103, P9673, DOI 10.1021/jp992177p; Tozzini V, 2013, PHYS CHEM CHEM PHYS, V15, P80, DOI 10.1039/c2cp42538f; Bogdanovic B, 2002, J ALLOY COMPD, V345, P77, DOI 10.1016/S0925-8388(02)00308-0; Dalebrook AF, 2013, CHEM COMMUN, V49, P8735, DOI 10.1039/c3cc43836h; Martis M, 2013, J PHYS CHEM C, V117, P22805, DOI 10.1021/jp4069027; Rubasinghege G, 2013, J PHYS CHEM A, V117, P11316, DOI 10.1021/jp408169w; Germain J, 2007, J MATER CHEM, V17, P4989, DOI 10.1039/b711509a; Tedsree K, 2011, NAT NANOTECHNOL, V6, P302, DOI [10.1038/nnano.2011.42, 10.1038/NNANO.2011.42]; Cejka J, 2012, CATAL TODAY, V179, P2, DOI 10.1016/j.cattod.2011.10.006; Ping Y, 2013, J MATER CHEM A, V1, P12188, DOI 10.1039/c3ta12724a; Lee H, 2005, NATURE, V434, P743, DOI 10.1038/nature03457; Sponholz P, 2013, CHEMSUSCHEM, V6, P1172, DOI 10.1002/cssc.201300186; Park JY, 2009, CATAL LETT, V129, P1, DOI 10.1007/s10562-009-9871-8; Farrauto R, 2003, ANNU REV MATER RES, V33, P1, DOI 10.1146/annurev.matsci.33.022802.091348; Pan L, 2004, J AM CHEM SOC, V126, P1308, DOI 10.1021/ja0392871; Anderson R, 2007, LANGMUIR, V23, P3440, DOI 10.1021/la063189m; Nielsen M, 2013, NATURE, V495, P85, DOI 10.1038/nature11891; Panella B, 2005, CARBON, V43, P2209, DOI 10.1016/j.carbon.2005.03.037; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Jae J, 2014, CHEMCATCHEM, V6, P508, DOI 10.1002/cctc.201300978; Kovtunov KV, 2010, CHEM COMMUN, V46, P5764, DOI 10.1039/c0cc01411g; Bae D, 2008, J PHYS CHEM SOLIDS, V69, P1152, DOI 10.1016/j.jpcs.2007.10.068; Contreras-Caceres R, 2009, ADV FUNCT MATER, V19, P3070, DOI 10.1002/adfm.200900481; Djega-Mariadassou G., 1984, KINETICS HETEROGENEO; Dominguez-Dominguez S, 2006, J CATAL, V243, P74, DOI 10.1016/j.jcat.2006.06.027; Iuga C, 2012, J PHYS CHEM C, V116, P2904, DOI 10.1021/jp2090846; Jiang XW, 2007, J MOL CATAL A-CHEM, V277, P102, DOI 10.1016/j.molcata.2007.07.021; Langmi HW, 2005, J ALLOY COMPD, V404, P637, DOI 10.1016/j.jallcom.2004.12.193; Leon A, 2008, GREEN ENERGY TECHNOL, P1; Lopez JM, 2010, MICROPOR MESOPOR MAT, V130, P239, DOI 10.1016/j.micromeso.2009.11.016; Mattsson A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4855176; Miguel-Garcia I, 2010, APPL CATAL B-ENVIRON, V98, P161, DOI 10.1016/j.apcatb.2010.05.025; Miguel-Garcia I, 2012, CATAL TODAY, V187, P2, DOI 10.1016/j.cattod.2012.02.015; Navlani-Garcia M, 2013, ENVIRON SCI TECHNOL, V47, P5851, DOI 10.1021/es304880b; Radhakrishnan S, 2013, CHEMCATCHEM, V5, P576, DOI 10.1002/cctc.201200464; Singh SK, 2011, EUR J INORG CHEM, P2232, DOI 10.1002/ejic.201100083; Zhou XC, 2008, CHEM COMMUN, P3540, DOI 10.1039/b803661f	50	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					364	371		10.1039/c4cy00667d		8	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200039		
J	Yamada, Y; Nomura, A; Tadokoro, H; Fukuzumi, S				Yamada, Yusuke; Nomura, Akifumi; Tadokoro, Hideyuki; Fukuzumi, Shunichi			A composite photocatalyst of an organic electron donor-acceptor dyad and a Pt catalyst supported on semiconductor nanosheets for efficient hydrogen evolution from oxalic acid	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							VISIBLE-LIGHT IRRADIATION; SHUTTLE REDOX MEDIATOR; Z-SCHEME PHOTOCATALYST; LOADED K4NB6O17 PHOTOCATALYST; RECENT PROGRESS; 2-PHENYL-4-(1-NAPHTHYL)QUINOLINIUM ION; ARTIFICIAL PHOTOSYNTHESIS; TRANSFER STATE; SOLAR-ENERGY; HETEROGENEOUS PHOTOCATALYSIS	A composite photocatalytic system for hydrogen evolution employing acidic oxalic acid as an electron donor has been successfully constructed by combining 2-phenyl-4-(1-naphthyl)quinolinium ion (QuPh(+)-NA), platinum (Pt) and nanosheets prepared by the exfoliation of K4Nb6O17 (niobate-NS) as an organic photosensitiser, a hydrogen-evolution catalyst and a semiconductor photocatalyst for the oxidation of oxalic acid, respectively. The composite photocatalyst, QuPh(+)-NA/niobate-NS (Pt), was prepared by a two-step route to locate a Pt catalyst near QuPh(+)-NA on the surface of niobate-NS: (i) supporting QuPh(+)-NA on niobate-NS by a cation exchange method and then (ii) supporting Pt on the QuPh(+)-NA/niobate-NS by a photodeposition method using PtCl42- as a precursor, which interacts repulsively with the negatively charged surface of niobate-NS. The precursor of PtCl42- was reduced to metallic Pt by the photocatalysis of QuPh(+)-NA in the presence of oxalate. Photocatalytic hydrogen evolution with the composite catalyst proceeds via photoexcitation of both niobate-NS and QuPh(+)-NA to produce an electron and a hole in the semiconductor and the ET state (QuPh(center dot)-NA(center dot+)), respectively. The photogenerated hole of niobate-NS oxidises oxalic acid to produce CO2 and CO2 center dot- with two protons, whereas the photogenerated electron and CO2 center dot- reduce QuPh(+)-NA and the electron-transfer (ET) state to produce two equivalents of QuPh(center dot)-NA, which inject electrons to the Pt catalyst to reduce protons to hydrogen. The utilisation of oxalic acid as an electron donor even under highly acidic conditions, which are thermodynamically favourable for proton reduction to evolve hydrogen but unfavourable for oxalate oxidation, has been made possible for the first time by combining QuPh(+)-NA, Pt and niobate-NS. Composite photocatalysts were also prepared by employing mesoporous silica-alumina and nanosheets prepared by the exfoliation of KTiNbO5 (titanoniobate-NS), which possesses a band structure different from niobate-NS, as supports to clarify the requirements for a building block to achieve an active composite photocatalyst.	[Yamada, Yusuke; Nomura, Akifumi; Tadokoro, Hideyuki; Fukuzumi, Shunichi] Osaka Univ, Grad Sch Engn, Japan Sci & Technol Agcy JST, Dept Mat & Life Sci,ALCA, Suita, Osaka 5650871, Japan	Yamada, Y (reprint author), Osaka Univ, Grad Sch Engn, Japan Sci & Technol Agcy JST, Dept Mat & Life Sci,ALCA, Suita, Osaka 5650871, Japan.	fukuzumi@chem.eng.osaka-u.ac.jp	Yamada, Yusuke/D-3359-2013; Fukuzumi, Shunichi /E-4728-2010		Japan Society for the Promotion of Science (JSPS) [24350069, 25600025]; ALCA project from the Japan Science and Technology Agency (JST); NRF of Korea through the GRL [2010-00353]	This work was supported by Grants-in-Aid (no. 24350069 and 25600025) for Scientific Research from the Japan Society for the Promotion of Science (JSPS), an ALCA project from the Japan Science and Technology Agency (JST), and NRF of Korea through the GRL (2010-00353) program. We sincerely acknowledge the Research Centre for Ultra-Precision Science & Technology, Osaka University for TEM measurements.	Abe R, 2011, J PHOTOCH PHOTOBIO C, V11, P179; Faunce TA, 2013, ENERG ENVIRON SCI, V6, P695, DOI 10.1039/c3ee00063j; Navarro RM, 2010, ENERG ENVIRON SCI, V3, P1865, DOI 10.1039/c001123a; Fukuzumi S, 2012, J MATER CHEM, V22, P4575, DOI 10.1039/c2jm15585k; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Osterloh FE, 2008, CHEM MATER, V20, P35, DOI 10.1021/cm7024203; Maeda K, 2013, ACS CATAL, V3, P1486, DOI 10.1021/cs4002089; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Townsend TK, 2011, CHEMSUSCHEM, V4, P185, DOI 10.1002/cssc.201000377; Tran PD, 2012, ENERG ENVIRON SCI, V5, P5902, DOI 10.1039/c2ee02849b; Yamada Y, 2012, ENERG ENVIRON SCI, V5, P6111, DOI 10.1039/c2ee03106j; Kamat PV, 2007, J PHYS CHEM C, V111, P2834, DOI 10.1021/jp066952u; Bizeto MA, 2004, MATER RES BULL, V39, P1729, DOI 10.1016/j.materresbull.2004.07.001; NAKATO T, 1992, CHEM MATER, V4, P128, DOI 10.1021/cm00019a027; MALINKA EA, 1995, J PHOTOCH PHOTOBIO A, V90, P153, DOI 10.1016/1010-6030(95)04093-U; Thoi VS, 2013, CHEM SOC REV, V42, P2388, DOI 10.1039/c2cs35272a; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; Yamada Y, 2013, J PHYS CHEM C, V117, P13143, DOI 10.1021/jp403925v; Sayama K, 2001, CHEM COMMUN, P2416, DOI 10.1039/b107673f; SCAIFE DE, 1980, SOL ENERGY, V25, P41, DOI 10.1016/0038-092X(80)90405-3; Fukuzumi S, 2011, ENERG ENVIRON SCI, V4, P2754, DOI 10.1039/c1ee01551f; Nocera DG, 2009, CHEM SOC REV, V38, P13, DOI 10.1039/b820660k; Kudo A, 2011, MRS BULL, V36, P32, DOI 10.1557/mrs.2010.3; Yourey JE, 2012, J PHYS CHEM C, V116, P3200, DOI 10.1021/jp211409x; Fukuzumi S, 2003, ORG BIOMOL CHEM, V1, P609, DOI 10.1039/b300053b; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Bullock RM, 2014, CHEM COMMUN, V50, P3125, DOI 10.1039/c3cc46135a; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Mori K, 2012, J PHYS CHEM C, V116, P18873, DOI 10.1021/jp3059799; Yamada Y, 2013, RSC ADV, V3, P25677, DOI 10.1039/c3ra44534h; Kotani H, 2011, CHEM-EUR J, V17, P2777, DOI 10.1002/chem.201002399; Wang M, 2012, ENERG ENVIRON SCI, V5, P6763, DOI 10.1039/c2ee03309g; Yang JH, 2013, ACCOUNTS CHEM RES, V46, P1900, DOI 10.1021/ar300227e; Maeda K, 2011, J PHYS CHEM C, V115, P3057, DOI 10.1021/jp110025x; van den Bosch B, 2013, CHEMSUSCHEM, V6, P790, DOI 10.1002/cssc.201200960; Uchida S, 1997, J CHEM SOC FARADAY T, V93, P3229, DOI 10.1039/a701101f; Kato H, 2003, J AM CHEM SOC, V125, P3082, DOI 10.1021/ja027751g; KIM YI, 1993, J PHYS CHEM-US, V97, P11802, DOI 10.1021/j100147a038; KUDO A, 1989, J CATAL, V120, P337, DOI 10.1016/0021-9517(89)90274-1; Frischmann PD, 2013, CHEM SOC REV, V42, P1847, DOI 10.1039/c2cs35223k; Kudo A, 2007, INT J HYDROGEN ENERG, V32, P2673, DOI 10.1016/j.ijhydene.2006.09.010; Fujishima A, 2007, INT J HYDROGEN ENERG, V32, P2664, DOI 10.1016/j.ijhydene.2006.09.009; Zhou H, 2011, CHEMCATCHEM, V3, P513, DOI 10.1002/cctc.201000266; Maeda K, 2008, CHEM MATER, V20, P6770, DOI 10.1021/cm801807b; Lee JS, 2005, CATAL SURV ASIA, V9, P217, DOI 10.1007/s10563-005-9157-0; Momirlan M, 2005, INT J HYDROGEN ENERG, V30, P795, DOI 10.1016/j.ijhydene.2004.10.011; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m; KUDO A, 1988, J CATAL, V111, P67, DOI 10.1016/0021-9517(88)90066-8; Fukuzumi S, 2012, P NATL ACAD SCI USA, V109, P15572, DOI 10.1073/pnas.1119994109; Halpin Y, 2013, DALTON T, V42, P16243, DOI 10.1039/c3dt52319e; MALINKA EA, 1994, J PHOTOCH PHOTOBIO A, V81, P193, DOI 10.1016/1010-6030(94)03789-2; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Maeda K, 2010, J AM CHEM SOC, V132, P5858, DOI 10.1021/ja1009025; Ji PF, 2010, RES CHEM INTERMEDIAT, V36, P327, DOI 10.1007/s11164-010-0142-5; Lei P, 2014, ACS APPL MATER INTER, V6, P2370, DOI 10.1021/am4046537; Sasaki Y, 2013, J AM CHEM SOC, V135, P5441, DOI 10.1021/ja400238r; Qu YQ, 2013, CHEM SOC REV, V42, P2568, DOI 10.1039/c2cs35355e; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Fukuzumi S, 2004, J AM CHEM SOC, V126, P1600, DOI 10.1021/ja038656q; Yamada Y, 2013, CHEM COMMUN, V49, P5132, DOI 10.1039/c3cc41575a; Moriya Y, 2013, COORDIN CHEM REV, V257, P1957, DOI 10.1016/j.ccr.2013.01.021; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Takanabe K, 2012, CHEMCATCHEM, V4, P1485, DOI 10.1002/cctc.201200324; Fukuzumi S, 2014, ACCOUNTS CHEM RES, V47, P1455, DOI 10.1021/ar400200u; BARD AJ, 1979, J PHOTOCHEM, V10, P59, DOI 10.1016/0047-2670(79)80037-4; Kotani H, 2012, FARADAY DISCUSS, V155, P89, DOI 10.1039/c1fd00084e; Higashi M, 2012, J AM CHEM SOC, V134, P6968, DOI 10.1021/ja302059g; Amao Y, 2011, CHEMCATCHEM, V3, P458, DOI 10.1002/cctc.201000293; Abe R, 2013, J AM CHEM SOC, V135, P16872, DOI 10.1021/ja4048637; Jia QX, 2014, CHEM SCI, V5, P1513, DOI 10.1039/c3sc52810c; Yerga RMN, 2009, CHEMSUSCHEM, V2, P471, DOI 10.1002/cssc.200900018; GUST D, 1993, ACCOUNTS CHEM RES, V26, P198, DOI 10.1021/ar00028a010; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Sasaki Y, 2008, J CATAL, V259, P133, DOI 10.1016/j.jcat.2008.07.017; Hou JG, 2012, J MATER CHEM, V22, P7291, DOI 10.1039/c2jm15791h; Yamada Y, 2011, J AM CHEM SOC, V133, P16136, DOI 10.1021/ja206079e; Maeda K, 2008, J CATAL, V254, P198, DOI 10.1016/j.jcat.2007.12.009; Bensaid S, 2012, CHEMSUSCHEM, V5, P500, DOI 10.1002/cssc.201100661; Maeda K, 2013, CHEM-EUR J, V19, P4986, DOI 10.1002/chem.201300158; Abe R, 2001, CHEM PHYS LETT, V344, P339, DOI 10.1016/S0009-2614(01)00790-4; Kotani H, 2006, J PHYS CHEM B, V110, P24047, DOI 10.1021/jp065215v; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; DOMEN K, 1986, J CHEM SOC CHEM COMM, P356, DOI 10.1039/c39860000356; DOMEN K, 1986, J CHEM SOC CHEM COMM, P1706, DOI 10.1039/c39860001706; Du GH, 2003, CHEM PHYS LETT, V377, P445, DOI 10.1016/S0009-2614(03)01202-8; Dunn S., 2004, ENCY ENERGY, V3, P241; Fan WQ, 2013, PHYS CHEM CHEM PHYS, V15, P2632, DOI 10.1039/c2cp43524a; Fukuzumi S, 2008, EUR J INORG CHEM, P1351, DOI 10.1002/ejic.200701369; GERISCHE.H, 1972, PHOTOCHEM PHOTOBIOL, V16, P243; Hagiwara H, 2009, CHEM-EUR J, V15, P12862, DOI 10.1002/chem.200901772; Hagiwara H, 2013, J PHOTOCH PHOTOBIO A, V272, P41, DOI 10.1016/j.jphotochem.2013.08.022; Hagiwara H, 2011, PHYS CHEM CHEM PHYS, V13, P18031, DOI 10.1039/c1cp22425e; Haytowitz D. B., 1984, AGR HDB, V8-11; KIM YI, 1991, J AM CHEM SOC, V113, P9561, DOI 10.1021/ja00025a021; Kotani H, 2007, PHYS CHEM CHEM PHYS, V9, P1487, DOI [10.1039/b612794k, 10.1039/b61279k]; Laurenczy G., 2010, ENCY CATALYSIS; Malinka E. A., 1993, REACT KINET CATAL LE, V52, P13; NASSAU K, 1969, J ELECTROCHEM SOC, V116, P348, DOI 10.1149/1.2411844; National Research Council, 2004, HYDR EC OPP COSTS BA; Nocera DG, 2012, ACCOUNTS CHEM RES, V45, P767, DOI 10.1021/ar2003013; SAYAMA K, 1991, J PHYS CHEM-US, V95, P1345, DOI 10.1021/j100156a058; SAYAMA K, 1990, CATAL LETT, V4, P217, DOI 10.1007/BF00765937; Sayama K, 1998, J PHOTOCH PHOTOBIO A, V114, P125, DOI 10.1016/S1010-6030(98)00202-0; WADSLEY AD, 1964, ACTA CRYSTALLOGR, V17, P623, DOI 10.1107/S0365110X64001530; Wasielewski MR, 2009, ACCOUNTS CHEM RES, V42, P1910, DOI 10.1021/ar9001735; Weast R.C., 1975, HDB CHEM PHYS; Yamada Y, 2012, PHYS CHEM CHEM PHYS, V14, P10564, DOI 10.1039/c2cp41906h; Youngblood WJ, 2009, ACCOUNTS CHEM RES, V42, P1966, DOI 10.1021/ar9002398	109	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					428	437		10.1039/c4cy01005a		10	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200046		
J	Muthukrishnan, A; Nabae, Y; Hayakawa, T; Okajima, T; Ohsaka, T				Muthukrishnan, Azhagumuthu; Nabae, Yuta; Hayakawa, Teruaki; Okajima, Takeyoshi; Ohsaka, Takeo			Fe-containing polyimide-based high-performance ORR catalysts in acidic medium: a kinetic approach to study the durability of catalysts	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							OXYGEN REDUCTION REACTION; METAL-FREE ELECTROCATALYSTS; NITROGEN-DOPED GRAPHENE; ELECTROLYTE FUEL-CELLS; CARBON NANOTUBE ARRAYS; RING-DISC ELECTRODE; ALKALINE-MEDIUM; EFFICIENT ELECTROCATALYSTS; COMPOSITE ELECTROCATALYST; IRON PHTHALOCYANINE	The ORR activity and durability of Fe-containing non-precious N-doped carbon catalysts in acidic medium were studied using a rotating ring-disk electrode voltammetry and XPS technique. The catalysts (Fe/PI) were synthesised from the pyrolysis of the Fe(acac)(3) and polyimide nanoparticle (PI) mixture. The catalytic activity and durability of Fe/PI are superior to that of the conventional phthalocyanine-based catalyst. The onset potential of ORR was 0.915 V vs. RHE in 0.5 M H2SO4 which is very close to that of a commercially available Pt/C catalyst. The Fe/PI catalyst sustains its activity and stability even after 11 110 repeating potential steps between 0.6 and 1.0 V vs. RHE in O-2-saturated 0.5 M H2SO4 and 1110 potential cycles between 1.0 and 1.5 V vs. RHE in argon-saturated 0.5 M H2SO4, respectively. The kinetic and mechanistic analyses of the ORR on this catalyst indicate that the ORR, as a whole, follows a 4-electron (parallel) pathway. The N 1s XPS spectra before and after the durability test indicate that pyridinic and graphite-like nitrogens take part in improving the ORR activity, whereas nitrogen oxides have a negative role in the ORR. The loss of ORR activity was observed after the acid washing of the catalysts, which suggests the role of Fe in the overall 4-electron reduction of O-2.	[Muthukrishnan, Azhagumuthu; Okajima, Takeyoshi; Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Nabae, Yuta; Hayakawa, Teruaki] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Muthukrishnan, A (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, G1-5,4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	ohsaka@echem.titech.ac.jp	AZHAGUMUTHU, MUTHUKRISHNAN/I-9728-2014	AZHAGUMUTHU, MUTHUKRISHNAN/0000-0001-9971-0093	New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The authors thank Dr. T. Fuchigami and Dr. D. Zhang for helpful discussions.	Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; WIESENER K, 1989, MATER CHEM PHYS, V22, P457, DOI 10.1016/0254-0584(89)90010-2; ALONSOVANTE N, 1995, ELECTROCHIM ACTA, V40, P567, DOI 10.1016/0013-4686(94)00377-D; Nabae Y, 2014, J MATER CHEM A, V2, P11561, DOI 10.1039/c4ta01828a; Liu ZW, 2011, ANGEW CHEM INT EDIT, V50, P3257, DOI 10.1002/anie.201006768; Ma GX, 2011, J PHYS CHEM C, V115, P25148, DOI 10.1021/jp208257r; Liang YY, 2011, NAT MATER, V10, P780, DOI [10.1038/nmat3087, 10.1038/NMAT3087]; VANVEEN JAR, 1981, J CHEM SOC FARAD T 1, V77, P2827, DOI 10.1039/f19817702827; Li YG, 2012, NAT NANOTECHNOL, V7, P394, DOI [10.1038/nnano.2012.72, 10.1038/NNANO.2012.72]; He CY, 2014, J MATER CHEM A, V2, P3231, DOI 10.1039/c3ta14070a; Yang Z, 2012, ACS NANO, V6, P205, DOI 10.1021/nn203393d; Yano H, 2010, PHYS CHEM CHEM PHYS, V12, P3806, DOI 10.1039/b923460h; Robson MH, 2013, ELECTROCHIM ACTA, V90, P656, DOI 10.1016/j.electacta.2012.11.025; Gojkovic SL, 1999, ELECTROCHIM ACTA, V45, P889, DOI 10.1016/S0013-4686(99)00294-7; Matter PH, 2006, J PHYS CHEM B, V110, P18374, DOI 10.1021/jp062206d; Zhou XJ, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301523; Chen Z, 2010, CARBON, V48, P3057, DOI 10.1016/j.carbon.2010.04.038; Stamenkovic V, 2003, J ELECTROANAL CHEM, V554, P191, DOI 10.1016/S0022-0728(03)00177-3; Jeon IY, 2011, CHEM MATER, V23, P3987, DOI 10.1021/cm201542m; Nabae Y, 2014, CATAL SCI TECHNOL, V4, P1400, DOI 10.1039/c4cy00119b; Meng H, 2010, ELECTROCHIM ACTA, V55, P6450, DOI 10.1016/j.electacta.2010.06.039; Nam G, 2014, NANO LETT, V14, P1870, DOI 10.1021/nl404640n; Jiang YY, 2013, ACS CATAL, V3, P1263, DOI 10.1021/cs4001927; Chen Z, 2010, ELECTROCHIM ACTA, V55, P4799, DOI 10.1016/j.electacta.2010.03.057; Kundu S, 2009, J PHYS CHEM C, V113, P14302, DOI 10.1021/jp811320d; Lefevre M, 2003, ELECTROCHIM ACTA, V48, P2749, DOI 10.1016/S0013-4686(03)00393-1; Wu G, 2009, ECS TRANSACTIONS, V25, P1299, DOI 10.1149/1.3210685; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Yu DS, 2010, J AM CHEM SOC, V132, P15127, DOI 10.1021/ja105617z; Li XG, 2010, J POWER SOURCES, V195, P6373, DOI 10.1016/j.jpowsour.2010.04.019; Bo XJ, 2013, PHYS CHEM CHEM PHYS, V15, P2459, DOI 10.1039/c2cp43541a; Chlistunoff J, 2011, J PHYS CHEM C, V115, P6496, DOI 10.1021/jp108350t; Wei W, 2014, ANGEW CHEM INT EDIT, V53, P1570, DOI 10.1002/anie.201307319; Maldonado S, 2005, J PHYS CHEM B, V109, P4707, DOI 10.1021/jp044442z; Wu G, 2011, ECS TRANSACTIONS, V41, P1709, DOI 10.1149/1.3635702; Nagaiah TC, 2010, ELECTROCHEM COMMUN, V12, P338, DOI 10.1016/j.elecom.2009.12.021; Geng DS, 2011, ENERG ENVIRON SCI, V4, P760, DOI 10.1039/c0ee00326c; Liu G, 2010, ELECTROCHIM ACTA, V55, P2853, DOI 10.1016/j.electacta.2009.12.055; Claude E, 1998, J APPL ELECTROCHEM, V28, P57; MARKOVIC NM, 1994, J ELECTROANAL CHEM, V377, P249, DOI 10.1016/0022-0728(94)03467-2; Zheng RP, 2014, CARBON, V69, P132, DOI 10.1016/j.carbon.2013.11.075; Wang SY, 2011, ACS NANO, V5, P6202, DOI 10.1021/nn200879h; Luo ZQ, 2011, J MATER CHEM, V21, P8038, DOI 10.1039/c1jm10845j; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Shanmugam S, 2011, CHEM COMMUN, V47, P4463, DOI 10.1039/c1cc10361j; Ohma A, 2011, ECS TRANSACTIONS, V41, P775, DOI 10.1149/1.3635611; Subramanian NP, 2009, J POWER SOURCES, V188, P38, DOI 10.1016/j.jpowsour.2008.11.087; Yu DS, 2012, J PHYS CHEM LETT, V3, P2863, DOI 10.1021/jz3011833; Ozaki J, 2010, ELECTROCHIM ACTA, V55, P1864, DOI 10.1016/j.electacta.2009.10.037; Yang LJ, 2011, ANGEW CHEM INT EDIT, V50, P7132, DOI 10.1002/anie.201101287; HSUEH KL, 1983, J ELECTROANAL CHEM, V153, P79, DOI 10.1016/S0022-0728(83)80007-2; Wang HB, 2012, ACS CATAL, V2, P781, DOI 10.1021/cs200652y; Rao CV, 2010, J PHYS CHEM LETT, V1, P2622, DOI 10.1021/jz100971v; Jaouen F, 2003, J PHYS CHEM B, V107, P1376, DOI 10.1021/jp021634q; Li Y, 2012, J AM CHEM SOC, V134, P15, DOI 10.1021/ja206030c; Chen Z, 2009, J PHYS CHEM C, V113, P21008, DOI 10.1021/jp908067v; Ratso S, 2014, CARBON, V73, P361, DOI 10.1016/j.carbon.2014.02.076; Bai JC, 2013, INT J HYDROGEN ENERG, V38, P1413, DOI 10.1016/j.ijhydene.2012.11.039; Gavrilov N, 2011, ELECTROCHIM ACTA, V56, P9197, DOI 10.1016/j.electacta.2011.07.134; Paulus UA, 2001, J ELECTROANAL CHEM, V495, P134, DOI 10.1016/S0022-0728(00)00407-1; GUPTA S, 1989, J APPL ELECTROCHEM, V19, P19, DOI 10.1007/BF01039385; Wu G, 2013, CHEM COMMUN, V49, P3291, DOI 10.1039/c3cc39121c; Jiang HL, 2014, CHEM-EUR J, V20, P3106, DOI 10.1002/chem.201304561; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Han CL, 2014, J MATER CHEM A, V2, P605, DOI 10.1039/c3ta13757k; Parvez K, 2012, ACS NANO, V6, P9541, DOI 10.1021/nn302674k; Yang W, 2011, J AM CHEM SOC, V133, P206, DOI 10.1021/ja108039j; Wakabayashi N, 2005, J ELECTROANAL CHEM, V574, P339, DOI 10.1016/j.jelechem.2004.08.013; Jaouen F, 2009, J PHYS CHEM C, V113, P15422, DOI 10.1021/jp900837e; Vikkisk M, 2014, APPL CATAL B-ENVIRON, V147, P369, DOI 10.1016/j.apcatb.2013.09.011; Xu PM, 2014, J COLLOID INTERF SCI, V421, P160, DOI 10.1016/j.jcis.2014.02.001; Wu G, 2012, ACS NANO, V6, P9764, DOI 10.1021/nn303275d; Bo X., 2014, ACS APPL MATER INTER, V6, P3013; Chokai M, 2010, J POWER SOURCES, V195, P5947, DOI 10.1016/j.jpowsour.2010.01.012; Chung HT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2944; DAMJANOV.A, 1966, J CHEM PHYS, V45, P4057, DOI 10.1063/1.1727457; Li Y., 2011, J AM CHEM SOC, V134, P15; Niwa H, 2013, J POWER SOURCES, V223, P30, DOI 10.1016/j.jpowsour.2012.09.031; Peng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01765; Radyushkina K. A., 1986, ELEKTROKHIMIYA, V22, P1155; Tian J, 2011, ELECTROCHIM ACTA, V56, P3276, DOI 10.1016/j.electacta.2011.01.029	81	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					475	483		10.1039/c4cy01001a		9	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200051		
J	Miyazaki, A; Matsuda, K; Papa, F; Scurtu, M; Negrila, C; Dobrescu, G; Balint, I				Miyazaki, Akane; Matsuda, Kahori; Papa, Florica; Scurtu, Mariana; Negrila, Catalin; Dobrescu, Gianina; Balint, Ioan			Impact of particle size and metal-support interaction on denitration behavior of well-defined Pt-Cu nanoparticles	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							DRINKING-WATER; PD-CU; BIMETALLIC CATALYSTS; NITRATE REDUCTION; ALUMINA DISSOLUTION; NITRITE REDUCTION; COPPER; HYDROGENATION; PALLADIUM; PLATINUM	Well-dispersed Pt-Cu nanoparticles with two average sizes were synthesized: small (approximate to 1.6 nm) and large (approximate to 4.8 nm), respectively. The effects of size and support on the catalytic behavior of the nanoparticles for denitration reaction were analyzed. Both the unsupported and alumina-supported nanoparticles of smaller average size (1.6 nm) were very active, completely converting NO3- and NO2- (an intermediate reaction product) to N-2 and NH4+. They were also more selective of N-2 compared to the larger particles. The effects of particle size and alumina support on the denitration rate constants were analyzed in detail. The kinetic investigation indicates that the catalytic behavior is strongly related to the size of Pt-Cu nanoparticles as well as to the metal-support interaction. Generally, the larger nanoparticles proved to be less active, but on the other hand, they are less influenced by the support than the smaller ones. The metal-support interaction for bimetallic nanoparticles with smaller average size proved to be a key factor both for nitrate and nitrite reduction. Consideration of the reaction mechanism is made in light of the experimental results.	[Miyazaki, Akane; Matsuda, Kahori] Japan Womens Univ, Fac Sci, Bunkyo Ku, Tokyo 1128681, Japan; [Papa, Florica; Scurtu, Mariana; Dobrescu, Gianina; Balint, Ioan] Acad Romana, Inst Phys Chem, Bucharest 060021, Romania; [Negrila, Catalin] Natl Inst Mat Phys, Magurele, Romania	Miyazaki, A (reprint author), Japan Womens Univ, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	miyazakia@fc.gvu.ac.jp; kaho_rabbit@yahoo.co.jp; frusu@icf.ro; mcarata@icf.ro; cnegrila@infim.ro; gdobrescu@icf.ro; ibalint@icf.ro			 [PNII-PTPCCA BICLEANBIOS 46/2012]	Financial support through grant PNII-PTPCCA BICLEANBIOS 46/2012 is greatly acknowledged.	STROHMEIER BR, 1985, J CATAL, V94, P514, DOI 10.1016/0021-9517(85)90216-7; Platzman I, 2008, J PHYS CHEM C, V112, P1101, DOI 10.1021/jp076981k; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; GATES BC, 1995, CHEM REV, V95, P511, DOI 10.1021/cr00035a003; SHYU JZ, 1988, APPL SURF SCI, V32, P246, DOI 10.1016/0169-4332(88)90085-2; Soares OSGP, 2009, APPL CATAL B-ENVIRON, V91, P441, DOI 10.1016/j.apcatb.2009.06.013; FAMILY F, 1985, J PHYS A-MATH GEN, V18, pL75, DOI 10.1088/0305-4470/18/2/005; Soares OSGP, 2011, DESALINATION, V279, P367, DOI 10.1016/j.desal.2011.06.037; Miyazaki A, 2001, J CATAL, V204, P364, DOI 10.1006/jcat.2001.3418; VORLOP KD, 1989, CHEM-ING-TECH, V61, P836, DOI 10.1002/cite.330611023; ERTL G, 1980, APPL SURF SCI, V5, P49, DOI 10.1016/0378-5963(80)90117-8; Cuenya BR, 2010, THIN SOLID FILMS, V518, P3127, DOI 10.1016/j.tsf.2010.01.018; Kusada K, 2010, J AM CHEM SOC, V132, P15896, DOI 10.1021/ja107362z; Witonska I, 2007, KINET CATAL+, V48, P823, DOI 10.1134/S0023158407060109; Papa F, 2011, J NANOPART RES, V13, P5057, DOI 10.1007/s11051-011-0486-9; Liou YH, 2012, CHEM ENG J, V181, P236, DOI 10.1016/j.cej.2011.11.071; Epron F, 2002, APPL CATAL A-GEN, V237, P253, DOI 10.1016/S0926-860X(02)00331-9; Barrabes N, 2006, APPL CATAL B-ENVIRON, V62, P77, DOI 10.1016/j.apcatb.2005.06.015; Balint I., 2007, T MAT RES SOC JPN, V32, P387; Balint I, 2001, CHEM MATER, V13, P932, DOI 10.1021/cm000693i; Balint I, 1999, CHEM MATER, V11, P378, DOI 10.1021/cm9806026; Balint I., 2005, APPL CATAL B-ENVIRON, V59, P72; Barrabes N, 2010, CATAL TODAY, V149, P341, DOI 10.1016/j.cattod.2009.05.029; Cazaux J, 2010, J ELECTRON SPECTROSC, V178, P357, DOI 10.1016/j.elspec.2009.03.007; Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2; Ebbesen SD, 2008, LANGMUIR, V24, P869, DOI 10.1021/la7027725; Krawczyk N, 2011, REACT KINET MECH CAT, V103, P311, DOI 10.1007/s11144-011-0321-4; LINDSAY WL, 1981, SOIL SCI SOC AM J, V45, P61; Marchesini FA, 2008, APPL CATAL A-GEN, V348, P60, DOI 10.1016/j.apcata.2008.06.026; Miyazaki A, 2005, CHEM COMMUN, P3730, DOI 10.1039/b505537g; Pintar A, 2006, APPL CATAL B-ENVIRON, V63, P150, DOI 10.1016/j.apcatb.2005.10.006; Rodriguez R, 2005, CATAL TODAY, V107-08, P100, DOI 10.1016/j.cattod.2005.07.070; Sa J, 2005, APPL CATAL A-GEN, V294, P226, DOI 10.1016/j.apcata.2005.07.046; Strukul G, 2000, CATAL TODAY, V55, P139, DOI 10.1016/S0920-5861(99)00233-3; Suzer S, 2010, J ELECTRON SPECTROSC, V176, P52, DOI 10.1016/j.elspec.2009.02.003; Wada K, 2012, CATAL TODAY, V185, P81, DOI 10.1016/j.cattod.2011.07.021; Witonska I, 2008, J MOL CATAL A-CHEM, V287, P87, DOI 10.1016/j.molcata.2008.01.044	37	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					492	503		10.1039/c4cy00929k		12	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200053		
J	Li, J; Zhu, QL; Xu, Q				Li, Jun; Zhu, Qi-Long; Xu, Qiang			Non-noble bimetallic CuCo nanoparticles encapsulated in the pores of metal-organic frameworks: synergetic catalysis in the hydrolysis of ammonia borane for hydrogen generation	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							POROUS COORDINATION POLYMERS; SYNERGISTIC CATALYSIS; PD NANOPARTICLES; NICKEL NANOPARTICLES; ROOM-TEMPERATURE; ALLOY NANOPARTICLES; STORAGE MATERIALS; FORMIC-ACID; DEHYDROGENATION; EFFICIENT	Non-noble bimetallic CuCo alloy nanoparticles (NPs) were successfully encapsulated in the pores of MIL-101 by using the double-solvent method combined with the overwhelming reduction approach. Compared with their monometallic counterparts, the bimetallic CuCo alloy NPs present much higher catalytic activity for hydrolytic dehydrogenation of ammonia borane (AB) to generate a stoichiometric amount of hydrogen at room temperature for chemical hydrogen storage. The synergistic effect between copper and cobalt species plays an important role for the improved performance in the catalytic hydrolysis of AB.	[Li, Jun; Zhu, Qi-Long; Xu, Qiang] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka, Japan; [Li, Jun; Xu, Qiang] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 657, Japan	Li, J (reprint author), Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka, Japan.	q.xu@aist.go.jp	Zhu, Qi-Long/B-9257-2012; Xu, Qiang/H-4997-2011		AIST; Kobe University	We acknowledge the reviewers for their valuable suggestions, Dr. Takeyuki Uchida for TEM measurements and AIST and Kobe University for financial support.	Jiang HL, 2011, J AM CHEM SOC, V133, P1304, DOI 10.1021/ja1099006; Singh AK, 2013, CHEMCATCHEM, V5, P652, DOI 10.1002/cctc.201200591; Moon HR, 2013, CHEM SOC REV, V42, P1807, DOI 10.1039/c2cs35320b; Zhu QL, 2014, CHEM SCI, V5, P195, DOI 10.1039/c3sc52448e; Jiang HL, 2011, J MATER CHEM, V21, P13705, DOI 10.1039/c1jm12020d; Ferey G, 2009, CHEM SOC REV, V38, P1380, DOI 10.1039/b804302g; Gutowska A, 2005, ANGEW CHEM INT EDIT, V44, P3578, DOI 10.1002/anie.200462602; Chen HM, 2012, CHEM SOC REV, V41, P5654, DOI 10.1039/c2cs35019j; Zhang XB, 2009, J AM CHEM SOC, V131, P2778, DOI 10.1021/ja808830a; Patel N, 2008, J PHYS CHEM C, V112, P6968, DOI 10.1021/jp7104192; Hammer B, 2000, ADV CATAL, V45, P71; Li SL, 2013, ENERG ENVIRON SCI, V6, P1656, DOI 10.1039/c3ee40507a; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Zhu QL, 2013, J AM CHEM SOC, V135, P10210, DOI 10.1021/ja403330m; Jiang HL, 2011, CATAL TODAY, V170, P56, DOI 10.1016/j.cattod.2010.09.019; Muller M, 2008, J MATER CHEM, V18, P5274, DOI 10.1039/b810989c; Umegaki T, 2010, J POWER SOURCES, V195, P8209, DOI 10.1016/j.jpowsour.2010.07.079; Zhong DC, 2012, CHEM COMMUN, V48, P11945, DOI 10.1039/c2cc36407g; Durap F, 2009, INT J HYDROGEN ENERG, V34, P7223, DOI 10.1016/j.ijhydene.2009.06.074; Jiang HL, 2011, CHEM COMMUN, V47, P10999, DOI 10.1039/c1cc13989d; Hermes S, 2005, ANGEW CHEM INT EDIT, V44, P6237, DOI 10.1002/anie.200462515; Basu S, 2009, J POWER SOURCES, V188, P238, DOI 10.1016/j.jpowsour.2008.11.085; Sanyal U, 2011, CHEMSUSCHEM, V4, P1731, DOI 10.1002/cssc.201100318; Kim SK, 2012, CHEM COMMUN, V48, P2021, DOI 10.1039/c2cc15931g; Chandra M, 2006, J POWER SOURCES, V156, P190, DOI 10.1016/j.jpowsour.2005.05.043; Li PZ, 2012, ANGEW CHEM INT EDIT, V51, P6753, DOI 10.1002/anie.201202055; Keaton RJ, 2007, J AM CHEM SOC, V129, P1844, DOI 10.1021/ja066860i; Gu XJ, 2011, J AM CHEM SOC, V133, P11822, DOI 10.1021/ja200122f; Aijaz A, 2014, J PHYS CHEM LETT, V5, P1400, DOI 10.1021/jz5004044; Huang ZG, 2012, ENERG ENVIRON SCI, V5, P9257, DOI 10.1039/c2ee23039a; Jiang HL, 2011, CHEM COMMUN, V47, P3351, DOI 10.1039/c0cc05419d; Lu G, 2012, NAT CHEM, V4, P310, DOI 10.1038/nchem.1272; Proch S, 2008, CHEM-EUR J, V14, P8204, DOI 10.1002/chem.200801043; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Li PZ, 2012, CHEM COMMUN, V48, P3173, DOI 10.1039/c2cc17302f; Metin O, 2010, J AM CHEM SOC, V132, P1468, DOI 10.1021/ja909243z; Chen BL, 2010, ACCOUNTS CHEM RES, V43, P1115, DOI 10.1021/ar100023y; Karahan S, 2012, CHEM COMMUN, V48, P1180, DOI 10.1039/c1cc15864c; Hamilton CW, 2009, CHEM SOC REV, V38, P279, DOI 10.1039/b800312m; Xu Q, 2006, J POWER SOURCES, V163, P364, DOI 10.1016/j.jpowsour.2006.09.043; Patel N, 2010, APPL CATAL B-ENVIRON, V95, P137, DOI 10.1016/j.apcatb.2009.12.020; Yadav M, 2012, ENERG ENVIRON SCI, V5, P9698, DOI 10.1039/c2ee22937d; Park YK, 2010, CHEM COMMUN, V46, P3086, DOI 10.1039/c000775g; Ferrando R, 2008, CHEM REV, V108, P845, DOI 10.1021/cr040090g; Umegaki T, 2009, INT J HYDROGEN ENERG, V34, P3816, DOI 10.1016/j.ijhydene.2009.03.003; Zhang JP, 2009, CHEM SOC REV, V38, P2385, DOI 10.1039/b900317g; Wang C, 2012, J AM CHEM SOC, V134, P7211, DOI 10.1021/ja300539p; Zhao D, 2011, ACCOUNTS CHEM RES, V44, P123, DOI 10.1021/ar100112y; Xu Q, 2007, J ALLOY COMPD, V446, P729, DOI 10.1016/j.jallcom.2007.01.040; Zhou XH, 2012, J MATER CHEM, V22, P13506, DOI 10.1039/c2jm31000g; Edwards PP, 2008, ENERG POLICY, V36, P4356, DOI 10.1016/j.enpol.2008.09.036; Kim SK, 2010, J AM CHEM SOC, V132, P9954, DOI 10.1021/ja101685u; Mohajeri N, 2007, J POWER SOURCES, V167, P482, DOI 10.1016/j.jpowsour.2007.02.059; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Yan JM, 2010, J POWER SOURCES, V195, P1091, DOI 10.1016/j.jpowsour.2009.08.067; Li J, 2014, CHEM COMMUN, V50, P5899, DOI 10.1039/c4cc00785a; Aijaz A, 2012, J AM CHEM SOC, V134, P13926, DOI 10.1021/ja3043905; Yan JM, 2008, ANGEW CHEM INT EDIT, V47, P2287, DOI 10.1002/anie.200704943; Zhu QL, 2014, CHEM SOC REV, V43, P5468, DOI 10.1039/c3cs60472a; Hermannsdorfer J, 2012, ANGEW CHEM INT EDIT, V51, P11473, DOI 10.1002/anie.201205078; Aranishi K, 2013, CHEMCATCHEM, V5, P2248, DOI 10.1002/cctc.201300143; Dhakshinamoorthy A, 2012, CHEM SOC REV, V41, P5262, DOI 10.1039/c2cs35047e; Henschel A, 2008, CHEM COMMUN, P4192, DOI 10.1039/b718371b; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Meilikhov M, 2010, EUR J INORG CHEM, P3701, DOI 10.1002/ejic.201000473; Schroder F, 2009, EUR J INORG CHEM, P3131, DOI 10.1002/ejic.200900138; Wagner C. D., 1978, HDB XRAY PHOTOELECTR	67	10	10	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					525	530		10.1039/c4cy01049c		6	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200056		
J	Yamamoto, A; Mizuno, Y; Teramura, K; Hosokawa, S; Shishido, T; Tanaka, T				Yamamoto, Akira; Mizuno, Yuto; Teramura, Kentaro; Hosokawa, Saburo; Shishido, Tetsuya; Tanaka, Tsunehiro			Visible-light-assisted selective catalytic reduction of NO with NH3 on porphyrin derivative-modified TiO2 photocatalysts	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							SENSITIZED TIO2; SOLAR-CELLS; SCR; DEGRADATION; FLUORESCENCE; DYNAMICS; MN	Porphyrin-derivative-modified TiO2 photocatalysts showed high photocatalytic activity for the selective catalytic reduction of NO with NH3 in the presence of O-2 under visible-light irradiation. Tetra(p-carboxyphenyl) porphyrin (TCPP) was the most effective photosensitizer among the five porphyrin derivatives investigated. NO conversion and N-2 selectivity of 79.0% and 100%, respectively, were achieved at a gas hourly space velocity of 50 000 h(-1). UV-Vis and photoluminescence spectroscopies revealed the presence of two species of TCPP on the TiO2 surface; one was a TCPP monomer and the other was an H-aggregate of the TCPP molecules. It was concluded that the TCPP monomer is an active species for the photo-assisted selective catalytic reduction (photo-SCR). Moreover, an increase in the fraction of H-aggregates with increasing TCPP loading amount resulted in a decrease in the photocatalytic activity of the photo-SCR.	[Yamamoto, Akira; Mizuno, Yuto; Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto Daigaku Katsura,Nishikyo Ku, Kyoto 6158510, Japan; [Teramura, Kentaro; Hosokawa, Saburo; Shishido, Tetsuya; Tanaka, Tsunehiro] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries E, Nishikyo Ku, Kyoto 6158245, Japan; [Teramura, Kentaro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Shishido, Tetsuya] Tokyo Metropolitan Univ, Dept Appl Chem, Grad Sch Urban Environm Sci, Hachioji, Tokyo 1920397, Japan	Yamamoto, A (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto Daigaku Katsura,Nishikyo Ku, Kyoto 6158510, Japan.	teramura@moleng.kyoto-u.ac.jp			Program for Element Strategy Initiative for Catalysts & Batteries (ESICB); Precursory Research for Embryonic Science and Technology (PRESTO) by Japan Science and Technology Agency (JST)	This study was partially supported by the Program for Element Strategy Initiative for Catalysts & Batteries (ESICB), commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and the Precursory Research for Embryonic Science and Technology (PRESTO), supported by the Japan Science and Technology Agency (JST). Akira Yamamoto would like to thank the JSPS Research Fellowships for Young Scientists.	Ismail AA, 2010, CHEMSUSCHEM, V3, P1057, DOI 10.1002/cssc.201000158; MAITI NC, 1995, J PHYS CHEM-US, V99, P17192, DOI 10.1021/j100047a024; Li JH, 2011, CATAL TODAY, V175, P147, DOI 10.1016/j.cattod.2011.03.034; Smirniotis PG, 2001, ANGEW CHEM INT EDIT, V40, P2479, DOI 10.1002/1521-3773(20010702)40:13<2479::AID-ANIE2479>3.0.CO;2-7; KAY A, 1993, J PHYS CHEM-US, V97, P6272, DOI 10.1021/j100125a029; Hagiwara H, 2006, ANGEW CHEM INT EDIT, V45, P1420, DOI 10.1002/anie.200503316; Maiti NC, 1998, J PHYS CHEM B, V102, P1528, DOI 10.1021/jp9723372; Mele G, 2003, J CATAL, V217, P334, DOI 10.1016/S0021-9517(03)00040-X; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; GOUTERMAN M, 1961, J MOL SPECTROSC, V6, P138, DOI 10.1016/0022-2852(61)90236-3; Imahori H, 2001, J AM CHEM SOC, V123, P100, DOI 10.1021/ja002154k; Koebel M, 2000, CATAL TODAY, V59, P335, DOI 10.1016/S0920-5861(00)00299-6; Verma S, 2010, J PHYS CHEM B, V114, P8327, DOI 10.1021/jp101643c; Forzatti P, 1996, HETEROGEN CHEM REV, V3, P33, DOI 10.1002/(SICI)1234-985X(199603)3:1<33::AID-HCR54>3.0.CO;2-R; Campbell WM, 2004, COORDIN CHEM REV, V248, P1363, DOI 10.1016/j.ccr.2004.01.007; Cherian S, 2000, J PHYS CHEM B, V104, P3624, DOI 10.1021/jp994459v; Bosch H., 1988, CATAL TODAY, V2, P369; Busca G, 1998, APPL CATAL B-ENVIRON, V18, P1, DOI 10.1016/S0926-3373(98)00040-X; GOUTERMA.M, 1974, J MOL SPECTROSC, V53, P88, DOI 10.1016/0022-2852(74)90263-X; Kasha M., 1965, Eighth European Congress on Molecular Spectroscopy, DOI 10.1351/pac196511030371; Li D, 2008, J PHYS CHEM C, V112, P14878, DOI 10.1021/jp800318k; Long RQ, 2002, CHEM COMMUN, P452, DOI 10.1039/b111382h; Murphy S, 2012, APPL CATAL B-ENVIRON, V119, P156, DOI 10.1016/j.apcatb.2012.02.027; Shishido T, 2011, CATAL SCI TECHNOL, V1, P541, DOI 10.1039/c1cy00104c; Tanaka T, 2002, CHEM COMMUN, P2742, DOI 10.1039/b208349c; Teramura K, 2004, APPL CATAL B-ENVIRON, V53, P29, DOI 10.1016/j.apcatb.2004.05.005; Yamamoto A, 2013, CATAL SCI TECHNOL, V3, P1771, DOI 10.1039/c3cy00022b; Yamazoe S, 2006, CATAL TODAY, V111, P266, DOI 10.1016/j.cattod.2005.10.056; Yamazoe S, 2007, J PHYS CHEM C, V111, P14189, DOI 10.1021/jp075033g	29	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					556	561		10.1039/c4cy00598h		6	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200060		
J	Hara, T; Kurihara, J; Ichikuni, N; Shimazu, S				Hara, Takayoshi; Kurihara, Jun; Ichikuni, Nobuyuki; Shimazu, Shogo			Epoxidation of cyclic enones with hydrogen peroxide catalysed by alkylcarboxylate-intercalated Ni-Zn mixed basic salts	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							LAYERED DOUBLE HYDROXIDES; ELECTRON-DEFICIENT ALKENES; ANION-EXCHANGE REACTIONS; SUPPORTED GOLD CATALYST; ALPHA,BETA-UNSATURATED KETONES; ASYMMETRIC EPOXIDATION; EFFICIENT EPOXIDATION; PROMOTED EPOXIDATION; CONTROLLED-RELEASE; DELIVERY-SYSTEM	The interlayer spacing of layered Ni-Zn mixed basic salts (NiZn) can be precisely controlled by the intercalation of various long alkyl chain carboxylate anions into the NiZn interlayer. The butyrate-exchanged NiZn (C3H7COO-/NiZn) catalyst effectively promotes the epoxidation of various cyclic enones with aqueous hydrogen peroxide in remarkably high yields. The C3H7COO-/NiZn-catalysed epoxidation of 2-cyclohexen-1-one with an equimolar amount of H2O2 proceeds in a highly efficient manner, with 97% efficiency of H2O2 utilization. This C3H7COO-/NiZn catalyst can be reused without any loss of its catalytic activity and selectivity.	[Hara, Takayoshi; Kurihara, Jun; Ichikuni, Nobuyuki; Shimazu, Shogo] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Hara, T (reprint author), Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi, Chiba 2638522, Japan.	shimazu@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25420824]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25420824).	Teramura K, 2012, ANGEW CHEM INT EDIT, V51, P8008, DOI 10.1002/anie.201201847; Nishimura S, 2013, GREEN CHEM, V15, P2026, DOI 10.1039/c3gc40405f; HOUSE HO, 1958, J AM CHEM SOC, V80, P2428, DOI 10.1021/ja01543a021; Urena-Amate MD, 2011, APPL CLAY SCI, V52, P368, DOI 10.1016/j.clay.2011.03.018; Jana SK, 2008, J CATAL, V255, P40, DOI 10.1016/j.jcat.2008.01.022; Conterosito E, 2013, PHYS CHEM CHEM PHYS, V15, P13418, DOI 10.1039/c3cp51235e; Taviot-Gueho C, 2010, DALTON T, V39, P5994, DOI 10.1039/c001678k; Morioka H, 1999, INORG CHEM, V38, P4211, DOI 10.1021/ic9812149; Yang JH, 2007, CHEM MATER, V19, P2679, DOI 10.1021/cm070259h; Lifchits O, 2013, J AM CHEM SOC, V135, P6677, DOI 10.1021/ja402058v; LONCHARICH RJ, 1989, J ORG CHEM, V54, P1129, DOI 10.1021/jo00266a026; Wang X, 2008, J AM CHEM SOC, V130, P6070, DOI 10.1021/ja801181u; Porter MJ, 2000, CHEM COMMUN, P1215, DOI 10.1039/b001780i; Khan AI, 2002, J MATER CHEM, V12, P3191, DOI 10.1039/b204076j; Yamaguchi K, 2000, J ORG CHEM, V65, P6897, DOI 10.1021/jo000247e; Hara T, 2011, CATAL SCI TECHNOL, V1, P1376, DOI 10.1039/c1cy00223f; Kamata K, 2011, CHEM-EUR J, V17, P7549, DOI 10.1002/chem.201101001; Kaneda K, 2000, CATAL SURV JPN, V4, P31, DOI 10.1023/A:1019048407764; Kuroda Y, 2013, CHEM MATER, V25, P2291, DOI 10.1021/cm400846k; Takehira K, 2007, CATAL SURV ASIA, V11, P1, DOI 10.1007/s10563-007-9016-2; Carja G, 2012, APPL CLAY SCI, V65-66, P37, DOI 10.1016/j.clay.2012.04.031; Liang JB, 2014, DALTON T, V43, P10355, DOI 10.1039/c4dt00425f; Rajamathi JT, 2008, LANGMUIR, V24, P11164, DOI 10.1021/la801730u; Sathisha TV, 2012, J ELECTROANAL CHEM, V674, P57, DOI 10.1016/j.jelechem.2012.03.020; Bull RMR, 2011, J MATER CHEM, V21, P1822, DOI 10.1039/c0jm03020a; YAMANAKA S, 1992, SOLID STATE IONICS, V53, P527, DOI 10.1016/0167-2738(92)90424-N; Hara T, 2009, GREEN CHEM, V11, P2034, DOI 10.1039/b918350g; YADAV VK, 1995, TETRAHEDRON, V51, P8573, DOI 10.1016/0040-4020(95)00472-K; Kandare E, 2006, INORG CHEM, V45, P3766, DOI 10.1021/ic060071k; HERRMANN WA, 1991, ANGEW CHEM INT EDIT, V30, P1638, DOI 10.1002/anie.199116381; Takahashi N, 2011, J MATER CHEM, V21, P14336, DOI 10.1039/c1jm10460h; Yang SG, 2007, TETRAHEDRON, V63, P5184, DOI 10.1016/j.tet.2007.03.167; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Lygo B, 1998, TETRAHEDRON LETT, V39, P1599, DOI 10.1016/S0040-4039(97)10779-1; Kandare E, 2005, J PHYS CHEM B, V109, P8469, DOI 10.1021/jp0465433; PAYNE GB, 1961, J ORG CHEM, V26, P651, DOI 10.1021/jo01062a003; Debecker DP, 2009, CHEM-EUR J, V15, P3920, DOI 10.1002/chem.200900060; Motokura K, 2005, J AM CHEM SOC, V127, P9674, DOI 10.1021/ja052386p; Lyakin OY, 2012, ACS CATAL, V2, P1196, DOI 10.1021/a300205n; Noujima A, 2011, ANGEW CHEM INT EDIT, V50, P2986, DOI 10.1002/anie.201007679; Nishizawa H, 1998, J SOLID STATE CHEM, V141, P229, DOI 10.1006/jssc.1998.7962; CATIVIELA C, 1995, TETRAHEDRON LETT, V36, P4125, DOI 10.1016/0040-4039(95)00675-3; MEYN M, 1993, INORG CHEM, V32, P1209, DOI 10.1021/ic00059a030; Evans DG, 2006, STRUCT BOND, V119, P1, DOI 10.1007/430_005; Kamata K, 2003, SCIENCE, V300, P964, DOI 10.1126/science.1083176; Yamaguchi K, 2005, J AM CHEM SOC, V127, P530, DOI 10.1021/ja043688e; Arizaga Gregorio Guadalupe Carbajal, 2007, Solid State Ionics: Diffusion and Reactions, V178, DOI 10.1016/j.ssi.2007.04.016; Arulraj J, 2007, SOLID STATE SCI, V9, P812, DOI 10.1016/j.solidstatesciences.2007.06.007; Bergaya F., 2013, DEV CLAY SCI B, V5B, P333; Braterman P. S., 2004, HDB LAYERED MAT, P373; Choudary BM, 1998, SYNLETT, P1203; Figueras F, 2006, CURR ORG CHEM, V10, P1627, DOI 10.2174/138527206778249658; Garcia R. J. L., 2005, J ORG CHEM, V70, P4300; Gomes AC, 2013, J ORGANOMET CHEM, V744, P53, DOI 10.1016/j.jorganchem.2013.04.046; Hara T, 2010, CHEM LETT, V39, P304, DOI 10.1246/cl.2010.304; Hiyoshi N, 2012, APPL CATAL A-GEN, V419, P164, DOI 10.1016/j.apcata.2012.01.026; Kantam ML, 2005, SYNLETT, P2329, DOI 10.1055/s-2005-872677; McQuaid KM, 2004, SYNLETT, P2403, DOI 10.1055/s-2004-832814; MIYASHITA M, 1987, CHEM LETT, P285, DOI 10.1246/cl.1987.285; Motokura K., 2012, GREEN CHEM, V13, P2416; Nakayama H., 2007, J PHYS CHEM SOLIDS, V69, P1552; Nityashree N, 2013, J PHYS CHEM SOLIDS, V74, P1164, DOI 10.1016/j.jpcs.2013.03.015; Oyama S. T., 2008, MECH HOMOGENEOUS HET, P1; Palomeque J, 2006, APPL CATAL A-GEN, V300, P100, DOI 10.1016/j.apcata.2005.10.037; Palomeque J, 2002, J CATAL, V211, P150, DOI 10.1002/jcat.2002.3706; Pillai UR, 2004, APPL CATAL A-GEN, V261, P69, DOI 10.1016/j.apcata.2003.10.030; Rives V, 2001, LAYERED DOUBLE HYDRO; Rojas R, 2008, MICROPOR MESOPOR MAT, V112, P262, DOI 10.1016/j.micromeso.2007.09.042; Rojas R, 2002, J MATER CHEM, V12, P1071, DOI 10.1039/b110145e; Russo A, 2009, SYNTHESIS-STUTTGART, P1551, DOI 10.1055/s-0029-1216638; Schoenfeldt NJ, 2010, CHEM COMMUN, V46, P1640, DOI 10.1039/b920391e; Shirotori M, 2014, CATAL SCI TECHNOL, V4, P971, DOI 10.1039/c3cy00980g; STRAUB TS, 1995, TETRAHEDRON LETT, V36, P663, DOI 10.1016/0040-4039(94)02346-D; Tamura H, 2004, SOLID STATE IONICS, V172, P607, DOI 10.1016/j.ssi.2004.04.035; Tichit D, 2003, CATTECH, V7, P206, DOI 10.1023/B:CATT.0000007166.65577.34; Yamaguchi K, 1999, J ORG CHEM, V64, P2966, DOI 10.1021/jo982347e; Yamaguchi K, 1999, NEW J CHEM, V23, P799, DOI 10.1039/a904446i; YAMANAKA S, 1995, MATER RES SOC SYMP P, V371, P131; YANG D, 1995, J ORG CHEM, V60, P3887, DOI 10.1021/jo00117a046	79	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					578	583		10.1039/c4cy01063a		6	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200063		
J	Kawabata, H; Koda, Y; Sumida, H; Shigetsu, M; Takami, A; Inumaru, K				Kawabata, Hisaya; Koda, Yuki; Sumida, Hirosuke; Shigetsu, Masahiko; Takami, Akihide; Inumaru, Kei			High three-way catalytic activity of rhodium particles on a Y-stabilized La-containing ZrO2 support: the effect of Y on the enhanced reducibility of rhodium and self-regeneration	CATALYSIS SCIENCE & TECHNOLOGY			English	Article							AUTOMOTIVE CATALYSTS; OXIDATIVE ATMOSPHERE; EXHAUST CATALYSTS; ALUMINA; RH; ZIRCONIA; NO; REDUCTION; EVOLUTION; HYDROGEN	A novel, highly active three-way catalyst, rhodium supported on Y- and La-added zirconia (Rh/Zr-Y-La-O), was found in this study. Rh/Zr-Y-La-O showed superior performance to a previously reported Rh on La-added ZrO2 (Rh/Zr-La-O) catalyst (Kawabata et al., Chem. Commun., 2013, 49.38), 4015; Catal. Sci. Technol. 2014, 4(3), 697). (21,22) The effects of Y addition to ZrO2-based supports were investigated in detail. CO temperature-programmed reduction and in situ Fourier transform infrared spectra of adsorbed NO species indicated that Y addition to La-containing ZrO2 enhanced the reducibility of rhodium supported on the catalyst and that more metallic Rh was exposed on the surface after the oxidation of Rh/Zr-Y-La-O than of Rh/Zr-La-O. Before and after an aging treatment at 1273 K that simulated 80 000 km travelled by vehicles, Rh/Zr-Y-La-O showed high steam reforming activity. After the aging treatment, Rh/Zr-Y-La-O was deactivated using an oxidation treatment, but its three-way catalysis activity was completely regenerated after a short (5 min) exposure to steam reforming reaction conditions, demonstrating self-regeneration capability. After the aging treatment, Rh/Zr-Y-La-O showed higher rhodium dispersion than other catalysts. This was attributed to the high surface area of the support after aging and the stabilization of ZrO2 by the addition of Y. Our findings highlight the role of catalyst supports in designing effective three-way catalysts with high tolerance to the oxidative conditions in new vehicles and engines.	[Kawabata, Hisaya; Koda, Yuki; Sumida, Hirosuke; Shigetsu, Masahiko; Takami, Akihide] Mazda Motor Corp, Tech Res Ctr, Adv Mat Res Field, Fuchu, Hiroshima 7308670, Japan; [Kawabata, Hisaya; Inumaru, Kei] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Kawabata, H (reprint author), Mazda Motor Corp, Tech Res Ctr, Adv Mat Res Field, 3-1 Shinchi, Fuchu, Hiroshima 7308670, Japan.	kawabata.h@mazda.co.jp; inumaru@hiroshima-u.ac.jp	Inumaru, Kei/J-9292-2015				Anderson J. A., 2005, SUPPORTED METALS CAT, P140; Tanabe T, 2012, CATAL TODAY, V184, P219, DOI 10.1016/j.cattod.2011.10.005; SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853; WengSieh Z, 1997, J CATAL, V170, P62, DOI 10.1006/jcat.1997.1738; Shelef M, 2000, CATAL TODAY, V62, P35, DOI 10.1016/S0920-5861(00)00407-7; Haneda M, 2008, J CATAL, V259, P223, DOI 10.1016/j.jcat.2008.08.007; SHELEF M, 1994, CATAL REV, V36, P433, DOI 10.1080/01614949408009468; MCCABE RW, 1995, J CATAL, V151, P385, DOI 10.1006/jcat.1995.1041; Muraki H, 2000, CATAL TODAY, V63, P337, DOI 10.1016/S0920-5861(00)00477-6; Gandhi HS, 2003, J CATAL, V216, P433, DOI 10.1016/S0021-9517(02)00067-2; Matsumoto SI, 2004, CATAL TODAY, V90, P183, DOI 10.1016/j.cattod.2004.04.048; Koltsakis GC, 1997, PROG ENERG COMBUST, V23, P1, DOI 10.1016/S0360-1285(97)00003-8; Hwang CP, 1999, CATAL TODAY, V51, P93, DOI 10.1016/S0920-5861(99)00011-5; Theis JR, 2012, CATAL TODAY, V184, P262, DOI 10.1016/j.cattod.2012.01.015; Shinjoh H, 2009, TOP CATAL, V52, P1967, DOI 10.1007/s11244-009-9371-5; Breen JP, 2002, APPL CATAL B-ENVIRON, V39, P65, DOI 10.1016/S0926-3373(02)00075-9; Newton MA, 2008, CHEM SOC REV, V37, P2644, DOI 10.1039/b707746g; Kawabata H, 2014, CATAL SCI TECHNOL, V4, P697, DOI 10.1039/c3cy00838j; Rogemond E, 1999, J CATAL, V186, P414, DOI 10.1006/jcat.1999.2585; BARBIER-JR J, 1994, APPL CATAL B-ENVIRON, V4, P105, DOI 10.1016/0926-3373(94)80046-4; Burch R, 1996, APPL CATAL A-GEN, V147, P375, DOI 10.1016/S0926-860X(96)00212-8; Burch R, 1996, APPL CATAL A-GEN, V143, P317, DOI 10.1016/0926-860X(96)00089-0; Chafik T, 1997, J PHYS CHEM B, V101, P7968, DOI 10.1021/jp971557c; Dohmae K, 2008, SURF INTERFACE ANAL, V40, P1751, DOI 10.1002/sia.3003; Domine ME, 2008, CATAL TODAY, V133, P565, DOI 10.1016/j.cattod.2007.12.062; Dujardin C, 2004, TOP CATAL, V30-1, P347, DOI 10.1023/B:TOCA.0000029773.89206.0f; Kawabata H, 2013, CHEM COMMUN, V49, P4015, DOI 10.1039/c3cc00006k; Newton MA, 2004, CHEM COMMUN, P2382, DOI 10.1039/b405694a; The Catalysis Society of Japan, 1985, SHOK KOUZ CAT DES, V5, P141; Uenishi M, 2008, CATAL COMMUN, V9, P311, DOI 10.1016/j.catcom.2007.05.041; YATES DJC, 1987, J CATAL, V106, P549, DOI 10.1016/0021-9517(87)90268-5; Zimowska M, 2006, CHEM PHYS LETT, V417, P137, DOI 10.1016/j.cplett.2005.09.112	32	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2044-4753	2044-4761		CATAL SCI TECHNOL	Catal. Sci. Technol.		2015	5	1					584	594		10.1039/c4cy01032a		11	Chemistry, Physical	Chemistry	AZ6WH	WOS:000348358200064		
J	Nakajima, Y; Kanno, T; Nagaya, T; Kuribayashi, K; Nakano, T; Gotoh, A; Nishizaki, T				Nakajima, Yasuhiro; Kanno, Takeshi; Nagaya, Toshio; Kuribayashi, Kozo; Nakano, Takashi; Gotoh, Akinobu; Nishizaki, Tomoyuki			Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Adenosine deaminase inhibitor; EHNA; Malignant pleural mesothelioma; Apoptosis	LUNG-CANCER CELLS; RECEPTOR MEDIATES APOPTOSIS; HUMAN HEPATOMA-CELLS; PROTEIN-KINASE; UP-REGULATION; ACTIVATION; EXPRESSION; GROWTH; PHOSPHODIESTERASE; DEOXYADENOSINE	Background/Aims: Malignant pleural mesothelioma (MPM) is an aggressive malignant tumor and an effective therapy has been little provided as yet. The present study investigated the possibility for the adenosine deaminase (ADA) inhibitor EHNA as a target of MPM treatment. Methods: MTT assay, TUNEL staining, monitoring of intracellular adenosine concentrations, and Western blotting were carried out in cultured human MPM cell lines without and with knocking-down ADA. The in vivo effect of EHNA was assessed in mice inoculated with NCI-H2052 MPM cells. Results: EHNA induced apoptosis of human MPM cell lines in a concentration (0.01-1 mM)- and treatment time (24-48 h)-dependent manner, but such effect was not obtained with another ADA inhibitor pentostatin. EHNA increased intracellular adenosine concentrations in a treatment time (3-9 h)-dependent manner. EHNA-induced apoptosis of MPM cells was mimicked by knocking-down ADA, and the effect was neutralized by the adenosine kinase inhibitor ABT-702. EHNA clearly suppressed tumor growth in mice inoculated with NCI-H2052 MPM cells. Conclusion: The results of the present study show that EHNA induces apoptosis of MPM cells by increasing intracellular adenosine concentrations, to convert to AMP, and effectively prevents MPM cell proliferation. This suggests that EHNA may be useful for treatment of the tragic neoplasm MPM. Copyright (C) 2015 S. Karger AG, Basel	[Nakajima, Yasuhiro; Kuribayashi, Kozo; Nakano, Takashi] Hyogo Coll Med, Div Resp Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Kanno, Takeshi; Nishizaki, Tomoyuki] Hyogo Coll Med, Div Bioinformat, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan; [Nagaya, Toshio; Gotoh, Akinobu] Hyogo Coll Med, Lab Cell & Gene Therapy, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan	Nishizaki, T (reprint author), Hyogo Coll Med, Dept Physiol, Div Bioinformat, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	tomoyuki@hyo-med.ac.jp			'the Takeda Science Foundation'; MEXT	This study was supported by research grants from 'the Takeda Science Foundation' and 'MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016'.	Tsuchiya A, 2012, CANCER LETT, V321, P65, DOI 10.1016/j.canlet.2012.02.023; Yang DQ, 2010, CELL BIOL TOXICOL, V26, P319, DOI 10.1007/s10565-009-9145-7; Kanno T, 2012, CELL PHYSIOL BIOCHEM, V30, P1159, DOI 10.1159/000343306; Saitoh M, 2004, BIOCHEM PHARMACOL, V67, P2005, DOI 10.1016/j.bcp.2004.01.020; Morello S, 2009, J CELL PHYSIOL, V221, P378, DOI 10.1002/jcp.21863; Yang DQ, 2011, CELL PHYSIOL BIOCHEM, V27, P71, DOI 10.1159/000325207; Saito M, 2010, CANCER LETT, V290, P211, DOI 10.1016/j.canlet.2009.09.011; Tamura K, 2012, J CELL BIOCHEM, V113, P1766, DOI 10.1002/jcb.24048; Kanno T, 2012, CELL PHYSIOL BIOCHEM, V30, P666, DOI 10.1159/000341447; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; Yasuda Y, 2009, J GASTROENTEROL, V44, P56, DOI 10.1007/s00535-008-2273-7; Otsuki T, 2012, CELL PHYSIOL BIOCHEM, V30, P210, DOI 10.1159/000339058; Nogi Y, 2012, CELL PHYSIOL BIOCHEM, V30, P61, DOI 10.1159/000339048; Nagaya H, 2013, J UROLOGY, V189, P321, DOI 10.1016/j.juro.2012.08.193; Kamiya H, 2012, CELL PHYSIOL BIOCHEM, V29, P687, DOI 10.1159/000312589; Yang DQ, 2007, BIOCHEM PHARMACOL, V73, P1665, DOI 10.1016/j.bcp.2007.01.020; Raja S, 2011, CURR ONCOL REP, V13, P259, DOI 10.1007/s11912-011-0177-9; Thompson WJ, 2000, CANCER RES, V60, P3338; Wu LF, 2006, ACTA PHARMACOL SIN, V27, P477, DOI 10.1111/j.1745-7254.2006.00302.x; Sai K, 2006, NEUROTOXICOLOGY, V27, P458, DOI 10.1016/j.neuro.2005.12.008; Bar-Yehuda S, 2008, INT J ONCOL, V33, P287, DOI 10.3892/ijo_00000008; CARSON DA, 1978, J IMMUNOL, V121, P1726; Haynes J, 1996, J PHARMACOL EXP THER, V276, P752; JANIK P, 1980, CANCER RES, V40, P1950; Kurzrock R, 2000, SEMIN ONCOL, V27, P64; MENTZ F, 1995, BRIT J HAEMATOL, V90, P957, DOI 10.1111/j.1365-2141.1995.tb05225.x; Niitsu N, 1998, BLOOD, V92, P3368; Panjehpour M, 2007, ONCOL RES, V16, P575, DOI 10.3727/000000007783629981	28	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2015	35	1					51	60		10.1159/000369674		10	Cell Biology; Physiology	Cell Biology; Physiology	AZ2ES	WOS:000348048000005		
J	Baba, A; Tachi, M; Maruyama, Y; Kazama, I				Baba, Asuka; Tachi, Masahiro; Maruyama, Yoshio; Kazama, Itsuro			Olopatadine Inhibits Exocytosis in Rat Peritoneal Mast Cells by Counteracting Membrane Surface Deformation	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Olopatadine; Mast cell stabilizing properties; Rat peritoneal mast cells; Exocytosis; Membrane capacitance; Plasma membrane deformation	K+-CHANNEL CURRENTS; MURINE THYMOCYTES; HISTAMINE-RELEASE; PATCH-CLAMP; IN-VITRO; ANTIHISTAMINES; DEGRANULATION; DRUGS; MODEL; SECRETION	Backgroud/Aims: Besides its anti-allergic properties as a histamine receptor antagonist, olopatadine stabilizes mast cells by inhibiting the release of chemokines. Since olopatadine bears amphiphilic features and is preferentially partitioned into the lipid bilayers of the plasma membrane, it would induce some morphological changes in mast cells and thus affect the process of exocytosis. Methods: Employing the standard patch-clamp whole-cell recording technique, we examined the effects of olopatadine and other anti-allergic drugs on the membrane capacitance (Cm) in rat peritoneal mast cells during exocytosis. Using confocal imaging of a water-soluble fluorescent dye, lucifer yellow, we also examined their effects on the deformation of the plasma membrane. Results: Low concentrations of olopatadine (1 or 10 mu M) did not significantly affect the GTP-gamma-S-induced increase in the Cm. However, 100 mu M and 1 mM olopatadine almost totally suppressed the increase in the Cm. Additionally, these doses completely washed out the trapping of the dye on the cell surface, indicating that olopatadine counteracted the membrane surface deformation induced by exocytosis. As shown by electron microscopy, olopatadine generated inward membrane bending in mast cells. Conclusion: This study provides electrophysiological evidence for the first time that olopatadine dose-dependently inhibits the process of exocytosis in rat peritoneal mast cells. Such mast cell stabilizing properties of olopatadine may be attributed to its counteracting effects on the plasma membrane deformation in degranulating mast cells. Copyright (C) 2015 S Karger AG, Basel	[Baba, Asuka; Maruyama, Yoshio; Kazama, Itsuro] Tohoku Univ Grad Sch Med, Dept Physiol 1, Sendai, Miyagi, Japan; [Tachi, Masahiro] Tohoku Univ Grad Sch Med, Dept Plast & Reconstruct Surg, Sendai, Miyagi, Japan	Kazama, I (reprint author), Tohoku Univ Grad Sch Med, Dept Physiol 1, Aoba Ku, Seiryo Cho, Sendai, Miyagi, Japan.	kazaitsu@med.tohoku.ac.jp					AKAGI M, 1983, AGENTS ACTIONS, V13, P149, DOI 10.1007/BF01967320; Queralt M, 2000, INFLAMM RES, V49, P355, DOI 10.1007/PL00000216; Brockman HL, 2003, OCUL IMMUNOL INFLAMM, V11, P247, DOI 10.1076/ocii.11.4.247.18261; Kazama I, 2013, IMMUNOPHARM IMMUNOT, V35, P28, DOI 10.3109/08923973.2012.723011; Kazama I, 2012, IMMUNOPHARM IMMUNOT, V34, P874, DOI 10.3109/08923973.2012.666249; Greeson JN, 2009, BIOPHYS J, V96, P510, DOI 10.1016/j.bpj.2008.09.016; Togo KA, 2009, CLIN IMMUNOL, V131, P145, DOI 10.1016/j.clim.2008.09.008; Yanni JM, 1996, J OCUL PHARMACOL TH, V12, P389, DOI 10.1089/jop.1996.12.389; Kazama I, 2012, J PHYSIOL SCI, V62, P267, DOI 10.1007/s12576-012-0195-x; Lorenz D, 1998, J GEN PHYSIOL, V112, P577, DOI 10.1085/jgp.112.5.577; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; Kawakubo T, 1999, AM J PHYSIOL-HEART C, V276, pH1827; Kazama I, 2014, CLIN APPL THROMB-HEM, V20, P318, DOI 10.1177/1076029612461845; Blank U, 2007, IMMUNOL REV, V217, P79, DOI 10.1111/j.1600-065X.2007.00503.x; Levi-Schaffer F, 2009, J INVEST DERMATOL, V129, P2549, DOI 10.1038/jid.2009.256; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193; Kazama I, 2014, PHARMACOL REP, V66, P712, DOI 10.1016/j.pharep.2014.03.002; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Kazama I, 2013, PHARM BIOL, V51, P760, DOI 10.3109/13880209.2013.764539; JOHNSON HG, 1979, AGENTS ACTIONS, V9, P239, DOI 10.1007/BF01966694; ODRISCOLL D, 1991, J CELL SCI, V100, P237; Holdsworth SR, 2008, J AM SOC NEPHROL, V19, P2254, DOI 10.1681/ASN.2008010015; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Kazama I, 2013, CELL PHYSIOL BIOCHEM, V31, P592, DOI 10.1159/000350079; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Brockman H, 2000, ACTA OPHTHALMOL SCAN, V78, P10, DOI 10.1034/j.1600-0420.2000.078s230010.x; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pE179; Assanasen P, 2002, ALLERGY IMMUNOL, V17, P101; de Benedictis FM, 2008, ALLERGY, V63, P1395, DOI 10.1111/j.1398-9995.2008.01771.x; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Gruber B L, 1995, Int Rev Immunol, V12, P259, DOI 10.3109/08830189509056717; Kaise T, 1995, JPN J PHARMACOL, V69, P435, DOI 10.1254/jjp.69.435; Kajita J, 2002, DRUG METAB DISPOS, V30, P1504, DOI 10.1124/dmd.30.12.1504; KAWASAKI Y, 1991, BIOCHIM BIOPHYS ACTA, V1067, P71, DOI 10.1016/0005-2736(91)90027-6; Kazama Itsuro, 2011, Nephron Extra, V1, P147, DOI 10.1159/000333018; LaPlaca MC, 2009, P IEEE ENG MED BIOL, V2009, P1113; Leonardi A, 2003, CLIN THER, V25, P2539, DOI 10.1016/S0149-2918(03)80315-6; Oshiro T, 1997, INT ARCH ALLERGY IMM, V112, P336; PENNER R, 1988, P NATL ACAD SCI USA, V85, P9856, DOI 10.1073/pnas.85.24.9856; Senda M, 2009, J NUCL MED, V50, P887, DOI 10.2967/jnumed.108.058537; Sharif NA, 1996, PHARM EXP THER, V278, P1252; Shimoda T, 2010, CLIN EXP DERMATOL, V35, P531, DOI 10.1111/j.1365-2230.2009.03650.x; SIMONS FER, 1992, J ALLERGY CLIN IMMUN, V90, P705, DOI 10.1016/0091-6749(92)90156-V; Tillement JP, 2000, ALLERGY, V55, P17, DOI 10.1034/j.1398-9995.2000.00003.x; Yanni JM, 1997, ANN ALLERG ASTHMA IM, V79, P541; Zhu P, 2011, J ANAL TOXICOL, V35, P113	46	4	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2015	35	1					386	396		10.1159/000369704		11	Cell Biology; Physiology	Cell Biology; Physiology	AZ2ES	WOS:000348048000035		
J	Ueda, M; Uesaka, A; Kimura, S				Ueda, Motoki; Uesaka, Akihiro; Kimura, Shunsaku			Selective disruption of each part of Janus molecular assemblies by lateral diffusion of stimuli-responsive amphiphilic peptides	CHEMICAL COMMUNICATIONS			English	Article							HELICAL PEPTIDES; RAFTS; PARTICLES; ANISOTROPY; NANOTUBES; DESIGN	Stimuli-responsive Janus-type assemblies with a round-bottom flask shape are prepared from amphiphilic helical peptides using the patchwork self-assembly technique. It can disassemble selectively at the neck or the round-bottom part of the Janus assemblies at low pH upon heat treatment accompanied by the lateral diffusion of the peptides.	[Ueda, Motoki] Kyoto Univ Hosp, Clin Div Diagnost Radiol, Kyoto 6068507, Japan; [Uesaka, Akihiro; Kimura, Shunsaku] Kyoto Univ Kyoto Daigaku Katsura, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan	Kimura, S (reprint author), Kyoto Univ Kyoto Daigaku Katsura, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	shun@scl.kyoto-u.ac.jp					Bhaskar S, 2011, SMALL, V7, P812, DOI 10.1002/smll.201001695; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t; Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Liu YJ, 2014, J AM CHEM SOC, V136, P2602, DOI 10.1021/ja412172f; Perro A, 2005, J MATER CHEM, V15, P3745, DOI 10.1039/b505099e; [Anonymous], 2000, MOL CELL BIOL; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Nisisako T, 2006, ADV MATER, V18, P1152, DOI 10.1002/adma.200502431; Coleman AC, 2011, NAT NANOTECHNOL, V6, P547, DOI [10.1038/nnano.2011.120, 10.1038/NNANO.2011.120]; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Uesaka A, 2014, LANGMUIR, V30, P1022, DOI 10.1021/la404784e; Ueda M, 2011, CHEM COMMUN, V47, P3204, DOI 10.1039/c0cc04209a; Beales PA, 2011, SOFT MATTER, V7, P1747, DOI 10.1039/c0sm01055c; Kaufmann T, 2012, J MATER CHEM, V22, P6190, DOI 10.1039/c2jm16807c; Sacanna S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2694; Seo KD, 2013, LANGMUIR, V29, P15137, DOI 10.1021/la403015y; Ueda M, 2011, LANGMUIR, V27, P4300, DOI 10.1021/la105140v; Ueda M, 2011, J PEPT SCI, V17, P94, DOI 10.1002/psc.1304; Ueda M, 2013, POLYM J, V45, P509, DOI 10.1038/pj.2013.4; Uesaka A, 2014, LANGMUIR, V30, P4273, DOI 10.1021/la500752x; Yan J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2520	24	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1601	1604		10.1039/c4cc08686d		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100010		
J	Miura, H; Tsutsui, K; Wada, K; Shishido, T				Miura, Hiroki; Tsutsui, Kentaro; Wada, Kenji; Shishido, Tetsuya			Coupling of carboxylic acids with internal alkynes by supported ruthenium catalysts: direct and selective syntheses of multi-substituted phthalide derivatives	CHEMICAL COMMUNICATIONS			English	Article							C-H BONDS; CRYPHONECTRIC ACID; ORGANIC-REACTIONS; DIRECT ARYLATION; BENZOIC-ACIDS; ALKENES; CERIA; ACTIVATION; FUNCTIONALIZATION; OLEFINATION	Supported ruthenium catalysts promote coupling of various kinds of aromatic carboxylic acids with internal alkynes, giving the corresponding multi-substituted phthalide derivatives in high yields. The supported Ru catalyst can be recycled at least five times with no loss of activity.	[Miura, Hiroki; Tsutsui, Kentaro; Shishido, Tetsuya] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan; [Miura, Hiroki; Shishido, Tetsuya] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Nishikyo Ku, Kyoto 6158520, Japan; [Wada, Kenji] Kagawa Univ, Grad Sch Med, Dept Med Chem, Kagawa 7610793, Japan	Shishido, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	shishido-tetsuya@tmu.ac.jp			Program for Element Strategy Initiative for Catalysts & Batteries (ESICB); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26820353]; Japan Synchrotron Radiation Research Institute (JASRI) [2013B1478]	A part of this study was partially supported by the Program for Element Strategy Initiative for Catalysts & Batteries (ESICB), and the Grants-in-Aid for Young Scientists (B) (No. 26820353), commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The XAFS experiment at the SPring-8 was carried out by the approval (proposal No. 2013B1478) of Japan Synchrotron Radiation Research Institute (JASRI).	Ackermann L, 2014, ACCOUNTS CHEM RES, V47, P281, DOI 10.1021/ar3002798; Anastas P. T., 1998, GREEN CHEMISTRY THEO; Wang F, 2010, ORG LETT, V12, P5430, DOI 10.1021/ol102241f; Parmar D, 2014, CHEM-EUR J, V20, P83, DOI 10.1002/chem.201303385; Nicolai S, 2010, ORG LETT, V12, P384, DOI 10.1021/ol9027286; Arnone A, 2002, J NAT PROD, V65, P48, DOI 10.1021/np0103012; Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6; Nising CF, 2012, CHEM SOC REV, V41, P988, DOI 10.1039/c1cs15167c; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Hyster TK, 2010, J AM CHEM SOC, V132, P10565, DOI 10.1021/ja103776u; Mochida S, 2009, J ORG CHEM, V74, P6295, DOI 10.1021/jo901077r; Sheldon RA, 1999, APPL CATAL A-GEN, V189, P163, DOI 10.1016/S0926-860X(99)00274-4; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Miura H, 2010, CHEMCATCHEM, V2, P1223, DOI 10.1002/cctc.201000144; Li HJ, 2014, CHEM COMMUN, V50, P4218, DOI 10.1039/c4cc00449c; Nishiumi M, 2010, ADV SYNTH CATAL, V352, P3045, DOI 10.1002/adsc.201000431; Shimura S, 2012, CHEMCATCHEM, V4, P2062, DOI 10.1002/cctc.201200342; Shimura S, 2011, CATAL SCI TECHNOL, V1, P1340, DOI 10.1039/c1cy00235j; Logrado LPL, 2010, EUR J MED CHEM, V45, P3480, DOI 10.1016/j.ejmech.2010.05.015; Sels BF, 2001, CATAL REV, V43, P443, DOI 10.1081/CR-120001809; Chinnagolla RK, 2012, CHEM COMMUN, V48, P2030, DOI 10.1039/c2cc16916a; Miura H, 2011, ADV SYNTH CATAL, V353, P2837, DOI 10.1002/adsc.201100415; Tada M, 2007, COORDIN CHEM REV, V251, P2702, DOI 10.1016/j.ccr.2007.06.008; Trost BM, 2002, ACCOUNTS CHEM RES, V35, P695, DOI 10.1021/ar010068z; Kakiuchi F, 2002, ACCOUNTS CHEM RES, V35, P826, DOI 10.1021/ar960318p; Liu C, 2011, CHEM REV, V111, P1780, DOI 10.1021/cr100379j; Mochida S, 2011, J ORG CHEM, V76, P3024, DOI 10.1021/jo200509m; Clark JH, 1996, CHEM SOC REV, V25, P303, DOI 10.1039/cs9962500303; Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674; Miura M, 1998, J ORG CHEM, V63, P5211, DOI 10.1021/jo980584b; Ueura K, 2007, J ORG CHEM, V72, P5362, DOI 10.1021/jo070735n; Uchiyama M, 2006, ORG LETT, V8, P5517, DOI 10.1021/ol062190+; Ackermann L, 2012, ORG LETT, V14, P930, DOI 10.1021/ol2034614; Stuart DR, 2010, J AM CHEM SOC, V132, P18326, DOI 10.1021/ja1082624; Wada K, 2013, J JPN PETROL INST, V56, P69; Manikandan R, 2014, ORG LETT, V16, P912, DOI 10.1021/ol403666s; Karmakar R, 2014, CHEM REV, V114, P6213, DOI 10.1021/cr400524q; Chou TH, 2008, J NAT PROD, V71, P1692, DOI 10.1021/np8004503; Shi W, 2011, CHEM SOC REV, V40, P2761, DOI 10.1039/c0cs00125b; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Ueura K, 2007, ORG LETT, V9, P1407, DOI 10.1021/ol070406h; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Kannan S, 2006, CATAL SURV ASIA, V10, P117, DOI 10.1007/s10563-006-9012-y; Itoh M, 2013, J ORG CHEM, V78, P8098, DOI 10.1021/jo401393b; Miura H, 2010, CHEM-EUR J, V16, P4186, DOI 10.1002/chem.200903564; Kanazawa C, 2007, TETRAHEDRON LETT, V48, P933, DOI 10.1016/j.tetlet.2006.12.015; Nising CF, 2008, CHEM SOC REV, V37, P1218, DOI 10.1039/b718357g; Hashimoto Y, 2012, ORG LETT, V14, P2058, DOI 10.1021/ol300579m; Zhao P, 2012, ORG LETT, V14, P4166, DOI 10.1021/ol3018352; Ritleng V, 2002, CHEM REV, V102, P1731, DOI 10.1021/cr0104330; Chen LL, 2014, CHEM COMMUN, V50, P14866, DOI 10.1039/c4cc06331g; Chinnagolla R. K., 2014, CHEM COMMUN, V50, P14573; Dyker G., 1999, ANGEW CHEM INT EDIT, V38, P1698, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1698::AID-ANIE1698>3.0.CO;2-6; IZUMI Y, 1992, ADV CATAL, V38, P245, DOI 10.1016/S0360-0564(08)60008-5; Kaneda K, 2007, SYNLETT, P999, DOI 10.1055/s-2007-977434; LASZLO P, 1986, ACCOUNTS CHEM RES, V19, P121, DOI 10.1021/ar00124a004; Mal D, 2007, TETRAHEDRON, V63, P11781, DOI 10.1016/j.tet.2007.08.048; Miura H, 2013, CHEM-EUR J, V19, P861, DOI 10.1002/chem.201203530; Miura H, 2009, CHEM COMMUN, P4112, DOI 10.1039/b901830a; Nishimura T, 2004, SYNLETT, P201, DOI 10.1055/s-2004-815412; Nishiumi M, 2012, ACS CATAL, V2, P1753; Ackermann L, 2011, ORG LETT, V13, P4153, DOI 10.1021/ol201563r; Qian B., 2012, CHEM-EUR J, V18, P9511; Toffano M, 2003, TETRAHEDRON-ASYMMETR, V14, P3365, DOI 10.1016/S0957-4166(03)00592-5	65	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1654	1657		10.1039/c4cc08461f		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100024		
J	Bui, PT; Nishino, T; Shiigi, H; Nagaoka, T				Phuc Tan Bui; Nishino, Tomoaki; Shiigi, Hiroshi; Nagaoka, Tsutomu			One-by-one single-molecule detection of mutated nucleobases by monitoring tunneling current using a DNA tip	CHEMICAL COMMUNICATIONS			English	Article							DOUBLE-STRANDED DNA; CONDUCTANCE MEASUREMENTS; ELECTRON-TRANSFER; TRANSPORT; JUNCTIONS; HYBRIDIZATION; CONDUCTIVITY; METHYLATION; BOND	A DNA molecule was utilized as a probe tip to achieve single-molecule genetic diagnoses. Hybridization of the probe and target DNAs resulted in electron tunneling along the emergent double-stranded DNA. Simple stationary monitoring of the tunneling current leads to single-molecule DNA detection and discovery of base mismatches and methylation.	[Phuc Tan Bui] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998570, Japan; [Nishino, Tomoaki; Shiigi, Hiroshi; Nagaoka, Tsutomu] Osaka Prefecture Univ, Dept Appl Chem, Sakai, Osaka 5998570, Japan	Bui, PT (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998570, Japan.	nishino@chem.osakafu-u.ac.jp			Special Coordination Funds for Promoting Science and Technology; JSPS KAKENHI [26288070, 26620122]	This work was supported by Special Coordination Funds for Promoting Science and Technology, commissioned by MEXT of Japan, and JSPS KAKENHI Grant Numbers 26288070 and 26620122.	Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Haiss W, 2004, PHYS CHEM CHEM PHYS, V6, P4330, DOI 10.1039/b404929b; Hihath J, 2005, P NATL ACAD SCI USA, V102, P16979, DOI 10.1073/pnas.0505175102; Xu BQ, 2004, NANO LETT, V4, P1105, DOI 10.1021/nl0494295; Lindsay SM, 2007, ADV MATER, V19, P23, DOI 10.1002/adma.200601140; Haiss W, 2003, J AM CHEM SOC, V125, P15294, DOI 10.1021/ja038214e; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Jung YJ, 2007, J AM CHEM SOC, V129, P9349, DOI 10.1021/ja0676105; Aradhya SV, 2013, NAT NANOTECHNOL, V8, P399, DOI 10.1038/nnano.2013.91; van Zalinge H, 2006, CHEMPHYSCHEM, V7, P94, DOI 10.1002/cphc.200500413; Nishino T, 2013, CHEM COMMUN, V49, P3437, DOI 10.1039/c3cc38992h; Tao NJ, 2006, NAT NANOTECHNOL, V1, P173, DOI 10.1038/nnano.2006.130; Nishino T, 2013, J AM CHEM SOC, V135, P4592, DOI 10.1021/ja311463b; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; McCreery RL, 2009, ADV MATER, V21, P4303, DOI 10.1002/adma.200802850; Hihath J, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/16/164204; Nishino T, 2010, CHEMPHYSCHEM, V11, P3405, DOI 10.1002/cphc.201000686; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; van Zalinge H, 2006, ANGEW CHEM INT EDIT, V45, P5499, DOI 10.1002/anie.200601263; WANG SH, 1995, BIOCHEMISTRY-US, V34, P4125, DOI 10.1021/bi00012a031	21	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1666	1669		10.1039/c4cc08227c		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100027		
J	Suenobu, T; Isaka, Y; Shibata, S; Fukuzumi, S				Suenobu, Tomoyoshi; Isaka, Yusuke; Shibata, Satoshi; Fukuzumi, Shunichi			Catalytic hydrogen production from paraformaldehyde and water using an organoiridium complex	CHEMICAL COMMUNICATIONS			English	Article							SOLUBLE IRIDIUM COMPLEX; CARBON-DIOXIDE; FORMIC-ACID; AQUEOUS-MEDIA; STORAGE MATERIAL; AQUA COMPLEXES; CO2; METHANOL; INTERCONVERSION; TEMPERATURE	Paraformaldehyde was decomposed using an organoiridium complex (1, [Ir-III(Cp*)(4-(1H-pyrazol-1-yl-kappa N-2)benzoic acid-kappa C-3)(H2O)](2)SO4) as a catalyst in water to produce H-2 and CO2 in a 2:1 molar ratio at room temperature. The catalytic cycle is composed of the reduction of 1 by paraformaldehyde under basic conditions to produce formic acid and the hydride complex, which reacts with protons to produce H-2. Formic acid further decomposed to H-2 and CO2 with 1.	[Suenobu, Tomoyoshi] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; ALCA, Japan Sci & Technol Agcy JST, Suita, Osaka 5650871, Japan	Suenobu, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	fukuzumi@chem.eng.osaka-u.ac.jp	Fukuzumi, Shunichi /E-4728-2010		Japan Science Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology, Japan [24550077]	This work was supported by an Advanced Low Carbon Technology Research and Development (ALCA) program from Japan Science Technology Agency (JST) (to S. F.) and a Grant-in-Aid (No. 24550077 to T. S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Mr Kengo Tachikawa, Prof Akira Onoda and Prof Takashi Hayashi in Osaka University are gratefully acknowledged for their technical support in ESI-MS measurements.	Qiao JL, 2014, CHEM SOC REV, V43, P631, DOI 10.1039/c3cs60323g; Hu P, 2014, ACS CATAL, V4, P2649, DOI 10.1021/cs500937f; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Maenaka Y, 2012, J AM CHEM SOC, V134, P367, DOI 10.1021/ja207785f; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Enthaler S, 2008, CHEMSUSCHEM, V1, P801, DOI 10.1002/cssc.200800101; Papp G, 2011, ANGEW CHEM INT EDIT, V50, P10433, DOI 10.1002/anie.201104951; Boddien A, 2011, ANGEW CHEM INT EDIT, V50, P6411, DOI 10.1002/anie.201101995; Maenaka Y, 2012, J AM CHEM SOC, V134, P9417, DOI 10.1021/ja302788c; Balaraman E, 2013, NAT CHEM, V5, P122, DOI [10.1038/nchem.1536, 10.1038/NCHEM.1536]; Joo F, 2008, CHEMSUSCHEM, V1, P805, DOI 10.1002/cssc.200800133; Fujita E, 2013, BBA-BIOENERGETICS, V1827, P1031, DOI 10.1016/j.bbabio.2012.11.004; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Maenaka Y, 2012, ENERG ENVIRON SCI, V5, P7360, DOI 10.1039/c2ee03315a; Rodriguez-Lugo RE, 2013, NAT CHEM, V5, P342, DOI [10.1038/nchem.1595, 10.1038/NCHEM.1595]; Tanaka R, 2011, ORGANOMETALLICS, V30, P6742, DOI 10.1021/om2010172; SENDE JAR, 1995, INORG CHEM, V34, P3339; Manaka Y, 2014, CATAL SCI TECHNOL, V4, P34, DOI 10.1039/c3cy00830d; Himeda Y, 2009, GREEN CHEM, V11, P2018, DOI 10.1039/b914442k; Liu Y, 2014, J POLYM SCI POL CHEM, V52, P472, DOI 10.1002/pola.27018; Badiei YM, 2013, INORG CHEM, V52, P12576, DOI 10.1021/ic401707u; Himeda Y, 2011, CHEMSUSCHEM, V4, P487, DOI 10.1002/cssc.201000327; Hayashi H, 2003, J AM CHEM SOC, V125, P14266, DOI 10.1021/ja036117f; Nielsen M, 2013, NATURE, V495, P85, DOI 10.1038/nature11891; Shibata S, 2013, ANGEW CHEM INT EDIT, V52, P12327, DOI 10.1002/anie.201307273; Anslyn E. V., 2006, MORDERN PHYS ORGANIC; Fukuzumi S, 2008, EUR J INORG CHEM, P1351, DOI 10.1002/ejic.200701369; Fukuzumi S., 2010, J AM CHEM SOC, V154, P1496; Hayashi H, 2004, CHEM COMMUN, P2714, DOI 10.1039/b411633j; Heim LE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4621; Hu BX, 2010, APPL CATAL A-GEN, V382, P277, DOI 10.1016/j.apcata.2010.05.008; Kaneko T, 1998, EUR MASS SPECTROM, V4, P107, DOI 10.1255/ejms.196; Kieman J. A., 2000, MICROSC TODAY, V8, P10; Ogo S, 2006, DALTON T, P4657, DOI 10.1039/b607993h; Suenobu T, 2014, CATAL SCI TECHNOL, V4, P3636, DOI 10.1039/c4cy00957f	35	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1670	1672		10.1039/c4cc06581f		3	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100028		
J	Taminato, S; Hirayama, M; Suzuki, K; Yamada, NL; Yonemura, M; Son, JY; Kanno, R				Taminato, S.; Hirayama, M.; Suzuki, K.; Yamada, N. L.; Yonemura, M.; Son, J. Y.; Kanno, R.			Highly reversible capacity at the surface of a lithium-rich manganese oxide: a model study using an epitaxial film system	CHEMICAL COMMUNICATIONS			English	Article							X-RAY-DIFFRACTION; ELECTROCHEMICAL PROPERTIES; STRUCTURAL-CHANGES; CATHODE MATERIALS; ION BATTERIES; THIN-FILMS; ELECTRODES; LI2MNO3; INTERFACE; INTERCALATION	Epitaxial films of Li2MnO3 were synthesized using pulsed laser deposition. A 12.6 nm film exhibited a high discharge capacity of over 300 mA h g(-1) following its fiftieth cycle and better stability than 29.8 and 47.8 nm films. The surfaces of such films are intrinsically active at the electrochemical interface.	[Taminato, S.; Hirayama, M.; Suzuki, K.; Kanno, R.] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yamada, N. L.; Yonemura, M.] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Div Neutron Sci, Tokai, Ibaraki 3191106, Japan; [Son, J. Y.] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan	Taminato, S (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	hitrayama@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	Research and Development Initiative for Scientific Innovation of New Generation Battery (RISING Project) of the New Energy and Industrial Technology Development Organization (NEDO; Japan); Japan Synchrotron Radiation Research Institute [2013B1530, 2013B1711]; Japan Proton Accelerator Research Complex [2013B0166]	This work was supported by the Research and Development Initiative for Scientific Innovation of New Generation Battery (RISING Project) of the New Energy and Industrial Technology Development Organization (NEDO; Japan). The synchrotron X-ray experiments were performed as projects approved by the Japan Synchrotron Radiation Research Institute (2013B1530 and 2013B1711), and the neutron experiments were performed as projects approved by the Japan Proton Accelerator Research Complex (2013B0166).	Zheng YM, 2012, J POWER SOURCES, V208, P447, DOI 10.1016/j.jpowsour.2012.02.044; Koyama Y, 2009, J POWER SOURCES, V189, P798, DOI 10.1016/j.jpowsour.2008.07.073; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; Koga H, 2013, J POWER SOURCES, V236, P250, DOI 10.1016/j.jpowsour.2013.02.075; Hirayama M, 2007, J POWER SOURCES, V168, P493, DOI 10.1016/j.jpowsour.2007.03.034; Xu B, 2011, ENERG ENVIRON SCI, V4, P2223, DOI 10.1039/c1ee01131f; Thackeray MM, 2005, J MATER CHEM, V15, P2257, DOI 10.1039/b417616m; Lim J, 2012, J MATER CHEM, V22, P11772, DOI 10.1039/c2jm30962a; Johnson CS, 2004, ELECTROCHEM COMMUN, V6, P1085, DOI 10.1016/j.elecom.2004.08.002; Wang X, 2003, J ALLOY COMPD, V354, P91, DOI 10.1016/S0925-8388(02)01350-6; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Sakamoto K, 2009, CHEM MATER, V21, P2632, DOI 10.1021/cm8033559; Sakamoto K, 2010, PHYS CHEM CHEM PHYS, V12, P3815, DOI 10.1039/b920271d; Galakhov VR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.113102; Yu DYW, 2009, J ELECTROCHEM SOC, V156, pA417, DOI 10.1149/1.3110803; Ohzuku T, 2011, J MATER CHEM, V21, P10179, DOI 10.1039/c0jm04325g; Zheng YM, 2012, THIN SOLID FILMS, V520, P4889, DOI 10.1016/j.tsf.2012.03.029; Mitamura K, 2013, POLYM J, V45, P100, DOI 10.1038/pj.2012.156; Ito A, 2008, J POWER SOURCES, V183, P344, DOI 10.1016/j.jpowsour.2008.04.086; Suzuki K, 2013, J POWER SOURCES, V226, P340, DOI 10.1016/j.jpowsour.2012.11.008; Kubota K, 2012, J POWER SOURCES, V216, P249, DOI 10.1016/j.jpowsour.2012.05.061; Yabuuchi N, 2011, J AM CHEM SOC, V133, P4404, DOI 10.1021/ja108588y; Robertson AD, 2003, CHEM MATER, V15, P1984, DOI 10.1021/cm030047u; Hirayama M, 2010, ELECTROCHEMISTRY, V78, P413; Ammundsen B, 2001, ADV MATER, V13, P943, DOI 10.1002/1521-4095(200107)13:12/13<943::AID-ADMA943>3.0.CO;2-J; Meng YS, 2005, CHEM MATER, V17, P2386, DOI 10.1021/cm047779m; Breger J, 2005, J SOLID STATE CHEM, V178, P2575, DOI 10.1016/j.jssc.2005.05.027; Armstrong AR, 2006, J AM CHEM SOC, V128, P8694, DOI 10.1021/ja062027+; Taminato S, 2014, J MATER CHEM A, V2, P17875, DOI 10.1039/c4ta02795g; Hirayama M, 2010, J AM CHEM SOC, V132, P15268, DOI 10.1021/ja105389t; Hong YS, 2005, SOLID STATE IONICS, V176, P1035, DOI 10.1016/j.ssi.2005.02.006; Kim S, 2014, CRYSTENGCOMM, V16, P1044, DOI 10.1039/c3ce42003e; Konishi H, 2014, J POWER SOURCES, V246, P365, DOI 10.1016/j.jpowsour.2013.07.051; Yamada N. L., 2011, EUR PHYS J PLUS, V126, P1	34	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1673	1676		10.1039/c4cc07758j		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100029		
J	Kamimura, T; Komura, M; Komiyama, H; Iyoda, T; Tani, F				Kamimura, Takuya; Komura, Motonori; Komiyama, Hideaki; Iyoda, Tomokazu; Tani, Fumito			Linear assembly of a porphyrin-C-60 complex confined in vertical nanocylinders of amphiphilic block copolymer films	CHEMICAL COMMUNICATIONS			English	Article							PHOTOINDUCED CHARGE SEPARATION; SOLAR-ENERGY CONVERSION; AG-NANOPARTICLE ARRAY; ALUMINUM-OXIDE; FULLERENES; NANOSTRUCTURES; SYSTEMS; DIMERS; HOSTS; C-60	Linear assemblies of a 1:1 porphyrin-fullerene C-60 complex were formed in vertical cylindrical polyether nanodomains of amphiphilic block copolymer films by a simple spin coating-annealing method. The nanocylinder structures were retained even with high contents of the complex in the polymer films.	[Kamimura, Takuya; Tani, Fumito] Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan; [Komura, Motonori] Numazu Coll, Natl Inst Technol, Shizuoka 4108501, Japan; [Komiyama, Hideaki; Iyoda, Tomokazu] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Komura, M (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	m-komura@numazu-ct.ac.jp; tanif@ms.ifoc.kyushu-u.ac.jp	Iyoda, Tomokazu/F-4731-2015	Iyoda, Tomokazu/0000-0002-9393-5387	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nano-Macro Materials, Devices and System Research Alliance Project of our institutes and Research Grants; Tokuyama Science and Technology Foundation; Iketani Science and Technology Foundation	This work was supported by Grants-in-Aid (No. 20108009 to F. T.) from Ministry of Education, Culture, Sports, Science and Technology of Japan, Research Grants from Nano-Macro Materials, Devices and System Research Alliance Project of our institutes and Research Grants to F. T. from Tokuyama Science and Technology Foundation and Iketani Science and Technology Foundation. We acknowledge Prof. K. Tamada of Kyushu University and Mr H. Takami and Ms S. Moriya of Asylum Technology Co. Ltd for their kind cooperation with AFM measurements.	Tseng YC, 2010, POLYMERS-BASEL, V2, P470, DOI 10.3390/polym2040470; Nobukuni H, 2007, ANGEW CHEM INT EDIT, V46, P8975, DOI 10.1002/anie.200704058; Kamat PV, 2007, J PHYS CHEM C, V111, P2834, DOI 10.1021/jp066952u; Li JZ, 2008, THIN SOLID FILMS, V516, P2577, DOI 10.1016/j.tsf.2007.04.126; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Yamamoto T, 2011, ADV FUNCT MATER, V21, P918, DOI 10.1002/adfm.201002069; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; Fukuzumi S, 2003, ORG BIOMOL CHEM, V1, P609, DOI 10.1039/b300053b; Li FY, 1998, CHEM MATER, V10, P2470, DOI 10.1021/cm980163a; Canevet D, 2011, ANGEW CHEM INT EDIT, V50, P9248, DOI 10.1002/anie.201101297; Tashiro K, 2007, CHEM SOC REV, V36, P189, DOI 10.1039/b614883m; KELLER F, 1953, J ELECTROCHEM SOC, V100, P411, DOI 10.1149/1.2781142; Imahori H, 2012, CHEM COMMUN, V48, P4032, DOI 10.1039/c2cc30621b; Jiang Q, 2014, CHEM SOC REV, V43, P2066, DOI 10.1039/c3cs60234f; Sakaguchi K, 2014, J ORG CHEM, V79, P2980, DOI 10.1021/jo500034f; Boyd PDW, 2005, ACCOUNTS CHEM RES, V38, P235, DOI 10.1021/ar040168f; Kamimura T, 2013, CHEM SCI, V4, P1451, DOI 10.1039/c3sc22065f; Komiyama H, 2014, MACROMOLECULES, V47, P1777, DOI 10.1021/ma402356z; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m; Kira A, 2009, J AM CHEM SOC, V131, P3198, DOI 10.1021/ja8096465; Fukuzumi S, 2013, DALTON T, V42, P15846, DOI 10.1039/c3dt51883c; Guldi DM, 2005, ACCOUNTS CHEM RES, V38, P38, DOI 10.1021/ar040222s; Kim JK, 2010, PROG POLYM SCI, V35, P1325, DOI 10.1016/j.progpolymsci.2010.06.002; Martin N, 2007, ACCOUNTS CHEM RES, V40, P1015; Bottari G, 2012, COORDIN CHEM REV, V256, P2453, DOI 10.1016/j.ccr.2012.03.011; Nobukuni H, 2010, CHEM-EUR J, V16, P11611, DOI 10.1002/chem.201001815; Schuster DI, 2013, J ORG CHEM, V78, P6811, DOI 10.1021/jo4007078; Wang ZP, 2014, ACS APPL MATER INTER, V6, P6369, DOI 10.1021/am405740c; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Nobukuni H, 2009, J PHYS CHEM C, V113, P19694, DOI 10.1021/jp9076849; El-Khouly ME, 2004, J PHOTOCH PHOTOBIO C, V5, P79, DOI 10.1016/j.jphotochemrev.2004.01.003; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Tian YQ, 2002, MACROMOLECULES, V35, P3739, DOI 10.1021/ma011859j; Gust D, 2012, FARADAY DISCUSS, V155, P9, DOI 10.1039/c1fd00110h; Asaoka S, 2011, MACROMOLECULES, V44, P7645, DOI 10.1021/ma201119u; Brettreich M., 2005, FULLERENES CHEM REAC; Chen A, 2008, ADV MATER, V20, P763, DOI 10.1002/adma.200702010; D'Souza F, 2009, CHEM COMMUN, P4913, DOI 10.1039/b905753f; Dong BX, 2013, MACROMOL RAPID COMM, V34, P492, DOI 10.1002/marc.201200766; Echegoyen L., 2000, FULLERENES CHEM PHYS, P1; Fukuzumi S., 2001, ELECT TRANSFER CHEM, V2, P270; Goda T, 2012, J MATER CHEM, V22, P9477, DOI 10.1039/c2jm16818a; Guldi D. M., 2003, FULLERENES SYNTHESIS, P237; ITAYA K, 1984, J CHEM ENG JPN, V17, P514, DOI 10.1252/jcej.17.514; Kadish K. K., 2010, HDB PORPHYRIN SCI; Kadish K. M., 2000, PORPHYRIN HDB; Kanaizuka K, 2013, ACS APPL MATER INTER, V5, P6879, DOI 10.1021/am401123r; Komura M, 2007, MACROMOLECULES, V40, P4106, DOI 10.1021/ma0704008; Komura M, 2009, CHEM LETT, V38, P408, DOI 10.1246/cl.2009.408; Li JZ, 2007, ADV MATER, V19, P1267, DOI 10.1002/adma.200602851; Li JZ, 2010, ULTRAMICROSCOPY, V110, P1338, DOI 10.1016/j.ultramic.2010.06.006; van Grieken R. E., 2002, HDB XRAY SPECTROMETR, P47; Watanabe R, 2008, J MATER CHEM, V18, P5482, DOI 10.1039/b806378h; Watanabe S, 2007, ANGEW CHEM INT EDIT, V46, P1120, DOI 10.1002/anie.200603516; Zhang JH, 2014, RSC ADV, V4, P27389, DOI 10.1039/c4ra04583a; Zhao D., 2012, CHEM SOC REV, P4054	56	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1685	1688		10.1039/c4cc09262g		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100032		
J	Liu, H; Lu, H; Zhou, ZK; Shimizu, S; Li, ZF; Kobayashi, N; Shen, Z				Liu, Hui; Lu, Hua; Zhou, Zhikuan; Shimizu, Soji; Li, Zhifang; Kobayashi, Nagao; Shen, Zhen			Asymmetric core-expanded aza-BODIPY analogues: facile synthesis and optical properties	CHEMICAL COMMUNICATIONS			English	Article							STOKES SHIFT; PHOTOPHYSICAL PROPERTIES; SPECTROSCOPIC PROPERTIES; CHARGE-TRANSFER; DYES; FLUORESCENCE; DERIVATIVES; INHIBITION; COMPLEXES; TRANSPORT	Significantly large Stokes shifts and enhanced solid state emissions were achieved in a novel series of asymmetric core-expanded aza-BODIPY analogues, 4a-4d, synthesized by a facile and scalable two-step reaction in high yields.	[Liu, Hui; Lu, Hua; Li, Zhifang] Hangzhou Normal Univ, Minist Educ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou 310012, Zhejiang, Peoples R China; [Zhou, Zhikuan; Shen, Zhen] Nanjing Univ, Nanjing Natl Lab Microstruct, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Lu, Hua; Kobayashi, Nagao] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Shimizu, Soji] Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Fukuoka 8190395, Japan	Lu, H (reprint author), Hangzhou Normal Univ, Minist Educ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou 310012, Zhejiang, Peoples R China.	hualu@hznu.edu.cn; zshen@nju.edu.cn	LU, Hua/K-1544-2013; Shimizu, Soji/D-5786-2011		National Natural Science Foundation of China [21371090, 21471042]; Zhejiang Provincial Natural Science Foundation of China [LY14B010003]	Financial support was provided by the National Natural Science Foundation of China (no. 21371090 and 21471042) and the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY14B010003). Theoretical calculations were carried out at the Computational Center for Molecular Design of Organosilicon Compounds, Hangzhou Normal University.	Burrows PE, 1996, J APPL PHYS, V79, P7991, DOI 10.1063/1.362350; Lu H, 2010, CHEM COMMUN, V46, P3565, DOI 10.1039/b926300d; Gao NX, 2014, DALTON T, V43, P7121, DOI 10.1039/c4dt00138a; Lu H, 2014, CHEM SOC REV, V43, P4778, DOI 10.1039/c4cs00030g; Lu H, 2011, CHEM-ASIAN J, V6, P1026, DOI 10.1002/asia.201000641; Kollmannsberger M, 1998, J PHYS CHEM A, V102, P10211, DOI 10.1021/jp982701c; Grabowski ZR, 2003, CHEM REV, V103, P3899, DOI 10.1021/cr940745l; Qu XY, 2012, CHEM COMMUN, V48, P4600, DOI 10.1039/c2cc31011b; Yu YH, 2006, CHEM-ASIAN J, V1, P176, DOI 10.1002/asia.200600042; Gai LZ, 2014, CHEM-EUR J, V20, P1091, DOI 10.1002/chem.201303291; Lu H, 2012, CHEM-EUR J, V18, P7852, DOI 10.1002/chem.201200169; Boens N, 2012, CHEM SOC REV, V41, P1130, DOI 10.1039/c1cs15132k; Gai LZ, 2013, SENSOR ACTUAT B-CHEM, V182, P1, DOI 10.1016/j.snb.2013.02.106; Ulrich G, 2008, ANGEW CHEM INT EDIT, V47, P1184, DOI 10.1002/anie.200702070; Liu H, 2014, CHEM COMMUN, V50, P1074, DOI 10.1039/c3cc48316a; Wang XQ, 2014, NEW J CHEM, V38, P1277, DOI 10.1039/c3nj01361h; Kamkaew A, 2013, CHEM SOC REV, V42, P77, DOI 10.1039/c2cs35216h; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; Cornil J, 2001, ADV MATER, V13, P1053, DOI 10.1002/1521-4095(200107)13:14<1053::AID-ADMA1053>3.0.CO;2-7; Ozdemir T, 2009, ORG LETT, V11, P2105, DOI 10.1021/ol9005568; Schon JH, 2000, SCIENCE, V287, P1022, DOI 10.1126/science.287.5455.1022; Araneda JF, 2011, ANGEW CHEM INT EDIT, V50, P12214, DOI 10.1002/anie.201105228; Frath D., 2014, ANGEW CHEM INT EDIT, V53, P2; Frisch M. J., GAUSSIAN 09; Zhang DK, 2008, CHEM COMMUN, P4777, DOI 10.1039/b808681h	25	7	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1713	1716		10.1039/c4cc06704e		4	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100039		
J	Kodama, R; Sumaru, K; Morishita, K; Kanamori, T; Hyodo, K; Kamitanaka, T; Morimoto, M; Yokojima, S; Nakamura, S; Uchida, K				Kodama, Ryuhei; Sumaru, Kimio; Morishita, Kana; Kanamori, Toshiyuki; Hyodo, Kengo; Kamitanaka, Takashi; Morimoto, Masakazu; Yokojima, Satoshi; Nakamura, Shinichiro; Uchida, Kingo			A diarylethene as the SO2 gas generator upon UV irradiation	CHEMICAL COMMUNICATIONS			English	Article							THIOPHENE 1,1-DIOXIDE; CELLS; LIGHT	A closed-ring isomer of a diarylethene having a sulfone group works as the reagent for SO2 gas generation with thermal stability even at 70 degrees C, and it rapidly reverts to the open-ring isomer and generates the SO2 gas to induce cell death upon UV irradiation.	[Kodama, Ryuhei; Hyodo, Kengo; Uchida, Kingo] Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan; [Sumaru, Kimio; Morishita, Kana; Kanamori, Toshiyuki] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058565, Japan; [Kamitanaka, Takashi] Ind Res Ctr Shiga Prefecture, Ritto, Shiga 5203004, Japan; [Morimoto, Masakazu] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan; [Morimoto, Masakazu] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan; [Yokojima, Satoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Yokojima, Satoshi; Nakamura, Shinichiro] RIKEN, Res Cluster Innovat, Nakamura Lab, Wako, Saitama 3510198, Japan	Sumaru, K (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba Cent 5th,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	k.sumaru@aist.go.jp; uchida@rins.ryukoku.ac.jp	Morimoto, Masakazu/F-3232-2013	Morimoto, Masakazu/0000-0002-7494-0404	Japan Science and Technology Agency (JST); MEXT (Ministry of Education, Culture, Sports, Science and Technology)	This work was partially supported by A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R&D) FS stage: Exploratory Research from the Japan Science and Technology Agency (JST) and MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities. The authors are also grateful to Zeon Co., Ltd, for providing octafluorocyclopentene to synthesize 10, T. Sakurai of JEOL Resonance Ltd for DOSY measurements, and J. Okuda and K. Takase for quantumyieldmeasurement of the SO<INF>2</INF> gas generated.	Fukaminato T, 2011, J AM CHEM SOC, V133, P4984, DOI 10.1021/ja110686t; Al-Atar U, 2009, J AM CHEM SOC, V131, P15966, DOI 10.1021/ja903070u; Malwal SR, 2012, J MED CHEM, V55, P553, DOI 10.1021/jm201023g; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Yi HL, 2012, ECOTOX ENVIRON SAFE, V78, P281, DOI 10.1016/j.ecoenv.2011.11.035; Fukaminato T, 2009, J PHYS CHEM C, V113, P11623, DOI 10.1021/jp902880d; Shoji H, 2013, CHEM COMMUN, V49, P2362, DOI 10.1039/c3cc00053b; Uno K, 2011, J AM CHEM SOC, V133, P13558, DOI 10.1021/ja204583e; Feringa BL, 2011, MOLECULAR SWITCHES, VOL 1, 2ND EDITION, P1, DOI 10.1002/9783527634408; Jeong YC, 2006, CHEM COMMUN, P1881, DOI 10.1039/b600754f; Jeong YC, 2005, B KOR CHEM SOC, V26, P1675; Nagasawa H, 1999, B CHEM SOC JPN, V72, P1919, DOI 10.1246/bcsj.72.1919; Nakayama J, 1997, J AM CHEM SOC, V119, P9077, DOI 10.1021/ja971934z; REED GA, 1986, P NATL ACAD SCI USA, V83, P7499, DOI 10.1073/pnas.83.19.7499; SHI XL, 1994, BIOCHEM BIOPH RES CO, V205, P141, DOI 10.1006/bbrc.1994.2641; Sumaru K, 2013, BIOTECHNOL BIOENG, V110, P348, DOI 10.1002/bit.24617; Uyama A, 2011, LANGMUIR, V27, P6395, DOI 10.1021/la2006524	17	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1736	1738		10.1039/c4cc07790c		3	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100045		
J	Li, P; Zhou, Y; Li, HJ; Xu, QF; Meng, XG; Wang, XY; Xiao, M; Zou, ZG				Li, Ping; Zhou, Yong; Li, Haijin; Xu, Qinfeng; Meng, Xianguang; Wang, Xiaoyong; Xiao, Min; Zou, Zhigang			All-solid-state Z-scheme system arrays of Fe2V4O13/RGO/CdS for visible light-driving photocatalytic CO2 reduction into renewable hydrocarbon fuel (vol 51, pg 800, 2015)	CHEMICAL COMMUNICATIONS			English	Correction									[Li, Ping; Zhou, Yong] Nanjing Univ, MOE, Inst Acoust, Dept Phys,Key Lab Modern Acoust, Nanjing 210093, Jiangsu, Peoples R China; [Li, Ping; Zhou, Yong; Xu, Qinfeng; Wang, Xiaoyong; Xiao, Min; Zou, Zhigang] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Li, Ping; Zhou, Yong; Li, Haijin; Zou, Zhigang] ERERC, Nanjing 210093, Jiangsu, Peoples R China; [Li, Haijin] Anhui Univ Technol, Sch Math & Phys, Maanshan 243002, Peoples R China; [Meng, Xianguang] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600814, Japan; [Meng, Xianguang] Int Ctr Mat Nanoarchitecn WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Meng, Xianguang] Environm Remediat Mat Unit, Tsukuba, Ibaraki 3050044, Japan	Zhou, Y (reprint author), Nanjing Univ, MOE, Inst Acoust, Dept Phys,Key Lab Modern Acoust, Nanjing 210093, Jiangsu, Peoples R China.	zhouyong1999@nju.edu.cn; zgzou@nju.edu.cn	Xiao, Min/F-6184-2013				Li P, 2015, CHEM COMMUN, V51, P800, DOI 10.1039/c4cc08744e	1	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	9					1743	1743		10.1039/c4cc90485k		1	Chemistry, Multidisciplinary	Chemistry	AZ4NU	WOS:000348200100047		
J	Konishi, H; Nagase, H; Manabe, K				Konishi, Hideyuki; Nagase, Hiroki; Manabe, Kei			Concise synthesis of cyclic carbonyl compounds from haloarenes using phenyl formate as the carbonyl source	CHEMICAL COMMUNICATIONS			English	Article							PALLADIUM-CATALYZED CARBONYLATION; ARYL HALIDES; ATMOSPHERIC-PRESSURE; N-FORMYLSACCHARIN; MONOXIDE SOURCE; VINYL HALIDES; CO SOURCE; AMINOCARBONYLATIONS; DECARBONYLATION; NUCLEOPHILES	Various cyclic carbonyl compounds were concisely synthesized by carbonylative cyclization of haloarenes bearing nucleophilic moieties under Pd catalysis. A broad substrate scope and a feasible large-scale synthesis clearly demonstrate the high applicability of the reaction as a general, user-friendly method for access to cyclic carbonyl compounds.	[Konishi, Hideyuki; Nagase, Hiroki; Manabe, Kei] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Manabe, K (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	manabe@u-shizuoka-ken.ac.jp			Uehara Memorial Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partly supported by the Uehara Memorial Foundation and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Cacchi S, 2003, ORG LETT, V5, P4269, DOI 10.1021/ol0354371; Ueda T, 2012, TETRAHEDRON LETT, V53, P5171, DOI 10.1016/j.tetlet.2012.07.057; CARPENTIER JF, 1991, TETRAHEDRON LETT, V32, P4705, DOI 10.1016/S0040-4039(00)92287-1; Ueda T, 2013, ANGEW CHEM INT EDIT, V52, P8611, DOI 10.1002/anie.201303926; Wu LP, 2014, ANGEW CHEM INT EDIT, V53, P6310, DOI 10.1002/anie.201400793; Wu XF, 2013, CHEM-EUR J, V19, P6230, DOI 10.1002/chem.201300537; Kiss G, 2001, CHEM REV, V101, P3435, DOI 10.1021/cr010328q; Martinelli JR, 2007, ANGEW CHEM INT EDIT, V46, P8460, DOI 10.1002/anie.200702943; Wan YQ, 2002, J ORG CHEM, V67, P6232, DOI 10.1021/jo025965a; Wu XF, 2013, CHEM REV, V113, P1, DOI 10.1021/cr300100s; Hoshimoto Y, 2014, J AM CHEM SOC, V136, P15877, DOI 10.1021/ja509171a; Hermange P, 2011, J AM CHEM SOC, V133, P6061, DOI 10.1021/ja200818w; Beck CM, 1999, ORGANOMETALLICS, V18, P5311, DOI 10.1021/om9905106; Martinelli JR, 2008, J ORG CHEM, V73, P7102, DOI 10.1021/jo801279r; Ueda T, 2012, ORG LETT, V14, P3100, DOI 10.1021/ol301192s; Lagerlund O, 2006, J COMB CHEM, V8, P4, DOI 10.1021/cc050102r; Li WF, 2014, J ORG CHEM, V79, P10410, DOI 10.1021/jo5020118; Morimoto T, 2007, J ORGANOMET CHEM, V692, P625, DOI 10.1016/j.jorganchem.2006.08.038; Wu XF, 2011, CHEM SOC REV, V40, P4986, DOI 10.1039/c1cs15109f; Fujihara T, 2012, CHEM COMMUN, V48, P8012, DOI 10.1039/c2cc33944g; NEGISHI E, 1989, J AM CHEM SOC, V111, P8018, DOI 10.1021/ja00202a055; Friis SD, 2011, J AM CHEM SOC, V133, P18114, DOI 10.1021/ja208652n; JENNER G, 1990, J ORGANOMET CHEM, V387, P315, DOI 10.1016/0022-328X(90)87180-L; OKANO T, 1982, TETRAHEDRON LETT, V23, P4967, DOI 10.1016/S0040-4039(00)85762-7; Ueda T, 2013, ORG LETT, V15, P5370, DOI 10.1021/ol4026815; Ueda T, 2012, ORG LETT, V14, P5370, DOI 10.1021/ol302593z; Morimoto T, 2004, ANGEW CHEM INT EDIT, V43, P5580, DOI 10.1002/anie.200301736; FENTON G, 1989, J MED CHEM, V32, P265, DOI 10.1021/jm00121a047; Fuji K, 2003, ANGEW CHEM INT EDIT, V42, P2409, DOI 10.1002/anie.200351384; HEDSTROM L, 1984, BIOCHEMISTRY-US, V23, P1753, DOI 10.1021/bi00303a026; Koistinen H, 2008, PROSTATE, V68, P1143, DOI 10.1002/pros.20773; Konishi H., 2014, SYNLETT, P1971; Konishi H., 2014, ORG SYNTH, V91, P39; KRANTZ A, 1990, J MED CHEM, V33, P464, DOI 10.1021/jm00164a002; Morgan JS, 1916, J CHEM SOC, V109, P274, DOI 10.1039/ct9160900274; Negishi E, 1998, TETRAHEDRON, V54, P1095, DOI 10.1016/S0040-4020(97)10210-1; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; Odell LR, 2012, SYNLETT, P685, DOI 10.1055/s-0031-1290350; Yalfani MS, 2013, GREEN CHEM, V15, P1146, DOI 10.1039/c3gc36877g	39	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	10					1854	1857		10.1039/c4cc09413a		4	Chemistry, Multidisciplinary	Chemistry	AZ4SN	WOS:000348213200018		
J	Ugai, T; Minami, A; Fujii, R; Tanaka, M; Oguri, H; Gomi, K; Oikawa, H				Ugai, Takahiro; Minami, Atsushi; Fujii, Ryuya; Tanaka, Mizuki; Oguri, Hiroki; Gomi, Katsuya; Oikawa, Hideaki			Heterologous expression of highly reducing polyketide synthase involved in betaenone biosynthesis	CHEMICAL COMMUNICATIONS			English	Article							ASPERGILLUS-ORYZAE; LOVASTATIN BIOSYNTHESIS; ALTERNARIA-SOLANI; PHOMA; RECONSTITUTION; INHIBITORS; REDUCTASE; CLUSTER; FR; METABOLITES	A unique highly reducing polyketide synthase (HR-PKS) with a reductase domain was identified in a betaenone biosynthetic gene cluster. Successful heterologous expression and characterization of the HR-PKS and trans-acting enoyl reductase (ER) provide insights into the core structure formation with a decalin scaffold and allow reconstitution of the betaenone biosynthetic machinery.	[Ugai, Takahiro; Minami, Atsushi; Fujii, Ryuya; Tanaka, Mizuki; Oguri, Hiroki; Oikawa, Hideaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan; [Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Oikawa, H (reprint author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan.	hoik@sci.hokudai.ac.jp	Minami, Atsushi/A-4314-2012; Oguri, Hiroki/F-9541-2015		MEXT [22108002]	We are grateful to Prof. Masanori Arita of the National Institute of Genetics for meaningful discussions about the phylogenetic analysis of the KS domain of PKS. This work was financially supported by a MEXT research grant on innovation area 22108002 to H. Oikawa.	Fujii R, 2011, BIOSCI BIOTECH BIOCH, V75, P1813, DOI 10.1271/bbb.110366; Tagami K, 2013, J AM CHEM SOC, V135, P1260, DOI 10.1021/ja3116636; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Wasil Z, 2013, CHEM SCI, V4, P3845, DOI 10.1039/c3sc51785c; Xu W, 2013, ANGEW CHEM INT EDIT, V52, P6472, DOI 10.1002/anie.201302406; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Boettger D, 2013, CHEMBIOCHEM, V14, P28, DOI 10.1002/cbic.201200624; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Heneghan MN, 2010, CHEMBIOCHEM, V11, P1508, DOI 10.1002/cbic.201000259; Ames BD, 2012, P NATL ACAD SCI USA, V109, P11144, DOI 10.1073/pnas.1113029109; Dabrah TT, 1997, J AM CHEM SOC, V119, P1594, DOI 10.1021/ja961000v; Tagami K, 2014, CHEMBIOCHEM, V15, P2076, DOI 10.1002/cbic.201402195; OIKAWA H, 1994, J AM CHEM SOC, V116, P3605, DOI 10.1021/ja00087a059; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Cole R. J., 2003, HDB SECONDARY FUNGAL; Cox R. J., 2010, COMPREHENSIVE NATURA, V1, P347; Dabrah T. T., 1997, J ANTIBIOT, V50, P9933; DAWSON MJ, 1992, J ANTIBIOT, V45, P639; ICHIHARA A, 1983, J AM CHEM SOC, V105, P2907, DOI 10.1021/ja00347a070; ICHIHARA A, 1983, AGR BIOL CHEM TOKYO, V47, P2965; Izumi Y, 2012, MOL PLANT MICROBE IN, V25, P1419, DOI 10.1094/MPMI-06-12-0155-R; Kasahara K, 2006, CHEMBIOCHEM, V7, P920, DOI 10.1002/cbic.200600034; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; Matsuda Y, 2014, J AM CHEM SOC, V136, P15326, DOI 10.1021/ja508127q; MIKI S, 1990, J CHEM SOC PERK T 1, P1228, DOI 10.1039/p19900001228; OIKAWA H, 1988, J CHEM SOC CHEM COMM, P600, DOI 10.1039/c39880000600; Oikawa H., 1995, J CHEM SOC CHEM COMM, P908; OIKAWA H, 1990, J CHEM SOC CHEM COMM, P908, DOI 10.1039/c39900000908; OIKAWA H, 1984, J CHEM SOC CHEM COMM, P814, DOI 10.1039/c39840000814; Sorensen JL, 2012, ENVIRON MICROBIOL, V14, P1159, DOI 10.1111/j.1462-2920.2011.02696.x; Turner W. B., 1982, FUNGAL METABOLITES, V2; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g	33	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	10					1878	1881		10.1039/c4cc09512j		4	Chemistry, Multidisciplinary	Chemistry	AZ4SN	WOS:000348213200024		
J	Ishida, N; Ishikawa, N; Sawano, S; Masuda, Y; Murakami, M				Ishida, Naoki; Ishikawa, Norikazu; Sawano, Shota; Masuda, Yusuke; Murakami, Masahiro			Construction of tetralin skeletons based on rhodium-catalysed site-selective ring opening of benzocyclobutenols	CHEMICAL COMMUNICATIONS			English	Article							DIASTEREOSELECTIVE TOTAL-SYNTHESIS; QUATERNARY STEREOGENIC CENTERS; C BOND ACTIVATION; ENANTIOSELECTIVE SYNTHESIS; ELECTROCYCLIC REACTIONS; ORGANIC-SYNTHESIS; FORMAL SYNTHESIS; (-)-MORPHINE; CYCLOADDITION; QUINODIMETHANES	Tetralins (tetrahydronaphthalenes) are synthesised from benzocyclo-butenols based on the rhodium-catalysed site-selective ring opening followed by intermolecular/intramolecular conjugate addition of the resulting arylrhodium species to electron-deficient alkenes. The produced structures make a remarkable contrast with those available from the same compounds under thermal reaction conditions.	[Ishida, Naoki; Ishikawa, Norikazu; Sawano, Shota; Masuda, Yusuke; Murakami, Masahiro] Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	Murakami, M (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	murakami@sbchem.kyoto-u.ac.jp			MEXT; ACT-C program of the JST	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis", a Grant-in-Aid for Scientific Research (B) from MEXT, and the ACT-C program of the JST. This communication is dedicated to Professor Ming-Chang P. Yeh (National Taiwan Normal University) on the occasion of his 60th birthday.	Jung CK, 2006, J AM CHEM SOC, V128, P17051, DOI 10.1021/ja066198q; TSUKAMOTO H, 1984, CHEM PHARM BULL, V32, P2730; Parker KA, 2006, J ORG CHEM, V71, P449, DOI 10.1021/jo0513008; Segura JL, 1999, CHEM REV, V99, P3199, DOI 10.1021/cr990011e; Leisch H, 2009, TETRAHEDRON, V65, P9862, DOI 10.1016/j.tet.2009.09.052; SLOUGH GA, 1989, J AM CHEM SOC, V111, P938, DOI 10.1021/ja00185a025; Matsuda T, 2013, ORG BIOMOL CHEM, V11, P3424, DOI 10.1039/c3ob40436f; Xu T, 2012, ANGEW CHEM INT EDIT, V51, P7567, DOI 10.1002/anie.201202771; Chavan SP, 2012, TETRAHEDRON, V68, P8509, DOI 10.1016/j.tet.2012.07.020; Dolbier WR, 1996, ACCOUNTS CHEM RES, V29, P471; Suzuki T, 2008, ANGEW CHEM INT EDIT, V47, P2248, DOI 10.1002/anie.200705630; STEVENS RV, 1982, J ORG CHEM, V47, P2396, DOI 10.1021/jo00133a032; Ishida N, 2012, J AM CHEM SOC, V134, P17502, DOI 10.1021/ja309013a; Korenaga T, 2009, ORG LETT, V11, P2325, DOI 10.1021/ol900719z; Magnus P, 2009, J AM CHEM SOC, V131, P16045, DOI 10.1021/ja9085534; Gokhale A, 1998, HELV CHIM ACTA, V81, P251, DOI 10.1002/hlca.19980810207; Varin M, 2008, CHEM-EUR J, V14, P6606, DOI 10.1002/chem.200800744; Trost BM, 2005, J AM CHEM SOC, V127, P14785, DOI 10.1021/ja054449+; Cauble DF, 2003, J AM CHEM SOC, V125, P1110, DOI 10.1021/ja0211095; Chtchemelinine A, 2011, J ORG CHEM, V76, P9157, DOI 10.1021/jo201632c; Yoshida K, 2002, J AM CHEM SOC, V124, P10984, DOI 10.1021/ja0271025; Koizumi H, 2010, CHEM-ASIAN J, V5, P2192, DOI 10.1002/asia.201000458; Tanimoto H, 2008, TETRAHEDRON LETT, V49, P358, DOI 10.1016/j.tetlet.2007.11.037; Xu T, 2012, J AM CHEM SOC, V134, P20005, DOI 10.1021/ja309978c; Seiser T, 2008, ANGEW CHEM INT EDIT, V47, P9294, DOI 10.1002/anie.200804281; Stork G, 2009, J AM CHEM SOC, V131, P11402, DOI 10.1021/ja9038505; MILES DH, 1989, J NAT PROD, V52, P896, DOI 10.1021/np50064a045; Seiser T, 2010, CHEM-EUR J, V16, P3383, DOI 10.1002/chem.200903225; Xia Y, 2014, J AM CHEM SOC, V136, P3013, DOI 10.1021/ja500118w; CHARLTON JL, 1987, TETRAHEDRON, V43, P2873, DOI 10.1016/S0040-4020(01)86825-3; Matsuo K, 2010, ORG LETT, V12, P5346, DOI 10.1021/ol102407k; Chen PH, 2014, ANGEW CHEM INT EDIT, V53, P1674, DOI 10.1002/anie.201310100; Li Y, 2013, J ORG CHEM, V78, P11357, DOI 10.1021/jo4019123; Ding LN, 2014, J AM CHEM SOC, V136, P169, DOI 10.1021/ja407422q; Zhao PJ, 2006, J AM CHEM SOC, V128, P3124, DOI 10.1021/ja058550q; Arnold B. J., 1974, J CHEM SOC PERKIN TR, V1, P409; BRANDS M, 1991, J CHEM SOC CHEM COMM, P1541, DOI 10.1039/c39910001541; CHOY W, 1988, J ORG CHEM, V53, P5796, DOI 10.1021/jo00259a041; Di Marco A., 1964, CANCER CHEMOTH REP, V38, P31; Flores-Gaspar A., 2013, SYNTHESIS-STUTTGART, P0563; Hickman DN, 1996, TETRAHEDRON, V52, P2235, DOI 10.1016/0040-4020(95)01054-8; KUNDIG EP, 1991, J CHEM SOC CHEM COMM, P1713, DOI 10.1039/c39910001713; MORITANI Y, 1995, J CHEM SOC CHEM COMM, P671, DOI 10.1039/c39950000671; OPPOLZER W, 1978, SYNTHESIS-STUTTGART, P793; Rosa D., 2012, SYNTHESIS-STUTTGART, P1885; Taylor SJ, 2000, J AM CHEM SOC, V122, P4528, DOI 10.1021/ja9944453; Zezula J, 2005, SYNLETT, P388, DOI 10.1055/s-2005-862383	47	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	10					1882	1885		10.1039/c4cc09327e		4	Chemistry, Multidisciplinary	Chemistry	AZ4SN	WOS:000348213200025		
J	Kashima, A; Sakate, M; Ota, H; Fuyuhiro, A; Sunatsuki, Y; Suzuki, T				Kashima, Ayana; Sakate, Mika; Ota, Hiromi; Fuyuhiro, Akira; Sunatsuki, Yukinari; Suzuki, Takayoshi			Thyminate(2-)-bridged cyclic tetranuclear rhodium(III) complexes formed by a template of a sodium, calcium or lanthanoid ion	CHEMICAL COMMUNICATIONS			English	Article							ALKALI-METAL IONS; HALF-SANDWICH; MOLECULAR RECOGNITION; BIOORGANOMETALLIC CHEMISTRY; IRIDIUM COMPLEXES; ADENOSINE; METALLACROWNS; ENCAPSULATION; COORDINATION; NUCLEOBASES	In the thyminate(2-)-bridged tetranuclear Cp*Rh-III complexes incorporating a Na+, Ca2+ or Ln(3+) cation, homochiral aggregation of four Rh-III centres was achieved to form metallacalix[4] arene-type clusters. The thyminate(2-) bridged two RhIII and the third metal ionwith a mu(3)-1 kappa N-1:2 kappa N-2(3),O-2:3 kappa O-2 mode in the Na+ and Ca2+ complexes, while in the Ln(3+) analogues it exhibited a different bridging mode, mu(3)-1 kappa N-1:2 kappa N-2(3),O-4:3 kappa O-2.	[Kashima, Ayana; Sakate, Mika; Sunatsuki, Yukinari; Suzuki, Takayoshi] Okayama Univ, Fac Sci, Dept Chem, Okayama 7008530, Japan; [Ota, Hiromi] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Fuyuhiro, Akira] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	Suzuki, T (reprint author), Okayama Univ, Fac Sci, Dept Chem, Okayama 7008530, Japan.	suzuki@okayama-u.ac.jp	SUZUKI, Takayoshi/B-1457-2011		Ministry of Education, Culture, Sports, Science, and Technology, Japan [25410070]	This work was financially supported by a Grant-in-Aid for Scientific Research No. 25410070 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Amouri H, 2001, ANGEW CHEM INT EDIT, V40, P3636, DOI 10.1002/1521-3773(20011001)40:19<3636::AID-ANIE3636>3.0.CO;2-I; Annen P, 2000, INORG CHIM ACTA, V307, P115, DOI 10.1016/S0020-1693(00)00212-7; Tegoni M, 2012, COORDIN CHEM REV, V256, P289, DOI 10.1016/j.ccr.2011.06.007; Yamanari K, 2001, ANGEW CHEM INT EDIT, V40, P2268, DOI 10.1002/1521-3773(20010618)40:12<2268::AID-ANIE2268>3.0.CO;2-K; Khutia A, 2011, CHEM-EUR J, V17, P4195, DOI 10.1002/chem.201002722; Han YF, 2008, ORGANOMETALLICS, V27, P4088, DOI 10.1021/om800426e; Carmona D, 1999, CHEM-EUR J, V5, P1544, DOI 10.1002/(SICI)1521-3765(19990503)5:5<1544::AID-CHEM1544>3.0.CO;2-T; Mirtschin S, 2008, INORG CHEM, V47, P6375, DOI 10.1021/ic800410x; Mezei G, 2007, CHEM REV, V107, P4933, DOI 10.1021/cr078200h; Wang GL, 2010, INORG CHEM, V49, P2193, DOI 10.1021/ic902011v; Fish RH, 2003, ORGANOMETALLICS, V22, P2166, DOI 10.1021/om0300777; Fish RH, 1999, COORDIN CHEM REV, V185-6, P569, DOI 10.1016/S0010-8545(99)00011-9; Galindo MA, 2008, CHEM COMMUN, P3735, DOI 10.1039/b805705b; John RP, 2007, SUPRAMOL CHEM, V19, P295, DOI 10.1080/10610270701275083; Katho A, 2000, J ORGANOMET CHEM, V593, P299, DOI 10.1016/S0022-328X(99)00433-7; Khutia A, 2010, INORG CHEM, V49, P7635, DOI 10.1021/ic100794s; Korn S, 1997, INORG CHIM ACTA, V254, P85, DOI 10.1016/S0020-1693(96)05146-8; Korn S, 1997, J CHEM SOC DALTON, P2191, DOI 10.1039/a700976c; Lehaire ML, 2004, INORG CHEM, V43, P1609, DOI 10.1021/ic035328i; Navarro JAR, 2000, CHEM COMMUN, P235, DOI 10.1039/a909150e; NUTTON A, 1981, J CHEM SOC DALTON, P1997, DOI 10.1039/dt9810001997; Pecoraro VL, 1997, PROG INORG CHEM, V45, P83; Piotrowski H., 2001, CHEM-EUR J, V7, P3197; Piotrowski H, 2001, J AM CHEM SOC, V123, P2699, DOI 10.1021/ja005804t; Rauchfuss T. B., 2008, ORGANIC NANOSTRUCTUR; RAUTER H, 1992, J CHEM SOC CHEM COMM, P1385, DOI 10.1039/c39920001385; Rauterkus MJ, 2004, ANGEW CHEM INT EDIT, V43, P1300, DOI 10.1002/anie.200352950; Severin K, 2003, COORDIN CHEM REV, V245, P3, DOI 10.1016/S0010-8545(03)00028-6; Severin K, 2006, CHEM COMMUN, P3859, DOI 10.1039/b606632c; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Yamanari K, 2002, INORG CHEM, V41, P6824, DOI 10.1021/ic020449o; Yamanari K, 2003, DALTON T, P380, DOI 10.1039/b209148h	32	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	10					1889	1892		10.1039/c4cc09087j		4	Chemistry, Multidisciplinary	Chemistry	AZ4SN	WOS:000348213200027		
J	Tanaka, S; Itami, K; Sunahara, K; Tatsuta, G; Mori, A				Tanaka, Shota; Itami, Kazuki; Sunahara, Kazuhiro; Tatsuta, Go; Mori, Atsunori			Ethylaluminum as an ethylene source for the Mizoroki-Heck-type reaction. Rhodium-catalyzed preparation of stilbene derivatives	CHEMICAL COMMUNICATIONS			English	Article							ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; CROSS-COUPLING REACTION; BOND-FORMING REACTIONS; KHAND-TYPE REACTION; CONJUGATE ADDITION; STOICHIOMETRIC REDUCTANT; ASYMMETRIC 1,4-ADDITION; ALUMINUM REAGENTS; GRIGNARD-REAGENTS; ARYLBORONIC ACIDS	Treatment of an organoaluminum reagent bearing aryl and ethyl groups furnishes 1,2-diarylethene derivatives in good to excellent yields by the catalysis of a rhodium complex, in which the ethyl group of the aluminum reagent serves as an ethylene source in the product formation.	[Tanaka, Shota; Itami, Kazuki; Sunahara, Kazuhiro; Tatsuta, Go; Mori, Atsunori] Kobe Univ, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Mori, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	amori@kobe-u.ac.jp	Mori, Atsunori/C-2476-2011	Mori, Atsunori/0000-0002-1163-264X	MEXT, Japan; JSPS	This work was supported financially by Kakenhi B by MEXT, Japan. ST thanks JSPS for the Research Fellowship for Young Scientists.	Gibson SE, 2003, ANGEW CHEM INT EDIT, V42, P1800, DOI 10.1002/anie.200200547; Smith SW, 2008, J AM CHEM SOC, V130, P12645, DOI 10.1021/ja805165y; Iwasaki T, 2014, J AM CHEM SOC, V136, P9260, DOI 10.1021/ja5043534; Cokoja M, 2011, ANGEW CHEM INT EDIT, V50, P8510, DOI 10.1002/anie.201102010; Wang DS, 2012, CHEM REV, V112, P2557, DOI 10.1021/cr200328h; Westermann J, 1998, EUR J INORG CHEM, P295; Molinaro C, 2003, J AM CHEM SOC, V125, P8076, DOI 10.1021/ja0361401; Lam HW, 2006, ORG LETT, V8, P3729, DOI 10.1021/ol061329d; Gao HJ, 2009, SYNLETT, P1321, DOI 10.1055/s-0028-1088127; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Koike T, 2003, ANGEW CHEM INT EDIT, V42, P89, DOI 10.1002/anie.200390061; Hawner C, 2008, ANGEW CHEM INT EDIT, V47, P8211, DOI 10.1002/anie.200803436; TAKAHASHI T, 1991, J AM CHEM SOC, V113, P6266, DOI 10.1021/ja00016a051; BUMAGIN NA, 1985, TETRAHEDRON LETT, V26, P4819, DOI 10.1016/S0040-4039(00)94960-8; Pucheault M, 2004, J AM CHEM SOC, V126, P15356, DOI 10.1021/ja044749b; Kakiuchi F, 2003, J AM CHEM SOC, V125, P1698, DOI 10.1021/ja029273f; Lautens M, 2001, J AM CHEM SOC, V123, P5358, DOI 10.1021/ja010402m; Shibata T, 2002, ORG LETT, V4, P1619, DOI 10.1021/ol025836g; Hayashi T, 2004, B CHEM SOC JPN, V77, P13, DOI 10.1246/bcsj.77.13; Kakiuchi F, 2005, J AM CHEM SOC, V127, P5936, DOI 10.1021/ja043334n; Montgomery J, 2004, ANGEW CHEM INT EDIT, V43, P3890, DOI 10.1002/anie.200300634; Mori A, 2001, J AM CHEM SOC, V123, P10774, DOI 10.1021/ja0159281; Punniyamurthy T, 2005, CHEM REV, V105, P2329, DOI 10.1021/cr050523v; Fagnou K, 2003, CHEM REV, V103, P169, DOI 10.1021/cr020007u; Schmidt F, 2006, CHEM SOC REV, V35, P454, DOI 10.1039/b600091f; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Tanabe Y, 2013, COORDIN CHEM REV, V257, P2551, DOI 10.1016/j.ccr.2013.02.010; Ueura K, 2005, ORG LETT, V7, P2229, DOI 10.1021/ol050590b; Morimoto T, 2004, ANGEW CHEM INT EDIT, V43, P5580, DOI 10.1002/anie.200301736; Bolm C, 2002, J AM CHEM SOC, V124, P14850, DOI 10.1021/ja028518l; Morimoto T, 2002, J AM CHEM SOC, V124, P3806, DOI 10.1021/ja0126881; Biradar DB, 2011, CHEM COMMUN, V47, P10467, DOI 10.1039/c1cc14206b; Ejiri S, 2010, ORG LETT, V12, P1692, DOI 10.1021/ol100210u; Fujii T., 2002, SYNLETT, P297; Hawner C, 2010, ANGEW CHEM INT EDIT, V49, P7769, DOI 10.1002/anie.201003300; Joensuu PM, 2008, J AM CHEM SOC, V130, P7328, DOI 10.1021/ja0775624; Koike T, 2002, SYNLETT, P301; Lautens M, 2004, SYNTHESIS-STUTTGART, P2006, DOI 10.1055/s-2004-829161; Lindsell W. E., 1995, COMPREHENSIVE ORGANO, V1, P57; Lu C. C., 2013, EUR J INORG CHEM, P3728; Martinez R, 2007, ORG LETT, V9, P3213, DOI 10.1021/ol071098q; Saito S, 1997, CHEM COMMUN, P1585, DOI 10.1039/a607464b; Takacs JM, 1996, TETRAHEDRON LETT, V37, P2749, DOI 10.1016/0040-4039(96)00421-2; Tanaka S., 2014, EUR J ORG CHEM, P1167; Yamamoto H., 2004, MAIN GROUP METALS IN; Zou G, 2003, CHEM COMMUN, P2438, DOI 10.1039/b305771m	46	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	10					1949	1952		10.1039/c4cc09306b		4	Chemistry, Multidisciplinary	Chemistry	AZ4SN	WOS:000348213200043		
J	Cho, KH; Jang, HS; Cheong, JS; Rodriguez-Vazquez, JF; Murakami, G; Abe, H				Cho, Kwang Ho; Jang, Hyung Suk; Cheong, Jin Sung; Francisco Rodriguez-Vazquez, Jose; Murakami, Gen; Abe, Hiroshi			Sensory pathways in the human embryonic spinal accessory nerve with special reference to the associated lower cranial nerve ganglia	CHILDS NERVOUS SYSTEM			English	Article						Spinal accessory nerve; Hypoglossal nerve; Froriep's occipital ganglion cells; Nociceptive pathways; Human fetus	HYPOGLOSSAL NERVE	Muscles supplied by the spinal accessory nerve are particularly prone to the development of trigger points characteristic of myofascial pain. This study aimed to confirm sensory pathways in the spinal accessory nerve and to describe sensory ganglion cell distributions along the lower cranial nerve roots. Using sagittal sections of ten human embryos at 6-7 weeks and horizontal sections of three 15- to 16-week-old embryos, we analyzed ganglion cell distributions along the lower cranial nerve roots, including the spinal accessory (XI) nerve. In all ten 6- to 7-week-old embryos, the XI nerve root contained abundant ganglion cells, which were evenly distributed along the XI nerve root at levels between the jugular foramen and the dorsal root of the second cervical nerve. However, the hypoglossal (XII) nerve roots did not contain ganglion cells and did not communicate with nearby roots in the dural space. Thus, the so-called Froriep's occipital ganglion is unlikely to be associated with the XII nerve but rather with the XI nerve roots. According to observations of three larger fetuses (15-16 weeks), most of Froriep's ganglion cells seemed to have degenerated during early fetal life. Nociceptive sensory pathways in the adult human XI nerve may be much more limited in number than would be expected based on previous animal studies. However, it is possible that sensory ganglion cells in the embryonic XI nerve root send axons toward the developing spinal accessory nerve fibers outside of the jugular foramen.	[Cho, Kwang Ho; Cheong, Jin Sung] Wonkwang Univ, Dept Neurol, Sch Med, Iksan, South Korea; [Jang, Hyung Suk] Wonkwang Univ, Fac Med Sci, Grad Sch, Iksan, South Korea; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Inst Embryol, E-28040 Madrid, Spain; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan; [Abe, Hiroshi] Akita Univ, Sch Med, Dept Anat, Akita 010, Japan; [Cho, Kwang Ho] Inst Wonkwang Med Sci, Jeonbuk Reg Cardiocerebrovasc Dis Ctr, Jeonbuk 570711, South Korea	Cho, KH (reprint author), Inst Wonkwang Med Sci, Jeonbuk Reg Cardiocerebrovasc Dis Ctr, 895 Muwang Ro, Jeonbuk 570711, South Korea.	neurlogy@wonkwang.ac.kr		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492	Wonkwang University	This paper was supported by Wonkwang University in 2014.	O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x; Shoja MM, 2014, CLIN ANAT, V27, P131, DOI 10.1002/ca.22342; Froriep A, 1985, ANAT ANZEIGER, V10, P688; KURATANI S, 1988, AM J ANAT, V182, P155, DOI 10.1002/aja.1001820206; ORAHILLY R, 1984, AM J ANAT, V169, P237, DOI 10.1002/aja.1001690302; Pearson AA, 1938, J COMP NEUROL, V68, P243, DOI 10.1002/cne.900680206; Sensenig EC, 1957, CONTR EMBRYOL, V248, P143; Streeter GL, 1904, AM J ANAT, V4, P83; WETMORE C, 1991, J COMP NEUROL, V305, P148, DOI 10.1002/cne.903050114	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2015	31	1					95	99		10.1007/s00381-014-2546-9		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AZ3GJ	WOS:000348115200011		
J	Hasegawa, M; Nouri, M; Nagahisa, S; Hayashi, T; Adachi, K; Hirose, Y; Abe, M				Hasegawa, Mitsuhiro; Nouri, Mohsen; Nagahisa, Shinya; Hayashi, Takuro; Adachi, Kazuhide; Hirose, Yuichi; Abe, Masato			Neuroepithelial cyst of the fourth ventricle	CHILDS NERVOUS SYSTEM			English	Article						Neuroepithelial cyst; Posterior fossa; Fourth ventricle	COLLOID CYSTS; VENTRICLE	Neuroepithelial cyst is considered an unusual differential diagnosis for cysts in the posterior fossa. Here, we present a paediatric case with such a pathology and review the pertinent literature. A 12-year old girl with headache, vertigo and disturbed gait was diagnosed with a cystic lesion in the fourth ventricle after brain MRI study. She was operated with the pre-operative diagnosis of arachnoid cyst. A transparent, colourless cyst was observed intra-operatively. As frozen sections were consistent with endodermal cyst, total removal of the cyst was attempted. Definite histopathological studies and immunohistochemistry stains were in favour of neuroepithelial cyst. No regrowth of the cyst or recurrence of the symptoms was observed in her 2-year follow-up. As neuroepithelial cyst is rarely encountered in the posterior fossa, the clinical, radiological and pathological characteristics of our case along with similar cases in the literature were reviewed and discussed.	[Hasegawa, Mitsuhiro; Nouri, Mohsen; Nagahisa, Shinya; Hayashi, Takuro; Adachi, Kazuhide; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701192, Japan; [Nouri, Mohsen] Zahedan Univ Med Sci, Razi Hosp, Dept Neurosurg, Saravan, Iran; [Abe, Masato] Fujita Hlth Univ Hosp, Dept Pathol, Toyoake, Aichi 4701192, Japan	Hasegawa, M (reprint author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	mhasegawah@yahoo.co.jp; nouri@gan-ac.ir					AFSHAR F, 1981, J NEUROSURG, V54, P836, DOI 10.3171/jns.1981.54.6.0836; Holman MA, 2013, J NEUROSURG-PEDIATR, V12, P317, DOI 10.3171/2013.6.PEDS1383; CHALLA VR, 1978, J NEUROSURG, V49, P457, DOI 10.3171/jns.1978.49.3.0457; CIRICILLO SF, 1990, J NEUROSURG, V72, P302, DOI 10.3171/jns.1990.72.2.0302; Heran NS, 2003, CAN J NEUROL SCI, V30, P393; HIRANO A, 1974, J NEUROPATH EXP NEUR, V33, P333, DOI 10.1097/00005072-197404000-00009; INOUE T, 1988, NEUROSURGERY, V23, P576; Inoue T, 1985, SURG NEUROL, V4, P57; KONDZIOLKA D, 1989, J NEUROSURG, V71, P91, DOI 10.3171/jns.1989.71.1.0091	9	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2015	31	1					155	159		10.1007/s00381-014-2478-4		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AZ3GJ	WOS:000348115200020		
J	Saito, K; Toda, M; Yoshida, K				Saito, Katsuya; Toda, Masahiro; Yoshida, Kazunari			Pilocytic astrocytoma with anaplastic features presenting good long-term clinical course after surgery alone: a case report	CHILDS NERVOUS SYSTEM			English	Article						Pilocystic astrocytoma; Anaplastic feature; Anaplastic pilocystic astrocytoma; Long-term outcome		Pilocytic astrocytomas (PAs) are the most common brain tumor in children and typically have an excellent prognosis. However, some PAs show histologically anaplastic features. It is reported that PAs with anaplastic features often need the postoperative radiation and chemotherapy due to aggressiveness such as early local recurrence and dissemination. We describe an interesting case of primary anaplastic PA with good clinical course in the long-term. A 10-year-old man presented with worsening headache and vomiting. Magnetic resonance imaging (MRI) showed a large cystic tumor with contrast-enhanced solid component in a right occipital lobe. Magnetic resonance spectroscopy (MRS) showed the decrease of N-acetylaspartate (NAA) and the increase of choline and lipids, which suggested the malignancy. The patient was operated with an occipital lobectomy. The tumor was incompletely resected due to the deep invasion to the inner wall of lateral ventricle. Pathological diagnosis was a pilocystic astrocytoma with anaplastic features. Although aggressive features were suspected from magnetic resonance spectroscopy and pathological findings, the remnant tumor showed no recurrence for 8 years without any postoperative treatments. PAs could exhibit variable behavior, and careful managements including wait-and-scan should be considered, because adjuvant therapies may cause child's growth disorder and malignant transformation.	[Saito, Katsuya; Toda, Masahiro; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Tokyo 160, Japan	Saito, K (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Tokyo 160, Japan.	csrbb415@yahoo.co.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2015	31	1					167	171		10.1007/s00381-014-2509-1		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AZ3GJ	WOS:000348115200022		
J	Okada, H; Takemura, G; Kanamori, H; Tsujimoto, A; Goto, K; Kawamura, I; Watanabe, T; Morishita, K; Miyazaki, N; Tanaka, T; Ushikoshi, H; Kawasaki, M; Miyazaki, T; Suzui, N; Nishigaki, K; Mikami, A; Ogura, S; Minatoguchi, S				Okada, Hideshi; Takemura, Genzou; Kanamori, Hiromitsu; Tsujimoto, Akiko; Goto, Kazuko; Kawamura, Itta; Watanabe, Takatomo; Morishita, Kentaro; Miyazaki, Nagisa; Tanaka, Toshiki; Ushikoshi, Hiroaki; Kawasaki, Masanori; Miyazaki, Tatsuhiko; Suzui, Natsuko; Nishigaki, Kazuhiko; Mikami, Atsushi; Ogura, Shinji; Minatoguchi, Shinya			Phenotype and Physiological Significance of the Endocardial Smooth Muscle Cells in Human Failing Hearts	CIRCULATION-HEART FAILURE			English	Article						biopsy; cardiomyopathy, dilated; heart failure; myocytes, smooth muscle; ultrastructure	GRANULATION-TISSUE; MYOCARDIAL-INFARCTION; TASK-FORCE; APOPTOSIS; CARDIOMYOPATHIES; DIFFERENTIATION; CLASSIFICATION; REPERFUSION; INHIBITION; DEFINITION	Background-Extravascular smooth muscle cells are often observed in the endocardium of human failing hearts. Here, we characterized the phenotype of those cells and investigated their physiological significance. Methods and Results-We examined left ventricular biopsy specimens obtained from 44 patients with dilated cardiomyopathy and 6 nonfailing hearts. In Masson trichrome-stained histological preparations, bundles of smooth muscle cells were seen localized in the endocardium in 23 of the 44 specimens (none of the 6 controls). These cells were immunopositive for a-smooth muscle actin, type 2 smooth muscle myosin, desmin, and calponin, but were negative for embryonic smooth muscle myosin, vimentin, fibronectin, and periostin. This profile is indicative of a late differentiation (contractile) smooth muscle phenotype. Electron microscopy confirmed that phenotype, revealing the cells to contain abundant myofilaments with dense bodies but little rough endoplasmic reticulum or Golgi apparatus. In the endocardial smooth muscle-positive group, the left ventricular end-systolic volume index (73 +/- 34 versus 105 +/- 50 mL/m(2); P=0.021), left ventricular peak wall stress (164 +/- 47 versus 196 +/- 43 dynes 10(3)/cm(2); P=0.023), and left ventricular end-systolic meridional wall stress (97 +/- 38 versus 121 +/- 37 dynes 10(3)/cm(2); P=0.036) were all significantly smaller, and the ejection fraction was larger (41 +/- 8.8 versus 33 +/- 9.3%; P=0.005) than in the endocardial smooth muscle-negative group. However, no histological parameters differed between the 2 groups. Conclusions-Endocardial smooth muscle cell bundles in hearts with dilated cardiomyopathy exhibit a mature contractile phenotype and may play a compensatory role mitigating heart failure by reducing left ventricular wall stress and systolic dysfunction.	[Okada, Hideshi; Morishita, Kentaro; Ushikoshi, Hiroaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Kanamori, Hiromitsu; Tsujimoto, Akiko; Goto, Kazuko; Kawamura, Itta; Watanabe, Takatomo; Miyazaki, Nagisa; Tanaka, Toshiki; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Takemura, Genzou] Asahi Univ, Dept Internal Med, Mizuho 5010296, Japan; [Miyazaki, Tatsuhiko; Suzui, Natsuko] Gifu Univ Hosp, Div Pathol, Gifu, Japan	Takemura, G (reprint author), Asahi Univ, Dept Internal Med, 1851 Hozumi, Mizuho 5010296, Japan.	gt@dent.asahi-u.ac.jp			Ministry of Education, Science, and Culture of Japan; Asahi University; Gifu University	This study was supported, in part, by Grants-in-Aid for scientific research from The Ministry of Education, Science, and Culture of Japan and Research Grants from Asahi University and Gifu University.	Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; NAGAI R, 1989, J BIOL CHEM, V264, P9734; von Harsdorf R, 2004, CIRC RES, V95, P554, DOI 10.1161/01.RES.0000143717.70275.8f; Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68; KIM HS, 1993, CIRCULATION, V88, P1804; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; [Anonymous], 1980, BR HEART J, V44, P672; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; CHAMLEYCAMPBELL JH, 1981, J CELL BIOL, V89, P379, DOI 10.1083/jcb.89.2.379; Ogino A, 2007, AM J PHYSIOL-HEART C, V293, pH2271, DOI 10.1152/ajpheart.00303.2007; Richardson P, 1996, CIRCULATION, V93, P841; WILSON JR, 1980, AM J MED, V68, P664, DOI 10.1016/0002-9343(80)90252-1; Fawcett DW, 1976, BLOOM FAWCETT TXB HI, P416; Ferrans VJ, 1991, CARDIOVASC PATHOL, P83; Kanamori H, 2007, AM J PHYSIOL-HEART C, V292, pH2184, DOI 10.1152/ajpheart.01235.2006; KENNEDY JW, 1970, AM HEART J, V80, P343, DOI 10.1016/0002-8703(70)90099-2; Kloner RA, 2008, CIRC RES, V103, P1, DOI 10.1161/CIRCRESAHA.108.180216; Manabe Ichiro, 2003, Curr Atheroscler Rep, V5, P214, DOI 10.1007/s11883-003-0027-9; Nakagawa M, 2008, CIRC RES, V103, P98, DOI 10.1161/CIRCRESAHA.108.177568; OKADA R, 1961, JPN HEART J, V2, P220; REICHEK N, 1982, CIRCULATION, V65, P99; Stehbens WE, 2000, CARDIOVASC PATHOL, V9, P161, DOI 10.1016/S1054-8807(00)00037-5; Suzuki T, 1996, CARDIOLOGY, V87, P23, DOI 10.1159/000177055; Takemura G, 2009, CARDIOVASC RES, V83, P269, DOI 10.1093/cvr/cvp032; Takemura G, 1998, CIRC RES, V82, P1130; THYBERG J, 1983, DIFFERENTIATION, V25, P156; UEGAITO T, 1991, INT J CARDIOL, V32, P93, DOI 10.1016/0167-5273(91)90048-T; YIN FCP, 1981, CIRC RES, V49, P829	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3289	1941-3297		CIRC-HEART FAIL	Circ.-Heart Fail.	JAN	2015	8	1					149	155		10.1161/CIRCHEARTFAILURE.114.001746		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ3RX	WOS:000348145400019		
J	Tentori, F; Wang, M; Bieber, BA; Karaboyas, A; Li, Y; Jacobson, SH; Andreucci, VE; Fukagawa, M; Frimat, L; Mendelssohn, DC; Port, FK; Pisoni, RL; Robinson, BM				Tentori, Francesca; Wang, Mia; Bieber, Brian A.; Karaboyas, Angelo; Li, Yun; Jacobson, Stefan H.; Andreucci, Vittorio E.; Fukagawa, Masafumi; Frimat, Luc; Mendelssohn, David C.; Port, Friedrich K.; Pisoni, Ronald L.; Robinson, Bruce M.			Recent Changes in Therapeutic Approaches and Association with Outcomes among Patients with Secondary Hyperparathyroidism on Chronic Hemodialysis: The DOPPS Study	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article						CKD; parathyroid hormone; hyperparathyroidism; ESRD; dialysis	CHRONIC KIDNEY-DISEASE; CLINICAL-PRACTICE GUIDELINE; PARATHYROID-HORMONE; PRACTICE PATTERNS; DIALYSIS PATIENTS; CARDIOVASCULAR-DISEASE; MAINTENANCE HEMODIALYSIS; PERITONEAL-DIALYSIS; MINERAL METABOLISM; RENAL REPLACEMENT	Background and objectivesElevated parathyroid hormone levels may be associated with adverse clinical outcomes in patients on dialysis. After the introduction of practice guidelines suggesting higher parathyroid hormone targets than those previously recommended, changes in parathyroid hormone levels and treatment regimens over time have not been well documented.Design, setting, participants, & measurementsUsing data from the international Dialysis Outcomes and Practice Patterns Study, trends in parathyroid hormone levels and secondary hyperparathyroidism therapies over the past 15 years and the associations between parathyroid hormone and clinical outcomes are reported; 35,655 participants from the Dialysis Outcomes and Practice Patterns Study phases 1-4 (1996-2011) were included.ResultsMedian parathyroid hormone increased from phase 1 to phase 4 in all regions except for Japan, where it remained stable. Prescriptions of intravenous vitamin D analogs and cinacalcet increased and parathyroidectomy rates decreased in all regions over time. Compared with 150-300 pg/ml, in adjusted models, all-cause mortality risk was higher for parathyroid hormone=301-450 (hazard ratio, 1.09; 95% confidence interval, 1.01 to 1.18) and >600 pg/ml (hazard ratio, 1.23; 95% confidence interval, 1.12 to 1.34). Parathyroid hormone >600 pg/ml was also associated with higher risk of cardiovascular mortality as well as all-cause and cardiovascular hospitalizations. In a subgroup analysis of 5387 patients not receiving vitamin D analogs or cinacalcet and with no prior parathyroidectomy, very low parathyroid hormone (<50 pg/ml) was associated with mortality (hazard ratio, 1.25; 95% confidence interval, 1.04 to 1.51).ConclusionsIn a large international sample of patients on hemodialysis, parathyroid hormone levels increased in most countries, and secondary hyperparathyroidism treatments changed over time. Very low and very high parathyroid hormone levels were associated with adverse outcomes. In the absence of definitive evidence in support of a specific parathyroid hormone target, there is an urgent need for additional research to inform clinical practice.	[Tentori, Francesca; Wang, Mia; Bieber, Brian A.; Karaboyas, Angelo; Li, Yun; Port, Friedrich K.; Pisoni, Ronald L.; Robinson, Bruce M.] Arbor Res Collaborat Hlth, Ann Arbor, MI 48104 USA; [Li, Yun] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Jacobson, Stefan H.] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden; [Andreucci, Vittorio E.] Univ Naples Federico II, Naples, Italy; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 25911, Japan; [Frimat, Luc] Ctr Hosp Univ Nancy, Inserm CIC EC, Vandoeuvre Les Nancy, France; [Frimat, Luc] Ctr Hosp Univ Nancy, Dept Nephrol, Vandoeuvre Les Nancy, France; [Mendelssohn, David C.] Humber River Reg Hosp, Dept Nephrol, Toronto, ON, Canada; [Mendelssohn, David C.] Univ Toronto, Toronto, ON, Canada; [Robinson, Bruce M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tentori, Francesca] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Tentori, F (reprint author), Arbor Res Collaborat Hlth, 340 East Huron Street, Suite 300, Ann Arbor, MI 48104 USA.	francesca.tentori@ArborResearch.org			Amgen; Kyowa Hakko Kirin; AbbVie Inc.; Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma, Ltd.; BHC Medical; Janssen; Takeda; Hexal; Deutsche Gesellschaft fur Nephrologie (DGfN); Shire; WiNe Institute in Germany; Japanese Society for Peritoneal Dialysis; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K01DK087762]	The Dialysis Outcomes and Practice Patterns Study Program is supported by Amgen, Kyowa Hakko Kirin, AbbVie Inc., Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma, Ltd. Additional support for specific projects and countries is also provided by Amgen, BHC Medical, Janssen, Takeda, and Kidney Foundation of Canada (for logistics support) in Canada; Hexal, Deutsche Gesellschaft fur Nephrologie (DGfN), Shire, and WiNe Institute in Germany; and the Japanese Society for Peritoneal Dialysis for Peritoneal Dialysis Outcomes and Practice Patterns Study in Japan. F.T. is supported, in part, by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Award K01DK087762.	Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Block GA, 2013, CLIN J AM SOC NEPHRO, V8, P2132, DOI 10.2215/CJN.04260413; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Lindberg JS, 2005, J AM SOC NEPHROL, V16, P800, DOI 10.1681/ASN.2004060512; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Fukagawa M, 2012, CLIN J AM SOC NEPHRO, V7, P1473, DOI 10.2215/CJN.13081211; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Malberti F, 2001, J AM SOC NEPHROL, V12, P1242; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Akizawa T, 2011, CLIN J AM SOC NEPHRO, V6, P2280, DOI 10.2215/CJN.11501210; Drechsler C, 2009, NEPHROL DIAL TRANSPL, V24, P3151, DOI 10.1093/ndt/gfp260; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Young EW, 2000, KIDNEY INT, V57, pS74; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Li SY, 2011, AM J KIDNEY DIS, V57, P602, DOI 10.1053/j.ajkd.2010.10.041; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Perkovic V, 2012, NEW ENGL J MED, V367, P2541, DOI 10.1056/NEJMe1212368; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Avram MM, 2001, AM J KIDNEY DIS, V38, P1351, DOI 10.1053/ajkd.2001.29254; Cameron AC, 2005, MICROECONOMICS METHO, P103; Chertow GM, 2000, CLIN NEPHROL, V54, P295; DEFRANCISCO AM, 1985, Q J MED, V55, P289; Elder Grahame, 2006, Nephrology (Carlton), V11 Suppl 1, pS230, DOI 10.1111/j.1440-1797.2006.00508.x; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, KIDNEY INT S, V113, pS1, DOI DOI 10.1038/KI.2009.188; Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x; Ledebo I, 2000, NEPHROL DIAL TRANSPL, V15, P1310, DOI 10.1093/ndt/15.9.1310; Li JN, 2013, NEPHROL DIAL TRANSPL, V28, P1516, DOI 10.1093/ndt/gfs598; Mactier R, 2011, NEPHRON CLIN PRACT, V118, pC27, DOI 10.1159/000328060; McMahon LP, 2012, NEPHROLOGY, V17, P17, DOI 10.1111/j.1440-1797.2011.01535.x; Mendelssohn DC, 2008, NEPHROL DIAL TRANSPL, V23, P3227, DOI 10.1093/ndt/gfn195; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Pisoni Ronald L, 2004, Am J Kidney Dis, V44, P7, DOI 10.1016/S0272-6386(04)01099-6; Raghunathan TE, 2002, IVEWARE IMPUTATION V; St Peter Wendy L, 2009, Clin J Am Soc Nephrol, V4, P354, DOI 10.2215/CJN.05241008; United States Renal Data System, 2012, 2012 US REN DAT SYST; Wooldridge J., 2008, INTRO ECONOMETRICS M	46	12	13	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	JAN	2015	10	1					98	109		10.2215/CJN.12941213		12	Urology & Nephrology	Urology & Nephrology	AY7BS	WOS:000347716900015		
J	Oka, T; Wang, QH; Katayama, K; Saif, LJ				Oka, Tomoichiro; Wang, Qiuhong; Katayama, Kazuhiko; Saif, Linda J.			Comprehensive Review of Human Sapoviruses	CLINICAL MICROBIOLOGY REVIEWS			English	Review							PORCINE ENTERIC CALICIVIRUS; VIRUS-LIKE PARTICLES; HEMORRHAGIC-DISEASE VIRUS; REVERSE TRANSCRIPTION-PCR; DAY-CARE-CENTER; INFECTIOUS INTESTINAL DISEASE; POLYMERASE-CHAIN-REACTION; BLOOD GROUP ANTIGENS; SAPPORO-LIKE VIRUSES; ACUTE VIRAL GASTROENTERITIS	Sapoviruses cause acute gastroenteritis in humans and animals. They belong to the genus Sapovirus within the family Caliciviridae. They infect and cause disease in humans of all ages, in both sporadic cases and outbreaks. The clinical symptoms of sapovirus gastroenteritis are indistinguishable from those caused by noroviruses, so laboratory diagnosis is essential to identify the pathogen. Sapoviruses are highly diverse genetically and antigenically. Currently, reverse transcription-PCR (RT-PCR) assays are widely used for sapovirus detection from clinical specimens due to their high sensitivity and broad reactivity as well as the lack of sensitive assays for antigen detection or cell culture systems for the detection of infectious viruses. Sapoviruses were first discovered in 1976 by electron microscopy in diarrheic samples of humans. To date, sapoviruses have also been detected from several animals: pigs, mink, dogs, sea lions, and bats. In this review, we focus on genomic and antigenic features, molecular typing/classification, detection methods, and clinical and epidemiological profiles of human sapoviruses.	[Oka, Tomoichiro; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Oka, Tomoichiro; Wang, Qiuhong; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA	Oka, T (reprint author), Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan.	oka-t@nih.go.jp; wang.655@osu.edu					Akihara S, 2005, J MED VIROL, V77, P595, DOI 10.1002/jmv.20497; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Harada S, 2009, J MED VIROL, V81, P1117, DOI 10.1002/jmv.21454; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oehmig A, 2003, J GEN VIROL, V84, P2837, DOI 10.1099/vir.0.19042-0; FLYNN WT, 1988, J CLIN MICROBIOL, V26, P206; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Phan TG, 2007, EUR J CLIN MICROBIOL, V26, P21, DOI 10.1007/s10096-006-0235-7; Meyers G, 2000, VIROLOGY, V276, P349, DOI 10.1006/viro.2000.0545; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13; MCSWIGGAN DA, 1978, LANCET, V1, P1215; Ludert JE, 2004, J CLIN MICROBIOL, V42, P835, DOI 10.1128/JCM.42.2.835-836.2004; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; Smiley JR, 2002, J VIROL, V76, P10089, DOI 10.1128/JVI.76.20.10089-10098.2002; Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031; Hansman GS, 2004, J CLIN MICROBIOL, V42, P1305, DOI 10.1128/JCM.42.3.1305-1307.2004; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Martella V, 2008, J CLIN MICROBIOL, V46, P1907, DOI 10.1128/JCM.00341-08; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Marin MS, 2000, J VIROL, V74, P10846, DOI 10.1128/JVI.74.22.10846-10851.2000; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Rasanen S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Hansman GS, 2007, EMERG INFECT DIS, V13, P1519, DOI 10.3201/eid1310.070402; Wang QH, 2012, APPL ENVIRON MICROB, V78, P3932, DOI 10.1128/AEM.06600-11; Benabbes L, 2013, FOOD ENVIRON VIROL, V5, P35, DOI 10.1007/s12560-012-9095-8; Nguyen TA, 2008, J TROP PEDIATRICS, V54, P102, DOI 10.1093/tropej/fmm096; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Oka T, 2005, ARCH VIROL, V150, P2539, DOI 10.1007/s00705-005-0591-0; Murray TY, 2013, J APPL MICROBIOL, V114, P1843, DOI 10.1111/jam.12167; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; Le Guyader FS, 2010, J CLIN MICROBIOL, V48, P915, DOI 10.1128/JCM.01664-09; Iizuka S, 2010, J MED VIROL, V82, P1247, DOI 10.1002/jmv.21791; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ueki Y, 2010, MICROBIOL IMMUNOL, V54, P483, DOI 10.1111/j.1348-0421.2010.00239.x; Wang QH, 2007, VACCINE, V25, P5453, DOI 10.1016/j.vaccine.2006.12.032; Leen EN, 2013, J VIROL, V87, P5318, DOI 10.1128/JVI.03151-12; Lorrot M, 2011, EUR J CLIN MICROBIOL, V30, P361, DOI 10.1007/s10096-010-1094-9; Oka T, 2005, J VIROL, V79, P7283, DOI 10.1128/JVI.79.12.7283-7290.2005; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; PARWANI AV, 1991, ARCH VIROL, V120, P115, DOI 10.1007/BF01310954; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sisay Z, 2013, ARCH VIROL, V158, P1583, DOI 10.1007/s00705-013-1619-5; Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231; Liu Y, 2012, J CLIN MICROBIOL, V50, P2384, DOI 10.1128/JCM.06790-11; FLYNN WT, 1988, AM J VET RES, V49, P819; Guntapong R, 2004, JPN J INFECT DIS, V57, P276; Rimoldi SG, 2011, ARCH VIROL, V156, P1583, DOI 10.1007/s00705-011-1037-5; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Akihara S, 2005, ARCH VIROL, V150, P2061, DOI 10.1007/s00705-005-0540-y; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; SAIF LJ, 1980, J CLIN MICROBIOL, V12, P105; Iwai M, 2009, APPL ENVIRON MICROB, V75, P1264, DOI 10.1128/AEM.01166-08; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Jin Y, 2009, J CLIN VIROL, V44, P238, DOI 10.1016/j.jcv.2008.12.010; Guo M, 2001, J VIROL, V75, P9239, DOI 10.1128/JVI.75.19.9239-9251.2001; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Roingeard P, 2008, BIOL CELL, V100, P491, DOI 10.1042/BC20070173; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Konig M, 1998, J VIROL, V72, P4492; Oka T, 2011, MICROBIOL IMMUNOL, V55, P108, DOI 10.1111/j.1348-0421.2010.00295.x; KJELDSBERG E, 1986, J VIROL METHODS, V14, P321, DOI 10.1016/0166-0934(86)90034-0; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Berke T, 1997, J MED VIROL, V52, P419, DOI 10.1002/(SICI)1096-9071(199708)52:4<419::AID-JMV13>3.0.CO;2-B; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12; Dove W, 2005, J MED VIROL, V77, P522, DOI 10.1002/jmv.20488; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; Trang NV, 2012, J MED VIROL, V84, P290, DOI 10.1002/jmv.23185; Hansman GS, 2007, REV MED VIROL, V17, P133, DOI 10.1002/rmv.533; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Wang QH, 2005, J CLIN MICROBIOL, V43, P5963, DOI 10.1128/JCM.43.12.5963-5972.2005; Bon F, 2004, J CLIN MICROBIOL, V42, P2218, DOI 10.1128/JCM.42.5.2218-2220.2004; Bon F, 2005, J CLIN MICROBIOL, V43, P4659, DOI 10.1128/JCM.43.9.4659-4664.2005; Bucardo F, 2012, EMERG INFECT DIS, V18, P1875, DOI 10.3201/eid1811.111581; Bull RA, 2011, VIRUS GENES, V42, P16, DOI 10.1007/s11262-010-0535-y; CDC, 2011, MMWR-MORBID MORTAL W, V60, P1; Chang KO, 2002, VIROLOGY, V304, P302, DOI 10.1006/viro.2002.1665; Chang KO, 2005, J VIROL, V79, P1409, DOI 10.1128/JVI.79.3.1409-1416.2005; Chanit W, 2009, EMERG INFECT DIS, V15, P1084, DOI 10.3201/eid1507.090153; Chan-it W, 2010, JPN J INFECT DIS, V63, P302; Chen R, 2004, J VIROL, V78, P6469, DOI 10.1128/JVI.78.12.6469-6497.2004; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chiba S, 2000, J INFECT DIS, V181, pS303, DOI 10.1086/315574; CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402; CHIBA S, 1980, J INFECT DIS, V142, P247; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; CUBITT WD, 1987, J INFECT DIS, V156, P806; CUBITT WD, 1987, J MED VIROL, V21, P361, DOI 10.1002/jmv.1890210408; CUBITT WD, 1979, J CLIN PATHOL, V32, P786, DOI 10.1136/jcp.32.8.786; CUBITT WD, 1981, LANCET, V2, P975; CUBITT WD, 1980, J CLIN PATHOL, V33, P1095, DOI 10.1136/jcp.33.11.1095; CUBITT WD, 1984, J GEN VIROL, V65, P1123, DOI 10.1099/0022-1317-65-6-1123; CUBITT WD, 1981, J CLIN PATHOL, V34, P924, DOI 10.1136/jcp.34.8.924; Dey SK, 2010, J TROP PEDIATRICS, V56, P205, DOI 10.1093/tropej/fmp082; Dey SK, 2012, EPIDEMIOL INFECT, V140, P74, DOI 10.1017/S0950268811000240; Dey SK, 2011, CLIN LAB, V57, P91; Di Bartolo I, 2013, FOOD ENVIRON VIROL, V5, P236, DOI 10.1007/s12560-013-9124-2; Farkas T, 2004, ARCH VIROL, V149, P1309, DOI 10.1007/s00705-004-0296-9; Farkas T, 2006, J CLIN MICROBIOL, V44, P3674, DOI 10.1128/JCM.01087-06; Frange P, 2012, J INFECT DIS, V206, P1269, DOI 10.1093/infdis/jis498; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Gallimore CI, 2005, EPIDEMIOL INFECT, V133, P41, DOI 10.1017/S0950268804003218; Gallimore CI, 2006, J MED VIROL, V78, P673, DOI 10.1002/jmv.20592; Gomes KA, 2007, J MED VIROL, V79, P1703, DOI 10.1002/jmv.20989; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Green KY, 2002, J VIROL, V76, P8582, DOI 10.1128/JVI.76.17.8582-8585.2002; GROHMANN G, 1991, J CLIN MICROBIOL, V29, P544; Gunson RN, 2006, J CLIN VIROL, V35, P321, DOI 10.1016/j.jcv.2005.11.001; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; Guo MZ, 2001, J CLIN MICROBIOL, V39, P1487, DOI 10.1128/JCM.39.4.1487-1493.2001; Gustavsson L, 2011, J CLIN VIROL, V51, P275, DOI 10.1016/j.jcv.2011.05.025; Hansman GS, 2007, EMERG INFECT DIS, V13, P133; Hansman GS, 2006, ARCH VIROL, V151, P551, DOI 10.1007/s00705-005-0630-x; Hansman GS, 2006, FEBS LETT, V580, P4047, DOI 10.1016/j.febslet.2006.06.040; Hansman GS, 2007, EMERG INFECT DIS, V13, P620; Hansman GS, 2005, EMERG INFECT DIS, V11, P1916; Hansman GS, 2007, EMERG INFECT DIS, V13, P786; Hansman GS, 2005, ARCH VIROL, V150, P21, DOI 10.1007/s00705-004-0406-8; Hansman GS, 2006, EMERG INFECT DIS, V12, P141; Hansman GS, 2005, ARCH VIROL, V150, P1433, DOI 10.1007/s00705-005-0506-0; Hansman GS, 2007, J CLIN MICROBIOL, V45, P1347, DOI 10.1128/JCM.01854-06; Hansman GS, 2008, VIRUS RES, V137, P261, DOI 10.1016/j.virusres.2008.07.002; Harada S, 2012, ARCH VIROL, V157, P1999, DOI 10.1007/s00705-012-1387-7; Harada S, 2013, JPN J INFECT DIS, V66, P454; Haramoto E, 2008, LETT APPL MICROBIOL, V46, P408, DOI 10.1111/j.1472-765X.2008.02330.x; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Honma S, 2001, J MED VIROL, V65, P413, DOI 10.1002/jmv.2050; Honma S, 2000, MICROBIOL IMMUNOL, V44, P411; HUMPHREY TJ, 1984, J HYG-CAMBRIDGE, V93, P293; Iizuka S, 2013, FOOD ENVIRON VIROL, V5, P119, DOI 10.1007/s12560-013-9109-1; Ike AC, 2008, J CLIN VIROL, V43, P37, DOI 10.1016/j.jcv.2008.04.003; Iritani N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/jmv.23883; Ishida S, 2008, JPN J INFECT DIS, V61, P504; Iwakiri A, 2009, ARCH VIROL, V154, P689, DOI 10.1007/s00705-009-0358-0; Jiang X, 1999, J VIROL METHODS, V78, P81, DOI 10.1016/S0166-0934(98)00169-4; Jiang X, 1997, ARCH VIROL, V142, P1813, DOI 10.1007/s007050050199; Jiang YX, 2014, J CLIN MICROBIOL, V52, P1266, DOI 10.1128/JCM.00245-14; Johansson PJH, 2005, SCAND J INFECT DIS, V37, P200, DOI 10.1080/0365540410020974; Johnsen CK, 2009, J CLIN VIROL, V46, P265, DOI 10.1016/j.jcv.2009.07.008; Katayama K, 2006, ARCH VIROL, V151, P1291, DOI 10.1007/s00705-005-0720-9; Katayama K, 2004, EMERG INFECT DIS, V10, P1874; Khamrin P, 2007, J MED VIROL, V79, P1921, DOI 10.1002/jmv.21004; Kim DS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004172; Kirkwood CD, 2001, J CLIN MICROBIOL, V39, P2722, DOI 10.1128/JCM.39.7.2722-2724.2001; Kitajima M, 2011, APPL ENVIRON MICROB, V77, P4226, DOI 10.1128/AEM.00088-11; Kitajima M, 2010, APPL ENVIRON MICROB, V76, P2461, DOI 10.1128/AEM.02739-09; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2456.2002; Kitamoto N, 2012, MICROBIOL IMMUNOL, V56, P760, DOI 10.1111/j.1348-0421.2012.00499.x; KJELDSBERG E, 1977, ACTA PATH MICRO IM B, V85, P351; Kobayashi S, 2012, ARCH VIROL, V157, P1995, DOI 10.1007/s00705-012-1394-8; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446; Li CSY, 2009, J MED VIROL, V81, P1903, DOI 10.1002/jmv.21611; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; LIU BL, 1995, ARCH VIROL, V140, P1345, DOI 10.1007/BF01322662; Liu BL, 1997, VIRUS GENES, V15, P25, DOI 10.1023/A:1007946628253; Logan C, 2007, J VIROL METHODS, V146, P36, DOI 10.1016/j.jviromet.2007.05.031; MADELEY CR, 1976, LANCET, V1, P199; Martinez N, 2002, J MED VIROL, V67, P289, DOI 10.1002/jmv.2220; MATSON DO, 1995, J MED VIROL, V45, P215, DOI 10.1002/jmv.1890450218; MATSON DO, 1989, J INFECT DIS, V159, P71; MATSON DO, 1990, PEDIATR INFECT DIS J, V9, P190, DOI 10.1097/00006454-199003000-00009; Mikula C, 2010, EMERG INFECT DIS, V16, P1186, DOI 10.3201/eid1607.091789; Miyoshi M, 2010, JPN J INFECT DIS, V63, P75; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Murray TY, 2013, FOOD ENVIRON VIROL, V5, P61, DOI 10.1007/s12560-012-9101-1; Murray TY, 2013, WATER SCI TECHNOL, V67, P2776, DOI 10.2166/wst.2013.203; Naing Z, 2013, J PAEDIATR CHILD H, V49, pE221, DOI 10.1111/jpc.12113; Nakagawa-Okamoto R, 2009, JPN J INFECT DIS, V62, P63; Nakamura K, 2010, J CLIN MICROBIOL, V48, P1215, DOI 10.1128/JCM.02130-09; Nakanishi K, 2011, MICROBIOL IMMUNOL, V55, P657, DOI 10.1111/j.1348-0421.2011.00358.x; Nakata S, 1998, J CLIN MICROBIOL, V36, P3160; NAKATA S, 1985, J INFECT DIS, V152, P274; NAKATA S, 1985, J CLIN MICROBIOL, V22, P519; Nakata S, 2000, J INFECT DIS, V181, P2029, DOI 10.1086/315500; NAKATA S, 1988, J CLIN MICROBIOL, V26, P2001; Ng Terry Fei Fan, 2012, J Virol, V86, P12161, DOI 10.1128/JVI.00869-12; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Niwa S, 2014, MICROBIOL IMMUNOL, V58, P68, DOI 10.1111/1348-0421.12107; Noel JS, 1997, J MED VIROL, V52, P173, DOI 10.1002/(SICI)1096-9071(199706)52:2<173::AID-JMV10>3.3.CO;2-6; Numata K, 1997, ARCH VIROL, V142, P1537, DOI 10.1007/s007050050178; Oka T, 2009, VIROLOGY, V394, P119, DOI 10.1016/j.virol.2009.08.018; Oka T, 2009, MICROBIOL IMMUNOL, V53, P417, DOI 10.1111/j.1348-0421.2009.00133.x; Oka T, 2007, J VIROL, V81, P6798, DOI 10.1128/JVI.02840-06; Oka T, 2009, MICROBIOL IMMUNOL, V53, P49, DOI 10.1111/j.1348-0421.2008.00086.x; Oka T, 2012, ARCH VIROL, V157, P349, DOI 10.1007/s00705-011-1161-2; Oka T, 2006, ARCH VIROL, V151, P399, DOI 10.1007/s00705-005-0613-y; Okada M, 2006, VIRUS GENES, V33, P157, DOI 10.1007/s11262-005-0051-7; Okada M, 2002, ARCH VIROL, V147, P1445, DOI 10.1007/s00705-002-0821-7; Ootsuka Y, 2009, JPN J INFECT DIS, V62, P246; Pang XL, 2000, J INFECT DIS, V181, pS288, DOI 10.1086/315590; Pang XLL, 2014, J MED VIROL, V86, P1594, DOI 10.1002/jmv.23851; Pang XLL, 2009, J INFECT DIS, V199, P547, DOI 10.1086/596210; Park S, 2012, CLIN LAB, V58, P1219, DOI 10.7754/Clin.Lab.2012.120118; Parra GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067592; PARWANI AV, 1990, ARCH VIROL, V112, P41, DOI 10.1007/BF01348984; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Phan TG, 2005, ARCH VIROL, V150, P371, DOI 10.1007/s00705-004-0401-0; Phan TG, 2005, ARCH VIROL, V150, P1415, DOI 10.1007/s00705-005-0514-0; Phan TG, 2006, EMERG INFECT DIS, V12, P865; Phan TG, 2007, INFECT GENET EVOL, V7, P542, DOI 10.1016/j.meegid.2007.02.004; Phan TG, 2006, J MED VIROL, V78, P839, DOI 10.1002/jmv.20632; Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084; Rachakonda G, 2008, J CLIN VIROL, V43, P42, DOI 10.1016/j.jcv.2008.05.006; Ratcliff RM, 2002, J CLIN MICROBIOL, V40, P4091, DOI 10.1128/JCM.40.11.4091-4099.2002; Robel Ivonne, 2008, J Virol, V82, P8085, DOI 10.1128/JVI.00693-08; Roos-Weil D, 2011, TRANSPLANTATION, V92, P61, DOI 10.1097/TP.0b013e31821c9392; Sakai Y, 2001, PEDIATR INFECT DIS J, V20, P849, DOI 10.1097/00006454-200109000-00005; SAKUMA Y, 1981, J MED VIROL, V7, P221, DOI 10.1002/jmv.1890070306; Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10; Schuffenecker I, 2001, ARCH VIROL, V146, P2115, DOI 10.1007/s007050170024; Shigemoto N, 2011, MICROBIOL IMMUNOL, V55, P369, DOI 10.1111/j.1348-0421.2011.00325.x; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Shirato-Horikoshi H, 2007, ARCH VIROL, V152, P457, DOI 10.1007/s00705-006-0883-z; Shivanna V, 2014, VIROLOGY, V456, P268, DOI 10.1016/j.virol.2014.04.002; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; SPRATT HC, 1978, J PEDIATR-US, V93, P922; SUZUKI H, 1979, J MED VIROL, V4, P321, DOI 10.1002/jmv.1890040410; Svraka S, 2009, J CLIN MICROBIOL, V47, P1674, DOI 10.1128/JCM.00307-09; TERASHIMA H, 1983, ARCH VIROL, V78, P1, DOI 10.1007/BF01310853; Gutierrez-Escolano AL, 2010, J MED VIROL, V82, P632, DOI 10.1002/jmv.21743; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034987; Usuku S, 2008, JPN J INFECT DIS, V61, P438; VANBEEK J, 2013, EURO SURVEILL, V18, P59209; Vinje J, 2000, J CLIN MICROBIOL, V38, P530; Wolf S, 2012, ARCH VIROL, V157, P1499, DOI 10.1007/s00705-012-1326-7; Wolfaardt M, 1997, J MED VIROL, V51, P290, DOI 10.1002/(SICI)1096-9071(199704)51:4<290::AID-JMV6>3.0.CO;2-0; Wright PJ, 1998, J MED VIROL, V55, P312, DOI 10.1002/(SICI)1096-9071(199808)55:4<312::AID-JMV10>3.0.CO;2-G; Wu FT, 2008, EMERG INFECT DIS, V14, P1169, DOI 10.3201/eid1407.071531; Yamashita Y, 2010, J MED VIROL, V82, P720, DOI 10.1002/jmv.21646; Yan H, 2005, J MED VIROL, V75, P475, DOI 10.1002/jmv.20292; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003; Yokoyama M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00312; Yoshida T, 2009, J CLIN VIROL, V45, P67, DOI 10.1016/j.jcv.2009.03.003; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	272	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0893-8512	1098-6618		CLIN MICROBIOL REV	Clin. Microbiol. Rev.	JAN	2015	28	1					32	53		10.1128/CMR.00011-14		22	Microbiology	Microbiology	AY3BU	WOS:000347460400002		
J	Sugiura, Y; Nagaishi, M; Takano, I; Tanaka, Y; Suzuki, K; Yokoo, H; Hyodo, A				Sugiura, Yoshiki; Nagaishi, Masaya; Takano, Issei; Tanaka, Yoshihiro; Suzuki, Kensuke; Yokoo, Hideaki; Hyodo, Akio			Convexity dural chondroma: a case report with pathological and molecular analysis	CLINICAL NEUROPATHOLOGY			English	Article						chondroma; isocitrate dehydrogenase; HMGA2; cartilaginous tumor; metaplastic meningioma	INTRACRANIAL CHONDROMA; HMGI-C; UTERINE LEIOMYOMATA; MESENCHYMAL TUMORS; EXPRESSION; MUTATIONS; IDH1; DISRUPTION; TISSUES	Chondromas are rare benign tumors that commonly originate from the base of the skull, while those arising from the dura mater are less common. Although the molecular mechanism underlying its pathogenesis remains largely unknown, 12q13-15 rearrangements followed by the activation of HMGA2, which is associated with cell proliferation, have been reported in soft tissue chondromas. A recent comprehensive analysis of mesenchymal tumors identified an IDH1/2 mutation in cartilaginous tumors. However, these alterations have not yet been examined in dural chondromas. We here describe clinical and pathological features in a new case of convexity dural chondroma with the wildtype IDH1/2 and expression of HMGA2 and reviewed the relevant literature.	[Sugiura, Yoshiki; Nagaishi, Masaya; Takano, Issei; Tanaka, Yoshihiro; Suzuki, Kensuke; Hyodo, Akio] Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Neurosurg, Saitama 3438555, Japan; [Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Gunma, Japan	Nagaishi, M (reprint author), Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Neurosurg, 2-1-50 Minami Koshigaya, Saitama 3438555, Japan.	nagaishi-nsu@umin.ac.jp					Dahlen A, 2003, MODERN PATHOL, V16, P1132, DOI 10.1097/01.MP.0000092954.42656.94; ASHAR HR, 1995, CELL, V82, P57; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; NAKAZATO Y, 1984, ACTA NEUROPATHOL, V64, P30; Zaidi MR, 2006, CANCER RES, V66, P7453, DOI 10.1158/0008-5472.CAN-06-0931; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Abeloos L, 2012, NEUROPATHOLOGY, V32, P306, DOI 10.1111/j.1440-1789.2011.01264.x; Arai M, 2012, BRAIN TUMOR PATHOL, V29, P201, DOI 10.1007/s10014-012-0085-1; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ozaki T, 2004, ANTICANCER RES, V24, P1721; Battista S, 1999, CANCER RES, V59, P4793; Gattas GJF, 1999, GENE CHROMOSOME CANC, V25, P316, DOI 10.1002/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.3.CO;2-S; Buddingh EP, 2003, CANCER GENET CYTOGEN, V141, P164, DOI 10.1016/S0165-4608(02)00726-4; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Rogalla P, 1996, AM J PATHOL, V149, P775; Patel A, 2009, NEUROPATHOLOGY, V29, P315, DOI 10.1111/j.1440-1789.2008.00957.x; Shadan FF, 2000, CANCER GENET CYTOGEN, V118, P144, DOI 10.1016/S0165-4608(99)00196-X; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; BERKMEN Y M, 1968, Clinical Radiology, V19, P327, DOI 10.1016/S0009-9260(68)80019-4; Broberg K, 2001, MODERN PATHOL, V14, P311, DOI 10.1038/modpathol.3880308; Brownlee RD, 1997, AM J NEURORADIOL, V18, P889; Duan FH, 2012, ACTA RADIOL, V53, P1146, DOI 10.1258/ar.2012.120433; FEJZO MS, 1995, GENOMICS, V26, P265, DOI 10.1016/0888-7543(95)80210-D; Higashida T, 2007, NEUROL SURG TOKYO, V35, P495; Kawabata Y, 2010, Neuroradiol J, V23, P496; Lacerte D, 1996, CAN J NEUROL SCI, V23, P132; Louis DN, 2007, WHO CLASSIFICATION T; Maheshwari Mehdi G, 2011, BMJ CASE REP, V12, P2011; MAPSTONE TB, 1983, NEUROSURGERY, V12, P111; Nagaishi M, 2010, NEUROPATHOLOGY, V30, P547, DOI 10.1111/j.1440-1789.2009.01087.x; NAKAZAWA T, 1993, SURG NEUROL, V40, P495, DOI 10.1016/0090-3019(93)90053-4; Nehete Rajendra, 2012, Indian J Plast Surg, V45, P550, DOI 10.4103/0970-0358.105974; Sawyer JR, 1998, CANCER, V82, P474; Sebbag M, 1990, J Radiol, V71, P495; Straver B, 1998, INT J ARTIF ORGANS, V21, P794; Tang HL, 2013, CHINESE J CANCER RES, V25, P112, DOI 10.3978/j.issn.1000-9604.2013.01.10	39	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JAN-FEB	2015	34	1					13	18		10.5414/NP300785		6	Clinical Neurology; Pathology	Neurosciences & Neurology; Pathology	AZ5FA	WOS:000348244600004		
J	Tomita, T; Sato, Y; Nakagami, T; Tsuchimine, S; Kaneda, A; Kaneko, S; Nakamura, K; Yasui-Furukori, N				Tomita, Tetsu; Sato, Yasushi; Nakagami, Taku; Tsuchimine, Shoko; Kaneda, Ayako; Kaneko, Sunao; Nakamura, Kazuhiko; Yasui-Furukori, Norio			Effects of Age on Paroxetine Efficacy in Patients With Major Depressive Disorder Who Do Not Exhibit an Early Response to Treatment	CLINICAL NEUROPHARMACOLOGY			English	Review						major depressive disorder; early response; response; placebo response; age	ANTIDEPRESSANTS; NONRESPONSE; PREDICTION; IMPACT; GENE	Objectives: We investigated the effects of age on the association between early and eventual responses to paroxetine treatment in patients with major depressive disorder (MDD). Methods: Eighty-nine patients with MDD were administered paroxetine and completed the 6-week protocol. On the basis of our previous study, we defined early responders as those patients with the Montgomery-Asberg Depression Rating Scale (MADRS) improvements higher than 35% at 2 weeks and responders as those patients with MADRS improvements higher than 50% at 6 weeks. The participants were divided into 4 groups in accordance with their responses: early response responders, early response nonresponders, nonearly response responders (NER-Rs), and nonearly response nonresponders (NER-NRs). Demographic data and the MADRS scores between the early response responders and the early response nonresponders and between the NER-Rs and the NER-NRs were compared. We used a receiver operating characteristic (ROC) curve to analyze age to determine the cutoff points for distinguishing responders and nonresponders in early and nonearly responders. Results: There was a significant difference in age between the NER-Rs and the NER-NRs, with the NER-Rs being younger than the NER-NRs. The threshold for the response in the early responders was 42 years old. The area under the curve of the ROC curve of the early responders was 0.548. The threshold for the response of the nonearly responders was 55 years old. The area under the curve of the ROC curve of the early responders was 0.733. Conclusions: The effects of age on the association between the responsiveness in the early phase of antidepressant treatment and the eventual response were identified in patients with MDD.	[Tomita, Tetsu; Sato, Yasushi; Nakagami, Taku; Tsuchimine, Shoko; Kaneda, Ayako; Kaneko, Sunao; Nakamura, Kazuhiko; Yasui-Furukori, Norio] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan	Tomita, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, 5 Zaifu Sho, Hirosaki, Aomori 0368562, Japan.	ttomita1984@yahoo.co.jp					Nakajima S, 2011, PROG NEURO-PSYCHOPH, V35, P1983, DOI 10.1016/j.pnpbp.2011.08.008; Calati R, 2013, J AFFECT DISORDERS, V147, P1, DOI 10.1016/j.jad.2012.11.053; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; van Praag HM, 2008, EUR ARCH PSY CLIN N, V258, P29, DOI 10.1007/s00406-008-2006-1; Lin CH, 2011, J CLIN PSYCHOPHARM, V31, P187, DOI 10.1097/JCP.0b013e318210856f; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Abela JRZ, 2005, J PERS DISORD, V19, P68, DOI 10.1521/pedi.19.1.68.62177; Blier P, 2009, EUR NEUROPSYCHOPHARM, V19, P457, DOI 10.1016/j.euroneuro.2009.01.015; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Cook IA, 2009, PSYCHIAT RES-NEUROIM, V174, P152, DOI 10.1016/j.pscychresns.2009.04.011; Tomita T, 2014, NEUROPSYCH DIS TREAT, V10, P599, DOI 10.2147/NDT.S57189; Jaworska N, 2013, CAN J PSYCHIAT, V58, P509; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Trivedi MH, 2009, INT CLIN PSYCHOPHARM, V24, P133, DOI 10.1097/YIC.0b013e3283277614; Sheline YI, 2004, NEUROPSYCHOPHARMACOL, V29, P2235, DOI 10.1038/sj.npp.1300555; Arias B, 2001, MOL PSYCHIATR, V6, P239, DOI 10.1038/sj.mp.4000818; BURROWS GD, 1988, J CLIN PSYCHIAT, V49, P18; Henkel V, 2009, J AFFECT DISORDERS, V115, P439, DOI 10.1016/j.jad.2008.10.011; Inagaki Takuji, 2008, Prim Care Companion J Clin Psychiatry, V10, P129; Jaworska N, 2013, EUR NEUROPSYCHOPHARM, V23, P1561, DOI 10.1016/j.euroneuro.2013.03.003; Kok RM, 2009, INT J GERIATR PSYCH, V24, P1299, DOI 10.1002/gps.2261; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Marinova Z, 2014, NEUROPATHOL APPL NEU, DOI [10.1111/nan.12167, DOI 10.1111/NAN.12167]	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-5664	1537-162X		CLIN NEUROPHARMACOL	Clin. Neuropharmacol.	JAN-FEB	2015	38	1					6	10		10.1097/WNF.0000000000000058		5	Clinical Neurology; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AZ3SK	WOS:000348146800002		
J	Long, NV; Yang, Y; Thi, CM; Hang, BT; Cao, YQ; Nogami, M				Nguyen Viet Long; Yang, Yong; Cao Minh Thi; Bui Thi Hang; Cao, Yanqin; Nogami, Masayuki			Controlled synthesis and characterization of iron oxide micro-particles for Fe-air battery electrode material	COLLOID AND POLYMER SCIENCE			English	Article						Colloidal oxide; Surfaces; Crystal structure; Fe2O3 oxides; Battery	LITHIUM-ION BATTERIES; MAGNETIC NANOPARTICLES; HIGH-PERFORMANCE; ELECTROCHEMICAL-BEHAVIOR; POTENTIAL APPLICATIONS; ALKALINE BATTERIES; NEGATIVE-ELECTRODE; BIOLOGICAL APPLICATIONS; THERMAL-DECOMPOSITION; FE2O3 NANOPARTICLES	In this research, novel homogeneous iron (Fe) oxide particles with the pure alpha-Fe2O3 structure are successfully synthesized with controlling and shaping via a modified polyol method with NaBH4 as an efficient reducing agent according to drying and heat treatment processes. In the critical synthetic and experimental conditions, large alpha-Fe2O3 particles exhibited homogeneously large sizes in the certain ranges of 1-5 mu m and 1-10 mu m, which are regarded as a discovery of controlled and shaped synthesis. The electrochemical measurements indicated that oxide powders containing as-prepared pure alpha-Fe2O3 microparticles were successfully used in the electrodes. Accordingly, the cyclic voltammetry (CV) and galvanostatic cycling measurements indicated their potential applications for next-generation Fe-air battery technology in comparison with commercial oxide products of Fe2O3 particles. Finally, we suggest that the sharp polyhedral shape and morphology of the engineered micro-particles, such as metal, alloy, and oxide micro-particles, are of importance because they have very high stability and durability with respect to their applied properties.	[Nguyen Viet Long; Yang, Yong; Cao, Yanqin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Nguyen Viet Long] Posts & Telecommun Inst Technol, Hanoi, Vietnam; [Nguyen Viet Long] Ho Chi Minh Vietnam Natl Univ, Lab Nanotechnol, Ho Chi Minh City, Vietnam; [Nguyen Viet Long] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Mol & Mat Sci, Kasuga, Fukuoka 8618580, Japan; [Nguyen Viet Long; Cao Minh Thi] Ho Chi Minh City Univ Technol, Ho Chi Minh City, Vietnam; [Bui Thi Hang] Hanoi Univ Sci & Technol, Int Training Inst Mat Sci, Hanoi, Vietnam; [Nogami, Masayuki] Toyota Motor Co Ltd, Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	Long, NV (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.	nguyenviet_long@yahoo.com; yangyong@mail.sic.ac.cn; hang@itims.edu.vn; mnogami@mtj.biglobe.ne.jp	Yang, Yong/D-3227-2011		NAFOSTED, Vietnam [103.02-2014.45]; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [103.02-2014.20]; Chinese Academy of Sciences through Visiting Fellowship for Researchers from Developing Countries [2013FFGB0007]; China Postdoctoral Science Foundation from Shanghai Institute of Ceramics (SIC), Chinese Academy of Sciences (CAS), Dingxi Road, Shanghai, China [2014M551462]; National Natural Science Foundation of China [51471182]	This work is supported by NAFOSTED Grant No. 103.02-2014.45, 2014, Vietnam. This is also supported by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under Grant No. 103.02-2014.20, 2014. We greatly thank and appreciate the financial supports and projects sponsored by Chinese Academy of Sciences through Visiting Fellowship for Researchers from Developing Countries (Grant No. 2013FFGB0007) and China Postdoctoral Science Foundation (No. 2014M551462) from Shanghai Institute of Ceramics (SIC), Chinese Academy of Sciences (CAS), Dingxi Road 1295, Shanghai 200050, China, and other Universities for our research on Novel Magnetic Nanoparticles for Catalysis, Biology and Medicine (Nanomedicine). The work was also supported by National Natural Science Foundation of China (Grant No. 51471182).	Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Hang BT, 2008, J POWER SOURCES, V178, P393, DOI 10.1016/j.jpowsour.2007.12.012; BALASUBRAMANIAN TS, 1993, J POWER SOURCES, V41, P99, DOI 10.1016/0378-7753(93)85008-C; Gong J, 2013, J MATER CHEM A, V1, P5247, DOI 10.1039/c3ta10316a; KALAIGNAN GP, 1987, J APPL ELECTROCHEM, V17, P1083, DOI 10.1007/BF01024374; Khaselev O, 1997, ELECTROCHIM ACTA, V42, P2333, DOI 10.1016/S0013-4686(96)00416-1; Long NV, 2014, RECENT PAT NANOTECH, V8, P52; Tang B, 2006, INORG CHEM, V45, P5196, DOI 10.1021/ic060097b; Qiao RR, 2009, J MATER CHEM, V19, P6274, DOI 10.1039/b902394a; Long NV, 2013, J NANOSCI NANOTECHNO, V13, P4799, DOI 10.1166/jnn.2013.7570; HAMPSON NA, 1974, ELECTROCHIM ACTA, V19, P397, DOI 10.1016/0013-4686(74)87015-5; Periasamy P, 1996, J POWER SOURCES, V58, P35, DOI 10.1016/0378-7753(95)02274-0; Yu WJ, 2012, J MATER CHEM, V22, P13756, DOI 10.1039/c2jm31442h; VIJAYAMOHANAN K, 1991, J POWER SOURCES, V34, P269, DOI 10.1016/0378-7753(91)80093-D; OJEFORS L, 1976, J ELECTROCHEM SOC, V123, P1139; SHOESMITH DW, 1978, ELECTROCHIM ACTA, V23, P903, DOI 10.1016/0013-4686(78)87014-5; Long NV, 2014, RSC ADV, V4, P8250, DOI 10.1039/c3ra46410e; JAYALAKSHMI M, 1992, J POWER SOURCES, V39, P113, DOI 10.1016/0378-7753(92)85011-X; Mou XL, 2012, CRYSTENGCOMM, V14, P5107, DOI 10.1039/c2ce25109d; Zeng H, 2008, ADV FUNCT MATER, V18, P391, DOI 10.1002/adfm.200701211; OJEFORS L, 1976, ELECTROCHIM ACTA, V21, P263, DOI 10.1016/0013-4686(76)80016-3; Long NV, 2013, NANO ENERGY, V2, P636, DOI 10.1016/j.nanoen.2013.06.001; Hang BT, 2013, J ELECTROCHEM SOC, V160, pA1442, DOI 10.1149/2.066309jes; Long NV, 2012, NEW J CHEM, V36, P1320, DOI 10.1039/c2nj40027h; Lacroix LM, 2011, NANO LETT, V11, P1641, DOI 10.1021/nl200110t; Periasamy P, 1996, J POWER SOURCES, V62, P9, DOI 10.1016/S0378-7753(96)02391-9; Rao PM, 2009, NANO LETT, V9, P3001, DOI 10.1021/nl901426t; CARTA R, 1988, J ELECTROANAL CHEM, V257, P257, DOI 10.1016/0022-0728(88)87046-3; Zhu HY, 2013, NANO LETT, V13, P2947, DOI 10.1021/nl401325u; Guo HB, 2013, ENERG ENVIRON SCI, V6, P561, DOI 10.1039/c2ee23253g; Caldas CA, 1998, J POWER SOURCES, V74, P108, DOI 10.1016/S0378-7753(98)00039-1; Long NV, 2014, RSC ADV, V4, P6383, DOI 10.1039/c3ra45925j; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Joseyphus RJ, 2010, MATER CHEM PHYS, V123, P487, DOI 10.1016/j.matchemphys.2010.05.001; Guo HB, 2013, J MATER CHEM A, V1, P27, DOI 10.1039/c2ta00523a; VIJAYAMOHANAN K, 1990, J POWER SOURCES, V32, P329, DOI 10.1016/0378-7753(90)87002-9; CHAKKARAVARTHY C, 1991, J POWER SOURCES, V35, P21, DOI 10.1016/0378-7753(91)80002-F; MICKA K, 1987, J POWER SOURCES, V19, P315, DOI 10.1016/0378-7753(87)87007-6; Murray CB, 2001, MRS BULL, V26, P985; Farrell D, 2003, J PHYS CHEM B, V107, P11022, DOI 10.1021/jp0351831; OJEFORS L, 1976, J ELECTROCHEM SOC, V123, P1691; CERNY J, 1993, J POWER SOURCES, V45, P267, DOI 10.1016/0378-7753(93)80016-I; Long NV, 2011, J COLLOID INTERF SCI, V359, P339, DOI 10.1016/j.jcis.2011.03.029; Guo J, 2012, J HAZARD MATER, V225, P63, DOI 10.1016/j.jhazmat.2012.04.065; Jang B, 2012, J AM CHEM SOC, V134, P15010, DOI 10.1021/ja305539r; Tong GX, 2011, J ALLOY COMPD, V509, P4320, DOI 10.1016/j.jallcom.2011.01.058; Poizot P, 2000, NATURE, V407, P496; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9; Long NV, 2014, COLLOID SURFACE A, V456, P184, DOI 10.1016/j.colsurfa.2014.05.001; Hou YL, 2007, ANGEW CHEM INT EDIT, V46, P6329, DOI 10.1002/anie.200701694; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Bai S, 2012, RSC ADV, V2, P10977, DOI 10.1039/c2ra21411c; Franzel L, 2012, APPL SURF SCI, V261, P332, DOI 10.1016/j.apsusc.2012.08.010; Rong CB, 2007, J PHYS D APPL PHYS, V40, P712, DOI 10.1088/0022-3727/40/3/003; CERNY J, 1989, J POWER SOURCES, V25, P111, DOI 10.1016/0378-7753(89)85003-7; MURALIDHARAN VS, 1985, J APPL ELECTROCHEM, V15, P675, DOI 10.1007/BF00620563; Teja AS, 2009, PROG CRYST GROWTH CH, V55, P22, DOI 10.1016/j.pcrysgrow.2008.08.003; Ming J, 2011, J MATER CHEM, V21, P17776, DOI 10.1039/c1jm12879e; Souza CAC, 2004, J POWER SOURCES, V132, P288, DOI 10.1016/j.jpowsour.2003.12.043; Yin JZ, 2010, ANGEW CHEM INT EDIT, V49, P6328, DOI 10.1002/anie.201002557; Peng S, 2006, J AM CHEM SOC, V128, P10676, DOI 10.1021/ja063969h; Mou XL, 2012, ANGEW CHEM INT EDIT, V51, P2989, DOI 10.1002/anie.201107113; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Blanco-Andujar C, 2012, J MATER CHEM, V22, P12498, DOI 10.1039/c2jm31295f; ARMSTRON.RD, 1972, J ELECTROANAL CHEM, V40, P325, DOI 10.1016/S0022-0728(72)80377-2; Bharathi S, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/1/015501; Cornell RM, 2003, IRON OXIDES STRUCTUR; Guo L, 2001, PHYS CHEM CHEM PHYS, V3, P1661, DOI 10.1039/b009951l; Hosokawa M, 2007, NANOPARTICLE TECHNOLOGY HANDBOOK, pV; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Hyeon T, 2003, CHEM COMMUN, P927, DOI 10.1039/b207789b; Jayalakshimi N, 1995, J POWER SOURCES, V56, P209; JAYALAKSHMI N, 1990, J POWER SOURCES, V32, P341, DOI 10.1016/0378-7753(90)87003-A; Jun YW, 2007, CHEM COMMUN, P1203, DOI 10.1039/b614735f; Li YX, 2013, COLLOID POLYM SCI, V291, P1287, DOI 10.1007/s00396-012-2857-x; MACDONAL.DD, 1973, J ELECTROCHEM SOC, V120, P317, DOI 10.1149/1.2403446; Majewski P, 2006, NANOMATERIALS WATER, P211; Medford JA, 2014, COLLOID POLYM SCI, V292, P1429, DOI 10.1007/s00396-014-3194-z; Miguel-Sancho N, 2012, IND ENG CHEM RES, V51, P8348, DOI 10.1021/ie3002974; Mou XL, 2012, EUR J INORG CHEM, P2684, DOI 10.1002/ejic.201101066; ANDERSSON B, 1976, J ELECTROCHEM SOC, V123, P824, DOI 10.1149/1.2132940; Periasamy P, 1996, J POWER SOURCES, V63, P79, DOI 10.1016/S0378-7753(96)02449-4; Schrebler-Guzman RS, 1979, J ELECTROCHIM ACTA, V24, P395; Shukla N, 2007, SURF SCI, V601, P2615, DOI 10.1016/j.susc.2006.11.074; Simeonidis K, 2007, J MAGN MAGN MATER, V316, pE1, DOI 10.1016/j.jmmm.2007.02.009; Song GP, 2004, COLLOID POLYM SCI, V282, P656, DOI 10.1007/s00396-003-0996-9; Song YJ, 2010, MATER LETT, V64, P1789, DOI 10.1016/j.matlet.2010.05.025; VASSIE PR, 1976, ELECTROCHIM ACTA, V21, P299, DOI 10.1016/0013-4686(76)80023-0; VIJAYAMOHANAN K, 1990, J ELECTROANAL CHEM, V295, P59, DOI 10.1016/0022-0728(90)85005-P; VIJAYAMOHANAN K, 1990, J ELECTROANAL CHEM, V289, P55, DOI 10.1016/0022-0728(90)87206-Y; Zhou X, 2012, J SOLID STATE CHEM, V196, P138, DOI 10.1016/j.jssc.2012.05.025	92	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					49	63		10.1007/s00396-014-3363-0		15	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100004		
J	Saito, T; Tsushima, Y; Sawada, H				Saito, Tomoya; Tsushima, Yusei; Sawada, Hideo			Facile creation of superoleophobic and superhydrophilic surface by using fluoroalkyl end-capped vinyltrimethoxysilane oligomer/calcium silicide nanocomposites-development of these nanocomposites to environmental cyclical type-fluorine recycle through formation of calcium fluoride	COLLOID AND POLYMER SCIENCE			English	Article						Fluoroalkyl end-capped oligomer; Calcium silicide; Nanocomposites; Surface modification; Superoleophobicity; Superhydrophilicity; Superhydrophobicity; Calcium fluoride	OIL-REPELLENT SURFACES; 800 DEGREES-C; OLIGOMERIC NANOCOMPOSITES; DISSOCIATION ENERGY; COATINGS; HYBRID; POLYMERIZATION; NANOPARTICLES; SI(111); DESIGN	Fluoroalkyl end-capped vinyltrimethoxysilane oligomer/calcium silicide nanocomposites [R-F-(VM-SiO2) (n) -R-F/CaSi2] were prepared by the sol-gel reactions of the corresponding fluorinated oligomer [R-F-(VM) (n) -R-F] with calcium silicide particles under alkaline conditions. These nanocomposites thus obtained can exhibit a good dispersibility and stability in traditional organic solvents such as methanol, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), and fluorinated aliphatic solvents (1:1 mixed solvents (AK-225) of 1,1-dichloro-2,2,3,3,3-pentafluoropropane and 1,3-dichloro-1,2,2,3,3-pentafluoropropane). Methanol sol solutions of R-F-(VM-SiO2) (n) -R-F/CaSi2 nanocomposites were applied to the surface modification of glass through the dipping technique. R-F-(VM-SiO2) (n) -R-F/CaSi2 nanocomposites, in which the contents of CaSi2 are 1-8 %, can give the superhydrophobic and highly oleophobic characteristics on the modified glass surfaces. In contrast, R-F-(VM-SiO2) (n) -R-F/CaSi2 nanocomposites, in which the contents of CaSi2 are 67-88 %, enabled the modified surfaces to give the both superoleophobic and superhydrophilic characteristics. In this way, the switching behavior between the superhydrophobic and superhydrophilic surfaces with the highly oleophobic characteristic can be easily observed by controlling the contents of CaSi2 in the fluorinated nanocomposites. In addition, R-F-(VM-SiO2) (n) -R-F/CaSi2 nanocomposites were found to give the calcium fluoride as the pyrolytic product through the calcination of these nanocomposites at 800 A degrees C, indicating that the present composites have high potential for the development to the new environmental cyclical type-fluorine recycle system.	[Saito, Tomoya; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Tsushima, Yusei] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan.	hideosaw@cc.hirosaki-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [24550220]	This work was partially supported by a Grant-in-Aid for Scientific Research 24550220 from the Ministry of Education, Science, Sports, and Culture, Japan.	Ameduri B, 2000, J FLUORINE CHEM, V104, P53, DOI 10.1016/S0022-1139(00)00227-X; Ameduri B, 2004, WELL ARCHITECTURED F; Taurino R, 2008, J COLLOID INTERF SCI, V325, P149, DOI 10.1016/j.jcis.2008.05.007; Goto Y, 2011, J COLLOID INTERF SCI, V362, P375, DOI 10.1016/j.jcis.2011.06.045; Boschet F, 2014, CHEM REV, V114, P927, DOI 10.1021/cr2002933; Ding CM, 2012, SOFT MATTER, V8, P9064, DOI 10.1039/c2sm25987g; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; Girard E, 2012, ACS MACRO LETT, V1, P270, DOI 10.1021/mz2001143; Liu XL, 2012, ADV MATER, V24, P3401, DOI 10.1002/adma.201200797; Johns K, 2000, J FLUORINE CHEM, V104, P5, DOI 10.1016/S0022-1139(00)00251-7; Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111; David G, 2006, CHEM REV, V106, P3936, DOI 10.1021/cr0509612; Ameduri B, 2009, CHEM REV, V109, P6632, DOI 10.1021/cr800187m; Shibuichi S, 1998, J COLLOID INTERF SCI, V208, P287, DOI 10.1006/jcis.1998.5813; Lee SG, 2013, LANGMUIR, V29, P15051, DOI 10.1021/la404005b; Liu MJ, 2009, ADV MATER, V21, P665, DOI 10.1002/adma.200801782; Feng J, 2009, J COLLOID INTERF SCI, V336, P268, DOI 10.1016/j.jcis.2009.03.025; Wang HD, 2013, ACS APPL MATER INTER, V5, P10221, DOI 10.1021/am4029679; Liu KS, 2013, PROG MATER SCI, V58, P503, DOI 10.1016/j.pmatsci.2012.11.001; Cheng YT, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895487; BLUE GD, 1963, J PHYS CHEM-US, V67, P877, DOI 10.1021/j100798a039; Canepa F, 2000, J ALLOY COMPD, V299, P20, DOI 10.1016/S0925-8388(99)00692-1; Chen YC, 2004, J POLYM SCI POL CHEM, V42, P1789, DOI 10.1002/pola.20033; Cho JW, 2001, SUL K I POLYM, V2, P135; Dolbier Jr WRJ, 2005, FLUOR CHEM, V126, P157; Dotsenko SA, 2012, PHYSCS PROC, V23, P41, DOI 10.1016/j.phpro.2012.01.011; Fabbri P, 2006, POLYMER, V47, P1055, DOI 10.1016/j.polymer.2005.12.028; Gillot B, 1998, J ALLOY COMPD, V270, P275, DOI 10.1016/S0925-8388(98)00527-1; Hsu SH, 2013, ACS APPL MATER INTER, V5, P2991, DOI 10.1021/am302446t; Nartowski AM, 2002, POLYHEDRON, V21, P187, DOI 10.1016/S0277-5387(01)00974-3; Pauling L., 1967, CHEM BOND; Saito T, 2013, POLYM ADVAN TECHNOL, V24, P532, DOI 10.1002/pat.3111; Sawada H, 1991, CHEM COMMUN, P677; Sawada H, 2010, B CHEM SOC JPN, V83, P75, DOI 10.1246/bcsj.20090204; Sawada H, 2011, J POLYM SCI POL CHEM, V49, P1070, DOI 10.1002/pola.24516; Sawada H, 2011, MACROMOLECULES, V44, P1114, DOI 10.1021/ma102532k; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; Sawada H, 2008, COLLOID POLYM SCI, V286, P1569, DOI 10.1007/s00396-008-1926-7; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Sawada H, 2010, POLYM J, V42, P167, DOI 10.1038/pj.2009.316; Sawada H, 1996, CHEM REV, V96, P1779, DOI 10.1021/cr9411482; Sawada HJ, 2000, FLUORINE CHEM, V105, P219; Sawada HJ, 2003, FLUORINE CHEM, V121, P111; Scheirs J., 1997, MODERN FLUOROPOLYMER; WALSH R, 1981, ACCOUNTS CHEM RES, V14, P246, DOI 10.1021/ar00068a004; Wen CL, 2011, J ALLOY COMPD, V509, P4583, DOI 10.1016/j.jallcom.2011.01.112; Wurz R, 2002, APPL SURF SCI, V190, P437, DOI 10.1016/S0169-4332(01)00911-4; Yano S, 1996, MACROMOL SYMP, V108, P279, DOI 10.1002/masy.19961080123	48	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					65	73		10.1007/s00396-014-3387-5		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100005		
J	Kosugi, K; Kawahara, S				Kosugi, Kenichiro; Kawahara, Seiichi			Natural rubber with nanomatrix of non-rubber components observed by focused ion beam-scanning electron microscopy	COLLOID AND POLYMER SCIENCE			English	Article						Natural rubber; Three-dimensional morphology; FIB-SEM; Nanomatrix structure; Viscoelastic properties	CRYSTALLIZATION BEHAVIOR; OSMIUM-TETROXIDE; PROTEIN; FIXATION; GLUTARALDEHYDE; COMPOSITE; LATEX; POLYISOPRENES; UREA	Naturally occurring nanomatrix structure formed in natural rubber was observed with a field emission scanning electron microscope equipped with a focused ion beam (FIB-SEM), and it was related to viscoelastic properties of the rubber. Film specimen used for the FIB-SEM observation was prepared from serum fraction of natural rubber latex, in which serum rubber contained about 15 w/w% proteins. Morphology of the film specimen was observed by FIB-SEM, after pinning the nanomatrix structure with glutaraldehyde followed by staining the serum rubber with OsO4. Three-dimensional image of the nanomatrix structure was successfully reconstructed in mesoscale without defects and voids, in which rubber particles of 200 nm in diameter were dispersed in the matrix of non-rubber components such as the proteins and phospholipids of several 10 nm in thickness. Storage modulus at plateau region of the serum rubber was about 500 times as high as that of deproteinized natural rubber, suggesting that the nanomatrix of the non-rubber components was completely continuous.	[Kosugi, Kenichiro; Kawahara, Seiichi] Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Niigata 9402188, Japan	Kawahara, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	kawahara@mst.nagaokaut.ac.jp			Japan Society for the Promotion of Science [21655080, 223501000]; JST-JICA SATREPS	This work was supported in part by a Grant-in-Aid (21655080) for Challenging Exploratory Research and Grant-in-Aid (223501000) for Scientific Research (B) from Japan Society for the Promotion of Science and JST-JICA SATREPS.	Akabori Keiichi, 2009, Journal of Physics: Conference Series, V184, DOI 10.1088/1742-6596/184/1/012027; AMSTERDA.A, 1966, J CELL BIOL, V29, P199, DOI 10.1083/jcb.29.2.199; Chaikumpollert O, 2012, COLLOID POLYM SCI, V290, P331, DOI 10.1007/s00396-011-2549-y; Tangpakdee J, 1997, RUBBER CHEM TECHNOL, V70, P707, DOI 10.5254/1.3538454; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; Potts JR, 2012, MACROMOLECULES, V45, P6045, DOI 10.1021/ma300706k; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Kawahara S, 2003, POLYMER, V44, P4527, DOI 10.1016/S0032-3861(03)00415-4; Tanaka Y, 2001, RUBBER CHEM TECHNOL, V74, P355, DOI 10.5254/1.3547643; Prasertsri S, 2012, POLYM TEST, V31, P593, DOI 10.1016/j.polymertesting.2012.03.003; Kawahara S, 2004, POLYM ADVAN TECHNOL, V15, P181, DOI 10.1002/pat.465; HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005; Migneault I, 2004, BIOTECHNIQUES, V37, P790; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Jinnai H, 2010, MACROMOLECULES, V43, P1675, DOI 10.1021/ma902035p; Ray SS, 2010, POLYMER, V51, P3966, DOI 10.1016/j.polymer.2010.06.025; BURFIELD DR, 1983, MACROMOLECULES, V16, P1170, DOI 10.1021/ma00241a024; CHAPMAN AV, 1988, NATURAL RUBBER SCI T, P589; DALLAM RD, 1957, J HISTOCHEM CYTOCHEM, V5, P178; Eng AH, 1993, J RUBBER RES, V8, P109; Jong L, 2005, J POLYM ENVIRON, V13, P329, DOI 10.1007/s10924-005-5526-z; Jong L, 2006, COMPOS PART A-APPL S, V37, P438, DOI 10.1016/j.compositesa.2005.05.042; Kato M, 2007, J POLYM SCI POL PHYS, V45, P677, DOI 10.1002/polb.21088; Kawahara S, 2000, J APPL POLYM SCI, V78, P1510, DOI 10.1002/1097-4628(20001121)78:8<1510::AID-APP70>3.0.CO;2-4; Kawahara S, 2011, POLYM ADVAN TECHNOL, V22, P2665, DOI 10.1002/pat.1803; Kawahara S, 2008, MACROMOLECULES, V41, P4510, DOI 10.1021/ma7028538; Kawahara S, 1999, RUBBER CHEM TECHNOL, V72, P174, DOI 10.5254/1.3538787; Klinklai W, 2004, J APPL POLYM SCI, V93, P555, DOI 10.1002/app.20463; Kosugi K, 2012, COLLOID POLYM SCI, V290, P1457, DOI 10.1007/s00396-012-2703-1; Li CP, 2013, POLYM COMPOSITE, V34, P88, DOI 10.1002/pc.22380; MAUPINSZAMIER P, 1978, J CELL BIOL, V77, P837, DOI 10.1083/jcb.77.3.837; Ohtake Y, 2013, POLYM DEGRAD STABIL, V98, P2489, DOI 10.1016/j.polymdegradstab.2013.08.027; TAKAYANAGI M, 1963, ZAIRYO, V12, P389, DOI DOI 10.2472/JSMS.12.389; Takayanagi M., 1964, J POLYM SCI C, V5, P113, DOI DOI 10.1002/POLC.5070050111; Tohsan A, 2012, POLYM ADVAN TECHNOL, V23, P1335, DOI 10.1002/pat.2051; Tunnicliffe LB, 2012, J MICROSC-OXFORD, V246, P77, DOI 10.1111/j.1365-2818.2011.03589.x; Yamamoto Y, 2010, J POLYM SCI POL CHEM, V48, P2418, DOI 10.1002/pola.24011	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					135	141		10.1007/s00396-014-3396-4		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100011		
J	Takeno, H; Yanagita, M; Motegi, Y; Kondo, S				Takeno, Hiroyuki; Yanagita, Michina; Motegi, Yuho; Kondo, Shingo			Relationship between helical aggregates and polymorphs in a 12-hydroxystearic acid gel: their thermal stability and formation kinetics	COLLOID AND POLYMER SCIENCE			English	Article						Small-angle X-ray scattering; Organogel; Polarized optical microscopy; Fibrillar aggregates	RACEMIC 12-HYDROXYOCTADECANOIC ACIDS; ANGLE NEUTRON-SCATTERING; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; STEARIC-ACID; ORGANIC-SOLVENTS; VEGETABLE-OIL; ORGANOGELS; FORM; NETWORKS	Structures of 12-hydroxystearic acid (12-HSA)/phenyl methyl silicone gel and the gelation process were investigated by means of synchrotron small-angle X-ray scattering (SAXS), wide-angle X-ray scattering (WAXS), and polarized optical microscopy (POM). Spherulite structures were formed at low temperatures, while helical aggregates without branching were observed at high temperatures. The morphological transformation from spherulites into helical aggregates occurred during a heating process but not vice versa. Combined synchrotron SAXS and POM studies reveal that the morphological transformation is associated with polymorphs of 12-HSA crystal. Thermal stability and formation kinetics of the aggregates and the polymorphs are discussed in the text.	[Takeno, Hiroyuki; Yanagita, Michina; Motegi, Yuho; Kondo, Shingo] Gunma Univ, Sch Sci & Technol, Dept Chem & Chem Biol, Kiryu, Gunma 3768515, Japan	Takeno, H (reprint author), Gunma Univ, Sch Sci & Technol, Dept Chem & Chem Biol, Kiryu, Gunma 3768515, Japan.	takeno@gunma-u.ac.jp					Rogers MA, 2007, J AM OIL CHEM SOC, V84, P899, DOI 10.1007/s11746-007-1122-9; Raghavan SR, 2009, LANGMUIR, V25, P8382, DOI 10.1021/la901513w; Li JL, 2009, J PHYS CHEM B, V113, P15467, DOI 10.1021/jp907963t; Huang X, 2005, J AM CHEM SOC, V127, P4336, DOI 10.1021/ja0426544; TERECH P, 1994, LANGMUIR, V10, P3406, DOI 10.1021/la00022a009; Liu XY, 2002, ADV MATER, V14, P421, DOI 10.1002/1521-4095(20020318)14:6<421::AID-ADMA421>3.0.CO;2-7; Mallia VA, 2009, LANGMUIR, V25, P8615, DOI 10.1021/la8042439; Toro-Vazquez JF, 2013, LANGMUIR, V29, P7642, DOI 10.1021/la400809a; Co E, 2013, J AM OIL CHEM SOC, V90, P529, DOI 10.1007/s11746-012-2196-6; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; TACHIBANA T, 1980, B CHEM SOC JPN, V53, P1714, DOI 10.1246/bcsj.53.1714; Liu XY, 2001, APPL PHYS LETT, V79, P3518, DOI 10.1063/1.1415609; Wu SW, 2013, CRYST GROWTH DES, V13, P1360, DOI 10.1021/cg400124e; Huang X, 2006, J AM CHEM SOC, V128, P15341, DOI 10.1021/ja0657206; Sakurai T, 2010, B CHEM SOC JPN, V83, P145, DOI 10.1246/bcsj.20090242; GOTO M, 1978, B CHEM SOC JPN, V51, P2456, DOI 10.1246/bcsj.51.2456; HOLLAND RF, 1962, J MOL SPECTROSC, V9, P436, DOI 10.1016/0022-2852(62)90250-3; Kamijo M, 1999, ANAL SCI, V15, P1291, DOI 10.2116/analsci.15.1291; KANEKO F, 1990, ACTA CRYSTALLOGR C, V46, P1490, DOI 10.1107/S0108270189012679; Kuwahara T, 1996, CHEM LETT, P435, DOI 10.1246/cl.1996.435; MALTA V, 1971, J CHEM SOC B, P548, DOI 10.1039/j29710000548; Co ED, 2012, J AM OIL CHEM SOC, V89, P749, DOI 10.1007/s11746-012-2049-3; Mullin J. W., 2001, CRYSTALLIZATION; TACHIBANA T, 1979, B CHEM SOC JPN, V52, P34, DOI 10.1246/bcsj.52.34; TACHIBAN.T, 1968, J COLLOID INTERF SCI, V28, P173, DOI 10.1016/0021-9797(68)90222-1; TACHIBAN.T, 1969, B CHEM SOC JPN, V42, P3422, DOI 10.1246/bcsj.42.3422; Takeno H, 2009, PROG COLL POL SCI S, V136, P47, DOI 10.1007/2882_2009_7; Takeno H, 2012, J PHYS CHEM B, V116, P7739, DOI 10.1021/jp3008514; Takeno H, 2012, SEN-I GAKKAISHI, V68, P248; Takeno H., 2014, Advanced Materials Research, V896, DOI 10.4028/www.scientific.net/AMR.896.300; Takeno H, 2013, COLLOID POLYM SCI, V291, P2783, DOI 10.1007/s00396-013-3011-0; TERECH P, 1991, COLLOID POLYM SCI, V269, P490, DOI 10.1007/BF00655887; TERECH P, 1992, J PHYS II, V2, P2181; von Sydow E, 1955, ARK KEMI, V9, P231; Weiss R. G., 2006, MOL GELS MAT SELF AS	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					199	207		10.1007/s00396-014-3404-8		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100017		
J	Pham, TD; Kobayashi, M; Adachi, Y				Tien Duc Pham; Kobayashi, Motoyoshi; Adachi, Yasuhisa			Adsorption of anionic surfactant sodium dodecyl sulfate onto alpha alumina with small surface area	COLLOID AND POLYMER SCIENCE			English	Article						SDS adsorption; Alpha alumina; Surface charge adjustment; Two-step adsorption model; Four-region model	VARIABLE-CHARGE SURFACES; SOLID-LIQUID INTERFACES; METAL-OXIDE SURFACES; WATER INTERFACE; IONIC SURFACTANTS; ADSORBED LAYER; CATIONIC SURFACTANTS; ORGANIC-COMPOUNDS; ISOTHERM EQUATION; CELLULOSIC FIBERS	Adsorption of sodium dodecyl sulfate (SDS) onto large alpha-alumina beads was systematically analyzed as functions of pH and NaCl concentration. The maximum adsorption density of SDS onto alpha-Al2O3 increases with decreasing pH due to the increase in equilibrium surface charge. Adsorption isotherms at different salt concentrations demonstrated a common intersection point (CIP) corresponding to charge neutralization. The obtained comprehensive data clarified the applicability of two-step adsorption and four-region models to describe the adsorption isotherms of SDS onto alpha-Al2O3 beads. Also, proton adsorption isotherms upon SDS uptake onto alpha-Al2O3 can be fitted by two-step adsorption model with almost the same parameters of surfactant adsorption for 0.001 and 0.01 M NaCl. Our finding indicates that proton adsorption takes place onto the adsorbed SDS. After passing through CIP, proton adsorption onto alpha-Al2O3 increases at low ionic strength while the amount of proton adsorption does not change for 0.1 M NaCl. Adsorption amount of proton as a function of SDS adsorption shows that only hemimicelles are plausible for case of low ionic strength. The increase in the proton adsorption is not significant at high ionic strength, suggesting the presence of admicelles on the surface of alpha-Al2O3 beads.	[Tien Duc Pham; Kobayashi, Motoyoshi; Adachi, Yasuhisa] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Kobayashi, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	kobayashi.moto.fp@u.tsukuba.ac.jp			JSPS KAKENHI [22248025, 23688027]; Vietnamese government	We are grateful for the financial support from JSPS KAKENHI (22248025, 23688027). Tien Duc Pham would like to thank the financial support from Vietnamese government scholarship (approved by VIED-MOET) for the doctoral study abroad. The authors thank the useful comments from two anonymous reviewers to improve the original manuscript.	Aloulou F, 2004, J COLLOID INTERF SCI, V280, P350, DOI 10.1016/j.jcis.2004.08.008; Goloub TP, 1997, LANGMUIR, V13, P673, DOI 10.1021/la960690d; Hu K, 1997, LANGMUIR, V13, P5418, DOI 10.1021/la970483t; BOHMER MR, 1992, LANGMUIR, V8, P2660, DOI 10.1021/la00047a015; FUERSTENAU DW, 1975, FARADAY DISCUSS, V59, P157, DOI 10.1039/dc9755900157; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Zhang R, 2006, ADV COLLOID INTERFAC, V123, P213, DOI 10.1016/j.cis.2006.07.004; Fan AX, 1997, LANGMUIR, V13, P506, DOI 10.1021/la9607215; KOOPAL LK, 1995, J COLLOID INTERF SCI, V170, P85, DOI 10.1006/jcis.1995.1075; Lopata JJ, 2010, J COLLOID INTERF SCI, V342, P415, DOI 10.1016/j.jcis.2009.10.072; BITTING D, 1987, LANGMUIR, V3, P500, DOI 10.1021/la00076a011; Atkin R, 2003, ADV COLLOID INTERFAC, V103, P219, DOI 10.1016/S0001-8686(03)00002-2; Song SH, 2013, LANGMUIR, V29, P12710, DOI 10.1021/la401119p; YESKIE MA, 1988, J PHYS CHEM-US, V92, P2346, DOI 10.1021/j100319a048; GU TR, 1990, COLLOID SURFACE, V44, P81, DOI 10.1016/0166-6622(90)80189-B; Goloub TP, 1996, LANGMUIR, V12, P3188, DOI 10.1021/la9505475; Adak A, 2006, COLLOID SURFACE A, V277, P63, DOI 10.1016/j.colsurfa.2005.11.012; Alila S, 2007, LANGMUIR, V23, P3723, DOI 10.1021/la063118n; Paria S, 2004, ADV COLLOID INTERFAC, V110, P75, DOI 10.1016/j.cis.2004.03.001; Paria S, 2008, ADV COLLOID INTERFAC, V138, P24, DOI 10.1016/j.cis.2007.11.001; Kobayashi M, 2009, COLLOID SURFACE A, V347, P2, DOI 10.1016/j.colsurfa.2008.09.054; Thongngam M, 2005, LANGMUIR, V21, P79, DOI 10.1021/la048711o; Koopal LK, 2004, J COLLOID INTERF SCI, V275, P360, DOI 10.1016/j.jcis.2004.02.061; Franks GV, 2007, J AM CERAM SOC, V90, P3373, DOI 10.1111/j.1551-2916.2007.02013.x; Ayame A, 2003, APPL CATAL A-GEN, V244, P59, DOI 10.1016/S0926-860X(02)00595-1; BOHMER MR, 1992, LANGMUIR, V8, P2649, DOI 10.1021/la00047a014; Alila S, 2005, LANGMUIR, V21, P8106, DOI 10.1021/la050367n; Nizri G, 2008, J COLLOID INTERF SCI, V320, P74, DOI 10.1016/j.jcis.2008.01.016; Attaphong C, 2010, J COLLOID INTERF SCI, V344, P126, DOI 10.1016/j.jcis.2009.10.035; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BOHMER MR, 1992, LANGMUIR, V8, P1594, DOI 10.1021/la00042a017; CHANDAR P, 1987, J COLLOID INTERF SCI, V117, P31, DOI 10.1016/0021-9797(87)90165-2; ESUMI K, 1991, COLLOID SURFACE, V57, P149, DOI 10.1016/0166-6622(91)80187-S; ESUMI K, 1995, J COLLOID INTERF SCI, V172, P116, DOI 10.1006/jcis.1995.1232; ESUMI K, 1991, J COLLOID INTERF SCI, V142, P582, DOI 10.1016/0021-9797(91)90088-P; FUERSTENAU DW, 1956, J PHYS CHEM-US, V60, P981, DOI 10.1021/j150541a039; FUERSTENAU DW, 1991, LANGMUIR, V7, P3138, DOI 10.1021/la00060a037; FUERSTENAU DW, 1959, J ELECTROCHEM SOC, V106, P336, DOI 10.1149/1.2427342; GAUDIN AM, 1955, T AM I MIN MET ENG, V202, P958; Hankins NP, 1996, IND ENG CHEM RES, V35, P2844, DOI 10.1021/ie9506375; HARWELL JH, 1985, LANGMUIR, V1, P251, DOI 10.1021/la00062a013; Hummel DO, 2000, HDB SURFACE ANAL; Lee EM, 1996, J COLLOID INTERF SCI, V177, P478, DOI 10.1006/jcis.1996.0061; Maczka E, 2013, J COLLOID INTERF SCI, V393, P228, DOI 10.1016/j.jcis.2012.09.085; MUKERJEE P, 1956, ANAL CHEM, V28, P870, DOI 10.1021/ac60113a026; PARTYKA S, 1989, LANGMUIR, V5, P297, DOI 10.1021/la00086a001; Pham TD, 2013, COLLOID SURFACE A, V436, P148, DOI 10.1016/j.colsurfa.2013.06.026; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Sabatini DA, 1992, ACS S SERIES, V491; SOMASUND.P, 1966, J PHYS CHEM-US, V70, P90, DOI 10.1021/j100873a014; SOMASUNDARAN P, 1989, COLLOID SURFACE, V37, P245, DOI 10.1016/0166-6622(89)80123-4; SOMASUNDARAN P, 1964, J PHYS CHEM-US, V68, P3562, DOI 10.1021/j100794a021; Tulpar A, 2004, J PHYS CHEM B, V108, P1667, DOI 10.1021/jp0347668; Wakamatsu T, 1968, ADV CHEM SCI, V79, P161, DOI 10.1021/ba-1968-0079.ch013; ZHU BY, 1989, J CHEM SOC FARAD T 1, V85, P3813, DOI 10.1039/f19898503813; ZHU BY, 1991, ADV COLLOID INTERFAC, V37, P1, DOI 10.1016/0001-8686(91)80037-K	56	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					217	227		10.1007/s00396-014-3409-3		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100019		
J	Yoshida, E				Yoshida, Eri			Morphology control of giant vesicles by composition of mixed amphiphilic random block copolymers of poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid)	COLLOID AND POLYMER SCIENCE			English	Article						Morphology control; Mixed amphiphilic random block copolymers; Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Photo-NMP-induced self-assembly; Giant vesicles; Poly(methacrylic acid) block length; Composition; Critical packing shapes	LYSOPHOSPHATIDIC ACID; POLYMERIZATION; LIPIDS; MEMBRANES; FISSION	The morphology of giant vesicles comprised of mixed amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid), PMAA-b-P(MMA-r-MAA), was effectively controlled by its composition. The mixed copolymers with different lengths of the hydrophilic PMAA blocks varied the morphology depending on the composition at a constant length of the hydrophobic P(MMA-r-MAA) block. Large contorted vesicles formed by the copolymer containing a short PMAA block (PMAA-S) were changed into more severely contorted vesicles, accompanied by the formation of much smaller spherical vesicles as the composition of the copolymer with a middle PMAA block (PMAA-M) increased. Spherical vesicles produced by the PMAA-M copolymer were transformed into worm-like vesicles, followed by key-shaped vesicles with the increasing composition of the copolymer with a long PMAA block (PMAA-L). Worm-like vesicles with an uneven surface formed by the PMAA-L copolymer were changed into various spherical and elliptical vesicles due to the coexistence of the PMAA-S copolymer.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; CRONAN JE, 1975, BACTERIOL REV, V39, P232; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Chambon P, 2012, MACROMOLECULES, V45, P5081, DOI 10.1021/ma300816m; Groison E, 2012, ACS MACRO LETT, V1, P47, DOI 10.1021/mz200035b; Blanazs A, 2011, J AM CHEM SOC, V133, P16581, DOI 10.1021/ja206301a; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; Schmidt A, 1999, NATURE, V401, P133; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; FLEISCHER B, 1974, Journal of Supramolecular Structure, V2, P737, DOI 10.1002/jss.400020517; Israelachvili JN, 2011, INTERMOLECULAR SURFA, V3rd, P559; KEENAN TW, 1970, BIOCHEMISTRY-US, V9, P19, DOI 10.1021/bi00803a003; Lodish H. F., 2013, MOL CELL BIOL; MIYAZAWA T, 1985, J ORG CHEM, V50, P1332, DOI 10.1021/jo00208a047; Sadava DE, 1993, CELL BIOL ORGANELLE, P130; Vance DE, 2008, BIOCH LIPIDS LIPOPRO, P10; Weigert R, 1999, NATURE, V402, P429; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2013, OPEN J POLYM CHEM, V3, P16	25	8	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	JAN	2015	293	1					249	256		10.1007/s00396-014-3403-9		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AY6SO	WOS:000347696100022		
J	Miura, A; Nagao, M; Takei, T; Watauchi, S; Mizuguchi, Y; Takano, Y; Tanaka, I; Kumada, N				Miura, Akira; Nagao, Masanori; Takei, Takahiro; Watauchi, Satoshi; Mizuguchi, Yoshikazu; Takano, Yoshihiko; Tanaka, Isao; Kumada, Nobuhiro			Structure, Superconductivity, and Magnetism of Ce(O,F)BiS2 Single Crystals	CRYSTAL GROWTH & DESIGN			English	Article							DISTORTION; CHEMISTRY; SYSTEM; CE; ND	The crystal structures of Ce(O,F)BiS2 synthesized from starting materials with five different F contents were determined by single-crystal X-ray analysis. An increase in F content in the starting materials slightly increased F incorporation in the grown single crystals. The grown crystals with various F contents showed similar layered structures, but minor structural changes were observed with different conductive and magnetic properties. Crystals grown from higher F content were found to have a nearly flat Bi-S plane and elongated Ce-(O,F) bond, and showed superconductive transition below similar to 3 K and spontaneous magnetization below similar to 7 K. The calculated density of states based on this structural analysis predicted that hybridized Bi 6p-S 3p orbitals intersect the Fermi level and that Ce states are located near the Fermi level. The effect of structural change on superconductivity and long-range magnetic ordering has been discussed.	[Miura, Akira; Nagao, Masanori; Takei, Takahiro; Watauchi, Satoshi; Tanaka, Isao; Kumada, Nobuhiro] Univ Yamanashi, Ctr Crystal Sci & Technol, Kofu, Yamanashi 4008511, Japan; [Nagao, Masanori; Mizuguchi, Yoshikazu; Takano, Yoshihiko] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Mizuguchi, Yoshikazu] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Hachioji, Tokyo 1920397, Japan	Miura, A (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	amiura@yamanashi.ac.jp; mnagao@yamanashi.ac.jp	Miura, Akira/C-6825-2014				Sugimoto T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201117; Yazici D, 2013, PHILOS MAG, V93, P673, DOI 10.1080/14786435.2012.724185; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Miura A, 2014, J SOLID STATE CHEM, V212, P213, DOI 10.1016/j.jssc.2014.01.035; MAEDA H, 1988, JPN J APPL PHYS 2, V27, pL209, DOI 10.1143/JJAP.27.L209; Deguchi K, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/5/054303; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Chen HJ, 2014, INORG CHEM, V53, P9, DOI 10.1021/ic4021993; Paris E, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/43/435701; Demura S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033708; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Nagao M, 2014, SOLID STATE COMMUN, V178, P33, DOI 10.1016/j.ssc.2013.10.019; CEOLIN R, 1976, ACTA CRYSTALLOGR B, V32, P1476, DOI 10.1107/S0567740876005591; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Clarke SJ, 2008, INORG CHEM, V47, P8473, DOI 10.1021/ic8009964; Nagao M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.113701; Jha R, 2013, J SUPERCOND NOV MAGN, V26, P499, DOI 10.1007/s10948-012-2097-9; WU MK, 1987, PHYS REV LETT, V58, P908, DOI 10.1103/PhysRevLett.58.908; Kobayashi Y, 2012, NAT MATER, V11, P507, DOI [10.1038/nmat3302, 10.1038/NMAT3302]; Usui H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220501; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Rohrbach A, 2003, J PHYS-CONDENS MAT, V15, P979, DOI 10.1088/0953-8984/15/6/325; Awana VPS, 2013, SOLID STATE COMMUN, V157, P21, DOI 10.1016/j.ssc.2012.11.021; Attfield JP, 2013, CRYST GROWTH DES, V13, P4623, DOI 10.1021/cg4011168; Awana V. P. S., 2002, STUDIES HIGH TEMPERA, V46; CHU CW, 1993, NATURE, V365, P323, DOI 10.1038/365323a0; Demura S., 2013, ARXIV, V1311, P4267; Jha R, 2013, J SUPERCOND NOV MAGN, V27, P1; Kitagawa S., 2011, PHYS REV LETT, V107, P27; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Masubuchi Y, 2014, J ALLOY COMPD, V582, P823, DOI 10.1016/j.jallcom.2013.08.140; Miura A, 2014, J ALLOY COMPD, V593, P154, DOI 10.1016/j.jallcom.2014.01.030; Mizuguchi Y., 2012, PHYS REV B, V86, P22; Morice C., 2013, ARXIV, V1312, P2615; Nachtrab T, 2006, CR PHYS, V7, P68, DOI 10.1016/j.crhy.2005.11.010; Sheldrick G. M., 1997, SHELXL 97 PROGRAM RE; Takeshita N, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.023711; TANRYVERDIEV VS, 1995, INORG MATER+, V31, P1361; Tezuka K, 2013, INORG CHEM, V52, P12972, DOI 10.1021/ic4013334; Tsujimoto Y, 2012, APPL SCI-BASEL, V2, P206, DOI 10.3390/app2010206; Wan X., 2013, PHYS REV B, V87, P11; Xing J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214518	42	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					39	44		10.1021/cg5005165		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500009		
J	Wagata, H; Zettsu, N; Yamaguchi, A; Nishikiori, H; Yubuta, K; Oishi, S; Teshima, K				Wagata, Hajime; Zettsu, Nobuyuki; Yamaguchi, Akiko; Nishikiori, Hiromasa; Yubuta, Kunio; Oishi, Shuji; Teshima, Katsuya			Chloride Flux Growth of La2Ti2O7 Crystals and Subsequent Nitridation To Form LaTiO2N Crystals	CRYSTAL GROWTH & DESIGN			English	Article							VISIBLE-LIGHT; PHOTOCATALYTIC ACTIVITY; HIGH-QUALITY; PARTICLES; CERAMICS; HYDROGEN; OXIDES; LAYER	Highly crystalline, platelike La(2)Ti(2)O7 were grown from a NaCl flux, and LaTiO2N crystals were obtained by subsequent nitridation under NH3 flow. The TEM analysis indicated that the flux-grown platelike La2Ti2O7 crystals are single-crystalline growing along the a axis. The shapes and sizes of the LaTiO2N crystals were almost unchanged from the La2Ti2O7 precursor. In addition, LaTiO2N crystals remained single-crystalline with a porous nanostructure. The optical absorption edges of the La2Ti2O7 and LaTiO2N crystals were approximately 320 and 600 nm.	[Wagata, Hajime; Zettsu, Nobuyuki; Yamaguchi, Akiko; Nishikiori, Hiromasa; Oishi, Shuji; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan; [Zettsu, Nobuyuki; Teshima, Katsuya] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan; [Yubuta, Kunio] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Teshima, K (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan.	teshima@shinshu-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency	This research was partially supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency.	Yan HX, 2009, J AM CERAM SOC, V92, P2270, DOI 10.1111/j.1551-2916.2009.03209.x; Feng JY, 2014, ADV FUNCT MATER, V24, P3535, DOI 10.1002/adfm.201304046; Matsukawa M, 2014, NANO LETT, V14, P1038, DOI 10.1021/nl404688h; Suzuki S, 2012, CRYSTENGCOMM, V14, P7178, DOI 10.1039/c2ce25901j; Wang R, 2011, CHEM ENG J, V168, P455, DOI 10.1016/j.cej.2011.01.035; Oishi S, 2004, J AM CHEM SOC, V126, P4768, DOI 10.1021/ja049678v; Kasahara A, 2003, J PHYS CHEM B, V107, P791, DOI 10.1021/jp026767q; Hwang DW, 2003, J PHYS CHEM B, V107, P4963, DOI 10.1021/jp034229n; FUIERER PA, 1991, J AM CERAM SOC, V74, P2876, DOI 10.1111/j.1151-2916.1991.tb06857.x; Minegishi T, 2013, CHEM SCI, V4, P1120, DOI 10.1039/c2sc21845c; Mizuno Y, 2013, CRYST GROWTH DES, V13, P479, DOI 10.1021/cg3012348; Meng FK, 2013, CATAL TODAY, V199, P48, DOI 10.1016/j.cattod.2012.05.038; Komarneni S, 1999, J SOL-GEL SCI TECHN, V15, P263, DOI 10.1023/A:1008793126735; Zhang FX, 2012, J AM CHEM SOC, V134, P8348, DOI 10.1021/ja301726c; Milanova MM, 1996, J ALLOY COMPD, V242, P6, DOI 10.1016/0925-8388(96)02323-7; Arney D, 2008, J PHOTOCH PHOTOBIO A, V199, P230, DOI 10.1016/j.jphotochem.2008.06.005; Chevire F, 2006, EUR J INORG CHEM, P1223, DOI 10.1002/ejic.200500743; Ebbinghaus SG, 2008, SOLID STATE SCI, V10, P709, DOI 10.1016/j.solidstatesciences.2007.03.01; ISHIZAWA N, 1982, ACTA CRYSTALLOGR B, V38, P368, DOI 10.1107/S0567740882002994; Kim HG, 1999, CHEM COMMUN, P1077, DOI 10.1039/a902892g; Logvinovich D, 2007, PROG SOLID STATE CH, V35, P281, DOI 10.1016/j.progsolidstchem.2007.01.006; Lu Y, 2013, CRYST GROWTH DES, V13, P4852, DOI 10.1021/cg4010196; Moriga T, 2006, PHYS STATUS SOLIDI A, V203, P2818, DOI 10.1002/pssa.200669579; Nashim A, 2014, RSC ADV, V4, P14633, DOI 10.1039/c3ra47037g; PRASADARAO AV, 1992, J MATER RES, V7, P2859, DOI 10.1557/JMR.1992.2859; SCHMALLE HW, 1993, ACTA CRYSTALLOGR B, V49, P235, DOI 10.1107/S010876819200987X; Yashima M, 2010, CHEM COMMUN, V46, P4704, DOI 10.1039/c0cc00573h	27	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					124	128		10.1021/cg5010006		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500018		
J	Kawashima, K; Hojamberdiev, M; Wagata, H; Yubuta, K; Oishi, S; Teshima, K				Kawashima, Kenta; Hojamberdiev, Mirabbos; Wagata, Hajime; Yubuta, Kunio; Oishi, Shuji; Teshima, Katsuya			Chloride Flux Growth of La2TiO5 Crystals and Nontopotactic Solid-State Transformation to LaTiO2N Crystals by Nitridation Using NH3	CRYSTAL GROWTH & DESIGN			English	Article							LAYERED PEROVSKITE; HIGHLY EFFICIENT; GD; TEMPERATURE; ND	Oxynitride perovskites and related phases have received considerable attention due to their potential application for visible-light-responsive photocatalyst and nontoxic inorganic pigments. The changes in bonding and structure by a partial replacement of O2- by N3- give rise to interesting dielectric behavior. Here, we report on the fabrication of highly crystalline La2TiO5 crystals by chloride flux growth method and their subsequent nitridation to form the LaTiO2N crystals using NH3 gas. The flux-grown La2TiO5 crystals had a columnar structure grown in the < 001 > direction. Using the NaCl flux, larger columnar La2TiO5 crystals were grown compared to those grown using the KCl flux. With increasing solute concentration, the aspect ratio of columnar La2TiO5 crystals decreased significantly. The columnar La2TiO5 crystals with smooth surface were readily converted by nitridation at 950 degrees C for 45 h followed by acid treatment into the LaTiO2N crystals with a highly porous structure that formed from the strong segregation of nanocrystals, leading to the largest specific surface area (16.5-18.4 m(2).g(-1)). For the La2TiO5 crystals grown using the chloride fluxes, the wavelength of the absorption edges was approximately 320 nm (E-g = 3.87 eV), whereas the absorption edges exhibited by the LaTiO2N crystals obtained by nitridation were approximately 600 nm (E-g = 2.06 eV). Particularly, the LaTiO2N crystals prepared in this study by nitriding the precursor La2TiO5 crystals did not show a noticeable absorption in the near-infrared region above 600 nm, which is generally attributable to some reduced Ti3+ species and nitrogen deficiency, even after a long nitridation process. The fabricated LaTiO2N crystals with low defect density will be advantageous for various applications that specially require higher specific surface area.	[Kawashima, Kenta; Hojamberdiev, Mirabbos; Wagata, Hajime; Oishi, Shuji; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Nagano 3808553, Japan; [Yubuta, Kunio] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Teshima, Katsuya] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan	Teshima, K (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, 4-17-1 Wakasato, Nagano 3808553, Japan.	teshima@shinshu-u.ac.jp	Hojamberdiev, Mirabbos/C-8182-2014	Hojamberdiev, Mirabbos/0000-0002-5233-2563	Japan Technological Research Association of Artificial Photosynthetic Chemical Process (ARPChem)	This research was partially supported by the Japan Technological Research Association of Artificial Photosynthetic Chemical Process (ARPChem).	Kim J, 2005, TOP CATAL, V35, P295, DOI 10.1007/s11244-005-3837-x; Diallo PT, 2002, J ALLOY COMPD, V341, P139, DOI 10.1016/S0925-8388(02)00098-1; Shepelev YF, 2008, INORG MATER+, V44, P1354, DOI 10.1134/S0020168508120170; Matsukawa M, 2014, NANO LETT, V14, P1038, DOI 10.1021/nl404688h; Hayun S, 2012, J SOLID STATE CHEM, V187, P70, DOI 10.1016/j.jssc.2011.12.033; Park NY, 2012, J MATER SCI, V47, P5333, DOI 10.1007/s10853-012-6420-4; Lu DL, 2004, CHEM MATER, V16, P1603, DOI 10.1021/cm0347887; Maegli AE, 2014, J PHYS CHEM C, V118, P16344, DOI 10.1021/jp4084162; Kim YI, 2004, CHEM MATER, V16, P1267, DOI 10.1021/cm034756j; Zhang FX, 2010, J SOLID STATE CHEM, V183, P2636, DOI 10.1016/j.jssc.2010.09.014; Siritanaratkul B, 2011, CHEMSUSCHEM, V4, P74, DOI 10.1002/cssc.201000207; NANAMATS.S, 1974, FERROELECTRICS, V8, P511; Zhang FX, 2012, J AM CHEM SOC, V134, P8348, DOI 10.1021/ja301726c; Kim K, 2003, SOLID STATE ELECTRON, V47, P2177, DOI 10.1016/S0038-1101(03)00193-X; Teshima K, 2011, CRYST GROWTH DES, V11, P4401, DOI 10.1021/cg200578r; Cwik M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.060401; Tracy CL, 2012, ACTA MATER, V60, P4477, DOI 10.1016/j.actamat.2012.05.005; Atuchin V. V., 2009, J PHYS D, V42; Herrera G, 2014, MATER CHARACT, V89, P13, DOI 10.1016/j.matchar.2013.12.013; Hwang DW, 2003, IND ENG CHEM RES, V42, P1184, DOI 10.1021/ie020457c; Mizuno Y, 2013, CRYSTENGCOMM, V15, P8133, DOI 10.1039/c3ce41315b; ZAKHAROV NA, 1978, PHYS STATUS SOLIDI A, V50, pK13, DOI 10.1002/pssa.2210500146	22	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					333	339		10.1021/cg501397x		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500041		
J	Danjo, H; Nakagawa, T; Katagiri, K; Kawahata, M; Yoshigai, S; Miyazawa, T; Yamaguchi, K				Danjo, Hiroshi; Nakagawa, Toshi; Katagiri, Kosuke; Kawahata, Masatoshi; Yoshigai, Seiki; Miyazawa, Toshifumi; Yamaguchi, Kentaro			Formation of Lanthanide(III)-Containing Metallosupramolecular Arrays Induced by Tris(spiroborate) Twin Bowl	CRYSTAL GROWTH & DESIGN			English	Article							PYRIDINE-N-OXIDE; METAL-ORGANIC FRAMEWORKS; DECORATED PYRIDINE; LANTHANIDE IONS; COMPLEXES; ASSEMBLIES; PLATFORMS; POLYMERS; ISOMER; RADII	Lanthanide(III)-containing metallosupramolecular arrays were prepared in the crystalline state simply by mixing trifluoromethanesulfonate salts of yttrium(III), lanthanum(III), europium(III), terbium(III), erbium(III), and ytterbium(III) with a rac-tris(spiroborate) twin bowl in N,N-dimethylformamide (DMF). In the crystal, the lanthanide(III) ion coordinated to eight or nine DMF molecules to form spherical tricationic complexes, and the spiroborate twin bowl iteratively glued the complexes to each other to form one-dimensional arrays that were unidirectionally packed in the crystal. In each case, the array structure was stabilized by many aromatic C-H center dot center dot center dot pi interactions and C-H center dot center dot center dot O hydrogen bonds between the twin bowls and the lanthanide(III) complexes. Among the lanthanide(III) ions, yttrium(III), terbium(III), erbium(III), and ytterbium(III) gave almost the same crystal lattice and packing, whereas a different array structure and crystal packing was observed when lanthanum(III) and europium(III) were used, probably due to the difference of the ionic radii of the lanthanide(III) ions.	[Danjo, Hiroshi; Nakagawa, Toshi; Katagiri, Kosuke; Miyazawa, Toshifumi] Konan Univ, Dept Chem, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Danjo, Hiroshi; Nakagawa, Toshi; Katagiri, Kosuke; Miyazawa, Toshifumi] Konan Univ, Grad Sch Nat Sci, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Kawahata, Masatoshi; Yoshigai, Seiki; Yamaguchi, Kentaro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan	Danjo, H (reprint author), Konan Univ, Dept Chem, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.	danjo@konan-u.ac.jp			Hyogo Science and Technology Association	This work was supported by the Hyogo Science and Technology Association. We thank Drs. G. Ueno and S. Baba (Japan Synchrotron Radiation Research Institute (JASRI)) for invaluable help in data collection in the X-ray analysis of 1 center dot[La(dmf)<INF>9</INF>]. Synchrotron radiation experiment was performed at the BL26B2 station of SPring-8 with the approval of JASRI (Proposal No. 2014A1214).	Danjo H, 2010, J AM CHEM SOC, V132, P15556, DOI 10.1021/ja1084964; Rowsell JLC, 2005, ANGEW CHEM INT EDIT, V44, P4670, DOI 10.1002/anie.200462786; Kurmoo M, 2009, CHEM SOC REV, V38, P1353, DOI 10.1039/b804757j; dos Santos CMG, 2008, COORDIN CHEM REV, V252, P2512, DOI 10.1016/j.ccr.2008.07.018; Rosario-Amorin D, 2013, INORG CHEM, V52, P3063, DOI 10.1021/ic3025342; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Cui YJ, 2014, COORDIN CHEM REV, V273, P76, DOI 10.1016/j.ccr.2013.10.023; Shibasaki M, 2002, CHEM REV, V102, P2187, DOI 10.1021/cr010297z; Zapata F, 2013, CHEM COMMUN, V49, P8157, DOI 10.1039/c3cc45404e; Molander GA, 2002, CHEM REV, V102, P2161, DOI 10.1021/cr010291+; D'Angelo P, 2011, INORG CHEM, V50, P4572, DOI 10.1021/ic200260r; Leonard JP, 2007, TOP CURR CHEM, V281, P1, DOI 10.1007/128_2007_142; Harrowfield JM, 2004, INORG CHIM ACTA, V357, P2358, DOI 10.1016/j.ica.2004.01.008; Kido J, 2002, CHEM REV, V102, P2357, DOI 10.1021/cr010448y; Benelli C, 2002, CHEM REV, V102, P2369, DOI 10.1021/cr010303r; Bunzli JCG, 2005, CHEM SOC REV, V34, P1048, DOI 10.1039/b406082m; Lundberg D, 2010, INORG CHEM, V49, P4420, DOI 10.1021/ic100034q; Polasek M, 2009, INORG CHEM, V48, P455, DOI 10.1021/ic801596v; Ouizem S, 2014, DALTON T, V43, P8368, DOI 10.1039/c3dt53611d; Bunzli JCG, 2002, CHEM REV, V102, P1897, DOI 10.1021/cr010299j; Bunzli JCG, 2006, ACCOUNTS CHEM RES, V39, P53, DOI 10.1021/ar0400894; Chu Y, 1999, POLYHEDRON, V18, P3723, DOI 10.1016/S0277-5387(99)00312-5; Danjo H, 2009, J AM CHEM SOC, V131, P1638, DOI 10.1021/ja8071435; Lindqvist-Reis P., 2000, CHEM SOC DALTON T, P2703; Ma L, 1999, INORG CHEM, V38, P5837, DOI 10.1021/ic990429v; Mishra S, 2007, DALTON T, P410, DOI 10.1039/b616800k; Polasek M, 2004, CHEM COMMUN, P2602, DOI 10.1039/b409996f; Scheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tan X.-J., 2006, ACTA CRYSTALLOGR E, VE62, pm2252	30	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					384	389		10.1021/cg5014686		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500047		
J	Imasato, K; Tokutomi, H; Ohmura, R				Imasato, Kazuki; Tokutomi, Hiroki; Ohmura, Ryo			Crystal Growth Behavior of Methane Hydrate in the Presence of Liquid Hydrocarbon	CRYSTAL GROWTH & DESIGN			English	Article							CLATHRATE-HYDRATE; NATURAL-GAS; FILM GROWTH; GUEST SUBSTANCE; WATER; MORPHOLOGY; INTERFACE; SYSTEM; CO2	This paper reports the visual observation of the formation and growth of methane hydrate crystals in the methane + decane + water three-phase quiescent system. This three-phase system is a simplified model of the condition within an oil-producing pipeline. A hydrate crystal nucleated at a random point on the water droplet surface and then became a hydrate film that covered the whole surface of the water droplet. The morphology of individual hydrate crystals grown at the water droplet surface were triangular or polygonal. The hydrate crystal size and the hydrate-covered water droplet shape distinctly varied depending on the system subcooling (?Tsub). The hydrate crystal size got smaller and more slender with the increase in subcooling, and the hydrate-covered water droplet shape collapsed even more at a lower subcooling. To estimate the effect of non-hydrate-forming liquid existence, we compared the observational results obtained in the systems with and without liquid hydrocarbon. Although the liquid hydrocarbon phase offers the resistance of the mass transfer of methane, the observations indicate that the results observed in the systems with liquid hydrocarbon are similar to the results observed in the system without liquid hydrocarbon. It turns out that the controlling process for the methane hydrate crystal growth would exist within the liquid water phase. It would be possible to transfer the observational results obtained from the system without liquid hydrocarbon to the hydrate growth behavior in the system with liquid hydrocarbon, which is relevant to the condition within an oil-producing pipeline.	[Imasato, Kazuki; Tokutomi, Hiroki; Ohmura, Ryo] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Ohmura, R (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	rohmura@mech.keio.ac.jp					Aman ZM, 2010, ENERG FUEL, V24, P5441, DOI 10.1021/ef100762r; Tanaka R, 2009, CRYST GROWTH DES, V9, P2529, DOI 10.1021/cg9001048; Lederhos JP, 1996, CHEM ENG SCI, V51, P1221, DOI 10.1016/0009-2509(95)00370-3; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Takeya S, 2000, J PHYS CHEM B, V104, P4164, DOI 10.1021/jp993759+; Katsuki D, 2006, PHILOS MAG, V86, P1753, DOI 10.1080/14786430500509062; Kitamura M, 2013, CRYST RES TECHNOL, V48, P511, DOI 10.1002/crat.201300095; Lee JD, 2006, CRYST GROWTH DES, V6, P1428, DOI 10.1021/cg0600647; Ohmura R, 2005, CRYST GROWTH DES, V5, P953, DOI 10.1021/cg049675u; Thomas S, 2003, ENERGY, V28, P1461, DOI 10.1016/S0360-5442(03)00124-5; Hammerschmidt EG, 1934, IND ENG CHEM, V26, P851, DOI 10.1021/ie50296a010; Watanabe S, 2011, CRYST GROWTH DES, V11, P3235, DOI 10.1021/cg2005024; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; Freer EM, 2001, FLUID PHASE EQUILIBR, V185, P65, DOI 10.1016/S0378-3812(01)00457-5; Ishida Y, 2011, CHEM-EUR J, V17, P9471, DOI 10.1002/chem.201002887; Saito K, 2010, IND ENG CHEM RES, V49, P7102, DOI 10.1021/ie1000696; Zerpa LE, 2011, IND ENG CHEM RES, V50, P188, DOI 10.1021/ie100873k; Ishida Y, 2012, CRYST GROWTH DES, V12, P3271, DOI 10.1021/cg300416x; Ohmura R, 2005, CRYST GROWTH DES, V5, P1821, DOI 10.1021/cg0501074; Saito K, 2011, CRYST GROWTH DES, V11, P295, DOI 10.1021/cg101310z; Servio P, 2003, CRYST GROWTH DES, V3, P61, DOI 10.1021/cg020044e; Sloan E.D., 2007, CLATHRATE HYDRATES N; Sloan E.D., 1998, CLATHRATE HYDRATES N; Smelik EA, 1997, AM MINERAL, V82, P88; Taylor C. J., 2007, CHEM ENG SCI, V62, P6542	26	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					428	433		10.1021/cg501500w		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500053		
J	Mamada, M; Katagiri, H; Sakanoue, T; Tokito, S				Mamada, Masashi; Katagiri, Hiroshi; Sakanoue, Tomo; Tokito, Shizuo			Characterization of New Rubrene Analogues with Heteroaryl Substituents	CRYSTAL GROWTH & DESIGN			English	Article							FIELD-EFFECT TRANSISTORS; SINGLE-CRYSTALS; ORGANIC SEMICONDUCTORS; CHARGE-TRANSPORT; ARYL CHLORIDES; HIGH-MOBILITY; DERIVATIVES; STABILITY; ACENES; PHOTOOXIDATION	New rubrene analogues, which are heteroaryl-tetrasubstituted tetracenes, have been developed using a simplified synthesis approach. Their stabilities in solution were improved compared to those of rubrene. The correlation among the molecular structures, crystal structures, and charge transport properties has been investigated and compared with rubrene and various rubrene analogues. Although twisted structures of a tetracene backbone have often been found in single crystal analyses, the planarity might be related to intermolecular interactions rather than the electron donating/withdrawing properties of the heteroaryl side groups. The packing motifs in thiophene-substituted derivatives did not include p-stacking of tetracene cores, which differ from the well-known structure of rubrene. However, furan-substituted derivatives can be crystallized in the pi-stacking manner. These differences in the packing structure affect hole transport properties.	[Mamada, Masashi; Katagiri, Hiroshi; Tokito, Shizuo] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Sakanoue, Tomo] Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan	Mamada, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan.	mamada@yz.yamagata-u.ac.jp	Katagiri, Hiroshi/E-2912-2014	Katagiri, Hiroshi/0000-0003-4100-9995	Japan Society for the Promotion of Science (JSPS) [26810106]; JSPS [26600048]; Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Prof. C. Shepherd for helpful discussions. This work was financially supported by the Grant-in-Aid for Young Scientists (B) (26810106) from the Japan Society for the Promotion of Science (JSPS), the Grant-in-Aid for Challenging Exploratory Research (26600048) from JSPS, the Japan Regional Innovation Strategy Program by the Excellence (creating international research hub for advanced organic electronics) of Japan Science and Technology Agency (JST), and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Anger F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4773520; Oyamada T, 2005, J APPL PHYS, V98, DOI 10.1063/1.2060932; Briseno AL, 2006, ADV MATER, V18, P2320, DOI 10.1002/adma.200600634; Liang ZX, 2008, ORG LETT, V10, P2007, DOI 10.1021/ol800620s; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Littke AF, 1999, ANGEW CHEM INT EDIT, V38, P2411, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2411::AID-ANIE2411>3.0.CO;2-T; Chi XL, 2008, ORG ELECTRON, V9, P234, DOI 10.1016/j.orgel.2007.11.009; Huang LW, 2010, J MATER CHEM, V20, P159, DOI 10.1039/b914334c; Matsukawa T, 2010, J CRYST GROWTH, V312, P310, DOI 10.1016/j.jcrysgro.2009.10.048; Kafer D, 2005, PHYS CHEM CHEM PHYS, V7, P2850, DOI 10.1039/b507620j; Veres J, 2003, ADV FUNCT MATER, V13, P199, DOI 10.1002/adfm.200390030; Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Zhang XT, 2014, J MATER CHEM C, V2, P884, DOI 10.1039/c3tc31794c; Seo JH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2363940; Mee SPH, 2004, ANGEW CHEM INT EDIT, V43, P1132, DOI 10.1002/anie.200352979; Chang JF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.066601; Troisi A, 2011, CHEM SOC REV, V40, P2347, DOI 10.1039/c0cs00198h; Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; Sakanoue T, 2010, NAT MATER, V9, P736, DOI [10.1038/nmat2825, 10.1038/NMAT2825]; Xie W, 2013, J PHYS CHEM C, V117, P11522, DOI 10.1021/jp402250v; Pascal RA, 2006, CHEM REV, V106, P4809, DOI 10.1021/cr050550l; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Kang MJ, 2011, ADV MATER, V23, P1222, DOI 10.1002/adma.201001283; Veres J, 2004, CHEM MATER, V16, P4543, DOI 10.1021/cm049598q; Littke AF, 2002, ANGEW CHEM INT EDIT, V41, P4176, DOI 10.1002/1521-3773(20021115)41:22<4176::AID-ANIE4176>3.0.CO;2-U; Richter MM, 2004, CHEM REV, V104, P3003, DOI 10.1021/cr020373d; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Roberson LB, 2005, J AM CHEM SOC, V127, P3069, DOI 10.1021/ja044586r; Marumoto K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075302; Anthony JE, 2008, ANGEW CHEM INT EDIT, V47, P452, DOI 10.1002/anie.200604045; Bergantin S, 2012, CRYST GROWTH DES, V12, P6035, DOI 10.1021/cg301130n; Braga D, 2011, EUR J ORG CHEM, P4160, DOI 10.1002/ejoc.201100033; Chapman BD, 2006, J CRYST GROWTH, V290, P479, DOI 10.1016/j.jcrysgro.2006.01.056; DODGE JA, 1990, J ORG CHEM, V55, P4190, DOI 10.1021/jo00300a043; Frisch M J, 2010, GAUSSIAN 09 REVISION; Gu XX, 2012, ORG LETT, V14, P1390, DOI 10.1021/ol300098p; Haas S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115203; Jurchescu OD, 2006, ACTA CRYSTALLOGR B, V62, P330, DOI 10.1107/S0108768106003053; Lee JW, 2009, ADV FUNCT MATER, V19, P704, DOI 10.1002/adfm.200801180; Li J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00754; Maliakal A, 2004, CHEM MATER, V16, P4980, DOI 10.1021/cm049060k; MALOY JT, 1971, J AM CHEM SOC, V93, P5968, DOI 10.1021/ja00752a004; McGarry KA, 2013, CHEM MATER, V25, P2254, DOI 10.1021/cm400736s; Mullenbach TK, 2013, ADV MATER, V25, P3689, DOI 10.1002/adma.201300641; Paraskar AS, 2008, CHEM-EUR J, V14, P10639, DOI 10.1002/chem.200800802; Schuck G, 2007, ACTA CRYSTALLOGR E, V63, pO2894, DOI 10.1107/S1600536807022490; Stingelin-Stutzmann N, 2005, NAT MATER, V4, P601, DOI 10.1038/nmat1426; Uttiya S, 2012, SYNTHETIC MET, V161, P2603, DOI 10.1016/j.synthmet.2011.08.006; Watanabe M, 2012, TETRAHEDRON LETT, V53, P2284, DOI 10.1016/j.tetlet.2012.02.060; Yagodkin E, 2010, TETRAHEDRON LETT, V51, P3037, DOI 10.1016/j.tetlet.2010.03.121; Yagodkin E, 2009, J PHYS CHEM C, V113, P16544, DOI 10.1021/jp904476z; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005; Zeis R, 2006, CHEM MATER, V18, P244, DOI 10.1021/cm0502626	54	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					442	448		10.1021/cg501519a		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500055		
J	Ohtake, A; Ha, N; Mano, T				Ohtake, Akihiro; Ha, Neul; Mano, Takaaki			Extremely High- and Low-Density of Ga Droplets on GaAs{111}A,B: Surface-Polarity Dependence	CRYSTAL GROWTH & DESIGN			English	Article							RECONSTRUCTIONS; GROWTH; GAAS(001)	Formation processes of Ga droplets on polar (111)A and (111)B surfaces of GaAs have been investigated. A single Ga atom forms a stable nucleus on the (111)A surface, so that the formation of extremely high-density of Ga droplets is achieved (2.8 x 10(12) cm(-2)). On the (111)B surface, the initial Ga deposition on both As-rich (2 X 2) and Ga-rich (root 19 x root 19) reconstructions leads to the formation of a two-dimensional GaAs layer having a more Ga-rich (3 x 2) reconstruction. The Ga droplets are formed on the (3 X 2) surface with their densities being 4 orders of magnitude lower than those for the (111)A orientation.	[Ohtake, Akihiro; Ha, Neul; Mano, Takaaki] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Ha, Neul] Kyushu Univ, NIMS, Grad Sch Engn, Tsukuba, Ibaraki 3050044, Japan	Ohtake, A (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan.	OHTAKE.Akihiro@nims.go.jp					WOOLF DA, 1993, APPL PHYS LETT, V62, P1370, DOI 10.1063/1.108682; Mano T, 2005, NANO LETT, V5, P425, DOI 10.1021/nl048192+; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; KOGUCHI N, 1991, J CRYST GROWTH, V111, P688, DOI 10.1016/0022-0248(91)91064-H; Ohtake A, 2008, SURF SCI REP, V63, P295, DOI 10.1016/j.surfrep.2008.03.001; Jo M, 2011, CRYST GROWTH DES, V11, P4647, DOI 10.1021/cg200930v; AbuWaar ZY, 2006, NANOTECHNOLOGY, V17, P4037, DOI 10.1088/0957-4484/17/16/007; BIEGELSEN DK, 1990, PHYS REV LETT, V65, P452, DOI 10.1103/PhysRevLett.65.452; Heyn C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075317; Jo M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4721663; Koga H, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113301; Mano T, 2009, J CRYST GROWTH, V311, P1828, DOI 10.1016/j.jcrysgro.2008.11.043; Mano T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.065203; Ohtake A, 2014, CRYST GROWTH DES, V14, P3110, DOI 10.1021/cg500355f; Taguchi A, 1999, PHYS REV B, V60, P11509, DOI 10.1103/PhysRevB.60.11509; TONG SY, 1984, PHYS REV LETT, V52, P1693, DOI 10.1103/PhysRevLett.52.1693; Treu J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733664	17	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	JAN	2015	15	1					485	488		10.1021/cg501545n		4	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AY6HK	WOS:000347667500060		
J	Kitashima, T; Suresh, KS; Yamabe-Mitarai, Y				Kitashima, T.; Suresh, K. S.; Yamabe-Mitarai, Y.			Present stage and future prospects of development of compressor material	CRYSTAL RESEARCH AND TECHNOLOGY			English	Article						titanium alloy; jet engine; compressor; high temperature	TITANIUM MATRIX COMPOSITES; COMMON CASTING TECHNIQUE; MECHANICAL-PROPERTIES; MICROSTRUCTURAL CHARACTERIZATION; ALPHA-TITANIUM; ISOTHERMAL OXIDATION; BORON ADDITION; ALLOYS; TI-6AL-4V; TEXTURE	Titanium alloys are attractive for use in the compressor of jet engines because of their high strength-to-density ratio. Titanium alloys with high temperature capability for high-pressure compressor components have been developed to increase thermal efficiency of jet engines, resulting in the reduction of CO2 emission and fuel consumption. This study describes the development of high-temperature titanium alloys, mainly focusing on the effects of alloy composition and microstructure on mechanical properties. Titanium matrix composites and titanium aluminides have also been extensively studied for future application in high-pressure compressors. In addition, in this study, melting technology of titanium alloys has been introduced because it is a key technology to improve the performance of high-temperature titanium components.	[Kitashima, T.; Suresh, K. S.; Yamabe-Mitarai, Y.] Natl Inst Mat Sci, High Temp Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Kitashima, T (reprint author), Natl Inst Mat Sci, High Temp Mat Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	KITASHIMA.Tomonori@nims.go.jp					BECKER S, 1992, OXID MET, V38, P425, DOI 10.1007/BF00665663; Gorsse S, 2003, ACTA MATER, V51, P2427, DOI 10.1016/S1359-6454(02)00510-4; Lu WJ, 2001, J ALLOY COMPD, V327, P248, DOI 10.1016/S0925-8388(01)01461-X; Kondoh K, 2009, COMPOS SCI TECHNOL, V69, P1077, DOI 10.1016/j.compscitech.2009.01.026; Chen W, 2010, INT J FATIGUE, V32, P627, DOI 10.1016/j.ijfatigue.2009.04.013; [Anonymous], 2013, MTU AER ENG; Lu WJ, 2001, J ALLOY COMPD, V327, P240, DOI 10.1016/S0925-8388(01)01445-1; [Anonymous], 2012, SUST AV CO2 ROADM 20; [Anonymous], 2011, 2011 ALL NIPP AIRW; Zhu J, 2003, MAT SCI ENG A-STRUCT, V339, P53, DOI 10.1016/S0921-5093(02)00102-8; Wang MM, 2006, MATER DESIGN, V27, P494, DOI 10.1016/j.matdes.2004.11.030; Tamirisakandala S, 2005, SCRIPTA MATER, V53, P1421, DOI 10.1016/j.scriptamat.2005.08.020; HACK JE, 1982, METALL TRANS A, V13, P1729, DOI 10.1007/BF02647828; Mitchell A, 1998, MAT SCI ENG A-STRUCT, V243, P257, DOI 10.1016/S0921-5093(97)00810-1; [Anonymous], 2010 ICAO; Turner R, 2011, ACTA MATER, V59, P3792, DOI 10.1016/j.actamat.2011.02.028; Tetsui T, 2002, SCRIPTA MATER, V47, P399, DOI 10.1016/S1359-6462(02)00158-6; Ari-Gur P, 1998, MAT SCI ENG A-STRUCT, V257, P118, DOI 10.1016/S0921-5093(98)00829-6; Chandravanshi VK, 2011, J ALLOY COMPD, V509, P5506, DOI 10.1016/j.jallcom.2011.02.114; Fujimura T., 2008, J IHI TECHNOLOGIES, V48, P153; Ghazal G, 2012, ISIJ INT, V52, P1, DOI 10.2355/isijinternational.52.1; Guclu M, 2013, KEY ENG MATER, V551, P186, DOI 10.4028/www.scientific.net/KEM.551.186; Jain TA, 1999, MATER T JIM, V40, P307; Kitashima T, 2014, MAT SCI ENG A-STRUCT, V597, P212, DOI 10.1016/j.msea.2013.12.099; Kitashima T, 2013, J ELECTROCHEM SOC, V160, pC441, DOI 10.1149/2.100309jes; Kitashima Tomonrori, 2014, Materials Science Forum, V783-786, DOI 10.4028/www.scientific.net/MSF.783-786.619; Lan B, 2014, ACTA MATER, V63, P107, DOI 10.1016/j.actamat.2013.10.012; Le Biavant K, 2002, FATIGUE FRACT ENG M, V25, P527, DOI 10.1046/j.1460-2695.2002.00480.x; Leyens C, 2003, ADV ENG MATER, V5, P399, DOI 10.1002/adem.200310093; Liu D, 2009, J ALLOY COMPD, V485, P156, DOI 10.1016/j.jallcom.2009.05.112; Luthra K. L., 1992, OXID MET, V38, P475; Miracle D.B., 2001, ASM HDB, V21; Murray J. L., 1987, ALTI ALUMINUM TITANI, P12; NAKAMURA M, 1994, METALL MATER TRANS A, V25, P321, DOI 10.1007/BF02647977; NEAL DF, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P287; RAMACHANDRA C, 1993, METALL TRANS A, V24, P1273, DOI 10.1007/BF02668196; Srinivasan R, 2008, MAT SCI ENG A-STRUCT, V487, P541, DOI 10.1016/j.msea.2007.10.053; Suresh K. S., 2014, MATER SCI FORUM, V783-786, P602; Threrujirapapong T, 2009, MATER TRANS, V50, P2757, DOI 10.2320/matertrans.MA200906; Williams J. C., 1980, TITANIUM80 SCI TECHN; Wood JR, 2002, JOM-J MIN MET MAT S, V54, P56, DOI 10.1007/BF02701077; Woodfield A. P., 2007, TI 2007 SCI TECHNOLO; Woodfiled A. P., 1995, TITANIUM 95 SCI TECH, P1116; Zhu J, 2001, MATER T JIM, V42, P336, DOI 10.2320/matertrans.42.336	44	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0232-1300	1521-4079		CRYST RES TECHNOL	Cryst. Res. Technol.	JAN	2015	50	1					28	37		10.1002/crat.201400156		10	Crystallography	Crystallography	AZ1AF	WOS:000347972100006		
J	Ando, S; Thanomphongphan, T; Seki, Y; Suzuki, E				Ando, Shin; Thanomphongphan, Theerasak; Seki, Yoichi; Suzuki, Einoshin			Ensemble anomaly detection from multi-resolution trajectory features	DATA MINING AND KNOWLEDGE DISCOVERY			English	Article						Behavioral data mining; Trajectory data mining; Multi-resolution features; Ensemble anomaly detection	DISTANCE-BASED OUTLIERS; NOVELTY DETECTION; NEURAL-NETWORK; TIME-SERIES; ALGORITHMS; PATTERNS; DATASETS; VIDEO	The numerical, sequential observation of behaviors, such as trajectories, have become an important subject for data mining and knowledge discovery research. Processing the raw observation into representative features of the behaviors involves an implicit choice of time-scale and resolution, which critically affect the final output of the mining techniques. The choice is associated with the parameters of data-processing, e.g., smoothing and segmentation, which unintuitively yet strongly influence the intrinsic structure of the numerical data. Data mining techniques generally require users to provide an appropriately processed input, but selecting a resolution is an arduous task that may require an expensive, manual examination of outputs between different settings. In this paper, we propose a novel ensemble framework for aggregating outcomes in different settings of scale and resolution parameters for an anomaly detection task. Such a task is difficult for existing ensemble approaches based on weighted combination because: (a) evaluating and weighing an output requires training samples of anomalies which are generally unavailable, (b) the detectability of anomalies can depend on the resolution, i.e., the distinction from normal instances may only be apparent within a small, selective range of parameters. In the proposed framework, predictions based on different resolutions are aggregated to construct meta-feature representations of the behavior instances. The meta-features provide the discriminative information for conducting a clustering-based anomaly detection. In the proposed framework, two interrelated tasks of the behavior analysis: processing the numerical data and discovering anomalous patterns, are addressed jointly, providing an intuitive alternative for a knowledge-intensive parameter selection. We also design an efficient clustering-based anomaly detection algorithm which reduces the computational burden of mining at multiple resolutions. We conduct an empirical study of the proposed framework using real-world trajectory data. It shows that the proposed framework achieves a significant improvement over the conventional ensemble approach.	[Ando, Shin; Seki, Yoichi] Gunma Univ, Div Elect & Informat, Kiryu, Gunma 376, Japan; [Thanomphongphan, Theerasak] Panason AVC Networks Thailand Co Ltd, Bangsaothong, Samutprakarn, Thailand; [Suzuki, Einoshin] Kyushu Univ, Dept Informat, ISEE, Fukuoka 812, Japan	Ando, S (reprint author), Gunma Univ, Div Elect & Informat, 1-5-1 Tenjincho, Kiryu, Gunma 376, Japan.	shinando@gunma-u.ac.jp; nices_jing@hotmail.com; seki@gunma-u.ac.jp; suzuki@inf.kyushu-u.ac.jp	Ando, Shin/H-6273-2013	Ando, Shin/0000-0002-4822-2804	Strategic International Cooperative Program - Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology [21300053, 25280085, 22500119]	The authors would like to thank the handling editor and the anonymous reviewers for their valuable comments and suggestions. Parts of this study are supported by the Strategic International Cooperative Program funded by Japan Science and Technology Agency and the Grant-in-Aid for Scientific Research on Fundamental Research (B) 21300053, (B) 25280085, and (C) 22500119 by the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ailon N, 2008, J ACM, V55, DOI 10.1145/1411509.1411513; Ando S, 2011, P 10 SIAM INT C DAT, P1; Angiulli F, 2010, DATA MIN KNOWL DISC, V20, P290, DOI 10.1007/s10618-009-0159-9; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI [10.1016/j.sigpro.2003.07.018, 10.1016/j.sigpro.2003.018]; Lin J, 2007, DATA MIN KNOWL DISC, V15, P107, DOI 10.1007/s10618-007-0064-z; Yang QA, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P20; Morris BT, 2008, IEEE T CIRC SYST VID, V18, P1114, DOI 10.1109/TCSVT.2008.927109; Roddick JF, 2002, IEEE T KNOWL DATA EN, V14, P750, DOI 10.1109/TKDE.2002.1019212; Ghoting A, 2008, DATA MIN KNOWL DISC, V16, P349, DOI 10.1007/s10618-008-0093-2; Lee JG, 2008, PROC INT CONF DATA, P140, DOI 10.1109/ICDE.2008.4497422; Bu YY, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P159; Piciarelli C, 2008, IEEE T CIRC SYST VID, V18, P1544, DOI 10.1109/TCSVT.2008.2005599; Morris BT, 2008, IEEE T INTELL TRANSP, V9, P425, DOI 10.1109/TITS.2008.922970; Morris B, 2009, PROC CVPR IEEE, P312; Anjum N, 2008, IEEE T CIRC SYST VID, V18, P1555, DOI 10.1109/TCSVT.2008.2005603; Angiulli F, 2006, IEEE T KNOWL DATA EN, V18, P145, DOI 10.1109/TKDE.2006.29; Giannotti F, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P330; Knorr EM, 2000, VLDB J, V8, P237, DOI 10.1007/s007780050006; Budhaditya S, 2009, IEEE DATA MINING, P722, DOI 10.1109/ICDM.2009.110; Markou M, 2003, SIGNAL PROCESS, V83, P2499, DOI 10.1016/j.sigpro.2003.07.019; Noto K, 2012, DATA MIN KNOWL DISC, V25, P109, DOI 10.1007/s10618-011-0234-x; Pham DT, 1998, P I MECH ENG I-J SYS, V212, P115, DOI 10.1243/0959651981539343; Pelekis N, 2011, KNOWL INF SYST, V28, P117, DOI 10.1007/s10115-010-0316-x; Yamanishi K, 2004, DATA MIN KNOWL DISC, V8, P275, DOI 10.1023/B:DAMI.0000023676.72185.7c; Blanchard G, 2010, J MACH LEARN RES, V11, P2973; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832; Breunig MM, 2000, SIGMOD REC, V29, P93; Jiang S, 2012, DATA MIN KNOWL DISC, V25, P478, DOI 10.1007/s10618-012-0264-z; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bache K, 2012, UCI MACHINE LEARNING; Banerjee A, 2004, P 10 ACM SIGKDD INT, P515, DOI 10.1145/1014052.1014112; Bonchi F, 2009, DATA MIN KNOWL DISC, V19, P227, DOI 10.1007/s10618-009-0141-6; Castro N, 2010, P SIAM INT C DAT MIN, P665; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Chiu B., 2003, P 9 ACM SIGKDD INT C, P493; Cotofrei P, 2002, P 2002 INT C COMP SC, P572; Daubechies I., 1992, 10 LECT WAVELETS; Dereszynski E, 2007, P 23 C UNC ART INT, P75; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1; Ester M, 1996, P 2 INT C KNOWL DISC, V96, P226; Fern X. Z., 2004, P 21 INT C MACH LEAR, P36, DOI DOI 10.1145/1015330.1015414; Freire A, 2009, PROB TH RELAT FIELDS, P1; Gaffney S., 1999, P 5 ACM SIGKDD INT C, P63, DOI DOI 10.1145/312129.312198; Gionis A., 2007, ACM T KNOWL DISCOV D, V1, P1, DOI DOI 10.1145/1217299.1217303; Han J., 2008, P 14 ACM SIGKDD INT; Hido S, 2011, KNOWL INF SYST, V26, P309, DOI 10.1007/s10115-010-0283-2; JOHNSON N, 1995, P 6 BRIT C MACH VIS, V2, P583; Keogh E, 2005, KNOWL INF SYST, V8, P154, DOI 10.1007/s10115-004-0172-7; Keogh E., 2005, P 5 IEEE INT C DAT M, P226, DOI [10.1109/ ICDM.2005.79, DOI 10.1109/ICDM.2005.79]; Khalid S, 2005, P 3 ACM INT WORKSH V, P45, DOI 10.1145/1099396.1099404; Naftel A, 2006, MULTIMEDIA SYST, V12, P227, DOI 10.1007/S00530-006-0058-5; Kim S, 2011, EXPERT SYST APPL, V38, P9587, DOI 10.1016/j.eswa.2011.01.162; Kroger T., 2010, SPRINGER TRAC ADV RO, V58; Kumar S, 2010, P 2010 IEEE WIC ACM, V02, P56; Lazarevic A., 2005, P 11 ACM SIGKDD INT, P157, DOI DOI 10.1145/1081870.1081891; Lehmann E. L, 2006, NONPARAMETRICS STAT; Liu Z, 2008, PROC INT CONF DATA, P1325, DOI 10.1109/ICDE.2008.4497544; Markou M, 2006, IEEE T PATTERN ANAL, V28, P1664, DOI 10.1109/TPAMI.2006.196; Nguyen HV, 2010, P 15 INT C DAT SYST, VI, P368, DOI DOI 10.1007/978-3-642-12026-8_; Piciarelli C, 2006, PATTERN RECOGN LETT, V27, P1835, DOI 10.1016/j.patrec.2006.02.004; Piciarelli C, 2007, P IEEE INT C ADV VID, P153; Porikli F., 2004, C COMP VIS PATT REC, V7, P114; Rosswog J, 2012, P ROBOTIK 2012 7 GER, P1; Saito N., 1994, THESIS YALE U NEW HA; Steland A, 1998, METRIKA, V47, P251, DOI 10.1007/BF02742877; Strehl A., 2002, J MACHINE LEARNING R, V3, P583, DOI DOI 10.1162/153244303321897735; Suzuki N., 2007, IEEE INT C SYST MAN, P498; Wan L, 2009, ACM T KNOWL DISCOV D, V3, P14; Wang Q, 2010, INFORM SYST, V35, P56, DOI 10.1016/j.is.2009.03.006; Wang XF, 2013, KNOWL INF SYST, V37, P305, DOI 10.1007/s10115-011-0471-8; Webb A., 2011, STAT PATTERN RECOGNI; Williams BH, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1119; Xiong Y, 2002, P IEEE INT C DAT MIN, P717; Yang Y, 2011, IEEE T KNOWL DATA EN, V23, P307, DOI 10.1109/TKDE.2010.112; Yankov D, 2008, KNOWL INF SYST, V17, P241, DOI 10.1007/s10115-008-0131-9; Zheng Y, 2011, COMPUTING WITH SPATIAL TRAJECTORIES, P1, DOI 10.1007/978-1-4614-1629-6	80	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1384-5810	1573-756X		DATA MIN KNOWL DISC	Data Min. Knowl. Discov.	JAN	2015	29	1					39	83		10.1007/s10618-013-0334-x		45	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	AZ0QD	WOS:000347948900003		
J	Hayashi, Y; Yamanishi, K				Hayashi, Yu; Yamanishi, Kenji			Sequential network change detection with its applications to ad impact relation analysis	DATA MINING AND KNOWLEDGE DISCOVERY			English	Article						Network change detection; Minimum description length principle; Dynamic model selection; Bayesian network; Information theory; Marketing	MODEL	We are concerned with the issue of tracking changes of variable dependencies from multivariate time series. Conventionally, this issue has been addressed in the batch scenario where the whole data set is given at once, and the change detection must be done in a retrospective way. This paper addresses this issue in a sequential scenario where multivariate data are sequentially input and the detection must be done in a sequential fashion. We propose a new method for sequential tracking of variable dependencies. In it we employ a Bayesian network as a representation of variable dependencies. The key ideas of our method are: (1) we extend the theory of dynamic model selection, which has been developed in the batch-learning scenario, into the sequential setting, and apply it to our issue, (2) we conduct the change detection sequentially using dynamic programming per a window where we employ the Hoeffding's bound to automatically determine the window size. We empirically demonstrate that our proposed method is able to perform change detection more efficiently than a conventional batch method. Further, we give a new framework of an application of variable dependency change detection, which we call Ad Impact Relation analysis (AIR). In it, we detect the time point when a commercial message advertisement has given an impact on the market and effectively visualize the impact through network changes. We employ real data sets to demonstrate the validity of AIR.	[Hayashi, Yu; Yamanishi, Kenji] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan	Yamanishi, K (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	nrd08569@nifty.com; yamanishi@mist.i.u-tokyo.ac.jp			MEXT KAKENHI [23240019]; Aihara Project; FIRST program from JSPS; CSTP; Hakuhodo Corporation; NTT Corporation; Microsoft Corporation (CORE6 Project)	This work was partially supported by MEXT KAKENHI 23240019, Aihara Project, the FIRST program from JSPS, initiated by CSTP, Hakuhodo Corporation, NTT Corporation, and Microsoft Corporation (CORE6 Project). Specifically we thank HAKUHODO Inc. for providing us data sets for AIR and valuable comments.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Talih M, 2005, J ROY STAT SOC B, V67, P321, DOI 10.1111/j.1467-9868.2005.00504.x; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Rissanen J, 2000, IEEE T INFORM THEORY, V46, P2537, DOI 10.1109/18.887861; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Hirose S, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1185; KRICHEVSKY RE, 1981, IEEE T INFORM THEORY, V27, P199, DOI 10.1109/TIT.1981.1056331; HOEFFDING W, 1963, J AM STAT ASSOC, V58, P13, DOI 10.2307/2282952; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Cheng J., 1997, P AI STAT 97, P83; Fearnhead P, 2007, J ROY STAT SOC B, V69, P589, DOI 10.1111/j.1467-9868.2007.00601.x; Geiger D, 1994, TECHNICAL REPORT; Grunwald P., 2007, MINIMUM DESCRIPTION; Guo F., 2007, P INT C MACH LEARN, V227, P321; Hayashi Y, 2012, IEEE DATA MINING, P280, DOI 10.1109/ICDM.2012.53; Hirai S, 2012, P KDD, P343; Hirai S, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P1031; Ide T., 2009, P 2009 SIAM INT C DA, P97; Ide T, 2004, P 10 ACM SIGKDD INT, DOI 10.1145/1014052.1014102; Shtarkov YM, 1987, TRANSLATED PROBLEMS, V23, P3; Silander T, 2008, P 4 EUR WORKSH PROB, P257; Silander T., 2006, P 22 ANN C UNC ART I, P445; Xuan X, 2007, P 24 INT C MACH LEAR, V227, P1055; Yamanishi K., 2005, P 11 ACM SIGKDD INT, P499, DOI 10.1145/1081870.1081927; Yamanishi K, 2007, IEEE T INFORM THEORY, V53, P2180, DOI 10.1109/TIT.2007.896890	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1384-5810	1573-756X		DATA MIN KNOWL DISC	Data Min. Knowl. Discov.	JAN	2015	29	1					137	167		10.1007/s10618-013-0338-6		31	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	AZ0QD	WOS:000347948900005		
J	Ogawa, R; Ma, YR; Yamaguchi, M; Ito, T; Watanabe, Y; Ohtani, T; Murakami, S; Uchida, S; De Gaspari, P; Uezumi, A; Nakamura, M; Miyagoe-Suzuki, Y; Tsujikawa, K; Hashimoto, N; Braun, T; Tanaka, T; Takeda, S; Yamamoto, H; Fukada, S				Ogawa, Ryo; Ma, Yuran; Yamaguchi, Masahiko; Ito, Takahito; Watanabe, Yoko; Ohtani, Takuji; Murakami, Satoshi; Uchida, Shizuka; De Gaspari, Piera; Uezumi, Akiyoshi; Nakamura, Miki; Miyagoe-Suzuki, Yuko; Tsujikawa, Kazutake; Hashimoto, Naohiro; Braun, Thomas; Tanaka, Teruyuki; Takeda, Shin'ichi; Yamamoto, Hiroshi; Fukada, So-ichiro			Doublecortin marks a new population of transiently amplifying muscle progenitor cells and is required for myofiber maturation during skeletal muscle regeneration	DEVELOPMENT			English	Article						Satellite cells; Myofiber maturation; Regeneration; Doublecortin	QUIESCENT SATELLITE CELLS; STEM-CELL; SELF-RENEWAL; MOLECULAR REGULATION; NEURONAL MIGRATION; PRECURSOR CELLS; GENE; MYOGENESIS; DISTINCT; NICHE	Muscle satellite cells are indispensable for muscle regeneration, but the functional diversity of their daughter cells is unknown. Here, we show that many Pax7(+)MyoD(-) cells locate both beneath and outside the basal lamina during myofiber maturation. A large majority of these Pax7(+)MyoD(-) cells are not self-renewed satellite cells, but have different potentials for both proliferation and differentiation from Pax7(+)MyoD(+) myoblasts (classical daughter cells), and are specifically marked by expression of the doublecortin (Dcx) gene. Transplantation and lineage-tracing experiments demonstrated that Dcx-expressing cells originate from quiescent satellite cells and that the microenvironment induces Dcx in myoblasts. Expression of Dcx seems to be necessary for myofiber maturation because Dcx-deficient mice exhibited impaired myofiber maturation resulting from a decrease in the number of myonuclei. Furthermore, in vitro and in vivo studies suggest that one function of Dcx in myogenic cells is acceleration of cell motility. These results indicate that Dcx is a new marker for the Pax7(+)MyoD(-) subpopulation, which contributes to myofiber maturation during muscle regeneration.	[Ogawa, Ryo; Ma, Yuran; Yamaguchi, Masahiko; Ito, Takahito; Watanabe, Yoko; Ohtani, Takuji; Murakami, Satoshi; Nakamura, Miki; Tsujikawa, Kazutake; Yamamoto, Hiroshi; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka 5650871, Japan; [Uchida, Shizuka] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, D-60590 Frankfurt, Germany; [De Gaspari, Piera; Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Uezumi, Akiyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi 4701192, Japan; [Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Regenerat Med, Oobu, Aichi 4748522, Japan; [Tanaka, Teruyuki] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Bunkyo Ku, Tokyo 1130033, Japan	Fukada, S (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	fukada@phs.osaka-u.ac.jp			JSPS KAKENHI grant [25702044]; Intramural Research Grant [22-5, 25-5]	This work was supported by a JSPS KAKENHI grant, Grant-in Aid for Young Scientists (A) [25702044 to S. F.] and by an Intramural Research Grant [22-5 to S.F. and 25-5 to S.F.] for Neurological and Psychiatric Disorders of NCNP.	Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Corbo JC, 2002, J NEUROSCI, V22, P7548; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; des Portes V, 1998, CELL, V92, P51; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Piens M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-64; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4	38	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	JAN 1	2015	142	1					51	61		10.1242/dev.112557		11	Developmental Biology	Developmental Biology	AZ5DM	WOS:000348240500010		
J	Nakazawa, H; Kamata, R; Okuno, S				Nakazawa, H.; Kamata, R.; Okuno, S.			Deposition of silicon-doped diamond-like carbon films by plasma-enhanced chemical vapor deposition using an intermittent supply of organosilane	DIAMOND AND RELATED MATERIALS			English	Article						Diamond-like carbon; Silicon; Chemical vapor deposition; Adhesion; Friction; Wear	TRIBOLOGICAL PROPERTIES; AMORPHOUS-CARBON; DLC FILMS; MULTILAYER FILMS; COATINGS; FRICTION; MODEL	We have deposited Si-doped DLC (Si-DLC) multilayer films by plasma-enhanced chemical vapor deposition (PECVD) using an intermittent supply of monomethylsilane (SiH3CH3; MMS) as the Si source. The mechanical and tribological properties of the multilayer films were compared with those of Si-DLC single-layer films. The internal stress decreased as the Si content increased. It was found that the internal stress values of the multilayer films were lower than those of the single-layer films. Scratch tests demonstrated that the multilayer films had higher adhesion strength than the single-layer films owing to the further reduction of the internal stress. We found that the multilayer films with low Si content presented low friction while maintaining the wear performance. Specifically, the multilayer film containing similar to 2 at.% Si showed a friction coefficient less than 0.08, while the addition of similar to 11 at% Si to the single-layer film was required for obtaining such a low friction coefficient. The wear rate increased with increasing Si content. In the case of the above two films, the single-layer film had a specific wear about rate two times higher than that of the multilayer film. (C) 2014 Elsevier B.V. All rights reserved.	[Nakazawa, H.; Kamata, R.; Okuno, S.] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan	Nakazawa, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, 3 Bunkyo, Hirosaki, Aomori 0368561, Japan.	hnaka@cc.hirosaki-u.ac.jp			Tohoku University; JSPS KAKENHI [24560812]	The authors would like to thank Professor Maki Suemitsu of the Research Institute of Electrical Communication, Tohoku University for his great support in the Raman spectroscopy measurements. This work was partly supported by JSPS KAKENHI Grant Number (24560812).	ALJISHI R, 1982, PHYS REV B, V26, P4514, DOI 10.1103/PhysRevB.26.4514; Zhang W, 2004, DIAM RELAT MATER, V13, P2166, DOI 10.1016/j.diamond.2004.06.041; GOGOLIDES E, 1995, JPN J APPL PHYS 1, V34, P261, DOI 10.1143/JJAP.34.261; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Kim MG, 1999, SURF COAT TECH, V112, P204, DOI 10.1016/S0257-8972(98)00770-1; Zhang W, 2005, DIAM RELAT MATER, V14, P1361, DOI 10.1016/j.diamond.2005.02.010; Ohana T, 2004, DIAM RELAT MATER, V13, P1500, DOI 10.1016/j.diamond.2003.11.019; Lee CS, 2002, DIAM RELAT MATER, V11, P198; Ikeyama M, 2005, SURF COAT TECH, V191, P38, DOI 10.1016/j.surfcoat.2004.08.075; Shin JK, 2001, APPL PHYS LETT, V78, P631, DOI 10.1063/1.1343840; Ban M., 2002, SURF COAT TECH, V162, P1; Camargo SS, 1998, DIAM RELAT MATER, V7, P1155, DOI 10.1016/S0925-9635(98)00165-4; Chouquet C, 2008, SURF COAT TECH, V203, P745, DOI 10.1016/j.surfcoat.2008.08.008; Fujimoto S, 2011, SURF COAT TECH, V206, P1011, DOI 10.1016/j.surfcoat.2011.03.106; HIOKI T, 1991, SURF COAT TECH, V46, P233, DOI 10.1016/0257-8972(91)90166-T; Meneve J, 1996, SURF COAT TECH, V86-7, P617, DOI 10.1016/S0257-8972(96)02998-2; Murakawa M, 2003, SURF COAT TECH, V163, P561, DOI 10.1016/S0257-8972(02)00624-2; MUTSUKURA N, 1992, J APPL PHYS, V72, P43, DOI 10.1063/1.352145; Nakazawa H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.116002; Nakazawa H, 2008, JPN J APPL PHYS, V47, P8491, DOI 10.1143/JJAP.47.8491; Nakazawa H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.015603; OGURI K, 1991, SURF COAT TECH, V47, P710, DOI 10.1016/0257-8972(91)90344-V; Papakonstantinou P, 2002, DIAM RELAT MATER, V11, P1074, DOI 10.1016/S0925-9635(01)00656-2	23	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	JAN	2015	51						7	13		10.1016/j.diamond.2014.10.010		7	Materials Science, Multidisciplinary	Materials Science	AZ9TB	WOS:000348556900002		
J	Takarada, A; Suzuki, T; Kanda, K; Niibe, M; Nakano, M; Ohtake, N; Akasaka, H				Takarada, Atsuyuki; Suzuki, Tsuneo; Kanda, Kazuhiro; Niibe, Masahito; Nakano, Masayuki; Ohtake, Naoto; Akasaka, Hiroki			Structural dependence of corrosion resistance of amorphous carbon films against nitric acid	DIAMOND AND RELATED MATERIALS			English	Article						Amorphous carbon; Structural dependence; Corrosion resistance; Nitric acid	DIFFRACTION GRATINGS; GRAPHITE; SENSOR	To investigate the structural dependence of the corrosion resistance of amorphous carbon (a-C:H) films, three different types of a-C:H films etched by nitric acid were evaluated using a surface plasmon resonance (SPR) device with a multilayer structure consisting of an a-C:H layer on Ag. Two non-hydrogenated amorphous carbon (a-C) films and one hydrogenated a-C:H film were synthesized to estimate the effects of the sp(2)/sp(3) ratio and hydrogenation, respectively. A flow cell for the introduction of nitric acid solution was placed on the amorphous carbon layer of the multilayer structure. A 0.3 mM nitric acid solution was used in the etching tests. The Kretschmann configuration was used for SPR measurement, and the SPR angle was determined as the angle with minimum reflectivity. The SPR angle decreased with increasing duration of nitric acid injection into the flow cell, indicating that the film was corroded by the nitric acid. The thickness of the films was calculated from the SPR angle. The rates of decrease in the thickness were 2.2, 0.8, and 1.6 nm/h for the a-C films with lower and higher sp(2) contents and the 17 at.% hydrogenated a-C:H film, respectively. Although the hydrogen content had little effect on the rate of change in the film thickness, the film thickness clearly decreased with decreasing sp(2)/sp(3) ratio. These results indicate that the sp(2)/sp(3) ratio is an important factor determining the chemical resistance to nitric acid solution. (C) 2014 Elsevier B.V. All rights reserved.	[Takarada, Atsuyuki; Ohtake, Naoto; Akasaka, Hiroki] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528552, Japan; [Suzuki, Tsuneo] Nagaoka Univ Technol, Extreme Energy Dens Res Inst, Nagaoka, Niigata 9402188, Japan; [Kanda, Kazuhiro; Niibe, Masahito] Univ Hyogo, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan; [Nakano, Masayuki] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan	Akasaka, H (reprint author), Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	akasaka@mech.titech.ac.jp			Tokyo Tech Engineering; MIKIYA Science and Technology Foundation	We would like to thank for iMott Inc. for the FCVA deposition. This work was supported by the Tokyo Tech Engineering Grant for New Associate Professor, and the MIKIYA Science and Technology Foundation.	Akasaka H, 2009, APPL SURF SCI, V256, P1236, DOI 10.1016/j.apsusc.2009.05.125; Lee J, 1998, DIAM RELAT MATER, V7, P999, DOI 10.1016/S0925-9635(97)00341-5; Fano U, 1941, J OPT SOC AM, V31, P213, DOI 10.1364/JOSA.31.000213; Bouleghlimat E, 2013, CARBON, V61, P124, DOI 10.1016/j.carbon.2013.04.076; Wood RW, 1912, PHILOS MAG, V23, P310; Dalibon EL, 2013, SURF COAT TECH, V235, P735, DOI 10.1016/j.surfcoat.2013.08.059; Kurihara K, 2002, SENSOR ACTUAT B-CHEM, V86, P49, DOI 10.1016/S0925-4005(02)00146-6; Ban M, 2009, SURF COAT TECH, V203, P2587, DOI 10.1016/j.surfcoat.2009.02.051; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3; Wood RW, 1902, PHILOS MAG, V4, P396; BATSON PE, 1993, PHYS REV B, V48, P2608, DOI 10.1103/PhysRevB.48.2608; Fujimoto S, 2011, SURF COAT TECH, V206, P1011, DOI 10.1016/j.surfcoat.2011.03.106; Hiratsuka M., 2013, J SOLID MECH MAT ENG, V7, P187; Kanda K, 2003, NUCL INSTRUM METH B, V206, P880, DOI 10.1016/S0168-583X(03)00888-7; Kishimoto S, 2008, JPN J APPL PHYS, V47, P8106, DOI 10.1143/JJAP.47.8106; KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428; Liedberg B., 1995, BIOSENS BIOELECTRON, V10, P1; Ohtake N., 2011, SURF COAT TECH, V206, P1011; Rayleigh L., 1907, P ROY SOC LOND A MAT, V79, P399, DOI DOI 10.1098/RSPA.1907.0051; ROBERTSON J, 1993, J NONCRYST SOLIDS, V164, P1115, DOI 10.1016/0022-3093(93)91194-8; Saikubo A, 2008, DIAM RELAT MATER, V17, P1743, DOI 10.1016/j.diamond.2008.01.095; Sasaki Y, 2012, DIAM RELAT MATER, V24, P104, DOI 10.1016/j.diamond.2011.12.006; Shin Y.-R., 2013, CARBON, V52, P493; Veerasamy V.S., 1993, J NONCRYST SOLIDS, V164-166, P1111, DOI 10.1016/0022-3093(93)91193-7; Ohkawara Y, 2001, JPN J APPL PHYS 1, V40, P3359, DOI 10.1143/JJAP.40.3359	26	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	JAN	2015	51						49	54		10.1016/j.diamond.2014.11.006		6	Materials Science, Multidisciplinary	Materials Science	AZ9TB	WOS:000348556900008		
J	Shimizu, S; Yagi, S				Shimizu, Senjo; Yagi, Shintaro			ON LOCAL L-p-L-q WELL-POSEDNESS OF INCOMPRESSIBLE TWO-PHASE FLOWS WITH PHASE TRANSITIONS: THE CASE OF NON EQUAL DENSITIES	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							NAVIER-STOKES EQUATIONS; CONDUCTION-CONVECTION PROBLEMS; L-Q REGULARITY; STEFAN PROBLEM; CLASSICAL SOLVABILITY; QUALITATIVE BEHAVIOR; SURFACE-TENSION; BOUNDED DOMAIN; MODEL PROBLEMS; FLUID-FLOW	The basic model for incompressible two-phase flows with phase transitions where the interface is nearly flat in the case of non-equal densities is considered. The local well-posedness of the model in L-p-setting was proved in Pruss and Shimizu [14]. In this paper, we prove local well-posedness of the model L-p in time L-q in space settting.	[Shimizu, Senjo] Shizuoka Univ, Dept Math, Shizuoka 4228529, Japan; [Yagi, Shintaro] Shizuoka Univ, Dept Informat Sci & Technol, Educ Div, Grad Sch Sci & Technol, Shizuoka 4228529, Japan	Shimizu, S (reprint author), Shizuoka Univ, Dept Math, Shizuoka 4228529, Japan.				JSPS - MEXT [24340025]	The research of S.S was partially supported by JSPS Grant-in-Aid for Scientific Research (B) - 24340025, MEXT.	Anderson DM, 2007, J FLUID MECH, V581, P323, DOI 10.1017/S0022112007005587; DIBENEDETTO E, 1986, J DIFFER EQUATIONS, V62, P129, DOI 10.1016/0022-0396(86)90095-1; Denk R, 2007, MATH Z, V257, P193, DOI 10.1007/s00209-007-0120-9; DIBENEDETTO E, 1993, ARCH RATION MECH AN, V123, P99, DOI 10.1007/BF00695273; Escher J, 2003, J REINE ANGEW MATH, V563, P1; Hoffmann K.-H., 1998, ADV MATH SCI APPL, V8, P185; Hoffmann K.-H., 1998, ADV MATH SCI APPL, V8, P173; Ishii M., 1975, COLLECTION DIRECTION, V22; Ishii M., 2006, THERMOFLUID DYNAMICS; Kohne M, 2013, MATH ANN, V356, P737, DOI 10.1007/s00208-012-0860-7; Kusaka Y, 2002, MATH MOD METH APPL S, V12, P365, DOI 10.1142/S0218202502001696; Kusaka Y, 1999, SIAM J MATH ANAL, V30, P584, DOI 10.1137/S0036141098334936; Pruss J, 2014, COMMUN PART DIFF EQ, V39, P1236, DOI 10.1080/03605302.2013.821131; Pruss J, 2012, EVOL EQU CONTROL THE, V1, P171, DOI 10.3934/eect.2012.1.171; Priiss J., 2011, PROGR NONLINEAR DIFF, V80, P507; Priiss J., ARCH RAT ME IN PRESS; Pruss J, 2010, INTERFACE FREE BOUND, V12, P311, DOI 10.4171/IFB/237; Pruss J, 2012, J EVOL EQU, V12, P917, DOI 10.1007/s00028-012-0161-3; Shibata Y, 2003, J DIFFER EQUATIONS, V191, P408, DOI 10.1016/S0022-0396(03)00023-8; Shibata Y, 2012, J MATH SOC JPN, V64, P561, DOI 10.2969/jmsj/06420561; Shibata Y, 2011, J DIFFER EQUATIONS, V251, P373, DOI 10.1016/j.jde.2011.04.005; Shibata Y, 2007, DIFFER INTEGRAL EQU, V20, P241; Shibata Y, 2008, J REINE ANGEW MATH, V615, P157, DOI 10.1515/CRELLE.2008.013	23	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JAN-FEB	2015	28	1-2					29	58				30	Mathematics, Applied; Mathematics	Mathematics	AZ1ND	WOS:000348004700003		
J	Secchi, S; Shioji, N; Squassina, M				Secchi, Simone; Shioji, Naoki; Squassina, Marco			CORON PROBLEM FOR FRACTIONAL EQUATIONS	DIFFERENTIAL AND INTEGRAL EQUATIONS			English	Article							CRITICAL SOBOLEV EXPONENT; BOUNDARY-VALUE-PROBLEMS; LAPLACIAN; TOPOLOGY; DOMAINS	We prove that the critical problem for the fractional Laplacian in an annular type domain, admits a positive solution provided that the inner hole is sufficiently small.	[Secchi, Simone] Univ Milano Bicocca, Dipartimento Matemat & Applicaz, I-20125 Milan, Italy; [Shioji, Naoki] Yokohama Natl Univ, Dept Math, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Squassina, Marco] Univ Verona, Dipartimento Informat, I-37134 Verona, Italy	Secchi, S (reprint author), Univ Milano Bicocca, Dipartimento Matemat & Applicaz, Edificio U5,Via Roberto Cozzi 55, I-20125 Milan, Italy.				FIRB; Japan Society for the Promotion of Science [21540214, 26400160]; PRIN	S. Secchi is supported by the 2012 FIRB Dispersive equations and Fourier analysis. N. Shioji is partially supported by the Grant-in-Aid for Scientific Research (C) (No. 21540214 and No. 26400160) from Japan Society for the Promotion of Science. M. Squassina is supported by 2009 PRIN Variational and Topological Methods in the Study of Nonlinear Phenomena.	DANCER EN, 1988, B LOND MATH SOC, V20, P600, DOI 10.1112/blms/20.6.600; Ros-Oton X, 2014, ARCH RATION MECH AN, V213, P587, DOI 10.1007/s00205-014-0740-2; Cotsiolis A, 2004, J MATH ANAL APPL, V295, P225, DOI 10.1016/j.jmaa.2004.03.034; Chen WX, 2006, COMMUN PUR APPL MATH, V59, P330, DOI 10.1002/cpa.20116; Capella A, 2011, COMMUN PUR APPL ANAL, V10, P1645, DOI 10.3934/cpaa.2011.10.1645; Caffarelli L, 2007, COMMUN PART DIFF EQ, V32, P1245, DOI 10.1080/03605300600987306; Fall MM, 2012, J FUNCT ANAL, V263, P2205, DOI 10.1016/j.jfa.2012.06.018; PASSASEO D, 1989, MANUSCRIPTA MATH, V65, P147, DOI 10.1007/BF01168296; BAHRI A, 1988, COMMUN PUR APPL MATH, V41, P253, DOI 10.1002/cpa.3160410302; Chen W., ARXIV13097499V1; CORON JM, 1984, CR ACAD SCI I-MATH, V299, P209; Di Castro A., PREPRINT; Di Nezza E., 2012, B SCI MATH, V136, P512; Ding W. Y., 1989, J PARTIAL DIFF EQNS, V2, P83; Iannizzotto A., PREPRINT; Servadei R., 2014, T AM MATH S IN PRESS; STRUWE M, 1984, MATH Z, V187, P511, DOI 10.1007/BF01174186; Willem M., 1996, PROGR NONLINEAR DIFF, V24	18	1	1	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	0893-4983			DIFFER INTEGRAL EQU	Differ. Integral Equ.	JAN-FEB	2015	28	1-2					103	118				16	Mathematics, Applied; Mathematics	Mathematics	AZ1ND	WOS:000348004700006		
J	Matsumura, H				Matsumura, Hajime			ON A SPANNING k-TREE IN WHICH SPECIFIED VERTICES HAVE DEGREE LESS THAN k	DISCUSSIONES MATHEMATICAE GRAPH THEORY			English	Article						spanning tree; degree bounded tree; degree sum condition	GRAPH	A k-tree is a tree with maximum degree at most k. In this paper, we give a degree sum condition for a graph to have a spanning k-tree in which specified vertices have degree less than k. We denote by sigma(k)(G) the minimum value of the degree sum of k independent vertices in a graph G. Let k >= 3 and s >= 0 be integers, and suppose G is a connected graph and sigma(k) (G) >= vertical bar V(G)vertical bar + s - 1. Then for any s specified vertices, G contains a spanning k-tree in which every specified vertex has degree less than k. The degree condition is sharp.	Ibaraki Univ, Coll Educ, Ibaraki 3108512, Japan	Matsumura, H (reprint author), Ibaraki Univ, Coll Educ, Ibaraki 3108512, Japan.	hajime-m@mx.ibaraki.ac.jp					Effingham M.N., 2002, J GRAPH THEOR, V39, P62, DOI [10.1002/jgt .10019, DOI 10.1002/JGT]; Enomoto H, 2010, J GRAPH THEOR, V65, P173, DOI 10.1002/jgt.20471; Matsuda H, 2006, GRAPH COMBINATOR, V22, P371, DOI 10.1007/s00373-006-0660-5; Matsuda H, 2009, DISCRETE MATH, V309, P3653, DOI 10.1016/j.disc.2007.12.099; NEUMANNLARA V, 1991, COMBINATORICA, V11, P55, DOI 10.1007/BF01375473; Ore O., 1963, J MATH PURE APPL, V42, P21, DOI DOI 10.2307/2308928; Ore O., 1960, AMER MATH MONTHLY, V67, P55; WIN S, 1989, GRAPH COMBINATOR, V5, P201, DOI 10.1007/BF01788671; Win S, 1975, ABH MATH SEM HAMBURG, V43, P263, DOI DOI 10.1007/BF02995957	9	0	0	UNIV ZIELONA GORA	ZIELONA GORA	C/O PROF Z SZAFRANA 4A, ZIELONA GORA, 65-516, POLAND	1234-3099	2083-5892		DISCUSS MATH GRAPH T	Discuss. Math. Graph Theory		2015	35	1					191	196		10.7151/dmgt.1778		6	Mathematics	Mathematics	AZ5HU	WOS:000348252000015		
J	Kado, Y; Soneda, Y; Yoshizawa, N				Kado, Yuya; Soneda, Yasushi; Yoshizawa, Noriko			Excellent Rate Capability of MgO-Templated Mesoporous Carbon as an Na-Ion Energy Storage Material	ECS ELECTROCHEMISTRY LETTERS			English	Editorial Material							HARD-CARBON; ANODE MATERIALS; BATTERIES; ELECTROLYTE; PERFORMANCE; SALTS	MgO-templated mesoporous carbon was investigated as an anode material for Na-ion storage. The mesoporous carbons exhibited a discharge capacity of 180 mAh g(-1) at a current density of 0.1 A g(-1) in a potential range of 2.00-0.01 V vs. Na+/Na. This capacity was comparable to that of commercial hard carbon materials. They also showed an outstanding rate capability: 70 mAh g(-1) at 4 A g(-1), which was 10-fold greater than the corresponding capability of commercial hard carbons. These results indicate that MgO-templated mesoporous carbon is a potential new anode material for high-power-density Na-ion batteries and capacitors. (C) 2014 The Electrochemical Society. All rights reserved.	[Kado, Yuya; Soneda, Yasushi; Yoshizawa, Noriko] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan	Kado, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058569, Japan.	y.kado@aist.go.jp					Laheaar A, 2012, ELECTROCHIM ACTA, V82, P309, DOI 10.1016/j.electacta.2012.04.149; Aurbach D, 1999, ELECTROCHIM ACTA, V45, P67, DOI 10.1016/S0013-4686(99)00194-2; Kim SW, 2012, ADV ENERGY MATER, V2, P710, DOI 10.1002/aenm.201200026; Morishita T, 2010, CARBON, V48, P2690, DOI 10.1016/j.carbon.2010.03.064; Stevens DA, 2000, J ELECTROCHEM SOC, V147, P1271, DOI 10.1149/1.1393348; Kuratani K, 2012, ELECTROCHIM ACTA, V76, P320, DOI 10.1016/j.electacta.2012.05.040; Nishi Y, 2001, J POWER SOURCES, V100, P101, DOI 10.1016/S0378-7753(01)00887-4; Vali R, 2014, ELECTROCHIM ACTA, V121, P294, DOI 10.1016/j.electacta.2013.12.149; Fu LJ, 2014, NANOSCALE, V6, P1384, DOI 10.1039/c3nr05374a; Mukai SR, 2004, CARBON, V42, P837, DOI 10.1016/j.carbon.2004.01.062; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Komaba S, 2011, ACS APPL MATER INTER, V3, P4165, DOI 10.1021/am200973k; Frackowiak E, 2002, CARBON, V40, P1775, DOI 10.1016/S0008-6223(02)00045-3; Ponrouch A, 2013, ELECTROCHEM COMMUN, V27, P85, DOI 10.1016/j.elecom.2012.10.038; Wenzel A, 2011, ENERG ENVIRON SCI, V4, P3342	16	5	5	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8726	2162-8734		ECS ELECTROCHEM LETT	ECS Electrochem. Lett.		2015	4	2					A22	A23		10.1149/2.0051502eel		2	Electrochemistry; Materials Science, Multidisciplinary	Electrochemistry; Materials Science	AZ6SP	WOS:000348350400001		
J	Satou, Y; Komine, S; Takai, S; Yao, T				Satou, Yoshinori; Komine, Shigeki; Takai, Shigeomi; Yao, Takeshi			Non-Equilibrium Li Insertion Paths in LiMn0.75Fe0.25PO4 Observed during the Relaxation Process	ECS ELECTROCHEMISTRY LETTERS			English	Article							LITHIUM BATTERIES; OLIVINE; LI-X(MNYFE1-Y)PO4; CATHODE	We observed in detail the XRD profiles of LiMn0.75Fe0.25PO4 taken during the relaxation time. We founded the peak position of the Li-rich phase shifted to lower angles during the relaxation process. We also founded that the intensity around the midpoint between the peak positions of the Li-rich phase and that of the Li-lean phase decreased immediately after the lithium insertion and the delay of the decrease in the intensity around the Li-rich phase. We consider that these happened due to the crystal structure peculiar to the lithium manganese iron phosphate. (C) 2015 The Electrochemical Society.	[Satou, Yoshinori; Komine, Shigeki] ADENSO Corp, Aichi 448866, Japan; [Satou, Yoshinori; Takai, Shigeomi; Yao, Takeshi] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6068501, Japan; [Yao, Takeshi] Kagawa Natl Coll Technol, Kagawa 7618058, Japan	Satou, Y (reprint author), ADENSO Corp, Aichi 448866, Japan.	t_yao@hera.eonet.ne.jp					Kobayashi G, 2009, J POWER SOURCES, V189, P397, DOI 10.1016/j.jpowsour.2008.07.085; HALDER NC, 1966, ACTA CRYSTALLOGR, V20, P312, DOI 10.1107/S0365110X66000628; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA747, DOI 10.1149/1.1375167; Yonemura M, 2004, J ELECTROCHEM SOC, V151, pA1352, DOI 10.1149/1.1773731; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA1153, DOI 10.1149/1.1401083; Chen GY, 2009, J ELECTROCHEM SOC, V156, pA756, DOI 10.1149/1.3167389; Malik R, 2013, J ELECTROCHEM SOC, V160, pA3179, DOI 10.1149/2.029305jes; Park S, 2011, SOLID STATE IONICS, V203, P29, DOI 10.1016/j.ssi.2011.09.014; Park S, 2012, ELECTROCHEM SOLID ST, V15, pA49, DOI 10.1149/2.012204esl; Park S, 2012, ELECTROCHEMISTRY, V80, P804, DOI 10.5796/electrochemistry.80.804; Satou Y, 2014, SOLID STATE IONICS, V262, P35, DOI 10.1016/j.ssi.2013.09.013; Seo I. S., 2013, ELECTROCHEM LETT, V2, pA72; Seo IS, 2013, ECS ELECTROCHEM LETT, V2, pA6, DOI 10.1149/2.007301eel; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA960, DOI 10.1149/1.1385377	15	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8726	2162-8734		ECS ELECTROCHEM LETT	ECS Electrochem. Lett.		2015	4	3					A37	A40		10.1149/2.0031503eel		4	Electrochemistry; Materials Science, Multidisciplinary	Electrochemistry; Materials Science	AZ9YN	WOS:000348570700004		
J	Habuka, H; Sakurai, A; Saito, A				Habuka, Hitoshi; Sakurai, Ayumi; Saito, Ayumi			By-Product Formation in a Trichlorosilane-Hydrogen System for Silicon Film Deposition	ECS JOURNAL OF SOLID STATE SCIENCE AND TECHNOLOGY			English	Article							EPITAXIAL-GROWTH; SIHCL3-H-2 SYSTEM; REACTOR	The process of by-product formation during silicon film deposition using trichlorosilane gas was studied by two types of the in situ measurement techniques, such as the langasite crystal microbalance (LCM) and the quadrupole mass spectra (QMS) analyzer, installed at the exhaust of the chemical vapor deposition (CVD) reactor. With the increasing hydrogen gas concentration, the QMS showed that the partial pressure related to SiCl2 decreased. Simultaneously, the deposition on the LCM surface decreased. Because SiCl2 gradually produces the burnable by-product of (SiCl2)(n) an oily silane, at the exhaust, the CVD parameters effective for suppressing the SiCl2 formation were evaluated. (C) The Author(s) 2014. Published by ECS. All rights reserved.	[Habuka, Hitoshi; Sakurai, Ayumi; Saito, Ayumi] Yokohama Natl Univ, Dept Chem & Energy Engn, Yokohama, Kanagawa 2408501, Japan	Habuka, H (reprint author), Yokohama Natl Univ, Dept Chem & Energy Engn, Yokohama, Kanagawa 2408501, Japan.	habuka1@ynu.ac.jp			JSPS KAKENHI [25420772]	The authors thank N. Enomoto of Halloran Electronic Co., Ltd., for his long and kind support of the piezoelectric crystal microbalance. Part of this study was supported by JSPS KAKENHI grant No. 25420772.	[Anonymous], 2013, [No title captured], Patent No. 2013045799; Habuka H, 2013, SURF COAT TECH, V230, P312, DOI 10.1016/j.surfcoat.2013.06.052; Habuka H, 1999, J CRYST GROWTH, V207, P77, DOI 10.1016/S0022-0248(99)00360-7; Habuka H, 1996, J CRYST GROWTH, V169, P61, DOI 10.1016/0022-0248(96)00376-4; Chapman JR, 1993, PRACTICAL ORGANIC MA; Comita P., 1997, ELECTROCHEM SOC P, P684; Crippa D., 2001, SILICON EPITAXY; deWijs GA, 1997, PHYS REV LETT, V78, P4877, DOI 10.1103/PhysRevLett.78.4877; Habuka H., 2012, ECS J SOLID STATE SC, V1, P62; Habuka H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.096505; Habuka H., 2013, J SURF ENG MAT ADV T, V3, P61; Habuka H, 2011, J CRYST GROWTH, V327, P1, DOI 10.1016/j.jcrysgro.2011.05.006; Kommu S, 2000, J ELECTROCHEM SOC, V147, P1538, DOI 10.1149/1.1393391; Lee T., 1998, BEGINNERS GUIDE MASS; Meyer D. J., 2005, ELECTROCHEM SOC P, V2005-06, P81; SU MD, 1993, J PHYS CHEM-US, V97, P9981, DOI 10.1021/j100141a015; Veneroni A, 2005, J CRYST GROWTH, V275, pE289, DOI 10.1016/j.jcrysgro.2004.10.108	17	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8769			ECS J SOLID STATE SC	ECS J. Solid State Sci. Technol.		2015	4	2					P16	P19		10.1149/2.0031502jss		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ7QD	WOS:000348412100006		
J	Shima, K; Shimizu, H; Momose, T; Shimogaki, Y				Shima, Kohei; Shimizu, Hideharu; Momose, Takeshi; Shimogaki, Yukihiro			Study on the Adhesion Strength of CVD-Cu Films with ALD-Co(W) Underlayers Made Using Amidinato Precursors	ECS JOURNAL OF SOLID STATE SCIENCE AND TECHNOLOGY			English	Article							CHEMICAL-VAPOR-DEPOSITION; ATOMIC LAYER DEPOSITION; ALD CO(W) FILMS; COPPER METALLIZATION; CRYSTAL ORIENTATION; DIFFUSION BARRIER; CONTACT-ANGLE; ICE ADHESION; RU; INTERCONNECTS	We investigated the adhesion strength of Cu films grown using chemical vapor deposition (CVD) on a Co(W) layer, which was grown using atomic layer deposition (ALD), for Cu interconnect applications in. ultra-large scale integration (ULSI). Co(W) forms an effective bather to the diffusion of Cu and forms an adhesion layer in a single bather. Amidinato precursors were used in the deposition of Co and W, which contain neither O nor F, and yielded high-purity Co(W) films. Furthermore, the use of an amidinato Cu precursor was also found to be important in enabling Cu deposition without interfacial contamination. The W content of the Co(W) layer was optimized to 14 at% via an evaluation of the diffusion barrier properties, the electrical conductivity, and the adhesion strength with the Cu layer. A CVD-Cu/ALD-Co(W) stack was formed using amidinato precursors for the growth of both films, and was found to exhibit favorable properties compared with a conventional PVD-Cu/PVD-Ta/TaN stack. It was also favorable to a PVD-Cu/PVD-Ru/TaN stack in terms of the diffusion barrier properties and electrical conductivity, with a similar adhesion strength for Cu. For these reasons, our Co(W) films have potential applications in reliable and high-performance Cu interconnects in next-generation ULSI. (C) 2014 The Electrochemical Society. All rights reserved.	[Shima, Kohei; Shimizu, Hideharu; Momose, Takeshi; Shimogaki, Yukihiro] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan	Shima, K (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.	shima@dpe.mm.t.u-tokyo.ac.jp	Shima, Kohei/N-1648-2014; Shimogaki, Yukihiro/B-9803-2008	Shimogaki, Yukihiro/0000-0002-1186-8636			Meuler AJ, 2010, ACS APPL MATER INTER, V2, P3100, DOI 10.1021/am1006035; Oh WS, 2002, J PROSTHET DENT, V88, P616, DOI 10.1067/mpr.2002.129805; GANGOPADHYAY U, 1995, J MATER SCI, V30, P94, DOI 10.1007/BF00352136; Hu CK, 1999, APPL PHYS LETT, V74, P2945, DOI 10.1063/1.123974; Lim BS, 2003, NAT MATER, V2, P749, DOI 10.1038/nmat1000; Shimizu H, 2013, ECS J SOLID STATE SC, V2, pP311, DOI 10.1149/2.008307jss; Szymczyk K, 2014, APPL SURF SCI, V288, P488, DOI 10.1016/j.apsusc.2013.10.059; VANDERLAAN G, 1981, PHYS REV B, V23, P4369, DOI 10.1103/PhysRevB.23.4369; Dotan A, 2009, J ADHES SCI TECHNOL, V23, P1907, DOI 10.1163/016942409X12510925843078; CARVER JC, 1972, J CHEM PHYS, V57, P973, DOI 10.1063/1.1678348; HOLLOWAY K, 1992, J APPL PHYS, V71, P5433, DOI 10.1063/1.350566; Kaloyeros AE, 2000, ANNU REV MATER SCI, V30, P363, DOI 10.1146/annurev.matsci.30.1.363; Kim H, 2007, J ELECTROCHEM SOC, V154, pG13, DOI 10.1149/1.2392984; Li ZW, 2005, INORG CHEM, V44, P1728, DOI 10.1021/ic048492u; Shimizu H, 2013, ECS J SOLID STATE SC, V2, pP471, DOI 10.1149/2.029311jss; Au Y, 2011, J ELECTROCHEM SOC, V158, pD248, DOI 10.1149/1.3556699; BARBARIS.MJ, 1967, NATURE, V215, P383, DOI 10.1038/215383a0; CHEN W, 1995, SURF SCI, V324, P169, DOI 10.1016/0039-6028(94)00726-8; Choi S.-M., 2004, P IEEE VLSI C HON; Dupre A., 1869, MECHANIQUE CHALEUR, P369; Edelstein D., 2001, P IEEE INT INT TECHN; FURUYA A, 1995, J APPL PHYS, V78, P5989, DOI 10.1063/1.360604; Gadre KS, 2003, J APPL PHYS, V93, P919, DOI 10.1063/1.1530362; Heylen N., 2010, P IEEE INT INT TECHN; Iwasaki T, 2000, COMPUT MECH, V25, P78, DOI 10.1007/s004660050017; Johnston S., 2003, P ADV MET C MONTR; Kim H., 2005, J ELECTROCHEMICAL SO, V152, P594; Kim H, 2006, JPN J APPL PHYS 1, V45, P2497, DOI 10.1143/JJAP.45.2497; Kim H, 2006, JPN J APPL PHYS 2, V45, pL233, DOI 10.1143/JJAP.45.L233; Kim H, 2006, APPL SURF SCI, V252, P3938, DOI 10.1016/j.apsusc.2005.09.042; Kim J. Y., 2004, P 106 ANN M AM CER S; Kokaze Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05FA01; Lane MW, 2003, J APPL PHYS, V93, P1417, DOI 10.1063/1.1532942; LI JG, 1992, MATER LETT, V14, P329, DOI 10.1016/0167-577X(92)90047-N; Li Z., 2005, ELECTROCHEM SOLID ST, V8, DOI DOI 10.1149/1.1924929; Li ZW, 2006, J ELECTROCHEM SOC, V153, pC787, DOI 10.1149/1.2338632; Liu HD, 2001, THIN SOLID FILMS, V384, P151, DOI 10.1016/S0040-6090(00)01818-6; Lu J., 2008, P ADV MET C AS SESS; Mallikarjunan A, 2000, ELECTROCHEM SOLID ST, V3, P437; Maruyama K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C022; Momose T, 2006, JPN J APPL PHYS 1, V45, P8618, DOI 10.1143/JJAP.45.8618; Nakamura N., 2009, P IEEE INT INT TECHN; Nishizawa H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.05FC03; Nogami T., 2010, P IEEE INT INT TECHN; NORMAN JAT, 1995, THIN SOLID FILMS, V262, P46, DOI 10.1016/0040-6090(94)05808-3; NORMAN JAT, 1993, MAT SCI ENG B-SOLID, V17, P87, DOI 10.1016/0921-5107(93)90085-2; Rios PF, 2007, J ADHES SCI TECHNOL, V21, P227, DOI 10.1163/156856107780684567; Shima K, 2014, ECS SOLID STATE LETT, V3, pP20, DOI 10.1149/2.005402ssl; Shimizu H, 2013, MICROELECTRON ENG, V106, P91, DOI 10.1016/j.mee.2012.08.008; Shimizu H., J MAT CHEM C UNPUB; Shimizu H, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.05E802, 10.1143/JJAP.51.05EB02]; Shimizu H, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.3666034; Shimizu H., 2012, P IEEE INT INT TECHN; Somorjai G. A., 1981, CHEM 2 DIMENSIONS SU, P31; The International Technology Roadmap for Semiconductors, 2012, INT; van der Straten O, 2006, J MATER RES, V21, P255, DOI 10.1557/JMR.2006.0040; Vanypre T, 2006, MICROELECTRON ENG, V83, P2373, DOI 10.1016/j.mee.2006.10.039; Victoria SN, 2010, ELECTROCHEM SOLID ST, V13, pH385, DOI 10.1149/1.3481948; Voss S, 2000, MICROELECTRON ENG, V50, P501, DOI 10.1016/S0167-9317(99)00383-4; Wang Q, 2004, APPL PHYS LETT, V84, P1380, DOI 10.1063/1.1650044; Xiao Q. Y., 2009, INT J PAVEMENT RES T, V2, P270; Yang C.-C., 2006, P IEEE INT INT TECHN; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005	63	1	1	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8769			ECS J SOLID STATE SC	ECS J. Solid State Sci. Technol.		2015	4	2					P20	P29		10.1149/2.0061502jss		10	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ7QD	WOS:000348412100007		
J	Yoo, WS; Kang, K; Ueda, T; Ishigaki, T; Nishigaki, H; Hasuike, N; Harima, H; Yoshimoto, M; Tan, CS				Yoo, Woo Sik; Kang, Kitaek; Ueda, Takeshi; Ishigaki, Toshikazu; Nishigaki, Hiroshi; Hasuike, Noriyuki; Harima, Hiroshi; Yoshimoto, Masahiro; Tan, Chuan Seng			Characterization of Hetero-Epitaxial Ge Films on Si Using Multiwavelength Micro-Raman Spectroscopy	ECS JOURNAL OF SOLID STATE SCIENCE AND TECHNOLOGY			English	Article							ROOM-TEMPERATURE-PHOTOLUMINESCENCE; THREADING-DISLOCATION DENSITIES; INTERFACE QUALITY; STRAIN RELAXATION; GROWTH; LAYER; PHOTODETECTORS; INTEGRATION; SI1-XGEX; SPECTRA	To meet various physical property requirements of materials for advanced applications for specific devices, combinations of Si/Ge, Ge/Si, Si1-xGex/Si, are frequently introduced in the device fabrication process. Epitaxy, condensation and annealing processes are commonly used. Since a small variation in composition, strain and crystallinity can result in reduced device performance or failure, the composition, strain and crystallinity must be carefully monitored and controlled throughout the manufacturing process. We have studied the dependence of Ge and Si intermixing on annealing temperature and Raman excitation wavelength. Using multiwavelength Raman spectroscopy, we found Ge and Si intermixing in epitaxially grown Ge(100)/Si(100) after successive thermal anneals. Very strong dependence of signal-to-noise (S/N) ratio measurements on excitation wavelength and film structure was observed. Suitable excitation wavelengths must be chosen to properly characterize Si and Ge-based heteroepitaxial layers based on the thickness, stacking order and composition of epitaxial films having different optical properties at different wavelengths. (C) The Author(s) 2014. Published by ECS. All rights reserved.	[Yoo, Woo Sik; Kang, Kitaek; Ueda, Takeshi; Ishigaki, Toshikazu] WaferMasters Inc, San Jose, CA 95112 USA; [Nishigaki, Hiroshi; Hasuike, Noriyuki; Harima, Hiroshi; Yoshimoto, Masahiro] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan; [Tan, Chuan Seng] Nanyang Technol Univ, Singapore 639798, Singapore	Yoo, WS (reprint author), WaferMasters Inc, San Jose, CA 95112 USA.	woosik.yoo@wafermasters.com					Ackland B., 2009, INT IM SENS WORKSH B; PEOPLE R, 1985, APPL PHYS LETT, V47, P322, DOI 10.1063/1.96206; Wang JA, 2011, SENSORS-BASEL, V11, P696, DOI 10.3390/s110100696; Reparaz JS, 2012, J APPL PHYS, V112, DOI 10.1063/1.4737486; Rath S, 2003, SEMICOND SCI TECH, V18, P566, DOI 10.1088/0268-1242/18/6/330; Malik A, 2013, IEEE PHOTONIC TECH L, V25, P1805, DOI 10.1109/LPT.2013.2276479; Colace L, 2000, APPL PHYS LETT, V76, P1231, DOI 10.1063/1.125993; Fama S, 2002, APPL PHYS LETT, V81, P586, DOI 10.1063/1.1496492; DeWolf I, 1996, SEMICOND SCI TECH, V11, P139, DOI 10.1088/0268-1242/11/2/001; LEGOUES FK, 1991, PHYS REV LETT, V66, P2903, DOI 10.1103/PhysRevLett.66.2903; Yamamoto Y, 2011, SOLID STATE ELECTRON, V60, P2, DOI 10.1016/j.sse.2011.01.032; COPEL M, 1989, PHYS REV LETT, V63, P632, DOI 10.1103/PhysRevLett.63.632; ALONSO MI, 1989, PHYS REV B, V39, P10056, DOI 10.1103/PhysRevB.39.10056; Pages O, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045201; Tan YH, 2012, THIN SOLID FILMS, V520, P2711, DOI 10.1016/j.tsf.2011.11.046; Luan HC, 1999, APPL PHYS LETT, V75, P2909, DOI 10.1063/1.125187; Samavedam SB, 1998, APPL PHYS LETT, V73, P2125, DOI 10.1063/1.122399; Sugiyama N, 2004, J APPL PHYS, V95, P4007, DOI 10.1063/1.1649812; Aggarwal RL, 2011, SOLID STATE COMMUN, V151, P553, DOI 10.1016/j.ssc.2011.01.011; Arguirov T, 2011, Journal of Physics: Conference Series, V281, DOI 10.1088/1742-6596/281/1/012021; Chang CW, 2012, AIP ADV, V2, DOI 10.1063/1.4711043; Chong GY, 2009, ELECTROCHEM SOLID ST, V12, pH408, DOI 10.1149/1.3207872; Damlencourt J. R., 2006, 3 INT SIGE TECHN DEV, P1; Darma Y, 2004, APPL SURF SCI, V224, P156, DOI 10.1016/j.apsusc.2003.08.108; de Wolf I., 2003, Spectroscopy Europe, V15; FITZGERALD EA, 1991, APPL PHYS LETT, V59, P811, DOI 10.1063/1.105351; Haynes W. M., 2014, CRC HDB CHEM PHYS; Hong MH, 2012, AIP ADV, V2, DOI 10.1063/1.4748294; Horn-von Hoegen M, 2003, SURF SCI, V537, P1, DOI 10.1016/S0039-6028(03)00700-3; ICHIMURA M, 1995, J APPL PHYS, V77, P5144, DOI 10.1063/1.359258; Jian SKJ, 2013, J MATER RES, V28, P1269, DOI 10.1557/jmr.2013.78; Liu JL, 2001, APPL PHYS LETT, V79, P3431, DOI 10.1063/1.1421092; Liu JL, 1999, APPL PHYS LETT, V75, P1586, DOI 10.1063/1.124762; Luan H. C., 1999, MRS P, V607, P279; Palik E.D., 1998, HDB OPTICAL CONSTANT, VIII; Perova TS, 2011, J APPL PHYS, V109, DOI 10.1063/1.3536508; Streetman Ben G., 2006, SOLID STATE ELECT DE; Tan CS, 2010, ELECTROCHEM SOLID ST, V13, pH27, DOI 10.1149/1.3266904; Tzeng YF, 2011, J MATER RES, V26, P739, DOI 10.1557/jmr.2010.62; Widulle F, 1999, PHYSICA B, V263, P381, DOI 10.1016/S0921-4526(98)01390-8; Yamamoto Y, 2014, ECS J SOLID STATE SC, V3, pP353, DOI 10.1149/2.0071411jss; Yoo WS, 2014, ECS J SOLID STATE SC, V3, pN142, DOI 10.1149/2.0181411jss; Yoo WS, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.116502; Zhang JM, 1998, PHYS REV B, V57, P1348, DOI 10.1103/PhysRevB.57.1348	44	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8769			ECS J SOLID STATE SC	ECS J. Solid State Sci. Technol.		2015	4	2					P9	P15		10.1149/2.0041502jss		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ7QD	WOS:000348412100005		
J	Kondo, T; Nagao, S; Yanagishita, T; Nguyen, NT; Lee, K; Schmuki, P; Masuda, H				Kondo, Toshiaki; Nagao, Sanami; Yanagishita, Takashi; Nhat Truong Nguyen; Lee, Kiyoung; Schmuki, Patrik; Masuda, Hideki			Ideally ordered porous TiO2 prepared by anodization of pretextured Ti by nanoimprinting process	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Porous TiO2; Anodization; Ti; Imprinting process; Nanotubes	TITANIA NANOTUBE ARRAYS; ANODIC ALUMINA; GROWTH; SQUARE; LENGTH	Ideally ordered anodic porous TiO2 was fabricated through the pretexturing of Ti by nanoimprinting using a metal mold with an ordered array of convexes. The shallow concaves prepared by nanoimprinting acted as initiation sites for hole development during the subsequent anodization and generated ideally hexagonally ordered porous or nanotubular TiO2. The hole interval of the ideally ordered TiO2 could be controlled by changing the pretexturing pattern. This process is a key step towards the preparation of various types of functional devices requiring ideally ordered defect-free hole or pore arrangements. (C) 2014 Elsevier B.V. All rights reserved.	[Kondo, Toshiaki; Nagao, Sanami; Yanagishita, Takashi; Masuda, Hideki] Tokyo Metropolitan Univ, Tokyo 1920397, Japan; [Nhat Truong Nguyen; Lee, Kiyoung; Schmuki, Patrik] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany	Masuda, H (reprint author), 1-1 Minamiosawa, Tokyo 1920397, Japan.	hideki-masuda@tmu.ac.jp	Nguyen, Nhat Truong/G-4234-2015; Lee, Kiyoung/J-8680-2013	Nguyen, Nhat Truong/0000-0002-7651-3174; Lee, Kiyoung/0000-0003-2432-6614			Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459; Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m; Masuda H, 1997, APPL PHYS LETT, V71, P2770, DOI 10.1063/1.120128; Sun LD, 2009, J ELECTROANAL CHEM, V637, P6, DOI 10.1016/j.jelechem.2009.09.023; Zhou XM, 2014, ELECTROCHEM COMMUN, V46, P157, DOI 10.1016/j.elecom.2014.06.021; Paulose M, 2006, J PHYS CHEM B, V110, P16179, DOI 10.1021/jp064020k; Tiainen H, 2012, ACTA BIOMATER, V8, P2384, DOI 10.1016/j.actbio.2012.02.020; Macak JM, 2005, ELECTROCHEM COMMUN, V7, P1133, DOI 10.1016/j.elecom.2005.08.013; Choi JS, 2004, ELECTROCHIM ACTA, V49, P2645, DOI 10.1016/j.electacta.2004.02.015; Sulka GD, 2010, ELECTROCHIM ACTA, V55, P4359, DOI 10.1016/j.electacta.2009.12.053; Chen B, 2011, CHEM COMMUN, V47, P10085, DOI 10.1039/c1cc13342j; Inoue K., 2004, PHOTONIC CRYSTALS; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Masuda H, 2001, ADV MATER, V13, P189, DOI 10.1002/1521-4095(200102)13:3<189::AID-ADMA189>3.0.CO;2-Z; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	JAN	2015	50						73	76		10.1016/j.elecom.2014.11.013		4	Electrochemistry	Electrochemistry	AZ5KO	WOS:000348260200018		
J	Asakura, D; Hosono, E; Niwa, H; Kiuchi, H; Miyawaki, J; Nanba, Y; Okubo, M; Matsuda, H; Zhou, HS; Oshima, M; Harada, Y				Asakura, Daisuke; Hosono, Eiji; Niwa, Hideharu; Kiuchi, Hisao; Miyawaki, Jun; Nanba, Yusuke; Okubo, Masashi; Matsuda, Hirofumi; Zhou, Haoshen; Oshima, Masaharu; Harada, Yoshihisa			Operando soft x-ray emission spectroscopy of LiMn2O4 thin film involving Li-ion extraction/insertion reaction	ELECTROCHEMISTRY COMMUNICATIONS			English	Article						Li-ion battery; LiMn2O4; Operando; In situ; Soft x-ray emission spectroscopy	SPECTRA; MN	We developed an electrochemical in situ cell for soft x-ray emission spectroscopy (XES) to accurately investigate the redox reaction and electronic structure of transition metals in the cathode materials for Li-ion battery. The in situ cell consists of a Li-metal counter electrode, an organic electrolyte solution, and a cathode on a membrane window which separates the liquid electrolyte from high vacuum and can pass the incoming and emitted photons. In this study, the Mn 3d electronic structure of LiMn204 thin-film electrode was clarified by the operand XES. At the charged state, the XES spectrum changed significantly from the open-circuit-voltage (OCV) state, suggesting oxidation of the Mn3+ component through Li-ion extraction. Upon discharge up to 3.0 V vs. Li/Li+, the XES spectrum almost returned to its profile at the OCV state with small difference, indicating the valence change of Mn: Mn3.6+ -> Mn4+ -> Mn33+ corresponding to the OCV, charged, and discharged states. (C) 2014 Elsevier B.V. All rights reserved.	[Asakura, Daisuke; Hosono, Eiji; Nanba, Yusuke; Okubo, Masashi; Matsuda, Hirofumi; Zhou, Haoshen] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Niwa, Hideharu; Miyawaki, Jun; Harada, Yoshihisa] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Niwa, Hideharu; Miyawaki, Jun; Oshima, Masaharu; Harada, Yoshihisa] Univ Tokyo, Synchrotron Radiat Res Org, Bunkyo Ku, Tokyo 1138586, Japan; [Kiuchi, Hisao] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138586, Japan	Asakura, D (reprint author), Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	daisuke-asakura@aist.go.jp	Okubo, Masashi/C-6360-2011; Hosono, Eiji/M-8402-2013		University of Tokyo [2012B7437, 2013A7445, 2013B7460]; JSPS KAKENHI [25871186]; Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies; "Nanotechnology Platform Program" of MEXT, Japan	The XAS and XES measurements were performed by the joint research in SRRO and ISSP, the University of Tokyo (Proposal Nos. 2012B7437, 2013A7445 and 2013B7460). D.A. acknowledges support from JSPS KAKENHI (25871186). This work is partially supported by the Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies. A part of this work was conducted at the AIST Nano-Processing Facility, supported by "Nanotechnology Platform Program" of MEXT, Japan.	Agui A, 2005, J PHYS SOC JPN, V74, P1772, DOI 10.1143/JPSJ.74.1772; Ghiringhelli G, 2009, EUR PHYS J-SPEC TOP, V169, P199, DOI 10.1140/epjst/e2009-00993-8; Harada Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3680559; Jiang P, 2010, ELECTROCHEM COMMUN, V12, P820, DOI 10.1016/j.elecom.2010.03.042; Tokushima T, 2008, CHEM PHYS LETT, V460, P387, DOI 10.1016/j.cplett.2008.04.077; Ito A, 2011, J POWER SOURCES, V196, P6828, DOI 10.1016/j.jpowsour.2010.09.105; THACKERAY MM, 1983, MATER RES BULL, V18, P461, DOI 10.1016/0025-5408(83)90138-1; Nedoseykina T, 2010, ELECTROCHIM ACTA, V55, P8876, DOI 10.1016/j.electacta.2010.08.037; Wadati H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463468; Ghiringhelli G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035111; Thackeray MM, 1997, PROG SOLID STATE CH, V25, P1, DOI 10.1016/S0079-6786(97)81003-5; Kotani A, 2001, REV MOD PHYS, V73, P203, DOI 10.1103/RevModPhys.73.203; Niwa H, 2013, ELECTROCHEM COMMUN, V35, P57, DOI 10.1016/j.elecom.2013.08.003; Goodenough JB, 2013, J AM CHEM SOC, V135, P1167, DOI 10.1021/ja3091438; de Groot F, 2008, ADV CONDENS MAT SCI, V6, P1; Hallmark H.M., 2010, J ELECTROCHEM SOC, V157, pA962; Liu X., 2013, NAT COMMUN, V4; Senba Y, 2011, NUCL INSTRUM METH A, V649, P58, DOI 10.1016/j.nima.2010.12.242	18	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1388-2481	1873-1902		ELECTROCHEM COMMUN	Electrochem. Commun.	JAN	2015	50						93	96		10.1016/j.elecom.2014.09.015		4	Electrochemistry	Electrochemistry	AZ5KO	WOS:000348260200022		
J	Hotta, K; Imai, K; Yamaguchi, Y; Kawata, N; Tanaka, M; Kakushima, N; Takizawa, K; Matsubayashi, H; Ono, H				Hotta, Kinichi; Imai, Kenichiro; Yamaguchi, Yuichiro; Kawata, Noboru; Tanaka, Masaki; Kakushima, Naomi; Takizawa, Kohei; Matsubayashi, Hiroyuki; Ono, Hiroyuki			Diminutive submucosally invasive cancers of the colon and rectum	ENDOSCOPY			English	Editorial Material							EARLY COLORECTAL NEOPLASMS; EFFICACY; PATTERN; DEPTH		[Hotta, Kinichi; Imai, Kenichiro; Yamaguchi, Yuichiro; Kawata, Noboru; Tanaka, Masaki; Kakushima, Naomi; Takizawa, Kohei; Matsubayashi, Hiroyuki; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka 4118777, Japan	Hotta, K (reprint author), Shizuoka Canc Ctr, Div Endoscopy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	k.hotta@scchr.jp		Imai, Kenichiro/0000-0002-9257-5842			Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Kudo Shin-ei, 2008, Gastrointest Endosc Clin N Am, V18, P581, DOI 10.1016/j.giec.2008.05.013; SHIMODA T, 1989, CANCER, V64, P1138, DOI 10.1002/1097-0142(19890901)64:5<1138::AID-CNCR2820640529>3.0.CO;2-A	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E2	E3		10.1055/s-0034-1377400		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300002		
J	Kawakami, H; Kuwatani, M; Abe, Y; Kubota, Y; Kawakubo, K; Kubo, K; Kawahata, S; Sakamoto, N				Kawakami, Hiroshi; Kuwatani, Masaki; Abe, Yoko; Kubota, Yoshimasa; Kawakubo, Kazumichi; Kubo, Kimitoshi; Kawahata, Shuhei; Sakamoto, Naoya			Direct peroral ultraslim endoscopy-guided biliary drainage in a patient with cystic duct carcinoma and an occluded self-expandable metallic stent	ENDOSCOPY			English	Editorial Material							ACUTE CHOLANGITIS		[Kawakami, Hiroshi; Abe, Yoko; Kubota, Yoshimasa; Kubo, Kimitoshi; Kawahata, Shuhei] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 0608648, Japan; [Kuwatani, Masaki] Hokkaido Univ Hosp, Div Endoscopy, Sapporo, Hokkaido 0608648, Japan; [Kawakubo, Kazumichi; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hiropon@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Itoi T, 2008, GASTROINTEST ENDOSC, V68, P84, DOI 10.1016/j.gie.2007.11.050; Itoi T, 2008, GASTROINTEST ENDOSC, V67, P328, DOI 10.1016/j.gie.2007.09.032; Lee YN, 2013, J GASTROEN HEPATOL, V28, P739, DOI 10.1111/jgh.12105	3	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E43	E44		10.1055/s-0034-1391258		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300023		
J	Nakaji, S; Hirata, N; Shiratori, T; Kobayashi, M; Yamauchi, K				Nakaji, So; Hirata, Nobuto; Shiratori, Toshiyasu; Kobayashi, Masayoshi; Yamauchi, Kenji			Endoscopic ultrasound-guided pancreaticojejunostomy with a forward-viewing echoendoscope as a treatment for stenotic pancreaticojejunal anastomosis	ENDOSCOPY			English	Editorial Material							EUS		[Nakaji, So; Hirata, Nobuto; Shiratori, Toshiyasu; Kobayashi, Masayoshi; Yamauchi, Kenji] Kameda Med Ctr, Dept Gastroenterol, Chiba, Japan	Nakaji, S (reprint author), 929 Higashi Cho, Chiba 2968602, Japan.	nakajisou1978@yahoo.co.jp					Itoi T, 2011, GASTROINTEST ENDOSC, V73, P398, DOI 10.1016/j.gie.2010.07.010; Bataille L, 2002, GASTROINTEST ENDOSC, V55, P740, DOI 10.1067/mge.2002.123621; Kinney TP, 2009, ENDOSCOPY, V41, P898, DOI 10.1055/s-0029-1215081; Matsubayashi H, 2013, ENDOSCOPY, V45, pE435, DOI 10.1055/s-0033-1358923	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E41	E42		10.1055/s-0034-1391245		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300022		
J	Nonaka, K; Ohata, K; Ban, S; Takita, M; Matsuyama, Y; Tashima, T; Minato, Y; Matsuhashi, N				Nonaka, Kouichi; Ohata, Ken; Ban, Shinichi; Takita, Maiko; Matsuyama, Yasushi; Tashima, Tomoaki; Minato, Yohei; Matsuhashi, Nobuyuki			In vivo imaging of duodenal follicular lymphoma with confocal laser endomicroscopy	ENDOSCOPY			English	Editorial Material									[Nonaka, Kouichi; Ohata, Ken; Takita, Maiko; Matsuyama, Yasushi; Tashima, Tomoaki; Minato, Yohei; Matsuhashi, Nobuyuki] NTT Med Ctr Tokyo, Dept Gastroenterol, Tokyo 1418625, Japan; [Ban, Shinichi] Saiseikai Kawaguchi Gen Hosp, Dept Pathol, Kawaguchi, Saitama, Japan	Ohata, K (reprint author), NTT Med Ctr Tokyo, Dept Gastroenterol, Shinagawa Ku, 5-9-22 Higashi Gotanda, Tokyo 1418625, Japan.	ken.ohata1974@gmail.com					Nonaka K, 2014, DIGEST ENDOSC, V26, P604, DOI 10.1111/den.12296; Yoshino T, 2000, AM J SURG PATHOL, V24, P688, DOI 10.1097/00000478-200005000-00007; Nadal E, 2002, ANN HEMATOL, V81, P228, DOI 10.1007/s00277-002-0436-9	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E16	E17		10.1055/s-0034-1390731		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300009		
J	Ono, H; Takizawa, K; Kakushima, N; Tanaka, M; Kawata, N				Ono, Hiroyuki; Takizawa, Kohei; Kakushima, Naomi; Tanaka, Masaki; Kawata, Noboru			Application of polyglycolic acid sheets for delayed perforation after endoscopic submucosal dissection of early gastric cancer	ENDOSCOPY			English	Editorial Material									[Ono, Hiroyuki; Takizawa, Kohei; Kakushima, Naomi; Tanaka, Masaki; Kawata, Noboru] Shizuoka Canc Ctr, Endoscopy Div, Shizuoka, Japan	Ono, H (reprint author), Shimonagakubo 1007, Nagaizumi, Shizuoka, Japan.	h.ono@scchr.jp					Hanaoka N, 2010, ENDOSCOPY, V42, P1112, DOI 10.1055/s-0030-1255932; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Ikezawa K, 2012, GASTRIC CANCER, V15, P111, DOI 10.1007/s10120-011-0089-2; Sekiguchi M, 2012, WORLD J GASTROENTERO, V18, P4224, DOI 10.3748/wjg.v18.i31.4224; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739	5	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E18	E19		10.1055/s-0034-1390730		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300010		
J	Sato, H; Sato, Y; Takeuchi, M; Takahashi, K; Takeda, S; Inoue, H; Kobayashi, M				Sato, Hiroki; Sato, Yuichi; Takeuchi, Manabu; Takahashi, Kazuya; Takeda, Shin-ryu; Inoue, Haruhiro; Kobayashi, Masaaki			Salvage peroral endoscopic myotomy for esophageal diverticulum	ENDOSCOPY			English	Editorial Material									[Sato, Hiroki; Sato, Yuichi; Takeuchi, Manabu; Takahashi, Kazuya] Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Niigata 9518510, Japan; [Takeda, Shin-ryu; Kobayashi, Masaaki] Niigata Univ, Med & Dent Hosp, Div Endoscopy, Niigata 9518510, Japan; [Inoue, Haruhiro] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Tokyo, Japan	Sato, H (reprint author), Niigata Univ, Med & Dent Hosp, Div Gastroenterol, Chuo Ku, 757-1 Asahimachidori, Niigata 9518510, Japan.	pyloki@yahoo.co.jp					Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Hirano Y, 2013, SURG TODAY, V43, P1, DOI 10.1007/s00595-012-0386-3; Onwugbufor MT, 2013, J SURG RES, V184, P120, DOI 10.1016/j.jss.2013.05.036	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E14	E15		10.1055/s-0034-1390735		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300008		
J	Tsujii, Y; Kato, M; Shinzaki, S; Takigawa, A; Hayashi, Y; Nishida, T; Iijima, H; Tsujii, M; Takehara, T				Tsujii, Yoshiki; Kato, Motohiko; Shinzaki, Shinichiro; Takigawa, Atsuo; Hayashi, Yoshito; Nishida, Tsutomu; Iijima, Hideki; Tsujii, Masahiko; Takehara, Tetsuo			Polyglycolic acid sheets for repair of refractory esophageal fistula	ENDOSCOPY			English	Editorial Material							ENDOSCOPIC SUBMUCOSAL DISSECTION		[Tsujii, Yoshiki; Kato, Motohiko; Shinzaki, Shinichiro; Takigawa, Atsuo; Hayashi, Yoshito; Nishida, Tsutomu; Iijima, Hideki; Tsujii, Masahiko; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp		Nishida, Tsutomu/0000-0003-4037-9003			Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Raju GS, 2014, DIGEST ENDOSC, V26, P95, DOI 10.1111/den.12191; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739	4	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy		2015	47			SUPP. 1;			E39	E40		10.1055/s-0034-1390914		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ3YH	WOS:000348159300021		
J	Tetteh, R; Yamaguchi, M; Wada, Y; Funada, R; Izuta, T				Tetteh, Rashied; Yamaguchi, Masahiro; Wada, Yoshiharu; Funada, Ryo; Izuta, Takeshi			Effects of ozone on growth, net photosynthesis and yield of two African varieties of Vigna unguiculata	ENVIRONMENTAL POLLUTION			English	Article						Ozone; Cowpea; Growth; Net photosynthesis; Yield	STOMATAL CONDUCTANCE; PHASEOLUS-VULGARIS; TROPOSPHERIC OZONE; EQUATORIAL AFRICA; LEAF CHLOROPHYLL; ELEVATED OZONE; L.; SENSITIVITY; RESPONSES; IMPACT	To assess the effects of O-3 on growth, net photosynthesis and yield of two African varieties of cowpea (Vigna unguiculata L.), Blackeye and Asontem were exposed as potted plants to air that was either filtered to remove O-3 (FA), non-filtered air (NF), non-filtered with added O-3 of approximately 50 nL L-1 (ppb) from 11:00 to 16:00 (NF + O-3) for 88 days in open-top chambers. The mean O-3 concentration (11:00-16:00) during the exposure period had a range from 16 ppb in the FA treatment to 118 ppb in the NF + O-3 treatment. Net photosynthetic rate and leaf area per plant were significantly reduced by exposure to O-3, reducing the growth of both varieties. Exposure to O-3 significantly reduced the 100-seed weight and number of seeds per pod. As a result, cowpea yield was significantly reduced by long-term exposure to O-3, with no difference in sensitivity between the varieties. (C) 2014 Elsevier Ltd. All rights reserved.	[Tetteh, Rashied] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; [Yamaguchi, Masahiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Wada, Yoshiharu] Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; [Funada, Ryo; Izuta, Takeshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Izuta, T (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan.	izuta@cc.tuat.ac.jp	Funada, Ryo/C-2020-2013; Izuta, Takeshi/C-9404-2013		Education Program for Field-Oriented Leaders in Asia and Africa (FOLENS) of Tokyo University of Agriculture and Technology, Japan	The first author is grateful to the Education Program for Field-Oriented Leaders in Asia and Africa (FOLENS) of Tokyo University of Agriculture and Technology, Japan, for financial support. I also thank Yu Taniguchi, Eri Kubota, Lijuan Sun and Mohammed Zia Uddin Kamal for their support during the experimental period.	Addo-Quaye A. A., 2011, Journal of Agricultural and Biological Science, V6, P34; ADEPIPE NO, 1979, Z PFLANZENPHYSIOL, V93, P259; Wilkinson S, 2012, J EXP BOT, V63, P527, DOI 10.1093/jxb/err317; Uddling J, 2007, PHOTOSYNTH RES, V91, P37, DOI 10.1007/s11120-006-9077-5; Black VJ, 2000, NEW PHYTOL, V147, P421, DOI 10.1046/j.1469-8137.2000.00721.x; Salvatori E, 2013, ENVIRON EXP BOT, V87, P79, DOI 10.1016/j.envexpbot.2012.09.008; SCHULZE ED, 1987, BIOSCIENCE, V37, P30, DOI 10.2307/1310175; Bouarar I, 2011, ATMOS CHEM PHYS, V11, P13395, DOI 10.5194/acp-11-13395-2011; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Morgan PB, 2003, PLANT CELL ENVIRON, V26, P1317, DOI 10.1046/j.0016-8025.2003.01056.x; Sauvage B, 2005, ATMOS CHEM PHYS, V5, P311; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Brosche M, 2010, PLANT CELL ENVIRON, V33, P914, DOI 10.1111/j.1365-3040.2010.02116.x; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Feng ZZ, 2007, PHOTOSYNTHETICA, V45, P441, DOI 10.1007/s11099-007-0073-6; Hall A. E., 2002, CHALLENGES OPPORTUNI, P14; Hall AE, 2004, EUR J AGRON, V21, P447, DOI 10.1016/j.eja.2004.07.005; Heagle AS, 2002, J ENVIRON QUAL, V31, P2008; [黄辉 Huang Hui], 2004, [大气科学, Chinese Journal of Atmospheric Sciences], V28, P601; IPCC, 2007, CONTRIBUTION WORKING; Kasetsart University, SUBJ NAT RES ENV; Keutgen AJ, 2005, ENVIRON EXP BOT, V53, P271, DOI 10.1016/j.envexpbot.2004.04.003; Langyintuo AS, 2003, FIELD CROP RES, V82, P215, DOI 10.1016/S0378-4290(03)00039-x; Leopold A.C., 1975, PLANT GROWTH DEV, P77; Malaiyandi M, 2014, OZONE-SCI ENG, V36, P36, DOI 10.1080/01919512.2013.824817; Ministry of Food and Agriculture (MoFA), 2010, B TROP LEG; Ojanpera K, 1998, NEW PHYTOL, V138, P451, DOI 10.1046/j.1469-8137.1998.00120.x; Padulosi S., 1997, ADV COWPEA RES; Pleijel H, 2006, ENVIRON EXP BOT, V56, P63, DOI 10.1016/j.envexpbot.2005.01.004; Pottorff M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-234; Rangserodsombat J., 2010, P 48 KAS U ANN C KAS; Royal Society, 2008, 1508 ROYAL SOC, P1; Singh B.B., 2002, CHALLENGES OPPORTUNI, P3; Tingey DT, 2002, WATER AIR SOIL POLL, V139, P325, DOI 10.1023/A:1015802823398; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; Tripathi R, 2012, ECOTOX ENVIRON SAFE, V85, P1, DOI 10.1016/j.ecoenv.2012.08.012; Umponstira C., 2009, NARESUAN U J, V17, P213; Umponstira C., 2006, SONGKLANAKARIN J SCI, V28, P861; Vandermeiren K, 1995, WATER AIR SOIL POLL, V85, P1455, DOI 10.1007/BF00477186; WHO (World Health Organization), 2006, AIR QUAL GUID GLOB U; WMO, 2011, CLIM CHANG FOOD SEC; World Meteorological Organization (WMO), 2008, UNEP MMO 7ORM M 18 2; Xu H, 2009, PHOTOSYNTHETICA, V47, P247, DOI 10.1007/s11099-009-0039-y	46	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	JAN	2015	196						230	238		10.1016/j.envpol.2014.10.008		9	Environmental Sciences	Environmental Sciences & Ecology	AY4ZR	WOS:000347583900027		
J	Ohura, T; Sakakibara, H; Watanabe, I; Shim, WJ; Manage, PM; Guruge, KS				Ohura, Takeshi; Sakakibara, Hiroyuki; Watanabe, Izumi; Shim, Won Joon; Manage, Pathmalal M.; Guruge, Keerth S.			Spatial and vertical distributions of sedimentary halogenated polycyclic aromatic hydrocarbons in moderately polluted areas of Asia	ENVIRONMENTAL POLLUTION			English	Article						ClPAHs; PAHs; Elements; Sediment; Indicator	YELLOW SEA; URBAN AIR; SURFACE SEDIMENTS; PARENT COMPOUNDS; CORE SEDIMENTS; MASAN BAY; SRI-LANKA; PAHS; CHINA; CONTAMINATION	The sedimentary halogenated (chlorinated and brominated) polycyclic aromatic hydrocarbons (Cl/BrPAHs), PAHs, and elements were analyzed to investigate contamination processes and sources. Assessments were conducted in sediments from three sites: surface sediments from the Yellow Sea and sediment cores from Kandy Lake and Negombo Lagoon, Sri Lanka. Most of ClPAHs targeted were detected in all sediments. Spatial distributions of total ClPAH concentrations in the Yellow Sea showed the presence of multiple hot spots that differed from those of total PAHs. In Kandy and Negombo sediments, total ClPAH concentrations were slightly higher in surface layers than in bottom layers; the opposite trend was observed for PAHs. Principal component analysis showed that the clusters of most ClPAHs were similar to those of anthropogenically derived elements, but were far from those of PAHs. Consequently, ClPAHs in sediments appear to be persistent contaminants, which may make them appropriate as indicators of anthropogenic sources. (C) 2014 Elsevier Ltd. All rights reserved.	[Ohura, Takeshi] Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan; [Sakakibara, Hiroyuki] Miyazaki Univ, Fac Agr, Miyazaki 8898526, Japan; [Watanabe, Izumi] Tokyo Univ Agr & Technol, United Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Shim, Won Joon] Korea Inst Ocean Sci & Technol, Oil & POPs Res Grp, Geoje Shi 656834, South Korea; [Manage, Pathmalal M.] Univ Sri Jayewardenepura, Fac Sci Appl, Nugegoda, Sri Lanka; [Guruge, Keerth S.] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Pathol & Pathophysiol Res Div, Tsukuba, Ibaraki 3050856, Japan	Ohura, T (reprint author), Meijo Univ, Fac Agr, 1-501 Shiogamaguchi, Nagoya, Aichi 4688502, Japan.	ohura@meijo-u.ac.jp	Watanabe, Izumi/C-2086-2013; Ohura, Takeshi/K-8552-2013	Watanabe, Izumi/0000-0003-2319-9713; Ohura, Takeshi/0000-0002-0204-175X	Ministry of Education, Culture, Sports, Science and Technology [23310011, 26340015]	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research (B) (No. 23310011) and Scientific Research (C) (No. 26340015).	Pathiratne KAS, 2007, B ENVIRON CONTAM TOX, V79, P135, DOI 10.1007/s00128-007-9092-z; Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019; Ohura T, 2013, ATMOS ENVIRON, V81, P84, DOI 10.1016/j.atmosenv.2013.08.044; Ma J, 2013, ENVIRON SCI TECHNOL, V47, P7615, DOI 10.1021/es400338h; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Liu LY, 2012, ENVIRON POLLUT, V167, P155, DOI 10.1016/j.envpol.2012.03.038; Ball A, 2013, ENVIRON SCI POLLUT R, V20, P4311, DOI 10.1007/s11356-013-1620-2; Lima ALC, 2005, ENVIRON FORENSICS, V6, P109, DOI 10.1080/15275920590952739; Wu Y, 2001, MAR CHEM, V76, P1, DOI 10.1016/S0304-4203(01)00040-8; Boonyatumanond R, 2006, MAR POLLUT BULL, V52, P942, DOI 10.1016/j.marpolbul.2005.12.015; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Ohura T, 2009, ENVIRON SCI TECHNOL, V43, P2269, DOI 10.1021/es803633d; Khim JS, 1999, ENVIRON SCI TECHNOL, V33, P4199, DOI 10.1021/es9904484; Ohura T, 2007, THESCIENTIFICWORLDJO, V7, P372, DOI 10.1100/tsw.2007.75; Arzayus KM, 2001, ENVIRON SCI TECHNOL, V35, P2178, DOI 10.1021/es001672s; Suzuki Y, 2007, CHEMOSPHERE, V68, P1270, DOI 10.1016/j.chemosphere.2007.01.053; BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628; Horii Y, 2009, ARCH ENVIRON CON TOX, V57, P651, DOI 10.1007/s00244-009-9372-1; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Ohura T, 2005, ENVIRON SCI TECHNOL, V39, P85, DOI 10.1021/es040433s; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451; Horii Y, 2008, ENVIRON SCI TECHNOL, V42, P1904, DOI 10.1021/es703001f; Ohura T, 2008, ENVIRON SCI TECHNOL, V42, P3296, DOI 10.1021/es703068n; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; WILD SR, 1995, ENVIRON POLLUT, V88, P91, DOI 10.1016/0269-7491(95)91052-M; Mastral AM, 2000, ENVIRON SCI TECHNOL, V34, P3051, DOI 10.1021/es001028d; Sun JL, 2013, CHEMOSPHERE, V90, P1751, DOI 10.1016/j.chemosphere.2012.10.094; Kitazawa A, 2006, ENVIRON SCI TECHNOL, V40, P4592, DOI 10.1021/es0602703; Wu Y, 2003, MAR POLLUT BULL, V46, P619, DOI 10.1016/S0025-326X(03)00035-3; Pereira WE, 1996, MAR ENVIRON RES, V41, P299, DOI 10.1016/0141-1136(95)00021-6; Barakat A.O., 2012, SOIL SEDIMENT CONTAM, V22, P315; Guerra R, 2012, WATER AIR SOIL POLL, V223, P85, DOI 10.1007/s11270-011-0841-6; Guruge KS, 2011, MAR POLLUT BULL, V62, P870, DOI 10.1016/j.marpolbul.2011.01.024; Guruge KS, 2007, MAR POLLUT BULL, V54, P1667, DOI 10.1016/j.marpolbul.2007.05.021; Hu J, 2008, J ENVIRON SCI HEAL A, V43, P382, DOI 10.1080/10934520701795582; Jeong KS, 2006, GEOSCI J, V10, P445, DOI 10.1007/BF02910438; Jiao WT, 2012, ENVIRON GEOCHEM HLTH, V34, P445, DOI 10.1007/s10653-011-9445-8; Leipe T, 2005, MAR POLLUT BULL, V50, P446, DOI 10.1016/j.marpolbul.2004.11.049; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039690; Mikac I, 2011, CHEMOSPHERE, V84, P1140, DOI 10.1016/j.chemosphere.2011.04.027; Ohura T, 2013, ENV CHEM SUSTAIN WOR, V3, P449, DOI 10.1007/978-94-007-6836-9_10; Sun JL, 2011, J ENVIRON MONITOR, V13, P2775, DOI 10.1039/c1em10465a; Zhang P, 2009, J ENVIRON SCI-CHINA, V21, P1080, DOI 10.1016/S1001-0742(08)62385-2	44	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	JAN	2015	196						331	340		10.1016/j.envpol.2014.10.028		10	Environmental Sciences	Environmental Sciences & Ecology	AY4ZR	WOS:000347583900039		
J	Matyssek, R; Baumgarten, M; Hummel, U; Haberle, KH; Kitao, M; Wieser, G				Matyssek, R.; Baumgarten, M.; Hummel, U.; Haeberle, K. -H.; Kitao, M.; Wieser, G.			Canopy-level stomatal narrowing in adult Fagus sylvatica under O-3 stress - Means of preventing enhanced O-3 uptake under high O-3 exposure?	ENVIRONMENTAL POLLUTION			English	Article						Ozone dose; Fagus sylvatica; Growing season; Stomata; Canopy conductance	FREE-AIR FUMIGATION; SAP FLOW MEASUREMENTS; OZONE UPTAKE; FOREST TREES; BETULA-PENDULA; GAS-EXCHANGE; BEECH TREES; CARBON SINK; SITE CONDITIONS; RISK-ASSESSMENT	Spatio-temporally consistent O-3 doses are demonstrated in adult Fagus sylvatica from the Kranzberg Forest free-air fumigation experiment, covering cross-canopy and whole-seasonal scopes through sap flow measurement. Given O-3-driven closure of stomata, we hypothesized enhanced whole-tree level O-3 influx to be prevented under enhanced O-3 exposure. Although foliage transpiration rate was lowered under twice-ambient O-3 around noon by 30% along with canopy conductance, the hypothesis was falsified, as O-3 influx was raised by 25%. Nevertheless, the twice-ambient/ambient ratio of O-3 uptake was smaller by about 20% than that of O-3 exposure, suggesting stomatal limitation of uptake. The O-3 response was traceable from leaves across branches to the canopy, where peak transpiration rates resembled those of shade rather than sun branches. Rainy/overcast-day and nightly O-3 uptake is quantified and discussed. Whole-seasonal canopy-level validation of modelled with sap flow-derived O-3 flux becomes available in assessing O-3 risk for forest trees. (C) 2014 Elsevier Ltd. All rights reserved.	[Matyssek, R.; Baumgarten, M.; Hummel, U.; Haeberle, K. -H.] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany; [Kitao, M.] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Wieser, G.] Fed Res & Training Ctr Forests Nat Hazards & Land, Dept Alpine Timberline Ecophysiol, A-6020 Innsbruck, Austria	Matyssek, R (reprint author), Tech Univ Munich, von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	matyssek@wzw.tum.de			"Deutsche Bundesstiftung Umwelt" (DBU)	The financial support by "Deutsche Bundesstiftung Umwelt" (DBU) of Dr. Ursula Hummel is gratefully acknowledged. Gratefully acknowledged is the technical assistance by Dipl.-Ing Thomas Feuerbach, Peter Kub,Josef Heckmeier and Ilse Suess.	Ader H.J., 2008, ADVISING RES METHODS, P572; Mills G, 2011, ATMOS ENVIRON, V45, P5064, DOI 10.1016/j.atmosenv.2011.06.009; Matyssek R, 2010, ENVIRON POLLUT, V158, P1990, DOI 10.1016/j.envpol.2009.11.033; Wieser G, 2003, ENVIRON POLLUT, V126, P5, DOI 10.1016/S0269-7491(03)00184-2; Kitao M, 2009, ENVIRON POLLUT, V157, P537, DOI 10.1016/j.envpol.2008.09.016; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Pretzsch H, 2010, ENVIRON POLLUT, V158, P1061, DOI 10.1016/j.envpol.2009.07.035; Matyssek R, 2003, PROG BOT, V64, P349; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; MATYSSEK R, 1995, TREE PHYSIOL, V15, P159; Karnosky DF, 2007, PLANT BIOLOGY, V9, P181, DOI 10.1055/s-2006-955915; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.arplant.40.1.503; Musselman RC, 2006, ATMOS ENVIRON, V40, P1869, DOI 10.1016/j.atmosenv.2005.10.064; Paoletti E, 2010, ENVIRON POLLUT, V158, P2664, DOI 10.1016/j.envpol.2010.04.024; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Cermak J, 2004, TREES-STRUCT FUNCT, V18, P529, DOI 10.1007/s00468-004-0339-6; GRANIER A, 1985, ANN SCI FOREST, V42, P193, DOI 10.1051/forest:19850204; Matyssek R, 2007, ENVIRON POLLUT, V146, P587, DOI 10.1016/j.envpol.2006.11.011; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Kitao M, 2012, ENVIRON POLLUT, V166, P108, DOI 10.1016/j.envpol.2012.03.014; Monks PS, 2009, ATMOS ENVIRON, V43, P5268, DOI 10.1016/j.atmosenv.2009.08.021; Nunn AJ, 2005, ENVIRON POLLUT, V137, P494, DOI 10.1016/j.envpol.2005.01.036; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Matyssek R, 2004, ATMOS ENVIRON, V38, P2271, DOI 10.1016/j.atmosenv.2003.09.078; Kostner B, 2008, FLORA, V203, P14, DOI 10.1016/j.flora.2007.09.001; Winwood J, 2007, PLANT BIOLOGY, V9, P265, DOI 10.1055/s-2006-924564; Matyssek R, 2010, ENVIRON POLLUT, V158, P2527, DOI 10.1016/j.envpol.2010.05.009; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Low M, 2006, TREES-STRUCT FUNCT, V20, P539, DOI 10.1007/s00468-006-0069-z; SCHULZE ED, 1985, OECOLOGIA, V66, P475, DOI 10.1007/BF00379337; Bueker P., 2012, ATMOS CHEM PHYS, V12, P5537, DOI DOI 10.5194/ACP-12-5537-2012; Burger H., 1950, Mitteilungen der Schweizerischen Anstalt fur das forstliche Versuchswesen, V26, P419; Derwent RG, 2004, ATMOS ENVIRON, V38, P1891, DOI 10.1016/j.atmosenv.2004.01.008; Fowler D., 2008, GROUND LEVEL OZONE 2, P132; Grote R, 2004, TREES-STRUCT FUNCT, V18, P596, DOI 10.1007/s00468-004-0352-9; Gruenhage L., 2012, TREES-STRUCT FUNCT, V26, P1713; Gruenhage L., 2000, Environmental Pollution, V109, P373; Grunhage L, 2013, DEV ENVIRONM SCI, V13, P251, DOI 10.1016/B978-0-08-098349-3.00012-8; Haeberle K.H., 2012, ECOL STUD, V220, P243; Hammel K., 2001, CHARAKERISIERUNG ANA; Hoshika Y., 2014, ENVIRON POLLUT, V196, P527; Hoshika Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039270; Keating TJ, 2004, HANDB ENVIRON CHEM, V4, P295; Kolb TE, 2001, ENVIRON POLLUT, V115, P373, DOI 10.1016/S0269-7491(01)00228-7; LRTAP Convention, 2010, MAPP MAN 2004 MAN ME; Matyssek R, 2014, PLANT ECOPHYSIOL, V9, P117, DOI 10.1007/978-94-017-9100-7_7; Matyssek R, 2012, ECOL STUD-ANAL SYNTH, V220, P433, DOI 10.1007/978-3-642-30645-7_19; Matyssek R, 2009, EUR J FOREST RES, V128, P579, DOI 10.1007/s10342-008-0243-5; Matyssek R, 2007, PLANT BIOLOGY, V9, P163, DOI 10.1055/s-2007-964883; Matyssek Rainer, 1995, P255; Niwa Y, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017474; Nunn AJ, 2007, ENVIRON POLLUT, V146, P629, DOI 10.1016/j.envpol.2006.06.015; Nunn AJ, 2010, ENVIRON POLLUT, V158, P2014, DOI 10.1016/j.envpol.2009.11.034; Nunn AJ, 2002, PHYTON-ANN REI BOT A, V42, P105; Onandia G, 2011, ENVIRON POLLUT, V159, P2350, DOI 10.1016/j.envpol.2011.06.001; Pretzsch H, 1998, FORSTWISS CENTRALBL, V117, P241, DOI 10.1007/BF02832979; Reiter IM, 2005, OECOLOGIA, V146, P337, DOI 10.1007/s00442-005-0146-9; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI 10.1016/B978-012505290-0/50024-7; SAURER M, 1995, OECOLOGIA, V103, P397, DOI 10.1007/BF00328677; Uddling J, 2009, TREE PHYSIOL, V29, P1367, DOI 10.1093/treephys/tpp070; Wagg S, 2013, ENVIRON POLLUT, V175, P82, DOI 10.1016/j.envpol.2012.11.027; Waring R.H., 2007, FOREST ECOSYSTEMS AN, P420; Werner H, 2002, ENVIRON SCI POLLUT R, V9, P117, DOI 10.1007/BF02987458; WIESER G, 1993, TREES-STRUCT FUNCT, V7, P227; WIESER G, 1995, TREE PHYSIOL, V15, P253; Wieser G., 2008, ITALIAN J AGRONOMY, V1, P34; Wipfler P, 2005, PLANT BIOLOGY, V7, P611, DOI 10.1055/s-2005-872871; Wittmann C, 2007, ENVIRON POLLUT, V150, P258, DOI 10.1016/j.envpol.2007.01.013	70	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	JAN	2015	196						518	526		10.1016/j.envpol.2014.06.029		9	Environmental Sciences	Environmental Sciences & Ecology	AY4ZR	WOS:000347583900063		
J	Hoshika, Y; Watanabe, M; Kitao, M; Haberle, KH; Grams, TEE; Koike, T; Matyssek, R				Hoshika, Yasutomo; Watanabe, Makoto; Kitao, Mitsutoshi; Haeberle, Karl-Heinz; Grams, Thorsten E. E.; Koike, Takayoshi; Matyssek, Rainer			Ozone induces stomatal narrowing in European and Siebold's beeches: A comparison between two experiments of free-air ozone exposure	ENVIRONMENTAL POLLUTION			English	Review						Tropospheric ozone; European beech (Fagus sylvatica L.); Siebold's beech (Fagus crenata); Stomatal narrowing; O-3 FACE	FAGUS-SYLVATICA L.; OPEN-TOP CHAMBERS; ADULT BEECH; FOREST TREES; GAS-EXCHANGE; BETULA-PENDULA; CLIMATE-CHANGE; WITHIN-CANOPY; MATURE TREES; ELEVATED CO2	Stomata tend to narrow under ozone (O-3) impact, leading to limitation of stomatal O-3 influx. Here, we review stomatal response under recently conducted free-air O-3 exposure experiments on two species of the same tree genus: Fagus sylvatica at Kranzberg Forest (Germany) and F. crenata at Sapporo Experimental Forest (Japan). Both beeches exhibited reduction in stomatal conductance (g(s)) by 10-20% under experimentally enhanced O-3 regimes throughout the summer relative to ambient-air controls. Stomatal narrowing occurred, in early summer, in the absence of reduced carboxylation capacity of Rubisco, although photosynthetic net CO2 uptake rate temporarily reflected restriction to some minor extent. Observed stomatal narrowing was, however, diminished in autumn, suggesting gradual loss of stomatal regulation by O-3. Monotonic decline in g(s) with cumulative O-3 exposure or flux in current modeling concepts appear to be unrealistic in beech. (C) 2014 Elsevier Ltd. All rights reserved.	[Hoshika, Yasutomo; Koike, Takayoshi] Hokkaido Univ, Sapporo, Hokkaido 0608689, Japan; [Watanabe, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan; [Kitao, Mitsutoshi] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Haeberle, Karl-Heinz; Grams, Thorsten E. E.; Matyssek, Rainer] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany	Koike, T (reprint author), Hokkaido Univ, Sapporo, Hokkaido 0608689, Japan.	hoshika0803@gmail.com; tkoike@for.agr.hokudai.ac.jp; matyssek@wzw.tum.de	Watanabe, Makoto/B-7464-2015; 	Watanabe, Makoto/0000-0003-2328-3990; Hoshika, Yasutomo/0000-0002-5263-2945	Environment Research & Technology Development Fund of Japan [B-1105]; Japanese Society for Promotion of Science [23380078, 26292075, 24710027, 24780239]; European Commission - Research Directorate-General, Environment Programme, "Natural Resources Management and Services" [EVK2-2002-00165]; German Research Foundation (DFG) [SFB 607]	We thank Dr. Manuela Baumgarten for providing ozone data at Kranzberg Forest. We are grateful for financial support by the Environment Research & Technology Development Fund of Japan (B-1105) and for a Grant-in-aid from the Japanese Society for Promotion of Science (Type B 23380078, 26292075, Young Scientists B 24710027 and ditto B 24780239, and Young Scientists for research abroad). Outcome from Kranzberg Forest/Germany was based on the CASIROZ project ("The carbon sink strength of beech in a changing environment: Experimental risk assessment by mitigation of chronic ozone impact") which was supported by the European Commission - Research Directorate-General, Environment Programme, "Natural Resources Management and Services" (EVK2-2002-00165, Ecosystem Vulnerability). In addition, research was supported by the German Research Foundation (DFG) through SFB 607 "Growth and Parasite Defense - Competition for Resources in Economic Plants from Agronomy and Forestry". The support also by these two funding sources is gratefully acknowledged.	Matyssek R, 2010, ENVIRON POLLUT, V158, P1990, DOI 10.1016/j.envpol.2009.11.033; Schafer KVR, 2000, PLANT CELL ENVIRON, V23, P365, DOI 10.1046/j.1365-3040.2000.00553.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121; Kitao M, 2009, ENVIRON POLLUT, V157, P537, DOI 10.1016/j.envpol.2008.09.016; Paoletti E, 2005, ENVIRON POLLUT, V134, P439, DOI 10.1016/j.envpol.2004.09.011; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Reich PB, 1987, TREE PHYSIOL, V3, P63; Watanabe M, 2013, ENVIRON POLLUT, V174, P50, DOI 10.1016/j.envpol.2012.11.006; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Pretzsch H, 2010, ENVIRON POLLUT, V158, P1061, DOI 10.1016/j.envpol.2009.07.035; Low M, 2007, PLANT BIOLOGY, V9, P197, DOI 10.1055/s-2006-924656; Matyssek R, 2003, PROG BOT, V64, P349; Paakkonen E, 1997, ENVIRON POLLUT, V95, P37, DOI 10.1016/S0269-7491(96)00113-3; Karnosky DF, 2007, PLANT BIOLOGY, V9, P181, DOI 10.1055/s-2006-955915; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Collins WJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014187; Karlsson P, 2007, ENVIRON POLLUT, V146, P608, DOI 10.1016/j.envpol.2006.06.012; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Grams TEE, 1999, NEW PHYTOL, V144, P95, DOI 10.1046/j.1469-8137.1999.00486.x; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; HANSON PJ, 1994, TREE PHYSIOL, V14, P1351; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Matyssek R, 2007, ENVIRON POLLUT, V146, P587, DOI 10.1016/j.envpol.2006.11.011; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Hoshika Y, 2012, ENVIRON POLLUT, V166, P152, DOI 10.1016/j.envpol.2012.03.013; Matyssek R, 1999, WATER AIR SOIL POLL, V116, P199, DOI 10.1023/A:1005267214560; Nunn AJ, 2005, ENVIRON POLLUT, V137, P494, DOI 10.1016/j.envpol.2005.01.036; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Watanabe M, 2010, LANDSC ECOL ENG, V6, P181, DOI 10.1007/s11355-009-0095-2; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Matyssek R, 2010, ENVIRON POLLUT, V158, P2527, DOI 10.1016/j.envpol.2010.05.009; Overmyer K, 2008, PLANT CELL ENVIRON, V31, P1237, DOI 10.1111/j.1365-3040.2008.01837.x; Warren CR, 2007, ENVIRON EXP BOT, V59, P130, DOI 10.1016/j.envexpbot.2005.11.004; Dumont J, 2014, PLANT CELL ENVIRON, V37, P2064, DOI 10.1111/pce.12293; Fang JY, 2006, J BIOGEOGR, V33, P1804, DOI 10.1111/j.1365-2699.2006.01533.x; Serengil Y, 2011, IFOREST, V4, P44, DOI 10.3832/ifor0566-004; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Low M, 2006, TREES-STRUCT FUNCT, V20, P539, DOI 10.1007/s00468-006-0069-z; Felzer B, 2004, TELLUS B, V56, P230, DOI 10.1111/j.1600-0889.2004.00097.x; Bortier K, 2000, NEW PHYTOL, V146, P271, DOI 10.1046/j.1469-8137.2000.00633.x; FARAGE PK, 1995, PHOTOSYNTH RES, V43, P11, DOI 10.1007/BF00029457; FURUKAWA A, 1990, TREES-STRUCT FUNCT, V4, P191; Gerosa G, 2008, ENVIRON POLLUT, V152, P274, DOI 10.1016/j.envpol.2007.06.045; Gessler A, 2009, TREE PHYSIOL, V29, P1349, DOI 10.1093/treephys/tpp066; Grams TEE, 2007, PLANT CELL ENVIRON, V30, P1023, DOI 10.1111/j.1365-3040.2007.01696.x; Grams TEE, 2011, TREES-STRUCT FUNCT, V25, P187, DOI 10.1007/s00468-010-0497-7; Grams TEE, 2010, ENVIRON POLLUT, V158, P1036, DOI 10.1016/j.envpol.2009.08.037; Haberle KH, 2012, ECOL STUD-ANAL SYNTH, V220, P243, DOI 10.1007/978-3-642-30645-7_11; Heagle AS, 2002, J ENVIRON QUAL, V31, P2008; Heath R.L., 1997, FOREST DECLINE OZONE, V127, P317; Herbinger K, 2005, ENVIRON POLLUT, V137, P476, DOI 10.1016/j.envpol.2005.01.034; Hoshika Y, 2013, ANN BOT-LONDON, V112, P1149, DOI 10.1093/aob/mct166; Hoshika Y, 2012, WATER AIR SOIL POLL, V223, P3893, DOI 10.1007/s11270-012-1158-9; Hoshika Y, 2013, ENVIRON POLLUT, V182, P242, DOI 10.1016/j.envpol.2013.07.033; Jehnes S, 2007, PLANT BIOLOGY, V9, P253, DOI 10.1055/s-2006-924650; Karriosky D., 2003, AIR POLLUTION GLOBAL; Kohno Y, 2005, Plant Responses to Air Pollution and Global Change, P243, DOI 10.1007/4-431-31014-2_27; Koike T., 1988, PLANT SPEC BIOL, V3, P77, DOI 10.1111/j.1442-1984.1988.tb00173.x; Kolb TE, 1997, ENVIRON POLLUT, V98, P195, DOI 10.1016/S0269-7491(97)00132-2; Kolb TE, 2001, ENVIRON POLLUT, V115, P373, DOI 10.1016/S0269-7491(01)00228-7; Kozovits AR, 2005, GLOBAL CHANGE BIOL, V11, P1387, DOI 10.1111/j.1365-2486.2005.00993.x; Kozovits AR, 2005, NEW PHYTOL, V167, P181, DOI 10.1111/j.1469-8137.2005.01391.x; LETHIEC D, 1994, NEW PHYTOL, V128, P671; Luedemann G, 2005, PLANT BIOLOGY, V7, P640, DOI 10.1055/s-2005-872902; Luedemann G, 2009, PLANT SOIL, V323, P47, DOI 10.1007/s11104-009-9945-9; Maier-Maercker U, 1989, TREES-STRUCT FUNCT, V3, P57; Matyssek R., 2014, ENVIRON POLLUT, V196, P518; Matyssek R, 2007, PLANT BIOLOGY, V9, P163, DOI 10.1055/s-2007-964883; Matyssek R., 2014, TREES CHANGING ENV E; McAinsh MR, 2002, NEW PHYTOL, V153, P441, DOI 10.1046/j.0028-646X.2001.00336.x; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; Mills G., 2010, MAPPING MANUAL 2004; Nabeshima E, 2008, ECOL RES, V23, P281, DOI 10.1007/s11284-007-0374-z; Nunn AJ, 2002, PHYTON-ANN REI BOT A, V42, P105; Nussbaum S, 2000, ENVIRON POLLUT, V109, P463, DOI 10.1016/S0269-7491(00)00049-X; Oksanen E, 2003, PLANT CELL ENVIRON, V26, P875, DOI 10.1046/j.1365-3040.2003.01020.x; Oksanen E, 2007, PLANT BIOLOGY, V9, P191, DOI 10.1055/s-2006-924176; Omasa K., 2002, AIR POLLUTION PLANT; OMASA K, 1990, Journal of Agricultural Meteorology, V45, P251; Paoletti E, 2005, ENVIRON POLLUT, V137, P483, DOI 10.1016/j.envpol.2005.01.035; PEARSON M, 1993, NEW PHYTOL, V123, P351, DOI 10.1111/j.1469-8137.1993.tb03745.x; Pons T. L., 2008, PLANT PHYSL ECOLOGY; Pretzsch H, 1998, FORSTWISS CENTRALBL, V117, P241, DOI 10.1007/BF02832979; Pritsch K, 2005, PLANT BIOLOGY, V7, P718, DOI 10.1055/s-2005-872972; REILING K, 1995, NEW PHYTOL, V129, P587, DOI 10.1111/j.1469-8137.1995.tb03026.x; Reiter IM, 2005, OECOLOGIA, V146, P337, DOI 10.1007/s00442-005-0146-9; Schulze E.D., 1982, ENCY PLANT ECOLOGY B, V12B, P182; Steppe K, 2011, TREE PHYSIOL SER, V4, P235, DOI 10.1007/978-94-007-1242-3_9; Terashima I., 2002, PHOTOSYNTHESIS, P125; Torsethaugen G., 1999, P NATL ACAD SCI USA, V96, P12577; Watanabe M, 2014, ENVIRON POLLUT, V184, P682, DOI 10.1016/j.envpol.2013.04.018; Watanabe Makoto, 2005, Journal of Agricultural Meteorology, V60, P1105; WEBER JA, 1993, TREE PHYSIOL, V13, P157; Werner H, 2002, ENVIRON SCI POLLUT R, V9, P117, DOI 10.1007/BF02987458; Wittmann C, 2007, ENVIRON POLLUT, V150, P258, DOI 10.1016/j.envpol.2007.01.013; Yamaguchi Masahiro, 2011, Asian Journal of Atmospheric Environment, V5, P65	99	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	JAN	2015	196						527	533		10.1016/j.envpol.2014.07.034		7	Environmental Sciences	Environmental Sciences & Ecology	AY4ZR	WOS:000347583900064		
J	Nirmalkar, J; Deb, MK; Deshmukh, DK; Tsai, YI; Verma, SK				Nirmalkar, Jayant; Deb, Manas K.; Deshmukh, Dhananjay K.; Tsai, Ying I.; Verma, Santosh K.			Molecular markers in ambient aerosol in the Mahanadi Riverside Basin of eastern central India during winter	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Biomass burning; Anhydrosugars; Sugars; Oxalic acid; Temporal variation; Correlation analysis	BIOMASS BURNING SMOKE; CHROMATOGRAPHY-MASS SPECTROMETRY; ATMOSPHERIC PARTICULATE MATTER; MIDCHAIN KETOCARBOXYLIC ACIDS; ORGANIC-COMPOUNDS PRESENT; LONG-RANGE TRANSPORT; DICARBOXYLIC-ACIDS; CHEMICAL-CHARACTERIZATION; ALPHA-DICARBONYLS; SEASONAL-VARIATIONS	Organic molecular markers are important atmospheric constituents. Their formation and sources are important aspects of the study of urban and rural air quality. We collected PM10 aerosol samples from the Mahanadi Riverside Basin (MRB), a rural part of eastern central India, during the winter of 2011. PM10 aerosols were characterized for molecular markers using ion chromatography. The concentration of PM10 ranged from 208.8 to 588.3 mu g m(-3) with a mean concentration of 388.9 mu g m(-3). Total concentration of anhydrosugars, sugar alcohols, primary sugars, and oxalate were found to be 3.25, 5.60, 10.52, and 0.37 mu g m(-3), respectively, during the study period. Glucose was the most abundant species followed by levoglucosan and mannitol. Significant positive correlation between the molecular markers, anhydrosugars, sugar alcohols, primary sugars, and oxalic acid confirmed that biomass burning, biogenic activity, and re-suspension of soil particles were the main sources of aerosol in the eastern central India study area.	[Nirmalkar, Jayant; Deb, Manas K.] Pt Ravishankar Shukla Univ, Sch Studies Chem, Raipur 492010, Madhya Pradesh, India; [Deshmukh, Dhananjay K.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Tsai, Ying I.] Chia Nan Univ Pharm & Sci, Dept Environm Resources Management, Tainan 71710, Taiwan; [Verma, Santosh K.] State Forens Sci Lab, Raipur 492010, Madhya Pradesh, India	Tsai, YI (reprint author), Chia Nan Univ Pharm & Sci, Dept Environm Resources Management, Tainan 71710, Taiwan.	mtsaiyi@mail.chna.edu.tw			National Science Council of Taiwan [NSC 99-2221-E-041-014-MY3, NSC 102-2221-E-041-003-MY3]	The authors are grateful to Head, School of Studies in Chemistry and School of Studies in Pharmacy, Pt. Ravishankar Shukla University Raipur, Chhattisgarh, India, for providing necessary laboratory support. The authors are also thankful to Department of Agro Meteorology, Indira Gandhi Agricultural University, Raipur (CG)-492 006 for providing meteorological data. We also gratefully thank the National Science Council of Taiwan (Grant Nos. NSC 99-2221-E-041-014-MY3 and NSC 102-2221-E-041-003-MY3) for financial support of this research.	Alier M, 2014, ENVIRON SCI POLLUT R, P1; Hennigan CJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043088; Sharma M, 2005, ATMOS ENVIRON, V39, P6015, DOI 10.1016/j.atmosenv.2005.04.041; Fu PQ, 2011, GEOCHEM J, V45, P297; Pietrogrande MC, 2013, ATMOS ENVIRON, V75, P279, DOI 10.1016/j.atmosenv.2013.04.023; Chang CH, 2013, AEROSOL AIR QUAL RES, V13, P474, DOI 10.4209/aaqr.2012.06.0150; Tiwari S, 2009, J ATMOS CHEM, V62, P193, DOI 10.1007/s10874-010-9148-z; Srivastava A, 2012, ENVIRON SCI POLLUT R, V19, P1144, DOI 10.1007/s11356-011-0633-y; Amodio M, 2012, ENVIRON SCI POLLUT R, V19, P3132, DOI 10.1007/s11356-012-0804-5; Jung JS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014339; Lelieveld J, 2001, SCIENCE, V291, P1031, DOI 10.1126/science.1057103; Tsai YI, 2010, ATMOS ENVIRON, V44, P3708, DOI 10.1016/j.atmosenv.2010.06.030; Agarwal S, 2010, ATMOS CHEM PHYS, V10, P5839, DOI 10.5194/acp-10-5839-2010; Medeiros PM, 2006, ATMOS ENVIRON, V40, P1694, DOI 10.1016/j.atmosenv.2005.11.001; Wan ECH, 2007, ENVIRON SCI TECHNOL, V41, P2459, DOI 10.1021/es062390g; Kawamura K, 2005, ATMOS ENVIRON, V39, P1945, DOI 10.1016/j.atmosenv.2004.12.014; Gao S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002324; Engling G, 2011, TELLUS B, V63, P117, DOI 10.1111/j.1600-0889.2010.00512.x; Kundu S, 2010, J AEROSOL SCI, V41, P118, DOI 10.1016/j.jaerosci.2009.08.006; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; Medeiros PM, 2007, J CHROMATOGR A, V1141, P271, DOI 10.1016/j.chroma.2006.12.017; Engling G, 2009, AEROSOL SCI TECH, V43, P662, DOI 10.1080/02786820902825113; Fu PQ, 2010, ATMOS CHEM PHYS, V10, P2663; Bencardino MM, 2014, ENVIRON SCI POLLUT R, V21, P4044, DOI 10.1007/s11356-013-2196-6; Simoneit BRT, 1999, ATMOS ENVIRON, V33, P173, DOI 10.1016/S1352-2310(98)00145-9; Karar K, 2006, ATMOS RES, V81, P36, DOI 10.1016/j.atmosres.2005.11.003; KAWAMURA K, 1993, ENVIRON SCI TECHNOL, V27, P2227, DOI 10.1021/es00047a033; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Godri KJ, 2010, ENVIRON SCI TECHNOL, V44, P8295, DOI 10.1021/es1016284; Pio CA, 2008, ATMOS ENVIRON, V42, P7530, DOI 10.1016/j.atmosenv.2008.05.032; Jacobson MC, 2000, REV GEOPHYS, V38, P267, DOI 10.1029/1998RG000045; Cheng MT, 2000, SCI TOTAL ENVIRON, V263, P101, DOI 10.1016/S0048-9697(00)00670-7; KAWAMURA K, 1987, ENVIRON SCI TECHNOL, V21, P105, DOI 10.1021/es00155a014; Simoneit BRT, 1999, ENVIRON SCI POLLUT R, V6, P159, DOI 10.1007/BF02987621; Graham B, 2004, ATMOS ENVIRON, V38, P1593, DOI 10.1016/j.atmosenv.2003.12.015; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Nirmalkar J, 2013, B ENVIRON CONTAM TOX, V90, P434, DOI 10.1007/s00128-012-0938-7; Hoffmann D, 2010, ENVIRON SCI TECHNOL, V44, P694, DOI 10.1021/es902476f; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Muller K, 2005, ATMOS ENVIRON, V39, P4219, DOI 10.1016/j.atmosenv.2005.02.008; Pietrogrande MC, 2011, ENVIRON POLLUT, V159, P1861, DOI 10.1016/j.envpol.2011.03.023; Kundu S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013973; Fu PQ, 2009, ENVIRON SCI TECHNOL, V43, P4022, DOI 10.1021/es803669a; Kundu S, 2010, ATMOS CHEM PHYS, V10, P2209; Pavagadhi S, 2013, ENVIRON SCI POLLUT R, V20, P2569, DOI 10.1007/s11356-012-1157-9; Schkolnik G, 2005, ENVIRON SCI TECHNOL, V39, P2744, DOI 10.1021/es048363c; Nolte CG, 2001, ENVIRON SCI TECHNOL, V35, P1912, DOI 10.1021/es001420r; Ravindra K, 2003, J ENVIRON MONITOR, V5, P260, DOI 10.1039/b211943a; Bauer H, 2008, ATMOS ENVIRON, V42, P588, DOI 10.1016/j.atmosenv.2007.10.013; Kerminen VM, 1999, ATMOS ENVIRON, V33, P2089, DOI 10.1016/S1352-2310(98)00350-1; Fu PQ, 2012, ATMOS ENVIRON, V55, P234, DOI 10.1016/j.atmosenv.2012.02.061; Wang GH, 2012, ENVIRON SCI TECHNOL, V46, P4783, DOI 10.1021/es204322c; Wang ZZ, 2009, ATMOS ENVIRON, V43, P3096, DOI 10.1016/j.atmosenv.2009.03.012; Kerminen VM, 2000, J AEROSOL SCI, V31, P349, DOI 10.1016/S0021-8502(99)00063-4; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Zhang ZS, 2010, ATMOS ENVIRON, V44, P3187, DOI 10.1016/j.atmosenv.2010.05.024; Chakraborty A, 2010, AEROSOL AIR QUAL RES, V10, P433, DOI 10.4209/aaqr.2009.11.0071; Yttri KE, 2007, ATMOS CHEM PHYS, V7, P4267; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Medeiros PM, 2008, ENVIRON SCI TECHNOL, V42, P8310, DOI 10.1021/es801533b; Deshmukh DK, 2010, J ATMOS CHEM, V66, P81, DOI 10.1007/s10874-011-9194-1; Li YC, 2005, ENVIRON SCI TECHNOL, V39, P7616, DOI 10.1021/es050896d; Kawamura K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014299; Deshmukh DK, 2012, AEROSOL AIR QUAL RES, V12, P683, DOI 10.4209/aaqr.2012.02.0040; Zhang YN, 2012, ENVIRON SCI POLLUT R, V19, P244, DOI 10.1007/s11356-011-0548-7; Yao XH, 2004, ATMOS ENVIRON, V38, P963, DOI 10.1016/j.atmosenv.2003.10.048; Tsai YI, 2013, ATMOS ENVIRON, V78, P93, DOI 10.1016/j.atmosenv.2012.09.040; Fraser MP, 2000, ENVIRON SCI TECHNOL, V34, P4560, DOI 10.1021/es991229l; Fu PQ, 2009, ENVIRON SCI TECHNOL, V43, P286, DOI 10.1021/es803046q; Fabbri D, 2009, ATMOS ENVIRON, V43, P2286, DOI 10.1016/j.atmosenv.2009.01.030; Warneck P, 2003, ATMOS ENVIRON, V37, P2423, DOI 10.1016/S1352-2310(03)00136-5; Xie MJ, 2010, SCI TOTAL ENVIRON, V408, P5452, DOI 10.1016/j.scitotenv.2010.07.029; Hegde P, 2012, ATMOS CHEM PHYS, V12, P6645, DOI 10.5194/acp-12-6645-2012; Chen SJ, 2013, AEROSOL AIR QUAL RES, V13, P649, DOI 10.4209/aaqr.2012.07.0176; Bracero OLM, 2002, J GEOPHYS RES, V107, P59; Burshtein N, 2011, ATMOS CHEM PHYS, V11, P829, DOI 10.5194/acp-11-829-2011; Carvalho A, 2003, ATMOS ENVIRON, V37, P1775, DOI 10.1016/S1352-2310(03)00066-9; Chowdhury Z, 2012, AEROSOL AIR QUAL RES, V12, P463, DOI 10.4209/aaqr.2011.10.0161; Das M, 2006, ENVIRON MONIT ASSESS, V122, P111, DOI 10.1007/s10661-005-9168-3; Fu PQ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009900; Giri B, 2013, ATMOS RES, V120, P312, DOI 10.1016/j.atmosres.2012.09.016; Graham B., 2002, J GEOPHYS RES, V107, P1; Graham B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003990; Ho KF, 2011, ATMOS CHEM PHYS, V11, P2197, DOI 10.5194/acp-11-2197-2011; Hsieh LY, 2009, ATMOS ENVIRON, V43, P4396, DOI 10.1016/j.atmosenv.2009.04.034; Hsieh LY, 2008, ATMOS ENVIRON, V42, P6836, DOI 10.1016/j.atmosenv.2008.05.021; Jolly A, 2010, ATMOS ENVIRON, V44, P4325; KAWAMURA K, 1990, J ATMOS CHEM, V11, P107, DOI 10.1007/BF00053670; Lin CH, 2008, AEROSOL AIR QUAL RES, V8, P233; Maenhaut W, 2012, SCI TOTAL ENVIRON, V437, P226, DOI 10.1016/j.scitotenv.2012.08.015; Miyazaki Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011790; Mochida M, 2003, J GEOPHYS RES-ATMOS, V108, DOI [10.1029/2002JD002355, 10.1029/2002JD003249]; Pachauri T, 2013, ENVIRON SCI POLLUT R, V20, P5737, DOI 10.1007/s11356-013-1584-2; Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7; Sanders EB, 2003, J ANAL APPL PYROL, V66, P29, DOI 10.1016/S0165-2370(02)00104-3; Seinfeld J.H., 1998, ATMOSPHERIC CHEM PHY, P1326; Sempere R, 2003, GLOBAL BIOGEOCHEM CY, V17, P2; Simoneit BRT, 2004, ENVIRON SCI TECHNOL, V38, P5939, DOI 10.1021/es0403099; Sullivan AP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010216; Vecchi R, 2008, ATMOS ENVIRON, V42, P1121, DOI 10.1016/j.atmosenv.2007.10.047; Vicente A, 2011, ATMOS ENVIRON, V45, P5172, DOI 10.1016/j.atmosenv.2011.06.021; Wang G, 2010, ATMOS CHEM PHYS, V10, P6087, DOI 10.5194/acp-10-6087-2010; Wang GH, 2002, ATMOS ENVIRON, V36, P1941, DOI 10.1016/S1352-2310(02)00180-2; Watson J. G., 2005, AEROSOL AIR QUAL RES, V5, P65; Whitman T, 2011, ENVIRON SCI TECHNOL, V45, P3687, DOI 10.1021/es103301k	108	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	JAN	2015	22	2					1220	1231		10.1007/s11356-014-3416-4		12	Environmental Sciences	Environmental Sciences & Ecology	AZ2EM	WOS:000348047400046		
J	Kuwano, H; Nishimura, Y; Oyama, T; Kato, H; Kitagawa, Y; Kusano, M; Shimada, H; Takiuchi, H; Toh, Y; Doki, Y; Naomoto, Y; Matsubara, H; Miyazaki, T; Muto, M; Yanagisawa, A				Kuwano, Hiroyuki; Nishimura, Yasumasa; Oyama, Tsuneo; Kato, Hiroyuki; Kitagawa, Yuko; Kusano, Motoyasu; Shimada, Hideo; Takiuchi, Hiroya; Toh, Yasushi; Doki, Yuichiro; Naomoto, Yoshio; Matsubara, Hisahiro; Miyazaki, Tatsuya; Muto, Manabu; Yanagisawa, Akio			Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society	ESOPHAGUS			English	Article						Clinical guidelines; Esophagus; Neoplasm			[Kuwano, Hiroyuki; Miyazaki, Tatsuya] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan; [Nishimura, Yasumasa] Kinki Univ, Fac Med, Dept Radiat Oncol, Osaka, Japan; [Oyama, Tsuneo] Saku Cent Hosp, Dept Gastroenterol, Nagano, Japan; [Kato, Hiroyuki] Dokkyo Med Univ, Dept Surg 1, Mibu, Tochigi, Japan; [Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Kusano, Motoyasu] Gunma Univ Hosp, Dept Endoscopy & Endoscop Surg, Maebashi, Gunma, Japan; [Shimada, Hideo] Tokai Univ, Dept Surg, Oiso Hosp, Oiso, Kanagawa, Japan; [Takiuchi, Hiroya] Osaka Med Coll, Ctr Canc Chemotherapy, Takatsuki, Osaka 569, Japan; [Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Naomoto, Yoshio] Kawasaki Med Univ, Dept Gen Surg, Okayama, Japan; [Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Muto, Manabu] Kyoto Univ, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Yanagisawa, Akio] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Surg Pathol, Kyoto, Japan	Kuwano, H (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	hkuwano@gunma-u.ac.jp			Japan Esophageal Society; Ministry of Health, Labour and Welfare Scientific Research; Taiho Pharmaceutical CO., LTD.; Chugai Pharmaceutical CO., LTD.; Kyowa Hakko Kirin CO., LTD.; Merck Serono CO., LTD.; Ono Pharmaceutical CO., LTD.; Novartis Pharma CO., LTD.; Yakult Honsha CO., LTD.; Bristol-Myers Squibb Daiichi Sankyo CO., LTD.; Shionogi CO., LTD.; Terumo Corporation; Torii Pharmaceutical Co., Ltd.; AstraZeneca CO., LTD.	Funds to support the development of these guidelines were provided by the Japan Esophageal Society and the Ministry of Health, Labour and Welfare Scientific Research (Study on the appropriate development and publication of guidelines for the diagnosis and treatment while maintaining full disclosure: Hirata's study group). Prof. Kitagawa has received grants from Taiho Pharmaceutical CO., LTD., Chugai Pharmaceutical CO., LTD., Kyowa Hakko Kirin CO., LTD., Merck Serono CO., LTD., Ono Pharmaceutical CO., LTD., Novartis Pharma CO., LTD., Yakult Honsha CO., LTD., Bristol-Myers Squibb Daiichi Sankyo CO., LTD., Shionogi CO., LTD., Terumo Corporation, Torii Pharmaceutical Co., Ltd., AstraZeneca CO., LTD. Other authors have no conflict of interest to declare with profit making or nonprofit organizations or providers of medical products and medical supplies. The Ethics Committee and Administrative Board of the Japan Esophageal Society required members of the Committee to Develop Guidelines for the Treatment of Carcinoma of the Esophagus and the Guideline Evaluation Committee to self-report any potential conflict of interest.		0	3	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					1	30		10.1007/s10388-014-0465-1		30	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900001		
J	Sugiyama, S; Koide, N; Takeuchi, D; Suzuki, A; Miyagawa, S				Sugiyama, Satoshi; Koide, Naohiko; Takeuchi, Daisuke; Suzuki, Akira; Miyagawa, Shinichi			Clinicopathological characteristics and outcomes of esophageal submucosal tumors upon treatment by thoracoscopic enucleation or endoscopic follow up alone	ESOPHAGUS			English	Article						Thoracoscopic enucleation; Submucosal tumor; Esophagus	GASTROINTESTINAL STROMAL TUMORS; NEEDLE-ASPIRATION BIOPSY; LEIOMYOMA; SCHWANNOMA; PATHOLOGY; RESECTION	We compared the clinicopathological features and outcomes of patients with submucosal tumor (SMT) of the thoracic esophagus treated by thoracoscopic enucleation. Of 11 patients with endoscopically detected SMTs in the thoracic esophagus, 6 underwent thoracoscopic enucleation and were endoscopically followed up. The thoracoscopically enucleated tumors were 3 leiomyomas, 2 schwannomas, and 1 gastrointestinal stromal tumor. Five tumors were not removed surgically but showed no enlargement over 3 years (range 42-84 months); 4 of these tumors were histologically diagnosed as leiomyomas by fine-needle aspiration analysis or routine biopsy. All patients who underwent thoracoscopic enucleation had dietary symptoms preoperatively, whereas those who did not undergo it were asymptomatic. Tumor size ranged from 30 to 45 mm for the surgical cases. In cases in which preoperative endoscopic biopsy was performed, the tumors were found to be adherent to the esophageal mucosa during enucleation surgery; however, neither mucosal injury nor postoperative leakage occurred. SMTs not treated by thoracoscopic enucleation were < 15 mm in diameter and showed no enlargement over a long-term follow-up period. No differences in clinical features, excluding schwannoma and GIST, were noted between cases with and without therapeutic enucleation. Thoracoscopic enucleation is useful and safe for the removal of thoracic esophageal SMTs ranging from 30 to 50 mm in diameter. Leiomyomas of the thoracic esophagus < 20 mm in diameter may be followed up endoscopically in asymptomatic cases.	[Sugiyama, Satoshi; Takeuchi, Daisuke; Suzuki, Akira; Miyagawa, Shinichi] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan; [Koide, Naohiko] Nagano Prefectural Kiso Hosp, Dept Surg, Nagano, Japan	Sugiyama, S (reprint author), Shinshu Univ, Sch Med, Dept Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	s.sugiyama1983@gmail.com					Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Miettinen M, 2000, AM J SURG PATHOL, V24, P211, DOI 10.1097/00000478-200002000-00007; Roviaro GC, 1998, THORAX, V53, P190; DeWitt J, 2011, SURG ENDOSC, V25, P2192, DOI 10.1007/s00464-010-1522-z; Agaimy A, 2006, VIRCHOWS ARCH, V448, P288, DOI 10.1007/s00428-005-0117-x; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; von Rahden BHA, 2004, SURG ENDOSC, V18, P924, DOI 10.1007/s00464-003-9130-9; Bonavina L, 1995, J Am Coll Surg, V181, P257; Claus CMP, 2013, SURG ENDOSC, V27, P3364, DOI 10.1007/s00464-013-2918-3; Dapri G, 2010, SURG ENDOSC, V24, P215, DOI 10.1007/s00464-009-0514-3; Flercher CD, 2002, HUM PATHOL, V33, P495; Hatch GF, 2000, WORLD J SURG, V24, P401; Jiang G, 2009, DIS ESOPHAGUS, V22, P279, DOI 10.1111/j.1442-2050.2008.00883.x; Kent M, 2007, J THORAC CARDIOV SUR, V134, P176, DOI 10.1016/j.jtcvs.2006.10.082; Koide N, 2004, DIS ESOPHAGUS, V17, P104, DOI 10.1111/j.1442-2050.2004.00364.x; Matsui M, 1998, ENDOSCOPY, V30, P750, DOI 10.1055/s-2007-1001416; Matsuki A, 2009, Dis Esophagus, V22, pE6, DOI 10.1111/j.1442-2050.2007.00712.x; Murase K, 2001, J GASTROENTEROL, V36, P772, DOI 10.1007/s005350170020; Ohno M, 2000, SURG TODAY, V30, P59; Takada N, 1999, SURG ENDOSC-ULTRAS, V13, P228, DOI 10.1007/s004649900950; TAKUBO K, 1981, HUM PATHOL, V12, P1006, DOI 10.1016/S0046-8177(81)80257-2; Tokunaga T, 2007, SURG TODAY, V37, P500, DOI 10.1007/s00595-006-3436-x; Vander Noot MR, 2004, CANCER CYTOPATHOL, V102, P157, DOI 10.1002/cncr.20360; Yamada H, 2011, J LAPAROENDOSC ADV S, V21, P635, DOI 10.1089/lap.2011.0264; Zaninotto G, 2006, SURG ENDOSC, V20, P1904, DOI 10.1007/s00464-005-0838-6; Zhu X, 2007, WORLD J GASTROENTERO, V13, P768	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					31	37		10.1007/s10388-014-0446-4		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900002		
J	Fujita, T; Daiko, H				Fujita, Takeo; Daiko, Hiroyuki			Optimal duration of prophylactic antimicrobial administration and risk of postoperative infectious events in thoracic esophagectomy with three-field lymph node dissection: short-course versus prolonged antimicrobial administration	ESOPHAGUS			English	Article						Esophageal cancer; Esophagectomy; Surgical site infection; Prophylactic antimicrobial agent	ANTIBIOTIC-PROPHYLAXIS; SURGERY; PREVENTION; COMPLICATIONS; CARCINOMA; CANCER	For prevention of surgical site infections, the current guidelines of Center of Disease Control recommend the maintenance of therapeutic levels of prophylactic antimicrobial agents throughout operations and, at most, for a few hours after incision closure. However, in literature supporting these recommendations, most reports have described combinations of various types of surgical procedures. Consequently, the optimal duration of prophylactic antimicrobial administration in esophagectomy with three-field lymph node dissection has not been fully addressed. We randomly assigned 257 patients with esophageal cancer who underwent esophagectomy with three-field lymph node dissection into two groups and analyzed the incidences of surgical site and remote infections. Antimicrobial administration began 30 min before the skin incision was made and repeated every 3 h during the procedure in the short-course administration group, whereas additional administration was postoperatively continued the day after operation in the prolonged administration group. Among the 128/129 patients in the short-course/prolonged administration group, surgical site infections occurred in 26.5 %/24.0 % (p = 0.64), anastomotic leakage in 11.7 %/15.5 % (p = 0.37), and incisional surgical site infections in 14.8 %/8.5 % patients, respectively (p = 0.11). Remote infections occurred in 11.7 %/11.6 % (p = 0.86) patients, respectively, and the median postoperative hospital stay was 14 days (p = 0.86) in both groups. In esophagectomy with three-field lymph node dissection, short-course antimicrobial administration was sufficient for the prevention of postoperative infectious events.	[Fujita, Takeo; Daiko, Hiroyuki] Natl Canc Ctr Hosp East, Div Esophageal Surg, Kashiwa, Chiba 2770882, Japan	Fujita, T (reprint author), Natl Canc Ctr Hosp East, Div Esophageal Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	takfujit@east.ncc.go.jp					CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; STONE HH, 1976, ANN SURG, V184, P443, DOI 10.1097/00000658-197610000-00007; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Daiko H, 2012, SURG ENDOSC, V26, P673, DOI 10.1007/s00464-011-1934-4; Culver DH, 1991, AM J MED S3B, V91, P152; Fujita T, 2012, EUR SURG RES, V48, P79, DOI 10.1159/000336574; LEWIS RT, 1982, CAN J SURG, V25, P561; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; Neoral C, 2012, SURG INFECT, V13, P159, DOI 10.1089/sur.2011.024; NICHOLS RL, 1982, AM J SURG, V143, P94, DOI 10.1016/0002-9610(82)90136-2; NICHOLS RL, 1994, CHEST, V106, P1493, DOI 10.1378/chest.106.5.1493; Uchiyama K, 2007, HEPATO-GASTROENTEROL, V54, P1487; Uemura Y, 2006, J INFECT CHEMOTHER, V12, P257; Zhang CD, 2013, WORLD J GASTROENTERO, V19, P2104, DOI 10.3748/wjg.v19.i13.2104	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					38	43		10.1007/s10388-014-0451-7		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900003		
J	Mori, N; Fujita, H; Tanaka, T; Matono, S; Nishimura, K; Hino, H; Shirouzu, K; Komukai, S; Yanagawa, T				Mori, Naoki; Fujita, Hiromasa; Tanaka, Toshiaki; Matono, Satoru; Nishimura, Kohei; Hino, Haruhiro; Shirouzu, Kazuo; Komukai, Shou; Yanagawa, Takashi			Gastric tube ulcer after esophagectomy	ESOPHAGUS			English	Article						Gastric tube ulcer; Esophagectomy; Risk factor	POSTOPERATIVE RADIOTHERAPY; 3-FIELD LYMPHADENECTOMY; CANCER; CARCINOMA; ESOPHAGUS; REPLACEMENT; STOMACH	An ulcer occasionally develops in the gastric tube as an esophageal substitute after esophagectomy. The aim of the present study was to investigate the risk factors for a gastric tube ulcer. We reviewed the medical records of all 826 patients who underwent esophageal reconstruction using a gastric tube following esophagectomy, in Kurume University Hospital between 1985 and 2010. Potential risk factors for a gastric tube ulcer were investigated by comparing the clinical characteristics between patients with a gastric tube ulcer and those without, using a multivariate logistic regression model. Among the 826 patients, 30 patients (3.6 %) developed a gastric tube ulcer. In 19 cases without any signs or symptoms, the ulcer was found using upper endoscopy. In the other 11 patients, there were symptoms including hematemesis, chest pain, and/or abdominal pain. In 3 cases, the patient developed a severe complication from the ulceration such as perforation. Of these 3 cases, one patient died of massive bleeding from the left brachiocephalic vein. The multivariate analysis revealed that (1) a past history of a peptic ulcer, and (2) the period of treatment (meaning the more recent period after the introduction of systematic prevention and treatment for a gastric tube ulcer) were the only two risk factors for a gastric tube ulcer (p < 0.0001, and p = 0.033, respectively). Systematic prevention and treatment for a gastric tube ulcer including follow-up endoscopy, proton pump inhibitors administration according to 24-h pH monitoring, eradication of H. pylori, and others may decrease the incidence of a gastric tube ulcer. In particular, for patients with a past history of a peptic ulcer, the subcutaneous route of esophageal reconstruction is recommended to prevent fatal complications.	[Mori, Naoki; Fujita, Hiromasa; Tanaka, Toshiaki; Matono, Satoru; Nishimura, Kohei; Hino, Haruhiro; Shirouzu, Kazuo] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 8300023, Japan; [Komukai, Shou; Yanagawa, Takashi] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 8300023, Japan	Mori, N (reprint author), Kurume Univ, Sch Med, Dept Surg, 67 Asahi Machi, Kurume, Fukuoka 8300023, Japan.	mori1118@med.kurume-u.ac.jp					AIKO S, 1993, J CLIN GASTROENTEROL, V17, pS161, DOI 10.1097/00004836-199312001-00028; Ajao O G, 1977, J Natl Med Assoc, V69, P655; Akiyama H, 1990, SURGERY CANCER ESOPH, P54; FOK M, 1993, SURGERY, V113, P138; WANG LS, 1992, ANN THORAC SURG, V53, P289; Lerut T, 2004, ANN SURG, V240, P962, DOI 10.1097/01.sla.0000145925.70409.d7; FUJITA H, 1995, ANN SURG, V222, P654, DOI 10.1097/00000658-199511000-00008; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Gutschow C, 2001, ANN SURG, V233, P509, DOI 10.1097/00000658-200104000-00005; Koide N, 2001, J GASTROEN HEPATOL, V16, P137, DOI 10.1046/j.1440-1746.2001.02415.x; Maier A, 2001, HEPATO-GASTROENTEROL, V48, P899; Matono S, 2001, J JPN SURG ASS, V62, P1441; Motoyama S, 2003, HEPATO-GASTROENTEROL, V50, P666; OI M, 1963, AM J SURG, V106, P49, DOI 10.1016/0002-9610(63)90190-9; Okamoto N, 2004, ANN THORAC SURG, V77, P1189, DOI 10.1016/j.athoracsur.2003.09.071; Oki E, 2011, SURG TODAY, V41, P966, DOI 10.1007/s00595-010-4402-1; SHIMA I, 1991, JPN J SURG, V21, P96, DOI 10.1007/BF02470872; Ubukata H, 2011, SURG TODAY, V41, P612, DOI 10.1007/s00595-010-4476-9; UCHIDA Y, 1987, JPN J SURG, V17, P190, DOI 10.1007/BF02470598; Yamaguchi H, 2011, ESOPHAGUS-TOKYO, V8, P137, DOI 10.1007/s10388-011-0275-7; Yasuda T, 2012, DIS ESOPHAGUS, V25, P687, DOI 10.1111/j.1442-2050.2011.01309.x	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					44	49		10.1007/s10388-014-0453-5		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900004		
J	Yamashita, H; Ashida, K; Kawaguchi, S; Fukuchi, T; Nagatani, Y; Hasegawa, T; Koga, H; Eguchi, T; Ubukata, S; Tanaka, T; Ito, D				Yamashita, Hiroshi; Ashida, Kiyoshi; Kawaguchi, Shinpei; Fukuchi, Takumi; Nagatani, Yoshiaki; Hasegawa, Takashi; Koga, Hideaki; Eguchi, Takaaki; Ubukata, Satoshi; Tanaka, Toshio; Ito, Dai			The pathogenesis of persistent non-erosive reflux disease treated with proton-pump inhibitors as measured with the Symptom Index	ESOPHAGUS			English	Article						Nonerosive reflux disease (NERD); Combined multichannel intraluminal impedance-pH; Monitoring (MII-pH); High-resolution manometry (HRM); Symptom Index (SI)	INTRALUMINAL IMPEDANCE TECHNOLOGY; REDUCE GASTROESOPHAGEAL-REFLUX; CLINICAL CHARACTERISTICS; ESOPHAGEAL MOTILITY; AGONIST BACLOFEN; PH-METRY; OMEPRAZOLE; ACID; NERD; EPIDEMIOLOGY	Non-erosive reflux disease (NERD) includes a heterogeneous patient group with varying clinical and pathophysiological characteristics. This study aims to elucidate the pathogenesis of persistent NERD despite of continuous proton-pump inhibitors (PPI) treatment using 24-h combined multichannel intraluminal impedance-pH monitoring (MII-pH). We enrolled fifty-four consecutive Japanese patients with typical gastroesophageal reflux disease symptoms, despite treatment with 10-mg rabeprazole twice daily. All patients underwent upper endoscopy, esophageal high-resolution manometry (HRM), and 24-h MII-pH monitoring. Twenty-nine (53.7 %) of the patients had a positive and 25 (46.3 %) had a negative Symptom Index (SI). The number of mean reflux episodes over 24 h in an upright position was significantly greater in the SI-positive than the SI-negative group. The majority of episodes were non-acid reflux, while the proportion of proximal reflux episodes consisting of non-acid, liquid or mixed components were significantly greater in the SI-positive group in comparison to the SI-negative group (50.4 vs. 33.1 %, P < 0.001, 46.1 vs. 32.3 %, P < 0.001, 54.4 vs. 40.9 %, P < 0.001, respectively). The SI-positive group had a higher rate of abnormal motility as measured by HRM. Reflux reaching the proximal esophagus and defective esophageal motility play key roles in the pathogenesis of NERD. The majority of PPI-resistant NERD patients showed no association with acid reflux. The SI patterns suggest that NERD patients are a heterogeneous group. Therefore, therapy may be tailored to each patient according to SI patterns.	[Yamashita, Hiroshi; Ashida, Kiyoshi; Kawaguchi, Shinpei; Fukuchi, Takumi; Nagatani, Yoshiaki; Hasegawa, Takashi; Koga, Hideaki; Eguchi, Takaaki; Ubukata, Satoshi; Tanaka, Toshio; Ito, Dai] Saiseikai Nakatsu Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Osaka 5300012, Japan	Yamashita, H (reprint author), Saiseikai Nakatsu Hosp, Dept Gastroenterol & Hepatol, Kita Ku, 2-10-39 Shibata, Osaka 5300012, Japan.	onakaryoko0310@gmail.com					Adachi K, 2003, J GASTROEN HEPATOL, V18, P1392, DOI 10.1046/j.1440-1746.2003.03190.x; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Modlin IM, 2009, DIGESTION, V80, P74, DOI 10.1159/000219365; Furuta T, 2011, J GASTROENTEROL, V46, P1273, DOI 10.1007/s00535-011-0446-2; Fass R, 2007, J CLIN GASTROENTEROL, V41, P131, DOI 10.1097/01.mcg.0000225631.07039.6d; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; Zhang Q, 2002, GUT, V50, P19, DOI 10.1136/gut.50.1.19; WIENER GJ, 1988, AM J GASTROENTEROL, V83, P358; WEUSTEN BLAM, 1994, GASTROENTEROLOGY, V107, P1741; Iwakiri K, 2010, DIGESTION, V82, P156, DOI 10.1159/000309483; Tamhankar AP, 2004, J GASTROINTEST SURG, V8, P890, DOI 10.1016/j.gassur.2004.08.001; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Savarino E, 2012, J GASTROENTEROL, V47, P159, DOI 10.1007/s00535-011-0480-0; Emerenziani S, 2009, NEUROGASTROENT MOTIL, V21, P253, DOI 10.1111/j.1365-2982.2008.01203.x; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1053/S1542-3565(04)00288-5; Savarino E, 2008, AM J GASTROENTEROL, V103, P2685, DOI 10.1111/j.1572-0241.2008.02119.x; Bhat YM, 2006, EUR J GASTROEN HEPAT, V18, P263, DOI 10.1097/00042737-200603000-00006; Blondeau R., 2010, NEUROGASTROENT MOTIL, V22, P836; Chen CL, 2014, J GASTROEN HEPATOL, V29, P296, DOI 10.1111/jgh.12367; Ciccaglione AF, 2003, GUT, V52, P464, DOI 10.1136/gut.52.4.464; Fass R, 2003, AM J GASTROENTEROL, V98, pS2, DOI 10.1016/S0002-9270(03)00009-1; Frazzoni M, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12080; Frazzoni M, 2011, ALIMENT PHARM THER, V33, P601, DOI 10.1111/j.1365-2036.2010.04550.x; Kahrilas PJ, 1996, JAMA-J AM MED ASSOC, V276, P983, DOI 10.1001/jama.276.12.983; Karamanolis G, 2008, NEUROGASTROENT MOTIL, V20, P291, DOI 10.1111/j.1365-2982.2007.01028.x; KASAPIDIS P, 1993, AM J GASTROENTEROL, V88, P1893; MaColl E, 2005, AM J GASTROENTEROL, V100, P11; Martinek J, 2008, SCAND J GASTROENTERO, V43, P794, DOI 10.1080/00365520801908928; MEDICI M, 1989, CURR MED RES OPIN, V11, P398, DOI 10.1185/03007998909110141; Orr WC, 2012, NEUROGASTROENT MOTIL, V24, P553, DOI 10.1111/j.1365-2982.2012.01900.x; Penagini R, 1998, GUT, V42, P251; Quigley EMM, 1997, QJM-MON J ASSOC PHYS, V90, P75; SENGUPTA JN, 1989, J NEUROPHYSIOL, V61, P1001; Sifrim D, 2007, ALIMENT PHARM THER, V23; Khaitan L, 2004, J GASTROINTEST SURG, V8, P897; Tsoukali Emmanouela, 2010, J Neurogastroenterol Motil, V16, P258, DOI 10.5056/jnm.2010.16.3.258; Wu JCY, 2007, CLIN GASTROENTEROL H, V5, P690, DOI 10.1016/j.cgh.2007.02.023; Zerbib F, 2008, GUT, V57, P56	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					50	56		10.1007/s10388-014-0452-6		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900005		
J	Shirakawa, Y; Noma, K; Koujima, T; Maeda, N; Tanabe, S; Ohara, T; Sakurama, K; Fujiwara, T				Shirakawa, Yasuhiro; Noma, Kazuhiro; Koujima, Takeshi; Maeda, Naoaki; Tanabe, Shunsuke; Ohara, Toshiaki; Sakurama, Kazufumi; Fujiwara, Toshiyoshi			Operative technique of antethoracic esophageal reconstruction with pedicled jejunal flap	ESOPHAGUS			English	Article						Esophageal reconstruction; Pedicled jejunal flap; Supercharge; Superdrainage	COLON INTERPOSITION; CERVICAL ESOPHAGUS; SURGICAL-MANAGEMENT; CANCER-PATIENTS; REPLACEMENT; CARCINOMA; SUPERCHARGE; HYPOPHARYNX; SURGERY; GRAFT	Esophageal reconstruction using intestine is often performed for esophageal cancer patients in cases where the stomach cannot be used. We have previously performed reconstruction using ileocolon with supercharge and drainage as our first choice in those cases. However, a less invasive, simpler, and safer reconstructive technique using jejunum without vascular anastomosis has recently become popular at our facility. This study describes the technique of esophageal reconstruction with jejunum, compares the surgical outcomes to those of standard reconstruction using ileocolon, and discusses the clinical significance of this new concept. Subjects comprised 53 patients (52 males, 1 female) who underwent esophageal reconstruction using jejunum between January 2008 and July 2013. Patient characteristics, technical details, and outcomes were compared with those of 51 subjects who had undergone esophageal reconstruction using ileocolon. When making the pedicled jejunal flap, the first jejunal vascular arcade was preserved, which in most cases allowed it to be pulled up to the cervical region by processing and transection up to the second jejunal vascular branch. The vascular anastomosis techniques were used in 80.4 % (41/51) of esophageal reconstructions using colon, compared with only 24.5 % (13/53) of reconstructions using jejunum. No difference in the frequency of postoperative adverse effects was seen between groups, but the frequency of diarrhea was significantly lower with reconstruction using jejunum. Esophageal reconstruction using jejunum with the blood vessel processing technique results in both simpler and safer pulling up. Thus the need to perform supercharge and superdrainage is reduced.	[Shirakawa, Yasuhiro; Noma, Kazuhiro; Koujima, Takeshi; Maeda, Naoaki; Tanabe, Shunsuke; Ohara, Toshiaki; Sakurama, Kazufumi; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Kita Ku, Okayama 7008558, Japan	Shirakawa, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	yasuwr@md.okayama-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; LONGMIRE WP, 1947, SURGERY, V22, P94; Blackmon SH, 2012, ANN THORAC SURG, V94, P1104, DOI 10.1016/j.athoracsur.2012.05.123; Bottger T, 1999, EUR J SURG, V165, P940; Kesler KA, 2013, ANN THORAC SURG, V95, P1162, DOI 10.1016/j.athoracsur.2013.01.006; Daiko H, 2007, J SURG ONCOL, V96, P166, DOI 10.1002/jso.20795; Triboulet JP, 2001, ARCH SURG-CHICAGO, V136, P1164, DOI 10.1001/archsurg.136.10.1164; Yasuda T, 2011, ANN THORAC CARDIOVAS, V17, P103; Mine S, 2009, ANN THORAC SURG, V88, P1647, DOI 10.1016/j.athoracsur.2009.05.081; Burgos L, 2010, J PEDIATR SURG, V45, P341, DOI 10.1016/j.jpedsurg.2009.10.065; Doki Y, 2008, DIS ESOPHAGUS, V21, P132, DOI 10.1111/j.1442-2050.2007.00738.x; Furst H, 2000, ANN SURG, V231, P173, DOI 10.1097/00000658-200002000-00004; GAISSERT HA, 1993, J THORAC CARDIOV SUR, V106, P860; Hamai Y, 2012, SURG TODAY, V42, P342, DOI 10.1007/s00595-011-0103-7; HIRABAYASHI S, 1993, SURGERY, V113, P515; Ikeguchi M, 2009, SURG TODAY, V39, P925, DOI 10.1007/s00595-008-4050-x; Iwata N, 2012, WORLD J SURG, V36, P2622, DOI 10.1007/s00268-012-1736-4; Klink CD, 2010, SURGERY, V147, P491, DOI 10.1016/j.surg.2009.10.045; Motoyama S, 2007, ANN THORAC SURG, V83, P1273, DOI 10.1016/j.athoracsur.2006.11.049; OCHSNER A, 1949, ANN OTO RHINOL LARYN, V58, P1171; Ozawa S, 2011, ESOPHAGUS-TOKYO, V8, P9, DOI 10.1007/s10388-011-0266-8; Poh M, 2011, ANN SURG, V253, P1122, DOI 10.1097/SLA.0b013e318217e875; Saeki H, 2013, DIS ESOPHAGUS, V26, P50, DOI 10.1111/j.1442-2050.2012.01327.x; Sekido M, 2003, SURGERY, V134, P420, DOI 10.1067/S0039-6060(03)00219-8; Shirakawa Y, 2006, LANGENBECK ARCH SURG, V391, P19, DOI 10.1007/s00423-005-0010-8; Shirakawa Y, 2004, LANGENBECK ARCH SURG, V389, P387, DOI 10.1007/s00423-004-0501-z; Sobin LH, 2009, TNM CLASSIFICATION M; The Japan Esophageal Society, 2008, JAP CLASS ES CANC; Yamada E, 2012, J SURG RES, V178, P700, DOI 10.1016/j.jss.2012.07.057; Yasuda T, 2011, SURG TODAY, V41, P745, DOI 10.1007/s00595-011-4513-3	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					57	64		10.1007/s10388-014-0455-3		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900006		
J	Katada, N; Shibuya, J; Ichikawa, T; Hosoda, K; Yamashita, K; Watanabe, M				Katada, Natsuya; Shibuya, Jiro; Ichikawa, Takafumi; Hosoda, Kei; Yamashita, Keishi; Watanabe, Masahiko			Morphologic characteristics of esophageal epithelium in a rat model of duodenoesophageal reflux and protective effect of lafutidine	ESOPHAGUS			English	Article						Duodenoesophageal reflux; Rat model; Lafutidine	HISTAMINE H-2-RECEPTOR ANTAGONIST; DISEASE; EPIDEMIOLOGY; NEURONS	The objectives of this study were to delineate differences in the morphologic characteristics of reflux esophagitis between a rat gastroesophageal reflux (GER) model and a duodenoesophageal reflux (DER) model and to evaluate the effects of H2-receptor antagonists on morphologic characteristics of reflux esophagitis in DER model. Wistar rats were divided into 3 groups: GER model group (Group G), DER model group (Group D), and control group (Group C). Rats in each group were sacrificed 1 or 12 weeks after surgery. Intraesophageal pH was measured, and the excised esophagus was examined macroscopically and histologically. Subgroups of rats in Group D were given famotidine (10 mg/kg) or lafutidine (30 mg/kg) orally once daily for 1 week after surgery. The rats were then sacrificed, and histological findings were compared. Intraesophageal pH was significantly lower in Group G than in Group C. At 12 weeks, the epithelium of the lower esophagus in Groups G and D was significantly thicker than that in Group C and showed remarkable hyperplastic changes in Group D. The thickness of the epithelium in Group D + famotidine did not differ significantly from that in Group D. In contrast, the epithelium was significantly thinner in Group D + lafutidine than in Group D. As a rat model of reflux esophagitis, DER causes severer damage to the esophageal epithelium, including hyperplastic changes, than does GER. Famotidine had no apparent effect on esophageal epithelial damage caused by DER, whereas lafutidine was suggested to attenuate such damage.	[Katada, Natsuya; Shibuya, Jiro; Hosoda, Kei; Yamashita, Keishi; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520380, Japan; [Ichikawa, Takafumi] Kitasato Univ, Grad Sch Med Sci, Dept Biochem Regulat, Sagamihara, Kanagawa 2520380, Japan	Katada, N (reprint author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, 2-1-1 Asamizodai, Sagamihara, Kanagawa 2520380, Japan.	katada@kitasato-u.ac.jp			Taiho Pharmaceutical Co., Ltd., Tokyo, Japan	Takafumi Ichikawa is currently receiving grants from Taiho Pharmaceutical Co., Ltd., Tokyo, Japan. The remaining authors declare no conflict of interests related to this study or publication of this report.	Akiba Y, 2010, DIGEST DIS SCI, V55, P3063, DOI 10.1007/s10620-010-1379-y; Omura N, 1999, SCAND J GASTROENTERO, V34, P948; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; Kang JY, 2004, ALIMENT PHARM THERAP, V20, P705, DOI 10.1111/j.1365-2036.2004.02165.x; Goldstein SR, 1997, CARCINOGENESIS, V18, P2265, DOI 10.1093/carcin/18.11.2265; JAMIESON JR, 1992, AM J GASTROENTEROL, V87, P1102; Fujimoto K, 2004, ALIMENT PHARM THERAP, V20, P5, DOI 10.1111/j.1365-2036.2004.02220.x; CALDWELL MTP, 1995, BRIT J SURG, V82, P657, DOI 10.1002/bjs.1800820528; Holzer P, 1998, GASTROENTEROLOGY, V114, P823, DOI 10.1016/S0016-5085(98)70597-9; Ichikawa T, 2009, MINI-REV MED CHEM, V9, P581; Katada N, 1999, DIGEST DIS SCI, V44, P301, DOI 10.1023/A:1026698232718; Miyashita T, 2013, INT J CANCER, V132, P1496, DOI 10.1002/ijc.27824; Nakano M, 2012, PHARMACOLOGY, V90, P205, DOI 10.1159/000342386; Okayama M, 2004, DIGEST DIS SCI, V49, P1696, DOI 10.1023/B:DDAS.0000043389.96490.76; Saegusa Y, 2008, SCAND J GASTROENTERO, V43, P531, DOI 10.1080/00365520701811693; STOKER DL, 1991, GUT, V32, P1090, DOI 10.1136/gut.32.10.1090; Umeda M, 1999, J GASTROEN HEPATOL, V14, P859, DOI 10.1046/j.1440-1746.1999.01976.x	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					65	72		10.1007/s10388-014-0457-1		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900007		
J	Kubota, K; Okada, A; Kuroda, J; Yoshida, M; Horiguchi, Y; Origuchi, N; Obitsu, Y; Kitajima, M				Kubota, Keisuke; Okada, Akihiro; Kuroda, Junko; Yoshida, Masashi; Horiguchi, Yuta; Origuchi, Nobuto; Obitsu, Yukio; Kitajima, Masaki			Utility of transjejunostomal endoscopy following bypass surgery for refractory esophageal ulceration after thoracic aortic aneurysm operation in a patient with Marfan's syndrome	ESOPHAGUS			English	Article						Refractory esophageal ulceration; Bypass surgery; Thoracic aortic aneurysm; Marfan's syndrome; Transjejunostomal endoscopy	ISOPERISTALTIC GASTRIC TUBE; STENT-GRAFT PLACEMENT; AORTOESOPHAGEAL FISTULA; BARRETTS ULCER; KIRSCHNER OPERATION; DUODENAL-ULCERS; PERFORATION; CYSTEAMINE; RATS; CANCER	Refractory esophageal ulcerations occur rarely after cardiovascular surgery, occasionally leading to perforation. There is little consensus on their optimal management. Herein, we present a case of refractory esophageal ulceration after cardiovascular surgery. A 62-year-old woman with Marfan's syndrome was referred to our hospital with cardiac failure due to aortic regurgitation. She underwent root replacement by the modified Bentall method. Refractory esophageal ulceration developed 3 months later and persisted for 3 months despite conservative therapy. With the patient's informed consent, Kirschner bypass surgery was performed. A jejunostomy using a 20 Fr. Nelaton catheter was made in the Roux-en-Y loop of the jejunum for postoperative endoscopy. The postoperative course was uneventful and transjejunostomal endoscopy revealed excellent healing of the ulceration. Esophageal bypass surgery and transjejunostomal endoscopy were very effective in this patient with refractory esophageal ulceration.	[Kubota, Keisuke; Okada, Akihiro; Kuroda, Junko; Yoshida, Masashi; Kitajima, Masaki] Int Univ Hlth & Welf, Mita Hosp, Dept Surg Gastroenterol, Minato Ku, Tokyo 1088329, Japan; [Horiguchi, Yuta; Origuchi, Nobuto; Obitsu, Yukio] Int Univ Hlth & Welf, Mita Hosp, Dept Vasc Surg, Tokyo 1088329, Japan	Kubota, K (reprint author), Int Univ Hlth & Welf, Mita Hosp, Dept Surg Gastroenterol, Minato Ku, Mita 1-4-3, Tokyo 1088329, Japan.	kubota@iuhw.ac.jp					Ishiguro T, 2010, INTERNAL MED, V49, P1957, DOI 10.2169/internalmedicine.49.3667; DEMEESTER TR, 1988, ANN SURG, V208, P460, DOI 10.1097/00000658-198810000-00008; Czerny M, 2005, ANN THORAC SURG, V80, P1117, DOI 10.1016/j.athoracsur.2004.02.136; Eggebrecht H, 2009, JACC-CARDIOVASC INTE, V2, P570, DOI 10.1016/j.jcin.2009.03.010; Chan YC, 2009, EUR J CARDIO-THORAC, V35, P365, DOI 10.1016/j.ejcts.2008.09.049; Chandrashekar G, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-12; Cseke L, 1997, Acta Chir Hung, V36, P49; Guillem P, 2003, DIS ESOPHAGUS, V16, P259, DOI 10.1046/j.1442-2050.2003.00339.x; Guillem PG, 2000, ANN THORAC SURG, V69, P1707, DOI 10.1016/S0003-4975(00)01310-2; Heimlich H J, 1970, Ann Thorac Surg, V10, P203; Jin LX, 2008, DIGEST DIS SCI, V53, P2878, DOI 10.1007/s10620-008-0385-9; Kijima M, 1987, MED J, V34, P405; MANNELL A, 1982, ANN ROY COLL SURG, V64, P256; Nakamura T, 2007, J GASTROEN HEPATOL, V22, P749, DOI 10.1111/j.1440-1746.2006.04353.x; Nakamura T, 2008, DIGEST DIS SCI, V53, P2422, DOI 10.1007/s10620-007-0159-9; Nigro JJ, 2002, ANN THORAC SURG, V73, P302, DOI 10.1016/S0003-4975(01)02757-6; POSTLETHWAIT RW, 1979, ANN SURG, V189, P673, DOI 10.1097/00000658-197906000-00001; Roeher H D, 1981, World J Surg, V5, P543; Whooley BP, 2002, ARCH SURG-CHICAGO, V137, P1228, DOI 10.1001/archsurg.137.11.1228; YAMAGISH.M, 1970, ARCH SURG-CHICAGO, V100, P689	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					73	76		10.1007/s10388-013-0406-4		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900008		
J	Tachibana, T; Orita, Y; Fujisawa, M; Hiramatsu, Y; Ogawara, Y; Matsuyama, Y; Abe, I; Uchino, K; Morishita, H; Nobuhisa, T; Uesaka, K; Nishizaki, K				Tachibana, Tomoyasu; Orita, Yorihisa; Fujisawa, Masayoshi; Hiramatsu, Yasushi; Ogawara, Yuya; Matsuyama, Yuko; Abe, Iku; Uchino, Kaori; Morishita, Hirofumi; Nobuhisa, Tetsuji; Uesaka, Koichi; Nishizaki, Kazunori			Diffuse large B-cell lymphoma of the thyroid which caused esophageal fistula	ESOPHAGUS			English	Article						Thyroid; Diffuse large B-cell lymphoma; Esophageal fistula	TRACHEOESOPHAGEAL FISTULA; TUBERCULOSIS; INFARCTION; PATIENT	We describe a rare case of thyroidal Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly (EBV(+)DLBCLe) in which diagnosis was difficult and spontaneous esophageal fistula developed. A 79-year-old woman presented with acute swelling of the anterior neck with tenderness, general fatigue, and continual fever. Malignant lymphoma of the thyroid was suspected. Histologically, the thyroid lesion showed extensive necrosis, including a few Ziehl-Neelsen-positive substances. No evidence of tuberculosis was detected by any other examinations. While performing examinations, left recurrent nerve palsy and a tumorous lesion in the pharynx appeared. Computed tomography and gastrointestinal fiberscopy revealed esophageal fistula. Biopsy specimens from the pharyngeal lesion showed diffuse proliferation of large atypical lymphoid cells that were strongly positive for CD20 and EBV early RNAs. The final diagnosis was thyroidal EBV(+)DLBCLe with infiltration of surrounding organs. The esophageal fistula had healed 6 months after beginning treatment of EBV(+)DLBCLe.	[Tachibana, Tomoyasu; Ogawara, Yuya; Matsuyama, Yuko; Abe, Iku] Himeji Red Cross Hosp, Dept Otolaryngol, Himeji, Hyogo 6708540, Japan; [Tachibana, Tomoyasu] Himeji Red Cross Hosp, Dept Otolaryngol Head & Neck Surg, Himeji, Hyogo 6708540, Japan; [Orita, Yorihisa; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008530, Japan; [Fujisawa, Masayoshi; Uchino, Kaori] Himeji Red Cross Hosp, Dept Pathol, Himeji, Hyogo 6708540, Japan; [Hiramatsu, Yasushi; Morishita, Hirofumi; Uesaka, Koichi] Himeji Red Cross Hosp, Dept Internal Med, Himeji, Hyogo 6708540, Japan; [Nobuhisa, Tetsuji] Himeji Red Cross Hosp, Dept Surg, Himeji, Hyogo 6708540, Japan	Tachibana, T (reprint author), Himeji Red Cross Hosp, Dept Otolaryngol Head & Neck Surg, 12-1 Shimoteno,1 Cho Me, Himeji, Hyogo 6708540, Japan.	tomoyasutachibana@hotmail.co.jp					Aerts S, 2009, ACTA CHIR BELG, V109, P805; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Hoeller S, 2010, HUM PATHOL, V41, P352, DOI 10.1016/j.humpath.2009.07.024; Gan YJ, 2002, AM J PATHOL, V160, P781, DOI 10.1016/S0002-9440(10)64900-0; Chang CY, 2013, DRUG DES DEV THER, V7, P53, DOI 10.2147/DDDT.S39247; Chen CY, 2012, EUR J CLIN MICROBIOL, V31, P1059, DOI 10.1007/s10096-011-1407-7; Das DK, 2009, ACTA CYTOL, V53, P571, DOI 10.1159/000325386; EMERY P, 1980, J LARYNGOL OTOL, V94, P553, DOI 10.1017/S0022215100089246; Hosoya Y, 2004, DIS ESOPHAGUS, V17, P266, DOI 10.1111/j.1442-2050.2004.00401.x; Jaremko JL, 2007, AUSTRALAS RADIOL, V51, pB193, DOI 10.1111/j.1440-1673.2007.01791.x; MELNYK A, 1995, THORAX, V50, P1120, DOI 10.1136/thx.50.10.1120; Nickel Barbara J, 2012, Med Health R I, V95, P300; PERRY RR, 1989, SURGERY, V105, P770; Rau AR, 2003, DIAGN CYTOPATHOL, V29, P222, DOI 10.1002/dc.10229; Swerdlow S, 2008, WHO CLASSIFICATION T; Takahashi Tsutomu, 2010, J Clin Exp Hematop, V50, P59; Tas A, 2005, J LARYNGOL OTOL, V119, P54; The Treatment Committee of the Japanese Society for Tuberculosis, 2011, KEKKAKU, V86, P29	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					77	81		10.1007/s10388-013-0408-2		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900009		
J	Izumo, W; Ota, M; Narumiya, K; Shirai, Y; Kudo, K; Yamamoto, M				Izumo, Wataru; Ota, Masaho; Narumiya, Kosuke; Shirai, Yushi; Kudo, Kenji; Yamamoto, Masakazu			Esophageal metastasis of renal cancer 10 years after nephrectomy	ESOPHAGUS			English	Article						Renal cancer; Esophageal metastasis; Surgery	CELL CARCINOMA	The patient was a 65-year-old man, who had undergone right nephrectomy for renal cancer in 2002. At that time, histopathological examination revealed clear cell carcinoma (pT3a, pN0, M0, and pStage III). Postoperatively, he received natural interferon alpha (6 million units 3 times a week) from November 2002 to February 2005, and showed no evidence of recurrence. However, he noticed dysphagia in March 2012. Endoscopy revealed a pedunculated polypoid tumor in the mid-esophagus and biopsies were taken showing a clear cell carcinoma. Contrast-enhanced thoracoabdominal CT scanning identified a pedunculated polypoid tumor in the mid-thoracic esophagus and enlargement of a lymph node adjacent to the right main bronchus. With a diagnosis of esophageal and lymph node metastases of renal cancer, the patient underwent esophagectomy with right thoracotomy with reconstruction by a posterior mediastinal stomach tube. Postoperative histopathological examination revealed clear cell carcinoma. Because esophageal metastasis of renal cancer is extremely rare, this case is reported here together with discussions of the relevant literature.	[Izumo, Wataru; Ota, Masaho; Narumiya, Kosuke; Shirai, Yushi; Kudo, Kenji; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo 1628666, Japan	Izumo, W (reprint author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	izumo@ige.twmu.ac.jp					Antonelli Alessandro, 2005, Arch Ital Urol Androl, V77, P125; de los Monteros-Sanchez AE, 2004, HEPATO-GASTROENTEROL, V51, P163; ENG J, 1989, ANN THORAC SURG, V48, P287; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Mizobuchi S, 1997, JPN J CLIN ONCOL, V27, P410, DOI 10.1093/jjco/27.6.410; Satomi Y, 1987, Nihon Hinyokika Gakkai Zasshi, V78, P1394; Tanis PJ, 2009, BRIT J SURG, V96, P579, DOI 10.1002/bjs.6606; Tongaonkar HB, 1983, AM J GASTROENTEROL, V78, P9; Trentino P, 1997, AM J GASTROENTEROL, V92, P1381	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					91	94		10.1007/s10388-013-0411-7		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900012		
J	Desaki, R; Okumura, H; Uchikado, Y; Sasaki, K; Owaki, T; Nakajo, A; Ishigami, S; Kitajima, S; Natsugoe, S				Desaki, Ryosuke; Okumura, Hiroshi; Uchikado, Yasuto; Sasaki, Ken; Owaki, Tetsuhiro; Nakajo, Akihiro; Ishigami, Sumiya; Kitajima, Shinichi; Natsugoe, Shoji			A case of synchronous thyroid metastasis from esophageal squamous cell carcinoma	ESOPHAGUS			English	Article						Esophageal squamous cell carcinoma; Metastasis to thyroid gland	CANCER	Thyroid metastasis of esophageal cancer is rare. We report herein a case of synchronous thyroid metastasis of esophageal squamous cell carcinoma. A 54-year-old man with lower thoracic esophageal cancer and left thyroid tumor was admitted to our hospital. We diagnosed synchronous double cancer comprising esophagus squamous cell carcinoma and thyroidal papillary cancer. Simultaneous excision of both tumors after neoadjuvant chemoradiotherapy to the esophageal cancer was planned. Intraoperatively, thyroid tumor and cervical lymph nodes were pathologically diagnosed as metastases of esophageal cancer. We then converted the treatment strategy to perform total thyroidectomy, merging excision of the larynx and trachea with construction of an eternal trachea aperture without lymphadenectomy and esophagectomy, followed by chemoradiotherapy and chemotherapy. The patient has remained alive as of 18 months after neoadjuvant chemoradiotherapy. We recommend that once synchronous thyroid metastasis of esophageal squamous cell carcinoma has been confirmed, multimodal treatment should be taken into consideration.	[Desaki, Ryosuke; Okumura, Hiroshi; Uchikado, Yasuto; Sasaki, Ken; Owaki, Tetsuhiro; Nakajo, Akihiro; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med, Dept Digest Surg & Breast & Thyroid Surg, Kagoshima 8908520, Japan; [Kitajima, Shinichi] Kagoshima Univ, Grad Sch Med, Dept Human Pathol, Field Oncol, Kagoshima 8908520, Japan	Okumura, H (reprint author), Kagoshima Univ, Grad Sch Med, Dept Digest Surg & Breast & Thyroid Surg, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	hokumura@m.kufm.kagoshima-u.ac.jp					[Anonymous], 2012, DATABASE JAPANESE SO; ELLIOTT RHE, 1960, ANN SURG, V151, P551, DOI 10.1097/00000658-196004000-00015; Willis RAW, 1931, AM J PATHOL, V7, P187; Basu S, 2005, Indian J Cancer, V42, P205; Cumbo-Nacheli G, 2007, THYROID, V17, P267, DOI 10.1089/thy.2006.0293; Hanashi Y, 1997, RINSHO GEKA, V52, P405; Inoue M, 2003, SYOKAKI GEKA, V26, P1155; Nakhjavani MK, 1997, CANCER, V79, P754; Natsugoe S, 2006, EJSO, V32, P544, DOI 10.1016/j.ejso.2006.02.014; Rosai J, 1992, TUMORS THYROID GLAND, P289; Shomaf MS, 2002, ANN SAUDI MED, V22, P224; The Japan Esophageal Society, 2008, JAP CLASS ES CANC; The Japanese Society of Thyroid Surgery, 2005, GEN RUL DESCR THYR C	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	JAN	2015	12	1					95	99		10.1007/s10388-013-0412-6		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ3LM	WOS:000348128900013		
J	Yamamoto, T; Yoshimatsu, H; Narushima, M; Yamamoto, N; Hayashi, A; Koshima, I				Yamamoto, T.; Yoshimatsu, H.; Narushima, M.; Yamamoto, N.; Hayashi, A.; Koshima, I.			Indocyanine Green Lymphography Findings in Primary Leg Lymphedema	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						Lymphedema; Primary; Idiopathic; Edema; Indocyanine green; Lymphography	LOWER-EXTREMITY-LYMPHEDEMA; LYMPHATICOVENULAR ANASTOMOSIS; MR LYMPHANGIOGRAPHY; CLASSIFICATION; SYSTEM; LYMPHOSCINTIGRAPHY; LYMPHOEDEMA; CELLULITIS; CANCER; LIMBS	Objectives: Indocyanine green (ICG) lymphography has been reported to be useful for the evaluation of secondary lymphedema, but no study has reported characteristic findings of ICG lymphography in primary lymphedema. This study aimed to classify characteristic ICG lymphography patterns in primary lymphedema. Methods: The study was a retrospective observational study. Thirty one primary lower extremity lymphedema (LEL) patients with a total of 62 legs were studied. ICG lymphography patterns were categorized according to the visibility of lymphatics and dermal backflow (DB) extension. Clinical demographics were compared with categorized ICG lymphography patterns. Results: All symptomatic legs showed abnormal patterns, and all asymptomatic legs showed normal patterns on ICG lymphography. Abnormal lymphographic patterns could be classified into proximal DB (PDB), distal DB (DDB), less enhancement (LE), and no enhancement (NE) patterns. There were significant differences between PDB (16 patients), DDB (6 patients), LE (4 patients), and NE patterns (5 patients) in age (37.3 +/- 18.3 vs. 61.8 +/- 19.2 vs. 50.8 +/- 27.7 vs. 29.2 +/- 18.0 years, p = .035), onset of edema (23.9 +/- 19.4 vs. 46.8 +/- 27.0 vs. 43.0 +/- 31.3 vs. 6.6 +/- 14.2 years, p = .020), laterality (bilateral; 18.8% vs. 66.7% vs. 75.0% vs. 0%, p = .016), cellulitis history (56.3% vs. 100% vs. 25.0% vs. 0%, p = .007), and LEL index (292.2 +/- 32.8 vs. 254.2 +/- 28.6 vs. 243.3 +/- 9.4 vs. 295.2 +/- 44.8, p = .016). Conclusions: ICG lymphography findings in primary lymphedema could be classified into four patterns with. different patient characteristics. (c) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.	[Yamamoto, T.; Yoshimatsu, H.; Narushima, M.; Yamamoto, N.; Hayashi, A.; Koshima, I.] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp			Takeda Science Foundation	A grant obtained from the Takeda Science Foundation covered the cost of manuscript preparation.	Akita S, 2013, PLAST RECONSTR SURG, V131, P283, DOI 10.1097/PRS.0b013e318277870f; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Unno N, 2011, LYMPHOLOGY, V44, P113; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Connell FC, 2013, CLIN GENET, V84, P303, DOI 10.1111/cge.12173; Szuba A, 2003, J NUCL MED, V44, P43; Schook CC, 2011, PLAST RECONSTR SURG, V127, P2419, DOI 10.1097/PRS.0b013e318213a218; KINMONTH JB, 1976, ANN ROY COLL SURG, V58, P278; Liu NF, 2012, EUR J VASC ENDOVASC, V44, P345, DOI 10.1016/j.ejvs.2012.06.019; Shin SU, 2013, INT J CARDIOVAS IMAG, V29, P135, DOI 10.1007/s10554-013-0332-5; WOLFE JHN, 1981, ARCH SURG-CHICAGO, V116, P1157; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Van Balkom IDC, 2002, AM J MED GENET, V112, P412, DOI 10.1002/ajmg.10707; Becker C, 2012, CLIN PLAST SURG, V39, P377, DOI 10.1016/j.cps.2012.08.001; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Baulieu F, 2013, LYMPHOLOGY, V46, P106; Bellini C, 2009, LYMPHOLOGY, V42, P36; BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91; Connell F, 2010, CLIN GENET, V77, P438, DOI 10.1111/j.1399-0004.2010.01394.x; Granzow JW, 2014, ANN SURG ONCOL, V21, P1195, DOI 10.1245/s10434-014-3518-8; International Society of Lymphology, 2013, LYMPHOLOGY, V46, P1; Keeley VL, 2008, BRIT J DERMATOL, V158, P1175, DOI 10.1111/j.1365-2133.2008.08590.x; Lee BB, 2014, INT ANGIOL; Lee BB, 2010, EUR J VASC ENDOVASC, V39, P646, DOI 10.1016/j.ejvs.2010.01.018; LEWIS JM, 1984, J PEDIATR-US, V104, P641, DOI 10.1016/S0022-3476(84)80937-3; Murdaca G, 2012, AM J MED, V125, P134, DOI 10.1016/j.amjmed.2011.06.032; Northup KA, 2003, LYMPHOLOGY, V36, P162; Notohamiprodjo M, 2012, RADIOLOGY, V264, P78, DOI 10.1148/radiol.12110229; Salgado CJ, 2009, ANN PLAS SURG, V63, P302, DOI 10.1097/SAP.0b013e31818d45aa; Suehiro Kotaro, 2014, Ann Vasc Dis, V7, P21, DOI 10.3400/avd.oa.13-00107; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2013, J VASC SURG VENOUS L, V1, P400	35	4	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1078-5884	1532-2165		EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	JAN	2015	49	1					95	102		10.1016/j.ejvs.2014.10.023		8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AZ5MK	WOS:000348264800017		
J	Tatokoro, M; Koga, F; Yoshida, S; Kihara, K				Tatokoro, Manabu; Koga, Fumitaka; Yoshida, Soichiro; Kihara, Kazunori			HEAT SHOCK PROTEIN 90 TARGETING THERAPY: STATE OF THE ART AND FUTURE PERSPECTIVE	EXCLI JOURNAL			English	Review						Hsp90 inhibitor; cancer; clinical trial; bladder cancer	INVASIVE BLADDER-CANCER; HSP90 INHIBITOR GANETESPIB; PHASE-II; BREAST-CANCER; DOSE-ESCALATION; SOLID TUMORS; OPEN-LABEL; GELDANAMYCIN; CELLS; CHEMORADIOTHERAPY	Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone that plays a role in stabilizing and activating more than 200 client proteins. It is required for the stability and function of numerous oncogenic signaling proteins that determine the hallmarks of cancer. Since the initial discovery of the first Hsp90 inhibitor in the 1970s, multiple phase II and III clinical trials of several Hsp90 inhibitors have been undertaken. This review provides an overview of the current status on clinical trials of Hsp90 inhibitors and future perspectives on novel anticancer strategies using Hsp90 inhibitors.	[Tatokoro, Manabu; Yoshida, Soichiro; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo, Japan; [Koga, Fumitaka] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo 1138677, Japan	Koga, F (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	f-koga@cick.jp					Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Jhaveri K, 2012, CLIN CANCER RES, V18, P5090, DOI 10.1158/1078-0432.CCR-11-3200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI [10.2217/fon.09.30, 10.2217/FON.09.30]; Bisht KS, 2003, CANCER RES, V63, P8984; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; WHITESELL L, 1992, CANCER RES, V52, P1721; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796; Gartner EM, 2012, BREAST CANCER RES TR, V131, P933, DOI 10.1007/s10549-011-1866-7; Jhaveri K, 2014, CLIN BREAST CANCER, V14, P154, DOI 10.1016/j.clbc.2013.12.012; Miyajima N, 2013, CANCER RES, V73, P7022, DOI 10.1158/0008-5472.CAN-13-1156; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; DEBOER C, 1970, J ANTIBIOT, V23, P442; Tatokoro M, 2012, INT J CANCER, V131, P987, DOI 10.1002/ijc.26475; Saxman SB, 1997, J CLIN ONCOL, V15, P2564; Lancet JE, 2010, LEUKEMIA, V24, P699, DOI 10.1038/leu.2009.292; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Eiseman JL, 2005, CANCER CHEMOTH PHARM, V55, P21, DOI 10.1007/s00280-004-0865-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Gandhi N, 2013, CANCER BIOL THER, V14, P347, DOI 10.4161/cbt.23626; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; HOUSSET M, 1993, J CLIN ONCOL, V11, P2150; Modi S, 2013, BREAST CANCER RES TR, V139, P107, DOI 10.1007/s10549-013-2510-5; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Koga F, 2009, ANTICANCER RES, V29, P797; Neckers L, 2014, CLIN CANCER RES, V20, P275, DOI 10.1158/1078-0432.CCR-13-2571; Sequist LV, 2010, J CLIN ONCOL, V28, P4953, DOI 10.1200/JCO.2010.30.8338; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Demetri GD, 2010, 2010 GASTR CANC S; Garon EB, 2012, J CLIN ONCOL S, V30; Goss GD, 2012, J CLIN ONCOL S, V30; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; Koga F, 2012, INT J UROL, V19, P388, DOI 10.1111/j.1442-2042.2012.02974.x; Koga F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027616; Koga F, 2008, UROLOGY, V72, P384, DOI 10.1016/j.urology.2008.03.017; Koga F, 2012, BJU INT, V109, P860, DOI 10.1111/j.1464-410X.2011.10425.x; Lee R, 2000, UROL CLIN N AM, V27, P1, DOI 10.1016/S0094-0143(05)70229-9; National Cancer Institute, 2014, SEER STAT FACT SHEET; National Cancer Institute, 2014, CLIN TRIALS SEARCH; Saif MW, 2013, CANCER CHEMOTH PHARM, V71, P1345, DOI 10.1007/s00280-013-2134-9; Sessa C, 2009, J CLIN ONCOL, V27; SHIPLEY WU, 1987, JAMA-J AM MED ASSOC, V258, P931, DOI 10.1001/jama.258.7.931; Sidera K, 2014, RECENT PAT ANTI-CANC, V9, P1; Squibb BM, 2011, PHAS 2 CLIN TRIAL IN; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Synta Pharmaceuticals, 2014, SP SYNT ANN RES FIN; Synta Pharmaceuticals, 2014, HDC PLATF; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Ying WW, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-1619; Yoshida S, 2011, CELL CYCLE, V10, P4291, DOI 10.4161/cc.10.24.18616	58	1	1	EXCLI JOURNAL MANAGING OFFICE	DORTMUND	LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY	1611-2156			EXCLI J	EXCLI J.		2015	14						48	58				11	Biology	Life Sciences & Biomedicine - Other Topics	AZ4KJ	WOS:000348189500004		
J	Sugano, K				Sugano, Kentaro			How do we manage serious gastrointestinal adverse events associated with anti-thrombotic therapy?	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Editorial Material						anti-coagulants; anti-platelet drugs; anti-thrombotic therapy; gastrointestinal bleeding; gastrointestinal ulcer; proton pump inhibitor	LOW-DOSE ASPIRIN; ANTIPLATELET THERAPY; RISK; CLOPIDOGREL; DISEASE; ANTICOAGULANT; METAANALYSIS; PREVENTION	Antithrombotic therapy (ATTs) is increasingly used worldwide for preventing primary or recurrent thrombotic events. Moreover, newer oral anti-platelet drugs and anti-coagulants have been introduced for clinical use, accelerating the number of patients under ATT. Not infrequently, these drugs are used in combination. These drugs, however, are well-known for adverse events in which gastrointestinal bleeding (GIB) is most common. Bleeding during ATT can be fatal, but even when patients survive, their prognosis is rather poor. Therefore, it is imperative to minimize such events. So far, co-prescription of proton pump inhibitor (PPI) has been documented to be the most effective in reducing upper GI injury and bleeding, though deliberate use of PPIs is required to minimize drug interaction and associated adverse events with acid suppression. In addition, we should note that PPI is not effective in preventing mid-or lower-GI injury/bleeding for which only limited evidence on preventive measures is available.	Jichi Med Univ, Dept Med, Shimotsuke, Tochigi 3290498, Japan	Sugano, K (reprint author), Jichi Med Univ, Dept Med, 3311-1 Shimotsuke, Shimotsuke, Tochigi 3290498, Japan.	sugano@jichi.ac.jp					Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Valkhoff VE, 2012, BEST PRACT RES CL GA, V26, P125, DOI 10.1016/j.bpg.2012.01.011; Chan FKL, 2012, CLIN GASTROENTEROL H, V10, P753, DOI 10.1016/j.cgh.2012.03.027; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Arroyo RC, 2012, HEART, V98, P718, DOI 10.1136/heartjnl-2012-301632; Hsu PI, 2011, GASTROENTEROLOGY, V140, P791, DOI 10.1053/j.gastro.2010.11.056; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Baron TH, 2014, CLIN GASTROENTEROL H, V12, P187, DOI 10.1016/j.cgh.2013.05.020; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Lin KJ, 2011, GASTROENTEROLOGY, V141, P71, DOI 10.1053/j.gastro.2011.03.049; Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; Collins R, 2009, LANCET, V373, P1849; García Rodríguez Luis A, 2011, Circulation, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Hayashi Y, 2009, J GASTROENTEROL, V44, P57, DOI 10.1007/s00535-008-2277-3; Kamal AK, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008076.pub2; Ng EH, 2008, AM J GASTROENTEROL, V103, P865; Nicolsky E, 2009, J AM COLL CARDIOL, V54, P1293; Serebruany VL, 2013, CARDIOLOGY, V126, P35, DOI 10.1159/000350961	20	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	JAN	2015	9	1					5	8		10.1586/17474124.2014.945913		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZU	WOS:000348034900002		
J	Chayama, K; Mitsui, F; Hayes, CN				Chayama, Kazuaki; Mitsui, Fukiko; Hayes, C. Nelson			Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						direct-acting antiviral agents; NS5A inhibitor; polymerase inhibitor; protease inhibitor; sustained viral response	GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; CHRONIC HCV INFECTION; TREATMENT-EXPERIENCED PATIENTS; DIRECT-ACTING ANTIVIRALS; ONCE-DAILY SIMEPREVIR; PROTEASE INHIBITOR; PEGYLATED INTERFERON; RIBAVIRIN THERAPY	Treatment of chronic hepatitis C virus infection has substantially improved following the advent of direct acting antiviral (DAA) agents. Although the first generation protease inhibitors telaprevir and boceprevir improved sustained viral response (SVR) rates, adverse events remain severe and immature termination of the therapy is frequent; however, intensive dose modification has improved completion and SVR rates. Interferon-free DAA combination therapies, such as asunaprevir and daclatasvir dual therapy are under development and promise higher SVR rates with fewer adverse events. Resistance monitoring and modification of DAA therapy based on pre-existing or de novo resistance variants should be considered. Future therapies are expected to have pan-genotypic activity with shorter duration and improved tolerability, even among cirrhotic and liver transplant patients.	[Chayama, Kazuaki; Mitsui, Fukiko; Hayes, C. Nelson] Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348551, Japan; [Chayama, Kazuaki; Hayes, C. Nelson] RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima 7348551, Japan; [Chayama, Kazuaki; Mitsui, Fukiko; Hayes, C. Nelson] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan	Chayama, K (reprint author), Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work is partially supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Rosenquist A, 2014, J MED CHEM, V57, P1673, DOI 10.1021/jm401507s; Ozeki I, 2011, J GASTROENTEROL, V46, P929, DOI 10.1007/s00535-011-0411-0; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Gerber L, 2013, LIVER INT, V33, P85, DOI 10.1111/liv.12068; Murakami E, 2014, ANTIMICROB AGENTS CH, V58, P2105, DOI 10.1128/AAC.02068-13; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Saxena V, 2014, ALIMENT PHARM THER, V39, P1213, DOI 10.1111/apt.12718; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Vaidya A, 2013, DRUGS, V73, P2093, DOI 10.1007/s40265-013-0153-9; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee C, 2011, ARCH PHARM RES, V34, P1403, DOI 10.1007/s12272-011-0921-6; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Chayama K, 2010, HEPATOL RES, V40, P1155, DOI 10.1111/j.1872-034X.2010.00726.x; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Boccaccio V, 2014, LIVER INT, V34, P38, DOI 10.1111/liv.12391; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Berman K, 2009, CLIN LIVER DIS, V13, P429, DOI 10.1016/j.cld.2009.05.008; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Pawlotsky JM, 2013, J HEPATOL, V59, P375, DOI 10.1016/j.jhep.2013.03.030; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Bourliere M, 2013, LIVER INT, V33, P46, DOI 10.1111/liv.12067; CHAYAMA K, 1991, HEPATOLOGY, V13, P1040; Degasperi Elisabetta, 2014, Hepat Med, V6, P25, DOI 10.2147/HMER.S44375; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gane EJ, 2014, LIVER INT, DOI [10.1111/liv.12588, DOI 10.1111/LIV.12588.]; Hofmann WP, 2008, LIVER INT, V28, P1332, DOI 10.1111/j.1478-3231.2008.01896.x; Kawakami Y, 2014, ANTIVIR THER, V19, P277, DOI 10.3851/IMP2706; Lawitz E, 2013, 20 C RETR OPP INF 3; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sewell JL, 2009, EUR J GASTROEN HEPAT, V21, P225, DOI 10.1097/MEG.0b013e32831101b7; Stedman C, 2014, THER ADV GASTROENTER, V7, P131, DOI 10.1177/1756283X13515825; Strader DB, 2012, CLIN LIVER DIS, V1, P6; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Virlogeux V, 2014, J VIRAL HEPATITIS, V21, pE98, DOI 10.1111/jvh.12237; Wendt Astrid, 2014, Clin Pharmacol, V6, P1, DOI 10.2147/CPAA.S30338; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	82	2	2	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	JAN	2015	9	1					21	30		10.1586/17474124.2015.960394		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZU	WOS:000348034900004		
J	Naganuma, M; Hisamatsu, T; Kanai, T; Ogata, H				Naganuma, Makoto; Hisamatsu, Tadakazu; Kanai, Takanori; Ogata, Haruhiko			Magnetic resonance enterography of Crohn's disease	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Review						Crohn's disease; diagnostic accuracy; endoscopic remission; enteroscopy; magnetic resonance enterography	INFLAMMATORY-BOWEL-DISEASE; MR ENTEROGRAPHY; CAPSULE ENDOSCOPY; CT ENTEROGRAPHY; ORAL CONTRAST; CONVENTIONAL ENTEROCLYSIS; PEDIATRIC POPULATION; FOLLOW-THROUGH; DIAGNOSIS; THERAPY	Magnetic resonance enterography (MRE) has been reported to be a useful modality for the evaluation of luminal inflammation and extraintestinal complications in Crohn's disease (CD). A recent study indicated that the diagnostic ability of MRE was comparable to the diagnostic ability of other devices, such as ileocolonoscopy. MRE can be performed repeatedly because there is no radiation exposure. Therefore, MRE is useful as a method of follow-up for younger patients with established CD. It is useful for evaluating the efficacy of medical treatments, such as biologics. MRE can detect small intestinal lesions even if the endoscope does not pass through the stenosis. The concerns of availability of expertise and the costs associated with MRE should be addressed so MRE can be widely used for CD patients in the near future.	[Naganuma, Makoto; Ogata, Haruhiko] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, Tokyo 1608582, Japan; [Hisamatsu, Tadakazu; Kanai, Takanori] Keio Univ, Sch Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1608582, Japan	Naganuma, M (reprint author), Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	nagamakoto@z7.keio.jp					Albert JG, 2005, GUT, V54, P1721, DOI 10.1136/gut.2005.069427; Schill G, 2013, INFLAMM BOWEL DIS, V19, P983, DOI 10.1097/MIB.0b013e31828029dd; Negaard A, 2008, SCAND J GASTROENTERO, V43, P44, DOI 10.1080/00365520701494813; Castiglione F, 2013, INFLAMM BOWEL DIS, V19, P991, DOI 10.1097/MIB.0b013e3182802b87; Grand DJ, 2012, EUR J RADIOL, V81, pE763, DOI 10.1016/j.ejrad.2012.02.011; Lee SS, 2009, RADIOLOGY, V251, P751, DOI 10.1148/radiol.2513081184; Fidler JL, 2009, RADIOGRAPHICS, V29, P1811, DOI 10.1148/rg.296095507; Dagia C, 2008, J MED IMAG RADIAT ON, V52, P480, DOI 10.1111/j.1440-1673.2008.01993.x; Absah I, 2012, AM J ROENTGENOL, V199, pW367, DOI 10.2214/AJR.11.8363; Panes J, 2013, J CROHNS COLITIS, V7, P556, DOI 10.1016/j.crohns.2013.02.020; Makanyanga JC, 2013, AM J ROENTGENOL, V201, P56, DOI 10.2214/AJR.12.10406; Siddiki HA, 2009, AM J ROENTGENOL, V193, P113, DOI 10.2214/AJR.08.2027; Masselli G, 2012, RADIOLOGY, V264, P333, DOI 10.1148/radiol.12111658; Fiorino G, 2011, INFLAMM BOWEL DIS, V17, P1073, DOI 10.1002/ibd.21533; Koh DM, 2001, AM J ROENTGENOL, V177, P1325; Schnitzler F, 2009, GUT, V58, P492, DOI 10.1136/gut.2008.155812; Punwani S, 2009, RADIOLOGY, V252, P712, DOI 10.1148/radiol.2523082167; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Fallis SA, 2013, COLORECTAL DIS, V15, P1273, DOI 10.1111/codi.12361; Bourreille A, 2009, ENDOSCOPY, V41, P618, DOI 10.1055/s-0029-1214790; Negaard A, 2007, EUR RADIOL, V17, P2294, DOI 10.1007/s00330-007-0648-4; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Doherty GA, 2011, GASTROINTEST ENDOSC, V74, P167, DOI 10.1016/j.gie.2011.01.067; Sinha R, 2011, AM J ROENTGENOL, V197, P76, DOI 10.2214/AJR.10.7253; Tillack C, 2008, INFLAMM BOWEL DIS, V14, P1219, DOI 10.1002/ibd.20466; Schreyer AG, 2004, CLIN GASTROENTEROL H, V2, P491, DOI 10.1053/S1542-3565(04)00168-5; Masselli G, 2008, EUR RADIOL, V18, P438, DOI 10.1007/s00330-007-0763-2; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Quencer KB, 2013, ABDOM IMAGING, V38, P705, DOI 10.1007/s00261-013-9981-z; Van Assche G, 2013, J CROHNS COLITIS, V7, P950, DOI 10.1016/j.crohns.2013.01.011; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Golder SK, 2006, INT J COLORECTAL DIS, V21, P97, DOI 10.1007/s00384-005-0755-0; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Papadia C, 2013, INFLAMM BOWEL DIS, V19, P1896, DOI 10.1097/MIB.0b013e31828f19a5; Horsthuis K, 2010, J PEDIATR GASTR NUTR, V51, P603, DOI 10.1097/MPG.0b013e3181dee5bd; Tielbeek JAW, 2013, INFLAMM BOWEL DIS, V19, P1943, DOI 10.1097/MIB.0b013e3182905536; Schreyer AG, 2005, INFLAMM BOWEL DIS, V11, P388, DOI 10.1097/01.MIB.0000164022.72729.06; Jensen MD, 2011, SCAND J GASTROENTERO, V46, P1449, DOI 10.3109/00365521.2011.613947; Macarini L, 2013, RADIOL MED, V118, P181, DOI 10.1007/s11547-012-0841-7; Zappa M, 2011, INFLAMM BOWEL DIS, V17, P984, DOI 10.1002/ibd.21414; Tolan DJM, 2010, RADIOGRAPHICS, V30, P367, DOI 10.1148/rg.302095028; Dionisio PM, 2010, AM J GASTROENTEROL, V105, P1240, DOI 10.1038/ajg.2009.713; Crook DW, 2009, EUR J GASTROEN HEPAT, V21, P54, DOI 10.1097/MEG.0b013e32830ce7a7; Dillman JR, 2011, PEDIATR RADIOL, V41, P1552, DOI 10.1007/s00247-011-2186-0; Fiorino G, 2013, DIGEST DIS SCI, V58, P3246, DOI 10.1007/s10620-013-2781-z; Giles E, 2013, ALIMENT PHARM THER, V37, P1121, DOI 10.1111/apt.12323; Giles E, 2012, J PEDIATR GASTR NUTR, V54, P758, DOI 10.1097/MPG.0b013e3182460111; Hyun SB, 2011, INFLAMM BOWEL DIS, V17, P1063, DOI 10.1002/ibd.21510; Korman U, 2005, ABDOM IMAGING, V30, P564, DOI 10.1007/s00261-005-0331-7; Lohan D, 2007, CLIN RADIOL, V62, P804, DOI 10.1016/j.crad.2007.02.010; Naganuma M, 2014, DIGEST ENDOSC, V26, P20, DOI 10.1111/den.12161; Naganuma M, 2014, GASTROENTEROLOGY S1, V146, ps; Novak KL, 2014, GASTROENTEROLOGY, V146, P334, DOI 10.1053/j.gastro.2013.12.020; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Schleder S, 2013, ROFO-FORTSCHR RONTG, V185, P992, DOI 10.1055/s-0033-1335445; Spieler B, 2013, CLIN RADIOL, V68, P1024, DOI 10.1016/j.crad.2013.04.014; Takenaka K, 2014, GASTROENTEROLOGY; Tielbeek JAW, 2013, AM J ROENTGENOL, V201, P1220, DOI 10.2214/AJR.12.10341	58	1	1	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	JAN	2015	9	1					37	45		10.1586/17474124.2014.939631		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZU	WOS:000348034900006		
J	Yamamoto, T				Yamamoto, Takayuki			Diagnosis and monitoring of postoperative recurrence in Crohn's disease	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Review						capsule endoscopy; Crohn's disease; computed tomography; fecal calprotectin; fecal lactoferrin; ileocolonoscopy; MRI; postoperative recurrence; surgery; ultrasonography	INFLAMMATORY-BOWEL-DISEASE; WIRELESS CAPSULE ENDOSCOPY; ILEOCOLIC RESECTION; POSTSURGICAL RECURRENCE; ANASTOMOTIC RECURRENCE; FECAL CALPROTECTIN; CONTROLLED-TRIAL; MR ENTEROCLYSIS; ILEAL RESECTION; ACTIVITY INDEX	Despite advances in medical management, many patients with Crohn's disease (CD) require intestinal surgery throughout their lives. Surgery is not a cure, and postoperative recurrence is common in patients with CD. Ileocolonoscopy has been considered to be the gold standard in the diagnosis and monitoring of postoperative recurrence. However, the optimal monitoring strategy for postoperative recurrence has yet to be established. Capsule endoscopy and cross-sectional imaging techniques, including ultrasonography, computed tomography and MRI, have been used in the postoperative setting, and their usefulness in the monitoring of disease activity has been evaluated in recent clinical trials. The value of fecal markers, such as calprotectin and lactoferrin, has been also assessed in several studies. This review was to identify optimized methods for the diagnosis and monitoring of postoperative recurrence in CD.	[Yamamoto, Takayuki] Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Mie, Japan; [Yamamoto, Takayuki] Yokkaichi Hazu Med Ctr, Dept Surg, Yokaichi, Mie, Japan	Yamamoto, T (reprint author), Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Mie, Japan.	nao-taka@sannet.ne.jp					Andreoli A, 1998, AM J GASTROENTEROL, V93, P1117; RUTGEERTS P, 1984, GUT, V25, P665, DOI 10.1136/gut.25.6.665; Landsend E, 2006, SCAND J GASTROENTERO, V41, P1204, DOI 10.1080/00365520600731018; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Rutgeerts P, 2005, GASTROENTEROLOGY, V128, P856, DOI 10.1053/j.gastro.2005.01.010; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Vuitton L, 2013, DRUGS, V73, P1749, DOI 10.1007/s40265-013-0128-x; Panes J, 2013, J CROHNS COLITIS, V7, P556, DOI 10.1016/j.crohns.2013.02.020; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Bourreille A, 2006, GUT, V55, P978, DOI 10.1136/gut.2005.081851; Fiorino G, 2011, INFLAMM BOWEL DIS, V17, P1073, DOI 10.1002/ibd.21533; De Cruz P, 2012, INFLAMM BOWEL DIS, V18, P758, DOI 10.1002/ibd.21825; [Anonymous], 2008, CONSUM REP; Walters TD, 2011, INFLAMM BOWEL DIS, V17, P1547, DOI 10.1002/ibd.21524; Biancone L, 1997, DIGEST DIS SCI, V42, P1549, DOI 10.1023/A:1018843516651; Mao R, 2013, INFLAMM BOWEL DIS, V19, P977, DOI 10.1097/MIB.0b013e318280758c; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Bourreille A, 2009, ENDOSCOPY, V41, P618, DOI 10.1055/s-0029-1214790; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P118, DOI 10.1002/ibd.21355; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Sipponen T, 2010, SCAND J GASTROENTERO, V45, P325, DOI 10.3109/00365520903483650; Gisbert JP, 2009, INFLAMM BOWEL DIS, V15, P1190, DOI 10.1002/ibd.20933; Koilakou S, 2010, INFLAMM BOWEL DIS, V16, P198, DOI 10.1002/ibd.21003; Biancone L, 2007, INFLAMM BOWEL DIS, V13, P1256, DOI 10.1002/ibd.20199; Biancone L, 2003, INFLAMM BOWEL DIS, V9, P343, DOI 10.1097/00054725-200311000-00001; Calabrese E, 2009, INFLAMM BOWEL DIS, V15, P1635, DOI 10.1002/ibd.20948; Castiglione F, 2008, INFLAMM BOWEL DIS, V14, P1240, DOI 10.1002/ibd.20469; Dave-Verma Hetal, 2008, Curr Probl Diagn Radiol, V37, P279, DOI 10.1067/j.cpradiol.2007.08.007; Fujii T, 2014, DIGESTION, V89, P24, DOI 10.1159/000356210; Gallego Ojea J. C., 2011, RADIOLOGIA, V53, P552; Hafeez R, 2011, BRIT J RADIOL, V84, P508, DOI 10.1259/bjr/65972479; Hashash JG, 2012, EXPERT REV GASTROENT, V6, P637, DOI [10.1586/egh.12.45, 10.1586/EGH.12.45]; Jung YS, 2013, INFLAMM BOWEL DIS, V19, P1852, DOI 10.1097/MIB.0b013e31828c844f; Kamm MA, 2014, 9 C EUR CROHNS COL O; Lasson A, 2014, J CROHNS COLITIS; Lobatón Triana, 2013, J Crohns Colitis, V7, pe641, DOI 10.1016/j.crohns.2013.05.005; Maconi G, 2001, ANN SURG, V233, P345, DOI 10.1097/00000658-200103000-00007; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Minordi LM, 2009, EUR RADIOL, V19, P2432, DOI 10.1007/s00330-009-1423-5; Nos P, 2007, GASTROINTEST ENDOSC, V66, P533; Orlando A, 2006, Eur Rev Med Pharmacol Sci, V10, P17; Pallotta N, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-69; Rispo A, 2006, INFLAMM BOWEL DIS, V12, P486, DOI 10.1097/00054725-200606000-00007; Sailer J, 2008, EUR RADIOL, V18, P2512, DOI 10.1007/s00330-008-1034-6; Soyer P, 2010, RADIOLOGY, V254, P755, DOI 10.1148/radiol.09091165; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Yamamoto T, 2013, UNITED EUR GASTROENT, V1, P294, DOI 10.1177/2050640613495197; Yamamoto T, 2013, UNITED EUR GASTROENT, V1, P368, DOI 10.1177/2050640613501818; Yamamoto T, 2013, COLORECTAL DIS, V15, P1471, DOI 10.1111/codi.12326	50	1	1	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	JAN	2015	9	1					55	66		10.1586/17474124.2014.940318		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZU	WOS:000348034900008		
J	Hoyo, Y; Tsuyuzaki, S				Hoyo, Yuri; Tsuyuzaki, Shiro			Sexual and vegetative reproduction of the sympatric congeners Drosera anglica and Drosera rotundifolia	FLORA			English	Article						Reproductive strategy; Daughter ramets; Size-dependency; Survival; Growth	NATURAL HABITAT; NORTHERN JAPAN; SPECIES RARITY; LIFE-HISTORY; PLANT; CONSERVATION; WIDESPREAD; ALLOCATION; INTERMEDIA; CARNIVORY	Two Drosera species, D. anglica and D. rotundifolia, are established in Sarobetsu mire, Northern Japan. D. anglica is an endangered species in Japan because of its small numbers and population sizes, whereas D. rotundifolia is widespread throughout the country. We hypothesized that the reproductive strategies of these species are closely related to the differences in their population dynamics. To test this hypothesis, we monitored the plant size; flower development; daughters, formed by dormant buds; survival; and growth of the two Drosera species in five 300 cm x 40 cm plots in a post-mined Sphagnum peatland in Sarobetsu mire from 2009 to 2011. The two Drosera species maximized their total leaf area in mid-July; all D. anglica individuals flowered at precisely the same time, but D. rotundifolia flowered two weeks after D. anglica. The dormant buds were formed in the late fall of the previous year. Both D. anglica and D. rotundifolia increased their sexual and vegetative reproduction with increasing shoot size. However, seed production was lower in D. anglica than in D. rotundifolia, and the production of daughters was more than three times higher for D. anglica than for D. rotundifolia. These results indicate that D. anglica and D. rotundifolia populations are primarily maintained by vegetative reproduction and sexual reproduction, respectively. Vegetative reproduction does not allow for long-distance migration; thus, D. anglica established in restricted habitats and was characterized by a reduced population size and endangered status. Further, these results suggest that employing very careful management strategies to protect endangered species is important, with particular focus on providing preferable habitats rather than increasing population sizes. (C) 2014 Elsevier GmbH. All rights reserved.	[Hoyo, Yuri; Tsuyuzaki, Shiro] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0500810, Japan	Hoyo, Y (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Kita 10 Nishi 5, Sapporo, Hokkaido 0500810, Japan.	hoyo@ees.hokudai.ac.jp			Japan Society for the Promotion of Science; Global COE	We thank members of the Plant Ecology Laboratory in Hokkaido University for providing support and T. Kubo for statistical analyses. We are grateful to the staff members of the Ministry of Environment of Japan and the Toyotomi Town Office for granting research permission and support. This study was partly supported by grants from the Japan Society for the Promotion of Science and Global COE grants to Hokkaido University.	Martinez-Sanchez JJ, 2011, FLORA, V206, P423, DOI 10.1016/j.flora.2010.11.006; Munzbergova Z, 2005, AM J BOT, V92, P1987, DOI 10.3732/ajb.92.12.1987; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Ott JP, 2011, AM J BOT, V98, P1293, DOI 10.3732/ajb.1000264; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; KIRKMAN LK, 1994, ECOL APPL, V4, P177, DOI 10.2307/1942127; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; CROWDER AA, 1990, J ECOL, V78, P233, DOI 10.2307/2261048; Burne HM, 2003, BIOL CONSERV, V114, P53, DOI 10.1016/S0006-3207(02)00420-2; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Karlsson P. Staffan, 2005, P1, DOI 10.1016/B978-012088386-8/50001-6; Young AS, 2007, AM J BOT, V94, P228, DOI 10.3732/ajb.94.2.228; Nordbakken JF, 1996, ECOGRAPHY, V19, P114, DOI 10.1111/j.1600-0587.1996.tb00162.x; Zietsman J, 2008, BIOL CONSERV, V141, P1475, DOI 10.1016/j.biocon.2008.03.017; Espeland EK, 2011, BIODIVERS CONSERV, V20, P963, DOI 10.1007/s10531-011-0007-2; Grime J. P., 2001, PLANT STRATEGIES VEG; Hoyo Y, 2014, WETLANDS, V34, P943, DOI 10.1007/s13157-014-0555-9; Jennings DE, 2011, BIOL CONSERV, V144, P1356, DOI 10.1016/j.biocon.2011.03.013; KARLSSON PS, 1990, OIKOS, V59, P393, DOI 10.2307/3545151; Koyama A, 2013, J VEG SCI, V24, P473, DOI 10.1111/j.1654-1103.2012.01474.x; Lenssen JPM, 2000, NEW PHYTOL, V145, P61, DOI 10.1046/j.1469-8137.2000.00557.x; Ministry of the Environment Government of Japan, 2013, RED LIST THREAT PLAN; Murza GL, 2003, CAN J BOT, V81, P1129, DOI [10.1139/B03-104, 10.1139/b03-104]; Nishimura A, 2009, ECOL RES, V24, P237, DOI 10.1007/s11284-008-0499-8; Nordbakken JF, 2004, J ECOL, V92, P110, DOI 10.1046/j.0022-0477.2004.00839.x; R Core Team, 2012, R LANG ENV STAT COMP; THUM M, 1989, OECOLOGIA, V81, P401; THUM M, 1988, OECOLOGIA, V75, P472, DOI 10.1007/BF00376954; van Kleunen M, 2002, EVOLUTION, V56, P2168, DOI 10.1554/0014-3820(2002)056[2168:ELHESO]2.0.CO;2; Verhulst J, 2008, OECOLOGIA, V156, P95, DOI 10.1007/s00442-008-0980-7; Walck JL, 2001, J BIOGEOGR, V28, P1221, DOI 10.1046/j.1365-2699.2001.00620.x; Wolf E., 2006, DROSERA ANGLICA HUDS; Worley AC, 1996, J ECOL, V84, P195, DOI 10.2307/2261355	35	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0367-2530	1618-0585		FLORA	Flora		2015	210						60	65		10.1016/j.flora.2014.10.003		6	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CA0SY	WOS:000348627900008		
J	Hasegawa, K; Wurita, A; Minakata, K; Gonmori, K; Nozawa, H; Yamagishi, I; Watanabe, K; Suzuki, O				Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu			Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms	FORENSIC TOXICOLOGY			English	Article						AB-CHMINACA; 5-Fluoro-AMB; Diphenidine; Synthetic cannabinoid; Adipose tissue; Postmortem distribution	CHROMATOGRAPHY-MASS SPECTROMETRY; SYNTHETIC CANNABINOIDS; ALPHA-PYRROLIDINOVALEROPHENONE; CATHINONE DERIVATIVES; ILLEGAL PRODUCTS; WHOLE-BLOOD; PYRROLIDINOBUTIOPHENONE; COEXISTENCE; PREVALENCE	We encountered an autopsy case in which the cause of death was judged as poisoning by multiple drugs, including AB-CHMINACA, 5-fluoro-AMB, and diphenidine. The deceased was a 30-year-old man. The postmortem interval to autopsy was estimated to be 3.5 days. Femoral vein blood, right heart blood, left heart blood, urine, and eight solid tissues including adipose tissue were collected and frozen until analysis. Extraction of the three drugs, and internal standards phencyclidine and 5-fluoro-AB-PINACA was performed by a modified QuEChERS method, followed by analysis by liquid chromatography-tandem mass spectrometry. Because this study dealt with various kinds of human matrices, we used the standard addition method to overcome the matrix effects. Quantitation of all three compounds was only achieved for the adipose tissue, whereas the levels of 5-fluoro-AMB were below the lower limit of quantitation (about 1 ng/g or ml) in all other samples. AB-CHMINACA was quantitated for all solid tissues, but not for all body fluid specimens. Diphenidine showed high concentrations in all specimens; it was highest in the adipose tissue (11,100 +/- A 1,120 ng/g), an order of magnitude lower in other solid tissue specimens, and two orders of magnitude lower in body fluid samples. The results suggest that adipose tissue is the best specimen for detection of lipophilic drugs, such as AB-CHMINACA, 5-fluoro-AMB, and diphenidine, in their unchanged forms. In this poisoning case, diphenidine appeared to have played the major role in the cause of death, because the concentrations of diphenidine were much higher than those of the synthetic cannabinoids in all specimens tested. To our knowledge, this is the first report to document the presence of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in actual postmortem specimens in a fatal poisoning case.	[Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hasegawa, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	07484771@hama-med.ac.jp					Zuba D, 2013, FORENSIC TOXICOL, V31, P21, DOI 10.1007/s11419-012-0159-0; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Wurita A, 2013, FORENSIC TOXICOL, V31, P272, DOI 10.1007/s11419-013-0188-3; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; BONILLA E, 1978, CLIN CHEM, V24, P471; Cayman Chemical, 2014, CAYM SPECTR LIBR; Chung H., 2013, FORENSIC TOXICOL, V32, P82; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2; Usui K, 2014, FORENSIC TOXICOL, V32, P139, DOI 10.1007/s11419-013-0199-0; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001	17	9	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					45	53		10.1007/s11419-014-0245-6		9	Toxicology	Toxicology	AZ3HG	WOS:000348117500004		
J	Fujii, H; Waters, B; Hara, K; Kashiwagi, M; Matsusue, A; Takayama, M; Kubo, S				Fujii, Hiroshi; Waters, Brian; Hara, Kenji; Kashiwagi, Masayuki; Matsusue, Aya; Takayama, Mio; Kubo, Shin-ichi			Direct-heating headspace solid-phase microextraction for the screening of illicit drugs	FORENSIC TOXICOLOGY			English	Article						Illicit drugs; Direct-heating; Solid-phase microextraction; Gas chromatography-mass spectrometry (GC-MS); Screening; Synthetic cannabinoids; Cathinones	CHROMATOGRAPHY-MASS SPECTROMETRY; SYNTHETIC CANNABINOIDS; GAS-CHROMATOGRAPHY; ILLEGAL PRODUCTS; DESIGNER DRUGS; IDENTIFICATION; DERIVATIVES	Illicit drugs, such as synthetic cannabinoids and cathinones, are produced in various forms, including volatile liquids, water-soluble liquids, powders and herbs. We developed a simple screening method to analyze illicit drugs in any form. In this method, a raw sample was directly placed in a solid-phase microextraction (SPME) vial, and an SPME fiber was inserted in the headspace of the vial. Illicit drugs were adsorbed onto the fiber at room temperature or by heating the vial directly. For samples that required heating, the vials were placed in a vessel filled with alumina balls (0.5 mm diameter) and heated on a hot plate. The inner-bottom temperature of the vial was measured over time, and the optimum adsorption times of the drugs were identified. After adsorption, the fiber was directly injected to the injection inlet of a gas chromatography-mass spectrometry instrument for desorption and analysis. For volatile liquids, such as nitrite esters, an adsorption time of 5 s at room temperature was sufficient. For water-soluble liquids containing compounds, such as phenethylamines and cathinones, an adsorption time of 30 s with heating was used. Furthermore, for refractory herbs, including tryptamines and synthetic cannabinoids, an adsorption time of 7 min with heating was used. Actual case samples in various forms were also tested using this method. This analysis method, called direct-heating headspace SPME, was effective for primary screening to quickly identify a number of illicit drugs in various forms.	[Fujii, Hiroshi] Minist Hlth Labour & Welf, Kyushu Reg Bur Hlth & Welf, Narcot Control Dept, Fukuoka, Japan; [Waters, Brian; Hara, Kenji; Kashiwagi, Masayuki; Matsusue, Aya; Takayama, Mio; Kubo, Shin-ichi] Fukuoka Univ, Fac Med, Dept Forens Med, Johnan Ku, Fukuoka 8140180, Japan	Kubo, S (reprint author), Fukuoka Univ, Fac Med, Dept Forens Med, Johnan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	kuboshin@fukuoka-u.ac.jp			Japanese Society for the Promotion of Science (JSPS), KAKENHI Grant [25933010]	This research was supported in part by the Japanese Society for the Promotion of Science (JSPS), KAKENHI Grant Number 25933010. We would like to thank Editage (https://www.editage.jp) for English language editing.	Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Ochiai N, 2012, J CHROMATOGR A, V1240, P59, DOI 10.1016/j.chroma.2012.03.097; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Vas G, 2004, J MASS SPECTROM, V39, P233, DOI 10.1002/jms.606; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Ball PW, 1997, GROUNDW MONIT REMEDI, V17, P104; Chung H, 2014, FORENSIC TOXICOL, V32, P82, DOI 10.1007/s11419-013-0213-6; Compliance and Narcotics Division Pharmaceutical and Food Safety Bureau Ministry of Health Labour and Welfare Japan, 2014, GEN SIT ADM MEAS NAR; Cox OA, 2012, J ANAL TOXICOL, V36, P293; Ogata J, 2013, FORENSIC SCI INT, V227, P33, DOI 10.1016/j.forsciint.2012.09.006; Presley CB, 2013, FORENSIC SCI REV, V25, P27; Schaffer M, 2013, FORENSIC TOXICOL, V31, P251, DOI 10.1007/s11419-013-0186-5; Suzuki J, 2010, ANN REP TOKYO METR I, V61, P163; Tsujikawa K, 2014, FORENSIC TOXICOL, V32, P201, DOI 10.1007/s11419-013-0221-6; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P9, DOI 10.1007/s11419-013-0194-5	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					61	68		10.1007/s11419-014-0252-7		8	Toxicology	Toxicology	AZ3HG	WOS:000348117500006		
J	Nakajima, J; Takahashi, M; Uemura, N; Seto, T; Fukaya, H; Suzuki, J; Yoshida, M; Kusano, M; Nakayama, H; Zaitsu, K; Ishii, A; Moriyasu, T; Nakae, D				Nakajima, Jun'ichi; Takahashi, Misako; Uemura, Nozomi; Seto, Takako; Fukaya, Haruhiko; Suzuki, Jin; Yoshida, Masao; Kusano, Maiko; Nakayama, Hiroshi; Zaitsu, Kei; Ishii, Akira; Moriyasu, Takako; Nakae, Dai			Identification of N,N-bis(1-pentylindol-3-yl-carboxy)naphthylamine (BiPICANA) found in an herbal blend product in the Tokyo metropolitan area and its cannabimimetic effects evaluated by in vitro [S-35]GTP gamma S binding assays	FORENSIC TOXICOLOGY			English	Article						N,N-Bis(1-pentylindol-3-yl-carboxy)naphtylamine (BiPICANA); Azepane isomers of AM-1220 and AM-2233; [S-35]GTP gamma S binding assay; X-ray crystallographic analysis; Synthetic cannabinoid	ILLEGAL PRODUCTS; DESIGNER DRUGS; SYNTHETIC CANNABINOIDS; CATHINONE DERIVATIVES; FUBINACA; ANALOG	During our careful survey of unregulated psychotropic drugs in June 2013 in the Tokyo metropolitan area, we found a new compound in a herbal product. It was identified as an analog of NNEI (MN-24) and differed in that its molecule possessed another N-pentyl indole-carbonyl group: N, N-bis(1-pentylindol-3-yl-carboxy)naphtylamine (BiPICANA, compound 2). Compound 2 was purified by silica and octadecyl group bonded type silica gel (C18, ODS) columns and confirmed by liquid chromatography-mass spectrometry, accurate mass spectrometry, nuclear magnetic resonance spectroscopy, and X-ray crystallography. No pharmacological information on compound 2 has been reported previously; our experiments on the binding ability of compound 2 to cannabinoid receptors revealed that it has affinities for CB1 and CB2 receptors (EC50 = 3.80 and 8.77 x 10(-7) M, respectively). This is the first report identifying compound 2 in a dubious herbal product and demonstrating its binding affinities to cannabinoid receptors. Binding affinities of azepane isomers (compounds 3 and 4) of AM-1220 and AM-2233, also found in commercial products in Japan, are also presented in this report.	[Nakajima, Jun'ichi; Takahashi, Misako; Uemura, Nozomi; Seto, Takako; Suzuki, Jin; Yoshida, Masao; Moriyasu, Takako; Nakae, Dai] Tokyo Metropolitan Inst Publ Hlth, Dept Pharmaceut & Environm Sci, Shinjuku Ku, Tokyo 1690073, Japan; [Fukaya, Haruhiko] Tokyo Univ Pharm & Life Sci, Instrumental Anal Ctr, Hachioji, Tokyo 19203, Japan; [Kusano, Maiko; Nakayama, Hiroshi; Zaitsu, Kei; Ishii, Akira] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Nagoya, Aichi 4648601, Japan	Nakajima, J (reprint author), Tokyo Metropolitan Inst Publ Hlth, Dept Pharmaceut & Environm Sci, Shinjuku Ku, 3-24-1 Hyakunincho, Tokyo 1690073, Japan.	Junichi_Nakajima@member.metro.tokyo.jp			Pharmaceutical Affairs Section, Tokyo Metropolitan Government, Tokyo, Japan	This work was supported by Pharmaceutical Affairs Section, Tokyo Metropolitan Government, Tokyo, Japan.	Uchiyama N, 2013, FORENSIC TOXICOL, V31, P93, DOI 10.1007/s11419-012-0171-4; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; [Anonymous], 2008, BRUK SUIT; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2012, FORENSIC TOXICOL, V30, P114, DOI 10.1007/s11419-012-0136-7; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Nakajima J, 2011, FORENSIC TOXICOL, V29, P95, DOI 10.1007/s11419-011-0108-3; Nakajima J, 2011, FORENSIC TOXICOL, V29, P132, DOI 10.1007/s11419-011-0114-5; Uchiyama N, 2009, FORENSIC TOXICOL, V27, P61, DOI 10.1007/s11419-009-0069-y; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Kneisel S, 2012, FORENSIC TOXICOL, V30, P126, DOI 10.1007/s11419-012-0137-6; Nakajima J, 2013, FORENSIC TOXICOL, V31, P76, DOI 10.1007/s11419-012-0169-y; Nakajima J, 2011, FORENSIC TOXICOL, V29, P51, DOI 10.1007/s11419-010-0101-2; Nakajima J, 2012, FORENSIC TOXICOL, V30, P33, DOI 10.1007/s11419-011-0130-5; Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Sheldrick G. M., 2008, SADABS BRUKER AXS AR; Uchiyama N, 2010, FORENSIC TOXICOL, V29, P25; Uchiyama N, 2014, FORENSIC SCI INT, V243, P1, DOI 10.1016/j.forsciint.2014.03.013; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P9, DOI 10.1007/s11419-013-0194-5; Uemura N, 2014, FORENSIC TOXICOL, V32, P45, DOI 10.1007/s11419-013-0201-x; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					84	92		10.1007/s11419-014-0253-6		9	Toxicology	Toxicology	AZ3HG	WOS:000348117500009		
J	Hasegawa, K; Wurita, A; Minakata, K; Gonmori, K; Yamagishi, I; Nozawa, H; Watanabe, K; Suzuki, O				Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Yamagishi, Itaru; Nozawa, Hideki; Watanabe, Kanako; Suzuki, Osamu			Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products	FORENSIC TOXICOLOGY			English	Article						5-Fluoro-ADB; Methyl (R)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate; Synthetic cannabinoid; Adipose tissue; Postmortem distribution; Herbal blend products	CHROMATOGRAPHY-MASS SPECTROMETRY; ALPHA-PYRROLIDINOVALEROPHENONE; POSTMORTEM DISTRIBUTION; CATHINONE DERIVATIVES; ILLEGAL PRODUCTS; BODY-FLUIDS; WHOLE-BLOOD; PYRROLIDINOBUTIOPHENONE; COEXISTENCE; PREVALENCE	Since late September 2014, there have been approximately 10 cases in Japan where people have died from inhaling smoke from herbal blends containing a newly emerged synthetic cannabinoid. Although the drug was tentatively identified by some drug-monitoring institutions as 5-fluoro-ADB, to our knowledge, its data have not been published in any scientific context. We recently encountered an autopsy case in which 5-fluoro-ADB was involved. The deceased was a 34-year-old man who was found dead in his room. The postmortem interval was estimated at 35-40 h. The direct cause of the death was asphyxia due to aspiration of stomach contents into the trachea, which likely took place during vomiting under low-consciousness conditions provoked by inhalation of the 5-fluoro-ADB smoke. The cadaver was subjected to autopsy at our department. Femoral vein blood, right heart blood, left heart blood, urine, stomach contents, and nine solid tissues including the adipose tissue were collected and frozen until analysis. The extraction of 5-fluoro-ADB and internal standard 5-fluoro-AMB was performed using a modified QuEChERS method plus filtration through Captiva ND Lipids cartridges, followed by liquid chromatography-tandem mass spectrometry (LC-MS-MS) analysis. Because this study dealt with various kinds of human matrices, we used the standard addition method for quantitation to overcome the matrix effects. The levels of 5-fluoro-ADB in the cadaver specimens were generally low; it could not be detected from blood or urine specimens. The levels of 5-fluoro-ADB in solid tissues were 1.17-7.95 ng/g. Because the highest levels were found for the adipose tissue and heart muscle, the final extracts of the adipose tissue and/or heart muscle were concentrated 10- and 200-fold to obtain product ion mass spectra of 5-fluoro-ADB using LC-MS-MS and its mass spectrum by gas chromatography-mass spectrometry, respectively. Both spectra completely coincided with those obtained from the reference standard 5-fluoro-ADB, confirming that the target compound was 5-fluoro-ADB. The quantitative results obtained by selected reaction monitoring of LC-MS-MS showed the highest level, at 7.95 ng/g, in the adipose tissue, followed by stomach contents, brain, heart muscle, pancreas, and spleen. For the lung, liver, kidney, and skeletal muscle, levels were below the quantitation limit (about 0.5 ng/g), although very small peaks above the detection limit (about 0.1 ng/g) could be observed for all of the above solid tissues. The low levels of 5-fluoro-ADB in the solid tissues were likely as a result of only a small amount of 5-fluoro-ADB incorporated into the body via the lungs due to the short period from the beginning of smoking the herb to the fatal asphyxia resulting from aspiration of a massive amount of stomach contents into the trachea under low-consciousness conditions. In addition, we measured the content of 5-fluoro-ADB in three packages, all of which were opened, that were found under a pillow near the deceased; their levels of 5-fluoro-ADB were 49.2 mg/g, 12.2 mu g/g, and 0.77 mu g/g. To our knowledge, this is the first reported identification and quantitation of 5-fluoro-ADB in human specimens and herbal products.	[Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Yamagishi, Itaru; Nozawa, Hideki; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hasegawa, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	07484771@hama-med.ac.jp					Zuba D, 2013, FORENSIC TOXICOL, V31, P21, DOI 10.1007/s11419-012-0159-0; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Wurita A, 2013, FORENSIC TOXICOL, V31, P272, DOI 10.1007/s11419-013-0188-3; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; BONILLA E, 1978, CLIN CHEM, V24, P471; Chung H., 2013, FORENSIC TOXICOL, V32, P82; Hasegawa K, 2015, FORENSIC TOXICOL, V33, P45, DOI 10.1007/s11419-014-0245-6; Namera A, 2014, FORENSIC TOXICOL, V32, P68, DOI 10.1007/s11419-013-0203-8; Sasaki C, 2015, FORENSIC TOXICOL, V33, P165, DOI 10.1007/s11419-014-0246-5; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P105, DOI 10.1007/s11419-013-0217-2; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001	17	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					112	121		10.1007/s11419-014-0259-0		10	Toxicology	Toxicology	AZ3HG	WOS:000348117500012		
J	Shima, N; Sasaki, K; Kamata, T; Matsuta, S; Katagi, M; Miki, A; Zaitsu, K; Sato, T; Nakanishi, T; Tsuchihashi, H; Suzuki, K				Shima, Noriaki; Sasaki, Keiko; Kamata, Tooru; Matsuta, Shuntaro; Katagi, Munehiro; Miki, Akihiro; Zaitsu, Kei; Sato, Takako; Nakanishi, Toyofumi; Tsuchihashi, Hitoshi; Suzuki, Koichi			Single-hair analysis of zolpidem on the supposition of its single administration in drug-facilitated crimes	FORENSIC TOXICOLOGY			English	Article						Zolpidem; Single-hair analysis; Single administration; Hypnotics; LC-MS/MS; MALDI-MS imaging	MASS-SPECTROMETRY; TOXICOLOGICAL ANALYSIS; METHAMPHETAMINE; METABOLITES; EXTRACTION; BLOOD; ABUSE	Little information is available on the amounts of hypnotics incorporated into hair after a single administration and about effective analytical procedures to document cases like drug-facilitated sexual assaults. To obtain basic information, single-hair specimens from a volunteer who took a single dose of 10-mg zolpidem (ZP) were analyzed by a newly established liquid chromatography-tandem mass spectrometry procedure, using a one-pot pulverization extraction method. The detection limit of ZP was 50 fg/2-cm single hair, and ZP in each segment was determined for the single black hair specimens (n = 15). ZP was detectable in 14 hairs (positive for all the proximal 0-2 cm segments, negative for all 2-4 cm segments), but was not detected in a single hair (probably in the telogen stage). The amounts of ZP detected in each positive 2-cm segment of single hair ranged from 27 to 63 pg (average 43 pg). The estimated total incorporation of ZP in the scalp hair (black hair similar to 110,000 strands) was about 4.7 mu g, which corresponds to about 0.06 % of the single 10-mg dose (8.03 mg as free ZP). In addition, the direct detection of single-dose ZP incorporated in hair and its imaging were successfully achieved by matrix-assisted laser desorption ionization-mass spectrometry. It is suggested that a combination of these methodologies will provide the highest-level evidence to document such exposure to a hypnotic drug.	[Shima, Noriaki; Sasaki, Keiko; Kamata, Tooru; Matsuta, Shuntaro; Katagi, Munehiro; Miki, Akihiro] Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, Osaka 5410053, Japan; [Zaitsu, Kei] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sato, Takako; Tsuchihashi, Hitoshi; Suzuki, Koichi] Osaka Med Coll, Dept Legal Med, Div Prevent & Social Med, Takatsuki, Osaka 5698686, Japan; [Nakanishi, Toyofumi] Osaka Med Coll, Dept Clin & Lab Med, Takatsuki, Osaka 5698686, Japan	Shima, N (reprint author), Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, 1-3-18 Hommachi, Osaka 5410053, Japan.	shima6499@hotmail.co.jp			Japan Society for the Promotion of Science [26915013, 24590065]	The authors gratefully appreciate Dr. Takashi Nirasawa and Yoshihiko Morishita, Bruker Daltonics, for their useful suggestions and expertise. The authors also acknowledge financial support from the Japan Society for the Promotion of Science, Grant nos. 26915013 and 24590065.	Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Cheze M, 2004, FORENSIC SCI INT, V145, P123, DOI 10.1016/j.forsciint.2004.04.066; Miki A, 2011, J MASS SPECTROM, V46, P411, DOI 10.1002/jms.1908; Miki A, 2011, FORENSIC TOXICOL, V29, P111, DOI 10.1007/s11419-011-0109-2; Cui XP, 2013, J ANAL TOXICOL, V37, P369, DOI 10.1093/jat/bkt035; Miyaguchi H, 2013, J CHROMATOGR A, V1293, P28, DOI 10.1016/j.chroma.2013.04.007; Miyaguchi H, 2007, J CHROMATOGR A, V1163, P43, DOI 10.1016/j.chroma.2007.06.017; Castro A., 2012, FORENSIC TOXICOL, V30, P193; Cone E.J., 1996, DRUG TESTING HAIR, P69; Cooper GA, 2011, FORENSIC SCI INT, V218, P20; Kamata T, 2013, 51 ANN M TIAFT 2013, P175; Kintz P., 2007, ANAL PRACTICAL ASPEC; Kintz P, 2014, FORENSIC TOXICOL, V32, P176, DOI 10.1007/s11419-013-0209-2; Kintz Pascal, 2005, J Clin Forensic Med, V12, P36, DOI 10.1016/j.jcfm.2004.08.005; Kintz P, 2014, J ANAL TOXICOL, V38, P304, DOI 10.1093/jat/bku014; Kintz P., 2008, CLARKES ANAL FORENSI, P153; Kintz P, 2012, FORENSIC TOXICOL, V30, P173, DOI 10.1007/s11419-012-0143-8; Kudo K, 2014, FORENSIC TOXICOL, V32, P97, DOI 10.1007/s11419-013-0215-4; LeBeau MA, 2009, WILEY ENCY FORENSIC, V1, P868, DOI [10.1002/9780470061589.fsa408, DOI 10.1002/9780470061589.FSA408]; Miki A, 2003, J ANAL TOXICOL, V27, P95; Nakahara Y, 1998, LIFE SCI, V63, P883, DOI 10.1016/S0024-3205(98)00345-2; NAKAHARA Y, 1992, J ANAL TOXICOL, V16, P253; Pecoraro V., 1990, HAIR HAIR DIS, P237; Pragst F, 1998, ILLEGAL THERAPEUTIC, P82; Shen M, 2014, J ANAL TOXICOL, V38, P306, DOI 10.1093/jat/bku033; Usui K, 2014, FORENSIC TOXICOL, V32, P139, DOI 10.1007/s11419-013-0199-0; Villain M., 2004, Forensic Science International, V143, P157, DOI 10.1016/j.forsciint.2004.04.019; WILKINS D, 1995, J ANAL TOXICOL, V19, P269	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					122	130		10.1007/s11419-014-0260-7		9	Toxicology	Toxicology	AZ3HG	WOS:000348117500013		
J	Hasegawa, K; Wurita, A; Minakata, K; Gonmori, K; Nozawa, H; Yamagishi, I; Watanabe, K; Suzuki, O				Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu			Postmortem distribution of PV9, a new cathinone derivative, in human solid tissues in a fatal poisoning case	FORENSIC TOXICOLOGY			English	Article						PV9; alpha-POP; 1-Phenyl-2-(pyrrolidin-1-yl)octan-1-one; Cathinone derivative; Distribution in human organs; LC-MS-MS	CHROMATOGRAPHY-MASS SPECTROMETRY; SYNTHETIC CANNABINOIDS; BODY-FLUIDS; WHOLE-BLOOD; DRUG; PRODUCT	In our previous study, we identified PV9 [1-phenyl-2-(pyrrolidin-1-yl)octan-1-one] in human blood and urine in a fatal poisoning case. The victim was an 18-year-old woman. After ingesting "aroma liquid" solution, the victim showed various symptoms including low levels of consciousness, and was taken to a hospital emergency department. Although the victim received intensive medical treatment including an intravenous drip infusion of a large volume of transfusion solution, she was pronounced dead about 20 h after admission. In this study, we carefully examined the postmortem distribution of PV9 in nine solid tissues of the victim collected at forensic autopsy. The extraction of PV9 and internal standard (IS) PV8 [1-phenyl-2-(1-pyrrolidinyl)-1-heptanone] was performed by acetonitrile deproteinization, followed by modified QuEChERS dispersive solid-phase extraction and filtration through Captiva ND Lipids cartridges. Anaysis was performed by liquid chromatography-tandem mass spectrometry. Because this study dealt with various kinds of human matrices, we used the standard addition method to overcome matrix effects. After thorough validations, such as checking the product ion mass spectra, selected reaction monitoring chromatograms, linearity of the standard addition calibration curves, the intraday and interday repeatability, matrix effects, and recovery rates for the method, the concentrations of PV9 in nine solid tissue specimens were measured using PV8 as IS. The highest level of PV9 was found in the kidney at 907 +/- A 19.5 ng/g followed by the skeletal muscle, pancreas, adipose tissue, liver, lung, spleen, heart muscle, and brain. The lowest level of PV9 in the brain was 212 +/- A 11.9 ng/g. The high level of PV9 in the kidney suggests that this drug tends to be rapidly excreted into urine via the kidney as was the case for alpha-pyrrolidinovalerophenone. The low concentration of PV9 in the brain was unexpected, because this drug is a psychotropic drug with a long hydrophobic side chain, and is considered to cross the blood-brain barrier very easily. To our knowledge, this is the first demonstration of the distribution of the new pyrrolidinophenone derivative PV9 in human solid tissues in a poisoning case.	[Hasegawa, Koutaro; Wurita, Amin; Minakata, Kayoko; Gonmori, Kunio; Nozawa, Hideki; Yamagishi, Itaru; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hasegawa, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	07484771@hama-med.ac.jp					Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Wurita A, 2013, FORENSIC TOXICOL, V31, P272, DOI 10.1007/s11419-013-0188-3; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Cayman Chemical, 2014, CAYM SPECTR LIB; Shima N, 2013, FORENSIC TOXICOL, V31, P101, DOI 10.1007/s11419-012-0172-3; Wurita A, 2014, FORENSIC TOXICOL, V32, P331, DOI 10.1007/s11419-014-0240-y; Wurita A, 2014, LEGAL MED-TOKYO, V16, P241, DOI 10.1016/j.legalmed.2014.05.001; Zaitsu K, 2014, FORENSIC TOXICOL, V32, P1, DOI 10.1007/s11419-013-0218-1	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					141	147		10.1007/s11419-014-0262-5		7	Toxicology	Toxicology	AZ3HG	WOS:000348117500015		
J	Minakata, K; Yamagishi, I; Nozawa, H; Hasegawa, K; Wurita, A; Gonmori, K; Suzuki, M; Watanabe, K; Suzuki, O				Minakata, Kayoko; Yamagishi, Itaru; Nozawa, Hideki; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Suzuki, Masako; Watanabe, Kanako; Suzuki, Osamu			Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry	FORENSIC TOXICOLOGY			English	Article						alpha-Pyrrolidinooctanophenone (PV9); Pyrrolidino cathinone derivatives; MALDI-Q-TOF mass spectrometry; alpha-Cyano-4-hydroxy cinnamic acid; Blood	ALPHA-PYRROLIDINOVALEROPHENONE; ILLEGAL PRODUCTS; DESIGNER; IDENTIFICATION; QUANTITATION; METABOLISM	A rapid and sensitive detection method using matrix-assisted laser desorption ionization (MALDI)-quadrupole time-of-flight-mass spectrometry (Q-TOF-MS) was developed for the analysis of six pyrrolidino cathinone derivatives, alpha-pyrrolidinopentiothiophenone (PVT), 4'-fluoro-alpha-pyrrolidinopentiophenone (F-PVP), 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP), alpha-pyrrolidinoheptanophenone (PV8), alpha-pyrrolidinooctanophenone (PV9) and 4'-fluoro-alpha-pyrrolidinooctanophenone (F-PV9), that were newly designated as illegal drugs in Japan. In this method, alpha-cyano-4-hydroxycinnamic acid was used as the matrix to assist the ionization of cathinones. MS spectra of these cathinones showed a protonated molecule [M+H](+) and iminium, respectively, and hence the main ions of MALDI-MS were a mixture of the main ions detected by liquid chromatography-electrospray ionization-mass spectrometry and that by gas chromatography-electron ionization-mass spectrometry. The quantification of these cathinones was performed using alpha-pyrrolidinopentiophenone as the internal standard. The limit of detection was 1 ng/ml and the quantification range was 2-100 ng/ml for these cathinones using 20 mu l of blood. We encountered a fatal poisoning case where PV9 was abused. The PV9 levels in postmortem blood samples from the right heart, left heart and femoral vein were 198, 209 and 163 ng/ml, respectively. The metabolites of PV9 were detected, and the peak height of an oxidized metabolite was higher than those of the protonated molecule and the other metabolites.	[Minakata, Kayoko; Yamagishi, Itaru; Nozawa, Hideki; Hasegawa, Koutaro; Wurita, Amin; Gonmori, Kunio; Watanabe, Kanako; Suzuki, Osamu] Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Masako] Hamamatsu Univ Sch Med, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan	Minakata, K (reprint author), Hamamatsu Univ Sch Med, Dept Legal Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kminakat@hama-med.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [2560867]	This work was supported by a Grant-in-Aid for Scientific Research (Number 2560867) from the Ministry of Education, Science, Sports and Culture of Japan.	Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P225, DOI 10.1007/s11419-014-0227-8; Springer D, 2003, J CHROMATOGR B, V789, P79, DOI 10.1016/S1570-0232(03)00043-6; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; Minakata K, 2014, FORENSIC TOXICOL, V32, P169, DOI 10.1007/s11419-013-0212-7; Shima N, 2014, FORENSIC TOXICOL, V32, P59, DOI 10.1007/s11419-013-0202-9; Uchiyama N, 2014, FORENSIC SCI INT, V243, P1, DOI 10.1016/j.forsciint.2014.03.013; VESTAL ML, 1995, RAPID COMMUN MASS SP, V9, P1044, DOI 10.1002/rcm.1290091115; Zaitsu K, 2014, FORENSIC TOXICOL, V32, P1, DOI 10.1007/s11419-013-0218-1	9	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					148	154		10.1007/s11419-014-0248-3		7	Toxicology	Toxicology	AZ3HG	WOS:000348117500016		
J	Saito, T; Sasaki, C; Namera, A; Kurihara, K; Inokuchi, S				Saito, Takeshi; Sasaki, Chizuko; Namera, Akira; Kurihara, Katsuyoshi; Inokuchi, Sadaki			Experimental study on external contamination of hair by synthetic cannabinoids and effect of hair treatment	FORENSIC TOXICOLOGY			English	Article						MAM-2201; NNEI; Synthetic cannabinoid; Hair analysis; External contamination; LC-MS-MS	CATHINONE DERIVATIVES; COEXISTENCE; PREVALENCE; PRODUCTS; DRUGS; BLOOD	We recently reported a fatal case of poisoning by N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide (NNEI). In this case, NNEI was detected from 13 sections of a 40 cm length of hair after washings. The concentrations of NNEI were generally similar among the hair segments. These results strongly suggested that externally contaminated NNEI could not be removed from the hair by washings. The aim of the present study is to demonstrate the adsorption and removal by washings for NNEI and [1-(5-fluoropentyl)-1H-indol-3-yl]-(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using liquid chromatography-tandem mass spectrometry. NNEI and MAM-2201 were detected in black hair even after a single immersion in NNEI and MAM-2201 aqueous solutions, followed by washings. However, their adsorption seemed less pronounced for dyed or bleached hair. Therefore, hair analysis cannot be considered effective in testing of synthetic cannabinoid abuse, because the external synthetic cannabinoid(s) can be easily adsorbed to hair of a non-user by passive exposure.	[Saito, Takeshi; Inokuchi, Sadaki] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 2591143, Japan; [Sasaki, Chizuko; Kurihara, Katsuyoshi] Kitasato Univ, Sch Med, Dept Legal Med, Sagamihara, Kanagawa 228, Japan; [Namera, Akira] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Forens Med, Hiroshima, Japan	Saito, T (reprint author), Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	saito@is.icc.u-tokai.ac.jp					Zuba D, 2013, FORENSIC TOXICOL, V31, P21, DOI 10.1007/s11419-012-0159-0; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Moosmann B, 2014, DRUG TEST ANAL, V6, P119, DOI 10.1002/dta.1474; Thorspecken J, 2004, CLIN CHEM, V50, P596, DOI 10.1373/clinchem.2003.026120; Hutter M, 2012, J CHROMATOGR B, V903, P95, DOI 10.1016/j.jchromb.2012.07.002; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Saito T, 2013, FORENSIC TOXICOL, V31, P328, DOI 10.1007/s11419-013-0183-8; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; Kintz P, 2012, FORENSIC SCI INT, V215, P73, DOI 10.1016/j.forsciint.2011.01.041; Chung H., 2013, FORENSIC TOXICOL, V32, P82; Kim J, 2013, ANAL BIOANAL CHEM, V405, P4769; Romano G, 2001, FORENSIC SCI INT, V123, P119, DOI 10.1016/S0379-0738(01)00539-4; Sasaki C, 2015, FORENSIC TOXICOL, V33, P165, DOI 10.1007/s11419-014-0246-5	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					155	158		10.1007/s11419-014-0250-9		4	Toxicology	Toxicology	AZ3HG	WOS:000348117500017		
J	Miyaguchi, H; Kuwayama, K				Miyaguchi, Hajime; Kuwayama, Kenji			Comparison of sample preparation methods for zolpidem extraction from hair	FORENSIC TOXICOLOGY			English	Article						Zolpidem; Hair analysis; Micropulverized extraction; Solid-liquid extraction; Melanin	DRUGS; BENZODIAZEPINES; MS/MS	The reported concentration of zolpidem in hair after a single administration is inconsistent between research papers by Villain et al. (Forensic Sci Int 143:157-161, 2004) in France (1.8-9.8 pg/mg) and Cui et al. (J Anal Toxicol 37:369-375, 2013) in China (135.0-554.6 pg/mg). In these two studies, the extraction methods used and ethnic origin of the hair samples were different. To address the differences in observed concentrations, tentative peak-area-based extraction efficiency of zolpidem from Japanese human hair was investigated using different sample pretreatment (cut into small pieces or powdered) and extraction methods. Both black and white hair samples derived from a gray-haired donor were analyzed separately. The method of micropulverized extraction (MPE) with 3.0 M ammonium phosphate (pH 8.4) resulted in the highest extraction efficiency. The extraction efficiency of the solid-liquid extraction method with 0.1 M sodium hydroxide was 77-89 % that of the MPE method for both cut and powdered samples. On the other hand, the extraction efficiency of the phosphate buffer (PB) method using solid-liquid extraction with 3.0 M ammonium phosphate (pH 8.4) was quite low (5.2-17 % of the MPE method) when pulverization was not performed prior to extraction. Therefore, the use of the PB method is discouraged for cut samples in the case of zolpidem analysis in hair. The observed tight interaction between zolpidem and Japanese black hair supports the reported high concentration of zolpidem in Asian black hair samples.	[Miyaguchi, Hajime; Kuwayama, Kenji] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan	Miyaguchi, H (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	miyaguchi@nrips.go.jp			JSPS KAKENHI Grant [24790649]	This work was supported by JSPS KAKENHI Grant number 24790649.	Lendoiro E, 2012, FORENSIC SCI INT, V217, P207, DOI 10.1016/j.forsciint.2011.11.006; Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Vogliardi S, 2011, ANAL BIOANAL CHEM, V400, P51, DOI 10.1007/s00216-011-4742-8; Villain M, 2005, J CHROMATOGR B, V825, P72, DOI 10.1016/j.jchromb.2004.12.036; Montesano C, 2014, J PHARMACEUT BIOMED, V88, P295, DOI 10.1016/j.jpba.2013.08.050; Xiang P, 2011, FORENSIC SCI INT, V204, P19, DOI 10.1016/j.forsciint.2010.04.046; Rust KY, 2012, FORENSIC SCI INT, V215, P64, DOI 10.1016/j.forsciint.2011.07.052; Cui XP, 2013, J ANAL TOXICOL, V37, P369, DOI 10.1093/jat/bkt035; Miyaguchi H, 2013, J CHROMATOGR A, V1293, P28, DOI 10.1016/j.chroma.2013.04.007; Kim J, 2013, J FORENSIC SCI, V58, P548, DOI 10.1111/1556-4029.12034; Cooper GAA, 2012, FORENSIC SCI INT, V218, P20, DOI 10.1016/j.forsciint.2011.10.024; Joseph RE, 1997, J PHARMACOL EXP THER, V282, P1228; Kintz P, 2014, FORENSIC TOXICOL, V32, P176, DOI 10.1007/s11419-013-0209-2; Kintz P, 2014, J ANAL TOXICOL, V38, P304, DOI 10.1093/jat/bku014; Kronstrand R, 2007, ANAL PRACTICAL ASPEC, P1; Madry MM, 2013, DRUG TEST ANAL, V6, P533; Miyaguchi H, 2014, ANAL METHODS-UK, V6, P5777, DOI 10.1039/c4ay00505h; Miyaguchi H, 2011, ANALYST, V136, P3503, DOI 10.1039/c0an00850h; Nakanishi-Sasaki K, 2013, JPN J FORENSIC SCI S, V18, P37; O'Neil M., 2001, MERCK INDEX; Shen M, 2014, J ANAL TOXICOL, V38, P306, DOI 10.1093/jat/bku033; United Nations Office on Drugs and Crime, 2011, GUID FOR AN DRUGS FA; Villain M., 2004, Forensic Science International, V143, P157, DOI 10.1016/j.forsciint.2004.04.019; Wada M, 2013, FORENSIC TOXICOL, V31, P2, DOI 10.1007/s11419-012-0153-6	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					159	164		10.1007/s11419-014-0256-3		6	Toxicology	Toxicology	AZ3HG	WOS:000348117500018		
J	Sasaki, C; Saito, T; Shinozuka, T; Irie, W; Murakami, C; Maeda, K; Nakamaru, N; Oishi, M; Nakamura, S; Kurihara, K				Sasaki, Chizuko; Saito, Takeshi; Shinozuka, Tatsuo; Irie, Wataru; Murakami, Chikako; Maeda, Kazuho; Nakamaru, Naomi; Oishi, Momoko; Nakamura, Shigeki; Kurihara, Katsuyoshi			A case of death caused by abuse of a synthetic cannabinoid N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide	FORENSIC TOXICOLOGY			English	Article						N-1-Naphthalenyl-1-pentyl-1H-indole-3-carboxamide; NNEI; Synthetic cannabinoid; Herbal blend; LC-MS-MS; GC-MS	CATHINONE DERIVATIVES; BLOOD; MAM-2201; HAIR	A man aged in his twenties was found dead on the floor in his room. A package containing dried herbal blend labeled "Fairy evolution" and smoking devices were found in the room. The postmortem interval of the deceased was estimated to be 3 days. The autopsy disclosed no marked findings explaining the cause of death. Toxicological analyses by gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry revealed the presence of N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide (NNEI) in the herbal blend and in specimens taken from the victim. The concentrations in the blood and adipose tissue specimens were 0.64-0.99 and 42.9 ng/ml, respectively. To our knowledge, this is the first report to describe NNEI concentrations in human specimens in the fatal poisoning case.	[Sasaki, Chizuko; Irie, Wataru; Murakami, Chikako; Maeda, Kazuho; Nakamaru, Naomi; Oishi, Momoko; Nakamura, Shigeki; Kurihara, Katsuyoshi] Kitasato Univ, Sch Med, Dept Legal Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Saito, Takeshi] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan; [Shinozuka, Tatsuo] Yokohama Coll Pharm, Dept Pathophysiol, Yokohama, Kanagawa, Japan	Sasaki, C (reprint author), Kitasato Univ, Sch Med, Dept Legal Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	sachizu@med.kitasato-u.ac.jp					Namera A, 2013, FORENSIC TOXICOL, V31, P338, DOI 10.1007/s11419-013-0192-7; Hasegawa K, 2014, FORENSIC TOXICOL, V32, P243, DOI 10.1007/s11419-014-0230-0; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Saito T, 2013, FORENSIC TOXICOL, V31, P328, DOI 10.1007/s11419-013-0183-8; Derungs A, 2013, FORENSIC TOXICOL, V31, P164, DOI 10.1007/s11419-012-0166-1; Kim J, 2013, ANAL BIOANAL CHEM, V405, P9769, DOI 10.1007/s00216-013-7423-y; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P266, DOI 10.1007/s11419-014-0238-5; Nakajima J, 2011, FORENSIC TOXICOL, V29, P95, DOI 10.1007/s11419-011-0108-3; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; Shevyrin V, 2013, FORENSIC SCI INT, V232, P1, DOI 10.1016/j.forsciint.2013.06.011	10	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1860-8965	1860-8973		FORENSIC TOXICOL	Forensic Toxicol.	JAN	2015	33	1					165	169		10.1007/s11419-014-0246-5		5	Toxicology	Toxicology	AZ3HG	WOS:000348117500019		
J	Toriyama, J; Hak, M; Imaya, A; Hirai, K; Kiyono, Y				Toriyama, Jumpei; Hak, Mao; Imaya, Akihiro; Hirai, Keizo; Kiyono, Yoshiyuki			Effects of forest type and environmental factors on the soil organic carbon pool and its density fractions in a seasonally dry tropical forest	FOREST ECOLOGY AND MANAGEMENT			English	Article						Seasonally dry tropical forest; Soil organic carbon; Density fractionation	MATTER FRACTIONS; LIGHT-FRACTION; DYNAMICS; STORAGE; MODEL; STABILIZATION; MECHANISMS; SEPARATION; RETENTION; PASTURE	Density fractionation is now a potential approach for distinguishing among the functions of different soil organic carbon (SOC) pools in a forest ecosystem. The co-existence of evergreen and deciduous forest types in seasonally dry tropics is favorable for clarifying the effect of contrasting plant functional trait on the size and quality of SOC pools under the high temperature regime. We examined whether forest type (deciduous vs. evergreen), mineral factor (aluminum and iron oxide) and climatic condition (temperature and precipitation) affect the size and quality of SOC pools in bulk soil and density fractions in a seasonally dry tropical forest of continental Southeast Asia. The forest type and mineral factor affected the quality and size, respectively, of SOC pools. The forest type had significant effects on carbon-to-nitrogen (C:N) ratios of leaf litter and free form of light fraction. However, variations in the size of the SOC pools at a depth of 0-30 cm and in each topsoil density fraction were explained exclusively by the mineral factor, i.e., aluminum oxide extractable by acid ammonium oxalate, regardless of variations in forest type and precipitation pattern. It was suggested that the surface area of clay mineral was the dominant factor for the storage capacity of SOC in the study area. The aluminum and related oxides might also increase intra-aggregate space for occluded form of light fraction. The impact of the climatic factor on the SOC pools was not found in a significant level though its effect including humid tropics on the composition of SOC remains a subject of future investigation. The linear models with variables of SOC and soil organic nitrogen favorably estimated the size of the C and N pools in the light fraction independent of the forest type. These regression models help to estimate the wide-area distribution of labile SOC pools of plant detritus form and its digital mapping, combined with a dataset of bulk SOC content. And it will provide incentives for C sequestration practice under forest management in seasonally dry tropical forests through the spatially-defined assessment of reduction effect of C emissions. (C) 2014 Elsevier B.V. All rights reserved.	[Toriyama, Jumpei; Imaya, Akihiro; Hirai, Keizo; Kiyono, Yoshiyuki] FFPRI, Tsukuba, Ibaraki 3058687, Japan; [Hak, Mao] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Hak, Mao] Minist Environm, Phnom Penh, Cambodia	Toriyama, J (reprint author), FFPRI, Bur Climate Change, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	jtori@affrc.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23710028]; Japanese Forestry Agency	The authors thank Drs. Rota Wagai and Yusuke Yonekura for their technical advice regarding the laboratory experiments; Drs. Eriko Ito and Yukako Monda for their valuable comments on forest types in Cambodia; and Dr. Masamichi Takahashi and Mr. Sum Thy for coordinating the collaborative research between Japan and Cambodia. This study was funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Young Scientists, no. 23710028) and the Japanese Forestry Agency (Emergency Project to Develop the Structure of Promoting REDD Action).	PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173; Coleman K, 1997, GEODERMA, V81, P29, DOI 10.1016/S0016-7061(97)00079-7; Guggenberger G, 1999, FOREST ECOL MANAG, V124, P93, DOI 10.1016/S0378-1127(99)00055-9; Cerli C, 2012, GEODERMA, V170, P403, DOI 10.1016/j.geoderma.2011.10.009; Kiyono Y, 2010, JARQ-JPN AGR RES Q, V44, P81; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Zimmermann M, 2007, EUR J SOIL SCI, V58, P658, DOI 10.1111/j.1365-2389.2006.00855.x; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Zinn YL, 2007, SOIL SCI SOC AM J, V71, P1204, DOI 10.2136/sssaj2006.0014; Liski J, 2005, ECOL MODEL, V189, P168, DOI 10.1016/j.ecolmodel.2005.03.005; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Schwendenmann L, 2006, PLANT SOIL, V288, P217, DOI 10.1007/s11104-006-9109-0; Rasmussen C, 2005, SOIL SCI SOC AM J, V69, P1711, DOI 10.2136/sssaj2005.0040; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; ORIANS GH, 1977, AM NAT, V111, P677, DOI 10.1086/283199; SOLLINS P, 1984, SOIL BIOL BIOCHEM, V16, P31, DOI 10.1016/0038-0717(84)90122-6; Toriyama J, 2011, JARQ-JPN AGR RES Q, V45, P309; Wagai R, 2009, SOIL SCI PLANT NUTR, V55, P13, DOI 10.1111/j.1747-0765.2008.00356.x; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Augusto L., BIOL REV IN PRESS; Christensen B.T., 1992, ADV SOIL SCI, P1; Ciais P, 2013, CLIMATE CHANGE 2013; Crocker CD, 1962, EXPLORATORY SURVEY S; ELLIOTT ET, 1991, AGR ECOSYST ENVIRON, V34, P443, DOI 10.1016/0167-8809(91)90127-J; Feller C., 1996, STRUCTURE ORGANIC MA, P309; Food and Agriculture Organization of the United Nations, 2006, 147 FAO; Food and Agriculture Organization of the United Nations IIASA ISRIC ISSCAS JRC, 2012, HARM WORLD SOIL DAT; Garcia-Oliva F, 2003, J TROP ECOL, V19, P179, DOI 10.1017/S026646703003201; GOFC-GOLD, 2013, SOURC METH PROC MON; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; Paul S, 2008, EUR J SOIL SCI, V59, P359, DOI 10.1111/j.1365-2389.2007.01010.x; R Development Core Team, 2011, R LANG ENV STAT COMP; Sakurai K., 1998, TROPICS, V8, P61; SOBRADO MA, 1991, FUNCT ECOL, V5, P608, DOI 10.2307/2389479; Toriyama J, 2013, JARQ-JPN AGR RES Q, V47, P217, DOI 10.6090/jarq.47.217; Tsutsumi T., 1966, SE ASIAN STUDIES, V4, P327; van Reeuwjkl L.M., 2002, 9 ISRIC FAO; Wagai R, 2008, GEODERMA, V147, P23, DOI 10.1016/j.geoderma.2008.07.010; Wakita K., 2004, DIGITAL GEOLOGIC MAP; Yonekura Y, 2013, PLANT SOIL, V372, P683, DOI 10.1007/s11104-013-1763-4	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1127	1872-7042		FOREST ECOL MANAG	For. Ecol. Manage.	JAN 1	2015	335						147	155		10.1016/j.foreco.2014.09.037		9	Forestry	Forestry	AY7KT	WOS:000347739900014		
J	Tateno, A; Sakayori, T; Takizawa, Y; Yamamoto, K; Minagawa, K; Okubo, Y				Tateno, Amane; Sakayori, Takeshi; Takizawa, Yuichi; Yamamoto, Ken; Minagawa, Kaoru; Okubo, Yoshiro			A case of Alzheimer's disease following mild traumatic brain injury	GENERAL HOSPITAL PSYCHIATRY			English	Editorial Material						Alzheimer's disease; Traumatic brain injury; Mild cognitive impairment; Beta-amyloid; Positron emission tomography	PITTSBURGH COMPOUND-B; COGNITIVE IMPAIRMENT; DEMENTIA	Objective: To report a case of Alzheimer's disease (AD) following mild traumatic brain injury (TBI). Method: Case report. Results: We report the time course of AD following mild TBI with evidence of AD pathology. A patient complained of minor memory disturbance 6 months after TBI and was diagnosed with mild cognitive impairment 1.5 years after TBI, and she was finally diagnosed as probable AD 4 years after TBI. Amyloid PET revealed brain accumulation of beta-amyloid at a pathological AD level. Conclusion: Our case well illustrated how TBI can accelerate the AD process. Clinicians should carefully follow up patients with persistent cognitive impairment after TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Tateno, Amane; Sakayori, Takeshi; Takizawa, Yuichi; Yamamoto, Ken; Minagawa, Kaoru; Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138602, Japan	Okubo, Y (reprint author), 1-1-5 Sendagi,Bunkyo Ku, Tokyo 1138602, Japan.	okubo-y@nms.ac.jp					Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Matsuda O, 2009, INT PSYCHOGERIATR, V21, P970, DOI 10.1017/S1041610209990330; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Homma A, 1992, JPN J GERIATR PSYCHI, V3, P647; Kemp S, 2005, BRAIN INJURY, V19, P1269, DOI 10.1080/02699050500309353; MCKHANN G, 1984, NEUROLOGY, V34, P939; Nandoe Rishi D. S., 2002, Journal of Alzheimer's Disease, V4, P303; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Wechsler D, 1997, WECHSLER ADULT INTEL	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	JAN-FEB	2015	37	1								10.1016/j.genhosppsych.2014.09.016		3	Psychiatry	Psychiatry	AZ2CQ	WOS:000348042700024		
J	Ito, T; Hoshino, R; Iinuma, M				Ito, Tetsuro; Hoshino, Ryosuke; Iinuma, Munekazu			Absolute Configuration of Resveratrol Oligomers Isolated from Hopea utilis	HELVETICA CHIMICA ACTA			English	Article							STEM BARK; AMPELOPSIN-B; C-GLUCOSIDE; OLIGOSTILBENOIDS; STILBENOIDS; DERIVATIVES; PARVIFLORA; EXALATA; DIMERS	Phytochemical studies on a stem of Hopea utilis (Dipterocarpaceae) resulted in the isolation of two new resveratrol derivatives, namely hopeaside E (1; resveratrol trimer) and hopeaside F (2; resveratrol pentamer), together with ten known resveratrol derivatives, 3-12. The structures of the new compounds were elucidated by spectroscopic analyses, including NMR experiments, and their absolute configurations were determined on the basis of a comparative configurational analysis using the beta-D-glucopyranosyl group and chiroptical data. The absolute configuration of (+)-balanocarpol (3) was also determined by acid-catalyzed skeletal conversion.	[Ito, Tetsuro; Hoshino, Ryosuke; Iinuma, Munekazu] Gifu Pharmaceut Univ, Lab Pharmacognosy, Gifu 5011196, Japan	Ito, T (reprint author), Gifu Pharmaceut Univ, Lab Pharmacognosy, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	teito@gifu-pu.ac.jp					Abe N, 2011, CHEM PHARM BULL, V59, P239, DOI 10.1248/cpb.59.239; Abe N, 2011, HETEROCYCLES, V83, P571, DOI 10.3987/COM-10-12116; Ge HM, 2006, J NAT PROD, V69, P1800, DOI 10.1021/np060242y; Patcharamun W, 2011, FITOTERAPIA, V82, P489, DOI 10.1016/j.fitote.2011.01.003; Ito T, 2003, CARCINOGENESIS, V24, P1489, DOI 10.1093/carcin/bgg105; OSHIMA Y, 1990, TETRAHEDRON, V46, P5121, DOI 10.1016/S0040-4020(01)87819-4; Ashton P. S., 1982, Flora Malesiana, I, Spermatophyta, V9, P237; Coggon P., 1965, CHEM SOC, P406; Dai JR, 1998, J NAT PROD, V61, P351, DOI 10.1021/np970519h; Ge HM, 2006, EUR J ORG CHEM, P5551, DOI 10.1002/ejoc.200600661; Ito T, 2014, TETRAHEDRON, V70, P5640, DOI 10.1016/j.tet.2014.06.074; Ito T, 2005, CHEM PHARM BULL, V53, P219, DOI 10.1248/cpb.53.219; Ito T, 2013, PHYTOCHEM LETT, V6, P193, DOI 10.1016/j.phytol.2013.01.003; Liu JY, 2005, HELV CHIM ACTA, V88, P2910, DOI 10.1002/hlca.200590234; Ohyama M, 1998, CHEM PHARM BULL, V46, P663; Ohyama M, 1999, BIOORG MED CHEM LETT, V9, P3057, DOI 10.1016/S0960-894X(99)00520-X; SARASWATHY A, 1992, PHYTOCHEMISTRY, V31, P2561, DOI 10.1016/0031-9422(92)83330-2; Takaya Y, 2002, TETRAHEDRON, V58, P9265, DOI 10.1016/S0040-4020(02)01191-2; Takaya Y, 2002, TETRAHEDRON, V58, P7259, DOI 10.1016/S0040-4020(02)00785-8; Tanaka T, 2001, CHEM PHARM BULL, V49, P785, DOI 10.1248/cpb.49.785; Tanaka T, 2000, PHYTOCHEMISTRY, V54, P63, DOI 10.1016/S0031-9422(00)00026-1; Tanaka T, 2001, HETEROCYCLES, V55, P729; Tanaka T, 2000, PHYTOCHEMISTRY, V53, P1015, DOI 10.1016/S0031-9422(00)00019-4; Weber JFF, 2001, TETRAHEDRON LETT, V42, P4895, DOI 10.1016/S0040-4039(01)00772-9	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	JAN	2015	98	1					32	46		10.1002/hlca.201400146		15	Chemistry, Multidisciplinary	Chemistry	AY8YN	WOS:000347836700002		
J	Lim, SG; Amarapurkar, DN; Chan, HLY; Crawford, DH; Gane, EJ; Han, KH; Ahn, SH; Jafri, W; Jia, JD; Kao, JH; Lesmana, LA; Lesmana, CRA; Mohamed, R; Phiet, PH; Piratvisuth, T; Sarin, SK; Sollarno, JD; Eguchi, Y; Mamun-Al Mahtab; Lee, KH				Lim, Seng Gee; Amarapurkar, Deepak N.; Chan, Henry Lik-Yuen; Crawford, Darrell H.; Gane, Edward J.; Han, Kwang-Hyub; Ahn, Sang Hoon; Jafri, Wasim; Jia, Jidong; Kao, Jia-Horng; Lesmana, Laurentius A.; Lesmana, C. Rinaldi A.; Mohamed, Rosmawati; Pham Hoang Phiet; Piratvisuth, Teerha; Sarin, Shiv K.; Sollarno, Jose D.; Eguchi, Yuichiro; Mamun-Al Mahtab; Lee, Keat Hong			Reimbursement policies in the Asia-Pacific for chronic hepatitis B	HEPATOLOGY INTERNATIONAL			English	Article						Hepatitis B; Reimbursement; Asia Pacific; Antiviral therapy	DISEASE; STRATEGIES; GUIDELINES; LAMIVUDINE; INFECTION; THERAPY; BURDEN	There is considerable variation in reimbursement policies in Asian countries and this is likely to have an impact on treatment practice for chronic hepatitis B (CHB). Consequently a survey of leading hepatologists was performed to evaluate such policies and their impact on management of CHB in the Asia Pacific region. A questionnaire was sent to key hepatologists in Asia Pacific for information on CHB reimbursement policy-its nature, coverage, funding source, duration, review strategy and impact on Asia Pacific Association for the Study of the Liver (APASL) CHB guidelines. The results were analysed and described. Leading hepatologists from 16 Asia Pacific countries responded. Almost all of the countries have reimbursement policies but eligibility varied from only a limited group (e.g. civil servants only) to universal access. In most instances reimbursement was from the central government (except China, Pakistan and Hong Kong). Reimbursement policies were usually created by Ministry of Health committees, who received input from medical professionals, although they may not be aware of the APASL guidelines. Policies were limited by available resources, funds and prioritization. Where there was a regular review this occurred between 1 and 5 years. The quantum of reimbursement varied from 50 % in Singapore to 100 % in the majority of other countries. The criteria for treatment reimbursement were based on doctor's opinion alone (Bangladesh, India, Pakistan, Philippines, Singapore and Vietnam) or specific clinical/laboratory criteria in the rest of the countries. In general, most countries offered unlimited duration for reimbursement except Taiwan, Indonesia and Pakistan. Monitoring tests for treatment response were reimbursed in all countries other than Vietnam. Viral resistance was diagnosed by viral or biochemical breakthrough, and viral resistance testing was uncommon. The main rescue therapy was adefovir. Reimbursement policies differed from country to country, the quantum and the proportion of patients who received reimbursement also varied significantly. Asia Pacific countries were able to follow APASL guidelines with variable success based on their reimbursement policies.	[Lim, Seng Gee; Lee, Keat Hong] Natl Univ Hlth Syst, Div Gastroenterol & Hepatol, Singapore, Singapore; [Amarapurkar, Deepak N.] Bombay Hosp & Med Res Ctr, Dept Gastroenterol & Hepatol, Mumbai, Maharashtra, India; [Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Crawford, Darrell H.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gane, Edward J.] Auckland City Hosp, New Zealand Liver Unit, Auckland, New Zealand; [Han, Kwang-Hyub; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Jafri, Wasim] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Jia, Jidong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China; [Kao, Jia-Horng] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Lesmana, Laurentius A.; Lesmana, C. Rinaldi A.] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia; [Mohamed, Rosmawati] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Pham Hoang Phiet] Univ Med & Pharm, Dept Immunol & Physiopathol, Ho Chi Minh City, Vietnam; [Piratvisuth, Teerha] Prince Songkla Univ, NKC Inst Gastroenterol & Hepatol, Hat Yai, Thailand; [Sarin, Shiv K.] Inst Liver & Biliary Sci, New Delhi, India; [Sollarno, Jose D.] Univ Santo Tomas, Dept Med, Manila, Philippines; [Eguchi, Yuichiro] Saga Med Sch, Ctr Liver, Div Hepatol, Saga, Japan; [Mamun-Al Mahtab] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka, Bangladesh	Lim, SG (reprint author), Natl Univ Hlth Syst, Div Gastroenterol & Hepatol, Singapore, Singapore.	seng_gee_lim@nuhs.edu.sg	Mamun, Abdullah/A-4673-2011; Chan, Henry Lik-Yuen/B-9636-2008		Roche; BMS; MSD; Novartis Pharmaceuticals	This article does not contain any studies with human or animal subjects. SG Lim is on the advisory board of Novartis, Merck Sharp and Dohme (MSD), Janssen, Achillion and Bristol-Myers Squibb (BMS) Pharmaceuticals, and is on the speakers' bureau for Glaxo-SmithKline (GSK), Novartis and BMS Pharmaceuticals. JH Kao is a consultant for Abbott, Abbvie, Bayer, Boehringer Ingelheim (BI), BMS, Gilead Sciences, GSK, Johnson & Johnson (JJ), MSD, Novartis, and Roche Pharmaceuticals, and is on the speakers' bureau for Abbott, Roche, Bayer, BMS, GSK and Novartis Pharmaceuticals. JD Jia is a consultant and speaker for BMS, MSD, Novartis and Roche Pharmaceuticals. Piratvisuth T is on the advisory board and holds a research grant from Roche, BMS, MSD and Novartis Pharmaceuticals, and is on the speakers' bureau for Roche, BMS, MSD, GSK and Novartis Pharmaceuticals. Ed Gane is on the advisory board of Achillion, Idenix, Gilead, Novartis, Roche, MSD and Janssen Pharmaceuticals, and is on the speakers' bureau for Janssen, Gilead, Novartis Pharmaceuticals. Amarapurkar D is a consultant for Abott, Janssen, BMS Pharmaceuticals, and is on the speakers' bureau for Novartis, Bayer and Roche Pharmaceuticals. Crawford D is on the advisory board of Gilead Sciences. Henry Chan is a speaker for BMS, Gilead, Novartis, Roche, Echosens, GSK, Abbvie Pharmaceuticals, advisor for BMS, Gilead, Novartis, Roche and MSD Pharmaceuticals, and has an unrestricted research grant from Roche. Keat Hong Lee, Kwang-Hyub Han, Sang Hoon Ahn, Wasim Jafri, Laurentius A. Lesmana, C. Rinaldi A. Lesmana, Rosmawati Mohamed, Pham Hoang Phiet, Shiv K. Sarin, Jose D. Sollarno, Yuichiro Eguchi and Mamun-Al-Mahtab declare no conflict of interests.	Abraham P, 2012, CLIN LAB MED, V32, P159, DOI 10.1016/j.cll.2012.03.003; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Yuen MF, 2007, ANTIVIR THER, V12, P1295; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Sendi PP, 2001, HEALTH ECON, V10, P675; Arama V, 2014, ANTIVIR THER, V19, P245, DOI 10.3851/IMP2719; Chainuvati S, 2009, HEPATOL INT, V3, P453, DOI 10.1007/s12072-009-9139-9; Dan YY, 2008, HEPATOL INT, V2, P284, DOI 10.1007/s12072-008-9049-2; Evans DB, 2005, BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; GAFNI A, 1993, CAN MED ASSOC J, V148, P913; Lee KH, 2013, HEPATOL INT, V7, P451, DOI 10.1007/s12072-012-9399-7; Lesmana LA, 2006, LIVER INT, V26, P3, DOI 10.1111/j.1478-3231.2006.01370.x; Lim SG, 2013, ANTIVIR THER, V18, P663, DOI 10.3851/IMP2482; Lozano, 2012, LANCET, V380, P2095; Tanaka A., 2014, HEPATOL RES, V44, P1; Van Herck P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078662; Yoo BC, 2012, CLIN MOL HEPATOL, V18, P109	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JAN	2015	9	1					43	51		10.1007/s12072-014-9593-x		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4XH	WOS:000348223800008		
J	Tamai, H; Mori, Y; Shingaki, N; Shimizu, R; Nuta, J; Moribata, K; Maeda, Y; Muraki, Y; Deguchi, H; Inoue, I; Maekita, T; Iguchi, M; Kato, J; Takifuji, K; Yamaue, H; Ichinose, M				Tamai, Hideyuki; Mori, Yoshiyuki; Shingaki, Naoki; Shimizu, Ryo; Nuta, Jyunya; Moribata, Kosaku; Maeda, Yoshimasa; Muraki, Yosuke; Deguchi, Hisanobu; Inoue, Izumi; Maekita, Takao; Iguchi, Mikitaka; Kato, Jun; Takifuji, Katsunari; Yamaue, Hiroki; Ichinose, Masao			Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis	HEPATOLOGY INTERNATIONAL			English	Article						Hepatitis C; Cirrhosis; Interferon; Prognosis; Splenectomy; Thrombocytopenia	HEPATOCELLULAR-CARCINOMA; VIROLOGICAL RESPONSE; ANTIVIRAL TREATMENT; RIBAVIRIN THERAPY; INFECTION; HYPERSPLENISM; MANAGEMENT; IL28B; ALPHA	Laparoscopic splenectomy enables patients with marked thrombocytopenia and hepatitis C virus (HCV)-related cirrhosis to receive sufficient interferon-based therapy. The purpose of this study was to evaluate whether the response to interferon after laparoscopic splenectomy contributes to the survival of cirrhotic patients with marked thrombocytopenia. Eighty-seven patients with marked thrombocytopenia and HCV-related cirrhosis who met the inclusion criteria were enrolled. Of the 87 patients, 65 underwent laparoscopic splenectomy for IFN therapy, and 22 patients declined laparoscopic splenectomy and IFN therapy. Finally, 61 patients received IFN therapy after splenectomy, and 26 patients did not receive IFN therapy. The numbers of patients in the sustained virological response (SVR) group, the transient response (TR) group, the no response (NR) group, and the no interferon (IFN) group were 25, 12, 24, and 26, respectively. Seven-year survival in the SVR group, the TR group, NR group, and the no IFN group was 86, 76, 44, and 42 %, respectively. When the response group was defined as the SVR or TR group, survival was significantly higher for the response group than for the other groups. However, there was no significant difference between survival in the NR and no IFN groups. On multivariate analysis, independent factors related to survival were the response to interferon, the presence of esophageal varices, and a history of treatment for hepatocellular carcinoma. A good response to interferon after splenectomy was associated with a favorable prognosis. Therefore, prediction of the efficacy of IFN therapy is crucial before splenectomy.	[Tamai, Hideyuki; Mori, Yoshiyuki; Shingaki, Naoki; Shimizu, Ryo; Nuta, Jyunya; Moribata, Kosaku; Maeda, Yoshimasa; Muraki, Yosuke; Deguchi, Hisanobu; Inoue, Izumi; Maekita, Takao; Iguchi, Mikitaka; Kato, Jun; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama 6410012, Japan; [Takifuji, Katsunari; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama 6410012, Japan	Tamai, H (reprint author), Wakayama Med Univ, Dept Internal Med 2, 811-1 Kimiidera, Wakayama 6410012, Japan.	tamahide@wakayama-med.ac.jp					Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; Ikeda N, 2014, HEPATOL RES, V44, P829, DOI 10.1111/hepr.12184; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Akahoshi T, 2010, SURG ENDOSC, V24, P680, DOI 10.1007/s00464-009-0653-6; Pockros PJ, 2010, HEPATOLOGY, V52, P1193, DOI 10.1002/hep.23809; Ikezawa K, 2010, J VIRAL HEPATITIS, V17, P488, DOI 10.1111/j.1365-2893.2009.01211.x; Imura S, 2010, HEPATOL RES, V40, P894, DOI 10.1111/j.1872-034X.2010.00688.x; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Boccaccio V, 2014, LIVER INT, V34, P38, DOI 10.1111/liv.12391; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; European Assoc Study L, 2011, J HEPATOL, V55, P245, DOI DOI 10.1016/J.JHEP.2011.02.023]; Ikegami T, 2008, HEPATOL RES, V38, P1159, DOI 10.1111/j.1872-034X.2008.00384.x; Kanda T, 2011, ONCOLOGY-BASEL, V80, P366, DOI 10.1159/000330549; Morihara D, 2009, HEPATOL RES, V39, P439, DOI 10.1111/j.1872-034X.2008.00481.x; Nagaoki Y, 2013, J GASTROENTEROL, V48, P847, DOI 10.1007/s00535-012-0679-8; Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9; Shigekawa Y, 2011, AM SURGEON, V77, P174; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JAN	2015	9	1					67	75		10.1007/s12072-014-9586-9		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4XH	WOS:000348223800011		
J	Toyoda, H; Kumada, T; Tada, T; Sone, Y; Maeda, A; Kaneoka, Y				Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi; Sone, Yasuhiro; Maeda, Atsuyuki; Kaneoka, Yuji			Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC	HEPATOLOGY INTERNATIONAL			English	Article						Hepatocellular carcinoma; Early stage; Gd-EOB-DTPA-enhanced MRI; Non-hypervascular hypointense nodules; Recurrence; Survival	GAMMA-CARBOXY PROTHROMBIN; SMALL HEPATOCELLULAR-CARCINOMA; ENZYME-IMMUNOASSAY KIT; HEPATOBILIARY PHASE; MAGNETIC-RESONANCE; INCREASED SENSITIVITY; CLINICAL-EVALUATION; SERUM-LEVELS; RECURRENCE; LIVER	In patients with hepatocellular carcinoma (HCC), gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) often identifies non-hypervascular hypointense hepatic nodules during the hepatobiliary phase, but their prognostic significance is unclear. We conducted a prospective observational study to investigate the impact of non-hypervascular hypointense hepatic nodules detected by Gd-EOB-DTPA-enhanced MRI on the outcome of patients with early-stage HCC. Post-treatment recurrence and survival rates were analyzed in 138 patients with non-recurrent, early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0 or A] and Child-Pugh A liver function according to the presence of non-hypervascular hypointense nodules on pretreatment Gd-EOB-DTPA-enhanced MRI. Non-hypervascular hypointense hepatic nodules were detected in 51 (37.0 %) patients with early-stage HCC on pretreatment Gd-EOB-DTPA-enhanced MRI. Recurrence rates were significantly higher in patients with non-hypervascular hypointense nodules (p < 0.0001). Based on a multivariate analysis, the presence of non-hypervascular hypointense hepatic nodules on Gd-EOB-DTPA-enhanced MRI was independently associated with an increased recurrence rate, independent of tumor progression or treatment (p = 0.0005). The survival rate was significantly lower in patients with non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI (p = 0.0108). In patients with early-stage typical HCC (BCLC 0 or A), the presence of concurrent non-hypervascular hypointense hepatic nodules in the hepatobiliary phase of pretreatment Gd-EOB-DTPA-enhanced MRI is an indicator of higher likelihood of recurrence after treatment and may be a marker for unfavorable outcome.	[Toyoda, Hidenori; Kumada, Takashi; Tada, Toshifumi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan; [Sone, Yasuhiro] Ogaki Municipal Hosp, Dept Radiol, Ogaki, Japan; [Maeda, Atsuyuki; Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Ogaki, Japan	Toyoda, H (reprint author), Ogaki Municipal Hosp, Dept Gastroenterol, 4-86 Minaminokawa, Ogaki, Gifu 5038502, Japan.	hmtoyoda@spice.ocn.ne.jp					Kumada T, 1997, HEPATOLOGY, V25, P87, DOI 10.1002/hep.510250116; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Kumada T, 2011, AM J ROENTGENOL, V197, P58, DOI 10.2214/AJR.10.5390; Granito A, 2013, ALIMENT PHARM THER, V37, P355, DOI 10.1111/apt.12166; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Vogl TJ, 1996, RADIOLOGY, V200, P59; Koda M, 2000, CANCER, V88, P529; HAMM B, 1995, RADIOLOGY, V195, P785; MATSUI O, 1991, RADIOLOGY, V178, P493; Reimer P, 1996, RADIOLOGY, V199, P177; Akai H, 2012, EUR J RADIOL, V81, P2973, DOI 10.1016/j.ejrad.2012.01.007; Golfieri R, 2011, EUR RADIOL, V21, P1233, DOI 10.1007/s00330-010-2030-1; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Kobayashi S, 2012, EUR J RADIOL, V81, P3002, DOI 10.1016/j.ejrad.2012.03.029; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; COX DR, 1972, J R STAT SOC B, V34, P187; Kogita S, 2010, EUR RADIOL, V20, P2405, DOI 10.1007/s00330-010-1812-9; Kim YK, 2012, RADIOLOGY, V265, P104, DOI 10.1148/radiol.12112649; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Nomura F, 1999, AM J GASTROENTEROL, V94, P650, DOI 10.1111/j.1572-0241.1999.00930.x; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; Toyoda H, 2013, J HEPATOL, V58, P1174, DOI 10.1016/j.jhep.2013.01.030; Mita Y, 1998, CANCER, V82, P1643, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B; Kitamoto M, 2003, AM J ROENTGENOL, V181, P997; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kokudo N., 2009, J GASTROENTEROL, V44, pS119; Liver Cancer Study Group of Japan, 2011, GEN RUL CLIN PATH ST, P54; Okuda H, 1999, CANCER, V85, P812, DOI 10.1002/(SICI)1097-0142(19990215)85:4<812::AID-CNCR8>3.0.CO;2-O; Okuda H, 2000, CANCER, V88, P544; Petro R, 1973, BIOMETRICS, V29, P579; TAKAYASU K, 1995, RADIOLOGY, V194, P101; TAKENAKA K, 1994, HEPATOLOGY, V19, P889, DOI 10.1016/0270-9139(94)90288-7; TSUDA H, 1988, GASTROENTEROLOGY, V95, P1664	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JAN	2015	9	1					84	92		10.1007/s12072-014-9553-5		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4XH	WOS:000348223800013		
J	Onishi, H; Nouso, K; Nakamura, S; Katsui, K; Wada, N; Morimoto, Y; Miyahara, K; Takeuchi, Y; Kuwaki, K; Yasunaka, T; Miyake, Y; Shiraha, H; Takaki, A; Kobayashi, Y; Sakaguchi, K; Kanazawa, S; Yamamoto, K				Onishi, Hideki; Nouso, Kazuhiro; Nakamura, Shinichiro; Katsui, Kuniaki; Wada, Nozomu; Morimoto, Yuki; Miyahara, Koji; Takeuchi, Yasuto; Kuwaki, Kenji; Yasunaka, Tetsuya; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Kobayashi, Yoshiyuki; Sakaguchi, Kohsaku; Kanazawa, Susumu; Yamamoto, Kazuhide			Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion	HEPATOLOGY INTERNATIONAL			English	Article						Hepatocellular carcinoma; Portal vein tumor thrombosis; Chemotherapy; Radiotherapy	3-DIMENSIONAL CONFORMAL RADIOTHERAPY; FINE-POWDER FORMULATION; TUMOR THROMBUS; VENOUS INVASION; INTRAARTERIAL 5-FLUOROURACIL; RADIATION HEPATITIS; NATIONWIDE SURVEY; INTERFERON-ALPHA; LIVER RESECTION; THERAPY	The presence of portal vein tumor thrombosis (PVTT) is a poor prognostic factor for patients with hepatocellular carcinomas (HCC). The purpose of this study was to determine the treatment effect of irradiation in combination with hepatic arterial infusion chemotherapy (HAIC) for these patients. We retrospectively examined the outcome of 67 HCC patients with PVTT of the main trunk or first branch who received HAIC alone or with concurrent irradiation for PVTT (CCRT). Thirty-four patients received HAIC, and 33 patients received CCRT. The time to progression (TTP) of PVTT in the CCRT group was significantly longer than in the HAIC group (p < 0.01), and the TTP of intrahepatic nodules in the CCRT group tended to be longer than in the HAIC group (p = 0.06). The objective response rates of intrahepatic nodules (52 vs. 18 %, p < 0.01) and PVTT (45 vs. 18 %, p = 0.01) were both significantly higher in the CCRT group than in the HAIC group, respectively. No significant difference in overall survival was found between the two groups (p = 0.14); however, the median survival time in the CCRT group was longer than that in the HAIC group (12.4 vs. 5.7 months, respectively). CCRT might be a promising treatment for advanced-stage HCC with PVTT. CCRT prolonged the TTP of intrahepatic nodules and PVTT, and it improved the objective response rate of intrahepatic nodules and PVTT.	[Onishi, Hideki; Nouso, Kazuhiro] Okayama Univ, Dept Mol Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Nakamura, Shinichiro; Wada, Nozomu; Morimoto, Yuki; Miyahara, Koji; Takeuchi, Yasuto; Kuwaki, Kenji; Yasunaka, Tetsuya; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Katsui, Kuniaki] Okayama Univ Hosp, Dept Radiol, Okayama 7008558, Japan; [Kobayashi, Yoshiyuki] Tokyo Med Univ, Hachioji Med Ctr, Dept Gastroenterol, Hachioji, Tokyo 1930998, Japan; [Sakaguchi, Kohsaku] Fukuyama City Hosp, Dept Internal Med, Fukuyama, Hiroshima 7218511, Japan; [Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan	Onishi, H (reprint author), Okayama Univ, Dept Mol Hepatol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ohnis-h1@cc.okayama-u.ac.jp			MSD	All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study. This article does not contain any studies with animal subjects. Kazuhiro Nouso and Hideki Onishi belong to a donation-funded department (Department of Molecular Hepatology, funded by MSD). Kazuhide Yamamoto, Susumu Kanazawa, Kohsaku Sakaguchi, Akinobu Takaki, Yoshiyuki Kobayashi, Hidenori Shiraha, Shinichiro Nakamura, Yasuhiro Miyake, Kuniaki Katsui, Tetsuya Yasunaka, Kenji Kuwaki, Yasuto Takeuchi, Koji Miyahara, Nozomu Wada and Yuki Morimoto declare that they have no conflict of interest.	Ando E, 2002, CANCER, V95, P588, DOI 10.1002/cncr.10694; Yamada K, 2003, INT J RADIAT ONCOL, V57, P113, DOI 10.1016/S0360-3016(03)00434-6; Kim DY, 2005, CANCER, V103, P2419, DOI 10.1002/cncr.21043; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yoshikawa M, 2008, HEPATOL RES, V38, P474, DOI 10.1111/j.1872-034X.2008.00338.x; YAMADA R, 1983, RADIOLOGY, V148, P397; Zeng ZC, 2005, INT J RADIAT ONCOL, V61, P432, DOI 10.1016/j.ijrobp.2004.05.025; Stuart KE, 1996, CANCER, V77, P2217, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M; Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Ueshima K, 2010, ONCOLOGY-BASEL, V78, P148, DOI 10.1159/000315244; Katamura Y, 2009, J GASTROENTEROL, V44, P492, DOI 10.1007/s00535-009-0033-y; Sakon M, 2002, CANCER, V94, P435, DOI 10.1002/cncr.10246; ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; LAWRENCE TS, 1995, INT J RADIAT ONCOL, V31, P1237, DOI 10.1016/0360-3016(94)00418-K; Ishikura S, 2002, AM J CLIN ONCOL-CANC, V25, P189, DOI 10.1097/00000421-200204000-00019; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; Choi Chihwan, 2014, Liver Cancer, V3, P405, DOI 10.1159/000343861; Fujino H, 2014, HEPATOL RES, DOI [10.1111/hepr.12392, DOI 10.1111/HEPR.12392]; Han KH, 2008, CANCER, V113, P995, DOI 10.1002/cncr.23684; Kondo M, 2011, JPN J CLIN ONCOL, V41, P69, DOI 10.1093/jjco/hyq145; Lee Dong Soo, 2014, Liver Cancer, V3, P18, DOI 10.1159/000343855; LEWIN K, 1973, ARCH PATHOL, V96, P21; Lin CS, 2006, JPN J CLIN ONCOL, V36, P212, DOI 10.1093/jjco/hyl006; Nakagawa K, 2005, WORLD J GASTROENTERO, V11, P7237; TOYODA H, 1995, ONCOLOGY, V52, P295; Yamada K, 2001, JPN J CLIN ONCOL, V31, P147, DOI 10.1093/jjco/hye029	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JAN	2015	9	1					105	112		10.1007/s12072-014-9592-y		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4XH	WOS:000348223800015		
J	Yashima, Y; Sato, S; Kawai, T; Sugimoto, T; Sato, T; Kanda, M; Obi, S				Yashima, Yoko; Sato, Shinpei; Kawai, Toshihiro; Sugimoto, Takafumi; Sato, Takahisa; Kanda, Miho; Obi, Shuntaro			Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma	HEPATOLOGY INTERNATIONAL			English	Article						Biliary carcinoma; Intraareterial infusion; 5-FU	ADVANCED HEPATOCELLULAR-CARCINOMA; HEPATIC ARTERIAL INFUSION; PORTAL VENOUS INVASION; INTRAHEPATIC CHOLANGIOCARCINOMA; COMBINATION THERAPY; PHASE-II; CISPLATIN; ALPHA; GEMCITABINE; MORTALITY	The prognosis in advanced biliary carcinoma has remained poor. The purpose of this study was to investigate the efficacy of intraarterial 5-fluorouracil and interferon therapy against unresectable biliary carcinoma. Patients with unresectable biliary carcinoma with performance status 0 or 1 were enrolled between January 2002 and September 2012. They received pegylated interferon-alpha 2a and intraarterial 5-FU every 4 weeks. The therapy was either terminated at the end of the first cycle for the patients with progressive disease or continued for at least three cycles. Patients' characteristics (physical, laboratory and radiographic) at the time of starting intraarterial 5-FU therapy were investigated. The relationship between the patients' characteristics and outcome, i.e., survival time and radiographic therapeutic evaluation of patients, was statistically analyzed. Tumor sites were the intrahepatic bile ducts in 23 patients and gallbladder in 2 patients. Previous treatment had been administered in ten patients. The overall response rate was 24 % (6 partial responses in 25 patients). Stable disease was observed in 13 patients. The median overall survival was 358 days. Among the six partial responses, three patients received surgery, and one patient received radiofrequency ablation because clinical downstaging was obtained. The treatment was well tolerated. The survival analyses revealed that two factors (serum albumin a parts per thousand yen3.5 and hypovascular tumor) were significantly associated with overall survival. Combination therapy with 5-FU and interferon-alpha was safe and may improve the prognosis of advanced biliary carcinomas.	[Yashima, Yoko; Sato, Shinpei; Kawai, Toshihiro; Sugimoto, Takafumi; Sato, Takahisa; Kanda, Miho; Obi, Shuntaro] Kyoundo Hosp, Dept Gastroenterol & Hepatol, Tokyo 1010062, Japan; [Yashima, Yoko] Kyoundo Hosp, Dept Gastroenterol, Chiyoda Ku, Tokyo 1010062, Japan	Yashima, Y (reprint author), Kyoundo Hosp, Dept Gastroenterol, Chiyoda Ku, 1-8 Kandasurugadai, Tokyo 1010062, Japan.	yashimay@gmail.com					Aljiffry M, 2009, WORLD J GASTROENTERO, V15, P4240, DOI 10.3748/wjg.15.4240; VAUTHEY JN, 1994, SEMIN LIVER DIS, V14, P109, DOI 10.1055/s-2007-1007302; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Kuroda M, 2007, HEPATO-GASTROENTEROL, V54, P518; Suzuki E, 2010, ONCOLOGY-BASEL, V79, P39, DOI 10.1159/000318020; Su CH, 1996, ANN SURG, V223, P384, DOI 10.1097/00000658-199604000-00007; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Kim JH, 2008, CANCER, V113, P1614, DOI 10.1002/cncr.23787; Monden M, 2012, HEPATOL RES, V42, P150, DOI 10.1111/j.1872-034X.2011.00905.x; Okabe H, 2009, ANN SURG ONCOL, V16, P2555, DOI 10.1245/s10434-009-0568-4; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Cantore M, 2002, ANN ONCOL, V13, P1687, DOI 10.1093/annonc/mdf262; Cantore M, 2005, CANCER-AM CANCER SOC, V103, P1402, DOI 10.1002/cncr.20964; Eun JR, 2009, SCAND J GASTROENTERO, V44, P1477, DOI 10.3109/00365520903367262; Kasai K, 2012, CANCER-AM CANCER SOC, V118, P3302, DOI 10.1002/cncr.26648	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	JAN	2015	9	1					142	148		10.1007/s12072-014-9583-z		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4XH	WOS:000348223800019		
J	Hiraga, K; Sakamoto, K; Arai, M; Seki, T; Toshinaga, H; Nakagawa, T; Uehara, K				Hiraga, Ken; Sakamoto, Kazumitsu; Arai, Maki; Seki, Tomohiro; Toshinaga, Hideki; Nakagawa, Tadao; Uehara, Kazuhiro			Dependency on Beamwidth in an SD Method Utilizing Two-Ray Fading Characteristics	IEEE ANTENNAS AND WIRELESS PROPAGATION LETTERS			English	Article						Beamwidth; parallel transmission; spatial division transmission; two-ray ground reflection		Using ray-tracing propagation calculation, we clarify the dependency on antenna element beamwidth of the channel capacity of a spatial division (SD) transmission method utilizing the characteristics of two-ray fading. It was clarified that the SD transmission method can be effectively applied to microstrip antennas or horn antennas with beamwidth of more than 10, but that it is not effective when applied to narrow-beam antennas with less than 10 beamwidth. In such cases, simple parallel transmission is a better way to utilize the narrow beam to increase channel capacity.	[Hiraga, Ken; Sakamoto, Kazumitsu; Arai, Maki; Seki, Tomohiro; Toshinaga, Hideki; Nakagawa, Tadao; Uehara, Kazuhiro] NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan	Hiraga, K (reprint author), NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan.	hiraga.ken@m.ieice.org; sakamoto.kazumitsu@lab.ntt.co.jp; arai.maki@lab.ntt.co.jp; seki.tomohiro@lab.ntt.co.jp; toshinaga.hideki@lab.ntt.co.jp; nakagawa.tadao@lab.ntt.co.jp; uehara.kazuhiro@lab.ntt.co.jp					Stutzman WL, 1998, IEEE ANTENNAS PROPAG, V40, P7, DOI 10.1109/74.730532; Kato A, 2001, IEICE T COMMUN, VE84B, P2530; Gilbert JM, 2008, IEEE MICRO, V28, P56, DOI 10.1109/MM.2008.20; Hiraga K, 2013, IEEE ANTENN WIREL PR, V12, P1622, DOI 10.1109/LAWP.2013.2294454; Hiraga K, 2014, IEEE ANTENN WIREL PR, V13, P126, DOI 10.1109/LAWP.2013.2297379; Hiraga K., 2013, IEICE COMMUN EXPRESS, V2, P193; Parsons D., 1992, MOBILE RADIO PROPAGA, P24; Tseng R, 2008, IEEE RADIO WIRELESS, P327, DOI 10.1109/RWS.2008.4463495; Uehara K., 1995, IEICE T J, VJ78-B-2, P593	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1225	1548-5757		IEEE ANTENN WIREL PR	IEEE Antennas Wirel. Propag. Lett.		2015	14						56	59		10.1109/LAWP.2014.2355258		4	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AZ9KX	WOS:000348534100015		
J	Itoh, K; Konno, K; Chen, Q; Inoue, S				Itoh, Kazuya; Konno, Keisuke; Chen, Qiang; Inoue, Shingo			Design of Compact Multiband Antenna for Triple-Band Cellular Base Stations	IEEE ANTENNAS AND WIRELESS PROPAGATION LETTERS			English	Article						Base station; front-to-back (F/B) ratio; half-power beamwidth; multiband antennas; tapered-slot antenna		In this letter, a tapered-slot antenna (TSA) that covers 1.5/2/2.4-GHz bands is designed for a 6-sector base station. It is shown that the TSA with desired half-power beamwidth and front-to-back (F/B) ratio at the frequency bands can be designed by loading the two pairs of slits and reflector. Results of numerical simulation show that the designed TSA radiates a sector beam with high F/B ratios over 20 dB at 1.5/2/2.4-GHz bands.	[Itoh, Kazuya; Konno, Keisuke; Chen, Qiang] Tohoku Univ, Dept Commun Engn, Sendai, Miyagi 9808579, Japan; [Inoue, Shingo] Hitachi Kokusai Yagi Solut Inc, Tokyo 1878511, Japan	Itoh, K (reprint author), Tohoku Univ, Dept Commun Engn, Sendai, Miyagi 9808579, Japan.	itok@ecei.tohoku.ac.jp; inoue.shingo@h-kokusai.com					Lai HW, 2006, IEEE T ANTENN PROPAG, V54, P564, DOI 10.1109/TAP.2005.863091; Luk KM, 2012, P IEEE, V100, P2297, DOI 10.1109/JPROC.2012.2187039; Cui YH, 2013, IEEE T ANTENN PROPAG, V61, P1132, DOI 10.1109/TAP.2012.2229377; Ebine Y., 1995, P 9 INT C ANT PROP A, V1, P340; Luo W., 2011, P CROSS STRAIT QUAD, V1, P483; Peng W., 2011, P MAPE INT S NOV, P493; Su D., 2007, P INT S MICR ANT PRO, P593; Voipio V, 2001, IEEE VTS VEH TECHNOL, P93, DOI 10.1109/VETECS.2001.944810; Wang Hui, 2006, Proceedings of the 2006 IEEE International Symposium on Electronics and the Environment (IEEE Cat. No. 06CH37796)	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1225	1548-5757		IEEE ANTENN WIREL PR	IEEE Antennas Wirel. Propag. Lett.		2015	14						64	67		10.1109/LAWP.2014.2354057		4	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AZ9KX	WOS:000348534100017		
J	Sun, C; Arakawa, A; Takeuchi, K				Sun, Chao; Arakawa, Asuka; Takeuchi, Ken			SEA-SSD: A Storage Engine Assisted SSD With Application-Coupled Simulation Platform	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						FTL; NAND flash memory; performance; simulation platform; SSD; storage engine	FLASH MEMORY	A storage engine assisted solid-state drive (SEA-SSD) has been proposed to improve the write performance of the SSDs for database applications. Since the SSD write performance bottleneck is caused by the garbage collection, the motivation of this work is to reduce the SSD garbage collection overhead by identifying, clustering and aggregating the data with similar activity in the same block of the NAND flash memory. This paper proposes the SEA-SSD to exploit the upstream information in the storage engine (SE) of database to classify the data pattern and predict the data activity. Hint information like the buffer pool/redo log size, page clean/dirty status, and frequency and access intervals are passed from the SE to the SSD controller. In order to co-design and optimize the database SE and SSD controller, an application-coupled platform has been developed and utilized for the evaluation of the SEA-SSD, which accelerates the simulation speed over 20-times and reduces the implementation complexity. Moreover, another two platforms are developed as well for the system-level optimizations of the SSDs, which are not specifically limited to the SEA-SSD. With the proposed SEA-SSD, maximum 24% performance improvement, 16% energy consumption reduction and 19% lifetime extension are achieved from the experimental results.	[Sun, Chao] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan; [Sun, Chao] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Arakawa, Asuka; Takeuchi, Ken] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan	Sun, C (reprint author), Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1128551, Japan.	sun@takeuchi-lab.org			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	This work was carried out as a part of "Development of High-speed Nonvolatile Memory Technology" project supported by the New Energy and Industrial Technology Development Organization (NEDO), and in part by the Ministry of Economy, Trade and Industry (METI). This paper was recommended by Associate Editor V. Chandra.	Agrawal N., 2008, P USENIX ANN TECHN C, P57; Kim Y, 2009, SIMUL: 2009 FIRST INTERNATIONAL CONFERENCE ON ADVANCES IN SYSTEM SIMULATION, P125; Gupta A, 2009, ACM SIGPLAN NOTICES, V44, P229; Chen F, 2011, INT S HIGH PERF COMP, P266; Caulfield AM, 2012, ASPLOS XVII: SEVENTEENTH INTERNATIONAL CONFERENCE ON ARCHITECTURAL SUPPORT FOR PROGRAMMING LANGUAGES AND OPERATING SYSTEMS, P387; Hu Y, 2013, IEEE T COMPUT, V62, P1141, DOI 10.1109/TC.2012.60; Huang PC, 2012, DES AUT CON, P882; Jung S, 2009, DES AUT CON, P907; BAN A, 1995, Patent No. 5404485; Bucy J. S., DISKSIM SIMULATION E; Canim M., 2010, P VLDB ENDOWMENT, V3; Caulfield Adrian M, 2010, Proceedings 2010 43rd Annual IEEE/ACM International Symposium on Microarchitecture (MICRO 2010), DOI 10.1109/MICRO.2010.33; Chen Z., 2005, Performance Evaluation Review, V33; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; HATANAKA T, 2010, P IEEE S VLSI CIRC J, P233; Katcher J., 1997, TR3022 NETW APPL; Kim J. K., 2008, P 8 ACM INT C EMB SO, P31, DOI 10.1145/1450058.1450064; Li X., 2005, P 4 USENIX C FIL STO, P115; Liu R. S., 2013, P ACML, P1; Ma D., 2011, P 2011 INT C MAN DAT, P1; Micron Technology Inc, MT29F512G08CUCAB DAT; Park D., 2011, PROCEEDINGS OF IEEE, P1; Park D., 2012, P ANN ACM S APPL COM, P1610; Peter S., 2014, P WORKSH HOT TOP STO; Seol J., 2009, P INT C COMP ARCH SY, P137, DOI 10.1145/1629395.1629416; Sun C, 2014, IEEE T CIRCUITS-I, V61, P382, DOI 10.1109/TCSI.2013.2268111; Synopsys Inc, 2010, SYN VIRT PROT SOL; Trivedi A., 2013, P USENIX WORKSH HOT, P4; Xu ZY, 2012, 2012 IEEE 31ST INTERNATIONAL PERFORMANCE COMPUTING AND COMMUNICATIONS CONFERENCE (IPCCC), P142	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	JAN	2015	62	1					120	129		10.1109/TCSI.2014.2343571		10	Engineering, Electrical & Electronic	Engineering	AY6XQ	WOS:000347706500013		
J	Fujisaka, H; Kamio, T; Ahn, CJ; Sakamoto, M; Haeiwa, K				Fujisaka, Hisato; Kamio, Takeshi; Ahn, Chang-Jun; Sakamoto, Masahiro; Haeiwa, Kazuhisa			A Sigma-Delta Domain Lowpass Wave Filter	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Digital filter; distributed parameter filter; lowpass filter; sigma-delta modulation	ARITHMETIC CIRCUITS; FIR FILTERS; MODULATION; REALIZATION; OPERATIONS; DESIGN	This paper presents a sigma-delta (SD) domain lowpass wave filter modeled after an analog distributed parameter filter (ADPF). The SD domain filter operating on SD modulated signals is built with two kinds of units, shift registers on which two-level-quantized waves propagate and sorter-based units that simulate reflection, transmission, and superposition of waves propagating on the transmission lines of the ADPF. The SD domain lowpass filter has the following advantages: First, design techniques for ADPFs can be applied directly to the SD domain filter. Secondly, the SD domain filter consists mainly of shift registers and sorting networks. Because the structures of the registers and the networks are spatially uniform and their internal connections are local, the filter architecture will mitigate difficulties in physical design and fabrication of filter circuits using nanometer-scale quantum effect devices. We confirmed by computer simulation that the designed SD domain filter possessed the same frequency response characteristics as the theoretical characteristics of the reference ADPF. Although internal units of SD domain filters generate SD modulation noise, it does not change to aliasing noise in the signal band because the operations of the units are linear. Therefore, the quantization noise contained in the outputs of SD domain filters is shaped like SD modulation noise.	[Fujisaka, Hisato; Kamio, Takeshi; Haeiwa, Kazuhisa] Hiroshima City Univ, Fac Informat Sci, Hiroshima 7313194, Japan; [Ahn, Chang-Jun] Chiba Univ, Fac Engn, Chiba 2638522, Japan; [Sakamoto, Masahiro] Saitama Inst Technol, Fac Engn, Saitama 3690293, Japan	Fujisaka, H (reprint author), Hiroshima City Univ, Fac Informat Sci, Hiroshima 7313194, Japan.	fujisaka@info.hiroshima-cu.ac.jp; kamio@info.hiroshima-cu.ac.jp; junny@faculty.chiba-u.jp; sakapon@sit.ac.jp; haeiwa-kazu@jcom.home.ne.jp					Banerjee SK, 2010, P IEEE, V98, P2032, DOI 10.1109/JPROC.2010.2064151; Lent CS, 1997, P IEEE, V85, P541, DOI 10.1109/5.573740; Haselman M, 2010, P IEEE, V98, P11, DOI 10.1109/JPROC.2009.2032356; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Nakajima K, 1991, IEEE T APPL SUPERCON, V1, P29, DOI 10.1109/77.80746; [Anonymous], 2011, INT TECHNOLOGY ROADM; Awano Y, 2010, P IEEE, V98, P2015, DOI 10.1109/JPROC.2010.2068030; de la Rosa JM, 2011, IEEE T CIRCUITS-I, V58, P1, DOI 10.1109/TCSI.2010.2097652; Likharev KK, 1991, IEEE T APPL SUPERCON, V1, P3, DOI 10.1109/77.80745; Vuillaume D, 2010, P IEEE, V98, P2111, DOI 10.1109/JPROC.2010.2063410; Arce GR, 2000, IEEE T SIGNAL PROCES, V48, P489, DOI 10.1109/78.823975; Candy J. C., 1992, OVERSAMPLING DELTA S, P1; Chopard B., 1998, CELLULAR AUTOMATA MO; DIAS VD, 1995, MICROELECTRON J, V26, P543; Dick C, 2000, IEEE SIGNAL PROC MAG, V17, P20, DOI 10.1109/79.814644; FREEDMAN M, 1990, SIGNAL PROCESS, V21, P25, DOI 10.1016/0165-1684(90)90024-S; Fujisaka H., 2013, NONLINEAR THEORY ITS, V4, P313; Fujisaka H, 2012, IEEE T CIRCUITS-I, V59, P1952, DOI 10.1109/TCSI.2011.2180451; Fujisaka H, 2012, IEEE T CIRCUITS-I, V59, P1966, DOI 10.1109/TCSI.2011.2180450; Goddard III W. A., 2012, HDB NANOSCIENCE ENG; Graham P, 2004, NANO, QUANTUM AND MOLECULAR COMPUTING: IMPLICATIONS TO HIGH LEVEL DESIGN AND VALIDATION, P39, DOI 10.1007/1-4020-8068-9_2; Hoekstra J., 2010, INTRO NANOELECTRONIC; Hong J. S., 2001, MICROSTRIP FILTERS R; Hosseini K, 2011, ANALOG CIRC SIG PROC, P1, DOI 10.1007/978-1-4614-0094-3; Huang C., 2010, LECT NOTES ELECT ENG, V58; JOHNS DA, 1993, IEEE T CIRCUITS-II, V40, P233, DOI 10.1109/82.224314; Jznowicz M. W., 2006, P ROY SOC A, V462, P2927; Kennedy M. P., 2012, NONLINEAR THEORY ITS, V3, P258; Kershaw SM, 1996, IEE P-CIRC DEV SYST, V143, P267, DOI 10.1049/ip-cds:19960708; Kouvaras N., 1978, Radio and Electronic Engineer, V48; Lagoyannis D., 1981, Radio and Electronic Engineer, V51; Lombardi  F., 2008, DESIGN TEST DIGITAL; Lyshevski S. E., 2007, NANO MOL ELECT HDB; Matthaei G., 1980, MICROWAVE FILTERS IM; PNEUMATIKAKIS A, 1995, INT J ELECTRON, V78, P1071, DOI 10.1080/00207219508926232; Pozar D. M., 2011, MICROWAVE ENG; Roy S, 2005, IEEE T NANOTECHNOL, V4, P441, DOI 10.1109/TNANO.2005.851251; Suzuki Y., 2007, P IEEE INT WORKSH NO, P18; van Engelen J., 1999, BANDPASS SIGMA DELTA; WONG PW, 1990, IEEE T ACOUST SPEECH, V38, P979, DOI 10.1109/29.56058; WONG PW, 1992, IEEE T SIGNAL PROCES, V40, P1605, DOI 10.1109/78.139273; Yasuno T., 2011, P EUR C CIRC THEOR D, P793	42	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	JAN	2015	62	1					167	176		10.1109/TCSI.2014.2348071		10	Engineering, Electrical & Electronic	Engineering	AY6XQ	WOS:000347706500018		
J	Aref, AF; Hone, TM; Negra, R				Aref, Ahmed F.; Hone, Thomas M.; Negra, Renato			A Study of the Impact of Delay Mismatch on Linearity of Outphasing Transmitters	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Amplifier linearization; linear amplification with nonlinear components (LINC); mobile communications; outphasing transmitter; RF power amplifier; signal component seperator (SCS)	LINC TRANSMITTERS; CALIBRATION; MODULATION; IMBALANCES	This paper presents an analytical study of the impact of delay mismatch on the linearity of outphasing transmitters. Analytical expressions are derived to quantify the impact of delaymismatch between the two amplifying paths on the adjacent channel power ratio and error vector magnitude of any complex modulated output signal. These expressions can be used to specify delay mismatch for any given requirement of linearity performance of an outphasing transmitter. A complete LTE transceiver physical layer model in simulink is used to simulate the whole transceiver chain. An embedded model of an outphasing transmitter with a variable delay mismatch is included to compare error vector magnitude simulation data with theoretically derived results for different LTE downlink channels of 1.4 MHz, 10 MHz and 20 MHz channel bandwidths. Outphasing signals are synthesized with different delays and uploaded to a vector signal generator such that adjacent channel power ratios can be measured. This allows for a comparison between hardware-probed results and the theoretical calculations for LTE channels of 1.4 MHz and 10 MHz channel bandwidths.	[Aref, Ahmed F.; Negra, Renato] Rhein Westfal TH Aachen, D-52074 Aachen, Germany; [Hone, Thomas M.] Toshiba RDC, Kawasaki, Kanagawa 2128582, Japan	Aref, AF (reprint author), Rhein Westfal TH Aachen, D-52074 Aachen, Germany.	aaref@ias.rwth-aachen.de; thone@ias.rwth-aachen.de; negra@umic.rwth-aachen.de					Hur J, 2011, IEEE T VEH TECHNOL, V60, P4184, DOI 10.1109/TVT.2011.2171062; Garcia P, 2005, IEEE T VEH TECHNOL, V54, P879, DOI 10.1109/TVT.2005.844641; [Anonymous], 2013, ERICSSON MOBILITY RE; Chung SW, 2010, IEEE MTT S INT MICR, P264; Romano L, 2006, IEEE T CIRCUITS-I, V53, P1572, DOI 10.1109/TCSI.2006.877886; Guan JQ, 2013, EUR MICROW CONF, P728; Chireix H, 1935, P IRE, V23, P1370, DOI 10.1109/JRPROC.1935.227299; Aref A. F., 2011, Proceedings of the 2011 Asia Pacific Microwave Conference (APMC); COX DC, 1974, IEEE T COMMUN, VCO22, P1942, DOI 10.1109/TCOM.1974.1092141; Godoy P. A., 2011, IEEE MTT S INT MICR, P1; Guan J., 2014, IEEE MTT S INT MICR; Hone T. M., 2014, P GERM MICR C GEMIC, P1; Huang XP, 2012, IEEE INT SYMP CIRC S, P1247; Kulkarni S., 2012, P IEEE INT C EL CIRC, P169; Laskar J, 2010, IEEE INT SYMP CIRC S, P821, DOI 10.1109/ISCAS.2010.5537441; Sundstrom L, 2000, IEEE T VEH TECHNOL, V49, P1474, DOI 10.1109/25.875287; Zhang XJ, 2001, IEEE T MICROW THEORY, V49, P2507, DOI 10.1109/22.971643	17	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	JAN	2015	62	1					254	262		10.1109/TCSI.2014.2349573		9	Engineering, Electrical & Electronic	Engineering	AY6XQ	WOS:000347706500027		
J	Sugimoto, Y; Sai, T; Watanabe, K; Abe, M				Sugimoto, Yasuhiro; Sai, Toru; Watanabe, Kei; Abe, Mikio			Feedback Loop Analysis and Optimized Compensation Slope of the Current-Mode Buck DC-DC Converter in DCM	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Buck DC-DC; current-mode; DCM; duty-independent frequency characteristics; quadratic slope	DISCONTINUOUS CONDUCTION MODE; PWM CONVERTERS; SCHEME; INPUT; CCM	Frequency characteristics of the total feedback loop of a current-mode buck DC-DC converter in the discontinuous conduction mode (DCM) are examined by formulating an equivalent small-signal transfer function using a proposed block structure that does not suffer direct influence from the current feedback. Utilizing this transfer function, it is clarified that the type of the compensation slope in a current feedback loop affects the loop frequency characteristics in DCM, and in terms of stability, high voltage gain and large 0-dB frequency bandwidth, the quadratic compensation slope is more effective than the linear compensation slope. The validity of the proposed block structure and formulations and the effectiveness of applying a quadratic compensation slope instead of a linear compensation slope in DCM are verified by comparing calculation results, SPICE simulation results and evaluation results using circuit and measurement data from an MOS current-mode buck DC-DC converter IC that had been previously fabricated. More than 10-dB higher voltage gain, three times larger 0-dB frequency bandwidth, more than 10-degree larger phase margin and faster recovery time in load current change are realizable in DCM compared with the case using a linear compensation slope.	[Sugimoto, Yasuhiro; Watanabe, Kei; Abe, Mikio] Chuo Univ, Tokyo 1128551, Japan; [Sai, Toru] Tokyo Polytech Univ, Tokyo 1640012, Japan	Sugimoto, Y (reprint author), Chuo Univ, Tokyo 1128551, Japan.	sugimoto@elect.chuo-u.ac.jp; t.sai@em.t-kougei.ac.jp; nabe12@elect.chuo-u.ac.jp; abe13@elect.chuo-u.ac.jp			VLSI Design and Education Center, the University of Tokyo	This work was supported by VLSI Design and Education Center, the University of Tokyo, which arranged the fabrication of the test chips. This paper was recommended by Associate Editor F. M. Neri.	Du MM, 2010, IEEE T CIRCUITS-I, V57, P2804, DOI 10.1109/TCSI.2010.2046258; Davoudi A, 2006, IEEE T POWER ELECTR, V21, P1003, DOI 10.1109/TPEL.2006.876848; Sun J, 2001, IEEE T POWER ELECTR, V16, P482; Umimura K, 2007, PROC EUR SOLID-STATE, P178; Reatti A, 2003, IEEE T CIRCUITS-I, V50, P65, DOI 10.1109/TCSI.2002.805709; Chang W. H., 2008, P INT C COMM CIRC SY, P1061; Erickson R. W., 2001, FUNDAMENTALS POWER E, P107; Fukushima K., 2006, P EPE PEMC, P1682; IFTIKHAR MU, 2008, P POW EL SPEC C, P2257; Bryant B, 2005, IEEE T CIRCUITS-I, V52, P2404, DOI 10.1109/TCSI.2005.853904; Lan PH, 2012, IEEE T CIRCUITS-I, V59, P2468, DOI 10.1109/TCSI.2012.2188937; Pressman A. I., 2009, SWITCHING POWER SUPP; Ramos J. L., 2000, P 2000 IEEE INT C CO, P548; Ridley R. B., P 21 ANN IEEE POW EL, P382; Sai T, 2012, IEICE T ELECTRON, VE95C, P677, DOI 10.1587/transele.E95.C.677; Sai T, 2009, IEEE ASIAN SOLID STA, P337, DOI 10.1109/ASSCC.2009.5357163; Sakurai H, 2005, IEICE T FUND ELECTR, VE88A, P490, DOI 10.1093/ietfec/E88-A.2.490; Su F., 2009, IEEE ISSCC, P446; Sugimoto Yasuhiro, 2009, Proceedings of the 35th European Solid-State Circuits Conference. ESSCIRC 2009, DOI 10.1109/ESSCIRC.2009.5325976; Vorperian V., 2002, FAST ANAL TECHNIQUES	20	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	JAN	2015	62	1					311	319		10.1109/TCSI.2014.2358313		9	Engineering, Electrical & Electronic	Engineering	AY6XQ	WOS:000347706500033		
J	Sekiguchi, S; Nitta, T; Karatsu, K; Sekimoto, Y; Okada, N; Tsuzuki, T; Kashima, S; Sekine, M; Okada, T; Shu, S; Naruse, M; Dominjon, A; Noguchi, T; Matsuo, H				Sekiguchi, Shigeyuki; Nitta, Tom; Karatsu, Kenichi; Sekimoto, Yutaro; Okada, Norio; Tsuzuki, Toshihiro; Kashima, Shingo; Sekine, Masakazu; Okada, Takashi; Shu, Shibo; Naruse, Masato; Dominjon, Agnes; Noguchi, Takashi; Matsuo, Hiroshi			Development of a Compact Cold Optics for Millimeter and Submillimeter Wave Observations	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Compact cold optics; high refractive lens; millimeter-wave astronomy	SILICON; CAMERA; BOLOMETERS; ANTENNAS; LENSES	We have developed an optics for 220 GHz observations, which is a compact cold re-imaging one from a telescope focal plane, with F / # = 6 to a detector plane with F / # = 1 at 100 mK. It employs two high refractive lenses, high purity alumina (n = 3.1) and silicon (n = 3.4). To reduce the incident stray light into the detector, a cold nested baffle composed of four reflectors with the same spherical shape has been developed. The stray light power is simulated to be 0.2 mu W which corresponds a quarter of that of a without-baffles case. The total transmittance of three kinds of IR blocking filters is 0.78 at the observation frequency, and less than 10(-10) above 6 THz. Thermal flow power into the detector, including the stray light power, is about 0.7 mu W. The cold optics with an 600 pixels MKID camera has been cooled down to 100 mK.	[Sekiguchi, Shigeyuki; Sekimoto, Yutaro; Sekine, Masakazu; Okada, Takashi; Shu, Shibo] Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1138654, Japan; [Sekiguchi, Shigeyuki; Nitta, Tom; Karatsu, Kenichi; Sekimoto, Yutaro; Okada, Norio; Tsuzuki, Toshihiro; Sekine, Masakazu; Okada, Takashi; Shu, Shibo; Dominjon, Agnes; Noguchi, Takashi; Matsuo, Hiroshi] Natl Astron Observ Japan, Adv Technol Ctr, Mitaka, Tokyo 1818588, Japan; [Nitta, Tom] JSPS Res, Chiyoda Ku, Tokyo 1028472, Japan; [Kashima, Shingo] Natl Astron Observ Japan, JASMINE Project, Mitaka, Tokyo 1818588, Japan; [Naruse, Masato] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	Sekiguchi, S (reprint author), Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1138654, Japan.	shigeyuki.sekiguchi@nao.ac.jp			MEXT/JSPS KAKENHI [21111003, 25247022, 24111712]; JSPS [25001164]	This work was supported by MEXT/JSPS KAKENHI Grants 21111003, 25247022, 24111712, and by a Grant-in-Aid for JSPS Fellows (No. 25001164).	Ade PAR, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/62; PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331; Naruse M, 2013, IEEE T THZ SCI TECHN, V3, P180, DOI 10.1109/TTHZ.2012.2237029; Hazumi M, 2012, PROC SPIE, V8442, DOI 10.1117/12.926743; Ade PAR, 2006, P SOC PHOTO-OPT INS, V6275, pU2750, DOI 10.1117/12.673162; Nitta T, 2013, IEEE T THZ SCI TECHN, V3, P56, DOI 10.1109/TTHZ.2012.2235123; IRWIN KD, 1995, APPL PHYS LETT, V66, P1998, DOI 10.1063/1.113674; RICHARDS PL, 1994, J APPL PHYS, V76, P1, DOI 10.1063/1.357128; Day PK, 2003, NATURE, V425, P817, DOI 10.1038/nature02037; Blain AW, 2002, PHYS REP, V369, P111, DOI 10.1016/S0370-1573(02)00134-5; Naruse M, 2012, J LOW TEMP PHYS, V167, P373, DOI 10.1007/s10909-011-0430-5; SWENSON CA, 1983, J PHYS CHEM REF DATA, V12, P179; Persky MJ, 1999, REV SCI INSTRUM, V70, P2193, DOI 10.1063/1.1149739; WACHTMAN JB, 1962, J AM CERAM SOC, V45, P319, DOI 10.1111/j.1151-2916.1962.tb11159.x; Atad-Ettedgui E, 2006, P SOC PHOTO-OPT INS, V6273, pH2732, DOI 10.1117/12.669231; Benford DJ, 2003, APPL OPTICS, V42, P5118, DOI 10.1364/AO.42.005118; Choi J, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4827081; Egan I, 2002, P SOC PHOTO-OPT INS, V4836, P321, DOI 10.1117/12.458116; Emerson J, 2002, P SOC PHOTO-OPT INS, V4836, P35, DOI 10.1117/12.456741; FILIPOVIC DF, 1993, IEEE T MICROW THEORY, V41, P1738, DOI 10.1109/22.247919; Guiderdoni B, 1998, MON NOT R ASTRON SOC, V295, P877, DOI 10.1046/j.1365-8711.1998.01308.x; Hollister MI, 2010, PROC SPIE, V7741, DOI 10.1117/12.856780; Ishii S, 2010, POLAR SCI, V3, P213, DOI 10.1016/j.polar.2009.08.001; Kermish ZD, 2012, PROC SPIE, V8452, DOI 10.1117/12.926354; KUNO N, 1993, INT J INFRARED MILLI, V14, P749, DOI 10.1007/BF02084285; Matsumura T, 2012, PROC SPIE, V8452, DOI 10.1117/12.926770; Matsuo H, 1998, PUBL ASTRON SOC JPN, V50, P359; Niemack MD, 2010, PROC SPIE, V7741, DOI 10.1117/12.857464; Nitta T, 2014, J LOW TEMP PHYS, V176, P677, DOI 10.1007/s10909-013-1059-3; Nitta T, 2014, J LOW TEMP PHYS, V176, P684, DOI 10.1007/s10909-013-1028-x; Pobell F., 1996, MATTER METHODS LOW T, V2; Sebring TA, 2006, P SOC PHOTO-OPT INS, V6267, pC2672, DOI 10.1117/12.668735; Sekimoto Y, 2014, PROC SPIE, V9153, DOI 10.1117/12.2055666; Sugimoto M, 2003, CRYOGENICS, V43, P435, DOI 10.1016/S0011-2275(03)00098-5; Tsuzuki T, 2014, PROC SPIE, V9153, DOI 10.1117/12.2055694; Wilson GW, 2008, MON NOT R ASTRON SOC, V386, P807, DOI 10.1111/j.1365-2966.2008.12980.x; Yoon K W, 2006, Proceedings of the SPIE - The International Society for Optical Engineering, V6275, DOI 10.1117/12.672652	37	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	JAN	2015	5	1					49	56		10.1109/TTHZ.2014.2367245		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AZ3KB	WOS:000348124900010		
J	Imada, H; Nagai, M; Kino, M; Seta, M; Ishii, S; Nakai, N				Imada, Hiroaki; Nagai, Makoto; Kino, Masaru; Seta, Masumichi; Ishii, Shun; Nakai, Naomasa			Condition of Optical Systems Independent of Frequency for Wide Field-of-View Radio Telescopes	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Electromagnetic diffraction		In this paper, we present a condition of optical systems to form images independent of frequency. The condition independent of frequency in case of a single Gaussian beam on an optical axis has been known, but that in case of a beam propagated off the axis or tilted beam, which appears in a wide field-of-view (FOV) telescope, has not been known. We first show relations between an arbitrary electric field on an object plane and an induced one on an image plane after passing through a lens with calculating Fresnel diffraction integrals. If the lens formula is met, there is a one-to-one correspondence between points on the object and image plane. This result enables to use geometrical optical methods. The condition and relations derived here are confirmed by simulations. We also applied them to a wide-FOV telescope.	[Imada, Hiroaki; Nagai, Makoto; Seta, Masumichi; Nakai, Naomasa] Univ Tsukuba, Dept Phys, Tsukuba, Ibaraki 3058571, Japan; [Kino, Masaru] Kyoto Univ, Dept Astron, Kyoto 6068502, Japan; [Ishii, Shun] Univ Tsukuba, Tsukuba, Ibaraki 3058571, Japan; [Ishii, Shun] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan	Imada, H (reprint author), Univ Tsukuba, Dept Phys, Tsukuba, Ibaraki 3058571, Japan.	s1330093@u.tsukuba.ac.jp			Japan Society for the Promotion of Science (JSPS)	This work of H. Imada was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows.	Fowler JW, 2007, APPL OPTICS, V46, P3444, DOI 10.1364/AO.46.003444; Born M., 1999, PRINCIPLES OPTICS, P186; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; Chang S, 2013, PROC SPIE, V8860, DOI 10.1117/12.2023433; CHU TS, 1983, IEEE T ANTENN PROPAG, V31, P614; Goodman J. W., 1968, INTRO FOURIER OPTICS; Kataza H, 2012, PROC SPIE, V8442, DOI 10.1117/12.926082; MARTIN DH, 1993, IEEE T MICROW THEORY, V41, P1676, DOI 10.1109/22.247911; Padin S, 2010, PROC SPIE, V7733, DOI 10.1117/12.856489; Terebizh V Yu, 2008, Bulletin of the Crimean Astrophysical Observatory, V104, DOI 10.3103/S0190271708010245	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	JAN	2015	5	1					57	63		10.1109/TTHZ.2014.2365680		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AZ3KB	WOS:000348124900011		
J	Tosaka, T; Fujii, K; Fukunaga, K; Kasamatsu, A				Tosaka, Toshihide; Fujii, Katsumi; Fukunaga, Kaori; Kasamatsu, Akifumi			Development of Complex Relative Permittivity Measurement System Based on Free-Space in 220-330-GHz Range	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Complex relative permittivity; continuous wave (CW); free-space method; measurement uncertainty; time-domain spectroscopy	TIME-DOMAIN SPECTROSCOPY	For measuring complex relative permittivity of more than 300 GHz in the THz region, time-domain spectroscopy (TDS) is usually used. On the other hand, a free-space method using a vector network analyzer (VNA) is used below 300 GHz. However, these methods have not been compared and continuity of complex relative permittivity measurement around 300 GHz has not been evaluated. We developed a system for measuring complex relative permittivity that can be operated at 220-330 GHz. This system is based on the free-space method. We compared the complex relative permittivity using a VNA and by TDS to evaluate our system and the continuity of complex relative permittivity measurement in the frequency domain. We first compared relative permittivity and dielectric loss between both methods. We then evaluated the measurement uncertainty in consideration of the thickness of materials under test (MUT), time span of the time-domain gating, linearity, stability, aperture alignment, and measurement repeatability. The dispersion in MUT thickness measurement was found to be the dominant source of uncertainty in measuring complex relative permittivity measurement. The maximum difference in relative permittivity and dielectric loss between both methods was less than 0.22 and 0.17 when MUT E was measured. For the measurement result with expanded uncertainty, the relative permittivity of VNA was 3.92 +/- 0.44 and that of TDS was 3.70 +/- 0.16 the dielectric loss of VNA was 0.30 +/- 0.52 and that of TDS was 0.13 +/- 0.02 respectively. The measured complex relative permittivity by using the VNA and by TDS were observed within the expanded uncertainty. We verified the availability of the measured complex relative permittivity by using our measurement system and the continuity of complex relative permittivity measurement at 300-GHz band.	[Tosaka, Toshihide; Fujii, Katsumi; Fukunaga, Kaori; Kasamatsu, Akifumi] Natl Inst Informat & Commun Technol, Tokyo 1848795, Japan	Tosaka, T (reprint author), Natl Inst Informat & Commun Technol, Tokyo 1848795, Japan.	tosaka@nict.go.jp			Ministry of Internal Affairs and Communications, Japan	This work was supported in part by "The research and development project for the expansion of radio spectrum resources" of the Ministry of Internal Affairs and Communications, Japan (Multi-tens gigabit wireless communication technology at sub-terahertz frequencies).	Dorney TD, 2001, J OPT SOC AM A, V18, P1562, DOI 10.1364/JOSAA.18.001562; [Anonymous], 2014, AS7500TSSI1E131; [Anonymous], 2008, 1002008 JCGM, V100, P2008; [Anonymous], 2013, ATTENUATION ATMOSPHE; [Anonymous], 2001, 85108A AG TECHN; GHODGAONKAR DK, 1990, IEEE T INSTRUM MEAS, V39, P387, DOI 10.1109/19.52520; CAMPBELL CK, 1978, IEEE T INSTRUM MEAS, V27, P54, DOI 10.1109/TIM.1978.4314617; Fukunaga K, 2012, C ELECT INSUL DIEL P, P448, DOI 10.1109/CEIDP.2012.6378816; Fukunaga K., 2007, P INT C EL ADV APPL, P332; RALPH SE, 1994, J OPT SOC AM B, V11, P2528, DOI 10.1364/JOSAB.11.002528; Satellite Regional Broadcasting Div. Inf. Commun. Bureau Ministry of Internal Affairs and Commun., 2014, NEW BREEZE 2014 SPRI, V26, P2; Tosaka T., 2013, P IRMMW SEP, P1; Wanke M. C., 2011, TRANSCEIVERS CONQUER; Wilk R, 2008, IEEE J SEL TOP QUANT, V14, P392, DOI 10.1109/JSTQE.2007.910981; Withayachumnankul W, 2014, J INFRARED MILLIM TE, V35, P610, DOI 10.1007/s10762-013-0042-z	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	JAN	2015	5	1					102	109		10.1109/TTHZ.2014.2362013		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AZ3KB	WOS:000348124900017		
J	Noguchi, M; Miura, N; Ando, T; Kubota, C; Hobo, S; Kawaguchi, H; Tanimoto, A				Noguchi, Michiko; Miura, Naoki; Ando, Takaaki; Kubota, Chikara; Hobo, Seiji; Kawaguchi, Hiroaki; Tanimoto, Akihide			Profiles of Reproductive Hormone in the Microminipig During the Normal Estrous Cycle	IN VIVO			English	Article						Miniature pig; hormone profiles; estrous cycle	PERIPHERAL CONCENTRATIONS; OVARIAN-STEROIDS; MINIATURE SWINE; INHIBIN-A; ESTRUS; OVULATION; TIME; GONADOTROPINS; PIGS; LH	We investigated changes in the peripheral plasma concentrations of ovarian steroids and gonadotropins throughout the estrous cycle of the Microminipig (MMpig), a novel experimental animal model. The mean (+/- standard error of the mean (SEM)) duration of estrous and the estrous cycle in seven animals was 66.0 +/- 5.2 h and 20.6 +/- 0.3 days, respectively. A luteinizing hormone (LH) surge was observed 16.5 +/- 6.5 h after the onset of estrous in six out of the seven animals. The LH peak and the duration of the LH surge were 14.0 +/- 4.5 ng/ml and 34.0 +/- 2.0 h, respectively. Plasma progesterone concentrations started to decline on Day 7 (Day 0 = the day of the LH peak) and increased from Day 4. Estradiol-17 beta levels increased from Day 3 and reached a maximum (37.0 +/- 1.6 pg/ml) on Day 0.75. Follicle-stimulating hormone (FSH) concentrations showed a first and second surge on Days 0 and 1.75. An inverse relationship between FSH and estradiol-17 beta concentrations was noted before the LH surge. The characteristics of estrous and the gonadotropin and ovarian steroid profiles throughout the estrous cycle of MMpigs are similar to those of domestic pigs and other miniature pig strains.	[Noguchi, Michiko; Hobo, Seiji] Kagoshima Univ, Joint Fac Vet Med, Labs Domest Anim Internal Med, Korimoto, Kagoshima, Japan; [Ando, Takaaki; Kubota, Chikara] Kagoshima Univ, Joint Fac Vet Med, Labs Vet Theriogenol, Korimoto, Kagoshima, Japan; [Kawaguchi, Hiroaki] Kagoshima Univ, Joint Fac Vet Med, Labs Vet Histophathol, Korimoto, Kagoshima, Japan; [Miura, Naoki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Korimoto, Kagoshima, Japan; [Tanimoto, Akihide] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Sakuragaoka, Kagoshima, Japan	Kawaguchi, H (reprint author), Kagoshima Univ, Joint Fac Vet Med, Dept Vet Histopathol, 1-21-35 Korimoto, Kagoshima 8900065, Japan.	k3038952@kadai.jp; akit09@m3.kufm.kagoshima-u.ac.jp			JSPS KAKENHI [26870455]; Ministry of Health, Labour and Welfare of Japan [33361105]; Adaptable and Seamless Technology Transfer Program from the Ministry of Education Culture, Sports, Science and Technology of Japan [AS2316907E]	This work was partly supported by JSPS KAKENHI Grant Numbers 26870455, Health Labour Sciences Research Grant (No. 33361105) from the Ministry of Health, Labour and Welfare of Japan (to AT and HK), Adaptable and Seamless Technology Transfer Program (A-Step No. AS2316907E) from the Ministry of Education Culture, Sports, Science and Technology of Japan (to AT and HK). We thank Dr. A.F. Parlow of the National Hormone and Peptide Program of the National Institute of Diabetes and Digestive and Kidney Diseases, Harbor-UCLA Medical Center, Torrance, CA, USA for providing the porcine FSH and LH immunoassay kits.	Almeida FRCL, 2000, THERIOGENOLOGY, V53, P1389, DOI 10.1016/S0093-691X(00)00281-8; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; SOEDE NM, 1994, J REPROD FERTIL, V101, P633; Waberski D, 1997, J REPROD FERTIL, V109, P29; Akioka K, 2014, IN VIVO, V28, P81; Noguchi M, 2010, REPRODUCTION, V139, P153, DOI 10.1530/REP-09-0018; SKINNER DC, 1995, ENDOCRINOLOGY, V136, P3230, DOI 10.1210/en.136.8.3230; SOEDE NM, 1995, J REPROD FERTIL, V104, P99; Sugiyama A, 2011, J PHARMACOL SCI, V115, P122, DOI 10.1254/jphs.10R21FM; BOOK SA, 1974, J ANIM SCI, V38, P997; Kaneko H, 2002, BIOL REPROD, V67, P38, DOI 10.1095/biolreprod67.1.38; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Steverink DWB, 1999, J ANIM SCI, V77, P801; Kaneko N, 2011, J PHARMACOL SCI, V115, P112, DOI 10.1254/jphs.10R16FM; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; Adams GP, 2008, THERIOGENOLOGY, V69, P72, DOI 10.1016/j.theriogenology.2007.09.026; DIEHL JR, 1986, BIOL REPROD, V35, P1261, DOI 10.1095/biolreprod35.5.1261; Glantz SA, 1990, PRIMER APPL REGRESSI, P381; GUTHRIE HD, 1993, DOMEST ANIM ENDOCRIN, V10, P127, DOI 10.1016/0739-7240(93)90018-7; HOWARD PK, 1983, J ANIM SCI, V57, P1517; Kakimoto T, 2014, IN VIVO, V28, P579; Kawaguchi H, 2012, J VET MED SCI, V74, P933, DOI 10.1292/jvms.11-0571; Kawaguchi H, 2013, IN VIVO, V27, P617; Kuge T, 2006, J REPROD DEVELOP, V52, P391, DOI 10.1262/jrd.17074; Lindloff G, 1976, Biol Reprod, V15, P303, DOI 10.1095/biolreprod15.3.303; Medan MS, 2003, BIOL REPROD, V69, P57, DOI 10.1095/biolreprod.102.013334; Miura N, 2014, VIVO IN PRESS; Miura N, 2013, IN VIVO, V27, P357; Miyoshi N, 2010, IN VIVO, V24, P671; Noguchi M, 2007, J VET MED SCI, V69, P1291, DOI 10.1292/jvms.69.1291; Ohnuma K, 2007, DOMEST ANIM ENDOCRIN, V33, P410, DOI 10.1016/j.domaniend.2006.08.004; Prather RS, 1997, THERIOGENOLOGY, V47, P433, DOI 10.1016/S0093-691X(97)00002-2; RHODES FM, 1995, J REPROD FERTIL, V104, P33; Takeishi K, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/472982; Yoshikawa T, 2013, TOXICOL PATHOL, V41, P109, DOI 10.1177/0192623312452489	35	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	JAN-FEB	2015	29	1					17	22				6	Medicine, Research & Experimental	Research & Experimental Medicine	AZ3NM	WOS:000348134300003		
J	Mabuchi, M; Shimizu, T; Ueda, M; Sasakawa, Y; Nakao, S; Ueda, Y; Kawamura, A; Tsujikawa, K; Tanaka, A				Mabuchi, Miyuki; Shimizu, Tadashi; Ueda, Masahiro; Sasakawa, Yuka; Nakao, Syuhei; Ueda, Yuko; Kawamura, Akio; Tsujikawa, Kazutake; Tanaka, Akito			Improving the Bioavailability and Anticancer Effect of the PCA-1/ALKBH3 Inhibitor HUHS015 Using Sodium Salt	IN VIVO			English	Article						HUHS015; PCA-1; ALKBH3; inhibitor; anti-prostate cancer drug	PROSTATE-CANCER	Prostate cancer antigen (PCA)-1/AlkB homologue 3 (ALKBH3) has been identified as a clinically significant factor and siRNA of PCA-1 inhibits DU145 proliferation both in vitro and in vivo. HUHS015 (1), a previous reported PCA-1 small-molecule inhibitor, was also effective without any obvious side-effects or toxicity. The potency of HUHS015, however, is not satisfying. We thought the reason is poor solubility of HUHS015 because insoluble material remained at the injection site after subcutaneous administration. To improve this inhibitor's solubility, we prepared various salts of HUHS015 and examined their solubility, which resulted in the selection of HUHS015 sodium salt (2) for further studies in vivo. Next, we compared the pharmacokinetics of 1 and 2 via several administration routes. We observed significant improvements in the pharmacokinetic parameters. For example, subcutaneous administration of 2 increased the area under the curve (AUC) 0-24 by 8-fold compared to 1 and increased the suppressive effect on the proliferation of DU145 cells in a xenograft model.	[Mabuchi, Miyuki; Shimizu, Tadashi; Ueda, Masahiro; Sasakawa, Yuka; Nakao, Syuhei; Tanaka, Akito] Hyogo Univ Hlth Sci, Adv Med Res Ctr, Biol Chem Lab, Kobe, Hyogo, Japan; [Mabuchi, Miyuki; Shimizu, Tadashi; Ueda, Masahiro; Nakao, Syuhei; Tanaka, Akito] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan; [Sasakawa, Yuka] MG Pharma Inc, Osaka, Japan; [Ueda, Yuko; Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka, Japan; [Kawamura, Akio] Shin Nippon Biomed Labs Ltd, Kainan, Japan	Tanaka, A (reprint author), Hyogo Univ Hlth Sci, Adv Med Res Ctr, Biol Chem Lab, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo, Japan.	tanaka-a@huhs.ac.jp			Program for Promotion of Fundamental Sciences in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Knowledge Cluster Initiative (Second Stage) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This research was supported in part by a Grant-in-Aid for Scientific Research (C) provided by the Program for Promotion of Fundamental Sciences in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and by a Grant-in-Aid from the Knowledge Cluster Initiative (Second Stage) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; DeFrancesco Laura, 2001, NAT MED, V7, P1076; Koike K, 2012, CURR CANCER DRUG TAR, V12, P847; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; Nakao S, 2014, BIOORG MED CHEM LETT, V24, P1071, DOI 10.1016/j.bmcl.2014.01.008; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x	6	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	JAN-FEB	2015	29	1					39	43				5	Medicine, Research & Experimental	Research & Experimental Medicine	AZ3NM	WOS:000348134300007		
J	Terkawi, MA; Cao, S; Herbas, MS; Nishimura, M; Li, Y; Moumouni, PFA; Pyarokhil, AH; Kondoh, D; Kitamura, N; Nishikawa, Y; Kato, K; Yokoyama, N; Zhou, JL; Suzuki, H; Igarashi, I; Xuan, XN				Terkawi, Mohamad Alaa; Cao, Shinuo; Herbas, Maria S.; Nishimura, Maki; Li, Yan; Moumouni, Paul Franck Adjou; Pyarokhil, Asadullah Hamid; Kondoh, Daisuke; Kitamura, Nobuo; Nishikawa, Yoshifumi; Kato, Kentaro; Yokoyama, Naoaki; Zhou, Jinlin; Suzuki, Hiroshi; Igarashi, Ikuo; Xuan, Xuenan			Macrophages Are the Determinant of Resistance to and Outcome of Nonlethal Babesia microti Infection in Mice	INFECTION AND IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; GAMMA-INTERFERON; PROTECTIVE IMMUNITY; T-CELL; MONONUCLEAR PHAGOCYTES; RODHAINI INFECTION; NITRIC-OXIDE; IN-VITRO; RESPONSES	In the present study, we examined the contributions of macrophages to the outcome of infection with Babesia microti, the etiological agent of human and rodent babesiosis, in BALB/c mice. Mice were treated with clodronate liposome at different times during the course of B. microti infection in order to deplete the macrophages. Notably, a depletion of host macrophages at the early and acute phases of infection caused a significant elevation of parasitemia associated with remarkable mortality in the mice. The depletion of macrophages at the resolving and latent phases of infection resulted in an immediate and temporal exacerbation of parasitemia coupled with mortality in mice. Reconstituting clodronate liposome-treated mice at the acute phase of infection with macrophages from naive mice resulted in a slight reduction in parasitemia with improved survival compared to that of mice that received the drug alone. These results indicate that macrophages play a crucial role in the control of and resistance to B. microti infection in mice. Moreover, analyses of host immune responses revealed that macrophage-depleted mice diminished their production of Th1 cell cytokines, including gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). Furthermore, depletion of macrophages at different times exaggerated the pathogenesis of the infection in deficient IFN-gamma(-/-) and severe combined immunodeficiency (SCID) mice. Collectively, our data provide important clues about the role of macrophages in the resistance and control of B. microti and imply that the severity of the infection in immunocompromised patients might be due to impairment of macrophage function.	[Terkawi, Mohamad Alaa; Cao, Shinuo; Herbas, Maria S.; Nishimura, Maki; Li, Yan; Moumouni, Paul Franck Adjou; Nishikawa, Yoshifumi; Kato, Kentaro; Yokoyama, Naoaki; Suzuki, Hiroshi; Igarashi, Ikuo; Xuan, Xuenan] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Pyarokhil, Asadullah Hamid; Kondoh, Daisuke; Kitamura, Nobuo] Obihiro Univ Agr & Vet Med, Lab Vet Anat, Obihiro, Hokkaido 080, Japan; [Zhou, Jinlin] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Xuan, XN (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	gen@obihiro.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for Promotion of Science (JSPS); JSPS	This study was supported by a grant from the Global COE Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (JSPS). M.A.T. was supported by a research grant fellowship from JSPS for young scientists.	Aguilar-Delfin I, 2001, INFECT IMMUN, V69, P7955, DOI 10.1128/IAI.69.12.7955-7958.2001; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Aichele P, 2003, J IMMUNOL, V171, P1148; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Yoneto T, 1999, INFECT IMMUN, V67, P2349; DeSouza JB, 1997, INFECT IMMUN, V65, P1593; Lykens JE, 2010, J IMMUNOL, V184, P877, DOI 10.4049/jimmunol.0902346; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Couper KN, 2008, J IMMUNOL, V180, P5771; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Aguilar-Delfin I, 2003, INFECT IMMUN, V71, P2002, DOI 10.1128/IAI.71.4.2002-2008.2003; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Chen QF, 2014, P NATL ACAD SCI USA, V111, P1479, DOI 10.1073/pnas.1323318111; Hildebrandt A, 2007, EUR J CLIN MICROBIOL, V26, P595, DOI 10.1007/s10096-007-0333-1; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Gubernot DM, 2009, TRANSFUSION, V49, P2759, DOI 10.1111/j.1537-2995.2009.02429.x; Beattie Lynette, 2006, J Immunol, V177, P2518; Brown WC, 2006, VET PARASITOL, V138, P75, DOI 10.1016/j.vetpar.2006.01.041; Chen DH, 2000, PARASITE IMMUNOL, V22, P81, DOI 10.1046/j.1365-3024.2000.00279.x; CLARK IA, 1975, LANCET, V2, P1128; Clawson ML, 2002, INFECT IMMUN, V70, P5304, DOI 10.1128/IAI.70.9.5304-5306.2002; Goff WL, 2002, ANN NY ACAD SCI, V969, P164; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Hemmer RM, 2000, PARASITOL RES, V86, P121, DOI 10.1007/s004360050021; Herbas MS, 2011, PARASITOL RES, V109, P1243, DOI 10.1007/s00436-011-2367-7; Igarashi I, 1999, INFECT IMMUN, V67, P4143; Johnson WC, 1996, ANN NY ACAD SCI, V791, P136, DOI 10.1111/j.1749-6632.1996.tb53520.x; Li Y, 2012, INFECT IMMUN, V80, P311, DOI 10.1128/IAI.05900-11; MONTEALEGRE F, 1985, INFECT IMMUN, V50, P523; Morikawa A, 2000, INFECT IMMUN, V68, P6209, DOI 10.1128/IAI.68.11.6209-6214.2000; Ooka H, 2012, J PARASITOL, V98, P1045, DOI 10.1645/GE-2999.1; Saeki H, 1996, VET PARASITOL, V61, P201, DOI 10.1016/0304-4017(95)00823-3; Shoda LKM, 2000, INFECT IMMUN, V68, P5139, DOI 10.1128/IAI.68.9.5139-5145.2000; STEVENSON MM, 1989, PARASITE IMMUNOL, V11, P529, DOI 10.1111/j.1365-3024.1989.tb00687.x; Whitmire JK, 2007, J IMMUNOL, V179, P1190; Zhao Y, 2009, TRANSFUSION, V49, P2583, DOI 10.1111/j.1537-2995.2009.02454.x	40	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JAN	2015	83	1					8	16		10.1128/IAI.02128-14		9	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ0SR	WOS:000347955500002		
J	Leslie, JL; Huang, S; Opp, JS; Nagy, MS; Kobayashi, M; Young, VB; Spence, JR				Leslie, Jhansi L.; Huang, Sha; Opp, Judith S.; Nagy, Melinda S.; Kobayashi, Masayuki; Young, Vincent B.; Spence, Jason R.			Persistence and Toxin Production by Clostridium difficile within Human Intestinal Organoids Result in Disruption of Epithelial Paracellular Barrier Function	INFECTION AND IMMUNITY			English	Article							IMMUNE HOMEOSTASIS; ANAEROBIC-BACTERIA; OXYGEN TOLERANCE; IN-VITRO; CELLS; MICE; DEPOLYMERIZATION; INFLAMMATION; INFECTION; PROTEINS	Clostridium difficile is the leading cause of infectious nosocomial diarrhea. The pathogenesis of C. difficile infection (CDI) results from the interactions between the pathogen, intestinal epithelium, host immune system, and gastrointestinal microbiota. Previous studies of the host-pathogen interaction in CDI have utilized either simple cell monolayers or in vivo models. While much has been learned by utilizing these approaches, little is known about the direct interaction of the bacterium with a complex host epithelium. Here, we asked if human intestinal organoids (HIOs), which are derived from pluripotent stem cells and demonstrate small intestinal morphology and physiology, could be used to study the pathogenesis of the obligate anaerobe C. difficile. Vegetative C. difficile, microinjected into the lumen of HIOs, persisted in a viable state for up to 12 h. Upon colonization with C. difficile VPI 10463, the HIO epithelium is markedly disrupted, resulting in the loss of paracellular barrier function. Since similar effects were not observed when HIOs were colonized with the nontoxigenic C. difficile strain F200, we directly tested the role of toxin using TcdA and TcdB purified from VPI 10463. We show that the injection of TcdA replicates the disruption of the epithelial barrier function and structure observed in HIOs colonized with viable C. difficile.	[Leslie, Jhansi L.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Huang, Sha; Nagy, Melinda S.; Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Opp, Judith S.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Ctr Organogenesis, Ann Arbor, MI USA; [Kobayashi, Masayuki] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan	Spence, JR (reprint author), Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	spencejr@umich.edu			NIH [5T32AI007528, K01DK091415, P30DK034933, U19 AI090871, R01GM0099549]	This work was funded by NIH grants 5T32AI007528 (J.L.L.), K01DK091415 (J.R.S.), P30DK034933 (Michigan Gastrointestinal Peptide Research Center), and U19 AI090871 and R01GM0099549 (V.B.Y.).	Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Catalioto RM, 2011, CURR MED CHEM, V18, P398; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; ROLFE RD, 1978, APPL ENVIRON MICROB, V36, P306; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Nam HJ, 2010, J BIOL CHEM, V285, P32888, DOI 10.1074/jbc.M110.162743; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; BRUSA T, 1989, CURR MICROBIOL, V19, P39, DOI 10.1007/BF01568901; Du Tim, 2004, Can J Infect Dis, V15, P83; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Green L, 2012, 22 EUR C CLIN MICR I; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Kasendra M, 2013, J INFECT DIS, V209, P1095; Lizer JT, 2013, J SWINE HEALTH PROD, V21, P22; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Madan R, 2013, INFECT IMMUN, V82, P341; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Reeves AE, 2010, GUT MICROBES, V2, P145; Riegler M, 1997, AM J PHYSIOL-GASTR L, V273, pG1014; Sugawara S, 2014, APPL BIOCHEM BIOTECH, V172, P206, DOI 10.1007/s12010-013-0544-0; Theriot Casey M, 2011, Gut Microbes, V2, P326, DOI 10.4161/gmic.19142; TRIADAFILOPOULOS G, 1987, GASTROENTEROLOGY, V93, P273; Wilson SS, 2014, MUCOSAL IMMUNOL	40	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JAN	2015	83	1					138	145		10.1128/IAI.02561-14		8	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ0SR	WOS:000347955500015		
J	Behler, F; Maus, R; Bohling, J; Knippenberg, S; Kirchhof, G; Nagata, M; Jonigk, D; Izykowski, N; Maegel, L; Welte, T; Yamasaki, S; Maus, UA				Behler, Friederike; Maus, Regina; Bohling, Jennifer; Knippenberg, Sarah; Kirchhof, Gabriele; Nagata, Masahiro; Jonigk, Danny; Izykowski, Nicole; Maegel, Lavinia; Welte, Tobias; Yamasaki, Sho; Maus, Ulrich A.			Macrophage-Inducible C-Type Lectin Mincle-Expressing Dendritic Cells Contribute to Control of Splenic Mycobacterium bovis BCG Infection in Mice	INFECTION AND IMMUNITY			English	Article							LUNG-PROTECTIVE IMMUNITY; STREPTOCOCCUS-PNEUMONIAE; MILIARY TUBERCULOSIS; ACTIVATING RECEPTOR; PATHOGENIC FUNGUS; CATHEPSIN-G; INFLAMMATION; IDENTIFICATION; RECRUITMENT; MALASSEZIA	The macrophage-inducible C-type lectin Mincle has recently been identified to be a pattern recognition receptor sensing mycobacterial infection via recognition of the mycobacterial cell wall component trehalose-6', 6-dimycolate (TDM). However, its role in systemic mycobacterial infections has not been examined so far. Mincle-knockout (KO) mice were infected intravenously with Mycobacterium bovis BCG to mimic the systemic spread of mycobacteria under defined experimental conditions. After intravenous infection with M. bovis BCG, Mincle-KO mice responded with significantly higher numbers of mycobacterial CFU in spleen and liver, while reduced granuloma formation was observed only in the spleen. At the same time, reduced Th1 cytokine production and decreased numbers of gamma interferon-producing T cells were observed in the spleens of Mincle-KO mice relative to the numbers in the spleens of wild-type (WT) mice. The effect of adoptive transfer of defined WT leukocyte subsets generated from bone marrow cells of zDC(+/DTR) mice (which bear the human diphtheria toxin receptor [DTR] under the control of the classical dendritic cell-specific zinc finger transcription factor zDC) to specifically deplete Mincle-expressing classical dendritic cells (cDCs) but not macrophages after diphtheria toxin application on the numbers of splenic and hepatic CFU and T cell subsets was then determined. Adoptive transfer experiments revealed that Mincle-expressing splenic cDCs rather than Mincle-expressing macrophages contributed to the reconstitution of attenuated splenic antimycobacterial immune responses in Mincle-KO mice after intravenous challenge with BCG. Collectively, we show that expression of Mincle, particularly by cDCs, contributes to the control of splenic M. bovis BCG infection in mice.	[Behler, Friederike; Maus, Regina; Bohling, Jennifer; Knippenberg, Sarah; Kirchhof, Gabriele; Maus, Ulrich A.] Hannover Med Sch, Dept Expt Pneumol, Hannover, Germany; [Jonigk, Danny; Izykowski, Nicole; Maegel, Lavinia] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Welte, Tobias] Hannover Med Sch, Clin Pneumol, Hannover, Germany; [Nagata, Masahiro; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 812, Japan; [Welte, Tobias; Maus, Ulrich A.] German Ctr Infect Dis DZIF, Hannover, Germany	Maus, UA (reprint author), Hannover Med Sch, Dept Expt Pneumol, Hannover, Germany.	Maus.Ulrich@mh-hannover.de			Society of Lower Saxony for the Control of Tuberculosis; Hannover Biomedical Research School (HBRS); Center for Infection Biology (ZIB) of Hannover Medical School	This work was supported by the Society of Lower Saxony for the Control of Tuberculosis, the Hannover Biomedical Research School (HBRS), and the Center for Infection Biology (ZIB) of Hannover Medical School.	Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Ray S, 2013, THER CLIN RISK MANAG, V9, P9, DOI 10.2147/TCRM.S29179; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Wells CA, 2008, J IMMUNOL, V180, P7404; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; Brumshagen C, 2012, INFECT IMMUN, V80, P4281, DOI 10.1128/IAI.00854-12; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Sharma SK, 2005, LANCET INFECT DIS, V5, P415, DOI 10.1016/S1473-3099(05)70163-8; Marakalala MJ, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/567571; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Maus UA, 2003, J IMMUNOL, V170, P3273; Steinwede K, 2012, J EXP MED, V209, P1937, DOI 10.1084/jem.20120983; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Ehlers Stefan, 2012, Front Immunol, V3, P411, DOI 10.3389/fimmu.2012.00411; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Heitmann L, 2013, IMMUNOBIOLOGY, V218, P506, DOI 10.1016/j.imbio.2012.06.005; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Matsumoto M, 1999, J Immunol, V163, P5039; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Srivastava M, 2007, CELL MICROBIOL, V9, P738, DOI 10.1111/j.1462-5822.2006.00824.x; STEG A, 1985, LANCET, V2, P899; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	39	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JAN	2015	83	1					184	196		10.1128/IAI.02500-14		13	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ0SR	WOS:000347955500019		
J	Kimoto, M; Tsubota, T; Uchino, K; Sezutsu, H; Takiya, S				Kimoto, Mai; Tsubota, Takuya; Uchino, Keiro; Sezutsu, Hideki; Takiya, Shigeharu			LIM-homeodomain transcription factor Awh is a key component activating all three fibroin genes, fibH, fibL and fhx, in the silk gland of the silkworm, Bombyx mori	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Bombyx mori; Silk gland; Fibroin; Awh; Transgenic	DNA-BINDING PROTEINS; SERICIN-1 GENE; EXPRESSION PATTERN; HEAVY-CHAIN; 5' FLANKING; DOMAIN; PROMOTER; UPSTREAM; SEQUENCE; CONTAINS	In the silkworm Bombyx mori, three fibroin genes, fibroin-heavy-chain (fibH), fibroin-light-chain (fibL) and fibrohexamerin (fhx), are coexpressed only in the posterior silk gland (PSG) cells, while the sericin genes encoding silk glue proteins are expressed in the middle silk gland (MSG) cells. Silk gland factor-2 (SGF-2) is a PSG-specific activator complex of fibH, composed of a LIM-homeodomain protein, Awh, and its cofactors, Ldb and Lcaf. We investigated whether SGF-2 can activate other fibroin genes using transgenic silkworms. The genes for Ldb and Lcaf were expressed ubiquitously in various tissues, while the gene for Awh was expressed strictly specific in PSG of the wild type silkworms. Misexpression of Awh in transgenic silkworms induced ectopic expression of fibL and fhx as well as fibH in MSG. Coincidently with the induction of fibL and fhx by Awh, binding of SGF-2 to the promoter of fibL and fhx was detected in vitro, and SGF-2 binds directly to the fhx core promoter. Ectopic expression of the fibroin genes was observed at high levels in the middle part of MSG. Moreover, fibL and fhx were induced in the anterior silk gland (ASG) of the transgenic silkworms, but fibH was not. These results indicate that Awh is a key activator of all three fibroin genes, and the activity is probably regulated in conjunction with additional factors. (C) 2014 Elsevier Ltd. All rights reserved.	[Kimoto, Mai; Takiya, Shigeharu] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Tsubota, Takuya; Uchino, Keiro; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Div Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Takiya, Shigeharu] Hokkaido Univ, Fac Sci, Ctr Genome Dynam, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Takiya, S (reprint author), Hokkaido Univ, Fac Sci, Div Biol Sci, Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	takiya@sci.hokudai.ac.jp			Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan;  [24.5323]	We are grateful to Ms. A. Kosaka and Mr. S. Ishikawa for their technical assistance. We are also grateful to Mr. K. Nakamura, Mr. K. Hashimoto and Mr. T. Misawa for rearing the silkworms. This work was partly supported by the Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan (to H.S.) and a Grant-in-aid for JSPS fellows (24.5323 to M.K.).	FUKUTA M, 1993, J BIOL CHEM, V268, P19471; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; BELLO B, 1994, B I PASTEUR, V92, P81; COUBLE P, 1985, NUCLEIC ACIDS RES, V13, P1801, DOI 10.1093/nar/13.5.1801; COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9; CURTISS J, 1995, DEVELOPMENT, V121, P3819; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Gustavson E, 1996, GENETICS, V142, P893; Horard B, 1997, MOL CELL BIOL, V17, P1572; HUI CC, 1990, J MOL BIOL, V213, P651, DOI 10.1016/S0022-2836(05)80253-0; Julien E, 2002, INSECT BIOCHEM MOLEC, V32, P377, DOI 10.1016/S0965-1748(01)00170-9; KIGUCHI K, 1981, J INSECT PHYSIOL, V27, P805, DOI 10.1016/0022-1910(81)90072-X; KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Kokubo H, 1997, DEV GENES EVOL, V206, P494, DOI 10.1007/s004270050080; MACH V, 1995, J BIOL CHEM, V270, P9340; Matsunami K, 1998, DEV GROWTH DIFFER, V40, P591; Nony P, 1995, BIOL CELL, V84, P43, DOI 10.1016/0248-4900(96)81317-7; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; Peel AD, 2006, P ROY SOC B-BIOL SCI, V273, P1733, DOI 10.1098/rspb.2006.3497; Shimizu K, 2007, INSECT BIOCHEM MOLEC, V37, P713, DOI 10.1016/j.ibmb.2007.03.016; SIMMONDS AJ, 1995, NATURE, V376, P424, DOI 10.1038/376424a0; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; SUZUKI Y, 1990, DEV GROWTH DIFFER, V32, P179; Takiya S, 1997, BIOCHEM J, V321, P645; Takiya S, 2005, NUCLEIC ACIDS RES, V33, P786, DOI 10.1093/nar/gki228; Takiya S, 2011, INSECT BIOCHEM MOLEC, V41, P592, DOI 10.1016/j.ibmb.2011.03.011; TAKIYA S, 1990, EMBO J, V9, P489; TSUDA M, 1983, P NATL ACAD SCI-BIOL, V80, P7442, DOI 10.1073/pnas.80.24.7442; TSUDA M, 1981, CELL, V27, P175, DOI 10.1016/0092-8674(81)90371-8; TSUJIMOTO Y, 1979, CELL, V18, P591, DOI 10.1016/0092-8674(79)90075-8; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Zhao X., 2014, PLOS ONE	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	JAN	2015	56						29	35		10.1016/j.ibmb.2014.11.003		7	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CA0SL	WOS:000348626700004		
J	Hanada, K; Adachi, K; Mishiro, T; Tanaka, S; Takahashi, Y; Yoshikawa, K; Kinoshita, Y				Hanada, Kozue; Adachi, Kyoichi; Mishiro, Tomoko; Tanaka, Shino; Takahashi, Yoshiko; Yoshikawa, Kazuaki; Kinoshita, Yoshikazu			Relationship between Esophageal Cardiac Glands and Gastroesophageal Reflux Disease	INTERNAL MEDICINE			English	Article						esophageal cardiac gland; reflux esophagitis; GERD; QUEST; endoscopy	HELICOBACTER-PYLORI INFECTION; JAPANESE PATIENTS; PERISTALTIC DYSFUNCTION; EROSIVE ESOPHAGITIS; ATROPHIC GASTRITIS; ACID; HEARTBURN; HYPERSENSITIVITY; CLASSIFICATION; CONTRACTION	Objective The role of esophageal cardiac glands has not been fully determined. This study was performed to clarify the protective role of esophageal cardiac glands against the development of gastroesophageal reflux disease (GERD). Methods The subjects included 2,656 Japanese individuals who visited our institution for a detailed medical checkup. GERD symptoms were assessed using the Japanese version of the Carlsson-Dent self-administered questionnaire (QUEST) and an upper gastrointestinal endoscopy examination in each subject. The presence of reflux esophagitis, size of diaphragmatic hiatus, degree of gastric mucosal atrophy and existence of visible esophageal cardiac glands in the distal esophagus, based on the detection of yellowish elevated areas, were determined using endoscopy. Results Esophageal cardiac glands were observed in 355 cases (13.4%). Reflux esophagitis was significantly less frequent in the cases with esophageal cardiac glands than in those without. The esophageal cardiac glands were mainly located on the left-posterior side of the esophageal wall of the distal esophagus. A multiple regression analysis showed that the presence of esophageal cardiac glands was an independent factor for preventing reflux esophagitis. On the other hand, the existence of these glands did not correlate with the presence of GERD symptoms (QUEST score of 6 or more). Conclusion The presence of visible esophageal cardiac glands may have a protective role against the development of reflux esophagitis.	[Hanada, Kozue; Adachi, Kyoichi; Mishiro, Tomoko; Tanaka, Shino; Takahashi, Yoshiko; Yoshikawa, Kazuaki] Shimane Environm & Hlth Public Corp, Ctr Hlth, Izumo, Shimane, Japan; [Kinoshita, Yoshikazu] Shimane Univ, Fac Med, Dept Internal Med 2, Matsue, Shimane, Japan	Adachi, K (reprint author), Shimane Environm & Hlth Public Corp, Ctr Hlth, Izumo, Shimane, Japan.	adachi@kanhokou.or.jp					Chiba H, 2012, INTERNAL MED, V51, P1293, DOI 10.2169/internalmedicine.51.7241; Fass R, 2001, AM J GASTROENTEROL, V96, P303; KORSTEN MA, 1991, AM J MED, V90, P701, DOI 10.1016/S0002-9343(05)80058-0; Lundell LR, 1999, GUT, V45, P172; Higuchi K, 2013, INTERNAL MED, V52, P1447, DOI 10.2169/internalmedicine.52.0349; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V94, P73; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Katsube T, 2006, J GASTROEN HEPATOL, V21, P1656, DOI 10.1111/j.1440-1746.2006.04297x; SONNENBERG A, 1982, GASTROENTEROLOGY, V83, P889; KAHRILAS PJ, 1986, GASTROENTEROLOGY, V91, P897; Wiklund I, 2006, SCAND J GASTROENTERO, V41, P288, DOI 10.1080/00365520500292970; Kinoshita Y, 2009, J GASTROENTEROL, V44, P812, DOI 10.1007/s00535-009-0092-0; Balaban DH, 1999, GASTROENTEROLOGY, V116, P29, DOI 10.1016/S0016-5085(99)70225-8; Ohara S, 2012, J GASTROENTEROL, V47, P1221, DOI 10.1007/s00535-012-0595-y; Azumi T, 2008, INTERNAL MED, V47, P691, DOI 10.2169/internalmedicine.47.0798; Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023; DODDS WJ, 1981, GASTROENTEROLOGY, V81, P376; Fawcett DW, 1998, BLOOM FAWCETT TXB HI, P597; Fujishiro H, 2001, J GASTROEN HEPATOL, V16, P1217, DOI 10.1046/j.1440-1746.2001.02618.x; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Kinoshita Y, 1997, GUT, V41, P452; Koike T, 1999, AM J GASTROENTEROL, V94, P3468; MIKI K, 1987, Gastroenterologia Japonica, V22, P133; Miwa H, 2004, ALIMENT PHARM THERAP, V20, P112, DOI 10.1111/j.1365-2036.2004.01990.x; Nagahara A, 2006, J CLIN GASTROENTEROL, V40, P891, DOI 10.1097/01.mcg.0000225673.76475.9d; Orlando RC, 1998, ALIMENT PHARM THERAP, V12, P191; Pehlivanov N, 2001, AM J PHYSIOL-GASTR L, V281, pG743; Rodriguez-Stanley S, 1999, AM J GASTROENTEROL, V94, P628; SATOH K, 1994, EUR J GASTROEN HEPAT, V6, pS85; Shirota T, 1999, J GASTROENTEROL, V34, P553, DOI 10.1007/s005350050372; Yagi K, 2005, DIG ENDOSC S, V17, pS11; Yagi K, 2006, ENDOSCOPY, V38, P652, DOI 10.1055/s-2006-925455	32	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					91	96		10.2169/internalmedicine.54.3179		6	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900001		
J	Takeuchi, T; Oota, K; Harada, S; Edogawa, S; Kojima, Y; Sanomura, M; Sakaguchi, M; Hayashi, K; Hongoh, Y; Itabashi, T; Kitae, H; Hoshimoto, M; Takeuchi, N; Higuchi, K				Takeuchi, Toshihisa; Oota, Kazuhiro; Harada, Satoshi; Edogawa, Shoko; Kojima, Yuichi; Sanomura, Makoto; Sakaguchi, Masahiro; Hayashi, Katsuyoshi; Hongoh, Yasushi; Itabashi, Tsukasa; Kitae, Hidehiro; Hoshimoto, Masahiro; Takeuchi, Nozomi; Higuchi, Kazuhide			Characteristics of Refractory Gastroesophageal Reflux Disease (GERD) Symptoms(-)Is Switching Proton Pump Inhibitors Based on the Patient's CYP2C19 Genotype an Effective Management Strategy?	INTERNAL MEDICINE			English	Article						omeprazole; rabeprazole; CYP2C19 genotype; gastroesophageal reflux disease; PPI-refractory GERD symptoms	FREQUENCY SCALE; RABEPRAZOLE; ESOPHAGITIS; THERAPY; DEPRESSION; OMEPRAZOLE; CONSENSUS; REGIMENS; EFFICACY; FSSG	Objective We investigated factors related to proton pump inhibitor (PPI) -refractory gastroesophageal reflux disease (GERD) symptoms, particularly with respect to acid, the CYP2C19 genotype and psychological aspects. Methods Patients with an Frequency Scale for the Symptoms of GERD (FSSG) score of >= 8 after the initial treatment were switched to therapy with rabeprazole at a dose of 20 mg once daily for eight weeks. We investigated the rate of improvement in PPI-refractory GERD symptoms, background factors, the Hospital Anxiety and Depression Scale (HADS) score and the CYP2C19 genotype. Patients Sixty patients endoscopically diagnosed with reflux esophagitis within the past six months who had received omeprazole at a dose of 20 mg once daily for eight weeks or longer were enrolled. Results In 71.6% of the patients, the FSSG score decreased to < 8 after treatment with omeprazole at a dose of 20 mg once daily for >= 8 weeks, resulting in improvements in their GERD symptoms. Significant factors related to omeprazole-refractory GERD symptoms included a longer disease duration (p=0.0004) and higher HADS score (p=0.01). Among the omeprazole-refractory cases, only 23.5% of the patients showed symptom improvement after switching to rabeprazole. There were no significant differences in the average scores for FSSG (p=0.089) or HADS (p=0.182), before or after the drug change. A total of 92% of the rabeprazole poor responders were homo/hetero extensive metabolizers for the CYP2C19 genotype. Conclusion Our findings suggest that switching the PPI from omeprazole (20 mg once daily) to rabeprazole (20 mg once daily) is not a significant effective therapeutic strategy for improving PPI-refractory GERD symptoms, taking into consideration possible psychometric factors and patients who require stronger acid suppression than that achieved with a double dose of PPIs for PPI-refractory GERD symptoms.	[Takeuchi, Toshihisa; Oota, Kazuhiro; Harada, Satoshi; Edogawa, Shoko; Kojima, Yuichi; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka, Japan; [Sanomura, Makoto] Hokusetsu Gen Hosp, Takatsuki, Osaka, Japan; [Sakaguchi, Masahiro] Moriguchi Keijinkai Hosp, Moriguchi, Osaka, Japan; [Hayashi, Katsuyoshi] Ishikiri Seiki Hosp, Higashiosaka, Osaka, Japan; [Hongoh, Yasushi] Hirakata City Hosp, Hirakata, Osaka, Japan; [Itabashi, Tsukasa] Hanwasumiyoshi Gen Hosp, Osaka, Japan; [Kitae, Hidehiro] Aoyama Hosp, Toyokawa, Japan; [Hoshimoto, Masahiro] Seikeikai Hosp, Sakai, Osaka, Japan; [Takeuchi, Nozomi] Settsu Clin, Settsu, Osaka, Japan	Takeuchi, T (reprint author), Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka, Japan.	in2097@poh.osaka-med.ac.jp			AstraZeneca K.K. Osaka, Japan	Financial support for the preparation of this paper was provided by AstraZeneca K.K. Osaka, Japan according to the publication support agreement.	Adachi K, 2004, J CLIN GASTROENTEROL, V38, P297, DOI 10.1097/00004836-200403000-00020; Adachi K, 2003, J GASTROENTEROL, V38, P830, DOI 10.1007/s00535-003-1157-0; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Furuta T, 2011, J GASTROENTEROL, V46, P1273, DOI 10.1007/s00535-011-0446-2; Higuchi K, 2013, INTERNAL MED, V52, P1447, DOI 10.2169/internalmedicine.52.0349; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Kim JY, 2013, J NEUROGASTROENTEROL, V19, P344, DOI 10.5056/jnm.2013.19.3.344; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Sugimoto M, 2004, CLIN PHARMACOL THER, V76, P290, DOI 10.1016/j.clpt.2004.06.008; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Wiklund I, 2006, SCAND J GASTROENTERO, V41, P288, DOI 10.1080/00365520500292970; [Anonymous], 2010, GASTR REFL DIS GERD, P44; Miyamoto M, 2010, INTERNAL MED, V49, P1469, DOI 10.2169/internalmedicine.49.3615; Fock KM, 2008, J GASTROEN HEPATOL, V23, P8, DOI 10.1111/j.1440-1746.2007.05249.x; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1053/S1542-3565(04)00288-5; McColl E, 2005, AM J GASTROENTEROL, V100, P11, DOI 10.1111/j.1572-0241.2005.40945.x; Beth D, 2004, BASIC CLIN BIOSTATIS; Cheung TK, 2009, CHEST, V135, P1181, DOI 10.1378/chest.08-1702; Dekkers CPM, 1999, ALIMENT PHARM THERAP, V13, P49; Madan K, 2004, DIS ESOPHAGUS, V17, P274, DOI 10.1111/j.1442-2050.2004.00424.x; Martin-Merino E, 2010, ALIMENT PHARM THER, V31, P1132, DOI 10.1111/j.1365-2036.2010.04280.x; Saitoh T, 2009, HEPATO-GASTROENTEROL, V56, P703; Shimatani T, 2006, CLIN PHARMACOL THER, V79, P144, DOI 10.1016/j.clpt.2005.09.012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	25	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					97	105		10.2169/internalmedicine.54.3412		9	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900002		
J	Nirei, K; Matsuoka, S; Nakamura, H; Matsumura, H; Moriyama, M				Nirei, Kazushige; Matsuoka, Shuniti; Nakamura, Hitomi; Matsumura, Hiroshi; Moriyama, Mitsuhiko			Incidence of Hepatocellular Carcinoma Reduced by Phlebotomy Treatment in Patients with Chronic Hepatitis C	INTERNAL MEDICINE			English	Article						carcinogenesis; hepatitis C; phlebotomy; iron overload; hepatocellular carcinoma	IRON REDUCTION THERAPY; CHRONIC HCV INFECTION; OXIDATIVE STRESS; HEREDITARY HEMOCHROMATOSIS; AMINOTRANSFERASE LEVELS; LIVER-CIRRHOSIS; HFE MUTATIONS; VIRUS; INTERFERON; RIBAVIRIN	Objective To determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C. Methods Study patients with chronic hepatitis C were treated with glycyrrhizin injection and oral ursodeoxycholic acid and either with (n=52) or without (n=50) phlebotomy during the period of 2005-2012. Six phlebotomized patients had previously received interferon therapy and were subsequently excluded from the data analysis. The serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, alkaline phosphatase, gamma-glutamyl transpeptidase, lactate dehydrogenase, ferritin, iron and albumin, as well as the hemoglobin concentration, platelet count and prothrombin time, were determined. We compared the long-term outcomes based on the incidence of HCC and laboratory values, including the baseline serum ferritin levels, in patients treated with versus without phlebotomy. Results In the phlebotomy group, the mean AST and ALT levels decreased significantly at each one-year interval over five years (p<0.01), whereas the platelet counts did not. The incidence of HCC in the phlebotomized patients was significantly lower than that observed in the patients treated without phlebotomy: 10.3% vs. 43.7%, respectively, during the 8-year observation period (p=0.04). The incidence of HCC was also lower in the phlebotomized patients with a normal baseline ferritin level: 0.0% vs. 36.0% in the matched subgroup treated without phlebotomy at year 8. Phlebotomy offered a risk ratio of 0.13, thus suggesting protection against the development of HCC. Conclusion The incidence of HCC can be reduced by phlebotomy treatment, which should be performed in patients with chronic hepatitis C not receiving or not responding to antiviral therapy.	[Nirei, Kazushige; Matsuoka, Shuniti; Nakamura, Hitomi; Matsumura, Hiroshi; Moriyama, Mitsuhiko] Nihon Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo 102, Japan	Nirei, K (reprint author), Nihon Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo 102, Japan.	nirei.kazushige@nihon-u.ac.jp					Abd Elmonem Elhamy, 2009, J Egypt Natl Canc Inst, V21, P333; Alexander J, 2007, LIVER INT, V27, P268, DOI 10.1111/j.1478-3231.2007.01449.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Sartori M, 2010, WORLD J GASTROENTERO, V16, P596, DOI 10.3748/wjg.v16.i5.596; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Akuta N, 2006, J MED VIROL, V78, P83, DOI 10.1002/jmv.20507; Moriya K, 2001, CANCER RES, V61, P4365; Beaton MD, 2013, ALIMENT PHARM THER, V37, P720, DOI 10.1111/apt.12255; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Valenti L, 2007, HAEMATOL-HEMATOL J, V92, P1037, DOI 10.3324/haematol.11281; Rino Y, 2006, ANTICANCER RES, V26, P2221; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Sartori M, 2007, GUT, V56, P693, DOI 10.1136/gut.2006.106641; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; Kumada H, 2002, ONCOLOGY-BASEL, V62, P94, DOI 10.1159/000048283; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; Tung BY, 2003, GASTROENTEROLOGY, V124, P318, DOI 10.1053/gast.2003.50046; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Bonkovsky HL, 2002, J HEPATOL, V37, P848, DOI 10.1016/S0168-8278(02)00305-7; Erhardt A, 2003, J HEPATOL, V38, P335, DOI 10.1016/S0168-8278(02)00415-4; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Hartridge-Lambert SK, 2012, HEPATOLOGY, V55, P634, DOI 10.1002/hep.25499; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Jin DY, 2007, FRONT BIOSCI, V12, P222, DOI 10.2741/2060; Kaito M, 2006, J GASTROENTEROL, V41, P921, DOI 10.1007/s00535-006-1871-5; NELSON RL, 1995, CANCER, V76, P875, DOI 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; Nocente R, 2003, HEPATO-GASTROENTEROL, V50, P1149; Rosen HR, 1999, MOL MED TODAY, V5, P393, DOI 10.1016/S1357-4310(99)01523-3; Tanaka N, 2009, J GASTROENTEROL, V44, P577, DOI 10.1007/s00535-009-0034-x; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka N, 2007, J GASTROENTEROL, V42, P49, DOI 10.1007/s00535-006-1967-y; Tarao K, 2005, CANCER EPIDEM BIOMAR, V14, P164; Wakusawa S, 2000, HEPATOL RES, V18, P54, DOI 10.1016/S1386-6346(99)00084-4	37	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					107	117		10.2169/internalmedicine.54.2715		11	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900003		
J	Kondo, C; Atsukawa, M; Tsubota, A; Shimada, N; Abe, H; Itokawa, N; Nakagawa, A; Fukuda, T; Matsushita, Y; Nakatsuka, K; Kawamoto, C; Iwakiri, K; Aizawa, Y; Sakamoto, C				Kondo, Chisa; Atsukawa, Masanori; Tsubota, Akihito; Shimada, Noritomo; Abe, Hiroshi; Itokawa, Norio; Nakagawa, Ai; Fukuda, Takeshi; Matsushita, Yoko; Nakatsuka, Katsuhisa; Kawamoto, Chiaki; Iwakiri, Katsuhiko; Aizawa, Yoshio; Sakamoto, Choitsu			Safety and Efficacy of Partial Splenic Embolization in Telaprevir-based Triple Therapy for Chronic Hepatitis C	INTERNAL MEDICINE			English	Article						partial splenic embolization; telaprevir; pegylated-interferon; ribavirin; chronic hepatitis C; thrombocytopenia	GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; PEGYLATED INTERFERON; ADVANCED FIBROSIS; PLUS RIBAVIRIN; COMBINATION THERAPY; ITPA POLYMORPHISM; GENOTYPE 1; PEGINTERFERON	Objective Pegylated-interferon/ribavirin (peg-IFN/RBV) therapy with a protease inhibitor is the standard therapy for genotype 1b chronic hepatitis C. Despite improving treatment outcomes, patients with thrombocytopenia are often difficult to treat because interferon commonly exacerbates thrombocytopenia. In this study, partial splenic embolization (PSE) was performed in patients with hypersplenism-induced thrombocytopenia to determine the effectiveness of this method as a potential treatment. Methods Patients were pretreated with PSE and then received triple combination therapy. The safety and efficacy of PSE was evaluated. Results Eighteen patients were analyzed, including 12 patients with the interleukin 28B (IL28B) major genotype and 12 patients with the inosine triphosphatase (ITPA) major genotype. The median embolization rate with PSE was 70% (range: 40-85%). PSE increased the patients' platelet counts from 71.5x10(3)/mu L (53-99x10(3)/mu L) to 121.5x10(3)/mu L (70-194x10(3)/mu L; p=0.0002). The patients' platelet counts fluctuated above 50x 10(3)/mu L during the treatment. Specifically, the increase in the platelet count was significantly associated with the ITPA major genotype compared with the minor genotype (p=0.0057 at 2 weeks, p=0.0031 at 3 weeks, and p=0.0148 at 4 weeks). Adherence to peg-IFN-alpha 2b was sufficient (1.38 mu g/kg/week). The rapid viral response rate was 72.2% (13/18), the end of treatment response rate was 88.9% (16/18), and the sustained virological response (SVR) rate was 66.7% (12/18). The SVR rate for patients with the IL28B major genotype was 83.3% (10/12). No adverse effect due to PSE pretreatment was found in any patients. Furthermore, no patient discontinued treatment due to thrombocytopenia. Conclusion PSE, in conjunction with triple combination therapy, is a useful and safe method to treat genotype 1b chronic hepatitis C patients with hypersplenism-induced thrombocytopenia.	[Kondo, Chisa; Atsukawa, Masanori; Itokawa, Norio; Nakagawa, Ai; Iwakiri, Katsuhiko] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Inzai, Chiba, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Res Ctr Med Sci, Core Res Facil Basic Sci, Tokyo, Japan; [Shimada, Noritomo] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Abe, Hiroshi; Aizawa, Yoshio] Jikei Univ, Katsushika Med Ctr, Sch Med, Dept Internal Med,Div Gastroenterol & Hepatol, Tokyo, Japan; [Fukuda, Takeshi; Matsushita, Yoko; Nakatsuka, Katsuhisa; Kawamoto, Chiaki; Sakamoto, Choitsu] Nippon Med Sch, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan	Atsukawa, M (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Inzai, Chiba, Japan.	momogachi@yahoo.co.jp					Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; Akuta N, 2012, J MED VIROL, V84, P1097, DOI 10.1002/jmv.23262; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Everson GT, 2006, HEPATOLOGY, V44, P1675, DOI 10.1002/hep.21440; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Thompson AJ, 2012, J HEPATOL, V56, P313, DOI 10.1016/j.jhep.2011.04.021; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Tanaka Y, 2011, HUM MOL GENET, V20, P3507, DOI 10.1093/hmg/ddr249; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Helbling B, 2006, J VIRAL HEPATITIS, V13, P762, DOI 10.1111/j.1365-2893.2006.00753.x; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ogawa E, 2013, ALIMENT PHARM THER, V38, P1076, DOI 10.1111/apt.12494; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Tahara H, 2011, J GASTROENTEROL, V46, P1010, DOI 10.1007/s00535-011-0407-9; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Bruno S, 2010, HEPATOLOGY, V51, P388, DOI 10.1002/hep.23340; Tsubota A, 2014, J GASTROEN HEPATOL, V29, P144, DOI 10.1111/jgh.12402; Miyake Y, 2008, HEPATOL RES, V38, P980, DOI 10.1111/j.1872-034X.2008.00357.x; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Foruny JR, 2005, EUR J GASTROEN HEPAT, V17, P1157, DOI 10.1097/00042737-200511000-00002; Takahara M, 2011, INTERNAL MED, V50, P2731, DOI 10.2169/internalmedicine.50.6143; Thompson AJ, 2012, HEPATOLOGY, V56, P373, DOI 10.1002/hep.25792	32	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					119	126		10.2169/internalmedicine.54.3066		8	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900004		
J	Wada, T; Zeniya, M				Wada, Takashi; Zeniya, Mikio			Background of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease	INTERNAL MEDICINE			English	Article						liver fibrosis; non-alcoholic fatty liver disease; ultrasound; general health checkup; sex difference	FIBROSIS; STEATOHEPATITIS; VALIDATION; SYSTEM; NAFLD	Objective We investigated the distribution and characteristics of the FIB-4 index of liver fibrosis in 1,441 Japanese men (age 50.7 +/- 10.2 years) and 304 women (age 53.9 +/- 10.3 years) who underwent comprehensive general health checkups and were identified as having non-alcoholic fatty liver disease. With respect to the FIB-4 index, differences according to sex, metabolic indices, and ultrasonic findings were investigated. Methods Among 9,255 individuals who underwent comprehensive general health checkups, 2,750 (29.8%) were found to have mild fatty liver or fatty liver based on ultrasound findings. After excluding patients who consumed >= 150 g alcohol/week (818 individuals), those testing positive for hepatitis B surface antigens or hepatitis C virus antibody (184 individuals), and those for whom data were insufficient (three individuals), we investigated the FIB-4 indices in the remaining 1,745 subjects. Results There were no sex differences in the FIB-4 index. A total of 1,370 patients (78.5%) exhibited a low cut-off index (COI) (<1.30), 357 (20.5%), exhibited an indeterminate COI (1.30-2.67), and 18 (1.0%) exhibited a high COI (>2.67). There were no associations between the FIB-4 index and the constituent factors of metabolic syndrome. In contrast, there was a significant difference in the ln FIB-4 index between the patients with and without mild fatty liver or fatty liver on ultrasound among men (0.006 +/- 0.43 and -0.092 +/- 0.39, p<0.001), but not women. Conclusion The FIB-4 index was is significantly lower in men, but not women, with fatty liver. The FIB-4 index must be calculated separately during medical checkups and evaluated in conjunction with ultrasound findings.	[Wada, Takashi; Zeniya, Mikio] Jikei Univ, Sch Med, Hlth Care Ctr, Tokyo, Japan	Wada, T (reprint author), Jikei Univ, Sch Med, Hlth Care Ctr, Tokyo, Japan.	t_wada@jikei.ac.jp					Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; Kakuta Y, 2011, KANZO, V52, P390; Matsumoto T, 2011, MED B FUKUOKA U, V38, P1; Okanoues T, 2009, KANZO, V50, P741; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Vuppalanchi R, 2007, HEPATOLOGY, V46, P582; Wieckowska A, 2009, HEPATOLOGY, V49, P306	15	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					127	132		10.2169/internalmedicine.54.2685		6	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900005		
J	Takahashi, K; Sasanuma, N; Itani, Y; Tanaka, T; Domen, K; Masuyama, T; Ohyanagi, M; Suzuki, K				Takahashi, Keiko; Sasanuma, Naoki; Itani, Yusuke; Tanaka, Takashi; Domen, Kazuhisa; Masuyama, Tohru; Ohyanagi, Mitsumasa; Suzuki, Keiichiro			Impact of Early Interventions by a Cardiac Rehabilitation Team on the Social Rehabilitation of Patients Resuscitated from Cardiogenic Out-of-hospital Cardiopulmonary Arrest	INTERNAL MEDICINE			English	Article						cardiac rehabilitation; cardiopulmonary arrest; after resuscitation; interprofessional work; social rehabilitation	OUTCOMES; THERAPY	Objective We examined the effects of intervention performed by a multidisciplinary cardiac rehabilitation (CR) team on the social rehabilitation of patients with cardiogenic out-of-hospital cardiopulmonary arrest (OHCA) in the acute phase. Methods This study included 122 patients who were resuscitated after cardiogenic OHCA during a 10-year period. They were divided into two groups: including a non-CR group of patients (n=58) who were admitted before the CR team started performing systematic intervention and a CR group (n=64) who were admitted after the intervention was initiated. The following items were examined for each group: treatment condition at onset, contents of treatment, primary disease, presence or absence of underlying disease, presence or absence of complications, general physical and neurological outcome, duration of hospital stay, and status of social rehabilitation. Results Although the number of patients with cardiogenic OHCA did not markedly change, the number of bystanders participating in cardiopulmonary resuscitation (CPR) was significantly higher in the CR group versus the non-CR group (p<0.01). The effect of bystanders participating in CPR also significantly reduced the mortality outcome (p<0.05 versus the group without CPR), and patients in the CR group were more likely to achieve social rehabilitation (p<0.05 versus the group without CPR). Moreover, the number of patients who returned to society one year later was increased in the CR group versus the non-CR group (p<0.05). The incidence of respiratory complications was also significantly lower in the CR group versus the non-CR group (p<0.05). Conclusion Along with the usefulness of rapid pre-hospital aid, our results suggest that systemic intervention performed by the CR team administered while the patient was in the acute phase may have promoted social rehabilitation of patients resuscitated after cardiogenic OHCA.	[Takahashi, Keiko; Suzuki, Keiichiro] Hyogo Coll Med, Med Educ Ctr, Nishinomiya, Hyogo, Japan; [Takahashi, Keiko; Ohyanagi, Mitsumasa] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo, Japan; [Sasanuma, Naoki; Itani, Yusuke; Tanaka, Takashi] Hyogo Coll Med Hosp, Dept Rehabil, Nishinomiya, Hyogo, Japan; [Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo, Japan; [Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo, Japan	Takahashi, K (reprint author), Hyogo Coll Med, Med Educ Ctr, Nishinomiya, Hyogo, Japan.	keiko@hyo-med.ac.jp					Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Abe T, 2009, RESUSCITATION, V80, P431, DOI 10.1016/j.resuscitation.2008.12.010; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Henrich NJ, 2011, CRIT CARE MED, V39, P1000, DOI 10.1097/CCM.0b013e31820a92fb; Fernandez JF, 2012, CHEST, V142, P231, DOI 10.1378/chest.11-2420; Manzo-Silberman S, 2013, RESUSCITATION, V84, P609, DOI 10.1016/j.resuscitation.2012.10.001; Donnino MW, 2012, CIRCULATION, V126, P1478, DOI 10.1161/CIRCULATIONAHA.111.067256; Roter DL, 2006, J GEN INTERN MED, V21, pS28, DOI 10.1111/j.1525-1497.2006.00306.x; Bruce D, 2012, RESUSCITATION, V80, P65; Cameron J, 2012, WORK, V42, P461, DOI 10.3233/WOR-2012-1370; Fan E, 2012, RESP CARE, V57, P933, DOI 10.4187/respcare.01634; Furtos-Vivar F, 2011, J CRIT CARE, V26, P502; Giraldi F, 2011, J AM COLL CARDIOL, V58, P483, DOI 10.1016/j.jacc.2011.02.065; Goldberg RJ, 2008, AM J CARDIOL, V102, P1595, DOI 10.1016/j.amjcard.2008.08.008; JCS Joint Working Group, GUID REH PAT CARD DI; Lamm G, 1982, Adv Cardiol, V31, P107; Safar P., 1981, BRAIN FAILURE RESUSC, P155; Nagao K, 2007, LANCET, V369, P920; Takahashi K, 2013, NIHON SHINZO REHABIL, V18, P39; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	21	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					133	139		10.2169/internalmedicine.54.2825		7	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900006		
J	Nishi, S; Imai, N; Yoshita, K; Ito, Y; Ueno, M; Saeki, T				Nishi, Shinichi; Imai, Naofumi; Yoshita, Kazuhiro; Ito, Yumi; Ueno, Mitsuhiro; Saeki, Takako			Ultrastructural Studies of IgG4-related Kidney Disease	INTERNAL MEDICINE			English	Article						plasma cell; electron dense deposit; immune complex	TUBULOINTERSTITIAL NEPHRITIS; AUTOIMMUNE PANCREATITIS; BASEMENT-MEMBRANE; SYSTEMIC-DISEASE; RENAL-TRANSPLANT; IGG4; NEPHROPATHY; DEPOSITS; LESIONS	Objective Ultrastructural studies of IgG4-related kidney disease (IgG4-RKD) characterized by tubulointerstitial nephritis (TIN) are limited in previous reports due to the rarity of the condition. In the present report, we performed ultrastructural examinations and assessed the pathogenesis of this disease. Patients Clinicopathological studies were conducted in eight patients diagnosed with IgG4-RKD. Routine light, immunofluorescence and electron microscopy examinations and immunohistochemical assessments of IgG4 were performed using renal biopsy samples. Results Hypocomplementemia, positive anti-nuclear antibodies and eosinophilia were confirmed in more than half of the cases. Electron dense deposits (EDDs) were frequently found in the glomeruli and interstitium. The rate of deposition was 62.5% in both mesangial areas and Bowman's capsule. EDDs were frequently detected on the tubular basement membrane (TBM) (87.5% of patients). The interstitium also contained EDDs on collagen fibers in 87.5% of the cases and on basement membrane-like materials in areas of fibrosis in 37.5% of the cases. The creatinine clearance levels were significantly lower in the patients with the latter pattern. Meanwhile, the rate of immunoglobulin and/or complement deposition on the TBM was observed in less than 37.5% of patients, and these findings were not entirely coincident with the cases of EDDs on the TBM. Conclusion EDDs are frequently found in the glomeruli and interstitium in patients with IgG4-RKD; however, immunohistological studies do not provide evidence that IgG4-RKD involves TIN with immune complex nephropathy. The presence of interstitial EDDs may be related to the progression of interstitial fibrosis in the setting of IgG4-RKD.	[Nishi, Shinichi] Kobe Univ, Grad Sch Med, Div Nephrol, Kobe, Hyogo, Japan; [Nishi, Shinichi] Kobe Univ, Grad Sch Med, Kidney Ctr, Kobe, Hyogo, Japan; [Imai, Naofumi; Yoshita, Kazuhiro; Ito, Yumi] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol, Niigata 95021, Japan; [Imai, Naofumi; Yoshita, Kazuhiro; Ito, Yumi] Niigata Univ, Grad Sch Med & Dent Sci, Div Rheumatol, Niigata 95021, Japan; [Ueno, Mitsuhiro] Joetsu Univ Educ, Joetsu, Japan; [Saeki, Takako] Nagaoka Red Cross Hosp, Dept Internal Med, Niigata, Japan	Nishi, S (reprint author), Kobe Univ, Grad Sch Med, Div Nephrol, Kobe, Hyogo, Japan.	snishi@med.kobe-u.ac.jp			Ministry Labour and Welfare of Japan; Ministry of Education [24591199]	This study was supported in part by a Grant-in-Aid for Progressive Renal Disease Research, Research on Rare and Intractable Diseases and Research on Amyloidosis from the Ministry Labour and Welfare of Japan and a Grant-in-Aid issue number 24591199 from the Ministry of Education.	AALBERSE RC, 1983, CLIN REV ALLERG, V1, P289; Deshpande V, 2009, MODERN PATHOL, V22, P1287, DOI 10.1038/modpathol.2009.94; Saeki T, 2014, KIDNEY INT, V85, P251, DOI 10.1038/ki.2013.393; Zen Y, 2009, AM J SURG PATHOL, V33, P1833; Cornell LD, 2007, AM J SURG PATHOL, V31, P1586; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Nishi S, 2011, CLIN EXP NEPHROL, V15, P810, DOI 10.1007/s10157-011-0526-x; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Watson SJW, 2006, AM J SURG PATHOL, V30, P1472, DOI 10.1097/01.pas.0000213308.43929.97; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Yamaguchi Y, 2012, HUM PATHOL, V43, P536, DOI 10.1016/j.humpath.2011.06.002; AALBERSE RC, 1983, J IMMUNOL, V130, P722; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Yoshita K, 2012, NEPHROL DIAL TRANSPL, V27, P2755, DOI 10.1093/ndt/gfr761; Raissian Y, 2011, J AM SOC NEPHROL, V22, P1343, DOI 10.1681/ASN.2011010062; Detlefsen S, 2010, HISTOPATHOLOGY, V57, P825, DOI 10.1111/j.1365-2559.2010.03717.x; Kawano M., 2012, INT J RHEUMATOL, V2012; Mori Yasukiyo, 2005, Clin Exp Nephrol, V9, P79, DOI 10.1007/s10157-004-0338-3; ORFILA C, 1991, NEPHRON, V57, P149; ORFILA C, 1990, ULTRASTRUCT PATHOL, V14, P121; Saeki T, 2007, INTERNAL MED, V46, P1365, DOI 10.2169/internalmedicine.46.0183; Saeki T, 2009, CLIN NEPHROL, V71, P173; Saeki Takako, 2007, Clin Exp Nephrol, V11, P168, DOI 10.1007/s10157-007-0464-9; Shiozawa S, 2002, CLIN TRANSPLANT, V16, P68, DOI 10.1034/j.1399-0012.16.s8.12.x; Tsubata Y, 2010, INTERNAL MED, V49, P1593, DOI 10.2169/internalmedicine.49.3787; Uchiyama-Tanaka Yoko, 2004, Am J Kidney Dis, V43, pe18, DOI 10.1053/j.ajkd.2003.12.006	26	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					147	153		10.2169/internalmedicine.54.2581		7	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900008		
J	Asai, M; Tanaka, T; Kozu, R; Kitagawa, C; Tabusadani, M; Senjyu, H				Asai, Masaharu; Tanaka, Takako; Kozu, Ryo; Kitagawa, Chika; Tabusadani, Mitsuru; Senjyu, Hideaki			Effect of a Chronic Obstructive Pulmonary Disease (COPD) Intervention on COPD Awareness in a Regional City in Japan	INTERNAL MEDICINE			English	Article						chronic obstructive pulmonary disease (COPD); awareness; intervention; elderly; Japanese	HEALTH CHECK; PRIMARY-CARE; PREVALENCE; SMOKING; SMOKERS	Objective The purpose of this study was to examine the effect of an intervention for chronic obstructive pulmonary disease (COPD) on COPD awareness in a regional city in Japan. Methods Self-administered questionnaires were completed by the residents of the city of Matsuura, Japan. Residents (>= 50 years) of the mainland in Matsuura were included in a COPD intervention project (mainland group), while residents of the islands district received no intervention due to geographical issues (island group). The rates of COPD awareness and accuracy of responses to the questions about COPD were compared between the two groups. Materials The study included 5,891 residents 40 to 74 years of age of Matsuura in 2013. The mainland group comprised 4,419 subjects, and the island group 1,472 included subjects. Results The overall response rate to the questionnaire was 24.6%, with similar response rates between the two groups. The rate of COPD awareness in the mainland group was 24.5%, which was significantly higher than that observed in the island group (11.8%) (p<0.01). The rate of awareness tended to decrease in association with increasing age. Among 276 responders who stated they were aware of COPD, the accuracy rate for responses to the questions about COPD was not significantly different between the groups. Conclusion In the present study, there was a difference in COPD awareness between the two groups, suggesting that COPD interventions may increase awareness of the disease. However, the level of knowledge regarding COPD remained low and modifications to the intervention are required to improve awareness of the condition, especially among elderly subjects.	[Asai, Masaharu; Tanaka, Takako; Senjyu, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Japan; [Asai, Masaharu] Tagami Hosp, Dept Rehabil Med, Okinawa, Japan; [Kozu, Ryo] Nagasaki Univ Hosp, Dept Rehabil Med, Nagasaki, Japan; [Kitagawa, Chika] Nagasaki Resp Rehabil Clin, Dept Rehabil Med, Nagasaki, Japan; [Tabusadani, Mitsuru] Nagasaki Univ, Univ & Govt Cooperat, Ctr Ind, Nagasaki, Japan	Senjyu, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Japan.	senjyu@nagasaki-u.ac.jp					Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Ayanian JZ, 1999, JAMA-J AM MED ASSOC, V281, P1019, DOI 10.1001/jama.281.11.1019; Geijer RMM, 2005, FAM PRACT, V22, P485, DOI 10.1093/fampra/cmi049; Kawakami M, 2000, INTERNAL MED, V39, P720, DOI 10.2169/internalmedicine.39.720; Kimura K, 2011, INTERNAL MED, V50, P2135, DOI 10.2169/internalmedicine.50.5517; Komase Y, 2008, INTERNAL MED, V47, P1791, DOI 10.2169/internalmedicine.47.1006; Kornmann O, 2003, RESPIRATION, V70, P67, DOI 10.1159/000068417; Lange P, 2012, DAN MED J, V59; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ministry of Health Labour and Welfare, 2013, VIT STAT; Ministry of Health Labour and Welfare, 2012, REP NEXT NAT HLTH CA; Ministry of Health Labour and Welfare, 2013, PAT SURV; National Heart Lung and Blood Institute, 2011, GLOB IN CHRON OBSTR; Ryujin Y, 2013, RESPIROLOGY, V18, P134; Takahashi TU, 2003, RESPIROLOGY, V8, P504, DOI 10.1046/j.1440-1843.2003.00501.x; Uno T, 2013, NIHON KOKYUKI GAKKAI, V2, P536	22	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					163	169		10.2169/internalmedicine.54.2916		7	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900010		
J	Yanagida, T; Fujimoto, S; Inoue, T; Suzuki, S				Yanagida, Tomoko; Fujimoto, Shigeru; Inoue, Takuya; Suzuki, Satoshi			Prehospital Delay and Stroke-related Symptoms	INTERNAL MEDICINE			English	Article						acute stroke; bystander; prehospital delay; sign; symptom	ACUTE ISCHEMIC-STROKE; KNOWLEDGE; CARE	Objective Prehospital delay is the major cause of treatment delay in stroke. This study was conducted to clarify the contribution of specific stroke-related symptoms to prehospital delay. Methods A consecutive series of 469 patients hospitalized within 2 weeks of stroke onset was collected. In this study, prehospital delay was defined as the time interval from recognition of stroke-related symptoms to hospital arrival. The prevalence of each symptom or sign and prehospital delay were analyzed. Results Weakness of the lower limb (43.5%) was the most common symptom followed by weakness of the upper limb (37.1%) and dysarthria (31.6%). Conversely, the most common sign was weakness of the upper limb (54.1%) followed by dysarthria (53.3%), weakness of the lower limb (53.1%), and sensory disturbance (39.0%). The presence of confusion/decreased level of consciousness (p<0.001), aphasia (p<0.001), headache (p=0.017), and nausea/vomiting (p=0.035) were associated with earlier hospital visitation compared with the absence of these symptoms in univariate analyses. Conversely, the presence of sensory disturbance (p=0.0017) and vertigo/dizziness (p=0.044) were associated with a significant delay in hospital visitation compared with the absence of these symptoms. There was a discrepancy in the prevalence between symptoms recognized by the patients or bystanders and signs diagnosed by the physicians. Conclusion There was a significant overall correlation between prehospital delay and the National Institute of Health Stroke Scale scores. Public education is therefore necessary to encourage early hospital visitation even with the appearance of mild symptoms.	[Yanagida, Tomoko; Fujimoto, Shigeru; Inoue, Takuya; Suzuki, Satoshi] Steel Mem Yawata Hosp, Stroke Ctr, Kitakyushu, Fukuoka, Japan	Suzuki, S (reprint author), Steel Mem Yawata Hosp, Stroke Ctr, Kitakyushu, Fukuoka, Japan.	sasuzuki-nsu@umin.ac.jp					Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116; Kleindorfer D, 2010, AM J EMERG MED, V28, P607, DOI 10.1016/j.ajem.2009.02.016; Evenson KR, 2001, NEUROEPIDEMIOLOGY, V20, P65, DOI 10.1159/000054763; Fussman C, 2010, STROKE, V41, P1501, DOI 10.1161/STROKEAHA.110.578195; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Teuschl Y, 2010, INT J STROKE, V5, P187, DOI 10.1111/j.1747-4949.2010.00428.x; Evenson KR, 2009, INT J STROKE, V4, P187, DOI 10.1111/j.1747-4949.2009.00276.x; Chang KC, 2004, STROKE, V35, P700, DOI 10.1161/01.STR.0000117236.90827.17; Hong ES, 2011, EMERG MED J, V28, P790, DOI 10.1136/emj.2010.094425; Jin H, 2012, STROKE, V43, P363; Jorgensen HS, 1996, NEUROLOGY, V47, P383; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Tanaka Y, 2009, INTERNAL MED, V48, P1739, DOI 10.2169/internalmedicine.48.2378	15	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					171	177		10.2169/internalmedicine.54.2684		7	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900011		
J	Nagayasu, E; Yoshida, A; Hombu, A; Horii, Y; Maruyama, H				Nagayasu, Eiji; Yoshida, Ayako; Hombu, Amy; Horii, Yoichiro; Maruyama, Haruhiko			Paragonimiasis in Japan: A Twelve-year Retrospective Case Review (2001-2012)	INTERNAL MEDICINE			English	Review						paragonimiasis; lung fluke; immunodiagnosis; eosinophilic pneumonia; immigrants; re-emergence		Objective Paragonimiasis, or lung fluke infection, is a food-borne parasitic disease caused by infection with trematodes belonging to the genus Paragonimus. Although paragonimiasis was once considered successfully controlled in the 1970s, new cases began to emerge in the late 1980s. To apprehend the current-day situation of the re-emergent cases of paragonimiasis in Japan, we conducted a retrospective review of 443 patients who were referred to our laboratory and diagnosed as having paragonimiasis during 2001-2012. Methods Patients were diagnosed as having paragonimiasis based primarily on immunodiagnostic methods in addition to clinical, laboratory, and radiographic findings. Patient data were extracted from consultation sheets from attending physicians and were analyzed. Results Majority of the patients were residents of Kyushu Island. However, a substantial number of cases were also from other parts of Japan. Immigrants (mostly from China, Thailand, and Korea) accounted for a quarter of the cases. Native Japanese contracted paragonimiasis by consuming wild boar meat or freshwater crabs, whereas immigrants contracted the infection almost exclusively by consumption of freshwater crabs. Eosinophilia and elevated serum IgE levels were found in around 80% of the patients. Parasite egg detection was documented only in 11.7% of the cases, showing the reliance on serological tests for diagnosing paragonimiasis in current clinical practice. Conclusion Paragonimiasis remains a public health issue in Japan, and the situation should be closely monitored.	[Nagayasu, Eiji; Yoshida, Ayako; Hombu, Amy; Maruyama, Haruhiko] Miyazaki Univ, Grad Sch Med & Vet Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan; [Horii, Yoichiro] Miyazaki Univ, Grad Sch Med & Vet Med, Dept Vet Sci, Lab Vet Parasit Dis, Miyazaki, Japan	Maruyama, H (reprint author), Miyazaki Univ, Grad Sch Med & Vet Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan.	hikomaru@med.miyazaki-u.ac.jp			Health and Labor Sciences Research Grants [H22-Seisakusouyaku-Ippan-003, H23-Shinko-Ippan-014, H24-Kokui-Shitei-004, H25-Iryougijutsu-Shitei-012]	This study was supported by Health and Labor Sciences Research Grants (H22-Seisakusouyaku-Ippan-003, H23-Shinko-Ippan-014, H24-Kokui-Shitei-004 and H25-Iryougijutsu-Shitei-012). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Singh TS, 2012, INDIAN J MED RES, V136, P192; Blair D, 2005, SYST PARASITOL, V60, P1, DOI 10.1007/s11230-004-1378-5; Bunnag D, 2000, HUNTERS TROPICAL MED, P847; Katamine D, 1972, NETTAI IGAKU, V14, P186; Maruyama Haruhiko, 1996, Japanese Journal of Parasitology, V45, P192; Maruyama Haruhiko, 2012, Nihon Rinsho, V70, P2205; Matano S, 2012, J INFECT CHEMOTHER, V18, P558, DOI 10.1007/s10156-011-0336-9; Mukae H, 2005, GEN THORACIC SURG, P1309; Nakamura-Uchiyama F, 2001, Clin Infect Dis, V32, pe151; Nakamura-Uchiyama F, 2003, INTERNAL MED, V42, P222, DOI 10.2169/internalmedicine.42.222; Nawa Y, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P342; Nawa Y, 2005, ASIAN PARASITOLOGY, P125; Norimatsu Y., 1986, KOKYU, V5, P144; Obara A, 2004, INTERNAL MED, V43, P388, DOI 10.2169/internalmedicine.43.388; Procop GW, 2009, CLIN MICROBIOL REV, V22, P415, DOI 10.1128/CMR.00005-08; Steinert D., 2008, FOCUS J          JUL, V22; Sugiyama H, 2009, JPN J INFECT DIS, V62, P324; Sugiyama Hiromu, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P102; Uchiyama Fukumi, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P686; Yokogawa M, 1971, Naika, V27, P436; Yokogawa M., 1958, NAIKA NO RYOIKI, V6, P239	21	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					179	186		10.2169/internalmedicine.54.1733		8	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900012		
J	Nakano, K; Motoi, N; Takahashi, S				Nakano, Kenji; Motoi, Noriko; Takahashi, Shunji			The CYVADIC Regimen as a Combination Chemotherapy Treatment Option for Advanced Soft Tissue Sarcomas Originating from the Non-Extremities	INTERNAL MEDICINE			English	Article						soft tissue sarcoma; chemotherapy; CYVADIC	EUROPEAN-ORGANIZATION; RETROSPECTIVE ANALYSIS; PROGNOSTIC-FACTORS; DOXORUBICIN; IFOSFAMIDE; SURVIVAL; TRIAL	Objective Soft tissue sarcoma (STS) originating from the non-extremities has a poor prognosis and risk for visceral crisis; therefore, combination chemotherapy with a high response rate is desired. Methods We retrospectively reviewed the cases of 30 patients with advanced STS that originated from the non-extremities who were treated between October 2005 and February 2012 at our institute with the CYVADIC chemotherapy regimen, which consists of cyclophosphamide, vincristine, doxorubicin, and dacarbazine. The patients' objective responses, progression-free survival (PFS), and overall survival (OS) were evaluated, and a statistical analysis was conducted to identify the predictive factors related to response and survival. Results The median follow-up time was 16.5 months. The response rate was 33%, the median PFS was 7.4 months, and the 1-year OS was 81% (the OS did not reach the median). The median number of treatment cycles was six. Eleven patients failed to complete 6 cycles due to disease progression. The number of involved organs (>3) was a significant predictive factor of early refractoriness by the logistic regression analysis. Thirteen patients had an objective response or PFS longer than 1 year, and an alkaline phosphatase (ALP) level within the normal limits were the significant predictive factors of a good response. Conclusion The patients' responses to the CYVADIC therapy for advanced STS originating from the non-extremities were moderate; therefore, CYVADIC therapy may be a treatment option of choice as combination chemotherapy for such patients. We propose that the number of involved organs and ALP concentration may be useful measures to predict the response to the CYVADIC therapy.	[Nakano, Kenji; Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan; [Motoi, Noriko] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo, Japan	Takahashi, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan.	s.takahashi-chemotherapy@jfcr.or.jp					Karavasilis V, 2008, CANCER-AM CANCER SOC, V112, P1585, DOI 10.1002/cncr.23332; Lorigan P, 2007, J CLIN ONCOL, V25, P3144, DOI 10.1200/JCO.2006.09.7717; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Le Cesne A, 2012, EUR J CANCER, V48, P3036, DOI 10.1016/j.ejca.2012.05.012; Casali PG, 2010, ANN ONCOL, V21, pv198, DOI 10.1093/annonc/mdq209; SANTORO A, 1995, J CLIN ONCOL, V13, P1537; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Van Glabbeke M, 1999, J CLIN ONCOL, V17, P150; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.20.3.791; Brennan MF, 2012, MANAGEMENT SOFT TISS, P37; Kobayashi Shuichiro, 2010, Hinyokika Kiyo, V56, P531; Nagaoka H, 1994, HAIGAN, V34, P1037; Shimada K, 2004, NIHON SHOKAKIGEKA GA, V37, P39; Takano M, 1999, Gan To Kagaku Ryoho, V26, P1487; YAP BS, 1980, CANCER TREAT REP, V64, P93	16	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					187	193		10.2169/internalmedicine.54.1703		7	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900013		
J	Takano, Y; Yamamura, E; Gomi, K; Tohata, M; Endo, T; Suzuki, R; Hayashi, M; Nakanishi, T; Hanamura, S; Asonuma, K; Ino, S; Kuroki, Y; Maruoka, N; Nagahama, M; Inoue, K; Takahashi, H				Takano, Yuichi; Yamamura, Eiichi; Gomi, Kuniyo; Tohata, Misako; Endo, Toshiyuki; Suzuki, Reika; Hayashi, Masafumi; Nakanishi, Toru; Hanamura, Shotaro; Asonuma, Kunio; Ino, Satoshi; Kuroki, Yuichiro; Maruoka, Naotaka; Nagahama, Masatsugu; Inoue, Kazuaki; Takahashi, Hiroshi			Successful Conservative Treatment of Emphysematous Gastritis	INTERNAL MEDICINE			English	Article						emphysematous gastritis; conservative treatment; endoscopic findings		Emphysematous gastritis is an extremely rare disease with an unfavorable prognosis. To date, very few studies have been conducted regarding the intragastric recovery process based on endoscopic findings. We herein report a case of emphysematous gastritis that improved with long-term (five months) conservative treatment in which we were able to observe the intragastric recovery process endoscopically. In cases in which emphysematous gastritis is suspected, it is important to provide prompt diagnostic imaging (including CT) and early appropriate treatment in order to improve the prognosis.	[Takano, Yuichi; Yamamura, Eiichi; Gomi, Kuniyo; Tohata, Misako; Endo, Toshiyuki; Suzuki, Reika; Hayashi, Masafumi; Nakanishi, Toru; Hanamura, Shotaro; Asonuma, Kunio; Ino, Satoshi; Kuroki, Yuichiro; Maruoka, Naotaka; Nagahama, Masatsugu; Inoue, Kazuaki; Takahashi, Hiroshi] Showa Univ, Fujigaoka Hosp, Div Gastroenterol, Tokyo, Japan	Takano, Y (reprint author), Showa Univ, Fujigaoka Hosp, Div Gastroenterol, Tokyo, Japan.	yuichitakano1028@yahoo.co.jp					Jung JH, 2007, J KOREAN MED SCI, V22, P923; Grayson DE, 2002, RADIOGRAPHICS, V22, P543; MOOSVI AR, 1990, REV INFECT DIS, V12, P848; Arezzo A, 2011, CLIN GASTROENTEROL H, V9, pE30, DOI 10.1016/j.cgh.2010.10.024; Bajaj M, 2004, Arch Dis Child Fetal Neonatal Ed, V89, pF188, DOI 10.1136/adc.2003.034272; Fraenkel E, 1889, ARCH PATHOL ANAT PHY, V118, P526; Michels NA, 1955, BLOOD SUPPLY ANATOMY, P208; Ocepek A, 2004, Z GASTROENTEROL, V42, P735, DOI 10.1055/s-2004-813238; Paul Manju, 2010, J Med Case Rep, V4, P140, DOI 10.1186/1752-1947-4-140; Pauli EM, 2011, CASE REP SURG, V2011; Shipman P J, 2001, Australas Radiol, V45, P64, DOI 10.1046/j.1440-1673.2001.00878.x; Szuchmacher Mauricio, 2013, Int J Surg Case Rep, V4, P456, DOI 10.1016/j.ijscr.2012.12.021; van Mook WNKA, 2002, EUR J GASTROEN HEPAT, V14, P1155, DOI 10.1097/00042737-200210000-00018	13	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					195	198		10.2169/internalmedicine.54.3337		4	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900014		
J	Naito, T; Shiga, H; Endo, K; Kuroha, M; Kakuta, Y; Kinouchi, Y; Shimosegawa, T				Naito, Takeo; Shiga, Hisashi; Endo, Katsuya; Kuroha, Masatake; Kakuta, Yoichi; Kinouchi, Yoshitaka; Shimosegawa, Tooru			De novo Crohn's Disease Following Orthotopic Liver Transplantation: A Case Report and Literature Review	INTERNAL MEDICINE			English	Review						Crohn's disease; de novo Crohn's disease; orthotopic liver transplantation; immunosuppressive agents	INFLAMMATORY-BOWEL-DISEASE; PRIMARY SCLEROSING CHOLANGITIS; REGULATORY T-CELLS; OF-THE-LITERATURE; ULCERATIVE-COLITIS; CYTOMEGALOVIRUS-INFECTION; CASE SERIES; ORGAN-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; ORAL TACROLIMUS	The development of de novo Crohn's disease (CD) after orthotopic liver transplantation (OLT) is rare, possibly due to the continuous use of immunosuppressive treatment. Although several cases of CD following OLT have been reported worldwide, there are currently so such cases in Japan. We herein report the case of a patient who newly developed CD after undergoing OLT for congenital biliary atresia. The patient subsequently underwent ileocecal resection and has since maintained clinical remission. This is the first report of this condition in Japan. We also review the literature concerning cases of de novo inflammatory bowel disease (IBD) developing after OLT, and discuss the causes of and role of immunosuppressive agents in treating IBD.	[Naito, Takeo; Shiga, Hisashi; Endo, Katsuya; Kuroha, Masatake; Kakuta, Yoichi; Shimosegawa, Tooru] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kinouchi, Yoshitaka] Tohoku Univ, Hlth Adm Ctr, Ctr Adv Higher Educ, Sendai, Miyagi 980, Japan	Naito, T (reprint author), Tohoku Univ, Div Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan.	takeo.naito24@gmail.com					Ogata H, 2006, GUT, V55, P1255, DOI 10.1136/gut.2005.081794; Riley TR, 1997, AM J GASTROENTEROL, V92, P279; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831; Papatheodoridis GV, 1998, GUT, V43, P639; Befeler AS, 1998, TRANSPLANTATION, V65, P393, DOI 10.1097/00007890-199802150-00017; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Haagsma EB, 2003, ALIMENT PHARM THERAP, V18, P33, DOI 10.1046/j.0269-2813.2003.01613.x; Venkatesh PGK, 2011, J DIGEST DIS, V12, P245, DOI 10.1111/j.1751-2980.2011.00511.x; Verdonk RC, 2010, AM J PATHOL, V176, P3098, DOI 10.2353/ajpath.2010.100101; Papadakis KA, 2004, GUT, V53, P1389, DOI 10.1136/gut.2004.042523; Rostaing L, 1999, CLIN TRANSPLANT, V13, P400, DOI 10.1034/j.1399-0012.1999.130506.x; Bentz GL, 2006, J VIROL, V80, P11539, DOI 10.1128/JVI.01016-06; Nepal S, 2013, INFLAMM BOWEL DIS, V19, P1518, DOI 10.1097/MIB.0b013e3182813365; Verdonk RC, 2006, SCAND J GASTROENTERO, V41, P205, DOI 10.1080/00365520500206293; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Joshi D, 2013, LIVER INT, V33, P53, DOI 10.1111/j.1478-3231.2011.02677.x; Sandhu A, 2012, ALIMENT PHARM THER, V36, P159, DOI 10.1111/j.1365-2036.2012.05141.x; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200; Barritt AS, 2008, INFLAMM BOWEL DIS, V14, P1695, DOI 10.1002/ibd.20528; Chalasani N, 1998, AM J GASTROENTEROL, V93, P481; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P552, DOI 10.1002/lt.21077; Cuoco L, 1997, AM J GASTROENTEROL, V92, P2134; Dehghani SM, 2009, EXP CLIN TRANSPLANT, V7, P145; deMaar EF, 1996, TRANSPLANT INT, V9, P576; GAVALER JS, 1991, DIGEST DIS SCI, V36, P321, DOI 10.1007/BF01318204; Hampton DD, 2008, CLIN IMMUNOL, V128, P287, DOI 10.1016/j.clim.2008.06.011; Ho GT, 2005, EUR J GASTROEN HEPAT, V17, P1379, DOI 10.1097/00042737-200512000-00018; Jorgensen KK, 2012, GASTROENTEROLOGY, V142, pS; Khan S, 1999, J PEDIATR GASTR NUTR, V28, P206, DOI 10.1097/00005176-199902000-00023; Koskinen P K, 1994, Transpl Int, V7 Suppl 1, pS363; Lautenschlager I, 2006, TRANSPL INFECT DIS, V8, P21, DOI 10.1111/j.1399-3062.2006.00122.x; MacLean AR, 2003, DIS COLON RECTUM, V46, P1124, DOI 10.1097/01.DCR.0000080168-33599.FB; Mahmud SA, 2013, JAKSTAT, V2, DOI DOI 10.4161/JKST.23154; Onyeagocha C, 2009, AM J PATHOL, V175, P2034, DOI 10.2353/ajpath.2009.090471; Ramji A, 2002, DIGEST DIS SCI, V47, P522, DOI 10.1023/A:1017951632444; Safadi R, 1999, TRANSPLANT P, V31, P1896, DOI 10.1016/S0041-1345(99)00144-X; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sakamoto T, 2012, TRANSPL P, V44, P570, DOI 10.1016/j.transproceed.2012.01.007; SHAKED A, 1992, ANN SURG, V215, P598, DOI 10.1097/00000658-199206000-00006; Shaked A, 1992, ANN SURG, V215, P4; Tamaki H, 2008, J GASTROENTEROL, V43, P774, DOI 10.1007/s00535-008-2229-y; Thin LWY, 2013, INFLAMM BOWEL DIS, V19, P1490, DOI 10.1097/MIB.0b013e318281f362; Van de Vrie W, 2003, EUR J GASTROEN HEPAT, V15, P657, DOI 10.1097/01.meg.0000059133.68845.f7; Verdonka RC, 2006, AM J TRANSPLANT, V6, P1422, DOI 10.1111/j.1600-6143.2006.01333.x; Vu F, 2006, GASTROEN CLIN BIOL, V30, P1096, DOI 10.1016/S0399-8320(06)73484-4; Wong NACS, 2002, EUR J GASTROEN HEPAT, V14, P231, DOI 10.1097/00042737-200203000-00005; Worns MA, 2006, AM J GASTROENTEROL, V101, P1931, DOI 10.1111/j.1572-0241.00624.x	47	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					199	204		10.2169/internalmedicine.54.3156		6	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900015		
J	Kutoku, Y; Ohsawa, Y; Kuwano, R; Ikeuchi, T; Inoue, H; Ataka, S; Shimada, H; Mori, H; Sunada, Y				Kutoku, Yumiko; Ohsawa, Yutaka; Kuwano, Ryozo; Ikeuchi, Takeshi; Inoue, Haruhisa; Ataka, Suzuka; Shimada, Hiroyuki; Mori, Hiroshi; Sunada, Yoshihide			A Second Pedigree with Amyloid-less Familial Alzheimer's Disease Harboring an Identical Mutation in the Amyloid Precursor Protein Gene (E693delta)	INTERNAL MEDICINE			English	Article						Alzheimer's disease; familial Alzheimer's disease; APP gene; A beta oligomers; PET	A-BETA; OLIGOMER	A 59-year-old woman developed early-onset, slowly progressive dementia and spastic paraplegia. positron emission tomography (PET) imaging revealed a large reduction in the level of glucose uptake without amyloid deposition in the cerebral cortex. We identified a homozygous microdeletion within the amyloid beta (A beta) coding sequence in the amyloid precursor protein (APP) gene (c.2080_ 2082delGAA, p.E693del) in three affected siblings and a heterozygous microdeletion in an unaffected sibling. The identical mutation was previously reported in the first Alzheimer's pedigree without amyloid deposits. Furthermore, an increase in high-molecular-weight A beta-reactive bands was detected in the patient's CSF. Our findings suggest that soluble A beta-oligomers induce neuronal toxicity, independent of insoluble A beta fibrils.	[Kutoku, Yumiko; Ohsawa, Yutaka; Sunada, Yoshihide] Kawasaki Med Univ, Dept Neurol, Kawasaki, Kanagawa, Japan; [Kuwano, Ryozo; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Mol Genet,Bioresource Sci Branch, Niigata 95021, Japan; [Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068501, Japan; [Ataka, Suzuka; Shimada, Hiroyuki] Osaka City Univ, Grad Sch Med, Dept Geriatr & Neurol, Osaka, Japan; [Mori, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Neurosci, Osaka, Japan	Sunada, Y (reprint author), Kawasaki Med Univ, Dept Neurol, Kawasaki, Kanagawa, Japan.	ysunada@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [C-20591013, C-23591261, C-26461285, C-21591101]; National Center of Neurology and Psychiatry [23-5, 26-8, 20B-13]; Kawasaki Medical School [22-A24, 23-B60, 22-T1, 23-P1]; Ministry of Health, Labour and Welfare of Japan [H20-018]	Dr. Ohsawa received support from the Japan Society for the Promotion of Science (C-20591013, C-23591261, C-26461285), National Center of Neurology and Psychiatry (23-5, 26-8) and Kawasaki Medical School (22-A24, 23-B60). Dr. Sunada received support from the Japan Society for the Promotion of Science (C-21591101), National Center of Neurology and Psychiatry (20B-13), Ministry of Health, Labour and Welfare of Japan (H20-018) and Kawasaki Medical School (22-T1, 23-P1).	Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069	11	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					205	208		10.2169/internalmedicine.54.3021		4	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900016		
J	Kadoya, M; Onoue, H; Kadoya, A; Ikewaki, K; Kaida, K				Kadoya, Masato; Onoue, Hiroyuki; Kadoya, Akiko; Ikewaki, Katsunori; Kaida, Kenichi			Refractory Status Epilepticus Caused by Anti-NMDA Receptor Encephalitis that Markedly Improved Following Combination Therapy with Rituximab and Cyclophosphamide	INTERNAL MEDICINE			English	Article						status epilepticus; anti-NMDA receptor antibody; limbic encephalitis; second-line immunotherapy; rituximab; cyclophosphamide	IMMUNOTHERAPY; TUMOR	We herein describe the case of a 48-year-old woman who presented with nonconvulsive status epilepticus refractory to antiepileptic drugs caused by anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis without any tumors. She developed nausea and psychiatric symptoms, followed by fever and an acute progressive disturbance of consciousness. On admission to our hospital, she presented with involuntary orofacial movements and central hypoventilation, and an electroencephalogram showed a generalized slow activity consistent with nonconvulsive status epilepticus. The patient's drug-resistant status epilepticus markedly improved following second-line immunotherapy with rituximab and cyclophosphamide. Physicians should consider the early initiation of second-line therapy in certain cases of anti-NMDAR encephalitis.	[Kadoya, Masato; Onoue, Hiroyuki; Kadoya, Akiko; Ikewaki, Katsunori; Kaida, Kenichi] Natl Def Med Coll, Dept Neurol & Antiaging Med, Tokorozawa, Saitama, Japan	Kaida, K (reprint author), Natl Def Med Coll, Dept Neurol & Antiaging Med, Tokorozawa, Saitama, Japan.	adiak901@ndmc.ac.jp					Johnson N, 2010, NEUROLOGY, V75, P1480, DOI 10.1212/WNL.0b013e3181f8831a; Kashyape P, 2012, EUR J PAEDIATR NEURO, V16, P74, DOI 10.1016/j.ejpn.2011.07.005; Ishiura H, 2008, NEUROLOGY, V71, P1921, DOI 10.1212/01.wnl.0000336648.43562.59; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Schmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8; Ikeguchi R, 2012, INTERNAL MED, V51, P1585, DOI 10.2169/internalmedicine.51.6874; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Kirkpatrick MP, 2011, EPILEPSY BEHAV, V20, P392, DOI 10.1016/j.yebeh.2010.11.020; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Gabilondo I, 2011, NEUROLOGY, V77, P996, DOI 10.1212/WNL.0b013e31822cfc6b	12	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					209	213		10.2169/internalmedicine.54.2047		5	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900017		
J	Hirota, S; Ito, S; Fukui, T; Murate, K; Shima, S; Kizawa, M; Ueda, A; Asakura, K; Mutoh, T				Hirota, Seiko; Ito, Shinji; Fukui, Takao; Murate, Kenichiro; Shima, Sayuri; Kizawa, Madoka; Ueda, Akihiro; Asakura, Kunihiko; Mutoh, Tatsuro			Voriconazole-responsive Disseminated Nodular Lesions on Spinal MRI	INTERNAL MEDICINE			English	Article						meningitis; deep mycosis; MRI; voriconazole	INVASIVE FUNGAL-INFECTIONS; CENTRAL-NERVOUS-SYSTEM; ELSBERG-SYNDROME; DIAGNOSIS; ASPERGILLOSIS; INJECTIONS	A 74-year-old woman was hospitalized due to dysuria, weakness and dysesthesia of the lower extremities. She was in an immunosuppressed state following the administration of methylprednisolone therapy for idiopathic interstitial pneumonia. Cerebrospinal fluid and blood cultures were negative, and no infectious biomarkers were found. A gadolinium (Gd)-enhanced T1-weighted image of magnetic resonance imaging (MRI) revealed disseminated nodular lesions along the spinal cord. We suspected a diagnosis of seronegative deep mycosis and initiated anti-fungal therapy with voriconazole, which subsequently alleviated all of the patient's symptoms and MRI findings. Therefore, the presence of Gd-enhanced disseminated nodules on spinal MRI may be a good marker of deep meningeal mycosis.	[Hirota, Seiko; Ito, Shinji; Fukui, Takao; Murate, Kenichiro; Shima, Sayuri; Kizawa, Madoka; Ueda, Akihiro; Asakura, Kunihiko; Mutoh, Tatsuro] Fujita Hlth Univ, Sch Med, Dept Neurol, Toyoake, Aichi, Japan	Mutoh, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Neurol, Toyoake, Aichi, Japan.	tmutoh@fujita-hu.ac.jp					Schuetz AN, 2013, CLIN LAB MED, V33, P505, DOI 10.1016/j.cll.2013.03.009; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; Tung GA, 2003, AM J NEURORADIOL, V24, P1110; Eberhardt O, 2004, NEUROLOGY, V63, P758; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Dusart A, 2013, ACTA NEUROL BELG, V113, P179, DOI 10.1007/s13760-012-0151-9; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Malani AN, 2013, JAMA-J AM MED ASSOC, V309, P2465, DOI 10.1001/jama.2013.6293; Mathur M, 2012, NEUROIMAG CLIN N AM, V22, P609, DOI 10.1016/j.nic.2012.04.004; Matsumoto H, 2012, INTERNAL MED, V51, P651, DOI 10.2169/internalmedicine.51.6514	12	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					215	218		10.2169/internalmedicine.54.3148		4	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900018		
J	Ueno, S; Miyamoto, N; Shimura, H; Ueno, Y; Watanabe, M; Hayashi, A; Hattori, N; Urabe, T				Ueno, Shinichi; Miyamoto, Nobukazu; Shimura, Hideki; Ueno, Yuji; Watanabe, Masao; Hayashi, Akito; Hattori, Nobutaka; Urabe, Takao			Successful Immune Moderation Treatment for Progressive Encephalomyelitis with Rigidity and Myoclonus	INTERNAL MEDICINE			English	Article						progressive encephalomyelitis with rigidity and myoclonus; stiff person syndrome; levetiracetam; intravenous immunoglobulin	STIFF-MAN SYNDROME; RECEPTOR ANTIBODIES; CLINICAL-FEATURES; PERSON SYNDROME; GLYCINE	Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare disease. PERM consists of the same symptoms as stiff person syndrome, in addition to sensory, brainstem and autonomic features. We herein report a case of PERM in a 48-year-old woman who initially presented with spasticity of the lower limbs and subsequently developed upper limb spasticity, perioral myoclonus and restlessness after three months. The onset of potentially fatal dysautonomia was observed at the peak of the disease. Treatment with high-dose immunoglobulin (400 mg/kg, 5 days), levetiracetam and azathioprine resulted in a drastic and sustained improvement of these symptoms. This is an interesting case of PERM in which the patient showed a dramatic improvement following immune moderation.	[Ueno, Shinichi; Miyamoto, Nobukazu; Shimura, Hideki; Ueno, Yuji; Watanabe, Masao; Urabe, Takao] Juntendo Univ, Urayasu Hosp, Dept Neurol, Tokyo, Japan; [Hayashi, Akito] Juntendo Univ, Urayasu Hosp, Dept Rehabil, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan	Miyamoto, N (reprint author), Juntendo Univ, Urayasu Hosp, Dept Neurol, Tokyo, Japan.	nobu-m@juntendo.ac.jp					AMATO AA, 1994, NEUROLOGY, V44, P1652; Mas N, 2011, J NEUROL NEUROSUR PS, V82, P1399, DOI 10.1136/jnnp.2010.229104; MOERSCH FP, 1956, P STAFF M MAYO CLIN, V31, P421; Hutchinson M, 2008, NEUROLOGY, V71, P1291, DOI 10.1212/01.wnl.0000327606.50322.f0; Shugaiv E, 2013, EUR NEUROL, V69, P257, DOI 10.1159/000342237; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; McKeon A, 2012, ARCH NEUROL-CHICAGO, V69, P230, DOI 10.1001/archneurol.2011.991; Turner MR, 2011, NEUROLOGY, V77, P439, DOI 10.1212/WNL.0b013e318227b176; Barker RA, 1998, J NEUROL NEUROSUR PS, V65, P633, DOI 10.1136/jnnp.65.5.633; Carvajal-Gonzalez A, 2014, BRAIN, V137, P2178, DOI 10.1093/brain/awu142; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Fogan L, 1996, ANN NEUROL, V40, P451, DOI 10.1002/ana.410400315; Ruegg SJ, 2004, NEUROLOGY, V62, P338	13	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					219	221		10.2169/internalmedicine.54.3760		3	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900019		
J	Kaku, Y; Kodama, S; Higuchi, M; Nakamura, A; Nakamura, M; Kaieda, T; Takahama, S; Minami, R; Miyamura, T; Suematsu, E; Yamamoto, M				Kaku, Yu; Kodama, Shoko; Higuchi, Makiko; Nakamura, Akihiro; Nakamura, Masataka; Kaieda, Tomoe; Takahama, Soichiro; Minami, Rumi; Miyamura, Tomoya; Suematsu, Eiichi; Yamamoto, Masahiro			Corticoid Therapy for Overlapping Syndromes in an HIV-positive Patient	INTERNAL MEDICINE			English	Article						human immunodeficiency virus (HIV); polymyositis (PM); Sjogren's syndrome (SS); autoimmune hepatitis (AIH); steroid; combined antiretroviral therapy (cART)	IMMUNODEFICIENCY-VIRUS-INFECTION; SJOGREN-LIKE SYNDROME; AUTOIMMUNE HEPATITIS; RHEUMATIC MANIFESTATIONS; DISEASE	Human immunodeficiency virus (HIV) infection disturbs the host's immune function and often coexists with various autoimmune and/or systemic rheumatic diseases with manifestations that sometimes overlap with each other. We herein present the case of a 43-year-old Japanese man infected with HIV who exhibited elevated serum creatine kinase and transaminases levels without any symptoms. He was diagnosed with autoimmune hepatitis, polymyositis and Sjogren's syndrome and received combined antiretroviral therapy (cART); however, the laboratory abnormalities persisted. We successfully administered cART with the addition of oral prednisolone, and the patient's condition recovered without side effects related to the metabolic or immunosuppressive effects of these drugs.	[Kaku, Yu; Kodama, Shoko; Higuchi, Makiko; Nakamura, Akihiro; Nakamura, Masataka; Kaieda, Tomoe; Takahama, Soichiro; Minami, Rumi; Miyamura, Tomoya; Suematsu, Eiichi; Yamamoto, Masahiro] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Internal Med, Tokyo, Japan	Yamamoto, M (reprint author), Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Internal Med, Tokyo, Japan.	inb@kyumed.jp					Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Suzuki A, 2011, HEPATOLOGY, V54, P931, DOI 10.1002/hep.24481; Puius YA, 2008, J CLIN GASTROENTEROL, V42, P425, DOI 10.1097/01.mcg.0000225591.08825.3e; Yao Q, 2008, CLIN EXP RHEUMATOL, V26, P799; Abe M, 2011, J GASTROENTEROL, V46, P1136, DOI 10.1007/s00535-011-0421-y; Efe C, 2012, EUR J GASTROEN HEPAT, V24, P531, DOI 10.1097/MEG.0b013e328350f95b; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Zhang X, 2007, J RHEUMATOL, V34, P1760; Vergani D, 2008, WORLD J GASTROENTERO, V14, P3306, DOI 10.3748/wjg.14.3306; Capetti Amedeo F, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P201, DOI 10.1177/1545109710372671; Cherqaoui R, 2014, J THYROID RES, V2014; Christodoulou MI, 2010, J AUTOIMMUN, V34, P400, DOI 10.1016/j.jaut.2009.10.004; Cozzolino I, 2012, INFEZ MED, V2, P35; Crum-Cianflone N, 2010, CLIN GASTROENTEROL H, V8, P183, DOI 10.1016/j.cgh.2009.09.025; Heckmann JM, 2010, NEUROMUSCULAR DISORD, V20, P735, DOI 10.1016/j.nmd.2010.06.007; Henriksson G, 2000, RHEUMATOLOGY, V39, P142, DOI 10.1093/rheumatology/39.2.142; Hu S, 2009, ARTHRITIS RHEUM-US, V60, P81, DOI 10.1002/art.24150; Kole Alakes Kumar, 2013, Indian J Sex Transm Dis, V34, P107, DOI 10.4103/0253-7184.120542; Kulthanan K, 2002, INT J DERMATOL, V41, P417, DOI 10.1046/j.1365-4362.2002.01529.x; Lawson E, 2012, BRIT MED BULL, V103, P203, DOI 10.1093/bmb/lds022; Louthrenoo W, 1997, J Clin Rheumatol, V3, P258, DOI 10.1097/00124743-199710000-00004; Masanes F, 1996, CLIN NEUROPATHOL, V15, P221; Misterska-Skora M, 2013, RHEUMATOL INT, V33, P3083, DOI 10.1007/s00296-012-2556-4; Moodie EEM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004517; Oh Hyo Jeong, 2013, Clin Mol Hepatol, V19, P305, DOI 10.3350/cmh.2013.19.3.305; Panayiotakopoulos GD, 2003, RHEUMATOLOGY, V42, P1164, DOI 10.1093/rheumatology/keg316; Rojas-Villarraga A., 2012, AUTOIMMUNE DIS, V2012; Romic Z, 2011, RHEUMATOL INT, V31, P1607, DOI 10.1007/s00296-010-1539-6; ROUJEAU JC, 1985, LANCET, V1, P609; SCHUVAL SJ, 1993, J RHEUMATOL, V20, P1578; Sipsas NV, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3262; Walker UA, 2008, RHEUMATOLOGY, V47, P952, DOI 10.1093/rheumatology/ken132; Yamamoto M, 2002, Mod Rheumatol, V12, P333, DOI 10.3109/s101650200059; Yang JJ, 2013, J MICROBIOL IMMUNOL	34	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					223	230		10.2169/internalmedicine.54.3094		8	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900020		
J	Nara, M; Komatsuda, A; Togashi, M; Wakui, H				Nara, Mizuho; Komatsuda, Atsushi; Togashi, Masaru; Wakui, Hideki			Relapsing Polychondritis with Encephalitis: A Case Report and Literature Review	INTERNAL MEDICINE			English	Review						encephalitis; relapsing polychondritis; steroid pulse therapy	LIMBIC ENCEPHALITIS; MENINGOENCEPHALITIS; MENINGITIS; DEMENTIA; PATIENT	We herein report the case of a 39-year-old man who developed bilateral auricular chondritis, conjunctivitis, and central neurological symptoms. He was diagnosed with encephalitis associated with relapsing polychondritis (RP) based on the findings of an ear cartilage biopsy, cerebrospinal fluid examination and magnetic resonance imaging. Although oral prednisolone (60 mg/day) was administered, the initial steroid therapy did not improve his symptoms. In contrast, methylprednisolone (mPSL) pulse therapy followed by prednisolone gradually ameliorated his condition. There were no episodes of recurrence during the two-year follow-up period. A review of the literature revealed that meningoencephalitis and encephalitis are rare, but important, complications of RP responsive to mPSL pulse therapy.	[Nara, Mizuho; Komatsuda, Atsushi; Togashi, Masaru; Wakui, Hideki] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan; [Wakui, Hideki] Akita Univ, Grad Sch Engn & Resource Sci, Dept Life Sci, Akita 010, Japan	Komatsuda, A (reprint author), Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan.	komatsud@med.akita-u.ac.jp					Cantarini L, 2014, J AUTOIMMUN, V48-49, P53, DOI 10.1016/j.jaut.2014.01.026; Fujiki F, 2004, J NEUROL NEUROSUR PS, V75, P1646, DOI 10.1136/jnnp.2003.035170; Arnaud L, 2014, AUTOIMMUN REV, V13, P90, DOI 10.1016/j.autrev.2013.07.005; Choi HJ, 2011, JCR-J CLIN RHEUMATOL, V17, P329, DOI 10.1097/RHU.0b013e31822e071b; Erten-Lyons D, 2008, J NEUROL NEUROSUR PS, V79, P609, DOI 10.1136/jnnp.2007.131425; Fujioka S, 2008, MOVEMENT DISORD, V23, P2421, DOI 10.1002/mds.22345; Garcia-Egido A, 2011, RHEUMATOLOGY, V50, P1721, DOI 10.1093/rheumatology/ker184; HANSLIK T, 1994, CLIN EXP RHEUMATOL, V12, P539; Kao KT, 2007, CLIN RHEUMATOL, V26, P1985, DOI 10.1007/s10067-007-0600-7; Kashihara K, 2009, J NEUROL SCI, V287, P275, DOI 10.1016/j.jns.2009.08.004; Kumar N, 2009, AJNR Am J Neuroradiol, V30, pE96, DOI 10.3174/ajnr.A1631; Kuwabara M, 2008, RADIAT MED, V26, P438, DOI 10.1007/s11604-008-0247-6; Mathew SD, 2011, SEMIN ARTHRITIS RHEU, V42, P70; Mihara T, 2006, FEBS LETT, V580, P4991, DOI 10.1016/j.febslet.2006.08.013; Ohta Y, 2004, J NEUROL SCI, V220, P85, DOI 10.1016/j.jns.2004.02.010; Sampaio L, 2010, JOINT BONE SPINE, V77, P616; Storey K, 2011, J NEUROL, V258, P159, DOI 10.1007/s00415-010-5691-4; Wang ZJ, 2011, J CLIN NEUROSCI, V18, P1608, DOI 10.1016/j.jocn.2011.04.012; Yan M, 2006, PATHOLOGY, V38, P596, DOI 10.1080/0313020601023989; Yang SM, 2004, JCR-J CLIN RHEUMATOL, V10, P83, DOI 10.1097/01.rhu.0000120900.55459.33	20	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					231	234		10.2169/internalmedicine.54.3568		4	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900021		
J	Tsuji, Y; Tashiro, M; Ashizawa, N; Ota, Y; Obi, H; Nagura, S; Narukawa, M; Fukahara, K; Yoshimura, N; To, H; Yamamoto, Y				Tsuji, Yasuhiro; Tashiro, Masato; Ashizawa, Nobuyuki; Ota, Yukio; Obi, Hayato; Nagura, Saori; Narukawa, Munetoshi; Fukahara, Kazuaki; Yoshimura, Naoki; To, Hideto; Yamamoto, Yoshihiro			Treatment of Mediastinitis due to Methicillin-resistant Staphylococcus aureus in a Renal Dysfunction Patient Undergoing Adjustments to the Linezolid Dose	INTERNAL MEDICINE			English	Article						linezolid; mediastinitis; methicillin-resistant Staphylococcus aureus; renal dysfunction; therapeutic drug monitoring	POSTOPERATIVE MEDIASTINITIS; INDUCED THROMBOCYTOPENIA; PHARMACOKINETICS; SURGERY; TISSUE; SERUM	This study is the first case report of the treatment of methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis using therapeutic drug monitoring of the serum and wound exudate concentrations of linezolid in a renal dysfunction patient. In the present study, the serum trough concentration of linezolid was maintained between 2 and 7 mu g/mL. Therapeutic drug monitoring dosage adjustments may be especially useful in patients with renal dysfunction and severe MRSA infection.	[Tsuji, Yasuhiro; Ota, Yukio; To, Hideto] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Med Pharmaceut, Toyama, Japan; [Tashiro, Masato; Ashizawa, Nobuyuki; Narukawa, Munetoshi; Yamamoto, Yoshihiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Infect Dis, Toyama, Japan; [Obi, Hayato; Nagura, Saori; Fukahara, Kazuaki; Yoshimura, Naoki] Toyama Univ, Grad Sch Med, Dept Surg, Toyama, Japan	Yamamoto, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Infect Dis, Toyama, Japan.	yamamoto@med.u-toyama.ac.jp					Wu VC, 2006, CLIN INFECT DIS, V42, P66, DOI 10.1086/498509; Pea F, 2012, J ANTIMICROB CHEMOTH, V67, P2034, DOI 10.1093/jac/dks153; Sasaki T, 2011, ANTIMICROB AGENTS CH, V55, P1867, DOI 10.1128/AAC.01185-10; Nukui Y, 2013, J ANTIMICROB CHEMOTH, V68, P2128, DOI 10.1093/jac/dkt133; Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839; Gardlund B, 2002, EUR J CARDIO-THORAC, V21, P825, DOI 10.1016/S1010-7940(02)00084-2; Ashley ESD, 2004, CLIN INFECT DIS, V38, P1555; Attassi K, 2002, CLIN INFECT DIS, V34, P695, DOI 10.1086/338403; Brier ME, 2003, ANTIMICROB AGENTS CH, V47, P2775, DOI 10.1128/AAC.47.9.2775-2780.2003; Cossu AP, 2014, EUR J CLIN PHARMACOL, V70, P23, DOI 10.1007/s00228-013-1585-6; FARINAS MC, 1995, CLIN INFECT DIS, V20, P272; Hiraki Y, 2012, SCAND J INFECT DIS, V44, P60, DOI 10.3109/00365548.2011.608712; Kosaka T, 2009, INT J ANTIMICROB AG, V33, P368, DOI 10.1016/j.ijantimicag.2008.10.006; Majcher-Peszynska J, 2008, EUR J CLIN PHARMACOL, V64, P1093, DOI 10.1007/s00228-008-0531-5; Sacar S, 2009, J SURG RES, V152, P89, DOI 10.1016/j.jss.2008.03.040; Sisson TL, 2002, EUR J CLIN PHARMACOL, V57, P793, DOI 10.1007/s00228-001-0380-y; Tsuji Y, 2011, J INFECT CHEMOTHER, V17, P70, DOI 10.1007/s10156-010-0080-6; Tsuji Y, 2013, J CLIN PHARMACOL, V53, P967, DOI 10.1002/jcph.133; Tsuji Y, 2013, INT J INFECT DIS, V17, pE1060, DOI 10.1016/j.ijid.2013.03.008	19	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					235	239		10.2169/internalmedicine.54.2292		5	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900022		
J	Kiyotoki, S; Nishikawa, J; Tajima, K; Sakaida, I				Kiyotoki, Shu; Nishikawa, Jun; Tajima, Kunihiko; Sakaida, Isao			Gastric Ulcer Caused by the Retention of Rice Cakes	INTERNAL MEDICINE			English	Editorial Material						gastric ulcer; rice cakes			[Kiyotoki, Shu; Nishikawa, Jun; Tajima, Kunihiko; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan	Nishikawa, J (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan.	junnis@yamaguchi-u.ac.jp					Fujii M, 2006, J GASTROENTEROL, V41, P282, DOI 10.1007/s00535-005-1755-0; Miura T, 2011, INTERNAL MED, V50, P2737, DOI 10.2169/internalmedicine.50.6152	2	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	2					241	242		10.2169/internalmedicine.54.2760		2	Medicine, General & Internal	General & Internal Medicine	AZ3MO	WOS:000348131900023		
J	Jiao, XH; Zhang, JY; Shen, TL; Kako, J				Jiao, Xiaohong; Zhang, Jiangyan; Shen, Tielong; Kako, Junichi			Adaptive air-fuel ratio control scheme and its experimental validations for port-injected spark ignition engines	INTERNATIONAL JOURNAL OF ADAPTIVE CONTROL AND SIGNAL PROCESSING			English	Article						port-injected SI engine; air-fuel ratio control; transient fueling dynamics; uncertain parameters; fuel injection; adaptive control; parameter estimation	INTERNAL-COMBUSTION ENGINES; INPUT; MODEL	To maintain the stoichiometric air-fuel ratio (AFR), this paper presents a model-based adaptive AFR control scheme for port-injected spark ignition engines. The utilized mean-value model in control design accounts for the impingement and the evaporation process of the injected fuel on the walls and calculates on the uncertainties in the dynamics of the intake manifold and crankshaft rotation. A fueling controller with adaptive update laws is derived for estimating the uncertain parameters related to inaccuracies in air flow and fuel delivery into the cylinders and engine torque production, which is implemented by utilizing engine speed, manifold pressure and temperature, air mass flow rate at the throttle, and the universal exhaust gas oxygen (UEGO) sensor information, without knowledge of the fuel flow mass. Theoretical analysis shows that the proposed strategy is able to regulate the AFR against the parameter uncertainties. Moreover, both simulation and experiment on an engine test bench demonstrate the capability of the adaptive controller to recover the performance and robustness properties of the control system in the presence of various operating conditions and uncertainties including air path and fuel path perturbations and load torque disturbance as well. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Jiao, Xiaohong] Yanshan Univ, Inst Elect Engn, Qinhuangdao 066004, Peoples R China; [Zhang, Jiangyan] Dalian Nationalities Univ, Coll Electromech & Informat Engn, Dalian 116600, Peoples R China; [Zhang, Jiangyan; Shen, Tielong] Sophia Univ, Dept Engn & Appl Sci, Tokyo 1028554, Japan; [Kako, Junichi] Toyota Motor Co Ltd, Nagoya, Aichi 4718572, Japan	Shen, TL (reprint author), Sophia Univ, Dept Engn & Appl Sci, Tokyo 1028554, Japan.	tetu-sin@sophia.ac.jp					Rupp D, 2010, CONTROL ENG PRACT, V18, P873, DOI 10.1016/j.conengprac.2010.03.011; Tang HJ, 2009, IEEE-ASME T MECH, V14, P93, DOI 10.1109/TMECH.2008.2004806; Orlov Y, 2009, INT J ADAPT CONTROL, V23, P150, DOI 10.1002/acs.1033; Stotsky A, 2004, INT J ADAPT CONTROL, V18, P125, DOI 10.1002/acs.785; Yildiz Y, 2010, CONTROL ENG PRACT, V18, P1369, DOI 10.1016/j.conengprac.2010.06.011; Tang HJ, 2010, T I MEAS CONTROL, V32, P225, DOI 10.1177/0142331209339870; Arsie I, 2003, CONTROL ENG PRACT, V11, P303, DOI 10.1016/S0967-0661(02)00040-0; CHOI SB, 1994, IEEE DECIS CONTR P, P1609, DOI 10.1109/CDC.1994.411212; Chos D, 1989, ASME J DYNAMIC SYSTE, V111, P568; Francheks MA, 2006, ASME J DYNAMIC SYSTE, V128, P499; Guzzellas L, 2004, INTRO MODELING CONTR; Kahveci NE, 2010, P AMER CONTR CONF, P2236; Kolmanovsky I, 2006, INT J ADAPT CONTROL, V20, P225, DOI 10.1002/acs.899; Souder JS, 2004, INT J ROBUST NONLIN, V14, P525, DOI 10.1002/rnc.901; Suns J, 2005, P AM CONTR C PORTL O, P3271; Suns J, 2004, INT J ADAPT CONTROL, V18, P145; Wang SW, 2005, INT J AUTOMATION COM, V2, P125, DOI 10.1007/s11633-005-0125-y; Wons M, 1998, IEEE T CONTR SYST T, V6, P678; Yildiz Y, 2008, P AMER CONTR CONF, P2058, DOI 10.1109/ACC.2008.4586796; Zhang JY, 2010, CONTROL ENG PRACT, V18, P1285, DOI 10.1016/j.conengprac.2010.01.010; Zhangs F, 2007, ASME J DYNAMIC SYSTE, V129, P404	21	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0890-6327	1099-1115		INT J ADAPT CONTROL	Int. J. Adapt. Control Signal Process.	JAN	2015	29	1					41	63		10.1002/acs.2456		23	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AY8AQ	WOS:000347777200003		
J	Kono, H; Teshirogi, T				Kono, Hiroyuki; Teshirogi, Taku			Cyclodextrin-grafted chitosan hydrogels for controlled drug delivery	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Carboxymethyl chitosan; Carboxymethyl cyclodextrin; Hydrogel; Acetylsalicylic acid; Controlled drug release	TISSUE ENGINEERING APPLICATIONS; ESTERIFICATION CROSS-LINKING; A ADSORPTION CAPACITY; BETA-CYCLODEXTRIN; BIOMEDICAL APPLICATIONS; 1,2,3,4-BUTANETETRACARBOXYLIC DIANHYDRIDE; CHITIN; NANOPARTICLES; RELEASE; COMPLEXATION	A series of beta-cyclodextrin-grafted carboxymethyl chitosan hydrogels (CD-g-CMCs) were prepared from carboxymethyl chitosan (CMC) and carboxymethyl beta-chitosan (CMCD) using a water-soluble carbodiimide as a crosslinker in the presence of N-hydroxysuccinimide. Details of the hydrogel structures were determined via FTIR and solid-state NMR spectroscopic analyses. Increasing the feed ratio of CMCD to CMC in the reaction mixture led to an increase in CD grafting within the gel networks comprising CMC; this was confirmed by SEM observations and rheological analysis of the swollen hydrogels. The prepared CD-g-CMC hydrogels exhibited absorption properties toward acetylsalicylic acid (ASA, or Aspirin) due to the presence of CD in the structure; the amount of ASA absorbed into the hydrogels was enhanced with an increase in the amount of CD incorporated within the hydrogels. In addition, CD-g-CMC hydrogels provided a slower release of the entrapped ASA in comparison to the ASA release profile of a solely CMC-containing hydrogel. From these results, CD-g-CMC hydrogels have the potential to function as a biodegradable active material with controlled drug release ability. (C) 2014 Elsevier B.V. All rights reserved.	[Kono, Hiroyuki; Teshirogi, Taku] Tomakomai Natl Coll Technol, Dept Sci & Engn Mat, Tomakomai, Hokkaido 0591275, Japan	Kono, H (reprint author), Tomakomai Natl Coll Technol, Dept Sci & Engn Mat, Nishikioka 443, Tomakomai, Hokkaido 0591275, Japan.	kono@sem.tomakomai-ct.ac.jp			Japan Society for Promotion of Science (JSPS) [C-25410134]; Grant-in-Aid for the Adaptable and Seamless Technology Transfer Program through Targetdrive RD [241FT0160, AS242Z03384M]; Japan Science and Technology Agency (JST)	This work was supported in part by a Grant-in-Aid for Scientific Research (C-25410134) from the Japan Society for Promotion of Science (JSPS), a Grant-in-Aid for the Adaptable and Seamless Technology Transfer Program through Targetdrive R&D (241FT0160 and AS242Z03384M), and a Grant-in-Aid for the Promoting Patent Licensing from Universities and Public Research Institutions to Industries from the Japan Science and Technology Agency (JST).	Sathe M, 2010, BIOORG MED CHEM LETT, V20, P1792, DOI 10.1016/j.bmcl.2009.12.078; Weickenmeier M, 1997, MACROMOL RAPID COMM, V18, P1117, DOI 10.1002/marc.1997.030181216; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Miretzky P, 2009, J HAZARD MATER, V167, P10, DOI 10.1016/j.jhazmat.2009.01.060; Crini G, 2003, BIORESOURCE TECHNOL, V90, P193, DOI 10.1016/S0960-8524(03)00111-1; Hassan HA, 2007, J PHARMACEUT BIOMED, V45, P243, DOI 10.1016/j.jpba.2007.06.011; Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Kono H, 2014, CARBOHYD POLYM, V106, P84, DOI 10.1016/j.carbpol.2014.02.020; RINAUDO M, 1992, INT J BIOL MACROMOL, V14, P122, DOI 10.1016/S0141-8130(05)80001-7; Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026; Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001; Wang J, 2010, J PHYS CHEM C, V114, P18940, DOI 10.1021/jp105906p; Lopez-Leon T, 2005, J COLLOID INTERF SCI, V283, P344, DOI 10.1016/j.jcis.2004.08.186; Totosaus A, 2002, INT J FOOD SCI TECH, V37, P589, DOI 10.1046/j.1365-2621.2002.00623.x; Kono H, 2012, CARBOHYD POLYM, V87, P2582, DOI 10.1016/j.carbpol.2011.11.045; Jayakumar R, 2006, J BIOACT COMPAT POL, V21, P327, DOI 10.1177/0883911506066929; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021; Alvarez-Lorenzo C, 2013, ADV DRUG DELIVER REV, V65, P1148, DOI 10.1016/j.addr.2013.04.016; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Kono H, 2013, CARBOHYD POLYM, V98, P784, DOI 10.1016/j.carbpol.2013.06.065; Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019; Tamura H, 2011, CARBOHYD POLYM, V84, P820, DOI 10.1016/j.carbpol.2010.06.001; JEUNIAUX C, 1991, BIOCHEM SYST ECOL, V19, P347, DOI 10.1016/0305-1978(91)90051-Z; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9; Zhang JX, 2013, ADV DRUG DELIVER REV, V65, P1215, DOI 10.1016/j.addr.2013.05.001; Deligkaris K, 2010, SENSOR ACTUAT B-CHEM, V147, P765, DOI 10.1016/j.snb.2010.03.083; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002; Rathbone MJ, 2002, DRUG DISCOV TODAY, V7, P823, DOI 10.1016/S1359-6446(02)02362-0; Peter M, 2010, CARBOHYD POLYM, V79, P284, DOI 10.1016/j.carbpol.2009.08.001; Nagahama H, 2008, CARBOHYD POLYM, V73, P295, DOI 10.1016/j.carbpol.2007.11.034; CANET D, 1976, J MAGN RESON, V23, P361, DOI 10.1016/0022-2364(76)90220-1; CHASE HA, 1984, J CHROMATOGR, V297, P179, DOI 10.1016/S0021-9673(01)89041-5; CHOI HS, 1992, B KOREAN CHEM SOC, V13, P474; Concheiro A, 2013, ADV DRUG DELIVER REV, V65, P1188, DOI 10.1016/j.addr.2013.04.015; de Freitas RA, 2010, MAT SCI ENG C-MATER, V30, P34, DOI 10.1016/j.msec.2009.08.005; Denizli BK, 2004, POLYMER, V45, P6431, DOI 10.1016/j.polymer.2004.07.067; Fernandez M, 2004, PROCESS BIOCHEM, V39, P535, DOI 10.1016/S0032-9592(03)00069-4; Gamal AE, 1986, INT J PHARMACEUT, V31, P25; Gomez-Mascaraque LG, 2014, ACTA BIOMATER, V10, P798, DOI 10.1016/j.actbio.2013.10.003; Kerman K, 2004, ANAL CHEM, V76, P1877, DOI 10.1021/ac0351872; Kitchin SJ, 1999, APPL MAGN RESON, V17, P283; Kono H, 2013, REACT FUNCT POLYM, V73, P97, DOI 10.1016/j.reactfunctpolym.2012.08.016; Kono H, 2013, J APPL POLYM SCI, V127, P478, DOI 10.1002/app.37736; Kono H, 2013, REACT FUNCT POLYM, V73, P1096, DOI 10.1016/j.reactfunctpolym.2013.04.006; Kono H, 2014, CARBOHYD POLYM, V111, P830, DOI 10.1016/j.carbpol.2014.05.050; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Luo YC, 2013, FOOD HYDROCOLLOID, V31, P332, DOI 10.1016/j.foodhyd.2012.11.011; Nishioka F., 1984, J INCLUSION PHENOM, V2, P701, DOI 10.1007/BF00662238; Ostrowska-Czubenko J., 2009, CARBOHYD POLYM, V77, P590; Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781; Prabaharan M, 2009, INT J BIOL MACROMOL, V44, P320, DOI 10.1016/j.ijbiomac.2009.01.005; Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9; Shekh I., 2011, INT J PHARM LIFE SCI, V2, P704; VERMA KK, 1986, ANAL CHEM, V58, P821, DOI 10.1021/ac00295a037; WESTER PW, 1985, TOXICOLOGY, V36, P325, DOI 10.1016/0300-483X(85)90034-4	63	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	JAN	2015	72						299	308		10.1016/j.ijbiomac.2014.08.030		10	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY4XH	WOS:000347577900041		
J	Yan, CY; Gu, JW; Hou, DP; Jing, HY; Wang, J; Guo, YZ; Katsumi, H; Sakane, T; Yamamoto, A				Yan, Cheng-yun; Gu, Ji-wei; Hou, Da-ping; Jing, Hong-ying; Wang, Jing; Guo, Yu-zhi; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira			Synthesis of Tat tagged and folate modified N-succinyl-chitosan self-assembly nanoparticles as a novel gene vector	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Gene delivery; N-Succinyl-chitosan; Tat peptide; Folic acid; Self-assembly nanoparticles	CELL-PENETRATING PEPTIDE; VITRO DRUG-RELEASE; IN-VITRO; ANTITUMOR-ACTIVITY; TARGETED PEG; DELIVERY; RECEPTOR; THERAPY; CANCER; POLYPLEXES	The purpose of this research was to prepare a novel type of Tat tagged and folate modified N-succinyl-chitosan (Tat-Suc-FA) self-assembly nanoparticles, to provide a new vector for tumor gene therapy. In this study, Tat-Suc-FA polymers was synthesized and characterized using H-1 NMR and FT-IR. The copolymer had a mean diameter of 65 +/- 22.6 nm, a zeta potential of 40 +/- 0.2 mV. The cytotoxicity assay showed that Tat-Suc-FA polymers were less toxic than chitosan in the tested concentration range (from 2 to 500 mu g/ml). Tat-Suc-FA/DNA complexes at various weight ratios were formulated and characterized. Particle sizes of Tat-Suc-FA/DNA complexes were between 54 and 106 nm as determined by dynamic light scattering. Accordingly, Transmission electron microscope photo of Tat-Suc-FA/DNA complexes exhibited a spherical and compact morphology. Zeta potentials of these complexes changed as the weight ratio varied (from 3 to 44 mV). Agarose gel electrophoresis assay showed that Tat-Suc-FA could efficiently condense the DNA, when the weight ratio was above 1.5/1. Together, these results suggest that the low toxic Tat-Suc-FA cationic polymers could be considered for use as a novel type of gene delivery vectors. (C) 2014 Elsevier B.V. All rights reserved.	[Yan, Cheng-yun] Guilin Med Univ, Coll Pharm, Guilin 541004, Peoples R China; [Yan, Cheng-yun; Gu, Ji-wei; Hou, Da-ping; Jing, Hong-ying; Wang, Jing; Guo, Yu-zhi] Jiamusi Univ, Affiliated Hosp 1, Jiamusi 154000, Peoples R China; [Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan	Yan, CY (reprint author), Guilin Med Univ, Coll Pharm, Guilin 541004, Peoples R China.	hademan@126.com			National Natural Science Foundation of China [81260484]; Program of Hei Longjiang and Guangxi Provincial Natural Science Foundation of China [D201054, 2013GXNSFAA019226]	This work was supported by the National Natural Science Foundation of China (No. 81260484) and the Program of Hei Longjiang and Guangxi Provincial Natural Science Foundation of China (D201054 and 2013GXNSFAA019226).	Yan CY, 2006, J PHARM PHARMACOL, V58, P1177, DOI 10.1221/jpp.58.9.0003; Kwon OJ, 2013, J CONTROL RELEASE, V169, P257, DOI 10.1016/j.jconrel.2013.03.030; Vives E, 2005, J CONTROL RELEASE, V109, P77, DOI 10.1016/j.jconrel.2005.09.032; Yoo HS, 2004, J CONTROL RELEASE, V96, P273, DOI 10.1016/j.jconrel.2004.02.003; Guo WJ, 1999, J NUCL MED, V40, P1563; LEAMON CP, 1991, P NATL ACAD SCI USA, V88, P5572, DOI 10.1073/pnas.88.13.5572; Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023; Kamiyama K, 1999, BIOL PHARM BULL, V22, P179; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Jean M, 2012, EUR J PHARM SCI, V45, P138, DOI 10.1016/j.ejps.2011.10.029; Teng Z, 2013, J AGR FOOD CHEM, V61, P2556, DOI 10.1021/jf4001567; ROSS JF, 1994, CANCER, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Dube D, 2002, BIOCONJUGATE CHEM, V13, P685, DOI 10.1021/bc010084g; SONG YH, 1993, INT J PHARM, V98, P121, DOI 10.1016/0378-5173(93)90048-K; Ciobanasu C, 2010, BIOPHYS J, V99, P153, DOI 10.1016/j.bpj.2010.03.065; Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2; Yang SJ, 2010, BIOCONJUGATE CHEM, V21, P679, DOI 10.1021/bc9004798; Liu YM, 2005, J AM CHEM SOC, V127, P3004, DOI 10.1021/ja0436446; Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016; Aronov O, 2003, BIOCONJUGATE CHEM, V14, P563, DOI 10.1021/bc025642l; van Steenis JH, 2003, J CONTROL RELEASE, V87, P167, DOI 10.1016/S0168-3659(02)00361-9; Richard I, 2013, BIOMACROMOLECULES, V14, P1732, DOI 10.1021/bm4000713; Datta P, 2013, J BIOMED NANOTECHNOL, V9, P870, DOI 10.1166/jbn.2013.1592; Dauty E, 2002, BIOCONJUGATE CHEM, V13, P831, DOI 10.1021/bc0255182; De Luca M, 2009, BRIT J DERMATOL, V161, P19, DOI 10.1111/j.1365-2133.2009.09243.x; Hattoni Y, 2004, J CONTROL RELEASE, V97, P173, DOI 10.1016/j.jconrel.2004.03.007; Izume M., 1998, CHITIN CHITOSAN RES, V4, P12; Jiang HL, 2007, GENE THER, V14, P1389, DOI 10.1038/sj.gt.3302997; Kato Y, 2003, MACROMOL RES, V11, P382; Kochanek S., 2010, HUM GENE THER, P791; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Lin WJ, 2007, CARBOHYD POLYM, V67, P474, DOI 10.1016/j.carbpol.2006.06.017; Mavroudi M, 2014, J CANCER RES THER, V2, P22, DOI 10.14312/2052-4994.2014-4; Perche F, 2011, J DRUG TARGET, V19, P315, DOI 10.3109/1061186X.2010.504262; Ramesan RM, 2012, NANOMEDICINE-UK, V7, P5, DOI [10.2217/nnm.11.170, 10.2217/NNM.11.170]; Saini A, 2013, BIOSCI TRENDS, V7, P209, DOI 10.5582/bst.2013.v7.5.209	37	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	JAN	2015	72						751	756		10.1016/j.ijbiomac.2014.09.031		6	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY4XH	WOS:000347577900098		
J	Tomizawa, N; Nojo, T; Inoh, S; Nakamura, S				Tomizawa, Nobuo; Nojo, Takeshi; Inoh, Shinichi; Nakamura, Sunao			Difference of coronary artery disease severity, extent and plaque characteristics between patients with hypertension, diabetes mellitus or dyslipidemia	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Coronary artery disease; Diabetes mellitus; Dyslipidemia; Hypertension; Plaque	INTERNATIONAL MULTICENTER REGISTRY; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; CT ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CLINICAL-OUTCOMES; CONFIRM; SCORE	The purpose of this study was to investigate the difference of coronary artery disease (CAD) severity and extent as well as plaque characteristics between patients with either one of hypertension (HT), diabetes mellitus (DM) or dyslipidemia (DL). We retrospectively reviewed the records of 1,161 patients (HT 442, DM 77, DL 248, no disease 394) who underwent coronary computed tomography angiography. Stenosis severity was classified as normal, non-obstructive (1-49 % stenosis), moderate (50-69 % stenosis) or severe (a parts per thousand yen70 % stenosis). Segment involvement score (SIS) and segment severity score (SSS) was calculated. We defined patients at risk as patients with obstructive CAD or non-obstructive CAD with extensive disease (SIS a parts per thousand yen 5). Plaque characteristics were evaluated including positive remodeling, low attenuation and spotty calcification. Obstructive CAD was most frequent in DM patients, followed by HT and DL patients (34, 19 and 15 %, respectively, p < 0.0001). DM patients had more extensive disease than HT and DL patients (SIS 3.1 vs 2.1 vs 1.4, SSS 4.0 vs 2.7 vs 2.0). DM patients were more at risk than HT and DL patients (p < 0.05). The prevalence of positive remodeling, low attenuation and spotty calcium were all highest in DM patients (p < 0.005, vs HT and DL), while low attenuation was more frequent in DL than HT patients (p < 0.005). The median calcium score of HT and DM patients were higher than DL patients (p < 0.01 and p < 0.005, respectively), while no significant difference was observed between HT and DM patients. In conclusion, DM patients possessed more high risk plaque and obstructive as well as extensive CAD compared with HT and DL patients. Coronary calcification was similarly high in HT and DM patients. Low attenuation plaque was more frequent in DL than HT patients.	[Tomizawa, Nobuo; Nojo, Takeshi; Inoh, Shinichi; Nakamura, Sunao] New Tokyo Hosp, Dept Cardiol, Matsudo, Chiba 2702232, Japan; [Tomizawa, Nobuo; Nojo, Takeshi; Inoh, Shinichi; Nakamura, Sunao] New Tokyo Hosp, Dept Cardiol, Matsudo, Chiba 2702232, Japan	Tomizawa, N (reprint author), New Tokyo Hosp, Dept Cardiol, 1271 Wanagaya, Matsudo, Chiba 2702232, Japan.	tomizawa-tky@umin.ac.jp					Achenbach S, 2010, J CARDIOVASC COMPUT, V4, P110, DOI 10.1016/j.jcct.2010.01.013; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Loffroy R, 2009, ARCH CARDIOVASC DIS, V102, P607, DOI 10.1016/j.acvd.2009.04.007; Rana JS, 2012, DIABETES CARE, V35, P1787, DOI 10.2337/dc11-2403; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Ibebuogu UN, 2009, INT J CARDIOVAS IMAG, V25, P717, DOI 10.1007/s10554-009-9483-9; Zeb I, 2013, ATHEROSCLEROSIS, V231, P198, DOI 10.1016/j.atherosclerosis.2013.08.019; Ferencik M, 2012, AM J CARDIOL, V110, P183, DOI 10.1016/j.amjcard.2012.02.066; Nakazato R, 2014, EUR HEART J-CARD IMG, V15, P586, DOI 10.1093/ehjci/jet132; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Morise AP, 1997, AM J MED, V102, P350, DOI 10.1016/S0002-9343(97)00086-7; Madhavan MV, 2014, J AM COLL CARDIOL, V63, P1703, DOI 10.1016/j.jacc.2014.01.017; Kodama T, 2012, JACC-CARDIOVASC INTE, V5, P636, DOI 10.1016/j.jcin.2012.02.016; Bittencourt MS, 2014, CIRC-CARDIOVASC IMAG, V7, P282, DOI 10.1161/CIRCIMAGING.113.001047; Braunwald E, 2006, J AM COLL CARDIOL, V47, pC101, DOI 10.1016/j.jacc.2005.10.072; Cademartiri F, 2005, EUR RADIOL, V15, P1428; de Araujo Goncalves P, 2012, INT J CARDIOVAS IMAG, V29, P1105; Hadamitzky M, 2013, J AM COLL CARDIOL, V62, P468, DOI 10.1016/j.jacc.2013.04.064; Kamimura M, 2012, INT HEART J, V53, P23; Kuzuya Takeshi, 1999, Journal of the Japan Diabetes Society, V42, P385; Prado CM, 2006, INT J EXP PATHOL, V87, P425, DOI 10.1111/j.1365-2613.2006.00506.x; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Teramoto T, 2007, JAPAN ATHEROSCLEROSI, P6	23	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	JAN	2015	31	1					205	212		10.1007/s10554-014-0542-5		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AZ3JI	WOS:000348123000025		
J	Menezes, AM; Landis, SH; Han, MLK; Muellerova, H; Aisanov, Z; van der Molen, T; Oh, YM; Ichinose, M; Mannino, DM; Davis, KJ				Menezes, Ana M.; Landis, Sarah H.; Han, MeiLan K.; Muellerova, Hana; Aisanov, Zaurbek; van der Molen, Thys; Oh, Yeon-Mok; Ichinose, Masakazu; Mannino, David M.; Davis, Kourtney J.			Continuing to Confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management	INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						chronic obstructive pulmonary disease; physician survey; patient survey; beliefs; perceptions	OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; CARE; GUIDELINES; ADHERENCE; REGIONS; LIFE	Purpose: Using data from the Continuing to Confront COPD International Physician and Patient Surveys, this paper describes physicians' attitudes and beliefs regarding chronic obstructive pulmonary disease (COPD) prognosis, and compares physician and patient perceptions with respect to COPD. Methods: In 12 countries worldwide, 4,343 patients with COPD were identified through systematic screening of population samples, and 1,307 physicians who regularly saw patients with COPD were sampled from in-country professional databases. Both patients and physicians completed surveys about their COPD knowledge, beliefs, and perceptions; physicians answered further questions about diagnostic methods and treatment choices for COPD. Results: Most physicians (79%) responded that the long-term health outlook for patients with COPD has improved over the past decade, largely attributed to the introduction of better medications. However, patient access to medication remains an issue in many countries, and some physicians (39%) and patients (46%) agreed/strongly agreed with the statement "there are no truly effective treatments for COPD". There was strong concordance between physicians and patients regarding COPD management practices, including the use of spirometry (86% of physicians and 76% of patients reporting they used/had undergone a spirometry test) and smoking cessation counseling (76% of physicians reported they counseled their smoking patients at every clinic visit, and 71% of smoking patients stated that they had received counseling in the past year). However, the groups differed in their perception about the role of smoking in COPD, with 78% of physicians versus 38% of patients strongly agreeing with the statement "smoking is the cause of most cases of COPD". Conclusion: The Continuing to Confront COPD International Surveys demonstrate that while physicians and patients largely agreed about COPD management practices and the need for more effective treatments for COPD, a gap exists about the causal role of smoking in COPD.	[Menezes, Ana M.] Univ Fed Pelotas, Pelotas, Brazil; [Landis, Sarah H.; Muellerova, Hana] GlaxoSmithKline, Worldwide Epidemiol, Uxbridge UB11 1BT, Middx, England; [Han, MeiLan K.] Univ Michigan, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA; [Aisanov, Zaurbek] Pulmonol Res Inst, Moscow, Russia; [van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Davis, Kourtney J.] GlaxoSmithKline, Worldwide Epidemiol, Wavre, Belgium	Landis, SH (reprint author), GlaxoSmithKline, Worldwide Epidemiol, Stockley Pk West, Uxbridge UB11 1BT, Middx, England.	sarah.h.landis@gsk.com	Menezes, Ana/G-7266-2012		GlaxoSmithKline (GSK)	The survey was conducted by Abt SRBI, a global survey research firm that specializes in health surveys. The authors acknowledge editorial support in the form of draft manuscript development, assembling tables, collating author comments, and copyediting, which was provided by Kate Hollingworth of Continuous Improvement Ltd. The authors further acknowledge the analytical support provided by Joe Maskell. This support was funded by GlaxoSmithKline (GSK).	Aisanov Z, 2012, INT J CHRONIC OBSTR, V7, P271, DOI 10.2147/COPD.S28059; Corrado A, 2012, RESP MED, V106, P989, DOI 10.1016/j.rmed.2012.03.008; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Restrepo Ruben D, 2008, Int J Chron Obstruct Pulmon Dis, V3, P371; Glaab T, 2012, INT J CHRONIC OBSTR, V7, P101, DOI 10.2147/COPD.S27887; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Desalu OO, 2013, PRIM CARE RESP J, V22, P79, DOI 10.4104/pcrj.2013.00014; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Barr R Graham, 2005, Am J Med, V118, P1415; Bjarnason NH, 2010, J SMOK CESSAT, V5, P15; Davis KJ, INT J CHRON IN PRESS; Fukuhara S, 2005, RESPIROLOGY, V10, P341, DOI 10.1111/j.1440-1843.2005.00717.x; Hernandez P, 2013, CAN RESPIR J, V20, P97; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Landis S, 2014, INT J CHRONIC OBSTR, V9, P1; Laniado-Laborín Rafael, 2013, J Prim Care Community Health, V4, P172, DOI 10.1177/2150131913475817; Ramirez-Venegas A, 2007, HOT TOPICS RESP MED, V4, P7; Rutschmann OT, 2004, RESP MED, V98, P932, DOI 10.1016/j.rmed.2004.03.018; Sayiner A, 2012, RESP MED, V106, pS60, DOI 10.1016/S0954-6111(12)70015-X; Walsh JW, 2012, J THORAC DIS, V4, P676, DOI 10.3978/j.issn.2072-1439.2012.10.03; World Health Organization, 2014, PREV TOB US AD AD; Yawn Barbara P, 2008, Int J Chron Obstruct Pulmon Dis, V3, P311	23	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2005			INT J CHRONIC OBSTR	Int. J. Chronic Obstr. Pulm. Dis.		2015	10						159	+		10.2147/COPD.S74315		14	Respiratory System	Respiratory System	AZ3GI	WOS:000348115100001		
J	Ishikawa, N; Hattori, N; Kohno, N; Kobayashi, A; Hayamizu, T; Johnson, M				Ishikawa, Nobuhisa; Hattori, Noboru; Kohno, Nobuoki; Kobayashi, Akihiro; Hayamizu, Tomoyuki; Johnson, Malcolm			Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls	INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						chronic obstructive pulmonary disease; inflammatory cells; biomarkers; sputum; serum	OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; ECLIPSE COHORT; LUNG-DISEASE; SPUTUM; NEUTROPHILS; BIOMARKERS; MEDIATORS; SMOKERS; ASTHMA	Purpose: To assess the importance of inflammation in chronic obstructive pulmonary disease (COPD) by measuring airway and systemic inflammatory biomarkers in Japanese patients with the disease and relevant control groups. Patients and methods: This was the first study of its type in Japanese COPD patients. It was a non-treatment study in which 100 participants were enrolled into one of three groups: nonsmoking controls, current or ex-smoking controls, and COPD patients. All participants underwent standard lung function assessments and provided sputum and blood samples from which the numbers of inflammatory cells and concentrations of biomarkers were measured, using standard procedures. Results: The overall trends observed in levels of inflammatory cells and biomarkers in sputum and blood in COPD were consistent with previous reports in Western studies. Increasing levels of neutrophils, interleukin 8 (IL-8), surfactant protein D (SP-D), and Krebs von den Lungen 6 (KL-6) in sputum and clara cell 16 (CC-16), high-sensitivity C-reactive protein (hs-CRP), and KL-6 in serum and plasma fibrinogen were seen in the Japanese COPD patients compared with the non-COPD control participants. In sputum, significant correlations were seen between total cell count and matrix metalloproteinase 9 (MMP-9; P < 0.001), neutrophils and MMP-9 (P < 0.001), macrophages and KL-6 (P < 0.01), total cell count and IL-8 (P < 0.05), neutrophils and IL-8 (P < 0.05), and macrophages and MMP-9 (P < 0.05). Significant correlations were also observed between some inflammatory cells in sputum and biomarkers in serum, with the most significant between serum CC-16 and both total cell count (P < 0.005) and neutrophils (P < 0.005) in sputum. Conclusion: These results provide evidence for the first time that COPD in Japanese patients is a multicomponent disease, involving both airway and systemic inflammation, in addition to airway obstruction. Therefore, intervention with anti-inflammatory therapy may provide additional benefit in disease management of COPD in Japan.	[Ishikawa, Nobuhisa] Hiroshima Prefectural Hosp, Dept Resp Med, Hiroshima, Japan; [Hattori, Noboru; Kohno, Nobuoki] Hiroshima Univ, Dept Mol & Internal Med, Hiroshima, Japan; [Kobayashi, Akihiro] GlaxoSmithKline, Biomed Data Sci Dept, Shibuya Ku, Tokyo 1518566, Japan; [Hayamizu, Tomoyuki] GlaxoSmithKline, Med Affairs Resp Dept, Shibuya Ku, Tokyo 1518566, Japan; [Johnson, Malcolm] GlaxoSmithKline, Resp Global Franchise, Uxbridge, Middx, England	Hayamizu, T (reprint author), GlaxoSmithKline, Med Affairs Resp Dept, Shibuya Ku, 6-15 Sendagaya,4 Chome, Tokyo 1518566, Japan.	tomoyuki.3.hayamizu@gsk.com			GlaxoSmithKline [NCT00356642]	Funding for this study was provided by GlaxoSmithKline (NCT00356642). All listed authors meet the criteria for authorship set forth by the International Committee for Medical Journal Editors. The authors wish to acknowledge the following individuals for their contributions: members of Hiroshima University who participated in subject recruitment: Hiroshi Murai, Yoshinori Haruta, Kazunori Fujitaka, Shinichiro Ohshimo, Hiroshi Iwamoto, and Taku Nakashima. The authors would also like to thank the following members of the GlaxoSmithKline team who developed the study protocol: Etsuko Hayashi, Hideo Kikkawa, and Daisuke Yoshimoto; SRL Medisearch Inc, for performing the biomarker analyses; and the Institute of Japanese Union of Scientists and Engineers, for performing the data management and statistical analysis.	Agustí Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Iwamoto H, 2014, EUR RESPIR J, V43, P421, DOI 10.1183/09031936.00024313; MacNee W, 2013, ANN MED, V45, P291, DOI 10.3109/07853890.2012.732703; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Duvoix A, 2013, THORAX, V68, P670, DOI 10.1136/thoraxjnl-2012-201871; Sugiyama A, 2013, RESP MED, V107, P875, DOI 10.1016/j.rmed.2013.03.005; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Fujimoto K, 2005, EUR RESPIR J, V25, P640, DOI 10.1183/09031936.05.00047504; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; van Durme YMTA, 2009, AM J RESP CRIT CARE, V179, P375, DOI 10.1164/rccm.200810-1540OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Barnes N, 2007, THORAX, V62, P927, DOI 10.1136/thx.2007.082677; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Bizeto L, 2008, BRAZ J MED BIOL RES, V41, P193, DOI 10.1590/S0100-879X2008005000010; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Global initiative For Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huertas Alice, 2011, Ther Adv Respir Dis, V5, P217, DOI 10.1177/1753465811400490; Ishikawa Nobuhisa, 2012, Respir Investig, V50, P3, DOI 10.1016/j.resinv.2012.02.001; Makris D, 2009, RESP MED, V103, P1130, DOI 10.1016/j.rmed.2009.03.002; Nakagawa M, 2014, RESPIROLOGY; Paggiaro P L, 2002, Eur Respir J Suppl, V37, p3s; Ropcke S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046207; The Japanese Respiratory Society, 2013, GUID DIAGN TREATM CO; Toungoussova O, 2007, RESP MED, V101, P1543, DOI 10.1016/j.rmed.2006.12.009; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820	33	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2005			INT J CHRONIC OBSTR	Int. J. Chronic Obstr. Pulm. Dis.		2015	10						185	192		10.2147/COPD.S74557		8	Respiratory System	Respiratory System	AZ8BQ	WOS:000348440100001		
J	O'Charoen, S; Hayakawa, S; Ogawa, M				O'Charoen, Siwaporn; Hayakawa, Shigeru; Ogawa, Masahiro			Food properties of egg white protein modified by rare ketohexoses through Maillard reaction	INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY			English	Article						Egg white protein; food properties; Maillard reaction; rare sugars	D-PSICOSE; EMULSIFYING PROPERTIES; ANTIOXIDATIVE ACTIVITY; FOAMING PROPERTIES; SWEETENERS; SUGAR	D-psicose (Psi), a rare ketohexose, improves food properties of proteins through the Maillard reaction (MR) much more than D-fructose (Fru). This encouraged us to investigate the improvement of food properties of proteins through MR with various rare ketohexoses (D-psicose, Psi; D-tagatose, Tag; and D-sorbose, Sor). The food properties of egg white protein (EWP) after reaction with Psi, Tag, Sor and Fru were studied. Psi-EWP (43.3 mu mol TE g(-1)) and Tag-EWP (43.4 mu mol TE g(-1)) had the highest antioxidant activity, followed by Sor-EWP (38.4 mu mol TE g(-1)) and Fru-EWP (38.9 mu mol TE g(-1)). MR enhanced the breaking stress of heat-induced EWP gels by 224-267%. The breaking stress was higher in Psi-EWP (81.1 kN m(-2)), Tag-EWP (80.0 kN m(-2)) and Sor-EWP (77.8 kN m(-2)) than in Fru-EWP (71.6 kN m(-2)). Furthermore, the foaming capacity was highest in Psi-EWP and Sor-EWP. Rare ketohexoses improved food properties of EWP more than Fru. Overall, Psi offered the greatest functional improvement.	[O'Charoen, Siwaporn; Hayakawa, Shigeru; Ogawa, Masahiro] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Hayakawa, S (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	hayakawa@ag.kagawa-u.ac.jp			City Area Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Dr. Ken Izumori, Rare Sugar Research Centre, Kagawa University for distributing Psi. This work was partially supported by the City Area Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank Peter Lutes, Faculty of Agriculture, Kagawa University, for language editing.	Raikos V, 2007, FOOD RES INT, V40, P347, DOI 10.1016/j.foodres.2006.10.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Fayle SE, 2001, ELECTROPHORESIS, V22, P1518, DOI 10.1002/1522-2683(200105)22:8<1518::AID-ELPS1518>3.0.CO;2-U; Handa A, 1999, J AGR FOOD CHEM, V47, P1845, DOI 10.1021/jf9811018; Philippe RN, 2014, CURR OPIN BIOTECH, V26, P155, DOI 10.1016/j.copbio.2014.01.004; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Fukada K, 2012, CHEM LETT, V41, P1686, DOI 10.1246/cl.2012.1686; Song WO, 2012, NUTRITION, V28, P1137, DOI 10.1016/j.nut.2012.03.008; Chung YM, 2012, J FOOD SCI, V77, pH53, DOI 10.1111/j.1750-3841.2011.02571.x; PATEL MT, 1990, J DAIRY SCI, V73, P2731; Huang XQ, 2012, FOOD RES INT, V48, P866, DOI 10.1016/j.foodres.2012.06.036; PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041; Sun Y, 2004, J FOOD SCI, V69, pC427; PHILLIPS LG, 1990, J FOOD SCI, V55, P1441, DOI 10.1111/j.1365-2621.1990.tb03953.x; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; DAMODARAN S, 1997, FOOD PROTEINS THEIR, P57; Dickinson E., 1992, INTRO FOOD COLLOIDS, P123; Doyle JP, 2006, CARBOHYD POLYM, V64, P391, DOI 10.1016/j.carbpol.2005.12.019; Hatta H., 1997, HEN EGGS THEIR BASIC, P117; Hodge J. E., 1976, PRINCIPLES FOOD SC 1, P41; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; Izumori K, 2006, J BIOTECHNOL, V124, P712; Lau K., 2004, J FOOD SCI, V69, P232; Levin Gilbert V., 2002, Journal of Medicinal Food, V5, P23, DOI 10.1089/109662002753723197; OAKENFULL D, 1997, FOOD PROTEINS THEIR, P111; Roberts M.W., 2012, INT J DENT, V2012, P1; SARDESAI VM, 1991, J NUTR BIOCHEM, V2, P236, DOI 10.1016/0955-2863(91)90081-F; Sun Y, 2008, J AGR FOOD CHEM, V56, P4789, DOI 10.1021/jf800050d; Sun YX, 2006, BIOSCI BIOTECH BIOCH, V70, P2859, DOI 10.1271/bbb.62056	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-5423	1365-2621		INT J FOOD SCI TECH	Int. J. Food Sci. Technol.	JAN	2015	50	1					194	202		10.1111/ijfs.12607		9	Food Science & Technology	Food Science & Technology	AZ6TR	WOS:000348353800025		
J	Suzuki, T; Oh, I; Ohmine, K; Meguro, A; Mori, M; Fujiwara, S; Yamamoto, C; Nagai, T; Ozawa, K				Suzuki, Takahiro; Oh, Iekuni; Ohmine, Ken; Meguro, Akiko; Mori, Masaki; Fujiwara, Shin-ichiro; Yamamoto, Chihiro; Nagai, Tadashi; Ozawa, Keiya			Distribution of serum erythropoietin levels in Japanese patients with myelodysplastic syndromes	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myelodysplastic syndromes (MDS); Anemia; Erythropoietin; Erythropoiesis-stimulating agents (ESAs)	COLONY-STIMULATING FACTOR; G-CSF; ANEMIA; SURVIVAL; MDS	Erythropoiesis-stimulating agents (ESAs) are used to ameliorate anemia in lower-risk myelodysplastic syndromes (MDS). Serum erythropoietin (EPO) level < 500 IU/L is widely accepted as a major predictive factor for response to ESAs. However, few data about EPO levels in the Japanese population are available. We therefore evaluated distribution of serum EPO levels in Japanese patients with MDS. Forty-three cases were analyzed; 30 were classified as lower-risk MDS (low or intermediate-1 by the international prognostic scoring system). Twenty-two cases were transfusion dependent. The overall median hemoglobin level was 7.7 g/dL. The median value of serum EPO was 254 IU/L (range: 16.4-23,000). Serum EPO levels had a strong inverse correlation with hemoglobin levels, and a significantly larger proportion of patients showed high EPO levels (> 500 IU/L) in the transfusion-dependent group. In the higher-risk group, no significant correlation between EPO and hemoglobin was observed. Regression analyses showed that serum EPO of 500 IU/L corresponds to 8.29 g/dL of hemoglobin in lower-risk MDS. The results indicate that patients with hemoglobin levels of 8.0 g/dL or more, who are still transfusion independent, may be good candidates for ESA treatment.	[Suzuki, Takahiro; Oh, Iekuni; Ohmine, Ken; Meguro, Akiko; Mori, Masaki; Fujiwara, Shin-ichiro; Yamamoto, Chihiro; Nagai, Tadashi; Ozawa, Keiya] Jichi Med Univ, Div Hematol, Dept Med, Shimotsuke, Tochigi 3290498, Japan	Suzuki, T (reprint author), Jichi Med Univ, Div Hematol, Dept Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	tasuzuki@jichi.ac.jp			Kyowa Hakko Kirin Co. Ltd.; Ministry of Health, Labor and Welfare of Japan	This study was supported by Grant-in-Aid from Kyowa Hakko Kirin Co. Ltd., and Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan. We thank Gary Baley as academic editor.	Park S, 2010, LEUKEMIA RES, V34, P1430, DOI 10.1016/j.leukres.2010.05.030; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Thompson JA, 2000, BLOOD, V95, P1175; Park S, 2008, BLOOD, V111, P574, DOI 10.1182/blood-2007-06-096370; Gabrilove J, 2008, BRIT J HAEMATOL, V142, P379, DOI 10.1111/j.1365-2141.2008.07181.x; Jadersten M, 2008, J CLIN ONCOL, V26, P3607, DOI 10.1200/JCO.2007.15.4906; Balleari E, 2011, LEUKEMIA RES, V35, P1472, DOI 10.1016/j.leukres.2011.05.025; Ferrini Pierluigi Rossi, 1998, British Journal of Haematology, V103, P1070; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; Jadersten M, 2005, BLOOD, V106, P803, DOI 10.1182/blood-2004-10-3872; Nakazaki K, 2014, INT J HEMATOL, V99, P53, DOI 10.1007/s12185-013-1485-7; NCCN, 2014, CLIN PRACT GUID ONC, V2014; URABE A, 1992, INT J CELL CLONING, V10, P333	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					32	36		10.1007/s12185-014-1699-3		5	Hematology	Hematology	AY6WM	WOS:000347703500006		
J	Kobayashi, T; Kuroda, J; Fuchida, S; Kaneko, H; Yagi, H; Shibayama, H; Tanaka, H; Kosugi, S; Uoshima, N; Kobayashi, M; Adachi, Y; Ohta, K; Ishii, K; Uchiyama, H; Matsuda, M; Nakatani, E; Tsudo, M; Shimazaki, C; Takaori-Kondo, A; Nomura, S; Matsumura, I; Taniwaki, M; Kanakura, Y				Kobayashi, Tsutomu; Kuroda, Junya; Fuchida, Shin-ichi; Kaneko, Hitomi; Yagi, Hideo; Shibayama, Hirohiko; Tanaka, Hirokazu; Kosugi, Satoru; Uoshima, Nobuhiko; Kobayashi, Masayuki; Adachi, Yoko; Ohta, Kensuke; Ishii, Kazuyoshi; Uchiyama, Hitoji; Matsuda, Mitsuhiro; Nakatani, Eiji; Tsudo, Mitsuru; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Nomura, Shosaku; Matsumura, Itaru; Taniwaki, Masafumi; Kanakura, Yuzuru		KMF Investigators	Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Lenalidomide; Multiple myeloma; Relapse; Refractory	INTERNATIONAL STAGING SYSTEM; PLUS DEXAMETHASONE; THALIDOMIDE; THERAPY; SURVIVAL; POMALIDOMIDE; COMBINATION	We retrospectively investigated the prognostic factor of lenalidomide plus low-dose dexamethasone (Rd) in Japanese patients with refractory or relapsed multiple myeloma (RRMM) registered in the Kansai Myeloma Forum from January 2006 to December 2013. A total of 140 patients were analyzed. The median age was 66 years. The overall response rate was 68.6 %, including 33.1 % with a better than very good partial response. At 13.0 months median follow-up, the median overall survival (OS) and progression-free survival (PFS) were 34.2 and 17.0 months, respectively. In univariate analyses, patients with one or two prior therapies had significantly longer OS (41.2 vs. 21.5 months; P = 0.002) and PFS (29.0 vs. 13.0 months; P = 0.006) than patients treated with three or more prior therapies. Prior use of thalidomide was associated with significantly shorter PFS (19.0 vs. 16.0 months; P = 0.045). The prior use of bortezomib or high-dose therapy with stem cell transplantation, and the International Staging System had no impact on long-term outcome. Multivariate analysis showed that only the number of prior therapies was a significant predictor of both OS and PFS. Our findings suggest that greater benefit may occur when Rd therapy is used at the first or second relapse in RRMM.	[Kobayashi, Tsutomu; Kuroda, Junya; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Grad Sch Med, Div Hematol & Oncol, Kamigyo Ku, Kyoto 6028566, Japan; [Fuchida, Shin-ichi; Shimazaki, Chihiro] Japan Community Hlth Care Org Kyoto, Dept Hematol, Kuramaguchi Med Ctr, Kyoto, Japan; [Kaneko, Hitomi; Tsudo, Mitsuru] Osaka Red Cross Hosp, Dept Hematol, Osaka, Japan; [Yagi, Hideo] Kinki Univ, Nara Hosp, Fac Med, Dept Hematol, Nara, Japan; [Shibayama, Hirohiko; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan; [Tanaka, Hirokazu; Matsumura, Itaru] Kinki Univ, Fac Med, Dept Internal Med, Div Hematol & Rheumatol, Higashiosaka, Osaka 577, Japan; [Kosugi, Satoru] Toyonaka City Hosp, Dept Hematol, Toyonaka, Osaka, Japan; [Uoshima, Nobuhiko; Uchiyama, Hitoji] Japanese Red Cross Kyoto Daini Hosp, Dept Hematol, Kyoto, Japan; [Uoshima, Nobuhiko] Matsushita Mem Hosp, Dept Hematol, Moriguchi, Osaka, Japan; [Kobayashi, Masayuki; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Adachi, Yoko] Japan Community Hlth Care Org, Dept Internal Med, Kobe Cent Hosp, Kobe, Hyogo, Japan; [Ohta, Kensuke] Osaka Saiseikai Nakatsu Hosp, Dept Hematol, Osaka, Japan; [Ishii, Kazuyoshi; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka, Japan; [Matsuda, Mitsuhiro] PL Gen Hosp, Dept Hematol, Tondabayashi, Japan; [Nakatani, Eiji] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kyoto, Japan	Kobayashi, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med, Div Hematol & Oncol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	t-koba@koto.kpu-m.ac.jp			Celgene Corporation (Summit, NJ)	This work was partly supported by a research fund from the Celgene Corporation (Summit, NJ).	Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Stadtmauer EA, 2009, EUR J HAEMATOL, V82, P426, DOI 10.1111/j.1600-0609.2009.01257.x; Hideshima T, 2000, BLOOD, V96, P2943; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Avet-Loiseau H, 2013, LEUKEMIA, V27, P711, DOI 10.1038/leu.2012.282; Palumbo A, 2011, BLOOD, V118, P4519, DOI 10.1182/blood-2011-06-358812; Avet-Loiseau H, 2010, LEUKEMIA, V24, P623, DOI 10.1038/leu.2009.273; Harousseau JL, 2010, HAEMATOL-HEMATOL J, V95, P1738, DOI 10.3324/haematol.2009.015917; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Dimopoulos MA, 2001, ANN ONCOL, V12, P991, DOI 10.1023/A:1011132808904; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Barlogie B, 2008, BLOOD, V112, P3115, DOI 10.1182/blood-2008-03-145235; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Brioli A, 2014, BRIT J HAEMATOL, V165, P441, DOI 10.1111/bjh.12805; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Bataille R, 2013, CL LYMPH MYELOM LEUK, V13, P635, DOI 10.1016/j.clml.2013.07.003; Iida S, 2010, INT J HEMATOL, V92, P118, DOI 10.1007/s12185-010-0624-7; Kuroda J, 2014, INT J HEMATOL, V99, P441, DOI 10.1007/s12185-014-1539-5	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					37	45		10.1007/s12185-014-1696-6		9	Hematology	Hematology	AY6WM	WOS:000347703500007		
J	Okamura, I; Imai, H; Mori, K; Ogura, K; Isoda, A; Mihara, K; Matsumoto, M; Saito, R; Takahashi, T; Ikeda, T				Okamura, Ikue; Imai, Hisao; Mori, Keita; Ogura, Kazuto; Isoda, Atsushi; Mihara, Keichiro; Matsumoto, Morio; Saito, Ryusei; Takahashi, Toshiaki; Ikeda, Takashi			Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Non-Hodgkin lymphoma; MALT lymphoma; BALT lymphoma; Rituximab	B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; LOW-GRADE; CLINICAL-FEATURES; MALT LYMPHOMA; MALIGNANT-LYMPHOMA; BALT LYMPHOMA; LUNG; PSEUDOLYMPHOMA; CHEMOTHERAPY	Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare extranodal lymphoma with a 5-year survival rate of 80-95 %. There is no standard treatment strategy for pulmonary MALT lymphoma. In the present study, we performed a retrospective evaluation of systemic rituximab monotherapy (375 mg m(-2) day(-1), 4-8 cycles) as first-line treatment in patients with pulmonary MALT lymphoma. Of the eight patients enrolled, five achieved complete response, one achieved partial response, and two showed stable disease. Median progression-free survival was 66.0 months (range 9.7-87.2 months). Treatment was well tolerated and all patients were alive during the median follow-up period of 64.0 months. Rituximab monotherapy was efficacious in patients with pulmonary MALT lymphoma, demonstrating long-term disease stabilization and symptom reduction. Larger prospective studies are warranted to further assess the efficacy of rituximab monotherapy. In conclusion, rituximab monotherapy may be considered for first-line therapy in patients with pulmonary MALT lymphoma.	[Okamura, Ikue; Ogura, Kazuto; Ikeda, Takashi] Shizuoka Canc Ctr, Div Hematol & Stem Cell Transplantat, Nagaizumi, Shizuoka 4118777, Japan; [Imai, Hisao; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Nagaizumi, Shizuoka 4118777, Japan; [Isoda, Atsushi; Matsumoto, Morio] Nishigunma Hosp, Natl Hosp Org, Dept Hematol, Gunma 3778511, Japan; [Mihara, Keichiro] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Minami Ku, Hiroshima 7348553, Japan; [Saito, Ryusei] Nishigunma Hosp, Natl Hosp Org, Dept Resp Med, Gunma 3778511, Japan	Imai, H (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	m06701014@gunma-u.ac.jp					Adam P, 2014, BRIT J HAEMATOL, V164, P804, DOI 10.1111/bjh.12703; Ahmed S, 2002, CANCER INVEST, V20, P1059, DOI 10.1081/CNV-120005924; Kurtin PJ, 2001, AM J SURG PATHOL, V25, P997, DOI 10.1097/00000478-200108000-00003; Borie R, 2009, EUR RESPIR J, V34, P1408, DOI 10.1183/09031936.00039309; CORDIER JF, 1993, CHEST, V103, P201, DOI 10.1378/chest.103.1.201; Graham BB, 2005, ANN THORAC SURG, V80, P1248, DOI 10.1016/j.athoracsur.2005.04.014; Imai H, 2009, INTERNAL MED, V48, P301, DOI 10.2169/internalmedicine.48.1438; Schechter NR, 1998, J CLIN ONCOL, V16, P1916; Zucca E, 2000, BLOOD, V96, P410; KOSS MN, 1983, HUM PATHOL, V14, P1024; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Ferraro P, 2000, ANN THORAC SURG, V69, P993, DOI 10.1016/S0003-4975(99)01535-0; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Zucca E, 2003, BLOOD, V101, P2489, DOI 10.1182/blood-2002-04-1279; Zinzani PL, 1999, J CLIN ONCOL, V17, P1254; ISAACSON P, 1983, CANCER, V52, P1410, DOI 10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3; ADDIS BJ, 1988, HISTOPATHOLOGY, V13, P1, DOI 10.1111/j.1365-2559.1988.tb02000.x; HAMMEL P, 1995, J CLIN ONCOL, V13, P2524; Conconi A, 2003, BLOOD, V102, P2741, DOI 10.1182/blood-2002-11-3496; Berinstein NL, 1998, ANN ONCOL, V9, P995, DOI 10.1023/A:1008416911099; Thieblemont C, 2000, BLOOD, V95, P802; Zinzani PL, 2013, HEMATOL ONCOL, V31, P183, DOI 10.1002/hon.2039; Armitage JO, 2005, CA-CANCER J CLIN, V55, P368; Ahmed S, 2004, EUR J CANCER, V40, P1320, DOI 10.1016/j.ejca.2004.02.006; Pinotti G, 1997, LEUKEMIA LYMPHOMA, V26, P527; Zucca E, 2013, J CLIN ONCOL, V31, P565, DOI 10.1200/JCO.2011.40.6272; Thieblemont C, 1997, J CLIN ONCOL, V15, P1624; Tsang RW, 2001, INT J RADIAT ONCOL, V50, P1258, DOI 10.1016/S0360-3016(01)01549-8; SALTZSTEIN SL, 1963, CANCER, V16, P928, DOI 10.1002/1097-0142(196307)16:7<928::AID-CNCR2820160709>3.0.CO;2-H; Bilici A, 2011, J KOREAN MED SCI, V26, P574, DOI 10.3346/jkms.2011.26.4.574; Cavalli F, 2001, HEMATOLOGY, V1, P241, DOI DOI 10.1182/ASHEDUCATION-2001.1.241; Grillo-Lopez AJ, 2002, INT J HEMATOL, V76, P385, DOI 10.1007/BF02982803; HERBERT A, 1984, HUM PATHOL, V15, P415, DOI 10.1016/S0046-8177(84)80074-X; Hitchcock S, 2002, INT J RADIAT ONCOL, V52, P1058, DOI 10.1016/S0360-3016(01)02714-6; LI G, 1990, HISTOPATHOLOGY, V16, P519, DOI 10.1111/j.1365-2559.1990.tb01157.x; Maloney DG, 2001, ANTI-CANCER DRUG, V12, pS1; NCCN clinical practice guidelines in oncology, NONH LYMPH; NICHOLSON AG, 1995, HISTOPATHOLOGY, V26, P405; Raderer M, 2003, ONCOLOGY-BASEL, V65, P306, DOI 10.1159/000074641; Seker Mesut, 2009, Leuk Res, V33, pe154, DOI 10.1016/j.leukres.2009.03.026; Swerdlow SH, 2008, EXTRANODAL MARGINAL	41	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					46	51		10.1007/s12185-014-1694-8		6	Hematology	Hematology	AY6WM	WOS:000347703500008		
J	Kato, M; Manabe, A; Saito, AM; Koh, K; Inukai, T; Ogawa, C; Goto, H; Tsuchida, M; Ohara, A				Kato, Motohiro; Manabe, Atsushi; Saito, Akiko M.; Koh, Katsuyoshi; Inukai, Takeshi; Ogawa, Chitose; Goto, Hiroyuki; Tsuchida, Masahiro; Ohara, Akira			Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute lymphoblastic leukemia; Relapse; Very late; Children	RANDOMIZED CONTROLLED-TRIAL; TEL-AML1 FUSION; MARROW RELAPSE; STANDARD-RISK; UKALL 2003; AIEOP-BFM; CELL; PREDNISOLONE; ADOLESCENTS; REINDUCTION	Relapse period is strongly associated with second relapse risk in relapsed acute lymphoblastic leukemia (ALL) in children. In this context, the treatment outcome of very late relapse should be better; however, data regarding very late relapse is limited. We retrospectively analyzed the outcomes of two consecutive Tokyo Children's Cancer Study Group (TCCSG) ALL trials (1995-2004) with a focus on late relapse, which was divided into two categories: late relapse (6-24 months from the end of therapy, n = 48) and very late relapse (> 24 months from the end of therapy, n = 57). Forty-three patients (29 late relapse and 14 very late relapse) received allogeneic hematopoietic stem cell transplantation (HSCT) at second remission. The event-free survival (EFS) probabilities of late relapse and very late relapse were 54.5 +/- A 7.3 and 64.8 +/- A 6.8 % at 7 years, respectively (P = 0.36), and were not significantly different. However, the second relapse incidence of late relapse (34.7 +/- A 7.1 %) was higher than that of very late relapse (15.5 +/- A 5.1 %, P = 0.03). The second relapse risk was low for very late relapse ALL, which suggests that these patients should be treated without allogeneic HSCT.	[Kato, Motohiro] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, Motohiro] Univ Tokyo, Dept Cell Therapy & Transplantat Med, Tokyo 1138655, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Saito, Akiko M.] Natl Hosp Org, Clin Res Ctr, Nagoya Med Cente, Lab Clin Epidemiol & Hlth Serv Res, Nagoya, Aichi, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Inukai, Takeshi] Univ Yamanashi, Dept Pediat, Kofu, Yamanashi, Japan; [Ogawa, Chitose] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan; [Goto, Hiroyuki] Kanagawa Childrens Med Ctr, Div Hematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Tsuchida, Masahiro] Ibaraki Childrens Hosp, Dept Hematol Oncol, Ibaraki, Japan; [Ohara, Akira] Toho Univ, Dept Pediat, Tokyo, Japan	Kato, M (reprint author), Univ Tokyo, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	katom-tky@umin.ac.jp					Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; Igarashi S, 2005, J CLIN ONCOL, V23, P6489, DOI 10.1200/JCO.2005.01.982; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Hasegawa D, 2012, PEDIATR BLOOD CANCER, V58, P23, DOI 10.1002/pbc.22965; Kato M, 2014, BRIT J HAEMATOL, V164, P376, DOI 10.1111/bjh.12632; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Vora A, 1998, BLOOD, V92, P2334; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Borgmann A, 2003, BLOOD, V101, P3835, DOI 10.1182/blood.V101.10.3835; Vora A, 2014, LANCET ONCOL, V15, P809, DOI 10.1016/S1470-2045(14)70243-8; Eckert C, 2013, J CLIN ONCOL, V31, P2736, DOI 10.1200/JCO.2012.48.5680; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; Bailey LC, 2008, LANCET ONCOL, V9, P873, DOI 10.1016/S1470-2045(08)70229-8; Buchanan GR, 2000, CANCER-AM CANCER SOC, V88, P1166, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1166::AID-CNCR29>3.0.CO;2-W; CHESSELLS JM, 1994, BRIT J HAEMATOL, V86, P48, DOI 10.1111/j.1365-2141.1994.tb03251.x; Inukai T, 2006, LEUKEMIA, V20, P363, DOI 10.1038/sj.leu.2404077; Konrad M, 2003, BLOOD, V101, P3635, DOI 10.1182/blood-2002-10-3252; Pui CH, 2014, REVISED DEFINITION C; Rizzari C, 2004, HAEMATOLOGICA, V89, P427; van den Berg H, 2011, PEDIATR BLOOD CANCER, V57, P210, DOI 10.1002/pbc.22946	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					52	57		10.1007/s12185-014-1710-z		6	Hematology	Hematology	AY6WM	WOS:000347703500009		
J	Watamoto, K; Kohno, A; Adachi, Y; Umemura, K; Yamaguchi, Y; Tatekawa, S; Ozeki, K; Morishita, Y				Watamoto, Koichi; Kohno, Akio; Adachi, Yoshitaka; Umemura, Kohji; Yamaguchi, Yohei; Tatekawa, Shotaro; Ozeki, Kazutaka; Morishita, Yoshihisa			Contribution of non-infectious transplantation-related complications to the outcome of hematopoietic stem cell transplantation in patients with acute myeloid leukemia: a single institute analysis	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Hematopoietic stem cell transplantation; Cord blood transplantation; Non-infectious transplantation-related complications; Acute myeloid leukemia	BONE-MARROW-TRANSPLANTATION; CORD-BLOOD TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; VERSUS-HOST-DISEASE; ADULT PATIENTS; UNRELATED DONORS; HEMATOLOGIC MALIGNANCIES; CONDITIONING REGIMEN; MICROANGIOPATHY; THERAPY	Cord blood (CB) is becoming an increasingly attractive alternative stem cell source for allogeneic hematopoietic stem cell transplantation (HSCT), but the outcomes of CB transplantation (CBT) are inconsistent. In the present study, we compared non-infectious transplantation-related complications (NITRCs) post-CBT in patients with acute myeloid leukemia (AML) with those following related bone marrow and peripheral blood transplantation and unrelated BM transplantation. We analyzed 108 patients with AML who received HSCT at the Konan Kosei Hospital between 1992 and 2013. After a median follow-up of 74 months, the 3-year overall survival (OS) rate was 49.4 % with no differences between graft sources. The cumulative incidence of total NITRCs was 36 % at day 100. After adjusted analyses, patients with NITRCs showed significantly decreased OS [relative risk (RR) 3.51; p < 0.001) and increased non-relapse mortality (NRM) (RR 6.49; p < 0.001) compared with patients without NITRCs. Although the cumulative NITRC incidence did not differ among transplantation groups, NRM in patients with NITRCs was significantly lower in CB recipients than in other graft recipients (11.2 versus 68.4 %, p = 0.015). These data suggest that NITRCs contribute significantly to the outcome of HSCT and that the low virulence of NITRCs favored CBT for adult AML.	[Watamoto, Koichi; Kohno, Akio; Adachi, Yoshitaka; Umemura, Kohji; Yamaguchi, Yohei; Ozeki, Kazutaka; Morishita, Yoshihisa] JA Aichi Konan Kosei Hosp, Div Hematol & Oncol, Konan, Aichi 4838704, Japan; [Tatekawa, Shotaro] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto, Japan	Watamoto, K (reprint author), JA Aichi Konan Kosei Hosp, Div Hematol & Oncol, Konan, Aichi 4838704, Japan.	watamoto51@yahoo.co.jp					Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Cho BS, 2010, TRANSPLANTATION, V90, P918, DOI 10.1097/TP.0b013e3181f24e8d; Murata M, 2013, BIOL BLOOD MARROW TR, V19, P1183, DOI 10.1016/j.bbmt.2013.05.003; Ueda N, 2014, BIOL BLOOD MARROW TR, V20, P1335, DOI 10.1016/j.bbmt.2014.04.030; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Kishi Y, 2005, TRANSPLANTATION, V80, P34, DOI 10.1097/01.TP.0000163289.20406.86; Duval M, 2010, J CLIN ONCOL, V28, P3730, DOI 10.1200/JCO.2010.28.8852; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; MCDONALD GB, 1993, ANN INTERN MED, V118, P255; Inamoto Y, 2009, BONE MARROW TRANSPL, V44, P43, DOI 10.1038/bmt.2008.419; Slovak ML, 2000, BLOOD, V96, P4075; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; CLARK JG, 1993, AM REV RESPIR DIS, V147, P1601; Hamza NS, 2004, BRIT J HAEMATOL, V124, P488, DOI 10.1046/j.1365-2141.2003.04792.x; Imamura M, 2006, INT J HEMATOL, V83, P164, DOI 10.1532/IJH97.05134; Kanda J, 2013, INT J HEMATOL, V98, P300, DOI 10.1007/s12185-013-1405-x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Nurnberger W, 1997, ANN HEMATOL, V74, P221, DOI 10.1007/s002770050288; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Uchida Naoyuki, 2008, Biol Blood Marrow Transplant, V14, P583, DOI 10.1016/j.bbmt.2008.03.003	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					83	91		10.1007/s12185-014-1695-7		9	Hematology	Hematology	AY6WM	WOS:000347703500013		
J	Kodama, Y; Fukano, R; Noguchi, M; Okamura, J; Inagaki, J				Kodama, Yuichi; Fukano, Reiji; Noguchi, Maiko; Okamura, Jun; Inagaki, Jiro			Folinic acid after MTX as prophylaxis for GVHD in pediatric bone marrow transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Folinic acid; Methotrexate; Graft-versus-host disease; Children	VERSUS-HOST-DISEASE; ACUTE GRAFT; METHOTREXATE; CYCLOSPORINE; REGIMEN	The effect of folinic acid (FA) on toxicity secondary to the use of methotrexate (MTX) for the prevention of graft-versus-host disease (GVHD) has not been determined. We retrospectively analyzed data from 111 patients who received allogeneic bone marrow transplantation (allo-BMT) in our institution. Fifty patients did not receive FA (non-FA), 37 received FA four times (low dose, LD-FA), and 24 received FA 25 times (high dose, HD-FA) in BMT. No significant differences were observed in the severity of stomatitis after allo-BMT among the three groups while the median of peak value of ALT in HD-FA was significantly lower (P = 0.031). The median time to neutrophil engraftment after allo-BMT in the HD-FA group was significantly shorter than that in the non-FA group (P = 0.034). No significant difference in the median time to neutrophil engraftment was observed between the LD-FA and non-FA groups (P = 0.44). Stepwise multiple regression analysis revealed that the determinants of the shorter duration of neutropenia were transfused total nucleated cell dose (P = 0.001) and the administration of HD-FA (P = 0.036). There was no significant difference in 3-year overall survival among the three groups. Frequent administration of FA may reduce the time to neutrophil engraftment after hematopoietic stem cell transplantation.	[Kodama, Yuichi; Fukano, Reiji; Noguchi, Maiko; Okamura, Jun; Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Pediat, Minami Ku, Fukuoka, Japan	Inagaki, J (reprint author), Kyushu Natl Canc Ctr, Dept Pediat, Minami Ku, 3-1-1 Notame, Fukuoka, Japan.	inagakij@nk-cc.go.jp					STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; Ramsey LB, 2013, BLOOD, V121, P898, DOI 10.1182/blood-2012-08-452839; Ruutu T, 1997, BONE MARROW TRANSPL, V19, P759, DOI 10.1038/sj.bmt.1700745; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Bhurani D, 2008, BONE MARROW TRANSPL, V42, P547, DOI 10.1038/bmt.2008.197; GRATWOHL AA, 1978, ACTA HAEMATOL-BASEL, V60, P233; Hudspeth MP, 2013, BONE MARROW TRANSPL, V48, P46, DOI 10.1038/bmt.2012.82; Lindqvist H, 2013, BIOL BLOOD MARROW TR, V19, P325, DOI 10.1016/j.bbmt.2012.09.024; NEVILL TJ, 1992, BONE MARROW TRANSPL, V9, P349; Peters C, 2000, BONE MARROW TRANSPL, V26, P405, DOI 10.1038/sj.bmt.1702524; RUSSELL JA, 1994, BONE MARROW TRANSPL, V14, P397; Sugita J, 2012, BONE MARROW TRANSPL, V47, P258, DOI 10.1038/bmt.2011.53	12	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					92	98		10.1007/s12185-014-1712-x		7	Hematology	Hematology	AY6WM	WOS:000347703500014		
J	Imataki, O; Ota, S; Aoyama, M; Kubo, H; Hamasaki, Y; Kida, J; Oku, M; Uemura, M; Ohue, Y				Imataki, Osamu; Ota, Sayoko; Aoyama, Mariko; Kubo, Hiroyuki; Hamasaki, Yukiko; Kida, Jun-ichiro; Oku, Maki; Uemura, Makiko; Ohue, Yukiko			Delayed flare reaction of draining vein due to subcutaneous bortezomib more likely to occur at the inner thigh	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Multiple myeloma; Injection site reaction; Flare reaction; Hypersensitivity; Chemotherapy	INJECTION SITE REACTIONS		[Imataki, Osamu; Kubo, Hiroyuki; Hamasaki, Yukiko; Kida, Jun-ichiro; Oku, Maki; Uemura, Makiko] Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol & Stem Cell Transplantat, Miki, Kagawa 7610793, Japan; [Ota, Sayoko; Aoyama, Mariko; Ohue, Yukiko] Kagawa Univ Hosp, Nursing Div, Miki, Kagawa 7610793, Japan	Imataki, O (reprint author), Kagawa Univ, Fac Med, Dept Internal Med, Div Hematol & Stem Cell Transplantat, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	oima@med.kagawa-u.ac.jp					Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Kamimura T, 2013, INT J HEMATOL, V98, P694, DOI 10.1007/s12185-013-1469-7; Kamimura T, 2013, EUR J HAEMATOL, V90, P157, DOI 10.1111/ejh.12055; Schuenke M, 2014, THIEME ATLAS ANATOMY, P521	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					99	101		10.1007/s12185-014-1683-y		3	Hematology	Hematology	AY6WM	WOS:000347703500015		
J	Kohashi, S; Mori, T; Hashida, R; Kato, J; Saburi, M; Kikuchi, T; Koda, Y; Toyama, T; Yamane, Y; Yamanaka, S; Okamoto, S				Kohashi, Sumiko; Mori, Takehiko; Hashida, Risa; Kato, Jun; Saburi, Masuho; Kikuchi, Taku; Koda, Yuya; Toyama, Takaaki; Yamane, Yusuke; Yamanaka, Satomi; Okamoto, Shinichiro			Reduced-dose cyclophosphamide in combination with fludarabine and anti-thymocyte globulin as a conditioning regimen for allogeneic hematopoietic stem cell transplantation for aplastic anemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Letter							ALTERNATIVE DONOR TRANSPLANTS; TOTAL-BODY IRRADIATION; SAA WORKING PARTY; ALEMTUZUMAB		[Kohashi, Sumiko; Mori, Takehiko; Hashida, Risa; Kato, Jun; Saburi, Masuho; Kikuchi, Taku; Koda, Yuya; Toyama, Takaaki; Yamane, Yusuke; Yamanaka, Satomi; Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Med, Div Hematol,Shinjuku Ku, Tokyo 1608582, Japan	Mori, T (reprint author), Keio Univ, Sch Med, Dept Med, Div Hematol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tmori@a3.keio.jp					Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324/haematol.2009.018267; Srinivasan R, 2006, BRIT J HAEMATOL, V133, P305, DOI 10.1111/j.1365-2141.2006.06019.x; Kanda Y, 2013, AM J HEMATOL, V88, P294, DOI 10.1002/ajh.23392; Bacigalupo A, 2005, BONE MARROW TRANSPL, V36, P947, DOI 10.1038/sj.bmt.1705165; Mori T, 2010, INT J HEMATOL, V91, P588, DOI 10.1007/s12185-010-0569-x; Ashizawa M, 2014, INT J HEMATOL, V99, P311, DOI 10.1007/s12185-014-1501-6; Gandhi S, 2013, INT J HEMATOL, V97, P573, DOI 10.1007/s12185-013-1333-9; Nakao S, 2013, INT J HEMATOL, V97, P551, DOI 10.1007/s12185-013-1325-9; Okuda S, 2009, AM J HEMATOL, V84, P167, DOI 10.1002/ajh.21355; Resnick IB, 2006, BRIT J HAEMATOL, V133, P649, DOI 10.1111/j.1365-2141.2006.06084.x; Yoshida N, 2012, BLOOD, V120	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2015	101	1					102	105		10.1007/s12185-014-1697-5		4	Hematology	Hematology	AY6WM	WOS:000347703500016		
J	Yoshino, T; Yamamoto, A; Ono, Y				Yoshino, Toshiaki; Yamamoto, Atsuhiko; Ono, Yoshihiro			Innovative Regeneration Technology to Solve Peri-implantitis by Er:YAG Laser Based on the Microbiologic Diagnosis: A Case Series	INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY			English	Article							ER-YAG LASER; OSSEOINTEGRATED IMPLANTS; PERIODONTAL THERAPY; ROOT SURFACES; IRRADIATION; RADIATION; HISTORY	Peri-implantitis is an emerging problem, and corrective therapy requires a method for decontaminating the complex surface structure of the implant body and sterilizing the surrounding tissue. The erbium:yttrium-aluminum-garnet (Er:YAG) laser has proven to effectively allow tissue to regenerate when used for peri-implantitis. The power of the Er:YAG laser is absorbed by a water molecule; therefore, its target neither rises in temperature nor carbonizes. An antibacterial remedy based on the bacteriologic diagnosis, followed by debridement and sterilization of the implant surface and peri-implant tissues by Er:YAG laser is efficacious for peri-implantitis treatment. The aim of this report was to present the effectiveness of the Er:YAG laser for peri-im plant bone regeneration. This case series of two patients showed that antibiotic therapy reduced the bacterial amount from the peri-implantitis sites significantly and that Er:YAG laser therapy, along with the bone augmentation, enhanced bone regeneration in the peri-im plant bony defects.	[Yoshino, Toshiaki; Yamamoto, Atsuhiko; Ono, Yoshihiro] Japan Inst Adv Dent Studies, Tokyo, Japan	Yoshino, T (reprint author), Yoshino Dent Off, Nishi Ku, Yokohamanishikyodo Bldg 5F,Kitasaiwai 1-2-13, Yokohama, Kanagawa, Japan.	yoshino@yoshino-do.jp					ALBREKTSSON T, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P365; Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Califano JV, 2003, J PERIODONTOL, V74, P1696; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Mombelli A, 1992, Clin Oral Implants Res, V3, P162, DOI 10.1034/j.1600-0501.1992.030402.x; Rosenberg ES, 1991, CLIN ORAL IMPLAN RES, V2, P135, DOI 10.1034/j.1600-0501.1991.020306.x; Folwaczny M, 2003, AM J DENT, V16, P3; Grunder U, 2005, INT J PERIODONT REST, V25, P113; Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x; Gomi K, 2007, J PERIODONTOL, V78, P422, DOI 10.1902/jop.2007.060247; MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P124; Aleksic V, 2010, LASER MED SCI, V25, P559, DOI 10.1007/s10103-010-0761-5; Lang NP, 2004, INT J ORAL MAX IMPL, V19, P150; Quirynen M, 2007, J CLIN PERIODONTOL, V34, P805, DOI 10.1111/j.1600-051X.2007.01106.x; Matsuyama T, 2003, J CLIN LASER MED SUR, V21, P7, DOI 10.1089/10445470360516680; Folwaczny M, 2003, J PERIODONTOL, V74, P360, DOI 10.1902/jop.2003.74.3.360; FRIBERG B, 1991, International Journal of Oral and Maxillofacial Implants, V6, P142; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Quirynen M, 1990, CLIN ORAL IMPLAN RES, V1, P8, DOI 10.1034/j.1600-0501.1990.010102.x; Schwarz F, 2007, LASER SURG MED, V39, P428, DOI 10.1002/lsm.20509; Yamaguchi H, 1997, J PERIODONTOL, V68, P1151; Yamamoto A, 2013, INT J PERIODONT REST, V33, P21; Yoshino T, 2009, J PERIODONTOL, V80, P82, DOI 10.1902/jop.2009.080097 	23	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0198-7569	1945-3388		INT J PERIODONT REST	Int. J. Periodontics Restor. Dent.	JAN-FEB	2015	35	1					67	74				8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ1NJ	WOS:000348005300010		
J	Abe, T; Sasahara, H				Abe, Takeyuki; Sasahara, Hiroyuki			Development of the Shell Structures Fabrication CAM System for Direct Metal Lamination Using Arc Discharge-Lamination Height Error Compensation by Torch Feed Speed Control-	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Additive manufacturing; Arc discharge; CAM; Lamination path; Rapid manufacturing; Welding	OPTIMIZATION	The direct metal lamination is a kind of the additive manufacturing process using the arc welding technology; where the molten metal made by the arc discharge is accumulated successively in this process. Overhanging shapes can be fabricated without support materials but lamination height error is caused in largely inclined area. In this paper, the lamination height error was estimated by using the accumulated metal shape model. Then, the lamination height error was compensated by changing welding torch feed speed so that the top surface of the laminated layer became horizontal. As a result, not only the lamination height error was decreased by 50%, but average inclination angle error was decreased by 50%.	[Abe, Takeyuki; Sasahara, Hiroyuki] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan	Abe, T (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	take8abe@gmail.com	Sasahara, Hiroyuki/C-8770-2013		 [25.7728]	This work was supported by Grant-in-Aid for JSPS Fellows Grant Number 25.7728.	Abe T., 2012, P AM SOC PREC ENG, P296; Abe T., 2012, INT J AUTOMATION TEC, V6, P611; Song YA, 2005, INT J MACH TOOL MANU, V45, P1063, DOI 10.1016/j.ijmachtools.2004.11.022; Buchbinder D, 2011, PHYSCS PROC, V12, P271, DOI 10.1016/j.phpro.2011.03.035; Chatterjee S., 2012, REGRESSION ANAL EXAM, P43; Furumoto T, 2013, CIRP ANN-MANUF TECHN, V62, P223, DOI 10.1016/j.cirp.2013.03.032; Kamioka T., 2012, T JAPAN SOC MECH E C, V78, P282; Kruth J. P., 1998, CIRP ANN-MANUF TECHN, V47, P525, DOI DOI 10.1016/S0007-8506(07)63240-5; Suryakumar S, 2011, COMPUT AIDED DESIGN, V43, P331, DOI 10.1016/j.cad.2011.01.006; Tanaka K., 2013, T JAPAN SOC MECH E C, V79, P1168; Wohlers Associates Inc, 2013, WOHL REP 2013, p[23, 38]	11	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	JAN	2015	16	1					171	176		10.1007/s12541-015-0022-4		6	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AZ1WM	WOS:000348025700022		
J	Cho, TT; Meng, Y; Sugiyama, S; Yanagimoto, J				Cho, Thet Thet; Meng, Yi; Sugiyama, Sumio; Yanagimoto, Jun			Separation Technology of Tramp Elements in Aluminium Alloy Scrap by Semisolid Processing	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Aluminium alloy scraps; Backward extrusion; Semisolid processing; Tramp elements		A growing number of studies suggest that the accumulation of unwanted elements is a growing problem in all recycled material streams. Thus, the separation of tramp elements from aluminium alloy scrap is very important in the aluminium recycling process. In this paper, a new technique of backward extrusion in the semisolid state is reported for separating the tramp elements from aluminium alloy scrap and obtaining high-purity aluminium easily and quickly. In this process, partial solidification is adopted to condense tramp elements in the liquid phase on the grain boundary. In experimental trials, four aluminium alloys were selected: cast aluminium alloy (AC4C), two kinds of wrought aluminium alloy (A7N01, A7075) and aluminium beverage can scraps. From the results of macro-and optical microscopic analysis, Rockwell hardness testing and electron probe micro-analyser (EPMA) analysis, it was confirmed that the backward extrusion in the semisolid state could separate the tramp elements from the aluminium alloy scrap easily and high-purity aluminium was obtained.	[Cho, Thet Thet; Meng, Yi; Sugiyama, Sumio; Yanagimoto, Jun] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Cho, TT (reprint author), Univ Tokyo, Inst Ind Sci, 4-6-1 Komaba Meguro Ku, Tokyo 1538505, Japan.	thet-cho@iis.u-tokyo.ac.jp	MENG, YI/I-5258-2013	MENG, YI/0000-0003-1863-9884	MEXT, Japan [22102005]	This study was financially supported by a Grant-in-Aid for Scientific Research on the Innovative Area, "Bulk Nanostructured Metals" through MEXT, Japan (contract No. 22102005).	Alihosseini H, 2012, MATER LETT, V68, P204, DOI 10.1016/j.matlet.2011.10.037; Das SK, 2006, MATER SCI FORUM, V519-521, P1239; Chayong S, 2005, MAT SCI ENG A-STRUCT, V390, P3, DOI 10.1016/j.msea.2004.05.004; Boender W, 2002, LIGHT MET, P1061; Chinella J. F., 2011, ARLTR5660 DTIC; Ichikawa K, 1997, MATER T JIM, V38, P622; Kahveci A. I., 2000, P 4 INT S REC MET EN, P979; MEHRABIA.R, 1974, METALL TRANS, V5, P785, DOI 10.1007/BF02644681; Sugiyama S, 2013, SOLID STATE PHENOMEN, V192-193, P494, DOI 10.4028/www.scientific.net/SSP.192-193.494; Sugiyama S., 2009, J SOLID MECH MAT ENG, V3, P227	10	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	JAN	2015	16	1					177	183		10.1007/s12541-015-0023-3		7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AZ1WM	WOS:000348025700023		
J	Fujioka, T				Fujioka, Terutaka			Assessment methods for Bree-type ratcheting without the necessity of linearization of stresses and strains	INTERNATIONAL JOURNAL OF PRESSURE VESSELS AND PIPING			English	Article						Ratcheting; Stress classification; Design criteria; Plasticity		This paper proposes methods for assessing Bree-type ratcheting in a cylinder subjected to constant internal pressure and cyclic thermal loading. The proposed methods are elastic analysis-route and elastic plastic analysis-route. The former is based on the polynomial approximation of the elastic stress distributions for thermal stresses and the reference stress concept for estimating primary stress. The latter elastic plastic route method is based on the concept of relative elastic core size. The methods proposed were validated by performing elastic plastic finite element analyses of a smooth cylinder that exhibited Bree-type ratcheting. (C) 2014 Elsevier Ltd. All rights reserved.	Toyo Univ, Kawagoe, Saitama 3508585, Japan	Fujioka, T (reprint author), Toyo Univ, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	fujioka@toyo.jp					AFCEN, 1993, DES CONSTR RUL MECH; [Anonymous], 2003, ASS PROC HIGH TEMP R; Bradford RAW, 2012, INT J PRES VES PIP, V99, P44, DOI 10.1016/j.ijpvp.2012.07.014; Asada S, 2010, P ASME 2010 PRESS VE; ASME, 2004, SUBS NH CLASS 1 COMP; ASME, 2004, SECT 3 RUL CONSTR NU; Bradford RAW, 2013, INT J PRESS VESSELS, P32; Bree J, 1989, J STRAIN ANAL, P322; Bree J., 1967, J STRAIN ANAL, V2, P226, DOI 10.1243/03093247V023226; Fujioka T., 2013, P ASME 2013 PRESS VE; IIDA K, 1987, NUCL ENG DES, V98, P305, DOI 10.1016/0029-5493(87)90008-2; JSME, 2008, SNC1 JSME; Miller DR, 1959, J BASIC ENG, P190; Okamoto A, 2002, ASME2002, V439, P57; Penny RK, 1971, DESIGN CREEP	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-0161	1879-3541		INT J PRES VES PIP	Int. J. Pressure Vessels Pip.	JAN	2015	125						78	84		10.1016/j.ijpvp.2014.10.001		7	Engineering, Multidisciplinary; Engineering, Mechanical	Engineering	AZ5LR	WOS:000348263000008		
J	Askalany, AA; Saha, BB				Askalany, Ahmed A.; Saha, Bidyut Baran			Experimental and theoretical study of adsorption kinetics of Difluoromethane onto activated carbons	INTERNATIONAL JOURNAL OF REFRIGERATION-REVUE INTERNATIONALE DU FROID			English	Article						Adsorption kinetics; Activated carbon; Difluoromethane; LDF; FD	COOLING SYSTEMS; HEAT; ISOTHERMS; ADSORBENT; DRIVEN; AIR	This paper presents theoretical and experimental adsorption kinetics of Difluoromethane (HFC-32) onto activated carbon powder of type Maxsorb III and activated carbon fiber of type A-20. The experimental runs have been conducted on an apparatus that has been designed and built specially for this purpose. The adsorption kinetics have been determined at different adsorption temperatures ranging from 25 degrees C to 65 degrees C. The experimental data are reduced and fitted with linear driving force (LDF) and Fickian diffusion (FD) models. It has been found that both LDF and FD models are able to simulate the adsorption kinetics of HFC-32 onto activated carbon powder and fiber with an error of +/- 5%. (C) 2014 Elsevier Ltd and IIR. All rights reserved.	[Askalany, Ahmed A.] Sohag Univ, Fac Ind Educ, Dept Mech Engn, Sohag 82524, Egypt; [Saha, Bidyut Baran] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Saha, Bidyut Baran] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Askalany, AA (reprint author), Sohag Univ, Fac Ind Educ, Dept Mech Engn, Sohag 82524, Egypt.	ahmed_askalany3@yahoo.com					Dawoud B, 2013, APPL THERM ENG, V50, P1645, DOI 10.1016/j.applthermaleng.2011.07.013; Alam KCA, 2013, APPL THERM ENG, V50, P1603, DOI 10.1016/j.applthermaleng.2011.09.028; Gordeeva L, 2014, APPL ENERG, V117, P127, DOI 10.1016/j.apenergy.2013.11.073; Glaznev IS, 2008, INT J HEAT MASS TRAN, V51, P5823, DOI 10.1016/j.ijheatmasstransfer.2008.04.061; Sircar S, 2000, ADSORPTION, V6, P137, DOI 10.1023/A:1008965317983; Ng KC, 2013, DESALINATION, V308, P161, DOI 10.1016/j.desal.2012.07.030; El-Sharkawy II, 2006, INT J HEAT MASS TRAN, V49, P3104, DOI 10.1016/j.ijheatmasstransfer.2006.02.029; Sharafian A, 2014, RENEW SUST ENERG REV, V30, P440, DOI 10.1016/j.rser.2013.10.031; Askalany AA, 2012, RENEW SUST ENERG REV, V16, P493, DOI 10.1016/j.rser.2011.08.013; Chan KC, 2012, INT J HEAT MASS TRAN, V55, P3214, DOI 10.1016/j.ijheatmasstransfer.2012.02.054; Askalany AA, 2013, INT J REFRIG, V36, P1037, DOI 10.1016/j.ijrefrig.2012.11.009; Askalany AA, 2013, J CHEM ENG DATA, V58, P2828, DOI 10.1021/je4005678; Atakan A, 2013, APPL THERM ENG, V58, P273, DOI 10.1016/j.applthermaleng.2013.04.037; Dassler I., 2012, ENERGY PROCEDIA, V30, P921, DOI [10.1016/j.egypro.2012.11.104, DOI 10.1016/J.EGYPR0.2012.11.104]; Habib K, 2010, INT J REFRIG, V33, P706, DOI 10.1016/j.ijrefrig.2010.01.006; Khattab NM, 2012, ENRGY PROCED, V18, P709, DOI 10.1016/j.egypro.2012.05.086; Ruthven D. M., 1984, PRINCIPLES ADSORPTIO, P128; Tso G. Y., 2012, INT J REFRIG, V35, P1626	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0140-7007	1879-2081		INT J REFRIG	Int. J. Refrig.-Rev. Int. Froid	JAN	2015	49						160	168		10.1016/j.ijrefrig.2014.10.009		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	AZ1QG	WOS:000348012500018		
J	Sengoku, Y; Nakamura, K; Ogata, H; Nabekura, Y; Nagasaka, S; Tokuyama, K				Sengoku, Yasuo; Nakamura, Kazuteru; Ogata, Hitomi; Nabekura, Yoshiharu; Nagasaka, Shoichiro; Tokuyama, Kumpel			Continuous Glucose Monitoring During a 100-km Race: A Case Study in an Elite Ultramarathon Runner	INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE			English	Article						prolonged exercise; endurance capacity; glucose metabolism	EXERCISE; INSULIN; MEN	The current case study intended to measure blood glucose fluctuation in 2 marathon runners during a 100-km race using a continuous glucose-monitoring system (CGMS) and investigate the relationship between glucose profile and change in running speed. Two experienced ultramarathon runners participated in this study. A CGMS glucose sensor was inserted into the subcutaneous abdominal tissue at 35 h before the 100-km race, and the glucose profile was monitored continuously until the end of the race. Race pace and energy intake during the race were recorded. Participants finished the race in 6h:51min:17s (runner A) and 8h:56min:04s (runner B), and the race-pace decrement ratios were 17.6% for runner A and 27.2% for runner B. The average relative intensity throughout the 100-km race was 89.9% +/- 5.8% lactate threshold (LT) in runner A and 78.4% +/- 8.6% LT in runner B. The total amount of carbohydrate intake during the race was 249 g and 366 g in runners A and B, respectively. Despite lower carbohydrate intake, runner A maintained a normal glucose level throughout the race, while runner B rapidly decreased blood glucose and became hypoglycemic after the 80-km point. These results suggest that elite ultramarathon runners may have the ability to prevent a large decrement in blood glucose level regardless of the amount of energy intake during the race to maintain higher relative running intensity.	[Sengoku, Yasuo; Ogata, Hitomi; Nabekura, Yoshiharu; Tokuyama, Kumpel] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Kazuteru] Ibaraki Christian Univ, Dept Food Sci, Hitachi, Ibaraki, Japan; [Nagasaka, Shoichiro] Jichi Med Univ, Dept Internal Med, Shimotsuke, Japan	Sengoku, Y (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan.	sengoku@taiiku.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors would like to thank Mr Ryuji Takada and the member of the Tsurunuma Ultramarathonian Club for all the heartwarming support for this investigation.	Cauza E, 2005, INT J SPORTS MED, V26, P774, DOI 10.1055/s-2004-830561; Koschinsky T, 2001, DIABETES-METAB RES, V17, P113, DOI 10.1002/dmrr.188; Fallon KE, 1998, INT J SPORT NUTR, V8, P24; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Harger-Domitrovich SG, 2007, MED SCI SPORT EXER, V39, P2171, DOI 10.1249/mss.0b013e318157a650; KJAER M, 1984, J APPL PHYSIOL, V57, P21; Macdonald AL, 2006, MED SCI SPORT EXER, V38, P201, DOI 10.1249/01.mss.0000183852.31164.5a; Nishida Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE809, DOI 10.1152/ajpendo.00237.2001; Noakes T., 2001, LORE OF RUNNING, V4th; Weitgasser R, 1999, CLIN CHEM, V45, P1821	11	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1555-0265	1555-0273		INT J SPORT PHYSIOL	Int. J. Sport Physiol. Perform.	JAN	2015	10	1					124	127		10.1123/ijspp.2013-0493		4	Physiology; Sport Sciences	Physiology; Sport Sciences	AZ8TD	WOS:000348486500021		
J	Tarnawski, VR; Momose, T; McCombie, ML; Leong, WH				Tarnawski, V. R.; Momose, T.; McCombie, M. L.; Leong, W. H.			Canadian Field Soils III. Thermal-Conductivity Data and Modeling	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Canadian soils; Mineral composition; Quartz; Series-parallel model; Thermal conductivity; Thermal probe	WATER-CONTENT; TEMPERATURE; DIFFUSIVITY; PROBE	Forty field soil samples, from nine Canadian Provinces, were laboratory tested for their ability to conduct heat, i.e., thermal conductivity (), using a non-stationary probe technique. The measurements were carried out on moderately compacted samples at room temperature, and over a full range of degree of saturation ( ranging from dryness to full saturation. The analysis of data revealed a strong nonlinear variation of versus that can be sub-analyzed in four -based domains, i.e., residual, transitory meniscus, micro/macro-porous capillary, and superfluous. In the residual domain (, a very small variation is observed. In the transitory meniscus domain (, for the majority of soils, a sharp increase was observed. In the micro/macro-porous capillary domain (, a moderate increase was noted. Finally, in the superfluous domain (, a very slight increase was generally noted. On average, the highest values (from 1.9 to 3.2 were obtained from saturated soil samples with high quartz content, e.g., samples from sites in Nova Scotia and Prince Edward Island. On the other hand, the lowest (from 1.1 to 1.4 was observed from saturated soil samples with lower quartz content, e.g., British Columbia samples. The measured data were used to verify a recently developed series-parallel (S-) model for unsaturated soils. On average, estimates of the S- model, with a parallel arrangement of air and water in the third of three conductive paths, were within of experimental data. However, the S- model, with a series arrangement of air and water in the third conductive path, showed slightly better estimates when it was applied to fine-textured soils. In addition, there was no strong correlation noted between the performance of the S- models and soil quartz content. Consequently, it is recommended to compare estimates from both models when they are applied to experimental data.	[Tarnawski, V. R.; McCombie, M. L.] St Marys Univ, Div Engn, Halifax, NS B3H 3C3, Canada; [Momose, T.] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan; [Leong, W. H.] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada	Tarnawski, VR (reprint author), St Marys Univ, Div Engn, 923 Robie St, Halifax, NS B3H 3C3, Canada.	vlodek.tarnawski@smu.ca			Natural Sciences and Engineering Research Council (NSERC) Canada	This study was supported by Discovery Grants from Natural Sciences and Engineering Research Council (NSERC) Canada. Sincere thanks to Geological Survey of Bavaria (Germany) for providing XRD/XRF analyses. Special thanks to Dr. Tusheng Ren of China Agricultural University, Beijing, China, for his useful comments during the final preparation of the manuscript.	RAWLS WJ, 1982, T ASAE, V25, P1316; CAMPBELL GS, 1994, SOIL SCI, V158, P307, DOI 10.1097/00010694-199411000-00001; Tarnawski VR, 2009, INT J THERMOPHYS, V30, P949, DOI 10.1007/s10765-009-0596-0; Tarnawski VR, 2002, INT J ENERG RES, V26, P143, DOI 10.1002/er.772; HORAI KI, 1971, J GEOPHYS RES, V76, P1278, DOI 10.1029/JB076i005p01278; GHUMAN BS, 1985, SOIL SCI, V139, P74, DOI 10.1097/00010694-198501000-00011; Ren T, 1999, SOIL SCI SOC AM J, V63, P450; Tarnawski VR, 2012, INT J THERMOPHYS, V33, P1191, DOI 10.1007/s10765-012-1282-1; BRISTOW KL, 1994, SOIL SCI SOC AM J, V58, P1288; BRIGAUD F, 1989, GEOPHYS J INT, V98, P525, DOI 10.1111/j.1365-246X.1989.tb02287.x; CLAPP RB, 1978, WATER RESOUR RES, V14, P601, DOI 10.1029/WR014i004p00601; PARIKH RJ, 1979, SOIL SCI SOC AM J, V43, P1050; Lu S, 2007, SOIL SCI SOC AM J, V71, P8, DOI 10.2136/sssaj2006.0041; Tarnawski VR, 2011, INT J THERMOPHYS, V32, P984, DOI 10.1007/s10765-011-0975-1; [Anonymous], 1995, GUID EXPR UNC MEAS; SEPASKHAH AR, 1979, SOIL SCI SOC AM J, V43, P439; Ochsner TE, 2001, SOIL SCI SOC AM J, V65, P1641; Bachmann J, 2001, SOIL SCI SOC AM J, V65, P1675; Blake BR., 1986, AGRON MONOGR, V9, P377; Campbell G.S., 1985, SOIL PHYS BASIC TRAN; Clauser C, 1995, ROCK PHYS PHASE RELA, V3, P105, DOI DOI 10.1029/RF003P0105; Farouki O.T., 1986, THERMAL PROPERTIES S; HOLTAN HN, 1968, MOISTURE TENSION DAT, P41; HOLTON R, 1982, SOIL SCI, V133, P397; JOHANSEN O, 1977, THESIS TRONDHEIM NOR; KASUBUCHI T, 2007, T JAP SOC IRRIGATION, V251, P53; Kersten M, 1949, BULLETIN, V28; LICHTENECKER, 1926, ZEIISCHRIFT, V27; MCINNESS KJ, 1981, THESIS WASHINGTON ST; MOSTAGHIMI J, 1980, WARME STOFFUBERTRAG, V13, P3, DOI 10.1007/BF00997628; NAKSHABANDI G. AL, 1965, AGR METEOROL, V2, P271; PENNER E, 1975, CAN GEOTECH J, V12, P271, DOI 10.1139/t75-033; RIHA SJ, 1980, SOIL SCI SOC AM J, V44, P1323; SAWADA S, 1985, P 4 INT S GROUND FRE, P53; SCHONENBERGER J, 2012, INT J THERMOPHYS, V33; SMITH WO, 1939, SOIL SCI SOC AM P, V193, P32; Tarnawski VR, 2000, TRANSPORT POROUS MED, V41, P137, DOI 10.1023/A:1006738727206; Tarnawski VR, 2009, GEOTECHNIQUE, V59, P331, DOI 10.1680/geot.2009.59.4.331; Tarnawski VR, 2012, INT J THERMOPHYS, V33, P843, DOI 10.1007/s10765-012-1184-2; YAMAZAKI Y, 2003, T JSIRRE, V226, P497	40	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	JAN	2015	36	1					119	156		10.1007/s10765-014-1793-z		38	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	AZ4JJ	WOS:000348187000010		
J	Baba, T; Homma, Y; Momomura, R; Kobayashi, H; Matsumoto, M; Futamura, K; Mogami, A; Kanda, A; Morohashi, I; Kaneko, K				Baba, Tomonori; Homma, Yasuhiro; Momomura, Rei; Kobayashi, Hideo; Matsumoto, Mikio; Futamura, Kentaro; Mogami, Atsuhiko; Kanda, Akio; Morohashi, Itaru; Kaneko, Kazuo			New classification focusing on implant designs useful for setting therapeutic strategy for periprosthetic femoral fractures	INTERNATIONAL ORTHOPAEDICS			English	Article						Periprosthetic femoral fracture; Vancouver classification; New classification; Implant design	TOTAL HIP-ARTHROPLASTY; VANCOUVER CLASSIFICATION; FEMUR; MANAGEMENT	Purpose In periprosthetic femoral fractures, our hypothesis was that when the bone and implant are stable, the fracture does not occur at the biologic or cement fixation regions but occurs at the no fixation region. The aim of this study was to investigate the validity of our new classification for periprosthetic femoral fractures and compare reliability of radiographic evaluation for implant stability between our classification and the Vancouver classification. Patients and methods Sixty-six patients with periprosthetic femoral fracture were operatively treated by us between 2005 and 2013. We investigated the sensitivity and specificity of our new classification with actual implant stability. Twenty patients were randomly selected from 66 patients. After fully explaining the Vancouver and our new classification to four orthopaedic surgeons, plain radiographs acquired in two directions at the time of injury were presented, and the interobserver reliability based on the two classifications and accuracy rates of stem stability were investigated. Results The specificity of the new classification was 89 %, and sensitivity was 94 %. The positive and negative predictive values were 84 % and 96 %, respectively. Interobserver agreement was separately assessed among all possible pairs of orthopaedic surgeons. The kappa values for the Vancouver and the new classification were 0.36 (0.19-0.49) and 0.76 (0.66-1.0), respectively. Conclusions Our classification is based on a completely new concept and was prepared to overcome periprosthetic femoral fracture failures by objective evaluation. We believe this new classification is useful to establish a therapeutic strategy for femoral fractures around the stem.	[Baba, Tomonori; Homma, Yasuhiro; Momomura, Rei; Kobayashi, Hideo; Matsumoto, Mikio; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 113, Japan; [Futamura, Kentaro; Mogami, Atsuhiko; Kanda, Akio; Morohashi, Itaru] Juntendo Univ, Shizuoka Hosp, Dept Orthoped Surg, Izunokunishi, Shizuoka, Japan	Baba, T (reprint author), Juntendo Univ, Sch Med, Dept Orthoped Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 113, Japan.	tobaba@juntendo.ac.jp					Rayan F, 2008, J BONE JOINT SURG BR, V90B, P1576, DOI 10.1302/0301-620X.90B12.20681; Naqvi GA, 2012, J ARTHROPLASTY, V27, P1047, DOI 10.1016/j.arth.2011.11.021; Corten K, 2009, J BONE JOINT SURG BR, V91B, P1424, DOI 10.1302/0301-620X.91B11.22292; KAVANAGH BF, 1992, ORTHOP CLIN N AM, V23, P249; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Learmonth ID, 2004, J BONE JOINT SURG BR, V86B, P13, DOI 10.1302/0301-620X.86B1.14864; Neumann D, 2012, INT ORTHOP, V36, P1045, DOI 10.1007/s00264-011-1371-y; Laurer HL, 2011, ARCH ORTHOP TRAUM SU, V131, P983, DOI 10.1007/s00402-011-1272-y; Ahuja S, 2002, INJURY, V33, P47, DOI 10.1016/S0020-1383(01)00112-7; Tsiridis E, 2003, INJURY, V34, P107, DOI 10.1016/S0020-1383(02)00161-4; Davidson D, 2008, J BONE JOINT SURG AM, V90A, P2000, DOI [10.2106/JBJS.H.00331, 10.2106/JBJS.G.00331]; Baba Tomonori, 2013, Eur J Orthop Surg Traumatol, V23, P437, DOI 10.1007/s00590-012-1005-0; Canbora Kerem, 2013, Eur J Orthop Surg Traumatol, V23, P545, DOI 10.1007/s00590-012-1024-x; Duncan C P, 1995, Instr Course Lect, V44, P293; JOHANSSON JE, 1981, J BONE JOINT SURG AM, V63, P1435; Masri BA, 2004, CLIN ORTHOP RELAT R, P80; Moloney GB, 2014, ARCH ORTHOP TRAUM SU, V134, P9, DOI 10.1007/s00402-013-1883-6; Montijo H, 1989, J Arthroplasty, V4, P115, DOI 10.1016/S0883-5403(89)80063-4	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JAN	2015	39	1					1	5		10.1007/s00264-014-2476-x		5	Orthopedics	Orthopedics	AY7GX	WOS:000347730200001		
J	Shoji, T; Yasunaga, Y; Yamasaki, T; Izumi, S; Hachisuka, S; Ochi, M				Shoji, Takeshi; Yasunaga, Yuji; Yamasaki, Takuma; Izumi, Soutarou; Hachisuka, Susumu; Ochi, Mitsuo			Low femoral antetorsion and total hip arthroplasty: a risk factor	INTERNATIONAL ORTHOPAEDICS			English	Article						Total hip arthroplasty; Three-dimensional motion analysis; Femoral antetorsion; Bony impingement	POSTERIOR DISLOCATION; IN-VITRO; MOTION; RANGE; REPLACEMENT; ANTEVERSION; COMPONENTS; HEADS; JOINT; RATES	Purpose The purpose of this study was to evaluate whether femoral antetorsion affects the range of motion (ROM) following total hip arthroplasty (THA) using 3D dynamic analysis. Methods Using 3D computed tomography (CT) data of 71 patients (71 hips) who underwent THA, we calculated antetorsion of the femoral neck, flexion range of motion (Flex ROM), internal rotation (Int-R) and external rotation (Ext-R). Evaluation of the relationship between antetorsion, ROM and the impingement site was performed. As for implant position, anteversion of the femoral implant was set to be the same as natural antetorsion of the femoral neck, and the acetabular component was set 45 degrees of total anteversion in all cases. Results We found a significant decrease in Flex ROM and Int-R inversely proportional to femoral antetorsion. In patients with lower antetorsion, Flex ROM and Int-R decreased due to bony impingement (the anterior great trochanteric region of the femur impinges on the anteroinferior edge of the anteroinferior iliac spine). However, in Ext-R, there was no relationship between ROM and femoral antetorsion. Conclusions We demonstrated that lower femoral antetorsion substantially affects Flex ROM and Int-R due to bony impingement. For these patients, consideration must be given to retaining femoral anterior offset in THA.	[Shoji, Takeshi; Yamasaki, Takuma; Izumi, Soutarou; Hachisuka, Susumu; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima, Japan; [Yasunaga, Yuji] Hiroshima Prefectural Rehabil Ctr, Dept Orthopaed Surg, Minami Ku, Hiroshima 7348551, Japan	Shoji, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima, Japan.	readymade_jpn@yahoo.co.jp					Kessler O, 2008, J ORTHOP RES, V26, P443, DOI 10.1002/jor.20541; Dorr LD, 2009, J BONE JOINT SURG AM, V91A, P2598, DOI 10.2106/JBJS.H.01225; Garbuz DS, 2012, CLIN ORTHOP RELAT R, V470, P351, DOI 10.1007/s11999-011-2146-x; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; Incavo SJ, 2011, J ARTHROPLASTY, V26, P391, DOI 10.1016/j.arth.2010.02.001; Bozic KJ, 2012, J ARTHROPLASTY, V27, P37, DOI 10.1016/j.arth.2012.03.031; Widmer KH, 2004, J ORTHOPAED RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001; Caton J, 2011, INT ORTHOP, V35, P185, DOI 10.1007/s00264-010-1197-z; Ranawat CS, 2001, J ARTHROPLASTY, V16, P715, DOI 10.1054/arth.2001.24442; Dorr LD, 2009, CLIN ORTHOP RELAT R, V467, P119, DOI 10.1007/s11999-008-0598-4; Schileo E, 2008, J BIOMECH, V41, P356, DOI 10.1016/j.jbiomech.2007.09.009; Jolles BM, 2002, J ARTHROPLASTY, V17, P282, DOI 10.1054/arth.2002.30286; Rousseau MA, 2009, J ARTHROPLASTY, V24, P22, DOI 10.1016/j.arth.2007.12.015; D'Lima DD, 2000, J BONE JOINT SURG AM, V82A, P315; Bartz RL, 2000, J BONE JOINT SURG AM, V82A, P1300; Burroughs BR, 2005, J ARTHROPLASTY, V20, P11, DOI 10.1016/j.arth.2004.07.008; Caton JH, 2014, INT ORTHOP, V38, P1125, DOI 10.1007/s00264-014-2313-2; Dorr LD, 1998, CLIN ORTHOP RELAT R, P144; DORR LD, 1983, CLIN ORTHOP RELAT R, P151; Lachiewicz PF, 2013, CLIN ORTHOP RELAT R, V471, P439, DOI 10.1007/s11999-012-2379-3; Morrey BF, 1997, CLIN ORTHOP RELAT R, P179; Nevelos J, 2013, CLIN ORTHOP RELAT R, V471, P519, DOI 10.1007/s11999-012-2559-1; Shoji T, 2013, INT ORTHOP, V37, P1897, DOI 10.1007/s00264-013-1979-1; Suzuki Koji, 2002, J Orthop Sci, V7, P433, DOI 10.1007/s007760200075	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JAN	2015	39	1					7	12		10.1007/s00264-014-2452-5		6	Orthopedics	Orthopedics	AY7GX	WOS:000347730200002		
J	Oe, K; Iida, H; Ueda, N; Nakamura, T; Okamoto, N; Ueda, Y				Oe, Kenichi; Iida, Hirokazu; Ueda, Narumi; Nakamura, Tomohisa; Okamoto, Naofumi; Ueda, Yusuke			Pre-operative scoring system to determine the surgical strategy for periprosthetic hip infection	INTERNATIONAL ORTHOPAEDICS			English	Article						Infection; Total hip arthroplasty; One-stage revision; Two-stage revision; Scoring system	ONE-STAGE REVISION; DIRECT-EXCHANGE ARTHROPLASTY; DEEP INFECTION; JOINT INFECTIONS; FOLLOW-UP; REPLACEMENT; MANAGEMENT; OUTCOMES	Purpose The aim of this study was to evaluate the results of one- and two-stage revision total hip arthroplasties (THAs) and to determine a rational surgical treatment strategy for periprosthetic hip infections. Methods We constructed a 12-point preoperative scoring system to suggest either one- or two-stage revision THAs, based on a retrospective analysis of 55 operative procedures. Prosthesis survival was analysed using the Kaplan-Meier method, and the validity of the scoring system was evaluated using receiver-operating characteristic curves. Results At the end point of implant removal due to recurrent infection, the ten year survival rates were 94 and 87 % for one- and two-stage revision THAs, respectively. One-stage revision THA was recommended for patients scoring >9 points. The risk of recurrent infection in patients scoring 4 points was 83 %. The sensitivity and specificity of a cut-off value of 4 points, determined by the scoring system, were 83 and 100 %, respectively. Conclusions The novel pre-operative scoring system was useful for the management of periprosthetic hip infections.	[Oe, Kenichi; Iida, Hirokazu; Ueda, Narumi; Nakamura, Tomohisa; Okamoto, Naofumi; Ueda, Yusuke] Kansai Med Univ, Dept Orthopaed Surg, Hirakata, Osaka 5731010, Japan	Oe, K (reprint author), Kansai Med Univ, Dept Orthopaed Surg, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	oeken@hirakata.kmu.ac.jp					Langlais F, 2003, J BONE JOINT SURG BR, V85B, P637, DOI 10.1302/0301-620X.85B5.14413; Hanssen AD, 2000, CLIN ORTHOP RELAT R, P91; RAUT VV, 1994, J BONE JOINT SURG BR, V76B, P721; Jackson WO, 2000, CLIN ORTHOP RELAT R, P101; Oussedik SIS, 2010, J BONE JOINT SURG BR, V92B, P1222, DOI 10.1302/0301-620X.92B9.23663; Ure KJ, 1998, J BONE JOINT SURG AM, V80A, P961; McPherson EJ, 2002, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000030172.56585.c6; Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9; Klouche S, 2012, ORTHOP TRAUMATOL-SUR, V98, P144, DOI 10.1016/j.otsr.2011.08.018; Haddad FS, 1999, CLIN ORTHOP RELAT R, P144; BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342; Della Valle C, 2010, J AM ACAD ORTHOP SUR, V18, P760; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Giulieri SG, 2004, INFECTION, V32, P222, DOI 10.1007/s15010-004-4020-1; Callaghan JJ, 1999, CLIN ORTHOP RELAT R, P139; ELSON RA, 1993, ORTHOP CLIN N AM, V24, P761; GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576; GARVIN KL, 1994, CLIN ORTHOP RELAT R, P97; HOPE PG, 1989, J BONE JOINT SURG BR, V71, P851; Hsieh PH, 2005, J BONE JOINT SURG BR, V87B, P770, DOI 10.1302/0301-620X.87B6; Lange Jeppe, 2012, Clin Epidemiol, V4, P57, DOI 10.2147/CLEP.S29025; MILEY GB, 1982, CLIN ORTHOP RELAT R, P76; Parvizi Javad, 2012, J Bone Joint Surg Am, V94, pe104, DOI 10.2106/JBJS.K.01417; Rudelli S, 2008, J ARTHROPLASTY, V23, P1165, DOI [10.1016/j.arth.2007.08.010, 10.1016/.j.arth.2007.08.010]; SANZEN L, 1988, CLIN ORTHOP RELAT R, P165; WROBLEWSKI BM, 1986, CLIN ORTHOP RELAT R, P103	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JAN	2015	39	1					19	25		10.1007/s00264-014-2493-9		7	Orthopedics	Orthopedics	AY7GX	WOS:000347730200004		
J	Furihata, M; Iida, Y; Furihata, T; Ito, E				Furihata, Makoto; Iida, Yuuki; Furihata, Tadashi; Ito, Eisaku			A Giant Lymphatic Cyst of the Adrenal Gland: Report of a Rare Case and Review of the Literature	INTERNATIONAL SURGERY			English	Review						Giant adrenal cyst; Adrenal gland; Lymphatic cyst; Endothelial cyst	PSEUDOCYST; MANAGEMENT; PREGNANCY; MASSES	Lymphatic type of adrenal cysts is most common; however, this type of endothelial cyst is quite rare in excessively large adrenal cysts. A 37-year-old Japanese woman was admitted to our institution with distension of her left flank and the upper quadrant of her abdomen. Abdominal ultrasonography revealed a cystic lesion with a homogenous anechoic texture, and measuring 21 cm in diameter. Computed tomography and magnetic resonance imaging displayed a giant cystic lesion adjacent to the liver, pancreas, kidney, and spleen. The origin of the cyst was not identified. We were not able to make a preoperative diagnosis; therefore, the patient underwent resection of the mass by open laparotomy for therapeutic diagnosis. Intraoperatively, the mass was identified to be cystic and adhered to the left adrenal gland. It was filled with more than 2000 mL of serous brown-red fluid. The content of the cyst contained no atypical cells on cytological examination. The wall of the cyst was composed of a lining of a single layer of lymphatic vessel-derived cells, and the cyst was pathologically classified as a true cyst. No abdominal symptoms were observed and a postoperative radiological work-up showed no evidence of recurrence during a 6-year follow-up period. We describe a case of a patient with a giant lymphatic cyst of the adrenal gland. The preset data suggest that surgeons should decide treatment strategy for large adrenal cysts in consideration of hormonal function, degree of size, and possibility of malignancy.	[Furihata, Makoto; Iida, Yuuki] Mutual Aid Assoc Teachers & Off Sanraku Hosp, Dept Surg, Chiyoda Ku, Tokyo 1018326, Japan; [Furihata, Tadashi] Kyouwa Chuo Hosp, Dept Gen Surg, Ibaraki 3091195, Japan; [Ito, Eisaku] Tokyo Med & Dent Univ, Div Surg Pathol, Tokyo, Japan	Furihata, M (reprint author), Mutual Aid Assoc Teachers & Off Sanraku Hosp, Dept Surg, Chiyoda Ku, 2-5 Kandasurugadai, Tokyo 1018326, Japan.	ryoutamankeitaman@yahoo.co.jp					ABESHOUSE GA, 1959, J UROLOGY, V81, P711; Parnaby CN, 2008, SURG ENDOSC, V22, P617, DOI 10.1007/s00464-007-9709-7; Karaman K, 2011, SURG TODAY, V41, P153, DOI 10.1007/s00595-009-4207-2; Gupta V, 2012, J GASTROEN HEPATOL, V27, P183, DOI 10.1111/j.1440-1746.2011.06955.x; Neri LM, 1999, AM SURGEON, V65, P151; Erickson LA, 2004, CANCER, V101, P1537, DOI 10.1002/cncr.20555; ARMITAGE HV, 1959, ARCH SURG-CHICAGO, V79, P148; Balci O, 2008, J OBSTET GYNAECOL RE, V34, P399, DOI 10.1111/j.1447-0756.2008.00729.x; Bettaïeb I, 2007, Pathologica, V99, P19; Cantisani V, 2013, EUR REV MED PHARMACO, V17, P2546; Chatterjee Chandan, 2013, South Asian J Cancer, V2, P141, DOI 10.4103/2278-330X.114123; DAVENPORT M, 1988, POSTGRAD MED J, V64, P71; Doran AHG, 1908, BRIT MED J, V1908, P1558; El-Hefnawy AS, 2009, BJU INT, V104, P847, DOI 10.1111/j.1464-410X.2009.08537.x; ELLIOTT GB, 1964, ANN SURG, V159, P275, DOI 10.1097/00000658-196402000-00013; ELLIS FH, 1952, ANN SURG, V136, P217; ESQUIVEL E, 1965, J UROLOGY, V94, P635; FOSTER DG, 1966, ARCH SURG-CHICAGO, V92, P131; Friedrich-Rust M, 2008, AM J ROENTGENOL, V191, P1852, DOI 10.2214/AJR.07.3565; INCZE JS, 1979, AM J PATHOL, V95, P423; Karayiannakis Anastasios J, 2002, Urology, V59, P946, DOI 10.1016/S0090-4295(02)01617-5; Kasperlik-Zaluska AA, 2008, LANGENBECK ARCH SURG, V393, P121, DOI 10.1007/s00423-007-0238-6; Koksoy FN, 2001, SURG LAPARO ENDO PER, V11, P379, DOI 10.1097/00019509-200112000-00009; Masumori N, 1998, UROLOGY, V52, P572, DOI 10.1016/S0090-4295(98)00277-5; SELL J, 1994, COMPUT MED IMAG GRAP, V18, P469, DOI 10.1016/0895-6111(94)90086-8; Sivasankar A, 2006, THESCIENTIFICWORLDJO, V6, P2381, DOI 10.1100/tsw.2006.369; STEWART JOR, 1962, POSTGRAD MED J, V38, P709; Stimac G, 2008, MED PRIN PRACT, V17, P419, DOI 10.1159/000141509; Tagge DU, 1997, AM SURGEON, V63, P744; Tait DL, 1997, AM J PERINAT, V14, P461, DOI 10.1055/s-2007-994180; THOMPSON AG, 1966, CAN MED ASSOC J, V94, P90; Trauffer PML, 1996, J REPROD MED, V41, P195; Ujam Atheer B, 2011, Int J Surg Case Rep, V2, P306, DOI 10.1016/j.ijscr.2011.10.002; URETZKY G, 1978, EUR UROL, V4, P97	34	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					2	8		10.9738/INTSURG-D-14-00125.1		7	Surgery	Surgery	AZ3LJ	WOS:000348128600002		
J	Tokuoka, M; Ide, Y; Takeda, M; Hashimoto, Y; Matsuyama, J; Yokoyama, S; Morimoto, T; Fukushima, Y; Nomura, T; Kodama, K; Sasaki, Y				Tokuoka, Masayoshi; Ide, Yoshihito; Takeda, Mitsunobu; Hashimoto, Yasuji; Matsuyama, Jin; Yokoyama, Shigekazu; Morimoto, Takashi; Fukushima, Yukio; Nomura, Takashi; Kodama, Ken; Sasaki, Yo			Single-Incision Plus One-Port Laparoscopic Abdominoperineal Resection With Bilateral Pelvic Lymph Node Dissection for Advanced Rectal Cancer: A Case Report	INTERNATIONAL SURGERY			English	Article						Single-incision laparoscopic surgery; Abdominoperineal resection; Rectal cancer; Reduced port surgery	RIGHT HEMICOLECTOMY; COLON-CANCER; COLECTOMY; SURGERY	With regard to laparoscopic and robotic abdominoperineal resection (APR) for primary rectal malignancies, limited data have been published in the literature. Single-incision laparoscopic surgery (SLS) has been successfully introduced for treating colorectal cancer. Here we describe our experience of APR with SLS plus one port (SLS + 1) for treating advanced rectal cancer. A 65-year-old man underwent the procedure, which involved a 35-mm incision in the left side of the umbilicus for the insertion of a single multichannel port as well as the insertion of a 5-mm port into the right lower quadrant. The sigmoid colon and rectum were mobilized from the pelvic floor using a medial and lateral approach. After the rectum with the mesorectum was completely mobilized according to the total mesorectal excision, the sigmoid colon was intracorporeally transected. The specimen was removed through the perineal wound. Terminal colostomy was fashioned at the left lower trocar site. Lateral pelvic lymph node dissection was bilaterally performed. There were no perioperative complications. The total operating time was 592 minutes, and the estimated blood loss was 180 mL. To our knowledge, this is the first reported case of SLS + 1 APR with lateral pelvic lymph node dissection for treating rectal cancer. We conclude that SLS + 1 APR is a technically promising alternative method for treating selected patients with advanced rectal cancer.	[Tokuoka, Masayoshi; Ide, Yoshihito; Takeda, Mitsunobu; Hashimoto, Yasuji; Matsuyama, Jin; Yokoyama, Shigekazu; Morimoto, Takashi; Fukushima, Yukio; Nomura, Takashi; Kodama, Ken; Sasaki, Yo] Yao Municipal Hosp, Dept Surg, Osaka, Japan	Tokuoka, M (reprint author), 1-3-1 Ryuge, Yao, Osaka 5810069, Japan.	mtokuoka1017@yahoo.co.jp					Champagne BJ, 2012, ANN SURG, V255, P66, DOI 10.1097/SLA.0b013e3182378442; Geisler DP, 2010, COLORECTAL DIS, V12, P941, DOI 10.1111/j.1463-1318.2009.02115.x; Poon JTC, 2012, SURG ENDOSC, V26, P2729, DOI 10.1007/s00464-012-2262-z; Chambers WM, 2011, COLORECTAL DIS, V13, P393, DOI 10.1111/j.1463-1318.2009.02158.x; Hirano Y, 2012, SCAND J SURG, V101, P283; Choi SI, 2010, WORLD J GASTROENTERO, V16, P275, DOI 10.3748/wjg.v16.i2.275; Yasuda K, 2004, BRIT J SURG, V91, P1061, DOI 10.1002/bjs.4615; Champagne BJ, 2011, DIS COLON RECTUM, V54, P183, DOI 10.1007/DCR.0b013e3181fd48af; Chen WTL, 2011, SURG ENDOSC, V25, P1887, DOI 10.1007/s00464-010-1481-4; Ramos-Valadez DI, 2010, SURG ENDOSC, V24, P2613, DOI 10.1007/s00464-010-1017-y; Merchant AM, 2009, DIS COLON RECTUM, V52, P1021, DOI 10.1007/DCR.0b013e3181a4fabe; Bulut O, 2010, INT J COLORECTAL DIS, V25, P1261, DOI 10.1007/s00384-010-0947-0; Cahill RA, 2010, DIS COLON RECTUM, V53, P1143, DOI 10.1007/DCR.0b013e3181dd062f; Fujita S, 2003, BRIT J SURG, V90, P1580, DOI 10.1002/bjs.4350; Hamzaoglu I, 2011, ARCH SURG-CHICAGO, V146, P75, DOI 10.1001/archsurg.2010.300; Inomata M, 2014, SURGERY CURR RES, V4, P175; Japanese Society for Cancer of the Colon and Rectum, 1998, GEN RUL CLIN PATH ST; Moriya Y, 1997, WORLD J SURG, V21, P728; Nagpal A, 2011, INT J COLORECTAL DIS, V26, P525, DOI 10.1007/s00384-010-0989-3; Ramos-Valadez DI, 2012, SURG ENDOSC, V26, P96, DOI 10.1007/s00464-011-1833-8; Tan K K, 2013, Med J Malaysia, V68, P348; Uematsu D, 2010, DIS COLON RECTUM, V53, P496, DOI 10.1007/DCR.0b013e3181ce677a; Ueno H, 2001, ANN SURG, V234, P190, DOI 10.1097/00000658-200108000-00008	23	2	2	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					15	20		10.9738/INTSURG-D-14-00232.1		6	Surgery	Surgery	AZ3LJ	WOS:000348128600004		
J	Ryu, Y; Akagi, Y; Yagi, M; Sasatomi, T; Kinugasa, T; Yamaguchi, K; Oka, Y; Fukahori, S; Shiratsuchi, I; Yoshida, T; Gotanda, Y; Tanaka, N; Ohchi, T; Romeo, K; Shirouzu, K				Ryu, Yasuhiko; Akagi, Yoshito; Yagi, Minoru; Sasatomi, Teruo; Kinugasa, Tetsushi; Yamaguchi, Keizo; Oka, Yousuke; Fukahori, Suguru; Shiratsuchi, Ichitaro; Yoshida, Takefumi; Gotanda, Yukito; Tanaka, Natsuki; Ohchi, Takafumi; Romeo, Kansakar; Shirouzu, Kazuo			Fecoflowmetric Analysis of Anorectal Motor Function in Postoperative Anal-Preserving Surgery Patients With Low Rectal Cancer Comparison With the Wexner Score and Anorectal Manometry	INTERNATIONAL SURGERY			English	Article						Anorectal manometry; Anal-preserving surgery; Fecoflowmetry; Incontinence; Rectal cancer	LOW ANTERIOR RESECTION; INTERSPHINCTERIC RESECTION; COLOANAL ANASTOMOSIS; FECAL INCONTINENCE; SPHINCTER; CARCINOMA	The aim of this study was to elucidate whether fecoflowmetry (FFM) could evaluate more detailed evacuative function than anorectal manometry by comparing between FFM or anorectal manometric findings and the clinical questionnaires and the types of surgical procedure in the patients who received anal-preserving surgery. Fifty-three patients who underwent anal-preserving surgery for low rectal cancer were enrolled. The relationships between FFM or the manometric findings and the clinical questionnaires and the types of procedure of anal-preserving surgery were evaluated. There were significant differences between FFM markers and the clinical questionnaire and the types of the surgical procedure, whereas no significant relationship was observed between the manometric findings and the clinical questionnaire and the types of the surgical procedure. FFM might be feasible and useful for the objective assessment of evacuative function and may be superior to manometry for patients undergoing anal-preserving surgery.	[Ryu, Yasuhiko; Akagi, Yoshito; Sasatomi, Teruo; Kinugasa, Tetsushi; Yamaguchi, Keizo; Oka, Yousuke; Shiratsuchi, Ichitaro; Yoshida, Takefumi; Gotanda, Yukito; Tanaka, Natsuki; Ohchi, Takafumi; Romeo, Kansakar; Shirouzu, Kazuo] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 8300011, Japan; [Yagi, Minoru; Fukahori, Suguru] Kurume Univ, Sch Med, Dept Pediat Surg, Kurume, Fukuoka 8300011, Japan	Ryu, Y (reprint author), Kurume Univ, Sch Med, Dept Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	ryuu_yasuhiko@kurume-u.ac.jp					Koda K, 2005, DIS COLON RECTUM, V48, P210, DOI 10.1007/s10350-004-0814-6; Bretagnol F, 2004, DIS COLON RECTUM, V47, P832, DOI 10.1007/s10350-004-0523-1; PARKS AG, 1982, BRIT J SURG, V69, P301, DOI 10.1002/bjs.1800690602; JEHLE EC, 1995, AM J SURG, V169, P147, DOI 10.1016/S0002-9610(99)80124-X; Ito M, 2009, DIS COLON RECTUM, V52, P64, DOI 10.1007/DCR.0b013e31819739a0; SCHIESSEL R, 1994, BRIT J SURG, V81, P1376, DOI 10.1002/bjs.1800810944; Jehle EC, 1995, AM J SURG, V169, P52; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Kayaba H, 2002, J PEDIATR SURG, V37, P623, DOI 10.1053/jpsu.2002.31622; Kobayashi Y, 2011, INT SURG, V96, P201; Kobayashi Yasuo, 2009, Int J Colorectal Dis, V24, P1321, DOI 10.1007/s00384-009-0763-6; Lindgren R, 2011, DIS COLON RECTUM, V54, P747, DOI 10.1007/DCR.0b013e3182138e79; MCDONALD PJ, 1983, BRIT J SURG, V70, P727, DOI 10.1002/bjs.1800701211; Morihiro M, 2008, INT J COLORECTAL DIS, V23, P883, DOI 10.1007/s00384-008-0485-1; PATY PB, 1994, ANN SURG, V219, P365, DOI 10.1097/00000658-199404000-00007; Rullier E, 1999, DIS COLON RECTUM, V42, P1168, DOI 10.1007/BF02238569; Saito N, 2004, DIS COLON RECTUM, V47, P459, DOI 10.1007/s10350-003-0088-4; SHAFIK A, 1991, J CLIN GASTROENTEROL, V13, P259, DOI 10.1097/00004836-199106000-00004; SHAFIK A, 1992, EUR SURG RES, V24, P61, DOI 10.1159/000129189; Shirouzu K, 2003, Tech Coloproctol, V7, P203, DOI 10.1007/s10151-003-0036-2; Takagi A, 2010, INT SURG, V95, P350; WILLIAMS NS, 1980, BRIT J SURG, V67, P203, DOI 10.1002/bjs.1800670313; Yagi M, 2005, J PEDIATR SURG, V40, P551, DOI 10.1016/j.jpedsurg.2004.11.025; Yamada K, 2009, DIS COLON RECTUM, V52, P1065, DOI 10.1007/DCR.0b013e31819f5fa2	24	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					29	37		10.9738/INTSURG-D-13-00142.1		9	Surgery	Surgery	AZ3LJ	WOS:000348128600006		
J	Komine-Aizawa, S; Masuda, H; Mazaki, T; Shiono, M; Hayakawa, S; Takayama, T				Komine-Aizawa, Shihoko; Masuda, Hideki; Mazaki, Takerou; Shiono, Motomi; Hayakawa, Satoshi; Takayama, Tadatoshi			Plasma Osteopontin Predicts Inflammatory Bowel Disease Activities	INTERNATIONAL SURGERY			English	Article						Inflammatory bowel disease; Osteopontin; Ulcerative colitis; Crohn's disease; Cytokine	CROHNS-DISEASE; ULCERATIVE-COLITIS; EXPRESSION; JOINTS; ETA-1; GENE; MICE	A glycoprotein osteopontin (OPN) is involved in inflammatory diseases, but its roles in inflammatory bowel disease (IBD) are controversial. To analyze the involvement of the systemic immune response, we simultaneously examined plasma OPN levels and 17 cytokines. This study included 24 ulcerative colitis (UC) patients, 17 Crohn's disease (CD) patients, and 23 normal controls. Clinical parameters were also examined. The plasma OPN levels of the UC and CD patients were significantly higher than those of the normal controls and correlated significantly with their clinical activity indices. In the UC patients, significant relationships were observed between the levels of plasma OPN and multiple cytokines, including interleukin (IL)-1 beta, IL-4, IL-5, IL-6, IL-7, IL-13, interferon-gamma, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor. In the CD patients, the correlation was not significant except for IL-8. Our findings reflect different inflammatory states of the colon and rectum in both diseases.	[Komine-Aizawa, Shihoko; Hayakawa, Satoshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Masuda, Hideki; Mazaki, Takerou; Shiono, Motomi; Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Surg, Tokyo 1738610, Japan	Masuda, H (reprint author), Nihon Univ, Sch Med, Dept Surg, Itabashi Ku, 30-1 Oyaguchikamicho, Tokyo 1738610, Japan.	masuda.hideki@nihon-u.ac.jp					Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Jansson M, 2002, J IMMUNOL, V168, P2096; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; TALSTAD I, 1976, SCAND J GASTROENTERO, V11, P403; Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Masuda H, 2005, J GASTROENTEROL, V40, P409, DOI 10.1007/s00535-005-1567-2; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; DEDOMBAL FT, 1987, GUT, V28, P474, DOI 10.1136/gut.28.4.474; Denhardt D T, 1998, J Cell Biochem Suppl, V30-31, P92; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; Hanai H, 2006, WORLD J GASTROENTERO, V12, P3393; MAHMUD N, 1995, EUR J GASTROEN HEPAT, V7, P215; Masuda H, 2003, J SURG RES, V111, P85, DOI 10.1016/S0022-4804(03)00046-5; PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225	21	1	1	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					38	43		10.9738/INTSURG-D-13-00160.1		6	Surgery	Surgery	AZ3LJ	WOS:000348128600007		
J	Ozawa, T; Yamaguchi, H; Kiyomatsu, T; Saito, S; Ishihara, S; Sunami, E; Kitayama, J; Watanabe, T				Ozawa, Tsuyoshi; Yamaguchi, Hironori; Kiyomatsu, Tomomichi; Saito, Shinsuke; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			A Case Report of Idiopathic Systemic Capillary Leak Syndrome That Occurred During the Postoperative Period of Abdominoperineal Resection for Colorectal Cancer	INTERNATIONAL SURGERY			English	Article						Idiopathic systemic capillary leak syndrome (ISCLS); Surgery; Abdominoperineal resection	DISEASE	A 57-year-old woman without any past medical history underwent abdominoperineal resection for rectal cancer in our department. On postoperative day 15, the patient complained of sudden abdominal pain, and high fever was noted in addition to the appearance of erythema around the stoma. The diagnosis of phlegmon was made, and antibiotic infusion was started. However, a few days later, the patient developed hypovolemic shock with hypoalbuminemia and hemoconcentration. Fasciotomy was performed to exclude the necrotizing fasciitis, though all cultures were negative. Upon exclusion of the differential diagnoses, idiopathic systemic capillary leak syndrome (ISCLS) was diagnosed. She was successfully treated with massive fluid infusion under ventilation and continuous hemodiafiltration. Here, we report the first case of ISCLS that occurred during the postoperative period of colorectal surgery.	[Ozawa, Tsuyoshi; Yamaguchi, Hironori; Kiyomatsu, Tomomichi; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo 1138655, Japan; [Saito, Shinsuke] Doaikinen Hosp, Dept Surg, Tokyo, Japan	Ozawa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tsu443@hotmail.com					Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6; Lesterhuis WJ, 2009, AM J MED, V122, pE5, DOI 10.1016/j.amjmed.2009.01.020; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; Baron D, 2006, CLIN ONCOL-UK, V18, P90, DOI 10.1016/j.clon.2005.09.003; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; Dowden AM, 2009, J ALLERGY CLIN IMMUN, V124, P1111, DOI 10.1016/j.jaci.2009.06.043; DRODER RM, 1992, AM J MED, V92, P523, DOI 10.1016/0002-9343(92)90749-2; Gousseff M, 2011, ANN INTERN MED, V154, DOI [10.7326/0003-4819-154-7-201104050-00004, 10.1059/0003-4819-154-7-201104050-00004]; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; LISSONI P, 1990, International Journal of Biological Markers, V5, P195; Nakagawa N, 2011, INTERNAL MED, V50, P597, DOI 10.2169/internalmedicine.50.4857; Rechner Ian, 2003, Hematol J, V4, P54, DOI 10.1038/sj.thj.6200211; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735	14	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					58	62		10.9738/INTSURG-D-13-00206.1		5	Surgery	Surgery	AZ3LJ	WOS:000348128600009		
J	Matsuhashi, N; Takahashi, T; Ichikawa, K; Yawata, K; Tanahashi, T; Imai, H; Sasaki, Y; Tanaka, Y; Okumura, N; Yamaguchi, K; Osada, S; Yoshida, K				Matsuhashi, Nobuhisa; Takahashi, Takao; Ichikawa, Kengo; Yawata, Kazunori; Tanahashi, Toshiyuki; Imai, Hisashi; Sasaki, Yoshiyuki; Tanaka, Yoshihiro; Okumura, Naoki; Yamaguchi, Kazuya; Osada, Shinji; Yoshida, Kazuhiro			A Single Case of Single-Port Access Laparoscopic Appendectomy During the Puerperium	INTERNATIONAL SURGERY			English	Article						PLA (single-port laparoscopic appendectomy); Puerperium	SURGERY SILS; APPENDICITIS; CHOLECYSTECTOMY	Laparoscopic appendectomy is now widely practiced for the treatment of acute appendicitis. As result of increased demand for minimally invasive surgery, single-incision access was introduced and is being performed in various abdominal surgeries. Conventional laparoscopic appendectomy (LA) is gradually being performed in pregnant women. A 33-year-old woman was referred to our department at 39 weeks and 1 day of gestation due to abdominal pain. She was aware of her gastroepiploic pain even after the delivery. Though it was past 2 days, she was not recovering from right lower abdominal pain, so she was transferred to the Department of Gynecology at our hospital on the same day. Although an antibiotic was administered, the right abdominal pain did not improve, and she was referred to our department from the Department of Gynecology. We performed single-port LA (SP-LA). The total operation time was 63 minutes, and the estimated blood loss was 0 mL. She was discharged with no complications on postoperative day 7. We report our initial experience with single-port LA (SP-LA) using the glove technique for treatment of acute appendicitis in a postpartum woman. SP-LA using the glove technique was performed successfully during the puerperium without prolongation of operation time. This approach is less invasive, offers a much better cosmetic result than with conventional methods, and can be performed safely and at low cost.	[Matsuhashi, Nobuhisa; Takahashi, Takao; Ichikawa, Kengo; Yawata, Kazunori; Tanahashi, Toshiyuki; Imai, Hisashi; Sasaki, Yoshiyuki; Tanaka, Yoshihiro; Okumura, Naoki; Yamaguchi, Kazuya; Osada, Shinji; Yoshida, Kazuhiro] Gifu Univ, Sch Med, Gifu 5011194, Japan	Yoshida, K (reprint author), Gifu Univ, Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	kyoshida@gifu-u.ac.jp					Andersson REB, 2001, INT J EPIDEMIOL, V30, P1281, DOI 10.1093/ije/30.6.1281; Chow A, 2010, SURG ENDOSC, V24, P2567, DOI 10.1007/s00464-010-1004-3; Chow A, 2009, SURG INNOV, V16, P211, DOI 10.1177/1553350609344413; Merchant AM, 2009, J GASTROINTEST SURG, V13, P159, DOI 10.1007/s11605-008-0737-y; Yau KK, 2007, J AM COLL SURGEONS, V205, P60, DOI 10.1016/j.jamcollsurg.2007.03.017; Buckley FP, 2014, SURG ENDOSC, V28, P626, DOI 10.1007/s00464-013-3219-6; Carter JT, 2014, J AM COLL SURGEONS, V218, P950, DOI 10.1016/j.jamcollsurg.2013.12.052; Leggett PL, 2000, SURG ENDOSC-ULTRAS, V14, P32, DOI 10.1007/s004649900006; Livraghi L, 2012, MINIM INVASIVE SURG, V2012, DOI 10.1155/2012/415430; Pearl JP, 2008, J GASTROINTEST SURG, V12, P1293, DOI 10.1007/s11605-007-0424-4	10	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					101	104		10.9738/INTSURG-D-14-00123.1		4	Surgery	Surgery	AZ3LJ	WOS:000348128600015		
J	Suzumura, K; Iimuro, Y; Hirano, T; Asano, Y; Kuroda, N; Okada, T; Tanaka, S; Nakasho, K; Fujimoto, J				Suzumura, Kazuhiro; Iimuro, Yuji; Hirano, Tadamichi; Asano, Yasukane; Kuroda, Nobukazu; Okada, Toshihiro; Tanaka, Shogo; Nakasho, Keiji; Fujimoto, Jiro			Granulocyte Colony-Stimulating Factor-Producing Cholangiocellular Carcinoma	INTERNATIONAL SURGERY			English	Article						Granulocyte colony-stimulating factor; Cholangiocellular carcinoma; FDG-PET; Immunohistochemistry; Leukocytosis	AUTOCRINE GROWTH; CANCER	A 61-year-old female was admitted to our hospital with epigastric pain and fever. The laboratory data showed severe inflammatory reactions. Computed tomography revealed an irregular tumor in the left hepatic lobe and swelling of lymph nodes. 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) showed high uptake by the tumor, with diffuse uptake in the spine. Based on the elevated leukocyte count and FDG-PET findings, the patient was diagnosed with a granulocyte colony-stimulating factor (G-CSF)-producing tumor (G-CSF, 213 pg/mL). We performed left trisegmentectomy of the liver, bile duct resection, and lymph node dissection. Histologically, the tumor was a poorly differentiated adenocarcinoma with some lymph nodes metastasis. Immunohistochemical staining of the tumor cells was positive for G-CSF. Therefore, the tumor was diagnosed as G-CSF-producing cholangiocellular carcinoma. The inflammatory reactions and serum G-CSF level transiently improved immediately after surgery. However, 1 month later, the leukocyte count and serum G-CSF level increased again, and recurrence was observed in the remnant liver. The patient died 3 months after the operation. G-CSF-producing cholangiocellular carcinoma is rare. This tumor progresses rapidly, and surgical treatment for advanced condition should be carefully selected.	[Suzumura, Kazuhiro; Iimuro, Yuji; Hirano, Tadamichi; Asano, Yasukane; Kuroda, Nobukazu; Okada, Toshihiro; Tanaka, Shogo; Fujimoto, Jiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Nakasho, Keiji] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Suzumura, K (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	ssuzumu@hyo-med.ac.jp					Aizawa M, 1997, INTERNAL MED, V36, P232, DOI 10.2169/internalmedicine.36.232; Sugawara Y, 1998, J CLIN ONCOL, V16, P173; ASANO S, 1977, BLOOD, V49, P845; Asakawa H, 1999, ANTICANCER RES, V19, P761; Ikeda T, 2005, SURG TODAY, V35, P590, DOI 10.1007/s00595-004-2981-4; Kakinoki K, 2000, Nihon Shokakibyo Gakkai Zasshi, V97, P1165; Masuda J, 2000, Nihon Shokakibyo Gakkai Zasshi, V97, P347; Mueller MM, 1999, AM J PATHOL, V155, P1557, DOI 10.1016/S0002-9440(10)65472-7; Sohda Tetsuro, 2006, Int J Clin Oncol, V11, P246, DOI 10.1007/s10147-006-0560-y; TACHIBANA M, 1995, CANCER RES, V55, P3438; Tamai O, 1995, JPN J GASTROENTEROL, V28, P1100	11	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					123	127		10.9738/INTSURG-D-13-00183.1		5	Surgery	Surgery	AZ3LJ	WOS:000348128600020		
J	Nishikawa, G; Minamiguchi, S; Hata, H; Ogiso, S; Yamaguchi, T; Otani, T; Ikai, I				Nishikawa, Gen; Minamiguchi, Sachiko; Hata, Hiroaki; Ogiso, Satoshi; Yamaguchi, Takashi; Otani, Tethushi; Ikai, Iwao			Dedifferentiated Liposarcoma Involving the Spleen and Splenic Hilum: A Report of a Case With a Rare Growth Pattern	INTERNATIONAL SURGERY			English	Article						Dedifferentiated liposarcoma; Spleen; Retroperitoneal tumor; Chondroosseous differentiation	CLINICOPATHOLOGICAL ANALYSIS; NEOPLASMS; MASSES	We present a rare case of dedifferentiated liposarcoma confined to the spleen and splenic hilum. An 81-year-old man was referred to our hospital with a large asymptomatic splenic tumor. The patient underwent splenectomy, and the adipose tissue surrounding the splenic hilum was also resected. Microscopically, the tumor mainly consisted of high-grade spindle cells similar to those seen in undifferentiated pleomorphic liposarcoma. In the splenic hilum, scattered atypical cells were detected in the sclerosing component and adipose tissue. Immunohistochemically, both the spindle cells in the spleen and the atypical cells in the splenic hilum were positive for MDM2 and CDK4. The histopathologic diagnosis was dedifferentiated liposarcoma derived from an atypical lipomatous tumor/well-differentiated liposarcoma of the adipose tissue in the splenic hilum with extension into the spleen. Dedifferentiated liposarcoma in the spleen and splenic hilum should be considered as a differential diagnosis of splenic tumors.	[Nishikawa, Gen; Minamiguchi, Sachiko; Hata, Hiroaki; Ogiso, Satoshi; Yamaguchi, Takashi; Otani, Tethushi; Ikai, Iwao] Natl Hosp Org, Kyoto Med Ctr, Div Surg, Kyoto, Japan	Nishikawa, G (reprint author), Natl Canc Ctr, Dept Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	gennishikawa@msn.com					Comperat E, 2007, ARCH PATHOL LAB MED, V131, P965; Shanbhogue AK, 2012, RADIOGRAPHICS, V32, P795, DOI [10.1148/rg.323115020, 10.1148/rg.23115020]; O'Reilly RA, 1998, WESTERN J MED, V169, P88; Szklaruk J, 2003, RADIOGRAPHICS, V23, P403, DOI 10.1148/rg.232025089; Binh MBN, 2005, AM J SURG PATHOL, V29, P1340, DOI 10.1097/01.pas.0000170343.09562.39; MCCORMICK D, 1994, AM J SURG PATHOL, V18, P1213, DOI 10.1097/00000478-199412000-00004; EVANS HL, 1979, AM J SURG PATHOL, V3, P507, DOI 10.1097/00000478-197912000-00004; Coindre JM, 2010, VIRCHOWS ARCH, V456, P167, DOI 10.1007/s00428-009-0815-x; Abbott RM, 2004, RADIOGRAPHICS, V24, P1137, DOI 10.1148/rg.244045006; Kraus MD, 2001, CANCER, V91, P2001, DOI 10.1002/1097-0142(20010601)91:11<2001::AID-CNCR1225>3.0.CO;2-3; Henricks WH, 1997, AM J SURG PATHOL, V21, P271, DOI 10.1097/00000478-199703000-00002; Stoeckle E, 2001, CANCER, V92, P359, DOI 10.1002/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y; Dei Tos AP, 2013, WHO CLASSIFICATION T, P30; EASLER RE, 1969, ARCH PATHOL, V88, P557; Nomura R, 2013, INT SURG, V98, P219, DOI 10.9738/INTSURG-D-13-00076.1	15	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					128	132		10.9738/INTSURG-D-13-00203.1		5	Surgery	Surgery	AZ3LJ	WOS:000348128600021		
J	Yajima, H; Omura, N; Takahashi, N; Yoshida, K; Yanaga, K				Yajima, Hiroshi; Omura, Noburo; Takahashi, Naoto; Yoshida, Kazuhiko; Yanaga, Katsuhiko			Additional Gastrectomy After Endoscopic Mucosal Resection for Early Gastric Cancer	INTERNATIONAL SURGERY			English	Article						Gastric cancer; Endoscopic mucosal resection; Surgical treatment; Residual cancer; Lymph node metastasis		The aim of this study was to examine the clinicopathological characteristics of cases undergoing additional gastrectomy after endoscopic mucosal resection (EMR) for early gastric cancer (EGC) and the appropriate strategy for treating those after incomplete EMR. We studied 16 patients who underwent additional gastrectomy after EMR for EGC. The reasons for additional gastrectomy were positive horizontal margin (8 cases), indeterminate horizontal margin (2 cases), positive vertical margin (4 cases), submucosal invasion (7 cases), lymphatic invasion (4 cases), venous invasion (1 case), and local recurrence (2 cases, including overlapped cases). Residual cancer was found in 6 of the 13 cases (46%), while no lymph node metastasis was found in any case; there were cases in which local resection was possible depending on tumor location and cases in which additional gastrectomy was performed due to suspected residual cancer but the specimens were free of cancer; followup without intervention appears to be feasible in some of these cases. When performing additional gastrectomy after EMR, themost appropriate method should be chosen so as not to worsen the quality of life of the patient while taking radical cure into consideration.	[Yajima, Hiroshi; Yoshida, Kazuhiko] Jikei Univ, Katsushika Med Ctr Hosp, Sch Med, Dept Surg, Tokyo, Japan; [Yajima, Hiroshi; Takahashi, Naoto] Jikei Univ, Kashiwa Hosp, Sch Med, Dept Surg, Chiba, Japan; [Omura, Noburo; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Yajima, H (reprint author), Jikei Univ, Katsushika Med Ctr, Sch Med, Dept Surg, Tokyo, Japan.	h-yajima@u01.gate01.com					Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Ryu KW, 2007, ANN SURG ONCOL, V14, P3428, DOI 10.1245/s10434-007-9536-z; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Chung YS, 2007, SURG TODAY, V37, P114, DOI 10.1007/s00595-006-3328-0; Etoh T, 2006, J CLIN GASTROENTEROL, V40, P801, DOI 10.1097/01.mcg.0000225608.63975.26; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kondo H, 2001, Ann Ital Chir, V72, P27; Korenaga D, 1998, BRIT J SURG, V85, P1563; Nagano Hideki, 2005, Gastric Cancer, V8, P149, DOI 10.1007/s10120-005-0328-5; Ohshiba Saburo, 1994, Stomach and Intestine, V29, P1162; Shiraishi N, 1999, DIG ENDOSC, V11, P132, DOI 10.1111/j.1443-1661.1999.tb00210.x; Tadokoro Y, 1992, PROG DIG ENDOSC, V41, P119; Tajiri H, 2001, CANCER DETECT PREV, V25, P166; TAKEKOSHI T, 1994, ENDOSCOPY, V26, P352, DOI 10.1055/s-2007-1008990; Tani M, 2001, Gastric Cancer, V4, P122, DOI 10.1007/PL00011734; Yoshii T, 1971, STOMACH INTESTINE, V6, P1568	18	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					169	172		10.9738/INTSURG-D-14-00144.1		4	Surgery	Surgery	AZ3LJ	WOS:000348128600027		
J	Muroi, H; Nakajima, M; Satomura, H; Takahashi, M; Domeki, Y; Murakami, M; Nakamura, T; Takada, A; Kato, H				Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Domeki, Yasushi; Murakami, Masao; Nakamura, Tatsuya; Takada, Akinori; Kato, Hiroyuki			Effectiveness of Proton Beam Therapy on Liver Metastases of Esophageal Cancer: Report of a Case	INTERNATIONAL SURGERY			English	Article						proton beam therapy; esophageal cancer; liver metastasis	HEPATOCELLULAR-CARCINOMA	A 53-year-old man with multiple liver metastasis of esophageal cancer underwent four courses of chemotherapy. After four courses of chemotherapy, positron emission tomography showed progressive disease. Because it was difficult to control the cancer only by chemotherapy, we performed proton beam therapy (PBT) combined with chemotherapy. The irradiated parts were the primary tumor, liver metastases (S2/S4/S6), and mediastinal lymph nodes. The primary tumor including the mediastinal lymph nodes and the S2/S4/S6 metastases received proton beam irradiation at a total dose of 68.2 Gy in 31 fractions and 66.0 Gy in 30 fractions, respectively, according to tumor location. This resulted in a complete response as shown by positron emission tomography. In our experience, PBT exerted a curative effect on liver metastases of esophageal cancer. It is thought that PBT may be effective in the treatment of esophageal cancer. This is the first report about PBT for liver metastases of esophageal cancer.	[Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Murakami, Masao; Kato, Hiroyuki] Dept Surg 1, Cambridge, MA USA; [Muroi, Hiroto; Nakajima, Masanobu; Satomura, Hitoshi; Takahashi, Masakazu; Domeki, Yasushi; Kato, Hiroyuki] Dept Radiol, Cambridge, MA USA; [Murakami, Masao] Dokkyo Med Univ, Mibu, Tochigi 3210293, Japan; [Nakamura, Tatsuya; Takada, Akinori] Southern Tohoku Proton Therapy Ctr, Koriyama, Fukushima 9638563, Japan	Muroi, H (reprint author), Dokkyo Med Univ, Dept Surg 1, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	muroi-h@dokkyomed.ac.jp					Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Oshiro Y, 2012, J THORAC ONCOL, V7, P370, DOI 10.1097/JTO.0b013e31823c485f; Kawashima M, 2005, J CLIN ONCOL, V23, P1839, DOI 10.1200/JCO.2005.00.620; Chiba T, 2005, CLIN CANCER RES, V11, P3799, DOI 10.1158/1078-0432.CCR-04-1350; Bush DA, 2011, CANCER-AM CANCER SOC, V117, P3053, DOI 10.1002/cncr.25809; Hata M, 2006, STRAHLENTHER ONKOL, V182, P713, DOI 10.1007/s00066-006-1564-2; Hata M, 2007, INT J RADIAT ONCOL, V69, P805, DOI 10.1016/j.ijrobp.2007.04.016; Ikeda Y, 2003, HEPATO-GASTROENTEROL, V50, P532; Mizumoto M, 2012, INT J RADIAT ONCOL, V82, pE529, DOI 10.1016/j.ijrobp.2011.05.056	9	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	JAN-FEB	2015	100	1					180	184		10.9738/INTSURG-D-13-00188.1		5	Surgery	Surgery	AZ3LJ	WOS:000348128600029		
J	Garcia-Contreras, R; Nunez-Lopez, L; Jasso-Chavez, R; Kwan, BW; Belmont, JA; Rangel-Vega, A; Maeda, T; Wood, TK				Garcia-Contreras, Rodolfo; Nunez-Lopez, Leslie; Jasso-Chavez, Ricardo; Kwan, Brian W.; Belmont, Javier A.; Rangel-Vega, Adrian; Maeda, Toshinari; Wood, Thomas K.			Quorum sensing enhancement of the stress response promotes resistance to quorum quenching and prevents social cheating	ISME JOURNAL			English	Article							CELL-CELL COMMUNICATION; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; BIOFILM FORMATION; EXPRESSION; VIRULENCE; CATALASE; SPECIFICITY; INHIBITION	Quorum sensing (QS) coordinates the expression of virulence factors and allows bacteria to counteract the immune response, partly by increasing their tolerance to the oxidative stress generated by immune cells. Despite the recognized role of QS in enhancing the oxidative stress response, the consequences of this relationship for the bacterial ecology remain unexplored. Here we demonstrate that QS increases resistance also to osmotic, thermal and heavy metal stress. Furthermore a QS-deficient lasR rhlR mutant is unable to exert a robust response against H2O2 as it has less induction of catalase and NADPH-producing dehydrogenases. Phenotypic microarrays revealed that the mutant is very sensitive to several toxic compounds. As the anti-oxidative enzymes are private goods not shared by the population, only the individuals that produce them benefit from their action. Based on this premise, we show that in mixed populations of wild-type and the mexR mutant (resistant to the QS inhibitor furanone C-30), treatment with C-30 and H2O2 increases the proportion of mexR mutants; hence, oxidative stress selects resistance to QS compounds. In addition, oxidative stress alone strongly selects for strains with active QS systems that are able to exert a robust anti oxidative response and thereby decreases the proportion of QS cheaters in cultures that are otherwise prone to invasion by cheats. As in natural environments stress is omnipresent, it is likely that this QS enhancement of stress tolerance allows cells to counteract QS inhibition and invasions by social cheaters, therefore having a broad impact in bacterial ecology.	[Garcia-Contreras, Rodolfo; Nunez-Lopez, Leslie; Jasso-Chavez, Ricardo; Belmont, Javier A.] Natl Inst Cardiol, Dept Biochem, Mexico City 14080, DF, Mexico; [Kwan, Brian W.; Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Rangel-Vega, Adrian] Natl Med Ctr Siglo XXI, IMSS, Special Hosp, Dept Internal Med, Mexico City, DF, Mexico; [Maeda, Toshinari] Kyushu Inst Technol, Dept Biol Funct Engn, Kitakyushu, Fukuoka 804, Japan; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Garcia-Contreras, R (reprint author), Natl Inst Cardiol, Dept Biochem, Juan Badiano 1,Secc 16, Mexico City 14080, DF, Mexico.	garrod13420@cardiologia.org.mx		Wood, Thomas/0000-0002-6258-529X	SEP/CONACyT-Mexico [152794]; NIH [R01 GM089999]; Harvard Medical School; College of Pharmacy CHA University, South Korea	This work was supported by grants from SEP/CONACyT-Mexico No. 152794 to R-GC and by NIH (R01 GM089999) to TKW. TKW is the Biotechnology Endowed Chair at the Pennsylvania State University. We thank Dr Frederick Ausubel from the Harvard Medical School and Dr You-Hee Cho from the College of Pharmacy CHA University, South Korea for the PA14 strains. We thank M Geovanni Santiago-Martinez for his help with some experiments.	Telford G, 1998, INFECT IMMUN, V66, P36; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Ghoul M, 2014, J EVOLUTION BIOL, V27, P551, DOI 10.1111/jeb.12319; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Lee J, 2013, NAT CHEM BIOL, V9, P339, DOI [10.1038/nchembio.1225, 10.1038/NCHEMBIO.1225]; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Friman VP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0548; Ren DC, 2001, ENVIRON MICROBIOL, V3, P731, DOI 10.1046/j.1462-2920.2001.00249.x; Garcia-Contreras R, 2013, APPL ENVIRON MICROB, V79, P6840, DOI 10.1128/AEM.02378-13; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Maeda T, 2012, ISME J, V6, P493, DOI 10.1038/ismej.2011.122; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Dossel J, 2012, CELL MICROBIOL, V14, P1364, DOI 10.1111/j.1462-5822.2012.01801.x; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Leid JG, 2005, J IMMUNOL, V175, P7512; Dandekar AA, 2013, SCIENCE, V338, P264; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; Garcia-Contreras R, 2013, PATHOG DIS, V70, P95; Ikonomidis A, 2008, LETT APPL MICROBIOL, V47, P298, DOI 10.1111/j.1472-765X.2008.02430.x; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Jousset A, 2014, NAT COMMUN, V4, P2573; Kuang ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027091; Laarman AJ, 2013, J IMMUNOL, V188, P386; Ma JF, 1998, J BACTERIOL, V180, P1741; McDougald D, 2003, MICROBIOL-SGM, V149, P1923, DOI 10.1099/mic.0.26321-0; Park SY, 2005, J MICROBIOL, V43, P443; PERRY ACF, 1991, MOL MICROBIOL, V5, P163, DOI 10.1111/j.1365-2958.1991.tb01837.x; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Takahama U, 2005, FREE RADICAL RES, V39, P737, DOI 10.1080/10715760500043561; THURMAN RG, 1969, ANN NY ACAD SCI, V168, P348, DOI 10.1111/j.1749-6632.1969.tb43121.x	47	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	JAN	2015	9	1					115	125		10.1038/ismej.2014.98		11	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	AZ4SK	WOS:000348212800010		
J	Schluter, J; Nadell, CD; Bassler, BL; Foster, KR				Schluter, Jonas; Nadell, Carey D.; Bassler, Bonnie L.; Foster, Kevin R.			Adhesion as a weapon in microbial competition	ISME JOURNAL			English	Article							VIBRIO-CHOLERAE; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; INTERCELLULAR-ADHESION; MULTISPECIES BIOFILMS; FLUORESCENT PROTEIN; MEMBRANE-PROTEIN; EVOLUTION; GENE	Microbes attach to surfaces and form dense communities known as biofilms, which are central to how microbes live and influence humans. The key defining feature of biofilms is adhesion, whereby cells attach to one another and to surfaces, via attachment factors and extracellular polymers. While adhesion is known to be important for the initial stages of biofilm formation, its function within biofilm communities has not been studied. Here we utilise an individual-based model of microbial groups to study the evolution of adhesion. While adhering to a surface can enable cells to remain in a biofilm, consideration of within-biofilm competition reveals a potential cost to adhesion: immobility. Highly adhesive cells that are resistant to movement face being buried and starved at the base of the biofilm. However, we find that when growth occurs at the base of a biofilm, adhesion allows cells to capture substratum territory and force less adhesive, competing cells out of the system. This process may be particularly important when cells grow on a host epithelial surface. We test the predictions of our model using the enteric pathogen Vibrio cholerae, which produces an extracellular matrix important for biofilm formation. Flow cell experiments indicate that matrix-secreting cells are highly adhesive and form expanding clusters that remove non-secreting cells from the population, as predicted by our simulations. Our study shows how simple physical properties, such as adhesion, can be critical to understanding evolution and competition within microbial communities.	[Schluter, Jonas; Foster, Kevin R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Schluter, Jonas; Foster, Kevin R.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Schluter, Jonas] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan; [Nadell, Carey D.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nadell, Carey D.; Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Schluter, J (reprint author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa 2400193, Japan.	jonas@soken.ac.jp; kevin.foster@zoo.ox.ac.uk		Foster, Kevin/0000-0003-4687-6633			Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Malik S, 2013, APPL ENVIRON MICROB, V79, P4576, DOI 10.1128/AEM.00926-13; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Sutherland IW, 2001, MICROBIOL-UK, V147, P3; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Vidal O, 1998, J BACTERIOL, V180, P2442; Shahid SA, 2012, NAT METHODS, V9, P1212, DOI [10.1038/nmeth.2248, 10.1038/NMETH.2248]; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; NALIN DR, 1979, INFECT IMMUN, V25, P768; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Picioreanu C, 1997, WATER SCI TECHNOL, V36, P147, DOI 10.1016/S0273-1223(97)00347-8; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Liu CH, 2008, P NATL ACAD SCI USA, V105, P3951, DOI 10.1073/pnas.0709266105; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Alam M, 2006, APPL ENVIRON MICROB, V72, P2849, DOI 10.1128/AEM.72.4.2849-2855.2006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Nadell CD, 2011, P NATL ACAD SCI USA, V108, P14181, DOI 10.1073/pnas.1111147108; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Kim W, 2014, P NATL ACAD SCI USA, V111, pE1639, DOI 10.1073/pnas.1323632111; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Bockelmann U, 2003, J MICROBIOL METH, V55, P201, DOI 10.1016/S0167-7012(03)00144-1; Boris S, 1998, INFECT IMMUN, V66, P1985; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; Cash HL, 2006, SCIENCE, V80, P313; Chattopadhyay S, 2012, J BIOL CHEM, V287, P6150, DOI 10.1074/jbc.M111.303735; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; Derrien M., 2010, GUT MICROBES, V1, P254, DOI [DOI 10.4161/GMIC.1.4.12778, DOI 10.4161/GMIC.1.4.12778.PUBMED:21327032]; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Pradhan AK, 2014, BIOPROC BIOSYST ENG, V37, P139, DOI 10.1007/s00449-013-0976-5; Sachs JL, 2008, TRENDS ECOL EVOL, V23, P245, DOI 10.1016/j.tree.2008.02.003; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Shahid SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00803; TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187; TOJO M, 1988, J INFECT DIS, V157, P713; Veenstra GJC, 1996, J BACTERIOL, V178, P537	64	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	JAN	2015	9	1					139	149		10.1038/ismej.2014.174		11	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	AZ4SK	WOS:000348212800012		
J	Park, HB; Heo, R; Hartaigh, BO; Cho, I; Gransar, H; Nakazato, R; Leipsic, J; Mancini, GBJ; Koo, BK; Otake, H; Budoff, MJ; Berman, DS; Erglis, A; Chang, HJ; Min, JK				Park, Hyung-Bok; Heo, Ran; Hartaigh, Briain O.; Cho, Iksung; Gransar, Heidi; Nakazato, Ryo; Leipsic, Jonathon; Mancini, G. B. John; Koo, Bon-Kwon; Otake, Hiromasa; Budoff, Matthew J.; Berman, Daniel S.; Erglis, Andrejs; Chang, Hyuk-Jae; Min, James K.			Atherosclerotic Plaque Characteristics by CT Angiography Identify Coronary Lesions That Cause Ischemia	JACC-CARDIOVASCULAR IMAGING			English	Article						coronary artery disease; coronary computed tomography angiography; coronary plaque; fractional flow reserve; myocardial ischemia	FRACTIONAL FLOW RESERVE; MULTIDETECTOR COMPUTED-TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; INTRAVASCULAR ULTRASOUND; ENDOTHELIAL DYSFUNCTION; MULTIVESSEL EVALUATION; STABLE ANGINA; QUANTIFICATION; INTERVENTION; SEVERITY	OBJECTIVES This study evaluated the association between atherosclerotic plague characteristics (APCs) by coronary computed tomographic angiography (CTA), and lesion ischemia by fractional flow reserve (FFR). BACKGROUND FFR is the gold standard for determining lesion ischemia. Although APCs by CIA including aggregate plaque volume % (%APV), positive remodeling (PR), low attenuation plague (LAP), and spotty calcification (SC)-are associated with future coronary syndromes, their relationship to lesion ischemia is unclear. METHODS 252 patients (17 centers, 5 countries; mean age 63 years; 71% males) underwent coronary CTA, with FFR performed for 407 coronary lesions. Coronary CTA was interpreted for <50% and >= 50% stenosis, with the latter considered obstructive. APCs by coronary CTA were defined as: 1) PR, lesion diameter/reference diameter >1.10; 2) LAP, any voxel <30 Hounsfield units; and 3) SC, nodular calcified plague <3 mm. Odds ratios (OR) and net reclassification improvement of APCs for lesion ischemia, defined by FFR <= 0.8, were analyzed. RESULTS By FFR, ischemia was present in 151 lesions (37%). %APV was associated with a 50% increased risk of ischemia per 5% additional APV. PR, LAP, and SC were associated with ischemia, with a 3 to 5 times higher prevalence than in nonischemic lesions. In multivariable analyses, a stepwise increased risk of ischemia was observed for 1 (OR: 4.0, p <0.001) and >= 2 (OR: 12.1, p < 0.001) APCs. These findings were APC dependent, with PR (OR: 5.3, p <0.001) and LAP (OR: 2.1, p = 0.038) associated with ischemia, but not SC. When examined by stenosis severity, PR remained a predictor of ischemia for all Lesions, whereas %APV and LAP were associated with ischemia for only 50%, but not for <50%, stenosis. CONCLUSIONS %APV and APCs by coronary CTA improve identification of coronary Lesions that cause ischemia. PR is associated with all ischemia-causing lesions, whereas %APV and LAP are only associated with ischemia-causing Lesions >= 50%. (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography; NCT01233518) (C) 2015 by the American College of Cardiology Foundation..	[Park, Hyung-Bok; Heo, Ran; Hartaigh, Briain O.; Cho, Iksung; Min, James K.] New York Presbyterian Hosp, Dept Radiol, New York, NY USA; [Park, Hyung-Bok; Heo, Ran; Cho, Iksung; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Park, Hyung-Bok; Heo, Ran; Cho, Iksung; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Park, Hyung-Bok] Myongji Hosp, Ctr Cardiovasc, Goyang, South Korea; [Gransar, Heidi; Berman, Daniel S.] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Dept Imaging, Los Angeles, CA 90048 USA; [Gransar, Heidi; Berman, Daniel S.] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Dept Med, Los Angeles, CA 90048 USA; [Nakazato, Ryo] St Lukes Int Hosp, Ctr Cardiovasc, Tokyo, Japan; [Mancini, G. B. John] Univ British Columbia, St Pauls Hosp, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Mancini, G. B. John] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Med, Seoul 110744, South Korea; [Otake, Hiromasa] Kobe Univ, Grad Sch Med, Dept Internal Med, Kobe, Hyogo 657, Japan; [Budoff, Matthew J.] Harbor UCLA Med Ctr, Dept Med, Los Angeles, CA USA; [Erglis, Andrejs] Pauls Stradins Clin Univ Hosp, Dept Med, Riga, Latvia	Min, JK (reprint author), Weill Cornell Med Coll, 413 East 69th St,Suite 108, New York, NY 10065 USA.	jkm2001@med.cornell.edu			ICT R&D program of MSIP/IITP [10044910]; National Institutes of Health [RO1HL115150, R0IEL118019]	This work was supported by the ICT R&D program of MSIP/IITP [10044910, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases] and the National Institutes of Health (RO1HL115150 and R0IEL118019).	Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Lavi S, 2009, HEART, V95, P1525, DOI 10.1136/hrt.2009.166017; Ito T, 2011, AM J CARDIOL, V107, P1270, DOI 10.1016/j.amjcard.2010.12.036; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Nakazato R, 2013, EUR RADIOL, V23, P2109, DOI 10.1007/s00330-013-2822-1; Kristensen TS, 2011, J AM COLL CARDIOL, V58, P502, DOI 10.1016/j.jacc.2011.01.058; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Leber AW, 2003, AM J CARDIOL, V91, P714, DOI 10.1016/S0002-9149(02)03411-2; De Bruyne B, 2001, CIRCULATION, V104, P2401, DOI 10.1161/hc4501.099316; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; FALK E, 1995, CIRCULATION, V92, P657; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Nakazato R, 2013, J AM COLL CARDIOL, V62, P460, DOI 10.1016/j.jacc.2013.04.062; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Kristensen TS, 2010, INT J CARDIOL, V144, P200, DOI 10.1016/j.ijcard.2009.04.024; Brosh D, 2005, AM HEART J, V150, P338, DOI 10.1016/j.ajh.2004.09.007; CLARKSON TB, 1994, JAMA-J AM MED ASSOC, V271, P289, DOI 10.1001/jama.271.4.289; Kennedy K, SAS MACRO COMPUTE AD; Kim HS, 2012, JACC-CARDIOVASC INTE, V5, P1037, DOI 10.1016/j.jcin.2012.06.016; Masoli O, 2000, J NUCL CARDIOL, V7, P199, DOI 10.1016/S1071-3581(00)70007-9; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Schindler TH, 2004, J NUCL MED, V45, P419; Tanaka S, 2010, J CARDIOL, V55, P296, DOI 10.1016/j.jjcc.2009.12.001; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	31	14	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	JAN	2015	8	1					1	10		10.1016/j.jcmg.2014.11.002		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AZ4GZ	WOS:000348181000001		
J	Kusunose, K; Cremer, PC; Tsutsui, RS; Grimm, RA; Thomas, JD; Griffin, BP; Popovic, ZB				Kusunose, Kenya; Cremer, Paul C.; Tsutsui, Rayji S.; Grimm, Richard A.; Thomas, James D.; Griffin, Brian P.; Popovic, Zoran B.			Regurgitant Volume Informs Rate of Progressive Cardiac Dysfunction in Asymptomatic Patients With Chronic Aortic or Mitral Regurgitation	JACC-CARDIOVASCULAR IMAGING			English	Article						aortic regurgitation; echocardiography; mitrat regurgitation; natural history	STROKE WORK RELATIONSHIP; HUMAN LEFT-VENTRICLE; VALVE DISEASE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; QUANTIFICATION; VALIDATION; GUIDELINES; MANAGEMENT; SEVERITY	OBJECTIVES This study hypothesized that regurgitation severity, as determined by using the regurgitant volume index, would better delineate differential cardiac dysfunction in asymptomatic patients with moderate to severe aortic regurgitation (AR) and mitral regurgitation (MR). BACKGROUND Frequent surveillance echocardiography is considered appropriate in asymptomatic patients with moderate to severe AR and MR. However, the evidence to support this practice and to define the appropriate frequency is Limited. METHODS This was an observational cohort study of consecutive patients with moderate to severe asymptomatic AR or MR who underwent exercise echocardiography. Our cohort included 130 patients with moderate to severe asymptomatic MR and 130 patients with moderate to severe asymptomatic AR who were matched according to age and regurgitant volume index. All patients underwent yearly echocardiographic follow-up studies. Regurgitation severity was determined according to regurgitant volume index, with a Level >= 30 ml/m(2) considered a marker of severe regurgitation. RESULTS During follow-up, regardless of etiology, patients with severe regurgitation demonstrated increasing left ventricular volume indexes (4.2 +/- 1.5 ml/m(2) per year; p = 0.01) and decreasing left ventricular ejection fractions (1.3 +/- 0.4% per year; p = 0.002). In patients with moderate regurgitation, left ventricular volumes and ejection fractions did not significantly change. In addition, patients with severe regurgitation experienced a similar drop in contractility (end-systolic pressure/end-systolic volume ratio and single-beat pre-Load recruitable stroke work) during follow-up independent of regurgitation etiology. Contractility parameters did not change in patients with moderate regurgitation. CONCLUSIONS These asymptomatic patients with moderate AR or MR had stable cardiac function during 3 years of follow-up; thus, frequent echocardiography without a change in clinical status may not be necessary. In the setting of severe regurgitation, further cardiac deterioration occurred at a similar rate and manner irrespective of whether the dysfunction was related to AR or MR. (C) 2015 by the American College of Cardiology Foundation.	[Kusunose, Kenya] Tokushima Univ Hosp, Tokushima, Japan; [Kusunose, Kenya; Cremer, Paul C.; Tsutsui, Rayji S.; Grimm, Richard A.; Thomas, James D.; Griffin, Brian P.; Popovic, Zoran B.] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44195 USA	Popovic, ZB (reprint author), Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, 9500 Euclid Ave,Desk J1-5, Cleveland, OH 44195 USA.	popoviz@ccf.org					Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Kim ESH, 2007, J AM COLL CARDIOL, V50, P1867, DOI 10.1016/j.jacc.2007.08.003; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Lee WS, 2003, AM J PHYSIOL-HEART C, V284, pH744, DOI 10.1152/ajpheart.00455.2002; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; STARLING MR, 1993, J AM COLL CARDIOL, V22, P239; DEVEREUX RB, 1977, CIRCULATION, V55, P613; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Bolen MA, 2011, RADIOLOGY, V260, P98, DOI 10.1148/radiol.11102064; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; Gaasch WH, 2008, CIRCULATION, V118, P2298, DOI 10.1161/CIRCULATIONAHA.107.755942; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Kass DA, 1998, CIRC RES, V82, P519; KELLY RP, 1992, CIRCULATION, V86, P513; Kusunose K, 2013, CIRC-CARDIOVASC IMAG, V6, P167, DOI 10.1161/CIRCIMAGING.112.000162; URABE Y, 1992, CIRC RES, V70, P131; Bonow RO, 2006, J AM COLL CARDIOL, V48, pel, DOI DOI 10.1016/J.JACC.2006.05.021; Carabetto BA., 1995, J HEART VALVE DIS S2, V4, P5132; Carabetto BA., 1995, J HEART VALVE DIS S2, V4, P5138; FEIRING AJ, 1992, CIRCULATION, V85, P1423; Fitzmaurice G, 2004, APPL LONGITUDINAL AN; Glantz S, 1990, PRIMER APPL REGRESSI; Karunanithi MK, 2000, J AM COLL CARDIOL, V35, P502, DOI 10.1016/S0735-1097(99)00566-5; Kusunose K, 2014, CIRC-CARDIOVASC IMAG, V7, P352, DOI 10.1161/CIRCIMAGING.113.001177; Lancellotti P, 2013, CIRC-CARDIOVASC IMAG, V6, P840, DOI 10.1161/CIRCIMAGING.113.000474; Leung DY, 1996, J AM COLL CARDIOL, V28, P1198, DOI 10.1016/S0735-1097(96)00281-1; Sopko NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015187; STARLING MR, 1991, J AM COLL CARDIOL, V17, P887; Thavendiranathan P, 2012, J AM COLL CARDIOL, V60, P1470, DOI 10.1016/j.jacc.2012.05.048; Uretsky S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-32; Vaishnava P, 2011, NAT REV CARDIOL, V8, P173, DOI 10.1038/nrcardio.2010.203; WISENBAUGH T, 1984, J AM COLL CARDIOL, V3, P916; Yamano T, 2009, AM HEART J, V157, P875, DOI 10.1016/j.ahj.2009.03.001	34	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	JAN	2015	8	1					14	23		10.1016/j.jcmg.2014.09.017		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AZ4GZ	WOS:000348181000003		
J	Tahara, N; Tahara, A; Honda, A; Nitta, Y; Igata, S; Nakamura, Y; Takeuchi, Y; Akashi, H; Tanaka, H; Morioka, M; Narula, J; Yamagishi, S; Fukumoto, Y				Tahara, Nobuhiro; Tahara, Atsuko; Honda, Akihiro; Nitta, Yoshikazu; Igata, Sachiyo; Nakamura, Yukihiko; Takeuchi, Yasuharu; Akashi, Hidetoshi; Tanaka, Hiroyuki; Morioka, Motohiro; Narula, Jagat; Yamagishi, Sho-ichi; Fukumoto, Yoshihiro			Noninvasive Evaluation of Bone-Forming Activity Within the Calcified Atherosclerotic Lesions by Tc 99m HMDP Scintigraphy	JACC-CARDIOVASCULAR IMAGING			English	Letter									[Tahara, Nobuhiro] Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan	Tahara, N (reprint author), Dept Med, Div Cardiovasc Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	ntahara@med.kurume-u.ac.jp					Suga T, 2011, J ATHEROSCLER THROMB, V18, P670; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	JAN	2015	8	1					108	109		10.1016/j.jcmg.2014.03.018		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AZ4GZ	WOS:000348181000019		
J	Tamaki, N				Tamaki, Nagara			The year for our new endeavor: 2015	JAPANESE JOURNAL OF RADIOLOGY			English	Editorial Material							GUIDELINES		Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Tamaki, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.						[Anonymous], JPN J RADIOL; Ehara S, 2011, JPN J RADIOL, V29, P1, DOI 10.1007/s11604-010-0535-9; Miyayama S, 2014, JPN J RADIOL, V32, P242, DOI 10.1007/s11604-014-0292-2; Ohno I, 2013, JPN J RADIOL, V31, P546, DOI 10.1007/s11604-013-0226-4	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					1	2		10.1007/s11604-014-0365-2		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100001		
J	Nakayama, T; Ehara, S				Nakayama, Tetsuo; Ehara, Shigeru			Spondylolytic spondylolisthesis: various imaging features and natural courses	JAPANESE JOURNAL OF RADIOLOGY			English	Review						Spondylolysis; Spondylolisthesis; Spondylolytic spondylolisthesis; Ithmic spondylolysis; Retroisthmic cleft; Pedicular (retrosomatic) cleft	PEDICLE STRESS-FRACTURE; LOW-BACK-PAIN; LUMBAR SPINE; PARS INTERARTICULARIS; RETROISTHMIC CLEFT; UNILATERAL SPONDYLOLYSIS; CONTRALATERAL PEDICLE; MRI; APPEARANCE; CLASSIFICATION	The purpose of this paper is to review typical and atypical imaging features of spondylolytic spondyolisthesis and natural courses. Imaging features of the typical pars defect in early phase include bone marrow edema of the isthmus on MR imaging with progression of bone defect on plain radiography or CT. There are various defect types (pedicular cleft, retroisthmic cleft) and locations (upper lumbar spine and unilateral lesions). Natural courses also vary, with different patterns of progression and stabilization. Clinical correlation of the imaging and clinical features is often difficult.	[Nakayama, Tetsuo; Ehara, Shigeru] Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan	Nakayama, T (reprint author), Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan.	nakayama0110@yahoo.co.jp; ehara@iwate-med.ac.jp					Abraham T, 1997, CLIN NUCL MED, V22, P161, DOI 10.1097/00003072-199703000-00005; Kalichman L, 2009, SPINE, V34, P199, DOI 10.1097/BRS.0b013e31818edcfd; WORTZMAN G, 1984, RADIOLOGY, V152, P713; Rankine JJ, 2010, SPINE, V35, pE1111, DOI 10.1097/BRS.0b013e3181de8b72; McGregor AH, 2002, SPINE, V27, P1582, DOI 10.1097/01.BRS.0000018484.33812.97; Fujii K, 2004, J BONE JOINT SURG BR, V86B, P225, DOI 10.1302/0301-620X.86B2.14339; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Logroscino G, 2001, CHILD NERV SYST, V17, P644; Leone A, 2011, SKELETAL RADIOL, V40, P683, DOI 10.1007/s00256-010-0942-0; WILTSE LL, 1962, J BONE JOINT SURG AM, V44, P539; Ikata T, 1996, AM J SPORT MED, V24, P94, DOI 10.1177/036354659602400117; Floman Y, 2000, SPINE, V25, P342, DOI 10.1097/00007632-200002010-00014; Amari R, 2009, ARCH ORTHOP TRAUM SU, V129, P397, DOI 10.1007/s00402-008-0685-8; Sakai T, 2009, SPINE, V34, P2346, DOI 10.1097/BRS.0b013e3181b4abbe; SZYPRYT EP, 1989, SPINE, V14, P977, DOI 10.1097/00007632-198909000-00011; Axelsson P, 2000, SPINE, V25, P1710; BENSAID AH, 1992, NEURORADIOLOGY, V34, P107; Brooks BK, 2010, SKELETAL RADIOL, V39, P669, DOI 10.1007/s00256-009-0825-4; Campbell RSD, 2005, SKELETAL RADIOL, V34, P63, DOI 10.1007/s00256-004-0878-3; Cryron BM, 1976, J BONE JT SURG BR, V58, P462; Doita M, 2008, J SPINAL DISORD TECH, V21, P531, DOI 10.1097/BSD.0b013e31815b7e05; Dunn AJ, 2008, SKELETAL RADIOL, V37, P443, DOI 10.1007/s00256-008-0449-0; Einstein S, 1978, J BONE JT SURG BR, V60, P4988; FARFAN HF, 1976, CLIN ORTHOP RELAT R, P40; FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699; GARBER JE, 1986, SPINE, V11, P63, DOI 10.1097/00007632-198601000-00018; Guillodo Y, 2000, SPINE, V25, P2541, DOI 10.1097/00007632-200010010-00019; Ha KY, 2003, SPINE, V28, pE158, DOI 10.1097/00007632-200304150-00024; Hammerberg KW, 2005, SPINE, V30, pS4, DOI 10.1097/01.brs.0000155576.62159.1c; Hollenberg GM, 2002, SPINE, V27, P181, DOI 10.1097/00007632-200201150-00012; Horner CW, 1996, AM J NEURORADIOL, V17, P397; JACKSON A M, 1978, Spine, V3, P260, DOI 10.1097/00007632-197809000-00012; JOHANSEN JG, 1984, AM J NEURORADIOL, V5, P835; JOHANSEN JG, 1983, RADIOLOGY, V148, P447; Lee JH, 1999, CLIN IMAG, V23, P389, DOI 10.1016/S0899-7071(99)00158-8; Lowe J, 1987, J BONE JT SURG BR, V69, P260; Marchetti Pier Giorgio, 1997, P1211; Masharawi YM, 2007, SPINE, V32, pE176, DOI 10.1097/01.brs.0000257565.41856.0f; Merbs CF, 2002, AM J PHYS ANTHROPOL, V119, P156, DOI 10.1002/ajpa.10100; Mihara H, 2003, SPINE, V28, P235, DOI 10.1097/00007632-200302010-00006; NATHAN H, 1959, J BONE JOINT SURG AM, V41, P303; Park JS, 2010, AM J ROENTGENOL, V194, P207, DOI 10.2214/AJR.09.2937; RAVICHANDRAN G, 1981, INT ORTHOP, V5, P31; Sairyo K, 2005, AM J SPORT MED, V33, P583, DOI 10.1177/0363546504269035; Sairyo K, 2006, SPINE, V31, P206, DOI 10.1097/01.brs.0000195161.60549.67; Sairyo K, 2011, INT J SPINE SURG, P22; Sairyo K, 2001, Spine J, V1, P171, DOI 10.1016/S1529-9430(01)00018-3; Sherif H, 2004, EUR RADIOL, V14, P970, DOI 10.1007/s00330-004-2235-2; TROUP JDG, 1976, CLIN ORTHOP RELAT R, P59; Ulmer JL, 1997, AM J ROENTGENOL, V169, P233; Ward CV, 2007, SPINE, V32, pE35; Wick LF, 2000, SKELETAL RADIOL, V29, P162; WILTSE LL, 1976, CLIN ORTHOP RELAT R, P23; Wistle LL, 1969, S SPIN AM AC ORTH SU, P143	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					3	12		10.1007/s11604-014-0371-4		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100002		
J	Okada, S; Shiraishi, A; Yamashiro, Y; Inoue, T; Tsuge, D; Aida, M; Kuwatsuru, R				Okada, Shingo; Shiraishi, Akihiko; Yamashiro, Yuki; Inoue, Tatsuro; Tsuge, Daisuke; Aida, Mari; Kuwatsuru, Ryohei			A retrospective statistical analysis of the late complications associated with central venous port placements	JAPANESE JOURNAL OF RADIOLOGY			English	Article						CV ports; CRBSI; Catheter trouble; Complication	ACCESS PORTS; INFECTIOUS COMPLICATIONS; CANCER-PATIENTS; EXPERIENCE; CHEMOTHERAPY; CATHETERS; SYSTEMS; DEVICES	Purpose Central venous (CV) ports are being used increasingly in both hospital and home care settings. Here, we investigated the rates and causes of CV port complications. Materials and methods We retrospectively analyzed the placement of 264 consecutive CV ports in 239 consecutive patients admitted to our hospital between September 2009 and February 2012. All CV ports were inserted under fluoroscopy and ultrasound visualization by interventional radiologists using maximum barrier precautions. CV port complications were checked in detail and analyzed statistically. Results Total indwelling time for all CV ports was 51,033 catheter days. Of the 264 CV ports assessed, 50 were removed during the study period because of any complication and 147 remained at the end of the study period. In 33 cases, the patient died before the end of the study. Of the 50 patients who underwent CV port removal, 13 were diagnosed as having catheter-related bloodstream infection (CRBSI). The total rate of CV port removal because of any complication was 0.98 cases per 1,000 catheter days, that of catheter troubles was 0.22 cases per 1,000 catheter days and that of CRBSI was 0.25 cases per 1,000 catheter days. Steroid administration and total parenteral nutrition (TPN) were associated with increased rates of infection. It seems that chemotherapy and indwelling time were also considered important factors. Conclusion Steroid administration and TPN were associated with increased rates of infection. In addition, patients receiving chemotherapy or whose CV ports are left in place for a long time should be carefully observed to decrease these complications.	[Okada, Shingo; Shiraishi, Akihiko; Yamashiro, Yuki; Inoue, Tatsuro; Tsuge, Daisuke; Aida, Mari; Kuwatsuru, Ryohei] Juntendo Univ Hosp, Dept Radiol, Bunkyo Ku, Tokyo 1138431, Japan	Kuwatsuru, R (reprint author), Juntendo Univ Hosp, Dept Radiol, Bunkyo Ku, 3-1-3 Hongo, Tokyo 1138431, Japan.	kuwaturu@juntendo.ac.jp					Biffi R, 1998, ANN ONCOL, V9, P767, DOI 10.1023/A:1008392423469; Vardy J, 2004, BRIT J CANCER, V91, P1045, DOI 10.1038/sj.bjc.6602082; Kock HJ, 1998, WORLD J SURG, V22, P12; [Anonymous], 2002, MORBIDITY MORTALITY, V51; Kuriakose P, 2002, J VASC INTERV RADIOL, V13, P179, DOI 10.1016/S1051-0443(07)61936-8; Akahane A, 2011, CARDIOVASC INTER RAD, V34, P1222, DOI 10.1007/s00270-010-0051-4; TORRAMADE JR, 1993, EUR J SURG, V159, P323; Bassi KK, 2012, INDIAN J CANCER, V49, P114, DOI 10.4103/0019-509X.98934; Chang LL, 2003, AM J INFECT CONTROL, V31, P34, DOI 10.1067/mic.2003.29; Fagnani D, 2009, BLOOD COAGUL FIBRIN, V20, P35, DOI 10.1097/MBC.0b013e32831bc2f8; Gebauer B, 2009, EUR J RADIOL, V69, P517, DOI 10.1016/j.ejrad.2007.10.018; Lorch H, 2001, CARDIOVASC INTER RAD, V24, P180, DOI 10.1007/s002700001721; Takehara K, 2011, J JPN SOC SURG INFEC, V8, P699; Yamaguchi K, 2011, J SURG METAB NUTR, V45, P185	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					21	25		10.1007/s11604-014-0375-0		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100004		
J	Nishizawa, M; Tanaka, H; Watanabe, Y; Kunitomi, Y; Tsukabe, A; Tomiyama, N				Nishizawa, Mitsuo; Tanaka, Hisashi; Watanabe, Yoshiyuki; Kunitomi, Yuuki; Tsukabe, Akio; Tomiyama, Noriyuki			Model-based iterative reconstruction for detection of subtle hypoattenuation in early cerebral infarction: a phantom study	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Model-based iterative reconstruction; Computed tomography; Dose reduction; Lesion detectability; Noise power spectrum	FILTERED BACK-PROJECTION; IMPROVED IMAGE QUALITY; HEAD CT; IMPROVED DELINEATION; DOSE REDUCTION; ABDOMINAL CT; STANDARD; NOISE; ANGIOGRAPHY; ARTERY	Purpose Model-based iterative reconstruction (MBIR) was recently shown to enable dose reduction in computed tomography (CT). The detectability of low-contrast lesions was assessed on CT images reconstructed with MBIR compared with the conventional filtered back-projection (FBP) method. Materials and methods A phantom simulating brain gray matter containing small lesions mimicking early cerebral infarctions was scanned at tube currents of 50, 100, 200, and 400 mA. Images were reconstructed by use of both methods. Round regions were cropped from the reconstructed images, half with a lesion, the other half without. Eight radiologists reviewed the images and scored the certainty of lesion detection on a 5-point scale. Overall performance was analyzed by use of a receiver operating characteristic curve. Results For the tube currents investigated, the analysis showed that the mean areas under the curves for the reviewers were 0.65, 0.70, 0.82, and 0.83 for FBP and 0.70, 0.76, 0.78, and 0.90 for MBIR. For each current, there was no significant difference between the areas under the curves for the different reconstruction methods (p = 0.32, 0.24, 0.49, and 0.17). Conclusion For the small, low-contrast lesions in the phantom model used in this study, no significant difference between detectability was observed for MBIR and FBP.	[Nishizawa, Mitsuo; Tanaka, Hisashi; Watanabe, Yoshiyuki; Kunitomi, Yuuki; Tsukabe, Akio; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka 5650871, Japan; [Nishizawa, Mitsuo] Osaka Med Coll, Dept Diagnost Radiol, Takatsuki, Osaka 5698686, Japan	Nishizawa, M (reprint author), Osaka Med Coll, Dept Diagnost Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	m-nishizawa@radiol.med.osaka-u.ac.jp					Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Machida H, 2013, AM J NEURORADIOL, V34, P971, DOI 10.3174/ajnr.A3320; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Deak Z, 2013, RADIOLOGY, V266, P197, DOI 10.1148/radiol.12112707; Suzuki S, 2013, AM J ROENTGENOL, V200, P652, DOI 10.2214/AJR.12.8689; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Wu TH, 2013, EUR RADIOL, V23, P2612, DOI 10.1007/s00330-013-2846-6; Shuman WP, 2013, AM J ROENTGENOL, V200, P1071, DOI 10.2214/AJR.12.8986; Machida H, 2013, AM J ROENTGENOL, V200, P442, DOI 10.2214/AJR.11.7826; Kilic K, 2011, AM J NEURORADIOL, V32, P1578, DOI 10.3174/ajnr.A2585; Cohnen M, 2000, AM J NEURORADIOL, V21, P1654; LOO LND, 1984, PHYS MED BIOL, V29, P837, DOI 10.1088/0031-9155/29/7/007; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Mullins ME, 2004, AM J NEURORADIOL, V25, P533; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Rapalino O, 2012, AM J NEURORADIOL, V33, P609, DOI 10.3174/ajnr.A2826; Siewerdsen JH, 1998, MED PHYS, V25, P614, DOI 10.1118/1.598243; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Vorona GA, 2013, AM J NEURORADIOL, V34, P205, DOI 10.3174/ajnr.A3122; Smith EA, 2014, RADIOLOGY, V270, P526, DOI 10.1148/radiol.13130362; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Mieville FA, 2013, PHYS MEDICA, V29, P99, DOI 10.1016/j.ejmp.2011.12.004; Vardhanabhuti V, 2013, AM J ROENTGENOL, V200, P545, DOI 10.2214/AJR.12.9424; Baker ME, 2012, AM J ROENTGENOL, V199, P8, DOI 10.2214/AJR.11.7421; Barrett HH, 2004, FDN IMAGE SCI, P801; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; GIGER ML, 1984, MED PHYS, V11, P797, DOI 10.1118/1.595583; HANSON K M, 1979, Medical Physics (Woodbury), V6, P441; Nishida J, 2014, RADIOLOGY, V270, P282, DOI 10.1148/radiol.13122019; Pan X, 2009, INVERSE PROBL, V25, P1; Scheffel H, 2012, EUR J RADIOL, V81, pE363, DOI 10.1016/j.ejrad.2011.11.051; Schindera Sebastian T, 2013, Radiology, V269, P511, DOI 10.1148/radiol.13122349; Tanaka C, 2006, AM J NEURORADIOL, V27, P40; Volders David, 2013, Radiology, V269, P469, DOI 10.1148/radiol.13130002; Wagner RF, 1978, PHOTOGR SCI ENG, V22, P1; Yu Z, 2010, IEEE T IMAGE PROCESS, V20, P161	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					26	32		10.1007/s11604-014-0376-z		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100005		
J	Kawada, H; Inaba, Y; Yamaura, H; Sato, Y; Kato, M; Kashima, M; Murata, S; Kanematsu, M				Kawada, Hiroshi; Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kashima, Masataka; Murata, Shinichi; Kanematsu, Masayuki			Esophageal stenting after penetrating complete esophageal obstruction using a trocar stylet via a gastrostomy route: a case report	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Esophageal obstruction; Esophageal stent; Trocar stylet needle of TIPS kit	SHARP RECANALIZATION; RETROGRADE DILATION; COMBINED ANTEGRADE; MANAGEMENT; STRICTURE	Complete esophageal obstruction developed after radiation and endoscopic submucosal dissection therapy for a cervical esophageal cancer in a 77-year-old woman. After failure to recanalize the esophageal obstruction by endoscopic and catheterization techniques, the esophageal obstruction was penetrated using a trocar stylet needle via a gastrostomy route. A covered stent was placed across the esophageal obstruction, letting her take water and liquid food until she died 2 months later. There was no complication related to the procedures except transient chest discomfort and pain that subsided with symptomatic treatment.	[Kawada, Hiroshi; Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kashima, Masataka; Murata, Shinichi] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, Nagoya, Aichi 4640021, Japan; [Kawada, Hiroshi; Kanematsu, Masayuki] Gifu Univ Hosp, Dept Radiol, Gifu 5011194, Japan; [Kanematsu, Masayuki] Gifu Univ Hosp, Dept Radiol Serv, Gifu 5011194, Japan	Kawada, H (reprint author), Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4640021, Japan.	hiro-k14@hotmail.co.jp					Maple JT, 2006, GASTROINTEST ENDOSC, V64, P822, DOI 10.1016/j.gie.2006.06.026; Bueno R, 2001, GASTROINTEST ENDOSC, V54, P368, DOI 10.1067/mge.2001.117517; Laurell G, 2003, CANCER, V97, P1693, DOI 10.1002/cncr.11236; Dellon ES, 2010, GASTROINTEST ENDOSC, V71, P1122, DOI 10.1016/j.gie.2009.12.057; Inaba Y, 2004, BRIT J RADIOL, V77, P787, DOI 10.1259/bjr/93367963; Inaba Y, 2013, JPN J CLIN ONCOL, V43, P713, DOI 10.1093/jjco/hyt069; Keussen I, 2014, CARDIOVASC INTER RAD, V37, P1381, DOI 10.1007/s00270-013-0768-y; Moyer MT, 2006, GASTROINTEST ENDOSC, V64, P789, DOI 10.1016/j.gie.2006.06.081; Song HY, 1997, RADIOLOGY, V203, P747; Thornton RH, 2006, GASTROINTEST ENDOSC, V64, P793, DOI 10.1016/j.gie.2006.07.029	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					43	45		10.1007/s11604-014-0374-1		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100008		
J	Tomizawa, N; Kanno, S; Maeda, E; Akahane, M; Torigoe, R; Ohtomo, K				Tomizawa, Nobuo; Kanno, Shigeaki; Maeda, Eriko; Akahane, Masaaki; Torigoe, Rumiko; Ohtomo, Kuni			In reply to: Minimizing the radiation dose in coronary CT angiography using prospective ECG-triggering, low tube voltage and iterative reconstruction technologies	JAPANESE JOURNAL OF RADIOLOGY			English	Letter									[Tomizawa, Nobuo; Kanno, Shigeaki; Maeda, Eriko; Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Tokyo, Japan; [Tomizawa, Nobuo] New Tokyo Hosp, Dept Radiol, Matsudo, Chiba 2702232, Japan; [Akahane, Masaaki] NTT Med Ctr Tokyo, Dept Radiol, Tokyo, Japan; [Torigoe, Rumiko] Toshiba Med Syst Corp, Tokyo, Japan	Tomizawa, N (reprint author), Univ Tokyo, Dept Radiol, Tokyo, Japan.	tomizawa-tky@umin.ac.jp					Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Chen Y, 2013, RADIOLOGY, V267, P76; Saglam M, JPN J RADIOL, DOI [10.1007/s11604-014-0321-1, DOI 10.1007/S11604-014-0321-1]; Tomizawa N, 2013, INT J CARDIOVAS IMAG, V29, P1613, DOI 10.1007/s10554-013-0238-2	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	JAN	2015	33	1					48	49		10.1007/s11604-014-0363-4		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3EI	WOS:000348110100010		
J	Aoki, K; Isozaki, Y; Yamamoto, A; Sakata, S; Hirata, T				Aoki, Kazumasa; Isozaki, Yukio; Yamamoto, Atsushi; Sakata, Shuhei; Hirata, Takafumi			Mid-Paleozoic arc granitoids in SW Japan with Neoproterozoic xenocrysts from South China: New zircon U-Pb ages by LA-ICP-MS	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						U-Pb age; Zircon; Paleozoic; Kurosegawa; South China	DETRITAL ZIRCON; CONVERGENT MARGINS; SUBDUCTION EROSION; CONTINENTAL-CRUST; TECTONIC EROSION; NORTHEAST JAPAN; NATURAL ZIRCON; BLOCK; BELT; EVOLUTION	The Kurosegawa belt in SW Japan preserves fragments of Early-Middle Paleozoic granitoids traditionally called the Mitaki igneous rocks and previously dated ca. 470-435 Ma by several isotope analyses such as Rb-Sr, K-Ar and U-Pb, together with high-grade metamorphic rocks and Silurian strata, in a narrow belt. However, the timing of the oldest arc-related plutonism in Japan is constrained by laser-ablation inductively coupled plasma-mass spectrometry (LA-ICP-MS) U-Pb ages of zircon from Mitaki granitoids in 3 areas in SW Japan; i.e. Kyushu, Shikoku, and Kii Peninsula. Weighted mean U-Pb ages of these zircons are 431.8 +/- 3.9 for a granodiorite from the Mt. Mitaki area in Shikoku, 444.1 +/- 5.8 Ma for a granodiorite from Kuraoka area in central Kyushu, and 444.5 +/- 7.6 Ma for a quartzdiorite from the Nabaenohana area in western Kii peninsula, respectively. These ages confirm that the Mitaki igneous rocks have ca. 445-435 Ma (late Ordovician to mid-Silurian) ages. They are some of the oldest subduction-related plutonic rocks in SW japan. Particularly noteworthy is a "tonalite" from the Nabaenohana area, which has a unique spectrum of zircon U-Pb ages with distinct 3 clusters; ca. 700-500 Ma (Neoproterozoic-Cambrian), ca. 1350-830 Ma (Meo-Neoproterozoic), and ca. 3230-1560 Ma (Paleoarchean-Mesoproterozoic). Of the 44 dated zircon grains, the youngest (possibly xenocrystic) grains are ca. 500 Ma. Older zircon grains with ages >500 Ma range up to 3230 Ma and are interpreted as inherited xenocrysts in the "tonalite". The Mitaki igneous rocks are interpreted to have been derived by melting of post-500 Ma terrigenous sedimentary rocks that yielded a unique tonalitic S-type granitoid magma. From the presence of abundant 1350-700 Ma (Meso- to Neoproterozoic) zircon grains in the "tonalite" we conclude that during the Early Paleozoic, proto-japan was located close to the Cathaysian margin of South China. (C) 2014 Elsevier Ltd. All rights reserved.	[Aoki, Kazumasa; Isozaki, Yukio] Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan; [Aoki, Kazumasa] Okayama Univ Sci, Dept Appl Sci, Okayama 7000005, Japan; [Yamamoto, Atsushi] Kinki Univ, Dept Life Sci, Osaka 5778502, Japan; [Sakata, Shuhei; Hirata, Takafumi] Kyoto Univ, Dept Geol & Mineral, Kyoto 6068502, Japan	Aoki, K (reprint author), Okayama Univ Sci, Dept Appl Sci, Okayama 7000005, Japan.	kazumasa@das.ous.ac.jp	Isozaki, Yukio/A-1806-2009		Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists [23-6135]; JSPS [20224012]	Ken Collerson provided editorial corrections for the manuscript, and also provided helpful geological comments. T. Kani, D. Kofukuda, T. Sato, and R. Hayashi helped in sample preparation. T. Komiya, A. Ishikawa and M. Ogawa provided constructive comments. Constructive comments by B.M. Jahn, T. Tsujimori and anonymous reviewer are quite helpful in revision. This study was supported by a Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists (23-6135 to K.A.) and a Grant-in-Aid of the JSPS (20224012 to Y.I.).	Slama J, 2008, CHEM GEOL, V249, P1, DOI 10.1016/j.chemgeo.2007.11.005; Wang YJ, 2010, TECTONICS, V29, DOI 10.1029/2010TC002750; Zhu XQ, 2014, GONDWANA RES, V25, P383, DOI 10.1016/j.gr.2013.04.009; Aoki K, 2011, J ASIAN EARTH SCI, V42, P355, DOI 10.1016/j.jseaes.2011.05.001; VONHUENE R, 1991, REV GEOPHYS, V29, P279, DOI 10.1029/91RG00969; Wang YJ, 2011, LITHOS, V127, P239, DOI 10.1016/j.lithos.2011.07.027; Fujisaki W, 2014, J ASIAN EARTH SCI, V88, P62, DOI 10.1016/j.jseaes.2014.02.006; VONHUENE R, 1990, GEOL SOC AM BULL, V102, P704, DOI 10.1130/0016-7606(1990)102<0704:TEATJA>2.3.CO;2; Shu LS, 2014, AM J SCI, V314, P154, DOI 10.2475/01.2014.05; Lee JKW, 1997, NATURE, V390, P159, DOI 10.1038/36554; Liu XM, 2008, AM J SCI, V308, P421, DOI 10.2475/04.2008.02; von Huene R, 2004, GEOLOGY, V32, P913, DOI 10.1130/G20563.1; Iizuka T, 2004, GEOCHEM J, V38, P229; Sakashima T, 2003, J ASIAN EARTH SCI, V21, P1019, DOI 10.1016/S1367-9120(02)00108-6; Aitchison JC, 1996, J SOUTHE ASIAN EARTH, V14, P53, DOI 10.1016/S0743-9547(96)00045-1; Wiedenbeck M, 2004, GEOSTAND GEOANAL RES, V28, P9, DOI 10.1111/j.1751-908X.2004.tb01041.x; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x; MATSUDA T, 1971, TECTONOPHYSICS, V11, P5, DOI 10.1016/0040-1951(71)90076-X; Hirata T, 2005, J ANAL ATOM SPECTROM, V20, P696, DOI 10.1039/b504153h; Vannucchi P, 2008, NATURE, V451, P699, DOI 10.1038/nature06486; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; Wang YJ, 2013, GONDWANA RES, V23, P1273, DOI 10.1016/j.gr.2012.02.019; Darby BJ, 2006, J ASIAN EARTH SCI, V26, P637, DOI 10.1016/j.jseaes.2004.12.005; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Jahn BM, 2010, AM J SCI, V310, P1210, DOI 10.2475/10.2010.02; Tsujimori T, 2005, INT GEOL REV, V47, P1048, DOI 10.2747/0020-6814.47.10.1048; Isozaki Y, 2010, GONDWANA RES, V18, P82, DOI 10.1016/j.gr.2010.02.015; Aoki K, 2012, GEOLOGY, V40, P1087, DOI 10.1130/G33414.1; Ehiro M., 1997, PALAEONTOLOGY HIST G, V12, P18; Gradstein F. M., 2012, GEOLOGIC TIME SCALE; Hada S., 1979, BASEMENT JAPANESE IS, P341; HADA S, 1974, Journal of Geosciences Osaka City University, V17, P1; Hada S., 2000, MEMOIRS GEOLOGICAL S, V56, P183; Hamada T, 1959, J GEOLOGICAL SOC JAP, V65, P688; Hayase I., 1969, GEOCHEM J, V3, P45; Ichikawa K., 1956, J GEOL SOC JAPAN, V62, P82; Isozaki Y., 2011, J GEOGR, V120, P65, DOI DOI 10.5026/JGE0GRAPHY.120.65; Isozaki Y., 1996, ISL ARC, V5, P289, DOI DOI 10.1111/J.1440-1738.1996.TB00033.X; Isozaki Y, 2014, PALEONTOL RES, V18, P250, DOI 10.2517/2014PR022; Isozaki Y., 1991, J GEOL SOC JPN, V97, P431; Isozaki Y, 2014, GFF, V136, P116, DOI 10.1080/11035897.2014.893254; Jin W., 2002, GONDWANA RES, V5, P95; Kato M., 1990, PRECRETACEOUS TERRAN, P307; Kido E., 2005, FUKUOKA U SCI REPORT, V35, P11; Kobayashi Y., 2000, MEM GEOL SOC JPN, V56, P65; Kunugiza K., 2010, J GEOGR, V119, P279; Ludwig K., 2003, ISOPLOT 3 0, V4; MARUYAMA S, 1981, Journal of the Geological Society of Japan, V87, P569; Nakai H., 1981, T P PALAEONTOLOGICAL, V123, P139; Nakama T., 2010, J GEOGR, V119, P1161; Nakama T., 2010, J GEOGR, V119, P270; Nakazawa Keiji, 1991, SHALLOW TETHYS, V3, P3; NOHDA S, 1973, EARTH PLANET SC LETT, V20, P140, DOI 10.1016/0012-821X(73)90151-9; Nutman AP, 2006, J ASIAN EARTH SCI, V26, P99, DOI 10.1016/j.seaes.2004.10.002; Okawa H., 2013, MEM FUKUI PREFECT DI, V12, P35; Osanai Y., 2014, JAPANESE MAGAZINE MI, V43, P71; Shimojo M., 2010, J GEOGR, V119, P257; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; Suzuki K., 2010, J GEOGR, V119, P1172; Tagiri M, 2011, ISL ARC, V20, P259, DOI 10.1111/j.1440-1738.2011.00764.x; Tsujimori T, 2004, J METAMORPH GEOL, V22, P301, DOI 10.1111/j.1525-1314.2004.00515.x; Tsukada Kazuhiro, 1997, Journal of the Geological Society of Japan, V103, P171; Umeda M., 1986, J GEOLOGICAL SOC JAP, V92, P155; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; Yasui T., 1984, EARTH SCI, V38, P89; Yoshikura S., 1990, PRECRETACEOUS TERRAN, P185; Yoshikura S., 1985, J GEOSCI-OSAKA CITY, V28, P45; Yoshikura S., 1979, BASEMENT JAPANESE IS, P319	68	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	JAN 1	2015	97		A				125	135		10.1016/j.jseaes.2014.10.018		11	Geosciences, Multidisciplinary	Geology	AY5FD	WOS:000347597500009		
J	Tanimoto, Y; Shimoyama, K; Mori, S				Tanimoto, Youichi; Shimoyama, Kou; Mori, Shoichi			Continuous Daily Observation of the Marine Atmospheric Boundary Layer over the Kuroshio by a Helicopter Shuttle Service	JOURNAL OF ATMOSPHERIC AND OCEANIC TECHNOLOGY			English	Article							SEA-SURFACE TEMPERATURE; EASTERN EQUATORIAL PACIFIC; LOW-LEVEL WINDS; GULF-STREAM; IN-SITU; VARIABILITY; SATELLITE	This paper describes a new initiative in which in situ observations of the marine atmospheric boundary layer (MABL) are made by a helicopter shuttle connecting six islands south of Tokyo. This observation method aims to make frequent measurements of temperature and moisture in the MABL across an ocean front, where direct measurements of the MABL have been limited. An onboard observation system to meet flight regulations was developed. Observed temperature and moisture as a function of pressure at 1-s intervals provided vertical profiles up to the 900-hPa level above each of the islands, from 24 December 2010 to 6 April 2011, with the exception of an accidental power down inmid-February 2011. The observed values are validated by intercomparison with surface measurements from weather stations, atmospheric soundings, and mesoscale weather analysis provided by the Japan Meteorological Agency. Temperature and moisture values obtained using the system described here at the surface are significantly correlated with those from the weather station. The meridional changes revealed by the observed vertical profiles depict rich MABL structures, such as a cold-air intrusion and a strong near-surface inversion, that are not captured by the mesoscale weather analysis. However, this discrepancy is probably due to insufficient treatment in the mesoscale numerical model rather than observational errors. Additional intercomparisons indicate no influence from either artificial mixing by the helicopter rotor or by dynamic pressure caused by the fast-moving helicopter when obtaining the vertical profiles. Following these validations, the continuation of the initiative will allow for examining the influence of the ocean front on the overlying MABL on a synoptic time scale.	[Tanimoto, Youichi] Hokkaido Univ, Grad Sch Environm Sci, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Tanimoto, Youichi] JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Shimoyama, Kou; Mori, Shoichi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan	Tanimoto, Y (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Fac Environm Earth Sci, Kita Ku, N10 W5, Sapporo, Hokkaido 0600810, Japan.	tanimoto@ees.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22340132, 22106007, 26241003]	We thank Mr. N. Naito, Mr. T. Miyauchi, Mr. T. Asakura, and Mr. T. Namiki of Toho Air Service Co., Ltd., for helping and supporting our observation on Tokyo Island Shuttle. Tokyo Metropolitan Islands Promotion Corporation has approved our observational initiative. Practical advice from Mr. K. Shinbori and Mr. S. Nakatsubo, and the other members in the Technical Division of the Institute of Low Temperature Science, Hokkaido University, were helpful in developing the observation system. This study was supported partially by Grants-In-Aid for Scientific Research by the Ministry of Education, Culture, Sports, Science and Technology of Japan (22340132, 22106007, and 26241003).	Adachi S, 2007, SOLA, V3, P113, DOI 10.2151/sola.2007-029; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; Song QT, 2009, J CLIMATE, V22, P146, DOI 10.1175/2008JCLI2488.1; Tanimoto Y, 2009, J CLIMATE, V22, P1360, DOI 10.1175/2008JCLI2420.1; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Nakamura H, 2012, J CLIMATE, V25, P7772, DOI 10.1175/JCLI-D-12-00326.1; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; HAYES SP, 1989, J CLIMATE, V2, P1500, DOI 10.1175/1520-0442(1989)002<1500:TIOSST>2.0.CO;2; de Camargo R, 2013, J GEOPHYS RES-ATMOS, V118, P6266, DOI 10.1002/jgrd.50492; Iizuka S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012576; Kawamura H, 2010, J OCEANOGR, V66, P61; Moninger WR, 2003, B AM METEOROL SOC, V84, P203, DOI 10.1175/BAMS-84-2-203; Ninomiya K., 1977, J METEOR SOC JAPAN, V55, P431; Pezzi LP, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011379; Pezzi LP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023866; SWEET W, 1981, MON WEATHER REV, V109, P1042, DOI 10.1175/1520-0493(1981)109<1042:ASIEIT>2.0.CO;2; Tokinaga H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025102	20	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0739-0572	1520-0426		J ATMOS OCEAN TECH	J. Atmos. Ocean. Technol.	JAN	2015	32	1					3	21		10.1175/JTECH-D-14-00067.1		19	Engineering, Ocean; Meteorology & Atmospheric Sciences	Engineering; Meteorology & Atmospheric Sciences	AZ4WL	WOS:000348221100001		
J	Yano, S; Teramoto, N; Miyamoto, R; Nakajima, E; Hashimoto, K; Shibata, M				Yano, Shinya; Teramoto, Naozumi; Miyamoto, Rikako; Nakajima, Eiichi; Hashimoto, Kazuaki; Shibata, Mitsuhiro			Fibroblast cell proliferation on photo-cured trehalose cinnamoyl ester thin films	JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS			English	Article						Trehalose; cinnamoyl ester; photocuring; biocompatibility; cell proliferation; contact angle	SUBSTRATUM-BOUND FIBRONECTIN; LIQUID-CRYSTAL ALIGNMENT; CROSS-LINKING; SIDE-CHAIN; MAIN-CHAIN; POLYMERS; ADHESION; BIOCOMPATIBILITY; SURFACES; ACID	Trehalose cinnamoyl esters (TCs) were synthesized by esterification of trehlaose with cinnamoyl chloride. Two TCs with different degrees of substitution were synthesized, and trehalose cinnamoyl ester thin film-coated glass plates were prepared by a dip-coating method. Photocuring of the TCs was confirmed by ultraviolet-visible spectral changes. The surface of photo-cured TCs were found smooth as observed in a scanning electron microscope. The cell proliferation on the photo-cured TCs was investigated using 3T3 Swiss Albino mouse embryo fibroblasts. The results of the cell proliferation assay revealed that the photo-cured TCs with higher degrees of substitution promoted the cell proliferation compared with a polystyrene culture plate and the photo-cured TCs with lower degrees of substitution. The contact angle of the photo-cured TCs with higher degrees of substitution was 101.0 degrees +/- 1.6 degrees, which is much higher than that of the polystyrene culture plate, and it is out of the range known to be suitable for cell adhesion. Nevertheless, the cell unexpectedly grew best on the photo-cured TCs with higher degrees of substitution. Fibronectin binding assay was carried out using fluorescent probe-modified fibronectin, and more fibronectin was found adsorbed onto photo-cured TCs than a polystyrene culture plate.	[Yano, Shinya; Teramoto, Naozumi; Miyamoto, Rikako; Nakajima, Eiichi; Hashimoto, Kazuaki; Shibata, Mitsuhiro] Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, Narashino, Chiba 2750016, Japan	Teramoto, N (reprint author), Chiba Inst Technol, Dept Life & Environm Sci, Fac Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	teramoto.naozumi@it-chiba.ac.jp					ALTANKOV G, 1995, EXP CELL RES, V216, P299, DOI 10.1006/excr.1995.1038; Anderson K, 2012, BIOMACROMOLECULES, V13, P2229, DOI 10.1021/bm300471n; Kawatsuki N, 2000, CHEM MATER, V12, P1549, DOI 10.1021/cm000066t; Mancini RJ, 2012, J AM CHEM SOC, V134, P8474, DOI 10.1021/ja2120234; Zhu CC, 2013, ACTA BIOMATER, V9, P7362, DOI 10.1016/j.actbio.2013.03.041; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Patist A, 2005, COLLOID SURFACE B, V40, P107, DOI 10.1016/j.colsurfb.2004.05.003; Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J; Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013; Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18; Rochette JM, 2013, MACROMOLECULES, V46, P2134, DOI 10.1021/ma302354a; GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308; Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688; Kawatsuki N, 1997, MACROMOLECULES, V30, P6680, DOI 10.1021/ma9703315; Matsusaki M, 2001, J APPL POLYM SCI, V82, P2357; Srinivasachari S, 2006, J AM CHEM SOC, V128, P8176, DOI 10.1021/ja0585580; AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Miyamoto K, 2004, J BIOMED MATER RES A, V70A, P550, DOI 10.1002/jbm.a.30112; ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Belsito D, 2007, FOOD CHEM TOXICOL, V45, pS1, DOI 10.1016/j.fct.2007.09.087; Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291; Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005; Boudreau LH, 2009, NEW J CHEM, V33, P1932, DOI 10.1039/b907878a; Cristescu R, 2007, J PHYS CONF SER, V59, P144, DOI 10.1088/1742-6596/59/1/031; Dong CM, 2005, BIOMATERIALS, V26, P4041, DOI 10.1016/j.biomaterials.2004.10.017; GRINNELL F, 1982, J BIOL CHEM, V257, P4888; KURITA K, 1994, MACROMOLECULES, V27, P7544, DOI 10.1021/ma00104a007; Matsusaki M, 2005, BIOMATERIALS, V26, P6263, DOI 10.1016/j.biomaterials.2005.03.044; Miura Y, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/2/024407; Miura Y, 2004, J POLYM SCI POL CHEM, V42, P4598, DOI 10.1002/pola.20385; Nagata M, 2009, EUR POLYM J, V45, P1111, DOI 10.1016/j.eurpolymj.2009.01.007; NUTLEY BP, 1994, FOOD CHEM TOXICOL, V32, P877, DOI 10.1016/0278-6915(94)90085-X; Park OJ, 2000, BIOTECHNOL BIOENG, V70, P208, DOI 10.1002/1097-0290(20001020)70:2<208::AID-BIT10>3.3.CO;2-S; Sharma A, 2010, BIOORGAN MED CHEM, V18, P4711, DOI 10.1016/j.bmc.2010.05.015; SHINDO Y, 1989, EUR POLYM J, V25, P1033, DOI 10.1016/0014-3057(89)90133-X; Teramoto N, 2004, CARBOHYD POLYM, V56, P1, DOI 10.1016/j.carbpol.2003.03.002; Teramoto N, 2006, CARBOHYD POLYM, V64, P78, DOI 10.1016/j.carbpol.2005.10.029; Teramoto N, 2008, MOLECULES, V13, P1773, DOI 10.3390/molecules13081773; Teramoto N, 2007, POLYM J, V39, P975, DOI 10.1295/polymj.PJ2006279; Teramoto N, 2007, POLYM ADVAN TECHNOL, V18, P971, DOI 10.1002/pat.942; Teramoto N, 2005, CARBOHYD POLYM, V59, P217, DOI 10.1016/j.carbpol.2004.09.010; Wada M, 2011, POLYM CHEM-UK, V2, P1822, DOI 10.1039/c1py00072a; Yamaguchi J, 2007, J APPL POLYM SCI, V104, P44, DOI 10.1002/app.24176	45	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0883-9115	1530-8030		J BIOACT COMPAT POL	J. Bioact. Compat. Polym.	JAN	2015	30	1					87	98		10.1177/0883911514558012		12	Biotechnology & Applied Microbiology; Materials Science, Biomaterials; Polymer Science	Biotechnology & Applied Microbiology; Materials Science; Polymer Science	AZ0YB	WOS:000347966700007		
J	Endo, T				Endo, Tamao			Glycobiology of alpha-dystroglycan and muscular dystrophy	JOURNAL OF BIOCHEMISTRY			English	Review						dystroglycan; glycan biosynthesis; glycosyltransferase; muscular dystrophy; O-mannosyl glycan	WALKER-WARBURG-SYNDROME; PROTEIN O-MANNOSYLATION; GDP-MANNOSE PYROPHOSPHORYLASE; RABBIT SKELETAL-MUSCLE; LAMININ-BINDING; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; GENE POMT1; MUTATIONS; GLYCANS	Most proteins are modified by glycans, which can modulate the biological properties and functions of glycoproteins. The major glycans can be classified into N-glycans and O-glycans according to their glycan-peptide linkage. This review will provide an overview of the O-mannosyl glycans, one subtype of O-glycans. Originally, O-mannosyl glycan was only known to be present on a limited number of glycoproteins, especially alpha-dystroglycan (alpha-DG). However, once a clear relationship was established between O-mannosyl glycan and the pathological mechanisms of some congenital muscular dystrophies in humans, research on the biochemistry and pathology of O-mannosyl glycans has been expanding. Because alpha-DG glycosylation is defective in congenital muscular dystrophies, which also feature abnormal neuronal migration, these disorders are collectively called alpha-dystroglycanopathies. In this article, I will describe the structure, biosynthesis and pathology of O-mannosyl glycans.	[Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Tokyo 1730015, Japan; [Endo, Tamao] Inst Gerontol, Tokyo 1730015, Japan	Endo, T (reprint author), Tokyo Metropolitan Geriatr Hosp, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	endo@tmig.or.jp			NCNP [26-8]	This work was supported in part by a Gran-in-Aid for Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders of NCNP.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V410, P632, DOI 10.1016/j.bbrc.2011.06.042; Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V320, P39, DOI 10.1016/j.bbrc.2004.05.129; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; de Bernabe DBV, 2002, AM J HUM GENET, V71, P1033; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; Yuen CT, 1997, J BIOL CHEM, V272, P8924; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Kobayashi K, 1998, NATURE, V394, P388; Xu CC, 2013, SCIENCE, V340, P978, DOI 10.1126/science.1234055; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Yang AC, 2013, MOL GENET METAB, V110, P345, DOI 10.1016/j.ymgme.2013.06.016; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Martinez T, 2007, J CHROMATOGR A, V1156, P183, DOI 10.1016/j.chroma.2007.04.050; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1327.2000.01781.x; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature000838; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Ashikov A, 2013, GLYCOBIOLOGY, V23, P303, DOI 10.1093/glycob/cws153; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Chiba A, 1997, J BIOL CHEM, V272, P2156; Fernandez F, 2002, GLYCOBIOLOGY, V12, P555, DOI 10.1093/glycob/cwf068; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Kuga A, 2012, J BIOL CHEM, V287, P9560, DOI 10.1074/jbc.M111.271767; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Manya H, 2008, NEUROMUSCULAR DISORD, V18, P45, DOI 10.1016/j.nmd.2007.08.002; Manya H, 2010, J BIOCHEM, V147, P337, DOI 10.1093/jb/mvp170; Nakagawa N, 2012, J BIOL CHEM, V287, P30823, DOI 10.1074/jbc.M112.363036; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Shaheen R, 2013, NEUROGENETICS, V14, P243, DOI 10.1007/s10048-013-0367-8; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	81	6	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JAN	2015	157	1					1	12		10.1093/jb/mvu066		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ5LX	WOS:000348263500001		
J	Miyata, S; Kitagawa, H				Miyata, Shinji; Kitagawa, Hiroshi			Mechanisms for modulation of neural plasticity and axon regeneration by chondroitin sulphate	JOURNAL OF BIOCHEMISTRY			English	Review						axon regeneration; chondroitin sulphate proteoglycan; critical period plasticity; glycosaminoglycan; perineuronal net	ADULT VISUAL-CORTEX; OCULAR DOMINANCE PLASTICITY; CRITICAL PERIOD PLASTICITY; PERINEURONAL NET FORMATION; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; MOLECULAR-CLONING; EXTRACELLULAR-MATRIX; N-ACETYLGALACTOSAMINE; CAENORHABDITIS-ELEGANS	Chondroitin sulphate proteoglycans (CSPGs), consisting of core proteins linked to one or more chondroitin sulphate (CS) chains, are major extracellular matrix (ECM) components of the central nervous system (CNS). Multi-functionality of CSPGs can be explained by the diversity in structure of CS chains that undergo dynamic changes during development and under pathological conditions. CSPGs, together with other ECM components, form mesh-like structures called perineuronal nets around a subset of neurons. Enzymatic digestion or genetic manipulation of CSPGs reactivates neural plasticity in the adult brain and improves regeneration of damaged axons after CNS injury. Recent studies have shown that CSPGs not only act as non-specific physical barriers that prevent rearrangement of synaptic connections but also regulate neural plasticity through specific interaction of CS chains with its binding partners in a manner that depends on the structure of the CS chain.	[Miyata, Shinji; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan; [Miyata, Shinji] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kitagawa, H (reprint author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobephanna-u.ac.jp			Ministry of Education, Culture, Sports, Science & Technology, Japan [25860057, 23110003]	This work was supported by Grants-in-Aid for Young Scientists (B) No. 25860057 (to S.M.) and for Scientific Research on Innovative Areas No. 23110003 (to H.K.) and by the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H.K.) from the Ministry of Education, Culture, Sports, Science & Technology, Japan.	Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Vo T, 2013, MOL CELL NEUROSCI, V56, P186, DOI 10.1016/j.mcn.2013.04.009; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Bekku Y, 2012, J COMP NEUROL, V520, P1721, DOI 10.1002/cne.23009; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Dick G, 2013, J BIOL CHEM, V288, P27384, DOI 10.1074/jbc.M111.310029; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Giamanco KA, 2010, NEUROSCIENCE, V170, P1314, DOI 10.1016/j.neuroscience.2010.08.032; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Gu Y, 2013, NEURON, V79, P335, DOI 10.1016/j.neuron.2013.05.016; Geissler M, 2013, J NEUROSCI, V33, P7742, DOI 10.1523/JNEUROSCI.3275-12.2013; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Xue YX, 2014, J NEUROSCI, V34, P6647, DOI 10.1523/JNEUROSCI.5390-13.2014; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Morawski M, 2010, NEUROSCIENCE, V169, P1347, DOI 10.1016/j.neuroscience.2010.05.022; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; HARTIG W, 1992, NEUROREPORT, V3, P869; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Happel MFK, 2014, P NATL ACAD SCI USA, V111, P2800, DOI 10.1073/pnas.1310272111; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Weber P, 1999, J NEUROSCI, V19, P4245; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; de Vivo L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2491; Despras G, 2013, CHEM-EUR J, V19, P530, DOI 10.1002/chem.201202173; FUKUTA M, 1995, J BIOL CHEM, V270, P18575; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Lin R., 2011, PLOS ONE, V6, P21499; Miyata S, 2005, NEUROSCIENCE, V136, P95, DOI 10.1016/j.neuroscience.2005.07.031; Suttkus A., 2014, CELL DEATH DIS, V5, P1119; Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Yamada S, 2012, ADV EXP MED BIOL, V749, P47, DOI 10.1007/978-1-4614-3381-1_4; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	92	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JAN	2015	157	1					13	22		10.1093/jb/mvu067		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ5LX	WOS:000348263500002		
J	Suzuki, T				Suzuki, Tadashi			The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder	JOURNAL OF BIOCHEMISTRY			English	Review						Ngly1; PNGase; ERAD; genetic disorder; basic science	RETICULUM-ASSOCIATED DEGRADATION; BETA-N-ACETYLGLUCOSAMINIDASE; UBIQUITIN-PROTEASOME PATHWAY; ER-ASSOCIATED DEGRADATION; PROTEIN-PROTEIN INTERACTION; I-RESTRICTED EPITOPE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; FREE OLIGOSACCHARIDES; MEMBRANE-PROTEIN	Peptide:N-glycanase (PNGase) is a de-N-glycosylating enzyme that cleaves intact N-glycans from glycoproteins/glycopeptides. The activity of the cytoplasmic PNGase in several mammalian-derived cultured cells was first reported in 1993, and 7 years later, the gene encoding the enzyme was identified in budding yeast. Although the gene-PNG1 in budding yeast and NGLY1/Ngly1 in mammalian cells appears to be well conserved throughout eukaryotes, the biological significance of this enzyme has remained elusive until recently. However, discovery of a human genetic disorder involving the NGLY1 gene clearly indicates that this enzyme plays a critical role in human biology. This review summarizes the research history of cytoplasmic PNGase. The importance of curiosity-driven, pure 'basic science' will also be discussed.	[Suzuki, Tadashi] RIKEN, Global Res Cluster, Max Planck Joint Res Ctr Syst Chem Biol, Glycometabolome Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Suzuki, T (reprint author), RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp			Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [25291030, 25650041, 26110725]	This research in the Suzuki laboratory is supported by the Yamada Science Foundation as well as Grant-In-Aids (25291030, 25650041, 26110725) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anantharaman V, 2001, HUM MOL GENET, V10, P1627, DOI 10.1093/hmg/10.16.1627; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V453, P213, DOI 10.1016/j.bbrc.2014.05.075; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Chantret I, 2011, J BIOL CHEM, V286, P41786, DOI 10.1074/jbc.M111.251371; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; Hagihara S, 2007, GLYCOBIOLOGY, V17, P1070, DOI 10.1093/glycob/cwm079; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; Habibi-Babadi N, 2010, J NEUROSCI, V30, P1766, DOI 10.1523/JNEUROSCI.4962-08.2010; Masahara-Negishi Y, 2012, BBA-GEN SUBJECTS, V1820, P1457, DOI 10.1016/j.bbagen.2012.05.009; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Wang T, 2014, PROTEIN PEPTIDE LETT, V21, P976; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.0142/BJ20030384; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Li GT, 2005, P NATL ACAD SCI USA, V102, P15809, DOI 10.1073/pnas.0507155102; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Qu DF, 1996, J BIOL CHEM, V271, P22791; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Xin FX, 2008, BIOCHEM BIOPH RES CO, V368, P907, DOI 10.1016/j.bbrc.2008.02.017; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Yoshida Y, 2010, BBA-GEN SUBJECTS, V1800, P172, DOI 10.1016/j.bbagen.2009.07.029; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; Suzuki T, 2001, BIOCHEM BIOPH RES CO, V287, P1083, DOI 10.1006/bbrc.2001.5688; Grotzke JE, 2013, P NATL ACAD SCI USA, V110, P3393, DOI 10.1073/pnas.1300328110; Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; HARTWELL LH, 1967, J BACTERIOL, V93, P1662; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Dalet A, 2011, P NATL ACAD SCI USA, V108, pE323, DOI 10.1073/pnas.1101892108; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Schauber C, 1998, NATURE, V391, P715; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Makarova KS, 1999, PROTEIN SCI, V8, P1714; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Katiyar S, 2002, J BIOL CHEM, V277, P12953, DOI 10.1074/jbc.M111383200; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Biederer T, 1996, EMBO J, V15, P2069; Caglayan AO, 2015, EUR J MED GENET, V58, P39, DOI 10.1016/j.ejmg.2014.08.008; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Costanzi E, 2006, BBA-GEN SUBJECTS, V1760, P1580, DOI 10.1016/j.bbagen.2006.06.011; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Dieterle MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010703; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545; Gosain A, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-9; Gosain A, 2014, INDIAN J EXP BIOL, V52, P197; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Kamiya Y, 2009, GLYCOBIOLOGY RES TRE, P27; Kamiya Y, 2012, FEBS LETT, V586, P1141, DOI 10.1016/j.febslet.2012.03.027; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 2007, J BIOCHEM, V142, P175, DOI 10.1093/jb/mvm117; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Might M, 2014, GENET MED, V16, P736, DOI 10.1038/gim.2014.23; Misaghi S, 2006, CELL DEATH DIFFER, V13, P163, DOI 10.1038/sj.cdd.4401716; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Park S, 2014, HISTOCHEM CELL BIOL, V142, P153, DOI 10.1007/s00418-014-1204-3; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; SEKO A, 1991, J BIOL CHEM, V266, P22110; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; SUZUKI T, 1994, GLYCOCONJUGATE J, V11, P469, DOI 10.1007/BF00731283; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; Suzuki T, 2006, J BIOL CHEM, V281, P22152, DOI 10.1074/jbc.M603236200; SUZUKI T, 1995, GLYCOCONJUGATE J, V12, P183, DOI 10.1007/BF00731318; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V358, P837, DOI 10.1016/j.bbrc.2007.04.199; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V302, P1, DOI 10.1016/S0006-291X(03)00052-4; SUZUKI T, 1995, J BIOL CHEM, V270, P15181; SUZUKI T, 1994, GLYCOBIOLOGY, V4, P777, DOI 10.1093/glycob/4.6.777; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Tzelepis G, 2014, BIOCHEM BIOPH RES CO, V449, P256, DOI 10.1016/j.bbrc.2014.05.017; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757; Yamaguchi Y, 2007, BIOCHEM BIOPH RES CO, V362, P712, DOI 10.1016/j.bbrc.2007.08.056; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	117	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JAN	2015	157	1					23	34		10.1093/jb/mvu068		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ5LX	WOS:000348263500003		
J	Numamoto, M; Sasano, Y; Hirasaki, M; Sugiyama, M; Maekawa, H; Harashima, S				Numamoto, Minori; Sasano, Yu; Hirasaki, Masataka; Sugiyama, Minetaka; Maekawa, Hiromi; Harashima, Satoshi			The protein phosphatase Siw14 controls caffeine-induced nuclear localization and phosphorylation of Gln3 via the type 2A protein phosphatases Pph21 and Pph22 in Saccharomyces cerevisiae	JOURNAL OF BIOCHEMISTRY			English	Article						Gln3; intracellular localization; phosphorylation; Saccharomyces cerevisiae; Siw14	TOR SIGNALING PATHWAY; REGULATORY SUBUNIT; SIT4 PHOSPHATASE; CELL-GROWTH; YEAST; TAP42; MORPHOGENESIS; KINASE; GENES; ASSOCIATION	The Saccharomyces cerevisiae Siw14, a tyrosine phosphatase involved in the response to caffeine, participates in regulation of the phosphorylation and intracellular localization of Gln3, a GATA transcriptional activator of nitrogen catabolite repression-sensitive genes. In Delta siw14 cells, the phosphorylation level of Gln3 is decreased and the nuclear localization of Gln3 is stimulated by caffeine. However, the mechanism by which Siw14 controls the localization and function of Gln3 remains unclear, although the nuclear localization of Gln3 is known to be induced by activation of the type 2A phosphatases (PP2As) Pph21 and Pph22, and the type 2A-related phosphatase Sit4. In this study, we show that the increased nuclear localization of Gln3 in response to caffeine caused by disruption of the SIW14 gene is dependent on the Sit4 and PP2A phosphatases. We also show that decreased phosphorylation of Gln3 caused by disruption of the SIW14 gene is completely suppressed by deletion of both PPH21 and PPH22, but only partially suppressed by deletion of SIT4. Taking these results together, we conclude that Siw14 functions upstream of Pph21 and Pph22 as an inhibitor of the phosphorylation and localization of Gln3, and that Sit4 acts independently of Siw14.	[Numamoto, Minori; Sasano, Yu; Hirasaki, Masataka; Sugiyama, Minetaka; Harashima, Satoshi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Maekawa, Hiromi] Osaka Univ, Grad Sch Engn, Yeast Genet Resources Lab, Suita, Osaka 5650871, Japan	Harashima, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	harashima@bio.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19380193]	This work was supported by a Grant-in-Aid for Scientific Research B 19380193, 2007-09, to S.H. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. M.N. expresses special thanks to the Global COB (center of excellence) Program 'Global Education and Research Center for Bio-Environment Chemistry' of Osaka University.	Beck T, 1999, NATURE, V402, P689; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hermansyah, 2009, ARCH MICROBIOL, V191, P721, DOI 10.1007/s00203-009-0498-3; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; SUTTON A, 1991, MOL CELL BIOL, V11, P2133; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; CLOTET J, 1995, EUR J BIOCHEM, V229, P207, DOI 10.1111/j.1432-1033.1995.tb20457.x; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162; HEALY AM, 1991, MOL CELL BIOL, V11, P5767; Hermansyah, 2010, ARCH MICROBIOL, V192, P157, DOI 10.1007/s00203-009-0531-6; Hirasaki M, 2008, GENE, V409, P34, DOI 10.1016/j.gene.2007.11.005; Hirasaki M, 2010, J BIOSCI BIOENG, V109, P433, DOI 10.1016/j.jbiosc.2009.10.023; Koren R, 2004, J BIOL CHEM, V279, P48598, DOI 10.1074/jbc.M409359200; Lavina W.A., 2013, J BIOSCI BIOENG, V117, P135; Lavina WA, 2013, J BIOSCI BIOENG, V115, P138, DOI 10.1016/j.jbiosc.2012.08.022; LIN FC, 1995, EMBO J, V14, P2745; NOJIMA H, 1994, NUCLEIC ACIDS RES, V22, P5279, DOI 10.1093/nar/22.24.5279; RONNE H, 1991, MOL CELL BIOL, V11, P4876; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Sambrook E. F., 1989, MOL CLONING LAB MANU; Shu YM, 1997, MOL CELL BIOL, V17, P3242; SNEDDON AA, 1990, EMBO J, V9, P4339; Sugiyama M, 2005, BIOTECHNIQUES, V38, P909, DOI 10.2144/05386RR01; VANZYL W, 1992, MOL CELL BIOL, V12, P4946; Wang YC, 1997, MOL CELL BIOL, V17, P620	42	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	JAN	2015	157	1					53	64		10.1093/jb/mvu055		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ5LX	WOS:000348263500006		
J	Furuita, K; Kataoka, S; Sugiki, T; Hattori, Y; Kobayashi, N; Ikegami, T; Shiozaki, K; Fujiwara, T; Kojima, C				Furuita, Kyoko; Kataoka, Saori; Sugiki, Toshihiko; Hattori, Yoshikazu; Kobayashi, Naohiro; Ikegami, Takahisa; Shiozaki, Kazuhiro; Fujiwara, Toshimichi; Kojima, Chojiro			Utilization of paramagnetic relaxation enhancements for high-resolution NMR structure determination of a soluble loop-rich protein with sparse NOE distance restraints	JOURNAL OF BIOMOLECULAR NMR			English	Article						Paramagnetic relaxation enhancement; PRE; Structure determination; Soluble protein; RDC; Sin1	MOLECULAR-STRUCTURE DETERMINATION; NUCLEAR-MAGNETIC-RESONANCE; TORSION ANGLE DYNAMICS; RICTOR-MTOR COMPLEX; BACKBONE DYNAMICS; XPLOR-NIH; KINASE; PHOSPHORYLATION; SPECTROSCOPY; TOR	NMR structure determination of soluble proteins depends in large part on distance restraints derived from NOE. In this study, we examined the impact of paramagnetic relaxation enhancement (PRE)-derived distance restraints on protein structure determination. A high-resolution structure of the loop-rich soluble protein Sin1 could not be determined by conventional NOE-based procedures due to an insufficient number of NOE restraints. By using the 867 PRE-derived distance restraints obtained from the NOE-based structure determination procedure, a high-resolution structure of Sin1 could be successfully determined. The convergence and accuracy of the determined structure were improved by increasing the number of PRE-derived distance restraints. This study demonstrates that PRE-derived distance restraints are useful in the determination of a high-resolution structure of a soluble protein when the number of NOE constraints is insufficient.	[Furuita, Kyoko; Kataoka, Saori; Sugiki, Toshihiko; Hattori, Yoshikazu; Kobayashi, Naohiro; Ikegami, Takahisa; Fujiwara, Toshimichi; Kojima, Chojiro] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shiozaki, Kazuhiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Kojima, C (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kojima@protein.osaka-u.ac.jp			MEXT/JSPS KAKENHI; TPRP; Platform for Drug Discovery, Informatics, and Structural Life Science	We thank Dr. Peter Guntert for letting us use CYANA 3.95. We thank Momoko Yoneyama, and Yuki Nishigaya for sample preparation and mass spectrometry measurements, respectively. This work was supported in part by Grants from MEXT/JSPS KAKENHI, TPRP, Platform for Drug Discovery, Informatics, and Structural Life Science to K.S., T.F. and C.K., and Grants-in-Aid for JSPS Fellows to K.F. and S.K.	MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gottstein D, 2012, STRUCTURE, V20, P1019, DOI 10.1016/j.str.2012.03.010; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Yang YH, 2010, J AM CHEM SOC, V132, P11910, DOI 10.1021/ja105080h; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Madl T, 2011, ANGEW CHEM INT EDIT, V50, P3993, DOI 10.1002/anie.201007168; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Ikeda K, 2008, CELL CYCLE, V7, P358; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1016/S0022-2836(05)80134-2; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Goddard, 2008, SPARKY 3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; Huang YPJ, 2003, J MOL BIOL, V327, P521, DOI 10.1016/S0022-2836(03)00061-5; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kataoka S, 2014, BIOMOL NMR ASSIGN, DOI [10.1007/s12104-014-9550-6, DOI 10.1007/S12104-014-9550-6]; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Madl T, 2010, J AM CHEM SOC, V132, P7285, DOI 10.1021/ja1014508; Nilges M, 1997, FOLD DES, V2, pS53, DOI 10.1016/S1359-0278(97)00064-3; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	JAN	2015	61	1					55	64		10.1007/s10858-014-9882-7		10	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	AZ7UY	WOS:000348424400006		
J	Itatani, R; Namimoto, T; Takaoka, H; Katahira, K; Noda, S; Toyonari, N; Yamashita, Y				Itatani, Ryo; Namimoto, Tomohiro; Takaoka, Hiroko; Katahira, Kazuhiro; Noda, Seiichiro; Toyonari, Nobuyuki; Yamashita, Yasuyuki			Clinical Impact of 3-Dimensional Balanced Turbo-Field-Echo Magnetic Resonance Cholangiopancreatography at 3 T: Prospective Intraindividual Comparison With 3-Dimensional Turbo-Spin-Echo Magnetic Resonance Cholangiopancreatography	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						MRCP; BTFE; VISTA; 3D	MR CHOLANGIOGRAPHY; INITIAL-EXPERIENCE; HEALTHY-VOLUNTEERS; ACQUISITION; SEQUENCE; SPACE	Objective: The objective of this study was to evaluate the clinical utility of 3-dimensional (3D) balanced turbo-field-echo (BTFE) magnetic resonance cholangiopancreatography (MRCP) with gate and track acquisition at 3 T. Methods: Using a 3-T unit, we subjected 52 consecutive patients to 3D BTFE MRCP with the navigator-gated technique and 3D turbo-spin-echo volume isotropic T2-weighted acquisition (VISTA) MRCP with the navigator-triggered technique. Two radiologists independently rated the image quality and visibility of the right and left hepatic duct, cystic duct, common bile duct, gallbladder, and main pancreatic duct using a 4-point scale. The signal-to-noise ratio, contrast-to-noise ratio, and the acquisition time were evaluated by quantitative analysis. Results: The visual scores of the cystic duct, common bile duct, gallbladder, and overall image quality were significantly higher for BTFE than VISTA MRCP (P < 0.01). The score for the main pancreatic duct was significantly higher with VISTA MRCP (P < 0.01). The image acquisition time was significantly shorter with BTFE than VISTA MRCP (139.8 +/- 45.4 vs 416.9 +/- 108.3 seconds, P < 0.01). There was no significant difference in signal-to-noise ratio and contrast-to-noise ratio. Conclusions: Three-dimensional BTFE MRCP yields significantly better image quality and visibility of large biliary structures than VISTA MRCP at a significantly shorter acquisition time. Volume isotropic T2-weighted acquisition MRCP provides detailed information on the main pancreatic duct that tends to be obscure on the 3D BTFE sequence.	[Itatani, Ryo; Namimoto, Tomohiro; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan; [Itatani, Ryo; Takaoka, Hiroko; Katahira, Kazuhiro; Noda, Seiichiro; Toyonari, Nobuyuki] Kumamoto City Hosp, Dept Radiol, Kumamoto, Japan	Itatani, R (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	banguliao@gmail.com					Chang KJ, 2008, RADIOGRAPHICS, V28, P1983, DOI 10.1148/rg.287075154; Seo JM, 2011, ACTA RADIOL, V52, P1119, DOI 10.1258/ar.2011.110328; Yoshida A, 2013, J COMPUT ASSIST TOMO, V37, P84, DOI 10.1097/RCT.0b013e318271f216; Merkle EM, 2006, AM J ROENTGENOL, V186, P1524, DOI 10.2214/AJR.05.0932; Sodickson A, 2006, RADIOLOGY, V238, P549, DOI 10.1148/radiol.2382032065; Lim D, 2013, EUR J RADIOL, V82, P2296, DOI 10.1016/j.ejrad.2013.08.013; Isoda H, 2007, J MAGN RESON IMAGING, V25, P1000, DOI 10.1002/jmri.20892; Itatani R, 2013, EUR RADIOL, V23, P1911, DOI 10.1007/s00330-013-2790-5; Botnar RM, 1999, CIRCULATION, V99, P3139; Sakurai K, 2013, J NEURORADIOLOGY, V40, P19, DOI 10.1016/j.neurad.2012.02.005; Limanond P, 2004, J MAGN RESON IMAGING, V19, P209, DOI 10.1002/jmri.10446; Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0; Irie H, 2001, RADIOGRAPHICS, V21, P23; Arizono S, 2008, J MAGN RESON IMAGING, V28, P685, DOI 10.1002/jmri.21484; Arizono S, 2010, EUR J RADIOL, V73, P114, DOI 10.1016/j.ejrad.2008.08.003; Coenegrachts KL, 2004, RADIOLOGY, V231, P237, DOI 10.1148/radioi.2311030044; Hori M, 2011, RADIOLOGY, V258, P154, DOI 10.1148/radiol.10100866; HRICAK H, 1983, RADIOLOGY, V147, P481; Kuhl CK, 2008, RADIOLOGY, V246, P675, DOI 10.1148/radiol.2463060881; Merkle EM, 2006, AM J ROENTGENOL, V186, P516, DOI 10.2214/AJR.04.1484; Morakkabati-Spitz N, 2006, RADIOLOGY, V241, P538, DOI 10.1148/radiol.2412050877; Nakaura T, 2013, J MAGN RESON IMAGING, V38, P1014, DOI 10.1002/jmri.24033; O'Regan DP, 2005, BRIT J RADIOL, V78, P894, DOI 10.1259/bjr/28094700; Takayama Y, 2015, J MAGN RESON IMAGING, V41, P339, DOI 10.1002/jmri.24554; Taylor ACF, 2002, GASTROINTEST ENDOSC, V55, P17, DOI 10.1067/mge.2002.120324	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2015	39	1					19	24				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ4IG	WOS:000348184200004		
J	Nakai, G; Kitano, R; Yamamoto, K; Higashiyama, A; Juri, H; Tsuboyama, T; Yamamoto, K; Yamada, T; Hirose, Y; Ohmichi, M; Narumi, Y				Nakai, Go; Kitano, Remi; Yamamoto, Kiyohito; Higashiyama, Akira; Juri, Hiroshi; Tsuboyama, Takahiro; Yamamoto, Kazuhiro; Yamada, Takashi; Hirose, Yoshinobu; Ohmichi, Masahide; Narumi, Yoshifumi			Magnetic Resonance Imaging Findings in Atypical Polypoid Adenomyoma	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						atypical polypoid adenomyoma; uterine polypoid tumor; MRI; MRI findings; uterine polypoid lesion	UTERUS; ENDOMETRIUM	Objectives: This article describes magnetic resonance imaging (MRI) findings in 3 cases of atypical polypoid adenomyoma (APAM). Methods: Clinical and MRI manifestations of 3 patients with APAM were evaluated. High b value diffusion-weighted and dynamic contrast-enhanced images were performed. The size, shape, site of origin, and signal intensity (SI) of MRI findings were evaluated. Results: All patients (age range, 37-47 years; mean age, 40 years) had a chief complaint of atypical genital bleeding with no history of pregnancy. In 2 cases, cytology of the endometrium was positive, and pathological analysis of curettage specimens indicated endometrioid adenocarcinoma. The MRI revealed an endometrial polypoid mass arising from the upper corpus (50%) or lower uterine segment (50%). Except for 1 tumor that seemed to invade the myometrium of the uterine wall due to its irregular margin, all tumors were well circumscribed. On T2-weighted MRI scans, the SI of the tumor was homogenous and marginally hyperintense, and contained markedly hyperintense cystic foci. On T1-weighted images, all the tumors were isointense relative to the myometrium, and in 1 case, a number of cystic foci showed high SIs. In a dynamic contrast-enhanced study, solid portions other than the cystic foci showed contrast enhancement in the arterial phase and demonstrated a washout pattern or plateau pattern in the late phase. All tumors demonstrated high SIs on diffusion-weighted images. Conclusions: Differentiating APAM from other malignant polypoid uterine endometrial tumors may still pose difficulties, especially when the tumor seems to invade the myometrium on MRI. Comprehensive clinical information about the patient including age, pathological assessment of the endometrium, and MRI findings should be essential to provide indication for a diagnosis of APAM.	[Nakai, Go; Kitano, Remi; Yamamoto, Kiyohito; Higashiyama, Akira; Juri, Hiroshi; Tsuboyama, Takahiro; Yamamoto, Kazuhiro; Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan; [Yamada, Takashi; Hirose, Yoshinobu] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 5698686, Japan; [Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan	Nakai, G (reprint author), Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	rad091@poh.osaka-med.ac.jp					Teo SY, 2008, AM J ROENTGENOL, V191, P278, DOI 10.2214/AJR.07.3281; YOUNG RH, 1986, AM J CLIN PATHOL, V86, P139; Heatley MK, 2006, HISTOPATHOLOGY, V48, P609, DOI 10.1111/j.1365-2559.2005.02315.x; MAZUR MT, 1981, AM J SURG PATHOL, V5, P473, DOI 10.1097/00000478-198107000-00006; Koyama T, 1999, AM J ROENTGENOL, V173, P767; CLEMENT PB, 1987, INT J GYNECOL PATHOL, V6, P104, DOI 10.1097/00004347-198706000-00002; DELPRADO WJ, 1985, PATHOLOGY, V17, P522; Di Spiezio Sardo A, 2008, FERTIL STERIL, V89; KIM KR, 1990, AM J SURG PATHOL, V14, P925, DOI 10.1097/00000478-199010000-00005; Longacre TA, 1996, AM J SURG PATHOL, V20, P1, DOI 10.1097/00000478-199601000-00001; Matsumoto T, 2013, GYNECOL ONCOL, V129, P54, DOI 10.1016/j.ygyno.2012.12.040; YAMASHITA Y, 1995, COMPUT MED IMAG GRAP, V19, P351, DOI 10.1016/0895-6111(95)00017-8	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2015	39	1					32	36				5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ4IG	WOS:000348184200006		
J	Itatani, R; Namimoto, T; Takaoka, H; Katahira, K; Morishita, S; Kitani, K; Hamada, Y; Kitaoka, M; Nakaura, T; Yamashita, Y				Itatani, Ryo; Namimoto, Tomohiro; Takaoka, Hiroko; Katahira, Kazuhiro; Morishita, Syoji; Kitani, Kosuke; Hamada, Yasuyuki; Kitaoka, Mitsuhiko; Nakaura, Takeshi; Yamashita, Yasuyuki			Extracapsular Extension of Prostate Cancer: Diagnostic Value of Combined Multiparametric Magnetic Resonance Imaging and Isovoxel 3-Dimensional T2-Weighted Imaging at 1.5 T	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						multiparametric MRI; VISTA; prostate cancer; extracapsular extension	TRANSRECTAL ULTRASONOGRAPHY; ECHO SEQUENCE; VOLUME; 3D; LOCALIZATION; ACCURATE; FEATURES; MRI	Objective: The objective of this study was to assess whether adding isovoxel 3-dimensional T2-weighted imaging (volume isotropic T2-weighted acquisition [VISTA]) to multiparametric magnetic resonance imaging (mp-MRI) improves the ability to diagnose the extracapsular extension (ECE) of prostate cancer. Methods: Two radiologists independently evaluated ECE on images acquired with mp-MRI only (method A) and mp-MRI plus VISTA (method B) in 50 men who had undergone prostatectomy. We also compared the signal-to-noise ratio of the tumor on T2WI and VISTA scans. Results: Sensitivity, specificity, and accuracy were higher with method B. For both readers, specificity, accuracy, and the area under the receiver operating characteristic curve of method B were significantly higher than those of method A (reader 1: P = 0.028, 0.025, and 0.006; reader 2: P = 0.017, 0.0071, and 0.018). The signal-to-noise ratio was significantly higher on T2-weighted imaging than VISTA images (9.21 [SD, 2.46] vs 7.30 [SD, 1.87], P < 0.01). Conclusions: The addition of VISTA to mp-MRI improves the diagnostic value for ECE significantly.	[Itatani, Ryo; Namimoto, Tomohiro; Yamashita, Yasuyuki] Kumamoto Univ, Dept Diagnost Radiol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Takaoka, Hiroko; Katahira, Kazuhiro; Morishita, Syoji] Kumamoto City Hosp, Dept Radiol, Kumamoto, Japan; [Kitani, Kosuke; Hamada, Yasuyuki] Kumamoto City Hosp, Dept Urol, Kumamoto, Japan; [Kitaoka, Mitsuhiko] Kumamoto City Hosp, Dept Pathol, Kumamoto, Japan; [Nakaura, Takeshi] Amakusa Med Ctr, Dept Diagnost Radiol, Kumamoto, Japan	Itatani, R (reprint author), Kumamoto Univ, 1-1-1 Honjo, Kumamoto 8608556, Japan.	banguliao@gmail.com					Allen DJ, 2004, BJU INT, V94, P534, DOI 10.1111/j.1464-410X.2004.05023.x; Bloch BN, 2007, RADIOLOGY, V245, P176, DOI 10.1148/radiol.2451061502; OHORI M, 1994, J UROLOGY, V152, P1714; Seo JM, 2011, ACTA RADIOL, V52, P1119, DOI 10.1258/ar.2011.110328; SCHIEBLER ML, 1993, RADIOLOGY, V189, P339; Lim D, 2013, EUR J RADIOL, V82, P2296, DOI 10.1016/j.ejrad.2013.08.013; Zakian KL, 2005, RADIOLOGY, V234, P804, DOI 10.1148/radiol.2343040363; Turkbey B, 2011, J UROLOGY, V186, P1818, DOI 10.1016/j.juro.2011.07.013; Kwon JW, 2012, CLIN RADIOL, V67, P106, DOI 10.1016/j.crad.2011.06.011; Lichy MP, 2005, INVEST RADIOL, V40, P754, DOI 10.1097/01.rli.0000185880.92346.9e; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P446, DOI 10.2214/AJR.09.3217; Akin O, 2006, RADIOLOGY, V239, P784, DOI 10.1148/radiol.2392050949; Hosseinzadeh K, 2004, J MAGN RESON IMAGING, V20, P654, DOI 10.1002/jmri,20159; Haider MA, 2007, AM J ROENTGENOL, V189, P323, DOI 10.2214/AJR.07.2211; Kikuchi E, 2004, J UROLOGY, V172, P508, DOI 10.1097/01.ju.0000130481.04082.1a; Yerram NK, 2012, BJU INT, V110, pE783, DOI 10.1111/j.1464-410X.2012.11646.x; Sakurai K, 2013, J NEURORADIOLOGY, V40, P19, DOI 10.1016/j.neurad.2012.02.005; Mullerad M, 2004, RADIOLOGY, V232, P140, DOI 10.1148/radiol.2321031254; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Hricak H, 2007, RADIOLOGY, V243, P28, DOI 10.1148/radiol.2431030580; Ekici S, 1999, BJU INT, V83, P796; EPSTEIN JI, 1993, CANCER, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y; Hori M, 2011, RADIOLOGY, V258, P154, DOI 10.1148/radiol.10100866; Ikonen S, 1998, J UROLOGY, V159, P915, DOI 10.1016/S0022-5347(01)63770-4; Jager GJ, 1996, AM J ROENTGENOL, V166, P845; Morakkabati-Spitz N, 2006, RADIOLOGY, V241, P538, DOI 10.1148/radiol.2412050877; Perrotti M, 1996, J UROLOGY, V156, P106, DOI 10.1016/S0022-5347(01)65955-X; SanchezChapado M, 1997, EUR UROL, V32, P140; Takayama Y, 2015, J MAGN RESON IMAGING, V41, P339, DOI 10.1002/jmri.24554; Yoshida A, 2013, J COMPUT ASSIST TOMO, V37, P84	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2015	39	1					37	43				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ4IG	WOS:000348184200007		
J	Matsubayashi, RN; Imanishi, M; Nakagawa, S; Takahashi, R; Akashi, M; Momosaki, S; Muranaka, T				Matsubayashi, Roka Namoto; Imanishi, Mika; Nakagawa, Shino; Takahashi, Ryuji; Akashi, Momoko; Momosaki, Seiya; Muranaka, Toru			Breast Ultrasound Elastography and Magnetic Resonance Imaging of Fibrotic Changes of Breast Disease: Correlations Between Elastography Findings and Pathologic and Short Tau Inversion Recovery Imaging Results, Including the Enhancement Ratio and Apparent Diffusion Coefficient	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						elastography; breast; fibrosis; MRI	FIBROSIS	Purpose: Ultrasound (US) elastography provides information regarding tissue hardness and is expected to become a novel diagnostic tool for breast disease. In contrast, magnetic resonance (MR) images reflect the tissue characteristics. Fibrosis of the stroma of breast diseases may affect their hardness. We investigated the correlation among elasticity score (ES) and signal intensity of short Tau inversion recovery MR images, enhancement ratio, apparent diffusion coefficient (ADC), and the fibrosis in the breast lesions. Materials and Methods: We reviewed the findings of US elastography and MR imaging from 41 consecutive patients with breast lesions (25 invasive ductal carcinoma, 3 fibroadenoma, 1 phyllodes tumor, 2 ductal hyperplasia, 2 primary malignant lymphoma, 3 mastopathy, 1 metastasis, 1 tubular adenoma, 1 ductal carcinoma in situ, 1 diabetic mastopathy, and 1 intraductal papilloma). In each patient, elastography images were classified based on Tsukuba ES. We calculated the ratio of signal intensity of the lesion to the muscle on short Tau inversion recovery images (L/M ratio), enhancement ratio of early to precontrast and early to delayed images, and ADC for each lesion. The ES and MR findings were correlated with the degree of fibrosis (based on Masson trichrome stain). Results: The ES significantly correlated with the L/M ratio (P = 0.0306) and the ADC (P = 0.0256). The stromal fibrosis also correlated with ES (P = 0.0023), the L/M ratio (P = 0.0344), and enhancement ratio of the early-to-delayed images (P = 0.049). Conclusions: The ES and L/M ratio are correlated significantly with each other, and they are correlated with the fibrosis. These results suggest that they will provide the information on the fibrosis and may help the diagnosis of breast lesions.	[Matsubayashi, Roka Namoto; Nakagawa, Shino; Takahashi, Ryuji; Akashi, Momoko] Natl Kyushu Med Ctr, Breast Care Ctr, Fukuoka 8108563, Japan; [Matsubayashi, Roka Namoto; Nakagawa, Shino; Takahashi, Ryuji; Akashi, Momoko; Muranaka, Toru] Natl Kyushu Med Ctr, Clin Res Inst, Fukuoka 8108563, Japan; [Imanishi, Mika] Kumamoto Med Ctr, Natl Hosp Org, Dept Radiol, Fukuoka, Japan; [Nakagawa, Shino; Takahashi, Ryuji; Akashi, Momoko] Natl Kyushu Med Ctr, Dept Surg, Fukuoka 8108563, Japan; [Momosaki, Seiya] Natl Kyushu Med Ctr, Dept Pathol, Fukuoka 8108563, Japan; [Muranaka, Toru] Natl Kyushu Med Ctr, Dept Radiol, Fukuoka 8108563, Japan	Matsubayashi, RN (reprint author), Natl Kyushu Med Ctr, Breast Care Ctr, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan.	radmad311@yahoo.co.jp					OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; Parker KJ, 1998, ULTRASOUND MED BIOL, V24, P1437, DOI 10.1016/S0301-5629(98)00123-9; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Matsubayashi R, 2000, RADIOLOGY, V217, P841; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Chaturvedi P, 1998, IEEE T ULTRASON FERR, V45, P1022, DOI 10.1109/58.710585; Kuroki Yoshifumi, 2004, Magn Reson Med Sci, V3, P79, DOI 10.2463/mrms.3.79; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35	11	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2015	39	1					94	101				8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ4IG	WOS:000348184200016		
J	Matsuura, N; Urashima, M; Fukumoto, W; Sunamori, H; Tatsugami, F; Toyota, N; Awai, K				Matsuura, Noriaki; Urashima, Masaki; Fukumoto, Wataru; Sunamori, Hiroshi; Tatsugami, Fuminari; Toyota, Naoyuki; Awai, Kazuo			Radiation Dose Reduction at Coronary Artery Calcium Scoring by Using a Low Tube Current Technique and Hybrid Iterative Reconstruction	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						coronary artery calcium; computed tomography; iterative reconstruction; radiation dose reduction	ELECTRON-BEAM CT; ULTRAFAST COMPUTED-TOMOGRAPHY; HIGH-RESOLUTION KERNEL; TRIGGERED 64-SLICE CT; IMAGE QUALITY; CARDIAC CT; ANGIOGRAPHY; REPRODUCIBILITY; CALCIFICATION; QUANTIFICATION	Purpose: The aim of this study was to compare the accuracy of coronary artery calcium scoring (CACS) on cardiac computed tomographic images using hybrid iterative reconstruction (hIR) and a low tube current as well as on images acquired with a filtered back projection (FBP) algorithm and a normal tube current. Subjects and Methods: Patients (N = 77) with suspected coronary artery disease were subjected to 2 CACS evaluations based on their Agatston, volume, and mass scores. One CACS evaluation was performed on images obtained with a 364-mA tube current and reconstructed with FBP; the other was performed on images obtained with a 73-mA tube current and reconstructed with hIR at iDose(4). All scans were performed with the prospective electrocardiogram-triggered method using a 256-slice computed tomographic scanner (Brilliance iCT; Philips). We assessed agreement between calcium scores obtained with FBP and with IR using the percentage difference and Bland-Altman analysis. Results: The effective radiation doses for CACS at 80 mA s with FBP and at 16 mA s with IR were 1.20 and 0.24 mSv, respectively (k = 0.014). The mean Agatston, volume, and mass scores at 80 mA s with FBP as well as at 16 mA s with IR were 390.7, 146.5, and 63.2 as well as 377.7, 142.5, and 62.2, respectively. The percentage difference between FBP and hIR for the Agatston, volume, and mass score was 20.7%, 20.7%, and 27.1%, respectively. Bland-Altman analysis showed that there was no systemic bias. Conclusions: The radiation dose for CACS can be reduced at a low tube current and hIR without affecting the calcium score.	[Matsuura, Noriaki; Toyota, Naoyuki] Kure Med Ctr, Dept Diagnost Radiol, Kure, Japan; [Urashima, Masaki; Sunamori, Hiroshi] Hirohsima City Hosp, Dept Diagnost Radiol, Hiroshima 7308518, Japan; [Fukumoto, Wataru; Tatsugami, Fuminari; Awai, Kazuo] Hiroshima Univ Hosp, Dept Diagnost Radiol, Hiroshima, Japan	Matsuura, N (reprint author), Hirohsima City Hosp, Dept Radiol, Naka Ku, 7-33 Motomachi, Hiroshima 7308518, Japan.	matsuura.noriaki@gmail.com					Achenbach S, 2001, J COMPUT ASSIST TOMO, V25, P569, DOI 10.1097/00004728-200107000-00010; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Ohnesorge B, 2002, EUR RADIOL, V12, P1532, DOI 10.1007/s00330-002-1394-2; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; Budoff MJ, 2009, AM J ROENTGENOL, V192, P613, DOI 10.2214/AJR.08.1242; Funama Y, 2012, ACAD RADIOL, V19, P1324, DOI 10.1016/j.acra.2012.06.013; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Jakobs TF, 2002, EUR RADIOL, V12, P1081, DOI 10.1007/s00330-001-1278-x; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Oda S, 2013, EUR J RADIOL, V82, P288, DOI 10.1016/j.ejrad.2012.11.003; Renker M, 2011, RADIOLOGY, V260, P390, DOI 10.1148/radiol.11103574; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Oda S, 2012, AM J ROENTGENOL, V198, P1126, DOI 10.2214/AJR.11.7117; Callister TQ, 1998, RADIOLOGY, V208, P807; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Becker CR, 2000, AM J ROENTGENOL, V174, P543; Begemann PGC, 2007, EUR RADIOL, V17, P1985, DOI 10.1007/s00330-006-0564-z; BIELAK LF, 1994, RADIOLOGY, V192, P631; Budoff Matthew J, 2008, Acad Radiol, V15, P58, DOI 10.1016/j.acra.2007.08.011; DEVRIES S, 1995, AM J CARDIOL, V75, P973, DOI 10.1016/S0002-9149(99)80706-1; Esteves FP, 2011, INT J CARDIOL, V147, P424, DOI 10.1016/j.ijcard.2009.09.550; Goldin JG, 2001, RADIOLOGY, V221, P213, DOI 10.1148/radiol.2211001038; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Horiguchi J, 2009, ACAD RADIOL, V16, P187, DOI 10.1016/j.acra.2008.05.017; Horiguchi J, 2009, KOREAN J RADIOL, V10, P340, DOI 10.3348/kjr.2009.10.4.340; Horiguchi Jun, 2006, AJR Am J Roentgenol, V187, pW1, DOI 10.2214/AJR.05.0052; Itatani R, 2013, CLIN RADIOL, V68, pE128, DOI 10.1016/j.crad.2012.10.014; KAJINAMI K, 1993, CORONARY ARTERY DIS, V4, P1103, DOI 10.1097/00019501-199312000-00011; Lim S, 2012, INT J CARDIOL, V155, P126, DOI 10.1016/j.ijcard.2011.05.054; Mao SS, 2001, RADIOLOGY, V220, P707, DOI 10.1148/radiol.2203001129; Raff GL, 2009, JAMA-J AM MED ASSOC, V301, P2340, DOI 10.1001/jama.2009.814; Shields J P, 1995, Am J Card Imaging, V9, P62; Valentin J, 2007, Ann ICRP, V37, P1; Versteylen MO, 2013, INT J CARDIOL, V167, P121, DOI 10.1016/j.ijcard.2011.12.016; Wang SJ, 1996, AM HEART J, V132, P550, DOI 10.1016/S0002-8703(96)90237-9	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	JAN-FEB	2015	39	1					119	124				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ4IG	WOS:000348184200020		
J	Akashi, M; Hashikawa, K; Sakakibara, A; Komori, T; Terashi, H				Akashi, Masaya; Hashikawa, Kazunobu; Sakakibara, Akiko; Komori, Takahide; Terashi, Hiroto			Long-term Follow-up Study of Radial Forearm Free Flap Reconstruction After Hemiglossectomy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Tongue cancer; Hemiglossectomy; Radial forearm free flap; Postoperative status; Long-term follow-up	QUALITY-OF-LIFE; ANTEROLATERAL THIGH FLAP; FUNCTIONAL ASSESSMENT; NECK RECONSTRUCTION; TONGUE RECONSTRUCTION; PHARYNGEAL CANCER; TOTAL GLOSSECTOMY; PRIMARY SURGERY; VOLUME CHANGES; HEAD	Previous studies on postoperative long-term results in patients who underwent reconstructive free flap transfer following hemiglossectomy had some issues, including the heterogeneity of the patient population and the observation period. The present study aimed to evaluate changes of reconstructed tongues in patients who underwent radial forearmfree flap (RFFF) after hemiglossectomy with long-term follow-up. We enrolled 23 patients who underwent RFFFafter hemiglossectomy with a postoperative follow-up of 5 years or more. Postoperative status (eating, speech, sensation function) was assessed by concisemedical inquiries. Morphological changes of flaps were evaluated by reviewing clinical photographs. Hemiglossectomy involving the base of the tongue was performed in 4 cases (17.4%) and was limited to the mobile tongue in 19 cases (82.6%). The mean follow-up was 85.4 months (range, 60-122 months). All patients experienced gradually improved postoperative status. The most significant improvement was found between 1 and 5 years after surgery (P = 0.007), but not between 1 and 3 years (P = 0.075) or between 3 and 5 years (P = 0.530). In almost all of the flaps, there were few morphological changes throughout the follow-up period. Postoperative status in patients who underwent reconstructive RFFF following hemiglossectomy improved sequentially.	[Akashi, Masaya; Sakakibara, Akiko; Komori, Takahide] Kobe Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Hashikawa, Kazunobu; Terashi, Hiroto] Kobe Univ, Dept Plast Surg, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Akashi, M (reprint author), Kobe Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Chuo Ku, Kusunoki Cho 7-5-2, Kobe, Hyogo 6500017, Japan.	akashim@med.kobe-u.ac.jp					Infante-Cossio P, 2009, INT J ORAL MAX SURG, V38, P1052, DOI 10.1016/j.ijom.2009.06.008; Yun IS, 2010, J CRANIOFAC SURG, V21, P111, DOI 10.1097/SCS.0b013e3181c46692; Yamaguchi K, 2012, HEAD NECK-J SCI SPEC, V34, P1403, DOI 10.1002/hed.21944; Vriens JPM, 1996, PLAST RECONSTR SURG, V98, P649, DOI 10.1097/00006534-199609001-00008; Hsiao HT, 2002, ANN PLAS SURG, V49, P612, DOI 10.1097/01.SAP.0000024760.06545.E7; Bjordal K, 1999, J CLIN ONCOL, V17, P1008; Kimata Y, 2003, LARYNGOSCOPE, V113, P905, DOI 10.1097/00005537-200305000-00024; Hsiao HT, 2008, J RECONSTR MICROSURG, V24, P85, DOI 10.1055/s-2008-1076097; Loewen IJ, 2010, HEAD NECK-J SCI SPEC, V32, P85, DOI 10.1002/hed.21155; Wei FC, 2002, PLAST RECONSTR SURG, V109, P2219, DOI 10.1097/00006534-200206000-00007; Brown JS, 2006, INT J ORAL MAX SURG, V35, P208, DOI 10.1016/j.ijom.2005.09.005; de Vicente JC, 2008, J ORAL MAXIL SURG, V66, P2270, DOI 10.1016/j.joms.2008.01.018; Engel H, 2010, PLAST RECONSTR SURG, V126, P1967, DOI 10.1097/PRS.0b013e3181f44742; Hara I, 2003, INT J ORAL MAX SURG, V32, P593, DOI 10.1054/ijom.2002.0436; Joo YH, 2013, AURIS NASUS LARYNX, V40, P303, DOI 10.1016/j.anl.2012.07.012; Joo YH, 2011, ORAL ONCOL, V47, P72, DOI 10.1016/j.oraloncology.2010.11.001; KAPUR KK, 1990, ARCH ORAL BIOL, V35, P397, DOI 10.1016/0003-9969(90)90187-F; Katou F, 1995, ORAL SURG ORAL MED O, V80, P638, DOI 10.1016/S1079-2104(05)80243-4; Klug C, 2002, INT J ORAL MAX SURG, V31, P664, DOI 10.1054/ijom.2002.0301; Li WL, 2013, HEAD NECK-J SCI SPEC, V35, P1808, DOI 10.1002/hed.23254; Markkanen-Leppanen M, 2006, ORAL ONCOL, V42, P501, DOI 10.1016/j.oraloncology.2005.10.007; Rhemrev R, 2007, J PLAST RECONSTR AES, V60, P588, DOI 10.1016/j.bjps.2006.10.016; Rogers SN, 2002, J CRANIO MAXILL SURG, V30, P125, DOI 10.1054/jems.2001.0273; SHINDO ML, 1995, LARYNGOSCOPE, V105, P1290, DOI 10.1288/00005537-199512000-00005; URKEN ML, 1990, LARYNGOSCOPE, V100, P161; URKEN ML, 1994, ARCH OTOLARYNGOL, V120, P26	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2015	26	1					48	51		10.1097/SCS.0000000000001176		4	Surgery	Surgery	AZ0SH	WOS:000347954400045		
J	Layliev, J; Marchac, A; Tanaka, R; Szapalski, C; Henderson, R; Rubin, MS; Saadeh, PB; Warren, SM				Layliev, John; Marchac, Alexander; Tanaka, Rica; Szapalski, Caroline; Henderson, Raven; Rubin, Marcie S.; Saadeh, Pierre B.; Warren, Stephen M.			Endogenous Cell Therapy Improves Bone Healing	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Bony healing; progenitor cell; vasculogenesis; osteogenesis; AMD3100; parathyroid hormone; cellular homing	ENDOTHELIAL PROGENITOR CELLS; PARATHYROID-HORMONE TREATMENT; DISTRACTION OSTEOGENESIS; CXCR4 ANTAGONIST; STEM-CELLS; IN-VIVO; ANGIOGENESIS; MOBILIZATION; AMD3100; NEOVASCULARIZATION	Background: Although bone repair is often a relatively rapid and efficient process, many bone defects do not heal. Because an adequate blood supply is essential for new bone formation, we hypothesized that augmenting new blood vessel formation by increasing the number of circulating vasculogenic progenitor cells (PCs) with AMD3100 and enhancing their trafficking to the site of injury with recombinant human parathyroid hormone (rhPTH) will improve healing. Methods: Critical-sized 3-mm cranial defects were trephined into the right parietal bone of C57BLKS/J 6 mice (N = 120). The mice were divided into 4 equal groups (n = 30 for each). The first group received daily subcutaneous injections of AMD3100 (5 mg/kg). The second group received daily subcutaneous injections of rhPTH (5 mg/kg). The third group received both AMD3100 and rhPTH. The fourth group received subcutaneous injections of saline. Circulating vasculogenic PC numbers, new blood vessel formation, and bony regeneration were assessed. Progenitor cell adhesion, migration, and tubule formation were assessed in the presence of rhPTH and AMD3100. Results: Flow cytometry demonstrated that combination therapy significantly increased the number of circulating PCs compared with all other groups. In vitro, AMD3100-treated PCs had significantly increased adhesion migration, and tubule formation was assessed in the presence of rhPTH. Combination therapy significantly improved new blood vessel formation in those with cranial defect compared with all other groups. Finally, bony regeneration was significantly increased in the combination therapy group compared with all other groups. Conclusions: The combination of a PC-mobilizing and traffic-enhancing agent improved bony regeneration of calvarial defects in mice.	[Layliev, John; Marchac, Alexander; Szapalski, Caroline; Henderson, Raven; Rubin, Marcie S.; Saadeh, Pierre B.; Warren, Stephen M.] NYU, Med Ctr, Dept Plast Surg, Inst Reconstruct Plast Surg Labs, New York, NY 10016 USA; [Tanaka, Rica] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 113, Japan	Warren, SM (reprint author), 875 Pk Ave, New York, NY 10075 USA.	stephen.warren.md@gmail.com			American Society of Maxillofacial Surgeons/Maxillofacial Surgeons Foundation Research Grant Award; Arbeitsgemeinschaft fur Osteosynthesefragen CranioMaxillofacial Foundation-AOCMF Grant	Supported in part by American Society of Maxillofacial Surgeons/Maxillofacial Surgeons Foundation Research Grant Award, 2010 (awarded to C.S.), and Arbeitsgemeinschaft fur Osteosynthesefragen CranioMaxillofacial Foundation-AOCMF Grant 2010 (awarded to S. M. W.).	Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Wang XX, 2011, PLAST RECONSTR SURG, V128, P395, DOI 10.1097/PRS.0b013e31821e6e10; Asahara T, 1999, CIRC RES, V85, P221; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Brunner S, 2008, EXP HEMATOL, V36, P1157, DOI 10.1016/j.exphem.2008.03.014; Huber BC, 2011, CARDIOVASC RES, V90, P529, DOI 10.1093/cvr/cvr014; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Barnes GL, 2008, J BONE JOINT SURG AM, V90A, P120, DOI 10.2106/JBJS.G.01443; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Cetrulo CL, 2005, PLAST RECONSTR SURG, V116, P1053, DOI 10.1097/01.prs.0000178403.79051.70; Huber BC, 2010, AM J PHYSIOL-HEART C, V298, P1466; Jiao C, 2006, DIABETOLOGIA, V49, P2786, DOI 10.1007/s00125-006-0406-1; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; Lo DD, 2012, J VIS EXP, V68, P1; Mori S, 1998, BONE, V22, P99, DOI 10.1016/S8756-3282(97)00248-2; Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8; Schantz JT, 2012, J MECH BEHAV BIOMED, V11, P132, DOI 10.1016/j.jmbbm.2012.02.008; Schwartz A, 2004, CYTOM PART B-CLIN CY, V57B, P1, DOI 10.1002/cyto.b.10066; Tadros M, 2008, FACIAL PLAST SURG, V24, P135, DOI 10.1055/s-2008-1037455; Tan Y, 2009, CARDIOVASC RES, V82, P513, DOI 10.1093/cvr/cvp044; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI [10.1097/PRS.0b013e3181715218, 10.1097/PRS.Ob013e3181715218]; Warren SM, 2003, TISSUE ENG, V9, P187, DOI 10.1089/107632703764664666; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2015	26	1					300	305		10.1097/SCS.0000000000001306		6	Surgery	Surgery	AZ0SH	WOS:000347954400105		
J	Takahashi, Y; Zheng, XD; Mito, H; Noma, K; Kakizaki, H				Takahashi, Yasuhiro; Zheng, Xiaodong; Mito, Hidenori; Noma, Kazunami; Kakizaki, Hirohiko			Recurrent Ptosis in a Patient With Blepharochalasis: Clinical and Histopathologic Findings	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Blepharochalasis; edema; levator aponeurosis; temporal peaking; recurrent bouts	SURGERY	A 37-year-old woman presented with right upper eyelid blepharochalasis with ptosis. Right upper eyelid edema had occurred 2 to 3 times per year by 30 years old, although the frequency decreased with age. The edema occurred spontaneously and resolved within 1 to 2 days. She underwent a right levator tucking surgery at 22 years old, and the ptosis recurred 2 years postoperatively. She again underwent ptosis surgery with skin excision at 37 years old. The intraoperative findings showed a thin levator aponeurosis. The white line was therefore advanced to the upper tarsal edge, resulting in an appropriate height and curvature. Three months later, the patient's eyelid height was 1.5 mm higher with a little temporal peaking. The levator aponeurosis was histopathologically shown to contain many capillaries. The increased vascularity of the levator aponeurosis may contribute to recurrent bouts of edema resulting in stretching and disinsertion of the aponeurosis.	[Takahashi, Yasuhiro; Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan; [Zheng, Xiaodong] Ehime Univ, Dept Ophthalmol, Sch Med, Toon, Ehime, Japan; [Mito, Hidenori] Ide Eye Hosp, Yamagata, Japan; [Noma, Kazunami] Noma Eye Clin, Hiroshima, Japan	Kakizaki, H (reprint author), Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan.	cosme@d1.dion.ne.jp					BERGIN DJ, 1988, BRIT J OPHTHALMOL, V72, P863, DOI 10.1136/bjo.72.11.863; ANDERSON RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1123; COLLIN JRO, 1991, OPHTHALMIC PLAST REC, V7, P153, DOI 10.1097/00002341-199109000-00001; Kakizaki H, 2004, ACTA OPHTHALMOL SCAN, V82, P240, DOI 10.1046/j.1600-0420.2003.00191.x; Koursh DM, 2009, SURV OPHTHALMOL, V54, P235, DOI 10.1016/j.survophthal.2008.12.005	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2015	26	1					E52	E53		10.1097/SCS.0000000000001081		2	Surgery	Surgery	AZ0SH	WOS:000347954400026		
J	Odawara, M; Kadowaki, T; Naito, Y				Odawara, Masato; Kadowaki, Takashi; Naito, Yusuke			Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus (R) to Oral Hypoglycemic Agents (ALOHA) study	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Hypoglycemia; Insulin glargine; Type 2 diabetes; Microvascular complications; Multivariate analysis	BLOOD-GLUCOSE CONTROL; REAL-LIFE ALOHA; GLYCEMIC CONTROL; RISK-FACTORS; ASSOCIATION; MANAGEMENT; MELLITUS; TRIAL; HYPERGLYCEMIA; METAANALYSIS	Aims: The aim of this study is to evaluate effectiveness and safety of basal supported oral therapy (BOT) using insulin glargine in insulin-naive Japanese patients, with and without microvascular complications. Methods: This sub-group analysis of observational, non-interventional ALOHA study, assessed changes in glycemic parameters and glargine dose, at 24 weeks or at glargine discontinuation. Count of hypoglycemic episodes was based on physicians' documentation of patient reports. Patients were stratified according to presence/absence of microvascular complications, at baseline. Relationships between baseline patient characteristics and achievement of HbA1 c <7% were examined by multivariate regression analysis. Results: A total of 3631 patients, included during 2007-2009, were stratified in sub-groups: no complications (n = 1889), retinopathy (n = 318), neuropathy (n = 297), nephropathy (n = 356), retinopathy + neuropathy (n = 174), retinopathy + nephropathy (n = 154), neuropathy + nephropathy (n = 142), and retinopathy + neuropathy + nephropathy (n = 301). Changes in HbA1c, fasting and postprandial plasma glucose, and glargine daily dose were similar among patients with and without complications. Response-rate for achieving HbA1c <7.0% was highest in patients without complications (19.1%). In multivariate analysis, patients without complications showed significantly higher odds of attaining HbA1 c< 7%, independent of diabetes duration and baseline HbA1 c levels. Patients with retinopathy + nephropathy had the lowest response-rate (8.8%) and highest hypoglycemic-rate (3.2%). Conclusion: Japanese insulin-naive patients without complications, on BOT with glargine, show higher chances of attaining HbA1c <7.0% than those with complications. (C) 2015 The Authors. Published by Elsevier Inc.	[Odawara, Masato] Tokyo Med Univ, Dept Diabetol Metab & Endocrinol, Shinjuku Ku, Tokyo 1600023, Japan; [Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Naito, Yusuke] Sanofi KK, Shinjuku Ku, Tokyo 1631488, Japan	Naito, Y (reprint author), Tokyo Opera City Tower,3-20-2,Nishi Shinjuku, Tokyo 1631488, Japan.	odawara@tokyo-med.ac.jp; kadowaki-3im@h.u-tokyo.ac.jp; Yusuke.Naito@sanofi.com			Sanofi K.K	The authors would like to thank all physicians from 987 hospitals and clinics who participated in the ALOHA study. This study was funded and conducted by Sanofi K.K. Editorial assistance in preparing this manuscript was provided by Dr. (Ms.) Jai Tilak-Jain, Anahita Gouri, and Dr. Alina Gomes from Sanofi, India and was funded by Sanofi K.K.	Patel A, 2008, NEW ENGL J MED, V358, P2560; American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Tsai ST, 2011, J DIABETES, V3, P208, DOI 10.1111/j.1753-0407.2011.00137.x; Abdul-Ghani M, 2006, ISRAEL MED ASSOC J, V8, P378; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Shichiri M, 2000, DIABETES CARE, V23, pB21; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Sabanayagam C, 2009, DIABETOLOGIA, V52, P1279, DOI 10.1007/s00125-009-1360-5; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Blickle JF, 2009, DIABETES OBES METAB, V11, P379, DOI 10.1111/j.1463-1326.2008.00980.x; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Calles-Escandon J, 2010, DIABETES CARE, V33, P721, DOI 10.2337/dc09-1471; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Davis TME, 2010, J CLIN ENDOCR METAB, V95, P2240, DOI 10.1210/jc.2009-2828; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Odawara M, 2012, DIABETES TECHNOL THE, V14, P635, DOI 10.1089/dia.2011.0220; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Barnett Anthony H, 2006, Vasc Health Risk Manag, V2, P59, DOI 10.2147/vhrm.2006.2.1.59; Boussageon R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4169; European Medicines Agency, GOOD PHARM PRACT; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI DOI 10.2337/DIACLIN.26.2.77; Freemantle N, 2012, DIABETES OBES METAB, V14, P901, DOI 10.1111/j.1463-1326.2012.01613.x; Gerich JE, 2005, AM J MED, V118, p7S, DOI 10.1016/j.amjmed.2005.07.051; Hemmingsen B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6898; Ishii H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036361; Kadowaki T., 2013, DIABETOLOGY INT, V4, P16; Kawamori R., 2011, INT DIAB FED 2011 WO, pP; Kawamori R., 2003, RINSHO IYAKU, V19, P445; Kumano Shinsaku, 2012, Folia Pharmacologica Japonica, V140, P81; Lin YY, 2010, YONSEI MED J, V51, P367, DOI 10.3349/ymj.2010.51.3.367; Marrero David G, 2007, Clin Cornerstone, V8, P33; Odawara M, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-20; Ohtani T., 2011, SHINYAKU TO RINSHO, V60, P458; PAISEY RB, 1984, DIABETES CARE, V7, P428, DOI 10.2337/diacare.7.5.428; Ramachandran A, 1999, J Assoc Physicians India, V47, P1152; Rodbard HW, 2009, ENDOCR PRACT, V15, P540; Suzuki Daisuke, 2012, Tokai J Exp Clin Med, V37, P41; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Turner RC, 1998, LANCET, V352, P837	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	JAN-FEB	2015	29	1					127	133				7	Endocrinology & Metabolism	Endocrinology & Metabolism	AZ5EY	WOS:000348244400025		
J	Akter, MP; Mekhilef, S; Tan, NML; Akagi, H				Akter, Md Parvez; Mekhilef, Saad; Tan, Nadia Mel Lin; Akagi, Hirofumi			Model Predictive Control of Bidirectional AC-DC Converter for Energy Storage System	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						Model predictive control (MPC); Bidirectional AC-DC converter; Unity power factor; Reactive power; Energy storage system	DIRECT POWER-CONTROL; CONNECTED DC/AC CONVERTERS; DIRECT TORQUE CONTROL; INDUCTION-MOTOR; RECTIFIERS; INVERTER; QUALITY	Energy storage system has been widely applied in power distribution sectors as well as in renewable energy sources to ensure uninterruptible power supply. This paper presents a model predictive algorithm to control a bidirectional AC-DC converter, which is used in an energy storage system for power transferring between the three-phase AC voltage supply and energy storage devices. This model predictive control (MPC) algorithm utilizes the discrete behavior of the converter and predicts the future variables of the system by defining cost functions for all possible switching states. Subsequently, the switching state that corresponds to the minimum cost function is selected for the next sampling period for firing the switches of the AC-DC converter. The proposed model predictive control scheme of the AC-DC converter allows bidirectional power flow with instantaneous mode change capability and fast dynamic response. The performance of the MPC controlled bidirectional AC-DC converter is simulated with MATLAB/Simulink (R) and further verified with 3.0kW experimental prototypes. Both the simulation and experimental results show that, the AC-DC converter is operated with unity power factor, acceptable THD (3.3% during rectifier mode and 3.5% during inverter mode) level of AC current and very low DC voltage ripple. Moreover, an efficiency comparison is performed between the proposed MPC and conventional VOC-based PWM controller of the bidirectional AC-DC converter which ensures the effectiveness of MPC controller.	[Akter, Md Parvez; Mekhilef, Saad] Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia; [Tan, Nadia Mel Lin] Univ Tenaga Nas, Dept Elect Power Engn, Kajang, Malaysia; [Akagi, Hirofumi] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 152, Japan	Mekhilef, S (reprint author), Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia.	parvez0602025@gmail.com; saad@um.edu.my; nadia@uniten.edu.my; akagi@ee.titech.ac.jp	Mekhilef, Saad/B-9652-2010; Engineering, Faculty /I-7935-2015	Mekhilef, Saad/0000-0001-8544-8995; Engineering, Faculty /0000-0002-4848-7052	Ministry of Higher Education; University of Malaya through HIR-MOHE [UM.C/HIR/MOHE/ENG/24]; UMRG [RP006E-13ICT]	The authors would like to thank the Ministry of Higher Education and University of Malaya for providing financial support through HIR-MOHE project UM.C/HIR/MOHE/ENG/24 and UMRG project No. RP006E-13ICT.	Alias A., 2011, CLEAN EN TECHN CET 2, P337; Singh B, 2008, IEEE T POWER ELECTR, V23, P260, DOI 10.1109/TPEL.2007.911880; Vazquez S, 2008, IEEE T IND ELECTRON, V55, P1647, DOI 10.1109/TIE.2008.917113; Lascu C, 2000, IEEE T IND APPL, V36, P122, DOI 10.1109/28.821806; Carrasco JM, 2006, IEEE T IND ELECTRON, V53, P1002, DOI 10.1109/TIE.2006.878356; Quevedo DE, 2012, IEEE T POWER ELECTR, V27, P3128, DOI 10.1109/TPEL.2011.2179672; Zhi DW, 2009, IEEE T POWER ELECTR, V24, P1280, DOI 10.1109/TPEL.2009.2012497; Hu JB, 2011, IEEE T POWER ELECTR, V26, P210, DOI 10.1109/TPEL.2010.2057518; TAKAHASHI I, 1989, IEEE T IND APPL, V25, P257, DOI 10.1109/28.25540; Noguchi T, 1998, IEEE T IND APPL, V34, P473, DOI 10.1109/28.673716; Singh B, 2004, IEEE T IND ELECTRON, V51, P641, DOI 10.1109/TIE.2004.825341; Kouro S, 2009, IEEE T IND ELECTRON, V56, P1826, DOI 10.1109/TIE.2008.2008349; Bouafia A, 2009, IEEE T IND ELECTRON, V56, P1984, DOI 10.1109/TIE.2009.2014746; Tan NML, 2012, IEEE T POWER ELECTR, V27, P1237, DOI 10.1109/TPEL.2011.2108317; Chen Y, 2008, IEEE T POWER ELECTR, V23, P2301, DOI 10.1109/TPEL.2009.2003025; Cortes P, 2008, IEEE T POWER ELECTR, V23, P2516, DOI 10.1109/TPEL.2008.2002065; Hu XL, 2013, 2013 IEEE ECCE ASIA DOWNUNDER (ECCE ASIA), P291; Malinowski M, 2003, IEEE T POWER ELECTR, V18, P1390, DOI 10.1109/TPEL.2003.818871; Parvez M., 2014, P ITEC, P1; Rodriguez J, 2007, IEEE T IND ELECTRON, V54, P495, DOI 10.1109/TIE.2006.888802; Rodriguez J., 2013, IEEE T POWER ELECT; Uddin M., 2014, P IPEC HIR 2014 ECCE, P3574; Uddin M, 2014, ELECTR POW COMPO SYS, V42, P1059, DOI 10.1080/15325008.2014.913739; Uddin SMM, 2013, C IND ELECT APPL, P1769; UDDIN SMM, 2013, P IEEE INT C CIRC SY, P81; Verdelho P, 1998, IEEE T IND ELECTRON, V45, P263, DOI 10.1109/41.681225; Yau H.-T., 2013, SCI WORLD J, V2013; Zhi DW, 2008, ICEMS 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ELECTRICAL MACHINES AND SYSTEMS, VOLS 1- 8, P1157	28	3	3	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	JAN	2015	10	1					165	175		10.5370/JEET.2015.10.1.165		11	Engineering, Electrical & Electronic	Engineering	AZ1OT	WOS:000348008800019		
J	Zhu, XM; Yang, XD; Chen, P				Zhu, Xiaoming; Yang, Xiaodong; Chen, Peng			Compact Band-notched UWB Antenna Design Based On Transmission Line Model	JOURNAL OF ELECTRICAL ENGINEERING & TECHNOLOGY			English	Article						UWB antenna; Notched band; Transmission line model; Gradual stepped impedance matching; Parasitic element; Window aperture	SLOT ANTENNA; WLAN BAND; GHZ WLAN	In order to avoid the interference from existing narrowband communication systems, this paper proposes a compact band-notched UWB (ultra wideband) antenna with size of 12mmx22mm x1.6mm. Transmission line model is applied to analyzing wide impedance matching characteristic of the modified base antenna, which has a gradual stepped impedance feeder structure. The proposed antenna realizes dual band-notched function by combining two biased T-shaped parasitic elements on the rear side with a window aperture on the radiation patch. The simulation current distributions of the antenna reflect resonant suppression validity of the two methods. In addition, the measured radiation characteristics demonstrate the proposed antenna prevents signal interference from WLAN (5.15-5.825GHz) and WiMAX (3.4-3.69GHz) effectively, and the measured patterns show the antenna omnidirectional radiation in working frequencies.	[Zhu, Xiaoming; Yang, Xiaodong; Chen, Peng] Harbin Engn Univ, Coll Informat & Commun Engn, Harbin, Peoples R China; [Zhu, Xiaoming] Heilongjiang Inst Technol, Coll Elect & Informat Engn, Harbin, Heilongjiang, Peoples R China; [Yang, Xiaodong] Meisei Univ, Collaborat Res Ctr, Tokyo, Japan	Zhu, XM (reprint author), Harbin Engn Univ, Coll Informat & Commun Engn, Harbin, Peoples R China.	zhuxiaoming213@hrbeu.edu.cn; yangxiaodong@hrbeu.edu.cn; chenpeng@hrbeu.edu.cn			Natural Science Foundation of Heilongjiang Province, China [ZD201115]; Youth Science Foundation of Heilongjiang Institute of Technology, China [2013QJ09]	This work was supported by the Natural Science Foundation of Heilongjiang Province, China (Grant No. ZD201115) and the Youth Science Foundation of Heilongjiang Institute of Technology, China (Grant No. 2013QJ09).	Dissanayake T, 2007, IEEE T ANTENN PROPAG, V55, P3320, DOI 10.1109/TAP.2007.908792; Nguyen DT, 2012, IEEE ANTENN WIREL PR, V11, P411, DOI 10.1109/LAWP.2012.2192900; Zhang M, 2010, MICROW OPT TECHN LET, V52, P90, DOI 10.1002/mop.24856; Abbosh AM, 2009, IEEE T ANTENN PROPAG, V57, P796, DOI 10.1109/TAP.2009.2013449; Barbarino S, 2010, PROG ELECTROMAGN RES, V104, P1, DOI 10.2528/PIER10040507; CAI Yun-long, 2009, J TSINGHUA U SCI TEC, V49, P944; [曹海林 CAO Hai-lin], 2009, [重庆大学学报. 自然科学版, Journal of Chongqing University. Natural Science Edition], V32, P328; Eshtiaghi R, 2010, IEEE T ANTENN PROPAG, V58, P1397, DOI 10.1109/TAP.2010.2041159; Federal Communications Commission, 2002, 1 FCC, P98; Habib MA, 2010, PROG ELECTROMAGN RES, V106, P17, DOI 10.2528/PIER10011905; LI Ying-song, 2011, INT J ELECT COMMUNIC, V65, P961; MOGHADASI M N, 2009, IEEE ANTENN WIREL PR, V8, P1382; NIKOLAOU S, 2011, P IEEE INT S ANT PRO, P178; Lin Peng, 2009, Microwave and Optical Technology Letters, V51, DOI 10.1002/mop.24247; Su M, 2010, J ELECTROMAGNET WAVE, V24, P2001; Wei YQ, 2011, J ELECTROMAGNET WAVE, V25, P693, DOI 10.1163/156939311794827302; Zamel HANY M, 2007, P RAD SCI C CAIR EG, P1	17	0	0	KOREAN INST ELECTR ENG	SEOUL	901 KSTC, 635-4 YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1975-0102	2093-7423		J ELECTR ENG TECHNOL	J. Electr. Eng. Technol.	JAN	2015	10	1					338	343		10.5370/JEET.2015.10.1.338		6	Engineering, Electrical & Electronic	Engineering	AZ1OT	WOS:000348008800039		
J	Kosuge, M; Kimura, K				Kosuge, Masami; Kimura, Kazuo			Low QRS voltage and attenuation of the amplitude of QRS complexes in takotsubo cardiomyopathy	JOURNAL OF ELECTROCARDIOLOGY			English	Letter									[Kosuge, Masami; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 2320024, Japan	Kosuge, M (reprint author), Yokohama City Univ, Med Ctr, Div Cardiol, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	masami-kosuge@pop06.odn.ne.jp					Kosuge M, 2014, J ELECTROCARDIOL, V47, P684, DOI 10.1016/j.jelectrocard.2014.03.004; Aoyama N, 2002, CIRC J, V66, P133, DOI 10.1253/circj.66.133; Madias John E, 2014, Eur Heart J Acute Cardiovasc Care, V3, P28, DOI 10.1177/2048872613504311; Madias JE, 2014, J ELECTROCARDIOL, V47, P760, DOI 10.1016/j.jelectrocard.2014.05.007; Madias JE, 2001, J AM COLL CARDIOL, V38, P756, DOI 10.1016/S0735-1097(01)01429-2	5	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0022-0736	1532-8430		J ELECTROCARDIOL	J. Electrocardiol.	JAN-FEB	2015	48	1					126	126		10.1016/j.jelectrocard.2014.09.004		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ5GU	WOS:000348249100026		
J	Suzuki, Y; Takida, T				Suzuki, Yoshihiro; Takida, Toshiyuki			Concentration of Cryptosporidium oocysts from river water by coagulation and foam separation combined with acid dissolution of ferric flocs	JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING			English	Article						Cryptosporidium oocysts; foam separation; ferric flocs dissolution; Concentration method	GIARDIA; REMOVAL; PARVUM; PCR; SAMPLES	Cryptosporidium is an extremely virulent microorganism; contamination of water works systems by Cryptosporidium oocysts is a serious issue in public health. However, a great deal of effort is required to detect oocysts in source water for drinking, because the oocysts have to be concentrated from a large volume of water before detection. In this study, the concentration of oocysts in oocyst-polluted artificial river water was examined by coagulation and foam separation. The oocysts concentrated in the foam water were purified using immunomagnetic separation and assessed using epifluorescence microscopy. When ferric coagulation was performed prior to foam separation, oocysts were effectively removed from the river water and concentrated in the foam within 10min. The removal efficiency was greater than 96% at the optimum iron and casein concentrations of 5mg-Fe L-1 and 20mg L-1, respectively. Furthermore, the number of recovered oocysts in the solution obtained by the dissolution of the collected ferric flocs from foam water was the same as that obtained using the Japanese standard procedure for detection of Cryptosporidium in water using membrane filtration. This is a novel method of concentrating Cryptosporidium oocysts for detection in river water using a coagulation and foam separation combined with acid dissolution of ferric flocs; the method is easy to use, rapid, and efficient.	[Suzuki, Yoshihiro; Takida, Toshiyuki] Miyazaki Univ, Fac Engn, Miyazaki 8892192, Japan	Suzuki, Y (reprint author), Miyazaki Univ, Fac Engn, Miyazaki 8892192, Japan.	suzuki@civil.miyazaki-u.ac.jp					DiGiorgio CL, 2002, APPL ENVIRON MICROB, V68, P5952, DOI 10.1128/AEM.68.12.5952-5955.2002; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Guy RA, 2003, APPL ENVIRON MICROB, V69, P5178, DOI 10.1128/AEM.69.9.5178-5185.2003; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Carey CM, 2004, WATER RES, V38, P818, DOI 10.1016/j.watres.2003.10.012; APHA; AWWA; WEF, 1998, STAND METH EX WAT WA, P8; Carpenter C, 1999, EMERG INFECT DIS, V5, P579; Chung E, 1999, J MICROBIOL METH, V38, P119, DOI 10.1016/S0167-7012(99)00087-1; Coupe S, 2006, FEMS IMMUNOL MED MIC, V47, P351, DOI 10.1111/j.1574-695X.2006.00098.x; Gradus M. Stephen, 1994, Clinical Microbiology Newsletter, V16, P57, DOI 10.1016/0196-4399(94)90073-6; HAAS CN, 1995, J AM WATER WORKS ASS, V87, P81; Japan Water Works Association (JWWA), 2003, CRYPT EXPL TEST METH, P51; Oda T., 2002, JPN J WATER TREAT BI, V38, P153; Ongerth JE, 2013, WATER RES, V47, P2479, DOI 10.1016/j.watres.2013.02.015; Suzuki Y, 2005, SEPAR SCI TECHNOL, V40, P3407, DOI 10.1080/01496390500423755; Suzuki Y, 2002, WATER SCI TECHNOL, V46, P183; Suzuki Y, 2002, WATER RES, V36, P2195, DOI 10.1016/S0043-1354(01)00439-0; Suzuki Y., 2001, THESIS MIYAZAKI U, P118; U.S. Environmental Protection Agency, 2001, 1623 US EPA, P68; Yamamoto N., 2000, JPN J INFECT DIS, V74, P518	22	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1093-4529	1532-4117		J ENVIRON SCI HEAL A	J. Environ. Sci. Health Part A-Toxic/Hazard. Subst. Environ. Eng.		2015	50	3					311	316		10.1080/10934529.2015.981121		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AZ4OD	WOS:000348201000008		
J	Saragih, SA; Takemoto, S; Hisamoto, Y; Fujii, M; Sato, H; Kamata, N				Saragih, Syaiful Amri; Takemoto, S.; Hisamoto, Y.; Fujii, M.; Sato, H.; Kamata, N.			Quantitative real-time PCR (qPCR) - Based tool for detection and quantification of Cordyceps militaris in soil	JOURNAL OF INVERTEBRATE PATHOLOGY			English	Article						Entomopathogenic fungus; Culture-independent method; Genomic DNA; Soil DNA; Amplification efficiency	LINK CLAVICIPITALES; BEECH CATERPILLAR; PUNCTATELLA; NOTODONTIDAE; INFECTION; FOREST	A quantitative real-time PCR using a primer pair CM2946F/CM3160R was developed for specific detection and quantification of Cordyceps militaris from soil. Standard curves were obtained for genomic DNA and DNA extracts from autoclaved soil with a certain dose of C. militaris suspension. C. militaris was detected from two forest soil samples out of ten that were collected when fruit bodies of C. militaris were found. This method seemed effective in detection of C. militaris in the soil and useful for rapid and reliable quantification of C militaris in different ecosystems. (C) 2014 Elsevier Inc. All rights reserved.	[Saragih, Syaiful Amri] Univ Tokyo, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Educ & Res Ctr,Bunkyo Ku, Tokyo 1138657, Japan; [Takemoto, S.] Univ Tokyo, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Univ Tokyo Tanashi Forest,Nishi Ku, Tokyo 1880002, Japan; [Hisamoto, Y.] Univ Tokyo, Univ Tokyo Chiba Forest, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Chiba 2995503, Japan; [Fujii, M.; Kamata, N.] Univ Tokyo, Univ Tokyo Chichibu Forest, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Chichibu, Saitama 3680034, Japan; [Sato, H.] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan	Saragih, SA (reprint author), Univ Tokyo, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Educ & Res Ctr,Bunkyo Ku, Tokyo 1138657, Japan.	akhi_amree@yahoo.com			Japan Society for the Promotion of Science (JSPS) [25292084]	This work was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) to NK (25292084).	Kamata N, 2000, POPUL ECOL, V42, P267, DOI 10.1007/PL00012005; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ng TB, 2005, J PHARM PHARMACOL, V57, P1509, DOI 10.1211/jpp.57.12.0001; CUNNINGHAM KG, 1950, NATURE, V166, P949, DOI 10.1038/166949a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Castrillo LA, 2007, MYCOL RES, V111, P324, DOI 10.1016/j.mycres.2007.01.010; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Kamata N, 1997, J APPL ENTOMOL, V121, P17; Sato H, 1997, APPL ENTOMOL ZOOL, V32, P249	11	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2011	1096-0805		J INVERTEBR PATHOL	J. Invertebr. Pathol.	JAN	2015	124						70	72		10.1016/j.jip.2014.11.002		3	Zoology	Zoology	AZ5HK	WOS:000348250600011		
J	Hirahara, N; Matsubara, T; Hayashi, H; Takai, K; Fujii, Y; Tajima, Y				Hirahara, Noriyuki; Matsubara, Takeshi; Hayashi, Hikota; Takai, Kiyoe; Fujii, Yusuke; Tajima, Yoshitsugu			Easy and Secure Closure of Petersen's Defect After Laparoscopic Distal Gastrectomy with Roux-en-Y Reconstruction	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							GASTRIC BYPASS; INTERNAL HERNIA; BARIATRIC SURGERY; MORBID-OBESITY	Background: Previously it has reported that the incidence of internal hernia can be decreased by closing Petersen's defect, but the perfect closure method, in fact, has not been discovered yet. In this study we have developed an easy and reliable method for closing Petersen's defect in the Roux-en-Y reconstruction after a laparoscopic distal gastrectomy. Materials and Methods: We performed intracorporeal Roux-en-Y reconstruction after laparoscopic distal gastrectomy with antiperistaltic gastrojejunostomy. The greater omentum is placed on the cranial side of the transverse colon through the defect between the elevated jejunum and the transverse mesocolon. Anastomosis is performed of the transverse mesocolon attached to the transverse colon, the greater omentum is passed through the Petersen's defect, and the stump of the mesojejunum is attached to the elevated jejunum by an interrupted suture. Petersen's defect is spread and straightened to stabilize the visual field. The thread is inserted first at the base of the stump of the elevated mesojejunum, next to the greater omentum, which has passed through Petersen's defect, and then to the transverse mesocolon to set the starting point of continuous suture. The stitches of continuous suture are sewn toward the transverse colon. Petersen's defect is closed completely. Results: We performed this technique in 37 patients. All procedures were completed without intraoperative complication or conversion to laparotomy. During the follow-up period, none of the patients developed complications related to the internal hernia, such as Petersen's hernia. Conclusions: We have indicated a novel, easy, and secure closure procedure of Petersen's defect following laparoscopic distal gastrectomy with Roux-en-Y reconstruction.	[Hirahara, Noriyuki; Matsubara, Takeshi; Hayashi, Hikota; Takai, Kiyoe; Fujii, Yusuke; Tajima, Yoshitsugu] Shimane Univ Fac Med, Dept Digest & Gen Surg, Izumo, Shimane 6938501, Japan	Hirahara, N (reprint author), Shimane Univ Fac Med, Dept Digest & Gen Surg, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	norinorihirahara@yahoo.co.jp					Ahmed AR, 2007, OBES SURG, V17, P1563, DOI 10.1007/s11695-007-9260-6; Higa KD, 2003, OBES SURG, V13, P350, DOI 10.1381/096089203765887642; Comeau E, 2005, SURG ENDOSC, V19, P34, DOI 10.1007/s00464-003-8515-0; Hoya Y, 2009, SURG TODAY, V39, P647, DOI 10.1007/s00595-009-3964-2; Bothe FA, 1929, ANN SURG, V89, P886, DOI 10.1097/00000658-192906000-00007; Carmody Brennan, 2005, Surg Obes Relat Dis, V1, P543, DOI 10.1016/j.soard.2005.08.005; Kojima K, 2008, ANN SURG, V247, P962, DOI 10.1097/SLA.0b013e31816d9526; Muller MK, 2008, BRIT J SURG, V95, P1375, DOI 10.1002/bjs.6297; Nguyen NT, 2004, OBES SURG, V14, P190, DOI 10.1381/096089204322857546; Paroz A, 2006, OBES SURG, V16, P1482, DOI 10.1381/096089206778870102; Paroz A, 2009, OBES SURG, V19, P527, DOI 10.1007/s11695-008-9770-x; Petersen W, 1900, LANGENBECKS ARCH KLI, V62, P94; Podnos YD, 2003, ARCH SURG-CHICAGO, V138, P957, DOI 10.1001/archsurg.138.9.957	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	JAN 1	2015	25	1					55	59		10.1089/lap.2014.0402		5	Surgery	Surgery	AZ6JD	WOS:000348325200011		
J	Zhang, YX; Gao, XD; Seiji, K				Zhang Yanxi; Gao Xiangdong; Seiji, Katayama			Weld appearance prediction with BP neural network improved by genetic algorithm during disk laser welding	JOURNAL OF MANUFACTURING SYSTEMS			English	Article						Molten pool; BP neural network; Genetic algorithm; High-power disk laser welding; Principal components analysis	SEAM TRACKING; OPTIMIZATION; PARAMETERS; SELECTION; MODEL	The appearance of welds is the external manifestation of welding quality. The morphology of molten pools is significantly associated with the weld appearance, but the approach to measure the morphology of molten pools during laser welding remains an outstanding challenge up to now. In this study, the shadows of molten pools were formed to describe the morphology of molten pools. Principal components analysis (PCA) is applied to analyze the characteristics of the molten pools' shadow in order to reduce their redundancy. Then BP neural network improved by genetic algorithm (GABP) is established to model the relation between welding appearance and the characteristics of the molten-pool-shadows. The effectiveness of the established model is analyzed through two different welding speed experiments, and the results verify its prediction performance. The work provides an effective way to predict the weld appearance and assess the welding quality in real-time. (C) 2014 The Society of Manufacturing Engineers. Published by Elsevier Ltd. All rights reserved.	[Zhang Yanxi; Gao Xiangdong] Guangdong Univ Technol, Sch Electromech Engn, Higher Educ Mega Ctr, Guangzhou 510006, Guangdong, Peoples R China; [Seiji, Katayama] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Gao, XD (reprint author), Guangdong Univ Technol, Sch Electromech Engn, Higher Educ Mega Ctr, 100 West Waihuan Rd, Guangzhou 510006, Guangdong, Peoples R China.	gaoxd666@126.com			National Natural Science Foundation of China [51175095]; Natural Science Foundation of Guangdong Province, China [10251009001000001]; Guangdong Provincial Project of Science and Technology Innovation of Discipline Construction, China [2013KJCX0063]; Guangzhou Science and Technology Plan Project, China [1563000554]; JSPS Invitation Fellowship Programs for Research in Japan	This work was partly supported by the National Natural Science Foundation of China (Grant No. 51175095), the Natural Science Foundation of Guangdong Province, China (Grant No. 10251009001000001), the Guangdong Provincial Project of Science and Technology Innovation of Discipline Construction, China (Grant No. 2013KJCX0063), the Guangzhou Science and Technology Plan Project, China (Grant No. 1563000554) and the JSPS Invitation Fellowship Programs for Research in Japan.	Zhang MJ, 2013, APPL SURF SCI, V280, P868, DOI 10.1016/j.apsusc.2013.05.081; Kaplan AFH, 2012, APPL SURF SCI, V258, P9732, DOI 10.1016/j.apsusc.2012.06.020; Tan WD, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/5/055501; Devos O, 2014, FOOD CHEM, V148, P124, DOI 10.1016/j.foodchem.2013.10.020; Gao XD, 2014, INT J PRECIS ENG MAN, V15, P399, DOI 10.1007/s12541-014-0350-9; Zhang YX, 2014, INT J ADV MANUF TECH, V70, P1979, DOI 10.1007/s00170-013-5442-7; Suganthi XH, 2013, INT J ADV MANUF TECH, V68, P339, DOI 10.1007/s00170-013-4731-5; Gao XD, 2012, IEEE T IND ELECTRON, V59, P4315, DOI 10.1109/TIE.2012.2193854; Yu HW, 2013, J MATER PROCESS TECH, V213, P707, DOI 10.1016/j.jmatprotec.2012.11.016; Yamada T, 2012, J LASER MICRO NANOEN, V7, P244, DOI 10.2961/j1mn.2012.03.0002; Cho WI, 2012, J MATER PROCESS TECH, V212, P262, DOI 10.1016/j.jmatprotec.2011.09.011; Gao XD, 2012, MECHATRONICS, V22, P370, DOI 10.1016/j.mechatronics.2011.09.005; Bachmann M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/3/035201; Campana G, 2009, APPL SURF SCI, V255, P5588, DOI 10.1016/j.apsusc.2008.07.169; Datta S, 2009, J MANUF SYST, V28, P55, DOI 10.1016/j.jmsy.2009.08.001; Gao X., 2013, WELD J, V92, P251; Luo ZJ, 2012, J MANUF SYST, V31, P2, DOI 10.1016/j.jmsy.2011.03.005; Oktem H, 2009, INT J ADV MANUF TECH, V43, P852, DOI 10.1007/s00170-008-1763-3; Oreski S, 2014, EXPERT SYST APPL, V41, P2052, DOI 10.1016/j.eswa.2013.09.004; Scott DJ, 2007, J EUR CERAM SOC, V27, P4425, DOI 10.1016/j.jeurceramsoc.2007.02.212; Zhang LQ, 2013, INT J ADV MANUF TECH, V65, P517, DOI 10.1007/s00170-012-4190-4	21	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0278-6125	1878-6642		J MANUF SYST	J. Manuf. Syst.	JAN	2015	34						53	59		10.1016/j.jmsy.2014.10.005		7	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	AZ5NH	WOS:000348267000006		
J	Kamegawa, T; Ishiguro, Y; Seto, H; Yamashita, H				Kamegawa, Takashi; Ishiguro, Yasushi; Seto, Hiroki; Yamashita, Hiromi			Enhanced photocatalytic properties of TiO2-loaded porous silica with hierarchical macroporous and mesoporous architectures in water purification	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							TITANIUM-DIOXIDE; HETEROGENEOUS PHOTOCATALYSIS; CATALYTIC-ACTIVITIES; TIO2 PHOTOCATALYST; ACTIVATED CARBON; X-RAY; DEGRADATION; NANOPARTICLES; OXIDATION; REDUCTION	Porous silica with hierarchical macroporous and mesoporous architectures (MacroMeso-SiO2) was prepared by a solvent evaporation method using a precursor solution for the synthesis of mesoporous silica (Meso-SiO2) and poly(methyl methacrylate) (PMMA) colloidal crystals as a hard template and used as an advanced support for TiO2 photocatalysts. The porous structure and state of TiO2 were investigated by various characterisation techniques. Reflecting the structure of aligned PMMA microspheres, MacroMeso-SiO2 has a uniform and hierarchical macroporous structure with interconnecting networks even after the loading of TiO2 particles. Based on its advantageous porous structure, TiO2-loaded MacroMeso-SiO2 exhibited specific characteristics, i.e., the easy transportation of relatively large molecules and unique adsorption properties to condense organic compounds, and enhanced photocatalytic properties in the degradation of organic compounds in water as compared to TiO2-loaded Meso-SiO2 under UV light irradiation.	[Kamegawa, Takashi; Ishiguro, Yasushi; Seto, Hiroki; Yamashita, Hiromi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Kamegawa, Takashi] Osaka Prefecture Univ, Nanosci & Nanotechnol Res Ctr, Naka Ku, Sakai, Osaka 5998570, Japan; [Yamashita, Hiromi] Kyoto Univ, ESICB, Kyoto 6158520, Japan	Yamashita, H (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@mat.eng.osaka-u.ac.jp			Tokuyama Science Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26420786, 26220911]	This study was supported by the Tokuyama Science Foundation. We also acknowledge partial support from a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (no. 26420786, 26220911). The X-ray absorption measurements were performed at the BL-9A facility of the Photon Factory at the National Laboratory for High-Energy Physics, Tsukuba, Japan (2012G126).	Chen LX, 1997, J PHYS CHEM B, V101, P10688, DOI 10.1021/jp971930g; Ohko Y, 2001, ENVIRON SCI TECHNOL, V35, P2365, DOI 10.1021/es001757t; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Stein A, 2013, CHEM SOC REV, V42, P2763, DOI 10.1039/c2cs35317b; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Wang JF, 2003, J AM CHEM SOC, V125, P13966, DOI 10.1021/ja036967v; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Yamashita H, 1998, J PHYS CHEM B, V102, P10707, DOI 10.1021/jp982835q; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Torimoto T, 1997, J PHOTOCH PHOTOBIO A, V103, P153, DOI 10.1016/S1010-6030(96)04503-0; Lang XJ, 2014, ACCOUNTS CHEM RES, V47, P355, DOI 10.1021/ar4001108; Kamegawa T, 2012, ACS APPL MATER INTER, V4, P6635, DOI 10.1021/am3017762; Zhang DQ, 2013, CHEM-ASIAN J, V8, P26, DOI 10.1002/asia.201200123; Ogawa M, 1996, CHEM COMMUN, P1149, DOI 10.1039/cc9960001149; KAMAT PV, 1993, CHEM REV, V93, P267, DOI 10.1021/cr00017a013; Sun ZK, 2011, CHEM MATER, V23, P2176, DOI 10.1021/cm103704s; Ding Z, 2000, J PHYS CHEM B, V104, P4815, DOI 10.1021/jp993819b; Kominami H, 2014, CHEM COMMUN, V50, P4558, DOI 10.1039/c3cc49340g; Shiraishi Y, 2010, ANGEW CHEM INT EDIT, V49, P1656, DOI 10.1002/anie.200906573; Kamegawa T, 2012, ADV MATER, V24, P3697, DOI 10.1002/adma.201201037; Deng YH, 2007, CHEM MATER, V19, P3271, DOI 10.1021/cm070600y; Bian ZF, 2012, J PHYS CHEM LETT, V3, P1422, DOI 10.1021/jz3005128; Kamegawa T, 2011, ENERG ENVIRON SCI, V4, P1411, DOI 10.1039/c0ee00389a; Furube A, 1999, J PHYS CHEM B, V103, P3120, DOI 10.1021/jp984162h; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Fowler CE, 2001, CHEM COMMUN, P2028, DOI 10.1039/b104879c; LIU ZF, 1994, J PHYS CHEM-US, V98, P1253, DOI 10.1021/j100055a035; Palmisano G, 2010, CHEM COMMUN, V46, P7074, DOI 10.1039/c0cc02087g; LASSALETTA G, 1995, J PHYS CHEM-US, V99, P1484, DOI 10.1021/j100005a019; Okada S, 2011, CHEM-EUR J, V17, P9047, DOI 10.1002/chem.201101241; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; Qian XF, 2014, CHEMSUSCHEM, V7, P1528, DOI 10.1002/cssc.201400111; Fuku K, 2012, CHEM-ASIAN J, V7, P1366, DOI 10.1002/asia.201100984; Kominami H, 2002, J PHYS CHEM B, V106, P10501, DOI 10.1021/jp0147224; Sakthivel S, 2003, ANGEW CHEM INT EDIT, V42, P4908, DOI 10.1002/anie.200351577; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; Qian XF, 2013, J PHYS CHEM C, V117, P19544, DOI 10.1021/jp4071373; Kamegawa T, 2013, ANGEW CHEM INT EDIT, V52, P916, DOI 10.1002/anie.201206839; Kamegawa T, 2010, J PHYS CHEM C, V114, P15049, DOI 10.1021/jp105526d; Sadakane M, 2007, B CHEM SOC JPN, V80, P677, DOI 10.1246/bcsj.80.677; Kuwahara Y, 2009, J PHYS CHEM C, V113, P1552, DOI 10.1021/jp809191v; Berens A. R., 1997, POLYM ENG SCI, V33, P391; Egeblad K, 2008, CHEM MATER, V20, P946, DOI 10.1021/cm702224p; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Fuku K, 2011, CATAL SCI TECHNOL, V1, P586, DOI 10.1039/c0cy00040j; GREEGOR RB, 1983, J NON-CRYST SOLIDS, V55, P27, DOI 10.1016/0022-3093(83)90005-4; Inumaru K, 2005, CHEM COMMUN, P2131, DOI 10.1039/b417558a; Kamegawa T, 2011, LANGMUIR, V27, P2873, DOI 10.1021/la1048634; Kamegawa T, 2013, PHYS CHEM CHEM PHYS, V15, P13323, DOI 10.1039/c3cp51022k; Kamegawa T, 2013, J MATER CHEM A, V1, P891, DOI 10.1039/c2ta00331g; Kubacka A., 2011, CHEM REV, V112, P1555; Kuwahara Y, 2010, CURR ORG CHEM, V14, P616; Ocampo-Perez R, 2013, ADSORPTION, V19, P945, DOI 10.1007/s10450-013-9502-y; Stein A, 2001, CURR OPIN SOLID ST M, V5, P553, DOI 10.1016/S1359-0286(01)00022-5; Wei W, 2013, CHEM-EUR J, V19, P565, DOI 10.1002/chem.201202691; Xue C., 2009, CHEM MATER, V22, P494; ZOU D, 1992, J POLYM SCI POL CHEM, V30, P137, DOI 10.1002/pola.1992.080300118	59	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	5					2323	2330		10.1039/c4ta06020b		8	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AZ3SI	WOS:000348146600070		
J	Zhao, M; Xu, H; Chen, HR; Ouyang, SX; Umezawa, N; Wang, DF; Ye, JH				Zhao, Ming; Xu, Hua; Chen, Hungru; Ouyang, Shuxin; Umezawa, Naoto; Wang, Defa; Ye, Jinhua			Photocatalytic reactivity of {121} and {211} facets of brookite TiO2 crystals	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							ANATASE TIO2; SINGLE-CRYSTALS; H-2 EVOLUTION; NANOPARTICLES; NANOSHEETS; NANOMATERIALS; SPHERES; PHASE	For the facet engineering of brookite TiO2, the surface atomic structure is known but the electronic structure has been rarely studied to date. Herein, we investigated both the surface atomic and electronic structure of brookite TiO2 with various facets exposed. Theoretical calculations reveal that the {121} surface contains more undercoordinated Ti atoms and a higher surface energy than that of the {211} surface, and the experimental results show that brookite TiO2 nanorods exposed with majority {121} facets (T-121) have a lower valence band (VB) potential; those above-mentioned superior properties enable T-121 to show excellent performance in RhB photodegradation. Nevertheless, the electronic structure analyzed from the Density of State (DOS) plots revealed that the electron density is dispersed in the bulk for TiO2 covered with a {121} surface, indicating that the electrons might be more reluctant to migrate from bulk to surface, which might be the reason for the poor H-2 productivity of T-121. In contrast, brookite TiO2 nanosheets exposed with dominant {211} facets (T-211) exhibited a much higher conduction band (CB) potential resulting in a much higher H-2 evolution rate (801 mmol h(-1)) in photocatalytic water splitting. Accordingly, combining the analyses of the surface atomic structure and electronic band structure, it is suggested that, for brookite TiO2, the {121} surface is beneficial for photocatalytic oxidation reactions while the {211} surface can facilitate the photocatalytic reduction process.	[Zhao, Ming; Xu, Hua; Ouyang, Shuxin; Umezawa, Naoto; Wang, Defa; Ye, Jinhua] Tianjin Univ, Sch Mat Sci & Engn, Key Lab Adv Ceram & Machining Technol, TU NIMS Joint Res Ctr,Minist Educ, Tianjin 300072, Peoples R China; [Zhao, Ming; Xu, Hua; Ouyang, Shuxin; Wang, Defa; Ye, Jinhua] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 30072, Peoples R China; [Chen, Hungru; Umezawa, Naoto; Ye, Jinhua] Natl Inst Mat Sci, Environm Remediat Mat Unit, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Umezawa, Naoto] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Xu, H (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Key Lab Adv Ceram & Machining Technol, TU NIMS Joint Res Ctr,Minist Educ, 92 Weijin Rd, Tianjin 300072, Peoples R China.	xuhua@tju.edu.cn; Jinhua.YE@nims.go.jp			973 Program, China [2014CB239301]; Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), China; World Premier International Research Center Initiative on Materials Nanoarchitectonics (MANA), MEXT, Japan	This work was partially supported by the 973 Program (no. 2014CB239301), China, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), China, and the World Premier International Research Center Initiative on Materials Nanoarchitectonics (MANA), MEXT, Japan.	Pan J, 2011, ANGEW CHEM INT EDIT, V50, P2133, DOI 10.1002/anie.201006057; Chen JS, 2010, J AM CHEM SOC, V132, P6124, DOI 10.1021/ja100102y; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kandiel TA, 2013, PHOTOCH PHOTOBIO SCI, V12, P602, DOI 10.1039/c2pp25217a; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Kandiel TA, 2010, CHEM MATER, V22, P2050, DOI 10.1021/cm903472p; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; De Angelis F, 2014, CHEM REV, V114, P9708, DOI 10.1021/cr500055q; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; D'Arienzo M, 2011, J AM CHEM SOC, V133, P17652, DOI 10.1021/ja204838s; Jiang J, 2012, J AM CHEM SOC, V134, P4473, DOI 10.1021/ja210484t; Shibata T, 2004, PHYS CHEM CHEM PHYS, V6, P1359, DOI 10.1039/b315777f; Di Paola A, 2013, CATALYSTS, V3, P36, DOI 10.3390/catal3010036; Xi GC, 2010, CHEM COMMUN, V46, P1893, DOI 10.1039/b923435g; Liu SW, 2011, CHEM MATER, V23, P4085, DOI 10.1021/cm200597m; Yu JG, 2014, J AM CHEM SOC, V136, P8839, DOI 10.1021/ja5044787; Ismail AA, 2010, J PHOTOCH PHOTOBIO A, V216, P183, DOI 10.1016/j.jphotochem.2010.05.016; Sofianou MV, 2014, APPL CATAL B-ENVIRON, V158, P91, DOI 10.1016/j.apcatb.2014.02.030; Chen HH, 2012, CHEM REV, V112, P5919, DOI 10.1021/cr3002092; Wu NQ, 2010, J AM CHEM SOC, V132, P6679, DOI 10.1021/ja909456f; Lin HF, 2012, J AM CHEM SOC, V134, P8328, DOI 10.1021/ja3014049; Dambournet D, 2011, J MATER CHEM, V21, P3085, DOI 10.1039/c0jm03258a; Zhao XW, 2011, ADV FUNCT MATER, V21, P3554, DOI 10.1002/adfm.201100629; Liu G, 2011, CHEM COMMUN, V47, P6763, DOI 10.1039/c1cc10665a; Buonsanti R, 2008, J AM CHEM SOC, V130, P11223, DOI 10.1021/ja803559b; Zhu GL, 2013, J MATER CHEM A, V1, P9650, DOI 10.1039/c3ta11782k; Katsumata K, 2012, ACS APPL MATER INTER, V4, P4846, DOI 10.1021/am301183t; Jiang HY, 2013, J PHYS CHEM C, V117, P20029, DOI 10.1021/jp406834d; Bi Y, 2011, J AM CHEM SOC, V133, P6490, DOI 10.1021/ja2002132; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Kubacka A, 2012, CHEM REV, V112, P1555, DOI 10.1021/cr100454n; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752; Hu WB, 2009, CRYST GROWTH DES, V9, P3676, DOI 10.1021/cg9004032; Xu H, 2013, CHEM MATER, V25, P405, DOI 10.1021/cm303502b; Zhang JF, 2014, PHYS CHEM CHEM PHYS, V16, P20382, DOI 10.1039/c4cp02201g; Liu G, 2014, CHEM REV, V114, P9559, DOI 10.1021/cr400621z; Ohno T, 2014, APPL CATAL B-ENVIRON, V152, P309, DOI 10.1016/j.apcatb.2014.01.048; Xu H, 2012, J PHYS CHEM C, V116, P3833, DOI 10.1021/jp209378t; Zhao ML, 2013, CHEM COMMUN, V49, P7046, DOI 10.1039/c3cc43416h; TOMPSETT GA, 1995, J RAMAN SPECTROSC, V26, P57, DOI 10.1002/jrs.1250260110; Murakami N, 2009, J PHYS CHEM C, V113, P3062, DOI 10.1021/jp809104t; Han X, 2012, PLASMONICS, V7, P7, DOI 10.1007/s11468-011-9268-6; Li JG, 2004, J AM CERAM SOC, V87, P1358, DOI 10.1111/j.1151-2916.2004.tb07735.x; Zhao B, 2009, CHEM COMMUN, P5115, DOI 10.1039/b909883f	45	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	5					2331	2337		10.1039/c4ta06087c		7	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AZ3SI	WOS:000348146600071		
J	Fujita, S				Fujita, Shinsaku			Stereoisograms for three-membered heterocycles: I. Symmetry-itemized enumeration of oxiranes under an RS-stereoisomeric group	JOURNAL OF MATHEMATICAL CHEMISTRY			English	Article						Oxirane; Enumeration; Stereoisogram; RS-stereoisomeric group	CATALYTIC ASYMMETRIC EPOXIDATION; SUBDUCED CYCLE INDEXES; POINT MATRIX-METHOD; CHEMICAL-STRUCTURES; USCI APPROACH; COMBINATORIAL ENUMERATION; RESTRUCTURING STEREOCHEMISTRY; 3-DIMENSIONAL TREES; COSET REPRESENTATIONS; SPHERICITY INDEXES	For the purpose of characterizing the stereochemistry and stereoisomerism of oxirane derivatives, the RS-stereoisomeric group of order 8 has been defined by starting point group of order 4, which specifies the geometric features of an oxirane skeleton. The isomorphism between and the point group of order 8 is discussed algebraically and diagrammatically. The data necessary to combinatorial enumeration under , e.g., the non-redundant set of subgroups, the subduction of coset representations, and the inverse of the mark table, are prepared by referring to the data of . The fixed-point-matrix method and the partial-cycle-index method, which have been originally developed to accomplish combinatorial enumeration under point groups in the unit-subduced-cycle-index approach (Fujita in Symmetry and combinatorial enumeration in chemistry. Springer, Berlin, 1991), are extended and applied to the combinatorial enumeration of oxirane derivatives under the RS-stereoisomeric group . Thereby, the numbers of inequivalent quadruplets are calculated in an itemized fashion with respect to the subgroups of , where each quadruplet contained in a stereoisogram is counted once. Such quadruplets are further categorized into five types (type I-V). The enumeration of oxiranes under the point group as well as under the RS-permutation group is also conducted and the results are compared with those of the RS-stereoisomeric group .	Shonan Inst Chemoinformat & Math Chem, Ooimachi, Kanagawa 2580019, Japan	Fujita, S (reprint author), Shonan Inst Chemoinformat & Math Chem, Kaneko 479-7 Ooimachi, Ooimachi, Kanagawa 2580019, Japan.	shinsaku_fujita@nifty.com					Aggarwal V. K., 2006, AZIRIDINES EPOXIDES, P1, DOI 10.1002/3527607862.ch1; FUJITA S, 1989, THEOR CHIM ACTA, V76, P247, DOI 10.1007/BF00532007; Fujita S, 2012, B CHEM SOC JPN, V85, P793, DOI 10.1246/bcsj.20120008; Li AH, 1997, CHEM REV, V97, P2341, DOI 10.1021/cr960411r; Fujita S, 2005, THEOR CHEM ACC, V113, P73, DOI 10.1007/s00214-004-0605-0; Fujita S, 2004, TETRAHEDRON, V60, P11629, DOI 10.1016/j.tet.2004.09.068; Fujita S, 2012, B CHEM SOC JPN, V85, P811, DOI 10.1246/bcsj.20120009; Fujita S, 2012, J MATH CHEM, V50, P2202, DOI 10.1007/s10910-012-0025-7; Xia QH, 2005, CHEM REV, V105, P1603, DOI 10.1021/cr0406458; FUJITA S, 1991, TETRAHEDRON, V47, P31, DOI 10.1016/0040-4020(91)80005-M; Fujita S, 2014, J MATH CHEM, V52, P508, DOI 10.1007/s10910-013-0276-y; Fujita S, 2004, J ORG CHEM, V69, P3158, DOI 10.1021/jo030393v; Fujita S, 2011, B CHEM SOC JPN, V84, P1192, DOI 10.1246/bcsj.20110195; Fujita S, 2014, J MATH CHEM, V52, P543, DOI 10.1007/s10910-013-0277-x; Fujita S, 2012, J MATH CHEM, V50, P2168, DOI 10.1007/s10910-012-0024-8; Fujita S, 2004, J MATH CHEM, V35, P265, DOI 10.1023/B:JOMC.0000033259.61553.25; GAO Y, 1987, J AM CHEM SOC, V109, P5765, DOI 10.1021/ja00253a032; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Fujita S, 1990, J MATH CHEM, V5, P121, DOI 10.1007/BF01166424; Fujita S, 2012, TETRAHEDRON-ASYMMETR, V23, P623, DOI 10.1016/j.tetasy.2012.04.020; HOFT E, 1993, TOP CURR CHEM, V164, P63; Cano I, 2012, ANGEW CHEM INT EDIT, V51, P10856, DOI 10.1002/anie.201204771; Fujita S, 2007, MATCH-COMMUN MATH CO, V57, P299; Fujita S, 2002, B CHEM SOC JPN, V75, P1863, DOI 10.1246/bcsj.75.1863; Fujita S, 2010, B CHEM SOC JPN, V83, P1, DOI 10.1246/bcsj.20090008; Fujita S, 2008, J MATH CHEM, V43, P141, DOI 10.1007/s10910-006-9187-5; Fujita S, 2007, THEOR CHEM ACC, V117, P353, DOI 10.1007/s00214-006-0162-9; FUJITA S, 1990, TETRAHEDRON, V46, P365, DOI 10.1016/S0040-4020(01)85422-3; Fujita S, 2006, THEOR CHEM ACC, V115, P37, DOI 10.1007/s00214-005-0674-8; FUJITA S, 1990, J AM CHEM SOC, V112, P3390, DOI 10.1021/ja00165a021; Fujita S, 2003, J MATH CHEM, V33, P113, DOI 10.1023/A:1023251932146; Fujita S., 1991, SYMMETRY COMBINATORI; Fujita S., 2007, J COMPUT CHEM JPN, V6, P59, DOI 10.2477/jccj.6.59; Fujita S, 2005, MATCH-COMMUN MATH CO, V54, P39; Fujita S, 2007, THEOR CHEM ACC, V117, P339, DOI 10.1007/s00214-006-0163-8; Fujita S, 2002, J MATH CHEM, V32, P1, DOI 10.1023/A:1021287622494; Fujita S, 2007, MATCH-COMMUN MATH CO, V57, P265; FUJITA S, 1992, THEOR CHIM ACTA, V82, P473, DOI 10.1007/BF01129104; Fujita S, 2002, J ORG CHEM, V67, P6055, DOI 10.1021/jo020329t; Fujita S, 2005, THEOR CHEM ACC, V113, P80, DOI 10.1007/s00214-004-0606-z; Fujita S., 2013, COMBINATORIAL ENUMER; Fujita S, 2007, MATCH-COMMUN MATH CO, V58, P5; FUJITA S, 1990, B CHEM SOC JPN, V63, P315, DOI 10.1246/bcsj.63.315; FUJITA S, 1990, B CHEM SOC JPN, V63, P203, DOI 10.1246/bcsj.63.203; FUJITA S, 1971, B CHEM SOC JPN, V44, P1975, DOI 10.1246/bcsj.44.1975; Fujita S., 2007, DIAGRAMMATICAL APPRO; Fujita S, 2009, MATCH-COMMUN MATH CO, V61, P71; Fujita S., 2007, J COMPUT CHEM JPN, V6, P73, DOI 10.2477/jccj.6.73; Fujita S, 2002, CHEM REC, V2, P164, DOI 10.1002/tcr.10018; Johnson R. A., 1991, COMPREHENSIVE ORGANI, V7, P389; Katsuki T., 1996, ORG REACTIONS, V48, P1; McCoull W, 2000, SYNTHESIS-STUTTGART, P1347, DOI 10.1055/s-2000-7097; Padwa A, 2006, ARKIVOC, P6	53	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0259-9791	1572-8897		J MATH CHEM	J. Math. Chem.	JAN	2015	53	1					260	304		10.1007/s10910-014-0426-x		45	Chemistry, Multidisciplinary; Mathematics, Interdisciplinary Applications	Chemistry; Mathematics	AY7CO	WOS:000347719200019		
J	Fujita, S				Fujita, Shinsaku			Stereoisograms for three-membered heterocycles: II. Chirality, RS-stereogenicity, and ortho-stereogenicity on the basis of the proligand-promolecule model	JOURNAL OF MATHEMATICAL CHEMISTRY			English	Article						Oxirane; Stereoisogram; RS-Stereoisomeric group; Stereoisomeric group; Notation	SYMMETRY-ITEMIZED ENUMERATION; RESTRUCTURING STEREOCHEMISTRY; UNAMBIGUOUS SPECIFICATION; STEREOISOMERIC GROUPS; USCI APPROACH; DOUBLE BOND; NOMENCLATURE; HOLANTIMERS; PSEUDOASYMMETRY; PROCHIRALITY	The stereoisogram approach is applied to promolecules derived from an oxirane skeleton. First, the four substitution positions of the oxirane skeleton are examined under the action of the RS-stereoisomeric group , where point groups for chirality (or enantiomeric relationships), RS-permutation groups for RS-stereogenicity (or RS-diastereomeric relationships), and ligand-reflection groups for sclerality (or holantimeric relationships) are integrated in a consistent way. A notation system for giving -descriptors is proposed to specify the absolute configurations of oxirane derivatives on the basis of RS-stereogenicity (or RS-diastereomeric relationships) inherent in type-I, -III, or -V stereoisograms. The concept of chirality faithfulness is revised to give a rational judgement on whether -descriptors are labelled in uppercase or lowercase letters. Pseudoasymmetry and extended pseudoasymmetry are discussed on the basis of type-V stereoisograms. Second, the stereoisomeric group , which is a supergroup of the RS-stereoisomeric group , is used to characterize the cis/trans- or Z/E-isomerism, where multiple stereoisograms are introduced as graphic representations of stereoisomeric groups. The notation system of specifying Z/E-descriptors is modified to be applicable to oxirane derivatives by adopting ortho-stereogenicity (or ortho-diastereomeric relationships). Finally, the isoskeletal group , which is a supergroup of the stereoisomeric group , is used to characterize total features of isomerism based on an oxirane skeleton. Multiple stereoisogram sets are introduced as graphic representations of such isoskeletal groups, where flowcharts for determining types of multiple stereoisogram sets are proposed.	Shonan Inst Chemoinformat & Math Chem, Ooimachi, Kanagawa 2580019, Japan	Fujita, S (reprint author), Shonan Inst Chemoinformat & Math Chem, Kaneko 479-7 Ooimachi, Ooimachi, Kanagawa 2580019, Japan.	shinsaku_fujita@nifty.com					PRELOG V, 1982, ANGEW CHEM INT EDIT, V21, P567, DOI 10.1002/anie.198205671; Fujita S, 2004, TETRAHEDRON, V60, P11629, DOI 10.1016/j.tet.2004.09.068; Fujita S, 2014, J MATH CHEM, V52, P508, DOI 10.1007/s10910-013-0276-y; Fujita S, 2004, J ORG CHEM, V69, P3158, DOI 10.1021/jo030393v; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Fujita S, 2014, J MATH CHEM, V52, P543, DOI 10.1007/s10910-013-0277-x; Moss GP, 1996, PURE APPL CHEM, V68, P2193, DOI 10.1351/pac199668122193; Fujita S, 2004, J MATH CHEM, V35, P265, DOI 10.1023/B:JOMC.0000033259.61553.25; Fujita S, 2014, J MATH CHEM, V52, P1514, DOI 10.1007/s10910-014-0326-0; Fujita S, 2012, TETRAHEDRON-ASYMMETR, V23, P623, DOI 10.1016/j.tetasy.2012.04.020; BLACK KA, 1990, J CHEM EDUC, V67, P141; BLACKWOO.JE, 1968, J AM CHEM SOC, V90, P509, DOI 10.1021/ja01004a063; BLACKWOO.JE, 1968, J CHEM DOC, V8, P30, DOI 10.1021/c160028a007; Connelly N.G., 2005, NOMENCLATURE INORGAN; Fujita S, 2014, MATCH-COMMUN MATH CO, V71, P575; Fujita S., 2009, J COMPUT AIDED CHEM, V10, P16; Fujita S., 2012, CHEM INFORM COMPUTAT, P223; Fujita S, 2014, MATCH-COMMUN MATH CO, V71, P537; Fujita S, 2005, MATCH-COMMUN MATH CO, V54, P39; Fujita S., 2005, MEMOIRS FACULTY ENG, V53, P19; Fujita S, 2005, MATCH-COMMUN MATH CO, V53, P147; Fujita S., 2004, MATCH COMMUN MATH CO, V52, P3; Fujita S, 2014, MATCH-COMMUN MATH CO, V71, P511; Fujita S, 2004, J CHEM INF COMP SCI, V44, P1719, DOI 10.1021/ci040103r; Helmchen G., 1996, STEREOSELECTIVE SYNT, V1, P1; IUPAC Chemical Nomenclature and Structure Representation Division Provisional Recommendations, 2004, NOM ORG CHEM; MISLOW K, 1977, B SOC CHIM BELG, V86, P595; Mislow K., 1965, INTRO STEREOCHEMISTR; Ronbinson M.J.T., 2000, ORGANIC STEREOCHEMIS; The Commission on the Nomenclature of Organic Chemistry of IUPAC, 1976, PURE APPL CHEM, V45, P11; von Zelewsky A., 1996, STEREOCHEMISTRY COOR	31	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0259-9791	1572-8897		J MATH CHEM	J. Math. Chem.	JAN	2015	53	1					305	352		10.1007/s10910-014-0427-9		48	Chemistry, Multidisciplinary; Mathematics, Interdisciplinary Applications	Chemistry; Mathematics	AY7CO	WOS:000347719200020		
J	Fujita, S				Fujita, Shinsaku			Stereoisograms for three-membered heterocycles: III. R/S-stereodescriptors for characterizing the RS-stereogenic aspect of absolute configuration	JOURNAL OF MATHEMATICAL CHEMISTRY			English	Article						Oxirane; Stereoisogram; RS-Stereoisomeric group; R/S-Stereodescriptor	CORRELATION DIAGRAMS; PSEUDOASYMMETRY; NOMENCLATURE; HOLANTIMERS; TERMINOLOGY; CHIRALITY	The stereoisogram approach presumes the presence of three pairs of attributes, i.e., chirality/achirality, RS-stereogenicity/RS-astereogenicity, and sclerality/asclerality, in contrast to the modern stereochemistry which presumes the presence of a single pair of chirality/achirality. From this viewpoint of the stereoisogram approach, the scope and limitations of R/S-stereodescriptors of the Cahn-Ingold-Prelog (CIP) system are discussed, where oxirane derivatives are used as probes. In particular, correlation diagrams of stereoisograms are used to comprehend the global and local symmetries of oxirane derivatives. Thereby, R/S-stereodescriptors of the CIP system are found to specify local symmetries at each positions of an oxirane derivative, so that the global symmetry of the oxirane derivative requires the other types of descriptors proposed in Part II of this series (-descriptors and Z/E-descriptors). A correlation diagram of each position clarifies that R/S-stereodescriptors characterize the RS-stereogenic aspect of absolute configuration in the specification of local symmetries, but by no means the chiral aspect of absolute configuration. In other words, a pair of R/S-stereodescriptors is assigned to a pair of RS-diastereomers, not to a pair of enantiomers. This fact stems from the misleading foundation of the modern stereochemistry that it presumes a pair of chirality/achirality as a single pair of attributes. The pair of R/S-stereodescriptors originally assigned to a pair of RS-diastereomers should be interpreted subsidiarily to characterize the corresponding pair of enantiomers, where the concept of chirality faithfulness is necessary. Chirality-unfaithful cases are discussed by means of stereoisograms. Exceptional cases in the practices of the modern stereochemistry, e.g., pseudoasymmetry and 'geometric enantiomers', are discussed in a rational fashion according to the stereoisogram approach.	Shonan Inst Chemoinformat & Math Chem, Ooimachi, Kanagawa 2580019, Japan	Fujita, S (reprint author), Shonan Inst Chemoinformat & Math Chem, Kaneko 479-7 Ooimachi, Ooimachi, Kanagawa 2580019, Japan.	shinsaku_fujita@nifty.com					PRELOG V, 1982, ANGEW CHEM INT EDIT, V21, P567, DOI 10.1002/anie.198205671; Fujita S, 2004, TETRAHEDRON, V60, P11629, DOI 10.1016/j.tet.2004.09.068; Fujita S, 2004, J ORG CHEM, V69, P3158, DOI 10.1021/jo030393v; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Fujita S, 2014, J MATH CHEM, V52, P1514, DOI 10.1007/s10910-014-0326-0; Rein T, 1996, ACTA CHEM SCAND, V50, P369, DOI 10.3891/acta.chem.scand.50-0369; BESTMANN HJ, 1969, ANGEW CHEM INT EDIT, V8, P763, DOI 10.1002/anie.196907631; Fujita S, 2010, MATCH-COMMUN MATH CO, V63, P3; Fujita S, 2011, J MATH CHEM, V49, P95, DOI 10.1007/s10910-010-9732-0; Fujita S, 2010, MATCH-COMMUN MATH CO, V63, P25; Fujita S, 2004, J CHEM INF COMP SCI, V44, P1719, DOI 10.1021/ci040103r; Fujita S, 2010, J MATH CHEM, V47, P145, DOI 10.1007/s10910-009-9539-z; Helmchen G., 1996, STEREOSELECTIVE SYNT, V1, P1; PRELOG V, 1972, HELV CHIM ACTA, V55, P2581, DOI 10.1002/hlca.19720550736	14	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0259-9791	1572-8897		J MATH CHEM	J. Math. Chem.	JAN	2015	53	1					353	373		10.1007/s10910-014-0428-8		21	Chemistry, Multidisciplinary; Mathematics, Interdisciplinary Applications	Chemistry; Mathematics	AY7CO	WOS:000347719200021		
J	Yoon, SJ; Chen, DD; Han, SW; Choi, NS; Arakawa, K				Yoon, Sang-Jae; Chen, Dingding; Han, Seung-Wook; Choi, Nak-Sam; Arakawa, Kazuo			AE analysis of delamination crack propagation in carbon fiber-reinforced polymer materials	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Acoustic emission (AE) analysis; CFRP composite; Damage mechanism; VARTM process	TRANSFER MOLDING VARTM; FLOW; ENHANCEMENT; COMPOSITES	Delamination fracture behavior was investigated using acoustic emission (AE) analysis on carbon fiber-reinforced polymer (CFRP) samples manufactured using vacuum-assisted resin transfer molding (VARTM). CFRP plate was fabricated using unidirectional carbon fiber fabric with a lay-up of six plies [+30/-30](6), and a Teflon film was inserted as a starter crack. Test pieces were sectioned from the inlet and vent of the mold, and packed between two rectangular epoxy plates to load using a universal testing machine. The AE signals were monitored during tensile loading using two sensors. The average tensile load of the inlet specimens was slightly larger than that of the vent specimens; however, the data exhibited significant scattering due to non-uniform resin distribution, and there was no statistically significant different between the strength of the samples sectioned from the inlet or outlet of the mold. Each of the specimens exhibited similar AE characteristics, regardless of whether they were from the inlet or vent of the mold. Four kinds of damage mechanism were observed: micro-cracking, fiber-resin matrix debonding, fiber pull-out, and fiber failure; and three stages of the crack propagation process were identified.	[Yoon, Sang-Jae; Arakawa, Kazuo] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan; [Chen, Dingding] Natl Univ Def Technol, Coll Basic Educ Commanding Officers, Changsha 410073, Hunan, Peoples R China; [Han, Seung-Wook] Hanyang Univ, Grad Sch, Dept Mech Engn, Seoul 133791, South Korea; [Choi, Nak-Sam] Hanyang Univ, Dept Mech Engn, Ansan 426791, South Korea	Arakawa, K (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga Koen 6-1, Fukuoka 8168580, Japan.	k.arakaw@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Society for Promotion of Science [26630496]; Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University	This work was partly supported by a research grant from the Japan Society for Promotion of Science (#26630496), and by the Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University.	Bender D, 2006, COMPOS SCI TECHNOL, V66, P2265, DOI 10.1016/j.comscitech.2005.12.008; Kuentzer N, 2007, COMPOS PART A-APPL S, V38, P802, DOI 10.1016/j.compositesa.2006.08.005; Timmerman JF, 2002, COMPOS SCI TECHNOL, V62, P1249, DOI 10.1016/S0266-3538(02)00063-5; Correia NC, 2004, J FLUID ENG-T ASME, V126, P210, DOI 10.1115/1.1669032; Ohya Y, 2010, ENERGIES, V3, P634, DOI 10.3390/en3040634; Lin LY, 2006, COMPOS SCI TECHNOL, V66, P2116, DOI 10.1016/j.compscitech.2005.12.025; Rachmadini Y, 2010, J REINF PLAST COMP, V29, P2782, DOI 10.1177/0731684409359103; Johnson RJ, 2003, COMPOS SCI TECHNOL, V63, P2201, DOI 10.1016/S0266-3538(03)00179-9; Bozza J., 1996, P 28 INT SAMPE TECHN; Han SW, 2012, J MECH SCI TECHNOL, V26, P1477, DOI 10.1007/s12206-012-0341-7; Haque A., 2003, J MATER SCI LETT, V20, P1439; Johnson RJ, 2007, COMPOS SCI TECHNOL, V67, P669, DOI 10.1016/j.compscitech.2006.04.012; Miravete A., 2007, PROCESSING MANUFACTU; Zhao JL, 2004, MATER LETT, V58, P163, DOI 10.1016/S0167-577X(03)00437-3	14	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	JAN	2015	29	1					17	21		10.1007/s12206-014-1203-2		5	Engineering, Mechanical	Engineering	AZ0UE	WOS:000347959500003		
J	Muramatsu, M; Suzuki, T; Nakasone, Y				Muramatsu, Mayu; Suzuki, Takayuki; Nakasone, Yuji			Effects of microstructure on material properties of modified 9Cr-1Mo steel subject to creep-fatigue	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Creep-fatigue property; Electron backscatter diffraction; High temperature; Modified 9Cr-1Mo steel; Transmission electron microscopy	LOW-CYCLE FATIGUE; HIGH-TEMPERATURE; FERRITIC STEEL; MARTENSITIC STEEL; DAMAGE ASSESSMENT; STAINLESS-STEELS; PART I; BEHAVIOR; DEFORMATION; EVOLUTION	The creep-fatigue properties of modified 9Cr-1Mo steel were studied to elucidate the effects of the microstructure on specimens deformed by fatigue and creep-fatigue via stress holding for 30 min at 550 degrees C. First, creep-fatigue behaviors up to 7.8% nominal strains were obtained with respect to the deformation conditions. Next, the micro Vickers hardness values were determined to measure the creep-fatigue properties of the deformed materials. Electron backscatter diffraction (EBSD) and transmission electron microscopy (TEM) were used to determine the grain diameters and grain average misorientations (GAMs) and distributions of dislocations and precipitates, respectively. These observations explained the creep-fatigue properties of the deformed specimens. The differences in the properties of materials subjected to fatigue and creep-fatigue are discussed both macroscopically and microscopically.	[Muramatsu, Mayu; Suzuki, Takayuki] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Tsukuba 3058564, Japan; [Nakasone, Yuji] Tokyo Univ Sci, Fac Engn, Tokyo 1258585, Japan	Muramatsu, M (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Tsukuba 3058564, Japan.	mayu-muramatsu@aist.go.jp					Okamura H, 1999, NUCL ENG DES, V193, P243, DOI 10.1016/S0029-5493(99)00181-8; Cerri E, 1998, MAT SCI ENG A-STRUCT, V245, P285, DOI 10.1016/S0921-5093(97)00717-X; JONES WB, 1991, METALL TRANS A, V22, P1049, DOI 10.1007/BF02661098; Fujiyama K, 2009, MAT SCI ENG A-STRUCT, V510-11, P195, DOI 10.1016/j.msea.2008.08.045; Giroux PF, 2010, PROCEDIA ENGINEER, V2, P2141, DOI 10.1016/j.proeng.2010.03.230; Bharasi NS, 2012, METALL MATER TRANS A, V43A, P561, DOI 10.1007/s11661-011-0884-8; Klueh RL, 2009, T INDIAN I METALS, V62, P81; AOTO K, 1994, NUCL ENG DES, V153, P97, DOI 10.1016/0029-5493(94)90024-8; Giroux PF, 2010, MAT SCI ENG A-STRUCT, V527, P3984, DOI 10.1016/j.msea.2010.03.001; MECKING H, 1981, ACTA METALL MATER, V29, P1865, DOI 10.1016/0001-6160(81)90112-7; Sawada K, 2005, ISIJ INT, V45, P1934, DOI 10.2355/isijinternational.45.1934; Yoda R, 2010, MATER CHARACT, V61, P913, DOI 10.1016/j.matchar.2010.05.006; Shrestha T, 2012, J NUCL MATER, V423, P110, DOI 10.1016/j.jnucmat.2012.01.005; Ishitsuka T, 2004, OXID MET, V61, P125, DOI 10.1023/B:OXID.0000016280.81734.3f; WEERTMAN J, 1955, J APPL PHYS, V26, P1213, DOI 10.1063/1.1721875; Takahashi Y, 2008, INT J PRES VES PIP, V85, P406, DOI 10.1016/j.ijpvp.2007.11.008; Kimura M, 2006, INT J FATIGUE, V28, P300, DOI 10.1016/j.ijfatigue.2005.04.013; Mungole MN, 2008, MAT SCI ENG A-STRUCT, V476, P140, DOI 10.1016/j.msea.2007.04.105; Shankar V, 2006, MAT SCI ENG A-STRUCT, V437, P413, DOI 10.1016/j.msea.2006.07.146; Mannan SL, 2006, INT J MECH SCI, V48, P160, DOI 10.1016/j.ijmecsci.2005.08.004; Byun TS, 2008, ACTA MATER, V56, P1044, DOI 10.1016/j.actamat.2007.10.061; Dieter G. E., 1988, MECH METALLUGY, P442; EBI G, 1984, FATIGUE ENG MATER, V7, P299, DOI 10.1111/j.1460-2695.1984.tb00198.x; Fournier B., 2008, METALL MATER TRANS A, V40, P330; Hull D., 2001, INTRO DISLOCATIONS, P195; KANAZAWA K, 1979, MATER SCI ENG, V40, P89, DOI 10.1016/0025-5416(79)90011-9; Kannan R, 2009, J NUCL MATER, V384, P286, DOI 10.1016/j.jnucmat.2008.11.036; Kitahara H, 2006, ACTA MATER, V54, P1279, DOI 10.1016/j.actamat.2005.11.001; Klueh RL, 2004, CURR OPIN SOLID ST M, V8, P239, DOI 10.1016/j.cossms.2004.09.004; KOCKS UF, 1976, J ENG MATER-T ASME, V98, P76; Koo GH, 2007, J MECH SCI TECHNOL, V21, P699, DOI 10.1007/BF02916348; Koo GH, 2011, J MECH SCI TECHNOL, V25, P1193, DOI 10.1007/s12206-011-0222-5; Kunz L, 2001, MAT SCI ENG A-STRUCT, V319, P555, DOI 10.1016/S0921-5093(01)01094-2; LUBELL MS, 1960, REV SCI INSTRUM, V31, P207, DOI 10.1063/1.1716932; Maruyama K, 2001, ISIJ INT, V41, P641, DOI 10.2355/isijinternational.41.641; Mott B. W., 1956, MICROINDENTATION HAR, P157; Suresh S., 1998, FUNDAMENTALS FUNCTIO, P1, DOI DOI 10.1017/CB09780511806575.003; VASINA R, 1995, FATIGUE FRACT ENG M, V18, P27, DOI 10.1111/j.1460-2695.1995.tb00139.x; Wendell B. J., 1991, METALL T A, V22, P1049; Yaguchi M, 1996, NUCL ENG DES, V162, P97, DOI 10.1016/0029-5493(95)01122-6; Zhang GD, 2011, NUCL ENG DES, V241, P4856, DOI 10.1016/j.nucengdes.2011.08.076	41	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	JAN	2015	29	1					121	129		10.1007/s12206-014-1219-7		9	Engineering, Mechanical	Engineering	AZ0UE	WOS:000347959500019		
J	Hasegawa, J				Hasegawa, Junichi			Sonoembryological evaluations of the development of placenta previa and velamentous cord insertion	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						placenta previa; sonoembryology; trophotropism; ultrasound; vasa previa; velamentous cord insertion	IN-VITRO FERTILIZATION; VASA-PREVIA; UMBILICAL-CORD; SONOGRAPHIC DIAGNOSIS; PRENATAL-DIAGNOSIS; EMBRYO-TRANSFER; WEEKS GESTATION; RISK-FACTOR; LOWER 3RD; ABRUPTION	Longitudinal and cross-sectional investigations using ultrasound examinations during pregnancy can be used to clarify the mechanisms and pathophysiology of abnormal fetal and placental development. Such sonoembryological assessments are useful as a method for clarifying the etiology of disease. In the present review, we describe current knowledge based on our experience with applying sonoembryological methods to determine the developmental mechanisms of placenta previa and velamentous cord insertion.	[Hasegawa, Junichi] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan	Hasegawa, J (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Fung TY, 1998, ULTRASOUND OBST GYN, V12, P430, DOI 10.1046/j.1469-0705.1998.12060430.x; Schachter M, 2002, FERTIL STERIL, V78, P642, DOI 10.1016/S0015-0282(02)03253-3; GAVRIIL P, 1993, PEDIATR PATHOL, V13, P453; Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Hasegawa J, 2012, J MATERN-FETAL NEO M, V25, P2795, DOI 10.3109/14767058.2012.712570; Catanzarite V, 2001, ULTRASOUND OBST GYN, V18, P109, DOI 10.1046/j.1469-0705.2001.00448.x; EDDLEMAN KA, 1992, AM J PERINAT, V9, P123, DOI 10.1055/s-2007-994684; Hasegawa J, 2010, PRENATAL DIAG, V30, P1121, DOI 10.1002/pd.2618; Toivonen S, 2002, AM J PERINAT, V19, P451, DOI 10.1055/s-2002-36868; Heinonen S, 1996, OBSTET GYNECOL, V87, P112, DOI 10.1016/0029-7844(95)00339-8; Oyelese Y, 2004, OBSTET GYNECOL, V103, P937, DOI 10.1097/01.AOG.0000123245.48645.98; Lee W, 2000, OBSTET GYNECOL, V95, P572, DOI 10.1016/S0029-7844(99)00600-6; Ananth CV, 1996, OBSTET GYNECOL, V88, P309, DOI 10.1016/0029-7844(96)00088-9; Delbaere I, 2007, HUM REPROD, V22, P2763, DOI 10.1093/humrep/dem191; Francois K, 2003, J REPROD MED, V48, P771; Hasegawa J, 2005, INT J GYNECOL OBSTET, V90, P26, DOI 10.1016/j.ijgo.2005.03.028; Hasegawa J, 2006, ULTRASOUND OBST GYN, V28, P183, DOI 10.1002/uog.2839; Hasegawa J, 2011, FETAL DIAGN THER, V30, P203, DOI 10.1159/000329308; Hasegawa J, 2011, J OBSTET GYNAECOL RE, V37, P1698, DOI 10.1111/j.1447-0756.2011.01555.x; Hasegawa J, 2006, ULTRASOUND OBST GYN, V27, P425, DOI 10.1002/uog.2645; Hasegawa J, 2009, J PERINAT MED, V37, P481, DOI 10.1515/JPM.2009.088; Hasegawa J, 2007, FETAL DIAGN THER, V22, P358, DOI 10.1159/000103296; Hasegawa J, 2011, J OBSTET GYNAECOL RE, V37, P1346, DOI 10.1111/j.1447-0756.2011.01525.x; MCLENNAN JE, 1968, AM J OBSTET GYNECOL, V101, P1124; MONIE IW, 1965, AM J OBSTET GYNECOL, V93, P276; Oyelese K O, 1999, Obstet Gynecol Surv, V54, P138, DOI 10.1097/00006254-199902000-00024; QUEK SP, 1972, AUST NZ J OBSTET GYN, V12, P206, DOI 10.1111/j.1479-828X.1972.tb00503.x	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					1	5		10.1111/jog.12531		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000001		
J	Era, S; Matsunaga, S; Matsumura, H; Murayama, Y; Takai, Y; Seki, H				Era, Sumiko; Matsunaga, Shigetaka; Matsumura, Hideyoshi; Murayama, Yoshihiko; Takai, Yasushi; Seki, Hiroyuki			Usefulness of shock indicators for determining the need for blood transfusion after massive obstetric hemorrhage	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						blood transfusion; coagulation factor; fibrinogen; massive obstetric hemorrhage; shock index	POSTPARTUM HEMORRHAGE; HEMOSTATIC CHANGES; VISUAL ESTIMATION; PREGNANCY; COAGULOPATHY; MANAGEMENT; FIBRINOGEN; DELIVERY; TRAUMA; INDEX	AimMassive obstetric hemorrhage (MOH) requires prompt transfusion of red blood cells and coagulation factors. Because MOH has a diverse pathogenesis, the shock index (SI) alone may be insufficient for determining blood transfusion. Here, we retrospectively analyzed patients with MOH to determine usefulness of the indicators of shock including the SI in evaluating the need for blood transfusion. MethodsWe reviewed records of 80 emergency referral patients who had received blood transfusions at our department between 1January 2009 and 31July 2011. The shock indicators for blood transfusion are estimated blood loss, fibrinogen level, hemoglobin concentration, the Japan Society of Obstetrics and Gynecology disseminated intravascular coagulation (JSOG DIC) score and the SI. The strength of the correlation of each shock indicator with the transfusion volume was ranked using Spearman's rank correlation coefficient- and multivariate analysis. ResultsAlthough the SI showed significant positive correlation with blood transfusion volume for red blood cell concentrate (RCC) and fresh frozen plasma (FFP) in patients with dilutional coagulopathy, a stronger correlation was seen with the fibrinogen level and JSOG DIC score. In patients with consumptive coagulopathy, the strongest correlation was seen between RCC transfusion volume and fibrinogen level, and between FFP transfusion volume and JSOG DIC score followed by fibrinogen level. In multivariate analysis, only fibrinogen level was significantly associated with both RCC and FFP massive transfusion. ConclusionBecause MOH has a diverse pathogenesis, various indicators should be evaluated. Among shock indicators, fibrinogen level was the best indicator of the need for blood transfusion following MOH.	[Era, Sumiko; Matsunaga, Shigetaka; Matsumura, Hideyoshi; Murayama, Yoshihiko; Takai, Yasushi; Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Ctr Maternal Fetal & Neonatal Med, Kawagoe, Saitama 3508550, Japan	Matsunaga, S (reprint author), Saitama Med Univ, Saitama Med Ctr, Ctr Maternal Fetal & Neonatal Med, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	shige_m@saitama-med.ac.jp					Charbit B, 2007, J THROMB HAEMOST, V5, P266, DOI 10.1111/j.1538-7836.2007.02297.x; Patel A, 2006, INT J GYNECOL OBSTET, V93, P220, DOI 10.1016/j.ijgo.2006.02.014; Santoso JT, 2005, OBSTET GYNECOL SURV, V60, P827, DOI 10.1097/01.ogx.0000189154.98227.4b; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1053/ybeha.2003.260; [Anonymous], PREV POSTP HEM IN; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Dildy GA, 2004, OBSTET GYNECOL, V104, P601, DOI 10.1097/01.AOG.0000137873.07820.34; Thachil J, 2009, BLOOD REV, V23, P167, DOI 10.1016/j.blre.2009.04.002; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; DUTHIE SJ, 1991, EUR J OBSTET GYN R B, V38, P119, DOI 10.1016/0028-2243(91)90188-Q; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Ahonen J, 2010, ACTA ANAESTH SCAND, V54, P1164, DOI 10.1111/j.1399-6576.2010.02309.x; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Kikuchi M, 2013, J OBSTET GYNAECOL RE, V39, P770, DOI 10.1111/j.1447-0756.2012.02058.x; Basu H K, 1969, J Obstet Gynaecol Br Commonw, V76, P481; Callcut RA, 2013, J TRAUMA ACUTE CARE, V74, P59, DOI 10.1097/TA.0b013e3182788b34; De Lloyd L, 2012, INT J OBSTET ANESTH, V11, P135; Drite J., 1997, BRIT J OBSTET GYNAEC, V104, P275; Japan Society of Obstetrics and Gynecology, CORR GUID MAN CRIT B; Kamei Y, 2009, OBSTET GYNECOL THER, V99, P279; King RW, 1996, ACAD EMERG MED, V3, P1041, DOI 10.1111/j.1553-2712.1996.tb03351.x; Matsunaga S, 2012, ISRN OBSTET GYNECOL, V2012; Ministry of Health Labour and Welfare, GUID PERT US BLOOD P; Mitra B, 2014, INJURY, V45, P61, DOI 10.1016/j.injury.2013.01.010; National Institutes of Health, 1989, AM J OBSTET GYNECOL, V160, P278; PRITCHARD JA, 1962, AM J OBSTET GYNECOL, V84, P1271; Schneider MC, 1997, CLIN PROBLEMS OBSTET, P50; Schwartz SI, 1999, SOCIAL PSYCHOL CULTU, P107; SHER G, 1977, AM J OBSTET GYNECOL, V129, P164; Terao T, 1986, BLOOD VESSELS, V17, P543	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					39	43		10.1111/jog.12480		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000007		
J	Kasai, J; Aoki, S; Kamiya, N; Hasegawa, Y; Kurasawa, K; Takahashi, T; Hirahara, F				Kasai, Junko; Aoki, Shigeru; Kamiya, Natsuko; Hasegawa, Yoshimi; Kurasawa, Kentaro; Takahashi, Tsuneo; Hirahara, Fumiki			Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						clinical feature; differential diagnosis; gestational thrombocytopenia; immune thrombocytopenia; pregnancy outcomes	PLATELET COUNT; MANAGEMENT; GUIDELINES; DELIVERY; PURPURA; TREAT	AimTo investigate the clinical features of gestational thrombocytopenia (GT) difficult to differentiate from immune thrombocytopenia (ITP) during pregnancy. MethodsThe January 2000-December 2012 hospital database was analyzed to identify women with ITP or GT (after excluding other possible causes of thrombocytopenia) among those first noted to have platelet counts of less than 100000/L during pregnancy. The maternal characteristics, platelet count fluctuations and pregnancy outcomes were compared between women with ITP and GT. ResultsThere were 23 pregnancies (22 women) with thrombocytopenia (GT, 13; ITP, 10). The GT group included five twin pregnancies (38.5%), whereas all pregnancies of the ITP group were singleton pregnancies, with significantly more twin pregnancies in the GT group (P=0.046). Thrombocytopenia in the first trimester occurred in 70% (7/10) of ITP cases and 23.1% (3/13) of even GT cases. The nadir platelet count was less than 70000/L in 100% (10/10) of ITP cases and 30.8% (4/13) of GT cases (P<0.001). Maternal treatment was required in 80% (8/10) of ITP cases, but in none of the GT cases. The pregnancy outcomes were favorable in both groups, and no case required fetal treatment. ConclusionGestational thrombocytopenia with platelet counts of less than 100000/L occurred more frequently in twin pregnancies. Although onset of thrombocytopenia in the first trimester and a platelet count of less than 70000/L is more common in ITP, these findings were not uncommon in GT. Differentiation between ITP and GT may be feasible only with post-partum changes in the platelet count.	[Kasai, Junko; Aoki, Shigeru; Kamiya, Natsuko; Hasegawa, Yoshimi; Kurasawa, Kentaro; Takahashi, Tsuneo] Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Yokohama, Kanagawa 2320024, Japan; [Hirahara, Fumiki] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Aoki, S (reprint author), Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Minami Ku, 4-57 Urafunecho, Yokohama, Kanagawa 2320024, Japan.	smyyaoki@yahoo.co.jp		Aoki, Shigeru/0000-0001-5307-575X			Ajzenberg N, 1998, BLOOD, V92, P4573; American College of Obstetricians and Gynecologists, 1999, INT J GYNECOL OBSTET, V67, P117; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; Gernsheimer T, 2013, BLOOD, V121, P38, DOI 10.1182/blood-2012-08-448944; Win N, 2005, HEMATOLOGY, V10, P69, DOI 10.1080/10245330400020421; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; BURROWS RF, 1993, NEW ENGL J MED, V329, P1463, DOI 10.1056/NEJM199311113292005; George JN, 1996, BLOOD, V88, P3; Allford SL, 2003, BRIT J HAEMATOL, V120, P556, DOI 10.1046/j.1365-2141.2003.04049.x; ANTEBY E, 1994, AM J HEMATOL, V47, P118, DOI 10.1002/ajh.2830470210; BARTHOLOMEW JR, 1989, J REPROD MED, V34, P234; Provan D, 2003, BRIT J HAEMATOL, V120, P574; BURROWS RF, 1988, NEW ENGL J MED, V319, P142, DOI 10.1056/NEJM198807213190304; Burrows R F, 1993, Obstet Gynecol Surv, V48, P781, DOI 10.1097/00006254-199312000-00003; Minakami H, 2000, Lancet, V356, P1354, DOI 10.1016/S0140-6736(05)74263-X; Minakami H, 1998, GYNECOL OBSTET INVES, V46, P41, DOI 10.1159/000009995; PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004; Ruggeri M, 1997, HAEMATOLOGICA, V82, P341; Shehata N, 1999, CLIN OBSTET GYNECOL, V42, P327, DOI 10.1097/00003081-199906000-00017; Song TB, 2001, HAEMATOLOGIA, V31, P25, DOI 10.1163/15685590151092661; Tsunoda T, 2002, ACTA OBSTET GYN SCAN, V81, P840, DOI 10.1034/j.1600-0412.2002.810907.x	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					44	49		10.1111/jog.12496		6	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000008		
J	Sukegawa, A; Ohshige, K; Arai, S; Sakanashi, K; Usui, M; Hirahara, F; Miyagi, E				Sukegawa, Akiko; Ohshige, Kenji; Arai, Suzuko; Sakanashi, Kaoru; Usui, Masami; Hirahara, Fumiki; Miyagi, Etsuko			Three-year questionnaire survey on human papillomavirus vaccination targeting new female college students	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						cervical cancer; fixed point observation; human papillomavirus vaccine; questionnaire survey; young women	CERVICAL-CANCER PREVENTION; HPV VACCINATION; HONG-KONG; ADOLESCENT FEMALES; WOMEN; GIRLS; PERCEPTIONS; KNOWLEDGE; BARRIERS; VIRUS	AimA questionnaire survey was conducted at fixed points to describe changes over a 3-year period in the human papillomavirus (HPV) vaccination uptake rate among young women. Several factors obtained from the questionnaire were investigated in relation to HPV vaccination. MethodsThe study was conducted at two universities in Yokohama City, Japan. Newly enrolled female students of the universities were recruited to participate in this study in 2011, 2012 and 2013. The study participants were asked about their HPV vaccination status. They were also questioned about factors that potentially influenced HPV vaccination, such as current age, place of residence during high school, and knowledge related to cervical cancer and HPV vaccination. ResultsThe proportion of vaccinated participants dramatically increased in 2013 (48.7%) in comparison to 2011 (5.4%) and 2012 (13.5%). Three factors were positively related to HPV vaccination: being 18 years old in 2013, which means that they were eligible for a financial support program (P<0.001); living in the study city, in which HPV vaccination was well conducted (P<0.001); and proper knowledge of cervical cancer and HPV vaccination (P<0.001). ConclusionThe HPV vaccination uptake rate in 2013 dramatically increased from that in 2011. Official financial support and publicity work were likely to have had an effect on the HPV vaccination uptake rate.	[Sukegawa, Akiko; Hirahara, Fumiki] Yokohama City Univ, Sch Med, Dept Obstet & Gynecol, Yokohama, Kanagawa 232, Japan; [Sakanashi, Kaoru; Usui, Masami] Yokohama City Univ, Sch Med, Coll Nursing Care, Yokohama, Kanagawa 232, Japan; [Ohshige, Kenji] Yokohama Natl Univ, Ctr Hlth Serv Sci, Yokohama, Kanagawa 240, Japan; [Arai, Suzuko] Yokohama City Univ, Int Coll Arts & Sci, Yokohama, Kanagawa 232, Japan; [Sakanashi, Kaoru] Kanto Gakuin Univ, Sch Nursing, Yokohama, Kanagawa, Japan; [Miyagi, Etsuko] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa 2360004, Japan	Miyagi, E (reprint author), Yokohama City Univ Med, Dept Obstet & Gynecol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	emiyagi@med.yokohama-cu.ac.jp	Ohshige, Kenji/O-6331-2014	Ohshige, Kenji/0000-0001-9453-8896	Ministry of Health, Labor and Welfare, Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare, Japan (fiscal year, 2011-2013; chief researcher: Dr Etsuko Miyagi).	Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P2045; Kwan TTC, 2011, PATIENT EDUC COUNS, V84, P118, DOI 10.1016/j.pec.2010.06.018; Ratanasiripong NT, 2013, VACCINE, V31, P1370, DOI 10.1016/j.vaccine.2013.01.001; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Bartlett JA, 2011, J SCH NURS, V27, P434, DOI 10.1177/1059840511415861; Dorell CG, 2011, PEDIATRICS, V128, P830, DOI 10.1542/peds.2011-0950; Onuki M, 2009, CANCER SCI, V100, P1312, DOI 10.1111/j.1349-7006.2009.01161.x; Hilton S, 2010, SOC SCI MED, V70, P942, DOI 10.1016/j.socscimed.2009.11.027; Hamlish T, 2012, VACCINE, V30, P6472, DOI 10.1016/j.vaccine.2012.07.085; Bynum SA, 2011, J HEALTH CARE POOR U, V22, P549, DOI 10.1353/hpu.2011.0060; Chan CYZ, 2011, ASIAN PAC J CANCER P, V12, P2539; Donati S, 2012, VACCINE, V30, P2075, DOI 10.1016/j.vaccine.2012.01.057; Fujiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084126; GLOBOCAN, 2012, EST CANC INC MORT PR; Hayashi Y, 2012, VACCINE, V30, P5547, DOI 10.1016/j.vaccine.2012.06.038; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Morales-Campos DY, 2013, J ADOLESCENT HEALTH, V52, pS69, DOI 10.1016/j.jadohealth.2012.09.020; Siu JYM, 2013, CULT HEALTH SEX, V15, P1071, DOI 10.1080/13691058.2013.807518; Walsh CD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-368	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					99	106		10.1111/jog.12500		8	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000016		
J	Yanazume, S; Kamio, M; Karakida, N; Gibo, A; Nakajo, Y; Togami, S; Douchi, T				Yanazume, Shintaro; Kamio, Masaki; Karakida, Noriko; Gibo, Akiko; Nakajo, Yukiko; Togami, Shinichi; Douchi, Tsutomu			Identification of new risk factors for wound separation in gynecologic malignancy surgery	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						gynecology; subcutaneous drain; subcuticular suture; surgery; wound preparation	SUBCUTANEOUS TISSUE; CESAREAN DELIVERY; PREVENTION; INFECTION; DRAINAGE	AimThe purpose of this study was to compare prophylactic subcutaneous drainage plus subcuticular sutures versus staples for the risk of wound separation after skin closure following gynecologic malignancy surgery, and to investigate the risk factors of this procedure. Material and MethodsPatients were divided into two groups: 120 patients who were treated with subcutaneous drainage plus subcuticular sutures (Suture group) and 201 patients with staples plus subcutaneous sutures (Staples group). In the Suture group, subcuticular tissue was approximated with interrupted 4-0 polydioxanone sutures, and adhesive closure strips were used on the skin surface. A 3.3-mm closed drainage was implicated in subcutaneous tissue. In the Staples group, subcutaneous tissue was approximated with interrupted polyglactin (Vicryl, Ethicon) sutures. ResultsBaseline characteristics were not significantly different between the two groups. Mean operation times were compatible (201 vs 196min, P=0.16). The incidence of wound separation was less in the Suture group than in the Staples group (3/120 vs 17/201, P=0.033). Multiple logistic regression analysis revealed that the Staples group was an independent risk factor for wound separation (odds ratio 7.34, 95% confidence interval: 1.59-33.91, P=0.011), independent of obesity, International Federation of Gynecology and Obstetrics stages, and operation time. None of the 14 obese patients in the Suture group showed surgical wound separation. ConclusionsThe combination of a prophylactic subcutaneous drain and subcuticular sutures reduced wound separation after skin closure following gynecologic malignancy surgery. With the information regarding risk factors established in this study, the above method provides the best results to minimize the risk, particularly in obese patients.	[Yanazume, Shintaro; Kamio, Masaki; Karakida, Noriko; Gibo, Akiko; Nakajo, Yukiko; Togami, Shinichi; Douchi, Tsutomu] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908520, Japan	Yanazume, S (reprint author), Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	s-yana@m3.kufm.kagoshima-u.ac.jp					Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2; Basha SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.011; Clay FSH, 2011, AM J OBSTET GYNECOL, V204, P378, DOI 10.1016/j.ajog.2010.11.018; Culver DH, 1991, AM J MED S3B, V91, P152; Gallup DC, 1996, AM J OBSTET GYNECOL, V175, P358, DOI 10.1016/S0002-9378(96)70146-1; Hellums EK, 2007, AM J OBSTET GYNECOL, V197, P229, DOI 10.1016/j.ajog.2007.05.023; Inotsume-Kojima Y, 2011, J HOSP INFECT, V77, P162, DOI 10.1016/j.jhin.2010.07.016; KIVISAARI J, 1975, ANN SURG, V181, P823, DOI 10.1097/00000658-197506000-00011; Leaper D, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1924; Pearl ML, 2004, J REPROD MED, V49, P662; Ramsey PS, 2005, OBSTET GYNECOL, V105, P967, DOI 10.1097/01.AOG.0000158866.68311.d1; SOISSON AP, 1993, GYNECOL ONCOL, V51, P330, DOI 10.1006/gyno.1993.1299; SOPER DE, 1995, AM J OBSTET GYNECOL, V173, P465, DOI 10.1016/0002-9378(95)90267-8; Soper DE, 1995, AM J OBSTET GYNECOL, V173, P9	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					107	113		10.1111/jog.12509		7	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000017		
J	Maeda, K; Imoto, I; Kaji, T; Yoshida, Y; Nakayama, S; Irahara, M				Maeda, Kazuhisa; Imoto, Issei; Kaji, Takashi; Yoshida, Yukiko; Nakayama, Soichiro; Irahara, Minoru			Case of non-mosaic trisomy 20 in amniotic fluid cultures without anomalies in the fetus: Cytogenetic discrepancy between amniocytes and fetal blood	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						amniocentesis; confined placental mosaicism; cordocentesis; non-mosaic trisomy 20; prenatal diagnosis	PRENATAL-DIAGNOSIS; CHORIONIC VILLUS; TISSUES; ORIGIN	We report a case of non-mosaic trisomy 20 detected prenatally by amniocentesis during the 16th week of pregnancy. Fetal blood sampling showed a normal karyotype and no fetal, neonatal or infant abnormalities were observed. Amniotic fluid cell karyotyping revealed a trisomy 20 (47,XY,+20) with 100% trisomic cells (38/38); however, a subsequent cordocentesis revealed a normal male karyotype. Moreover, a follow-up ultrasonographic examination did not reveal any major congenital malformations, and a healthy male infant was delivered subsequently at an appropriate gestational age without obvious anomalies. Cytogenetic analysis of blood lymphocytes from the infant revealed a normal karyotype, but cultured cells from the term placenta showed a mosaic karyotype 47,XY,+20/46,XY with 88% trisomic cells (44 of 50). Furthermore, no anomalies or developmental delays were observed in the neonatal period, thus suggesting two possibilities: confined placental mosaicism with the presence of normal and abnormal cell lineages, or generalized mosaicism affecting a limited number of tissues in both the placenta and fetus.	[Maeda, Kazuhisa] Shikoku Med Ctr Children & Adults, Gen Perinatal Med Ctr, Zentsuji, Japan; [Maeda, Kazuhisa; Kaji, Takashi; Nakayama, Soichiro; Irahara, Minoru] Tokushima Univ Hosp, Dept Obstet & Gynecol, Tokushima, Japan; [Imoto, Issei; Yoshida, Yukiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 770, Japan	Maeda, K (reprint author), 2-1-1 Senyu Cho, Zentsuji, Kagawa 7658507, Japan.	maeda-k@shikoku-med.jp					Robinson WP, 2005, PRENATAL DIAG, V25, P239, DOI 10.1002/pd.1121; Bianca S, 2008, AM J MED GENET A, V146A, P1897, DOI 10.1002/ajmg.a.32338; BUI TH, 1984, PRENATAL DIAG, V4, P145, DOI 10.1002/pd.1970040710; Hsieh Ching-Chang, 1992, Journal of the Formosan Medical Association, V91, P543; HSU LYF, 1987, PRENATAL DIAG, V7, P581, DOI 10.1002/pd.1970070809; Micale MA, 1996, PRENATAL DIAG, V16, P893; Morales C, 2010, EUR J MED GENET, V53, P197, DOI 10.1016/j.ejmg.2010.03.007; Robinson WP, 2002, PRENATAL DIAG, V22, P1076, DOI 10.1002/pd.483; Stein QP, 2008, PRENATAL DIAG, V28, P1169, DOI 10.1002/pd.2147; Warren NS, 2001, PRENATAL DIAG, V21, P1111	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					141	144		10.1111/jog.12488		4	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000022		
J	Mabuchi, S; Kawano, M; Isohashi, F; Kuroda, H; Sasano, T; Kimura, T				Mabuchi, Seiji; Kawano, Mahiru; Isohashi, Fumiaki; Kuroda, Hiromasa; Sasano, Tomoyuki; Kimura, Tadashi			First two cases of primary carcinoma of the vagina successfully treated with concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high-dose-rate interstitial brachytherapy: A case report and published work review	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						carboplatin; concurrent chemoradiotherapy; paclitaxel; vaginal carcinoma	SQUAMOUS-CELL CARCINOMA; RECTOVAGINAL SEPTUM; CERVICAL-CANCER; CHEMORADIATION; ADENOCARCINOMA; THERAPY	Vaginal carcinoma is rare, accounting for only 2% of all gynecological malignancies. Due to a lack of prospective randomized studies, the role of concurrent chemoradiotherapy in the treatment of primary vaginal carcinoma remains unclear. We report the first two cases of primary vaginal carcinoma successfully treated with a regimen involving concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high-dose-rate interstitial brachytherapy. These cases strongly indicate that definitive chemoradiation involving carboplatin plus paclitaxel may be a reasonable treatment for primary vaginal carcinoma.	[Mabuchi, Seiji; Kawano, Mahiru; Kuroda, Hiromasa; Sasano, Tomoyuki; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Isohashi, Fumiaki] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan	Mabuchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabuchi@gyne.med.osaka-u.ac.jp					Samant R, 2007, INT J RADIAT ONCOL, V69, P746, DOI 10.1016/j.ijrobp.2007.04.015; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Frank SJ, 2005, INT J RADIAT ONCOL, V62, P138, DOI 10.1016/j.ijrobp.2004.09.032; Dalrymple JL, 2004, INT J GYNECOL CANCER, V14, P110, DOI 10.1111/j.1048-891x.2004.014066.x; Ghia AJ, 2011, INT J GYNECOL CANCER, V21, P378, DOI 10.1097/IGC.0b013e3182072e44; PEREZ CA, 1988, INT J RADIAT ONCOL, V15, P1283; Beller U, 2006, INT J GYNECOL OBSTET, V95, pS29, DOI 10.1016/S0020-7292(06)60029-5; Berek JS, 2004, PRACTICAL GYNECOLOGI, P585; Guiou M, 2008, INT J GYNECOL CANCER, V18, P1118, DOI 10.1111/j.1525-1438.2007.01124.x; Kitagawa R, 2012, J CLIN ONCOL S, V30; Mabuchi S, 2013, INT J GYNECOL CANCER, V23, P1279, DOI 10.1097/IGC.0b013e31829c3e32; Miyamoto DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065048; Nashiro T, 2008, INT J CLIN ONCOL, V13, P335, DOI 10.1007/s10147-007-0758-7; Yazbeck C, 2005, INT J GYNECOL CANCER, V15, P1203, DOI 10.1111/j.1525-1438.2005.00167.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					156	161		10.1111/jog.12492		6	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000026		
J	Morimoto, A; Tsubamoto, H; Inoue, K; Ikeda, Y; Hirota, S				Morimoto, Atsushi; Tsubamoto, Hiroshi; Inoue, Kayo; Ikeda, Yuuki; Hirota, Seiichi			Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						c-kit; endometrial stromal sarcoma; fertility-sparing management; leuprolide; recurrence	LOW-GRADE; CONSERVATIVE MANAGEMENT; TRANSITION; PREGNANCY; UTERUS	Several cases of the uterus being preserved after diagnosis of endometrial stromal sarcoma (ESS) have been reported. Most of these patients were alive and did not experience relapse, but this might have reflected the short follow-up period, given the indolent recurrence of ESS. We report the first fatal case of ESS 10 years after fertility-sparing management. A specimen obtained from the last operation showed loss of estrogen receptor status and expression of c-kit without c-kit or PDGFR- gene mutations.	[Morimoto, Atsushi; Tsubamoto, Hiroshi; Inoue, Kayo; Ikeda, Yuuki] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Inoue, Kayo] Meiwa Gen Hosp, Dept Obstet & Gynecol, Nishinomiya, Hyogo, Japan	Tsubamoto, H (reprint author), Hyogo Coll Med, Dept Obstet & Gynecol, Mukogawa 1-1, Nishinomiya, Hyogo 6638501, Japan.	tsuba@hyo-med.ac.jp					Amant F, 2007, BRIT J CANCER, V97, P1994; Amant F, 2006, GYNECOL ONCOL, V103, P1137, DOI 10.1016/j.ygyno.2006.07.013; Anderson MC, 2002, PATHOLOGY FEMALE REP, P361; Cheng X, 2011, GYNECOL ONCOL, V121, P323, DOI 10.1016/j.ygyno.2010.12.360; NORRIS HJ, 1966, CANCER, V19, P755, DOI 10.1002/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U; Dong RY, 2014, ONCOL LETT, V7, P1039, DOI 10.3892/ol.2014.1858; Bai HM, 2014, GYNECOL ONCOL, V132, P654, DOI 10.1016/j.ygyno.2013.12.032; Stadsvold JL, 2005, GYNECOL ONCOL, V99, P243, DOI 10.1016/j.ygyno.2005.06.039; Delaney AA, 2012, OBSTET GYNECOL, V120, P486, DOI 10.1097/AOG.0b013e31825a7397; Koskas M, 2009, ANTICANCER RES, V29, P4147; Feng WW, 2013, HISTOPATHOLOGY, V62, P675, DOI [10.1111/j.1365-2559.2011.04115.x, 10.1111/j.1365-2559.2011.04120.x]; Flam F, 1996, HUM REPROD, V11, P2797; Inoue K, 2014, J OBSTET GYNAECOL RE, V40, P576, DOI 10.1111/jog.12180; Kalender ME, 2009, CANCER CHEMOTH PHARM, V63, P555, DOI 10.1007/s00280-008-0786-7; Kanda M, 2013, EUR J GYNAECOL ONCOL, V34, P358; Lissoni A, 1997, INT J GYNECOL CANCER, V7, P364, DOI 10.1046/j.1525-1438.1997.00012.x; MANSI JL, 1990, GYNECOL ONCOL, V36, P113, DOI 10.1016/0090-8258(90)90120-A; Ohta Y, 2010, INT J GYNECOL PATHOL, V29, P374, DOI 10.1097/PGP.0b013e3181cef14b; Sakane R, 2011, SANFUJINKA NO SHINPO, V63, P99	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	JAN	2015	41	1					162	166		10.1111/jog.12506		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AY6ZL	WOS:000347711000027		
J	Chen, DY; Liu, X; Matsuki, T				Chen, Dian-Yong; Liu, Xiang; Matsuki, Takayuki			Prediction of isoscalar charmoniumlike structures in the hidden-charm di-eta decays of higher charmonia	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						hidden-charm dipion decay; charmonium-like state; charmonium	MESON; VECTOR	Considering the situation that a single chiral particle, eta is initially emitted, we study the hidden- charm di- eta decays of the charmoniumlike state Y(4660) and the predicted charmonium Psi(4790), i.e., Y(4660)/Psi(4790) -> J/Psi eta eta through the inetermediates eta[D-(*)(D) over bar ((*))] and/or eta[D-s(+(*))+ D-s(-(*))] , and answer the important question of whether there exist isoscalar charmoniumlike structures in the D-(*)(D) over bar ((*)) and/or Ds+(*)Ds-(*) channels. Our results predict that there will be enhancement structures near D (D) over bar (*), D-*(D) over bar (*) and D-s(*)(D) over bar (*)(s) thresholds for Y(4660) and near D-*(D) over bar (*), D-s(D) over bar (*)(s) and D-s(*)(D) over bar (*)(s) thresholds for psi(4790) in the M-max (J/psi eta) distributions of Y(4660)/psi(4790) -> eta eta J/psi, respectively. These peaks are accessible in future experiments, especially BESIII, Belle, BaBar, and the forthcoming BelleII.	[Chen, Dian-Yong; Liu, Xiang] Lanzhou Univ, Res Ctr Hadron & CSR Phys, Lanzhou 730000, Peoples R China; [Chen, Dian-Yong; Liu, Xiang] Inst Modern Phys CAS, Lanzhou 730000, Peoples R China; [Liu, Xiang] Lanzhou Univ, Sch Phys Sci & Technol, Lanzhou 730000, Peoples R China; [Chen, Dian-Yong] Chinese Acad Sci, Inst Modern Phys, Nucl Theory Grp, Lanzhou 730000, Peoples R China; [Matsuki, Takayuki] Tokyo Kasei Univ, Itabashi Ku, Tokyo 1738602, Japan	Chen, DY (reprint author), Lanzhou Univ, Res Ctr Hadron & CSR Phys, Lanzhou 730000, Peoples R China.	chendy@impcas.ac.cn; xiangliu@lzu.edu.cn; matsuki@tokyo-kasei.ac.jp	Chen, Dian-Yong/C-3769-2015; 	Chen, Dian-Yong/0000-0002-3906-7531	National Natural Science Foundation of China [11222547, 11175073, 11005129, 11375240, 11035006]; Ministry of Education of China (FANEDD) [200924]; Ministry of Education of China (SRFDP) [2012021111000]; Ministry of Education of China (NCET); Fok Ying Tung Education Foundation [131006]; West Doctoral Project of Chinese Academy of Sciences	This project is supported by the National Natural Science Foundation of China under Grant No. 11222547, No. 11175073, No. 11005129, No. 11375240 and No. 11035006, the Ministry of Education of China (FANEDD under Grant No. 200924, SRFDP under Grant No. 2012021111000, and NCET), the Fok Ying Tung Education Foundation (No. 131006), and the West Doctoral Project of Chinese Academy of Sciences.	Ablikim M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.252001; JOUSSET J, 1990, PHYS REV D, V41, P1389, DOI 10.1103/PhysRevD.41.1389; Chen DY, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.094003; Wang XL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.142002; WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002; Oh Y, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.034901; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bondar A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.122001; Cabibbo N, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.121801; Casalbuoni R., 1997, PHYS REP, V281, P145, DOI DOI 10.1016/S0370-1573(96)00027-0; Chen DY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.232001; COFFMAN D, 1989, PHYS REV D, V40, P3788, DOI 10.1103/PhysRevD.40.3788.2; COFFMAN D, 1988, PHYS REV D, V38, P2695, DOI 10.1103/PhysRevD.38.2695; Colangelo P, 2002, PHYS LETT B, V542, P71, DOI 10.1016/S0370-2693(02)02306-7; Haglin KL, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.031902; HATEGAN C, 1976, J PHYS-PARIS, V37, P45, DOI 10.1051/jphys:0197600370204500; KAYMAKCALAN O, 1984, PHYS REV D, V30, P594, DOI 10.1103/PhysRevD.30.594; Lees J P, 2012, ARXIV12116271HEPEX; van Beveren E, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/61002	19	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	JAN	2015	42	1							015002	10.1088/0954-3899/42/1/015002		11	Physics, Nuclear; Physics, Particles & Fields	Physics	AZ3LW	WOS:000348130000003		
J	Tagami, S; Shimizu, YR; Dudek, J				Tagami, Shingo; Shimizu, Yoshifumi R.; Dudek, Jerzy			Tetrahedral symmetry in Zr nuclei: calculations of low-energy excitations with Gogny interaction	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						tetrahedral symmetry; Gogny interaction; quantum number projection	NUMBER PROJECTION; FORCE; FISSION; STATE	We report on the results of the calculations of the low energy excitation patterns for three Zirconium isotopes, viz Zr-80(40), Zr-96(56) and Zr-110(70), reported by other authors to be doubly-magic tetrahedral nuclei (with tetrahedral magic numbers Z = 40 and N = 40, 56 and 70). We employ the realistic Gogny effective interactions using three variants of their parametrization and the particle-number, parity and the angular-momentum projection techniques. We confirm quantitatively that the resulting spectra directly follow the pattern expected from the group theory considerations for the tetrahedral symmetric quantum objects. We also find out that, for all the nuclei studied, the correlation energy obtained after the angular momentum projection is very large for the tetrahedral deformation as well as other octupole deformations. The lowering of the energies of the resulting configurations is considerable, i.e. by about 10 MeV or even more, once again confirming the significance of the angular-momentum projections techniques in the mean-field nuclear structure calculations.	[Tagami, Shingo; Shimizu, Yoshifumi R.] Kyushu Univ, Dept Phys, Fac Sci, Fukuoka 8128581, Japan; [Dudek, Jerzy] CNRS, IN2P3, Inst Pluridisciplinaire Hubert Curien, F-67037 Strasbourg, France; [Dudek, Jerzy] Univ Strasbourg, F-67037 Strasbourg, France	Tagami, S (reprint author), Kyushu Univ, Dept Phys, Fac Sci, Fukuoka 8128581, Japan.	Jerzy.Dudek@IPHC.CNRS.Fr			Japan Society for the Promotion of Science [25.949, 22540285]; Polish-French COPIN collaboration [04-113]	This work is supported in part by Grant-in-Aid for Scientific Research No. 25.949 and No. 22540285 from Japan Society for the Promotion of Science, and by the Polish-French COPIN collaboration under project number 04-113.	Anguiano M, 2001, NUCL PHYS A, V696, P467, DOI 10.1016/S0375-9474(01)01219-2; Egido JL, 1997, PHYS LETT B, V393, P13, DOI 10.1016/S0370-2693(96)01602-4; Chappert F, 2008, PHYS LETT B, V668, P420, DOI 10.1016/j.physletb.2008.09.017; DECHARGE J, 1980, PHYS REV C, V21, P1568, DOI 10.1103/PhysRevC.21.1568; Hilaire S, 2007, EUR PHYS J A, V33, P237, DOI 10.1140/epja/i2007-10450-2; Anguiano M, 2001, NUCL PHYS A, V683, P227, DOI 10.1016/S0375-9474(00)00445-0; Rodriguez TR, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.064323; Goriely S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.242501; BERGER JF, 1991, COMPUT PHYS COMMUN, V63, P365, DOI 10.1016/0010-4655(91)90263-K; LISTER CJ, 1987, PHYS REV LETT, V59, P1270, DOI 10.1103/PhysRevLett.59.1270; Dudek J, 2007, INT J MOD PHYS E, V16, P516, DOI 10.1142/S0218301307005958; Dudek J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.252502; Dudek J, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/5/054007; Firestone R.B., 1996, TABLE ISOTOPES; Herzberg G., 1945, MOL SPECTRA MOL STRU, VII; Herzberg G., 1966, MOL SPECTRA MOL STRU; Miskiewicz M, 2004, INT J MOD PHYS E, V13, P127, DOI 10.1142/S0218301304001849; Ring P, 1980, NUCL MANY BODY PROBL; Robledo LM, 2010, J PHYS G NUCL PARTIC, V37, DOI 10.1088/0954-3899/37/6/064020; Rodriguez TR, 2011, PHYS LETT B, V705, P255, DOI 10.1016/j.physletb.2011.10.003; Schunck N, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.061305; Staszczak A, 2010, EUR PHYS J A, V46, P85, DOI 10.1140/epja/i2010-11018-9; Tagami S, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/5/054013; Tagami S, 2012, PROG THEOR PHYS, V127, P79; Yamagami K M, 2001, NUCL PHYS A, V693, P579; Zberecki K, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.051302	26	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	JAN	2015	42	1							015106	10.1088/0954-3899/42/1/015106		22	Physics, Nuclear; Physics, Particles & Fields	Physics	AZ3LW	WOS:000348130000012		
J	Maeda, K; Nagata, H; Ojima, M; Amano, A				Maeda, Kazuhiko; Nagata, Hideki; Ojima, Miki; Amano, Atsuo			Proteomic and Transcriptional Analysis of Interaction between Oral Microbiota Porphyromonas gingivalis and Streptococcus rails	JOURNAL OF PROTEOME RESEARCH			English	Article						Porphyromonas gingivalis; Streptococcus oralis; biofilm; microbiology; interaction; shotgun; proteomics; quantitative RT PCR	PENICILLIN-BINDING PROTEIN-3; SIGNAL RECOGNITION PARTICLE; TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; BIOFILM FORMATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SHOTGUN PROTEOMICS; GENE-EXPRESSION; POLYNUCLEOTIDE PHOSPHORYLASE; PSEUDOMONAS-AERUGINOSA	Porphyromonas gingivalis, a major periodontal pathogen, forms biofilm with other oral bacteria such as streptococci. Here, by using shotgun proteomics, we examined the molecular basis of mixed-biofilm formation by P. gingivalis with Streptococcus oralis. We identified a total of 593 bacterial proteins in the biofilm. Compared to the expression profile in the P. gingivalis monobiofilm, the expression of three proteins was induced and that of 31 proteins was suppressed in the mixed biofilm. Additionally, the expression of two S. oralis proteins was increased, while that of two proteins was decreased in the mixed biofilm, as compared to its monotypic profile. mRNA expression analysis of selected genes using a quantitative reverse transcription polymerase chain reaction confirmed the proteomics data, which included overexpression of P. gingivalis FimA and S. oralis glyceraldehyde-3-phosphate dehydrogenase in association with the biofilm. The results also indicated that S. oralis regulates the transcriptional activity of P. gingivalis luxS to influence autoinducer-2-dependent signaling. These findings suggest that several functional molecules are involved in biofilm formation between P. gingivalis and S. oralis.	[Maeda, Kazuhiko; Nagata, Hideki; Ojima, Miki; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan	Maeda, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prevent Dent, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kmaeda@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [24593147]	This work was supported by a Grand-in-Aid for Scientific Research (C) (24593147) from the Japan Society for the Promotion of Science. We thank Kazuaki Takafuji of the Center for Medical Research and Education, Faculty of Medicine, Osaka University for the expert technical assistance.	Abe N, 2004, BIOL CHEM, V385, P1041, DOI 10.1515/BC.2004.135; Ammann T.W., 2013, PLOS ONE, V8, P1; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Amano A, 1997, J DENT RES, V76, P852; Chen W, 2006, FEMS MICROBIOL LETT, V264, P15, DOI 10.1111/j.1574-6968.2006.00426.x; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Nanbu T, 2013, MOL CELL BIOL, V33, P1175, DOI 10.1128/MCB.01713-12; HARA H, 1991, J BACTERIOL, V173, P4799; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; Caillet J, 2003, MOL MICROBIOL, V47, P961, DOI 10.1046/j.1365-2958.2003.03364.x; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Vera M, 2013, PROTEOMICS, V13, P1133, DOI 10.1002/pmic.201200386; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Maeda K, 2004, INFECT IMMUN, V72, P1341, DOI 10.1128/IAI.72.3.1341-1348.2004; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Perez-Cheeks BA, 2012, MOL MICROBIOL, V86, P1007, DOI 10.1111/mmi.12039; Blaze MTM, 2012, ANALYST, V137, P5018, DOI 10.1039/c2an35922g; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Maeda K, 2004, INFECT IMMUN, V72, P5475, DOI 10.1128/IAI.72.9.5475-5477.2004; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; Wang Y, 2011, FEMS MICROBIOL LETT, V316, P36, DOI 10.1111/j.1574-6968.2010.02189.x; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Reichmann P, 2011, J BACTERIOL, V193, P2888, DOI 10.1128/JB.00321-11; SLOTS J, 1978, INFECT IMMUN, V19, P254; Luppens SBI, 2008, ORAL MICROBIOL IMMUN, V23, P183, DOI 10.1111/j.1399-302X.2007.00409.x; Fermin D, 2011, PROTEOMICS, V11, P1340, DOI 10.1002/pmic.201000650; Maltz MA, 2012, APPL ENVIRON MICROB, V78, P7760, DOI 10.1128/AEM.01858-12; HIRATSUKA K, 1992, ARCH ORAL BIOL, V37, P717, DOI 10.1016/0003-9969(92)90078-M; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Burgess NA, 2002, MICROBIOL-SGM, V148, P763; GOULBOURNE PA, 1991, J BACTERIOL, V173, P5266; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Gutierrez JA, 1999, MICROBIOL-UK, V145, P357; FUJITA M, 1994, MOL MICROBIOL, V13, P1071, DOI 10.1111/j.1365-2958.1994.tb00498.x; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Kishi M, 2012, MOL ORAL MICROBIOL, V27, P458, DOI 10.1111/j.2041-1014.2012.00659.x; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Nagata H, 2009, INFECT IMMUN, V77, P5130, DOI 10.1128/IAI.00439-09; Maeda K, 2013, INFECT IMMUN, V81, P753, DOI 10.1128/IAI.00875-12; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Giaouris E, 2013, INT J FOOD MICROBIOL, V162, P105, DOI 10.1016/j.ijfoodmicro.2012.12.023; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Jacobs AC, 2013, ANTIMICROB AGENTS CH, V57, P26, DOI 10.1128/AAC.01640-12; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Wu J, 2008, FEMS MICROBIOL LETT, V282, P188, DOI 10.1111/j.1574-6968.2008.01116.x; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Chung WSO, 2001, J BACTERIOL, V183, P3903, DOI 10.1128/JB.183.13.3903-3909.2001; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Beebe KD, 2000, BIOCHEMISTRY-US, V39, P3149, DOI 10.1021/bi992709s; Bermudez-Cruz RM, 2005, BIOCHIMIE, V87, P737, DOI 10.1016/j.biochi.2005.03.005; Calasso M, 2013, APPL ENVIRON MICROB, V79, P2657, DOI 10.1128/AEM.03625-12; Carzaniga T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-270; DiDone L, 2011, YEAST, V28, P561, DOI 10.1002/yea.1860; Diego I. D., 2013, J BIOL CHEM, V288, P14287; Guo FB, 2013, DNA RES, V20, P273, DOI 10.1093/dnares/dst009; Hadidi S, 2001, IMMUNOL LETT, V77, P97, DOI 10.1016/S0165-2478(01)00208-5; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; HARA H, 1989, J BACTERIOL, V171, P5882; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; Hulsen T., 2008, BMC GENOMICS, V16, P488; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; KAMAGUCHI A, 1995, MICROBIOL IMMUNOL, V39, P521; Kirkland PA, 2008, J PROTEOME RES, V7, P5033, DOI 10.1021/pr800517a; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Kuramitsu HK, 2005, J PERIODONTOL, V76, P2047, DOI 10.1902/jop.2005.76.11-S.2047; LAMONT RJ, 1992, ORAL MICROBIOL IMMUN, V7, P193, DOI 10.1111/j.1399-302X.1992.tb00024.x; Maeda K, 2008, MOL MICROBIOL, V69, P1153, DOI 10.1111/j.1365-2958.2008.06338.x; Mangalappalli-Illathu AK, 2006, ANTIMICROB AGENTS CH, V50, P3588, DOI 10.1128/AAC.00573-06; Mazmanian S. K., 2001, BACILLUS SUBTILIS IT, P150; NAGASAWA H, 1989, J BACTERIOL, V171, P5890; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; Oh H, 2003, CLIN MICROBIOL INFEC, V9, P512, DOI 10.1046/j.1469-0691.2003.00725.x; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okano S, 2006, PROTEOMICS, V6, P251, DOI 10.1002/pmic.200401338; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Pallen MJ, 1997, MOL MICROBIOL, V26, P411, DOI 10.1046/j.1365-2958.1997.5591911.x; Sistek V, 2012, CLIN MICROBIOL INFEC, V18, P1089, DOI 10.1111/j.1469-0691.2011.03684.x; STINSON MW, 1991, INFECT IMMUN, V59, P102; Tanaka H, 2012, NEUROCHEM INT, V61, P240, DOI 10.1016/j.neuint.2012.05.008; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Winram SB, 1996, MICROBIOL-SGM, V142, P2311; Yamaguchi T, 1998, J PERIODONTAL RES, V33, P460; Yamamoto M, 2003, BIOCHEM BIOPH RES CO, V312, P1297, DOI 10.1016/j.bbrc.2003.11.078; Yamamoto M, 2010, EXTREMOPHILES, V14, P79, DOI 10.1007/s00792-009-0289-4; Zarei Omid, 2011, Avicenna Journal of Medical Biotechnology, V3, P79; Zhang XJ, 2012, BIOTECHNOL PROGR, V28, P60, DOI 10.1002/btpr.716	104	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JAN	2015	14	1					82	94		10.1021/pr500848e		13	Biochemical Research Methods	Biochemistry & Molecular Biology	AY3UA	WOS:000347506600008		
J	Cheng, KK; Akasaki, Y; Lecommandeur, E; Lindsay, RT; Murfitt, S; Walsh, K; Griffin, JL				Cheng, Kian-Kai; Akasaki, Yuichi; Lecommandeur, Emmanuelle; Lindsay, Ross T.; Murfitt, Steven; Walsh, Kenneth; Griffin, Julian L.			Metabolomic Analysis of Akt1-Mediated Muscle Hypertrophy in Models of Diet-Induced Obesity and Age-Related Fat Accumulation	JOURNAL OF PROTEOME RESEARCH			English	Article						Protein kinase B; metabonomics; obesity; type 2 diabetes	INCREASES ENERGY-EXPENDITURE; PROTEIN-KINASE-B; IN-VIVO; CARNOSINE; GROWTH; AKT1; MICE; CANCER; SPECTROSCOPY; INHIBITION	Akt1 is a serine/threonine kinase that promotes cell growth and survival. Previously, Akt1 activation in a double transgenic (DTG) mouse model fed a high-fat/high-sucrose (HF/HS) diet was found to promote type IIb muscle growth and to lead to a significant reduction in obesity. Here, we have used metabolomics to examine the metabolic perturbations in blood serum and liver and gastrocnemius tissues of the DTG mice. Multivariate statistics highlighted consistent metabolic changes in gastrocnemius muscle following Akt1 activation, which included significant reductions of serine and histidine-containing dipeptides (anserine and carnosine), in addition to increased concentrations of phosphorylated sugars. In addition, Akt1-mediated regression in obesity could be associated with increased glycolysis in gastrocnemius muscle as well as increased gluconeogenesis, glycogenolysis, and ketogenesis in the liver. In old DTG animals, Akt1 activation was found to improve glucose metabolism and confer a beneficial effect in the regression of age-related fat accumulation. This study identifies metabolic changes induced by Akt1-mediated muscle growth and demonstrates a cross-talk between distant organs that leads to a regression of fat mass. The current findings indicate that agents that promote Akt1 induction in muscle have utility in the regression of obesity.	[Cheng, Kian-Kai; Lecommandeur, Emmanuelle; Lindsay, Ross T.; Murfitt, Steven; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Cheng, Kian-Kai; Lecommandeur, Emmanuelle; Lindsay, Ross T.; Murfitt, Steven; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Cheng, Kian-Kai] Univ Teknol Malaysia, Dept Bioproc Engn, Johor Baharu 81310, Johor, Malaysia; [Cheng, Kian-Kai] Univ Teknol Malaysia, Innovat Ctr Agritechnol, Johor Baharu 81310, Johor, Malaysia; [Akasaki, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Akasaki, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Med & Hypertens, Kagoshima 8908520, Japan; [Griffin, Julian L.] Med Res Council MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England	Griffin, JL (reprint author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	jules.griffin@mrc-hnr.cam.ac.uk			Universiti Teknologi Malaysia; Royal Society, UK; Medical Research Council, UK [UD99999906]; Wellcome Trust (UPLC QToF MS based lipidomics) [093148/Z/10/Z]; National Institutes of Health [AG034972, HL081587, HL116591, HL120160]	The authors gratefully thank the support from Universiti Teknologi Malaysia (K-K.C.), the Royal Society, UK (J.L.G.), the Medical Research Council, UK (Lipid Profiling and Signalling programme grant; UD99999906; J.L.G.), the Wellcome Trust (UPLC QToF MS based lipidomics; 093148/Z/10/Z; J.L.G.), and the National Institutes of Health (AG034972, HL081587, HL116591, and HL120160; K.W.).	Akasaki Y, 2014, AGING CELL, V13, P80, DOI 10.1111/acel.12153; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Salek R, 2011, METHOD ENZYMOL, V500, P337, DOI 10.1016/B978-0-12-385118-5.00017-7; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Holliday R, 2000, BIOCHEMISTRY-MOSCOW+, V65, P843; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Gariballa SE, 2000, AGE AGEING, V29, P207, DOI 10.1093/ageing/29.3.207; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Holliday R, 1996, BRIT J CANCER, V73, P966, DOI 10.1038/bjc.1996.189; Jia HJ, 2009, REGUL PEPTIDES, V154, P69, DOI 10.1016/j.regpep.2008.12.004; Maemura H., 2006, INT J SPORT HLTH SCI, V4, P86, DOI 10.5432/ijshs.4.86; MORRISON WR, 1964, J LIPID RES, V5, P600; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2	32	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JAN	2015	14	1					342	352		10.1021/pr500756u		11	Biochemical Research Methods	Biochemistry & Molecular Biology	AY3UA	WOS:000347506600029		
J	Hiraga, Y; Sato, Y; Smith, RL				Hiraga, Yuya; Sato, Yoshiyuki; Smith, Richard L., Jr.			Development of a simple method for predicting CO2 enhancement of H-2 gas solubility in ionic liquids	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						H-2 solubility; Biomass; Hydrogenolysis; Hydrogenation; Equation of state	PRESSURE PHASE-BEHAVIOR; CARBON-DIOXIDE; CO2-EXPANDED LIQUIDS; 1-BUTYL-3-METHYLIMIDAZOLIUM BIS(TRIFLUOROMETHYLSULFONYL)IMIDE; RHEOLOGICAL PROPERTIES; HYDROGEN SOLUBILITY; EXPANDED LIQUIDS; ROOM-TEMPERATURE; 283 K; CELLULOSE	The solubility of hydrogen in an ionic liquid (IL) is important for hydrogenolysis and hydrogenation used in biomass transformations. In this work, we formulate an enhancement ratio (ER) for H-2-CO2-IL systems that is defined in terms of the ternary system H-2 molality, the binary H-2 molality at constant temperature and the isofugacity condition. Literature data were used to demonstrate the utility of the definition for ER and to develop a predictive model for ionic liquids that dissolve cellulose. The ER is greater than one when CO2 can be used to increase Hy solubility in the IL. Although the solubility of H-2 in many IL can be enhanced by CO2, for some ILs the presence of CO2 reduces Hy solubility in the IL. The ER for [hmirn][Tf2N] was found to be less than one at low CO2 concentrations. Temperature affected the ER of ionic liquids in different ways with some IL exhibiting maximum hydrogen solubility ([bmim][PF6]) and others having an ER that monotonically increased with temperature ([Tf(2)N1-containing IL). Correlation of the ER with literature data is proposed in terms of Henry's constant of Hy and CO2 and the solubility parameter of the ionic liquid. The correlation was applied to six ionic liquids at conditions of 313-453 K and at CO2 molalities up to 5 mol/kg to give a sum of squares of the residuals of 1.4 x 10(-3) in Delta m(H2). Solubility enhancement ratios for Hy gas by CO2 for ionic liquids that dissolve cellulose were estimated with the predictive model to be as high as 1.2 per unit molality CO2 in the IL. Vapor-liquid equilibrium measurements of mixed gases (H-2-CO2, CO-CO2, O-2-CO2) with ionic liquids that dissolve biomass are urgently needed to promote development of methods for transforming biomass into biofuels and chemicals. (C) 2014 Elsevier B.V. All rights reserved.	[Hiraga, Yuya; Smith, Richard L., Jr.] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Sato, Yoshiyuki; Smith, Richard L., Jr.] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Sendai, Miyagi 9808579, Japan	Smith, RL (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Aramaki Aza Aoba 6-6-11, Sendai, Miyagi 9808579, Japan.	smith@scf.che.tohoku.ac.jp	Smith Jr, Richard/E-3495-2012	Smith Jr, Richard/0000-0002-9174-7681	Japan Society for the Promotion of Science (JSPS) [25289272]	The authors gratefully acknowledge support of this work by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid Scientific Research (B) research grant number 25289272 and a Grant-in-Aid for JSPS Fellows.	Ruppert AM, 2012, ANGEW CHEM INT EDIT, V51, P2564, DOI 10.1002/anie.201105125; Qi XH, 2009, CHEMSUSCHEM, V2, P944, DOI 10.1002/cssc.200900199; Schilderman AM, 2007, FLUID PHASE EQUILIBR, V260, P19, DOI 10.1016/j.fluid.2007.06.003; Afzal W, 2013, J CHEM THERMODYN, V63, P88, DOI 10.1016/j.jct.2013.03.007; Wei M, 2002, J AM CHEM SOC, V124, P2513, DOI 10.1021/ja0114411; De S, 2012, CHEMSUSCHEM, V5, P1826, DOI 10.1002/cssc.201200031; PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011; Subramaniam B, 2014, CHEM ENG SCI, V115, P3, DOI 10.1016/j.ces.2014.03.001; Jessop PG, 2007, CHEM REV, V107, P2666, DOI 10.1021/cr040199o; Shin EK, 2008, J SUPERCRIT FLUID, V45, P282, DOI 10.1016/j.supflu.2008.01.020; Gomes MFC, 2007, J CHEM ENG DATA, V52, P472, DOI 10.1021/je0604129; Jacquemin J, 2008, GREEN CHEM, V10, P944, DOI 10.1039/b802761g; Finotello A, 2008, IND ENG CHEM RES, V47, P3453, DOI 10.1021/ie0704142; Ramdin M, 2012, IND ENG CHEM RES, V51, P8149, DOI 10.1021/ie3003705; Aki SNVK, 2004, J PHYS CHEM B, V108, P20355, DOI [10.1021/jp046895+, 10.1021/jp046895]; Malik MA, 2011, CHEM ENG J, V171, P242, DOI 10.1016/j.cej.2011.03.041; Kumelan J, 2010, J CHEM ENG DATA, V55, P165, DOI 10.1021/je900298e; Zhao YS, 2011, FLUID PHASE EQUILIBR, V302, P60, DOI 10.1016/j.fluid.2010.08.017; Yim JH, 2011, J CHEM ENG DATA, V56, P1197, DOI 10.1021/je101100d; Raeissi S, 2011, J CHEM ENG DATA, V56, P1105, DOI 10.1021/je101060k; Vitz J, 2009, GREEN CHEM, V11, P417, DOI 10.1039/b818061j; Wang LJ, 2014, CARBOHYD POLYM, V110, P292, DOI 10.1016/j.carbpol.2014.03.091; Gericke M, 2009, BIOMACROMOLECULES, V10, P1188, DOI 10.1021/bm801430x; Valderrama JO, 2009, IND ENG CHEM RES, V48, P6890, DOI 10.1021/ie900250g; Jacquemin J, 2006, FLUID PHASE EQUILIBR, V240, P87, DOI 10.1016/j.fluid.2005.12.003; Valderrama JO, 2012, IND ENG CHEM RES, V51, P7838, DOI 10.1021/ie202934g; Sun XF, 2014, GREEN CHEM, V16, P2736, DOI 10.1039/c4gc00085d; Jacquemin J, 2006, J CHEM THERMODYN, V38, P490, DOI 10.1016/j.jct.2005.07.002; Shariati A, 2005, AICHE J, V51, P1532, DOI 10.1002/aic.10384; Carvalho PJ, 2010, J PHYS CHEM LETT, V1, P774, DOI 10.1021/jz100009c; Kuang QL, 2008, J PHYS CHEM B, V112, P10234, DOI 10.1021/jp804167n; TSANG CY, 1981, CHEM ENG SCI, V36, P993, DOI 10.1016/0009-2509(81)80085-1; Chae IS, 2014, CHEM ENG J, V251, P343, DOI 10.1016/j.cej.2014.04.017; Raeissi S, 2009, J CHEM ENG DATA, V54, P382, DOI 10.1021/je800433r; Brandt A, 2013, GREEN CHEM, V15, P550, DOI 10.1039/c2gc36364j; Beichel W, 2013, PHYS CHEM CHEM PHYS, V15, P8821, DOI 10.1039/c3cp43306d; Yuan XL, 2006, J CHEM ENG DATA, V51, P645, DOI 10.1021/je050437s; Hiraga Y, 2012, J SUPERCRIT FLUID, V66, P49, DOI 10.1016/j.supflu.2011.08.003; Chen KY, 2013, CHEMSUSCHEM, V6, P613, DOI 10.1002/cssc.201200940; Liu SB, 2014, ACS SUSTAIN CHEM ENG, V2, P1819, DOI 10.1021/sc5001463; Lee BC, 2006, J CHEM ENG DATA, V51, P892, DOI 10.1021/je050357o; Wang H, 2012, CHEM SOC REV, V41, P1519, DOI 10.1039/c2cs15311d; Iguchi M, 2013, CELLULOSE, V20, P1353, DOI 10.1007/s10570-013-9884-8; Ren W, 2010, J CHEM THERMODYN, V42, P305, DOI 10.1016/j.jct.2009.08.018; Raeissi S, 2013, J SUPERCRIT FLUID, V73, P126, DOI 10.1016/j.supflu.2012.09.003; Carvalho PJ, 2009, J PHYS CHEM B, V113, P6803, DOI 10.1021/jp901275b; Jacquemin J, 2007, J SOLUTION CHEM, V36, P967, DOI 10.1007/s10953-007-9159-9; Fukaya Y, 2006, BIOMACROMOLECULES, V7, P3295, DOI 10.1021/bm060329d; Deng Y, 2010, CHEMSUSCHEM, V3, P377, DOI 10.1002/cssc.200900241; Oh DJ, 2006, KOREAN J CHEM ENG, V23, P800, DOI 10.1007/BF02705931; Kumelan J, 2007, FLUID PHASE EQUILIBR, V260, P3, DOI 10.1016/j.fluid.2006.06.010; Akien GR, 2009, GREEN CHEM, V11, P1083, DOI 10.1039/b904097h; Carvalho PJ, 2009, J SUPERCRIT FLUID, V50, P105, DOI 10.1016/j.supflu.2009.05.008; Carvalho PJ, 2014, J SUPERCRIT FLUID, V88, P46, DOI 10.1016/j.supflu.2014.01.011; Dyson PJ, 2003, CHEM COMMUN, P2418, DOI 10.1039/b308309h; Hert DG, 2005, CHEM COMMUN, P2603, DOI 10.1039/b419157a; Jang S., 2010, FLUID PHASE EQUILIBR, V299, P216, DOI 10.1016/j.fluid.2010.09.039; Kato A., 2014, MEASUREMENT CALCULAT; Kroon MC, 2005, J CHEM ENG DATA, V50, P173, DOI 10.1021/je049753h; Kumelan J, 2006, J CHEM ENG DATA, V51, P1364, DOI 10.1021/je060087p; Kumelan J, 2006, J CHEM ENG DATA, V51, P1802, DOI 10.1021/je060190e; Kumelan J, 2011, FLUID PHASE EQUILIBR, V311, P9, DOI 10.1016/j.fluid.2011.08.013; Kumelan J, 2006, J CHEM ENG DATA, V51, P11, DOI 10.1021/je050362s; Lichtenthaler R.N., 1986, MOL THERMODYNAMICS F; Lopez-Castillo ZK, 2006, IND ENG CHEM RES, V45, P5351, DOI 10.1021/ie0601091; Lopez-Castillo ZK, 2008, IND ENG CHEM RES, V47, P570, DOI 10.1021/ie070105b; Poling BE, 2001, PROPERTIES GASES LIQ; Raeissi S, 2012, AICHE J, V58, P3553, DOI 10.1002/aic.13742; Toussaint VA, 2013, J CHEM THERMODYN, V59, P239, DOI 10.1016/j.jct.2012.12.013; Wei M, 2004, GREEN CHEM, V6, P387, DOI 10.1039/b310523g; Xie XN, 2014, CATAL TODAY, V233, P70, DOI 10.1016/j.cattod.2013.09.061; Xie ZZ, 2009, J CHEM ENG DATA, V54, P1633, DOI 10.1021/je900148e; Zhou LY, 2013, J CHEM THERMODYN, V59, P28, DOI 10.1016/j.jct.2012.11.030	73	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	JAN	2015	96				SI		162	170		10.1016/j.supflu.2014.09.010		9	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	AZ1SE	WOS:000348017300018		
J	Goto, M; Kanda, H; Wahyudiono; Machmudah, S				Goto, Motonobu; Kanda, Hideki; Wahyudiono; Machmudah, Siti			Extraction of carotenoids and lipids from algae by supercritical CO2 and subcritical dimethyl ether	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Algae; Lipid; Carotenoid; Extraction; Carbon dioxide; Dimethyl ether	CHLORELLA-VULGARIS; ASTAXANTHIN; MICROALGAE; BIOMASS; FOOD; ANTIOXIDANT; FUCOXANTHIN; ETHANOL; LIQUID; WATER	Algae contain lipids and functional compounds such as carotenoids. Especially, microalgae are recently focused as a source of biofuel. To extract these components, organic solvent or supercritical carbon dioxide have been used. We have been developing wet extraction process using liquefied (subcritical) dimethyl ether (DME) as solvent at around 0.59 MPa. The extraction process usually requires energy consuming drying and grinding process as in the case of supercritical CO2. We have applied liquefied DME for the extraction of lipids and functional compounds from various kinds of algae. Since the liquefied DME extraction process can eliminate the process for drying, cell disruption, and solvent evaporation, it can realize simpler and low energy consumption system. In this paper, our studies on the extraction from algae by using supercritical CO2 or subcritical DME are reviewed. (C) 2014 Elsevier B.V. All rights reserved.	[Goto, Motonobu; Kanda, Hideki] Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kanda, Hideki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020076, Japan; [Wahyudiono] Univ Surabaya, Dept Chem Engn, Raya Kalirungkut 60293, Surabaya, Indonesia; [Machmudah, Siti] Sepuluh Nopember Inst Technol, Sukolilo 60111, Surabaya, Indonesia	Goto, M (reprint author), Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	mgoto@nuce.nagoya-u.ac.jp	Kanda, Hideki/K-5371-2012; Machmudah, Siti/K-2813-2013; 	Machmudah, Siti/0000-0002-4927-0402; Kanda, Hideki/0000-0002-8393-4276	New Energy and Industrial Technology Development Organization of Japan [09B40009c]; Japan Science and Technology Agency	A part of this research was supported by Industrial Technology Research Grant Program (Project ID: 09B40009c, H. Kanda) from New Energy and Industrial Technology Development Organization of Japan and a grant from the Precursory Research for Embryonic Science and Technology Program (PRESTO; H. Kanda) of Japan Science and Technology Agency.	Bensebia O, 2009, J SUPERCRIT FLUID, V49, P161, DOI 10.1016/j.supflu.2009.01.007; Kanda H, 2010, FUEL, V89, P2104, DOI 10.1016/j.fuel.2010.02.019; Naito M, 2005, J LOSS PREVENT PROC, V18, P469, DOI 10.1016/j.jlp.2005.07.001; Catchpole OJ, 2003, J AGR FOOD CHEM, V51, P4853, DOI 10.1021/jf0301246; Durante M, 2014, INT J MOL SCI, V15, P6725, DOI 10.3390/ijms15046725; Machmudah S, 2006, IND ENG CHEM RES, V45, P3652, DOI 10.1021/ie051357k; Lorenz RT, 2000, TRENDS BIOTECHNOL, V18, P160, DOI 10.1016/S0167-7799(00)01433-5; Kanda H, 2013, FUEL, V105, P535, DOI 10.1016/j.fuel.2012.08.032; Kanda H, 2013, FOOD BIOPROD PROCESS, V91, P376, DOI 10.1016/j.fbp.2013.02.001; Gouveia L, 2003, AQUACULT NUTR, V9, P123, DOI 10.1046/j.1365-2095.2003.00233.x; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; JOHNSON EA, 1991, CRIT REV BIOTECHNOL, V11, P297, DOI 10.3109/07388559109040622; Casas L, 2010, J FOOD ENG, V96, P304, DOI 10.1016/j.jfoodeng.2009.08.002; Kanda H, 2011, FUEL, V90, P1264, DOI 10.1016/j.fuel.2010.10.057; Kanda H, 2008, ADSORPTION, V14, P467, DOI 10.1007/s10450-008-9120-2; Gouveia L, 2007, FOOD CHEM, V101, P717, DOI 10.1016/j.foodchem.2006.02.027; Mendes RL, 2005, CHEM ENG J, V105, P147, DOI 10.1016/j.cej.2004.10.006; Kanda H, 2012, FUEL, V95, P88, DOI 10.1016/j.fuel.2011.11.064; Billakanti J. M., 2012, 10 INT S SUP FLUIDS; Billakanti JM, 2013, PROCESS BIOCHEM, V48, P1999, DOI 10.1016/j.procbio.2013.09.015; Boye J. I., 2012, GREEN TECHNOLOGIES F; Casas L, 2007, J SUPERCRIT FLUID, V41, P43, DOI 10.1016/j.supflu.2006.09.001; Catchpole O, 2010, J SUPERCRIT FLUID, V53, P34, DOI 10.1016/j.supflu.2010.02.014; Catchpole OJ, 2008, J SUPERCRIT FLUID, V45, P314, DOI 10.1016/j.supflu.2008.01.004; Catchpole OJ, 2007, CHEM ENG TECHNOL, V30, P501, DOI 10.1002/ceat.200600351; Catchpole OJ, 2006, Extraction of highly unsaturated lipids with liquid dimethyl ether, Patent No. [WO2007136281 (A1), 2007136281]; Eltringham W, 2007, J CHEM ENG DATA, V52, P363, DOI 10.1021/je060283w; European Food Safety Authority, 2009, EFSA J, V984, P1; Gouveia L, 2002, AQUAC RES, V33, P987, DOI 10.1046/j.1365-2109.2002.00751.x; Gouveia L, 2006, EUR FOOD RES TECHNOL, V222, P362, DOI 10.1007/s00217-005-0105-z; HOLLDORFF H, 1988, FLUID PHASE EQUILIBR, V44, P195, DOI 10.1016/0378-3812(88)80111-0; Kanda H., 2002, Method for removing water contained in solid using liquefied material, Patent number, Patent No. [WO2003/101579 A1, 2003101579]; Kanda H., 2006, Patent number, Patent No. [US7803253 B2, 7803253]; Kanda H, 2011, WATER ENVIRON RES, V83, P23, DOI 10.2175/106143010X12609736966847; Kanda H, 2008, ADSORPT SCI TECHNOL, V26, P345; Kanda H., 2009, J ENV ENG, V4, P356; Kanda H., 2008, J JAPAN SOC WASTE MA, V19, P409; Kanda H, 2010, DRY TECHNOL, V28, P30, DOI 10.1080/07373930903423814; Kanda H., 2007, Patent number, Patent No. [WO2008/093707 A1, 2008093707]; Kanda H, 2014, MAR DRUGS, V12, P2383, DOI 10.3390/md12052383; Kanda H., 2006, Patent number, Patent No. [JP4542517 B2, 4542517]; Kitada K., 2008, J CHEM TECHNOL BIOT, V84, P657; Li P, 2014, FUEL, V116, P370, DOI 10.1016/j.fuel.2013.08.020; Ohsita K., 2010, CHEMOSPHERE, V78, P1148; Ruen-ngam D, 2012, CHEM ENG TECHNOL, V35, P255, DOI 10.1002/ceat.201100251; Sato S, 2003, J JPN PETROL INST, V46, P375, DOI 10.1627/jpi.46.375; Shi J, 2009, J FOOD ENG, V93, P431, DOI 10.1016/j.jfoodeng.2009.02.008; Shi XQ, 2013, LWT-FOOD SCI TECHNOL, V51, P433, DOI 10.1016/j.lwt.2012.11.003; Takaoka M., 2008, ORGANOHALOGEN COMPOU, V70, P2264; Varlet V, 2014, FOOD CHEM, V142, P311, DOI 10.1016/j.foodchem.2013.07.036; Wu JT, 2011, J PHYS CHEM REF DATA, V40, DOI 10.1063/1.3582533; Yuan JP, 1996, BIOTECHNOL TECH, V10, P655	52	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	JAN	2015	96				SI		245	251		10.1016/j.supflu.2014.10.003		7	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	AZ1SE	WOS:000348017300025		
J	Nakata, Y; Watanabe, Y; Otake, H; Nakamura, T; Oiso, G; Sawa, T				Nakata, Yoshinori; Watanabe, Yuichi; Otake, Hiroshi; Nakamura, Toshihito; Oiso, Giichiro; Sawa, Tomohiro			Productivity Change of Surgeons in an Academic Year	JOURNAL OF SURGICAL EDUCATION			English	Article						Malmquist index; efficiency change; technical change; surgical training	DATA-ENVELOPMENT ANALYSIS; OPERATING-ROOM; SURGICAL-PROCEDURES; EFFICIENCY; TIME	OBJECTIVE: The goal of this study was to calculate total factor productivity of surgeons in an academic year and to evaluate the effect of surgical trainees on their productivity. STUDY DESIGN: We analyzed all the surgical procedures performed from April 1 through September 30, 2013 in the Teikyo University Hospital. The nonradial and nonoriented Malmquist model under the variable returns-to-scale assumptions was employed. A decision-making unit is defined as a surgeon with the highest academic rank in the surgery. Inputs were defined as the number of physicians who assisted in surgery, and the time of surgical operation from skin incision to skin closure. The output was defined as the surgical fee for each surgery. April is the beginning month of a new academic year in Japan, and we divided the study period into April to June and July to September 2013. We computed each surgeon's Malmquist index, efficiency change, and technical change. RESULTS: We analyzed 2789 surgical procedures that were performed by 105 surgeons. The Malmquist index of all surgeons was significantly greater than 1 (p = 0.0033). The technical change was significantly greater than 1 (p < 0.0001). However, the efficiency change was not statistically significantly different from 1 (p = 0.1817). CONCLUSIONS: The surgeons are less productive in the beginning months of a new academic year. The main factor of this productivity loss is considered to be surgical training. (C) 2014 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.	[Nakata, Yoshinori; Watanabe, Yuichi] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 1738605, Japan; [Otake, Hiroshi] Showa Univ, Sch Med, Dept Anesthesia, Tokyo 142, Japan; [Nakamura, Toshihito] Chiba Univ Hosp, Dept Hlth Policy Aged Soc, Chiba, Japan; [Oiso, Giichiro] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; [Sawa, Tomohiro] Teikyo Univ, Med Informat & Syst Res Ctr, Tokyo 1738605, Japan	Nakata, Y (reprint author), Teikyo Univ, Grad Sch Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ynakata@med.teikyo-u.ac.jp			JSPS KAKENHI [25670337]	This work was supported by JSPS KAKENHI Grant no. 25670337, which was given to Dr Yoshinori Nakata.	Dexter F, 2004, ANESTH ANALG, V99, P1492, DOI 10.1213/01.ANE.0000136469.40853.11; Eappen S, 2004, ANESTHESIOLOGY, V101, P1210, DOI 10.1097/00000542-200411000-00022; Basson MD, 2006, AM J SURG, V192, P649, DOI 10.1016/j.amjsurg.2006.07.005; Hayashida K, 2005, HEALTH POLICY, V74, P24, DOI 10.1016/j.healthpol.2004.12.005; O'Neill L, 2007, ANESTH ANALG, V104, P355, DOI 10.1213/01.ane.0000253092.04322.23; Papandria D, 2012, J SURG EDUC, V69, P149, DOI 10.1016/j.jsurg.2011.08.003; Coelli TJ, 2005, INTRO EFFICIENCY PRO, p[289, 76]; Cooper WW, 2007, DATA ENVELOPMENT ANA, P328; Fare R, 1994, DATA ENVELOPMENT ANA, P253; Glantz SA, 1990, PRIMER APPLIED REGRE, P272; Hollingsworth B, 2008, EFFICIENCY MEASUREME, P37; Ozcan Y. A., 2008, HLTH CARE BENCHMARKI; Paradi JC, 2011, INT SER OPER RES MAN, V164, P315, DOI 10.1007/978-1-4419-6151-8_13; Posner KL, 2004, ANESTH ANALG, V98, P437, DOI 10.1213/01.ANE.0000097173.20740.06; Social Insurance Institute (Shakaihoken Kenkyuusho), 2012, INT MED REIMB SCAL A, P622; Thanassoulis E., 2008, MEASUREMENT PRODUCTI, P251	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-7204	1878-7452		J SURG EDUC	J. Surg. Educ.	JAN-FEB	2015	72	1					128	134		10.1016/j.jsurg.2074.06.022		7	Education, Scientific Disciplines; Surgery	Education & Educational Research; Surgery	AZ5GS	WOS:000348248900020		
J	Liu, FH; Hsu, CS; Lo, ST; Chuang, C; Huang, LI; Woo, TP; Liang, CT; Fukuyama, Y; Yang, Y; Elmquist, RE; Wang, PJ; Lin, X				Liu, Fan-Hung; Hsu, Chang-Shun; Lo, Shun-Tsung; Chuang, Chiashain; Huang, Lung-I; Woo, Tak-Pong; Liang, Chi-Te; Fukuyama, Y.; Yang, Y.; Elmquist, R. E.; Wang, Pengjie; Lin, Xi			Thermometry for Dirac fermions in graphene	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Graphene; Dirac fermions; Weak localization; Thermometry	2-DIMENSIONAL ELECTRON-GAS; QUANTUM HALL TRANSITION; EPITAXIAL GRAPHENE; MAGNETIC-FIELD; TRANSPORT; INSULATOR; SYSTEM; OSCILLATIONS; FILMS; HETEROSTRUCTURES	We use both the zero-magnetic-field resistivity and the phase coherence time determined by weak localization as independent thermometers for Dirac fermions (DF) in multilayer graphene. In the high current (I) region, there exists a simple power law T (DF) ae I (similar to 0.5), where T (DF) is the effective Dirac fermion temperature for epitaxial graphene on SiC. In contrast, T (DF) ae I (similar to 1) in exfoliated multilayer graphene. We discuss possible reasons for the different power laws observed in these multilayer graphene systems. Our experimental results on DF-phonon scattering may find applications in graphene-based nanoelectronics.	[Liu, Fan-Hung; Hsu, Chang-Shun; Lo, Shun-Tsung] Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 106, Taiwan; [Chuang, Chiashain; Huang, Lung-I; Woo, Tak-Pong; Liang, Chi-Te] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan; [Fukuyama, Y.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Yang, Y.; Elmquist, R. E.] NIST, Gaithersburg, MD 20899 USA; [Wang, Pengjie; Lin, Xi] Peking Univ, Int Ctr Quantum Mat, Beijing 100871, Peoples R China	Liu, FH (reprint author), Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 106, Taiwan.	ctliang@phys.ntu.edu.tw	Liang, Chi-Te/A-3902-2009; 	Wang, Pengjie/0000-0002-1427-6599	National Taiwan University [103R7552-2]; National Science Council (NSC), Taiwan [NSC 102-2119-M-002-016-MY3, NSC 102-2811-M-002-086]; NSFC [11274020, 11322435]	This work was partly funded by National Taiwan University (Grant no: 103R7552-2). C.T.L. and T.P.W. acknowledge support from the National Science Council (NSC), Taiwan (grant no: NSC 102-2119-M-002-016-MY3 and NSC 102-2811-M-002-086). The work at PKU was funded by NSFC (Grant No. 11274020 and 11322435).	Wang J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819378; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Eda G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937846; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Juang JR, 2003, J APPL PHYS, V94, P3181, DOI 10.1063/1.1594818; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Baker AMR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045414; Song SH, 1997, PHYS REV LETT, V78, P2200, DOI 10.1103/PhysRevLett.78.2200; Roy P, 2014, NEW J CHEM, V38, P4946, DOI 10.1039/c4nj01185f; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Appleyard NJ, 1998, PHYS REV LETT, V81, P3491, DOI 10.1103/PhysRevLett.81.3491; Betz AC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056805; McCann E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146805; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; RIDLEY BK, 1991, REP PROG PHYS, V54, P169, DOI 10.1088/0034-4885/54/2/001; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Wang J, 2012, CARBON, V50, P4061, DOI 10.1016/j.carbon.2012.04.053; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Balkan N, 1995, PHYS REV B, V52, P17210, DOI 10.1103/PhysRevB.52.17210; Kubakaddi SS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075417; Teh WH, 2003, J MICROELECTROMECH S, V12, P641, DOI 10.1109/JMEMS.2003.817891; Tzalenchuk A, 2010, NAT NANOTECHNOL, V5, P186, DOI [10.1038/nnano.2009.474, 10.1038/NNANO.2009.474]; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; BRANDES T, 1994, PHYS REV LETT, V72, P3582, DOI 10.1103/PhysRevLett.72.3582; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen JH, 2006, J KOREAN PHYS SOC, V48, P1539; Chen KY, 2009, J KOREAN PHYS SOC, V55, P173; Chen PZ, 2007, J KOREAN PHYS SOC, V50, P1662; Chen TM, 2004, CHINESE J PHYS, V42, P307; Cho KS, 2008, J KOREAN PHYS SOC, V53, P2419; Hang DR, 2003, J APPL PHYS, V93, P2055, DOI 10.1063/1.1539286; Hsu CS, 2013, SOLID STATE COMMUN, V156, P45, DOI 10.1016/j.ssc.2012.11.019; Huang DH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155308; Huang TY, 2004, PHYSICA E, V22, P240, DOI 10.1016/j.physe.2003.11.258; Huang TY, 2005, MICROELECTRON J, V36, P466, DOI 10.1016/j.mejo.2005.02.091; KOCH S, 1995, SEMICOND SCI TECH, V10, P209, DOI 10.1088/0268-1242/10/2/015; Lara-Avila S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.166602; LEADLEY DR, 1989, SEMICOND SCI TECH, V4, P879, DOI 10.1088/0268-1242/4/10/009; Liang CT, 2014, CHINESE J PHYS, V52, P1175, DOI 10.6122/CJP.52.1175; Liang CT, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912526; Liang CT, 1999, PHYS REV B, V60, P10687, DOI 10.1103/PhysRevB.60.10687; Lin SK, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847694; Liu FH, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-360; Lo ST, 2014, SCI REP-UK, V4, DOI 10.1038/srep05438; Lo ST, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-640; Lo ST, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245201; Lo ST, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4889847; Mittal A, 1996, SURF SCI, V361, P537, DOI 10.1016/0039-6028(96)00464-5; Nair P R, 2008, SCIENCE, V320, P1308; Nemutudi R, 2006, J KOREAN PHYS SOC, V48, P1312; Real MA, 2013, IEEE T INSTRUM MEAS, V62, P1454, DOI 10.1109/TIM.2012.2225962; SCHERER H, 1995, SEMICOND SCI TECH, V10, P959, DOI 10.1088/0268-1242/10/7/010; Wang YT, 2014, J KOREAN PHYS SOC, V64, P1407, DOI 10.3938/jkps.64.1407; Wang YT, 2014, J KOREAN PHYS SOC, V64, P1572, DOI 10.3938/jkps.64.1572; WEI HP, 1994, PHYS REV B, V50, P14609, DOI 10.1103/PhysRevB.50.14609; WENNBERG AKM, 1986, PHYS REV B, V34, P4409, DOI 10.1103/PhysRevB.34.4409	57	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	JAN	2015	66	1					1	6		10.3938/jkps.66.1		6	Physics, Multidisciplinary	Physics	AZ3PQ	WOS:000348139700001		
J	Rehman, R; Jawed, S; Zaidi, SF; Baig, M; Ahmed, K				Rehman, Rehana; Jawed, Shireen; Zaidi, Syed Faisal; Baig, Mukhtiar; Ahmed, Kanwal			Role of Interleukin-I beta in conception after intracytoplasmic sperm injection	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Intracytoplasmic sperm injection; Interleukins; Implantation	RECEPTOR ANTAGONIST; OVARIAN STIMULATION; HORMONAL PROFILE; FOLLICULAR-FLUID; EMBRYO-TRANSFER; PREGNANCY; SERUM; IMPLANTATION; CYTOKINE; REPRODUCTION	Objective: To identify the role of Interleukin-I Beta(IL- I beta) in patients undergoing intracytoplasmic sperm injection. Methods: The quasi-experimental study was conducted at an infertility clinic in Islamabad from June 2010 to August 2011, and comprised couples opting for intracytoplasmic sperm injection. Down regulation of ovaries was followed by calculated stimulation, ovulation induction, oocytes retrieval, intracytoplasmic sperm injection, in vitro maturation of embryos and embryo transfer. Serum Interleukin-I Beta was measured by enzyme-linked immunosorbent assay onovulation induction day. Patients were grouped as non-pregnant with beta human chorionic gonadotropin 5-25 mIU/ml, pre-clinical abortion; beta human chorionic gonadotropin >25 mIU/ml with no cardiac activity and clinical pregnancy with foetal heart confirmation by trans-vaginal scan after 4 weeks of transfer. SPSS 15 was used for statistical analysis. Results: Of the total 323 patients initially registered, embryo transfer could be carried out in 282(87.30%). Clinical pregnancy was achieved in 101(36%) patients, clinical abortions was the result in 61(22%) cases, while 120(42%) subjects did not conceive at all. Clinical pregnancy was achieved in subjects with high mean Interleukin-I Beta levels; 155.84 +/- 51.65 compared to 41.81 +/- 11.77and 118.46 +/- 35.62pg/mlin non-pregnant, preclinical abortion groups respectively (p=0.001). Conclusion: The production of Interleukin-I Beta was associated with oocyte maturation, fertilisation, endometrial receptivity and implantation in patients undergoing intracytoplasnnic sperm injection.	[Rehman, Rehana] Bahria Univ Med & Dent Coll, Dept Physiol, Karachi, Pakistan; [Jawed, Shireen] Islam Med & Dent Coll, Dept Physiol, Sailkoat, Punjab, Pakistan; [Zaidi, Syed Faisal] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Basic Med Sci, Jeddah, Saudi Arabia; [Baig, Mukhtiar] King Abdulaziz Univ, Fac Med, Jeddah 21413, Saudi Arabia; [Ahmed, Kanwal] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Div Gastrointestinal Pathophysiol, Toyama 930, Japan	Rehman, R (reprint author), Bahria Univ Med & Dent Coll, Dept Physiol, Karachi, Pakistan.	drrehana7@gmail.com					Abuelghar WM, 2013, MIDDLE E FERTIL SOC, V18, P31; Aktan Erdal, 2004, Archives of Gynecology and Obstetrics, V269, P134, DOI 10.1007/s00404-003-0533-6; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; Karagouni E, 1998, FERTIL STERIL, V70, P553, DOI 10.1016/S0015-0282(98)00243-X; Kondapalli LA, 2012, HUM REPROD, V27, P2690, DOI 10.1093/humrep/des216; Schmidt L, 2006, DAN MED BULL, V53, P390; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Rehman R, 2013, IRAN J REPROD MED, V11, P717; Rehman R, 2013, J PAK MED ASSOC, V63, P609; Asimakopoulos B, 2006, HUM REPROD, V21, P3091, DOI 10.1093/humrep/del207; Bonetti TCS, 2010, HUM REPROD, V25, P2101, DOI 10.1093/humrep/deq171; Carroll JS, 2000, STRENGTHENING FAMILI, P278; Cateni Chiara, 2003, Reprod Biol Endocrinol, V1, P25, DOI 10.1186/1477-7827-1-25; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Guzeloglu-Kayisli Ozlem, 2009, Semin Reprod Med, V27, P62, DOI 10.1055/s-0028-1108011; Guzeloglu-Kayisli O, 2007, REPROD BIOMED ONLINE, V15, P728; Huang HY, 2001, J CLIN ENDOCR METAB, V86, P1387, DOI 10.1210/jc.86.3.1387; Khalid S N, 2012, HUM REPROD S2, V27, pii7; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Mendoza C, 1999, HUM REPROD, V14, P628, DOI 10.1093/humrep/14.3.628; Rehman Rehana, 2012, J Ayub Med Coll Abbottabad, V24, P3; Rehman R, 2012, RAWAL MED J, V37, P194; Sharma A, 2011, INT J CLIN CASES INV, V3, P17; WATANABE H, 1994, HUM REPROD, V9, P9	25	0	0	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	JAN	2015	65	1					49	53				5	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AY7KX	WOS:000347740200011		
J	Cui, HW; Jiu, JT; Sugahara, T; Nagao, S; Suganuma, K; Uchida, H; Schroder, KA				Cui, Hui-Wang; Jiu, Jin-Ting; Sugahara, Tohru; Nagao, Shijo; Suganuma, Katsuaki; Uchida, Hiroshi; Schroder, Kurt A.			Using the Friedman method to study the thermal degradation kinetics of photonically cured electrically conductive adhesives	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Electrically conductive adhesives; Friedman method; Thermal degradation; Kinetics; Photonic curing	PRESSURE-SENSITIVE ADHESIVES; BORON-NITRIDE PARTICLES; MICRON SILVER FLAKES; CARBON NANOTUBES; FUNCTIONAL EPOXY; ISOCONVERSIONAL METHODS; MECHANICAL-PROPERTIES; ACTIVATION-ENERGIES; DECOMPOSITION; BEHAVIOR	In this study, the electrically conductive adhesives were fabricated using vinyl ester resin and micro silver flakes, and then a high-intensity pulsed light was introduced to cure the adhesives under an ambient atmosphere at room temperature. The thermal degradation kinetics of photonically cured products was studied using the Friedman method and deduced by assuming a variable activation energy (E). The value of E spanned from 110 to 233 kJ mol(-1), which first increased, then decreased, and finally increased again as the thermal degradation proceeded. The kinetic equation of thermal degradation was obtained as d alpha/dt = e(26.62) (1 - alpha)(2.22)alpha(1.85)e((-E(alpha)/RT)) with E(alpha) = 961.73 alpha(3) - 1453.9 alpha(2) + 669.79 alpha + 79.859, alpha is an element of (0, 1), where alpha was the fractional extent conversion at a given time (or given temperature). The overall order of reaction was 4.07 and >1, demonstrating that the thermal degradation was complex. With the Friedman method, a comprehensive and in-depth understanding of the thermal degradation kinetics of photonically cured electrically conductive adhesives has been achieved.	[Cui, Hui-Wang; Jiu, Jin-Ting; Sugahara, Tohru; Nagao, Shijo; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Osaka, Ibaraki 5670047, Japan; [Uchida, Hiroshi] Showa Denko Co Ltd, Inst Polymers & Chem, Business Dev Ctr, Ichihara, Chiba 2900067, Japan; [Schroder, Kurt A.] NCC Nano LLC, Austin, TX 78728 USA	Cui, HW (reprint author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Osaka, Ibaraki 5670047, Japan.	cuihuiwang@hotmail.com	Nagao, Shijo/E-4870-2012; Hui-Wang, Cui/B-9232-2012	Nagao, Shijo/0000-0002-2764-3458; Hui-Wang, Cui/0000-0001-7640-8350			Abderrahmen R, 2011, INT J ADHES ADHES, V31, P629, DOI 10.1016/j.ijadhadh.2011.06.003; KAMAL MR, 1973, POLYM ENG SCI, V13, P59, DOI 10.1002/pen.760130110; Tang J, 2013, ACS APPL MATER INTER, V5, P3867, DOI 10.1021/am4005495; Zhang ZX, 2011, J ADHES SCI TECHNOL, V25, P1465, DOI 10.1163/016942410X549924; Czech Z, 2012, INT J ADHES ADHES, V36, P20, DOI 10.1016/j.ijadhadh.2012.04.004; Ortiz-Landeros J, 2012, J THERM ANAL CALORIM, V108, P647, DOI 10.1007/s10973-011-2063-y; Kwon Y, 2011, MICROELECTRON RELIAB, V51, P812, DOI 10.1016/j.microrel.2010.11.005; Liu NL, 2011, POLYM TEST, V30, P390, DOI 10.1016/j.polymertesting.2011.02.008; Carmona VB, 2014, J THERM ANAL CALORIM, V115, P153, DOI 10.1007/s10973-013-3259-0; Yin Q, 2007, J POWER SOURCES, V165, P717, DOI 10.1016/j.jpowsour.2006.12.019; Nassar NN, 2013, J THERM ANAL CALORIM, V114, P465, DOI 10.1007/s10973-013-3024-4; Jiu J, 2012, J MATER CHEM, V22, P23561, DOI 10.1039/c2jm35545k; Si GY, 2013, NANOSCALE, V5, P6243, DOI 10.1039/c3nr01419c; Yoonessi M, 2013, POLYMER, V54, P2776, DOI 10.1016/j.polymer.2013.03.015; Zhang Y, 2011, SYNTHETIC MET, V161, P516, DOI 10.1016/j.synthmet.2011.01.004; Mothe CG, 2013, J THERM ANAL CALORIM, V113, P497, DOI 10.1007/s10973-013-3163-7; Cui HW, 2014, J THERM ANAL CALORIM, V117, P1365, DOI 10.1007/s10973-014-3902-4; Cui HW, 2013, POLYM INT, V62, P1644, DOI 10.1002/pi.4461; Galwey AK, 2012, J THERM ANAL CALORIM, V109, P1625, DOI 10.1007/s10973-011-1851-8; Araki T, 2011, IEEE ELECTR DEVICE L, V32, P1424, DOI 10.1109/LED.2011.2161663; Cui HW, 2013, INT J ADHES ADHES, V44, P220, DOI 10.1016/j.ijadhadh.2013.03.004; Cui HW, 2014, RSC ADV, V4, P15914, DOI 10.1039/c4ra00292j; Araki T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PD01; Chandran K, 2013, J THERM ANAL CALORIM, V112, P63, DOI 10.1007/s10973-012-2646-2; Cui HW, 2013, J ADHESION, V89, P19, DOI 10.1080/00218464.2012.725621; Cui HW, 2013, POLYM ADVAN TECHNOL, V24, P114, DOI 10.1002/pat.3059; Cui HW, 2014, ELECTRON MATER LETT, V10, P183, DOI 10.1007/s13391-013-3089-z; Cui HW, 2013, ELECTRON MATER LETT, V9, P1, DOI 10.1007/s13391-012-2114-y; Cui HW, 2013, ELECTRON MATER LETT, V9, P299, DOI 10.1007/s13391-013-2243-y; Cui HW, 2013, J ADHESION, V89, P714, DOI 10.1080/00218464.2012.757696; Cui HW, 2013, INT J ADHES ADHES, V44, P232, DOI 10.1016/j.ijadhadh.2013.03.007; FLYNN JH, 1991, J THERM ANAL, V37, P293, DOI 10.1007/BF02055932; Gallego J, 2013, J THERM ANAL CALORIM, V114, P597, DOI 10.1007/s10973-013-2987-5; Han YQ, 2013, J THERM ANAL CALORIM, V112, P683, DOI 10.1007/s10973-012-2591-0; Ho LN, 2012, J ELECTRON MATER, V41, P2527, DOI 10.1007/s11664-012-2102-x; Hu R. Z., 2001, THERMAL ANAL KINETIC; Inoue M, 2009, J ELECTRON MATER, V38, P2013, DOI 10.1007/s11664-009-0837-9; Kozlov A, 2012, J THERM ANAL CALORIM, V109, P1311, DOI 10.1007/s10973-012-2626-6; Kunzel M, 2014, J THERM ANAL CALORIM, V115, P289, DOI 10.1007/s10973-013-3265-2; Li Z, 2013, J MATER CHEM C, V1, P4368, DOI 10.1039/c3tc30612g; Liu J, 1999, CONDUCTIVE ADHESIVES; Liu J, 2011, RELIABILITY OF MICROTECHNOLOGY: INTERCONNECTS, DEVICES AND SYSTEMS, P1, DOI 10.1007/978-1-4419-5760-3; Saad GR, 2012, J THERM ANAL CALORIM, V110, P1425, DOI 10.1007/s10973-011-2074-8; Suhir E., 2007, MICRO OPTOELECTRONIC; Tan FT, 2006, INT J ADHES ADHES, V26, P406, DOI 10.1016/j.ijadhadh.2005.06.005; Wang XJ, 2014, J THERM ANAL CALORIM, V115, P55, DOI 10.1007/s10973-013-3230-0; Wm Wendlandt W., 1986, THERMAL ANAL; Yang XJ, 2012, J MATER SCI-MATER EL, V23, P108, DOI 10.1007/s10854-011-0485-8; Zhong XH, 2013, PHYS CHEM CHEM PHYS, V15, P3861, DOI 10.1039/c3cp44085k; Zhu XY, 2012, RARE METALS, V31, P64, DOI 10.1007/s12598-012-0464-0	50	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JAN	2015	119	1					425	433		10.1007/s10973-014-4195-3		9	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	AY2HA	WOS:000347408300045		
J	Wang, MH; Wen, JX; Sawada, Y; Hoshi, Y; Hou, ZX				Wang, Meihan; Wen, Jiaxing; Sawada, Yutaka; Hoshi, Yoichi; Hou, Zhaoxia			Effect of oxygen and WO3 additive on anatase-to-rutile phase transformation in TiO2 nanoparticles	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Phase transformation; P25; Pure anatase (PA); Oxygen; WO3	TITANIA POWDERS; PHOTOCATALYST; DIFFUSION; TUNGSTEN; GROWTH; SIZE; P25	Phase transformation of TiO2 powder (P25) and pure anatase (PA) was investigated under pure oxygen as well as vacuum from 500 to 1,000 degrees C. The rutile percentage calculated based on the XRD data was used to estimate the phase transformation process. It was found that the vacuum suppressed the phase transformation of P25 relative to pure oxygen atmosphere. A model was proposed to explain the effect of oxygen on the phase transformation of TiO2. Furthermore, P25 samples showed lower phase transformation temperature (between 600 and 800 degrees C) compared with PA (over 1,000 degrees C). The existed rutile phase in P25 was regarded as a transformation inducer due to an interface between anatase and rutile phases since the nucleation activation energy on the interface is lower than that on the surface. And this interface effect is also adopted to explain the role of additive WO3, which retarded the phase transformation of P25 but promoted the phase transformation of PA.	[Wang, Meihan; Wen, Jiaxing; Hou, Zhaoxia] Shenyang Univ, Sch Mech Engn, Shenyang 110044, Peoples R China; [Sawada, Yutaka; Hoshi, Yoichi] Tokyo Polytech Univ, Ctr Hyper Media Res, Atsugi, Kanagawa 2430297, Japan	Wang, MH (reprint author), Shenyang Univ, Sch Mech Engn, Shenyang 110044, Peoples R China.	wangmhdicp@aliyun.com			National Natural Science Foundation of China [51302175, 51272162]; Program for Liaoning Excellent Talents in University [LJQ2014132]; Natural Science Foundation of Liaoning Province of China [2013020132]	The authors gratefully acknowledge the National Natural Science Foundation of China for financial support to this work (No. 51302175 and No. 51272162). And this work was also supported by Program for Liaoning Excellent Talents in University (No. LJQ2014132) and Natural Science Foundation of Liaoning Province of China (No. 2013020132).	Mahlambi MM, 2012, J THERM ANAL CALORIM, V110, P847, DOI 10.1007/s10973-011-1852-7; Ohno T, 2001, J CATAL, V203, P82, DOI 10.1006/jcat.2001.3316; Yu JG, 2006, J MOL CATAL A-CHEM, V253, P112, DOI 10.1016/j.molcata.2006.03.021; Raj KJA, 2009, INDIAN J CHEM A, V48, P1378; Zhang J, 2009, J PHYS CHEM C, V113, P1698, DOI 10.1021/jp808013k; Thompson TL, 2006, CHEM REV, V106, P4428, DOI 10.1021/cr050172k; Su WG, 2008, J PHYS CHEM C, V112, P7710, DOI 10.1021/jp7118422; Zhang Z, 2010, J PHYS CHEM C, V114, P3059, DOI 10.1021/jp910358w; Rezaee M, 2010, J ALLOY COMPD, V507, P484, DOI 10.1016/j.jallcom.2010.07.213; Gouma PI, 2001, J AM CERAM SOC, V84, P619; Zhang HZ, 2000, J MATER RES, V15, P437, DOI 10.1557/JMR.2000.0067; Colon G, 2006, J PHOTOCH PHOTOBIO A, V179, P20, DOI 10.1016/j.jphotochem.2005.07.007; Ding XZ, 1998, J MATER RES, V13, P2556, DOI 10.1557/JMR.1998.0356; BICKLEY RI, 1991, J SOLID STATE CHEM, V92, P178, DOI 10.1016/0022-4596(91)90255-G; DATYE AK, 1995, J SOLID STATE CHEM, V115, P236, DOI 10.1006/jssc.1995.1126; Gilbert B, 2003, GEOCHEM T, V4, P20, DOI 10.1039/b309073f; Green IX, 2010, J PHYS CHEM C, V114, P16649, DOI 10.1021/jp1061489; Habibi MH, 2013, J THERM ANAL CALORIM, V112, P1179, DOI 10.1007/s10973-012-2563-4; Jagtap N, 2005, THERMOCHIM ACTA, V427, P37, DOI 10.1016/j.tca.2004.08.011; KING DA, 1971, J CHEM PHYS, V55, P3236, DOI 10.1063/1.1676572; Lu CW, 2014, J THERM ANAL CALORIM, V116, P1241, DOI 10.1007/s10973-014-3740-4; Wang GH, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/265760; Yu XF, 2001, J MATER CHEM, V11, P3337, DOI 10.1039/b100971k; Zhu ZF, 2010, RARE METAL MAT ENG, V39, P771	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	JAN	2015	119	1					435	439		10.1007/s10973-014-4204-6		5	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	AY2HA	WOS:000347408300046		
J	Hirano, T; Takano, M; Tsujita, H				Hirano, Toshiyuki; Takano, Mizuki; Tsujita, Hoshio			Effect of Double Air Injection on Performance Characteristics of Centrifugal Compressor	JOURNAL OF THERMAL SCIENCE			English	Article						Centrifugal Compressor; Performance; Nozzle Injection; Surge		In the operation of a centrifugal compressor of turbocharger, instability phenomena such as rotating stall and surge are induced at a lower flow rate close to the maximum pressure ratio. In this study, for the suppression of surge phenomenon resulting in the extension of the stable operating range of centrifugal compressor to lower flow rate, the compressed air at the compressor exit was re-circulated and injected into the impeller inlet by using the double injection nozzle system. The experiments were performed to find out the optimum circumferential position of the second nozzle relative to the fixed first one and the optimum inner diameter of the injection nozzles, which are able to most effectively reduce the flow rate of surge inception. Moreover, in order to examine the universality of these optimum values, the experiments were carried out for two types of compressors.	[Hirano, Toshiyuki] Kokushikan Univ, Dept Sci & Engn, Mech Engn Course, Setagaya City, Tokyo 1548515, Japan; [Takano, Mizuki] Tokyo Metropolitan Coll Ind Technol, Adv Course Mech Engn Program, Shinagawa City, Tokyo 1400011, Japan; [Tsujita, Hoshio] Hosei Univ, Dept Mech Engn, Fac Sci & Engn, Koganei, Tokyo 1848584, Japan	Hirano, T (reprint author), Kokushikan Univ, Dept Sci & Engn, Mech Engn Course, 4-28-1 Setagaya, Setagaya City, Tokyo 1548515, Japan.						Chen H., 2012, P ASME GT2012 69340; Gu R., 2007, P IGTC2007 TOK; Gu R., 2005, JSAE PAPER, V36; Mizuki S., 2000, 2000GT429ASME; Skoch G. J., 2004, NASATM2004213182; Suzuki A., 1999, P 4 INT S AER INT FL, VII, P226; Tamaki H., 2012, P ASME COP DENM; Willemas F., 2000, 2000GT527 ASME	8	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JAN-FEB	2015	24	1					10	16		10.1007/s11630-015-0749-3		7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	AY6FB	WOS:000347661600002		
J	Wakaki, D; Sakuka, Y; Inokuchi, Y; Ueda, K; Yamasaki, N; Yamagata, A				Wakaki, Daich; Sakuka, Yuta; Inokuchi, Yuzo; Ueda, Kosuke; Yamasaki, Nobuhiko; Yamagata, Akihiro			CFD Simulation of Pulsation Noise in a Small Centrifugal Compressor with Volute and Resonance Tube	JOURNAL OF THERMAL SCIENCE			English	Article						Pulsation Tone Noise; CFD; URANS; Centrifugal Compressor; Turbocharger; Volute	SOUND; FANS	The rotational frequency tone noise emitted from the automobile turbocharger is called the pulsation noise. The cause of the pulsation noise is not fully understood, but is considered to be due to some manufacturing errors, which is called the mistuning. The effects of the mistuning of the impeller blade on the noise field inside the flow passage of the compressor are numerically investigated. Here, the flow passage includes the volute and duct located downstream of the compressor impeller. Our numerical approach is found to successfully capture the wavelength of the pulsation noise at given rotational speeds by the comparison with the experiments. One of the significant findings is that the noise field of the pulsation noise in the duct is highly one-dimensional although the flow fields are highly three-dimensional.	[Wakaki, Daich; Sakuka, Yuta; Inokuchi, Yuzo; Ueda, Kosuke; Yamasaki, Nobuhiko] Kyushu Univ, Fukuoka 8190395, Japan; [Yamagata, Akihiro] IHI Corp, Yokohama, Kanagawa 2358501, Japan	Wakaki, D (reprint author), Kyushu Univ, Fukuoka 8190395, Japan.						Shi F, 2001, J FLUID ENG-T ASME, V123, P466, DOI 10.1115/1.1385835; CREMER L, 1971, J SOUND VIB, V16, P1, DOI 10.1016/0022-460X(71)90391-9; Hayashi I, 2014, J FLUID STRUCT, V45, P216, DOI 10.1016/j.jfluidstructs.2013.11.012; NEISE W, 1975, J SOUND VIB, V43, P61, DOI 10.1016/0022-460X(75)90205-9; Raitor T, 2008, J SOUND VIB, V314, P738, DOI 10.1016/j.jsv.2008.01.034; Rammal H., 2010, P 9 INT C TURB TURB; Sun H, 2006, J SOUND VIB, V289, P999, DOI 10.1016/j.jsv.2005.03.004; Wagner C., 2007, NUMERICAL METHODS; Wakaki D, 2014, J THERM SCI, V23, P53, DOI 10.1007/s11630-014-0676-8	9	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JAN-FEB	2015	24	1					24	29		10.1007/s11630-015-0751-9		6	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	AY6FB	WOS:000347661600004		
J	Ghopa, WAW; Harun, Z; Funazaki, K; Miura, T				Ghopa, Wan Aizon W.; Harun, Zambri; Funazaki, Ken-ichi; Miura, Takemitsu			Aero-Thermal Performances of Leakage Flows Injection from the Endwall Slot in Linear Cascade of High-Pressure Turbine	JOURNAL OF THERMAL SCIENCE			English	Article						endwall filmcooling; leakage flows; econdary flows; aerodynamic loss; film cooling effectiveness	HEAT-TRANSFER; 3-DIMENSIONAL FLOW	The existence of a gap between combustor and turbine endwall in the real gas turbine induces to the leakages phenomenon. However, the leakages could be used as a coolant to protect the endwall surfaces from the hot gas since it could not be completely prevented. Thus, present study investigated the potential of leakage flows as a function of film cooling, hi present study, the flow field at the downstream of high-pressure turbine blade has been investigated by 5-holes pitot tube. This is to reveal the aerodynamic performances under the influenced of leakage flows while the temperature measurement was conducted by thermochromic liquid crystal (TLC). Experimental has significantly captured theaerodynamics effect of leakage flows near the blade downstream. Furthermore, TLC measurement illustrated that the film cooling effectiveness contours were strongly influenced by the secondary flows behavior on the endwall region. Aero-thermal results were validated by the numerical simulation adopted by commercial software, ANSYS CFX 13. Both experimental and numerical simulation indicated almost similar trendinaero and also thermal behavior as the amount of leakage flows increases.	[Ghopa, Wan Aizon W.; Harun, Zambri] Univ Kebangsaan Malaysia, Dept Mech & Mat Engn, Bangi 43600, Malaysia; [Funazaki, Ken-ichi; Miura, Takemitsu] Iwate Univ, Dept Mech Engn, Morioka, Iwate 0208551, Japan	Ghopa, WAW (reprint author), Univ Kebangsaan Malaysia, Dept Mech & Mat Engn, Bangi 43600, Malaysia.				Hitachi Ltd., Japan	The authors are grateful acknowledgement to Hitachi Ltd., Japan for the financial support in this study.	Aizon W.G., 2012, APPL MECH MAT, V229-231, P737; Wright LM, 2007, J THERMOPHYS HEAT TR, V21, P754, DOI 10.2514/1.30382; Han S, 2006, J TURBOMACH, V128, P798, DOI 10.1115/1.2221326; Rehder HJ, 2007, J TURBOMACH, V129, P608, DOI 10.1115/1.2720484; TAKEISHI K, 1990, J TURBOMACH, V112, P488, DOI 10.1115/1.2927684; BLAIR MF, 1974, J HEAT TRANS-T ASME, V96, P524; LANGSTON LS, 1977, J ENG POWER-T ASME, V99, P21; GOLDSTEIN RJ, 1988, J HEAT TRANS-T ASME, V110, P862; Funazaki K., 2000, J GAS TURBINE SOC JA, V28, P397; Graziani R.A., ASME J ENG POWER, V102, P257; Kang M. B., 1999, J TURBOMACH, V122, P255; Radomsky RW, 2000, J TURBOMACH, V122, P699, DOI 10.1115/1.1312807; Sieverding C. H., 1984, ASME J ENG GAS TURBI, V107, P248; Sundaram N., 2009, J TURBOMACHINERY, V131; Thrift A.A., 2011, GT2011455 ASME; Wang H. P., 1995, 95GT7 ASME; Wright L.M., ASME J TURBOMACH, V131	17	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JAN-FEB	2015	24	1					49	57		10.1007/s11630-015-0755-5		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	AY6FB	WOS:000347661600008		
J	Bin Yusof, MH; Katanoda, H; Morita, H				Bin Yusof, Mohd Hazwan; Katanoda, Hiroshi; Morita, Hiromitsu			Temperature and Pressure Measurements at Cold Exit of Counter-flow Vortex Tube with Flow Visualization of Reversed Flow	JOURNAL OF THERMAL SCIENCE			English	Article						Vortex tube; Reversed flow; Flow visualization; Pressure measurement; Temperature measurement	ENERGY SEPARATION; PERFORMANCE; GEOMETRY	In order to clarify the structure of the cold flow discharged from the counter-flow vortex tube (VT), the temperature and pressure of the cold flow were measured, and the existence and behavior of the reversed flow at the cold exit was studied using a simple flow visualization technique consisting of a 0.75mm-diameter needle, and an oil paint droplet. It is observed through this experiment that the Pitot pressure at the cold exit center can either be lower or higher than atmospheric pressure, depending on the inlet pressure and the cold fraction, and that a reversed flow is observed when the Pitot pressure at the cold exit center is lower than atmospheric pressure. In addition, it is observed that when reducing the cold fraction from unity at any arbitrary inlet pressure, the region of reversed and colder flow in the central part of cold exit extends in the downstream direction.	[Bin Yusof, Mohd Hazwan; Katanoda, Hiroshi] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Morita, Hiromitsu] Natl Inst Adv Ind Sci & Technol, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Bin Yusof, MH (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.						Alimov R.Z., 1966, J ENG PHYS THERMOPH+, V10, P251, DOI 10.1007/BF00837815; Ameri M, 2009, J THERM SCI, V18, P370, DOI 10.1007/s11630-009-0370-4; Xue YP, 2012, INT J HEAT MASS TRAN, V55, P5853, DOI 10.1016/j.ijheatmasstransfer.2012.05.081; GORE RW, 1964, AICHE J, V10, P83, DOI 10.1002/aic.690100126; HILSCH R, 1947, REV SCI INSTRUM, V18, P108, DOI 10.1063/1.1740893; Aydin O, 2010, APPL THERM ENG, V30, P2505, DOI 10.1016/j.applthermaleng.2010.06.024; Avci M, 2013, APPL THERM ENG, V50, P302, DOI 10.1016/j.applthermaleng.2012.06.048; Behera U, 2008, INT J HEAT MASS TRAN, V51, P6077, DOI 10.1016/j.ijheatmasstransfer.2008.03.029; Dutta T, 2011, INT J REFRIG, V34, P2118, DOI 10.1016/j.ijrefrig.2011.06.004; Eiamsa-Ard S, 2008, RENEW SUST ENERG REV, V12, P1822, DOI 10.1016/j.rser.2007.03.006; Katanoda H., 2014, P INT C FLUID MECH H, P1252; LINDERST.CU, 1971, J FLUID MECH, V45, P161, DOI 10.1017/S0022112071003057; Markal B, 2010, EXP THERM FLUID SCI, V34, P966, DOI 10.1016/j.expthermflusci.2010.02.013; Nimbalkar SU, 2009, APPL THERM ENG, V29, P509, DOI 10.1016/j.applthermaleng.2008.03.032; Ranque G.J., 1933, J PHYS RADIUM, V7, P112; WILKINSON J, 1988, INT J HEAT FLUID FL, V9, P373, DOI 10.1016/0142-727X(88)90003-3; Wu YT, 2007, INT J REFRIG, V30, P1042, DOI 10.1016/j.ijrefrig.2007.01.013	17	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JAN-FEB	2015	24	1					67	72		10.1007/s11630-015-0757-3		6	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	AY6FB	WOS:000347661600010		
J	Makouloutou, P; Suzuki, K; Yokoyama, M; Takeuchi, M; Yanagida, T; Sato, H				Makouloutou, Patrice; Suzuki, Kazuo; Yokoyama, Mayumi; Takeuchi, Masahiko; Yanagida, Tetsuya; Sato, Hiroshi			INVOLVEMENT OF TWO GENETIC LINEAGES OF SARCOPTES SCABIEI MITES IN A LOCAL MANGE EPIZOOTIC OF WILD MAMMALS IN JAPAN	JOURNAL OF WILDLIFE DISEASES			English	Article						Ecosystem health; haplotype; Japan; mange; Sarcoptes scabiei; wildlife mammals	NORTHERN AUSTRALIA; ACARI; MITOCHONDRIAL; EPIDEMIOLOGY; POPULATIONS; LIKELIHOOD; ACCURATE; ANIMALS; DISEASE; BIOLOGY	Similar to wild mammals on the continents, mange caused by the mange mite, Sarcoptes scabiei (Acari: Sarcoptidae) is spreading in wild mammals in most of Japan. We collected crusted or alopetic skin from 120 raccoon dogs (Nyctereutes procyonoides viverrinus), three, raccoons (Procyon lotor), six Japanese badgers (Meles anakuma), one Japanese marten (Martes melampus), one stray dog (Canis lupus familiaris), four wild boars (Sus scrofa leucomystax), and one Japanese serow (Capricornis crispus), mainly in an area where mangy wild animals have been increasingly noted in the past 4 yr. The second internal transcribed spacer (IT52) region of the ribosomal RNA gene and the partial 16S and cytochrome c oxidase subunit I (cox-1) genes of mitochondrial DNA (mtDNA) were characterized in these skin samples. The IT52 sequencing (404 base pairs [bp]) identified the causative mite for mangy skin lesions of 128 animals as S. scabiei, regardless of host origin. The cat mite (Notoedres cati) was the cause in one raccoon dog and one raccoon. Most mites had almost identical ITS2 nucleotide sequences to those recorded in a variety of mammals worldwide. Partial 16S and cox-1 fragments of mtDNA amplified and sequenced successfully (331 bp and 410 bp, respectively) showed an identical nucleotide sequence except for one site (C vs. T) for the former and four sites (G, C, C, C vs. A, T, T, T, respectively) for the latter fragment. These substitutions were always synchronized, with the two mitochondrial DNA haplotypes (i.e., C/GCCC and T/ATTI') appearing to separately colonize in geographic units. The T/ATIT haplotype fell into a clade where animal-derived mites worldwide dominated, whereas the C/GCCC haplotype formed a geographic branch unique to Japanese isolates. These results suggest that heterologous populations of monospecific S. scabiei are expanding their populations and distributions regardless of host species in an apparently local mange epizootic of wild mammals in Japan.	[Makouloutou, Patrice; Yanagida, Tetsuya; Sato, Hiroshi] Yamaguchi Univ, Joint Fac Vet Med, Parasitol Lab, Yamaguchi 7538515, Japan; [Suzuki, Kazuo] Hikiiwa Pk Ctr, Tanabe 6460051, Japan; [Yokoyama, Mayumi] Univ Hyogo, Inst Nat & Environm Sci, Nat & Environm Div, Tanba, Hyogo 6693842, Japan; [Takeuchi, Masahiko] NARO Agr Res Ctr, Agroinformat Div, Tsukuba, Ibaraki 3058666, Japan	Sato, H (reprint author), Yamaguchi Univ, Joint Fac Vet Med, Parasitol Lab, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	sato7dp4@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [25450478]	Sincere thanks to the trappers and municipal and prefectural officers engaged in the protection of wild mammals in Wakayama Prefecture, Japan, who made this study possible. Our study was supported in part by the Grant-in-Aid (25450478) from the Japan Society for the Promotion of Science.	Alasaad S, 2011, INT J INFECT DIS, V15, pE294, DOI 10.1016/j.ijid.2011.01.012; Alasaad S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-151; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Alasaad S, 2009, VET PARASITOL, V159, P181, DOI 10.1016/j.vetpar.2008.10.001; Walton SF, 1999, AM J TROP MED HYG, V61, P542; Gu XB, 2008, INT J ACAROL, V34, P183; Alasaad S, 2008, PARASITOL RES, V104, P101, DOI 10.1007/s00436-008-1165-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; NAVAJAS M, 1994, EXP APPL ACAROL, V18, P351, DOI 10.1007/BF00116316; Pence DB, 2002, REV SCI TECH OIE, V21, P385; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; ARLIAN LG, 1989, ANNU REV ENTOMOL, V34, P139; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Zahler M, 1999, INT J PARASITOL, V29, P759, DOI 10.1016/S0020-7519(99)00034-X; Skerratt LF, 2002, PARASITOL RES, V88, P376, DOI 10.1007/s00436-001-0556-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Berrilli F, 2002, PARASITOL RES, V88, P772, DOI 10.1007/s00436-002-0655-y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; FAIN A, 1978, INT J DERMATOL, V17, P20, DOI 10.1111/j.1365-4362.1978.tb06040.x; Bornstein Set, 2001, P107, DOI 10.1002/9780470377000.ch5; CURRIER R. W., 2012, ANN NY ACAD SCI, V1230, pE50; Fain A, 1968, ACTA ZOOL PATHOL ANT, V47, P7; Gakuya F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-193; Holt DC, 2013, CURR OPIN INFECT DIS, V26, P110, DOI 10.1097/QCO.0b013e32835eb986; SAMUEL WM, 1981, J WILDLIFE DIS, V17, P343; SOGLIA D, 2007, IT J ANIM SCI, V7, P214; Takahashi M, 2001, J VET MED SCI, V63, P457, DOI 10.1292/jvms.63.457; Takahashi Mamoru, 2001, Medical Entomology and Zoology, V52, P297; Yamamoto Sadaji, 1998, Medical Entomology and Zoology, V49, P217	35	0	0	WILDLIFE DISEASE ASSOC, INC	LAWRENCE	810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA	0090-3558	1943-3700		J WILDLIFE DIS	J. Wildl. Dis.	JAN	2015	51	1					69	78		10.7589/2014-04-094		10	Veterinary Sciences	Veterinary Sciences	AZ1LS	WOS:000348001200008		
J	Oda, S; Kabeya, H; Sato, S; Shimonagane, A; Inoue, K; Hayashidani, H; Takada, N; Fujita, H; Kawabata, H; Maruyama, S				Oda, Shinya; Kabeya, Hidenori; Sato, Shingo; Shimonagane, Ai; Inoue, Kai; Hayashidani, Hideki; Takada, Nobuhiro; Fujita, Hiromi; Kawabata, Hiroki; Maruyama, Soichi			Isolation of Pathogenic Yersinia enterocolitica 1B/O:8 from Apodemus Mice in Japan	JOURNAL OF WILDLIFE DISEASES			English	Article						Japan; rodents; Yersinia enterocolitica; yersiniosis	1ST ISOLATION; O8; INFECTIONS; PSEUDOTUBERCULOSIS; SEPTICEMIA; PREFECTURE; VIRULENCE; ANIMALS; RODENTS; POLAND	Yersinia enterocolitica was isolated from 15.7% (88/560) of wild rodents captured in 15 prefectures in Japan. Prevalences by rodent species were 18.0% (70/388) in Japanese field mice (Apodemus speciosus), 20% (14/71) in small Japanese field mice (Apodemus argenteus), and 11% (4138) in gray red-backed vole (Myodes rufocanus bedfordiae), suggesting that these rodent species are important reservoirs of Y. enterocolitica. Although most of the isolates were identified as biotype 1A, the pathogenic bioserotype 1B/O:8 was detected in one of the A. speciosus and in three of the A. argenteus captured in Aomori Prefecture. It is suggested that Apodemus mice may be an important reservoir of Y. enterocolitica, and that there are foci of the pathogenic bioserotype 1B/O:8 in Aomori Prefecture, because human sporadic cases by the serotype have been reported in this prefecture.	[Oda, Shinya; Kabeya, Hidenori; Sato, Shingo; Shimonagane, Ai; Inoue, Kai; Maruyama, Soichi] Nihon Univ, Dept Vet Med, Coll Bioresource Sci, Lab Vet Publ Hlth, Fujisawa, Kanagawa 2520880, Japan; [Hayashidani, Hideki] Tokyo Univ Agr & Technol, Inst Agr, Div Anim Life Sci, Fuchu, Tokyo 1838538, Japan; [Takada, Nobuhiro] Univ Fukui, Senior Fellow Lab, Fukui 9101193, Japan; [Fujita, Hiromi] Mahara Inst Med Acarol, Tokushima 7791510, Japan; [Kawabata, Hiroki] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo 1628640, Japan	Sato, S (reprint author), Nihon Univ, Dept Vet Med, Coll Bioresource Sci, Lab Vet Publ Hlth, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	sato.shingo@nihon-u.ac.jp	HAYASHIDANI, HIDEKI/G-1126-2013		Ministry of Education, Culture, Sports, Science and Technology, Japan [23580429]; Ministry of Health, Labor and Welfare, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (23580429) and the Strategic Research Base Development Program, International Research on Epidemiology of Zoonoses, and Training for Young Researchers by Ministry of Education, Culture, Sports, Science and Technology, Japan. It was also supported in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Japan.	ADESIYUN AA, 1986, VET MICROBIOL, V12, P289, DOI 10.1016/0378-1135(86)90058-1; ALDOVA E, 1977, ZBL BAKT-INT J MED M, V239, P208; Schubert S, 2003, EUR J CLIN MICROBIOL, V22, P66, DOI 10.1007/s10096-002-0859-1; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257; Rastawicki W, 2009, EUR J CLIN MICROBIOL, V28, P535, DOI 10.1007/s10096-008-0647-7; Farzan A, 2010, ZOONOSES PUBLIC HLTH, V57, P388, DOI 10.1111/j.1863-2378.2009.01248.x; Sakai T, 2005, JPN J INFECT DIS, V58, P257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; TAUXE RV, 1987, LANCET, V1, P1129; LAIRD WJ, 1980, J CLIN MICROBIOL, V11, P430; Gierczynski R, 2009, J CLIN MICROBIOL, V47, P1225, DOI 10.1128/JCM.01321-08; AULISIO CCG, 1980, APPL ENVIRON MICROB, V39, P135; Backhans A, 2011, EPIDEMIOL INFECT, V139, P1230, DOI 10.1017/S0950268810002463; BERCOVIER H, 1978, CURR MICROBIOL, V1, P353, DOI 10.1007/BF02621369; DEVENISH JA, 1981, CAN J MICROBIOL, V27, P937; DOYLE MP, 1981, APPL ENVIRON MICROB, V42, P661; FUKUSHIMA H, 1990, J CLIN MICROBIOL, V28, P2448; HAYASHIDANI H, 1995, J CLIN MICROBIOL, V33, P1253; HAYASHIDANI H, 1994, J VET MED B, V41, P504; Hosaka S, 1997, J CLIN MICROBIOL, V35, P3346; ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846; IINUMA Y, 1992, J CLIN MICROBIOL, V30, P240; KANEKO K, 1981, APPL ENVIRON MICROB, V41, P635; KATO Y, 1985, APPL ENVIRON MICROB, V49, P198; KEET EE, 1974, NEW YORK STATE J MED, V74, P2226; OSTROFF SM, 1994, EPIDEMIOL INFECT, V112, P133; Saitoh M, 1994, Kansenshogaku Zasshi, V68, P960; SHAYEGANI M, 1986, APPL ENVIRON MICROB, V52, P420; Tashiro K, 1990, J VET MED SCI, V53, P23; Tatsukawa K, 1976, PHYSL ECOL JPN, V17, P133	30	0	0	WILDLIFE DISEASE ASSOC, INC	LAWRENCE	810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA	0090-3558	1943-3700		J WILDLIFE DIS	J. Wildl. Dis.	JAN	2015	51	1					260	264		10.7589/2014-02-053		5	Veterinary Sciences	Veterinary Sciences	AZ1LS	WOS:000348001200031		
J	Hakozaki, A; Niki, Y; Enomoto, H; Toyama, Y; Suda, Y				Hakozaki, Akihiro; Niki, Yasuo; Enomoto, Hiroyuki; Toyama, Yoshiaki; Suda, Yasunori			Clinical significance of T2*-weighted gradient-echo MRI to monitor graft maturation over one year after anatomic double-bundle anterior cruciate ligament reconstruction: A comparative study with proton density-weighted MRI	KNEE			English	Article						Anterior cruciate ligament; Magnetic resonance imaging; Anatomic double-bundle reconstruction; Graft maturation	SERIAL MAGNETIC-RESONANCE; HAMSTRING TENDON GRAFTS; OF-THE-LITERATURE; PATELLAR TENDON; MUCOID DEGENERATION; AUTOGRAFTS; KNEE; REVASCULARIZATION	Purpose: This study examined the feasibility of T2*-weighted imaging (T2*WI) gradient=echo MRI to reflect actual function of the graft after anatomic double-bundle ACL reconstruction. T2*WI and proton density-weighted imaging (PDWI) were compared in the assessment of ACL grafts. Method: Sixty-one patients underwent T2*WI and PDWI at 3, 6, and 12 months postoperatively. Signal intensity of the anteromedial bundle (AMB) or posterolateral bundle (PLB) graft standardized to the intensity of the PCL was defined as signal intensity ratio (SIR). Correlations between degree of knee instability and SIR were assessed for each bundle, each time point, and each sequence. The diagnostic efficacy of T2*WI sequence to detect poorly functioning knee with anteroposterior translation >= 4 mm was assessed. Results: Significant correlations were observed between SIR and KT values for both AMB and PLB at 12 months on T2*WI (r=0.39 and 0.53, respectively), but not on PDWI. Notably, 9 of 10 patients with poorly functioning graft showing anteroposterior translation mm at 12 months formed an isolated group with high T2*WI-SIR. Six of the 10 patients displayed an increase in SIR from 6 to 12 months. Defining anteroposterior translation >= 4 mm at 12 months as the diagnostic standard for poorly functioning graft, increasing T2*WI-SIR offered 60% sensitivity add >90% specificity. Conclusions: ACL graft intensity on T2*WI is more strongly associated with actual function of the graft than that on PDWI. An increasing trend in T2*WI-SIR from 6 to 12 months postoperatively represents a possible surrogate indicator for poorly functioning grafts. (C) 2014 Elsevier B.V. All rights reserved.	[Hakozaki, Akihiro; Niki, Yasuo; Enomoto, Hiroyuki; Toyama, Yoshiaki; Suda, Yasunori] Keio Univ, Dept Orthopaed Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Niki, Y (reprint author), Keio Univ, Dept Orthopaed Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	y.niki@lib.belckoame.ne.jp					Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; FISCHER SP, 1991, J BONE JOINT SURG AM, V73A, P2; Hara K, 2009, AM J SPORT MED, V37, P2386, DOI 10.1177/0363546509340404; ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217; Saupe N, 2008, RADIOLOGY, V249, P581, DOI 10.1148/radiol.2492071651; HOWELL SM, 1991, AM J SPORT MED, V19, P42, DOI 10.1177/036354659101900107; Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x; Yoshioka H, 2006, SKELETAL RADIOL, V35, P288, DOI 10.1007/s00256-005-0070-4; Muramatsu K, 2008, ARTHROSCOPY, V24, P1038, DOI 10.1016/j.arthro.2008.05.014; Sanchez M, 2010, ARTHROSCOPY, V26, P470, DOI 10.1016/j.arthro.2009.08.019; Claes S, 2011, AM J SPORT MED, V39, P2476, DOI 10.1177/0363546511402662; Arai Y, 2008, KNEE SURG SPORT TR A, V16, P342, DOI 10.1007/s00167-007-0478-6; Cha JR, 2013, KNEE SURG SPORT TR A, V21, P658, DOI 10.1007/s00167-012-1991-9; Ellingson AM, 2014, J ORTHOP RES; Farrow LD, 2007, J BONE JOINT SURG AM, V89A, P2150, DOI 10.2106/JBJS.F.01191; Hoppe S, 2012, EUR RADIOL, V22, P2013, DOI 10.1007/s00330-012-2448-8; HOWELL SM, 1992, ARTHROSCOPY, V8, P350, DOI 10.1016/0749-8063(92)90067-L; Janssen RPA, 2011, KNEE SURG SPORT TR A, V19, P1299, DOI 10.1007/s00167-011-1419-y; Jansson KA, 2001, SKELETAL RADIOL, V30, P8; JOHNSON LL, 1993, ARTHROSCOPY, V9, P131, DOI 10.1016/S0749-8063(05)80362-7; Kiekara T, 2012, SKELETAL RADIOL, V41, P835, DOI 10.1007/s00256-011-1285-1; Lintz F, 2011, KNEE SURG SPORT TR A, V19, P1326, DOI 10.1007/s00167-011-1433-0; Murakami Y, 1998, J COMPUT ASSIST TOMO, V22, P270, DOI 10.1097/00004728-199803000-00021; Niki Y, 2010, J ORTHOP SCI, V15, P251, DOI 10.1007/s00776-009-1432-x; Ntoulia A, 2013, SKELETAL RADIOL, V42, P541, DOI 10.1007/s00256-012-1534-y; Ntoulia A, 2011, AM J SPORT MED, V39, P1478, DOI 10.1177/0363546511398039; Pauzenberger L, 2013, ARTHROSCOPY, V29, P1712, DOI 10.1016/j.arthro.2013.05.009; Sasaki Taisuke, 1998, Nippon Acta Radiologica, V58, P572; Schatz JA, 1997, AM J ROENTGENOL, V169, P223; Sonoda M, 2007, AM J SPORT MED, V35, P936, DOI 10.1177/0363546506298110; Waltz RA, 2014, AM J SPORT MED, V42, P1652, DOI 10.1177/0363546514532335; Weiler A, 2001, AM J SPORT MED, V29, P751; YASUDA K, 1989, CLIN ORTHOP RELAT R, P217	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0968-0160	1873-5800		KNEE	Knee	JAN	2015	22	1					4	10		10.1016/j.knee.2014.11.004		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AZ5JQ	WOS:000348257900002		
J	Albogha, MH; Takahashi, I; Sawan, MN				Albogha, Mhdl-Hassan; Takahashi, Ichiro; Sawan, Mhd Naser			Early treatment of anterior open bite: Comparison of the vertical and horizontal morphological changes induced by magnetic bite-blocks and adjusted rapid molar intruders	KOREAN JOURNAL OF ORTHODONTICS			English	Article						Early treatment; Anterior open bite; Rapid molar intruder; Magnets	SKELETAL OPEN BITE; POSTERIOR TEETH; INTRUSION; CORRECTOR; MALOCCLUSIONS	Objective: This prospective clinical study aims to determine the differences between two treatment modalities for anterior open bite in growing patients. The treatment modalities involved the use of magnetic bite-blocks (MBBs) or rapid molar intruders (RM1s) applied with posterior bite-blocks. Methods: Fifteen consecutive patients with a mean age of 11.2 (standard deviation [SD] = 1.6) years and a mean open bite of 3.9 mm were treated with 1V1BBs. Another 15 consecutive patients with a mean age of 10.9 (SD = 1.8) years and a mean open bite of 3.8 mm were treated with R1V1ls applied on biteblocks. Cephalometric radiographs were obtained before (Ti) and immediately after appliance removal (T2). The treatments lasted four months, during which the appliances were cemented to the teeth. The morphological changes were measured in each group and compared using logistic regression analysis. Results: The MBB group exhibited significantly greater decreases in SNA angle, ANB angle, overjet, and maxillary incisor angle (p < 0.05). The MBBs induced greater effects on the maxilla and maxillary dentition. The MBBs restrained maxillary forward growth and retracted the maxillary incisors more effectively than did the RM1s. Consequently, changes in the intermaxillary relationships and overjets were more distinct in the MBB group. Conclusions: The anteroposterior differences between the appliances suggest that MBBs should be preferred for the treatment of patients with Class 11 open bites and maxillary incisor protrusions.	[Albogha, Mhdl-Hassan; Sawan, Mhd Naser] Damascus Univ, Fac Dent, Dept Orthodont, Damascus, Syria; [Takahashi, Ichiro] Kyushu Univ, Grad Sch Dent Sci, Sect Orthodont, Fukuoka 812, Japan	Albogha, MH (reprint author), Damascus Univ, Fac Dent, Dept Orthodont, Al Mazeh St Med Campus, Damascus, Syria.	hassanbuga@hotmail.com	Albogha, Mhd Hassan/B-1840-2015	Albogha, Mhd Hassan/0000-0001-9063-520X	Damascus University, Syria	This study was carried out at and funded by the Damascus University, Syria.	KILIARIDIS S, 1990, EUR J ORTHODONT, V12, P447; Meral O, 2003, ANGLE ORTHOD, V73, P716; BARBRE RE, 1991, ANGLE ORTHOD, V61, P93; Bourauel C, 2002, AM J ORTHOD DENTOFAC, V122, P155, DOI 10.1067/mod.2002.125566; Buschang PH, 2013, SEMIN ORTHOD, V19, P212, DOI 10.1053/j.sodo.2013.07.002; CANGIALOSI TJ, 1984, AM J ORTHOD DENTOFAC, V85, P28, DOI 10.1016/0002-9416(84)90120-9; Carano A, 2005, AM J ORTHOD DENTOFAC, V128, P781, DOI 10.1016/j.ajodo.2004.11.029; Cinsar A, 2007, ANGLE ORTHOD, V77, P632, DOI 10.2319/071406-292; Dahlberg G, 1940, STAT METHODS MED BIO; DELLINGER EL, 1986, AM J ORTHOD DENTOFAC, V89, P428, DOI 10.1016/0002-9416(86)90075-8; Dellinger EL, 1996, AM J ORTHOD DENTOFAC, V110, P145, DOI 10.1016/S0889-5406(96)70102-6; English JD, 2002, AM J ORTHOD DENTOFAC, V121, P563, DOI 10.1067/mod.2002.124166; Gurton AU, 2004, ANGLE ORTHOD, V74, P454; ISCAN H N, 1992, European Journal of Orthodontics, V14, P54; Iscan HN, 1997, AM J ORTHOD DENTOFAC, V112, P171, DOI 10.1016/S0889-5406(97)70243-9; Kalra V, 1989, AM J ORTHOD DENTOFAC, V95, P467; Kuster R, 1992, Eur J Orthod, V14, P489; McNamara J A Jr, 1987, J Clin Orthod, V21, P598; MELSEN B, 1995, AM J ORTHOD DENTOFAC, V108, P500, DOI 10.1016/S0889-5406(95)70050-1; Sankey VVL, 2000, AM J ORTHOD DENTOFAC, V118, P317; WOODS MG, 1988, ANGLE ORTHOD, V58, P136	21	0	0	KOREAN ASSOC ORTHODONTISTS	SEOUL	603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH KOREA	2234-7518	2005-372X		KOREAN J ORTHOD	Korean J. Orthod.	JAN	2015	45	1					38	46		10.4041/kjod.2015.45.1.38		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA0RH	WOS:000348623800006		
J	Kurahara, H; Maemura, K; Mataki, Y; Sakoda, M; Iino, S; Kijima, Y; Ishigami, S; Ueno, S; Shinchi, H; Natsugoe, S				Kurahara, Hiroshi; Maemura, Kosei; Mataki, Yuko; Sakoda, Masahiko; Iino, Satoshi; Kijima, Yuko; Ishigami, Sumiya; Ueno, Shinichi; Shinchi, Hiroyuki; Natsugoe, Shoji			Predictors of early stages of histological progression of branch duct IPMN	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Invasive IPMN; Minimally invasive IPMN; CA 19-9; Cystic tumor	PAPILLARY-MUCINOUS NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; PANCREATIC-CANCER; MALIGNANCY; CARCINOMA; RESECTION; EXPERIENCE; PROGNOSIS; CONSENSUS; OUTCOMES	An appropriate timing for surgical resection of branch duct-type intraductal papillary mucinous neoplasm (BD-IPMN) to achieve sufficient postoperative survival is still unknown. Of 80 patients with histologically proven IPMNs, 61 patients who had BD-IPMN without pancreatic cancer concomitant with IPMN were enrolled in this study. We divided BD-IPMN into four groups according to disease progression: low to intermediate grade of dysplasia (LGD/IGD-IPMN), high grade of dysplasia (HGD-IPMN), minimally invasive IPMN (MI-IPMN: T1a), and invasive IPMN (IN-IPMN: a parts per thousand yenT1b). Indicators of surgical resection were investigated on the basis of pathological findings and postoperative prognosis. Postoperative survival was distinctly worse for patients with IN-IPMN than for patients with MI-IPMN, HGD-IPMN, and LGD/IGD-IPMN. Postoperative disease-specific 5-year survival rate was 100 % in patients with IN-IPMN, HGD-IPMN, and LGD/IGD-IPMN, by contrast, 40 % in patients with IN-IPMN. The presence of two of the three factors (pancreatitis, serum carbohydrate antigen [CA] 19-9 levels > 13 U/mL, and mural nodules) could distinguish HGD-IPMN from LGD/IGD-IPMN with a sensitivity of 92.9 %, specificity of 90.2 %, positive predictive value of 76.5 %, negative predictive value of 97.4 %, and accuracy of 90.9 %. To manage patients with BD-IPMN and achieve a good postoperative prognosis, surgical resection should be performed before progression to IN-IPMN.	[Kurahara, Hiroshi; Maemura, Kosei; Mataki, Yuko; Sakoda, Masahiko; Iino, Satoshi; Kijima, Yuko; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan; [Ueno, Shinichi] Kagoshima Univ, Dept Clin Oncol, Kagoshima 8908520, Japan; [Shinchi, Hiroyuki] Kagoshima Univ, Grad Sch Med Sci, Dept Hlth Sci, Kagoshima 8908520, Japan	Kurahara, H (reprint author), Kagoshima Univ, Grad Sch Med Sci, Dept Digest Surg Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	h-krhr@m3.kufm.kagoshima-u.ac.jp					Niedergethmann M, 2008, WORLD J SURG, V32, P2253, DOI 10.1007/s00268-008-9692-8; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Levy P, 2006, CLIN GASTROENTEROL H, V4, P460, DOI 10.1016/j.cgh.2006.01.018; Salvia R, 2007, GUT, V56, P1086, DOI 10.1136/gut.2006.100628; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Akita H, 2011, AM J SURG, V202, P214, DOI 10.1016/j.amjsurg.2010.06.020; Kim KW, 2014, ANN SURG, V259, P72, DOI 10.1097/SLA.0b013e31829385f7; Pedrazzoli S, 2011, ANN SURG, V254, P971, DOI 10.1097/SLA.0b013e3182383137; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Nakata K, 2011, PANCREAS, V40, P581, DOI 10.1097/MPA.0b013e318214fa86; Adsay NV, 2004, AM J SURG PATHOL, V28, P839, DOI 10.1097/00000478-200407000-00001; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Fritz S, 2011, BRIT J SURG, V98, P104, DOI 10.1002/bjs.7280; Katz MHG, 2010, ANN SURG ONCOL, V17, P1794, DOI 10.1245/s10434-010-0943-1; Ohno E, 2012, PANCREAS, V41, P855, DOI 10.1097/MPA.0b013e3182480c44; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Maire F, 2002, GUT, V51, P717, DOI 10.1136/gut.51.5.717; Nara S, 2008, AM J SURG PATHOL, V32, P243, DOI 10.1097/PAS.0b013e3181484f1e; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; LaFemina J, 2013, ANN SURG ONCOL, V20, P440, DOI 10.1245/s10434-012-2702-y; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Wada K, 2005, AM J SURG, V189, P632, DOI 10.1016/j.amjsurg.2005.01.020; Baiocchi GL, 2012, ANN SURG ONCOL, V19, P3574, DOI 10.1245/s10434-012-2234-5; Fernandez-del Castillo C, 2010, GASTROENTEROLOGY, V139, pe701, DOI DOI 10.1053/J.GASTR0.2010.07.025; Jones NB, 2009, HPB, V11, P664, DOI 10.1111/j.1477-2574.2009.00114.x; Takahashi H, 2006, ANN SURG ONCOL, V13, P955, DOI 10.1245/ASO.2006.05.043	27	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	JAN	2015	400	1					49	56		10.1007/s00423-014-1259-6		8	Surgery	Surgery	AY6WR	WOS:000347704100006		
J	Okada, K; Kawai, M; Hirono, S; Miyazawa, M; Shimizu, A; Kitahata, Y; Tani, M; Yamaue, H				Okada, Ken-ichi; Kawai, Manabu; Hirono, Seiko; Miyazawa, Motoki; Shimizu, Atsushi; Kitahata, Yuji; Tani, Masaji; Yamaue, Hiroki			A replaced right hepatic artery adjacent to pancreatic carcinoma should be divided to obtain R0 resection in pancreaticoduodenectomy	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Replaced right hepatic artery; Pancreaticoduodenectomy; Borderline resectable disease	INTERNATIONAL STUDY-GROUP; LONG-TERM SURVIVAL; CONTROLLED-TRIAL; SURGERY ISGPS; R1 RESECTION; CANCER; ADENOCARCINOMA; DEFINITION; GEMCITABINE; FOLFIRINOX	The aim of the present study was to clarify the optimal surgical strategy in the patients with right hepatic artery (RHA) variation undergoing pancreaticoduodenectomy (PD) based on the tumor position and the R1 resection rate. A total of 180 consecutive patients who underwent PD for pancreatic ductal adenocarcinoma between January 2000 and May 2013 were evaluated for RHA variation, surgical outcome, and the R1 resection rate retrospectively. In this study, we defined three types of tumors: (i) the resectable type, where tumors were situated more than 10 mm away from the root of the replaced right hepatic artery (rRHA)/replaced common hepatic artery (rCHA); (ii) the adjacent type, where tumors were situated within 10 mm from the root of the rRHA/rCHA without tumor abutment of the superior mesenteric artery (SMA); and (iii) the borderline resectable type, where the tumor abuts the SMA, but does not to exceed 180A degrees of the circumference of the vessel wall. Twenty-five patients were identified to have a RHA variation in preoperative imaging studies. There were 16 patients with resectable type tumors, five with adjacent type tumors, and four with borderline resectable tumors. The rRHA/rCHA was preserved in 14 (88 %) patients with the resectable type, all of the patients with the adjacent type and none of the patients with the borderline type pancreatic carcinomas. The R1 resection rates were significantly higher in patients with adjacent/borderline resectable type tumors (78 %) compared to those with resectable type tumors (6 %) (p = 0.001). The rRHA of the adjacent type pancreatic carcinoma should be divided to improve the rate of R0 resection.	[Okada, Ken-ichi; Kawai, Manabu; Hirono, Seiko; Miyazawa, Motoki; Shimizu, Atsushi; Kitahata, Yuji; Tani, Masaji; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	okada@wakayama-med.ac.jp; kawai@wakayama-med.ac.jp; seiko-h@wakayama-med.ac.jp; mo-0702@wakayama-med.ac.jp; atsus28@wakayama-med.ac.jp; yuji-kh@wakayama-med.ac.jp; matani@wakayama-med.ac.jp; yamaue-h@wakayama-med.ac.jp					Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Kanda M, 2010, ANN SURG, V251, P483, DOI 10.1097/SLA.0b013e3181cf9171; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Okada K, 2013, SURGERY, V153, P365, DOI 10.1016/j.surg.2012.07.036; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Tempero MA, 2010, J NATL COMPR CANC NE, V8, P972; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; HIATT JR, 1994, ANN SURG, V220, P50, DOI 10.1097/00000658-199407000-00008; Tani M, 2006, ANN SURG, V243, P316, DOI 10.1097/01.sla.0000201479.84934.ca; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Eshuis WJ, 2011, HPB, V13, P161, DOI 10.1111/j.1477-2574.2010.00258.x; Tempero MA, 2012, J NATL COMPR CANC NE, V10, P703; Mahaseth H, 2013, PANCREAS, V42, P1311, DOI 10.1097/MPA.0b013e31829e2006; Verbeke CS, 2006, BRIT J SURG, V93, P1232, DOI 10.1002/bjs.5397; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Yekebas EF, 2008, ANN SURG, V247, P300, DOI 10.1097/SLA.0b013e31815aab22; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Edge SB, 2010, AJCC CANC STAGING MA; Kim PT, 2013, HPB OXFORD, DOI [10.1111/hpb.12120, DOI 10.1111/HPB.12120]; Motoi F, 2013, ANN SURG ONCOL; Rau BM, 2012, SURGERY, V152, pS103, DOI 10.1016/j.surg.2012.05.015; Turrini O, 2010, J GASTROINTEST SURG, V14, P1813, DOI 10.1007/s11605-010-1272-1; Winston CB, 2007, AM J ROENTGENOL, V189, pW13, DOI 10.2214/AJR.04.1374	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	JAN	2015	400	1					57	65		10.1007/s00423-014-1255-x		9	Surgery	Surgery	AY6WR	WOS:000347704100007		
J	Matsuda, T; Iwasaki, T; Mitsutsuji, M; Hirata, K; Maekawa, Y; Tsugawa, D; Sugita, Y; Sumi, Y; Shimada, E; Kakeji, Y				Matsuda, Takeru; Iwasaki, Takeshi; Mitsutsuji, Masaaki; Hirata, Kenro; Maekawa, Yoko; Tsugawa, Daisuke; Sugita, Yutaka; Sumi, Yasuo; Shimada, Etsuji; Kakeji, Yoshihiro			Cranially approached radical lymph node dissection around the middle colic vessels in laparoscopic colon cancer surgery	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Cranial approach; Laparoscopy; Colon cancer	SHORT-TERM OUTCOMES; RANDOMIZED-TRIAL; OPEN COLECTOMY; TRANSVERSE; ANATOMY; TRUNK	Laparoscopic lymph node (LN) dissection around the middle colic vessels is technically demanding, thus raising controversy regarding the role of laparoscopic surgery for transverse colon cancer. We herein describe a cranial approach method to perform radical LN dissection around the middle colic vessels. The key characteristic of this approach is early division of middle colic vessels prior to mobilization of the colon. From April 2010 to September 2013, 27 patients with colon cancer received laparoscopic LN dissection around the middle colic vessels using this cranial approach. Their surgical and short-term outcomes were reviewed. The mean number of harvested LNs was 29 (range, 6-50). The mean operative time and intraoperative blood loss were 274 min (range, 160-362 min) and 42 mL (range, 3-247 mL), respectively. There were no serious intraoperative complications or conversions to open surgery. There were two patients with stage 0, 7 with stage I, 12 with stage II, and 6 with stage III. No recurrent case was observed with a median follow-up period of 30 months (range, 9-48 months). We consider this approach feasible and useful for radical LN dissection around the middle colic vessels during laparoscopic colon cancer surgery.	[Matsuda, Takeru; Iwasaki, Takeshi; Mitsutsuji, Masaaki; Hirata, Kenro; Maekawa, Yoko; Tsugawa, Daisuke; Sugita, Yutaka; Shimada, Etsuji] Natl Hosp Org, Kobe Med Ctr, Dept Surg, Suma Ku, Kobe, Hyogo 6540155, Japan; [Sumi, Yasuo; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan	Matsuda, T (reprint author), Natl Hosp Org, Kobe Med Ctr, Dept Surg, Suma Ku, 3-1-1 Nishi Ochiai, Kobe, Hyogo 6540155, Japan.	takerumatsuda@nifty.com					Yamamoto M, 2012, SURG ENDOSC, V26, P1566, DOI 10.1007/s00464-011-2071-9; Akiyoshi T, 2010, J GASTROINTEST SURG, V14, P818, DOI 10.1007/s11605-010-1182-2; Jin G, 2006, AM J SURG, V191, P100, DOI 10.1016/j.amjsurg.2005.10.009; Yamaguchi S, 2002, DIS COLON RECTUM, V45, P1337, DOI 10.1097/01.DCR.0000027284.76452.84; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Kim HJ, 2009, SURG ENDOSC, V23, P1812, DOI 10.1007/s00464-009-0348-z; Fujita J, 2001, SURG TODAY, V31, P93; Hasegawa S, 2007, SURG ENDOSC, V21, P1657, DOI 10.1007/s00464-007-9305-x; Ignjatovic D, 2010, AM J SURG, V199, P249, DOI 10.1016/j.amjsurg.2009.03.010; Matsuda Takeru, 2013, Asian J Endosc Surg, V6, P186, DOI 10.1111/ases.12017; Nakanishi M, 2012, DIGESTION, V85, P121, DOI 10.1159/000334683; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Takakura Y, 2009, WORLD J SURG, V33, P2683, DOI 10.1007/s00268-009-0244-7; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Yada H, 1997, WORLD J SURG, V21, P109; Yamamoto S, 2009, DIGEST SURG, V26, P487, DOI 10.1159/000253875	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	JAN	2015	400	1					113	117		10.1007/s00423-014-1250-2		5	Surgery	Surgery	AY6WR	WOS:000347704100013		
J	Fang, HH; Yang, J; Feng, J; Yamao, T; Hotta, S; Sun, HB				Fang, Hong-Hua; Yang, Jie; Feng, Jing; Yamao, Takeshi; Hotta, Shu; Sun, Hong-Bo			Functional organic single crystals for solid-state laser applications (vol 8, pg 687, 2014)	LASER & PHOTONICS REVIEWS			English	Correction						organic crystal; laser oscillation; optical resonator; light-emitting field effect transistor; stimulated emission		In the article by Hong-Hua Fang et al. (doi: ), published in Laser Photonics Rev. 8, 687-715 (2014), the names of two authors in references were wrongly spelt and citations in the text were missing. This erratum is published to correct this.	[Fang, Hong-Hua; Yang, Jie; Feng, Jing; Sun, Hong-Bo] Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, Changchun 130012, Peoples R China; [Yamao, Takeshi; Hotta, Shu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Macromol Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan; [Sun, Hong-Bo] Jilin Univ, Coll Phys, Changchun 130023, Peoples R China; [Yang, Jie] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	Sun, HB (reprint author), Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, 2699 Qianjin St, Changchun 130012, Peoples R China.	hbsun@jlu.edu.cn					Gierschner J, 2013, J MATER CHEM C, V1, P5818, DOI 10.1039/c3tc31062k; Varghese S, 2013, J PHYS CHEM LETT, V4, P1597, DOI 10.1021/jz400659b; Fang HH, 2014, LASER PHOTONICS REV, V8, P687, DOI 10.1002/lpor.201300222	3	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1863-8880	1863-8899		LASER PHOTONICS REV	Laser Photon. Rev.	JAN	2015	9	1					128	128		10.1002/lpor.201480222		1	Optics; Physics, Applied; Physics, Condensed Matter	Optics; Physics	AZ3QG	WOS:000348141200012		
J	Yamakita, T; Yamamoto, H; Nakaoka, M; Yamano, H; Fujikura, K; Hidaka, K; Hirota, Y; Ichikawa, T; Kakehi, S; Kameda, T; Kitajimal, S; Kogure, K; Komatsu, T; Kumagai, NH; Miyamoto, H; Miyashita, K; Morimoto, H; Nakajima, R; Nishida, S; Nishiuchi, K; Sakamoto, S; Sano, M; Sudo, K; Sugisaki, H; Tadokoro, K; Tanaka, K; Jintsu-Uchifune, Y; Watanabe, K; Watanabe, H; Yara, Y; Yotsukura, N; Shirayama, Y				Yamakita, Takehisa; Yamamoto, Hiroyuki; Nakaoka, Masahiro; Yamano, Hiroya; Fujikura, Katsunori; Hidaka, Kiyotaka; Hirota, Yuichi; Ichikawa, Tadafumi; Kakehi, Shigeho; Kameda, Takahiko; Kitajimal, Satoshi; Kogure, Kazuhiro; Komatsu, Teruhisa; Kumagai, Naoki H.; Miyamoto, Hiroomi; Miyashita, Kazushi; Morimoto, Haruyuki; Nakajima, Ryota; Nishida, Shuhei; Nishiuchi, Kou; Sakamoto, Shingo; Sano, Masayoshi; Sudo, Kenji; Sugisaki, Hiroya; Tadokoro, Kazuaki; Tanaka, Katsuhiko; Jintsu-Uchifune, Yoshie; Watanabe, Kentaro; Watanabe, Hiromi; Yara, Yumiko; Yotsukura, Norishige; Shirayama, Yoshihisa			Identification of important marine areas around the Japanese Archipelago: Establishment of a protocol for evaluating a broad area using ecologically and biologically significant areas selection criteria	MARINE POLICY			English	Article						Algal-; Seagrass bed; Coral reef; Plankton; Deep-sea; Marine protected areas (MPAs); Complementarity	POTENTIAL DISTRIBUTION; CLIMATE-CHANGE; BIODIVERSITY; SEA; ECOSYSTEMS; COASTAL; OCEAN	After the adoption of the Aichi Target, data accumulation and evaluation regarding biodiversity have progressed rapidly. The use of ecologically and biologically significant areas (EBSAs) criteria to evaluate important areas enables the identification of effective and prioritized areas for ecosystem management. This includes strategic environmental assessment and discussions aimed at establishing protected marine areas based on scientific data. This paper reviews previous and current ideas as well as the methods used, for the identification of EBSAs. In particular, the following issues are addressed: problems associated with different types of marine ecosystems in the Japanese Archipelago, such as seagrass and seaweed beds, coral reefs, offshore pelagic plankton, and deep-sea benthic ecosystems; and problems associated with the integration of multiple criteria that are not totally exclusive. Several candidate variables accounting for each of the 7 criteria used to identify ecologically important areas are presented. Data availability is the most important criterion that allowed for the comprehensive evaluation of different types of ecosystems in the same localities. In particular, for coastal ecosystems such as seagrass, seaweed beds, and coral reefs, it is possible to carry out broad spatial comparisons using variables representing most of these 7 criteria. Regarding methods for the quantitative evaluation of each criterion and their integration, application of these methods to kelp forest ecosystems in Hokkaido, Northern Japan is presented as a case study. (C) 2014 The Authors. Published by Elsevier Ltd.	[Nakaoka, Masahiro; Watanabe, Kentaro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido 0881113, Japan; [Sudo, Kenji] Hokkaido Univ, Akkeshi Marine Stn, Grad Sch Environm Sci, Akkeshi, Hokkaido 0881113, Japan; [Yotsukura, Norishige] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido 0600809, Japan; [Miyashita, Kazushi] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido 0418611, Japan; [Kogure, Kazuhiro; Komatsu, Teruhisa; Nishida, Shuhei; Sakamoto, Shingo; Sano, Masayoshi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Yamano, Hiroya; Kumagai, Naoki H.; Yara, Yumiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Yamakita, Takehisa; Yamamoto, Hiroyuki; Fujikura, Katsunori; Nakajima, Ryota; Jintsu-Uchifune, Yoshie; Watanabe, Hiromi; Shirayama, Yoshihisa] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Tanaka, Katsuhiko] Tokai Univ, Shimizu Ku, Shimizu, Shizuoka 4248610, Japan; [Kakehi, Shigeho; Miyamoto, Hiroomi; Tadokoro, Kazuaki] Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; [Hidaka, Kiyotaka; Hirota, Yuichi; Ichikawa, Tadafumi] Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Morimoto, Haruyuki] Japan Sea Natl Fisheries Res Inst, Chuou Ku, Niigata 9518121, Japan; [Kameda, Takahiko; Kitajimal, Satoshi] Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan; [Nishiuchi, Kou; Sugisaki, Hiroya] Fisheries Res Agcy, Nishi Ku, Yokohama, Kanagawa 2206115, Japan	Yamakita, T (reprint author), Japan Agcy Marine Earth Sci & Technol, Natsushimacho 2-15, Yokosuka, Kanagawa 2370061, Japan.	yamakitat@jamstec.go.jp					Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; McKinnon AD, 2014, ANNU REV MAR SCI, V6, P415, DOI 10.1146/annurev-marine-010213-135042; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Dunn DC, 2014, MAR POLICY, V49, P137, DOI 10.1016/j.marpol.2013.12.002; Clark MR, 2014, OCEAN COAST MANAGE, V91, P65, DOI 10.1016/j.ocecoaman.2014.01.016; Makino A, 2014, DIVERS DISTRIB, V20, P859, DOI 10.1111/ddi.12184; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; Vierod ADT, 2014, DEEP-SEA RES PT II, V99, P6, DOI 10.1016/j.dsr2.2013.06.010; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Arakida H, 2011, AQUAT CONSERV, V21, P553, DOI 10.1002/aqc.1215; Ball I.R., 2000, MARXAN V1 8 2 MARINE; Bundy A, 2013, MAR POLICY, V38, P277, DOI 10.1016/j.marpol.2012.06.003; CBD Secretariat, 2013, UNEPCBDSBSTTA176; CBD Secretariat, 2012, UNEPCBDSBSTTA16INF9; CBD Secretariat, 2010, GLOB BIOD OUTL 3, P3; CBD Secretariat, 2010, C PART CONV BIOL DIV; CBD Secretariat, 2004, C PART CONV BIOL DIV; CBD Secretariat, 2007, EXP WORKSH EC CRIT B; DFO-MPO, 2004, 20042004006 DFOMPO C; Dudley N., 2008, GUIDELINES APPL PROT; Environment Agency of Japan, 2000, THREAT WILDL JAP RED, V2nd; ESRI, CLASS NUM FIELDS GRA; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; Gaston KJ, 2009, BIODIVERSITY INTRO; Inui R, 2014, ICHTHYOL RES, V61, P83, DOI 10.1007/s10228-013-0370-y; Kadoya T, 2011, ECOL INDIC, V11, P1396, DOI 10.1016/j.ecolind.2011.03.001; Katayama N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093359; Kenchington E, 2011, 20112011071 DFO CAN, V2011; KK Toyo Aerosurvey Co. Ltd, 1980, 3 NAT SURV NAT ENV R; Magurran AE, 2011, BIOL DIVERSITY FRONT; Marine Net Hokkaido, 2014, MAR NET HOKK DAT; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Ministry of the Environment Japan, 2012, REP ID MAR AR PART I; Moilanen A., 2009, ZONATION FRAMEWORK S, P196; Moilanen A., 2009, SPATIAL CONSERVATION; Nakajima R, 2014, DIVERS DIST IN PRESS; Pressey RL, 2009, C PLAN CONSERVATION, P211; R Core Team, 2012, R LANG ENV STAT COMP; Tanoue H, 2012, FISHERIES SCI, V78, P533, DOI 10.1007/s12562-012-0470-z; Taranto GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042950; Uchifune Y, ECOLOGICAL RES UNPUB; Underwood A.J., 1997, EXPT ECOLOGY THEIR L; UNEP CBD, 2002, 6 M C PART CONV BIOL; Yamakita T, 2011, JAPANESE J INT FORES, V1515, P48; Yamakita T, 2014, ECOL RES MONOGR, P131, DOI 10.1007/978-4-431-54783-9_7; Zeiler M., 2010, MODELING OUR WORLD E	54	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-597X	1872-9460		MAR POLICY	Mar. Pol.	JAN	2015	51						136	147		10.1016/j.marpol.2014.07.009		12	Environmental Studies; International Relations	Environmental Sciences & Ecology; International Relations	AZ1MS	WOS:000348003700016		
J	Horasawa, N; Yamashita, T; Uehara, S; Udagawa, N				Horasawa, Noriko; Yamashita, Teruhito; Uehara, Shunsuke; Udagawa, Nobuyuki			High-performance scaffolds on titanium surfaces: Osteoblast differentiation and mineralization promoted by a globular fibrinogen layer through cell-autonomous BMP signaling	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Bioactive scaffolds; Fibrinogen; Titanium; Osteoblasts; BMP	CHLORIDE-ACTIVATED TITANIUM; DENTAL IMPLANTS; IN-VIVO; BONE; FIBRONECTIN; HYDROXYAPATITE; ADSORPTION; TISSUE; OSSEOINTEGRATION; INTEGRATION	Titanium has been widely used as a dental implant material. However, it takes several months for the implant body to bind with the jawbone. To develop new bioactive modification on titanium surfaces to achieve full osseointegration expeditiously, we used fibrinogen and fibronectin as bioacfive scaffolds on the titanium plate, which are common extracellular matrix (ECM) proteins. We analyzed the features of the surface of ECM-modified titanium plates by atomic force microscopy and Fourier transform infrared spectrophotometry. We also evaluated the effect of ECM modification on promoting the differentiation and mineralization of osteoblasts on these surfaces. Fibrinogen had excellent adsorption on titanium surfaces even at low concentrations, due to the binding ability of fibrinogen via its RGD motif. The surface was composed of a fibrinogen monolayer, in which the ratio of beta-sheets was decreased. Osteoblast proliferation on ECM-modified titanium surface was significantly promoted compared with titanium alone. Calcification on the modified surface was also accelerated. These ECM-promoting effects correlated with increased expression of bone morphogenetic proteins (BMPs) by the osteoblasts themselves and were inhibited by Noggin, a BMP inhibitor. These results suggest that the fibrinogen monolayer-modified titanium surface is recognized as bioactive scaffolds and promotes bone formation, resulting in the acceleration of osseointegration. (C) 2014 Elsevier B.V. All rights reserved.	[Horasawa, Noriko] Matsumoto Dent Univ, Dept Dent Mat, Shiojiri, Nagano 3990781, Japan; [Yamashita, Teruhito] Matsumoto Dent Univ, Inst Oral Sci, Shiojiri, Nagano 3990781, Japan; [Uehara, Shunsuke; Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Shiojiri, Nagano 3990781, Japan	Horasawa, N (reprint author), Matsumoto Dent Univ, Dept Dent Mat, 1780 Hiro Oka, Shiojiri, Nagano 3990781, Japan.	horasawa@po.mdu.ac.jp			Matsumoto Dental University; Japan Society for the Promotion of Science	This work was supported by specially promoted research grants from the Matsumoto Dental University and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; CARLSSON L, 1986, ACTA ORTHOP SCAND, V57, P285; BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0; Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]; Sano K, 2006, J AM CHEM SOC, V128, P1717, DOI 10.1021/ja057262r; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Vieira EP, 2009, LANGMUIR, V25, P9879, DOI 10.1021/la9009948; Yang Q, 2007, ANAL CHIM ACTA, V597, P58, DOI 10.1016/j.aca.2007.06.025; Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m; Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019; Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q; Petersson IU, 2009, BIOMATERIALS, V30, P4471, DOI 10.1016/j.biomaterials.2009.05.042; Tugulu S, 2010, J MATER SCI-MATER M, V21, P2751, DOI 10.1007/s10856-010-4138-x; Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304; Morimoto N, 2005, BIOMACROMOLECULES, V6, P1829, DOI 10.1021/bm050156x; Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Vidigal GM, 2009, IMPLANT DENT, V18, P353, DOI 10.1097/ID.0b013e3181ac9a3d; Abtahi J, 2010, INT J ORAL MAX SURG, V39, P673, DOI 10.1016/j.ijom.2010.04.002; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004; Hayakawa T, 2005, J BIOMED MATER RES B, V73B, P271, DOI 10.1002/jbm.b.30207; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Sul YT, 2008, INT J ORAL MAX IMPL, V23, P631; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Badr NA, 2007, IMPLANT DENT, V16, P297, DOI 10.1097/ID.0b013e31805d7dc4; Bae IH, 2010, J BIOMED MATER RES B, V93B, P484, DOI 10.1002/jbm.b.31606; Bayeler M., 2010, EXP CELL RES, V316, P1202; Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x; Boukari A, 2006, J BIOMED MATER RES A, V78A, P466, DOI 10.1002/jbm.a.30778; Brien O.J., 2000, EUR J BIOCHEM, V267, P5421; Chakravorty N, 2014, CLIN ORAL IMPLAN RES, V25, P475, DOI 10.1111/clr.12178; Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q; Costa Cde A., 2005, BRAZ DENT J, V16, P75; Hilbig H, 2007, EUR J MED RES, V12, P6; Ishibe T., 2010, ORAL SURG ORAL MED O, V108, P867; Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060; Lamberg A, 2009, ACTA ORTHOP, V80, P499, DOI 10.3109/17453670903153519; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Nara M, 2006, EXP BIOL MED, V231, P166; Noha H., 2007, BIOMATERIALS, V28, P405; Pauthe E, 2002, BBA-PROTEIN STRUCT M, V1597, P12, DOI 10.1016/S0167-4838(02)00271-6; Sharma C.P., 1981, ENG MED, V10, P11; Xua L.C., 2007, BIOMATERIALS, V28, P3273; Yamada T, 2002, CLIN CANCER RES, V8, P2010; Yoshinari M., 1997, J DENT RES, V76, P1486	51	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JAN 1	2015	46						86	96		10.1016/j.msec.2014.10.025		11	Materials Science, Biomaterials	Materials Science	AY7RQ	WOS:000347757100011		
J	Tozawa, H; Maekawa, T; Kimura, H; Fujii, T				Tozawa, Hideto; Maekawa, Toshiro; Kimura, Hiroshi; Fujii, Teruo			A novel effect of parylene-based surface coating on HepG2 cell function	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Parylene; Cell adhesion; Collagen; Gene expression; Surface treatment; Cytochrome P450	EXTRACELLULAR-MATRIX; GEOMETRIC CONTROL; INDUCTION; METABOLISM; DIFFERENTIATION; FAMILY; CYP1A1; SHAPE; RHOA; 1B1	Parylene-C (diX C) has been used as-a surface coating material with many biological applications; diX AM, a member of the diX C parylene family, retains biocompatible features. Previously, it has been reported that diX AM shows high cell adhesiveness; however, the effect of diX AM on the function of cells remains unknown. In this study, we investigated cell morphology and gene expression in human hepatocellular carcinoma (HepG2) cells cultured on diX AM. Our results show that HepG2 cells adhered to the surface of diX AM, and retained morphology similar to that of the cells cultured on collagen-coated surfaces. Furthermore, microarray analysis has revealed that the expression of CYP1A1 and CYP1A2 was highly induced in HepG2 cells cultured on diX AM without any additional factors. Moreover, CYP1 enzymatic activity measured by ethoxyresorufin-O-dealkylase (EROD) assay corresponded with the induction of gene expression. These results indicate a novel effect of diX AM on HepG2 cell function for the first time and diX AM could be used as non-animal-derived material for cell culture. (C) 2014 Elsevier B.V. All rights reserved.	[Tozawa, Hideto; Maekawa, Toshiro; Kimura, Hiroshi; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Maekawa, Toshiro; Fujii, Teruo] Univ Tokyo, CNRS, IIS, LIMMS,Meguro Ku, Tokyo 1538505, Japan	Fujii, T (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	tfujii@iis.u-tolwo.ac.jp			KISCO Ltd. (Osaka, Japan); Daisan Kasei Co Ltd. (Tokyo, Japan)	We are grateful to Dr. Yuichi Niikura for the support of this study and Ms. Hiroko Nakamura and Ms. Sayaka Omura for their technical assistance. We also thank Editage for providing editorial assistance. This study was conducted as a part of collaboration with KISCO Ltd. (Osaka, Japan) and Daisan Kasei Co Ltd. (Tokyo, Japan), and was partially funded by them. The diX AM-coated plates were provided by these collaborators.	Wang HW, 2001, DRUG METAB DISPOS, V29, P1229; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Vakharia DD, 2001, TOXICOL APPL PHARM, V170, P93, DOI 10.1006/taap.2000.9087; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Hsu JM, 2009, IEEE T BIO-MED ENG, V56, P23, DOI 10.1109/TBME.2008.2002155; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Buesen R, 2002, TOXICOL APPL PHARM, V183, P168, DOI 10.1006/taap.2002.9484; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Hoshino T, 2012, BIOTECHNOL PROGR, V28, P587, DOI 10.1002/btpr.739; Kato Y., 2006, C P IEEE ENG MED BIO, P660; Kato YX, 2009, NEUROSCI LETT, V464, P26, DOI 10.1016/j.neulet.2009.08.007; LIPP HP, 1992, ARCH TOXICOL, V66, P220, DOI 10.1007/BF01974019; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; LOEB GE, 1977, IEEE T BIO-MED ENG, V24, P121, DOI 10.1109/TBME.1977.326115; LOEB GE, 1977, J BIOMED MATER RES, V11, P195, DOI 10.1002/jbm.820110206; MOORE SM, 1990, J BIOCHEM TOXICOL, V5, P237, DOI 10.1002/jbt.2570050406	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	JAN 1	2015	46						190	194		10.1016/j.msec.2014.10.030		5	Materials Science, Biomaterials	Materials Science	AY7RQ	WOS:000347757100024		
J	Guo, WC; Lai, FC; Zeng, DZ				Guo, Wen-Chung; Lai, Fu-Chuan; Zeng, Dao-Zhi			A Hotelling model with production	MATHEMATICAL SOCIAL SCIENCES			English	Article							SPATIAL RETAIL MARKETS; COMPETITION; DIFFERENTIATION; STABILITY; DUOPOLY; FIRMS	This paper extends the Hotelling model of spatial competition by incorporating the production technology and labor inputs. A duopolistic game is constructed in which firms choose their locations simultaneously in the first stage, and decide the prices of the product and wages of labor in the second stage. We find that the equilibrium locations depend on the production technology. Specifically, when productivity increases, the two firms change from dispersion to agglomeration and then to dispersion again. We then analyze the case with a minimum wage requirement and show the robustness of the equilibrium locations. Furthermore, the socially optimal locations do not depend on the production technology and the minimum wage requirement. However, a higher minimum wage increases unemployment and prices, which may reduce the total welfare level. (C) 2014 Elsevier B.V. All rights reserved.	[Guo, Wen-Chung] Natl Taipei Univ, Dept Econ, Taipei 23741, Taiwan; [Lai, Fu-Chuan] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 11529, Taiwan; [Lai, Fu-Chuan] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan; [Zeng, Dao-Zhi] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan	Zeng, DZ (reprint author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Aoba 6-3-09, Sendai, Miyagi 9808579, Japan.	guowc@ntu.edu.tw; uiuclai@gate.sinica.edu.tw; zeng@se.is.tohoku.ac.jp			JSPS KAKENHI of Japan [26380282, 24330072, 24243036]	We wish to thank two anonymous referees for their highly valuable and detailed comments. The financial support from JSPS KAKENHI of Japan (Grant Numbers 26380282, 24330072 and 24243036) for the third author is acknowledged.	ANDERSON SP, 1988, ECONOMICA, V55, P479, DOI 10.2307/2553910; ANDERSON SP, 1994, ECONOMICA, V61, P125, DOI 10.2307/2554952; Lambertini L, 1997, J URBAN ECON, V41, P407, DOI 10.1006/juec.1996.2007; Fleckinger P, 2010, MATH SOC SCI, V60, P61, DOI 10.1016/j.mathsocsci.2010.03.006; DASPREMONT C, 1979, ECONOMETRICA, V47, P1145, DOI 10.2307/1911955; Mai CC, 1999, REG SCI URBAN ECON, V29, P463, DOI 10.1016/S0166-0462(99)00007-1; Irmen A, 1998, J ECON THEORY, V78, P76, DOI 10.1006/jeth.1997.2348; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Brekke KR, 2004, REG SCI URBAN ECON, V34, P275, DOI 10.1016/S0166-0462(03)00046-2; Bhaskar V., 2003, EUROPEAN EC REV, V47, P371, DOI 10.1016/S0014-2921(01)00180-5; Bhaskar V, 1999, ECON J, V109, P190, DOI 10.1111/1468-0297.00427; Braid RM, 1996, J REGIONAL SCI, V36, P217, DOI 10.1111/j.1467-9787.1996.tb01266.x; CLAYCOMBE RJ, 1991, INT J IND ORGAN, V9, P303, DOI 10.1016/S0167-7187(05)80010-4; CLAYCOMBE RJ, 1993, INT J IND ORGAN, V11, P283, DOI 10.1016/0167-7187(93)90008-Z; ECONOMIDES N, 1986, ECON LETT, V21, P67, DOI 10.1016/0165-1765(86)90124-2; ECONOMIDES N, 1989, REG SCI URBAN ECON, V19, P21, DOI 10.1016/0166-0462(89)90031-8; Kaas L, 2010, ECON THEOR, V43, P167, DOI 10.1007/s00199-008-0412-2; Lai FC, 2012, REG SCI URBAN ECON, V42, P1017, DOI 10.1016/j.regsciurbeco.2011.09.001; Matsumura T, 2012, J REGIONAL SCI, V52, P420, DOI 10.1111/j.1467-9787.2011.00735.x; McConnell C.R., 1999, ECONOMICS; NEVEN DJ, 1986, ECON LETT, V21, P121, DOI 10.1016/0165-1765(86)90049-2; PORTER ME, 1995, HARVARD BUS REV, V73, P55; Raith M, 1996, INT J IND ORGAN, V14, P447, DOI 10.1016/0167-7187(95)00484-X; Sun CH, 2013, ANN REGIONAL SCI, V50, P953, DOI 10.1007/s00168-012-0528-y; TABUCHI T, 1994, REG SCI URBAN ECON, V24, P207, DOI 10.1016/0166-0462(93)02031-W; TABUCHI T, 1995, INT J IND ORGAN, V13, P213, DOI 10.1016/0167-7187(94)00449-C	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-4896	1879-3118		MATH SOC SCI	Math. Soc. Sci.	JAN	2015	73						40	49		10.1016/j.mathsocsci.2014.11.005		10	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	AZ5KR	WOS:000348260500006		
J	Koie, T; Ohyama, C; Yamamoto, H; Imai, A; Hatakeyama, S; Yoneyama, T; Hashimoto, Y; Yoneyama, T; Tobisawa, Y				Koie, Takuya; Ohyama, Chikara; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Yoneyama, Tohru; Tobisawa, Yuki			Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer	MEDICAL ONCOLOGY			English	Article						Muscle-invasive bladder cancer; Recurrence pattern; Neoadjuvant chemotherapy; Cystectomy; Gemcitabine; Carboplatin	RADICAL CYSTECTOMY; IMMEDIATE CYSTECTOMY; GEMCITABINE; SURVIVAL; GUIDELINES; CARCINOMA; CISPLATIN; OUTCOMES; TUMORS	In patients with muscle-invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) confers a survival benefit compared to radical cystectomy (RC) alone. Recurrence is observed in many cases and is the most common cause of death in MIBC patients. However, the rate and pattern of recurrence after NAC in MIBC patients remain unclear. We retrospectively reviewed the charts of 348 consecutive patients who underwent RC and bilateral pelvic node dissection between May 1994 and July 2012. Our study focused on patients with MIBC who had histologically confirmed stage T2-T4a urothelial carcinoma of the bladder without lymph node or distant metastasis. Accordingly, 265 patients were included in this analysis, of whom 130 received NAC and 135 underwent RC alone. Propensity score matching was used to adjust for potential selection biases associated with treatment type. Recurrence was defined as local recurrence and distant metastasis, according to site. Propensity score matching analysis identified 130 matched pairs from the two groups. For the neoadjuvant gemcitabine and carboplatin (GCarbo) and RC alone groups, the 5-year overall survival rates were 89.2 and 51.4 %, respectively (P < 0.0001), and the recurrence-free survival rates were 85.4 and 57.0 %, respectively (P < 0.0001). However, the total number of local recurrences was markedly lower in the neoadjuvant GCarbo group than in the RC alone group. Neoadjuvant GCarbo was associated with improved oncological outcomes and a different recurrence pattern in MIBC patients compared to RC alone.	[Koie, Takuya; Ohyama, Chikara; Yamamoto, Hayato; Imai, Atsushi; Hatakeyama, Shingo; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Yoneyama, Tohru; Tobisawa, Yuki] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan	Koie, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	coyama@cc.hirosaki-u.ac.jp					Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Baumann BC, 2013, INT J RADIAT ONCOL, V85, P81, DOI 10.1016/j.ijrobp.2012.03.007; Hassan JM, 2006, J UROLOGY, V175, P2054, DOI 10.1016/S0022-5347(06)00323-5; Winquist E, 2004, J UROLOGY, V171, P561, DOI 10.1097/01.ju.0000090967.08622.33; POLLACK A, 1995, J UROLOGY, V154, P2059, DOI 10.1016/S0022-5347(01)66693-X; Dotan ZA, 2007, J UROLOGY, V178, P2308, DOI 10.1016/jjuro.2007.08.023; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027; Koie T, 2013, INT J CLIN ONCOL, V18, P724, DOI 10.1007/s10147-012-0447-z; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Zehnder P, 2011, J UROLOGY, V186, P1261, DOI 10.1016/j.juro.2011.06.004; Honma I, 2004, UROLOGY, V64, P744, DOI 10.1016/j.urology.2004.05.003; Gore JL, 2010, J NATL CANCER I, V102, P802, DOI 10.1093/jnci/djq121; Volkmer BG, 2009, J UROLOGY, V181, P1587, DOI 10.1016/j.juro.2008.11.112; Cornu JN, 2012, WORLD J UROL, V30, P821, DOI 10.1007/s00345-012-0936-8; Edge SB, 2010, AJCC CANC STAGING MA, P497; Hautman RE, 2012, EUR UROL, V261, P1039; Koie T, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0949-9; Koie T, 2012, EJSO-EUR J SURG ONC, V38, P1101, DOI 10.1016/j.ejso.2012.07.115; Manoharan M, 2009, BJU INT, V104, P1646, DOI 10.1111/j.1464-410X.2009.08626.x; Rink M, 2012, BJU INT, V111, pE30; Stein JP, 2001, J CLIN ONCOL, V19, P666; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Yafi FA, 2012, BJU INT, V110, P1317, DOI 10.1111/j.1464-410X.2012.11133.x	25	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	JAN	2015	32	1							421	10.1007/s12032-014-0421-x		6	Oncology	Oncology	AY7ZW	WOS:000347775200081		
J	Lian, X; Jiao, Y; Yang, Y; Wang, ZP; Xuan, QJ; Liu, H; Lu, S; Wang, ZX; Liu, Y; Li, S; Yang, YG; Guo, L; Zhao, L; Zhang, QY				Lian, Xin; Jiao, Yu; Yang, Yu; Wang, Zhipeng; Xuan, Qijia; Liu, Hang; Lu, Shan; Wang, Zunxian; Liu, Yue; Li, Shuo; Yang, Yuguang; Guo, Li; Zhao, Ling; Zhang, Qingyuan			CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways	MEDICAL ONCOLOGY			English	Article						CrkL; SDF-1/CXCR4; Erk1/2; Akt; Breast cancer	STEM-CELL MIGRATION; MMP-9 EXPRESSION; SDF-1/CXCR4 AXIS; INVASION; TUMOR; METASTASIS; INHIBITORS; CXCR4; LUNG; LINE	The adapter protein CrkL is required for regulating the malignant potential of human cancers. However, the regulatory mechanisms of CrkL on the stromal cell-derived factor 1 (SDF-1)/CXCR4 signaling pathways in breast cancer are not well characterized. Here, CXCR4 and CrkL proteins were tested in breast cancer cell lines and 60 primary breast cancer tissues. In vitro, the roles of CrkL in SDF-1-induced MDA-MB-231 cell cycle, invasion and migration were investigated. In the present study, CXCR4 and CrkL were highly expressed in MCF-7, MDA-MB-231, MDA-MB-231HM MDA-MB-468 and tumor tissues (80 and 60 %, respectively) and closely correlated with lymph node metastasis. In vitro studies revealed that SDF-1 induced the activation of CrkL, Erk1/2, Akt and matrix metallopeptidase 9 (MMP9) in MDA-MB-231 cells. The si-CrkL treatment significantly down-regulated the phosphorylated Erk1/2 (p-Erk1/2) and MMP9, but up-regulated p-Akt, compared with control. Importantly, wound-healing and transwell invasion assays showed that si-CrkL significantly impaired the wound closure and inhibited the SDF-1-induced invasion; similarly, flow cytometry showed that si-CrkL affected cell cycle. In conclusion, these results suggest that CrkL plays a regulatory role in the SDF-1-inducedErk1/2 and PI3K/Akt pathways and further managed the invasion and migration of breast cancer cells. Thus, CrkL may be recommended as an interesting therapeutic target for breast cancer.	[Lian, Xin; Wang, Zhipeng; Xuan, Qijia; Liu, Hang; Lu, Shan; Wang, Zunxian; Liu, Yue; Li, Shuo; Yang, Yuguang; Guo, Li; Zhao, Ling; Zhang, Qingyuan] Harbin Med Univ, Dept Med Oncol, Affiliated Hosp 3, Harbin 150081, Heilongjiang, Peoples R China; [Jiao, Yu] Harbin Bur Justice, Yu Quan Prison Hosp, Harbin 150000, Heilongjiang, Peoples R China; [Yang, Yu] Kyushu Univ, Dept Biol, Nomura Lab, Fac Sci, Fukuoka 8128581, Japan	Zhang, QY (reprint author), Harbin Med Univ, Dept Med Oncol, Affiliated Hosp 3, Haping Rd 150 Nangang Dist, Harbin 150081, Heilongjiang, Peoples R China.	zqydoctor@126.com					Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Chaussain-Miller C, 2006, J DENT RES, V85, P22; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Patel LR, 2011, FUTURE ONCOL, V7, P1285, DOI [10.2217/fon.11.112, 10.2217/FON.11.112]; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Tang ZP, 2013, TUMOR BIOL, V34, P2835, DOI 10.1007/s13277-013-0843-7; Yuan L, 2013, STEM CELLS DEV, V22, P2384, DOI 10.1089/scd.2012.0717; Sun GG, 2014, TUMOR BIOL, V35, P3819, DOI 10.1007/s13277-013-1504-6; Marquez-Curtis LA, 2013, BIOMED RES INT, DOI 10.1155/2013/561098; Feng XJ, 2014, TUMOR BIOL, V35, P149, DOI 10.1007/s13277-013-1018-2; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Yan YL, 2014, TUMOR BIOL, V35, P3047, DOI 10.1007/s13277-013-1395-6; Tseng D, 2011, BRIT J CANCER, V104, P1805, DOI 10.1038/bjc.2011.169; Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Cree IA, 2013, J CONTROL RELEASE, V172, P405, DOI 10.1016/j.jconrel.2013.07.007; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; Nguyen Tiffany, 2014, Gland Surg, V3, P128, DOI 10.3978/j.issn.2227-684X.2014.03.05; Schutz A, 2002, TUMOR BIOL, V23, P179, DOI 10.1159/000064034; Sehdev V, 2009, J ONCOL, DOI 10.1155/2009/121458; Stallings-Mann M, 2007, CELLS TISSUES ORGANS, V185, P104, DOI 10.1159/000101310; Sutnar A, 2007, TUMOR BIOL, V28, P247, DOI 10.1159/000110897; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587	25	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	JAN	2015	32	1							411	10.1007/s12032-014-0411-z		8	Oncology	Oncology	AY7ZW	WOS:000347775200071		
J	Lee, T; Nakai, M; Niinomi, M; Park, CH; Lee, CS				Lee, Taekyung; Nakai, Masaaki; Niinomi, Mitsuo; Park, Chan Hee; Lee, Chong Soo			Phase Transformation and Its Effect on Mechanical Characteristics in Warm-Deformed Ti-29Nb-13Ta-4.6Zr Alloy	METALS AND MATERIALS INTERNATIONAL			English	Article						titanium alloy; thermomechanical processing; mechanical properties; phase transformation; biomaterials	TI-NB-TA; DEFORMATION-INDUCED MARTENSITE; BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS; TENSILE PROPERTIES; MATERIALS SCIENCE; YOUNGS MODULUS; CARBON STEEL; ZR ALLOYS; MICROSTRUCTURE	Ti-29Nb-13Ta-4.6Zr (TNTZ) alloy has been extensively studied as it is promising for use in biomedical applications. Despite its potential, the effects of warm plastic deformation on the alloy have not yet been revealed. This study investigated the differences in phase constitution of two warm-deformed TNTZ alloys and revealed relevant mechanisms with particular attention to martensitic transformation. The influence of phase constituents on mechanical characteristics was discussed as well. The TNTZ alloy deformed at 823 K possessed alpha, beta, and omega phases as well as alpha '' martensite, and demonstrated a low Young's modulus and double-yielding phenomenon. In contrast, the alloy deformed at 723 K had no martensite but more omega phase, leading to increased strength, hardness, and Young's modulus. The absence of alpha '' martensite in the alloy deformed at 723 K was interpreted in light of beta-stability of the parent phase and reduced M-s temperature.	[Lee, Taekyung] Pohang Univ Sci & Technol POSTECH, Ctr Adv Aerosp Mat, Pohang 790784, South Korea; [Nakai, Masaaki; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Park, Chan Hee] Korea Inst Mat Sci, Light Met Div, Chang Won 641831, South Korea; [Lee, Chong Soo] Pohang Univ Sci & Technol POSTECH, GIFT, Pohang 790784, South Korea	Lee, CS (reprint author), Pohang Univ Sci & Technol POSTECH, GIFT, Pohang 790784, South Korea.	cslee@postech.ac.kr	Nakai, Masaaki/C-1919-2009; Niinomi, Mitsuo/B-5965-2011				Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Andersson JO, 2002, CALPHAD, V26, P273, DOI 10.1016/S0364-5916(02)00037-8; Hajizadeh K, 2014, MET MATER INT, V20, P343, DOI 10.1007/s12540-014-2014-9; Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3; Lee T, 2012, MATER LETT, V75, P169, DOI 10.1016/j.matlet.2012.02.012; Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064; Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007; MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135; Lee T, 2013, SCRIPTA MATER, V69, P785, DOI 10.1016/j.scriptamat.2013.08.028; Weiss I, 1999, MAT SCI ENG A-STRUCT, V263, P243, DOI 10.1016/S0921-5093(98)01155-1; Grosdidier T, 2000, METALL MATER TRANS A, V31, P1095, DOI 10.1007/s11661-000-0105-3; Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7; Lee T, 2012, MET MATER INT, V18, P391, DOI 10.1007/s12540-012-3002-6; Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155; Nag S, 2007, ACTA BIOMATER, V3, P369, DOI 10.1016/j.actbio.2006.08.005; Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8; Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x; MOFFAT DL, 1988, METALL TRANS A, V19, P2389, DOI 10.1007/BF02645466; Lee T, 2011, MAT SCI ENG A-STRUCT, V528, P6558, DOI 10.1016/j.msea.2011.05.007; Artemev A, 2000, ACTA MATER, V48, P2503, DOI 10.1016/S1359-6454(00)00071-9; Collings E.W., 1984, PHYS METALLURGY TITA; Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113; Ikeda M, 2002, MATER TRANS, V43, P2984, DOI 10.2320/matertrans.43.2984; Lee T, 2013, MAT SCI ENG A-STRUCT, V562, P180, DOI 10.1016/j.msea.2012.11.023; Lee Y. T., 2009, TITANIUM, P61; Najdahmadi A, 2014, MATER DESIGN, V54, P786, DOI 10.1016/j.matdes.2013.09.007; Nakai M, 2012, METALL MATER TRANS A, V43A, P294, DOI 10.1007/s11661-011-0860-3; Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008; Park SH, 2012, KOREAN J MET MATER, V50, P469, DOI 10.3365/KJMM.2012.50.6.469; Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014; Wang LQ, 2009, J ALLOY COMPD, V469, P512, DOI 10.1016/j.jallcom.2008.02.032; Won JW, 2014, MET MATER INT, V20, P1017, DOI 10.1007/s12540-014-6004-8; Woo KD, 2012, KOREAN J MET MATER, V50, P86, DOI 10.3365/KJMM.2012.50.1.086; Yilmazer H, 2012, J MECH BEHAV BIOMED, V10, P235, DOI 10.1016/j.jmbbm.2012.02.022; Yoo GY, 2013, KOREAN J MET MATER, V51, P307, DOI 10.3365/KJMM.2013.51.4.307	37	0	0	KOREAN INST METALS MATERIALS	SEOUL	KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881, SOUTH KOREA	1598-9623	2005-4149		MET MATER INT	Met. Mater.-Int.	JAN	2015	21	1					202	207		10.1007/s12540-015-1025-5		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ5FH	WOS:000348245300025		
J	Liu, DY; Ishikawa, H; Nishida, M; Tsuchiya, K; Takahashi, T; Kimura, M; Asakawa, S				Liu, Dongyan; Ishikawa, Hiroki; Nishida, Mizuhiko; Tsuchiya, Kazunari; Takahashi, Tomoki; Kimura, Makoto; Asakawa, Susumu			Effect of Paddy-Upland Rotation on Methanogenic Archaeal Community Structure in Paddy Field Soil	MICROBIAL ECOLOGY			English	Article							SUPEROXIDE-DISMUTASE; RIBOSOMAL-RNA; RICE-WHEAT; BACTERIA; METHANE; POPULATIONS; EMISSION; DYNAMICS; CATALASE; PASTURE	Methanogenic archaea are strict anaerobes and demand highly reduced conditions to produce methane in paddy field soil. However, methanogenic archaea survive well under upland and aerated conditions in paddy fields and exhibit stable community. In the present study, methanogenic archaeal community was investigated in fields where paddy rice (Oryza sativa L.) under flooded conditions was rotated with soybean (Glycine max [L.] Merr.) under upland conditions at different rotation histories, by polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) and real-time quantitative PCR methods targeting 16S rRNA and mcrA genes, respectively. Soil samples collected from the fields before flooding or seeding, during crop cultivation and after harvest of crops were analyzed. The abundance of the methanogenic archaeal populations decreased to about one-tenth in the rotational plots than in the consecutive paddy (control) plots. The composition of the methanogenic archaeal community also changed. Most members of the methanogenic archaea consisting of the orders Methanosarcinales, Methanocellales, Methanomicrobiales, and Methanobacteriales existed autochthonously in both the control and rotational plots, while some were strongly affected in the rotational plots, with fatal effect to some members belonging to the Methanosarcinales. This study revealed that the upland conversion for one or longer than 1 year in the rotational system affected the methanogenic archaeal community structure and was fatal to some members of methanogenic archaea in paddy field soil.	[Liu, Dongyan; Ishikawa, Hiroki; Kimura, Makoto; Asakawa, Susumu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nishida, Mizuhiko; Tsuchiya, Kazunari; Takahashi, Tomoki] NARO Tohoku Agr Res Ctr, Akita 0140120, Japan	Liu, DY (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	liu.dongyan@f.mbox.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported in part by a Grant-in-Aid (Soil eDNA) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; FETZER S, 1993, FEMS MICROBIOL ECOL, V12, P107; Watanabe T, 2013, SOIL BIOL BIOCHEM, V58, P235, DOI 10.1016/j.soilbio.2012.11.022; Watanabe T, 2006, SOIL BIOL BIOCHEM, V38, P1264, DOI 10.1016/j.soilbio.2005.09.020; Watanabe T, 2007, SOIL BIOL BIOCHEM, V39, P2877, DOI 10.1016/j.soilbio.2007.05.030; Watanabe T, 2009, SOIL BIOL BIOCHEM, V41, P276, DOI 10.1016/j.soilbio.2008.10.025; Simankova MV, 2003, SYST APPL MICROBIOL, V26, P312, DOI 10.1078/072320203322346173; Watanabe T, 2010, SOIL SCI PLANT NUTR, V56, P705, DOI 10.1111/j.1747-0765.2010.00511.x; Nicol GW, 2003, GLOBAL CHANGE BIOL, V9, P1451, DOI 10.1046/j.1365-2486.2003.00673.x; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Luton PE, 2002, MICROBIOL-SGM, V148, P3521; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Peters V, 1996, SOIL BIOL BIOCHEM, V28, P371, DOI 10.1016/0038-0717(95)00146-8; Aoki S, 1996, BLACK BOX DATA ANAL; Asakawa S, 1998, SOIL BIOL BIOCHEM, V30, P299, DOI 10.1016/S0038-0717(97)00130-2; ASAKAWA S, 1995, BIOL FERT SOILS, V20, P113, DOI 10.1007/BF00336589; Brioukhanov A, 2000, ARCH MICROBIOL, V174, P213, DOI 10.1007/s002030000180; Brioukhanov AL, 2002, MICROBIOLOGY+, V71, P281, DOI 10.1023/A:1015846409735; Degelmann DM, 2009, FEMS MICROBIOL ECOL, V68, P312, DOI 10.1111/j.1574-6941.2009.00681.x; Eusufzai MK, 2010, AGR ECOSYST ENVIRON, V139, P742, DOI 10.1016/j.agee.2010.11.003; Hu HW, 2013, SOIL BIOL BIOCHEM, V64, P18, DOI 10.1016/j.soilbio.2013.04.003; Lee HJ, 2014, FEMS MICROBIOL ECOL, V88, P195, DOI 10.1111/1574-6941.12282; Liu CT, 2008, CURR MICROBIOL, V56, P214, DOI 10.1007/s00284-007-9059-7; Liu DY, 2012, SOIL SCI PLANT NUTR, V58, P553, DOI 10.1080/00380768.2012.726598; Ma K, 2011, FEMS MICROBIOL ECOL, V75, P446, DOI 10.1111/j.1574-6941.2010.01018.x; MINAMI K, 1994, FERT RES, V37, P167, DOI 10.1007/BF00748935; Nishida M, 2013, SOIL SCI PLANT NUTR, V59, P208, DOI 10.1080/00380768.2012.762588; Nishimura S, 2011, SOIL SCI PLANT NUTR, V57, P167, DOI 10.1080/00380768.2010.551346; Nishimura S, 2005, SOIL SCI SOC AM J, V69, P1977, DOI 10.2136/sssaj2005.0035; Poplawski AB, 2007, J MICROBIOL METH, V69, P161, DOI 10.1016/j.mimet.2006.12.018; Scavino AF, 2013, ENVIRON MICROBIOL, V15, P2588, DOI 10.1111/1462-2920.12161; Shima S, 2001, APPL ENVIRON MICROB, V67, P3041, DOI 10.1128/AEM.67.7.3041-3045.2001; Shirato Y, 2011, SOIL SCI PLANT NUTR, V57, P597, DOI 10.1080/00380768.2011.591284; Takahashi T., 2013, Japanese Journal of Soil Science and Plant Nutrition, V84, P202	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	JAN	2015	69	1					160	168		10.1007/s00248-014-0477-3		9	Ecology; Marine & Freshwater Biology; Microbiology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	AY6WW	WOS:000347704500015		
J	Takemori, N; Takemori, A; Matsuoka, K; Morishita, R; Matsushita, N; Aoshima, M; Takeda, H; Sawasaki, T; Endo, Y; Higashiyama, S				Takemori, Nobuaki; Takemori, Ayako; Matsuoka, Kazuhiro; Morishita, Ryo; Matsushita, Natsuki; Aoshima, Masato; Takeda, Hiroyuki; Sawasaki, Tatsuya; Endo, Yaeta; Higashiyama, Shigeki			High-throughput synthesis of stable isotope-labeled transmembrane proteins for targeted transmembrane proteomics using a wheat germ cell-free protein synthesis system	MOLECULAR BIOSYSTEMS			English	Article							ABSOLUTE QUANTIFICATION; MEMBRANE-PROTEINS; FREE TRANSLATION; PEPTIDES; PURIFICATION; QUANTITATION; EXPRESSION; STANDARDS; SUBUNITS; COMPLEX	Using a wheat germcell-free protein synthesis system, we developed a high-throughput method for the synthesis of stable isotope-labeled full-length transmembrane proteins as proteoliposomes to mimic the in vivo environment, and we successfully constructed an internal standard library for targeted transmembrane proteomics by using mass spectrometry.	[Takemori, Nobuaki; Takemori, Ayako; Matsuoka, Kazuhiro; Takeda, Hiroyuki; Sawasaki, Tatsuya; Higashiyama, Shigeki] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 790, Japan; [Matsuoka, Kazuhiro; Takeda, Hiroyuki; Sawasaki, Tatsuya; Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Morishita, Ryo] CellFree Sci Co Ltd, Matsuyama, Ehime, Japan; [Matsushita, Natsuki] Ehime Univ Hosp, Translat Res Ctr, Matsuyama, Ehime, Japan; [Aoshima, Masato] KK AB SCIEX, Tokyo, Japan	Takemori, N (reprint author), Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 790, Japan.	takemori@m.ehime-u.ac.jp	Matsuoka, Kazuhiro/N-8419-2015		Ehime University [XA49003]	This study was supported by a grant from Ehime University (XA49003). We thank Dr Naoka Komori for reviewing the manuscript and providing helpful comments.	Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/nmeth.2015, 10.1038/NMETH.2015]; Fischer F, 2006, MOL CELL PROTEOMICS, V5, P444, DOI 10.1074/mcp.M500234-MCP200; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Singh S, 2009, J PROTEOME RES, V8, P2201, DOI 10.1021/pr800654s; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; [Anonymous], 2012, MOL CELL PROTEOMICS; Hanke S, 2008, J PROTEOME RES, V7, P1118, DOI 10.1021/pr7007175; Matsuoka K, 2010, J PROTEOME RES, V9, P4264, DOI 10.1021/pr9010553; Brun V, 2007, MOL CELL PROTEOMICS, V6, P2139, DOI 10.1074/mcp.M700163-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Schafer A, 2012, ANAL CHEM, V84, P8853, DOI 10.1021/ac3023026; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Ludwig C., 2012, MOL CELL PROTEOMICS, V11, pM111; Nozawa A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-35	23	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.		2015	11	2					361	365		10.1039/c4mb00556b		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ4SB	WOS:000348211900004		
J	Ohkubo, S; Kodama, Y; Muraoka, H; Hitotsumachi, H; Yoshimura, C; Kitade, M; Hashimoto, A; Ito, K; Gomori, A; Takahashi, K; Shibata, Y; Kanoh, A; Yonekura, K				Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko			TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90 alpha and beta, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models	MOLECULAR CANCER THERAPEUTICS			English	Article							ADVANCED SOLID TUMORS; HSP90 INHIBITOR; PHASE-I; GANETESPIB STA-9090; DOSE-ESCALATION; CANCER; CELLS; PHARMACOKINETICS; MALIGNANCIES; BIIB021	The molecular chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins. A number of HSP90 inhibitors have been developed clinically for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic. The 4-(1H-pyrazolo[3,4-b] pyridine-1-yl) benzamide TAS-116 is a selective inhibitor of cytosolic HSP90 alpha and beta that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1. Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90 alpha and beta alone was sufficient to exert antitumor activity in certain tumor models. One of the most notable HSP90-related adverse events universally observed to differing degrees in the clinical setting is visual disturbance. A two-week administration of the isoxazole resorcinol NVPAUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats. In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue. Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compound in subcutaneously xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina. Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors. Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are observed with other compounds of this class. (C) 2014 AACR.	[Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki 3002611, Japan; [Hitotsumachi, Hiroko] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan	Ohkubo, S (reprint author), Taiho Pharmaceut Co Ltd, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.	s-ohkubo@taiho.co.jp			Taiho Pharmaceutical Co., Ltd.	All research work was funded by Taiho Pharmaceutical Co., Ltd.	Aguila M, 2013, HUM MOL GENET, V23, P2164; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Hua YP, 2013, CLIN CANCER RES, V19, P6242, DOI 10.1158/1078-0432.CCR-13-2083; Rasola A, 2014, TRENDS CELL BIOL, V24, P455, DOI 10.1016/j.tcb.2014.03.005; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Samuni Y, 2010, FREE RADICAL BIO MED, V48, P1559, DOI 10.1016/j.freeradbiomed.2010.03.001; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Sessa C, 2013, CLIN CANCER RES, V19, P3671, DOI 10.1158/1078-0432.CCR-12-3404; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Mecklenburg L, 2007, TOXICOL PATHOL, V35, P252, DOI 10.1080/01926230601178199; Floris G, 2011, MOL CANCER THER, V10, P1897, DOI 10.1158/1535-7163.MCT-11-0148; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Nowakowski GS, 2006, CLIN CANCER RES, V12, P6087, DOI 10.1158/1078-0432.CCR-06-1015; Vilenchik M, 2004, CHEM BIOL, V11, P787, DOI 10.1016/j.chembiol.2004.04.008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/nchembio.1335, 10.1038/NCHEMBIO.1335]; Matsui Y, 2005, INT J ONCOL, V27, P681; Lundgren K, 2009, MOL CANCER THER, V8, P921, DOI 10.1158/1535-7163.MCT-08-0758; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Renouf DJ, 2012, J CLIN ONCOL, V30, P3277, DOI 10.1200/JCO.2011.41.5851; Smyth T, 2012, MOL CANCER THER, V11, P1799, DOI 10.1158/1535-7163.MCT-11-1046; Eiseman JL, 2005, CANCER CHEMOTH PHARM, V55, P21, DOI 10.1007/s00280-004-0865-3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Saif MW, 2014, CLIN CANCER RES, V20, P445, DOI 10.1158/1078-0432.CCR-13-1257; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Sequist LV, 2010, J CLIN ONCOL, V28, P4953, DOI 10.1200/JCO.2010.30.8338; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Chen WT, 2014, HEPATOLOGY, V59, P947, DOI 10.1002/hep.26711; Felip E, 2012, ANN ONCOL S9, V23, P4380; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Goldman JW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-152; Lee AS, 2014, HEPATOLOGY; Mahadevan D, 2012, J CLIN ONCOL S; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Uno T, 2013, MOL CANC THER S, V12; Wu Z, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Zhou D, 2013, TOXICOL APPL PHARM, V273, P401, DOI 10.1016/j.taap.2013.09.018	49	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	JAN	2015	14	1					14	22		10.1158/1535-7163.MCT-14-0219		9	Oncology	Oncology	AZ0MF	WOS:000347938700002		
J	Ando, Y; Ogi, M; Tachibana, Y				Ando, Yuta; Ogi, Masayo; Tachibana, Yoshihiro			Abnormal Winter Weather in Japan during 2012 Controlled by Large-Scale Atmospheric and Small-Scale Oceanic Phenomena	MONTHLY WEATHER REVIEW			English	Article							NORTHERN-HEMISPHERE; GEOPOTENTIAL HEIGHT; ARCTIC OSCILLATION; CIRCULATION; MONSOON; SUMMER; TEMPERATURE; VARIABILITY; PATTERNS; PACIFIC	Negative Arctic Oscillation (AO) and western Pacific (WP) indices persisted from October to December 2012 in the Northern Hemisphere. For the first time, the monthly AO and WP were both negative for three consecutive months since records have been kept. Although in general negative AO and WP phases cause Siberia, East Asia, and Japan to be abnormally cold, Japan was relatively warm in October 2012 even though both the AO and WP were strongly negative. The temperature of the Sea of Japan reached a record-breaking high in October 2012, and it was found that heating by these very warm waters, despite the small size of the Sea of Japan, overwhelmed the cooling effect of the strongly negative AO and WP in October. Linear regression analyses showed that Japan tends to be warm in years when the Sea of Japan is warm. Consequently, the temperature over Japan is controlled by interannual variations of small-scale oceanic phenomena as well as by large-scale atmospheric patterns. Previous studies have ignored such small-scale oceanic influences on island temperatures.	[Ando, Yuta; Tachibana, Yoshihiro] Mie Univ, Climate & Ecosyst Dynam Div, Tsu, Mie 5148507, Japan; [Ando, Yuta] Natl Inst Polar Res, Arctic Environm Res Ctr, Tokyo, Japan; [Ogi, Masayo] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Tachibana, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa, Japan	Ando, Y (reprint author), Mie Univ, Climate & Ecosyst Dynam Div, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	yuta.a468@gmail.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22106003]; Green Network of Excellence (GRENE) Program Arctic Climate Change Research Project; Canada Excellence Research Chairs (CERC) Program; Canada Research Chairs (CRC) Program	We extend special thanks to Dr. Kunihiko Kodera and Dr. Koji Yamazaki for their very insightful discussions. Graduate students at Mie University offered us fruitful advice. Suggestions by the reviewers, in particular those offered by Dr. Sumant Nigam, helped us to improve the paper. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research on Innovative Areas (Grant 22106003) and by the Green Network of Excellence (GRENE) Program Arctic Climate Change Research Project. The work of M. Ogi was supported by the Canada Excellence Research Chairs (CERC) Program and the Canada Research Chairs (CRC) Program. The Grid Analysis and Display System (GrADS) and the Generic Mapping Tools (GMT) were used to draw the figures.	Takaya K, 2013, J CLIMATE, V26, P9445, DOI 10.1175/JCLI-D-12-00842.1; Wakabayashi S, 2004, J METEOROL SOC JPN, V82, P1577, DOI 10.2151/jmsj.82.1577; Park TW, 2008, ADV ATMOS SCI, V25, P791, DOI 10.1007/s00376-008-0791-0; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Wang L, 2014, CHINESE SCI BULL, V59, P430, DOI 10.1007/s11434-013-0029-0; Park TW, 2011, J CLIMATE, V24, P68, DOI 10.1175/2010JCLI3529.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Otomi Y, 2013, CLIM DYNAM, V40, P1939, DOI 10.1007/s00382-012-1386-0; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Linkin ME, 2008, J CLIMATE, V21, P1979, DOI 10.1175/2007JCLI2048.1; Wang L, 2014, J CLIMATE, V27, P2361, DOI 10.1175/JCLI-D-13-00086.1; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Jeong JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023024; He SP, 2013, J GEOPHYS RES-ATMOS, V118, P12981, DOI 10.1002/2013JD020525; Ogi M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004514; Tachibana Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012894; Zhang ZY, 2009, J GEOGR SCI, V19, P471, DOI 10.1007/s11442-009-0471-8	21	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	JAN	2015	143	1					54	63		10.1175/MWR-D-14-00032.1		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AZ0DO	WOS:000347916700005		
J	Kitahara, D; Yamada, I				Kitahara, Daichi; Yamada, Isao			Algebraic phase unwrapping along the real axis: extensions and stabilizations	MULTIDIMENSIONAL SYSTEMS AND SIGNAL PROCESSING			English	Article						Algebraic phase unwrapping; Two-dimensional phase unwrapping; Path independence condition; Numerical stabilization; Sturm sequence; Subresultant sequence	RADAR INTERFEROMETRY; ZERO DISTRIBUTION; ALGORITHM; SIGNAL; SUBRESULTANTS; BISPECTRUM; RECOVERY; SONAR	The unwrapped phase of a complex function is defined with a line integral of the gradient of the arctangent of the ratio of the real and imaginary parts of the function. The phase unwrapping, which is a problem to reconstruct the unwrapped phase of an unknown complex function from its finite observed samples, has been a key for estimating useful physical quantity in many signal and image processing applications. In the light of the functional data analysis, it is natural to estimate first the unknown complex function by a certain piecewise complex polynomial and then to compute the exact unwrapped phase of the piecewise complex polynomial with the algebraic phase unwrapping algorithms (Yamada et al. in IEEE Trans Signal Process 46(6), 1639-1664, 1998; Yamada and Bose in IEEE Trans Circuits Syst I Fundam Theory Appl 49(3), 298-304, 2002; Yamada and Oguchi in Multidimens Syst Signal Process 22(1-3), 191-211, 2011). In this paper, we propose several useful extensions and numerical stabilizations of the algebraic phase unwrapping along the real axis which was established originally in Yamada and Oguchi (Multidimens Syst Signal Process 22(1-3), 191-211, 2011). The proposed extensions include (i) removal of a certain critical assumption premised in the original algebraic phase unwrapping, and (ii) algebraic phase unwrapping for a pair of bivariate polynomials. Moreover, in order to resolve certain numerical instabilities caused by the coefficient growth in an inductive step in the original algorithm, we propose to compute directly a certain subresultant sequence without passing through the inductive step. The extensive numerical experiments exemplify the notable improvement, in the performance of the algebraic phase unwrapping, made by the proposed numerical stabilization.	[Kitahara, Daichi; Yamada, Isao] Tokyo Inst Technol, Dept Commun & Comp Engn, Meguro Ku, Tokyo 1528550, Japan	Yamada, I (reprint author), Tokyo Inst Technol, Dept Commun & Comp Engn, Meguro Ku, 2-12-1-S3-60 Ookayama, Tokyo 1528550, Japan.	kitahara@sp.ce.titech.ac.jp; isao@sp.ce.titech.ac.jp			JSPS [B-21300091]	This work was supported in part by JSPS Grants-in-Aid (B-21300091).	Aho A. V., 1974, THE DESIGN AND ANALY; Anai H., 2011, ALGORITHMS OF QUANTI; SZUMOWSKI J, 1994, RADIOLOGY, V192, P555; FRIED DL, 1977, J OPT SOC AM, V67, P370, DOI 10.1364/JOSA.67.000370; GRAHAM LC, 1974, P IEEE, V62, P763, DOI 10.1109/PROC.1974.9516; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; JUDGE TR, 1994, OPT LASER ENG, V21, P199, DOI 10.1016/0143-8166(94)90073-6; Hayes MP, 2009, IEEE J OCEANIC ENG, V34, P207, DOI 10.1109/JOE.2009.2020853; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; [Anonymous], 1988, MULTIVARIATE SPLINES; Flynn TJ, 1997, J OPT SOC AM A, V14, P2692, DOI 10.1364/JOSAA.14.002692; HUDGIN RH, 1977, J OPT SOC AM, V67, P375, DOI 10.1364/JOSA.67.000375; MCGOWAN R, 1982, IEEE T ACOUST SPEECH, V30, P719, DOI 10.1109/TASSP.1982.1163965; Costantini M, 1998, IEEE T GEOSCI REMOTE, V36, P813, DOI 10.1109/36.673674; SILVERMAN BW, 1985, J R STAT SOC B, V47, P1; Apostol T. M., 1974, MATHEMATICAL ANALYSI; BROWN WS, 1971, J ACM, V18, P505, DOI 10.1145/321662.321665; BUCKLAND JR, 1995, APPL OPTICS, V34, P5100, DOI 10.1364/AO.34.005100; Busbee B. L., 1970, SIAM J NUMER ANAL, V7, P627; COLLINS GE, 1967, J ACM, V14, P128, DOI 10.1145/321371.321381; DENBIGH PN, 1994, IEEE J OCEANIC ENG, V19, P382, DOI 10.1109/48.312914; Galbis A, 2012, UNIVERSITEXT, P1, DOI 10.1007/978-1-4614-2200-6; Ghiglia D. C., 1996, J OPT SOC AM A, V13, P1; Ghiglia D. C., 1998, TWO DIMENSIONAL PHAS; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; GOLDSTEIN RM, 1988, RADIO SCI, V23, P713, DOI 10.1029/RS023i004p00713; Hansen R. E., 2003, P OC 2003 MTS IEEE S, P2438; Henrici P., 1974, APPLIED AND COMPUTAT, V1; Jakowatz C. V., 1996, SPOTLIGHT MODE SYNTH; Kitahara D., 2012, IEICE TECHNICAL REPO, V112, P1; LIN Q, 1994, APPL OPTICS, V33, P201, DOI 10.1364/AO.33.000201; Marden M., 1989, GEOMETRY OF POLYNOMI, V3; MARRON JC, 1990, J OPT SOC AM A, V7, P14, DOI 10.1364/JOSAA.7.000014; Mishra B., 1993, ALGORITHMIC ALGEBRA; Moon-Ho Song S, 1995, IEEE Trans Image Process, V4, P667, DOI 10.1109/83.382500; NegreteRegagnon P, 1996, J OPT SOC AM A, V13, P1557, DOI 10.1364/JOSAA.13.001557; NOLL RJ, 1978, J OPT SOC AM, V68, P139, DOI 10.1364/JOSA.68.000139; PRITT MD, 1994, IEEE T GEOSCI REMOTE, V32, P706, DOI 10.1109/36.297989; Ramsay J. O., 2005, FUNCTUINAL DATA ANAL; Rudin W., 1976, PRINCIPLES OF MATHEM; Sasaki T., 1989, Journal of Information Processing, V12; Sasaki T., 1997, ACM SIGSAM B, V31, P4, DOI 10.1145/271130.271131; Schumaker L. L., 2007, SPLINE FUNCTIONS BAS; Wahba G, 1990, SPLINE MODELS FOR OB; Yamada I, 2002, IEEE T CIRCUITS-I, V49, P298, DOI 10.1109/81.989163; Yamada I, 2011, MULTIDIM SYST SIGN P, V22, P191, DOI 10.1007/s11045-010-0141-0; Yamada I, 1998, IEEE T SIGNAL PROCES, V46, P1639, DOI 10.1109/78.678480; Ying L., 2006, WILEY ENCYCLOPEDIA O; ZEBKER HA, 1986, J GEOPHYS RES-SOLID, V91, P4993, DOI 10.1029/JB091iB05p04993	50	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-6082	1573-0824		MULTIDIM SYST SIGN P	Multidimens. Syst. Signal Process.	JAN	2015	26	1					3	45		10.1007/s11045-013-0234-7		43	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AZ0RT	WOS:000347953000002		
J	Wang, J; Jiu, JT; Araki, T; Nogi, M; Sugahara, T; Nagao, S; Koga, H; He, P; Suganuma, K				Wang, Jun; Jiu, Jinting; Araki, Teppei; Nogi, Masaya; Sugahara, Tohru; Nagao, Shijo; Koga, Hirotaka; He, Peng; Suganuma, Katsuaki			Silver Nanowire Electrodes: Conductivity Improvement Without Post-treatment and Application in Capacitive Pressure Sensors	NANO-MICRO LETTERS			English	Article						Silver nanowire; Pre-treatment; Transparent electrode; Pressure sensor	TRANSPARENT ELECTRODES; SOLAR-CELLS; METAL-ELECTRODE; FILMS; PERFORMANCE; NETWORKS; PERCOLATION	Transparent electrode based on silver nanowires (AgNWs) emerges as an outstanding alternative of indium tin oxide film especially for flexible electronics. However, the conductivity of AgNWs transparent electrode is still dramatically limited by the contact resistance between nanowires at high transmittance. Polyvinylpyrrolidone (PVP) layer adsorbed on the nanowire surface acts as an electrically insulating barrier at wire-wire junctions, and some devastating post-treatment methods are proposed to reduce or eliminate PVP layer, which usually limit the application of the substrates susceptible to heat or pressure and burden the fabrication with high-cost, time-consuming, or inefficient processes. In this work, a simple and rapid pre-treatment washing method was proposed to reduce the thickness of PVP layer from 13.19 to 0.96 nm and improve the contact between wires. AgNW electrodes with sheet resistances of 15.6 and 204 Omega sq(-1) have been achieved at transmittances of 90 and 97.5 %, respectively. This method avoided any post-treatments and popularized the application of high-performance AgNW transparent electrode on more substrates. The improved AgNWs were successfully employed in a capacitive pressure sensor with high transparency, sensitivity, and reproducibility.	[Wang, Jun; He, Peng] Harbin Inst Technol, State Key Lab Adv Welding & Joining, Harbin 150001, Peoples R China; [Wang, Jun; Jiu, Jinting; Araki, Teppei; Nogi, Masaya; Sugahara, Tohru; Nagao, Shijo; Koga, Hirotaka; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Osaka, Ibaraki 5670047, Japan	He, P (reprint author), Harbin Inst Technol, State Key Lab Adv Welding & Joining, Harbin 150001, Peoples R China.	jiu@eco.sanken.osaka-u.ac.jp; hithepeng@hit.edu.cn	Nagao, Shijo/E-4870-2012	Nagao, Shijo/0000-0002-2764-3458	Showa Denko Co. Ltd; COI Stream Project; China Scholarship Council;  [24226017]	This work was partly supported by Showa Denko Co. Ltd, Grant-in-Aid for Scientific Research (Kaken S, 24226017) and COI Stream Project. J. Wang acknowledges the financial support from China Scholarship Council for his PhD research in Osaka University.	Hu WL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794143; Mayousse C, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/21/215501; Tokuno T, 2012, LANGMUIR, V28, P9298, DOI 10.1021/la300961m; Tokuno T, 2011, NANO RES, V4, P1215, DOI 10.1007/s12274-011-0172-3; Araki T, 2014, NANO RES, V7, P236, DOI 10.1007/s12274-013-0391-x; Barnes TM, 2012, ADV ENERGY MATER, V2, P353, DOI 10.1002/aenm.201100608; Liu M, 2012, NANO-MICRO LETT, V4, P142, DOI 10.3786/nml.v4i3.p142-153; Lee J, 2013, ADV FUNCT MATER, V23, P4171, DOI 10.1002/adfm.201203802; Lee P, 2012, ADV MATER, V24, P3326, DOI 10.1002/adma.201200359; Peng P, 2012, J MATER CHEM, V22, P12997, DOI 10.1039/c2jm31979a; Jiu J, 2014, J MATER CHEM A, V2, P6326, DOI 10.1039/c4ta00502c; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Zhang ZT, 1996, J SOLID STATE CHEM, V121, P105, DOI 10.1006/jssc.1996.0015; Jiu JT, 2013, NANOSCALE, V5, P11820, DOI 10.1039/c3nr03152g; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Lee J, 2012, NANOSCALE, V4, P6408, DOI 10.1039/c2nr31254a; Tait JG, 2013, SOL ENERG MAT SOL C, V110, P98, DOI 10.1016/j.solmat.2012.09.005; Yang LQ, 2011, ACS APPL MATER INTER, V3, P4075, DOI 10.1021/am2009585; Lee J, 2013, SMALL, V9, P2887, DOI 10.1002/smll.201203142; De S, 2011, MRS BULL, V36, P774, DOI 10.1557/mrs.2011.236; Hecht DS, 2011, ADV MATER, V23, P1482, DOI 10.1002/adma.201003188; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Kim YH, 2013, ADV FUNCT MATER, V23, P3763, DOI 10.1002/adfm.201203449; Buhler V., 2005, POLYVINYLPYRROLIDONE, V2, P5, DOI [10.1007/3-540-27090-6_2, DOI 10.1007/3-540-27090-6_2]; Daniel L., 2013, NANOTECHNOLOGY, V24, DOI DOI 10.1088/0957-4484/24/45/452001; David S.H., 2011, NANOTECHNOLOGY, V22, DOI [10.1088/0957-4484/22/7/075201, DOI 10.1088/0957-4484/22/7/075201]; Hsu PC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3522; Jiu JT, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1588-3; Li XD, 2011, NANO-MICRO LETT, V3, P195, DOI 10.3786/nml.v3i3.p195-199; Zhi Y., 2012, NANO-MICRO LETT, V4, P1	30	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2311-6706	2150-5551		NANO-MICRO LETT	Nano-Micro Lett.	JAN	2015	7	1					51	58		10.1007/s40820-014-0018-0		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AZ3OY	WOS:000348137900007		
J	Amet, F; Bestwick, AJ; Williams, JR; Balicas, L; Watanabe, K; Taniguchi, T; Goldhaber-Gordon, D				Amet, F.; Bestwick, A. J.; Williams, J. R.; Balicas, L.; Watanabe, K.; Taniguchi, T.; Goldhaber-Gordon, D.			Composite fermions and broken symmetries in graphene	NATURE COMMUNICATIONS			English	Article							HEXAGONAL BORON-NITRIDE; DIRAC FERMIONS; SUSPENDED GRAPHENE; QUANTUM; SPIN; SUPERLATTICES; INTEGER; PHASE	The electronic properties of graphene are described by a Dirac Hamiltonian with a four-fold symmetry of spin and valley. This symmetry may yield novel fractional quantum Hall (FQH) states at high magnetic field depending on the relative strength of symmetry-breaking interactions. However, observing such states in transport remains challenging in graphene, as they are easily destroyed by disorder. In this work, we observe in the first two Landau levels the two-flux composite-fermion sequences of FQH states between each integer filling factor. In particular, the odd-numerator fractions appear between filling factors 1 and 2, suggesting a broken-valley symmetry, consistent with our observation of a gap at charge neutrality and zero field. Contrary to our expectations, the evolution of gaps in a parallel magnetic field suggests that states in the first Landau level are not spin-polarized even up to very large out-of-plane fields.	[Amet, F.; Goldhaber-Gordon, D.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Bestwick, A. J.; Williams, J. R.; Goldhaber-Gordon, D.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Balicas, L.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan	Amet, F (reprint author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	franz.amet@gmail.com; goldhaber-gordon@stanford.edu	WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	Center for Probing the Nanoscale; NSF NSEC [PHY-0830228]; US National Science Foundation [DMR-0654118]; State of Florida; US Department of Energy; Benchmark Stanford Graduate Fellowship	We thank Mark Goerbig, Dmitri Abanin, Steve Kivelson, Chi-Te Liang and Inti Sodemann for theoretical and conceptual insights. We are grateful for Jonathan Billings' and Alexey Suslov's technical help. This work was supported by the Center for Probing the Nanoscale, an NSF NSEC, under grant No. PHY-0830228. Part of the measurements were done at the National High Magnetic Field Laboratory, which is supported by the US National Science Foundation cooperative agreement no. DMR-0654118, the State of Florida and the US Department of Energy. A.J.B. was supported by a Benchmark Stanford Graduate Fellowship.	Alpakov V., 2006, PHYS REV LETT, V97; LAUGHLIN RB, 1983, PHYS REV LETT, V50, P1395, DOI 10.1103/PhysRevLett.50.1395; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Kharitonov M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155439; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Goerbig MO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.241405; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Yankowitz M, 2012, NAT PHYS, V8, P382, DOI [10.1038/nphys2272, 10.1038/NPHYS2272]; Kindermann M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115415; Gorbar EV, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045108; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Amet F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216601; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; DU RR, 1995, PHYS REV LETT, V75, P3926, DOI 10.1103/PhysRevLett.75.3926; Kou A, 2014, SCIENCE, V345, P55, DOI 10.1126/science.1250270; Song JCW, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.266801; Tworzydlo J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246802; Khveshchenko DV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153405; Papic Z, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.176802; Nomura K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256602; Alicea J, 2007, SOLID STATE COMMUN, V143, P504, DOI 10.1016/j.ssc.2007.06.035; Amet F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.196601; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Young AF, 2012, NAT PHYS, V8, P550, DOI 10.1038/nphys2307; Feldman BE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.076802; Shibata N, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104708; Archer AC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.246801; Sodemann I, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.126804; SONDHI SL, 1993, PHYS REV B, V47, P16419, DOI 10.1103/PhysRevB.47.16419; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; HALPERIN BI, 1983, HELV PHYS ACTA, V56, P75; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; DU RR, 1993, PHYS REV LETT, V70, P2944, DOI 10.1103/PhysRevLett.70.2944; Dean CR, 2011, NAT PHYS, V7, P693, DOI [10.1038/nphys2007, 10.1038/NPHYS2007]; Du X, 2009, NATURE, V462, P192, DOI 10.1038/nature08522; Abanin DA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115407; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Park K, 1998, PHYS REV LETT, V80, P4237, DOI 10.1103/PhysRevLett.80.4237; ZHANG SC, 1989, PHYS REV LETT, V62, P82, DOI 10.1103/PhysRevLett.62.82; Nilsson J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266801; Garcia AGF, 2012, NANO LETT, V12, P4449, DOI 10.1021/nl3011726; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Giovannetti G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073103; GIRVIN SM, 1987, PHYS REV LETT, V58, P1252, DOI 10.1103/PhysRevLett.58.1252; Goerbig MO, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161407; Papic Z, 2009, SOLID STATE COMMUN, V149, P1056, DOI 10.1016/j.ssc.2009.02.050; Peterson M., PREPRINT; Ponomarenko L. A., 2012, NAT PHYS, V7, P958; Roy B., PREPRINT; Toske C., 2012, J PHYS CONDENS MATT, V24; Tske C., 2007, PHYS REV B, V75; Tsoke C., 2006, PHYS REV B, V74; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; Wang L., 2014, SCIENCE, V342, P614	58	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JAN	2015	6								5838	10.1038/ncomms6838		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CA1XC	WOS:000348701200001		
J	Hara, H; Yokosuka, T; Hirakawa, H; Ishihara, C; Yasukawa, S; Yamazaki, M; Koseki, H; Yoshida, H; Saito, T				Hara, Hiromitsu; Yokosuka, Tadashi; Hirakawa, Hideki; Ishihara, Chitose; Yasukawa, Shinsuke; Yamazaki, Masanori; Koseki, Haruhiko; Yoshida, Hiroki; Saito, Takashi			Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-kappa B signalling	NATURE COMMUNICATIONS			English	Article							GUANYLATE KINASE DOMAINS; T-CELL COSTIMULATION; SRC HOMOLOGY 3; INTRAMOLECULAR INTERACTION; IMMUNOLOGICAL SYNAPSE; MALT LYMPHOMA; MAGUK FAMILY; C-THETA; PROTEIN; JUNCTION	CARMA1-mediated NF-kappa B activation controls lymphocyte activation through antigen receptors and survival of some malignant lymphomas. CARMA1 clusters are formed on physiological receptor-mediated activation or by its oncogenic mutation in activated B-cell-diffuse large B-cell lymphomas (ABC-DLBCLs) with constitutive NF-kappa B activation. However, regulatory mechanisms and relevance of CARMA1 clusters in the NF-kappa B pathway are unclear. Here we show that SH3 and GUK domain interactions of CARMA1 link CARMA1 clustering to signal activation. SH3 and GUK domains of CARMA1 interact by either intra-or intermolecular mechanisms, which are required for activation-induced assembly of CARMA1. Disruption of these interactions abolishes the formation of CARMA1 microclusters at the immunological synapse, CARMA-regulated signal activation following antigen receptor stimulation as well as spontaneous CARMA1 clustering and NF-kappa B activation by the oncogenic CARMA1 mutation in ABC-DLBCLs. Thus, the SH3-GUK interactions that regulate CARMA1 cluster formations are promising therapeutic targets for ABC-DLBCLs.	[Hara, Hiromitsu; Yamazaki, Masanori; Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga 8498501, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima 8908544, Japan; [Yokosuka, Tadashi; Saito, Takashi] RIKEN Ctr Integrat Med Sci, Lab Cell Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yokosuka, Tadashi; Ishihara, Chitose] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Dept Plant Genome Res, Lab Plant Genome Informat, Kisarazu, Chiba 2920818, Japan; [Yasukawa, Shinsuke] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, Fukuoka 8128582, Japan; [Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Hara, H (reprint author), Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, 5-1-1 Nabeshima, Saga 8498501, Japan.	harah@m2.kufm.kagoshima-u.ac.jp; takashi.saito@riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21390153]; Takeda Science Foundation; Naito Foundation; Tokyo Biochemical Research Foundation; Sagawa Foundation for Promotion of Cancer Research; NOVARTIS Foundation (Japan) for the Promotion of Science	We thank S. Kuhara, M. Nakaya, Y. Miyazaki, F. Miichi, H. Soejima, K. Jo and K. Nishioka for discussions; S. Furukawa and H. Yamaguchi for secretarial assistance; and Y. Shimokawa, Y. Baba, S. Takao, C. Yoshii and R. Yoshida for technical assistance. This work was supported by a Grant-in-Aids for Priority Area Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21390153; H.H.), The Takeda Science Foundation (H.H.), The Naito Foundation, The Tokyo Biochemical Research Foundation (H.H.), The Sagawa Foundation for Promotion of Cancer Research (H.H.) and NOVARTIS Foundation (Japan) for the Promotion of Science (H.H.).	Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Isaacson PG, 2004, NAT REV CANCER, V4, P644, DOI 10.1038/nrc1409; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Rossman JS, 2006, MOL BIOL CELL, V17, P2166, DOI 10.1091/mbc.EO5-10-0985; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944; Takeda K, 2008, INT IMMUNOL, V20, P1507, DOI 10.1093/intimm/dxn108; Zlatkine P, 1997, J CELL SCI, V110, P673; [Anonymous], 1997, BLOOD, V89, P3909; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hoskins R, 1996, DEVELOPMENT, V122, P97; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Hara Hiromitsu, 2010, J Blood Med, V1, P93, DOI 10.2147/JBM.S9772; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Masuko N, 1999, J BIOL CHEM, V274, P5782, DOI 10.1074/jbc.274.9.5782; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Pappu BP, 2006, EUR J IMMUNOL, V36, P3033, DOI 10.1002/eji.200535663; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shin HW, 2000, J NEUROSCI, V20, P3580; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun Jiyuan, 2010, World J Biol Chem, V1, P353, DOI 10.4331/wjbc.v1.i12.353; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JAN	2015	6								5555	10.1038/ncomms6555		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CA1AA	WOS:000348643500001		
J	Ida, K; Yoshinuma, M; Tsuchiya, H; Kobayashi, T; Suzuki, C; Yokoyama, M; Shimizu, A; Nagaoka, K; Inagaki, S; Itoh, K				Ida, K.; Yoshinuma, M.; Tsuchiya, H.; Kobayashi, T.; Suzuki, C.; Yokoyama, M.; Shimizu, A.; Nagaoka, K.; Inagaki, S.; Itoh, K.		LHD Expt Grp	Flow damping due to stochastization of the magnetic field	NATURE COMMUNICATIONS			English	Article							ELECTRON HEAT-TRANSPORT; TOKAMAK PLASMAS; PINCH; SPECTROSCOPY; CONFINEMENT; MODEL; LHD	The driving and damping mechanism of plasma flow is an important issue because flow shear has a significant impact on turbulence in a plasma, which determines the transport in the magnetized plasma. Here we report clear evidence of the flow damping due to stochastization of the magnetic field. Abrupt damping of the toroidal flow associated with a transition from a nested magnetic flux surface to a stochastic magnetic field is observed when the magnetic shear at the rational surface decreases to 0.5 in the large helical device. This flow damping and resulting profile flattening are much stronger than expected from the Rechester-Rosenbluth model. The toroidal flow shear shows a linear decay, while the ion temperature gradient shows an exponential decay. This observation suggests that the flow damping is due to the change in the non-diffusive term of momentum transport.	[Ida, K.; Yoshinuma, M.; Tsuchiya, H.; Kobayashi, T.; Suzuki, C.; Yokoyama, M.; Shimizu, A.; Nagaoka, K.; Itoh, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Inagaki, S.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Itoh, K (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	ida@nifs.ac.jp	Kyushu, RIAM/F-4018-2015		JSPS Japan [21224014, 23246164]; NIFS; RIAM Kyushu University [NIFS13KOCT001];  [NIFS10ULHH021]	This work is partly supported by the Grant-in-Aid for Scientific Research (No. 21224014 and 23246164) of JSPS Japan; by NIFS10ULHH021; and by the collaboration program of NIFS and RIAM Kyushu University (NIFS13KOCT001).	Inagaki S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.055002; Ida K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/6/064007; LICHTENBERG AJ, 1992, NUCL FUSION, V32, P495, DOI 10.1088/0029-5515/32/3/I12; Ida K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013061; RECHESTER AB, 1978, PHYS REV LETT, V40, P38, DOI 10.1103/PhysRevLett.40.38; Yoshinuma M, 2010, FUSION SCI TECHNOL, V58, P375; YOKOYAMA T, 1994, ASTROPHYS J, V436, pL197, DOI 10.1086/187666; Sarff JS, 2003, NUCL FUSION, V43, P1684, DOI 10.1088/0029-5515/43/12/014; Bartiromo R, 1999, PHYS REV LETT, V82, P1462, DOI 10.1103/PhysRevLett.82.1462; Biewer TM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045004; Fiksel G, 1996, PLASMA PHYS CONTR F, V38, pA213, DOI 10.1088/0741-3335/38/12A/016; Ida K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045003; Ida K, 2010, FUSION SCI TECHNOL, V58, P383; Inagaki S, 2006, NUCL FUSION, V46, P133, DOI 10.1088/0029-5515/46/1/015; Innocente P, 2007, NUCL FUSION, V47, P1092, DOI 10.1088/0029-5515/47/9/004; ITOH K, 1992, NUCL FUSION, V32, P1851, DOI 10.1088/0029-5515/32/10/I13; Itoh SI, 1996, PLASMA PHYS CONTR F, V38, P527, DOI 10.1088/0741-3335/38/4/006; Lee H, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/014011; LUCE TC, 1992, PHYS REV LETT, V68, P52, DOI 10.1103/PhysRevLett.68.52; Mahmood A., 2010, PHYS PLASMAS, V17; Parker E. M., 1963, AP J SUPPL, V8, P177, DOI DOI 10.1086/190087; Terry PW, 1996, PHYS PLASMAS, V3, P1999, DOI 10.1063/1.871996; Yakovlev M, 2005, PHYS PLASMAS, V12, DOI [10.1063/1.2044447, 10.1063/1.204447]	23	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JAN	2015	6								5816	10.1038/ncomms6816		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CA1WW	WOS:000348700600001		
J	Le Guyader, L; Savoini, M; El Moussaoui, S; Buzzi, M; Tsukamoto, A; Itoh, A; Kirilyuk, A; Rasing, T; Kimel, AV; Nolting, F				Le Guyader, L.; Savoini, M.; El Moussaoui, S.; Buzzi, M.; Tsukamoto, A.; Itoh, A.; Kirilyuk, A.; Rasing, T.; Kimel, A. V.; Nolting, F.			Nanoscale sub-100 picosecond all-optical magnetization switching in GdFeCo microstructures	NATURE COMMUNICATIONS			English	Article							ANGULAR-MOMENTUM TRANSFER; ELECTRIC-FIELD; SPIN DYNAMICS; REVERSAL; DRIVEN; NANOSTRUCTURES; MANIPULATION; EXCITATION	Ultrafast magnetization reversal driven by femtosecond laser pulses has been shown to be a promising way to write information. Seeking to improve the recording density has raised intriguing fundamental questions about the feasibility of combining ultrafast temporal resolution with sub-wavelength spatial resolution for magnetic recording. Here we report on the experimental demonstration of nanoscale sub-100 ps all-optical magnetization switching, providing a path to sub-wavelength magnetic recording. Using computational methods, we reveal the feasibility of nanoscale magnetic switching even for an unfocused laser pulse. This effect is achieved by structuring the sample such that the laser pulse, via both refraction and interference, focuses onto a localized region of the structure, the position of which can be controlled by the structural design. Time-resolved photo-emission electron microscopy studies reveal that nanoscale magnetic switching employing such focusing can be pushed to the sub-100 ps regime.	[Le Guyader, L.; El Moussaoui, S.; Buzzi, M.; Nolting, F.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Le Guyader, L.] Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, D-12489 Berlin, Germany; [Savoini, M.; Kirilyuk, A.; Rasing, T.; Kimel, A. V.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Tsukamoto, A.; Itoh, A.] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan	Le Guyader, L (reprint author), Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland.	loic.le_guyader@helmholtz-berlin.de	Kirilyuk, Andrei/D-7798-2012; 	Buzzi, Michele/0000-0001-7325-4632	European Community's Seventh Framework Programme FP7 [NMP3-SL-2008-214469, FP7-NMP-2011-SMALL-281043, 214810]; European Research Council ERC [257280]; Foundation for Fundamental Research; Technology Foundation; Netherlands Organization for Scientific Research; MEXT; Strategic Research Foundation	This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 (grants NMP3-SL-2008-214469 (UltraMagnetron), FP7-NMP-2011-SMALL-281043 (FEMTOSPIN) and 214810 (FANTOMAS)), the European Research Council ERC Grant agreement number 257280 (Femtomagnetism), the Foundation for Fundamental Research on Matter (FOM) and the Technology Foundation (STW), the Netherlands Organization for Scientific Research(NWO) and the MEXT- Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017. Part of this work was performed at the Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. We thank J. Honegger for his technical support and A. Weber for her support with the nanofabrication.	Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Graves CE, 2013, NAT MATER, V12, P293, DOI [10.1038/nmat3597, 10.1038/NMAT3597]; Khorsand AR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127205; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Kampfrath T, 2011, NAT PHOTONICS, V5, P31, DOI [10.1038/nphoton.2010.259, 10.1038/NPHOTON.2010.259]; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Scholl A, 2002, REV SCI INSTRUM, V73, P1362, DOI 10.1063/1.1445485; Kubacka T, 2014, SCIENCE, V343, P1333, DOI 10.1126/science.1242862; Krause S, 2007, SCIENCE, V317, P1537, DOI 10.1126/science.1145336; Mentink JH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.057202; Mangin S, 2014, NAT MATER, V13, P287, DOI [10.1038/nmat3864, 10.1038/NMAT3864]; Radu I, 2011, NATURE, V472, P205, DOI 10.1038/nature09901; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; Kim JW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166601; Koene B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733292; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Stipe BC, 2010, NAT PHOTONICS, V4, P484, DOI 10.1038/nphoton.2010.90; Finazzi M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177205; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Le Guyader L, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733965; Lambert CH, 2014, SCIENCE, V345, P1337, DOI 10.1126/science.1253493; Evans RFL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867015; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Battiato M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027203; Flechsig U, 2010, AIP CONF PROC, V1234, P319, DOI 10.1063/1.3463200; Tudosa I, 2004, NATURE, V428, P831, DOI 10.1038/nature02438; Le Guyader L, 2012, J ELECTRON SPECTROSC, V185, P371, DOI 10.1016/j.elspec.2012.03.001; Coppens ZJ, 2013, NANO LETT, V13, P1023, DOI 10.1021/nl304208s; Alebrand S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4759109; Bergeard N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4466; Hassdenteufel A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895933; Kovalenko O, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.266602; Le Guyader L. B. P. J., 2012, J MAGN SOC JPN, V36, P21; Ostler TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1666; Palik E. D., 1997, HDB OPTICAL CONSTANT; Pedrotti F. L., 2006, INTRO OPTICS; Peng CB, 2012, J APPL PHYS, V112, DOI 10.1063/1.4747912; Savoini M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.140404; Schubert C, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866803; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	JAN	2015	6								5839	10.1038/ncomms6839		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CA1XC	WOS:000348701200002		
J	Burton, AC; Nakamura, K; Roesch, MR				Burton, Amanda C.; Nakamura, Kae; Roesch, Matthew R.			From ventral-medial to dorsal-lateral striatum: Neural correlates of reward-guided decision-making	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Review						Striatum; Nucleus accumbens; Rat; Monkey; Value; Habit; Goal; Single unit	BASAL GANGLIA; NUCLEUS-ACCUMBENS; DORSOMEDIAL STRIATUM; PRIMATE STRIATUM; CIRCUITS; PARALLEL; ORGANIZATION; ACQUISITION; DOPAMINE; BEHAVIOR	The striatum is critical for reward-guided and habitual behavior. Anatomical and interference studies suggest a functional heterogeneity within striatum. Medial regions, such as nucleus accumbens core and dorsal medial striatum play roles in goal-directed behavior, while dorsal lateral striatum is critical for control of habitual action. Subdivisions of striatum are topographically connected with different cortical and subcortical structures forming channels that carry information related to limbic, associative, and sensorimotor functions. Here, we describe data showing that as one progresses from ventral-medial to dorsal-lateral striatum, there is a shift from more prominent value encoding to activity more closely related to associative and motor aspects of decision-making. In addition, we will describe data suggesting that striatal circuits work in parallel to control behavior and that regions within striatum can compensate for each other when functions are disrupted. (C) 2014 Elsevier Inc. All rights reserved.	[Burton, Amanda C.; Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Burton, Amanda C.; Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Nakamura, Kae] Kansai Med Univ, Dept Physiol, Hirakata, Osaka 5701010, Japan; [Nakamura, Kae] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama 3320012, Japan	Roesch, MR (reprint author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	mroesch@umd.edu			NIDA [R01DA031695]	This work was supported by Grants from the NIDA (R01DA031695, MR). Correspondence and requests for materials should be addressed to MR (email: mroesch@umd.edu).	Roesch MR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00130; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Burton AC, 2014, BIOL PSYCHIAT, V75, P132, DOI 10.1016/j.biopsych.2013.05.023; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; van der Meer MAA, 2011, CURR OPIN NEUROBIOL, V21, P387, DOI 10.1016/j.conb.2011.02.011; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Stalnaker TA, 2012, J NEUROSCI, V32, P10296, DOI 10.1523/JNEUROSCI.0832-12.2012; Nishizawa K, 2012, J NEUROSCI, V32, P13421, DOI 10.1523/JNEUROSCI.1969-12.2012; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; Nakamura K, 2012, J NEUROSCI, V32, P15963, DOI 10.1523/JNEUROSCI.1518-12.2012; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; McGinty VB, 2013, NEURON, V78, P910, DOI 10.1016/j.neuron.2013.04.010; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Roesch MR, 2009, J NEUROSCI, V29, P13365, DOI 10.1523/JNEUROSCI.2572-09.2009; Bissonette GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064673; Catanese J, 2013, NEURON, V78, P753, DOI 10.1016/j.neuron.2013.05.021; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Houk J. C., 1995, MODELS INFORMATION P, P249; Karachi C, 2002, J COMP NEUROL, V450, P122, DOI 10.1002/cne.10312; Lichtenberg NT, 2014, NEUROSCIENCE, V258, P340, DOI 10.1016/j.neuroscience.2013.11.028; Singh Teghpal, 2010, Front Integr Neurosci, V4, P126, DOI 10.3389/fnint.2010.00126; Stalnaker Thomas A, 2010, Front Integr Neurosci, V4, P12, DOI 10.3389/fnint.2010.00012; Takahashi Yuji, 2007, Front Integr Neurosci, V1, P11, DOI 10.3389/neuro.07.011.2007; Takahashi Yuji, 2008, Front Neurosci, V2, P86, DOI 10.3389/neuro.01.014.2008	43	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	JAN	2015	117				SI		51	59		10.1016/j.nlm.2014.05.003		9	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	AZ5HI	WOS:000348250400007		
J	Yamazaki, K; Matsui, T; Baym, G				Yamazaki, Kanako; Matsui, T.; Baym, Gordon			Entropy in the quark-hadron transition	NUCLEAR PHYSICS A			English	Article						Quark-hadron phase transition; PNJL model; Chiral phase transition; Confinement-deconfinement transition; Mesonic excitations	HEAVY-ION COLLISIONS; PNJL MODEL; INTERACTING QUARKS; PHASE-TRANSITION; DYNAMICAL MODEL; PLASMA; QCD; SUPERCONDUCTIVITY; HYDRODYNAMICS; EVOLUTION	We study, in the PNJL model, how the entropy of interacting quarks reflects the change in the effective degrees of freedom as the temperature increases through the quark-hadron phase transition. With inclusion of mesonic correlations, the effective degrees of freedom change from those of pi and sigma mesons at low temperatures to those of free quarks at high temperatures, with a resultant second order phase deconfinement transition in the chiral limit. (C) 2014 Elsevier B.V. All rights reserved.	[Yamazaki, Kanako; Matsui, T.] Univ Tokyo, Inst Phys, Tokyo 153, Japan; [Baym, Gordon] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Yamazaki, K (reprint author), Univ Tokyo, Inst Phys, 4-6-1 Komaba, Tokyo 153, Japan.	kyamazaki@hep1.c.u-tokyo.ac.jp			University of Tokyo Grants; School of Science Grants; JSPS; MEXT, Japan [25400247]; U.S. NSF Grant [PHY13-05891]; RIKEN iTHES project	We thank Professor Tetsuo Hatsuda and Professor Kenji Fukushima for useful discussions. KY would like to thank Professor Veronique Bernard and Professor Brigitte Hiller for informative discussions. KY's work has been supported by the University of Tokyo Grants for Ph.D. Research, Research Assistant for Creation of the Research Core in Physics, School of Science Grants for Ph.D. Students, and JSPS research fellowships for Young Scientists. TM's work is supported in part by the Grant-in-Aid # 25400247 of MEXT, Japan. GB's work is supported in part by U.S. NSF Grant PHY13-05891. In addition GB thanks the RIKEN iTHES project for partial support during the writing of this paper.	Fukushima K, 2004, PHYS LETT B, V591, P277, DOI 10.1016/j.physletb.2004.04.027; POLYAKOV AM, 1978, PHYS LETT B, V72, P477, DOI 10.1016/0370-2693(78)90737-2; Ratti C, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.014019; GYULASSY M, 1984, PHYS REV D, V29, P419, DOI 10.1103/PhysRevD.29.419; NAMBU Y, 1961, PHYS REV, V124, P246, DOI 10.1103/PhysRev.124.246; Ratti C, 2007, PHYS LETT B, V649, P57, DOI 10.1016/j.physletb.2007.03.038; SUSSKIND L, 1979, PHYS REV D, V20, P2610, DOI 10.1103/PhysRevD.20.2610; HATSUDA T, 1994, PHYS REP, V247, P221, DOI 10.1016/0370-1573(94)90022-1; BAYM G, 1983, NUCL PHYS A, V407, P541, DOI 10.1016/0375-9474(83)90666-8; BAYM G, 1984, NUCL PHYS A, V418, pC525; BAYM G, 1976, PHYS LETT B, V62, P241, DOI 10.1016/0370-2693(76)90517-7; Benic S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.016007; Bjorken J.D., 1983, PHYS REV D, V27, P865; Blaizot E., 2001, PHYS REV D, V63; Blaizot E., 1999, PHYS LEFT B, V470, P181; Blaizot JP, 1999, PHYS REV LETT, V83, P2906, DOI 10.1103/PhysRevLett.83.2906; Blaschke D., 2008, YAD FIZ, V71, P2012; Borsanyi S., 2013, POS LATTICS2013, P155; Hansen H, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.065004; Kadanoff L., 1962, QUANTUM STAT MECH, P15; KAJANTIE K, 1983, NUCL PHYS B, V214, P261, DOI 10.1016/0550-3213(83)90662-4; Landau L.D., 1965, COLLECTED PAPERS LD, V17, p[51, 569]; MATSUI T, 1986, PHYS LETT B, V178, P416, DOI 10.1016/0370-2693(86)91404-8; Megias E, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.065005; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Roessner S., 2008, NUCL PHYS A, V814, P118, DOI DOI 10.1016/J.NUCLPHYSA.2008.10.006; Schafer T, 1999, PHYS REV LETT, V82, P3956, DOI 10.1103/PhysRevLett.82.3956; Weinberg S., 1983, ASYMPTOTIC REALMS PH, P1; Wergieluk A., 2013, PHYS PART NUCL LETT, V10, P660; Yamamoto N, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.074001; Yamazaki K, 2014, NUCL PHYS A, V922, P237, DOI 10.1016/j.nuclphysa.2013.12.010; Yamazaki K, 2013, NUCL PHYS A, V913, P19, DOI 10.1016/j.nuclphysa.2013.05.018	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9474	1873-1554		NUCL PHYS A	Nucl. Phys. A	JAN	2015	933						245	255		10.1016/j.nuclphysa.2014.10.046		11	Physics, Nuclear	Physics	AY7SK	WOS:000347759000018		
J	Suenaga, M; Mizunuma, N; Shinozaki, E; Matsusaka, S; Ozaka, M; Ogura, M; Chin, K; Yamaguchi, T				Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Shinozaki, Eiji; Matsusaka, Satoshi; Ozaka, Masato; Ogura, Mariko; Chin, Keisho; Yamaguchi, Toshiharu			Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab	ONCOTARGETS AND THERAPY			English	Article						venous thromboembolism; Bev; anticoagulant therapy; colorectal cancer	CATHETER-RELATED THROMBOSIS; PHASE-III TRIAL; RISK-FACTORS; DOUBLE-BLIND; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; COMPLICATIONS; PREVENTION; PROPHYLAXIS	Background: Doppler ultrasound imaging is useful for management of venous thromboembolism associated with a subclavicular implantable central venous access system in patients receiving bevacizumab (Bev). We investigated the efficacy and safety of our anticoagulant regimen based on Doppler findings. Methods: Patients aged < 75 years with metastatic colorectal cancer, no history of thromboembolism, and no prior use of Bev received chemotherapy plus Bev. Doppler ultrasound imaging of the deep venous system to detect thrombosis was performed after the first course of Bev and repeated after the third course in patients with asymptomatic thrombosis. Indications for anticoagulant therapy in patients with asymptomatic thrombosis were as follows: enlarging thrombus (E), thrombus >40 mm in diameter (S), thrombus involving the superior vena cava (C), and decreased blood flow (V). Results: Among 79 patients enrolled in this study, asymptomatic thrombosis was detected in 56 patients (70.9%) by Doppler ultrasound imaging after the first course of Bev and there was no thrombus in 23 patients (29.1%). Of these 56 patients, 11 (19.6%) received anticoagulant therapy with warfarin, including eight after the first course and three after follow-up imaging. S + V was observed in four of 11 patients (36.4%), as well as V in two (18.2%), S + V + C in one (9.1%), E + S + V in one (9.1%), E + C in one (9.1%), E in one (9.1%), and C in one (9.1%). All patients resumed chemotherapy, including seven who resumed Bev. Improvement or stabilization of thrombi was achieved in ten patients (90.9%). Only one patient had symptomatic thromboembolism. Mild bleeding due to anticoagulant therapy occurred in six patients (54.5%), but there were no treatment-related severe adverse events or deaths. Severe thromboembolism was not observed in the other 68 patients. Conclusion: Our anticoagulant protocol for asymptomatic thrombosis detected by Doppler ultrasound imaging was effective at preventing severe thromboembolism during continued treatment with Bev.	[Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Shinozaki, Eiji; Matsusaka, Satoshi; Ozaka, Masato; Ogura, Mariko; Chin, Keisho; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Koto Ku, Tokyo 1358550, Japan	Suenaga, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Koto Ku, 3-8-35 Ariake, Tokyo 1358550, Japan.	m.suenaga@jfcr.or.jp					Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Couban S, 2005, J CLIN ONCOL, V23, P4063, DOI 10.1200/JCO.2005.10.192; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Scappaticci FA, 2007, J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/cjm086; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Karthaus M, 2006, ANN ONCOL, V17, P289, DOI 10.1093/annonc/mdj059; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Kozloff M, 2009, ONCOLOGIST, V14, P862, DOI 10.1634/theoncologist.2009-0071; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; MONREAL M, 1994, THROMB HAEMOSTASIS, V72, P548; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Cortelezzi A, 2005, BRIT J HAEMATOL, V129, P811, DOI 10.1111/j.1365-2141.2005.05529.x; DRAKOS PE, 1992, CANCER, V70, P1895, DOI 10.1002/1097-0142(19921001)70:7<1895::AID-CNCR2820700715>3.0.CO;2-I; Fagnani D, 2007, ANN ONCOL, V18, P551, DOI 10.1093/annonc/mdl431; KOKSOY C, 1995, AUST NZ J SURG, V65, P796, DOI 10.1111/j.1445-2197.1995.tb00563.x; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; LOKICH JJ, 1983, CANCER, V52, P1586, DOI 10.1002/1097-0142(19831101)52:9<1586::AID-CNCR2820520908>3.0.CO;2-4; NEWMAN KA, 1993, SUPPORT CARE CANCER, V1, P92, DOI 10.1007/BF00366902; Suenaga M, 2010, MED ONCOL, V27, P807, DOI 10.1007/s12032-009-9289-6; Verso M, 2005, J CLIN ONCOL, V23, P4057, DOI 10.1200/JCO.2005.06.084	27	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6930			ONCOTARGETS THER	OncoTargets Ther.		2015	8						243	249		10.2147/OTT.S75722		7	Biotechnology & Applied Microbiology; Oncology	Biotechnology & Applied Microbiology; Oncology	AZ7YZ	WOS:000348432900001		
J	Nakahara, T; Moroi, Y; Takayama, K; Itoh, E; Kido-Nakahara, M; Nakanishi, Y; Furue, M				Nakahara, Takeshi; Moroi, Yoichi; Takayama, Koichi; Itoh, Eriko; Kido-Nakahara, Makiko; Nakanishi, Yoichi; Furue, Masutaka			Changes in sebum levels and the development of acneiform rash in patients with non-small cell lung cancer after treatment with EGFR inhibitors	ONCOTARGETS AND THERAPY			English	Article						skin toxicity; cutaneous adverse event; gefitinib; erlotinib	SEBACEOUS GLANDS; CETUXIMAB; EFFICACY	Background: It has recently been shown that patients treated with epidermal growth factor receptor (EGFR) inhibitors often develop various cutaneous adverse events. While the pathogenesis underlying these events remains unclear, the relationship between skin toxicity induced by EGFR inhibitors and the sebaceous glands that express EGFR has been previously reported. Objectives: The primary aim of this study was to determine the relationship between cutaneous sebum levels and acneiform rash, a typical skin toxicity of EGFR inhibitors, by measuring the sebum levels before and after EGFR inhibitor treatment. Methods: Eight patients diagnosed with non-small cell lung cancer (NSCLC) (three men and five women with an average age of 69.3 years) who were initiated on treatment with EGFR inhibitors (either gefitinib [Iressa (R)] or erlotinib [Tarceva (R)]) were enrolled. Using a Sebumeter (R), sebum levels in the face, chest, and back of each patient were measured before and after EGFR inhibitor treatment. The development of acneiform rash in each skin region was also assessed. Results: Changes in sebum level along with the development of an acneiform rash were observed after patients were started on EGFR inhibitor treatment. Patients who developed an EGFR inhibitor-induced acneiform rash tended to have higher pretreatment sebum levels (baseline) than did patients who did not experience an acneiform rash. At each time point measurement, sebum levels were found to be significantly higher in patients who had developed an acneiform rash at that time. Patients who developed rash during treatment showed greater differences in sebum level compared with pretreatment baseline. Conclusion: Patients who had increased levels of sebum or whose sebum levels showed greater change from pretreatment baseline developed an acneiform rash, suggesting that sebaceous gland activity may be involved in the mechanism underlying the development of acneiform rash, in patients treated with EGFR inhibitors.	[Nakahara, Takeshi; Itoh, Eriko] Kyushu Univ, Grad Sch Med Sci, Div Skin Surface Sensing, Fukuoka 8128582, Japan; [Nakahara, Takeshi; Moroi, Yoichi; Itoh, Eriko; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan; [Takayama, Koichi; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 8128582, Japan	Nakahara, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Div Skin Surface Sensing, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nakahara@dermatol.med.kyushu-u.ac.jp			JASMIN	This study was supported by an unrestricted educational grant from the nonprofit organization JASMIN, given to Kyushu University Hospital. The authors have no other conflicts of interest in this work.	Guttman-Yassky E, 2010, EUR J CANCER, V46, P2010, DOI 10.1016/j.ejca.2010.04.028; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Orditura M, 2009, ONCOL REP, V21, P1023, DOI 10.3892/or_00000319; Alestas T, 2006, J MOL MED-JMM, V84, P75, DOI 10.1007/s00109-005-0715-8; Cufer T, 2013, EUR J CANCER, V49, P1216, DOI 10.1016/j.ejca.2012.11.021; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Iwata C, 2005, J INVEST DERMATOL, V125, P865, DOI 10.1111/j.0022-202X.2005.23866.x; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lichtenberger Beate M, 2013, Sci Transl Med, V5, p199ra111, DOI 10.1126/scitranslmed.3005886; Mascia F, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3005773; Takata T, 2012, J DERMATOL SCI, V66, P165, DOI 10.1016/j.jdermsci.2012.02.012	11	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6930			ONCOTARGETS THER	OncoTargets Ther.		2015	8						259	263		10.2147/OTT.S76860		5	Biotechnology & Applied Microbiology; Oncology	Biotechnology & Applied Microbiology; Oncology	AZ7ZA	WOS:000348433100002		
J	Kakizaki, H; Takahashi, Y; Mito, H; Nakamura, Y				Kakizaki, Hirohiko; Takahashi, Yasuhiro; Mito, Hidenori; Nakamura, Yasuhisa			Movement of the Lacrimal Canalicular Wall Under Intracanalicular Pressure Changes Observed With Dacryoendoscopy	OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							DRAINAGE SYSTEM; MECHANICS; BLINKING	Background: Movement of the lacrimal canalicular wall has been speculated to occur during blinking. Movement of the common internal ostium has been observed under nasal endoscopy, and pressure changes in the lacrimal canalicular cavity have been observed with a pressure sensor; however, lacrimal canalicular wall movement under pressure changes has not been observed. Purpose: To examine movement of the lacrimal canalicular wall under intracanalicular pressure changes using dacryoendoscopy. Methods: The authors examined 20 obstruction-free lacrimal canaliculi in 10 patients. A dacryoendoscope was inserted, and water was poured into the intracanalicular cavity via the dacryoendoscope's water channel. The water was then poured or suctioned to cause positive or negative pressure changes in the intracanalicular cavity, and movement of the lacrimal canalicular wall was examined. Results: The lacrimal canalicular wall moved flexibly with pressure changes. Under positive pressure, the intracanalicular cavity was dilated; however, it narrowed under negative pressure. The extent of movement was more dramatic in the common canalicular portion than the proximal canalicular portion. Conclusions: Intracanalicular pressure changes cause movement of the lacrimal canalicular wall. There was a consistent relationship between intracanalicular cavity changes and pressure changes, possibly contributing to lacrimal drainage of the canaliculus.	[Kakizaki, Hirohiko; Takahashi, Yasuhiro; Mito, Hidenori; Nakamura, Yasuhisa] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan; [Mito, Hidenori] Ide Eye Hosp, Yamagata, Japan	Kakizaki, H (reprint author), Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan.	cosme@d1.dion.ne.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	Supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan.	WILSON G, 1976, AM J OPTOM PHYS OPT, V53, P55; DOANE MG, 1981, OPHTHALMOLOGY, V88, P844; HILL JC, 1974, CAN J OPHTHALMOL, V9, P411; Kakizaki H, 2005, OPHTHALMOLOGY, V112, P710, DOI 10.1016/j.ophtha.2004.11.043; Kakizaki H, 2013, AM J OPHTHALMOL, V156, P1051, DOI 10.1016/j.ajo.2013.06.021; Kakizaki H, 2014, OPHTHAL PLAST RECONS, V30, P521, DOI 10.1097/IOP.0000000000000239; Loudon JK, 2013, CLIN MECH KINESIOLOG, P50; MAURICE D M, 1973, International Ophthalmology Clinics, V13, P103, DOI 10.1097/00004397-197301310-00009; Takahashi Y, 2014, OPHTHAL PLAST RECONS, V30, P313, DOI 10.1097/IOP.0000000000000099; Zhu H, 2007, CURR EYE RES, V32, P829, DOI 10.1080/02713680701598503; Zhu H, 2005, CURR EYE RES, V30, P621, DOI 10.1080/02713680590968628	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0740-9303	1537-2677		OPHTHAL PLAST RECONS	Ophthalmic Plast. Reconstr. Surg.	JAN-FEB	2015	31	1					73	74		10.1097/IOP.0000000000000316		2	Ophthalmology; Surgery	Ophthalmology; Surgery	AY7YP	WOS:000347772000026		
J	Yamamoto, M; Kubota, K; Okazaki, M; Dobashi, A; Hashiguchi, M; Doi, H; Suka, M; Mochizuki, M				Yamamoto, Michiko; Kubota, Kiyoshi; Okazaki, Mitsuhiro; Dobashi, Akira; Hashiguchi, Masayuki; Doi, Hirohisa; Suka, Machi; Mochizuki, Mayumi			Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan	PATIENT PREFERENCE AND ADHERENCE			English	Article						adverse drug reaction reporting system; patient safety; patient experience; pharmacovigilance		Background: Patients have been allowed to report adverse drug reactions (ADRs) directly to the government in some countries, which would contribute to pharmacovigilance. Objective: We started a pilot study to determine whether web-based patient ADR reporting would work in Japan. This article aims to describe the characteristics of the patient reporters, and to clarify patient views and experiences of reporting. Methods: Patients who submitted online ADR reports were contacted to respond to an ADR reporting questionnaire; only consenting reporters were included. Subjects with multiple responses were excluded from analysis. The questionnaire consisted of both closed and open questions. Questionnaire responses were examined using Pearson's chi-squared test. Results: A total of 220 web-based ADR reports were collected from January to December 2011; questionnaires were sent to 190 reporters, excluding those who gave multiple reports and those that refused to be contacted. Responses were obtained from 94 individuals (effective response rate: 49.5%). The median respondent age was 46.0 years. Sixty-three respondents found out about this pilot study on the Internet (67.0%). The numbers of respondents claiming that they had difficulty recalling the time/date of ADR occurrence were 16 patient reporters and three non-patient reporters. The number of reporters who found it difficult to complete the online reporting form was 22 patients (26.2%) and one non-patient (10%). Fifty-seven respondents (60.6%) expected feedback after reporting and many respondents wanted to know the process of ADR data collection and related information. Seventy-three respondents (77.7%) stated that they would report ADRs again in future. Conclusion: Throughout the entire questionnaire, online patient ADR reporting was received with a forward-looking, positive approach. To facilitate smoother web-based reporting experiences in future, some improvements may be required in online ADR reporting forms, particularly with regard to respondent feedback.	[Yamamoto, Michiko; Doi, Hirohisa] Showa Pharmaceut Univ, Clin Pharm Practice, Educ Ctr, Machida, Tokyo, Japan; [Kubota, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo 1138654, Japan; [Okazaki, Mitsuhiro; Dobashi, Akira] Tokyo Univ Pharm & Life Sci, Educ & Res Inst Informat Sci, Tokyo, Japan; [Hashiguchi, Masayuki; Mochizuki, Mayumi] Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Tokyo, Japan; [Suka, Machi] Jikei Univ, Dept Publ Hlth & Environm Med, Sch Med, Tokyo, Japan	Yamamoto, M (reprint author), Showa Pharmaceut Univ, Clin Pharm Practice, Educ Ctr, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo, Japan.	m-yamamoto@ac.shoyaku.ac.jp			Health and Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare (MHLW) [H201]	The study was approved by the Research Ethics Committee of the Faculty of Pharmacy, Keio University. The study was supported by a Health and Labour Sciences Research Grant (H201 in fiscal years 2009-2011) from the Ministry of Health, Labour, and Welfare (MHLW).	Blenkinsopp A, 2007, BRIT J CLIN PHARMACO, V63, P148, DOI 10.1111/j.1365-2125.2006.02746.x; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Hammond IW, 2007, EXPERT OPIN DRUG SAF, V6, P705, DOI 10.1517/14740338.6.6.705; Herxheimer A, 2010, DIRECT PATIENT REPOR; Kubota K, 2013, PHARMACOEPIDEM DR S, V22, P1134, DOI 10.1002/pds.3490; McLernon DJ, 2011, PHARMACOEPIDEM DR S, V20, P523, DOI 10.1002/pds.2117; Ministry of Health Labour and Welfare, 2010, FIN PROP REV DRUG AD; Moore N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1694; Raine J, 2007, PHARMACOVIGILANCE, V2nd, P553; van Hunsel F, 2010, PHARMACOEPIDEM DR S, V19, P26, DOI 10.1002/pds.1865; van Hunsel F, 2011, PHARMACOEPIDEM DR S, V20, P286, DOI 10.1002/pds.2092	11	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-889X			PATIENT PREFER ADHER	Patient Prefer. Adherence		2015	9						173	184		10.2147/PPA.S75761		12	Medicine, General & Internal	General & Internal Medicine	AZ7ZD	WOS:000348433400001		
J	Hasegawa, T; Kohno, H				Hasegawa, Takayuki; Kohno, Hideo			Splitting and joining in carbon nanotube/nanoribbon/nanotetrahedron growth	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							GRAPHENE NANORIBBONS; NANOTUBES; JUNCTIONS; FABRICATION; MECHANISM; CATALYST	We report a novel phenomenon for carbon nanotube growth that results in a new carbon nanotube morphology. A carbon nanotube grown via metal nanoparticle-catalyzed chemical vapor deposition splits into two flattened nanotubes during growth and the two flattened nanotubes merge to form a ring of carbon nanotube/nanoribbon. This novel process is revealed by transmission electron microscopy observations of the carbon nanostructures. We propose that the splitting-and-joining process involves only one metal catalyst nanoparticle and a self-folding mechanism that we have named the origami mechanism to explain the process and the formation of nanoribbons and nanotetrahedra.	[Hasegawa, Takayuki] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Kohno, Hideo] Kochi Univ Technol, Dept Environm Sci & Engn, Kami, Kochi 7828502, Japan	Kohno, H (reprint author), Kochi Univ Technol, Dept Environm Sci & Engn, Kami, Kochi 7828502, Japan.	kohno.hideo@kochi-tech.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D of the Japan Science and Technology Agency	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D of the Japan Science and Technology Agency. The authors thank S. Ichikawa for support.	Deepak FL, 2001, CHEM PHYS LETT, V345, P5, DOI 10.1016/S0009-2614(01)00849-1; Li WZ, 2001, APPL PHYS LETT, V79, P1879, DOI 10.1063/1.1404400; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Cano-Marquez AG, 2009, NANO LETT, V9, P1527, DOI 10.1021/nl803585s; ZHOU D, 1995, CHEM PHYS LETT, V238, P286, DOI 10.1016/0009-2614(95)00406-T; Kohno H, 2013, NANOSCALE, V5, P570, DOI 10.1039/c2nr32607h; Li J, 1999, NATURE, V402, P253; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Satishkumar BC, 2000, APPL PHYS LETT, V77, P2530, DOI 10.1063/1.1319185; Kim K, 2010, ACS NANO, V4, P1362, DOI 10.1021/nn901782g; Gothard N, 2004, NANO LETT, V4, P213, DOI 10.1021/nl0349294; Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z; Gan B, 2000, DIAM RELAT MATER, V9, P897, DOI 10.1016/S0925-9635(99)00357-X; Heyning OT, 2005, CHEM PHYS LETT, V409, P43, DOI 10.1016/j.cplett.2005.04.097; Meng GW, 2005, P NATL ACAD SCI USA, V102, P7074, DOI 10.1073/pnas.0502098102; Papadopoulos C, 2000, PHYS REV LETT, V85, P3476, DOI 10.1103/PhysRevLett.85.3476; Rodriguez-Manzo JA, 2009, ADV MATER, V21, P4477, DOI 10.1002/adma.200901321; Su LF, 2005, CHEM VAPOR DEPOS, V11, P351, DOI 10.1002/cvde.200506399; Tao XY, 2005, CHEM PHYS LETT, V409, P89, DOI 10.1016/j.cplett.2005.04.084; Terrones M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075505; Ting JM, 2004, CARBON, V42, P2997, DOI 10.1016/j.carbon.2004.07.014; Tsai S. H., 2000, CARBON, V38, P1879; Wang MS, 2005, ADV FUNCT MATER, V15, P1825, DOI 10.1002/adfm.200500215; Zhu HW, 2002, DIAM RELAT MATER, V11, P1349, DOI 10.1016/S0925-9635(01)00745-2	24	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	5					3009	3013		10.1039/c4cp05139d		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AZ4OW	WOS:000348203200010		
J	Saputro, AG; Kasai, H				Saputro, Adhitya G.; Kasai, Hideaki			Oxygen reduction reaction on neighboring Fe-N-4 and quaternary-N sites of pyrolized Fe/N/C catalyst	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							DENSITY-FUNCTIONAL THEORY; ELECTROLYTE FUEL-CELLS; NITROGEN-DOPED GRAPHENE; CARBON ALLOY CATALYSTS; PYROLYZED PORPHYRINS; ACTIVATION-ENERGIES; O-2 DISSOCIATION; EDGE SITES; ELECTROCATALYSTS; MECHANISM	We study the interaction between the TM-N-x and metal-free active sites of a pyrolized TM/N/C catalyst and its effect on their ORR activities. We particularly choose a Fe-N-4-edge-graphene and a quaternary-N- doped zigzag edge as representatives of TM-N-x and the metal-free active sites, respectively. We find that the interaction of the Fe-N-4 and quaternary-N-doped sites at the zigzag edge of graphene enhances the ORR free energy profile at the quaternary-N-doped site. However, the ORR free energy profile at the Fe-N-4 site is not affected by this interaction.	[Saputro, Adhitya G.; Kasai, Hideaki] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Kasai, Hideaki] Osaka Univ, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan; [Kasai, Hideaki] Osaka Univ, Ctr Continuing Profess Dev, Suita, Osaka 5650871, Japan	Kasai, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Phys, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kasai@dyn.ap.eng.osaka-u.ac.jp			Daihatsu Motor Co. Ltd MEXT [2203-22104008, 26248006]; JST ALCA Program "Development of Novel Metal-Air Secondary Battery Based on Fast Oxide Ion Conductor Nano Thickness Film''; JSPS Core-to-Core Program "A. Advanced Research Networks: Computational Materials Design on Green Energy''; Osaka University Joining and Welding Research Institute Cooperative Research Program	This work is supported in part by: Daihatsu Motor Co. Ltd MEXT Grant-in-Aid for Scientific Research on Innovative Areas Program (2203-22104008) and Scientific Research (A)(26248006); JST ALCA Program "Development of Novel Metal-Air Secondary Battery Based on Fast Oxide Ion Conductor Nano Thickness Film''; JSPS Core-to-Core Program "A. Advanced Research Networks: Computational Materials Design on Green Energy''; and the Osaka University Joining and Welding Research Institute Cooperative Research Program. Some of the numerical calculations presented here done using the computer facilities at the following institutes: CMC (Osaka University), ISSP, KEK, NIFS, and YITP. The authors are deeply grateful to Mr Fadjar Fathurrahman, Dr Febdian Rusydi, Dr Hiroshi Nakanishi, Dr Wilson A. Dino (Kasai Lab, Osaka University) and Dr Hirofumi Kishi (Daihatsu Motor Co. Ltd) for their insight and valuable discussions.	Anderson AB, 1999, ELECTROCHEM COMMUN, V1, P203, DOI 10.1016/S1388-2481(99)00039-9; Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d; Jaouen F, 2011, ENERG ENVIRON SCI, V4, P114, DOI 10.1039/c0ee00011f; Olson TS, 2010, J ELECTROCHEM SOC, V157, pB54, DOI 10.1149/1.3248003; Anderson AB, 1999, J AM CHEM SOC, V121, P11855, DOI 10.1021/ja992735d; Kattel S, 2013, J MATER CHEM A, V1, P10790, DOI 10.1039/c3ta12142a; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Iwazaki T, 2010, J POWER SOURCES, V195, P5840, DOI 10.1016/j.jpowsour.2009.12.135; Calle-Vallejo F, 2011, PHYS CHEM CHEM PHYS, V13, P15639, DOI 10.1039/c1cp21228a; Kattel S, 2014, J PHYS CHEM LETT, V5, P452, DOI 10.1021/jz402717r; Olson TS, 2010, J PHYS CHEM C, V114, P5049, DOI 10.1021/jp910572g; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Yang RZ, 2008, J ELECTROCHEM SOC, V155, pB79, DOI 10.1149/1.2803519; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Kattel S, 2014, PHYS CHEM CHEM PHYS, V16, P13800, DOI 10.1039/c4cp01634c; Biddinger EJ, 2010, J PHYS CHEM C, V114, P15306, DOI 10.1021/jp104074t; Lee DH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.175502; Zhang LP, 2011, J PHYS CHEM C, V115, P11170, DOI 10.1021/jp201991j; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Kattel S, 2013, PHYS CHEM CHEM PHYS, V15, P148, DOI 10.1039/c2cp42609a; Kramm UI, 2012, PHYS CHEM CHEM PHYS, V14, P11673, DOI 10.1039/c2cp41957b; Sidik RA, 2006, J PHYS CHEM B, V110, P1787, DOI 10.1021/jp055150g; Bahn SR, 2002, COMPUT SCI ENG, V4, P56, DOI 10.1109/5992.998641; Orellana W, 2013, J PHYS CHEM C, V117, P9812, DOI 10.1021/jp4002115; Kattel S, 2012, J PHYS CHEM C, V116, P17378, DOI 10.1021/jp3044708; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Huang SF, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235410; Ziegelbauer JM, 2008, J PHYS CHEM C, V112, P8839, DOI 10.1021/jp8001564; Bao XG, 2013, TOP CATAL, V56, P1623, DOI 10.1007/s11244-013-0097-z; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Curtin DE, 2004, J POWER SOURCES, V131, P41, DOI 10.1016/j.jpowsour.2004.01.023; Chen ZW, 2011, ENERG ENVIRON SCI, V4, P3167, DOI 10.1039/c0ee00558d; Wassmann T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096402; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Chen RR, 2009, J PHYS CHEM C, V113, P20689, DOI 10.1021/jp906408y; Qiao JL, 2006, J ELECTROCHEM SOC, V153, pA967, DOI 10.1149/1.2186768; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Aoki M, 2006, ELECTROCHEM COMMUN, V8, P1509, DOI 10.1016/j.elecom.2006.07.017; Iwazaki T, 2009, ELECTROCHEM COMMUN, V11, P376, DOI 10.1016/j.elecom.2008.11.045; Li MT, 2014, J CATAL, V314, P66, DOI 10.1016/j.jcat.2014.03.011; Studt F, 2013, CATAL LETT, V143, P58, DOI 10.1007/s10562-012-0918-x; Kim H, 2011, PHYS CHEM CHEM PHYS, V13, P17505, DOI 10.1039/c1cp21665a; Matter PH, 2006, CATAL LETT, V109, P115, DOI 10.1007/s10562-006-0067-1; Kurak KA, 2009, J PHYS CHEM C, V113, P6730, DOI 10.1021/jp811518e; Chokai M, 2010, J POWER SOURCES, V195, P5947, DOI 10.1016/j.jpowsour.2010.01.012; Dai JY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165414; Jain M, 2006, J PHYS CHEM B, V110, P4179, DOI 10.1021/jp055799l; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Medard C, 2006, ELECTROCHIM ACTA, V51, P3202, DOI 10.1016/j.electacta.2005.09.012; Saputro AG, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.024707; Saputro AG, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.114704; Tsuda M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1947187; Tsuda M, 2005, CHEM PHYS LETT, V402, P71, DOI 10.1016/j.cplett.2004.12.013; Vayner E, 2007, J PHYS CHEM C, V111, P9330, DOI 10.1021/jp071576e; Wang XL, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245434; Zagal J.H., 2006, N4 MACROCYCLIC METAL; Zhang J, 2013, J MOL MODEL, V19, P5515, DOI 10.1007/s00894-013-2047-x	59	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	5					3059	3071		10.1039/c4cp04811c		13	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AZ4OW	WOS:000348203200017		
J	Yamada, T; Aida, M				Yamada, Tomonori; Aida, Misako			Fundamental frequency from classical molecular dynamics	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							CANONICAL PERTURBATION-THEORY; VIBRATIONAL STRUCTURE-THEORY; SELF-CONSISTENT-FIELD; AB-INITIO; SEMICLASSICAL QUANTIZATION; POLYATOMIC-MOLECULES; INFRARED-SPECTRUM; PHASE-SPACE; ALGEBRAIC QUANTIZATION; ENERGY-LEVELS	We give a theoretical validation for calculating fundamental frequencies of a molecule from classical molecular dynamics (MD) when its anharmonicity is small enough to be treated by perturbation theory. We specifically give concrete answers to the following questions: (1) What is the appropriate initial condition of classical MD to calculate the fundamental frequency? (2) From that condition, how accurately can we extract fundamental frequencies of a molecule? (3) What is the benefit of using ab initio MD for frequency calculations? Our analytical approaches to those questions are classical and quantum normal form theories. As numerical examples we perform two types of MD to calculate fundamental frequencies of H2O with MP2/aug-cc-pVTZ: one is based on the quartic force field and the other one is direct ab initio MD, where the potential energies and the gradients are calculated on the fly. From those calculations, we show comparisons of the frequencies from MD with the post vibrational self-consistent field calculations, second-and fourth-order perturbation theories, and experiments. We also apply direct ab initio MD to frequency calculations of C-H vibrational modes of tetracene and naphthalene. We conclude that MD can give the same accuracy in fundamental frequency calculation as second-order perturbation theory but the computational cost is lower for large molecules.	Hiroshima Univ, Ctr Quantum Life Sci, Higashihiroshima 7398526, Japan; Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan	Yamada, T (reprint author), Univ Illinois, Dept Chem, 600 South Mathews Ave, Urbana, IL 61801 USA.	tyamada@illinois.edu	Aida, Misako/D-1670-2010	Aida, Misako/0000-0001-8788-1071	Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Dr So Hirata for his advice and support. This study was partially supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The calculations were carried out at the Center for Quantum Life Sciences (QuLiS) and at the Research Center for Computational Science, Okazaki National Research Institutes.	Aida M, 2003, J MOL STRUC-THEOCHEM, V633, P247, DOI 10.1016/S0166-1280(03)00280-X; Allen M. P., 1987, COMPUTER SIMULATION; Sugny D, 2000, J CHEM PHYS, V113, P7165, DOI 10.1063/1.1311967; Oschetzki D, 2012, CROAT CHEM ACTA, V85, P379, DOI 10.5562/cca2149; Cimas A, 2009, J CHEM THEORY COMPUT, V5, P2388, DOI 10.1021/ct900179d; Yamada T, 2010, J PHYS CHEM A, V114, P6273, DOI 10.1021/jp912269v; LAMON K, 1990, J PHYS A-MATH GEN, V23, P3875, DOI 10.1088/0305-4470/23/17/017; SAGE ML, 1989, J CHEM PHYS, V90, P7257, DOI 10.1063/1.456203; Hermes MR, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729602; SWIMM RT, 1979, J CHEM PHYS, V71, P1706, DOI 10.1063/1.438521; Birkhoff GD, 1917, T AM MATH SOC, V18, P199, DOI 10.2307/1988861; Jung JO, 1996, J CHEM PHYS, V105, P10332, DOI 10.1063/1.472960; Handgraaf JW, 2004, J CHEM PHYS, V121, P10111, DOI 10.1063/1.1809595; Kawai S, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022714; Cassam-Chenai P, 2003, INT J QUANTUM CHEM, V93, P245, DOI 10.1002/qua.10556; Kaledin M, 2006, J PHYS CHEM A, V110, P2933, DOI 10.1021/jp054374w; Christiansen O, 2007, PHYS CHEM CHEM PHYS, V9, P2942, DOI 10.1039/b618764a; Begue D, 2005, J PHYS CHEM A, V109, P4611, DOI 10.1021/jp0406114; Buch V, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2436870; Waalkens H, 2008, NONLINEARITY, V21, pR1, DOI 10.1088/0951-7715/21/1/R01; Yagi K, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767776; Bernasconi M, 1998, PHYS REV LETT, V81, P1235, DOI 10.1103/PhysRevLett.81.1235; Hermes MR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892614; Keceli M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3644895; SIBERT EL, 1988, J CHEM PHYS, V88, P4378, DOI 10.1063/1.453797; SERVIZI G, 1984, COMPUT PHYS COMMUN, V32, P201, DOI 10.1016/0010-4655(84)90071-7; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; NOID DW, 1977, J CHEM PHYS, V67, P404, DOI 10.1063/1.434901; Wong SYY, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3553179; Komatsuzaki T, 2002, ADV CHEM PHYS, V123, P79, DOI 10.1002/0471231509.ch2; Aida M, 2005, CHEM PHYS LETT, V401, P170, DOI 10.1016/j.cplett.2004.11.046; Yagi K, 2000, J CHEM PHYS, V113, P1005, DOI 10.1063/1.481881; Li CB, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2044707; Silvestrelli PL, 1997, CHEM PHYS LETT, V277, P478, DOI 10.1016/S0009-2614(97)00930-5; ROSENGAUS E, 1982, J MATH PHYS, V23, P2328, DOI 10.1063/1.525324; Yamada T, 2008, CHEM PHYS LETT, V452, P315, DOI 10.1016/j.cplett.2007.12.055; Christiansen O, 2012, PHYS CHEM CHEM PHYS, V14, P6672, DOI 10.1039/c2cp40090a; Thomas M, 2013, PHYS CHEM CHEM PHYS, V15, P6608, DOI 10.1039/c3cp44302g; Gaigeot MP, 2005, J CHEM THEORY COMPUT, V1, P772, DOI 10.1021/ct050029z; SHIRTS RB, 1982, J CHEM PHYS, V77, P5204, DOI 10.1063/1.443697; Vendrell O, 2009, ANGEW CHEM INT EDIT, V48, P352, DOI 10.1002/anie.200804646; Iftimie R, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1908950; Bowman JM, 2008, MOL PHYS, V106, P2145, DOI 10.1080/00268970802258609; GAILAR N, 1956, J CHEM PHYS, V24, P1139, DOI 10.1063/1.1742731; DRAGT AJ, 1979, J MATH PHYS, V20, P2649, DOI 10.1063/1.524029; Dupuis M., 2004, HONDO2004 BASED HOND; EZRA GS, 1987, J PHYS CHEM-US, V91, P3721, DOI 10.1021/j100298a003; FARRELLY D, 1986, J CHEM PHYS, V85, P308, DOI 10.1063/1.451657; FRIED LE, 1987, J COMPUT CHEM, V8, P397, DOI 10.1002/jcc.540080417; FRIED LE, 1987, J CHEM PHYS, V86, P6270, DOI 10.1063/1.452464; FRIED LE, 1988, COMPUT PHYS COMMUN, V51, P103, DOI 10.1016/0010-4655(88)90065-3; Frisch M. J., 2010, GAUSSIAN 09; Gaigeot MP, 2011, J PHYS CHEM B, V115, P5526, DOI 10.1021/jp111140f; Gaigeot MP, 2008, J PHYS CHEM A, V112, P13507, DOI 10.1021/jp807550j; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Gordon R.G., 1968, ADV MAGN RESON, V3, P1, DOI DOI 10.1103/PHYSREVB.75.155119; GUSTAVSO.FG, 1966, ASTRON J, V71, P670, DOI 10.1086/110172; Herzberg G., 1991, MOL SPECTRA MOL STRU; Herzberg G., 1989, MOL SPECTRA MOL STRU; JAFFE C, 1982, J CHEM PHYS, V77, P5191; Keller J. B., 1977, J CHEM PHYS, V4, P180; Makowski AJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062103; Sugny D, 2000, J CHEM PHYS, V112, P31, DOI 10.1063/1.480559; Teramoto H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017202; Teramoto H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973639; Torres-Vega G., 1990, ANN PHYS, V93, P8862; Yagi K, 2003, J CHEM PHYS, V118, P1653, DOI 10.1063/1.1531105	67	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	5					3227	3240		10.1039/c4cp04068f		14	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AZ4OW	WOS:000348203200031		
J	Atak, K; Golnak, R; Xiao, J; Pfluger, M; Brandenburg, T; Winter, B; Aziz, EF				Atak, Kaan; Golnak, Ronny; Xiao, Jie; Pflueger, Mika; Brandenburg, Tim; Winter, Bernd; Aziz, Emad F.			Co(III) protoporphyrin IX chloride in solution: spin-state and metal coordination revealed from resonant inelastic X-ray scattering and electronic structure calculations	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							APPROXIMATE COULOMB POTENTIALS; AUXILIARY BASIS-SETS; COBALT-PROTOPORPHYRIN; HEME OXYGENASE; MECHANISM; EMISSION; RN	The local electronic structure of the cobalt centre-ion of Co(III) protoporphyrin IX chloride dissolved in dimethyl sulfoxide (DMSO) liquid solution is studied by resonant inelastic X-ray scattering (RIXS) spectroscopy at the cobalt L-edge. The resulting cobalt 2p partial-fluorescence-yield (PFY) X-ray absorption (XA) spectrum, integrated from RIXS spectra, is simulated for various possible spin-states and coordination of the cobalt centre by using the newly developed density functional theory/restricted open shell single excitation configuration interaction (DFT/ROCIS) method. Comparison between experiment and calculation shows that the cobalt ion (3d(6) electronic configuration) adopts a low-spin state with all six 3d electrons paired, and the cobalt centre is either 5-coordinated by its natural ligands (one chloride ion and four nitrogen atoms), or 6-coordinated, when binding to an oxygen atom of a DMSO solvent molecule. Analysis of the measured RIXS spectra reveals weak 3d-3d electron correlation, and in addition a value of the local HOMO-LUMO gap at the Co sites is obtained.	[Atak, Kaan; Golnak, Ronny; Xiao, Jie; Pflueger, Mika; Brandenburg, Tim; Winter, Bernd; Aziz, Emad F.] Helmholtz Zentrum Berlin Mat & Energie, Inst Methods Mat Dev, D-12489 Berlin, Germany; [Atak, Kaan; Pflueger, Mika; Brandenburg, Tim; Aziz, Emad F.] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; [Aziz, Emad F.] Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Aziz, EF (reprint author), Helmholtz Zentrum Berlin Mat & Energie, Inst Methods Mat Dev, Albert Einstein Str 15, D-12489 Berlin, Germany.	emad.aziz@helmholtz-berlin.de	Xiao, Jie/E-9640-2012; Winter, Bernd/D-4657-2011; Atak, Kaan/O-9972-2015; 	Xiao, Jie/0000-0002-2320-6111; Pfluger, Mika/0000-0002-7814-8916	European Research Council [279344]; Helmholtz-Gemeinschaft [VH-NG-635]; Einstein Foundation Berlin	This work was supported by the European Research Council starting grant No. 279344 and Helmholtz-Gemeinschaft via the young investigator fund VH-NG-635. K. A. acknowledges the financial support of the Einstein Foundation Berlin for a postdoctoral scholarship.	Achkar AJ, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.081106; Gottfried JM, 2006, J AM CHEM SOC, V128, P5644, DOI 10.1021/ja0610333; Gel'mukhanov F, 1999, PHYS REP, V312, P87, DOI 10.1016/S0370-1573(99)00003-4; BROWN SB, 1969, NATURE, V223, P960, DOI 10.1038/223960a0; Roemelt M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4804607; Nordgren J, 2013, J ELECTRON SPECTROSC, V188, P3, DOI 10.1016/j.elspec.2012.11.004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; DUNLAP BI, 1979, J CHEM PHYS, V71, P3396, DOI 10.1063/1.438728; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Shubina TE, 2007, J AM CHEM SOC, V129, P9476, DOI 10.1021/ja072360t; Eichkorn K, 1997, THEOR CHEM ACC, V97, P119, DOI 10.1007/s002140050244; EICHKORN K, 1995, CHEM PHYS LETT, V240, P283, DOI 10.1016/0009-2614(95)00621-A; VAHTRAS O, 1993, CHEM PHYS LETT, V213, P514, DOI 10.1016/0009-2614(93)89151-7; Gotz MD, 2012, J PHYS CHEM LETT, V3, P1619, DOI 10.1021/jz300403n; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Atak K, 2014, J PHYS CHEM B, V118, P9938, DOI 10.1021/jp505129m; ADAMS PA, 1978, BIOINORG CHEM, V9, P479, DOI 10.1016/S0006-3061(00)80132-5; Baerends EJ, 1973, CHEM PHYS, V2, P41, DOI 10.1016/0301-0104(73)80059-X; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; COLLIER GS, 1979, BIOCHEM J, V179, P281; KOTANI M, 1969, ANN NY ACAD SCI, V158, P20, DOI 10.1111/j.1749-6632.1969.tb56212.x; Lewis D. F. V., 1996, GUIDE CYTOCHROMES ST; MAINES MD, 1977, BIOCHEMISTRY-US, V16, P419, DOI 10.1021/bi00622a012; Milgrom L. R., 1997, COLOURS LIFE INTRO C; Neese F., 2012, COMPUT MOL SCI, V2, P73, DOI DOI 10.1002/WCMS.81; Seidel R., 2011, J AM CHEM SOC, V134, P1600; SMITH A, 1993, J BIOL CHEM, V268, P7365; Song JD, 2011, INT J MOL MED, V28, P841, DOI 10.3892/ijmm.2011.736; Thurmer S, 2011, J AM CHEM SOC, V133, P12528, DOI 10.1021/ja200268b	29	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	5					3409	3414		10.1039/c4cp04703f		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AZ4OW	WOS:000348203200050		
J	Han, ZJ; Yamagiwa, K; Yabuuchi, N; Son, JY; Cui, YT; Oji, H; Kogure, A; Harada, T; Ishikawa, S; Aoki, Y; Komaba, S				Han, Zhen-Ji; Yamagiwa, Kiyofumi; Yabuuchi, Naoaki; Son, Jin-Young; Cui, Yi-Tao; Oji, Hiroshi; Kogure, Akinori; Harada, Takahiro; Ishikawa, Sumihisa; Aoki, Yasuhito; Komaba, Shinichi			Electrochemical lithiation performance and characterization of silicon-graphite composites with lithium, sodium, potassium, and ammonium polyacrylate binders	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							LI-ION BATTERIES; HIGH-CAPACITY; NEGATIVE ELECTRODES; RECHARGEABLE BATTERIES; CYCLE LIFE; ANODES; ADDITIVES; CARBONATE; CELLULOSE	Poly(acrylic acid) (PAH), which is a water soluble polycarboxylic acid, is neutralized by adding different amounts of LiOH, NaOH, KOH, and ammonia (NH4OH) aqueous solutions to fix neutralization degrees. The differently neutralized polyacid, alkali and ammonium polyacrylates are examined as polymeric binders for the preparation of Si-graphite composite electrodes as negative electrodes for Li-ion batteries. The electrode performance of the Si-graphite composite depends on the alkali chemicals and neutralization degree. It is found that 80% NaOH-neutralized polyacrylate binder (a pH value of the resultant aqueous solution is ca. 6.7) is the most efficient binder to enhance the electrochemical lithiation and de-lithiation performance of the Si-graphite composite electrode compared to that of conventional PVdF and the other binders used in this study. The optimum polyacrylate binder highly improves the dispersion of active material in the composite electrode. The binder also provides the strong adhesion, suitable porosity, and hardness for the composite electrode with 10% (m/m) binder content, resulting in better electrochemical reversibility. From these results, the factors of alkali-neutralized polyacrylate binders affecting the electrode performance of Si-graphite composite electrodes are discussed.	[Han, Zhen-Ji; Yamagiwa, Kiyofumi; Yabuuchi, Naoaki; Komaba, Shinichi] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Son, Jin-Young; Cui, Yi-Tao; Oji, Hiroshi] Japan Synchrotron Radiat Res Inst JASRI, Ind Applicat Div, Sayo Cho, Hyogo 6795198, Japan; [Kogure, Akinori] Shimadzu Techno Res INC, Hadano Shi, Kanagawa 2591304, Japan; [Harada, Takahiro; Ishikawa, Sumihisa; Aoki, Yasuhito] Toray Res Ctr Ltd, Otsu, Shiga 5208567, Japan	Komaba, S (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan.	komaba@rs.kagu.tus.ac.jp	Yabuuchi, Naoaki/F-8369-2012	Yabuuchi, Naoaki/0000-0002-9404-5693	Japan Science and Technology Agency through the Advanced Low Carbon Technology Research and Development Program (JST-ALCA)	This study was in part granted by the Japan Science and Technology Agency through the Advanced Low Carbon Technology Research and Development Program (JST-ALCA). The synchrotron radiation experiments, HAXPES, were performed at the BL46XU of SPring-8 as the Priority Research Proposal with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposals 2013B1546 and 2013A1399).	Bridel JS, 2010, CHEM MATER, V22, P1229, DOI 10.1021/cm902688w; Komaba S, 2011, ELECTROCHEMISTRY, V79, P6; Li J, 2010, ELECTROCHIM ACTA, V55, P2991, DOI 10.1016/j.electacta.2010.01.011; Li J, 2007, ELECTROCHEM SOLID ST, V10, pA17, DOI 10.1149/1.2398725; Madsen F, 1998, J CONTROL RELEASE, V50, P167, DOI 10.1016/S0168-3659(97)00138-7; Komaba S, 2012, J PHYS CHEM C, V116, P1380, DOI 10.1021/jp204817h; Buqa H, 2006, J POWER SOURCES, V161, P617, DOI 10.1016/j.jpowsour.2006.03.073; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Han ZJ, 2012, ENERG ENVIRON SCI, V5, P9014, DOI 10.1039/c2ee22292b; Komaba S, 2007, J ELECTROCHEM SOC, V154, pA322, DOI 10.1149/1.2472552; Chen LB, 2006, J APPL ELECTROCHEM, V36, P1099, DOI 10.1007/s10800-006-9191-2; Komaba S, 2010, J POWER SOURCES, V195, P6069, DOI 10.1016/j.jpowsour.2009.12.058; Komaba S, 2011, J PHYS CHEM C, V115, P13487, DOI 10.1021/jp201691g; Komaba S, 2003, ELECTROCHEM COMMUN, V5, P962, DOI 10.1016/j.elecom.2003.09.003; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]; Komaba S, 2008, CARBON, V46, P1184, DOI 10.1016/j.carbon.2008.04.021; Mazouzi D, 2009, ELECTROCHEM SOLID ST, V12, pA215, DOI 10.1149/1.3212894; Liu WR, 2005, ELECTROCHEM SOLID ST, V8, pA100, DOI 10.1149/1.1847685; Murase M, 2012, CHEMSUSCHEM, V5, P2307, DOI 10.1002/cssc.201200650; Beattie SD, 2008, J ELECTROCHEM SOC, V155, pA158, DOI 10.1149/1.2817828; Han ZJ, 2013, ECS ELECTROCHEM LETT, V2, pA17, DOI 10.1149/2.005302eel; Komaba S, 2009, ELECTROCHEM SOLID ST, V12, pA107, DOI 10.1149/1.3086262; Obrovac MN, 2007, J ELECTROCHEM SOC, V154, pA849, DOI 10.1149/1.2752985; Bridel JS, 2011, J ELECTROCHEM SOC, V158, pA750, DOI 10.1149/1.3581024; Komaba S, 2010, J ELECTROCHEM SOC, V157, pA1375, DOI 10.1149/1.3497306; Hochgatterer NS, 2008, ELECTROCHEM SOLID ST, V11, pA76, DOI 10.1149/1.2888173; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Li H, 1999, ELECTROCHEM SOLID ST, V2, P547, DOI 10.1149/1.1390899; Groult H, 2003, J ELECTROCHEM SOC, V150, pG67, DOI 10.1149/1.1531490; Hatchard TD, 2004, J ELECTROCHEM SOC, V151, pA838, DOI 10.1149/1.1739217; Komaba S, 2005, J POWER SOURCES, V146, P166, DOI 10.1016/j.jpowsour.2005.03.121; Komaba S, 2003, J POWER SOURCES, V119, P378, DOI 10.1016/S0378-7753(03)00224-6; Li CC, 2006, J ELECTROCHEM SOC, V153, pA809, DOI 10.1149/1.2177071; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421	35	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	5					3783	3795		10.1039/c4cp04939j		13	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AZ4OW	WOS:000348203200092		
J	Tsuboi, H; Hirai, Y; Maezawa, H; Notani, K; Inoue, N; Funahashi, M				Tsuboi, Hisanori; Hirai, Yoshiyuki; Maezawa, Hitoshi; Notani, Kenji; Inoue, Nobuo; Funahashi, Makoto			Effects of treadmill exercise on the LiCl-induced conditioned taste aversion in rats	PHYSIOLOGY & BEHAVIOR			English	Article						Forced exercise; Conditioned taste aversion; Memory	CEREBRAL-BLOOD-FLOW; NEUROTROPHIC FACTOR; HIPPOCAMPAL PLASTICITY; SPONTANEOUS-RECOVERY; FORCED EXERCISE; MILD EXERCISE; BRAIN; MEMORY; EXTINCTION; BDNF	Studies have shown that exercise can enhance learning and memory. Conditioned taste aversion (CTA) is an avoidance behavior induced by associative memory of the taste sensation for something pleasant or neutral with a negative visceral reaction caused by the coincident action of a toxic substance that is tasteless or administered systemically. We sought to measure the effects of treadmill exercise on CTA in rats by investigating the effects of exercise on acquisition, extinction and spontaneous recovery of CTA. We made two groups of rats: an exercise group that ran on a treadmill, and a control group that did not have structured exercise periods. To condition rats to disfavor a sweet taste, consumption of a 0.1% saccharin solution in place of drinking water was paired with 0.15 M LiCl (2% body weight, i.p.) to induce visceral discomfort. We measured changes of saccharin consumption during acquisition and extinction of CIA The exercise and no-exercise groups both acquired CTA to similar levels and showed maximum extinction of CTA around 6 days after acquisition. This result indicates that exercise affects neither acquisition nor extinction of CTA. However, in testing for preservation of CTA after much longer extinction periods that included exercise or not during the intervening period, exercising animals showed a significantly lower saccharin intake, irrespective of having exercised or not during the conditioning phase of the trial. This result suggests that exercise may help to preserve aversive memory (taste aversion in this example) as evidence by the significant spontaneous recovery of aversion in exercising animals. (C) 2014 Elsevier Inc. All rights reserved.	[Tsuboi, Hisanori; Notani, Kenji; Inoue, Nobuo] Hokkaido Univ, Grad Sch Dent Med, Div Oral Hlth Sci, Dept Gerodontol,Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Tsuboi, Hisanori; Hirai, Yoshiyuki; Maezawa, Hitoshi; Funahashi, Makoto] Hokkaido Univ, Grad Sch Dent Med, Div Oral Funct Sci, Dept Oral Physiol,Kita Ku, Sapporo, Hokkaido 0608586, Japan	Funahashi, M (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Physiol, Kita Ku, Kita 13,Nishi 7, Sapporo, Hokkaido 0608586, Japan.	tsubodon@den.hokudai.ac.jp; hirai@den.hokudai.ac.jp; maezawa@den.hokudai.ac.jp; kjnotani@den.hokudai.ac.jp; nobu@den.hokudai.ac.jp; mfuna@den.hokudai.ac.jp			Ministry of Education, Science and Culture of Japan [25462883]; Akiyama Life Science Foundation	This study is supported by the Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Science and Culture of Japan (25462883), and the Akiyama Life Science Foundation.	Adlard PA, 2004, NEUROSCI LETT, V363, P43, DOI 10.1016/j.neulet.2004.03.058; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; YAMAMOTO T, 1995, NEUROSCI RES, V22, P31, DOI 10.1016/0168-0102(95)00875-T; Albeck DS, 2006, BEHAV BRAIN RES, V168, P345, DOI 10.1016/j.bbr.2005.11.008; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; Itou Y, 2011, HIPPOCAMPUS, V21, P446, DOI 10.1002/hipo.20761; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Hasegawa Y, 2007, J DENT RES, V86, P64; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Masaki T, 2006, PHYSIOL BEHAV, V88, P411, DOI 10.1016/j.physbeh.2006.04.013; Okamoto M, 2012, P NATL ACAD SCI USA, V109, P13100, DOI 10.1073/pnas.1210023109; Momose T, 1997, ARCH ORAL BIOL, V42, P57, DOI 10.1016/S0003-9969(96)00081-7; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Miyake S, 2012, BRAIN RES, V1446, P34, DOI 10.1016/j.brainres.2012.01.011; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Forristall JR, 2007, BEHAV PROCESS, V74, P326, DOI 10.1016/j.beproc.2006.12.002; Fujiwara H, 2012, COGN NEURODYNAMICS, V6, P399, DOI 10.1007/s11571-012-9208-y; Inui T, 2009, EUR J NEUROSCI, V30, P110, DOI 10.1111/j.1460-9568.2009.06800.x; Kennard JA, 2012, PHYSIOL BEHAV, V106, P423, DOI 10.1016/j.physbeh.2012.02.023; KIMBLE DP, 1979, PHYSIOL BEHAV, V23, P217, DOI 10.1016/0031-9384(79)90357-3; Lett BT, 1996, PHYSIOL BEHAV, V59, P699, DOI 10.1016/0031-9384(95)02139-6; Mickley GA, 2004, BRAIN RES, V1016, P79, DOI 10.1016/j.brainres.2004.04.071; Mickley GA, 2013, BRAIN RES, V1493, P27, DOI 10.1016/j.brainres.2012.11.029; Mickley GA, 2012, PHYSIOL BEHAV, V105, P417; Nakajima S, 2006, PHYSIOL BEHAV, V88, P1, DOI 10.1016/j.physbeh.2006.02.006; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; Takata Y, 2009, J ORAL REHABIL, V36, P808, DOI 10.1111/j.1365-2842.2009.01998.x; Yasoshima Y, 2006, NEUROSCIENCE, V141, P35, DOI 10.1016/j.neuroscience.2006.03.019; Yasoshima Y, 2005, BEHAV NEUROSCI, V119, P1290, DOI 10.1037/0735-7044.119.5.1290	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN	2015	138						1	5		10.1016/j.physbeh.2014.10.015		5	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CA4OA	WOS:000348882900001		
J	Yasoshima, Y; Shimura, T				Yasoshima, Yasunobu; Shimura, Tsuyoshi			A mouse model for binge-like sucrose overconsumption: Contribution of enhanced motivation for sweetener consumption	PHYSIOLOGY & BEHAVIOR			English	Article						Binge-like consumption; Sweetness; Taste reward; Calorie; Hedonic motivation	FOOD-DEPRIVATION; ANIMAL-MODEL; EATING-DISORDER; PALATABLE FOOD; ACCUMBENS DOPAMINE; NUCLEUS-ACCUMBENS; ARCUATE NUCLEUS; BODY-WEIGHT; RATS; SUGAR	Behavioral and neural features of binge-like sugar overconsumption have been studied using rat models. However, few mouse models are available to examine the interaction between neural and genetic underpinnings of bingeing. In the present study, we first aim to establish a simple mouse model of binge-like sucrose overconsumption using daytime limited access training in food-restricted male mice. Trained mice received 4-h limited access to both 0.5 M sucrose solution and chow for 10 days. Three control groups received (1) 4-h sucrose and 20-h chow access, (2) 20-h sucrose and 4-h, or (3) 20-h chow access, respectively. Only the trained group showed progressively increased sucrose consumption during brief periods of time and developed binge-like excessive behavior. Next, we examined whether the present mouse model mimicked a human feature of binge eating known as "eating when not physically hungry." Trained mice consumed significantly more sucrose or non-caloric sweetener (saccharin) during post-training days even after they nocturnally consumed substantial chow prior to daytime sweetener access. In other trained groups, both a systemic administration of glucose and substantial chow consumption prior to the daytime limited sucrose access failed to reduce binge-like sucrose overconsumption. Our results suggest that even when caloric consumption is not necessarily required, limited access training shapes and triggers binge-like overconsumption of sweetened solution in trained mice. The binge-like behavior in trained mice may be mainly due to enhanced hedonic motivation for the sweetener's taste. The present study suggests that our mouse model for binge-like sugar overconsumption may mimic some human features of binge eating and can be used to investigate the roles of neural and genetic mechanisms in binge-like overconsumption of sweetened substances in the absence of physical hunger. (C) 2014 Elsevier Inc. All rights reserved.	[Yasoshima, Yasunobu; Shimura, Tsuyoshi] Osaka Univ, Grad Sch Human Sci, Dept Behav Sci, Div Behav Physiol, Suita, Osaka 5650871, Japan	Yasoshima, Y (reprint author), Osaka Univ, Grad Sch Human Sci, Dept Behav Sci, Div Behav Physiol, 1-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yasosima@hus.osaka-u.ac.jp			Mishima Kaiun Memorial Foundation; Asahi Beer Foundation; JSPS KAKENHI [24614006]	This study is supported by grants from Mishima Kaiun Memorial Foundation, Asahi Beer Foundation and Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 24614006) (Y.Y.). We thank Ms. Megumi Tanibuchi, Erina Yamagichi and Haruna Nishioka for their technical assistance.	Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; CARROLL ME, 1985, DRUG ALCOHOL DEPEN, V16, P95, DOI 10.1016/0376-8716(85)90109-7; Wojnicki FHE, 2007, PHYSIOL BEHAV, V92, P566, DOI 10.1016/j.physbeh.2007.05.002; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Hagan MM, 2002, PHYSIOL BEHAV, V77, P45, DOI 10.1016/S0031-9384(02)00809-0; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Yamamoto T, 1997, NEUROSCI LETT, V226, P127, DOI 10.1016/S0304-3940(97)00265-6; Brownley KA, 2007, INT J EAT DISORDER, V40, P337, DOI 10.1002/eat.20370; Boggiano MM, 2007, INT J OBESITY, V31, P1357, DOI 10.1038/sj.ijo.0803614; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Hoebel BG, 2009, J ADDICT MED, V3, P33, DOI 10.1097/ADM.0b013e31819aa621; WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286; Waters A, 2001, INT J EAT DISORDER, V29, P17, DOI 10.1002/1098-108X(200101)29:1<17::AID-EAT3>3.0.CO;2-R; Avena NM, 2006, NEUROSCIENCE, V139, P813, DOI 10.1016/j.neuroscience.2005.12.037; Carr KD, 1996, NEUROCHEM RES, V21, P1455, DOI 10.1007/BF02532386; Sturm R, 2008, PUBLIC HEALTH, V122, P739, DOI 10.1016/j.puhe.2008.01.004; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Halpern CH, 2013, J NEUROSCI, V33, P7122, DOI 10.1523/JNEUROSCI.3237-12.2013; Ahmed SH, 2013, CURR OPIN CLIN NUTR, V16, P434, DOI 10.1097/MCO.0b013e328361c8b8; Inoue K, 1998, BIOL PSYCHIAT, V44, P1329, DOI 10.1016/S0006-3223(97)00518-0; Bello NT, 2003, AM J PHYSIOL-REG I, V284, pR1260, DOI 10.1152/ajpregu.00716.2002; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Bake T, 2013, J NEUROENDOCRINOL, V25, P357, DOI 10.1111/jne.12008; Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Inui-Yamamoto C, 2009, PHYSIOL BEHAV, V96, P717, DOI 10.1016/j.physbeh.2009.01.013; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Furudono Y, 2006, BEHAV BRAIN RES, V175, P241, DOI 10.1016/j.bbr.2006.08.031; Avena NM, 2012, METHODS MOL BIOL, V829, P351, DOI 10.1007/978-1-61779-458-2_23; Hagan MM, 2003, INT J EAT DISORDER, V34, P183, DOI 10.1002/eat.10168; Yeomans MR, 2004, BRIT J NUTR, V92, pS3, DOI 10.1079/BJN20041134; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Corwin RL, 2004, PHYSIOL BEHAV, V82, P123, DOI 10.1016/j.physbeh.2004.04.036; Czyzyk TA, 2010, OBESITY, V18, P1710, DOI 10.1038/oby.2010.46; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Holland PC, 2002, PHYSIOL BEHAV, V76, P117, DOI 10.1016/S0031-9384(02)00688-1; Mathes WF, 2009, APPETITE, V52, P545, DOI 10.1016/j.appet.2009.03.005; Houchins JA, 2012, OBESITY, V20, P1844, DOI 10.1038/oby.2011.192; Arbel DM, 2009, OBESITY, V17, P2100; Avena NM, 2006, CURR PROTOC NEUROSCI; Becskei C, 2008, NEUROREPORT, V19, P105, DOI 10.1097/WNR.0b013e3282f380a2; Bulik CM, 2003, INT J EAT DISORDER, V34, pS39, DOI 10.1002/eat.10204; Campfield LA, 2003, PHYSIOL REV, V83, P25; Consoli D, 2009, INT J EAT DISORDER, V42, P402, DOI 10.1002/eat.20637; Corwin RL, 1998, PHYSIOL BEHAV, V65, P1; de Zwaan M, 2001, INT J OBESITY, V25, pS51; KUTSCHER CL, 1971, PHYSIOL BEHAV, V7, P395, DOI 10.1016/0031-9384(71)90320-9; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; MCKINNEY WT, 1974, PERSPECT BIOL MED, V17, P529; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mitra A, 2011, NEUROSCIENCE, V192, P459, DOI 10.1016/j.neuroscience.2011.06.033; MOOK DG, 1986, PHYSIOL BEHAV, V36, P887, DOI 10.1016/0031-9384(86)90448-8; Nasser JA, 2008, OBESITY, V16, P1816, DOI 10.1038/oby.2008.281; Odum AL, 1998, J EXP ANAL BEHAV, V69, P295, DOI 10.1901/jeab.1998.69-295; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; PALFAI T, 1971, PHYSIOL BEHAV, V6, P461, DOI 10.1016/0031-9384(71)90184-3; PANKSEPP J, 1975, PHYSIOL BEHAV, V15, P673, DOI 10.1016/0031-9384(75)90118-3; Peng XX, 2011, SYNAPSE, V65, P1024, DOI 10.1002/syn.20931; PINEL JPJ, 1976, PHYSIOL BEHAV, V16, P693, DOI 10.1016/0031-9384(76)90238-9; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P155, DOI 10.1016/S0149-7634(87)80020-9; SMITH GP, 1989, ANN NY ACAD SCI, V575, P63; Tanofsky-Kraff M, 2004, OBES RES, V12, P1361, DOI 10.1038/oby.2004.171; Ulrich-Lai YM, 2011, PHYSIOL BEHAV, V103, P104, DOI 10.1016/j.physbeh.2010.12.011; Ventura T, 2014, NUTRITION, V30, P252, DOI 10.1016/j.nut.2013.06.010	68	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN	2015	138						154	164		10.1016/j.physbeh.2014.10.035		11	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CA4OA	WOS:000348882900022		
J	Sakamoto, K; Matsumura, S; Okafuji, Y; Eguchi, A; Yoneda, T; Mizushige, T; Tsuzuki, S; Inoue, K; Fushiki, T				Sakamoto, Kazuhiro; Matsumura, Shigenobu; Okafuji, Yoko; Eguchi, Ai; Yoneda, Takeshi; Mizushige, Takafumi; Tsuzuki, Satoshi; Inoue, Kazuo; Fushiki, Tohru			The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance	PHYSIOLOGY & BEHAVIOR			English	Article						Dietary fat; Opioid; Naltrexone; Food preference	NUCLEUS-ACCUMBENS; CORN-OIL; BETA-ENDORPHIN; RECEPTOR STIMULATION; RATS; PREFERENCE; REWARD; MICE; SUCROSE; FOOD	The opioid system plays an important role in ingestive behavior, especially with regard to palatable high-fat or sweetened foods. In the present study, we investigated the role of the opioid system in the regulation of ingestive behavior in mice with regard to dietary fat intake, reinforcement, and particularly the processes involved in development of these behavior types. Subcutaneous administration of the non-selective opioid receptor antagonist naltrexone (0.5 or 2.0 mg/kg body weight [BW]) reduced the spontaneous intake of fat emulsion (Intralipid). We investigated the effect of naltrexone on reinforcement by using an operant behavioral paradigm under a progressive ratio schedule in which the number of lever presses required to obtain a test sample increased progressively. Mice showed stronger reinforcement by Intralipid as a function of concentration. However, naltrexone (0.5 or 2.0 mg/kg BW) did not affect reinforcement at any concentration of Intralipid in mice that had repeatedly ingested Intralipid before testing was carried out. Intralipid ingestion also induced conditioned place preference ( CPP), which is another evaluation index of reinforcement. High-dose naltrexone (2.0 mg/kg BW) administration during CPP conditioning suppressed the reinforcement induced by Intralipid ingestion, although the drug administration (0.5 or 2.0 mg/kg BW) during CPP testing did not affect reinforced behavior. These results suggest that the amount of fat ingestion and reinforcement for fat ingestion are separately regulated by the opioid system. Furthermore, our results indicate that the opioid system plays an important role in acquiring reinforcement for fat but is not required for maintenance of learned reinforcement. (C) 2014 Elsevier Inc. All rights reserved.	[Sakamoto, Kazuhiro; Matsumura, Shigenobu; Okafuji, Yoko; Eguchi, Ai; Yoneda, Takeshi; Mizushige, Takafumi; Tsuzuki, Satoshi; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab,Sakyo Ku, Kyoto 6068502, Japan	Sakamoto, K (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Nutr Chem Lab,Sakyo Ku, Oiwakecho, Kyoto 6068502, Japan.	rohizuka@kais.kyoto-u.ac.jp		Sakamoto, Kazuhiro/0000-0002-5166-9068	JSPS KAKENHI [25292071, 24688014]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This study was supported by the JSPS KAKENHI Grant Numbers 25292071, and 24688014, and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	ACKROFF K, 1990, APPETITE, V15, P171, DOI 10.1016/0195-6663(90)90018-4; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Katsuura Y, 2011, AM J PHYSIOL-REG I, V301, pR244, DOI 10.1152/ajpregu.00406.2010; Yoneda T, 2007, LIFE SCI, V81, P1585, DOI 10.1016/j.lfs.2007.09.020; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Glass MJ, 1996, AM J PHYSIOL-REG I, V271, pR217; Zheng HY, 2010, BRAIN RES, V1350, P131, DOI 10.1016/j.brainres.2010.03.061; Naleid AM, 2007, AM J PHYSIOL-REG I, V293, pR99, DOI 10.1152/ajpregu.00675.2006; Mizushige T, 2009, LIFE SCI, V84, P760, DOI 10.1016/j.lfs.2009.03.003; Ciccocioppo R, 2002, NEUROPSYCHOPHARMACOL, V27, P391, DOI 10.1016/S0893-133X(02)00302-0; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Matsumura S, 2012, FEBS LETT, V586, P1231, DOI 10.1016/j.febslet.2012.03.028; Lucas F, 1998, AM J PHYSIOL-REG I, V275, pR1511; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Shin AC, 2010, NEUROSCIENCE, V170, P580, DOI 10.1016/j.neuroscience.2010.07.017; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Liang NC, 2006, AM J PHYSIOL-REG I, V291, pR1236, DOI 10.1152/ajpregu.00226.2006; Yu WZ, 1999, PHARMACOL BIOCHEM BE, V64, P573, DOI 10.1016/S0091-3057(99)00124-0; Zhang M, 1997, PSYCHOPHARMACOLOGY, V132, P350, DOI 10.1007/s002130050355; Mizushige T, 2006, BIOMED RES-TOKYO, V27, P227, DOI 10.2220/biomedres.27.227; Chow BLC, 1997, BEHAV PHARMACOL, V8, P725, DOI 10.1097/00008877-199712000-00008; David V, 2002, PSYCHOPHARMACOLOGY, V160, P307, DOI 10.1007/s00213-001-0981-2; Delamater AR, 2000, PHARMACOL BIOCHEM BE, V65, P697, DOI 10.1016/S0091-3057(99)00251-8; Fukuwatari T, 2003, PHYSIOL BEHAV, V78, P579, DOI 10.1016/S0031-9384(03)00037-4; Glass MJ, 2001, AM J PHYSIOL-REG I, V281, pR1605; Gosnell BA, 2009, INT J OBESITY, V33, pS54, DOI 10.1038/ijo.2009.73; Hayward MD, 2002, J NEUROSCI, V22, P8251; Hayward MD, 2001, BRAIN RES BULL, V56, P537, DOI 10.1016/S0361-9230(01)00626-8; Hayward MD, 2006, PHARMACOL BIOCHEM BE, V85, P601, DOI 10.1016/j.pbb.2006.10.015; Hillemacher T, 2011, EXPERT OPIN INV DRUG, V20, P1073, DOI 10.1517/13543784.2011.592139; Imaizumi M, 2001, BEHAV BRAIN RES, V121, P129, DOI 10.1016/S0166-4328(00)00388-0; Imaizumi M, 2000, BRAIN RES, V870, P150, DOI 10.1016/S0006-8993(00)02416-1; Lenard NR, 2010, INT J OBES LOND, V34, P001; MARKSKAUFMAN R, 1982, PHARMACOL BIOCHEM BE, V16, P949, DOI 10.1016/0091-3057(82)90051-X; Matsumura S, 2009, NEUROSCI LETT, V450, P186; Mizushige T, 2006, BIOMED RES-TOKYO, V27, P259, DOI 10.2220/biomedres.27.259; Shader RI, 2003, J CLIN PSYCHOPHARM, V23, P321, DOI 10.1097/01.jcp.0000087502.38434.6c; Takeda M, 2001, NUTRITION, V17, P117, DOI 10.1016/S0899-9007(00)00513-X; Takeda M, 2000, LIFE SCI, V67, P197, DOI 10.1016/S0024-3205(00)00614-7; Carelli RM, 2014, NEUROPHARMACOLOGY, V76, P360, DOI 10.1016/j.neuropharm.2013.04.025; Yamamoto T, 2003, NUTR REV, V61, pS5, DOI 10.1301/nr.2003.may.S5-S9; Yamamoto T, 2000, PHYSIOL BEHAV, V69, P345, DOI 10.1016/S0031-9384(99)00252-8	43	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN	2015	138						227	235		10.1016/j.physbeh.2014.11.001		9	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CA4OA	WOS:000348882900031		
J	Sun, P; Zhang, Q; Zhang, Y; Wang, F; Wang, L; Yamamoto, R; Sugai, T; Kato, N				Sun, P.; Zhang, Q.; Zhang, Y.; Wang, F.; Wang, L.; Yamamoto, R.; Sugai, T.; Kato, N.			Fear conditioning suppresses large-conductance calcium-activated potassium channels in lateral amygdala neurons	PHYSIOLOGY & BEHAVIOR			English	Article						Fear conditioning; Amygdala; Calcium-activated potassium channel; Excitability	EXCITATORY SYNAPTIC-TRANSMISSION; HIPPOCAMPAL PYRAMIDAL NEURONS; CA2+-ACTIVATED K+ CHANNELS; TEMPORAL-LOBE EPILEPSY; BK CHANNEL; CELL EXCITABILITY; EXPRESSION; PLASTICITY; DEPOLARIZATION; MICE	It was previously shown that depression-like behavior is accompanied with suppression of the large-conductance calcium activated potassium (BK) channel in cingulate cortex pyramidal cells. To test whether BK channels are also involved in fear conditioning, we studied neuronal properties of amygdala principal cells in fear conditioned mice. After behavior, we made brain slices containing the amygdala, the structure critically relevant to fear memory. The resting membrane potential in lateral amygdala (LA) neurons obtained from fear conditioned mice (FC group) was more depolarized than in neurons from naive controls. The frequencies of spikes evoked by current injections were higher in neurons from FC mice, demonstrating that excitability of LA neurons was elevated by fear conditioning. The depolarization in neurons from FC mice was shown to depend on BK channels by using the BK channel blocker charybdotoxin. Suppression of BK channels in LA neurons from the FC group was further confirmed on the basis of the spike width, since BK channels affect the descending phase of spikes. Spikes were broader in the FC group than those in the naive control in a manner dependent on BK channels. Consistently, quantitative real-time PCR revealed a decreased expression of BK channel mRNA. The present findings suggest that emotional disorder manifested in the forms of fear conditioning is accompanied with BK channel suppression in the amygdala, the brain structure critical to this emotional disorder. (C) 2014 Elsevier Inc. All rights reserved.	[Sun, P.; Zhang, Q.; Zhang, Y.; Wang, F.; Wang, L.; Yamamoto, R.; Sugai, T.; Kato, N.] Kanazawa Med Univ, Dept Physiol, Uchinada, Ishikawa 9200293, Japan; [Sun, P.; Zhang, Q.; Wang, F.] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Zhang, Y.] Qinghai Univ, Coll Med, Xining, Peoples R China; [Wang, L.] China Japan Friendship Hosp, Beijing, Peoples R China	Kato, N (reprint author), Kanazawa Med Univ, Dept Physiol, Uchinada, Ishikawa 9200293, Japan.	kato@kanazawa-med.ac.jp			Kanazawa Medical University [H14-16]; Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan; Naito Foundation; General Insurance Association of Japan; Casio Science Promotion Foundation; Japan Society for the Promotion of Science [25870854]	We express our gratitude to Mr. H. Adachi, Mr. S. Muramoto, and Ms. K. Yamada for their assistance. This work was supported by Grants for High-Tech Research (H14-16) from Kanazawa Medical University, grants from the Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan, the Naito Foundation, the General Insurance Association of Japan and Casio Science Promotion Foundation, and a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (25870854).	Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Hu H, 2001, J NEUROSCI, V21, P9585; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Sakagami Y, 2005, EUR J NEUROSCI, V21, P3229, DOI 10.1111/j.1460-9568.2005.04165.x; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Kato N, 2009, NEUROSCI RES, V64, P3, DOI 10.1016/j.neures.2009.01.014; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lu R, 2006, J PHYSIOL-LONDON, V570, P65; Yamamoto R, 2014, NEUROPHARMACOLOGY, V82, P49, DOI 10.1016/j.neuropharm.2014.03.007; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Yamamoto K, 2011, J NEUROSCI, V31, P11100, DOI 10.1523/JNEUROSCI.6752-10.2011; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Higgins JJ, 2008, NEUROGENETICS, V9, P219, DOI 10.1007/s10048-008-0128-2; Sun P, 2011, J NEUROSCI, V31, P16464, DOI 10.1523/JNEUROSCI.1542-11.2011; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Cohen AS, 1999, J NEUROPHYSIOL, V82, P3139; Ermolinsky BS, 2011, NEUROSCI RES, V69, P73, DOI 10.1016/j.neures.2010.09.011; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714; Franklin K. B. J., 2007, MOUSE BRAIN STEREOTA; Hill KG, 2003, PSYCHOPHARMACOLOGY, V169, P108, DOI 10.1007/s00213-003-1472-4; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Sah P, 1996, J NEUROSCI, V16, P4537; Velazquez-Marrero C, 2011, J NEUROSCI, V31, P2436, DOI 10.1523/JNEUROSCI.5429-10.2011; Yamamoto R, 2007, J NEUROPHYSIOL, V98, P984, DOI 10.1152/jn.00204.2007; Yamamoto R, 2012, NEUROSCIENCE, V220, P119, DOI 10.1016/j.neuroscience.2012.06.008	38	3	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN	2015	138						279	284		10.1016/j.physbeh.2014.10.005		6	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CA4OA	WOS:000348882900039		
J	Okamoto, Y; Nakagawa, S				Okamoto, Yosuke; Nakagawa, Seiji			Effects of daytime light exposure on cognitive brain activity as measured by the ERP P300	PHYSIOLOGY & BEHAVIOR			English	Article						Monochromatic light; Daytime exposure; Cognition; Oddball task; Event-related potential (ERP)	BRIGHT-LIGHT; WAVELENGTH LIGHT; ACTION SPECTRUM; DUAL-TASK; PERFORMANCE; ALERTNESS; SLEEPINESS; MELATONIN; RESPONSES; HUMANS	Exposure to light modulates not only human alertness but also cognitive functions. The present study examined the temporal dynamics of the effects of light exposure on cortical activity related to cognitive processes. Event-related potentials (ERPs) were measured while participants performed an auditory oddball task during exposure to short-, medium- or long-wavelength light or darkness. Experiments were conducted in the daytime. After a 10-min period of darkness, one of the three lights was presented for 28 min. In the control condition, darkness was maintained for the entire session. The ERP component observed approximately 300 ms after the onset of the target stimulus (P300) was analyzed. The amplitude of P300 was larger after 5-20 min of exposure to short-wavelength light than at equivalent time points in the darkness. No differences were observed in the amplitude of P300 between the medium- or long-wavelength light condition and darkness at any time point. These results suggest that the amount of attentional resource allocated to the oddball task was increased by daytime exposure to short-wavelength light, and that following approximately 5 min of exposure the impact of light on cortical activity related to cognitive processes was able to be detected. (C) 2014 Elsevier Inc All rights reserved.	[Okamoto, Yosuke; Nakagawa, Seiji] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan	Okamoto, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	yos-okamoto@aist.go.jp			JSPS KAKENHI [23860073]	This work was supported by JSPS KAKENHI Grant Number 23860073.	CAMPBELL SS, 1990, PHYSIOL BEHAV, V48, P317, DOI 10.1016/0031-9384(90)90320-4; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Lockley SW, 2006, SLEEP, V29, P161; Sahin L, 2013, PHYSIOL BEHAV, V116, P1, DOI 10.1016/j.physbeh.2013.03.014; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Ruger M, 2006, AM J PHYSIOL-REG I, V290, pR1413, DOI 10.1152/ajpregu.00121.2005; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; THESSING VC, 1994, SLEEP, V17, P140; Chellappa SL, 2013, J SLEEP RES, V22, P573, DOI 10.1111/jsr.12050; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Figueiro MG, 2007, ACTA NEUROBIOL EXP, V67, P171; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Daurat A, 2000, BIOL SIGNAL RECEPT, V9, P309; Phipps-Nelson J, 2003, SLEEP, V26, P695; Brainard GC, 2001, J NEUROSCI, V21, P6405; An Ming, 2009, Journal of Physiological Anthropology, V28, P217, DOI 10.2114/jpa2.28.217; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Cajochen C, 1998, J SLEEP RES, V7, P145, DOI 10.1046/j.1365-2869.1998.00106.x; Figueiro MG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-105; Kahneman D., 1973, ATTENTION EFFORT; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; KRAMER AF, 1983, HUM FACTORS, V25, P597; Lowden A, 2004, J SLEEP RES, V13, P37; Okamoto Yosuke, 2014, BMC Res Notes, V7, P113, DOI 10.1186/1756-0500-7-113; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Vandewalle G, 2013, J COGNITIVE NEUROSCI, V25, P2027; Vandewalle G., 2007, PLOS ONE, V11, P1; Vandewalle G, 2013, NEUROIMAGING OF SLEEP AND SLEEP DISORDERS, P171	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JAN	2015	138						313	318		10.1016/j.physbeh.2014.10.013		6	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CA4OA	WOS:000348882900044		
J	Yoshino, M; Tsutsumi, K; Kanazawa, A				Yoshino, M.; Tsutsumi, K.; Kanazawa, A.			Profiles of embryonic nuclear protein binding to the proximal promoter region of the soybean beta-conglycinin alpha subunit gene	PLANT BIOLOGY			English	Article						DNA-protein interaction; electrophoretic mobility shift assay; embryogenesis; proximal promoter region; seed storage protein; beta-conglycinin	PHASEOLIN PROMOTER; FACTORS INTERACT; MAJOR PROTEINS; RY SEQUENCE; TRANSCRIPTION; SEED; EMBRYOGENESIS; EXPRESSION; ELEMENTS; ENHANCER	beta-Conglycinin, a major component of seed storage protein in soybean, comprises three subunits: , and . The expression of genes for these subunits is strictly controlled during embryogenesis. The proximal promoter region up to 245bp upstream of the transcription start site of the subunit gene sufficiently confers spatial and temporal control of transcription in embryos. Here, the binding profile of nuclear proteins in the proximal promoter region of the subunit gene was analysed. DNase I footprinting analysis indicated binding of proteins to the RY element and DNA regions including box I, a region conserved in cognate gene promoters. An electrophoretic mobility shift assay (EMSA) using different portions of box I as a probe revealed that multiple portions of box I bind to nuclear proteins. In addition, an EMSA using nuclear proteins extracted from embryos at different developmental stages indicated that the levels of major DNA-protein complexes on box I increased during embryo maturation. These results are consistent with the notion that box I is important for the transcriptional control of seed storage protein genes. Furthermore, the present data suggest that nuclear proteins bind to novel motifs in box I including 5-TCAATT-3 rather than to predicted cis-regulatory elements.	[Yoshino, M.; Kanazawa, A.] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Tsutsumi, K.] Iwate Univ, Cryobiosyst Res Ctr, Fac Agr, Ueda, Nagano, Japan	Kanazawa, A (reprint author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	kanazawa@res.agr.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Fuji Foundation for Protein Research	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from Fuji Foundation for Protein Research.	HARADA JJ, 1989, PLANT CELL, V1, P415, DOI 10.1105/tpc.1.4.415; Yoshino M, 2006, GENES GENET SYST, V81, P135, DOI 10.1266/ggs.81.135; Li C, 2011, HEREDITY, V106, P633, DOI 10.1038/hdy.2010.97; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Chern MS, 1996, PLANT J, V10, P135, DOI 10.1046/j.1365-313X.1996.10010135.x; LESSARD PA, 1991, PLANT MOL BIOL, V16, P397, DOI 10.1007/BF00023991; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; HIGGINS TJV, 1984, ANNU REV PLANT PHYS, V35, P191; ALLEN RD, 1989, PLANT CELL, V1, P623; Chandrasekharan MB, 2003, PLANT J, V33, P853, DOI 10.1046/j.1365-313X.2003.01678.x; Chern MS, 1996, PLANT CELL, V8, P305; DICKINSON CD, 1988, NUCLEIC ACIDS RES, V16, P371, DOI 10.1093/nar/16.1.371; Fauteux F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-126; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; HIGGINS TJV, 1988, PLANT MOL BIOL, V11, P683, DOI 10.1007/BF00017468; Imoto Y, 2008, GENES GENET SYST, V83, P469, DOI 10.1266/ggs.83.469; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Sakata Y, 1997, PLANT MOL BIOL, V34, P191, DOI 10.1023/A:1005841125832; Sundaram S, 2013, PLANT CELL, V25, P2601, DOI 10.1105/tpc.113.112714; THANH VH, 1978, J AGR FOOD CHEM, V26, P692, DOI 10.1021/jf60217a026; THANH VH, 1976, BIOCHIM BIOPHYS ACTA, V439, P326, DOI 10.1016/0005-2795(76)90068-4; Yoshino M, 2001, GENES GENET SYST, V76, P99, DOI 10.1266/ggs.76.99; Yoshino M, 2002, BREEDING SCI, V52, P285, DOI 10.1270/jsbbs.52.285	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	JAN	2015	17	1					147	152		10.1111/plb.12218		6	Plant Sciences	Plant Sciences	AY6YF	WOS:000347707900017		
J	Ishizuka, W; Ono, K; Hara, T; Goto, S				Ishizuka, W.; Ono, K.; Hara, T.; Goto, S.			Use of intraspecific variation in thermal responses for estimating an elevational cline in the timing of cold hardening in a sub-boreal conifer	PLANT BIOLOGY			English	Article						Abies sachalinensis; adaptation; cold acclimation; cold hardening; intraspecific variation; modelling; phenology	DOUGLAS-FIR SEEDLINGS; CHLOROPHYLL FLUORESCENCE; LOCAL ADAPTATION; FROST-HARDINESS; NORWAY SPRUCE; SCOTS PINE; BUD-BURST; ABIES-SACHALINENSIS; GENETIC-VARIATION; COMMON GARDEN	To avoid winter frost damage, evergreen coniferous species develop cold hardiness with suitable phenology for the local climate regime. Along the elevational gradient, a genetic cline in autumn phenology is often recognised among coniferous populations, but further quantification of evolutionary adaptation related to the local environment and its responsible signals generating the phenological variation are poorly understood. We evaluated the timing of cold hardening among populations of Abies sachalinensis, based on time series freezing tests using trees derived from four seed source populations x three planting sites. Furthermore, we constructed a model to estimate the development of hardening from field temperatures and the intraspecific variations occurring during this process. An elevational cline was detected such that high-elevation populations developed cold hardiness earlier than low-elevation populations, representing significant genetic control. Because development occurred earlier at high-elevation planting sites, the genetic trend across elevation overlapped with the environmental trend. Based on the trade-off between later hardening to lengthen the active growth period and earlier hardening to avoid frost damage, this genetic cline would be adaptive to the local climate. Our modelling approach estimated intraspecific variation in two model components: the threshold temperature, which was the criterion for determining whether the trees accumulated the thermal value, and the chilling requirement for trees to achieve adequate cold hardiness. A higher threshold temperature and a lower chilling requirement could be responsible for the earlier phenology of the high-elevation population. These thermal responses may be one of the important factors driving the elevation-dependent adaptation of A.sachalinensis.	[Ishizuka, W.] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Ono, K.; Hara, T.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Goto, S.] Univ Tokyo, Univ Tokyo Forests, Grad Sch Agr & Life Sci, Tokyo, Japan	Ishizuka, W (reprint author), Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan.	wataru.ishi@gmail.com			Japan Society for the Promotion of Science	The authors thank Akio Kurahashi for initially setting up the experimental site; Yasuo Takahashi and the staff of the University of Tokyo Hokkaido Forest for collecting shoot samples; Momoko Okada, Azusa Tabata, Takumi Fujibe and Edgard Alves Bontempo e Silva for help with the freezing tests. We are also grateful to Hiroyoshi Iwata and Naoko Miura for helpful comments on analyses and on the manuscript, respectively, and Sin-Ichi Morinaga for encouraging the manuscript writing. This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science.	Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Aitken SN, 2001, TREE PHYSIOL SER, V1, P23; JOLY RJ, 1989, FOREST SCI, V35, P987; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Chuine I, 2003, TASK VEG SC, V39, P217; REHFELDT GE, 1989, FOREST ECOL MANAG, V28, P203, DOI 10.1016/0378-1127(89)90004-2; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Vitasse Y, 2009, CAN J FOREST RES, V39, P1259, DOI 10.1139/X09-054; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/B03-141, 10.1139/b03-141]; LINDGREN K, 1993, TREE PHYSIOL, V13, P97; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Ishizuka W, 2012, EVOL APPL, V5, P229, DOI 10.1111/j.1752-4571.2011.00216.x; WORRALL J, 1983, SILVAE GENET, V32, P203; Notivol E, 2007, CAN J FOREST RES, V37, P540, DOI 10.1139/X06-243; Perks MP, 2004, NEW FOREST, V28, P49, DOI 10.1023/B:NEFO.0000031331.08847.49; SKROPPA T, 1993, SILVAE GENET, V42, P111; Cunningham SC, 2006, TREE PHYSIOL, V26, P1435; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; EIGA S, 1984, CAN J BOT, V62, P156; Leinonen I, 1996, ANN BOT-LONDON, V78, P687, DOI 10.1006/anbo.1996.0178; Beuker E, 1998, FOREST ECOL MANAG, V107, P87, DOI 10.1016/S0378-1127(97)00344-7; CANNELL MGR, 1985, J APPL ECOL, V22, P931, DOI 10.2307/2403241; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; DORMLING I, 1968, Silvae Genetica, V17, P44; Frank E., 2001, REGRESSION MODELING, P568; Greer DH, 2000, TREE PHYSIOL, V20, P107; Hannerz M, 1999, CAN J FOREST RES, V29, P9, DOI 10.1139/cjfr-29-1-9; Hanninen H, 2007, TREE PHYSIOL, V27, P291; Kohmann K, 2007, SCAND J FOREST RES, V22, P375, DOI 10.1080/02827580701520486; Kurahashi A., 1981, B TOKYO U FOR, V71, P101; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165; Morgenstern EK, 1996, GEOGRAPHIC VARIATION, P209; R Development Core Team, 2011, R LANG ENV STAT COMP; TIMMIS R, 1994, TREE PHYSIOL, V14, P855; VANDENDR.R, 1970, CAN J BOTANY, V48, P2129	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	JAN	2015	17	1					177	185		10.1111/plb.12214		9	Plant Sciences	Plant Sciences	AY6YF	WOS:000347707900021		
J	Wang, H; Matsushita, M; Tomaru, N; Nakagawa, M				Wang, H.; Matsushita, M.; Tomaru, N.; Nakagawa, M.			Differences in female reproductive success between female and hermaphrodite individuals in the subdioecious shrub Eurya japonica (Theaceae)	PLANT BIOLOGY			English	Article						dioecy; female reproductive success; fruit set; pollen limitation; seed germination; subdioecy	SILENE-ACAULIS CARYOPHYLLACEAE; SEXUAL-DIMORPHISM; POLLEN LIMITATION; FLOWERING PLANTS; HEBE-SUBALPINA; DIOECY; GYNODIOECY; EVOLUTION; CONSEQUENCES; MAINTENANCE	Subdioecy is thought to occupy a transitional position in the gynodioecy-dioecy pathway, explaining one of the evolutionary routes from hermaphroditism to dioecy. Quantifying any female reproductive advantage of females versus hermaphrodites is fundamental to examining the spectrum between subdioecy and dioecy; however, this is challenging, as multiple interacting factors, such as pollen limitation and resource availability, affect plant reproduction. We compared the female reproductive success of females and hermaphrodites via a field experiment in which we hand-pollinated individuals of the subdioecious shrub Eurya japonica of similar size growing under similar light conditions. Effects of pollen limitation and seed quality were also evaluated through comparing the results of hand- and natural-pollination treatments and performing additional laboratory and greenhouse experiments. Overall, females had higher fruit set and produced heavier fruit and more seeds than hermaphrodites, and these results were more pronounced for hand-pollinated than for natural-pollinated plants of both sexes. We also found that seeds naturally produced by females had a higher mean germination rate. These results indicate that females had a pronounced advantage in female reproductive success under conditions of no pollen limitation. The sexual difference in the degree of pollen limitation suggests a pollinator-mediated interaction, whereas the higher female reproductive success of females even under natural conditions implies that E.japonica is a good model species for elucidating the later stages of the gynodioecy-dioecy pathway.	[Wang, H.; Tomaru, N.; Nakagawa, M.] Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Ecol & Physiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Matsushita, M.] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan	Nakagawa, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Ecol & Physiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	miko@agr.nagoya-u.ac.jp					Aguirre A, 2007, BIOTROPICA, V39, P79, DOI 10.1111/j.1744-7429.2006.00230.x; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1006/bijl.1999.0372; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; CAMPBELL DR, 1993, ECOLOGY, V74, P1043, DOI 10.2307/1940474; Blaney CS, 2001, J APPL ECOL, V38, P1104, DOI 10.1046/j.1365-2664.2001.00663.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; Barrett SCH, 2002, HEREDITY, V88, P154, DOI 10.1038/sj/hdy/6800020; ASHMAN TL, 1994, AM NAT, V144, P300, DOI 10.1086/285676; Heilbuth JC, 2000, AM NAT, V156, P221, DOI 10.1086/303389; Ehlers BK, 2007, NEW PHYTOL, V174, P194, DOI 10.1111/j.1469-8137.2007.01975.x; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; PARRISH JAD, 1985, OECOLOGIA, V65, P247, DOI 10.1007/BF00379224; Spigler RB, 2012, ANN BOT-LONDON, V109, P531, DOI 10.1093/aob/mcr170; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Li JM, 2012, ANN BOT-LONDON, V109, P545, DOI 10.1093/aob/mcr279; Weiblen GD, 2000, AM NAT, V155, P46, DOI 10.1086/303303; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj/hdy/6800016; PRIMACK RB, 1990, AM NAT, V136, P638, DOI 10.1086/285120; Tsuji K, 2010, OIKOS, V119, P1848, DOI 10.1111/j.1600-0706.2010.18585.x; Delph LF, 1999, AM J BOT, V86, P140, DOI 10.2307/2656963; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Delph LF, 2001, EVOL ECOL RES, V3, P487; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Ashman TL, 2001, AM NAT, V157, P334, DOI 10.1086/319192; Ashman TL, 2000, ECOLOGY, V81, P2577, DOI 10.1890/0012-9658(2000)081[2577:PSAIIF]2.0.CO;2; ASSOUAD W, 1975, B SOC BOT FR, V122, P21; ATSATT PR, 1982, ANN MO BOT GARD, V69, P199, DOI 10.2307/2398790; Burd M, 1998, ECOLOGY, V79, P2123, DOI 10.1890/0012-9658(1998)079[2123:EFPASF]2.0.CO;2; Charlesworth B., 1999, SEX DETERMINATION PL, P25; Couvet D., 1990, Oxford Surveys in Evolutionary Biology, V7, P225; Darwin C. R., 1877, DIFFERENT FORMS FLOW, P352; DELPH LF, 1990, ECOLOGY, V71, P1342, DOI 10.2307/1938271; DELPH LF, 1993, J ECOL, V81, P287, DOI 10.2307/2261498; Dufay M., 2011, ANN BOT, V109, P505; Higo Mutsuki, 1994, Japanese Journal of Ecology (Sendai), V44, P141; KNOX RB, 1976, P NATL ACAD SCI USA, V73, P2788, DOI 10.1073/pnas.73.8.2788; LEWIS D., 1941, NEW PHYTOT, V40, P56, DOI 10.1111/j.1469-8137.1941.tb07028.x; Manabe T., 1991, J JPN SOC REVEGET TE, V17, P27; Manabe T., 1996, B KITAKYUSHU MUSEUM, V15, P137; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; McKone MJ, 1998, AM J BOT, V85, P776, DOI 10.2307/2446412; MURATA H, 1991, Journal of Japanese Botany, V66, P229; NIESENBAUM RA, 1993, J ECOL, V81, P315, DOI 10.2307/2261501; Oh G. S., 1996, J FOR RES, V1, P93, DOI 10.1007/BF02348310; Ohwi J., 1992, NEW FLORA JAPAN, P1716; R Development Core Team, 2011, R LANG ENV STAT COMP; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Satyal P, 2012, NAT PROD COMMUN, V7, P1233; SHYKOFF JA, 1992, AM J BOT, V79, P138, DOI 10.2307/2445100; Webb C. J., 1999, GENDER SEXUAL DIMORP, P61	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	JAN	2015	17	1					194	200		10.1111/plb.12189		7	Plant Sciences	Plant Sciences	AY6YF	WOS:000347707900023		
J	Nakagawa, M; Isogimi, T; Inanaga, M; Abe, K; Okada, T; Yoichi, W; Kobayakawa, K; Toyama, C; Ito, K; Kawashima, N; Otani, K; Hori, M; Tani, S; Higuchi, K; Asano, I; Kawahara, K; Yamauchi, A; Kato, D; Matsushita, M				Nakagawa, Michiko; Isogimi, Tomohiro; Inanaga, Michiko; Abe, Kosei; Okada, Tomoya; Yoichi, Watanabe; Kobayakawa, Koji; Toyama, Chikage; Ito, Keisuke; Kawashima, Naomichi; Otani, Kanae; Hori, Megumi; Tani, Saori; Higuchi, Keigo; Asano, Iku; Kawahara, Kazuma; Yamauchi, Ayaka; Kato, Daisuke; Matsushita, Michinari			Inter-specific and sexual differences in architectural traits of two dioecious Lindera species (Lauraceae)	PLANT ECOLOGY			English	Article						Allometry; Biomass; Ramification; Sexual dimorphism; Temperate forest; Wood density	TEMPERATE RAIN-FOREST; WOOD DENSITY; SHADE TOLERANCE; LIFE-HISTORY; LEAF SIZE; REPRODUCTIVE INVESTMENT; CLONAL INTEGRATION; ADULT STATURE; FEMALE PLANTS; TROPICAL TREE	The architecture of trees is a crucial determinant of their performance through light capture and mechanical stability. Comparison of architectural traits between closely related dioecious species is predicted to reveal both inter-specific and sexual differences. The former may reflect life-history characteristics such as microhabitat preferences, and the latter may reflect costs of reproductive allocation. We measured branching structure, leaf traits, wood density, and biomass of each vegetative component in the dioecious shrubs Lindera praecox and Lindera triloba to explore architectural differences according to species and gender. L. triloba was less branched but had a greater total leaf mass per shoot having larger and heavier leaves than L. praecox; most of these traits did not differ by gender. Allometric relationships between height and branch biomass corroborated our results of branching structure. The allometric relationships between tree size and leaf biomass demonstrated that in larger size classes females of both species had greater leaf biomass than males. Females of both species also showed lower tree height than males. This study suggests that tree architecture is influenced by both life-history strategy and resource-allocation pattern. Branching structure and branch biomass showed inter-specific differences, with the highly branched L. praecox apparently more shade tolerant than L. triloba; its tolerance is likely adaptive in its preferred microhabitat where is often lit poorly. Sexual differences in leaf biomass and tree height growth may reflect higher reproductive costs incurred by females.	[Nakagawa, Michiko; Isogimi, Tomohiro; Inanaga, Michiko; Abe, Kosei; Okada, Tomoya; Yoichi, Watanabe; Kobayakawa, Koji; Toyama, Chikage; Ito, Keisuke; Kawashima, Naomichi; Otani, Kanae; Hori, Megumi; Tani, Saori; Higuchi, Keigo] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Asano, Iku; Kawahara, Kazuma; Yamauchi, Ayaka; Kato, Daisuke] Nagoya Univ, Sch Agr Sci, Nagoya, Aichi 4648601, Japan; [Matsushita, Michinari] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan	Nakagawa, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	miko@agr.nagoya-u.ac.jp		Inanaga, Michiko/0000-0002-8736-7088			Aiba M, 2009, J ECOL, V97, P992, DOI 10.1111/j.1365-2745.2009.01522.x; Aiba M, 2009, FUNCT ECOL, V23, P265, DOI 10.1111/j.1365-2435.2008.01500.x; Aiba SI, 1997, J ECOL, V85, P611, DOI 10.2307/2960532; Aiba SI, 1996, J ECOL, V84, P207, DOI 10.2307/2261356; Kohyama T, 2003, J ECOL, V91, P797, DOI 10.1046/j.1365-2745.2003.00810.x; Barrett SCH, 2013, J EXP BOT, V64, P67, DOI 10.1093/jxb/ers308; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Iida Y, 2011, FUNCT ECOL, V25, P1260, DOI 10.1111/j.1365-2435.2011.01884.x; ALLEN GA, 1993, AM NAT, V141, P537, DOI 10.1086/285490; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; WARING RH, 1982, CAN J FOREST RES, V12, P556, DOI 10.1139/x82-086; Matsuyama S, 2008, ANN BOT-LONDON, V101, P1391, DOI 10.1093/aob/mcn048; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Nicotra AB, 2003, AM J BOT, V90, P347, DOI 10.3732/ajb.90.3.347; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Anderson DR, 1998, J APPL STAT, V25, P263; KOHYAMA T, 1990, FUNCT ECOL, V4, P515, DOI 10.2307/2389319; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Osada N, 2011, FUNCT ECOL, V25, P777, DOI 10.1111/j.1365-2435.2011.01833.x; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Bond WJ, 1999, EVOL ECOL, V13, P1, DOI 10.1023/A:1006581412580; Poorter L, 2003, ECOLOGY, V84, P602, DOI 10.1890/0012-9658(2003)084[0602:AORFTS]2.0.CO;2; Wheelwright NT, 2004, P NATL ACAD SCI USA, V101, P8051, DOI 10.1073/pnas.0402735101; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Larjavaara M, 2010, FUNCT ECOL, V24, P701, DOI 10.1111/j.1365-2435.2010.01698.x; BOND WJ, 1988, AM NAT, V131, P901, DOI 10.1086/284830; CIPOLLINI ML, 1994, AM J BOT, V81, P65, DOI 10.2307/2445564; CORNER EJH, 1949, ANN BOT-LONDON, V13, P367; Delph L.F., 1999, GENDER SEXUAL DIMORP, P149; Espirito-Santo MM, 2003, ANN BOT-LONDON, V91, P13, DOI 10.1093/aob/mcg001; Forero-Montana J, 2010, J TROP ECOL, V26, P433, DOI 10.1017/S0266467410000143; Harris MS, 2010, J ECOL, V98, P509, DOI 10.1111/j.1365-2745.2009.01623.x; Horikawa Y, 1972, ATLAS JAPANESE FLORA; Isogimi T, 2011, ANN BOT-LONDON, V107, P1029, DOI 10.1093/aob/mcr043; Isogimi T, 2014, FLORA, DOI [10.1016/j.flora.2014.08.006, DOI 10.1016/J.FLORA.2014.08.006]; Kenta T, 2007, BIOL CONSERV, V134, P298, DOI 10.1016/j.biocon.2006.07.023; King DA, 1990, FUNCT ECOL, V4, P23; King DA, 1998, TREES-STRUCT FUNCT, V12, P438, DOI 10.1007/s004680050172; Kohyama T, 1987, FUNCT ECOL, V1, P399, DOI 10.2307/2389797; KORPELAINEN H, 1992, OECOLOGIA, V89, P133, DOI 10.1007/BF00319025; MATSUI K, 1995, ECOL RES, V10, P65, DOI 10.1007/BF02347656; Matsushita M, 2012, BOTANY, V90, P1028, DOI 10.1139/b2012-074; Matsushita M, 2010, BOTANY, V88, P174, DOI 10.1139/B09-108; Matsushita M, 2011, J ECOL, V99, P1520, DOI 10.1111/j.1365-2745.2011.01866.x; Midgley JJ, 2010, S AFR J BOT, V76, P588, DOI 10.1016/j.sajb.2010.05.001; Nanami S, 2005, PLANT ECOL, V177, P209, DOI 10.1007/s11258-005-2210-2; Niklas KJ, 1997, ANN BOT-LONDON, V79, P265, DOI 10.1006/anbo.1996.0340; Obeso JR, 1998, AM J BOT, V85, P1602, DOI 10.2307/2446488; Osada N, 2005, CAN J BOT, V83, P1590, DOI 10.1139/b05-133; Poorter L, 2012, PLANT ECOL, V213, P707, DOI 10.1007/s11258-012-0032-6; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez-Vilas J, 2012, ANN BOT-LONDON, V110, P839, DOI 10.1093/aob/mcs157; Suzuki AA, 2005, AM J BOT, V92, P2003, DOI 10.3732/ajb.92.12.2003; Torimaru T, 2012, BOTANY, V90, P301, DOI 10.1139/B2012-004; Tozawa M, 2009, BOTANY, V87, P315, DOI 10.1139/B08-125; Ueno N, 2006, CAN J BOT, V84, P1852, DOI 10.1139/B06-142; Wheelwright NT, 2012, AM J BOT, V99, P1350, DOI 10.3732/ajb.1200182; Yamada T, 2000, FUNCT ECOL, V14, P731, DOI 10.1046/j.1365-2435.2000.00479.x; Yamada T, 2006, TREES-STRUCT FUNCT, V20, P186, DOI 10.1007/s00468-005-0025-3; Yamamoto K., 2008, LIA WIN32 LIA32; Zhang CY, 2012, EUR J FOREST RES, V131, P1287, DOI 10.1007/s10342-012-0598-5	67	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-0237	1573-5052		PLANT ECOL	Plant Ecol.	JAN	2015	216	1					99	109		10.1007/s11258-014-0419-7		11	Plant Sciences; Ecology; Forestry	Plant Sciences; Environmental Sciences & Ecology; Forestry	AY6SU	WOS:000347696700008		
J	Qian, JP; Lao, LL; Ren, QL; Wan, BN; Liu, HQ; Zeng, L; Luo, ZP; Hanada, K; Chen, DL; Shi, TH; Sun, YW; Shen, B; Xiao, BJ				Qian Jinping; Lao, L. L.; Ren Qilong; Wan Baonian; Liu Haiqin; Zeng Long; Luo Zhengping; Hanada, K.; Chen Dalong; Shi Tonghui; Sun Youwen; Shen Biao; Xiao Bingjia			Algorithm Validation of the Current Profile Reconstruction of EAST Based on Polarimeter/Interferometer	PLASMA SCIENCE & TECHNOLOGY			English	Article						plasma equilibrium; current profile; polarimeter/interferometer	CIRCULAR CROSS-SECTION; TOKAMAKS	The method of plasma current profile reconstruction using the polarimeter/interferometer (POINT) data from a simulated equilibrium is explored and validated. It is shown that the safety factor (q) profile can be generally reconstructed from the external magnetic and POINT data. The reconstructed q profile is found to reasonably agree with the initial equilibriums. Comparisons of reconstructed q and density profiles using the magnetic data and the POINT data with 3%, 5% and 10% random errors are investigated. The result shows that the POINT data could be used to a reasonably accurate determination of the q profile.	[Qian Jinping; Ren Qilong; Wan Baonian; Liu Haiqin; Zeng Long; Luo Zhengping; Chen Dalong; Shi Tonghui; Sun Youwen; Shen Biao; Xiao Bingjia] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China; [Lao, L. L.] Gen Atom Co, San Diego, CA 92037 USA; [Hanada, K.] Kuyushu Univ, Fukuoka 8160000, Japan	Qian, JP (reprint author), Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China.	jpqian@ipp.ac.cn			National Magnetic Confinement Fusion Program of China [2012GB101002, 2014GB106002, 2014GB103000, 2013GB10200]; National Natural Science Foundation of China [11105184, 11205199, 11375237]	supported by the National Magnetic Confinement Fusion Program of China (Nos. 2012GB101002, 2014GB106002, 2014GB103000, 2013GB10200) and National Natural Science Foundation of China (Nos. 11105184, 11205199 and 11375237)	LAO LL, 1985, NUCL FUSION, V25, P1421, DOI 10.1088/0029-5515/25/10/004; Qian JP, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/2/025003; LAO LL, 1990, NUCL FUSION, V30, P1035, DOI 10.1088/0029-5515/30/6/006; Brix M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2964180; Deng BH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2222332; LAO LL, 1985, NUCL FUSION, V25, P1611, DOI 10.1088/0029-5515/25/11/007; Liu GJ, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4811657; Liu HQ, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/11/C11002; LUXON JL, 1982, NUCL FUSION, V22, P813, DOI 10.1088/0029-5515/22/6/009; SOLTWISCH H, 1986, REV SCI INSTRUM, V57, P1939, DOI 10.1063/1.1138803	10	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1009-0630			PLASMA SCI TECHNOL	Plasma Sci. Technol.	JAN	2015	17	1					75	79		10.1088/1009-0630/17/1/14		5	Physics, Fluids & Plasmas	Physics	AZ2AO	WOS:000348037200014		
J	De, S; Mazumder, R; Ohta, T; Hegner, E; Yamada, K; Bhattacharyya, T; Chiarenzelli, J; Altermann, W; Arima, M				De, S.; Mazumder, R.; Ohta, T.; Hegner, E.; Yamada, K.; Bhattacharyya, T.; Chiarenzelli, J.; Altermann, W.; Arima, M.			Geochemical and Sm-Nd isotopic characteristics of the Late Archaean-Palaeoproterozoic Dhanjori and Chaibasa metasedimentary rocks, Singhbhum craton, E. India: Implications for provenance, and contemporary basin tectonics	PRECAMBRIAN RESEARCH			English	Article						Provenance; Sediment geochemistry; Palaeoproterozoic; Tectonics; Palaeoclimate; Singhbhum	SEDIMENT DEFORMATION STRUCTURES; EASTERN INDIA; CONTINENTAL-CRUST; TIDAL RHYTHMITES; SHEAR ZONE; WESTERN-AUSTRALIA; NORTH SINGHBHUM; EVOLUTION; SHALES; AGE	In significant contrast to other cratonic blocks of India, the Singhbhum cratonic successions record continuous depositional record from the Palaeoarchaean to Mesoproterozoic. Although the sedimentary facies characteristics and mode of stratigraphic sequence building of the Dhanjori and Chaibasa Formations are well known, sedimentary geochemistry, provenance and tectonic milieu of deposition of these two formations are hitherto unknown. The current manuscript presents geochemical and Sm-Nd isotopic data from the Dhanjori and Chaibasa Formations for the first time and combine previous sedimentological data with the goal to expand the framework for understanding the depositional and tectonic setting of these two formations. The Sm-Nd isotopic data for the Chaibasa clastics is unambiguous with respect to provenance. Average epsilon(Nd) (t = 2.2 Ga) = -0.8 +/- 1.0 and average Nd model age (TDM) = 2.51 +/- 0.08 Ga with average Sm-147/Nd-144 ratios = 0.1114 +/- 0.0041 for phyllites and quartzites indicate an extremely homogeneous source signature consistent with a late Archaean "juvenile" crustal provenance, possibly a dominantly upper crustal provenance. The Sm-Nd isotopic data from the older Dhanjori Formation also indicate broadly similar provenance as comparable lithologies in the younger Chaibasa Formation. Our Sm-Nd isotopic data is entirely consistent with the previous sedimentological data and confirms a terrestrial, riftdominated tectonic setting for the Dhanjori Formation (proximal sources, poorly mixed provenance) and a marginal marine to offshore setting for the more homogeneous Nd isotopic signature of the Chaibasa Formation (distal sources, well mixed provenance). (C) 2014 Elsevier B.V. All rights reserved.	[De, S.; Mazumder, R.] Indian Stat Inst, Geol Studies Unit, Kolkata 700108, India; [Mazumder, R.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Mazumder, R.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW 2052, Australia; [Ohta, T.; Yamada, K.] Waseda Univ, Dept Earth Sci, Sch Educ & Integrated Sci & Art, Shinjuku Ku, Tokyo 1698050, Japan; [Hegner, E.] Dept Earth & Environm Sceinces, D-80333 Munich, Germany; [Hegner, E.] GeoBio Ctr, D-80333 Munich, Germany; [Bhattacharyya, T.] Univ Calcutta, Dept Geol, Kolkata 700019, India; [Chiarenzelli, J.] St Lawrence Univ, Dept Geol, Canton, NY 13617 USA; [Altermann, W.] Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa; [Arima, M.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Mazumder, R (reprint author), Curtin Univ Sarawak, Dept Appl Geol, Sch Sci & Engn, CDT 250, Miri 98009, Sarawak, Malaysia.	rajatunsw@gmail.com	Ohta, Tohru/B-4379-2008	Ohta, Tohru/0000-0003-0641-3538	Department of Science and Technology, Government of India	This paper forms part of SD's doctoral dissertation under the supervision of RM and TB. SD gratefully acknowledges infrastructural facilities provided by the Geological Studies Unit, Indian Statistical Institute Kolkata and the Department of Geology, Calcutta University. SD and RM are grateful to the Department of Science and Technology, Government of India for financial support in form of a research fellowship and major research grant respectively. We are grateful to three anonymous reviewers, C. Fedo and R. Parrish for their critical but very helpful and constructive comments.	Acharyya S.K., 2003, GONDWANA GEOL MAG, V7, P9; Pal DC, 2011, ECON GEOL, V106, P1155; Saha A, 2004, EARTH PLANET SC LETT, V220, P91, DOI 10.1016/S0012-821X(04)00056-1; Mukhopadhyay D, 2001, GONDWANA RES, V4, P307, DOI 10.1016/S1342-937X(05)70331-2; BOSE MK, 1994, TECTONOPHYSICS, V231, P325, DOI 10.1016/0040-1951(94)90042-6; MCLENNAN SM, 1984, GEOCHIM COSMOCHIM AC, V48, P1, DOI 10.1016/0016-7037(84)90345-4; BLAIR TC, 1994, J SEDIMENT RES A, V64, P450; Mazumder R, 2005, EARTH-SCI REV, V69, P79, DOI 10.1016/j.earscirev.2004.07.004; Eriksson PG, 2006, EARTH-SCI REV, V79, P165, DOI 10.1016/j.earscirev.2006.07.001; MCLENNAN SM, 1983, GEOCHIM COSMOCHIM AC, V47, P1211, DOI 10.1016/0016-7037(83)90063-7; ROSER BP, 1986, J GEOL, V94, P635; Joy S, 1998, J STRUCT GEOL, V20, P1509, DOI 10.1016/S0191-8141(98)00033-9; Sugitani K, 2006, PRECAMBRIAN RES, V147, P124, DOI 10.1016/j.precamres.2006.02.006; Bhattacharya HN, 1998, SEDIMENT GEOL, V119, P239, DOI 10.1016/S0037-0738(98)00051-7; Acharyya SK, 2010, GEOCHEM J, V44, P81; Roy A, 2002, GEOCHEM J, V36, P503; Foix N, 2008, SEDIMENT GEOL, V205, P67, DOI 10.1016/j.sedgeo.2008.02.002; ROSER BP, 1988, CHEM GEOL, V67, P119, DOI 10.1016/0009-2541(88)90010-1; Mazumder R, 2012, GEOL SOC SPEC PUBL, V365, P31, DOI 10.1144/SP365.3; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Mazumder R, 2012, GEOL SOC SPEC PUBL, V365, P51, DOI 10.1144/SP365.4; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; ELDERFIELD H, 1982, NATURE, V296, P214, DOI 10.1038/296214a0; MCLENNAN SM, 1983, PRECAMBRIAN RES, V22, P93, DOI 10.1016/0301-9268(83)90060-8; Acharyya SK, 2010, J ASIAN EARTH SCI, V39, P527, DOI 10.1016/j.jseaes.2010.04.023; Prabhakar N, 2013, PRECAMBRIAN RES, V231, P106, DOI 10.1016/j.precamres.2013.03.009; Mazumder R, 2005, SEDIMENT GEOL, V176, P167, DOI 10.1016/j.sedgeo.2004.12.011; Mazumder R, 2000, J AFR EARTH SCI, V30, P201, DOI 10.1016/S0899-5362(00)00016-6; Eriksson PG, 1998, SEDIMENT GEOL, V120, P5, DOI 10.1016/S0037-0738(98)00026-8; Mukhopadhyay J, 2012, GEOL J, V47, P284, DOI 10.1002/gj.1314; KARIG DE, 1971, J GEOPHYS RES, V76, P2542, DOI 10.1029/JB076i011p02542; DEPAOLO DJ, 1981, NATURE, V291, P193, DOI 10.1038/291193a0; Mazumder R, 2006, SEDIMENT GEOL, V186, P19, DOI 10.1016/j.sedgeo.2005.12.002; Nelson DR, 2014, PRECAMBRIAN RES, V255, P412, DOI 10.1016/j.precamres.2014.09.024; BHATIA MR, 1986, CONTRIB MINERAL PETR, V92, P181, DOI 10.1007/BF00375292; COX R, 1995, GEOCHIM COSMOCHIM AC, V59, P2919, DOI 10.1016/0016-7037(95)00185-9; SETH A, 1990, SEDIMENT GEOL, V68, P279, DOI 10.1016/0037-0738(90)90015-L; Banerjee S, 2013, J STRUCT GEOL, V50, P199, DOI 10.1016/j.jsg.2012.08.007; Bhattacharya HN, 2008, PRECAMBRIAN RES, V162, P302, DOI 10.1016/j.precamres.2007.07.021; BHATTACHARYA HN, 1991, J GEOL SOC INDIA, V37, P47; Bhattacharya H.N., 2014, GEOL MAG; Bose PK, 1997, PRECAMBRIAN RES, V84, P63, DOI 10.1016/S0301-9268(97)00016-8; Busby C, 1995, TECTONICS SEDIMENTAR; Chaudhuri T, 2015, J AFR EARTH SCI, V101, P135, DOI 10.1016/j.jafrearsci.2014.09.014; Clark C, 2012, PRECAMBRIAN RES, V196, P23, DOI 10.1016/j.precamres.2011.11.001; Dasgupta S., 2004, SPECIAL PUBLICATIONS, V84, P33; DEPAOLO DJ, 1988, EARTH PLANET SC LETT, V90, P263, DOI 10.1016/0012-821X(88)90130-6; DePaolo D.J., 1988, NEODYMIUM ISOTOPE GE; Fedo CM, 1996, GEOCHIM COSMOCHIM AC, V60, P1751, DOI 10.1016/0016-7037(96)00058-0; Fedo CM, 1997, PRECAMBRIAN RES, V86, P201, DOI 10.1016/S0301-9268(97)00049-1; Ghosh M, 2006, J ASIAN EARTH SCI, V26, P555, DOI 10.1016/j.jseaes.2004.11.007; Gupta A, 2000, SPEC PUBL SURV INDIA, V55, P195; Gupta A., 1991, IND MINERALS, V45, P273; HARNOIS L, 1988, SEDIMENT GEOL, V55, P319, DOI 10.1016/0037-0738(88)90137-6; Hegner E, 2010, AM J SCI, V310, P916, DOI 10.2475/09.2010.07; HERRON MM, 1988, J SEDIMENT PETROL, V58, P820; Hofmann A., 2014, MEMOIR GEOL IN PRESS, V43; Joy S, 2000, J STRUCT GEOL, V22, P777, DOI 10.1016/S0191-8141(00)00008-0; Mallik L, 2012, MAR PETROL GEOL, V30, P43, DOI 10.1016/j.marpetgeo.2011.10.005; Mazumder R, 1999, J GEOL SOC INDIA, V53, P615; MAZUMDER R., 2002, THESIS JADAVPUR U KO; Mazumder R., 2014, MEMOIR GEOL IN PRESS, V43; Mazumder R, 2004, PRECAMBRIAN RES, V130, P267, DOI 10.1016/j.precamres.2003.12.005; Mazumder R, 2000, EARTH-SCI REV, V50, P113, DOI 10.1016/S0012-8252(00)00003-9; Mazumder R, 2013, MAR PETROL GEOL, V43, P320, DOI 10.1016/j.marpetgeo.2013.01.006; Mazumder R, 2009, J GEOL, V117, P455, DOI 10.1086/599197; Mazumder R, 2004, GEOLOGY, V32, P841, DOI 10.1130/G20424.1; Mazumder R, 2009, GEOL SOC SPEC PUBL, V323, P301, DOI 10.1144/SP323.15; McLennan SM, 2006, EVOLUTION DIFFERENTI, P92; McLennan SM, 1993, PROCESSES CONTROLLIN, V284, P21; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; MUKHOPADHYAY D., 1984, J INDIAN SOC EARTH S, P205; MUKHOPADHYAY D., 1976, INDIAN J EARTH SCI, V3, P208; Mukhopadhyay J., 2014, GEOLOGY; NAHA K., 1965, Q J GEOL MIN MET SOC, V37, P41; Nelson D.R., 2007, INT C PREC SED TECT; Nesbitt H.W., 2004, DEV PRECAMBRIAN GEOL, V12, P482; Ohta T, 2008, SEDIMENTOLOGY, V55, P1687, DOI 10.1111/j.1365-3091.2008.00963.x; PATCHETT PJ, 1984, CONTRIB MINERAL PETR, V87, P311, DOI 10.1007/BF00381287; Pettijohn F.J., 1975, SEDIMENTARY ROCKS, V7; Potter P. E., 2005, MUD MUDSTONES INTRO; Reddy S. M., 2009, INT ASS GONDWANA RES, V9, P17; Rollinson H., 1993, USING GEOCHEMICAL DA; Rollinson H., 2007, EARLY EARTH SYSTEMS; Saha A.K., 1994, GEOL SOC INDIA MEM, V27; SARKAR S. N., 1962, QUART J GEOL MIN MET, V34, P97; SARKAR S. N., 1986, DIAMOND JUBILEE MONO, P101; Sarkar S.C., 1984, GEOLOGY ORE MINERALI; SARKAR S.C., 1971, Q J GEOL MIN MET SOC, V43, P29; Sengupta S., 2004, GEOLOGICAL SURVEY IN, V84, P24; Taylor S.R., 1985, CONTINENTAL CRUST IT, P312; van de Kamp P.P., 1985, T ROY SOC EDINBURGH, V76, P411; Wilde P, 1996, SEDIMENT GEOL, V101, P43, DOI 10.1016/0037-0738(95)00020-8	93	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-9268	1872-7433		PRECAMBRIAN RES	Precambrian Res.	JAN	2015	256						62	78		10.1016/j.precamres.2014.10.020		17	Geosciences, Multidisciplinary	Geology	AZ2UZ	WOS:000348088900005		
J	Van Kranendonk, MJ; Mazumder, R; Yamaguchi, KE; Yamada, K; Ikehara, M				Van Kranendonk, Martin J.; Mazumder, Rajat; Yamaguchi, Kosei E.; Yamada, Koji; Ikehara, Minoru			Sedimentology of the Paleoproterozoic Kungarra Formation, Turee Creek Group, Western Australia: A conformable record of the transition from early to modern Earth	PRECAMBRIAN RESEARCH			English	Article						Paleoproterozoic; Sedimentology; Glacio-marine succession; Turee Creek Group; Western Australia	HUMMOCKY CROSS-STRATIFICATION; DENSITY TURBIDITY CURRENTS; GREAT OXIDATION EVENT; HAMERSLEY PROVINCE; SNOWBALL EARTH; ATMOSPHERIC OXYGEN; SOUTH-AFRICA; DEFORMATION STRUCTURES; SHELF SEDIMENTATION; HURONIAN SUPERGROUP	This paper presents the first, detailed sedimentological analysis of the Paleoproterozoic Kungarra Formation, the lowermost of three formations comprising the Turee Creek Group in Western Australia, which was deposited across the rise in atmospheric oxygen (the Great Oxidation Event, or GOE) and the transition from early to modern Earth. The data show that the Kungarra Formation has a gradational, conformable lower contact with underlying banded iron-formation of the Hamersley Group and predominantly comprises an upward-shallowing succession from deepwater shales and siltstones, through rippled fine-grained sandstones and stromatolitic carbonates, to tidal flat deposits that immediately underlie coastal-fluvial deposits of the overlying Koolbye Formation. At the base of the Kungarra Formation is a gradual transition from alternating units of magnetic green shale and thin units of banded iron-formation that pass upsection to units of non-magnetic shale and ferruginous chert and grey chert, reflecting a gradual loss of iron from the world's oceans accompanying the rise of atmospheric oxygen. A falling stage systems tract is recognised above this transition in the Hardey Syncline area, capped by stromatolitic carbonates and a period of exposure marked by an erosional unconformity and carbonate beachrock. Two glacio-eustatic cycles are recognised within the middle to upper parts of the Kungarra Formation, each of which is marked by the rapid onset of falling systems tracts and characterised by falling systems tracts during and following diamictite deposition. Stratigraphic data are used to infer a depobasin filled by a sediment wedge prograding from southeast to northwest, in contrast to previous models of a north-northeastward deepening foreland basin. The lack of seismites or internal unconformities within the formation precludes a foredeep setting. Rather, deposition is interpreted as having occurred within an intracratonic basin, with detritus sourced from erosion of uplifted bedrock to the southeast. (C) 2014 Elsevier B.V. All rights reserved.	[Van Kranendonk, Martin J.; Mazumder, Rajat] Univ New S Wales, Sch Biol Earth & Environm Sci, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia; [Yamaguchi, Kosei E.; Yamada, Koji] Toho Univ, Dept Chem, Chiba 2748510, Japan; [Yamada, Koji] NASA Astrobiol Inst, Yokosuka, Kanagawa, Japan; [Ikehara, Minoru] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi 7838502, Japan	Van Kranendonk, MJ (reprint author), Univ New S Wales, Sch Biol Earth & Environm Sci, Australian Ctr Astrobiol, Kensington, NSW 2052, Australia.	m.vankranendonk@unsw.edu.au			University of New South Wales, Australia (UNSW); Agouron Institute; UNSW; Japanese Society for Promotion of Sciences (JSPS KAKENHI) [20340146, 24654164]; Ito Science Foundation; Centre for Advanced Marine Core Research (CMCR), Kochi University [10A006, 10B006, 11A014, 11B012]	MVK would like to acknowledge funding support from University of New South Wales, Australia (UNSW) and the Agouron Institute. RM is grateful to the UNSW for a post-doctoral fellowship (2012-2013) and subsequently a Research Fellowship (2014) that enabled him to carry out this research. This study was partly supported by funding from the Japanese Society for Promotion of Sciences (JSPS KAKENHI, nos. 20340146 and 24654164) and from Ito Science Foundation to KEY. This study was performed under the cooperative research programme of the Centre for Advanced Marine Core Research (CMCR), Kochi University (nos. 10A006, 10B006, 11A014, and 11B012). David Flannery and Malcolm Walter are thanked for discussions regarding the carbonate beach rock. Two anonymous reviews provided many helpful comments that clarified the manuscript. This is publication number 500 of the Australian Centre for Excellence for Core to Crust Fluid Systems.	Allen J.R.L., 1984, SEDIMENTARY STRUCTUR; ALLEN JRL, 1970, SEDIMENTOLOGY, V14, P5, DOI 10.1111/j.1365-3091.1970.tb00179.x; Altermann W., 2007, SPACE SCI REV, V135, P55; ANDERTON R, 1976, SEDIMENTOLOGY, V23, P429, DOI 10.1111/j.1365-3091.1976.tb00062.x; Martin DM, 2000, PRECAMBRIAN RES, V99, P33, DOI 10.1016/S0301-9268(99)00053-4; LOWE DR, 1974, J SEDIMENT PETROL, V44, P484; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; DEBOER PL, 1989, J SEDIMENT PETROL, V59, P912; Hannah JL, 2004, EARTH PLANET SC LETT, V225, P43, DOI [10.1016/j.epsl.2004.06.013, 10.1016/j.espl.2004.06.013]; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; Mazumder R, 2005, EARTH-SCI REV, V69, P79, DOI 10.1016/j.earscirev.2004.07.004; ASHLEY GM, 1982, SEDIMENTOLOGY, V29, P67, DOI 10.1111/j.1365-3091.1982.tb01709.x; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Bekker A, 2001, AM J SCI, V301, P261, DOI 10.2475/ajs.301.3.261; Martin DM, 1998, ECON GEOL BULL SOC, V93, P1084; DOTT RH, 1982, GEOL SOC AM BULL, V93, P663, DOI 10.1130/0016-7606(1982)93<663:HSSOIV>2.0.CO;2; Pratt BR, 1998, SEDIMENT GEOL, V117, P1, DOI 10.1016/S0037-0738(98)00023-2; Shanmugam G, 2003, MAR PETROL GEOL, V20, P471, DOI 10.1016/S0264-8172(03)00063-1; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Bhattacharya HN, 1998, SEDIMENT GEOL, V119, P239, DOI 10.1016/S0037-0738(98)00051-7; Williford KH, 2011, GEOCHIM COSMOCHIM AC, V75, P5686, DOI 10.1016/j.gca.2011.07.010; JOHNSON HD, 1977, SEDIMENTOLOGY, V24, P245, DOI 10.1111/j.1365-3091.1977.tb00256.x; Ghienne JF, 2003, PALAEOGEOGR PALAEOCL, V189, P117, DOI 10.1016/S0031-0182(02)00635-1; Williams GE, 2000, REV GEOPHYS, V38, P37, DOI 10.1029/1999RG900016; Sakurai R, 2005, PRECAMBRIAN RES, V138, P255, DOI 10.1016/j.precamres.2005.05.008; Evans DA, 1997, NATURE, V386, P262, DOI 10.1038/386262a0; KNELLER BC, 1995, SEDIMENTOLOGY, V42, P607, DOI 10.1111/j.1365-3091.1995.tb00395.x; Plint AG, 2000, GEOL SOC SPEC PUBL, V172, P1, DOI 10.1144/GSL.SP.2000.172.01.01; Myrow PM, 2002, J SEDIMENT RES, V72, P641, DOI 10.1306/022102720641; Muller SG, 2005, GEOLOGY, V33, P577, DOI 10.1130/G21482.1; Basilici G, 2012, SEDIMENT GEOL, V267, P73, DOI 10.1016/j.sedgeo.2012.05.012; DUKE WL, 1985, SEDIMENTOLOGY, V32, P167, DOI 10.1111/j.1365-3091.1985.tb00502.x; SMITH RE, 1982, J PETROL, V23, P75; Stow DAV, 2000, MAR PETROL GEOL, V17, P145, DOI 10.1016/S0264-8172(99)00051-3; Barley ME, 1997, NATURE, V385, P55, DOI 10.1038/385055a0; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shanmugam G, 2002, EARTH-SCI REV, V58, P311, DOI 10.1016/S0012-8252(02)00065-X; Young GM, 2001, SEDIMENT GEOL, V141, P233, DOI 10.1016/S0037-0738(01)00076-8; NOTTVEDT A, 1987, GEOLOGY, V15, P357, DOI 10.1130/0091-7613(1987)15<357:MFTCOO>2.0.CO;2; Mazumder R, 2005, SEDIMENT GEOL, V176, P167, DOI 10.1016/j.sedgeo.2004.12.011; Dumas S, 2006, GEOLOGY, V34, P1073, DOI 10.1130/G22930A.1; Condie KC, 2009, EARTH PLANET SC LETT, V282, P294, DOI 10.1016/j.epsl.2009.03.033; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Martin DM, 2010, AUST J EARTH SCI, V57, P911, DOI 10.1080/08120099.2010.510172; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Eriksson PG, 1998, SEDIMENT GEOL, V120, P5, DOI 10.1016/S0037-0738(98)00026-8; JOPLING AV, 1968, J SEDIMENT PETROL, V38, P971; Dumas S, 2005, J SEDIMENT RES, V75, P501, DOI 10.2110/jsr.2005.039; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Eriksson PG, 1999, PRECAMBRIAN RES, V97, P269, DOI 10.1016/S0301-9268(99)00035-2; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Mazumder R, 2006, SEDIMENT GEOL, V186, P19, DOI 10.1016/j.sedgeo.2005.12.002; Myrow PM, 1996, J SEDIMENT RES, V66, P875; PRATT BR, 1994, GEOLOGY, V22, P1091, DOI 10.1130/0091-7613(1994)022<1091:SITMAF>2.3.CO;2; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Lien T, 2006, NORW J GEOL, V86, P71; BARRETT TJ, 1989, SEDIMENTOLOGY, V36, P221, DOI 10.1111/j.1365-3091.1989.tb00604.x; Bekker A, 2005, PRECAMBRIAN RES, V137, P167, DOI 10.1016/j.precamres.2005.03.009; BLAKE TS, 1992, TECTONICS, V11, P1415, DOI 10.1029/92TC00339; Boggs S, 2009, PETROLOGY SEDIMENTAR; BOSE PK, 1988, SEDIMENT GEOL, V59, P275, DOI 10.1016/0037-0738(88)90081-4; Bose PK, 1997, PRECAMBRIAN RES, V84, P63, DOI 10.1016/S0301-9268(97)00016-8; BOSE PK, 1983, GEOL MAG, V120, P73; Bouma A. H., 1962, SEDIMENTOLOGY SOME F; Lindsay JF, 2002, PRECAMBRIAN RES, V114, P1, DOI 10.1016/S0301-9268(01)00219-4; BRENCHLEY PJ, 1982, J SEDIMENT PETROL, V52, P1257; BRENCHLEY PJ, 1977, J SEDIMENT PETROL, V47, P819; COTTER E, 1990, SEDIMENT GEOL, V69, P245, DOI 10.1016/0037-0738(90)90052-U; Creager J.S., 1972, SHELF SEDIMENT TRANS, P447; De Raaf J. F. M., 1977, SEDIMENTOLOGY, V24, P431; Dzulyniski S., 1996, ROCZNIK POLSKIEGO TO, V64, P101; ERIKSSON KA, 1979, PRECAMBRIAN RES, V8, P153, DOI 10.1016/0301-9268(79)90027-5; Eriksson KA, 2000, GEOLOGY, V28, P831, DOI 10.1130/0091-7613(2000)28<831:QTOTRT>2.0.CO;2; Eriksson PG, 2014, GONDWANA RES, V25, P30, DOI 10.1016/j.gr.2012.08.005; Eyles N, 2008, PALAEOGEOGR PALAEOCL, V258, P89, DOI 10.1016/j.palaeo.2007.09.021; Halverson GP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000244; Harms J.C., 1975, SOC SED GEOL SEPM SH, V2; Hilburn IA, 2005, EARTH PLANET SC LETT, V232, P315, DOI 10.1016/j.epsl.2004.11.025; HOFMANN HJ, 1980, CAN J EARTH SCI, V17, P1351, DOI 10.1139/e80-142; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; HORWITZ RC, 1982, PRECAMBRIAN RES, V19, P191, DOI 10.1016/0301-9268(82)90059-6; Horwitz R.C., 1987, MG31 CSIRO DIV MIN G; Johnson HD, 1996, SEDIMENTARY ENV PROC, P232; Johnson S.P., 2013, BIRTH SUPERCONTINENT, P78; Krapez B, 1996, AUST J EARTH SCI, V43, P355, DOI 10.1080/08120099608728260; KULM LD, 1975, J GEOL, V83, P145; Leeder M.R., 1999, SEDIMENTOLOGY SEDIME; Lowe D. R., 1975, SEDIMENTOLOGY, V22, P175; LOWE DR, 1982, J SEDIMENT PETROL, V52, P279; Martin DM, 1999, GEOL SOC AM BULL, V111, P189, DOI 10.1130/0016-7606(1999)111<0189:DSAIOP>2.3.CO;2; Martin DM, 2008, PRECAMBRIAN RES, V166, P93, DOI 10.1016/j.precamres.2007.07.027; Mazumder R., 2014, PRECAMBRIAN IN PRESS; Mazumder R, 2013, MAR PETROL GEOL, V43, P320, DOI 10.1016/j.marpetgeo.2013.01.006; Mazumder R, 2004, GEOLOGY, V32, P841, DOI 10.1130/G20424.1; Mazumder R, 2013, PRECAMBRIAN RES, V231, P98, DOI 10.1016/j.precamres.2013.03.018; Mazumder R, 2009, GEOL SOC SPEC PUBL, V323, P301, DOI 10.1144/SP323.15; Melezhik V.A., 2012, READING ARCH EARTHS, P1059; MORRIS RC, 1983, PRECAMBRIAN RES, V21, P273, DOI 10.1016/0301-9268(83)90044-X; Nelson D.R., 2004, COMPILATION GEOCHRON; Pant CC, 1999, J ASIAN EARTH SCI, V17, P353, DOI 10.1016/S0743-9547(98)00060-9; Pattison S.A.J., 2005, J SEDIMENT RES, V75, P424; Powell C.McA., 1994, EXCURSION GUIDEBOOK; RAMSAY JG, 1961, J GEOL, V69, P84; REINECK H. E., 1980, DEPOSITIONAL SEDIMEN; SEILACHER A, 1984, MAR GEOL, V55, P1, DOI 10.1016/0025-3227(84)90129-4; Seymour D.B., 1998, GEOLOGICAL SERIES, P36; SHANMUGAM G, 1994, AAPG BULL, V78, P910; Shepard F.P., 1969, AAPG BULL, V53, P39; Simons D.B., 1965, SOC EC PALEONTOLOGIS, V12, P34; Southard J.B., 1990, J SEDIMENT PETROL, V60, P458; Stow D.A.V., 1996, SEDIMENTARY ENV PROC, P395; Swift D.J.P., 1991, INT ASS SEDIMENTOLOG, V14, P13; Takehara M., 2010, 5 INT ARCH S GEOL SU, P223; Taylor S., 1985, CONTINENTAL CRUST IT; Thorne A.M., 1996, GEOLOGICAL SERIES EX, P15; Trendall A.F., 1970, BULLETIN, V119; Trendall A.F., 1979, REVISION MOUNT BRUCE, P63; Trendall A.F., 1981, EARTHS PREPLEISTOCEN, P555; Van Kranendonk M. J., 2012, GEOLOGIC TIME SCALE, P299, DOI DOI 10.1016/B978-0-444-59425-9.00016-0; Van Kranendonk M.J., 2014, GEOL SOC AM IN PRESS; Van Kranendonk M.J., 2010, 201021 GEOL SURV W A; van Loon A.J., 2009, GEOLOGOS, V15, P3; Visser R., 1980, GEOLOGY, V8, P543; Walter MR, 1976, STROMATOLITES; Williams GE, 1997, EARTH PLANET SC LETT, V153, P157, DOI 10.1016/S0012-821X(97)00181-7	126	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-9268	1872-7433		PRECAMBRIAN RES	Precambrian Res.	JAN	2015	256						314	343		10.1016/j.precamres.2014.09.015		30	Geosciences, Multidisciplinary	Geology	AZ2UZ	WOS:000348088900019		
J	Morisaki, S; Miura, K; Higashijima, A; Abe, S; Miura, S; Hasegawa, Y; Yoshida, A; Kaneuchi, M; Yoshiura, K; Masuzaki, H				Morisaki, Shintaro; Miura, Kiyonori; Higashijima, Ai; Abe, Shuhei; Miura, Shoko; Hasegawa, Yuri; Yoshida, Atsushi; Kaneuchi, Masanori; Yoshiura, Koh-ichiro; Masuzaki, Hideaki			Effect of labor on plasma concentrations and postpartum clearance of cell-free, pregnancy-associated, placenta-specific microRNAs	PRENATAL DIAGNOSIS			English	Article							MATERNAL PLASMA; DNA; IDENTIFICATION; C19MC	Objective This study aimed to investigate the effect of labor on plasma concentrations of cell-free, pregnancy-associated, placenta-specific microRNAs (miRNAs) before and after delivery. Method In the non-labor group (32 women), cesarean section (C/S) was performed before the beginning of labor. In the labor group (32 women), C/S was performed after the beginning of labor. Plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs (miR-515-3p, miR-517a, miR-517c, and miR-518b) were measured by real-time quantitative PCR. Each miRNA concentration was compared between the non-labor and labor groups. Results Before C/S, plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs in the labor group were significantly higher than those in the non-labor group (P=0.001 for 515-3p, P=0.002 for 517a, P=0.001 for 517c, and P=0.003 for 518b). Twenty-four hours after delivery, plasma concentrations of cell-free, pregnancy-associated, placenta-specific miRNAs in the labor group were significantly higher than those in the non-labor group (P=0.002 for 515-3p, P=0.017 for 517a, P=0.043 for 517c, and P=0.009 for 518b). Conclusion The presence of labor affects cell-free, pregnancy-associated, placenta-specific miRNA levels in maternal plasma. Labor also affects postpartum clearance of these miRNAs 24h after delivery. (c) 2014 John Wiley & Sons, Ltd.	[Morisaki, Shintaro; Miura, Kiyonori; Higashijima, Ai; Abe, Shuhei; Miura, Shoko; Hasegawa, Yuri; Yoshida, Atsushi; Kaneuchi, Masanori; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan; [Yoshiura, Koh-ichiro] Nagasaki Univ, Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan	Miura, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 852, Japan.	kiyonori@nagasaki-u.ac.jp			JSPS KAKENHI [26462495, 24791712, 22591827]	K.M., S.M., and H.M. were supported by JSPS KAKENHI, by grant numbers 26462495, 24791712, and 22591827, respectively.	Avissar-Whiting M, 2010, REPROD TOXICOL, V29, P401, DOI 10.1016/j.reprotox.2010.04.004; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Mendell JT, 2005, CELL CYCLE, V4, P1179; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; Hasegawa Y, 2013, CLIN CHEM, V59, P1410, DOI 10.1373/clinchem.2013.206391; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Chiu RWK, 2010, CLIN CHEM, V56, P1656, DOI 10.1373/clinchem.2010.153684; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/18604124347821, DOI 10.1155/2013/186041, 10.1155/2013/186041]; Huis L, 2008, PRENAT DIAGN, V28, P304; Laus TK, 2000, AM J OBSTET GYNECOL, V183, P712; Lees RC, 1993, CELL, V75, P843; Los YM, 2007, NAT REV GENET, V8, P71; Luos SS, 2009, BIOL REPROD, V81, P717; Maccani MA, 2010, EPIGENETICS-US, V5, P583, DOI 10.4161/epi.5.7.12762; Maron JL, 2007, AM J MED GENET C, V145C, P5, DOI 10.1002/ajmg.c.30115; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Nahs DY, 2013, KOREAN CIRC J, V43, P255; Ngs EK, 2002, CLIN CHEM, V48, P1212	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-3851	1097-0223		PRENATAL DIAG	Prenat. Diagn.	JAN	2015	35	1					44	50		10.1002/pd.4479		7	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	AZ3GC	WOS:000348114500008		
S	Ohmori, K		Dinner, AR		Ohmori, Kenji			EXPLORING QUANTUM-CLASSICAL BOUNDARY	PROCEEDINGS OF THE 240 CONFERENCE: SCIENCE'S GREAT CHALLENGES	Advances in Chemical Physics		English	Review	240th Conference on Science's Great Challenges	SEP 13-15, 2012	Univ Chicago, Chicago, IL		Univ Chicago		WAVE-PACKET; INTERFERENCE		Natl Inst Nat Sci, Inst Mol Sci, Dept Photo Mol Sci, Okazaki, Aichi 4448585, Japan	Ohmori, K (reprint author), Natl Inst Nat Sci, Inst Mol Sci, Dept Photo Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.						Ohmori K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093002; Ohmori K, 2009, ANNU REV PHYS CHEM, V60, P487, DOI 10.1146/annurev.physchem.59.032607.093818; Katsuki H, 2006, SCIENCE, V311, P1589, DOI 10.1126/science.1121240; Goto H, 2011, NAT PHYS, V7, P383, DOI [10.1038/nphys1960, 10.1038/NPHYS1960]; Hosaka K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.180501; Katsuki H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014507; Katsuki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3801; Katsuki H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103602; Ohmori K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.243003; Okano Y, 2011, FARADAY DISCUSS, V153, P375, DOI 10.1039/c1fd00070e; Steeds J., 2003, PHYS WORLD MAY 2003, P20; Tonomura K., 1989, AM J PHYS, V57, P117	12	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0065-2385		978-1-118-95960-2; 978-1-118-95959-6	ADV CHEM PHYS	Adv. Chem. Phys.		2015	157						19	24				6	Physics, Atomic, Molecular & Chemical	Physics	BB9TT	WOS:000348650300003		
J	Ohashi, M; Saitoh, A; Yamada, M; Oka, JI; Yamada, M				Ohashi, Masanori; Saitoh, Akiyoshi; Yamada, Misa; Oka, Jun-Ichiro; Yamada, Mitsuhiko			Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice	PSYCHOPHARMACOLOGY			English	Article						Microdialysis; Innate anxiety; Animal model; Glutamate; Anxiolytics; Riluzole; Prelimbic; Anxiety disorder	OPEN-LABEL TRIAL; OBSESSIVE-COMPULSIVE DISORDER; GLUTAMATE RELEASE; AGENT RILUZOLE; RAT; DEPRESSION; CHANNELS; SODIUM; PROJECTIONS; MOOD	We previously demonstrated in mice that the activation of prelimbic medial prefrontal cortex (PL) with the sodium channel activator veratrine induces anxiety-like behaviors via NMDA receptor-mediated glutamatergic neurotransmission. Riluzole directly affects the glutamatergic system and has recently been suggested to have an anxiolytic-like effect in both experimental animals and patients with anxiety disorders. We investigated the effects of co-perfusion of riluzole on veratrine-induced anxiety-like behaviors in mice. Extracellular glutamate levels were measured in 7-week-old male C57BL6 mice by using an in vivo microdialysis-HPLC/ECD system, and behaviors were assessed simultaneously in an open field (OF) test. Basal levels of glutamate were measured by collecting samples every 10 min for 60 min. The medium containing drugs was perfused for 30 min, and the OF test was performed during the last 10 min of drug perfusion. After the drug treatments, the drug-containing medium was switched to perfusion of control medium lacking drugs, and then samples were collected for another 90 min. Riluzole co-perfusion attenuated veratrine-induced increase in extracellular glutamate levels in the PL and completely diminished veratrine-induced anxiety-like behaviors. Interestingly, riluzole perfusion alone in the PL did not affect the basal levels of glutamate and anxiety-like behaviors. Our results suggest that compounds like riluzole that inhibit glutamatergic function in the PL are possible candidates for novel anxiolytics.	[Ohashi, Masanori; Saitoh, Akiyoshi; Yamada, Misa; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo 1878553, Japan; [Ohashi, Masanori; Oka, Jun-Ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Chiba 2788510, Japan	Saitoh, A (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, 4-1-1 Ogawahigashimachi, Tokyo 1878553, Japan.	asaitoh@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan [24-2]	This research was supported by research grants from Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, Japan.	Abarca C, 2000, EUR J PHARMACOL, V403, P67, DOI 10.1016/S0014-2999(00)00502-1; Duprat F, 2000, MOL PHARMACOL, V57, P906; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Azbill RD, 2000, BRAIN RES, V871, P175, DOI 10.1016/S0006-8993(00)02430-6; Irifune M, 2007, ANESTH ANALG, V104, P1415, DOI 10.1213/01.ane.0000263267.04198.36; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Fumagalli E, 2008, EUR J PHARMACOL, V578, P171, DOI 10.1016/j.ejphar.2007.10.023; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Grant P, 2007, J CHILD ADOL PSYCHOP, V17, P761, DOI 10.1089/cap.2007.0021; Frizzo MED, 2004, CELL MOL NEUROBIOL, V24, P123, DOI 10.1023/B:CEMN.0000012717.37839.07; Coric V, 2003, PSYCHOPHARMACOLOGY, V167, P219, DOI 10.1007/s00213-003-1396-z; Perrot-Sinal TS, 2004, BRAIN RES, V1027, P161, DOI 10.1016/j.brainres.2004.08.056; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Pittenger C, 2008, CNS DRUGS, V22, P761, DOI 10.2165/00023210-200822090-00004; Coric V, 2005, BIOL PSYCHIAT, V58, P424, DOI 10.1016/j.biopsych.2005.04.043; Sugiyama A, 2012, NEUROPHARMACOLOGY, V62, P2489, DOI 10.1016/j.neuropharm.2012.02.012; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Enginar N, 2008, PHARMACOL BIOCHEM BE, V89, P450, DOI 10.1016/j.pbb.2008.02.001; Takahashi K, 2011, BEHAV BRAIN RES, V216, P46, DOI 10.1016/j.bbr.2010.07.002; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Mathew SJ, 2005, AM J PSYCHIAT, V162, P2379, DOI 10.1176/appi.ajp.162.12.2379; Wang SJ, 2004, NEUROSCIENCE, V125, P191, DOI 10.1016/j.neuroscience.2004.01.019; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; Jehle T, 2000, BRIT J PHARMACOL, V130, P1227, DOI 10.1038/sj.bjp.0703424; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; Paxinos G, 2008, MOUSE BRAIN STEREOTA; Sasaki-Hamada S, 2013, J PHARMACOL SCI, V122, P232, DOI 10.1254/jphs.13052SC; Takeda A, 2007, BEHAV BRAIN RES, V177, P1, DOI 10.1016/j.bbr.2006.11.023; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	37	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JAN	2015	232	2					391	398		10.1007/s00213-014-3676-1		8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AZ3IL	WOS:000348120700008		
J	Akamatsu, K; Shikazono, N; Saito, T				Akamatsu, Ken; Shikazono, Naoya; Saito, Takeshi			Localization Estimation of Ionizing Radiation-Induced Abasic Sites in DNA in the Solid State Using Fluorescence Resonance Energy Transfer	RADIATION RESEARCH			English	Article							DOUBLE-STRAND BREAKS; MULTIPLY DAMAGED SITES; ESCHERICHIA-COLI; APURINIC/APYRIMIDINIC SITES; EXONUCLEASE-III; TRACK STRUCTURE; EV ELECTRONS; HEAVY-IONS; IN-VIVO; LESIONS	Clustered DNA damage is considered an important factor in determining the biological consequences of ionizing radiation. In this study, we successfully estimated the localization of abasic sites (APs) in DNA exposed to ionizing radiation using fluorescence resonance energy transfer (FRET) without any involvement of repair enzyme functions. A linearized plasmid (pUC19 digested by Sma I) was irradiated with: Co-60 gamma rays; He-4(2+) (2.0 MeV/u) particles; and the C-12(5+) (0.37 MeV/u) particles in the solid state. A donor or acceptor fluorescent probe with a nucleophilic O-amino group was used to label APs. The results showed that the C-12(5+) particle likely produced close APs within a track. The apparent distance calculated from the observed FRET efficiency (E) of around 0.10 was estimated to be approximately 17 base pairs. On the other hand, E values of Co-60 gamma rays and the He-4(2+) beam were less than those of the C-12(5+) beam, increased with increasing AP density (the average number of APs per base pair), and were slightly greater than those of randomly distributed APs. We propose that the FRET method provides a degree of localization regardless of whether an AP cluster is single-stranded or bistranded DNA damage. (C) 2015 by Radiation Research Society	[Akamatsu, Ken; Shikazono, Naoya] Japan Atom Energy Agcy, Kansai Photon Sci Inst, Quantum Beam Sci Directorate, Irradiat Cell Anal Grp, Kizugawa, Kyoto 6190215, Japan; [Saito, Takeshi] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Akamatsu, K (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, 8-1-7 Umemidai, Kizugawa, Kyoto 6190215, Japan.	akamatsu.ken@jaea.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22310038]	We thank Dr. Kengo Moribayashi (Japan Atomic Energy Agency) for helpful discussions. This work was supported by Grants-in-aid for Scientific Research [Scientific Research (B): 22310038] from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akamatsu K, 2013, ANAL BIOCHEM, V433, P171, DOI 10.1016/j.ab.2012.10.004; Akamatsu K., 2010, RAD CHEM, V89, P3; Akamatsu K, 2007, ANAL BIOCHEM, V362, P229, DOI 10.1016/j.ab.2006.12.006; Albani JR, 2007, PRINCIPLES AND APPLICATIONS OF FLUORESCENCE SPECTROSCOPY, P197; Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Huels MA, 2003, J AM CHEM SOC, V125, P4467, DOI 10.1021/ja029527x; Sutherland BM, 2000, BIOCHEMISTRY-US, V39, P8026, DOI 10.1021/bi9927989; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Shikazono N, 2013, MUTAT RES-FUND MOL M, V749, P9, DOI 10.1016/j.mrfmmm.2013.07.010; Moribayashi K, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012702; Pearson CG, 2004, NUCLEIC ACIDS RES, V32, P263, DOI 10.1093/nar/gkh150; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; MAGEE JL, 1980, J PHYS CHEM-US, V84, P3529, DOI 10.1021/j100463a008; Terato H, 2008, J RADIAT RES, V49, P133, DOI 10.1269/jrr.07089; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Nakamura J, 1998, CANCER RES, V58, P222; Nikjoo H, 1997, INT J RADIAT BIOL, V71, P467; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; ROSA S, 1991, NUCLEIC ACIDS RES, V19, P5569, DOI 10.1093/nar/19.20.5569; Malyarchuk S, 2004, NUCLEIC ACIDS RES, V32, P5721, DOI 10.1093/nar/gkh911; Holley WR, 1996, RADIAT RES, V145, P188, DOI 10.2307/3579174; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Becker D, 1996, RADIAT RES, V146, P361, DOI 10.2307/3579297; Chaudhry MA, 1997, J BIOL CHEM, V272, P15650, DOI 10.1074/jbc.272.25.15650; CHAUDHRY MA, 1995, J MOL BIOL, V249, P914; D'souza DI, 2003, NUCLEIC ACIDS RES, V31, P4573, DOI 10.1093/nar/gkg493; Georgakilas AG, 2002, NUCLEIC ACIDS RES, V30, P2800, DOI 10.1093/nar/gkf393; Gromova M, 1998, INT J RADIAT BIOL, V74, P81, DOI 10.1080/095530098141753; Gromova M, 1998, J CHEM SOC PERK T 2, P1365, DOI 10.1039/a801069b; Harrison L, 2006, DNA REPAIR, V5, P324, DOI 10.1016/j.dnarep.2005.10.009; Harrison L, 1998, NUCLEIC ACIDS RES, V26, P932, DOI 10.1093/nar/26.4.932; IDE H, 1993, BIOCHEMISTRY-US, V32, P8276, DOI 10.1021/bi00083a031; Johnson I, 2010, MOZI COMPLETE TRANSL, P39; MOZUMDER A, 1974, J CHEM PHYS, V60, P1145, DOI 10.1063/1.1681125; NIST, XRAY MASS ATT COEFF; Ottolenghi A, 1997, RADIAT ENVIRON BIOPH, V36, P97, DOI 10.1007/s004110050060; Tanaka A, 1997, NUCL INSTRUM METH B, V129, P42, DOI 10.1016/S0168-583X(97)00131-6; Tanaka S, 1997, IRACM CODE SYSTEM CA, P97; Urushibara A, 2008, INT J RADIAT BIOL, V84, P23, DOI 10.1080/09553000701616072	43	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	JAN	2015	183	1					105	113		10.1667/RR13780.1		9	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AZ0WI	WOS:000347962400009		
J	Tanaka, A				Tanaka, Ayumu			The impacts of natural disasters on plants' growth: Evidence from the Great Hanshin-Awaji (Kobe) earthquake	REGIONAL SCIENCE AND URBAN ECONOMICS			English	Article						Natural disasters; Difference-in-difference; Plant growth		This study is the first attempt to examine the impacts of a natural disaster at the plant level, focusing on the Great Hanshin-Awaji (Kobe) earthquake, which occurred in 1995 and affected numerous plants in Kobe city. In this study, I use plant-level data to re-examine the creative disaster hypothesis, which states that natural disasters enhance growth of firms or plants in stricken areas. I employ the matching method together with the difference-in-difference (DID) approach to reveal the quake's effects. While most country and firm-level evidences support the creative disaster hypothesis, this study shows that the plants that survived in Kobe's most devastated districts faced severe negative effects from the quake in terms of employment and value added growth during the subsequent three years. (C) 2014 Elsevier B.V. All rights reserved.	RIETI, Tokyo 1008901, Japan	Tanaka, A (reprint author), RIETI, 1-3-1 Kasumigaseki Chiyoda Ku, Tokyo 1008901, Japan.	tanaka-ayumu@rieti.go.jp					Cuaresma JC, 2008, ECON INQ, V46, P214, DOI 10.1111/j.1465-7295.2007.00063.x; Horwich G, 2000, ECON DEV CULT CHANGE, V48, P521, DOI 10.1086/452609; Angelini P, 2008, AM ECON REV, V98, P426, DOI 10.1257/aer.98.1.426; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Belasen AR, 2009, J HUM RESOUR, V44, P251; Chang SE, 2000, J TRANSP GEOGR, V8, P53, DOI 10.1016/S0966-6923(99)00023-X; DuPont W., 2014, EC DEV CULT IN PRESS; Hayashi T., 2011, EC HUGE DISASTERS; Hondai S., 1998, KOKUMIN KEIZAI ZASSH, V178, P29; Loiter A.M., 2009, ENVIRON RESOUR ECON, V43, P333; Sasaki M., 2012, JAP LABOR REV, V9, P42; Sawada Y, 2008, J MONEY CREDIT BANK, V40, P463, DOI 10.1111/j.1538-4616.2008.00122.x; Sawada Y, 2007, APPL ECON LETT, V14, P303, DOI 10.1080/13504850500447364; Siodla J., 2012, RAZING SAN FRA UNPUB	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0462	1879-2308		REG SCI URBAN ECON	Reg. Sci. Urban Econ.	JAN	2015	50						31	41		10.1016/j.regsciurbeco.2014.11.002		11	Economics; Environmental Studies; Urban Studies	Business & Economics; Environmental Sciences & Ecology; Urban Studies	AZ5JJ	WOS:000348257200003		
J	Sato, Y; Xiao, W				Sato, Yasuhiro; Xiao, Wei			Land development, search frictions and city structure	REGIONAL SCIENCE AND URBAN ECONOMICS			English	Article						Land development; City structure; Search frictions; Spatial mismatch	SPATIAL MISMATCH HYPOTHESIS; WELFARE	This paper analyzes the interactions between labor and housing (and land) markets in a city. We develop a monocentric city model involving land development and frictional unemployment and characterize the city's spatial configurations in equilibrium. To better understand the properties of equilibria, we implement a comparative steady state analysis. Further, we explore the effects of policies such as (a) a tax on land development to subsidize residents' consumption, (b) a subsidy to improve the transportation infrastructure financed by a lump-sum tax, and (c) income transfers from employed to unemployed workers. Finally, we provide an extension wherein the job arrival rate is endogenous and depends on distance to jobs. (C) 2014 Elsevier B.V. All rights reserved.	[Sato, Yasuhiro] Osaka Univ, Grad Sch Econ, Suita, Osaka 565, Japan; [Xiao, Wei] Southwestern Univ Finance & Econ, Res Inst Econ & Management, Chengdu, Peoples R China	Xiao, W (reprint author), Southwestern Univ Finance & Econ, Res Inst Econ & Management, Chengdu, Peoples R China.	ysato@econ.osaka-u.ac.jp; xiaow@swufe.edu.cn					Alonso W., 1964, LOCATION AND LAND US; Wasmer E, 2002, J URBAN ECON, V51, P515, DOI 10.1006/juec.2001.2256; HOLZER HJ, 1991, URBAN STUD, V28, P105, DOI 10.1080/00420989120080071; Smith TE, 2003, J URBAN ECON, V54, P129, DOI 10.1016/S0094-1190(03)00040-8; Ihlanfeldt KR, 1998, HOUS POLICY DEBATE, V9, P849; Mills ES, 1967, AM ECON REV, V57, P197; Brueckner J.K., 1987, HDB REGIONAL URBAN E, V2, P821, DOI 10.1016/S1574-0080(87)80006-8; Coulson Edward N., 2001, J LABOR ECON, V19, P949; Fujita M., 1989, URBAN ECONOMIC THEOR; HARTWICK J, 1976, J ECON THEORY, V13, P396, DOI 10.1016/0022-0531(76)90049-1; Holzer HJ, 2000, J URBAN ECON, V48, P365, DOI 10.1006/juec.2000.2171; Ihlanfeldt KR, 1997, J URBAN ECON, V41, P218, DOI 10.1006/juec.1996.1098; Jencks C., 1990, INNER CITY POVERTY U, P187; Kain J., 1992, HOUS POLICY DEBATE, V3, P371, DOI DOI 10.1080/10511482.1992.9521100; KAIN JF, 1968, Q J ECON, V82, P175, DOI 10.2307/1885893; Kanemoto Y., 2002, J APPL REGIONAL SCI, V7, P1; Kawata K., 2012, EXPLICIT SPATIAL FRI; Muth R. F, 1969, CITIES HOUSING; Pissarides C., 2000, EQUILIBRIUM UNEMPLOY; Sato Y, 2001, J URBAN ECON, V50, P313, DOI 10.1006/juec.2001.2219; WHEATON WC, 1974, J ECON THEORY, V9, P223, DOI 10.1016/0022-0531(74)90068-4; WHEATON WC, 1976, J URBAN ECON, V3, P31, DOI 10.1016/0094-1190(76)90056-5; Xiao W, 2014, J REGIONAL SCI, V54, P422, DOI 10.1111/jors.12098; Zenou Y., 2000, EC CITIES THEORETICA, P343; Zenou Y., 2009, URB LAB EC	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0462	1879-2308		REG SCI URBAN ECON	Reg. Sci. Urban Econ.	JAN	2015	50						63	76		10.1016/j.regsciurbeco.2014.10.005		14	Economics; Environmental Studies; Urban Studies	Business & Economics; Environmental Sciences & Ecology; Urban Studies	AZ5JJ	WOS:000348257200005		
J	Tachikawa, Y; Nagasawa, Y; Furuhashi, S; Cui, L; Yamaguchi, E; Tada, N; Miura, T; Itoh, A				Tachikawa, Yuma; Nagasawa, Yoshitomo; Furuhashi, Sohei; Cui, Lei; Yamaguchi, Eiji; Tada, Norihiro; Miura, Tsuyoshi; Itoh, Akichika			Metal-free synthesis of imidazopyridine from nitroalkene and 2-aminopyridine in the presence of a catalytic amount of iodine and aqueous hydrogen peroxide	RSC ADVANCES			English	Article							VISIBLE-LIGHT IRRADIATION; ONE-POT SYNTHESIS; BETA-KETO-ESTERS; MOLECULAR-IODINE; MULTICOMPONENT SYNTHESIS; REGIOSPECIFIC SYNTHESIS; ORGANIC-MOLECULES; FLUORESCENT LAMP; PHENACYL IODIDES; BENZYL-ALCOHOLS	We have developed a metal-free synthetic method for 3-nitroimidazo[1,2-a] pyridines from nitroalkenes and 2-aminopyridines using catalytic amounts of iodine and aqueous hydrogen peroxide as a terminal oxidant.	[Tachikawa, Yuma; Nagasawa, Yoshitomo; Furuhashi, Sohei; Cui, Lei; Yamaguchi, Eiji; Tada, Norihiro; Itoh, Akichika] Gifu Pharmaceut Univ, Gifu 5011196, Japan; [Miura, Tsuyoshi] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan	Itoh, A (reprint author), Gifu Pharmaceut Univ, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	tmiura@toyaku.ac.jp; itoha@gifu-pu.ac.jp					ALMIRANT.L, 1965, J MED CHEM, V8, P305, DOI 10.1021/jm00327a007; Harrison TS, 2005, CNS DRUGS, V19, P65; Nair DK, 2012, ORG LETT, V14, P4580, DOI 10.1021/ol3020418; Cao H, 2014, ORG LETT, V16, P146, DOI 10.1021/ol4031414; Yan H, 2012, CHEM-ASIAN J, V7, P2028, DOI 10.1002/asia.201200319; Zhu CJ, 2011, CHEMSUSCHEM, V4, P1082, DOI 10.1002/cssc.201100228; Bienayme H, 1998, ANGEW CHEM INT EDIT, V37, P2234, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R; Nakayama H, 2007, TETRAHEDRON LETT, V48, P1131, DOI 10.1016/j.tetlet.2006.12.065; Filipan-Litvic M, 2008, TETRAHEDRON, V64, P5649, DOI 10.1016/j.tet.2008.04.040; Yan RL, 2012, J ORG CHEM, V77, P2024, DOI 10.1021/jo202447p; Mohan DC, 2013, J ORG CHEM, V78, P1266, DOI 10.1021/jo3025303; Rousseau AL, 2007, TETRAHEDRON LETT, V48, P4079, DOI 10.1016/j.tetlet.2007.04.008; Kariya A, 2014, RSC ADV, V4, P13191, DOI 10.1039/c3ra47863g; Bazin MA, 2013, TETRAHEDRON LETT, V54, P5378, DOI 10.1016/j.tetlet.2013.07.113; Stasyuk AJ, 2012, J ORG CHEM, V77, P5552, DOI 10.1021/jo300643w; Hanson SM, 2008, J MED CHEM, V51, P7243, DOI 10.1021/jm800889m; Santra S, 2013, ADV SYNTH CATAL, V355, P1065, DOI 10.1002/adsc.201201112; Gudmundsson KS, 2003, ORG LETT, V5, P1369, DOI 10.1021/ol0343616; Katritzky AR, 2003, J ORG CHEM, V68, P4935, DOI 10.1021/jo026797p; Husinec S, 2011, ORG LETT, V13, P2286, DOI 10.1021/ol200508x; Domling A, 2006, CHEM REV, V106, P17, DOI 10.1021/cr0505728; Uyanik M, 2014, SCIENCE, V345, P291, DOI 10.1126/science.1254976; Sun HP, 2012, J ORG CHEM, V77, P10745, DOI 10.1021/jo3021105; Cai YF, 2011, CHEM-EUR J, V17, P14916, DOI 10.1002/chem.201102453; Nobuta T, 2013, ORG LETT, V15, P574, DOI 10.1021/ol303389t; Maleki B, 2011, B KOREAN CHEM SOC, V32, P4366, DOI 10.5012/bkcs.2011.32.12.4366; Tada N, 2013, TETRAHEDRON LETT, V54, P256, DOI 10.1016/j.tetlet.2012.11.014; Ma LJ, 2011, CHEM COMMUN, V47, P11333, DOI 10.1039/c1cc13568f; Nobuta T, 2013, RSC ADV, V3, P10189, DOI 10.1039/c3ra41850b; Siddiqui IR, 2014, TETRAHEDRON LETT, V55, P1159, DOI 10.1016/j.tetlet.2013.12.088; Arias L, 2006, J HETEROCYCLIC CHEM, V43, P565; BARNES I, 1992, CHEM PHYS LETT, V196, P578, DOI 10.1016/0009-2614(92)85997-O; Enguehard-Gueiffier C, 2007, MINI-REV MED CHEM, V7, P888, DOI 10.2174/138955707781662645; Mishra S, 2011, SYNTHESIS-STUTTGART, P3463, DOI 10.1055/s-0030-1260255; Herath A, 2010, ORG LETT, V12, P412, DOI 10.1021/ol902433a; Jagadhane PB, 2014, SYNLETT, V25, P2636, DOI 10.1055/s-0034-1379185; Jereb M, 2004, CHEM COMMUN, P2614, DOI 10.1039/b409919b; Kanai N, 2010, ORG LETT, V12, P1948, DOI 10.1021/ol1003675; Kitagawa O., 1999, SYNLETT, P1191; LENGYEL I, 1993, INORG CHEM, V32, P5880, DOI 10.1021/ic00077a036; Kobayashi K, 2005, B CHEM SOC JPN, V78, P886, DOI 10.1246/bcsj.78.886; Nakayama H, 2006, CHEM PHARM BULL, V54, P1620, DOI 10.1248/cpb.54.1620; Nobuta T, 2010, SYNLETT, P2335; Nobuta T, 2012, SYNLETT, P2975, DOI 10.1055/s-0032-1317508; Nobuta T, 2011, ORG LETT, V13, P2576, DOI 10.1021/ol200681k; OHTA H, 1989, J ORG CHEM, V54, P1668, DOI 10.1021/jo00268a032; Omura K, 1996, J ORG CHEM, V61, P2006, DOI 10.1021/jo951455n; PAQUETTE J, 1985, CAN J CHEM, V63, P2444, DOI 10.1139/v85-404; Pavlinac J, 2006, SYNTHESIS-STUTTGART, P2603, DOI 10.1055/s-2006-942470; Pavlinac J, 2006, J ORG CHEM, V71, P1027, DOI 10.1021/jo052021n; Pavlinac J, 2007, ORG BIOMOL CHEM, V5, P699, DOI 10.1039/b614819k; Shomura M., 2011, SYNLETT, P2896; SUNDBERG RJ, 1988, J HETEROCYCLIC CHEM, V25, P129; Wang HG, 2011, ANGEW CHEM INT EDIT, V50, P5677, DOI 10.1002/anie.201100362; Wang XP, 2011, SYNTHESIS-STUTTGART, P2445, DOI 10.1055/s-0030-1260106; Yadav JS, 2000, SYNTHESIS-STUTTGART, P1532; Yan H, 2012, SYNLETT, P2961, DOI 10.1055/s-0032-1317685; Zamora HS, 2004, J HETEROCYCLIC CHEM, V41, P91; Zhu JP, 2003, EUR J ORG CHEM, P1133, DOI 10.1002/ejoc.200390167	59	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	13					9591	9593		10.1039/c4ra14970j		3	Chemistry, Multidisciplinary	Chemistry	AZ1BY	WOS:000347976500037		
J	Hasnat, MA; Islam, MA; Rashed, MA				Hasnat, Mohammad A.; Islam, Muhammad Amirul; Rashed, M. A.			Influence of electrode assembly on catalytic activation and deactivation of a Pt film immobilized H+ conducting solid electrolyte in electrocatalytic reduction reactions	RSC ADVANCES			English	Article							GLASSY-CARBON ELECTRODE; ORGANIC ELECTROCHEMISTRY; NITRATE REDUCTION; MEMBRANE REACTOR; SPE METHOD; PT-SPE; OXIDATION; PLATINUM; NANOPARTICLES; POLYMER	Symmetric (Cu-Pt vertical bar Nafion vertical bar Pt-Cu) and asymmetric (Pt vertical bar Nafion vertical bar Pt-Cu) assemblies were fabricated to study the nitrate reduction processes at the cathode. The electrocatalytic nitrate reduction reactions were performed in these assemblies in order to investigate the prerequisite for the enhanced catalytic activity, electrochemical cell durability as well as preferable product selectivity resulting from the reduction of nitrate at the cathode. It has been observed for the symmetric assembly that Cu particles were oxidized on the anode surface under an applied potential and the resulting copper ions migrated to the cathode surface through the Nafion membrane, which deposited as copper oxide on the cathode surface. The formation of this copper oxide covering layer on the Pt-Cu cathode surface is attributed as the reason for the deactivation of the cathode that governed the reduced nitrate reduction along with increasing nitrite selectivity. These problems were addressed and resolved with the asymmetric design of the electrocatalytic reactor, where enhanced hydrogen evolution activates the surface by eroding the CuO over layer as well as speeding up the slow rate determining hydrogenation reactions.	[Hasnat, Mohammad A.; Islam, Muhammad Amirul; Rashed, M. A.] Shahajalal Univ Sci & Technol, Dept Chem, Sylhet 3114, Bangladesh; [Islam, Muhammad Amirul] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Rashed, M. A.] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Hasnat, MA (reprint author), Shahajalal Univ Sci & Technol, Dept Chem, Sylhet 3114, Bangladesh.	mahtazim@yahoo.com			Shahjalal University of Science and Technology research center; UGC of Bangladesh	The authors acknowledge Prof. Masato Machida, Department of Nano Science and Technology, Kumamoto University, Japan for providing required materials and experimental setups. Shahjalal University of Science and Technology research center and UGC of Bangladesh is acknowledged for financial supports (2014-15).	Reyter D, 2008, ELECTROCHIM ACTA, V53, P5977, DOI 10.1016/j.electacta.2008.03.048; Lai JP, 2014, CHEMCATCHEM, V6, P2253, DOI 10.1002/cctc.201402147; Fang YM, 2009, LANGMUIR, V25, P555, DOI 10.1021/la802650e; Hasnat MA, 2014, APPL CATAL A-GEN, V478, P259, DOI 10.1016/j.apcata.2014.04.017; Birdja YY, 2014, ELECTROCHIM ACTA, V140, P518, DOI 10.1016/j.electacta.2014.06.011; OGUMI Z, 1985, ELECTROCHIM ACTA, V30, P121, DOI 10.1016/0013-4686(85)80069-4; Zhang ZY, 2012, APPL CATAL B-ENVIRON, V119, P40, DOI 10.1016/j.apcatb.2012.02.009; Green SK, 2012, CHEMSUSCHEM, V5, P2410, DOI 10.1002/cssc.201200416; Dieckmann GR, 1998, ELECTROCHIM ACTA, V44, P437, DOI 10.1016/S0013-4686(98)00061-9; Yang J, 2014, CHEM COMMUN, V50, P2148, DOI 10.1039/c3cc49224a; Hasnat MA, 2011, APPL CATAL B-ENVIRON, V107, P294, DOI 10.1016/j.apcatb.2011.07.028; Cao MN, 2014, CHEMCATCHEM, V6, P26, DOI 10.1002/cctc.201300647; Tao F, 2012, CHEM SOC REV, V41, P7980, DOI 10.1039/c2cs35185d; Shand M, 2013, CATAL SCI TECHNOL, V3, P879, DOI 10.1039/c3cy20851f; Kim JY, 2003, J AM CHEM SOC, V125, P10684, DOI 10.1021/ja0301673; OGUMI Z, 1983, ELECTROCHIM ACTA, V28, P1687, DOI 10.1016/0013-4686(83)85237-2; Dieckmann GR, 1997, J APPL ELECTROCHEM, V27, P1, DOI 10.1023/A:1026497229223; Jiang SP, 2004, J APPL ELECTROCHEM, V34, P1045, DOI 10.1023/B:JACH.0000042671.56349.da; Hasnat MA, 2014, J MOL CATAL A-CHEM, V383, P243, DOI 10.1016/j.molcata.2013.12.015; Hasnat MA, 2010, J MOL CATAL A-CHEM, V317, P61, DOI 10.1016/j.molcata.2009.10.022; Barrabes N, 2006, APPL CATAL B-ENVIRON, V62, P77, DOI 10.1016/j.apcatb.2005.06.015; Anastasopoulos A, 2013, J CATAL, V305, P27, DOI 10.1016/j.jcat.2013.04.010; Cui C. H., 2013, ACCOUNTS CHEM RES, V46, P142; KUWABATA S, 1986, INORG CHEM, V25, P3018, DOI 10.1021/ic00237a019; Miyazaki A, 2005, CHEM COMMUN, P3730, DOI 10.1039/b505537g; Nakayama Y, 2013, CHEM COMMUN, V49, P5228, DOI 10.1039/c3cc42149j; Otuska K., 1986, APPL CATAL, V26, P401; Ramirez EAB, 2014, ORG ELECTRON, V15, P1131, DOI 10.1016/j.orgel.2014.03.014; Setevich C, 2014, INT J HYDROGEN ENERG, V39, P8738, DOI 10.1016/j.ijhydene.2013.12.040; Siriwatcharapiboon W, 2014, CHEMELECTROCHEM, V1, P172, DOI 10.1002/celc.201300135; Woo LY, 2010, J ELECTROCHEM SOC, V157, pJ81, DOI 10.1149/1.3280263	31	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	13					9912	9919		10.1039/c4ra15950k		8	Chemistry, Multidisciplinary	Chemistry	AZ1BY	WOS:000347976500078		
J	Mogi, K; Hashimoto, Y; Tsukahara, T; Terano, M; Yoshino, M; Yamamoto, T				Mogi, Katsuo; Hashimoto, Yuki; Tsukahara, Takeshi; Terano, Motoki; Yoshino, Masahiko; Yamamoto, Takatoki			Nanometer-level high-accuracy molding using a photo-curable silicone elastomer by suppressing thermal shrinkage	RSC ADVANCES			English	Article							SOFT LITHOGRAPHY; MICROFLUIDIC DEVICES; TECHNOLOGIES; DISTORTIONS	Although the so-called "labs-on-a-chip" or micro total analysis systems (micro TAS) fields hold high promise for applications in many fields, conventional fabrication processes based on the semiconductor industry such as photolithography have limitations in terms of productivity. Silicone elastomers are widely used for micromodeling and offer biocompatibility and chemical stability, but they are generally thermosetting and undergo unacceptable levels of shape deformation during curing. In this study, a photocurable silicone elastomer that has recently become commercially available was examined, and its basic optical, mechanical, and other related characteristics, along with its shape transfer capabilities, particularly its nanostructure replication characteristics, were measured in comparison with those of a representative existing thermosetting silicone elastomer. As a result, the photo-cured elastomer was shown to be superior to existing heat-cured silicone elastomers, having mechanical strength approximately three times greater, and was shown to have the same optical transmittance, extending from the near-IR to the near-UV regions. In addition, it was shown that the elastomer is sensitive to light in a wide range of wavelengths, from 254 to 600 nm, with no large difference in its curing characteristics, indicating that curing can be performed under a variety of common forms of illumination. Most importantly, the photocured elastomer provided extremely high replication accuracy due to its thermal shrinkage of less than 0.02%, compared to 2.91% in the heat-cured elastomer.	[Mogi, Katsuo; Hashimoto, Yuki; Tsukahara, Takeshi; Terano, Motoki; Yoshino, Masahiko; Yamamoto, Takatoki] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528550, Japan	Yamamoto, T (reprint author), Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	yamamoto@mes.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [25289096]; CREST, JST	This work was conducted as part of the Four-University Nano-Micro Fabrication Kawasaki Consortium (Fab-4U). This work was supported by Kakenhi Grants-in-Aid (no. 25289096) from the Japan Society for the Promotion of Science (JSPS), and partly by CREST, JST.	Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Tudos AJ, 2001, LAB CHIP, V1, P83, DOI 10.1039/b106958f; Zheng B, 2003, J AM CHEM SOC, V125, P11170, DOI 10.1021/ja037166v; Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; Rogers JA, 1998, J VAC SCI TECHNOL B, V16, P88, DOI 10.1116/1.589841; Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h; Fujii T, 2002, MICROELECTRON ENG, V61-2, P907, DOI 10.1016/S0167-9317(02)00494-X; Carlborg CF, 2011, LAB CHIP, V11, P3136, DOI 10.1039/c1lc20388f; Hosokawa K, 2000, J MICROMECH MICROENG, V10, P415, DOI 10.1088/0960-1317/10/3/317; Lagally ET, 2001, ANAL CHEM, V73, P565, DOI 10.1021/ac001026b; Mogi K, 2013, LAB CHIP, V13, P1044, DOI 10.1039/c2lc40998d; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Ge HX, 2005, NANO LETT, V5, P179, DOI 10.1021/nl048618k; Mohammed MI, 2011, LAB CHIP, V11, P569, DOI 10.1039/c0lc00204f; Chou SY, 2002, NATURE, V417, P835, DOI 10.1038/nature00792; Arata HF, 2008, ANAL BIOANAL CHEM, V391, P2385, DOI 10.1007/s00216-008-1853-y; Daridon A, 2001, FRESEN J ANAL CHEM, V371, P261, DOI 10.1007/s002160101004; He QU, 2004, MATER CHEM PHYS, V83, P60, DOI 10.1016/j.matchemphys.2003.09.034; Mogi K, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055015; Mogi K, 2014, SENSOR ACTUAT B-CHEM, V201, P407, DOI 10.1016/j.snb.2014.05.047; Urushidani M., 2014, 17 INT S APPL LAS TE; Whitesides G. M., 1996, ABSTR PAP AM CHEM SO, V212, P31; Yamamoto T, 2002, LAB CHIP, V2, P197, DOI 10.1039/b205010b	24	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	14					10172	10177		10.1039/c4ra12062k		6	Chemistry, Multidisciplinary	Chemistry	AZ3RJ	WOS:000348144100012		
J	Yokozawa, S; Ohneda, N; Muramatsu, K; Okamoto, T; Odajima, H; Ikawa, T; Sugiyama, J; Fujita, M; Sawairi, T; Egami, H; Hamashima, Y; Egi, M; Akai, S				Yokozawa, Saori; Ohneda, Noriyuki; Muramatsu, Ken; Okamoto, Tadashi; Odajima, Hiromichi; Ikawa, Takashi; Sugiyama, Jun-ichi; Fujita, Masashi; Sawairi, Taira; Egami, Hiromichi; Hamashima, Yoshitaka; Egi, Masahiro; Akai, Shuji			Development of a highly efficient single-mode microwave applicator with a resonant cavity and its application to continuous flow syntheses	RSC ADVANCES			English	Article							ORGANIC-SYNTHESIS MACOS; ASSISTED SYNTHESIS; SCALE-UP; CHEMISTRY; TEMPERATURE; REACTORS; HETEROCYCLES; DERIVATIVES; PRESSURE; SYSTEMS	Microwave-assisted organic synthesis has many advantages and is widely applied to a variety of reactions. We have developed a new single-mode microwave applicator, specific to continuous flow synthesis, whose main feature is that it generates a uniform electromagnetic field inside its resonant cavity. Two well-known reactions, the Fischer indole synthesis and the Diels-Alder reaction, proceeded very quickly when a solution of substrates was pumped through a helical glass tube reactor inside the resonant cavity, under a pressure of 2.5 MPa. The desired products were obtained in high yields. This compact apparatus constitutes a new method for switching organic synthesis from batch to continuous flow, and enables continuous synthesis of products at a scale of 100 g h(-1) or more.	[Yokozawa, Saori; Ohneda, Noriyuki; Muramatsu, Ken; Okamoto, Tadashi; Odajima, Hiromichi] SAIDA FDS INC, Shizuoka 4250054, Japan; [Ikawa, Takashi; Akai, Shuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5670871, Japan; [Sugiyama, Jun-ichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Fujita, Masashi; Sawairi, Taira; Egami, Hiromichi; Hamashima, Yoshitaka; Egi, Masahiro] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Akai, S (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5670871, Japan.	akai@phs.osaka-u.ac.jp	Egami, Hiromichi/F-7744-2012		Shizuoka Industrial Foundation; NEDO Support Program for Ventures Involved in Innovation and Practical Application; University of Shizuoka	This work was financially supported by Shizuoka Industrial Foundation, NEDO Support Program for Ventures Involved in Innovation and Practical Application FY2012, and University of Shizuoka.	Shore G, 2008, CHEM COMMUN, P838, DOI 10.1039/b715709f; Kappe CO, 2013, ANGEW CHEM INT EDIT, V52, P1088, DOI 10.1002/anie.201204103; Nishioka M, 2013, IND ENG CHEM RES, V52, P4683, DOI 10.1021/1e400199r; Bergamelli F, 2010, ORG PROCESS RES DEV, V14, P926, DOI 10.1021/op100082w; Wahab B, 2010, TETRAHEDRON, V66, P3861, DOI 10.1016/j.tet.2010.03.005; Leadbeater NE, 2005, TETRAHEDRON, V61, P3565, DOI 10.1016/j.tot.2005.01.105; Bowman MD, 2008, ORG PROCESS RES DEV, V12, P1078, DOI 10.1021/op8001239; Horikoshi S, 2013, CHEM ENG PROCESS, V73, P59, DOI 10.1016/j.cep.2013.07.009; Gjuraj E, 2012, CHEM BIOCHEM ENG Q, V26, P285; Dastan A, 2012, GREEN CHEM, V14, P17, DOI 10.1039/c1gc15837f; Desroses M, 2011, TETRAHEDRON LETT, V52, P4417, DOI 10.1016/j.tetlet.2011.06.053; Horikoshi S, 2014, CATAL SCI TECHNOL, V4, P1197, DOI 10.1039/c3cy00753g; Glasnov TN, 2011, CHEM-EUR J, V17, P11956, DOI 10.1002/chem.201102065; Razzaq T, 2009, EUR J ORG CHEM, P1321, DOI 10.1002/ejoc.200900077; Amii H, 2013, BEILSTEIN J ORG CHEM, V9, P2793, DOI 10.3762/bjoc.9.314; Newman SG, 2013, GREEN CHEM, V15, P1456, DOI 10.1039/c3gc40374b; Kappe CO, 2013, CHEM SOC REV, V42, P4977, DOI 10.1039/c3cs00010a; Ohrngren P, 2012, ORG PROCESS RES DEV, V16, P1053, DOI 10.1021/op300003b; Majumder A, 2013, GREEN CHEM LETT REV, V6, P151, DOI 10.1080/17518253.2012.733032; Fukuyama T, 2014, GREEN CHEM, V16, P2042, DOI 10.1039/c3gc41789a; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Bagley MC, 2005, J ORG CHEM, V70, P7003, DOI 10.1021/jo0510235; Bagley MC, 2013, BEILSTEIN J ORG CHEM, V9, P1957, DOI 10.3762/bjoc.9.232; Bagley MC, 2010, FUTURE MED CHEM, V2, P1417, DOI [10.4155/fmc.10.217, 10.4155/FMC.10.217]; Chawla A., 2013, INT RES J PHARM, V4, P49; Christiaens S, 2014, MOLECULES, V19, P9986, DOI 10.3390/molecules19079986; Dallinger D, 2011, ORG PROCESS RES DEV, V15, P841, DOI 10.1021/op200090k; de la Hoz A., 2013, MICROWAVES IN ORGANI; DEXING Y, 1982, J ORG CHEM, V47, P140; Garella D, 2013, MEDCHEMCOMM, V4, P1323, DOI 10.1039/c3md00152k; Gawande MB, 2014, ACCOUNTS CHEM RES, V47, P1338, DOI 10.1021/ar400309b; Hassan HMA, 2012, AUST J CHEM, V65, P1647, DOI 10.1071/CH12366; Kappe C. O., 2012, MICROWAVES IN ORGANI; Karney MJ, 2013, RSC ADV, V3, P7106, DOI 10.1039/c3ra40783g; Konda V, 2014, ORG PROCESS RES DEV, V18, P1413, DOI 10.1021/op5001989; Marafie JA, 2010, ORG BIOMOL CHEM, V8, P2219, DOI 10.1039/b926537f; Patil NG, 2014, ORG PROCESS RES DEV, V18, P1400, DOI 10.1021/op500064k; Molina M. M., 2013, AUST J CHEM, V66, P131; Morschhauser R, 2012, GREEN PROCESS SYNTH, V1, P281, DOI 10.1515/gps-2012-0032; Raheem MA, 2013, SYNTHETIC COMMUN, V43, P260, DOI 10.1080/00397911.2011.596640; Reichart B, 2013, ORG PROCESS RES DEV, V17, P152, DOI 10.1021/op300273u; Rodriguez AM, 2012, SYNTHESIS-STUTTGART, V44, P2527, DOI 10.1055/s-0031-1290944; Rydfjord J, 2013, BEILSTEIN J ORG CHEM, V9, P2079, DOI 10.3762/bjoc.9.244; Sadler S, 2012, EXPERT OPIN DRUG DIS, V7, P1107, DOI 10.1517/17460441.2012.727393; Schon M, 2011, MOL DIVERS, V15, P639, DOI 10.1007/s11030-010-9295-9; Sultan N, 2013, SYNTHESIS-STUTTGART, V45, P2018, DOI 10.1055/s-0033-1338802; Ullah F, 2012, SYNTHESIS-STUTTGART, V44, P2547, DOI 10.1055/s-0031-1289791; Varma R. S., 2013, INNOVATION GREEN CHE, P115, DOI 10.1007/978-1-4614-5817-3_5	49	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	14					10204	10210		10.1039/c4ra12428f		7	Chemistry, Multidisciplinary	Chemistry	AZ3RJ	WOS:000348144100016		
J	Koike, T; Koudelova, P; Jaranilla-Sanchez, PA; Bhatti, AM; Nyunt, CT; Tamagawa, K				Koike, Toshio; Koudelova, Petra; Jaranilla-Sanchez, Patricia Ann; Bhatti, Asif Mumtaz; Nyunt, Cho Thanda; Tamagawa, Katsunori			River management system development in Asia based on Data Integration and Analysis System (DIAS) under GEOSS	SCIENCE CHINA-EARTH SCIENCES			English	Article						integrated water resources management tools; climate change impact assessment; Asian river basins; Asian Water Cycle Initiative	SNOW COVER; TIBETAN PLATEAU; CLIMATE-CHANGE; MODEL; PRECIPITATION; VALIDATION; SIMULATION; ATMOSPHERE; RAINFALL; PHYSICS	This paper introduces the process of development and practical use implementation of an advanced river management system for supporting integrated water resources management practices in Asian river basins under the framework of GEOSS Asia water cycle initiative (AWCI). The system is based on integration of data from earth observation satellites and in-situ networks with other types of data, including numerical weather prediction model outputs, climate model outputs, geographical information, and socio-economic data. The system builds on the water and energy budget distributed hydrological model (WEB-DHM) that was adapted for specific conditions of studied basins, in particular snow and glacier phenomena and equipped with other functions such as dam operation optimization scheme and a set of tools for climate change impact assessment to be able to generate relevant information for policy and decision makers. In situ data were archived for 18 selected basins at the data integration and analysis system of Japan (DIAS) and demonstration projects were carried out showing potential of the new system. It included climate change impact assessment on hydrological regimes, which is presently a critical step for sound management decisions. Results of such three case studies in Pakistan, Philippines, and Vietnam are provided here.	[Koike, Toshio; Koudelova, Petra; Jaranilla-Sanchez, Patricia Ann; Bhatti, Asif Mumtaz; Tamagawa, Katsunori] Univ Tokyo, Dept Civil Engn, River & Environm Engn Lab, Bunkyo Ku, Tokyo 1138656, Japan; [Nyunt, Cho Thanda] Hiroshima Univ, Dept Civil & Environm Engn, Hydraul Engn Lab, Higashihiroshima 7398527, Japan	Koudelova, P (reprint author), Univ Tokyo, Dept Civil Engn, River & Environm Engn Lab, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	petra@hydra.t.u-tokyo.ac.jp	Nyunt, Cho/K-6242-2015	Nyunt, Cho/0000-0002-6812-3459	Asia Pacific Network for Global Change Research (APN)	The authors express great appreciations to the Asia Pacific Network for Global Change Research (APN) for financial support of the AWCI activities through several projects funded under the APN programmes. The authors wish to also acknowledge continued collaboration and data support provided by the AWCI International Coordination Group members.	Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Ines AVM, 2006, AGR FOREST METEOROL, V138, P44, DOI 10.1016/j.agrformet.2006.03.009; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; Liston GE, 1999, J APPL METEOROL, V38, P1474, DOI 10.1175/1520-0450(1999)038<1474:IASDSA>2.0.CO;2; Negi HS, 2011, CRYOSPHERE, V5, P831, DOI 10.5194/tc-5-831-2011; Shrestha M, 2012, J HYDROMETEOROL, V13, P204, DOI 10.1175/JHM-D-10-05027.1; Kubota T, 2007, IEEE T GEOSCI REMOTE, V45, P2259, DOI 10.1109/TGRS.2007.895337; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; [Anonymous], 2008, GEOSS AWCI IMPLEMENT; Kawase H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011803; Yang K, 2007, J METEOROL SOC JPN, V85A, P229, DOI 10.2151/jmsj.85A.229; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Bae D, 2013, ARCP201105CMYBAE APN; Bhatti A M, 2014, ANN J HYDRAUL HYDRAU, V58, P121; Bobee B, 1995, US NATL REP IUGG; Dickinson R E, 1993, NCARTN3871STR72; Duran-Ballen S A, 2012, ANN J HYDRAUL HYDRAU, V56, P235; Duran-Ballen S A, 2012, FALL M AM GEOPH UN A; Global Water Partnership, 2009, HDB INT WAT RES MAN; HERSHFIE.DM, 1973, B AM METEOROL SOC, V54, P1013, DOI 10.1175/1520-0477(1973)054<1013:OTPOER>2.0.CO;2; Japan International Cooperation Agency (JICA), 2013, STUD WAT SEC MAST PL; Jaranilla-Sanchez PA, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009702; Jaranilla-Sanchez P A, 2013, ANN J HYDRAUL HYDRAU, V57, P13; Jaranilla-Sanchez P A, 2012, J SOC SOCIAL MANAGEM; Koike T, 2013, ARCP201102CMYKOIKE A; McKee T.B., 1993, P 8 C APPL CLIM 17 2, P179; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Nyunt C T, 2012, ANN J HYDRAUL HYDRAU, V56, P115; Nyunt C T, 2013, ANN J HYDRAUL HYDRAU, V57, pI19; Nyunt C T, 2013, THESIS U TOKYO TOKYO; Ohta T, 2014, ANN J HYDRAUL HYDRAU, V58, P265; Rasmy M, 2014, REMOTE SENS-BASEL, V6, P5306, DOI 10.3390/rs6065306; Rasmy M, 2011, IEEE T GEOSCI REMOTE, V49, P2847, DOI 10.1109/TGRS.2011.2112667; Rasmy M, 2013, ANN J HYDRAUL HYDRAU, V57, P133; Rasmy M, 2014, ANN J HYDRAUL HYDRAU, V58, P187; Rasmy M, 2012, IEEE T GEOSCI REMOTE, V50, P4227, DOI 10.1109/TGRS.2012.2190517; Saavedra O, 2009, HYDROLOG SCI J, V54, P909; Saavedra O., 2010, WATER RESOUR RES, V46, DOI [10.1029/2010WR009502, DOI 10.1029/2010WR009502]; Saavedra O, 2008, 4 C AS PAC ASS HYDR; Shibuo Y, 2014, ANN J HYDRAUL HYDRAU, V58, P397; Shrestha M, 2010, HYDROL EARTH SYST SC, V14, P2577, DOI 10.5194/hess-14-2577-2010; Sun SF, 2001, ADV ATMOS SCI, V18, P335; Tsujimoto K, 2012, J HYDROSCI HYDRAUL E, V30, P1; Tsujimoto K, 2013, ANN J HYDRAUL HYDRAU, V57, P511; Tsutsui H, 2009, J HYDROSCI HYDRAUL E, V27, P49; Tsutsui H, 2009, J REMOTE SENSING SOC, V29, P318; Wang L, 2009, ANN J HYDRAUL HYDRAU, V53, P103; Wang L, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010800; Wang L, 2010, J HYDROL, V377, P21; Xue YK, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003174; Yang DW, 2004, HYDROL PROCESS, V18, P3119, DOI 10.1002/hyp.5752; Yang ZL, 1997, J CLIMATE, V10, P353, DOI 10.1175/1520-0442(1997)010<0353:VOTSSO>2.0.CO;2; Yoshikane T, 2012, SOLA, V8, DOI 10.2151/sola.2012-033	54	2	3	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7313	1869-1897		SCI CHINA EARTH SCI	Sci. China-Earth Sci.	JAN	2015	58	1					76	95		10.1007/s11430-014-5004-3		20	Geosciences, Multidisciplinary	Geology	AY7DB	WOS:000347720400008		
J	Fang, JS; Zhang, L; Li, JT; Kato, C; Tamburini, C; Zhang, YZ; Dang, HY; Wang, GY; Wang, FP				Fang JiaSong; Zhang Li; Li JiangTao; Kato, Chiaki; Tamburini, Christian; Zhang YuZhong; Dang HongYue; Wang GuangYi; Wang FengPing			The POM-DOM piezophilic microorganism continuum (PDPMC)-The role of piezophilic microorganisms in the global ocean carbon cycle	SCIENCE CHINA-EARTH SCIENCES			English	Article						carbon cycle; deep ocean; DOM; PDPMC; piezophilic microorganisms; POM	DISSOLVED ORGANIC-MATTER; RESONANCE MASS-SPECTROMETRY; SULFATE-REDUCING BACTERIUM; HIGH HYDROSTATIC-PRESSURE; SEA HYDROTHERMAL VENT; DEEP-SEA; WATER-COLUMN; BIOGEOCHEMICAL CYCLES; ATTACHED BACTERIA; ENZYME-ACTIVITY	The deep ocean piezosphere accounts for a significant part of the global ocean, hosts active and diverse microbial communities which probably play a more important role than hitherto recognized in the global ocean carbon cycle. The conventional biological pump concept and the recently proposed microbial carbon pump mechanism provide a foundation for our understanding of the role of microorganisms in cycling of carbon in the ocean. However, there are significant gaps in our knowledge and a lack of mechanistic understanding of the processes of microbially-mediated production, transformation, degradation, and export of marine dissolved and particulate organic matter (DOM and POM) in the deep ocean and the ecological consequence. Here we propose the POM-DOM piezophilic microorganism continuum (PDPMC) conceptual model, to address these important biogeochemical processes in the deep ocean. We propose that piezophilic microorganisms (bacteria and archaea) play a pivotal role in deep ocean carbon cycle where microbial production of exoenzymes, enzymatic breakdown of DOM and transformation of POM fuels the rapid cycling of marine organic matter, and serve as the primary driver for carbon cycle in the deep ocean.	[Fang JiaSong; Li JiangTao] Tongji Univ, Sch Ocean & Earth Sci, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Fang JiaSong] Hawaii Pacific Univ, Dept Nat Sci, Kaneohe, HI 96744 USA; [Zhang Li] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Fac Earth Sci, Wuhan 430074, Peoples R China; [Kato, Chiaki] Inst Biogeosci Japan Agcy Marine Earth Sci & Tech, Yokosuka, Kanagawa 2370061, Japan; [Tamburini, Christian] Univ Toulon & Var, Aix Marseille Univ, CNRS, IRD,MIO 110, F-13288 Marseille, France; [Zhang YuZhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Dang HongYue] Xiamen Univ, State Key Lab Marine Environm Sci, Inst Marine Microbes & Ecospheres, Xiamen 361005, Peoples R China; [Wang GuangYi] Tianjin Univ, Ctr Marine Ecol & Environm Res, Tianjin 300072, Peoples R China; [Wang FengPing] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Wang FengPing] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, Shanghai 200240, Peoples R China	Fang, JS (reprint author), Tongji Univ, Sch Ocean & Earth Sci, State Key Lab Marine Geol, Shanghai 200092, Peoples R China.	jfang@hpu.edu			National Natural Science Foundation of China [91328208, 41240039, 41373071]; Specialized Research Fund for the Doctoral Program of Higher Education [201200-72110026]	We are grateful to Professor Wang Pinxian at the School of Ocean and Earth Science of Tongji University for his inspiration and encouragement, and Professor Zhao Meisun of Ocean University of China for his insightful comments and suggestions that greatly improved the manuscript. This work was supported by the National Natural Science Foundation of China (Grant Nos. 91328208, 41240039, 41373071) and the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 201200-72110026).	ALLDREDGE AL, 1990, CONT SHELF RES, V10, P41, DOI 10.1016/0278-4343(90)90034-J; Anderson TR, 1999, GLOBAL BIOGEOCHEM CY, V13, P337, DOI 10.1029/1999GB900013; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Alldredge AL, 2000, LIMNOL OCEANOGR, V45, P1245; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; JANNASCH HW, 1984, ANNU REV MICROBIOL, V38, P487, DOI 10.1146/annurev.mi.38.100184.002415; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Volkman JK, 2002, J OCEANOGR, V58, P265, DOI 10.1023/A:1015809708632; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Marteinsson VT, 1999, INT J SYST BACTERIOL, V49, P351; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; Grossart HP, 2007, FEMS MICROBIOL LETT, V266, P194, DOI 10.1111/j.1574-6968.2006.00520.x; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Ziervogel K, 2008, ENVIRON MICROBIOL, V10, P289, DOI 10.1111/j.1462-2920.2007.01451.x; Hopkinson CS, 1997, CONT SHELF RES, V17, P473, DOI 10.1016/S0278-4343(96)00046-5; Alazard D, 2003, INT J SYST EVOL MICR, V53, P173, DOI 10.1099/ijs.0.02323-0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P700, DOI 10.1016/j.dsr2.2008.07.021; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Tamburini C, 2003, AQUAT MICROB ECOL, V32, P209, DOI 10.3354/ame032209; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; KATO C, 1995, BIODIVERS CONSERV, V4, P1, DOI 10.1007/BF00115311; Beaupre SR, 2009, DEEP-SEA RES PT I, V56, P1717, DOI 10.1016/j.dsr.2009.05.008; KIRCHMAN DL, 1993, DEEP-SEA RES PT I, V40, P967, DOI 10.1016/0967-0637(93)90084-G; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; CARON DA, 1995, DEEP-SEA RES PT I, V42, P943, DOI 10.1016/0967-0637(95)00027-4; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; Tamburini C, 2006, AQUAT MICROB ECOL, V43, P267, DOI 10.3354/ame043267; Lefevre D, 1996, J MARINE SYST, V7, P281, DOI 10.1016/0924-7963(95)00003-8; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; Zeng X, 2009, ISME J, V3, P873, DOI 10.1038/ismej.2009.21; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Loh AN, 2004, NATURE, V430, P877, DOI 10.1038/nature02780; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Glud RN, 2013, NAT GEOSCI, V6, P284, DOI [10.1038/ngeo1773, 10.1038/NGEO1773]; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495; FUHRMAN JA, 1992, NATURE, V356, P148; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Alain K, 2002, INT J SYST EVOL MICR, V52, P1331, DOI 10.1099/ijs.0.02068-0; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Tamburini C, 2013, ENVIRON MICROBIOL, V15, P1262, DOI 10.1111/1462-2920.12084; D'Andrilli J, 2010, RAPID COMMUN MASS SP, V24, P643, DOI 10.1002/rcm.4421; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Williams PJL, 1998, NATURE, V394, P55; Bale SJ, 1997, INT J SYST BACTERIOL, V47, P515; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Ploug H, 2008, LIMNOL OCEANOGR, V53, P1878, DOI 10.4319/lo.2008.53.5.1878; Gardes A, 2011, ISME J, V5, P436, DOI 10.1038/ismej.2010.145; Azam F., 1984, FLOWS ENERGY MAT MAR, P345; Azam F, 2001, CARBON CYCLE ATMOSPH, P99; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BARTLETT DH, 2008, HIGHPR MICR, P195; Benner R., 2002, BIOGEOCHEMISTRY MARI, P59, DOI DOI 10.1016/B978-012323841-2/50005-1; Bianchi A, 1998, J MARINE SYST, V14, P45, DOI 10.1016/S0924-7963(98)00012-8; Chrost R J, 1991, MICROBIAL ENZYMES AQ, P29; delGiorgio PA, 1997, MICROBIAL ECOL, V34, P144; Ducklow H W., 2000, MICROBIAL ECOLOGY OC, P85; Erauso G, 1993, ARCHAEA LAB MANUAL, P25; FANG J, 2008, HIGHPR MICR, P237; Fang J, 2012, 2 INT C EARTH SYST S; Fang J, 2008, ENCY GLOBAL WARMING, P557; FANG J, 2010, DISCOVER, V31, P18; Gruber N, 2004, GLOBAL CARBON CYCLE, P1; Hansell D.A., 2001, OCEANOGRAPHY, V14, P41, DOI DOI 10.5670/OCEANOG.2001.05; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685, DOI DOI 10.1016/B978-012323841-2/50017-8; Hansell D.A., 2009, OCEANOGRAPHY, V22, P52, DOI DOI 10.5670/OCEANOG.2009.109; Hedges J.I., 2002, BIOGEOCHEMISTRY MARI, P1, DOI DOI 10.1016/B978-012323841-2/50003-8; Hermann A M, 2007, SOIL BIOL BIOCHEM, V39, P1835; Hopkinson CS, 2002, DEEP-SEA RES PT II, V49, P4461, DOI 10.1016/S0967-0645(02)00125-X; JANNASCH HW, 1973, SCIENCE, V180, P641, DOI 10.1126/science.180.4086.641; Jorgensen B B, 2009, MARINE GEOCHEMISTRY, P169; Kato C, 2008, HIGH PRESSURE MICROB, P203; Lauro F., 2007, EXTREMOPHILES, V12, P15, DOI DOI 10.1007/S00792-006-0059-5; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Ogawa H, 1999, DEEP-SEA RES PT I, V46, P1809, DOI 10.1016/S0967-0637(99)00027-8; Pradel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055130; Sato C, 2009, AM GEOPH UN FALL M S; Tamburini C., 2006, LIFE WE KNOW IT SERI, P1; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; Volk T., 1985, CARBON CYCLE ATMOSPH, P99, DOI 10.1029/GM032p0099; Yayanos AA, 1998, WILEY S ECO, P47	102	1	1	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7313	1869-1897		SCI CHINA EARTH SCI	Sci. China-Earth Sci.	JAN	2015	58	1					106	115		10.1007/s11430-014-4985-2		10	Geosciences, Multidisciplinary	Geology	AY7DB	WOS:000347720400010		
J	Tamura, Y; Yamada, S				Tamura, Yoshinobu; Yamada, Shigeru			AIR application for reliability analysis considering debugging process and network traffic in mobile clouds	SIMULATION MODELLING PRACTICE AND THEORY			English	Article						Mobile clouds; Reliability; Stochastic modeling; Software tool; Open source software	SOFTWARE; MODELS	Mobile clouds are used by many people via a network service to share the computing resources, because of the unification management of data and low cost. In case of the mobile device, the network access devices are frequently used by many software installed via the installer software. Considering the effect of the debugging process on mobile software in the development of a method of reliability assessment for the mobile clouds, it is necessary to grasp the situation of installer software, the network traffic, the installed software, etc. In this paper, we develop an integrated method of reliability assessment considering the software failure and network traffic based on a hazard rate model and neural network for the mobile clouds. In particular, we develop the AIR application for reliability analysis based on the proposed method. Then, we show the performance examples of the developed AIR application to analyze the method of software reliability assessment for the mobile clouds. (C) 2014 Elsevier B.V. All rights reserved.	[Tamura, Yoshinobu] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Yamada, Shigeru] Tottori Univ, Grad Sch Engn, Tottori 6808552, Japan	Tamura, Y (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Tokiwadai 2-16-1, Ube, Yamaguchi 7558611, Japan.	tamura@yamaguchi-u.ac.jp; yamada@sse.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24500066, 25350445]	This work was supported in part by the Grant-in-Aid for Scientific Research (C), Grant Nos. 24500066 and 25350445 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ullah N, 2012, IEEE ANNU SOFTW ENG, P187, DOI 10.1109/SEW.2012.26; Suo H, 2013, INT WIREL COMMUN, P655; Park J, 2012, LECT NOTES COMPUT SC, V7154, P263; Park N, 2011, STUD COMPUT INTELL, V381, P319; Cai KY, 2008, INFORM SOFTWARE TECH, V50, P1232, DOI 10.1016/j.infsof.2007.12.001; Cotroneo D, 2013, PROC INT SYMP SOFTW, P178, DOI 10.1109/ISSRE.2013.6698917; Flex.org-Adobe Flex Developer Resource, AD FLEX DEV RES; Gabner R., 2011, Proceedings of the 2011 IEEE 10th International Symposium on Network Computing and Applications (NCA 2011), DOI 10.1109/NCA.2011.33; Jelinski Z., 1972, STAT COMPUTER PERFOR, P465; Karnin E D, 1990, IEEE Trans Neural Netw, V1, P239, DOI 10.1109/72.80236; Khalifa A., 2013, P 4 INT C CLOUD COMP, P115; Li X, 2011, INFORM SOFTWARE TECH, V53, P929, DOI 10.1016/j.infsof.2011.04.005; Lyu M. R., 1996, HDB SOFTWARE RELIABI; MORANDA PB, 1979, IEEE T RELIAB, V28, P376; Musa J D, 1987, SOFTWARE RELIABILITY; SCHICK GJ, 1978, IEEE T SOFTWARE ENG, V4, P104, DOI 10.1109/TSE.1978.231481; Sharma K.K., 1978, RELIAB ENG SYST SAFE, V55, P9; Tamura Y., 2013, P IEEE INT C IND ENG; Tamura Y, 2013, SOFTW TEST VERIF REL, V23, P77, DOI 10.1002/stvr.455; Xie M., 1989, P RELIABILITY, V89, P5; Yamada S, 2014, SPRINGERBRIEF STAT, P1, DOI 10.1007/978-4-431-54565-1	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-190X	1878-1462		SIMUL MODEL PRACT TH	Simul. Model. Pract. Theory	JAN	2015	50				SI		165	175		10.1016/j.simpat.2014.03.010		11	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering	Computer Science	AY5GW	WOS:000347601800012		
J	Sato, S				Sato, Shin			Bounded response and the equivalence of nonmanipulability and independence of irrelevant alternatives	SOCIAL CHOICE AND WELFARE			English	Article							SOCIAL-WELFARE FUNCTIONS; STRATEGY-PROOFNESS; PREFERENCES	A social welfare function satisfies Bounded Response if the smallest change in the variable (i.e., preference profile) leads to the smallest change, if any, in the value (i.e., social preference). We show that each social welfare function on each connected domain satisfies Bounded Response and a nonmanipulability condition if and only if it satisfies a monotonicity condition and independence of irrelevant alternatives. Moreover, under Bounded Response, we show the equivalence of various notions of nonmanipulability of social welfare functions.	Fukuoka Univ, Fac Econ, Jonan Ku, Fukuoka 8140180, Japan	Sato, S (reprint author), Fukuoka Univ, Fac Econ, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	shinsato@adm.fukuoka-u.ac.jp					GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; Sato S, 2013, J ECON THEORY, V148, P259, DOI 10.1016/j.jet.2012.12.001; Black D, 1948, J POLIT ECON, V56, P23, DOI 10.1086/256633; KEMENY JG, 1959, DAEDALUS, V88, P577; ARROW KENNETH J., 1963, SOCIAL CHOICE INDIVI; BAIGENT N, 1987, Q J ECON, V102, P161, DOI 10.2307/1884686; Barbera S, 2010, HDB SOCIAL CHOICE WE, V2, P731; BLAIR D, 1983, J ECON THEORY, V30, P34, DOI 10.1016/0022-0531(83)90092-3; Bossert W, 2014, GAME ECON BEHAV, V85, P109, DOI 10.1016/j.geb.2014.01.015; BOSSERT W, 1992, SOC CHOICE WELFARE, V9, P345; Kemeny J. L., 1962, MATH MODELS SOCIAL S; Moulin H, 1988, AXIOMS COOPERATIVE D; SATTERTHWAITE MA, 1975, J ECON THEORY, V10, P187, DOI 10.1016/0022-0531(75)90050-2; YOUNG P, 1995, J ECON PERSPECT, V9, P51	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	JAN	2015	44	1					133	149		10.1007/s00355-014-0825-8		17	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AZ5SA	WOS:000348278800008		
J	Kulinich, SA; Honda, M; Zhu, AL; Rozhin, AG; Du, XW				Kulinich, S. A.; Honda, M.; Zhu, A. L.; Rozhin, A. G.; Du, X. W.			The icephobic performance of alkyl-grafted aluminum surfaces	SOFT MATTER			English	Article							ICE-ADHESION STRENGTH; SUPERHYDROPHOBIC SURFACES; HYDROPHOBIC SURFACES; STAINLESS-STEEL; WATER; FILMS; FABRICATION; MONOLAYERS; REPELLENT; COATINGS	This work analyzes the anti-icing performance of flat aluminum surfaces coated with widely used alkyl-group based layers of octadecyltrimethoxysilane, fluorinated alkylsilane and stearic acid as they are subjected to repeated icing/deicing cycles. The wetting properties of the samples upon long-term immersion in water are also evaluated. The results demonstrate that smooth aluminum surfaces grafted with alkyl groups are prone to gradual degradation of their hydrophobic and icephobic properties, which is caused by interactions and reactions with both ice and liquid water. This implies that alkyl-group based monolayers on aluminum surfaces are not likely to be durable icephobic coatings unless their durability in contact with ice and/or water is significantly improved.	[Kulinich, S. A.; Honda, M.] Tokai Univ, Inst Innovat Sci & Technol, Hiratsuka, Kanagawa 2591292, Japan; [Kulinich, S. A.; Rozhin, A. G.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Zhu, A. L.] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V6T 1Z4, Canada; [Du, X. W.] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China	Kulinich, SA (reprint author), Tokai Univ, Inst Innovat Sci & Technol, Hiratsuka, Kanagawa 2591292, Japan.	s_kulinich@yahoo.com	Du, Xi-Wen/A-7347-2011; Kulinich, Sergei/B-1887-2008	Kulinich, Sergei/0000-0002-1365-9221	Marie Curie International Incoming Fellowship from the European Commission	The help from Dr K. Nose (of UACJ Corp., Nagoya, Japan) with surface analysis of samples is greatly acknowledged. S.A.K. also acknowledges the Marie Curie International Incoming Fellowship from the European Commission.	Karmouch R, 2010, J PHYS CHEM C, V114, P4063, DOI 10.1021/jp911211m; Farhadi S, 2011, APPL SURF SCI, V257, P6264, DOI 10.1016/j.apsusc.2011.02.057; Liao RJ, 2014, APPL SURF SCI, V317, P701, DOI 10.1016/j.apsusc.2014.08.187; He Y, 2014, APPL SURF SCI, V305, P589, DOI 10.1016/j.apsusc.2014.03.139; Oberli L, 2014, ADV COLLOID INTERFAC, V210, P47, DOI 10.1016/j.cis.2013.10.018; Kulinich SA, 2007, THIN SOLID FILMS, V515, P8386, DOI [10.1016/j.tsf.2007.04.164, 10.1016/j.tsf2007.04.164]; Kulinich SA, 2012, RUSS J NON-FERR MET+, V53, P176, DOI 10.3103/S1067821212020071; Boinovich L, 2014, LANGMUIR, V30, P1659, DOI 10.1021/la403796g; Bharathidasan T, 2014, APPL SURF SCI, V314, P241, DOI 10.1016/j.apsusc.2014.06.101; Kulinich SA, 2009, LANGMUIR, V25, P8854, DOI 10.1021/la901439c; Rykaczewski K, 2013, LANGMUIR, V29, P5230, DOI 10.1021/la400801s; Arisio C, 2013, LANGMUIR, V29, P5145, DOI 10.1021/la400849j; Karmouch R, 2010, APPL SURF SCI, V257, P665, DOI 10.1016/j.apsusc.2010.07.041; Alizadeh A, 2012, LANGMUIR, V28, P3180, DOI 10.1021/la2045256; Fillion RM, 2014, RENEW SUST ENERG REV, V32, P797, DOI 10.1016/j.rser.2014.01.015; Lazauskas A, 2013, MATER CHARACT, V82, P9, DOI 10.1016/j.matchar.2013.04.017; Arianpour F, 2013, APPL SURF SCI, V265, P546, DOI 10.1016/j.apsusc.2012.11.042; Wang ZW, 2013, APPL SURF SCI, V271, P182, DOI 10.1016/j.apsusc.2013.01.158; Petrenko VF, 2003, CAN J PHYS, V81, P387, DOI 10.1139/P03-014; Meth S, 2003, THIN SOLID FILMS, V425, P49, DOI 10.1016/S0040-6090(02)01296-8; Saito H, 1997, SURF COAT INT, V80, P168, DOI 10.1007/BF02692637; Franquet A, 2001, THIN SOLID FILMS, V384, P37, DOI 10.1016/S0040-6090(00)01805-8; Boinovich L, 2012, ADV COLLOID INTERFAC, V179, P133, DOI 10.1016/j.cis.2012.06.010; Verho T, 2011, ADV MATER, V23, P673, DOI 10.1002/adma.201003129; Kulinich SA, 2004, APPL SURF SCI, V230, P232, DOI 10.1016/j.apsusc.2004.02.031; Susoff M, 2013, APPL SURF SCI, V282, P870, DOI 10.1016/j.apsusc.2013.06.073; Bahadur V, 2011, LANGMUIR, V27, P14143, DOI 10.1021/la200816f; Nosonovsky M, 2012, ACS NANO, V6, P8488, DOI 10.1021/nn302138r; Kulinich SA, 2011, LANGMUIR, V27, P25, DOI 10.1021/la104277q; Kulinich SA, 2009, APPL SURF SCI, V255, P8153, DOI 10.1016/j.apsusc.2009.05.033; Boinovich LB, 2013, ACS APPL MATER INTER, V5, P2549, DOI 10.1021/am3031272; Jung S, 2011, LANGMUIR, V27, P3059, DOI 10.1021/la104762g; Somlo B, 2001, MECH MATER, V33, P471, DOI 10.1016/S0167-6636(01)00068-0; Kulinich SA, 2011, COLD REG SCI TECHNOL, V65, P60, DOI 10.1016/j.coldregions.2010.01.001; Wang YY, 2013, ACS APPL MATER INTER, V5, P3370, DOI 10.1021/am400429q; Yao X, 2010, ADV FUNCT MATER, V20, P656, DOI 10.1002/adfm.200901775; Wang FC, 2013, J ADHES SCI TECHNOL, V27, P58, DOI 10.1080/01694243.2012.701506; MURASE H, 1994, J APPL POLYM SCI, V54, P2051, DOI 10.1002/app.1994.070541307; Che J., 2012, APPL PHYS LETT, V101; CROUTCH VK, 1992, J COATING TECHNOL, V64, P41; Lv FY, 2014, APPL SURF SCI, V321, P166, DOI 10.1016/j.apsusc.2014.09.147; Maccarini M, 2005, APPL SURF SCI, V252, P1941, DOI 10.1016/j.apsusc.2005.03.157; Ramachandran R, 2014, SOFT MATTER, V10, P7797, DOI 10.1039/c4sm01230e; THOMPSON WR, 1995, LANGMUIR, V11, P1720, DOI 10.1021/la00005a048; Thomsen L, 2005, SURF INTERFACE ANAL, V37, P472, DOI 10.1002/sia.2037; van Ooij W. J., 2005, Tsinghua Science and Technology, V10, DOI 10.1016/S1007-0214(05)70134-6; Zheng LQ, 2011, LANGMUIR, V27, P9936, DOI 10.1021/la201548k	47	9	9	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter		2015	11	5					856	861		10.1039/c4sm02204a		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Chemistry; Materials Science; Physics; Polymer Science	AZ4NH	WOS:000348198300004		
J	Yashima, S; Romero, V; Wandersman, E; Fretigny, C; Chaudhury, MK; Chateauminois, A; Prevost, AM				Yashima, S.; Romero, V.; Wandersman, E.; Fretigny, C.; Chaudhury, M. K.; Chateauminois, A.; Prevost, A. M.			Normal contact and friction of rubber with model randomly rough surfaces	SOFT MATTER			English	Article							ELASTIC CONTACT; DEFORMATION; GREENWOOD; MECHANICS	We report on normal contact and friction measurements of model multicontact interfaces formed between smooth surfaces and substrates textured with a statistical distribution of spherical micro-asperities. Contacts are either formed between a rigid textured lens and a smooth rubber, or a flat textured rubber and a smooth rigid lens. Measurements of the real area of contact A versus normal load P are performed by imaging the light transmitted at the microcontacts. For both interfaces, A(P) is found to be sub-linear with a power law behavior. Comparison with two multi-asperity contact models, which extend the Greenwood-Williamson (J. Greenwood and J. Williamson, Proc. Royal Soc. London Ser. A, 295, 300 (1966)) model by taking into account the elastic interaction between asperities at different length scales, is performed, and allows their validation for the first time. We find that long range elastic interactions arising from the curvature of the nominal surfaces are the main source of the non-linearity of A(P). At a shorter range, and except for very low pressures, the pressure dependence of both density and area of microcontacts remains well described by Greenwood-Williamson's model, which neglects any interaction between asperities. In addition, in steady sliding, friction measurements reveal that the mean shear stress at the scale of the asperities is systematically larger than that found for a macroscopic contact between a smooth lens and a rubber. This suggests that frictional stresses measured at macroscopic length scales may not be simply transposed to microscopic multicontact interfaces.	[Yashima, S.; Fretigny, C.; Chateauminois, A.] Univ Paris 06, CNRS, Soft Matter Sci & Engn Lab SIMM, UMR 7615,ESPCI, F-75005 Paris, France; [Romero, V.; Wandersman, E.; Prevost, A. M.] CNRS, UMR 8237, LJP, F-75005 Paris, France; [Romero, V.; Wandersman, E.; Prevost, A. M.] Univ Paris 06, Univ Paris 04, UMR 8237, Lab Jean Perrin, F-75005 Paris, France; [Yashima, S.] Hokkaido Univ, Grad Sch Life Sci, Lab Soft & Wet Matter, Sapporo, Hokkaido, Japan; [Chaudhury, M. K.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA	Prevost, AM (reprint author), CNRS, UMR 8237, LJP, F-75005 Paris, France.	alexis.prevost@upmc.fr			ANR [DYNALO NT09-499845]; CONICYT from Chile	We acknowledge funding from ANR (DYNALO NT09-499845). Many thanks are also due to J. P. Gong (Hokkaido University, Japan) for her kind support to this study. We are indebted to J. Teisseire for his support in the fabrication of the sol-gel structures, and to F. Martin for the SEM images of both RA and SA samples, and thank E. Barthel for stimulating discussions. V. Romero is also grateful for a CONICYT financial support from Chile.	Ciavarella M, 2006, J MECH PHYS SOLIDS, V54, P2569, DOI 10.1016/j.jmps.2006.05.006; Chateauminois A, 2008, EUR PHYS J E, V27, P221, DOI 10.1140/epje/i2008-10376-5; Hyun S, 2007, TRIBOL INT, V40, P1413, DOI 10.1016/j.triboint.2007.02.003; Ciavarella M, 2008, WEAR, V265, P729, DOI 10.1016/j.wear.2008.01.019; Dieterich JH, 1996, TECTONOPHYSICS, V256, P219, DOI 10.1016/0040-1951(95)00165-4; Romero V, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.094301; Carbone G, 2008, J MECH PHYS SOLIDS, V56, P2555, DOI 10.1016/j.jmps.2008.03.011; ARCHARD JF, 1957, PROC R SOC LON SER-A, V243, P190, DOI 10.1098/rspa.1957.0214; JOHNSON KL, 1985, INT J MECH SCI, V27, P383, DOI 10.1016/0020-7403(85)90029-3; Campana C, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/35/354013; Persson BNJ, 2001, J CHEM PHYS, V115, P3840, DOI 10.1063/1.1388626; Bowden F., 1958, FRICTION LUBRICATION; Gacoin E, 2006, TRIBOL LETT, V21, P245, DOI 10.1007/s11249-006-9030-y; GREENWOO.JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; GREENWOO.JA, 1967, J APPL MECH, V34, P153; Guidoni GM, 2010, J MECH PHYS SOLIDS, V58, P1571, DOI 10.1016/j.jmps.2010.07.009; Hyun S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026117; Johnson K.L., 1985, CONTACT MECH; Landau L. D., 1986, THEORY ELASTICITY; Letailleur A, 2010, CHEM MATER, V22, P3143, DOI 10.1021/cm100285b; Liu KK, 1998, J PHYS D APPL PHYS, V31, P294, DOI 10.1088/0022-3727/31/3/008; Manners W, 2003, INT J MECH SCI, V45, P1181, DOI 10.1016/S0020-7403(03)00143-7; Manners W, 1998, P ROY SOC A-MATH PHY, V454, P3203, DOI 10.1098/rspa.1998.0298; Nguyen D., 2011, J ADHESION, V87, P235; Piccardo M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0182; Prevost A, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13017-0; Westergaard H., 1939, T ASME             E, V6, pA49	27	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter		2015	11	5					871	881		10.1039/c4sm02346c		11	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Chemistry; Materials Science; Physics; Polymer Science	AZ4NH	WOS:000348198300006		
J	Seo, JH; Tsutsumi, Y; Kobari, A; Shimojo, M; Hanawa, T; Yui, N				Seo, Ji-Hun; Tsutsumi, Yusuke; Kobari, Akinori; Shimojo, Masayuki; Hanawa, Takao; Yui, Nobuhiko			Modulation of friction dynamics in water by changing the combination of the loop- and graft-type poly(ethylene glycol) surfaces	SOFT MATTER			English	Article							TITANIUM SURFACE; ELECTRODEPOSITION; IMMOBILIZATION; COEFFICIENT; MECHANICS; ADHESION; POLYMER; LAYERS; FORCE; MODEL	A Velcro-like poly(ethylene glycol) (PEG) interface was prepared in order to control the friction dynamics of material surfaces. Graft-and loop-type PEGs were formed on mirror-polished Ti surfaces using an electrodeposition method with mono- and di-amine functionalized PEGs. The friction dynamics of various combinations of PEG surfaces (i.e., graft-on-graft, loop-on-loop, graft-on-loop, and loop-on-graft) were investigated by friction testing. Here, only the Velcro-like combinations (graft-on-loop and loop-on-graft) exhibited a reversible friction behavior (i.e., resetting the kinetic friction coefficient and the reappearance of the maximum static friction coefficient) during the friction tests. The same tendency was observed when the molecular weights of loop- and graft-type PEGs were tested at 1 k and 10 k, respectively. This indicates that a Velcro-like friction behavior could be induced by simply changing the conformation of PEGs, which suggests a novel concept of altering polymer surfaces for the effective control of friction dynamics.	[Seo, Ji-Hun; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo 1010062, Japan; [Tsutsumi, Yusuke; Hanawa, Takao] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Metall Biomat, Tokyo 1010062, Japan; [Kobari, Akinori; Shimojo, Masayuki] Shibaura Inst Technol, Grad Sch Engn Sci, Tokyo 1358548, Japan	Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo 1010062, Japan.	yui.org@tmd.ac.jp			JSPS KAKENHI Grant [22240059, 25282142]	This work was supported by JSPS KAKENHI Grant number 22240059 and Grant number 25282142.	Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f; Coles JM, 2010, CURR OPIN COLLOID IN, V15, P406, DOI 10.1016/j.cocis.2010.07.002; Leger L, 1999, ADV POLYM SCI, V138, P185; Kyomoto M, 2014, BIOMATERIALS, V35, P6677, DOI 10.1016/j.biomaterials.2014.04.051; Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030; Chang DP, 2008, LANGMUIR, V24, P1183, DOI 10.1021/la702366t; Tanaka Y, 2007, MAT SCI ENG C-BIO S, V27, P206, DOI 10.1016/j.msec.2006.03.007; Drobek T, 2008, LANGMUIR, V24, P1484, DOI 10.1021/la702289n; JOHANNES VI, 1973, WEAR, V24, P381, DOI 10.1016/0043-1648(73)90166-X; Tanaka Y, 2010, J BIOMED MATER RES A, V95A, P1105, DOI 10.1002/jbm.a.32932; Blau PJ, 2001, TRIBOL INT, V34, P585, DOI 10.1016/S0301-679X(01)00050-0; Pettersson T, 2008, J COLLOID INTERF SCI, V324, P246, DOI 10.1016/j.jcis.2008.04.055; CHANG WR, 1988, J TRIBOL-T ASME, V110, P57; Seo JH, 2013, J AM CHEM SOC, V135, P5513, DOI 10.1021/ja400817q; Tanaka Y, 2010, J BIOMED MATER RES A, V92A, P350, DOI 10.1002/jbm.a.32375; Chang DP, 2009, SOFT MATTER, V5, P3438, DOI 10.1039/b907155e; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Tanaka Y, 2008, MATER TRANS, V49, P805, DOI [10.2320/matertrans.MRA2007317, 10.2320/matertrans.MRA20073171]; Hanawa T, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064102; Hanawa T., 2010, JPN DENT SCI REV, V46, P93; Kretschmann D, 2003, NAT MATER, V2, P775, DOI 10.1038/nmat1025; NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B; ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2	24	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter		2015	11	5					936	942		10.1039/c4sm02082k		7	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Chemistry; Materials Science; Physics; Polymer Science	AZ4NH	WOS:000348198300013		
J	White, KL; Wong, M; Li, P; Miyamoto, M; Higaki, Y; Takahara, A; Sue, HJ				White, K. L.; Wong, M.; Li, P.; Miyamoto, M.; Higaki, Y.; Takahara, A.; Sue, H. -J.			Interlayer structure and self-healing in suspensions of brush-stabilized nanoplatelets with smectic order	SOFT MATTER			English	Article							ALPHA-ZIRCONIUM PHOSPHATE; AMPLITUDE OSCILLATORY SHEAR; LIQUID-CRYSTALLINE POLYMER; LAMELLAR DIBLOCK COPOLYMER; MOLECULAR-DYNAMICS; BLOCK-COPOLYMERS; DISPERSE SYSTEMS; COMPLEX FLUIDS; RHEOLOGICAL BEHAVIOR; BEARING SURFACES	We have investigated the rheology of an uncured epoxy fluid containing high aspect ratio (length/thickness approximate to 160) alpha-zirconium phosphate (ZrP) nanoplatelets with smectic order. The nanoplatelets were exfoliated into monocrystalline sheets with uniform thickness using a monoamine-terminated oligomer. The oligomers were densely grafted to the plate surfaces and behave as a molecular brush. Suspensions containing similar to 2 vol.% ZrP and above show liquid crystalline order with scattering peaks characteristic of a smectic (layered) mesophase. At much higher loading, similar to 4 vol.% ZrP, there is a sharp transition in visual appearance, steady shear rheology, and linear and non-linear viscoelasticity that is attributed to the reversible interdigitation of oligomer chains between closely spaced layers. The oligomers are proposed to serve as inter-lamellar bridges that store elastic stresses for intermediate rates of deformation, but are able to relax on longer time scales. Under steady shearing conditions, the smectic suspensions with "overlapped" microstructure show a discontinuous flow curve characteristic of shear banding that is attributed to the dynamic pull-out of oligomer chains from the overlap region. At high shear rates, the limiting viscosity of the concentrated suspensions is on the same order of magnitude as the unfilled suspending fluid. When the rate of deformation is reduced below a critical time scale, the original network strength, and corresponding microstructure, is recovered through a passive self-healing process. The unique combination of concentration-dependent yield stress, low post-yield viscosity, and self-healing is potentially useful for various applications in the liquid state, and desirable for scalable processing of nanocomposite materials for structural applications.	[White, K. L.; Higaki, Y.; Takahara, A.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan; [White, K. L.; Higaki, Y.; Takahara, A.] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190395, Japan; [Wong, M.; Li, P.; Sue, H. -J.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA; [Miyamoto, M.] Kaneka US Mat Res Ctr, College Stn, TX 77845 USA	Sue, HJ (reprint author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.	hjsue@tamu.edu	Sue, HJ/A-4051-2008; Higaki, Yuji/O-4179-2015	Sue, HJ/0000-0002-3898-4469; 	KANEKA Corporation; World Premier International Research Center Initiative (WPI) MEXT, Japan	The authors acknowledge partial financial support by KANEKA Corporation. Sean Kohl and John Wilson from TA Instruments are also thanked for assistance with rheology measurements. K. L. W., Y.H., and A. T. acknowledge the support from the World Premier International Research Center Initiative (WPI) MEXT, Japan. Synchrotron X-ray diffraction measurements were performed at the SPring-8 facility in Hyogo, Japan under proposal 2013A1470 (BL40B2 beam line). K. L. W. also acknowledges Professor Randy Ewoldt for assistance with nonlinear viscoelastic analysis, and for providing the MITLAOS software.	ALT DJ, 1995, MACROMOLECULES, V28, P1575, DOI 10.1021/ma00109a032; Masunaga H, 2011, POLYM J, V43, P471, DOI 10.1038/pj.2011.18; White KL, 2014, J PHYS CHEM B, V118, P362, DOI 10.1021/jp4110272; Sun LY, 2005, CHEM MATER, V17, P5606, DOI 10.1021/cm051160i; Ewoldt RH, 2009, INTEGR COMP BIOL, V49, P40, DOI 10.1093/icb/icp010; Klein J, 1996, ANNU REV MATER SCI, V26, P581; Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074; Fragiadakis D, 2011, POLYMER, V52, P3175, DOI 10.1016/j.polymer.2011.04.045; GOULIAN M, 1995, PHYS REV LETT, V74, P1775, DOI 10.1103/PhysRevLett.74.1775; Ruokolainen J, 1999, MACROMOLECULES, V32, P1152, DOI 10.1021/ma980189n; Kumar SK, 2010, ANNU REV CHEM BIOMOL, V1, P37, DOI 10.1146/annurev-chembioeng-073009-100856; van der Kooij FM, 2000, NATURE, V406, P868; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/nmat2614, 10.1038/NMAT2614]; Kreer T, 2001, LANGMUIR, V17, P7804, DOI 10.1021/la010807k; KANNAN RM, 1994, MACROMOLECULES, V27, P1177, DOI 10.1021/ma00083a016; Li P, 2014, ACS APPL MATER INTER, V6, P10188, DOI 10.1021/am5015293; Ewoldt RH, 2008, J RHEOL, V52, P1427, DOI 10.1122/1.2970095; Lerouge S, 2000, LANGMUIR, V16, P6464, DOI 10.1021/la000269w; Boal AK, 2000, NATURE, V404, P746; LARSON RG, 1993, RHEOL ACTA, V32, P245, DOI 10.1007/BF00434188; BROCHARD F, 1992, LANGMUIR, V8, P3033, DOI 10.1021/la00048a030; Binder K, 2011, SOFT MATTER, V7, P7159, DOI 10.1039/c1sm05212h; Gupta VK, 1996, MACROMOLECULES, V29, P875, DOI 10.1021/ma950925c; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; KOPPI KA, 1992, J PHYS II, V2, P1941; Yamada S, 2002, TRIBOL LETT, V13, P167, DOI 10.1023/A:1020151824274; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Eckstein A, 1998, MACROMOLECULES, V31, P1335, DOI 10.1021/ma971270d; Hyun K, 2002, J NON-NEWTON FLUID, V107, P51, DOI 10.1016/S0377-0257(02)00141-6; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Watanabe H, 1999, PROG POLYM SCI, V24, P1253, DOI 10.1016/S0079-6700(99)00029-5; WITTEN TA, 1990, MACROMOLECULES, V23, P824, DOI 10.1021/ma00205a022; Betancourt BAP, 2013, SOFT MATTER, V9, P241, DOI 10.1039/c2sm26800k; Vermant J, 2007, J RHEOL, V51, P429, DOI 10.1122/1.2516399; Grest GS, 1996, PHYS REV LETT, V76, P4979, DOI 10.1103/PhysRevLett.76.4979; ROSSMURPHY SB, 1995, J RHEOL, V39, P1451, DOI 10.1122/1.550610; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; KOPPI KA, 1993, PHYS REV LETT, V70, P1449, DOI 10.1103/PhysRevLett.70.1449; Wong MH, 2014, CHEM MATER, V26, P1528, DOI 10.1021/cm402991c; Hobbie EK, 2010, RHEOL ACTA, V49, P323, DOI 10.1007/s00397-009-0422-4; PATEL SS, 1995, MACROMOLECULES, V28, P4313, DOI 10.1021/ma00116a038; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g; Fragiadakis D, 2005, POLYMER, V46, P6001, DOI 10.1016/j.polymer.2005.05.080; Vermant J, 2005, J PHYS-CONDENS MAT, V17, pR187, DOI 10.1088/0953-8984/17/4/R02; Shuai M, 2013, CRYSTENGCOMM, V15, P1970, DOI 10.1039/c2ce26402a; Sun LY, 2007, NEW J CHEM, V31, P39, DOI 10.1039/b604054c; Medronho B, 2010, LANGMUIR, V26, P11304, DOI 10.1021/la100627z; Olmsted PD, 1999, EUROPHYS LETT, V48, P339, DOI 10.1209/epl/i1999-00486-2; Kleshchanok D, 2012, J AM CHEM SOC, V134, P5985, DOI 10.1021/ja300527w; Demirel AL, 1996, PHYS REV LETT, V77, P2261, DOI 10.1103/PhysRevLett.77.2261; Olmsted PD, 2008, RHEOL ACTA, V47, P283, DOI 10.1007/s00397-008-0260-9; Bonaccurso E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144501; Trinkle S, 2001, RHEOL ACTA, V40, P322, DOI 10.1007/s003970000137; Tapadia P, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.196001, 10.1103/PhysRevLett.96.016001]; WOOL RP, 1981, J APPL PHYS, V52, P5953, DOI 10.1063/1.328526; WU SH, 1987, POLYMER, V28, P1144, DOI 10.1016/0032-3861(87)90257-6; WOOL RP, 1982, J POLYM SCI POL LETT, V20, P7, DOI 10.1002/pol.1982.130200102; Balko SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058392; Barnes HA, 1999, J NON-NEWTON FLUID, V81, P133, DOI 10.1016/S0377-0257(98)00094-9; Barnes HA, 2007, APPL RHEOL, V17; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; BATCHELO.GK, 1974, ANNU REV FLUID MECH, V6, P227, DOI 10.1146/annurev.fl.06.010174.001303; Berni MG, 2002, ADV COLLOID INTERFAC, V98, P217, DOI 10.1016/S0001-8686(01)00094-X; Bestaoui N, 2006, J MATER CHEM, V16, P759, DOI 10.1039/b511351b; Blanc C, 2005, PHIL MAG LETT, V85, P641, DOI 10.1080/14786430500402482; CLEARFIE.A, 1969, INORG CHEM, V8, P431, DOI 10.1021/ic50073a005; Clearfield A., 1996, COMPREHENSIVE SUPRAM, P107; COLBY RH, 1993, LIQ CRYST, V13, P233, DOI 10.1080/02678299308026297; Colby RH, 1997, RHEOL ACTA, V36, P498; Dealy J, 2009, RHEOL B, V78, P16; de Beer S, 2013, SOFT MATTER, V9, P7234, DOI 10.1039/c3sm50491c; DOI M, 1993, MACROMOLECULES, V26, P4935, DOI 10.1021/ma00070a030; FREDERICKSON GH, 1994, J RHEOL, V38, P1045, DOI 10.1122/1.550584; Fredrickson GH, 1996, ANNU REV MATER SCI, V26, P501, DOI 10.1146/annurev.ms.26.080196.002441; Galuschko A, 2010, LANGMUIR, V26, P6418, DOI 10.1021/la904119c; Gentile L., 2014, LANGMUIR, V28, P8316; Giannelis EP, 1999, ADV POLYM SCI, V138, P108; Gupta VK, 1996, MACROMOLECULES, V29, P1359, DOI 10.1021/ma951254l; Hanwell MD, 2012, J CHEMINFORMATICS, V4, P1; He XL, 2014, COLLOID SURFACE A, V452, P32, DOI 10.1016/j.colsurfa.2014.03.041; Hoppe R, 1997, LANGMUIR, V13, P7252, DOI 10.1021/la970551b; HUDSON SD, 1993, MACROMOLECULES, V26, P5643, DOI 10.1021/ma00073a017; Ishige R, 2014, MACROMOLECULES, V47, P3860, DOI 10.1021/ma500503z; Khil'ko SL, 2006, COLLOID J+, V68, P106, DOI 10.1134/S1061933X06010145; Kreer T, 2003, WEAR, V254, P827, DOI 10.1016/S0043-1648(03)00232-1; Kreer T, 2013, ACS MACRO LETT, V2, P944, DOI 10.1021/mz4004387; Kuchin IV, 2013, COLLOID J+, V75, P543, DOI 10.1134/S1061933X13050050; Lekkerkerker H, 2013, PHILOS T R SOC A, V371, P1, DOI [10.1016/j.cocis.2004.12.001, DOI 10.1016/J.COCIS.2004.12.001]; Litchfield D. W., 2006, RHEOL REV, P1; Liu P., 2012, MACROMOLECULES, V46, P463; MACLACHLAN DJ, 1992, J PHYS CHEM-US, V96, P3458, DOI 10.1021/j100187a053; MACLACHLAN DJ, 1990, J PHYS CHEM-US, V94, P7656, DOI 10.1021/j100382a062; Mewis J., 2012, COLLOIDAL SUSPENSION; MOLDENAERS P, 1989, MACROMOLECULES, V22, P960, DOI 10.1021/ma00192a071; Neto C, 2003, EUR PHYS J E, V12, P71, DOI 10.1140/epjed/e2003-01-018-0; Nommensen PA, 1999, PHYS REV E, V59, P3147, DOI 10.1103/PhysRevE.59.3147; Onogi S., 1970, MACROMOLECULES, V3, P109, DOI 10.1021/ma60014a001; SAFINYA CR, 1993, SCIENCE, V261, P588, DOI 10.1126/science.261.5121.588; Sun L, 2009, MACROMOL MATER ENG, V294, P103, DOI 10.1002/mame.200800258; Tadmor R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115503; TINDWA RM, 1985, J CHEM SOC FARAD T 1, V81, P545, DOI 10.1039/f19858100545; Uriev N. B., 2003, COLLOID J RUSS ACAD+, V65, P411; URIEV NB, 1994, COLLOID SURFACE A, V87, P1, DOI 10.1016/0927-7757(93)02611-H; Van Gurp M., 1998, RHEOL B, V67, P5; White K. L., 2011, POLYMER, V53, P37; White KL, 2013, POLYM ENG SCI, V53, P651, DOI 10.1002/pen.23309; White KL, 2014, RHEOL ACTA, V53, P571, DOI 10.1007/s00397-014-0783-1; White KL, 2011, POLYM ENG SCI, V51, P2245, DOI 10.1002/pen.21996; WINEY KI, 1993, MACROMOLECULES, V26, P2542, DOI 10.1021/ma00062a024; Wong M, 2014, NAT COMMUN, V5, P1	110	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter		2015	11	5					954	971		10.1039/c4sm01855a		18	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Chemistry; Materials Science; Physics; Polymer Science	AZ4NH	WOS:000348198300015		
J	Umemoto, H; Onaka, T; Miki, Y; Nakamura, A; Maegawa, T				Umemoto, Hideaki; Onaka, Takuya; Miki, Yasuyoshi; Nakamura, Akira; Maegawa, Tomohiro			Reactions of 2-[Lithio(trimethylsilyl)methyl]-2H-tetrazoles: Synthesis of 2-[1-(Trimethylsilyl) alkyl]-2H-tetrazoles and (2H-Tetrazol-2-yl) acetates	SYNLETT			English	Article						tetrazoles; synthetic methods; lithiation; synthons	5-SUBSTITUTED TETRAZOLES; N-(ALPHA-LITHIOALKYL)TETRAZOLES; ZOLARSARTAN; CANDESARTAN; ALKYLATION; INHIBITORS; LOSARTAN; ACIDS	The reaction of 2-[(trimethylsilyl) methyl]-2H-tetrazoles with various alkyl halides and carbonates using n-butyllithium or lithium diisopropylamide (LDA) gave 2-[1-(trimethylsilyl) alkyl]-2H-tetrazoles and (2H-tetrazol-2-yl) acetates as useful synthons of modified tetrazoles.	[Umemoto, Hideaki; Onaka, Takuya] Fujimoto Chem Co Ltd, Amagasaki, Hyogo 6600806, Japan; [Miki, Yasuyoshi; Nakamura, Akira; Maegawa, Tomohiro] Kinki Univ, Sch Pharmaceut Sci, Higashi Osaka 5778502, Japan	Umemoto, H (reprint author), Fujimoto Chem Co Ltd, 1-2-38 Kinrakuji Cho, Amagasaki, Hyogo 6600806, Japan.	h-umemoto@fujimoto-chem.co.jp; maegawa@phar.kindai.ac.jp					Alonen A, 2008, BIOCHEM PHARMACOL, V76, P763, DOI 10.1016/j.bcp.2008.07.006; Alonen A, 2008, BIOORG CHEM, V36, P148, DOI 10.1016/j.bioorg.2008.02.004; Tamura Y, 1998, J MED CHEM, V41, P640, DOI 10.1021/jm9707582; Rostom SAF, 2009, BIOORGAN MED CHEM, V17, P2410, DOI 10.1016/j.bmc.2009.02.004; Gagnon A, 2009, BIOORG MED CHEM LETT, V19, P1199, DOI 10.1016/j.bmcl.2008.12.074; Ichikawa M, 2012, BIOORGAN MED CHEM, V20, P3072, DOI 10.1016/j.bmc.2012.02.054; ZHANG SZ, 1995, J AM CHEM SOC, V117, P602, DOI 10.1021/ja00107a003; Onaka T, 2014, J ORG CHEM, V79, P6703, DOI 10.1021/jo500862t; Arora J., 2005, [No title captured], Patent No. [WO 2005 080 386, 2005080386, WO 2005, 080, 386]; Arora J., 2005, CHEM ABSTR, V143; Arzel E., 2009, CHEM ABSTR, V150; Arzel E., 2009, [No title captured], Patent No. [WO 2009 051 556, 2009151556]; Aureggi V, 2007, ANGEW CHEM INT EDIT, V46, P8440, DOI 10.1002/anie.200701045; Bavetsias V, 1996, BIOORG MED CHEM LETT, V6, P631, DOI 10.1016/0960-894X(96)00078-9; Butler R. N., 1996, COMPREHENSIVE HETERO, V4; Chul L. S., 2010, US Patent, Patent No. [8 501 436, 8501436]; Chul L.S., 2010, CHEM ABSTR, V154, P86383; EINBERG F, 1970, J ORG CHEM, V35, P3978, DOI 10.1021/jo00836a095; Herr R. J., 2002, J BIOORG MED CHEM, V10, P3379; Koldobskii GI, 2003, RUSS J ORG CHEM+, V39, P453, DOI 10.1023/A:1026125230589; Krylov AS, 2014, RUSS J ORG CHEM+, V50, P892, DOI 10.1134/S1070428014060219; Lachance N., 2008, CHEM ABSTR, V149; Lachance N., 2008, [No title captured], Patent No. [WO 2008 128 335, 2008128335, 2008/128335]; May BCH, 2002, J CHEM SOC PERK T 1, P172, DOI 10.1039/b109128j; MOODY CJ, 1991, J CHEM SOC PERK T 1, P323, DOI 10.1039/p19910000323; MOODY CJ, 1990, SYNLETT, P413; Roh J, 2012, EUR J ORG CHEM, P6101, DOI 10.1002/ejoc.201200469; Sun Y., 2008, [No title captured], Patent No. [WO 2008 021 733, 2008021733, WO 2008, 021, 733]; Sun Y., 2008, [No title captured], Patent No. [2008 019 289, 2008019289, WO 2008, 019, 289]; Sun Y., 2009, [No title captured], Patent No. [WO 2009 064 955, 2009064955, WO 2009, 064, 955]; Tehrani LR, 2005, BIOORG MED CHEM LETT, V15, P5061, DOI 10.1016/j.bmcl.2005.07.062; THOMAS EW, 1993, J ORG CHEM, V58, P1623, DOI 10.1021/jo00058a061; Wood H. B., 2009, [No title captured], Patent No. [WO 2009 129 036, 2009129036, WO 2009, 129, 036]; Wood H.B., 2008, CHEM ABSTR, V151	34	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	2					205	208		10.1055/s-0034-1378933		4	Chemistry, Organic	Chemistry	AZ0TO	WOS:000347958000011		
J	Arai, T; Joko, A; Sato, K				Arai, Takayoshi; Joko, Akinori; Sato, Katsuya			Design of a Chiral Secondary Amine Ligand for Copper-Catalyzed anti-Selective Henry Reaction	SYNLETT			English	Article						asymmetric catalysis; diastereoselectivity; copper; ligands; nitroaldol	ASYMMETRIC NITROALDOL REACTION; HIGHLY STEREOSELECTIVE-SYNTHESIS; ENANTIOSELECTIVE HENRY; CU-II; AROMATIC-ALDEHYDES; TRANSFER HYDROGENATION; MOLECULAR CATALYSTS; COMPLEXES; EFFICIENT; SYSTEM	A series of chiral binaphthyl-containing diphenylethylenediamine (binaph-dpen) ligands was designed and synthesized for the copper-catalyzed asymmetric Henry reaction. The N-monobenzyl (S)-binaph-(R, R)-dpen ligand, with a secondary amine portion, promoted the Cu(OAc)(2)-catalyzed Henry reaction with excellent enantioselectivity in an anti-selective manner.	[Arai, Takayoshi; Joko, Akinori; Sato, Katsuya] Chiba Univ, Dept Chem, Grad Sch Sci, Inage 2638522, Japan	Arai, T (reprint author), Chiba Univ, Dept Chem, Grad Sch Sci, 1-33 Yayoi, Inage 2638522, Japan.	tarai@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology (Japan); Workshop on Chirality at Chiba University (WCCU)	This work was supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Japan) and by the Workshop on Chirality at Chiba University (WCCU).	Leighty MW, 2012, J AM CHEM SOC, V134, P15233, DOI 10.1021/ja306225u; Jin W, 2010, CHEM-EUR J, V16, P8259, DOI 10.1002/chem.201000964; Wei YL, 2014, RSC ADV, V4, P37859, DOI 10.1039/c4ra06056c; Corey EJ, 1999, ANGEW CHEM INT EDIT, V38, P1931, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1931::AID-ANIE1931>3.0.CO;2-4; Ma KY, 2007, CHEM-EUR J, V13, P1863, DOI 10.1002/chem.200601220; SASAI H, 1995, J ORG CHEM, V60, P7388, DOI 10.1021/jo00128a005; Kitagaki S, 2013, CHEM COMMUN, V49, P4030, DOI 10.1039/c3cc41789a; Holmquist M, 2014, ORG LETT, V16, P1204, DOI 10.1021/ol500082d; Cheng LA, 2010, CHEM-EUR J, V16, P6761, DOI 10.1002/chem.201000650; Sohtome Y, 2008, ORG LETT, V10, P2231, DOI 10.1021/ol800653d; Ikariya T, 2006, ORG BIOMOL CHEM, V4, P393, DOI 10.1039/b513564h; Choudary BM, 2005, J AM CHEM SOC, V127, P13167, DOI 10.1021/ja0440248; Ikariya T, 2009, CHEM REC, V9, P106, DOI 10.1002/tcr.20172; Cheng HG, 2012, CHEM COMMUN, V48, P5596, DOI 10.1039/c2cc31907a; Mandal T, 2007, ORG LETT, V9, P943, DOI 10.1021/ol070209i; Palomo C, 2004, ANGEW CHEM INT EDIT, V43, P5442, DOI 10.1002/anie.200460506; Boobalan R, 2012, ADV SYNTH CATAL, V354, P2511, DOI 10.1002/adsc.201200337; Evans DA, 2003, J AM CHEM SOC, V125, P12692, DOI 10.1021/ja0373871; Ube H, 2009, BIOORG MED CHEM LETT, V19, P3895, DOI 10.1016/j.bmcl.2009.03.097; Angulo B, 2012, J ORG CHEM, V77, P5525, DOI 10.1021/jo3005974; Arai T, 2007, ORG LETT, V9, P3595, DOI 10.1021/ol7014362; Zhou ZM, 2012, ORG BIOMOL CHEM, V10, P2113, DOI 10.1039/c2ob06434k; White JD, 2012, ORG LETT, V14, P6270, DOI 10.1021/ol3030023; Arai T, 2008, CHEM-EUR J, V14, P2052, DOI 10.1002/chem.200701439; Kim HY, 2009, ORG LETT, V11, P5682, DOI 10.1021/ol902380z; Xiong Y, 2007, CHEM-EUR J, V13, P829, DOI 10.1002/chem.200601262; Arai T, 2008, J ORG CHEM, V73, P4903, DOI 10.1021/jo800412x; Vlatkovic M, 2014, CHEM COMMUN, V50, P7773, DOI 10.1039/c4cc00794h; Dai QP, 2013, ORG LETT, V15, P2922, DOI 10.1021/ol400900h; Jiang YT, 1998, J AM CHEM SOC, V120, P3817, DOI 10.1021/ja974095p; Kodama K, 2011, CHEM-EUR J, V17, P13584, DOI 10.1002/chem.201102136; Blay G, 2008, CHEM-EUR J, V14, P4725, DOI 10.1002/chem.200800069; Gao JX, 1996, ORGANOMETALLICS, V15, P1087, DOI 10.1021/om950833b; Arai T, 1996, CHEM-EUR J, V2, P1368, DOI 10.1002/chem.19960021107; Marcelli T, 2006, ANGEW CHEM INT EDIT, V45, P929, DOI 10.1002/anie.200503724; Park J, 2008, J AM CHEM SOC, V130, P16484, DOI 10.1021/ja807221s; Constable EC, 2009, NEW J CHEM, V33, P1064, DOI 10.1039/b821995h; Handa S, 2008, ANGEW CHEM INT EDIT, V47, P3230, DOI 10.1002/anie.200705617; Bandini M, 2007, ORG LETT, V9, P2151, DOI 10.1021/ol070636w; Qin DD, 2012, CHEM-EUR J, V18, P10515, DOI 10.1002/chem.201201565; Kowalczyk R, 2007, TETRAHEDRON-ASYMMETR, V18, P2581, DOI 10.1016/j.tetasy.2007.10.023; Jin W, 2011, J ORG CHEM, V76, P484, DOI 10.1021/jo101932a; Sohtome Y, 2007, CHEM-ASIAN J, V2, P1150, DOI 10.1002/asia.200700145; Ogawa T, 2013, ANGEW CHEM INT EDIT, V52, P6196, DOI 10.1002/anie.201302236; Zulauf A, 2009, J ORG CHEM, V74, P2242, DOI 10.1021/jo802769y; Uraguchi D, 2007, J AM CHEM SOC, V129, P12392, DOI 10.1021/ja075152+; Yao L, 2012, TETRAHEDRON, V68, P9119, DOI 10.1016/j.tet.2012.08.029; Noole A, 2010, J ORG CHEM, V75, P1313, DOI 10.1021/jo902664v; Hashimoto K, 2014, ORG LETT, V16, P3496, DOI 10.1021/ol501432h; SASAI H, 1992, J AM CHEM SOC, V114, P4418, DOI 10.1021/ja00037a068; Qin B, 2007, J ORG CHEM, V72, P9323, DOI 10.1021/jo701898r; Palomo C, 2005, ANGEW CHEM INT EDIT, V44, P3881, DOI 10.1002/anie.200463075; Trost BM, 2002, ANGEW CHEM INT EDIT, V41, P861, DOI 10.1002/1521-3773(20020301)41:5<861::AID-ANIE861>3.0.CO;2-V; Nitabaru T, 2009, J AM CHEM SOC, V131, P13860, DOI 10.1021/ja905885z; Lang K, 2012, ANGEW CHEM INT EDIT, V51, P1620, DOI 10.1002/anie.201107785; Breugst M, 2014, J ORG CHEM, V79, P6302, DOI 10.1021/jo501227m; Uraguchi D, 2010, ANGEW CHEM INT EDIT, V49, P7562, DOI 10.1002/anie.201004072; Xu K, 2012, CHEM-EUR J, V18, P12357, DOI 10.1002/chem.201201775; Arai T, 2006, ANGEW CHEM INT EDIT, V45, P5978, DOI 10.1002/anie.200602255; Arai T, 2010, CHEM COMMUN, V46, P7936, DOI 10.1039/c0cc03022h; Bandini M, 2007, CHEM COMMUN, P616, DOI 10.1039/b613019d; Blay G, 2011, SYNLETT, P1195, DOI 10.1055/s-0030-1260558; Blay G, 2010, ORG LETT, V12, P3058, DOI 10.1021/ol1010888; Chougnet A, 2011, ADV SYNTH CATAL, V353, P1797, DOI 10.1002/adsc.201100157; Christensen C, 2001, CHEM COMMUN, P2222, DOI 10.1039/b105929g; Das A, 2014, CHEMPLUSCHEM, V79, P1138, DOI 10.1002/cplu.201402078; da Silva ET, 2003, TETRAHEDRON LETT, V44, P3621, DOI 10.1016/S0040-4039(03)00709-3; Ji YQ, 2011, EUR J ORG CHEM, P4892, DOI 10.1002/ejoc.201100579; Ji YQ, 2011, TETRAHEDRON-ASYMMETR, V22, P2065, DOI 10.1016/j.tetasy.2011.12.010; Kogami Y, 2004, CHEM LETT, V33, P614, DOI 10.1246/cl.2004.614; Maheswaran H, 2006, CHEM COMMUN, P4066, DOI 10.1039/b610203d; Nakayama Y, 2013, SYNLETT, V24, P883, DOI 10.1055/s-0032-1318490; Nitabaru T, 2008, TETRAHEDRON LETT, V49, P272, DOI 10.1016/j.tetlet.2007.11.055; Ooi T, 2003, J AM CHEM SOC, V125, P2054, DOI 10.1021/ja029660p; Palacio C, 2011, ORG LETT, V13, P1298, DOI 10.1021/ol103089j; Palomo C, 2007, EUR J ORG CHEM, P2561, DOI 10.1002/ejoc.200700021; Qin DD, 2013, CHEM-EUR J, V19, P16541, DOI 10.1002/chem.201303650; Scharnagel D, 2014, CHEM COMMUN, V50, P6623, DOI 10.1039/c4cc02429j; Shibasaki M., 1999, COMPREHENSIVE ASYMME; Sohtome Y, 2006, EUR J ORG CHEM, P2894, DOI 10.1002/ejoc.200600307; Tur F, 2007, ORG LETT, V9, P5079, DOI 10.1021/ol702434t; Yoshimoto J, 2008, CHEM LETT, V37, P1294, DOI 10.1246/cl.2008.1294; Zheng B, 2011, TETRAHEDRON-ASYMMETR, V22, P1156, DOI 10.1016/j.tetasy.2011.06.032; Zhou YR, 2013, ANGEW CHEM INT EDIT, V52, P10265, DOI 10.1002/anie.201305148	84	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	2					209	214		10.1055/s-0034-1379607		6	Chemistry, Organic	Chemistry	AZ0TO	WOS:000347958000012		
J	Nishimura, Y; Cho, H				Nishimura, Yoshio; Cho, Hidetsura			Synthesis of 4,6-Unsubstituted 2-Aminodihydropyrimidine-5-carboxylates through Sequential Staudinger/Aza-Wittig/Cyclization Reactions	SYNLETT			English	Article						dihydropyrimidine; heterocycles; Staudinger reaction; aza-Wittig reaction; cyclization	SOLID-PHASE SYNTHESIS; DIHYDROPYRIMIDINES; ACID; POTENT; TAUTOMERISM; DERIVATIVES; INHIBITORS; AGENTS; RING	A novel method for constructing the dihydropyrimidine skeleton is developed. The method involves three sequential reactions: (1) the Staudinger reaction of (E)-ethyl 3-azido-2-{[(tert-butoxycarbonyl) amino] methyl} acrylate with triphenylphosphine; (2) aza-Wittig reaction of the resulting iminophosphorane with isocyanate; (3) intramolecular cyclization of the carbodiimide intermediate to give 4,6-unsubstituted 2-aminodihydropyrimidine-5-carboxylates in high overall yield. The method can be applied to various aromatic isocyanates, with substrates having electron-withdrawing groups showing high reactivities. In the case of aliphatic benzyl isocyanate, the reaction provides bicyclic dihydropyrimidine as the major product. The N-protecting group (Boc) can easily be removed to obtain N-unsubstituted dihydropyrimidines. All dihydropyrimidines in this study were previously unavailable and are difficult to synthesize by conventional methods.	[Nishimura, Yoshio] Yasuda Womens Univ, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan; [Cho, Hidetsura] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 8789540, Japan	Nishimura, Y (reprint author), Yasuda Womens Univ, Fac Pharm, Asaminami Ku, 6-13-1 Yasuhigashi, Hiroshima 7310153, Japan.	nishimura-y@yasuda-u.ac.jp			Sasakawa Scientific Research Grant from The Japan Science Society; JSPS KAKENHI Grant [24790122, 26810095]	This work was financially supported by the Sasakawa Scientific Research Grant from The Japan Science Society and JSPS KAKENHI Grant Number 24790122 and 26810095.	BARLUENGA J, 1989, TETRAHEDRON LETT, V30, P4573, DOI 10.1016/S0040-4039(01)80748-6; Nishimura Y, 2012, TETRAHEDRON, V68, P3342, DOI 10.1016/j.tet.2012.02.064; ATWAL KS, 1989, J ORG CHEM, V54, P5898, DOI 10.1021/jo00286a020; [Anonymous], 2001, TETRAHEDRON; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Matloobi M, 2007, J COMB CHEM, V9, P275, DOI 10.1021/cc0601377; Vedejs E, 2000, J ORG CHEM, V65, P5498, DOI 10.1021/jo0001277; Kappe CO, 2000, EUR J MED CHEM, V35, P1043, DOI 10.1016/S0223-5234(00)01189-2; Cho H, 2011, TETRAHEDRON, V67, P2661, DOI 10.1016/j.tet.2011.01.092; ATWAL KS, 1990, J MED CHEM, V33, P2629, DOI 10.1021/jm00171a044; Baskaran S, 2004, TETRAHEDRON LETT, V45, P2107, DOI 10.1016/j.tetlet.2004.01.056; CHO H, 1988, J AM CHEM SOC, V110, P4832, DOI 10.1021/ja00222a054; Cho H, 2011, TETRAHEDRON LETT, V52, P7185, DOI 10.1016/j.tetlet.2011.10.130; Cho H, 2013, HETEROCYCLES, V87, P1441, DOI 10.3987/REV-13-771; CHO H, 1985, J ORG CHEM, V50, P4227, DOI 10.1021/jo00222a009; Cho H, 2012, TETRAHEDRON LETT, V53, P1177, DOI 10.1016/j.tetlet.2011.12.111; CHO H, 1989, J MED CHEM, V32, P2399, DOI 10.1021/jm00130a029; Hamper BC, 1999, TETRAHEDRON LETT, V40, P4973, DOI 10.1016/S0040-4039(99)00961-2; Hirota S, 2008, EUR J ORG CHEM, P2075, DOI 10.1002/ejoc.200701131; Hirota S, 2010, TETRAHEDRON, V66, P653, DOI 10.1016/j.tet.2009.11.064; Kochubey V. S., 2006, CHEM HETEROCYCL COMP, V42, P897, DOI 10.1007/s10593-006-0177-0; Li J, 2008, TETRAHEDRON LETT, V49, P2761, DOI 10.1016/j.tetlet.2008.02.141; MCCORT GA, 1992, TETRAHEDRON LETT, V33, P4443, DOI 10.1016/S0040-4039(00)60105-3; Morimoto M, 2013, CHEM LETT, V42, P550, DOI 10.1246/cl.130082; Nishimura Y, 2014, TETRAHEDRON LETT, V55, P411, DOI 10.1016/j.tetlet.2013.11.038; Putatunda S, 2012, EUR J MED CHEM, V54, P223, DOI 10.1016/j.ejmech.2012.04.043; Sehon CA, 2008, J MED CHEM, V51, P6631, DOI 10.1021/jm8005096; WEIS AL, 1986, HETEROCYCLES, V24, P1433; Zhang D., 2014, TETRAHEDRON LETT, P1178; Zhang YJ, 2008, ANTI-CANCER AGENT ME, V8, P698	30	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	2					233	237		10.1055/s-0034-1378932		5	Chemistry, Organic	Chemistry	AZ0TO	WOS:000347958000016		
J	Yoshiokaa, E; Kohtani, S; Jichu, T; Fukazawa, T; Nagai, T; Takemoto, Y; Miyabe, H				Yoshiokaa, Eito; Kohtani, Shigeru; Jichu, Takahisa; Fukazawa, Takuya; Nagai, Toyokazu; Takemoto, Yoshiji; Miyabe, Hideto			Direct Photoinduced Electron Transfer from Excited State of Rhodamine B for Carbon-Radical Generation	SYNLETT			English	Article						radical reaction; cyclization; photochemistry; alkyl halides; fluorine	VISIBLE-LIGHT PHOTOCATALYSIS; ALPHA,BETA-UNSATURATED CARBOXYLIC-ACIDS; ARYL DIAZONIUM SALTS; C-H ARYLATION; PHOTOREDOX CATALYSIS; METAL-FREE; ROOM-TEMPERATURE; OXIDATIVE TRIFLUOROMETHYLATION; DEFICIENT ALKENES; AMINO-ACIDS	The photoinduced electron transfer (PIET) from the excited singlet state (S-1) of rhodamine B to i-C3F7I smoothly proceeded in the presence of water. This process was supported by the fluorescence quenching of rhodamine B with addition of i-C3F7I in ethanol. The present method was applied to the atom-transfer radical reaction involving the cyclization step.	[Yoshiokaa, Eito; Kohtani, Shigeru; Jichu, Takahisa; Fukazawa, Takuya; Nagai, Toyokazu; Miyabe, Hideto] Hyogo Univ Hlth Sci, Sch Pharm, Chuo Ku, Kobe, Hyogo 6508530, Japan; [Takemoto, Yoshiji] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Kohtani, S (reprint author), Hyogo Univ Hlth Sci, Sch Pharm, Chuo Ku, Kobe, Hyogo 6508530, Japan.	kohtani@huhs.ac.jp; miyabe@huhs.ac.jp			MEXT/JSPS KAKENHI [25460028, 23105007]	This work was supported by MEXT/JSPS KAKENHI Grant-in-Aid for Scientific Research (C) Grant Number 25460028 (to H.M.) and Grant-in-Aid for Scientific Research on Innovative Areas Grant Number 23105007 (to Y.T.).	Amatov T, 2011, ANGEW CHEM INT EDIT, V50, P4542, DOI 10.1002/anie.201007672; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Zeng R, 2012, ANGEW CHEM INT EDIT, V51, P3888, DOI 10.1002/anie.201107747; Dolbier WR, 1996, CHEM REV, V96, P1557, DOI 10.1021/cr941142c; BECKWITH ALJ, 1981, TETRAHEDRON, V37, P3073, DOI 10.1016/S0040-4020(01)98839-8; Zhao GL, 2012, CHEM COMMUN, V48, P2337, DOI 10.1039/c2cc17130a; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Mejia E, 2012, ACS CATAL, V2, P521, DOI 10.1021/cs300089y; Tucker JW, 2012, J ORG CHEM, V77, P1617, DOI 10.1021/jo202538x; Nakajima M, 2014, CHEM COMMUN, V50, P3619, DOI 10.1039/c4cc00753k; Zhang CP, 2011, CHEM COMMUN, V47, P6632, DOI 10.1039/c1cc11765c; Maity S, 2012, ANGEW CHEM INT EDIT, V51, P9562, DOI 10.1002/anie.201205137; Hari DP, 2014, ANGEW CHEM INT EDIT, V53, P725, DOI 10.1002/anie.201307051; Zhao JZ, 2013, CHEM SOC REV, V42, P5323, DOI 10.1039/c3cs35531d; Zou YQ, 2011, ANGEW CHEM INT EDIT, V50, P7171, DOI 10.1002/anie.201102306; Pham PV, 2011, ANGEW CHEM INT EDIT, V50, P6119, DOI 10.1002/anie.201101861; Nguyen JD, 2011, J AM CHEM SOC, V133, P4160, DOI 10.1021/ja108560e; Ischay MA, 2012, EUR J ORG CHEM, P3359, DOI 10.1002/ejoc.201101071; Zhang B, 2013, ANGEW CHEM INT EDIT, V52, P10792, DOI 10.1002/anie.201306082; Ryu I, 2011, ANGEW CHEM INT EDIT, V50, P1869, DOI 10.1002/anie.201004854; Meng QY, 2013, J AM CHEM SOC, V135, P19052, DOI 10.1021/ja408486v; Xia JB, 2013, J AM CHEM SOC, V135, P17494, DOI 10.1021/ja410815u; Grandjean JMM, 2013, ANGEW CHEM INT EDIT, V52, P3967, DOI 10.1002/anie.201210111; Oh SH, 2014, ORG LETT, V16, P1310, DOI 10.1021/ol403716t; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Herrmann AT, 2012, J AM CHEM SOC, V134, P6976, DOI 10.1021/ja302552e; Deb A, 2013, ANGEW CHEM INT EDIT, V52, P9747, DOI 10.1002/anie.201303576; Pitre SP, 2014, ACS CATAL, V4, P2530, DOI 10.1021/cs5005823; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Hafner A, 2013, J ORG CHEM, V78, P7938, DOI 10.1021/jo401145g; Yajima T, 2007, ORG LETT, V9, P2513, DOI 10.1021/ol0707620; Vallavoju N, 2014, ANGEW CHEM INT EDIT, V53, P5604, DOI 10.1002/anie.201310940; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; Jiang H, 2013, ANGEW CHEM INT EDIT, V52, P13289, DOI 10.1002/anie.201308376; Li ZJ, 2013, ORG LETT, V15, P406, DOI 10.1021/ol3034059; Zhu SQ, 2013, J AM CHEM SOC, V135, P1823, DOI 10.1021/ja309580a; Li L, 2014, ORG LETT, V16, P504, DOI 10.1021/ol403391v; Kalaitzakis D, 2012, ANGEW CHEM INT EDIT, V51, P8868, DOI 10.1002/anie.201204419; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Carboni A, 2014, ORG LETT, V16, P1240, DOI 10.1021/ol500374e; Miyake Y, 2012, J AM CHEM SOC, V134, P3338, DOI 10.1021/ja211770y; Wallentin CJ, 2012, J AM CHEM SOC, V134, P8875, DOI 10.1021/ja300798k; Nicewicz DA, 2014, ACS CATAL, V4, P355, DOI 10.1021/cs400956a; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Hari DP, 2012, J AM CHEM SOC, V134, P2958, DOI 10.1021/ja212099r; Yoshioka E, 2013, SYNLETT, V24, P1578, DOI 10.1055/s-0033-1339182; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Huang HC, 2014, J AM CHEM SOC, V136, P2280, DOI 10.1021/ja413208y; Pan YH, 2011, GREEN CHEM, V13, P2682, DOI 10.1039/c1gc15489c; Yoon TP, 2013, ACS CATAL, V3, P895, DOI 10.1021/cs400088e; Yoshioka E, 2012, J ORG CHEM, V77, P8588, DOI 10.1021/jo3015227; Yang F, 2014, CHEM COMMUN, V50, P936, DOI 10.1039/c3cc48131j; Hari DP, 2013, ANGEW CHEM INT EDIT, V52, P4734, DOI 10.1002/anie.201210276; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Yasu Y, 2014, ORG LETT, V16, P780, DOI 10.1021/ol403500y; Senaweera SM, 2014, J AM CHEM SOC, V136, P3002, DOI 10.1021/ja500031m; Zou YQ, 2013, ANGEW CHEM INT EDIT, V52, P11701, DOI 10.1002/anie.201307206; Ravelli D, 2013, CHEM SOC REV, V42, P97, DOI 10.1039/c2cs35250h; Larraufie MH, 2011, ANGEW CHEM INT EDIT, V50, P4463, DOI 10.1002/anie.201007571; Ohkubo K, 2011, ANGEW CHEM INT EDIT, V50, P8652, DOI 10.1002/anie.201102931; Seo S, 2013, CHEM COMMUN, V49, P6385, DOI 10.1039/c3cc41829d; Cai SY, 2012, ANGEW CHEM INT EDIT, V51, P8050, DOI 10.1002/anie.201202880; Neumann M, 2011, ANGEW CHEM INT EDIT, V50, P951, DOI 10.1002/anie.201002992; Iqbal N, 2014, ANGEW CHEM INT EDIT, V53, P539, DOI 10.1002/anie.201308735; Itoh Y, 2005, ORG LETT, V7, P4883, DOI 10.1021/ol0517574; Yang YD, 2013, CHEM COMMUN, V49, P5510, DOI 10.1039/c3cc41667d; Shi L, 2012, CHEM SOC REV, V41, P7687, DOI 10.1039/c2cs35203f; Miyazawa K, 2013, CHEM COMMUN, V49, P7249, DOI 10.1039/c3cc42695e; Xu P, 2014, CHEM COMMUN, V50, P2308, DOI 10.1039/c3cc48598f; Mizuta S, 2013, J AM CHEM SOC, V135, P2505, DOI 10.1021/ja401022x; Hamilton DS, 2012, J AM CHEM SOC, V134, P18577, DOI 10.1021/ja309635w; Park JH, 2012, ORG LETT, V14, P5502, DOI 10.1021/ol302584y; Farney EP, 2014, ANGEW CHEM INT EDIT, V53, P793, DOI 10.1002/anie.201308820; Majek M, 2013, CHEM COMMUN, V49, P5507, DOI 10.1039/c3cc41867g; Chen M, 2012, CHEM COMMUN, V48, P11686, DOI 10.1039/c2cc36866h; ARBELOA IL, 1986, CHEM PHYS LETT, V129, P607, DOI 10.1016/0009-2614(86)80409-2; Houk K. N., 1987, ORG CHEM, V52, P959; Jiao K, 2005, CHEM RES CHINESE U, V21, P145; Klan P., 2009, PHOTOCHEMISTRY ORGAN; Mchedlov-Petrossyan NO, 2003, J PHYS ORG CHEM, V16, P380, DOI 10.1002/poc.654; Miyabe H, 2012, SYNLETT, P1709, DOI 10.1055/s-0031-1290378; Miyabe H., 2013, UNIVERSAL ORG CHEM, V2, P1; Montalti M., 2006, HDB PHOTOCHEMISTRY; Rozhkov I. N., 1989, IAN SSSR KH, V10, P2222; Rozhkov I. N., 1990, B ACAD SCI USSR CH, V38, P2041; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Tonoi T, 2008, EUR J ORG CHEM, P1331, DOI 10.1002/ejoc.200701052; Turro N.J., 1991, MODERN MOL PHOTOCHEM; Zhang JL, 2013, CHEM COMMUN, V49, P11662, DOI 10.1039/c3cc46778c; Zhu R, 2013, ANGEW CHEM INT EDIT, V52, P12655, DOI 10.1002/anie.201307790	93	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JAN	2015	26	2					265	270		10.1055/s-0034-1379699		6	Chemistry, Organic	Chemistry	AZ0TO	WOS:000347958000021		
J	Konishi, H; Yokoyama, R; Hikawa, K; Nakada, T; Kobayashi, K; Morikawa, O				Konishi, Hisatoshi; Yokoyama, Rie; Hikawa, Katsuhiro; Nakada, Takehiro; Kobayashi, Kazuhiro; Morikawa, Osamu			SYNTHESIS OF METHYLENE-BRIDGED RESORCIN[4]ARENE DIMERS	SYNTHETIC COMMUNICATIONS			English	Article						Host-guest complex; molecular capsule; resorcinarene dimer	CAPSULE FORMATION; INCLUSION; METHANOL; RIM; RESORCINARENES; ENCAPSULATION; MOLECULES; POLYMERS; BEHAVIOR; RECEPTOR	Methylene-bridged resorcin[4]arene dimers were synthesized by the Sc(OTf)(3)-catalyzed hydroxymethylation of partially acetylated resorcin[4]arenes, and their preliminary complexation properties with tetraethylammonium ion were examined in CD3OD by H-1 NMR spectroscopy. The dimers adopted a closed capsular conformation in this solvent and bound the guest molecule into their cavity.	[Konishi, Hisatoshi; Yokoyama, Rie; Hikawa, Katsuhiro; Nakada, Takehiro; Kobayashi, Kazuhiro; Morikawa, Osamu] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 680, Japan	Konishi, H (reprint author), Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, 4-101 Koyama Minami, Tottori 680, Japan.	konis@chem.tottori-u.ac.jp					Agarawal Y. K., 2007, SYNTHETIC COMMUN, V37, P551; Ananchenko GS, 2008, CHEM COMMUN, P223, DOI 10.1039/b714738d; Rudkevich DA, 2002, B CHEM SOC JPN, V75, P393, DOI 10.1246/bcsj.75.393; Baldini L, 2008, EUR J ORG CHEM, P869, DOI 10.1002/ejoc.200700943; Li GK, 2007, TETRAHEDRON LETT, V48, P6096, DOI 10.1016/j.tetlet.2007.06.165; Conn MM, 1997, CHEM REV, V97, P1647, DOI 10.1021/cr9603800; Podoprygorina G, 2008, SUPRAMOL CHEM, V20, P59, DOI 10.1080/10610270701742561; [Anonymous], CHEM3D ULTR 8 0; Asfari Z., 2001, CALIXARENES 2001; Bottino A, 2000, TETRAHEDRON LETT, V41, P10065, DOI 10.1016/S0040-4039(00)01584-7; Cho YL, 2000, CHEM-EUR J, V6, P3788, DOI 10.1002/1521-3765(20001016)6:20<3788::AID-CHEM3788>3.0.CO;2-Y; Cram D. J., 1994, MONOGRAPHS SUPRA MOL; Gutsche C. D., 1998, CALIXARENES REVISITE; Hayashi Y, 1998, J CHEM SOC PERK T 2, P981, DOI 10.1039/a704762b; Hogberg A. G. S., 1980, J ORG CHEM, V45, P4498; Hwang GT, 2000, TETRAHEDRON LETT, V41, P5917, DOI 10.1016/S0040-4039(00)00972-2; Konishi H, 2003, TETRAHEDRON LETT, V44, P7425, DOI 10.1016/j.tetlet.2003.08.049; Kuhnert N, 2005, ORG BIOMOL CHEM, V3, P2175, DOI 10.1039/b502378e; Lucking U, 2000, J AM CHEM SOC, V122, P8880, DOI 10.1021/ja001562l; Mansikkamaki H, 2002, CHEM COMMUN, P1902, DOI 10.1039/b204937f; Moon K, 2004, J AM CHEM SOC, V126, P15016, DOI 10.1021/ja045587m; Morikawa O, 2004, TETRAHEDRON LETT, V45, P5731, DOI 10.1016/j.tetlet.2004.05.098; Morikawa O, 2006, PHOSPHORUS SULFUR, V181, P2877, DOI 10.1080/10426500600865152; Morikawa O, 2007, TETRAHEDRON LETT, V48, P7489, DOI 10.1016/j.tetlet.2007.08.057; Murayama K, 1998, CHEM COMMUN, P607, DOI 10.1039/a800340h; Rudzevich V, 2009, SYNLETT, P1887, DOI 10.1055/s-0029-1217513; Sherman J, 2003, CHEM COMMUN, P1617, DOI 10.1039/b208553b; Shivanyuk A, 2005, TETRAHEDRON, V61, P349, DOI 10.1016/j.tet.2004.10.089; Shivanyuk A, 1998, J ORG CHEM, V63, P6448, DOI 10.1021/jo981386n; Stastny V, 2002, TETRAHEDRON, V58, P7207, DOI 10.1016/S0040-4020(02)00799-8; Tilki T, 2005, TETRAHEDRON, V61, P9624, DOI 10.1016/j.tet.2005.07.078; Vatsouro I., 2008, ORG BIOMOL CHEM, V6, P998; Xu H, 2003, CHEM COMMUN, P2828, DOI 10.1039/b309580k; Zadmard R, 2008, SYNTHETIC COMMUN, V38, P1830, DOI 10.1080/00397910801982035; Zheng Q, 2007, SYNTHETIC COMMUN, V37, P2601, DOI 10.1080/00397910701462955	35	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0039-7911	1532-2432		SYNTHETIC COMMUN	Synth. Commun.		2015	45	5					615	620		10.1080/00397911.2011.560988		6	Chemistry, Organic	Chemistry	AZ8KB	WOS:000348463200006		
J	Ozawa, H; Shimokawa, S				Ozawa, Hisashi; Shimokawa, Shinya			Thermodynamics of a tropical cyclone: generation and dissipation of mechanical energy in a self-driven convection system	TELLUS SERIES A-DYNAMIC METEOROLOGY AND OCEANOGRAPHY			English	Article						thermodynamics; tropical cyclone; Carnot maximum efficiency; thermal dissipation; entropy production	MAXIMUM-ENTROPY PRODUCTION; HEAT ENGINE CONCEPT; HURRICANE INTENSITY; PRODUCTION PRINCIPLE; GLOBAL CLIMATE; PART II; CIRCULATION; ATMOSPHERE; STATE; EQUILIBRIUM	The formation process of circulatory motion of a tropical cyclone is investigated from a thermodynamic viewpoint. The generation rate of mechanical energy by a fluid motion under diabatic heating and cooling, and the dissipation rate of this energy due to irreversible processes are formulated from the first and second laws of thermodynamics. This formulation is applied to a tropical cyclone, and the formation process of the circulatory motion is examined from a balance between the generation and dissipation rates of mechanical energy in the fluid system. We find from this formulation and data analysis that the thermodynamic efficiency of tropical cyclones is about 40% lower than the Carnot maximum efficiency because of the presence of thermal dissipation due to irreversible transport of sensible and latent heat in the atmosphere. We show that a tropical cyclone tends to develop within a few days through a feedback supply of mechanical energy when the sea surface temperature is higher than 300 K, and when the horizontal scale of circulation becomes larger than the vertical height of the troposphere. This result is consistent with the critical radius of 50 km and the corresponding central pressure of about 995 hPa found in statistical properties of typhoons observed in the western North Pacific.	[Ozawa, Hisashi] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan; [Shimokawa, Shinya] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	Ozawa, H (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan.	hozawa@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [17540419, 17654090, 25400465]; Hiroshima University; National Research Institute of Earth Science and Disaster Prevention	The authors would like to thank Ralph Lorenz and one anonymous reviewer for valuable comments and suggestions to improve the quality of this paper. This study was supported by the Japan Society for the Promotion of Science through grants 17540419, 17654090 and 25400465, Hiroshima University project research grants, and by the National Research Institute of Earth Science and Disaster Prevention.	Pauluis O, 2002, J ATMOS SCI, V59, P140, DOI 10.1175/1520-0469(2002)059<0140:EBOAAI>2.0.CO;2; Emanuel KA, 1999, NATURE, V401, P665, DOI 10.1038/44326; Ozawa H, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000113; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Martyushev LM, 2006, PHYS REP, V426, P1, DOI 10.1016/j.physrep.2005.12.001; Pauluis O, 2000, J ATMOS SCI, V57, P989, DOI 10.1175/1520-0469(2000)057<0989:FDIAPA>2.0.CO;2; CHARNEY JG, 1964, J ATMOS SCI, V21, P68, DOI 10.1175/1520-0469(1964)021<0068:OTGOTH>2.0.CO;2; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; Makarieva AM, 2010, P ROY SOC A-MATH PHY, V466, P1893, DOI 10.1098/rspa.2009.0581; PALTRIDGE GW, 1975, Q J ROY METEOR SOC, V101, P475, DOI 10.1256/smsqj.42905; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Lorenz RD, 2001, GEOPHYS RES LETT, V28, P415, DOI 10.1029/2000GL012336; Yoshida Z, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2890189; Bister M, 2011, P ROY SOC A-MATH PHY, V467, P1, DOI 10.1098/rspa.2010.0087; Nolan DS, 2007, Q J ROY METEOR SOC, V133, P2085, DOI 10.1002/qj.170; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; LORENZ EN, 1955, TELLUS, V7, P157; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; Fujiwhara S, 1923, Q J ROY METEOR SOC, V49, P75; Nohguchi Y, 2009, PHYSICA D, V238, P20, DOI 10.1016/j.physd.2008.08.019; Emanuel K, 2000, MON WEATHER REV, V128, P1139, DOI 10.1175/1520-0493(2000)128<1139:ASAOTC>2.0.CO;2; Emanuel K, 2012, J ATMOS SCI, V69, P988, DOI 10.1175/JAS-D-11-0177.1; ASAI T, 1982, J METEOROL SOC JPN, V60, P425; BERGERON T, 1954, Q J ROY METEOR SOC, V80, P131, DOI 10.1002/qj.49708034402; Callen H B, 1985, THERMODYNAMICS INTRO; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; Clausius RJE, 1865, ANN PHYS, V125, P353; Fukumura Y., 2014, SECOND LAW ENTROPY P, P225; GOLITSYN GS, 1970, ICARUS, V13, P1, DOI 10.1016/0019-1035(70)90112-0; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Hardy B., 1998, P 3 INT S HUM MOIST, P1; Kleidon A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025373; Kurgansky MV, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026142; Landau LD, 1987, FLUID MECH; Landau LD, 1980, STAT PHYS 1; Lorenz E. N., 1967, NATURE THEORY GEN CI; Lorenz RD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013771; Ooyama K., 1964, GEOFIS INT, V4, P187; Ozawa H, 1997, PHYS REV E, V56, P2811, DOI 10.1103/PhysRevE.56.2811; Ozawa H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026303; Ozawa H, 1997, J CLIMATE, V10, P441, DOI 10.1175/1520-0442(1997)010<0441:TOAGMS>2.0.CO;2; Ozawa H., 2014, SECOND LAW ENTROPY P, P113; Palmen E. H., 1948, GEOPHYSICA, V3, P26; PALTRIDGE GW, 1978, Q J ROY METEOR SOC, V104, P927; RSMC Tokyo-Typhoon Center, 2014, BEST TRACK DAT; SAWADA Y, 1981, PROG THEOR PHYS, V66, P68, DOI 10.1143/PTP.66.68; Shimokawa S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030208; Shimokawa S., 2010, RES ACTIVITIES ATMOS; Shimokawa S., ASIAN J ENV DIS MANA, V6; Shimokawa S, 2002, Q J ROY METEOR SOC, V128, P2115, DOI 10.1256/003590002320603566; Shimokawa S, 2001, TELLUS A, V53, P266, DOI 10.1034/j.1600-0870.2001.00122.x; Ziegler H, 1961, ING ARCH, V30, P410, DOI 10.1007/BF00531783	53	0	0	CO-ACTION PUBLISHING	JARFALLA	RIPVAGEN 7, JARFALLA, SE-175 64, SWEDEN	0280-6495	1600-0870		TELLUS A	Tellus Ser. A-Dyn. Meteorol. Oceanol.		2015	67								24216	10.3402/tellusa.v67.24216		15	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	AZ3GW	WOS:000348116400001		
J	Kitano, A; Motohashi, H; Takayama, A; Inui, K; Yano, Y				Kitano, Asuka; Motohashi, Hideyuki; Takayama, Akira; Inui, Ken-ichi; Yano, Yoshitaka			Valacyclovir-Induced Acute Kidney Injury in Japanese Patients Based on the PMDA Adverse Drug Reactions Reporting Database	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						valacyclovir; acute kidney injury; Pharmaceuticals and Medical Devices Agency; acyclovir; Japan	PEPTIDE TRANSPORTERS PEPT1; ORGANIC ANION TRANSPORTERS; HERPES-ZOSTER; INDUCED NEPHROTOXICITY; EXPRESSION LEVELS; RENAL-FAILURE; ACYCLOVIR; PHARMACOKINETICS; VALACICLOVIR; ELIMINATION	Background: More than 250,000 reports of adverse drug events were included in the database of the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. However, these data have not been utilized sufficiently for analysis. While valacyclovir is the antiviral agent used worldwide, it is reported to induce nephrotoxicity. The aim of this study was to clarify the profiles of valacyclovir-induced adverse events using the PMDA database. Methods: Case reports were screened in the PMDA adverse event database from 2004 to 2011. The profiles of patients with acute kidney injury (AKI) were analyzed by sex, age, diseases, concomitant suspected drugs, and outcomes. Results: A total of 514 kidney-related adverse events were detected, and 344 were cases that included AKI. Of the AKI cases, 246 patients (71.5%) were female. There were 145 patients who were 70 to 79 years of age, which was the most affected of all age groups. Of the 344 patients, 183 patients had hypertension, and 65 had diabetes. Valacyclovir was the only drug used among 257 patients (74.1%). Conclusions: There were many reports of AKI involving valacyclovir and females, particularly in the 70- to 79-year age group in Japan. The results suggest that these patients were most likely to develop AKI after valacyclovir treatment.	[Kitano, Asuka; Motohashi, Hideyuki; Takayama, Akira; Inui, Ken-ichi; Yano, Yoshitaka] Kyoto Pharmaceut Univ, Educ & Res Ctr Clin Pharm, Kyoto 6078414, Japan	Motohashi, H (reprint author), Kyoto Pharmaceut Univ, Educ & Res Ctr Clin Pharm, Yamashina Ku, Kyoto 6078414, Japan.	motohasi@mb.kyoto-phu.ac.jp			Japan Society for the Promotion of Science KAKENHI [25460231]; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Nippon Shinyaku Co Ltd.	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Japan Society for the Promotion of Science KAKENHI (grant 25460231), the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research, and Nippon Shinyaku Co Ltd.	Sawada K, 1999, J PHARMACOL EXP THER, V291, P705; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Takeda M, 2002, J PHARMACOL EXP THER, V300, P918, DOI 10.1124/jpet.300.3.918; DosSantos MDF, 1997, J AM SOC NEPHROL, V8, P361; Perazella MA, 2003, AM J MED SCI, V325, P349, DOI 10.1097/00000441-200306000-00006; Ganapathy ME, 1998, BIOCHEM BIOPH RES CO, V246, P470, DOI 10.1006/bbrc.1998.8628; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595; Sakurai Y, 2004, PHARM RES, V21, P61, DOI 10.1023/B:PHAM.0000012153.71993.cb; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Motohashi H, 2002, J AM SOC NEPHROL, V13; Sakurai Y, 2005, PHARM RES, V22, P2016, DOI 10.1007/s11095-005-8383-5; Bennett W M, 1999, Geriatr Nephrol Urol, V9, P21, DOI 10.1023/A:1008316617665; Fleischer R, 2010, CASE REPORT MED, V2010; Gunness P, 2011, TRANSL RES, V158, P290, DOI 10.1016/j.trsl.2011.07.002; Gwak HS, 2005, J PHARM PHARMACOL, V57, P393, DOI 10.1211/0022357055533; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Jerkic Mirjana, 2001, International Urology and Nephrology, V32, P539, DOI 10.1023/A:1014484101427; Roberts DM, 2011, KIDNEY INT, V79, P574, DOI 10.1038/ki.2010.496; Sugimoto T, 2008, QJM-INT J MED, V101, P164, DOI 10.1093/qjmed/hcm154; Uwai Yuichi, 2004, Drug Metab Pharmacokinet, V19, P369, DOI 10.2133/dmpk.19.369; Wang LH, 1996, ANTIMICROB AGENTS CH, V40, P80	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	JAN	2015	49	1					81	85		10.1177/2168479014536897		5	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	AZ0XL	WOS:000347965200011		
J	Takeda, K; Morita, S				Takeda, Kentaro; Morita, Satoshi			Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						dose finding; phase I study design; historical data; prior effective sample size; continual reassessment method	CONTINUAL REASSESSMENT METHOD; EFFECTIVE SAMPLE-SIZE; CLINICAL-TRIALS; CAPECITABINE; CANCER; MODELS	Following phase I dose-finding oncology trials completed in Western countries, Asian investigators often conduct further phase I trials to determine the maximum tolerated dose for Asian patients. This may be due to concerns about possible differences in treatment tolerability between Caucasian and Asian patient groups. Our proposed approach aims to appropriately borrow strength from a previous Caucasian trial to improve the maximum tolerated dose determination in an Asian population of patients. We design an Asian phase I trial using the Bayesian continual reassessment method. First we analyze toxicity data from a Caucasian trial to derive the prior distributions for a subsequent Asian trial. Then, we calibrate the informativeness of the prior distributions according to prior effective sample size defined by Morita et al. Extensive simulation studies demonstrate favourable operating characteristics of the proposed method, compared with two methods based on power and noninformative priors, respectively.	[Takeda, Kentaro; Morita, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Takeda, Kentaro] Astellas Pharma Inc, Biostat Grp, Data Sci, Global Dev, Tokyo 1038411, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan	Takeda, K (reprint author), Astellas Pharma Inc, Biostat Grp, Data Sci, Global Dev,Chuo Ku, 2-5-1 Nihonbashi Honcho, Tokyo 1038411, Japan.	kentaro.takeda@astellas.com			Ministry of Health, Labour and Welfare of Japan [C-24500345]; nonprofit organization Epidemiological; nonprofit organization Epidemiological and Clinical Research Information Network	Satoshi Morita's work was supported in part by a Grant-in-Aid for Scientific Research (C-24500345) from the Ministry of Health, Labour and Welfare of Japan and by the nonprofit organization Epidemiological and by the nonprofit organization Epidemiological and Clinical Research Information Network.	Morita S, 2008, BIOMETRICS, V64, P595, DOI 10.1111/j.1541-0420.2007.00888.x; Schoenfeld DA, 2009, CLIN TRIALS, V6, P297, DOI 10.1177/1740774509339238; Neuenschwander B, 2009, STAT MED, V28, P3562, DOI 10.1002/sim.3722; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Mackean M, 1998, J CLIN ONCOL, V16, P2977; Thall PF, 2003, INT J GYNECOL CANCER, V13, P251, DOI 10.1046/j.1525-1438.2003.13202.x; Ibrahim JG, 2000, STAT SCI, V15, P46; Budman DR, 1998, J CLIN ONCOL, V16, P1795; Carter SK, 1973, DESIGN CLIN TRIALS C, P242; Gilks W. R, 1996, MARKOV CHAIN MONTE C; Goodman SN, 2005, CLIN TRIALS, V2, P305, DOI 10.1191/1740774505cn102oa; Liu Jen-pei, 2002, J Biopharm Stat, V12, P401, DOI 10.1081/BIP-120014568; Morita S, 2011, STAT MED, V30, P2090, DOI 10.1002/sim.3999; Morita S, 2012, BAYESIAN ANAL, V7, P591, DOI 10.1214/12-BA720; Morita S., 2010, STAT BIOSCI, V2, P1; Ogura T, 2014, THERAPEUTIC INNOVATI; Pharmaceuticals Medical Devices Agency, REV REP; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	JAN	2015	49	1					93	99		10.1177/2168479014546333		7	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	AZ0XL	WOS:000347965200013		
J	Yoshida, K; Awaji, N; Takenouchi, K; Asahara, Y; Hashigaki, S; Komiyama, O				Yoshida, Katsumi; Awaji, Naoto; Takenouchi, Kazumasa; Asahara, Yuko; Hashigaki, Satoshi; Komiyama, Osamu			How Should a Globalized CTD Be Created? An Introduction to the Japanese 3-Layer Approach	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						3-layer approach; multiregional trial; Common Technical Documents; benefit-risk		This article is based on the consensus of a task force of the Data Science Expert Committee, Japan Pharmaceutical Manufacturers Association. Common Technical Documents (CTDs) need to be harmonized in all of the ICH regions to enhance the scientific value and efficiency of these documents. Region-specific CTDs often require modifications for submission in different countriesan urgent issue not only for Japan but also for the countries where participation in the ICH framework will expand. CTDs themselves should be globalized, which means they should use not only a common format but also common contents, by incorporation of a 3-layer approach. In layer 1 of this approach, efficacy and safety of a study drug are evaluated through the overall study results; layer 2 entails evaluation of whether there is inconsistency in efficacy and/or safety of the study drug for a specific subgroup with overall results; and in layer 3, the results of layers 1 and 2 are used to evaluate benefits and risks in each applying country. The 3-layer approach can be used to create a globally common model using data collected in all countries in the study. This global evaluation allows benefits and risks to be evaluated in all countries and should allow globalized CTDs to be developed. Alignment between research and development sites by pharmaceutical companies and success of regulatory conventions can reduce the total amount of review time. Ultimately, these changes would lead to faster approval of new drugs.	[Yoshida, Katsumi] UCB Japan Co Ltd, Tokyo, Japan; [Awaji, Naoto] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Takenouchi, Kazumasa] Astellas Pharma Inc, Tokyo, Japan; [Asahara, Yuko] Novartis Pharma KK, Tokyo, Japan; [Hashigaki, Satoshi; Komiyama, Osamu] Pfizer Japan Inc, Tokyo, Japan	Yoshida, K (reprint author), UCB Japan Co Ltd, Shinjuku Ku, Shinjuku Grand Tower 8-17-1, Tokyo, Japan.	katsumi.yoshida@ucb.com					Li ZQ, 2007, DRUG INF J, V41, P47; European Medicines Agency, REFL PAP EXTR RES CL; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH HARM TRIP GUID E; Komiyama O, 2013, APPL CLIN TRIALS, V22, P25; Ministry of Health Labour and Welfare, BAS PRINC GLOB CLIN	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	JAN	2015	49	1					175	180		10.1177/2168479014533112		6	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	AZ0XL	WOS:000347965200023		
J	Miura, S; Tashiro, M; Suzuki, K; Noda, S; Hori, S; Nonomura, S				Miura, Shuhei; Tashiro, Masaki; Suzuki, Kazutoshi; Noda, Shinichi; Hori, Shigeo; Nonomura, Shuichi			Stacked nanoparticle-transparent conductive oxide substrate combining high haze with low surface roughness for improvement of thin film Si solar-cell performance	THIN SOLID FILMS			English	Article						Transparent conducting oxide; Nanoparticles; Light-scattering; Flat surface; Thin film solar cells; Silicon-based solar cells	MORPHOLOGY; ZNO; TEXTURE; POLYCRYSTALLINE; COATINGS; VAPOR	Surface-textured morphology of transparent conductive oxide (TCO) substrates enhances light absorption in Si thin films by scattering and trapping light, which results in an increase in the current density of Si thin film solar cells. However, the highly textured morphology often induces the formation of structural defects within the Si layer, which decreases the photovoltaic performance parameters of solar cells such as the open-circuit voltage (V-OC) and fill factor (FF). To overcome this trade-off, we propose a flattened light-scattering TCO substrate based on a strongly light-scattering metal-oxide nanoparticle (NP) layer in conjunction with a surface TCO layer of low surface roughness. Individual layers of ZnO, TiO2, and stacked TiO2/ZnO metal-oxide nanoparticles (NP-TiO2/NP-ZnO), which functioned as a light-scattering layer, were formed between a glass substrate and a low-resistivity Al-doped zinc oxide (AZO) layer to serve as substrates for Si thin film solar cells. After deposition of the AZO film, the nanoparticle AZO substrate demonstrated good flatness and high haze values, which were nearly equivalent to the haze values of the nanoparticle layers before coating by AZO. For thin film hydrogenated amorphous Si (a-Si:H) solar cells fabricated on the stacked AZO/NP-TiO2/NP-ZnO substrate, the short-circuit current increased with no corresponding decrease in the V-OC or FF. We attribute this result to an improved spectral response in a wavelength range lambda > 500 nm and a decrease in the structural defects within the Si layers. (C) 2014 Elsevier B.V. All rights reserved.	[Miura, Shuhei; Tashiro, Masaki; Suzuki, Kazutoshi; Noda, Shinichi; Hori, Shigeo; Nonomura, Shuichi] Gifu Univ, Grad Sch Engn, Environm & Renewal Energy Syst Div, Gifu 5011193, Japan	Miura, S (reprint author), Gifu Univ, Grad Sch Engn, Environm & Renewal Energy Syst Div, 1-1 Yanagido, Gifu 5011193, Japan.	r3815005@edu.gifu-u.ac.jp					Zeman M, 2013, SOL ENERG MAT SOL C, V119, P94, DOI 10.1016/j.solmat.2013.05.037; Tao P, 2011, J MATER CHEM, V21, P18623, DOI 10.1039/c1jm13093e; WENAS WW, 1991, JPN J APPL PHYS 2, V30, pL441, DOI 10.1143/JJAP.30.L441; Muller J, 2004, SOL ENERGY, V77, P917, DOI 10.1016/j.solener.2004.03.015; Springer J, 2005, SOL ENERG MAT SOL C, V85, P1, DOI 10.1016/j.solmat.2004.02.020; Tanemura S, 2003, APPL SURF SCI, V212, P654, DOI 10.1016/S0169-4332(03)00015-1; Zhu H, 2011, SOL ENERG MAT SOL C, V95, P964, DOI 10.1016/j.solmat.2010.11.033; SAKAI H, 1990, JPN J APPL PHYS 1, V29, P630, DOI 10.1143/JJAP.29.630; Ando E, 2001, THIN SOLID FILMS, V392, P289, DOI 10.1016/S0040-6090(01)01045-8; Li HBT, 2009, SOL ENERG MAT SOL C, V93, P338, DOI 10.1016/j.solmat.2008.11.013; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; Python M, 2008, J NON-CRYST SOLIDS, V354, P2258, DOI 10.1016/j.jnoncrysol.2007.09.084; Cox AJ, 2002, AM J PHYS, V70, P620, DOI 10.1119/1.1466815; Bass M., 1994, HDB OPTICS, V2; Bohren C. F., 1983, ABSORPTION SCATTERIN; Bottler W, 2012, J NON-CRYST SOLIDS, V358, P2474, DOI 10.1016/j.jnoncrysol.2011.12.100; Chu WP, 2012, OPT COMMUN, V285, P3325, DOI 10.1016/j.optcom.2012.02.088; Hu M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3593487; Huang Q, 2012, SOL ENERG MAT SOL C, V103, P134, DOI 10.1016/j.solmat.2012.03.033; Krogman KC, 2005, NANOTECHNOLOGY, V16, pS338, DOI 10.1088/0957-4484/16/7/005; Matsui T, 2002, J NON-CRYST SOLIDS, V299, P1152, DOI 10.1016/S0022-3093(01)01083-3; MIZUHASHI M, 1988, JPN J APPL PHYS 1, V27, P2053, DOI 10.1143/JJAP.27.2053; Moulin E, 2012, PHYS STATUS SOLIDI-R, V6, P65, DOI 10.1002/pssr.201105463; NAKADA T, 1991, JPN J APPL PHYS 1, V30, P3344, DOI 10.1143/JJAP.30.3344; Sai H., 2011, APPL PHYS LETT, V98; Sai H., 2009, J APPL PHYS, V105; Sato K., 1992, 42 AS GLASS CO LTD, V42, P129; Schropp REI, 2008, THIN SOLID FILMS, V516, P6818, DOI [10.1016/j.tsf.2007.12.089, 10.1016/j.tsf.2007.12.099]; Takayama S, 2003, J VAC SCI TECHNOL A, V21, P1351, DOI 10.1116/1.1563623	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	JAN 1	2015	574						78	83		10.1016/j.tsf.2014.11.086		6	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AZ2DK	WOS:000348044700013		
J	Nakazawa, H; Kamata, R; Miura, S; Okuno, S				Nakazawa, Hideki; Kamata, Ryosuke; Miura, Soushi; Okuno, Saori			Effects of frequency of pulsed substrate bias on structure and properties of silicon-doped diamond-like carbon films by plasma deposition	THIN SOLID FILMS			English	Article						Diamond-like carbon; Silicon; Pulsed substrate bias; Adhesion; Friction	CHEMICAL-VAPOR-DEPOSITION; A-C-H; BEAM-ASSISTED DEPOSITION; TRIBOLOGICAL PROPERTIES; DLC FILMS; SI-H; DECOMPOSITION; ENVIRONMENT; ADSORPTION; STABILITY	We have investigated the effects of the frequency of pulsed substrate bias on the structure and properties of Si-doped diamond-like carbon (Si-DLC) films deposited by radio-frequency plasma-enhanced chemical vapor deposition using CH4, Ar, and monomethylsilane (CH3SiH3) as the Si source. The Si/(Si + C) ratios in the Si-DLC films deposited using pulsed bias were higher than that of the dc-biased Si-DLC film, and the Si fraction increased with decreasing frequency. Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy analyses revealed that Si-C, Si-H-n, and C-H-n bonds in the Si-DLC films increased with decreasing frequency. The internal stress decreased as the frequency decreased, which is probably due to the increase in Si-C, Si-H-n, and C-H-n bonds in the films. It was found that the wear rate of the pulse-biased Si-DLC film deposited at the highest frequency in this study is comparable to that of the dc-biased, undoped DLC film. Furthermore, the friction coefficient of the former is about one third of that of the latter. (C) 2014 Elsevier B.V. All rights reserved.	[Nakazawa, Hideki; Kamata, Ryosuke; Miura, Soushi; Okuno, Saori] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan	Nakazawa, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, 3 Bunkyo, Hirosaki, Aomori 0368561, Japan.	hnaka@cc.hirosaki-u.ac.jp			JSPS KAKENHI [24560812]	The authors would like to thank Professor Toshimi Abe of the Department of Electronics and Intelligent System, Tohoku Institute of Technology for his great support in the XPS measurements. This work was partly supported by JSPS KAKENHI Grant Number (No. 24560812).	Choi WK, 1998, J APPL PHYS, V83, P4968, DOI 10.1063/1.367299; Nakazawa H, 2008, JPN J APPL PHYS, V47, P231, DOI 10.1143/JJAP.47.231; GOGOLIDES E, 1995, JPN J APPL PHYS 1, V34, P261, DOI 10.1143/JJAP.34.261; Kim MG, 1999, SURF COAT TECH, V112, P204, DOI 10.1016/S0257-8972(98)00770-1; Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5; Ohana T, 2004, DIAM RELAT MATER, V13, P1500, DOI 10.1016/j.diamond.2003.11.019; TAYLOR PA, 1992, J AM CHEM SOC, V114, P6754, DOI 10.1021/ja00043a020; Ronkainen H, 2001, WEAR, V249, P260, DOI 10.1016/S0043-1648(01)00558-0; Lee CS, 2002, DIAM RELAT MATER, V11, P198; Ikeyama M, 2005, SURF COAT TECH, V191, P38, DOI 10.1016/j.surfcoat.2004.08.075; LUCOVSKY G, 1979, SOLID STATE COMMUN, V29, P571, DOI 10.1016/0038-1098(79)90666-5; Yang SH, 2002, WEAR, V252, P70, DOI 10.1016/S0043-1648(01)00856-0; Ban M., 2002, SURF COAT TECH, V162, P1; Camargo SS, 1998, DIAM RELAT MATER, V7, P1155, DOI 10.1016/S0925-9635(98)00165-4; Di ZF, 2005, J APPL PHYS, V98, DOI 10.1063/1.2034651; Diaz J, 1996, PHYS REV B, V54, P8064, DOI 10.1103/PhysRevB.54.8064; Fujimoto S, 2011, SURF COAT TECH, V206, P1011, DOI 10.1016/j.surfcoat.2011.03.106; Hanaya M., 2004, KAGAKU BINRAN; HIOKI T, 1991, SURF COAT TECH, V46, P233, DOI 10.1016/0257-8972(91)90166-T; Li DJ, 1999, APPL SURF SCI, V137, P30, DOI 10.1016/S0169-4332(98)00485-1; Murakawa M, 2003, SURF COAT TECH, V163, P561, DOI 10.1016/S0257-8972(02)00624-2; MUTSUKURA N, 1992, J APPL PHYS, V72, P43, DOI 10.1063/1.352145; Nakazawa H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.116002; Nakazawa H, 2008, JPN J APPL PHYS, V47, P8491, DOI 10.1143/JJAP.47.8491; Nakazawa H, 2013, THIN SOLID FILMS, V539, P134, DOI 10.1016/j.tsf.2013.05.089; NISHIJIMA M, 1987, SURF SCI, V192, P383; OGURI K, 1991, SURF COAT TECH, V47, P710, DOI 10.1016/0257-8972(91)90344-V; Papakonstantinou P, 2002, DIAM RELAT MATER, V11, P1074, DOI 10.1016/S0925-9635(01)00656-2; Perrin J, 1998, J VAC SCI TECHNOL A, V16, P278, DOI 10.1116/1.580983; Suzuki M, 2004, DIAM RELAT MATER, V13, P2216, DOI 10.1016/j.diamond.2004.06.023; Wazumi K, 2003, DIAM RELAT MATER, V12, P1018, DOI 10.1016/S0925-9635(02)00391-6; Zhang W, 2002, THIN SOLID FILMS, V416, P145, DOI 10.1016/S0040-6090(02)00611-9	32	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	JAN 1	2015	574						93	98		10.1016/j.tsf.2014.11.078		6	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AZ2DK	WOS:000348044700015		
J	Oikawa, H; Akiyama, R; Kanazawa, K; Kuroda, S; Harayama, I; Nagashima, K; Sekiba, D; Ashizawa, Y; Tsukamoto, A; Nakagawa, K; Ota, N				Oikawa, H.; Akiyama, R.; Kanazawa, K.; Kuroda, S.; Harayama, I.; Nagashima, K.; Sekiba, D.; Ashizawa, Y.; Tsukamoto, A.; Nakagawa, K.; Ota, N.			Deposition and characterization of amorphous aluminum nitride thin films for a gate insulator	THIN SOLID FILMS			English	Article						Aluminum Nitride; Gate Insulator; Reactive Deposition; X-Ray Photoelectron Spectroscopy; Elastic Recoil Detection Analysis	RAY PHOTOELECTRON-SPECTROSCOPY; ELECTRICAL-PROPERTIES; ALN; TEMPERATURE; DIELECTRICS; IRON; MIS	Thin films of aluminum nitride (AlN) fabricated by reactive deposition were characterized in order to examine the electrical insulation properties suitable for a gate insulator. For a series of AlN films deposited with a variation of the amount of Al flux at a fixed N flux, compositional and chemical analyses were performed using X-ray photoelectron spectroscopy (XPS) and elastic recoil detection analysis (ERDA). Combined with the result of current-voltage (I-V) measurement, it is found that the insulation properties are correlated with the compositional ratio between Al and N estimated by the ERDA measurement; a good electrical insulation with a minimal leak current of the order of 10(-9) A/cm(2) at a high electric field 1MV/cm is achieved in the film of nearly stoichiometric compositional ratio of Al/N, in which the dominance of the Al-N bonding state is confirmed in the XPS measurement. On the other hand, the incorporation of oxygen, probably caused by the surface oxidization due to the exposure to the air, has little effect on the electrical properties. (C) 2014 Elsevier B.V. All rights reserved.	[Oikawa, H.; Akiyama, R.; Kanazawa, K.; Kuroda, S.] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Oikawa, H.; Akiyama, R.; Kuroda, S.; Harayama, I.; Ota, N.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba Nanotech Human Resource Dev Program, Tsukuba, Ibaraki 3058571, Japan; [Harayama, I.; Nagashima, K.; Sekiba, D.] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Sekiba, D.] Univ Tsukuba, Res Facil Ctr Sci & Technol, Tandem Accelerator Complex, Tsukuba, Ibaraki 3058577, Japan; [Ashizawa, Y.; Tsukamoto, A.; Nakagawa, K.] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan	Kuroda, S (reprint author), Univ Tsukuba, Inst Mat Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	kuroda@ims.tsukuba.ac.jp			Japan Society for the Promotion of Science; University of Tsukuba	This work has partially been supported by Grant-in-Aids from the Japan Society for the Promotion of Science. H. O. acknowledges a financial support from "Graduate Honors Program" of University of Tsukuba.	Aardahl CL, 1999, THIN SOLID FILMS, V346, P174, DOI 10.1016/S0040-6090(98)01618-6; Gredelj S, 2001, APPL SURF SCI, V174, P240, DOI 10.1016/S0169-4332(01)00169-6; Men CL, 2006, MAT SCI ENG B-SOLID, V133, P124, DOI 10.1016/j.mseb.2006.06.016; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Wilk GD, 2001, J APPL PHYS, V89, P5243, DOI 10.1063/1.1361065; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; LIAO HM, 1993, J VAC SCI TECHNOL A, V11, P2681, DOI 10.1116/1.578626; Chiba D, 2011, NAT MATER, V10, P853, DOI [10.1038/nmat3130, 10.1038/NMAT3130]; Engelmark F, 2003, IEEE T ELECTRON DEV, V50, P1214, DOI 10.1109/TED.2003.813231; Rosenberger L, 2008, SURF INTERFACE ANAL, V40, P1254, DOI 10.1002/sia.2874; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Adam T, 2001, APPL SURF SCI, V175, P428, DOI 10.1016/S0169-4332(01)00091-5; BEHRISCH R, 1992, NUCL INSTRUM METH B, V68, P245, DOI 10.1016/0168-583X(92)96085-D; Chiba D., 2006, APPL PHYS LETT, V89, P1; Georgiev DG, 2005, APPL SURF SCI, V249, P45, DOI 10.1016/j.apsusc.2004.11.027; Hassine N.B., 2009, J APPL PHYS, V105; Hwang Y.-H., 2013, J VAC SCI TECHNOL B, V31, P1; Jose F., 2010, J PHYS D, V43, P1; Placidi M, 2010, SURF SCI, V604, P63, DOI 10.1016/j.susc.2009.10.022; Sanghera HK, 1999, SURF INTERFACE ANAL, V27, P678, DOI 10.1002/(SICI)1096-9918(199907)27:7<678::AID-SIA562>3.3.CO;2-M	20	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	JAN 1	2015	574						110	114		10.1016/j.tsf.2014.11.081		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AZ2DK	WOS:000348044700018		
J	Wang, ZJ; Xu, YH; Meng, XN; Watari, FM; Liu, HD; Chen, X				Wang, Zhaojing; Xu, Yonghong; Meng, Xiangning; Watari, Fumio; Liu, Hudan; Chen, Xiao			Suppression of c-Myc is involved in multi-walled carbon nanotubes' down-regulation of ATP-binding cassette transporters in human colon adenocarcinoma cells	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Multi-walled carbon nanotubes; c-Myc; ABC transporters; Multi-drug resistance; Human colon adenocarcinoma; Reactive oxygen species	GENE-EXPRESSION; P-GLYCOPROTEIN; NEUROBLASTOMA-CELLS; ABC TRANSPORTERS; OXIDATIVE STRESS; PLASMA-MEMBRANE; RESISTANT CELLS; CANCER; APOPTOSIS; AGENTS	Over-expression of ATP-binding cassette (ABC) transporters, a large family of integral membrane proteins that decrease cellular drug uptake and accumulation by active extrusion, is one of the major causes of cancer multidrug resistance (MDR) that frequently leads to failure of chemotherapy. Carbon nanotubes (CNTs)-based drug delivery devices hold great promise in enhancing the efficacy of cancer chemotherapy. However, CNTs' effects on the ABC transporters remain under-investigated. In this study, we found that multiwalled carbon nanotubes (MWCNTs) reduced transport activity and expression of ABC transporters including ABCB1/Pgp and ABCC4/ MRP4 in human colon adenocarcinoma Caco-2 cells. Proto-oncogene c-Myc, which directly regulates ABC gene expression, was concurrently decreased in MWCNT-treated cells and forced over-expression of c-Myc reversed MWCNTs' inhibitory effects on ABCB1 and ABCC4 expression. MWCNT-cell membrane interaction and cell membrane oxidative damage were observed. However, antioxidants such as vitamin C, beta-mecaptoethanol and dimethylthiourea failed to antagonize MWCNTs' down-regulation of ABC transporters. These data suggest that MWCNTs may act on c-Myc, but not through oxidative stress, to down-regulate ABC transporter expression. Our findings thus shed light on CNTs' novel cellular effects that may be utilized to develop CNTs-based drug delivery devices to overcome ABC transporter-mediated cancer chemoresistance. (C) 2014 Elsevier Inc. All rights reserved.	[Wang, Zhaojing; Liu, Hudan; Chen, Xiao] Huazhong Univ Sci & Technol, Sch Pharm, Dept Pharmacol, Tone Med Coll, Wuhan 430030, Peoples R China; [Xu, Yonghong] Wuhan Univ, Renmin Hosp, Dept Ophthalmol, Inst Ophthalmol Res, Wuhan 430060, Peoples R China; [Meng, Xiangning] Northeastern Univ, Sch Met & Mat, Shenyang 110819, Peoples R China; [Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Dept Biomed Dent Mat & Engn, Sapporo, Hokkaido 0608586, Japan	Liu, HD (reprint author), Huazhong Univ Sci & Technol, Sch Pharm, Dept Pharmacol, 13 Hangkong Rd, Wuhan 430030, Peoples R China.	hudanliu@hust.edu.cn; mornsmile@yahoo.com			National Natural Science Foundation of China [81101149, 81200381]	This work was supported by the National Natural Science Foundation of China to X. C. (81101149) and H. L (81200381).	Fabbro C, 2012, CHEM COMMUN, V48, P3911, DOI 10.1039/c2cc17995d; Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832; Aliev AE, 2009, SCIENCE, V323, P1575, DOI 10.1126/science.1168312; Regev R, 1999, EUR J BIOCHEM, V259, P18, DOI 10.1046/j.1432-1327.1999.00037.x; Hirano S, 2008, TOXICOL APPL PHARM, V232, P244, DOI 10.1016/j.taap.2008.06.016; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Haber M, 1999, ONCOGENE, V18, P2777, DOI 10.1038/sj.onc.1202859; Kang B, 2010, SMALL, V6, P2362, DOI 10.1002/smll.201001260; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Chen X, 2010, CARBON, V48, P730, DOI 10.1016/j.carbon.2009.10.020; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Wallace EJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045101; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Manohar CF, 2004, ONCOGENE, V23, P753, DOI 10.1038/sj.onc.1207151; Zhang Q, 2011, CANCER LETT, V313, P201, DOI 10.1016/j.canlet.2011.09.005; Delogu LG, 2012, P NATL ACAD SCI USA, V109, P16612, DOI 10.1073/pnas.1208312109; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m; Dang CV, 1999, MOL CELL BIOL, V19, P1; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Diao S, 2012, J AM CHEM SOC, V134, P16971, DOI 10.1021/ja307966u; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; Antaris AL, 2013, ACS NANO, V7, P3644, DOI 10.1021/nn4006472; Cheng C, 2009, BIOMATERIALS, V30, P4152, DOI 10.1016/j.biomaterials.2009.04.019; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Blanc E, 2003, AM J PATHOL, V163, P321, DOI 10.1016/S0002-9440(10)63656-5; Chen X, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105104; Cheng JP, 2011, TOXICOL APPL PHARM, V250, P184, DOI 10.1016/j.taap.2010.10.012; Feugang JM, 2004, THERIOGENOLOGY, V61, P71, DOI 10.1016/S0093-691X(03)00191-2; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Huynh Tony, 2012, Front Oncol, V2, P178, DOI 10.3389/fonc.2012.00178; Ikemura K, 2009, EXPERT OPIN DRUG MET, V5, P907, DOI 10.1517/17425250903008525; Kang KW, 2009, MOL PHARMACEUT, V6, P627, DOI 10.1021/mp800116f; Kosuge H., 2012, AM HEART ASS, V1; Lee Y, 2012, MACROMOL BIOSCI, V12, P1060, DOI [10.1002/mabi.201200085, 10.1002/mabi.201290028, 10.1002/mabi.201200085]; Li RB, 2010, METHODS MOL BIOL, V625, P153, DOI 10.1007/978-1-60761-579-8_13; Liu B, 2009, NANO LETT, V9, P1386, DOI 10.1021/nl8030339; Liu JZ, 2008, CHEM RES TOXICOL, V21, P459, DOI 10.1021/tx700392b; Mahmood M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/4/045102; Makrigiorgos GM, 1997, FREE RADICAL BIO MED, V22, P93, DOI 10.1016/S0891-5849(96)00229-8; Moon H.K., 2009, ACS NANO, V3, P6; Patak P, 2011, CURR PHARM DESIGN, V17, P2787; Raffa V, 2010, NANOMEDICINE-UK, V5, P89, DOI [10.2217/nnm.09.95, 10.2217/NNM.09.95]; Sucapane A., 2009, J NANONEUROSCI, V1, P10, DOI DOI 10.1166/JNS.2009.002; Vassault A, 1983, METHOD ENZYMAT AN, V3, P118; Wartenberg M, 2001, J BIOL CHEM, V276, P17420, DOI 10.1074/jbc.M100141200; WASIL M, 1987, BIOCHEM J, V243, P867; Xu YH, 2010, J BIOMED NANOTECHNOL, V6, P260, DOI 10.1166/jbn.2010.1126; Yu M., 2013, CANCER METAST REV, V32, P21	57	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	JAN 1	2015	282	1					42	51		10.1016/j.taap.2014.11.002		10	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AZ5GL	WOS:000348248200005		
J	Suzuki, T; Iwahashi, Y				Suzuki, Tadahiro; Iwahashi, Yumiko			Low Toxicity of Deoxynivalenol-3-Glucoside in Microbial Cells	TOXINS			English	Article						deoxynivalenol-3-glucoside; DNA microarray; yeast; Chlamydomonas reinhardtii	CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; UDP-GLUCOSYLTRANSFERASE; ARABIDOPSIS-THALIANA; MYCOTOXIN DEOXYNIVALENOL; EXPRESSION ANALYSIS; MASKED MYCOTOXINS; B TRICHOTHECENES; MODEL SYSTEM; WHEAT	Host plants excrete a glucosylation enzyme onto the plant surface that changes mycotoxins derived from fungal secondary metabolites to glucosylated products. Deoxynivalenol-3-glucoside (DON3G) is synthesized by grain uridine diphosphate-glucosyltransferase, and is found worldwide, although information on its toxicity is lacking. Here, we conducted growth tests and DNA microarray analysis to elucidate the characteristics of DON3G. The Saccharomyces cerevisiae PDR5 mutant strain exposed to DON3G demonstrated similar growth to the dimethyl sulfoxide control, and DNA microarray analysis revealed limited differences. Only 10 genes were extracted, and the expression profile of stress response genes was similar to that of DON, in contrast to metabolism genes like SER3, which encodes 3-phosphoglycerate dehydrogenase. Growth tests with Chlamydomonas reinhardtii also showed a similar growth rate to the control sample. These results suggest that DON3G has extremely low toxicity to these cells, and the glucosylation of mycotoxins is a useful protective mechanism not only for host plants, but also for other species.	[Suzuki, Tadahiro; Iwahashi, Yumiko] Natl Food Res Inst, Appl Microbiol Div, Tsukuba, Ibaraki 3058642, Japan	Iwahashi, Y (reprint author), Natl Food Res Inst, Appl Microbiol Div, 2-1-12 Kannon Dai, Tsukuba, Ibaraki 3058642, Japan.	suzut@affrc.go.jp; yumiko@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25871096]	We are grateful to Mikio Tsuzuki and Shoko Fujiwara (Department of Applied Life Science, Tokyo University of Pharmacy and Life Science, Tokyo, Japan) for providing the C. reinhardtii strain and technical information. We are also grateful to Katsuhide Fujita and Makiko Fukuda [National Institute of Advanced Industrial Science and Technology (AIST), Technology Research Association for Single Wall Carbon Nanotubes (TASC)] for supporting microarray analysis. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25871096.	Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Kostelanska M, 2009, J AGR FOOD CHEM, V57, P3187, DOI 10.1021/jf803749u; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Nakagawa H, 2011, FOOD ADDIT CONTAM A, V28, P1447, DOI 10.1080/19440049.2011.597434; Berthiller F, 2009, FOOD ADDIT CONTAM A, V26, P507, DOI 10.1080/02652030802555668; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Ovando-Martinez M, 2013, TOXINS, V5, P2522, DOI 10.3390/toxins5122522; Berthiller F, 2011, TOXICOL LETT, V206, P264, DOI 10.1016/j.toxlet.2011.08.006; Nagl V, 2012, TOXICOL LETT, V213, P367, DOI 10.1016/j.toxlet.2012.07.024; SAVARD ME, 1991, J AGR FOOD CHEM, V39, P570, DOI 10.1021/jf00003a027; Berthiller F, 2009, ANAL BIOANAL CHEM, V395, P1243, DOI 10.1007/s00216-009-2874-x; Schweiger W, 2010, MOL PLANT MICROBE IN, V23, P977, DOI 10.1094/MPMI-23-7-0977; Desjardins AE, 2007, J AGR FOOD CHEM, V55, P6487, DOI 10.1021/jf0709193; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Gratz SW, 2013, APPL ENVIRON MICROB, V79, P1821, DOI 10.1128/AEM.02987-12; Alexander NJ, 1999, NAT TOXINS, V7, P265, DOI 10.1002/1522-7189(199911/12)7:6<265::AID-NT65>3.0.CO;2-5; Maragos CM, 2013, TOXINS, V5, P1299, DOI 10.3390/toxins5071299; Sirisattha S, 2004, WATER RES, V38, P61, DOI 10.1016/j.watres.2003.08.027; Fukuzawa Hideya, 2008, Tanpakushitsu Kakusan Koso, V53, P1133; Ghaffari Mohammad Reza, 2010, Iranian Journal of Biotechnology, V8, P112; Harris E.H., 1989, CHLAMYDOMONAS SOURCE, P1503; Iwahashi H, 2005, FEBS LETT, V579, P2847, DOI 10.1016/j.febslet.2005.03.100; Kam V, 1999, INT J PLANT SCI, V160, P1093, DOI 10.1086/314205; Kunikane Satoshi, 2008, Seikagaku, V80, P1033; Suzuki T, 2012, J AGR FOOD CHEM, V60, P9519, DOI 10.1021/jf3020975; Suzuki T, 2014, TOXINS, V6, P453, DOI 10.3390/toxins6020453; Suzuki T, 2009, FOOD SCI TECHNOL RES, V15, P453; Suzuki T., 2009, CHEM BIOINFORMATION, V9, P94; Yiannikouris A, 2006, BIOMACROMOLECULES, V7, P1147, DOI 10.1021/bm050968t	29	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	JAN	2015	7	1					187	200		10.3390/toxins7010187		14	Toxicology	Toxicology	AZ7MK	WOS:000348402800013		
J	Nerome, K; Sugita, S; Kuroda, K; Hirose, T; Matsuda, S; Majima, K; Kawasaki, K; Shibata, T; Poetri, ON; Soejoedono, RD; Mayasari, NLPI; Agungpriyono, S; Nerome, R				Nerome, Kuniaki; Sugita, Shigeo; Kuroda, Kazumichi; Hirose, Toshiharu; Matsuda, Sayaka; Majima, Kei; Kawasaki, Kazunori; Shibata, Toshikatsu; Poetri, Okti Nadia; Soejoedono, Retno D.; Mayasari, Ni L. P. Ika; Agungpriyono, Srihadi; Nerome, Reiko			The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae	VACCINE			English	Article						Vaccine; H5N1 influenza virus; Baculovirus; Virus-like particle	A H5N1; RECOMBINANT GLYCOPROTEINS; IMMUNE-RESPONSES; INSECT CELLS; BOMBYX-MORI; HEMAGGLUTININ; EXPRESSION; IMMUNOGENICITY; VECTOR; LARVAE	We successfully established a mass production system for art influenza virus-like particle (VLP) vaccine using a synthetic H5 hemagglutinin (HA) gene codon-optimized for the silkworm. A recombinant baculovirus containing the synthetic gene was inoculated into silkworm pupae. Four days after inoculation, the hemagglutination titer in homogenates from infected pupae reached a mean value of 0.8 million hemagglutination units (HAU), approximately 2,000 p,g HA protein per pupa, more than 50-fold higher than that produced with an embryonated chicken egg. VLPs ranging from 30 nm to 300 nm in diameter and covered with a large number of spikes were detected in the homogenates. The spikes were approximately 14 nm long, similar to an authentic influenza HA spike. Detailed electron micrographs indicated that the VLP spike density was similar to that of authentic influenza virus particles. The results clearly show that the expression of a single HA gene can efficiently produce VLPs in silkworm pupae. When chickens were immunized with the pupae homogenate, the hemagglutination inhibition titer in their sera reached values of 2,048-8,192 after approximately 1 month. This is the first report demonstrating that a large amount of VLP vaccine could be produced by single synthetic HA gene in silkworm pupae. Our system might be useful for future vaccine development against other viral diseases. (C) 2014 Elsevier Ltd. All rights reserved.	[Nerome, Kuniaki; Hirose, Toshiharu; Matsuda, Sayaka; Nerome, Reiko] Inst Biol Resources, Nago, Okinawa 9050004, Japan; [Sugita, Shigeo] Japan Racing Assoc, Equine Res Inst, Utsunomiya, Tochigi 3200856, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Div Microbiol, Itabashi Ku, Tokyo 1738610, Japan; [Majima, Kei] Baculotechnol Co Ltd, Takamatsu, Kagawa 7610301, Japan; [Kawasaki, Kazunori] Natl Inst Adv Sci & Technol AIST, Ikeda, Osaka 5638577, Japan; [Shibata, Toshikatsu] Nihon Univ, Sch Med, Div Gastroenterol & Hepatol, Itabshi Ku, Tokyo 1738610, Japan; [Poetri, Okti Nadia; Soejoedono, Retno D.; Mayasari, Ni L. P. Ika; Agungpriyono, Srihadi] Bogor Agr Univ IPB, Fac Vet Med, Bogor 16680, Indonesia	Nerome, K (reprint author), Inst Biol Resources, 893-2 Nakayama, Nago, Okinawa 9050004, Japan.	rnerome_ibr@train.ocn.ne.jp			Okinawa New Industry Creation Project; Okinawa Industry Promotion Public Corporation trusted from the Okinawa prefectural government	The authors thank Ms. Emiko Kobayashi for her assistance with microscope observations. The pCAGGS expression vector was kindly provided by Dr. Jun-ichi Miyazaki. This work was primarily supported by a grant from the Okinawa New Industry Creation Project for fiscal years 2011 and 2012 by the Okinawa Industry Promotion Public Corporation trusted from the Okinawa prefectural government.	Gomez-Casado E, 2011, PROTEIN EXPRES PURIF, V79, P35, DOI 10.1016/j.pep.2011.03.007; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; NIWA H, 1991, GENE, V108, P193; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Pan YS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/506363; Mabashi-Asazuma H, 2014, GLYCOBIOLOGY, V24, P325, DOI 10.1093/glycob/cwt161; Cox MMJ, 2008, CURR OPIN MOL THER, V10, P56; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Hiromoto Y, 2000, VIROLOGY, V272, P429, DOI 10.1006/viro.2000.0371; Palmberger D, 2014, BIOTECHNOL J, V9, P1206, DOI 10.1002/biot.201400061; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Galarza JM, 2005, VIRAL IMMUNOL, V18, P365, DOI 10.1089/vim.2005.18.365; TAKEUCHI K, 1994, J VIROL, V68, P911; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Dong JH, 2013, J VIROL METHODS, V194, P271, DOI 10.1016/j.jviromet.2013.08.040; Gavrilov V, 2011, J VIROL METHODS, V173, P364, DOI 10.1016/j.jviromet.2011.03.011; Hiromoto Y, 2000, J GEN VIROL, V81, P1293; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; KOBAYASHI J, 1992, CYTOTECHNOLOGY, V8, P103, DOI 10.1007/BF02525492; NEROME K, 1990, VACCINE, V8, P503, DOI 10.1016/0264-410X(90)90254-J; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Steel J, 2011, BIODRUGS, V25, P285, DOI 10.2165/11593870-000000000-00000; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; World Health Organization, 2014, H5N1 HIGHL PATH AV I	32	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-410X	1873-2518		VACCINE	Vaccine	JAN 1	2015	33	1					117	125		10.1016/j.vaccine.2014.11.009		9	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	AY6FX	WOS:000347663700020		
J	Takazawa, K				Takazawa, Kenji			Second derivative of photoplethysmogram	VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE			English	Editorial Material							AORTIC PRESSURE; BLOOD-PRESSURE; PULSE		Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1930998, Japan	Takazawa, K (reprint author), Tokyo Med Univ, Hachioji Med Ctr, 1163 Tatemachi Hachioji City, Tokyo 1930998, Japan.	takazawa@tokyo-med.ac.jp					Takazawa K, 1998, HYPERTENSION, V32, P365; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; KELLY R, 1989, CIRCULATION, V80, P1652; Millasseau SC, 2006, J HYPERTENS, V24, P1449, DOI 10.1097/01.hjh.0000239277.05068.87; MURGO JP, 1980, CIRCULATION, V62, P105; TAKAZAWA K, 1995, HYPERTENSION, V26, P520; Imanaga I, 1998, JPN HEART J, V39, P775; Takazawa K, 1996, Z KARDIOL, V85, P137; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Takazawa K, 2012, J HYPERTENS, V30, P908, DOI 10.1097/HJH.0b013e3283524910; Tanaka K, 2015, VASA, V44, P42	11	0	0	VERLAG HANS HUBER HOGREFE AG	BERN 9	LAENGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	0301-1526			VASA	Vasa	JAN	2015	44	1					3	4		10.1024/0301-7526/0000411		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ5HL	WOS:000348250700001		
J	Tanaka, K; Kamihira, K; Minoura, F; Watanabe, M; Fujiyoshi, E; Nakamura, K; Katafuchi, T				Tanaka, Kunihiko; Kamihira, Kimiko; Minoura, Fumie; Watanabe, Miyuki; Fujiyoshi, Emi; Nakamura, Koji; Katafuchi, Tetsuro			Postprandial decrease in vascular resistance correlated with change in second derivative of finger plethysmogram in young subjects	VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE			English	Article						Cardiac output; arterial pressure; photoplethysmograph; hypertension; vasodilation	PULSE-WAVE VELOCITY; CARDIAC-OUTPUT; BLOOD-FLOW; PHOTOPLETHYSMOGRAM; MEAL	Background: The second derivative of the finger plethysmogram (SDPTG) comprises five waves termed a to e. The magnitudes of waves b-e are normalized by that of wave a for within- and between-patient comparison. In the present study, affects of meal ingestion for SDPTG in young and elderly subjects are examined. Subjects and methods: Mean arterial pressure and SDPTG before and after meal ingestion in young and elderly subjects were measured. For young subjects, stroke volume and pulse rate were also measured, and the total peripheral resistance (TPR) of the blood vessels was analyzed. Relationship between TPR and the ratio of the peak of SDPTG in young subjects was also analyzed. Results: In young subjects, postprandial d/a was significantly larger and TPR was smaller than before intake and was linearly and significantly correlated with TPR. An increase in the postprandial d/a was also observed in the elderly subjects who were not undergoing hypertension treatment. However, this increase was not observed in elderly subjects who were treated for hypertension. Conclusions: Change in d/a is considered to be an index of change in TPR. TPR is considered to be decreased by agents for treatment of hypertension, and meal ingestion does not appear to further decrease TPR. These results are considered to be useful for understanding cardiodynamics surrounding meal ingestion.	[Tanaka, Kunihiko; Katafuchi, Tetsuro] Gifu Univ Med Sci, Dept Radiol Technol, Seki, Japan; [Kamihira, Kimiko; Minoura, Fumie; Watanabe, Miyuki; Fujiyoshi, Emi] Gifu Univ Med Sci, Dept Nursing, Seki, Japan; [Nakamura, Koji] Gifu Univ Med Sci, Dept Med Technol, Seki, Japan	Tanaka, K (reprint author), Gifu Univ Med Sci, 795-1 Nagamine Ichihiraga, Gifu 5013892, Japan.	ktanaka@u-gifu-ms.ac.jp			Gifu University of Medical Science [H22-B]	This work was supported by a research grant from Gifu University of Medical Science (H22-B).	Takazawa K, 1998, HYPERTENSION, V32, P365; Tanaka K, 2009, AUTON NEUROSCI-BASIC, V148, P90, DOI 10.1016/j.autneu.2009.03.007; Zafra C, 2004, GASTROENTEROLOGY, V126, P749, DOI 10.1053/j.gastro.2003.12.007; WAALER BA, 1991, ACTA PHYSIOL SCAND, V142, P33, DOI 10.1111/j.1748-1716.1991.tb09125.x; AVASTHI PS, 1987, AM J PHYSIOL, V252, pF1167; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Donald DE, 1983, HDB PHYSL 2, V3, P219; Hall JE, 2010, GUYTON HALL TXB MED, P273; Hall JE, 2010, GUYTON HALL TXB MED, P229; Hashimoto J, 2005, AM J HYPERTENS, V18, P477, DOI 10.1016/j.amjhyper.2004.11.009; Hlebowicz J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-26; Iketani Y, 2000, JPN CIRC J, V64, P110, DOI 10.1253/jcj.64.110; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Shelley K. H., 2001, CLIN MONITORING PRAC, P420; WAALER BA, 1990, ACTA PHYSIOL SCAND, V140, P167, DOI 10.1111/j.1748-1716.1990.tb08988.x	16	0	0	VERLAG HANS HUBER HOGREFE AG	BERN 9	LAENGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	0301-1526			VASA	Vasa	JAN	2015	44	1					43	48		10.7024/0301-1526/a000405		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ5HL	WOS:000348250700005		
J	Numata, D				Numata, Daisuke			How to increase collection of used lunch boxes	WASTE MANAGEMENT			English	Editorial Material									Fukushima Univ, Fac Econ & Business Adm, Fukushima, Japan	Numata, D (reprint author), Fukushima Univ, Fac Econ & Business Adm, Fukushima, Japan.						Numata D, 2011, P 22 ANN C JAP SOC M, P31; Tasaki T., 2010, 205R2052010 NAT I EN, V205	2	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	JAN	2015	35						II	III				2	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AY5CN	WOS:000347591000042		
J	Pall-Gergely, B; Hunyadi, A; Ablett, J; Van Luong, H; Naggs, F; Asami, T				Pall-Gergely, Barna; Hunyadi, Andras; Ablett, Jonathan; Hao Van Luong; Naggs, Fred; Asami, Takahiro			Systematics of the family Plectopylidae in Vietnam with additional information on Chinese taxa (Gastropoda, Pulmonata, Stylommatophora)	ZOOKEYS			English	Article						Anatomy; revision; taxonomy; new species; Plectopylidae; Corillidae; mating behaviour; Vietnam; China	LOVE-DART; STREPTAXIDAE; AFRICA; SNAILS; MUCUS; GENUS	Vietnamese species from the family Plectopylidae are revised based on the type specimens of all known taxa, more than 600 historical non-type museum lots, and almost 200 newly-collected samples. Altogether more than 7000 specimens were investigated. The revision has revealed that species diversity of the Vietnamese Plectopylidae was previously overestimated. Overall, thirteen species names (anterides Gude, 1909, bavayi Gude, 1901, congesta Gude, 1898, fallax Gude, 1909, gouldingi Gude, 1909, hirsuta Mollendorff, 1901, jovia Mabille, 1887, moellendorffi Gude, 1901, persimilis Gude, 1901, pilsbryana Gude, 1901, soror Gude, 1908, tenuis Gude, 1901, verecunda Gude, 1909) were synonymised with other species. In addition to these, Gudeodiscus hemmeni sp.n. and G. messageri raheemi ssp. n. are described from north-western Vietnam. Sixteen species and two subspecies are recognized from Vietnam. The reproductive anatomy of eight taxa is described. Based on anatomical information, Halongella gen. n. is erected to include Plectopylis schlumbergeri and P. fruhstorferi. Additionally, the genus Gudeodiscus is subdivided into two subgenera (Gudeodiscus and Veludiscus subgen. n.) on the basis of the morphology of the reproductive anatomy and the radula. The Chinese G. phlyarius werneri Pall-Gergely, 2013 is moved to synonymy of G. phlyarius. A spermatophore was found in the organ situated next to the gametolytic sac in one specimen. This suggests that this organ in the Plectopylidae is a diverticulum. Statistically significant evidence is presented for the presence of calcareous hook-like granules inside the penis being associated with the absence of embryos in the uterus in four genera. This suggests that these probably play a role in mating periods before disappearing when embryos develop. Sicradiscus mansuyi is reported from China for the first time.	[Pall-Gergely, Barna; Asami, Takahiro] Shinshu Univ, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Ablett, Jonathan; Naggs, Fred] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Hao Van Luong] Ctr Rescuing & Conservat Organisms, Hoang Lien Natl Pk, Sa Pa, Lao Cai, Vietnam	Pall-Gergely, B (reprint author), Shinshu Univ, Dept Biol, Matsumoto, Nagano 3908621, Japan.	pallgergely2@gmail.com			Japan Student Services Organization; Mitsubishi Corporation; Japan Society for the Promotion of Science	We are very grateful to all colleagues, who in various ways contributed to our revision. Colleagues who provided shell and alcohol material: Kanji Okubo, Kenji Ohara, Jamen Uiriamu Otani, Miu Yeung, Christa and Jens Hemmen, Jozef Grego and Wim J.M. Maassen; provided information, sent museum material or pictures: Philippe Bouchet and Virginie Heros (MNHN), Harold Taylor (NHM), Rose Sablon (RBINS), Sigrid Hof (SMF), Tyjuana Nickens and Robert Hershler (USNM), Gabor Majoros (Szent Istvan Egyetem, Budapest), Tom Schiotte (ZMUC); opened access to their museum collections: Anita Eschner ( NHMW), Eike Neubert, Ronald Janssen (SMF), Ana-Maria Papureanu (NHMS), Zoltan Feher (HNHM); provided helpful discussions: Miklos Szekeres, Anatoly Schileyko; helped in producing Figure 16: Attila Lengyel. We are also grateful to Eike Neubert (Naturhistorisches Museum, Bern), Josef Harl (NHMW) and Tamas Deli (Munkacsy Mihaly Muzeum, Bekescsaba) for taking photos of shells, to Koji Tojo (Shinshi University, Matsumoto) for help for SEM photos, and to Ben Rowson and Bram Breure for their comments on the manuscript. We are indebted to The Biodiversity Heritage Library for the multitude of rare literature made available to us (www.biodiversitylibrary.org). This study was supported by scholarships from Japan Student Services Organization and Mitsubishi Corporation to BPG and Grants-in-Aid from Japan Society for the Promotion of Science to TA.	Ancey C-F, 1885, B SOC MALACOLOGIQUE, V2, P113; Ancey C-F, 1888, NATURALISTE J ECHANG, V2, P70; Schileyko A. A., 2010, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V111, P13; Bouchet P, 2005, MALACOLOGIA, V47, P1; Chase R, 2006, P R SOC B, V273, P1471, DOI 10.1098/rspb.2006.3474; ATKINSON JW, 1987, T AM MICROSC SOC, V106, P126, DOI 10.2307/3226309; Benson WH, 1863, ANN MAGAZINE NATURAL, V3, P318; Blanford WT, 1869, P ZOOL SOC LOND, V27, P444; Blanford WT, 1865, J ASIATIC SOC BENGAL, V34, P66; CHANG K. M., 1999, B MALACOLOGY TAIWAN, V23, P21; Dautzenberg P, 1905, J CONCHYLIOL, V53, P85, DOI DOI 10.5962/BHL.TITLE.13158; Dautzenberg P, 1905, J CONCHYLIOL, V53, P343; Dautzenberg Ph., 1908, Journal de Conchyliologie, V56; Degner E, 1923, ARCH MOLLUSKENKD, V55, P14; de Winter AJ, 1999, J MOLLUS STUD, V65, P209, DOI 10.1093/mollus/65.2.209; Fischer H, 1898, J CONCHYLIOL, V46, P214; Fischer H, 1899, B BIOL FRANCE BELGIQ, V32, P329; Fischer H., 1904, MISSION PAVIE ETUDES, V3, P390; Fischer H, 1898, B BIOL FRANCE BELGIQ, V28, P310; Godwin-Austen HH, 1875, P ZOOL SOC LOND, P608; Godwin-Austen HH, 1879, J ASIATIC SOC BENGAL, V48, P1; GOMEZ BJ, 1991, ZOOMORPHOLOGY, V111, P95, DOI 10.1007/BF01632875; Gould AA, 1847, P BOSTON SOC NATURAL, V2; Gude GK, 1908, J CONCHYLIOL, V55, P345; Gude GK, 1897, SCI GOSSIP, V3, P332; Gude GK, 1901, J MALACOLOGY, V8, P46; Gude GK, 1914, FAUNA BRIT INDIA INC; Gude GK, 1897, SCI GOSSIP, V4, P138; Gude GK, 1915, REC INDIAN MUS, V8, P505; Gude GK, 1899, SCI GOSSIP, V6, P147; Gude G. K., 1911, Proceedings of the Malacological Society of London, V9; Gude GK, 1899, SCI GOSSIP, V6, P174; Gude GK, 1900, ANN MAGAZINE NATURAL, V7, P313, DOI [10.1080/00222930008678289, DOI 10.1080/00222930008678289]; Gude GK, 1899, SCI GOSSIP, V5, P332; Gude GK, 1901, J MALACOLOGY, V8, P110; Gude GK, 1901, J CONCHYLIOL, V49, P197; Gude GK, 1899, SCI GOSSIP, V6, P75; Gude G. K., 1909, Proceedings of the Malacological Society of London, V8; Haas F., 1933, Archiv fuer Molluskenkunde, V65, P230; Heude RPM, 1882, NOTES MOLLUSQUES TER, P1; Heude RPM, 1885, NOTES MOLLUSQUES TER, VIII, P89; JAECKEL SIEGFRIED. SEN, 1950, ARCH MOLLUSKENK, V79, P15; KERNEY MP, 1979, FIELD GUIDE LAND SNA; Kimura K, 2014, J EXP BIOL, V217, P1150, DOI 10.1242/jeb.095935; Koene JM, 1998, J MOLLUS STUD, V64, P75, DOI 10.1093/mollus/64.1.75; Kuroda T, 1941, MEM FS AGR TAIHOKU I, V22, P65; Mabille MJ, 1887, MOLLUSCORUM TONKINOR; Mabille MJ, 1887, B SOC MALACOLOGIQUE, V4, P73; Martens E von, 1875, JB DTSCH MALAKOZOOLO, V2, P126; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mollendorff O. von, 1901, NACHRICHTSBLATT DTSC, V33, P65; Mollendorff O.F. von, 1886, JB DTSCH MALAKOZOOLO, V13, P156; Morlet L, 1886, DIAGNOSES MOLLUSQUES, P1; Morlet L, 1886, J CONCHYLIOL, V34, P257; Pall-Gergely Barna, 2014, Genus (Wroclaw), V25, P527; Pall-Gergely B, 2013, ARCH MOLLUSKENKD, V142, P1, DOI 10.1127/arch.moll/1869-0963/142/001-066; Pfeiffer L, 1863, BESCHREIBUNG ABBUILD, V2, P139; Pilsbry HA, 1905, P MALACOLOGICAL SOC, V6, P286; Pilsbry HA, 1893, MANUAL CONCHOLOGY ST, V8; Pilsbry HA, 1904, NAUTILUS, V18, P58; Pilsbry HA, 1894, MANUAL CONCHOLOGY, V9, P49; Raheem DC, 2014, TROPICAL NATURAL H S, V4, P1; Schileyko A.A., 1998, Ruthenica Supplement, V2, P1; Schileyko AA, 2001, RUTHENICA S, V7, P881; Schileyko AA, 1999, RUTHENICA S, V2, P435; Schileyko A.A., 2003, Ruthenica Supplement, V2, P1309; Schileyko A.A., 2011, Ruthenica, V21, P1; Solem A., 1966, Spolia Zoologica Musei Hauniensis, V24, P1; SOLEM A, 1968, Veliger, V11, P24; Stoliczka F, 1871, J ASIATIC SOC BENGAL, V40, P217; Szekeres M., 1998, Basteria, V62, P175; Thanh D.N., 2008, SINH HOC J BIOL, V30, P1; Tompa A.S., 1984, P47; Tryon GW, 1887, ABHANDLUNGEN SENCKEN, VIII; Tryon GW, 1887, ABHANDLUNGEN SENCKEN, VI; Verdcourt A, 1979, J CONCHOL, V30, P101; VERDCOURT B, 1985, J CONCHOL, V32, P109; Visser M, 1973, ANN U STELLENBOSCH A, V48, P9; von Mollendorff O, 1901, NACHRICHTSBLATT DTSC, V33, P110; Yen T-C, 1939, ABHANDLUNGEN SENCKEN; Zilch A, 1959, HDB PALEOZOOLOGIE, V6, P481	81	1	1	PENSOFT PUBL	SOFIA	GEO MILEV STR 13A, SOFIA, 1111, BULGARIA	1313-2989	1313-2970		ZOOKEYS	ZooKeys		2015		473					1	118		10.3897/zookeys.473.8659		118	Zoology	Zoology	AZ3MJ	WOS:000348131300001		
J	Kojima, H; Fukatsu, K; Trivailo, PM				Kojima, Hirohisa; Fukatsu, Kosei; Trivailo, Pavel M.			Mission-function control of tethered satellite/climber system	ACTA ASTRONAUTICA			English	Article						Tethered satellite system; Space elevator; Mission-function control	ELECTRODYNAMIC TETHER; NONLINEAR CONTROL; DYNAMICS; SUBSATELLITE; DEPLOYMENT; RETRIEVAL; ELEVATOR; OPTIMIZATION; CLIMBER; MOTION	Because the tether of a tethered satellite system (TSS) can be extremely long, it would be difficult to inspect the damage to the tether. The ultimate configuration of a TSS could be a space elevator (SE). The tether needs to carry a crawler or climber to inspect damage to the tether or transport travelers on the SE. Coriolis force due to the climber motion causes librational motion of the tether. The numerical simulations have shown that the original mission-function (MF) control is not applicable to a TSS with a climber because it was intended for subsatellite deployment and retrieval control using a tether, not for a climber on the tether. This paper proposes a new MF control to suppress the librational motion of a tether with a climber. The proposed MF control is a modified version of the original MF control. The active force to drive the climber is determined from the MF. A simplified dynamic model of a TSS with a single climber is used to evaluate the derived controller. The effectiveness of the proposed method is verified through numerical simulations. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Kojima, Hirohisa; Fukatsu, Kosei] Tokyo Metropolitan Univ, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan; [Trivailo, Pavel M.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3083, Australia	Kojima, H (reprint author), Tokyo Metropolitan Univ, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	hkojima@tmu.ac.jp; trivailo@rmit.edu.au		Kojima, Hirohisa/0000-0002-8704-9362			DOBROWOLNY M, 1994, NUOVO CIMENTO C, V17, P1, DOI 10.1007/BF02506678; Williams P, 2008, NONLINEAR DYNAM, V52, P159, DOI 10.1007/s11071-007-9269-3; Jung WY, 2014, NONLINEAR DYNAM, V75, P267, DOI 10.1007/s11071-013-1064-8; Fujii HA, 2008, J GUID CONTROL DYNAM, V31, P436, DOI 10.2514/1.26240; Misra AK, 2008, ACTA ASTRONAUT, V63, P1169, DOI 10.1016/j.actaastro.2008.06.020; MISRA AK, 1988, ACTA ASTRONAUT, V17, P1059, DOI 10.1016/0094-5765(88)90189-0; Kojima H, 2007, J SPACECRAFT ROCKETS, V44, P280, DOI 10.2514/1.24537; Kojima H, 2011, ACTA ASTRONAUT, V69, P96, DOI 10.1016/j.actaastro.2011.02.009; Barnds W., 1997, ADV ASTRONAUTICAL SC, V97, P3; Carroll J.A., 934764 AIAA; Cohen SS, 2009, ACTA ASTRONAUT, V64, P538, DOI 10.1016/j.actaastro.2008.10.003; FUJII H, 1989, J GUID CONTROL DYNAM, V12, P243, DOI 10.2514/3.20397; Fujii HA, 2009, ACTA ASTRONAUT, V64, P313, DOI 10.1016/j.actaastro.2008.07.006; Fujii HA, 2003, J GUID CONTROL DYNAM, V26, P177, DOI 10.2514/2.5031; FUJII HA, 1994, J GUID CONTROL DYNAM, V17, P1292, DOI 10.2514/3.21347; Hoyt R., 2003, 20035219 AIAA; KATZ I, 1995, J GEOPHYS RES, V100, P1687, DOI 10.1029/94JA03142; KIM E, 1995, J GUID CONTROL DYNAM, V18, P1169, DOI 10.2514/3.21521; Koga N, 1997, ADV ASTRONAUT SCI, V96, P103; Kojima H, 2004, J GUID CONTROL DYNAM, V27, P229, DOI 10.2514/1.9166; Kruijff M., AIAA20087385; Lorenzini E. C., 1989, TETHERS SPACE HDB, V2nd; Lorenzini EC, 1996, J GUID CONTROL DYNAM, V19, P1148, DOI 10.2514/3.21757; LORENZINI EC, 1989, J GUID CONTROL DYNAM, V12, P404, DOI 10.2514/3.20422; MODI VJ, 1993, ACTA ASTRONAUT, V29, P429, DOI 10.1016/0094-5765(93)90036-V; Okazaki M, 2006, J GUID CONTROL DYNAM, V29, P822, DOI 10.2514/1.16552; Pelaez J, 2002, J GUID CONTROL DYNAM, V25, P1125, DOI 10.2514/2.4992; van Pelt M., 2009, SPACE TETHERS SPACE; Watanabe T., 2012, SOC AERONAUT SP SCI, V11, P1; Williams P, 2009, ACTA ASTRONAUT, V65, P399, DOI 10.1016/j.actaastro.2008.11.016; Williams P, 2010, ACTA ASTRONAUT, V66, P1458, DOI 10.1016/j.actaastro.2009.11.003; Williams SD, 1998, GEOPHYS RES LETT, V25, P445, DOI 10.1029/97GL03259	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	JAN-FEB	2015	106						24	32		10.1016/j.actaastro.2014.10.024		9	Engineering, Aerospace	Engineering	AY7WR	WOS:000347767200003		
J	Ohzone, A; Numata, S; Hamada, T; Fukuda, S; Teye, K; Shirakashi, Y; Kasai, H; Koga, H; Ishii, N; Sugiura, M; Hashimoto, T				Ohzone, Ayaka; Numata, Sanae; Hamada, Takahiro; Fukuda, Shunpei; Teye, Kwesi; Shirakashi, Yusuke; Kasai, Hiroko; Koga, Hiroshi; Ishii, Norito; Sugiura, Makoto; Hashimoto, Takashi			Anti-laminin-gamma 1 Pemphigoid Developed in a Case of Autosomal Recessive Congenital Ichthyosis	ACTA DERMATO-VENEREOLOGICA			English	Article							MUTATIONS		[Ohzone, Ayaka; Numata, Sanae; Hamada, Takahiro; Fukuda, Shunpei; Teye, Kwesi; Koga, Hiroshi; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; [Ohzone, Ayaka; Numata, Sanae; Hamada, Takahiro; Fukuda, Shunpei; Teye, Kwesi; Koga, Hiroshi; Ishii, Norito; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan; [Shirakashi, Yusuke; Kasai, Hiroko; Sugiura, Makoto] Shizuoka Municipal Shimizu Hosp, Shizuoka, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20390308, 20591331, 21659271, 23591634, 23791298, 23791299, 23791300, 23791301, 24659534, 24591672, 24591640, 24791185]; Ministry of Health, Labour and Welfare [H23-028, H24-038]	This study was supported by Grants-in-Aid for Scientific Research (No.20390308, 20591331, 21659271, 23591634, 23791298, 23791299, 23791300, 23791301, 24659534, 24591672, 24591640, 24791185) and Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology; and by 'Research on Measures for Intractable Diseases' Project: matching fund subsidy (H23-028 to K. Iwatsuki and H24-038 to T. Hashimoto) from the Ministry of Health, Labour and Welfare.	Israeli S, 2011, AM J HUM GENET, V88, P482, DOI 10.1016/j.ajhg.2011.02.011; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Terra JB, 2013, BRIT J DERMATOL, V169, P100, DOI 10.1111/bjd.12308; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Zillikens Detlef, 1996, Journal of Investigative Dermatology, V106, P1333, DOI 10.1111/1523-1747.ep12349283	10	0	0	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					93	94		10.2340/00015555-1875		2	Dermatology	Dermatology	AY7TR	WOS:000347762200019		
J	Sano, T; Minagawa, A; Koga, H; Uhara, H; Okuyama, R				Sano, Tasuku; Minagawa, Akane; Koga, Hiroshi; Uhara, Hisashi; Okuyama, Ryuhei			Melanocytic Naevus Shows Parallel Ridge Pattern due to the Melanin Columns Under the Ridges	ACTA DERMATO-VENEREOLOGICA			English	Article							EARLY ACRAL MELANOMA; DERMOSCOPY; SKIN		[Sano, Tasuku; Minagawa, Akane; Koga, Hiroshi; Uhara, Hisashi; Okuyama, Ryuhei] Shinshu Univ, Dept Dermatol, Sch Med, Matsumoto, Nagano 3908621, Japan	Sano, T (reprint author), Shinshu Univ, Dept Dermatol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	task1031@shinshu-u.ac.jp			Nagano Society for the Promotion of Science	These research results were aided by funding of Nagano Society for the Promotion of Science.	Ishihara Y, 2006, AM J DERMATOPATH, V28, P21, DOI 10.1097/01.dad.0000187931.05030.a0; Saida T, 2011, AM J DERMATOPATH, V33, P468, DOI 10.1097/DAD.0b013e318201ac8f; Saida T, 2002, CLIN DERMATOL, V20, P279, DOI 10.1016/S0738-081X(02)00219-5; Saida T, 2004, ARCH DERMATOL, V140, P1233, DOI 10.1001/archderm.140.10.1233	4	0	0	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					95	96		10.2340/00015555-1865		2	Dermatology	Dermatology	AY7TR	WOS:000347762200020		
J	Mizuno, Y; Kato, G; Shu, E; Ohnishi, H; Fukao, T; Ohara, O; Fukumoto, H; Katano, H; Seishima, M				Mizuno, Yuki; Kato, Genichi; Shu, En; Ohnishi, Hidenori; Fukao, Toshiyuki; Ohara, Osamu; Fukumoto, Hitomi; Katano, Harutaka; Seishima, Mariko			Merkel Cell Polyomavirus-positive Merkel Cell Carcinoma in a Patient with Epidermodysplasia Verruciformis	ACTA DERMATO-VENEREOLOGICA			English	Article									[Mizuno, Yuki; Kato, Genichi; Shu, En; Seishima, Mariko] Gifu Univ, Dept Dermatol, Grad Sch Med, Gifu 5011194, Japan; [Mizuno, Yuki; Kato, Genichi; Shu, En; Seishima, Mariko] Gifu Univ, Dept Pediat, Grad Sch Med, Gifu 5011194, Japan; [Ohara, Osamu] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu, Chiba, Japan; [Fukumoto, Hitomi; Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	Seishima, M (reprint author), Gifu Univ, Dept Dermatol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	marikoseishima@yahoo.co.jp					Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Hattori T, 2013, J DERMATOL SCI, V70, P99, DOI 10.1016/j.jdermsci.2013.02.010; Falchook GS, 2013, JAMA DERMATOL, V149, P322, DOI 10.1001/jamadermatol.2013.2023; Ly TY, 2012, HUM PATHOL, V43, P557, DOI 10.1016/j.humpath.2011.06.005; Halvorson CR, 2011, J AM ACAD DERMATOL, V65, P667, DOI 10.1016/j.jaad.2010.06.007; Kaibuchi-Noda Kana, 2011, J Am Acad Dermatol, V65, pe152, DOI 10.1016/j.jaad.2011.06.026; Kwon EKM, 2013, PEDIATR DERMATOL, V30, P505, DOI 10.1111/pde.12130; Mertz KD, 2011, DERMATOLOGY, V222, P87, DOI 10.1159/000321880; Nakamura T, 2010, VIROLOGY, V398, P273, DOI 10.1016/j.virol.2009.12.024; Oliveira WR, 2010, J AM ACAD DERMATOL, V62, P889, DOI 10.1016/j.jaad.2009.04.005	11	0	0	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					98	99		10.2340/00015555-1868		2	Dermatology	Dermatology	AY7TR	WOS:000347762200022		
J	Shimoura, N; Fukunaga, A; Nagai, H; Oka, M; Nishigori, C				Shimoura, Noriko; Fukunaga, Atsushi; Nagai, Hiroshi; Oka, Masahiro; Nishigori, Chikako			Epstein-Barr Virus-associated Methotrexate-induced Accelerated Rheumatoid Nodulosis	ACTA DERMATO-VENEREOLOGICA			English	Article							ARTHRITIS; THERAPY; PATIENT		[Shimoura, Noriko; Fukunaga, Atsushi; Nagai, Hiroshi; Oka, Masahiro; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Fukunaga, A (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	atsushi@med.kobe-u.ac.jp					Amini S, 2009, INT J DERMATOL, V48, P543, DOI 10.1111/j.1365-4632.2009.03894.x; Merrill JT, 1997, ARTHRITIS RHEUM, V40, P1308, DOI 10.1002/1529-0131(199707)40:7<1308::AID-ART16>3.0.CO;2-M; Kameda H, 2007, CLIN RHEUMATOL, V26, P1585, DOI 10.1007/s10067-006-0480-2; Berkun Y, 2007, J RHEUMATOL, V34, P1664; SEGAL R, 1988, ARTHRITIS RHEUM, V31, P1182, DOI 10.1002/art.1780310915; Bevin AA, 2006, CUTIS, V78, P133; Ishida M, 2013, INT J CLIN EXP PATHO, V6, P2237; KERSTENS PJSM, 1992, J RHEUMATOL, V19, P867; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P822, DOI 10.1002/art.1780290702; Patatanian E, 2002, PHARMACOTHERAPY, V22, P1157, DOI 10.1592/phco.22.13.1157.33525	10	0	1	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					100	101		10.2340/00015555-1866		2	Dermatology	Dermatology	AY7TR	WOS:000347762200023		
J	Fujimoto, N; Kito, K; Yoshida, T; Tanaka, T				Fujimoto, Noriki; Kito, Katsuyuki; Yoshida, Takashi; Tanaka, Toshihiro			Primary Cutaneous CD4/CD8(-/-) TCR alpha beta T-cell Lymphoma	ACTA DERMATO-VENEREOLOGICA			English	Article							NEGATIVE MYCOSIS-FUNGOIDES		[Fujimoto, Noriki; Tanaka, Toshihiro] Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan; [Kito, Katsuyuki] Shiga Univ Med Sci, Dept Hematol, Otsu, Shiga 5202192, Japan; [Yoshida, Takashi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan	Fujimoto, N (reprint author), Shiga Univ Med Sci, Dept Dermatol, Otsu, Shiga 5202192, Japan.	noriki@belle.shiga-med.ac.jp					Akkari H, 2012, Pathologica, V104, P78; Kempf W, 2010, HISTOPATHOLOGY, V56, P57, DOI 10.1111/j.1365-2559.2009.03455.x; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; Hodak E, 2006, J AM ACAD DERMATOL, V55, P276, DOI 10.1016/j.jaad.2006.01.020; Nofal A, 2012, J AM ACAD DERMATOL, V67, P748, DOI 10.1016/j.jaad.2011.07.043; Jones D, 2002, AM J SURG PATHOL, V26, P225, DOI 10.1097/00000478-200202000-00009; Kempf W, 2012, AM J DERMATOPATH, V34, P757, DOI 10.1097/DAD.0b013e31825b26d1; Mourtzinos N, 2010, J CUTAN PATHOL, V37, P491, DOI 10.1111/j.1600-0560.2009.01323.x; Nagase K, 2014, ACTA DERM-VENEREOL, V94, P89, DOI 10.2340/00015555-1618	10	0	1	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					106	107		10.2340/00015555-1883		2	Dermatology	Dermatology	AY7TR	WOS:000347762200026		
J	Nomura, T; Yoneta, A; Pohler, E; Suzuki, S; Osawa, R; Mizuno, O; Ohguchi, Y; Nomura, Y; Yamashita, T; McLean, WHI; Shimizu, H				Nomura, Toshifumi; Yoneta, Akihiro; Pohler, Elizabeth; Suzuki, Shotaro; Osawa, Rinko; Mizuno, Osamu; Ohguchi, Yuka; Nomura, Yukiko; Yamashita, Toshiharu; McLean, W. H. Irwin; Shimizu, Hiroshi			Punctate Palmoplantar Keratoderma Type 1: A Novel AAGAB Mutation and Efficacy of Etretinate	ACTA DERMATO-VENEREOLOGICA			English	Article							FAMILY		[Nomura, Toshifumi; Suzuki, Shotaro; Osawa, Rinko; Mizuno, Osamu; Ohguchi, Yuka; Nomura, Yukiko; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Yoneta, Akihiro; Yamashita, Toshiharu] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Pohler, Elizabeth; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Ctr Dermatol & Genet Med, Dundee, Scotland; [Pohler, Elizabeth; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland	Nomura, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	nomura@huhp.hokudai.ac.jp			Japan Society for the Promotion of Science [25860925, 24791130]; Wellcome Trust [092530/Z/10/Z, 098439/Z/12/Z]	This work was supported by Grants-in-Aid for Young Scientists (B) 25860925 (T. Nomura) and (B) 24791130 (R. Osawa), both from the Japan Society for the Promotion of Science. The Centre for Dermatology and Genetic Medicine was supported by grants from The Wellcome Trust (092530/Z/10/Z and 098439/Z/12/Z).	Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Itin PH, 2005, CLIN DERMATOL, V23, P15, DOI 10.1016/j.clindermatol.2004.09.005; Cui HZ, 2013, J INVEST DERMATOL, V133, P2631, DOI 10.1038/jid.2013.198; Erkek E, 2006, ARCH DERMATOL, V142, P1076, DOI 10.1001/archderm.142.8.1076; Giehl KA, 2012, AM J HUM GENET, V91, P754, DOI 10.1016/j.ajhg.2012.08.024; Kiritsi D, 2013, J INVEST DERMATOL, V133, P2483, DOI 10.1038/jid.2013.171; Li M, 2013, BRIT J DERMATOL, V169, P168, DOI 10.1111/bjd.12289; Li M, 2014, ACTA DERM-VENEREOL, V94, P339, DOI 10.2340/00015555-1724; Pohler E, 2012, NAT GENET, V44, P1272, DOI 10.1038/ng.2444; Pohler E, 2013, J INVEST DERMATOL, V133, P2805, DOI 10.1038/jid.2013.243; Stevens HP, 1996, BRIT J DERMATOL, V134, P720, DOI 10.1111/j.1365-2133.1996.tb06978.x	11	1	1	ACTA DERMATO-VENEREOLOGICA	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	0001-5555	1651-2057		ACTA DERM-VENEREOL	Acta Derm.-Venereol.		2015	95	1					110	111		10.2340/00015555-1832		2	Dermatology	Dermatology	AY7TR	WOS:000347762200028		
J	Gao, JT; Shen, YL; Jiang, XH; Li, J				Gao, Juntao; Shen, Yulong; Jiang, Xiaohong; Li, Jie			Source delay in mobile ad hoc networks	AD HOC NETWORKS			English	Article						MANETs; Packet dispatch; Source delay; Mean; Variance	WIRELESS NETWORKS; QUEUING MODEL; 2-HOP RELAY; CAPACITY; MANETS; QOS	Source delay, the time a packet experiences in its source node, serves as a fundamental quantity for delay performance analysis in networks. However, the source delay performance in highly dynamic mobile ad hoc networks (MANETs) is still largely unknown by now. This paper studies the source delay in MANETs based on a general packet dispatching scheme with dispatch limit f (PD-f for short), where a same packet will be dispatched out up to f times by its source node such that packet dispatching process can be flexibly controlled through a proper setting off. We first apply the Quasi-Birth-and-Death (QBD) theory to develop a theoretical framework to capture the complex packet dispatching process in PD-f MANETs. With the help of the theoretical framework, we then derive the cumulative distribution function as well as mean and variance of the source delay in such networks. Finally, extensive simulation and theoretical results are provided to validate our source delay analysis and illustrate how source delay in MANETs is related to network parameters. (C) 2014 Elsevier B.V. All rights reserved.	[Gao, Juntao] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 630192, Japan; [Shen, Yulong] Xidian Univ, State Key Lab Integrated Serv Networks, Xian 710071, Shaanxi, Peoples R China; [Shen, Yulong] Xidian Univ, Sch Comp Sci & Technol, Xian 710071, Shaanxi, Peoples R China; [Jiang, Xiaohong] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan; [Li, Jie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan	Gao, JT (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 630192, Japan.	jtgao@is.naist.jp; ylshen@mail.xidian.edu.cn; jiang@fun.ac.jp; lijie@cs.tsukuba.ac.jp			JSPS [24300026]	This work is partially supported by JSPS Grant (B) 24300026.	Spyropoulos T, 2008, IEEE ACM T NETWORK, V16, P77, DOI 10.1109/TNET.2007.897964; Grossglauser M, 2002, IEEE ACM T NETWORK, V10, P477, DOI 10.1109/TNET.2002.801403; Kulkarni SR, 2004, IEEE T INFORM THEORY, V50, P1041, DOI 10.1109/TIT.2004.828055; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Sharma G, 2007, IEEE ACM T NETWORK, V15, P981, DOI 10.1109/TNET.2007.905154; Ciullo D, 2011, IEEE ACM T NETWORK, V19, P1745, DOI 10.1109/TNET.2011.2140128; Jindal A, 2009, IEEE T MOBILE COMPUT, V8, P145, DOI 10.1109/TMC.2008.98; Haenggi M, 2013, IEEE T INFORM THEORY, V59, P1788, DOI 10.1109/TIT.2012.2227675; Gong ZH, 2013, IEEE T WIREL COMMUN, V12, P4766, DOI 10.1109/TWC.2013.081413.130134; Ibrahim M, 2007, PERFORM EVALUATION, V64, P933, DOI 10.1016/j.peva.2007.06.005; Hanzo L, 2007, IEEE COMMUN SURV TUT, V9, P50, DOI 10.1109/COMST.2007.382407; Andrews J, 2008, IEEE COMMUN MAG, V46, P94, DOI 10.1109/MCOM.2008.4689214; Liu RP, 2010, IEEE T WIREL COMMUN, V9, P2664, DOI 10.1109/TWC.2010.061010.091803; Liu JJ, 2012, IEEE ACM T NETWORK, V20, P1950, DOI 10.1109/TNET.2012.2187923; Goldsmith A, 2011, IEEE COMMUN MAG, V49, P195, DOI 10.1109/MCOM.2011.5762818; Li P, 2012, IEEE T MOBILE COMPUT, V11, P427, DOI 10.1109/TMC.2011.54; Neely MJ, 2005, IEEE T INFORM THEORY, V51, P1917, DOI 10.1109/TIT.2005.847717; Groenevelt R, 2005, PERFORM EVALUATION, V62, P210, DOI 10.1016/j.peva.2005.07.018; Baccelli F., 2010, INFOCOM; Blaszczyszyn B., TECHNICAL REPORT; Ciucu Florin, 2011, SIGMETRICS; Ciucu Florin, 2010, ANN ALL C COMM CONTR; Gamal A. E., 2006, IEEE T INFORM THEORY, V52, P2568, DOI DOI 10.1109/TIT.2006.874379; Gao J., 2013, 11 INT S MOD OPT MOB; Grinstead C., 1997, INTRO PROBABILITY; Hanbali A.A., 2007, P IFIP NETW, P191; Hanbali A.A., 2008, PERFORM EVALUATION, V65, P463; Hanbali AAL, 2014, PROBAB ENG INFORM SC, V28, P363, DOI 10.1017/S0269964814000059; Horn R. A., 1990, MATRIX ANAL; Latouche G., 1999, ASA SIAM SERIES STAT; Chen L, 2007, IEEE NETWORK, V21, P30, DOI 10.1109/MNET.2007.4395108; Liu J., 2012, WCNC; Liu JJ, 2011, IEEE T WIREL COMMUN, V10, P2738, DOI 10.1109/TWC.2011.062111.101976; Liu JJ, 2012, IEEE T WIREL COMMUN, V11, P4172, DOI 10.1109/TWC.2012.091812.120346; Nain P., 2013, ACM MOBICOM WORKSH C; Panagakis A., 2007, WIOPT; Small T., 2005, P ACM SIGCOMM WORKSH, P260, DOI 10.1145/1080139.1080144; Williams B., 2002, MOBIHOC	38	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	JAN	2015	24		A				109	120		10.1016/j.adhoc.2014.08.004		12	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AY4YP	WOS:000347581200008		
J	Harada, J				Harada, Junichi			BLOW-UP BEHAVIOR OF SOLUTIONS TO THE HEAT EQUATION WITH NONLINEAR BOUNDARY CONDITIONS	ADVANCES IN DIFFERENTIAL EQUATIONS			English	Article							SEMILINEAR PARABOLIC EQUATIONS; PROFILES; TIME	We study the asymptotic behavior of blow-up solutions of the heat equation with nonlinear boundary conditions. In particular, we classify the asymptotic behavior of blow-up solutions and investigate the spacial singularity of their blow-up profiles.	Akita Univ, Fac Educ & Human Studies, Akita 0108552, Japan	Harada, J (reprint author), Akita Univ, Fac Educ & Human Studies, 1-1 Tegata Gakuen Machi, Akita 0108552, Japan.						VELAZQUEZ JJL, 1993, INDIANA U MATH J, V42, P445, DOI 10.1512/iumj.1993.42.42021; Chlebik M, 2000, MATH METHOD APPL SCI, V23, P1323, DOI 10.1002/1099-1476(200010)23:15<1323::AID-MMA167>3.0.CO;2-W; FILIPPAS S, 1992, COMMUN PUR APPL MATH, V45, P821, DOI 10.1002/cpa.3160450703; HU B, 1994, T AM MATH SOC, V346, P117, DOI 10.2307/2154944; VELAZQUEZ JJL, 1993, T AM MATH SOC, V338, P441, DOI 10.2307/2154464; BEBERNES J, 1992, SIAM J MATH ANAL, V23, P852, DOI 10.1137/0523045; FILA M, 1991, MATH METHOD APPL SCI, V14, P197, DOI 10.1002/mma.1670140304; Chlebik M., 2000, BANACH CTR PUBL, V52, P61; Deng K., 1994, ACTA MATH U COMENIAN, V63, P169; FILIPPAS S, 1993, ANN I H POINCARE-AN, V10, P313; GIGA Y, 1989, COMMUN PUR APPL MATH, V42, P845, DOI 10.1002/cpa.3160420607; GIGA Y, 1985, COMMUN PUR APPL MATH, V38, P297, DOI 10.1002/cpa.3160380304; GIGA Y, 1987, INDIANA U MATH J, V36, P1, DOI 10.1512/iumj.1987.36.36001; Harada J., 2013, DIFFER EQU IN PRESS, V5; HERRERO MA, 1993, ANN I H POINCARE-AN, V10, P131; Herrero M. A., 1992, DIFFERENTIAL INTEGRA, V5, P973; HERRERO M.A., 1992, ANN SCUOLA NORM SUP, VXIX, P381; HERRERO MA, 1992, COMMUN PART DIFF EQ, V17, P205, DOI 10.1080/03605309208820839; Hitomatsu S., 1987, MATH FORMULA 3 IWANA; Kavian O., 1987, ANN I H POINCARE-AN, V4, P423; Ladyzenskaja O. A., 1968, AM MATH SOC T MATH M, V23; Lieberman G.M., 2005, 2 ORDER PARABOLIC DI; LIU WX, 1993, ROCKY MT J MATH, V23, P1287, DOI 10.1216/rmjm/1181072494; Merle F, 1998, GEOM FUNCT ANAL, V8, P1043, DOI 10.1007/s000390050123; Naito Y, 2007, J DIFFER EQUATIONS, V232, P176, DOI 10.1016/j.jde.2006.07.012; VELAZQUEZ JJL, 1992, COMMUN PART DIFF EQ, V17, P1567, DOI 10.1080/03605309208820896	26	0	0	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	1079-9389			ADV DIFFERENTIAL EQU	Adv. Differ. Equat.	JAN-FEB	2015	20	1-2					23	76				54	Mathematics, Applied; Mathematics	Mathematics	AZ1NE	WOS:000348004800002		
J	Yamazaki, T				Yamazaki, Taeko			ASYMPTOTIC BEHAVIOR FOR QUASILINEAR HYPERBOLIC EQUATIONS OF KIRCHHOFF TYPE WITH PERTURBATION HAVING INTEGRABLE COEFFICIENT	ADVANCES IN DIFFERENTIAL EQUATIONS			English	Article							PARABOLIC SINGULAR PERTURBATION; GLOBAL WELL-POSEDNESS; WEAK DISSIPATION; EXTERIOR DOMAINS; SOLVABILITY; SCATTERING	This paper is concerned with the abstract quasilinear hyperbolic equations of Kirchhoff type with perturbation whose coefficient is integrable in time. We show the unique existence of global solutions for small data in some class and that the solution has the same asymptotic behavior of a function obtained by a transformation of time variable from a solution of the free wave equation with an appropriate wave speed. Conversely, we show that there exists a solution of the Kirchhoff equation which has the same asymptotic behavior of a function obtained by a transformation of the time variable from the solution of the Cauchy problem of the free wave equation with an appropriate wave speed.	Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan	Yamazaki, T (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan.						DANCONA P, 1993, ARCH RATION MECH AN, V124, P201, DOI 10.1007/BF00953066; Dancona P, 1995, CHINESE ANN MATH B, V16, P413; DANCONA P, 1994, COMMUN PUR APPL MATH, V47, P1005, DOI 10.1002/cpa.3160470705; Ghisi M, 2012, MATH ANN, V354, P1079, DOI 10.1007/s00208-011-0765-x; Ghisi M, 2012, ADV DIFFERENTIAL EQU, V17, P1; Ghisi M, 1996, ANN MAT PUR APPL, V171, P293, DOI 10.1007/BF01759390; GREENBERG JM, 1980, Q APPL MATH, V38, P289; Hashimoto H, 2007, J DIFFER EQUATIONS, V237, P491, DOI 10.1016/j.jde.2007.02.005; Heiming C, 2000, NODEA-NONLINEAR DIFF, V7, P389, DOI 10.1007/PL00001432; Kajitani K, 2008, J MATH SOC JPN, V60, P665, DOI 10.2969/jmsj/06030665; Kajitani K., 2012, TSUKUBA J MATH, V36, P1; Kajitani K., 2009, BIRKHAUSER PROGR NON, V78, P141; Matsuyama T, 2010, J MATH SOC JPN, V62, P1167, DOI 10.2969/jmsj/06241167; Matsuyama T, 2006, REND LINCEI-MAT APPL, V17, P377; Matsuyama T, 2013, J MATH PURE APPL, V100, P220, DOI 10.1016/j.matpur.2012.12.002; Racke R., 1995, APPL ANAL, V58, P85, DOI 10.1080/00036819508840364; Rzymowski W, 2002, NONLINEAR ANAL-THEOR, V48, P209, DOI 10.1016/S0362-546X(00)00181-4; Yamazaki T, 2009, MATH METHOD APPL SCI, V32, P1893, DOI 10.1002/mma.1114; Yamazaki T, 2005, J DIFFER EQUATIONS, V210, P290, DOI 10.1016/j.jde.2004.10.012; Yamazaki T, 1998, J DIFFER EQUATIONS, V143, P1, DOI 10.1006/jdeq.1997.3372; Yamazaki T, 2004, MATH METHOD APPL SCI, V27, P1893, DOI 10.1002/mma.530	21	1	1	KHAYYAM PUBL CO INC	ATHENS	PO BOX 429, ATHENS, OH 45701 USA	1079-9389			ADV DIFFERENTIAL EQU	Adv. Differ. Equat.	JAN-FEB	2015	20	1-2					143	192				50	Mathematics, Applied; Mathematics	Mathematics	AZ1NE	WOS:000348004800005		
J	Utaminingrum, F; Uchimura, K; Koutaki, G				Utaminingrum, Fitri; Uchimura, Keiichi; Koutaki, Gou			Speedy filters for removing impulse noise based on an adaptive window observation	AEU-INTERNATIONAL JOURNAL OF ELECTRONICS AND COMMUNICATIONS			English	Article						Adaptive window; Impulse noise reduction; Filter	HIGHLY CORRUPTED IMAGES	A speedy filter for removing impulse noise based on an adaptive window observation is presented. The proposed method not only reduces specific content of impulse noise but also produces a low computational complexity in several noise densities, which exploits the adaptive concept. In this research, we use an adaptive window. It is a combination of the post filtered pixel and the pixel that would be filtered. Based on the adaptive window observation, we can get the output filter. The numerical results of using peak signal-to-noise ratio and computational time prove that the proposed method is able to reduce impulse noise and to produce a low computational complexity. Furthermore, the proposed method is capable of overcoming the drawback of previous studies and provides a satisfactory result. (C) 2014 Elsevier GmbH. All rights reserved.	[Utaminingrum, Fitri; Uchimura, Keiichi] Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, Kumamoto, Japan; [Utaminingrum, Fitri] Brawijaya Univ, East Java, Indonesia; [Koutaki, Gou] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan	Utaminingrum, F (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, 2-39-1 Kurokami, Kumamoto, Japan.	f3-ningrum@navi.cs.kumamoto-u.ac.jp					Wang Z, 1999, IEEE T CIRCUITS-II, V46, P78; Smolka B, 2010, PATTERN RECOGN LETT, V31, P484, DOI 10.1016/j.patrec.2009.09.012; Wu J, 2012, AEU-INT J ELECTRON C, V66, P847, DOI 10.1016/j.aeue.2012.03.002; Windyga PS, 2001, IEEE T IMAGE PROCESS, V10, P173, DOI 10.1109/83.892455; Srinivasan KS, 2007, IEEE SIGNAL PROC LET, V14, P189, DOI 10.1109/LSP.2006.884018; Wang GH, 2010, SIGNAL PROCESS, V90, P3213, DOI 10.1016/j.sigpro.2010.05.026; Awad AS, 2010, AEU-INT J ELECTRON C, V64, P904, DOI 10.1016/j.aeue.2009.07.012; Duan D, 2010, P INT C COMP APPL SY, P265; Fabijanska A, 2011, IET IMAGE PROCESS, V5, P472, DOI 10.1049/iet-ipr.2009.0178; Hamza A. B., 1999, Journal of Mathematical Imaging and Vision, V11, DOI 10.1023/A:1008395514426; Karthik VS, 2012, INT J EUR SCI RES, V70, P468; Sau K, 2011, INT J SIGNAL IMAGE P, V2, P33; Vijayarajan R., 2012, INT J COMPUT SCI, V4, P134	13	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-8411	1618-0399		AEU-INT J ELECTRON C	AEU-Int. J. Electron. Commun.		2015	69	1					95	100		10.1016/j.aeue.2014.07.017		6	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AY3PP	WOS:000347495600014		
J	Wang, XL; Sakagami, I; Ma, ZW; Mase, A; Yoshikawa, M				Wang, Xiaolong; Sakagami, Iwata; Ma, Zhewang; Mase, Atsushi; Yoshikawa, Masayuki			Generalized, miniaturized, dual-band Wilkinson power divider with a parallel RLC circuit	AEU-INTERNATIONAL JOURNAL OF ELECTRONICS AND COMMUNICATIONS			English	Article						Dual-band; Wilkinson power divider; Generalized; Parallel RLC; Coupled-line	DESIGN	In this paper, a generalized, dual-band Wilkinson power divider consisting of a parallel RLC circuit and two two-section transmission lines is presented, and its circuit parameters, bandwidth ratios for lower and upper bands and miniaturization are discussed. A coupled-line section of loose coupling is introduced to take place a straight transmission line for miniaturization under the assumptions of linear phase characteristics and equal phase velocities of the even- and odd-modes. The relationship between normalized frequency and phase shift as electrical length increased are newly presented, and their S-parameters have also been simulated and discussed in details. Experimental result for miniaturized power divider showed good agreement with theoretical result, and the proposed dividers reported can be applied for practical use. (C) 2014 Elsevier GmbH. All rights reserved.	[Wang, Xiaolong; Yoshikawa, Masayuki] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Sakagami, Iwata] Toyama Univ, Fac Engn, Toyama 9308555, Japan; [Ma, Zhewang] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Mase, Atsushi] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Fukuoka 8168580, Japan	Wang, XL (reprint author), Univ Tsukuba, Plasma Res Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	smalld729@hotmail.com			VLSI Design and Education Center (VDEC); University of Tokyo; Agilent Technologies Japan, Ltd.; Sasakawa Scientific Research from the Japan Science Society [26-211]	This work was supported by VLSI Design and Education Center (VDEC), the University of Tokyo in collaboration with Agilent Technologies Japan, Ltd. Lumped elements, chip capacitor and chip inductor, were provided by Murata Manufacturing Co., Ltd. This work was financially supported by the Sasakawa Scientific Research Grant (No. 26-211) from the Japan Science Society.	Ahn HR, 2001, IEEE T MICROW THEORY, V49, P1277, DOI 10.1109/22.932248; Wu Y, 2009, IET MICROW ANTENNA P, V3, P1079, DOI 10.1049/iet-map.2008.0314; Wang XL, 2012, IEEE T MICROW THEORY, V60, P952, DOI 10.1109/TMTT.2012.2184298; Cheng KKM, 2007, IEEE MICROW WIREL CO, V17, P664, DOI 10.1109/LMWC.2007.903454; Wu L, 2006, IEEE T MICROW THEORY, V54, P278, DOI 10.1109/TMTT.2005.860300; EKINGE RB, 1971, IEEE T MICROW THEORY, VMT19, P81, DOI 10.1109/TMTT.1971.1127448; Kawai T, 2008, IEICE T ELECTRON, VE91C, P1793, DOI 10.1093/ietele/e91-c.11.1793; Park MJ, 2008, IEEE MICROW WIREL CO, V18, P85, DOI 10.1109/LMWC.2007.915031; PARAD LI, 1965, IEEE T MICROW THEORY, VMT13, P91, DOI 10.1109/TMTT.1965.1125934; Press WH, 1992, NUMERICAL RECIPES FO; Sakagami I, 2011, IEEE T MICROW THEORY, V59, P2833, DOI 10.1109/TMTT.2011.2160086; Wang X, 2011, IEEE MTT S INT MICR; Wu YL, 2009, IEEE T MICROW THEORY, V57, P216, DOI 10.1109/TMTT.2008.2008981; Zhang H., 2008, IEEE MTT S INT MICR, P1223	14	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-8411	1618-0399		AEU-INT J ELECTRON C	AEU-Int. J. Electron. Commun.		2015	69	1					418	423		10.1016/j.aeue.2014.10.020		6	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AY3PP	WOS:000347495600054		
J	Takanashi, Y; Honkura, Y; Rodriguez-Vazquez, JF; Murakami, G; Kawase, T; Katori, Y				Takanashi, Yoshitaka; Honkura, Yohei; Francisco Rodriguez-Vazquez, Jose; Murakami, Gen; Kawase, Tetsuaki; Katori, Yukio			Pyramidal lobe of the thyroid gland and the thyroglossal duct remnant: A study using human fetal sections	ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER			English	Article						Thyroglossal duct; Thyroid gland; Pyramidal lobe; Development; Human embryo	LARYNX; DESCENT; ANATOMY; ORIGIN; LIFE	To investigate developmental changes in the thyroglossal duct, we observed serial sagittal sections of eight embryos (crown-rump length (CRL) 6-12 mm; approximately 5-6 weeks of gestation) as well as serial horizontal or cross-sections of 70 embryos and fetuses (CRL 15-110 mm; 6-15 weeks). In the sagittal sections, the thyroglossal duct was identified as a small sheet or mass of relatively large cells with vacuolization anterior, superior or inferior to the fourth pharyngeal arch artery. However, we found no continuous duct-like structure that reached the thyroid gland. Thus, previous classical schemes might have overestimated the continuity of the duct. Among cross-sections of 70 specimens, we found the thyroglossal duct remnant in only two specimens (CRL 15 mm and 100 mm), in contrast to the pyramidal lobe, which was seen in one-third of the specimens. The duct remnant ran downward along the lateral edge of the hyoid body to reach the anterior aspect of the thyroid cartilage. However, the connection between the pyramidal lobe and the duct remnant was interrupted by the anterior cervical muscles. Therefore, it was unlikely that the thyroglossal duct remnant would more frequently be evident in fetuses than in adults. The highly tortuous course of the duct along the lingual aspect of the hyoid body, which has been reported previously, appeared to become established near term. Descent of the thyroid gland was not evident after the CRL 20 mm stage (6 weeks): the gland appeared to retain its position at the level of the third-sixth cervical vertebrae. (C) 2014 Elsevier GmbH. All rights reserved.	[Takanashi, Yoshitaka; Honkura, Yohei; Kawase, Tetsuaki; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Sendai, Miyagi 980, Japan; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Inst Embryol, E-28040 Madrid, Spain; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabilitat Auditory Sci, Sendai, Miyagi 980, Japan	Takanashi, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Sendai, Miyagi 980, Japan.	y-takanashi@mti.biglobe.ne.jp		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492			Achiron R, 1998, CLIN ENDOCRINOL, V48, P259, DOI 10.1046/j.1365-2265.1998.00388.x; Hayashi S, 2011, ANAT REC, V294, P633, DOI 10.1002/ar.21351; Lieberman DE, 2001, ARCH ORAL BIOL, V46, P117, DOI 10.1016/S0003-9969(00)00108-4; BOCIANSOBKOWSKA J, 1992, HISTOL HISTOPATHOL, V7, P415; BocianSobkowska J, 1997, HISTOL HISTOPATHOL, V12, P79; BRINTNALL ES, 1954, AMA ARCH OTOLARYNGOL, V59, P282; Chou J, 2013, SURG RADIOL ANAT, V35, P875, DOI 10.1007/s00276-013-1115-3; ELLIS PDM, 1977, LARYNGOSCOPE, V87, P765; HORISAWA M, 1991, J PEDIATR SURG, V26, P766, DOI 10.1016/0022-3468(91)90134-F; Inoue S., 1973, ANN NUCL MED HIROSHI, V14, P33; Katori Y, 2011, ANN ANAT, V193, P149, DOI 10.1016/j.aanat.2011.01.003; Keibel F., 1912, MANUAL EMBRYOLOGY, V2, P316; Kinoshita Hideaki, 2013, Anat Cell Biol, V46, P39, DOI 10.5115/acb.2013.46.1.39; Maddalozzo J, 2010, LARYNGOSCOPE, V120, P1773, DOI 10.1002/lary.21043; Marshall C F, 1895, J Anat Physiol, V29, P234; Nishimura T, 2003, PRIMATES, V44, P41, DOI 10.1007/s10329-002-0005-9; Rodriguez-Vazquez JF, 2011, J ANAT, V219, P143, DOI 10.1111/j.1469-7580.2011.01387.x; Sittkou S., 1923, TOKYO IJI SHINPOU, V2358; ZAWTUN HA, 1985, ACTA ANAT, V122, P163	19	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-9602	1618-0402		ANN ANAT	Ann. Anat.-Anat. Anz.		2015	197						29	37		10.1016/j.aanat.2014.09.001		9	Anatomy & Morphology	Anatomy & Morphology	AY6HJ	WOS:000347667400006		
J	Yamada, Y; Higuchi, K; Nishikawa, K; Gotoh, M; Fuse, N; Sugimoto, N; Nishina, T; Amagai, K; Chin, K; Niwa, Y; Tsuji, A; Imamura, H; Tsuda, M; Yasui, H; Fujii, H; Yamaguchi, K; Yasui, H; Hironaka, S; Shimada, K; Miwa, H; Hamada, C; Hyodo, I				Yamada, Y.; Higuchi, K.; Nishikawa, K.; Gotoh, M.; Fuse, N.; Sugimoto, N.; Nishina, T.; Amagai, K.; Chin, K.; Niwa, Y.; Tsuji, A.; Imamura, H.; Tsuda, M.; Yasui, H.; Fujii, H.; Yamaguchi, K.; Yasui, H.; Hironaka, S.; Shimada, K.; Miwa, H.; Hamada, C.; Hyodo, I.			Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer	ANNALS OF ONCOLOGY			English	Article						advanced gastric cancer; oxaliplatin; cisplatin; S-1; phase III study	ORAL ANTICANCER AGENT; GASTROESOPHAGEAL ADENOCARCINOMA; 1ST-LINE TREATMENT; TRIAL; FLUOROURACIL; NONINFERIORITY; LEUCOVORIN; THERAPY	We evaluated the efficacy and safety of S-1 plus oxaliplatin (SOX) as an alternative to cisplatin plus S-1 (CS) in first-line chemotherapy for advanced gastric cancer (AGC). In this randomized, open-label, multicenter phase III study, patients were randomly assigned to receive SOX (80-120 mg/day S-1 for 2 weeks with 100 mg/m(2) oxaliplatin on day 1, every 3 weeks) or CS (S-1 for 3 weeks with 60 mg/m(2) cisplatin on day 8, every 5 weeks). The primary end points were noninferiority in progression-free survival (PFS) and relative efficacy in overall survival (OS) for SOX using adjusted hazard ratios (HRs) with stratification factors; performance status and unresectable or recurrent (+adjuvant chemotherapy) disease. Overall, 685 patients were randomized from January 2010 to October 2011. In per-protocol population, SOX (n = 318) was noninferior to CS (n = 324) in PFS [median, 5.5 versus 5.4 months; HR 1.004, 95% confidence interval (CI) 0.840-1.199; predefined noninferiority margin 1.30]. The median OS for SOX and CS were 14.1 and 13.1 months, respectively (HR 0.958 with 95% CI 0.803-1.142). In the intention-to-treat population (SOX, n = 339; CS, n = 337), the HRs in PFS and OS were 0.979 (95% CI 0.821-1.167) and 0.934 (95% CI 0.786-1.108), respectively. The most common a parts per thousand yengrade 3 adverse events (SOX versus CS) were neutropenia (19.5% versus 41.8%), anemia (15.1% versus 32.5%), hyponatremia (4.4% versus 13.4%), febrile neutropenia (0.9% versus 6.9%), and sensory neuropathy (4.7% versus 0%). SOX is as effective as CS for AGC with favorable safety profile, therefore SOX can replace CS.	[Yamada, Y.] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo 1040045, Japan; [Higuchi, K.] Kitasato Univ East Hosp, Dept Gastroenterol, Sagamihara, Kanagawa, Japan; [Nishikawa, K.] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Gotoh, M.] Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Takatsuki, Osaka, Japan; [Fuse, N.] Natl Canc Ctr Hosp East, Div Gastrointestinal Oncol & Digest Endoscopy, Kashiwa, Chiba, Japan; [Sugimoto, N.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Clin Oncol, Osaka, Japan; [Nishina, T.] Natl Hosp Org, Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan; [Amagai, K.] Ibaraki Cent Hosp, Dept Gastroenterol, Kasama, Ibaraki, Japan; [Chin, K.] Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan; [Niwa, Y.] Aichi Canc Ctr Hosp, Dept Endoscopy, Nagoya, Aichi 464, Japan; [Tsuji, A.] Kochi Hlth Sci Ctr, Dept Med Oncol, Kochi, Japan; [Imamura, H.] Sakai City Hosp, Dept Surg, Sakai, Osaka, Japan; [Tsuda, M.] Hyogo Canc Ctr, Dept Gastroenterol Oncol, Akashi, Hyogo, Japan; [Yasui, H.] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Fujii, H.] Jichi Med Univ, Div Clin Oncol, Shimotsuke, Japan; [Yamaguchi, K.] Saitama Canc Ctr, Div Gastroenterol, Saitama, Japan; [Yasui, H.] Natl Hosp Org, Kyoto Med Ctr, Dept Med Oncol, Kyoto, Japan; [Hironaka, S.] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba 2608717, Japan; [Shimada, K.] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan; [Miwa, H.] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Hamada, C.] Tokyo Univ Sci, Fac Engn, Tokyo 162, Japan; [Hyodo, I.] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan	Yamada, Y (reprint author), Natl Canc Ctr, Gastrointestinal Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yayamada@ncc.go.jp			Yakult Honsha	This work was supported by Yakult Honsha. No grant numbers applicable.	Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Ajani JA, 2013, EUR J CANCER, V49, P3616, DOI 10.1016/j.ejca.2013.07.003; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Koizumi W, 2010, ANN ONCOL, V21, P1001, DOI 10.1093/annonc/mdp464; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Vanhoefer U, 2000, J CLIN ONCOL, V18, P2648; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Comets E, 2003, J PHARMACOKINET PHAR, V30, P257, DOI 10.1023/A:1026142601822; Waters JS, 1999, BRIT J CANCER, V80, P269, DOI 10.1038/sj.bjc.6690350	16	9	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JAN	2015	26	1					141	148		10.1093/annonc/mdu472		8	Oncology	Oncology	AY2JP	WOS:000347416300021		
J	Van Cutsem, E; Boni, C; Tabernero, J; Massuti, B; Middleton, G; Dane, F; Reichardt, P; Pimentel, FL; Cohn, A; Follana, P; Clemens, M; Zaniboni, A; Moiseyenko, V; Harrison, M; Richards, DA; Prenen, H; Pernot, S; Ecstein-Fraisse, E; Hitier, S; Rougier, P				Van Cutsem, E.; Boni, C.; Tabernero, J.; Massuti, B.; Middleton, G.; Dane, F.; Reichardt, P.; Pimentel, F. L.; Cohn, A.; Follana, P.; Clemens, M.; Zaniboni, A.; Moiseyenko, V.; Harrison, M.; Richards, D. A.; Prenen, H.; Pernot, S.; Ecstein-Fraisse, E.; Hitier, S.; Rougier, P.			Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study	ANNALS OF ONCOLOGY			English	Article						antineoplastic agents; combined; platinum compounds; stomach neoplasms; taxoids	ADVANCED ESOPHAGOGASTRIC CANCER; ARBEITSGEMEINSCHAFT INTERNISTISCHE ONKOLOGIE; V-325 STUDY-GROUP; GASTROESOPHAGEAL JUNCTION; 1ST-LINE THERAPY; CISPLATIN; TRIAL; ADENOCARCINOMA; COMBINATION; EPIRUBICIN	Docetaxel/cisplatin/infusional 5-fluorouracil (5-FU; DCF) is a standard chemotherapy regimen for patients with advanced gastric cancer (GC). This phase II study evaluated docetaxel/oxaliplatin (TE), docetaxel/oxaliplatin/5-FU (TEF), and docetaxel/oxaliplatin/capecitabine (TEX) in patients with advanced GC. Patients with metastatic or locally recurrent gastric adenocarcinoma (including carcinoma of the gastro-oesophageal junction) were randomly assigned (1 : 1 : 1) to TE, TEF, or TEX. Each regimen was tested at two doses before full evaluation at optimized dose levels. The primary end point was progression-free survival (PFS). Overall survival (OS), tumour response, and safety were also assessed. A therapeutic index (median PFS relative to the incidence of febrile neutropenia) was calculated for each regimen and compared with DCF (historical data). Overall, 248 patients were randomly assigned to receive optimized dose treatment. Median PFS was longer with TEF (7.66 [95% confidence interval (CI): 6.97-9.40] months) versus TE (4.50 [3.68-5.32] months) and TEX (5.55 [4.30-6.37] months). Median OS was 14.59 (95% CI: 11.70-21.78) months for TEF versus 8.97 (7.79-10.87) months for TE and 11.30 (8.08-14.03) months for TEX. The rate of tumour response (complete or partial) was 46.6% (95% CI 35.9-57.5) for TEF versus 23.1% (14.3-34.0) for TE and 25.6% (16.6-36.4) for TEX. The frequency and type of adverse events (AEs) were similar across the three arms. Common grade 3/4 AEs were fatigue (21%), sensory neuropathy (14%), and diarrhoea (13%). Febrile neutropenia was reported in 2% (TEF), 14% (TE), and 9% (TEX) of patients. The therapeutic index was improved with TEF versus TEX, TE, or DCF. These results suggest that TEF is worthy of evaluation as an arm in a phase III trial or as a backbone regimen for new targeted agents in advanced GC.	[Van Cutsem, E.; Prenen, H.] Univ Hosp Leuven, B-3000 Leuven, Belgium; [Van Cutsem, E.] Katholieke Univ Leuven, Leuven, Belgium; [Boni, C.] Arcispedale S Maria Nuova IRCCS, Dept Oncol, Reggio Emilia, Italy; [Tabernero, J.] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain; [Tabernero, J.] Univ Autonoma Barcelona, Inst Oncol VHIO, E-08193 Barcelona, Spain; [Massuti, B.] Alicante Univ Hosp, Med Oncol Serv, Alicante, Spain; [Middleton, G.] Univ Birmingham, Dept Med Oncol, Birmingham, W Midlands, England; [Dane, F.] Marmara Univ, Fac Med, Dept Med Oncol, Istanbul, Turkey; [Reichardt, P.] HELIOS Klinikum Berlin Buch, Berlin, Germany; [Pimentel, F. L.] Hosp Sao Sebastiao, Santa Maria Feira, Portugal; [Cohn, A.] Rocky Mt Canc Ctr, US Oncol Res, Denver, CO USA; [Follana, P.] Ctr Antoine Lacassagne, Dept Med Oncol, F-06054 Nice, France; [Clemens, M.] Klinikum Mutterhaus Borromaeerinnen, Dept Internal Med 1, Trier, Germany; [Zaniboni, A.] Ist Osped, Fdn Poliambulanza, Brescia, Italy; [Moiseyenko, V.] NN Petrov Oncol SRI, St Petersburg, Russia; [Harrison, M.] Mt Vernon Canc Ctr, Dept Clin Oncol, Northwood, Middx, England; [Richards, D. A.] Texas Oncology Tyler, US Oncol Res, Tyler, TX USA; [Pernot, S.; Rougier, P.] Univ Paris 05, European Hosp Georges Pompidou, AP HP, Paris, France; [Ecstein-Fraisse, E.] Sanofi KK, Med Operat, Tokyo, Japan; [Hitier, S.] Sanofi, Stat, Chilly Mazarin, France	Van Cutsem, E (reprint author), Univ Hosp Leuven, Herestr 49, B-3000 Leuven, Belgium.	eric.vancutsem@uzleuven.be			Sanofi	This work was supported by Sanofi. Editorial assistance was provided by Adelphi Communications Ltd and supported by Sanofi.	KIM NK, 1993, CANCER, V71, P3813, DOI 10.1002/1097-0142(19930615)71:12<3813::AID-CNCR2820711205>3.0.CO;2-5; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Ajani JA, 2007, J CLIN ONCOL, V25, P3205, DOI 10.1200/JCO.2006.10.4968; Webb A, 1997, J CLIN ONCOL, V15, P261; Lordick F, 2014, GASTRIC CANCER, V17, P213, DOI 10.1007/s10120-013-0297-z; Al-Batran SE, 2008, ANN ONCOL, V19, P1882, DOI 10.1093/annonc/mdn403; Lorenzen S, 2007, ANN ONCOL, V18, P1673, DOI 10.1093/annonc/mdm269; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Amarantidis K, 2011, ONCOLOGY-BASEL, V80, P359, DOI 10.1159/000330199; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Ross P, 2002, J CLIN ONCOL, V20, P1996, DOI 10.1200/JCO.2002.08.105; Ajani JA, 2007, J CLIN ONCOL, V25, P3210, DOI 10.1200/JCO.2006.08.3956; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Vanhoefer U, 2000, J CLIN ONCOL, V18, P2648; Al-Batran SE, 2013, EUR J CANCER, V49, P835, DOI 10.1016/j.ejca.2012.09.025; Comella P, 2009, CANCER CHEMOTH PHARM, V64, P893, DOI 10.1007/s00280-009-0938-4; Di Lauro L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-34; Iwase H, 2011, ONCOLOGY-BASEL, V80, P76, DOI 10.1159/000328746; Kim JY, 2011, CANCER CHEMOTH PHARM, V67, P527, DOI 10.1007/s00280-010-1353-6; National Cancer Institute, 2012, SURV EP END RES; Richards D, 2008, ANN ONCOL, V19, P104, DOI 10.1093/annonc/mdm449; Wagner AD, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004064.PUB3; Waters JS, 1999, BRIT J CANCER, V80, P269, DOI 10.1038/sj.bjc.6690350	24	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JAN	2015	26	1					149	156		10.1093/annonc/mdu496		8	Oncology	Oncology	AY2JP	WOS:000347416300022		
J	Kobayashi, Y; Mitsudomi, T; Sakao, Y; Yatabe, Y				Kobayashi, Y.; Mitsudomi, T.; Sakao, Y.; Yatabe, Y.			Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth	ANNALS OF ONCOLOGY			English	Article						ALK; EGFR; ground-glass opacity; HER2; KRAS; lung cancer	THIN-SECTION CT; LUNG-CANCER; INTERNATIONAL-ASSOCIATION; COMPUTED-TOMOGRAPHY; FLEISCHNER-SOCIETY; FOLLOW-UP; OPACITY; EGFR; MUTATIONS; MANAGEMENT	Pulmonary ground-glass nodules (GGNs) include both malignant and benign lesions. Some GGNs become larger, whereas others remain unchanged for years. We have previously reported that smoking history and large diameters are predictors for growth. However, the genetic differences among GGNs remain unclear. GGNs with ground-glass component of a parts per thousand yen50% on a thin-section computed tomography scan that were resected between 2012 and 2014 were evaluated for clinicopathological features and the presence of EGFR/KRAS/ALK/HER2 mutations. 'Incidence of 2-mm growth' and 'Time to 2-mm growth' were analyzed according to the mutational status. Among 104 GGNs in 96 patients, this study included 3 atypical adenomatous hyperplasia (AAH), 19 adenocarcinoma in situ (AIS), 27 minimally invasive adenocarcinoma (MIA), and 55 invasive adenocarcinoma (IA). Among the 71 lesions evaluable for growth, 30 GGNs exhibited growth and 5 lesions remained unchanged for a parts per thousand yen2 years before surgery was carried out. We identified mutations or rearrangements in 75% of GGNs (78/104). EGFR mutations were noted in 64% of samples, KRAS in 4%, ALK in 3%, and HER2 in 4%. The remaining 26 quadruple-negative tumors were significantly associated with AAH/AIS (P < 0.01) and no-growth (P < 0.01) compared with driver mutation-positive tumors, whereas EGFR mutation-positive tumors were correlated with MIA/IA (P < 0.01) and growth (P < 0.01) compared with EGFR-negative tumors. Three fourths of resected GGNs were positive for EGFR, KRAS, ALK, or HER2 mutations. Quadruple-negative tumors were associated with a lack of GGN growth, whereas EGFR mutation-positive tumors displayed a correlation with growth.	[Kobayashi, Y.; Mitsudomi, T.] Kinki Univ, Fac Med, Dept Thorac Surg, Osaka, Japan; [Kobayashi, Y.; Sakao, Y.] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 4648681, Japan; [Yatabe, Y.] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan	Yatabe, Y (reprint author), Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yyatabe@aichi-cc.jp			Japan Society for the Promotion of Science [26893310]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 26893310).	Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Nakata M, 2005, J THORAC CARDIOV SUR, V129, P1226, DOI 10.1016/j.jtcvs.2004.10.032; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Matsuguma H, 2013, CHEST, V143, P436, DOI 10.1378/chest.11-3306; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Matsuguma H, 2002, J THORAC CARDIOV SUR, V124, P278, DOI 10.1067/mtc.122298; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Kobayashi Y, 2013, J THORAC ONCOL, V8, P309, DOI 10.1097/JTO.0b013e31827e2435; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Aoki T, 2001, RADIOLOGY, V220, P803, DOI 10.1148/radiol.2203001701; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kakinuma R, 2012, ACAD RADIOL, V19, P389, DOI 10.1016/j.acra.2011.12.002; Kohno T, 2013, CANCER SCI, V104, P1396, DOI 10.1111/cas.12275; Hiramatsu M, 2008, J THORAC ONCOL, V3, P1245, DOI 10.1097/JTO.0b013e318189f526; McCunney RJ, 2014, CHEST, V145, P618, DOI 10.1378/chest.13-1420; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kobayashi Yoshihisa, 2013, Transl Lung Cancer Res, V2, P354, DOI 10.3978/j.issn.2218-6751.2013.09.03; Kobayashi Y, 2014, LUNG CANCER, V83, P61, DOI 10.1016/j.lungcan.2013.10.017; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Yatabe Y, 2011, LUNG CANCER, V74, P7, DOI 10.1016/j.lungcan.2011.05.021	32	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JAN	2015	26	1					156	161		10.1093/annonc/mdu505		6	Oncology	Oncology	AY2JP	WOS:000347416300023		
J	Maeda, H; Kurokawa, T				Maeda, H.; Kurokawa, T.			Acceptance of surrogate end points in clinical trials supporting approval of drugs for cancer treatment by the Japanese regulatory agency	ANNALS OF ONCOLOGY			English	Article						drugs for cancer treatment; Japan; oncology drugs; PMDA; surrogate end point; survival	PROGRESSION-FREE SURVIVAL; ONCOLOGY DRUG; UNITED-STATES; METAANALYSIS; PERSPECTIVE; ORPHAN	This study investigated the historic use of different end points to support approval of drugs for cancer treatment in Japan. Anticancer drugs approved between April 2001 and April 2014 were comprehensively investigated using publicly available information. Before the revision of the guideline for oncology drugs in April 2006 in Japan, > 80% of end points supporting approval were response rate and overall survival (OS) was not frequent. After the revision of the guideline in Japan, using OS in pivotal clinical trials applied for approval increased to more than approximately one-third of oncology drugs, although trials with an end point of response rate decreased. Regarding drugs for major cancers including non-small-cell lung cancer, gastric cancer, colorectal cancer, and breast cancer, survival was used as an end point in 44.0%, whereas surrogate end points were used in 56.0%. Exploration of potential factors for using surrogate end points other than survival carried out through determinations of odds ratios and 95% confidence intervals identified 'orphan drug designation in Japan' and 'accelerated approval by the U.S. Food and Drug Administration' as significant factors. The revised guideline for oncology drugs in Japan requires the results of phase 3 studies with survival as an end point at the time of new drug application at least for major cancers. The regulatory agency in Japan also accepts surrogate end points as end points supporting approval besides survival; however, the number of surrogate end points has decreased after the revision of the guideline. We consider that accepting surrogate end points in the Japanese regulatory systems is important to approve oncology drugs quickly in Japan.	[Maeda, H.; Kurokawa, T.] Keio Univ, Grad Sch Pharmaceut Sci, Tokyo 1058512, Japan; [Maeda, H.] Astellas Pharma Inc, Tokyo, Japan	Maeda, H (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	hideki.maeda@astellas.com					Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Shea MB, 2013, CLIN CANCER RES, V19, P3722, DOI 10.1158/1078-0432.CCR-13-0316; Giessen C, 2013, CLIN CANCER RES, V19, P225, DOI 10.1158/1078-0432.CCR-12-1515; Martell RE, 2013, ONCOLOGIST, V18, P104, DOI 10.1634/theoncologist.2012-0235; Halabi S, 2014, CANCER-AM CANCER SOC, V120, P52, DOI 10.1002/cncr.28221; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; Farrell AT, 2006, ANN ONCOL, V17, P889, DOI 10.1093/annonc/mdj099; Pazdur R, 2008, ONCOLOGIST, V13, P19, DOI 10.1634/theoncologist.13-S2-19; Ocana A, 2011, J NATL CANCER I, V103, P16, DOI 10.1093/jnci/djq463; Ito Y, 2013, ANN ONCOL, V24, P1297, DOI 10.1093/annonc/mdt020; Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; Paoletti X, 2013, JNCI-J NATL CANCER I, V105, P1667, DOI 10.1093/jnci/djt269; Yonemori K, 2011, INVEST NEW DRUG, V29, P706, DOI 10.1007/s10637-011-9638-0; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Maeda H, 2014, INVEST NEW DRUG, V32, P661, DOI 10.1007/s10637-014-0080-y; BROWN JS, 1995, CLIN PHARMACOL THER, V58, P243, DOI 10.1016/0009-9236(95)90240-6; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Buyse M, 2009, CANCER J, V15, P421, DOI 10.1097/PPO.0b013e3181b9c602; Furuse K, 1995, JPN J CANC CHEMOTHER, V22, P611; Hirschfeld S, 2002, CRIT REV ONCOL HEMAT, V42, P137, DOI 10.1016/S1040-8428(02)00008-2; Japan Antibiotics Research Association, 1991, GUID EV METH ANT DRU; Lanthier ML, 2010, J CLIN ONCOL, V28, pE226, DOI 10.1200/JCO.2009.26.2121; Lee L, 2011, ANN ONCOL, V22, P1392, DOI 10.1093/annonc/mdq615; Ministry of Health Labour and Welfare, 2005, REV GUID CLIN EV MET; Verma S, 2011, ONCOLOGIST, V16, P25, DOI 10.1634/theoncologist.2010-0278	25	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JAN	2015	26	1					211	216		10.1093/annonc/mdu500		6	Oncology	Oncology	AY2JP	WOS:000347416300032		
J	Sugihara, K; Yoshida, M; Ishiguro, M				Sugihara, K.; Yoshida, M.; Ishiguro, M.			Reply to the Letter to the Editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al.	ANNALS OF ONCOLOGY			English	Letter							COMPLETE MESOCOLIC EXCISION; CENTRAL VASCULAR LIGATION; LYMPH-NODE DISSECTION; RANDOMIZED PHASE-III; COLORECTAL-CANCER; CHEMOTHERAPY; TRIAL; SURGERY; FLUOROURACIL; LEUCOVORIN		[Sugihara, K.] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan; [Yoshida, M.] Osaka Med Coll Hosp, Canc Chemotherapy Ctr, Osaka, Japan; [Ishiguro, M.] Tokyo Med & Dent Univ, Dept Translat Oncol, Tokyo, Japan	Sugihara, K (reprint author), Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan.	k-sugi.srg2@tmd.ac.jp					Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; West NP, 2012, J CLIN ONCOL, V30, P1763, DOI 10.1200/JCO.2011.38.3992; West NP, 2010, J CLIN ONCOL, V28, P272, DOI 10.1200/JCO.2009.24.1448; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Rousseau B, 2010, CANCER J, V16, P202, DOI 10.1097/PPO.0b013e3181ddc5bf; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; de Gramont A, 2011, SEMIN ONCOL, V38, P521, DOI 10.1053/j.seminoncol.2011.05.006; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Huseyin A, 2014, ANN ONCOL, V26, P245; Ishiguro M, 2013, COLORECT CANC, V2, P179; Ishiguro M, 2014, J AM COLL SURGEONS, V218, P969, DOI 10.1016/j.jamcollsurg.2013.12.046; Takiuchi H, 2012, J CLIN ONCOL, V30, p4s; Yoshida M, 2014, ANN ONCOL, V25, P1743, DOI 10.1093/annonc/mdu232	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	JAN	2015	26	1					245	246		10.1093/annonc/mdu476		2	Oncology	Oncology	AY2JP	WOS:000347416300038		
J	Seino, M; Okada, M; Shibuya, K; Seino, S; Suzuki, S; Takeda, H; Ohta, T; Kurachi, H; Kitanaka, C				Seino, Manabu; Okada, Masashi; Shibuya, Keita; Seino, Shizuka; Suzuki, Shuhei; Takeda, Hiroyuki; Ohta, Tsuyoshi; Kurachi, Hirohisa; Kitanaka, Chifumi			Differential Contribution of ROS to Resveratrol-induced Cell Death and Loss of Self-renewal Capacity of Ovarian Cancer Stem Cells	ANTICANCER RESEARCH			English	Article						Cancer initiating cells; chemoprevention; ovarian cancer; oxidative stress	TUMOR-INITIATING CAPACITY; OXIDATIVE STRESS; APOPTOSIS; ACTIVATION; ANTIOXIDANT; THERAPY; PATHWAY; FOCUS; JNK	Background/Aim: Cancer stem cells (CSCs) are considered to contribute to the poor prognosis of ovarian cancer as a major cause of fatal recurrence. Identification of effective measures to eliminate ovarian CSCs through induction of cell death and/or loss of self-renewal capacity would, therefore, be key to successful management of ovarian cancer. Materials and Methods: The effects of resveratrol on the viability and self-renewal capacity of CSCs derived from A2780 human ovarian cancer cells were examined. The involvement of reactive oxygen species (ROS) was also investigated. Results: At a non-toxic to normal human fibroblasts concentration, resveratrol effectively killed ovarian CSCs independently of ROS, while ROS-dependently impaired the self-renewal capacity of ovarian CSCs that survived resveratrol treatment. Conclusion: Our findings not only shed light on a novel mechanism of action for resveratrol but also suggest that resveratrol, or its analogs, may be useful for CSC-directed therapy against ovarian cancer.	[Seino, Manabu; Okada, Masashi; Shibuya, Keita; Seino, Shizuka; Suzuki, Shuhei; Takeda, Hiroyuki; Kitanaka, Chifumi] Yamagata Univ, Sch Med, Dept Mol Canc Sci, Yamagata 9909585, Japan; [Seino, Manabu; Ohta, Tsuyoshi; Kurachi, Hirohisa] Yamagata Univ, Sch Med, Dept Obstet & Gynecol, Yamagata 9909585, Japan; [Suzuki, Shuhei; Takeda, Hiroyuki] Yamagata Univ, Sch Med, Dept Clin Oncol, Yamagata 9909585, Japan; [Suzuki, Shuhei] Yamagata Univ, Sch Med, Dept Reg Canc Network, Yamagata 9909585, Japan; [Shibuya, Keita; Seino, Shizuka; Kitanaka, Chifumi] Yamagata Univ, Res Inst Adv Mol Epidemiol, Oncol Res Ctr, Yamagata 9909585, Japan; [Shibuya, Keita; Seino, Shizuka; Kitanaka, Chifumi] Japan Soc Promot Sci, Global COE Program Med Sci, Tokyo, Japan; [Seino, Shizuka; Kitanaka, Chifumi] Yamagata Univ, Sch Med, Res Inst Promot Med Sci, Yamagata 9909585, Japan; [Kurachi, Hirohisa] Osaka Med Ctr, Osaka, Japan; [Kurachi, Hirohisa] Res Inst Maternal & Child Hlth, Osaka, Japan	Kitanaka, C (reprint author), Yamagata Univ, Sch Med, Dept Mol Canc Sci, Yamagata 9909585, Japan.	ckitanak@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program of the Japan Society for the Promotion of Science; National Cancer Center Research and Development Fund [23-A-20]; Japan Brain Foundation	We thank Ms. Eriko Watanabe and Ms. Asuka Sugai for their technical and secretarial contributions to this study, respectively. This work was supported by Grants-in-Aid for Scientific Research, for Challenging Exploratory Research and for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a Grant-in-Aid from the Global COE Program of the Japan Society for the Promotion of Science, by the National Cancer Center Research and Development Fund (23-A-20) and by a grant from the Japan Brain Foundation.	Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; He S, 2013, CURR MED CHEM, V20, P1005; Sato A, 2014, STEM CELL RES, V12, P119, DOI 10.1016/j.scr.2013.09.012; Kao CL, 2009, INT J RADIAT ONCOL, V74, P219, DOI 10.1016/j.ijrobp.2008.12.035; Poveda A, 2014, CANCER TREAT REV, V40, P366, DOI 10.1016/j.ctrv.2013.08.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Timmers S, 2012, AGING-US, V4, P146; Hu LS, 2012, CANCER BIOL THER, V13, P516, DOI 10.4161/cbt.19601; Kopp P, 1998, EUR J ENDOCRINOL, V138, P619, DOI 10.1530/eje.0.1380619; Bursch W, 2000, ANN NY ACAD SCI, V926, P1; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Seino M, 2014, ANTICANCER RES, V34, P4723; Lee MH, 2009, CANCER RES, V69, P7449, DOI 10.1158/0008-5472.CAN-09-1266; Yang YP, 2012, J CELL PHYSIOL, V227, P976, DOI 10.1002/jcp.22806; Shah MM, 2014, GYNECOL ONCOL, V132, P483, DOI 10.1016/j.ygyno.2013.12.001; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Carrizzo A, 2013, FOOD CHEM TOXICOL, V61, P215, DOI 10.1016/j.fct.2013.07.021; Kwon MJ, 2013, INT J MOL SCI, V14, P6624, DOI 10.3390/ijms14046624; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Piotrowska H, 2012, TOXICOL APPL PHARM, V263, P53, DOI 10.1016/j.taap.2012.05.023; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Sato A, 2013, STEM CELL RES, V11, P601, DOI 10.1016/j.scr.2013.04.004; Hu FW, 2012, MOL NUTR FOOD RES, V56, P1247, DOI 10.1002/mnfr.201200150; Sato A, 2012, STEM CELL TRANSL MED, V1, P811, DOI 10.5966/sctm.2012-0058; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Gosslau A, 2005, BRIT J CANCER, V92, P513, DOI 10.1038/sj.bjc.6602300; Klionsky DJ, 2008, AUTOPHAGY, V4, P139; Lu KH, 2009, CHILD NERV SYST, V25, P543, DOI 10.1007/s00381-009-0826-6; Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065; Matsuda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00516; Maund SL, 2011, STEM CELL REV REP, V7, P307, DOI 10.1007/s12015-010-9205-7; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Tomao F, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-48	40	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					85	96				12	Oncology	Oncology	AY7IY	WOS:000347735300011		
J	Shinden, Y; Akiyoshi, S; Ueo, H; Nambara, S; Saito, T; Komatsu, H; Ueda, M; Hirata, H; Sakimura, S; Uchi, R; Takano, Y; Iguchi, T; Eguchi, H; Sugimachi, K; Kijima, Y; Ueo, H; Natsugoe, S; Mimori, K				Shinden, Yoshiaki; Akiyoshi, Sayuri; Ueo, Hiroki; Nambara, Syo; Saito, Tomoko; Komatsu, Hisateru; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Takano, Yuki; Iguchi, Tomohiro; Eguchi, Hidetoshi; Sugimachi, Keishi; Kijima, Yuko; Ueo, Hiroaki; Natsugoe, Shoji; Mimori, Koshi			Diminished Expression of MiR-15a Is an Independent Prognostic Marker for Breast Cancer Cases	ANTICANCER RESEARCH			English	Article						miR-15a; breast cancer; prognosis	MICRORNAS	Background/Aim: MiR-15a targets Cyclin El (CCNE1), which regulates the cell cycle and promotes cell proliferation and progression. Herein, we investigated the clinicopathological significance of miR-15a as a prognostic marker in breast cancer (BC) cases. Materials and Methods: We collected primary tumor samples of 230 BC cases, including 68 triple-negative cases. The expression levels of miR-15a in primal), tumors were measured by qRT-PCR assay. Results: Low expression of miR-15a in primary tumors was significantly correlated with shorter disease-free survival (p=0.0012) and overall survival (p=0.005) compared to the high miR-15a expression in triple-negative BC cases. Multivariate analysis indicated that low rniR-15a expression was an independent prognostic factor for overall survival [RR=2.56(1.03-7.18), p=0.04]. Conclusion: MiR-15a expression levels could be a promising biological and prognostic marker for overall survival especially in triple-negative BC cases.	[Shinden, Yoshiaki; Ueo, Hiroki; Nambara, Syo; Saito, Tomoko; Komatsu, Hisateru; Ueda, Masami; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Takano, Yuki; Iguchi, Tomohiro; Eguchi, Hidetoshi; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita 8740838, Japan; [Akiyoshi, Sayuri] Kyushu Canc Ctr, Natl Hosp Org, Minami Ku, Fukuoka, Japan; [Kijima, Yuko; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Sakuragaoka, Kagoshima, Japan; [Ueo, Hiroaki] Ueo Breast Surg Hosp, Haya, Oita, Japan	Mimori, K (reprint author), Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25830102]	The Authors would like to thank K. Oda, M. Kasagi, and S. Kono for their technical assistance. This work was supported in part by the Japan Society for the Promotion of Science (25830102).	Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Luo QF, 2013, INT J ONCOL, V43, P1212, DOI 10.3892/ijo.2013.2034; Ota D, 2011, INT J ONCOL, V38, P955, DOI 10.3892/ijo.2011.926; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Serpico D, 2014, CANCER TREAT REV, V40, P595, DOI 10.1016/j.ctrv.2013.11.002; Dong Chunjuan, 2009, Cancer Biol Ther, V8, P200, DOI 10.4161/cbt.8.3.7333; Liu XP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-57	11	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					123	127				5	Oncology	Oncology	AY7IY	WOS:000347735300015		
J	Shindo, Y; Yoshimura, K; Kuramasu, A; Watanabe, Y; Ito, H; Kondo, T; Oga, A; Ito, H; Yoshino, S; Hazama, S; Tamada, K; Yagita, H; Oka, M				Shindo, Yoshitaro; Yoshimura, Kiyoshi; Kuramasu, Atsuo; Watanabe, Yusaku; Ito, Hideaki; Kondo, Tomoko; Oga, Atsunori; Ito, Hiroshi; Yoshino, Shigefumi; Hazama, Shoichi; Tamada, Koji; Yagita, Hideo; Oka, Masaaki			Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor	ANTICANCER RESEARCH			English	Article						Cancer immunotherapy; 4-1BB; PD-1; immune checkpoint	T-CELLS; IMMUNE-RESPONSES; CANCER-THERAPY; ANTIBODIES; PATHWAY; COLON; COSTIMULATION; INFECTIONS; ANTI-PD-1; SIGNALS	Background/Aim: The purpose of the present study was to establish an effective immunotherapy by skewing the cosignal balance to be on the positive side by using the combination of monoclonal antibody (mAb) against 4-1BB also known as Cluster of Differentiation (CD) 137 as a co-stimulatory effector and to programmed death-I (PD-1) to blockade the immune checkpoint. Materials and Methods: Mice implanted with 1x10(5) CT26 cells were treated with anti 4-1BB mAb alone, anti PD-1 mAb alone, or both anti 4-1BB mAb and anti PD-1 mAb. Immune cell populations were analyzed by flow cytometry. Tumor-infiltrating T-cells were evaluated by immunohistochemistry. Results: Mice treated with the combination therapy had the best antitumor response that resulted in complete tumor rejection. The numbers of CD4(+) interferon (IFN)-gamma(+) and CD8(+) IFN-gamma(+) T-cells were significantly higher in the combination group. The number of tumor-infiltrating T-cells was significantly increased in the combination therapy. Conclusion: The therapeutic strategy of targeting co-signal molecules has promising clinical applications in the future.	[Shindo, Yoshitaro; Yoshimura, Kiyoshi; Watanabe, Yusaku; Yoshino, Shigefumi; Hazama, Shoichi; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 7558505, Japan; [Kuramasu, Atsuo] Yamaguchi Univ, Grad Sch Med, Dept Mol Pharmacol, Ube, Yamaguchi 7558505, Japan; [Ito, Hideaki; Kondo, Tomoko; Oga, Atsunori; Ito, Hiroshi] Yamaguchi Univ, Grad Sch Med, Dept Mol Pathol, Ube, Yamaguchi 7558505, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol, Ube, Yamaguchi 7558505, Japan; [Yoshimura, Kiyoshi] Natl Canc Ctr, Oncol Res & Clin Trial Ctr Tsukiji, Div Canc Immunotherapy, Chuo Ku, Tokyo 104, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan	Yoshimura, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	kyoshim6705@gmail.com			Japan Society for the Promotion of Science KAKENHI [30346564]	The Authors would like to thank Moeko Inoue B.S. for technical support. This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 30346564 (to K.Y).	Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Cho Y, 2003, CANCER RES, V63, P1555; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Wilcox RA, 2002, J IMMUNOL, V169, P4230; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Cannons JL, 2001, J IMMUNOL, V167, P1313; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Harris NL, 1999, IMMUNOL CELL BIOL, V77, P304, DOI 10.1046/j.1440-1711.1999.00835.x; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Lee CS, 2013, BRIT J CLIN PHARMACO, V76, P233, DOI 10.1111/bcp.12164; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Yoshimura K, 2001, CANCER GENE THER, V8, P9; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Yoshimura K, 2007, CANCER RES, V67, P10058, DOI 10.1158/0008-5472.CAN-07-0573; Wu YL, 2012, INT J BIOL SCI, V8, P1420, DOI 10.7150/ijbs.5273; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; CORBETT TH, 1975, CANCER RES, V35, P2434; Maeda N, 2014, ANN SURG ONCOL; Pentcheva-Hoang T, 2009, IMMUNOL REV, V229, P67, DOI 10.1111/j.1600-065X.2009.00763.x; Yamazaki Tomohide, 2005, J Immunol, V175, P1586	28	3	4	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					129	136				8	Oncology	Oncology	AY7IY	WOS:000347735300016		
J	Seki, K; Kinashi, Y; Takahashi, S				Seki, Keiko; Kinashi, Yuko; Takahashi, Sentaro			Influence of p53 Status on the Effects of Boron Neutron Capture Therapy in Glioblastoma	ANTICANCER RESEARCH			English	Article						Boron neutron capture therapy; neutron; p53; 53BP1; apoptosis	CELLS; APOPTOSIS; MUTATIONS; RADIATION; GENE; IDENTIFICATION; INDUCTION; GROWTH; TUMORS	Background/Aim: The tumor suppressor gene p53 is mutated in glioblastoma. We studied the relationship between the p53 gene and the biological effects of boron neutron capture therapy (BNCT). Materials and Methods: The human glioblastoma cells; A172, expressing wild-type p53, and T98G, with mutant p53, were irradiated by the Kyoto University Research Reactor (KUR). The biological effects after neutron irradiation were evaluated by the cell killing effect, 53BP1 foci assay and apoptosis induction. Results: The survival-fraction data revealed that A172 was more radiosensitive than T98G, but the difference was reduced when boronophenylalanine (BPA) was present. Both cell lines exhibited similar numbers of foci, suggesting that the initial levels of DNA damage did not depend on p53 function. Detection of apoptosis revealed a lower rate of apoptosis in the T98G. Conclusion: BNCT causes cell death in glioblastoma cells, regardless of p53 mutation status. In T98G cells, cell killing and apoptosis occurred effectively following BNCT.	[Seki, Keiko; Kinashi, Yuko; Takahashi, Sentaro] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Kinashi, Y (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	kinashi@rri.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26461884]; Kansai Genshi-ryoku Kondankai, Osaka Japan; KUR	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan No. 26461884; and by a research grant from Kansai Genshi-ryoku Kondankai, Osaka Japan and KUR research program for scientific basis of nuclear safety.	GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Oonishi K, 2012, RADIOTHER ONCOL, V105, P258, DOI 10.1016/j.radonc.2012.08.009; Zhao SG, 2008, MOL BIOL REP, V35, P421, DOI 10.1007/s11033-007-9102-6; Mori E, 2009, J RADIAT RES, V50, P37, DOI 10.1269/jrr.08075; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Duan X, 2008, INT J RADIAT BIOL, V84, P211, DOI 10.1080/09553000801902117; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Combs SE, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-9; Curtis C, 1993, NEW ENGL J MED, V329, P1318; Fujita Y, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-63; Fujita Y, 2011, INT J RADIAT BIOL, V87, P293, DOI 10.3109/09553002.2011.530336; Hiramatsu R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-192; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Joiner MC, 2009, BASIC CLIN RADIOBIOL, P1; Julian WK, 1993, NEUROSURGERY, V33, P824; Kageji Teruyoshi, 2014, J Med Invest, V61, P254; Kinashi Y, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-106; Levidou G, 2010, J NEURO-ONCOL, V100, P363, DOI 10.1007/s11060-010-0204-y; Marcova E, 2007, INT J RADIAT BIOL, V83, P319; OHGAKI H, 1991, CANCER RES, V51, P6202; Park CM, 2006, INT J ONCOL, V28, P119; Takahashi A, 2000, INT J RADIAT BIOL, V76, P335; Tchelebi L, 2014, MUTANT P53 MDM2 CANC, V85, P133, DOI DOI 10.1007/978-94-017-9211-0_	23	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					169	174				6	Oncology	Oncology	AY7IY	WOS:000347735300021		
J	Machioka, K; Mizokami, A; Yamaguchi, Y; Izumi, K; Hayashi, S; Namiki, M				Machioka, Kazuaki; Mizokami, Atsushi; Yamaguchi, Yuri; Izumi, Kouji; Hayashi, Shinichi; Namiki, Mikio			Active Estrogen Synthesis and its Function in Prostate Cancer-derived Stromal Cells	ANTICANCER RESEARCH			English	Article						Castration-resistant prostate cancer; estrogen; testosterone; prostate cancer-derived stromal cell; chimeric coculture	INCREASED SURVIVAL; ANDROGEN RECEPTOR; TUMOR-STROMA; CASTRATION; GROWTH; PROGRESSION; DIETHYLSTILBESTROL; MICROENVIRONMENT; TESTOSTERONE; CHEMOTHERAPY	Background: It remains unclear whether estrogen is produced in prostate cancer (PCa) and how it functions in PCa. Materials and Methods: To examine the production of estrogen in PCa cells, the concentration of estrogen in the medium in which LNCaP cells and PCa-derived stromal cells (PCaSC) were co-cultured, was measured by liquid chromatography-mass spectrometry/mass spectrometry (LCMS/MS), while aromatase (CYP19) mRNA expression was confirmed by real-time polymerase chain reaction (RT-PCR) methods. To verify whether estrogen is synthesized from testosterone in PCaSC functions, PCaSC were co-cultured with breast cancer MCF-7-E10 cells, which were stably-transfected with ERE-GFP, in the presence of testosterone. GFP expression was detected when PCaSCs could synthesize estrogen. The proliferation of PC-3 cells in the presence of PCaSC was determined by cell count. Results: PCaSC metabolized excessive testosterone to estrogen, which activated estrogen receptor in breast cancer cells. Moreover, estrogen synthesized from testosterone in PCaSC regulated the proliferation of PC-3 cell via repression of some unknown growth factors that were secreted from PCaSC. Conclusion: A chimeric co-culture method between breast cancer cells and PCaSC revealed the production of active estrogen in PCaSC. High-dose testosterone therapy might introduce a new potential strategy to treat CRPC.	[Machioka, Kazuaki; Mizokami, Atsushi; Izumi, Kouji; Namiki, Mikio] Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan; [Yamaguchi, Yuri] Saitama Canc Ctr, Div Breast Surg, Saitama, Japan; [Hayashi, Shinichi] Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan	Mizokami, A (reprint author), Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	mizokami@med.kanazawa-u.ac.jp	IZUMI, KOUJI/C-5973-2015		Ministry of Education, Culture, Sport, Science, and Technology of Japan [25670679]	The Authors would like to thank appreciate Ms. Fujinuma for technical support. A Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (25670679).	Alberti C, 2006, INT J BIOL MARKER, V21, P88; Mizokami A, 2009, ENDOCR-RELAT CANCER, V16, P1139, DOI 10.1677/ERC-09-0070; Fizazi K, 2007, LANCET ONCOL, V8, P994, DOI 10.1016/51470-2045(07)70284-X; WALSH PC, 1976, J CLIN INVEST, V57, P1093, DOI 10.1172/JCI108353; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Huggins C, 1941, CANCER RES, V1, P293; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Yamaguchi Y, 2005, CANCER RES, V65, P4653, DOI 10.1158/0008-5472.CAN-04-3236; Wen J, 2013, PROSTATE, V73, P1069, DOI 10.1002/pros.22654; Ho CKM, 2008, J ENDOCRINOL, V197, P483, DOI 10.1677/JOE-07-0470; Craft N, 1999, CANCER RES, V59, P5030; Ellem SJ, 2009, AM J PATHOL, V175, P1187, DOI 10.2353/ajpath.2009.081107; Bosset PO, 2012, BJU INT, V110, pE826, DOI 10.1111/j.1464-410X.2012.11206.x; Condon MS, 2005, SEMIN CANCER BIOL, V15, P132, DOI 10.1016/j.semcancer.2004.08.002; Gardiner RA, 2009, EUR UROL, V56, P245, DOI 10.1016/j.eururo.2009.04.030; Grenader T, 2014, ONCOL REP, V31, P428, DOI 10.3892/or.2013.2852; Harada S, 2001, PROSTATE, V46, P319, DOI 10.1002/1097-0045(20010301)46:4<319::AID-PROS1039>3.0.CO;2-C; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Ishii K, 2009, ENDOCR-RELAT CANCER, V16, P415, DOI 10.1677/ERC-08-0219; Izumi K, 2010, ANTICANCER RES, V30, P5201; Kaminski A, 2006, INT J MOL MED, V18, P941; Morris MJ, 2009, EUR UROL, V56, P237, DOI 10.1016/j.eururo.2009.03.073; Park II, 2009, ENDOCRINOLOGY, V150, P4594, DOI 10.1210/en.2008-1591; Slavin S, 2014, CARCINOGENESIS, V35, P1301, DOI 10.1093/carcin/bgt488; Taylor RA, 2008, CURR CANCER DRUG TAR, V8, P490, DOI 10.2174/156800908785699351; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802	27	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					221	227				7	Oncology	Oncology	AY7IY	WOS:000347735300027		
J	Katoh, S; Goi, T; Naruse, T; Ueda, Y; Kurebayashi, H; Nakazawa, T; Kimura, Y; Hirono, Y; Yamaguchi, A				Katoh, Shigeru; Goi, Takanori; Naruse, Takayuki; Ueda, Yuki; Kurebayashi, Hidetaka; Nakazawa, Toshiyuki; Kimura, Youhei; Hirono, Yasuo; Yamaguchi, Akio			Cancer Stem Cell Marker in Circulating Tumor Cells: Expression of CD44 Variant Exon 9 Is Strongly Correlated to Treatment Refractoriness, Recurrence and Prognosis of Human Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Colorectal cancer; CD44 variant exon 9; circulating tumor cells	INITIATING CELLS; GASTRIC-CANCER; IDENTIFICATION; COLON; TUMORIGENESIS; GROWTH	Background/Aim: The expression of the CD44 variant exon 9 (CD44v9) was investigated in order to elucidate its significance for cancer stem cells in circulating human colorectal cancer cells (CTCs). Materials and Methods: After peripheral blood was drawn from patients with colorectal cancer, CTCs were collected. Using the reverse transcription-polymerase chain reaction method, we examined the relationship between expression of CD44v9 mRNA and prognosis. Results: In 60 out of 150 patients with colorectal cancer, expression of CD44v9 mRNA was positive in CTCs. In patients with stage III disease, the 5-year survival rate was 89% for patients with negative CD44v9 expression, whereas it was 52.4% in patients with positive expression (p<0.05). In patients with stage IV unresectable cancer, the 2-year survival rate was 70.1% in cases with CD44v9-negative expression and 33.3% in cases of positive expression (p<0.05). Conclusion: CD44v9 mRNA in the CTCs of colorectal cancer is useful as a factor predicting recurrence, prognosis, and treatment efficacy.	[Katoh, Shigeru; Goi, Takanori; Naruse, Takayuki; Ueda, Yuki; Kurebayashi, Hidetaka; Nakazawa, Toshiyuki; Kimura, Youhei; Hirono, Yasuo; Yamaguchi, Akio] Univ Fukui, Dept Surg 1, Fukui, Japan	Goi, T (reprint author), Univ Fukui, Dept Surg 1, 23-3 Eiheiji Cho, Fukui, Japan.	tgoi@u-fukui.ac.jp			Organization for Life Science Advancement Programs; Translational Research Program	This work was supported in part by the Organization for Life Science Advancement Programs and Translational Research Program.	Ablett MP, 2013, ONCOTARGET, V5, P599; Kemper K, 2010, ONCOTARGET, V1, P387; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Nagano H, 2007, J SURG ONCOL, V96, P605, DOI 10.1002/jso.20716; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Yu L, 2013, ONCOTARGET, V4, P2326; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Guo W, 2014, ONCOGENE, V33, P537, DOI 10.1038/onc.2013.260; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Yamaguchi A, 2002, J SURG ONCOL, V79, P230, DOI 10.1002/jso.10082; Gotoda T, 2000, GUT, V46, P14, DOI 10.1136/gut.46.1.14; Kimura Y, 2013, ONCOTARGET, V4, P785; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Deneve E, 2013, CLIN CHEM, V59, P1384, DOI 10.1373/clinchem.2013.202846; Hirata K, 2013, BRIT J CANCER, V109, P379, DOI 10.1038/bjc.2013.314; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P190, DOI 10.1038/nrclinonc.2009.23; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Obata S, 2013, ANTICANCER RES, V33, P1881; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Sergeant G, 2008, J SURG RES, V150, P144, DOI 10.1016/j.jss.2008.02.012; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; HOFMANN M, 1991, CANCER RES, V51, P5292; Li XD, 2013, TUMORI, V99, P88, DOI 10.1700/1248.13794; Nguyen VN, 2000, NEOPLASMA, V47, P400; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; TERPE HJ, 1995, EUR J CANCER, V31A, P549, DOI 10.1016/0959-8049(95)00061-M; UICC International Union Against Cancer, 2002, TNM CLASSIFICATION M; Yamaguchi A, 1996, J CLIN ONCOL, V14, P1122	42	5	6	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					239	244				6	Oncology	Oncology	AY7IY	WOS:000347735300029		
J	Nakayama, S; Soejima, K; Yasuda, H; Yoda, S; Satomi, R; Ikemura, S; Terai, H; Sato, T; Yamaguchi, N; Hamamoto, J; Arai, D; Ishioka, K; Ohgino, K; Naoki, K; Betsuyaku, T				Nakayama, Sohei; Soejima, Kenzo; Yasuda, Hiroyuki; Yoda, Satoshi; Satomi, Ryosuke; Ikemura, Shinnosuke; Terai, Hideki; Sato, Takashi; Yamaguchi, Norihiro; Hamamoto, Junko; Arai, Daisuke; Ishioka, Kota; Ohgino, Keiko; Naoki, Katsuhiko; Betsuyaku, Tomoko			FOXD1 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer	ANTICANCER RESEARCH			English	Article						FOXD1; non-small cell lung cancer; microarray; pathway signature; PTEN	GENE-EXPRESSION; PTEN LOSS; BREAST-CANCER; DNA-BINDING; SIGNATURES; PROTEINS; AKT; ADENOCARCINOMA; METASTASIS; SUPPRESSOR	Aim: Clinical microarray datasets were analyzed to search for new therapeutic targets and prognostic markers of non-small cell lung cancer (NSCLC). Materials and Methods: Microarray datasets from 90 lung cancer specimens, were analyzed with focus on the FOXD1 gene. Levels of FOXDI mRNA were assessed in lung cancer cell lines and these levels were correlated with survival. Results: FOXD1-knockdown led to suppression of cell proliferation. Moreover, patients with high FOXDI expression survived for a significantly shorter time than those with low FOXDI expression. Conclusion: The expression status of FOXD1 is a novel prognostic factor and may lead to new treatment strategies for NSCLC.	[Nakayama, Sohei; Soejima, Kenzo; Yasuda, Hiroyuki; Yoda, Satoshi; Satomi, Ryosuke; Ikemura, Shinnosuke; Terai, Hideki; Sato, Takashi; Hamamoto, Junko; Arai, Daisuke; Ishioka, Kota; Ohgino, Keiko; Naoki, Katsuhiko; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 1608582, Japan; [Yamaguchi, Norihiro] Beth Israel Deaconess Med Ctr, Dept Internal Med, New York, NY USA; [Naoki, Katsuhiko] Keio Univ Hosp, Keio Canc Ctr, Tokyo, Japan	Soejima, K (reprint author), Keio Univ, Sch Med, Dept Med, Div Pulm Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ksoejima@cpnet.med.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590870]	The Authors thank Ms. Mikiko Shibuya for her technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K.S. (Grant #22590870).	Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Carreres MI, 2011, J NEUROSCI, V31, P5673, DOI 10.1523/JNEUROSCI.0394-11.2011; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; PIERROU S, 1994, EMBO J, V13, P5002; Lim WT, 2007, ONCOL REP, V17, P853; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Basseres DS, 2012, LUNG CANCER, V77, P31, DOI 10.1016/j.lungcan.2012.01.011; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Tang JM, 2006, LUNG CANCER-J IASLC, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Wei LX, 2013, TUMOR BIOL, V34, P941, DOI 10.1007/s13277-012-0629-3; DONALDSON LW, 1994, BIOCHEMISTRY-US, V33, P13509, DOI 10.1021/bi00250a001; Hong Z, CURR BIOL; Jessica DT, BMC MED GENOMICS, P12008; Ju W, 2009, ONCOL RES, V18, P47; Li HL, 1996, MOL BRAIN RES, V37, P96, DOI 10.1016/0169-328X(95)00276-X; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x	32	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					261	268				8	Oncology	Oncology	AY7IY	WOS:000347735300032		
J	Haruma, T; Nakamura, K; Nishida, T; Ogawa, C; Kusumoto, T; Seki, N; Hiramatsu, Y				Haruma, Tomoko; Nakamura, Keiichiro; Nishida, Takeshi; Ogawa, Chikako; Kusumoto, Tomoyuki; Seki, Noriko; Hiramatsu, Yuji			Pre-treatment Neutrophil to Lymphocyte Ratio Is a Predictor of Prognosis in Endometrial Cancer	ANTICANCER RESEARCH			English	Article						Endometrial cancer; neutrophil to lymphocyte ratio; prognosis	EPITHELIAL OVARIAN-CANCER; HUMAN-PLATELETS; SERUM CA-125; CARCINOMA; INFLAMMATION; ADENOCARCINOMA; MANAGEMENT; RELEASE; MARKERS	Background/Aim: Inflammation and tumor immunology are important in the prognosis of various cancers. We herein investigated whether pre-treatment neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and serum cancer antigen 125 (CAl25) predict recurrence and survival in patients with endometrial cancer (EC). Patients and Methods: We collected complete blood counts and clinicopathological data from medical records of 320 patients with EC; their pre-treatment NLR, PLR and CAl25 were analyzed for correlations with recurrence and survival, retrospectively. Results: Disease-free survival (DFS) and overall survival (OS) rates of patients with high NLR and CAl25 were significantly shorter than those for patients with low NLR and CAl25 (DFS: p=0.002 and p<0.001; OS: p<0.001 and p<0.001, respectively). Furthermore, NLR was also an independent predictive factor for mortality in multivariate analysis (hazard ratio (HR)=3.318; 95% confidence interval (CI). 1.154-9.538; p=0.026). Conclusion: Pre-treatment NLR is a predictor of poor prognosis in EC.	[Haruma, Tomoko; Nakamura, Keiichiro; Nishida, Takeshi; Ogawa, Chikako; Kusumoto, Tomoyuki; Seki, Noriko; Hiramatsu, Yuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Okayama 7008558, Japan	Nakamura, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	k-nakamu@cc.okayama-u.ac.jp					KAPLAN KL, 1979, BLOOD, V53, P604; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; TAKESHIMA N, 1994, GYNECOL ONCOL, V54, P321, DOI 10.1006/gyno.1994.1217; [Anonymous], 2013, ANN REP ONC COMM JAP; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; Suh DH, 2012, EUR J OBSTET GYN R B, V162, P206, DOI 10.1016/j.ejogrb.2012.02.028; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Tangjitgamol S, 2009, LANCET ONCOL, V10, P1119, DOI 10.1016/S1470-2045(09)70290-6; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jackson JR, 1997, FASEB J, V11, P457; Thavaramara Thaovalai, 2011, Journal of the Medical Association of Thailand, V94, P871; Wang D, 2013, ONCOTARGETS THER, V6, P211, DOI 10.2147/OTT.S41711; Creasman WT, 2012, CLIN GYNECOLOGIC ONC, P141; Dubernard V, 1997, ARTERIOSCL THROM VAS, V17, P2293; DUK JM, 1989, OBSTET GYNECOL, V73, P661; DUK JM, 1986, AM J OBSTET GYNECOL, V155, P1097; Gwak MS, 2007, J KOREAN MED SCI, V22, pS104; Ohashi Rina, 2006, Gan To Kagaku Ryoho, V33, P1595; Rebecca S, 2013, CA-CANCER J CLIN, V63, P11; ROSE PG, 1994, OBSTET GYNECOL, V84, P12; Sood AK, 1997, OBSTET GYNECOL, V90, P441, DOI 10.1016/S0029-7844(97)00286-X; SOPER JT, 1990, AM J OBSTET GYNECOL, V163, P1204	27	3	3	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					337	343				7	Oncology	Oncology	AY7IY	WOS:000347735300042		
J	Nishio, J; Iwasaki, H; Nabeshima, K; Naito, M				Nishio, Jun; Iwasaki, Hiroshi; Nabeshima, Kazuki; Naito, Masatoshi			Immunohistochemical, Cytogenetic, and Molecular Cytogenetic Characterization of Both Components of a Dedifferentiated Liposarcoma: Implications for Histogenesis	ANTICANCER RESEARCH			English	Article						Dedifferentiated liposarcoma; well-differentiated liposarcoma; ring chromosome; MDM2; CDK4	ADIPOCYTIC DIFFERENTIATION; TISSUE TUMORS; AMPLIFICATION; CDK4; OVEREXPRESSION; EXPRESSION	Dedifferentiated liposarcoma (DDLS) is a malignant adipocytic tumor showing transition from an atypical lipomatous tumor (ALT)/well-differentiated liposarcoma (WDLS) to a non-lipogenic sarcoma of variable histological grades. We present the immunohistochemical, cytogenetic, and molecular cytogenetic findings of DDLS arising in the right chest wall of a 76-year-old man. Magnetic resonance imaging exhibited a large mass composed of two components with heterogeneous signal intensities, suggesting the coexistence of a fatty area and another soft tissue component. The grossly heterogeneous mass was histologically composed of an ALT/WDLS component transitioning abruptly into a dedifferentiated component. Immunohistochemistry was positive for murine double-minute 2 (MDM2), cyclin-dependent kinase 4 (CDK4), and p16 in both components, although a more strong and diffuse staining was found in the dedifferentiated area. The MIB-1 labeling index was extremely higher in the dedifferentiated area compared to the ALT/WDLS area. Cytogenetic analysis of the ALT/WDLS component revealed the following karyotype: 46,X,-Y,+r. Notably, cytogenetic analysis of the dedifferentiated component revealed a similar but more complex karyotype. Spectral karyotyping demonstrated that the ring chromosome was entirely composed of material from chromosome 12. Interphase fluorescence in situ hybridization analysis revealed amplification of MDM2 and CDK4 in both components. These findings suggest that multiple abnormal clones derived from a single precursor cell would be present in DDLS, with one or more containing supernumerary rings or giant marker chromosomes.	[Nishio, Jun; Naito, Masatoshi] Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Fukuoka 8140180, Japan; [Iwasaki, Hiroshi; Nabeshima, Kazuki] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka 8140180, Japan	Nishio, J (reprint author), Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	jnishio@cis.fukuoka-u.ac.jp			Foundation for the Promotion of Medical Science; JSPS KAKENHI [25462355]	This study was supported in part by the Foundation for the Promotion of Medical Science and JSPS KAKENHI Grant Number 25462355.	Peng TS, 2011, LAB INVEST, V91, P392, DOI 10.1038/labinvest.2010.185; Snyder EL, 2009, J PATHOL, V218, P292, DOI 10.1002/path.2564; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Crago AM, 2012, CLIN CANCER RES, V18, P1334, DOI 10.1158/1078-0432.CCR-11-2820; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Lee SE, 2014, HISTOL HISTOPATHOL, V29, P127; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Hisaoka M, 2012, AM J PATHOL, V180, P2076, DOI 10.1016/j.ajpath.2012.01.042; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Tap WD, 2011, GENE CHROMOSOME CANC, V50, P95, DOI 10.1002/gcc.20835; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Nishio J, 2003, INT J ONCOL, V22, P535; Horvai AE, 2009, MODERN PATHOL, V22, P1477, DOI 10.1038/modpathol.2009.119; Dei Tos AP, 2013, WHO CLASSIFICATION T, P30; He M, 2009, PATHOL RES PRACT, V205, P386, DOI 10.1016/j.prp.2008.12.009; Jour G, MOD PATHOL IN PRESS; Nishio J, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/524067; Segura-Sanchez J, 2006, ANTICANCER RES, V26, P4937; Takahira T, 2005, MODERN PATHOL, V18, P1461, DOI 10.1038/modpathol.3800447	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					345	350				6	Oncology	Oncology	AY7IY	WOS:000347735300043		
J	Otake, A; Yoshino, K; Ueda, Y; Sawada, K; Mabuchi, S; Kimura, T; Kobayashi, E; Isobe, A; Egawa-Takata, T; Matsuzaki, S; Fujita, M; Kimura, T				Otake, Akiko; Yoshino, Kiyoshi; Ueda, Yutaka; Sawada, Kenjiro; Mabuchi, Seiji; Kimura, Toshihiro; Kobayashi, Eiji; Isobe, Aki; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Fujita, Masami; Kimura, Tadashi			Usefulness of Duloxetine for Paclitaxel-Induced Peripheral Neuropathy Treatment in Gynecological Cancer Patients	ANTICANCER RESEARCH			English	Article						CIPN; neuropathy; duloxetine; paclitaxel; gynecologic cancer	ONCOLOGY-GROUP; DOUBLE-BLIND; CHEMOTHERAPY; MANAGEMENT; PREGABALIN; TRIAL; PAIN; AMITRIPTYLINE; PREVENTION; RECURRENT	Aim: The present study aimed at evaluating the usefulness and adverse effects of duloxetine treatment for paclitaxel-induced peripheral neuropathy in gynecological cancer patients. Patients and Methods: Medical records of gynecological cancer patients treated with duloxetine were retrospectively studied to evaluate the drug's efficacy for paclitaxel-induced peripheral neuropathy. Results: Results from 25 patients showed that an improved response was observed in 14 (56%). By univariate and multivariate analysis, the patient's age, tumor origin, regimen of chemotherapy, accumulated doses of paclitaxel or carboplatin, previous medication, maintenance dosage and timing of treatment with duloxetine were found not to be associated with the effectiveness of duloxetine treatment. Adverse effects with duloxetine were mild and well-tolerated. Conclusion: As an option, duloxetine can be effectively used for paclitaxel-induced peripheral neuropathy in patients with gynecological cancers, irrespective of patients' age, origin of the tumor, regimen of chemotherapy, or previous medication.	[Otake, Akiko; Yoshino, Kiyoshi; Ueda, Yutaka; Sawada, Kenjiro; Mabuchi, Seiji; Kimura, Toshihiro; Kobayashi, Eiji; Isobe, Aki; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Fujita, Masami] Nissay Hosp, Dept Obstet & Gynecol, Nishi Ku, Osaka, Japan	Yoshino, K (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yoshino@gyne.med.osaka-u.ac.jp					Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Barton DL, 2011, SUPPORT CARE CANCER, V19, P833, DOI 10.1007/s00520-010-0911-0; Yang YH, 2012, SUPPORT CARE CANCER, V20, P1491, DOI 10.1007/s00520-011-1237-2; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Rao RD, 2007, CANCER, V110, P2110, DOI 10.1002/cncr.23008; Pectasides D, 2007, CANCER TREAT REV, V33, P177, DOI 10.1016/j.ctrv.2006.10.007; Kautio AL, 2009, ANTICANCER RES, V29, P2601; Kautio AL, 2008, J PAIN SYMPTOM MANAG, V35, P31, DOI 10.1016/j.jpainsymman.2007.02.043; Takenaka M, 2013, AM J HOSP PALLIAT ME, V30, P734, DOI 10.1177/1049909112463416; Stubblefield MD, 2009, J NATL COMPR CANC NE, V7, pS1; Aziz MT, 2014, ANN PHARMACOTHER, V48, P626, DOI 10.1177/1060028014525033; Tesfaye S, 2013, PAIN, V154, P2616, DOI 10.1016/j.pain.2013.05.043; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Calhoun EA, 2003, INT J GYNECOL CANCER, V13, P741, DOI 10.1111/j.1525-1438.2003.13603.x; Esin E, 2014, ONCOTARGETS THER, V7, P599, DOI 10.2147/OTT.S60995; Johnston SS, 2013, AM J HEALTH-SYST PH, V70, P2207, DOI 10.2146/ajhp130088; Moore KN, 2007, GYNECOL ONCOL, V105, P299, DOI 10.1016/j.ygyno.2006.12.031; Trivedi JR, 2013, NEUROL CLIN, V31, P377, DOI 10.1016/j.ncl.2013.01.003	19	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					359	363				5	Oncology	Oncology	AY7IY	WOS:000347735300045		
J	Hirano, G; Makiyama, A; Makiyama, C; Esaki, T; Oda, H; Uchino, K; Komoda, M; Tanaka, R; Matsushita, Y; Mitsugi, K; Shibata, Y; Kumagai, H; Arita, S; Ariyama, H; Kusaba, H; Akashi, K; Baba, E				Hirano, Gen; Makiyama, Akitaka; Makiyama, Chinatsu; Esaki, Taito; Oda, Hisanobu; Uchino, Keita; Komoda, Masato; Tanaka, Risa; Matsushita, Yuzo; Mitsugi, Kenji; Shibata, Yoshihiro; Kumagai, Hozumi; Arita, Shuji; Ariyama, Hiroshi; Kusaba, Hitoshi; Akashi, Koichi; Baba, Eishi			Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan	ANTICANCER RESEARCH			English	Article						Regorafenib; metastatic colorectal cancer; chemotherapy; adverse events	PHASE-3 TRIAL; MULTICENTER	Background: Salvage-line regorafenib monotherapy exhibited a marked survival benefit for metastatic colorectal cancer (mCRC). However, the toxicity of this regimen has resulted in the clinical use of a reduced dose of regorafenib. Patients and Methods: Thirty-two Japanese mCRC patients (median age=61 years) who had been treated with regorafenib were retrospectively examined. Results: Best objective response rate was 0% and stable disease (SD) was 31%. Median progression-free survival was 81 days and median overall survival was 233 days. Adverse events of any grade were observed in all patients: 17 (53%) patients suffered grade 3 or 4 adverse events including fatigue (13%), anorexia (13%), hand-foot skin reaction (22%) and elevations of alanine aminotransferase/aspartate aminotransferase (19%/16%). One patient with grade 5 liver dysfunction was identified (3%). Twenty-nine (91%) patients required treatment dose reduction or a delay in treatment. The relative dose intensity was 59%. Regorafenib treatments were terminated because of disease progression (59%) or adverse events (34%). Conclusion: Despite a decrease in the intensity of regorafenib treatment, because of severe adverse events, a fairly favorable efficacy was achieved in Japanese patients.	[Hirano, Gen; Makiyama, Akitaka; Makiyama, Chinatsu] Kyushu Hosp, Japan Community Hlth Care Org, Dept Hematol & Oncol, Kitakyushu, Fukuoka, Japan; [Esaki, Taito; Oda, Hisanobu] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Uchino, Keita; Komoda, Masato] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Dept Med Oncol, Fukuoka, Japan; [Tanaka, Risa; Matsushita, Yuzo; Mitsugi, Kenji] Hamanomachi Hosp, Dept Oncol, Fukuoka, Japan; [Shibata, Yoshihiro] Miyazaki Prefectural Miyazaki Hosp, Dept Chemotherapy, Miyazaki, Japan; [Kumagai, Hozumi; Arita, Shuji; Ariyama, Hiroshi; Kusaba, Hitoshi; Akashi, Koichi] Kyushu Univ Hosp, Dept Hematol & Oncol, Fukuoka 812, Japan; [Arita, Shuji; Baba, Eishi] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 8128582, Japan	Baba, E (reprint author), Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	e-baba@c-oncology.med.kyushu-u.ac.jp					Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Sunakawa Y, 2014, INVEST NEW DRUG, V32, P104, DOI 10.1007/s10637-013-9953-8; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Cutsem E.V., 2010, ANN ONCOL, V21, P93; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Matsuda A, 2013, JPN J CLIN ONCOL, V44, P388; Yamada Y, 2013, ANN ONCOL S9, V24, pix31; Yamazaki K, 2014, J CLIN ONCOL S, V32, p5s	9	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					371	377				7	Oncology	Oncology	AY7IY	WOS:000347735300047		
J	Fujii, T; Nishimura, N; Urayama, KY; Kanai, H; Ishimaru, H; Kawano, J; Takahashi, O; Yamauchi, H; Yamauchi, T				Fujii, Takeo; Nishimura, Naoki; Urayama, Kevin Y.; Kanai, Hisako; Ishimaru, Hiromasa; Kawano, Junko; Takahashi, Osamu; Yamauchi, Hideko; Yamauchi, Teruo			Differential Impact of Fosaprepitant on Infusion Site Adverse Events Between Cisplatin- and Anthracycline-based Chemotherapy Regimens	ANTICANCER RESEARCH			English	Article						Fosaprepitant; anthracycline; cisplatin; infusion site adverse events	INDUCED NAUSEA; PHARMACOKINETIC PROPERTIES; CONTROLLED TRIAL; BREAST-CANCER; DOUBLE-BLIND; APREPITANT; PREVENTION; TOLERABILITY; EPIRUBICIN; ANTAGONIST	Background: Fosaprepitant may be associated with infusion site adverse events (AEs), and these adverse events possibly vary according to chemotherapy regimen. Patients and Methods: 267 oncology patients who were administered anthracycline- or cisplatin-based regimens were retrospectively studied. Multivariate logistic regression was performed in stratified analyses to evaluate potential regimen-specific effects of fosaprepitant. Results: 41.7% of patients administered fosaprepitant experienced infusion site AEs. On the other hand, only 10.9% of patients administered aprepitant experienced AEs. Multivariate analysis showed a statistically significant overall increased risk of infusion site reaction associated with fosaprepitant (p<0.001), but when evaluated separately according to chemotherapy regimen, this relationship appeared to be largely confined to patients receiving an anthracycline-based regimen (OR=12.95, 95%CI=5.74-29.20). No association was observed among patients on cisplatin-based regimens. A test for interaction was statistically significant (p=0.001). Conclusion: Fosaprepitant is associated with an elevated risk of infusion site reaction in patients receiving anthracyclines.	[Fujii, Takeo; Yamauchi, Teruo] St Lukes Int Hosp, Dept Internal Med, Div Med Oncol, Chuo City, Tokyo 1048560, Japan; [Fujii, Takeo; Nishimura, Naoki] St Lukes Int Hosp, Dept Internal Med, Div Pulm Med, Chuo City, Tokyo 1048560, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Divers, Tokyo, Japan; [Urayama, Kevin Y.; Takahashi, Osamu] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Kanai, Hisako] St Lukes Int Hosp, Breast Ctr, Ctr Oncol, Chuo City, Tokyo 1048560, Japan; [Ishimaru, Hiromasa] St Lukes Int Hosp, Dept Pharmacol, Chuo City, Tokyo 1048560, Japan; [Kawano, Junko; Yamauchi, Hideko] St Lukes Int Hosp, Dept Breast Surg, Chuo City, Tokyo 1048560, Japan	Nishimura, N (reprint author), St Lukes Int Hosp, Dept Internal Med, Div Pulm Med, 9-1 Akashi Cho, Chuo City, Tokyo 1048560, Japan.	nina@luke.ac.jp					Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Coukell AJ, 1997, DRUGS, V53, P453; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; Rapoport BL, 2010, SUPPORT CARE CANCER, V18, P423, DOI 10.1007/s00520-009-0680-9; PLOSKER GL, 1993, DRUGS, V45, P788; Herrstedt J, 2009, J CLIN ONCOL, V27, P5363, DOI 10.1200/JCO.2009.21.8511; Lasseter KC, 2007, J CLIN PHARMACOL, V47, P834, DOI 10.1177/0091270007301800; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; Warr DG, 2005, J CLIN ONCOL, V23, P2822; Cocquyt V, 2001, EUR J CANCER, V37, P835, DOI 10.1016/S0959-8049(00)00416-0; Olver Ian N, 2008, Ther Clin Risk Manag, V4, P501; Van Belle S, 2002, CANCER, V94, P3032, DOI 10.1002/cncr.10516	12	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					379	383				5	Oncology	Oncology	AY7IY	WOS:000347735300048		
J	Tsubata, Y; Sutani, A; Okimoto, T; Murakami, I; Usuda, R; Okumichi, T; Kakegawa, SI; Togashi, KI; Kosaka, S; Yamashita, Y; Kishimoto, K; Kuraki, T; Isobe, T				Tsubata, Yukari; Sutani, Akihisa; Okimoto, Tamio; Murakami, Isao; Usuda, Ryosuke; Okumichi, Tsuneo; Kakegawa, Sei-Ichi; Togashi, Ken-Ichi; Kosaka, Shinji; Yamashita, Yoshinori; Kishimoto, Koji; Kuraki, Takashige; Isobe, Takeshi			Comparative Analysis of Tumor Angiogenesis and Clinical Features of 55 Cases of Pleomorphic Carcinoma and Adenocarcinoma of the Lung	ANTICANCER RESEARCH			English	Article						Pleomorphic carcinoma; angiogenesis; immunohistochemistry; vascular endothelial growth factor; hypoxia-inducible factor-1 alpha	ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC IMPLICATIONS; FACTOR EXPRESSION; CELL CARCINOMA; CANCER; HYPOXIA; NEOVASCULARIZATION; SURVIVAL	Background/Aim: Pleomorphic carcinoma (PC) of the lung is a rare tumor that usually has an aggressive clinical course and a poor prognosis. Clinical and pathological features remain unclear. The aim of this study was to determine whether tumor angiogenesis of PC is up-regulated compared to that in adenocarcinoma (AD). Materials and Methods: We collected 55 cases of PC and AD in Which the patients had undergone either lung resection or autopsy and immunohistochemically examined the expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor (HIF)-1 alpha and microvessel density (MVD) in tissue specimens. Results: VEGF was expressed in many cases of both PC and AD with no significant differences between the groups. In contrast, the expression of HIF-1 alpha and MVD were significantly greater in PC than AD. Median survival time of the PC group was 14.7 months and significantly shorter than that of the AD group. Conclusion: MVD and expression of HIF-1 alpha are associated with angiogenesis in PC and confer a poorer prognosis. Tumor angiogenesis provides significant prognostic information regarding clinical outcome in patients with PC.	[Tsubata, Yukari; Sutani, Akihisa; Okimoto, Tamio; Kuraki, Takashige; Isobe, Takeshi] Shimane Univ, Fac Med, Dept Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane 6938501, Japan; [Kishimoto, Koji] Shimane Univ, Fac Med, Dept Thorac Surg, Izumo, Shimane 6938501, Japan; [Murakami, Isao] Higashi Hiroshima Med Ctr, Dept Resp Med, Hiroshima, Japan; [Usuda, Ryosuke] Showa Univ, Fujigaoka Hosp, Dept Thorac Surg, Yokohama, Kanagawa 227, Japan; [Okumichi, Tsuneo] Yoshijima Hosp, Dept Surg, Hiroshima, Japan; [Kakegawa, Sei-Ichi] Nishigunma Natl Hosp, Dept Thorac Surg, Gunma, Japan; [Togashi, Ken-Ichi] Japanese Red Cross Nagaoka Hosp, Dept Thorac Surg, Nagaoka, Niigata, Japan; [Kosaka, Shinji] Shimane Prefectural Cent Hosp, Dept Thorac Surg, Izumo, Shimane, Japan; [Yamashita, Yoshinori] Chugoku Canc Ctr, Kure Med Ctr, Dept Thorac Surg, Kure, Hiroshima, Japan	Isobe, T (reprint author), Shimane Univ, Fac Med, Dept Internal Med, Div Med Oncol & Resp Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	isobeti@med.shimane-u.ac.jp					Aikawa H, 1999, ANTICANCER RES, V19, P4305; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Hockel M, 2001, J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Yohena T, 2009, J THORAC ONCOL, V4, P284, DOI 10.1097/JTO.0b013e31819852d5; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Toi M, 1996, CANCER, V77, P1101, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1101::AID-CNCR15>3.0.CO;2-5; Mochizuki T, 2008, AM J SURG PATHOL, V32, P1727, DOI 10.1097/PAS.0b013e3181804302; SENGER DR, 1986, CANCER RES, V46, P5629; Eisma RJ, 1997, AM J SURG, V174, P513; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Rossi G, 2003, AM J SURG PATHOL, V27, P311, DOI 10.1097/00000478-200303000-00004; TRAVIS WD, 1995, CANCER, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; SAMOTO K, 1995, CANCER RES, V55, P1189; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Folkman J, 1995, NEW ENGL J MED, V333, P1757; FISHBACK NF, 1994, CANCER, V73, P2936, DOI 10.1002/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U; Folkman J, 1990, CANCER, V82, P4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Nakajima M, 1999, CANCER, V86, P608, DOI 10.1002/(SICI)1097-0142(19990815)86:4<608::AID-CNCR9>3.0.CO;2-1; Takahashi Y, 1997, ARCH SURG-CHICAGO, V132, P541; Toi M, 2001, LANCET ONCOL, V2, P667, DOI 10.1016/S1470-2045(01)00556-3; Tsubata Y, 2012, ANTICANCER RES, V32, P3331; YAMAZAKI K, 1994, CANCER, V74, P2245, DOI 10.1002/1097-0142(19941015)74:8<2245::AID-CNCR2820740807>3.0.CO;2-X; Yano T, 2000, EUR J CANCER, V36, P601, DOI 10.1016/S0959-8049(99)00327-5	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					389	394				6	Oncology	Oncology	AY7IY	WOS:000347735300050		
J	Ito, S; Oki, E; Nakashima, Y; Ando, K; Hiyoshi, Y; Ohgaki, K; Saeki, H; Morita, M; Sakaguchi, Y; Maehara, Y				Ito, Shuhei; Oki, Eiji; Nakashima, Yuichiro; Ando, Koji; Hiyoshi, Yukiharu; Ohgaki, Kippei; Saeki, Hiroshi; Morita, Masaru; Sakaguchi, Yoshihisa; Maehara, Yoshihiko			Clinical Significance of Adjuvant Surgery Following Chemotherapy for Patients with Initially Unresectable Stage IV Gastric Cancer	ANTICANCER RESEARCH			English	Article						Gastric cancer; adjuvant surgery; non-curative clinical factor; peritoneal dissemination	RANDOMIZED CONTROLLED-TRIAL; S-1 PLUS CISPLATIN; PHASE-II; GASTRECTOMY; CARCINOMA; MORBIDITY; MORTALITY; D2	Background: More effective treatment is necessary to improve the poor prognosis for patients with unresectable gastric cancer. We investigated the efficacy and feasibility of adjuvant surgery following chemotherapy. Patients and Methods: Records of 70 patients with unresectable stage IV gastric cancer who underwent induction chemotherapy were reviewed retrospectively. Patients who developed an absence of non-curative clinical factors during chemotherapy underwent gastrectomy [adjuvant surgery (AS) group]; the others continued chemotherapy [non-AS group]. Results: Non-AS and AS groups contained 56 (80%) and 14 (20%) patients, respectively. In the AS group, 92.9% of patients had one non-curative clinical factor, while 482% of patients in the non-AS group had two or more non-curative clinical factors (p=0.0386). In the AS group, operative outcomes, including the postoperative complication rate (21.4%), were acceptable. The 3-year overall survival rate in the AS group was 65.6% versus 7.7% in the non-AS group (p<0.0001). In patients with one non-curative clinical factor of peritoneal dissemination, the median survival of the AS group was 29.5 months versus 11.4 months in the non-AS group (p=0.0230). Conclusion: Adjuvant surgery for initially unresectable stage IV gastric cancer was safe and feasible, and may improve the prognosis for patients with one non-curative clinical factor, such as peritoneal dissemination.	[Ito, Shuhei; Oki, Eiji; Nakashima, Yuichiro; Ando, Koji; Hiyoshi, Yukiharu; Ohgaki, Kippei; Saeki, Hiroshi; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Sakaguchi, Yoshihisa] Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Sakaguchi, Yoshihisa] Natl Kyushu Med Ctr, Clin Canc Res Inst, Fukuoka, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp					Inoue K, 2012, EJSO-EUR J SURG ONC, V38, P143, DOI 10.1016/j.ejso.2011.11.009; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Satoh S, 2012, GASTRIC CANCER, V15, P61, DOI 10.1007/s10120-011-0066-9; [Anonymous], 2011, GASTRIC CANC, V14, P101; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Biondi A, 2010, WORLD J GASTROENTERO, V16, P3358, DOI 10.3748/wjg.v16.i27.3358; Schmidt B, 2013, ANN SURG ONCOL, V20, P3512, DOI 10.1245/s10434-013-3024-4; PYRHONEN S, 1995, BRIT J CANCER, V71, P587, DOI 10.1038/bjc.1995.114; Oki E, 2014, ANN SURG ONCOL, V21, P2340, DOI 10.1245/s10434-014-3594-9; Suzuki T, 2010, ONCOL LETT, V1, P743, DOI 10.3892/ol_00000130; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Fearon KC, 2013, BRIT J SURG, V100, P15, DOI 10.1002/bjs.8988; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Fujiwara Y, 2011, ANN SURG ONCOL, V18, P3726, DOI 10.1245/s10434-011-1770-8; Hannaman MJ, 2013, MED CLIN N AM, V97, P1139, DOI 10.1016/j.mcna.2013.06.002; Kunisaki C, 2006, J AM COLL SURGEONS, V202, P223, DOI 10.1016/j.jamcollsurg.2005.10.020; Maruyama K, 2006, GASTRIC CANCER, V9, P51, DOI DOI 10.1007/S10120-006-0370-Y; Power DG, 2011, CRIT REV ONCOL HEMAT, V79, P251, DOI 10.1016/j.critrevonc.2010.08.001; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Tseng WH, 2011, ANN SURG, V254, P333, DOI 10.1097/SLA.0b013e31822513ed; TSUTSUI S, 1992, J SURG ONCOL, V49, P176, DOI 10.1002/jso.2930490310; Yamamoto M, 2013, ONCOLOGY-BASEL, V85, P241, DOI 10.1159/000354420	26	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					401	406				6	Oncology	Oncology	AY7IY	WOS:000347735300052		
J	Ito, S; Morita, M; Nanbara, S; Nakaji, Y; Ando, K; Hiyoshi, Y; Okamoto, T; Saeki, H; Oki, E; Kawanaka, H; Tanoue, Y; Maehara, Y				Ito, Shuhei; Morita, Masaru; Nanbara, Sho; Nakaji, Yu; Ando, Koji; Hiyoshi, Yukiharu; Okamoto, Tatsuro; Saeki, Hiroshi; Oki, Eiji; Kawanaka, Hirofumi; Tanoue, Yoshihisa; Maehara, Yoshihiko			Cardiac Tamponade Due to Bleeding as a Potential Lethal Complication After Surgery for Esophageal Cancer	ANTICANCER RESEARCH			English	Article						Cardiac tamponade; esophageal cancer; postoperative complication	EXTRAPERICARDIAL TAMPONADE; DIAGNOSIS	Background: Cardiac tamponade, due to bleeding in the pericardial space after esophagectomy for esophageal cancer, is an extremely rare complication and may be associated with sudden hemodynamic instability that can lead to death unless there is prompt diagnosis and appropriate treatment. Case Report: A 76-year-old man underwent subtotal esophagectomy via a cervico-right thoracoabdominal approach and reconstruction with a gastric tube through the retrosternal route. On postoperative day 4, the patient developed hypotension due to cardiac tamponade caused by bleeding into the pericardial space and he had a decreased level of consciousness. Pericardial resection and open drainage via a minimal left anterior thoracotomy was performed that resulted in hemodynamic improvement followed by an uneventful recovery. Conclusion: Cardiac tamponade due to postoperative bleeding, which is a rare but life-threatening complication, should be considered as a cause of hemodynamic instability in the early postoperative period after esophagectomy.	[Ito, Shuhei; Morita, Masaru; Nanbara, Sho; Nakaji, Yu; Ando, Koji; Hiyoshi, Yukiharu; Okamoto, Tatsuro; Saeki, Hiroshi; Oki, Eiji; Kawanaka, Hirofumi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Tanoue, Yoshihisa] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Fukuoka 8128582, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp					Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Khandaker MH, 2010, MAYO CLIN PROC, V85, P572, DOI 10.4065/mcp.2010.0046; Kuvin JT, 2002, ANN THORAC SURG, V74, P1148, DOI 10.1016/S0003-4975(02)03837-7; Canivet J L, 2004, Acta Anaesthesiol Belg, V55, P125; Celik S, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-123; Cherian V, 2001, J Postgrad Med, V47, P185; GRANKE K, 1990, J SURG ONCOL, V44, P273, DOI 10.1002/jso.2930440416; Kariya N, 2001, ANAESTH INTENS CARE, V29, P634; Kats Suzanne, 2007, Interact Cardiovasc Thorac Surg, V6, P238; Kitamura M, 1989, Nihon Kyobu Geka Gakkai Zasshi, V37, P17; Levitt MA, 1998, J CARDIOVASC SURG, V39, P245; Mizuguchi Yoshiaki, 2005, J Anesth, V19, P249, DOI 10.1007/s00540-005-0326-0; Morita M, 2011, ANN SURG ONCOL, V18, P1757, DOI 10.1245/s10434-010-1502-5; REDDY PS, 1978, CIRCULATION, V58, P265; Stewart Duncan, 2009, Interact Cardiovasc Thorac Surg, V8, P176, DOI 10.1510/icvts.2008.190561; Thangathurai D, 2005, EUR J ANAESTH, V22, P555, DOI 10.1017/S0265021505240942; Watanabe Masayuki, 2013, Fukuoka Acta Medica, V104, P389	17	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					407	411				5	Oncology	Oncology	AY7IY	WOS:000347735300053		
J	Nishida, S; Hirohashi, Y; Torigoe, T; Nojima, M; Inoue, R; Kitamura, H; Tanaka, T; Asanuma, H; Sato, N; Masumori, N				Nishida, Sachiyo; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Nojima, Masanori; Inoue, Ryuta; Kitamura, Hiroshi; Tanaka, Toshiaki; Asanuma, Hiroko; Sato, Noriyuki; Masumori, Naoya			Expression of Hepatocyte Growth Factor in Prostate Cancer May Indicate a Biochemical Recurrence After Radical Prostatectomy	ANTICANCER RESEARCH			English	Article						Cancer stem cell; hepatocyte growth factor; prostate cancer; prostatectomy; recurrence	C-MET; SIGNALING PATHWAY; INITIATING CELLS; SCATTER FACTOR; RECEPTOR	We previously found that prostate cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) express hepatocyte growth factor (HGF) and that the HGF/c-MET proto-oncogene product (c-MET) signal has a role in the maintenance of prostate CSCs/CICs in an autocrine fashion. HGF is, thus, a novel marker for prostate CSCs/CICs. We hypothesized that high expression of HGF might be related to early recurrence of prostate cancer after radical prostatectomy, and the purpose of the present study was to evaluate the relationship between expression of HGF in prostate tissues and biochemical recurrence after radical prostatectomy. One hundred-one patients with prostate cancer who underwent open or laparoscopic radical prostatectomy from November 2008 to October 2011 with an adequate prostate-specific antigen (PSA) follow-up period, were investigated. Immunohistochemical staining of HGF was compared to biochemical recurrence after radical prostatectomy. Patients with tumors exhibiting HGF positivity of 5% or more had a significantly shorter biochemical recurrence-free period than that of patients whose tumor HGF positivity was less than 5% (p=0.001). In multivariate Cox regression, preoperative PSA and HGF positivity were independent predictors of biochemical recurrence following prostatectomy. Our finding suggests a direct link between expression of HGF, a novel prostate marker of CSCs/CICs, and biochemical recurrence after radical prostatectomy in patients with prostate cancer.	[Nishida, Sachiyo; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Inoue, Ryuta; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Nishida, Sachiyo; Inoue, Ryuta; Kitamura, Hiroshi; Tanaka, Toshiaki; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Asanuma, Hiroko] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Adv Med Promot, Tokyo, Japan	Hirohashi, Y (reprint author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	hirohash@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [16209013, 17016061, 15659097, 24592399, 221S0001-5]; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan [15-17, 19-14]; Ono Cancer Research Fund; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; suharakinennzaidann Co., Ltd.; National Cancer Center Research and Development Fund [23-A-44]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant Nos. 16209013, 17016061, 15659097, 24592399, 221S0001-5) for Practical Application Research from the Japan Science and Technology Agency, and for Cancer Research (15-17 and 19-14) from the Ministry of Health, Labor and Welfare of Japan, Ono Cancer Research Fund (to N. S.) and Takeda Science Foundation (to Y. H.) Sagawa Foundation for Promotion of Cancer Research (to Y.H.) and suharakinennzaidann Co., Ltd. (to Y.H.). This work was supported in part by the National Cancer Center Research and Development Fund (23-A-44).	Ryan CJ, 2013, CLIN CANCER RES, V19, P215, DOI 10.1158/1078-0432.CCR-12-2605; Knudsen BS, 2004, ADV CANCER RES, V91, P31, DOI 10.1016/S0065-230X(04)91002-0; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Nishida S, 2013, CANCER SCI, V104, P431, DOI 10.1111/cas.12104; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Punnen S, 2013, EUR UROL, V64, P905, DOI 10.1016/j.eururo.2013.05.025; Edge SB, 2010, AJCC CANC STAGING MA; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI [10.2217/imt.10.10, 10.2217/IMT.10.10]; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Kasai S, 1996, BIOCHEM BIOPH RES CO, V228, P646, DOI 10.1006/bbrc.1996.1710; Kitamura H, 2013, MODERN PATHOL, V26, P117, DOI 10.1038/modpathol.2012.139; Naughton M, 2001, J UROLOGY, V165, P1325, DOI 10.1016/S0022-5347(01)69893-8; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; van Leenders GJLH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026753	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					413	418				6	Oncology	Oncology	AY7IY	WOS:000347735300054		
J	Hosoda, K; Yamashita, K; Katada, N; Moriya, H; Mieno, H; Sakuramoto, S; Kikuchi, S; Watanabe, M				Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Sakuramoto, Shinichi; Kikuchi, Shiro; Watanabe, Masahiko			Benefit of Neoadjuvant Chemotherapy for Siewert Type II Esophagogastric Junction Adenocarcinoma	ANTICANCER RESEARCH			English	Article						Siewert type II adenocarcinoma; neoadjuvant chemotherapy; DCS regimen	RANDOMIZED CONTROLLED-TRIAL; LYMPH-NODE DISSECTION; GASTRIC-CANCER; PERIOPERATIVE CHEMOTHERAPY; GASTROESOPHAGEAL JUNCTION; ADJUVANT CHEMOTHERAPY; ESOPHAGEAL; SURGERY; TRANSFUSION; CARDIA	Aim: Our objective was to clarify if preoperative chemotherapy was associated with improved survival in Japanese patients with Siewert type II adenocarcinoma of the esophagogastric junction. Patients and Methods: We retrospectively reviewed the medical records of 86 patients with Siewert type II adenocarcinoma who underwent RO resection at the Kitasato University between 1997 and 2013. Cox regression analysis using a backward stepwise selection method was performed to identify independent prognostic factors for relapse-free survival (RFS). Results: The median age was 67 years. The male:female ratio was 74:12. Right thoracic, left thoracic and transhiatal approaches were performed in 10, 10 and 66 patients, respectively, and perioperative transfusion in 16 patients. Preoperative chemotherapy was administered to 19 patients; out of these, 13 received chemotherapy using the DCS regimen (docetaxel 40 mg/m(2), day 1; cisplatin 60 mg/m(2), day 1; S-1 80-120 mg/body, days 1-14; every 28 days). A median of three cycles of preoperative DCS chemotherapy were used. Histological responses of 1b, 2, 3 and unknown grades were obtained in three, three, four and three patients, respectively. The 5-year RFS rate was 55%, and the median follow-up period was 36 months. Cox regression analysis regarding RFS identified (y)pN1-3 [hazard ratio (HR)=4.44; 95% confidence interval (CI)=1.98-11.27], performance of perioperative transfusion (HR=4.71; 95% CI=1.69-11.88) and no preoperative chemotherapy (HR=3.75; 95% CI=1.22-14 26) as significant and independent indicators of poor prognosis. Conclusion: Preoperative chemotherapy using DCS is potentially beneficial for Japanese patients with Siewert type II adenocarcinoma. Further prospective clinical studies are required to confirm our findings.	[Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Sakuramoto, Shinichi] Saitama Med Univ, Int Med Ctr, Dept Gastrointestinal Surg, Saitama, Japan	Hosoda, K (reprint author), Kitasato Univ, Dept Surg, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	k.hosoda@kitasato-u.ac.jp					Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Blaser MJ, 2002, EUR J GASTROEN HEPAT, V14, P107, DOI 10.1097/00042737-200202000-00003; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Yamashita K, 2011, WORLD J GASTROENTERO, V17, P3390, DOI 10.3748/wjg.v17.i29.3390; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Lange MM, 2009, BRIT J SURG, V96, P734, DOI 10.1002/bjs.6636; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Fujitani K, 2013, GASTRIC CANCER, V16, P301, DOI 10.1007/s10120-012-0183-0; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Rudiger Siewert J, 2000, ANN SURG, V232, P353; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin LH, 2010, TNM CLASSIFICATION M; van Hilten JA, 2004, BRIT MED J, V328, P1281, DOI 10.1136/bmj.38103.735266.55; Weitz J, 2003, J CLIN ONCOL, V21, P4597, DOI 10.1200/JCO.2003.12.136	25	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					419	425				7	Oncology	Oncology	AY7IY	WOS:000347735300055		
J	Morishige, M; Muramatsu, K; Tominaga, Y; Hashimoto, T; Taguchi, T				Morishige, Masashi; Muramatsu, Keiichi; Tominaga, Yasuhiro; Hashimoto, Takahiro; Taguchi, Toshihiko			Surgical Treatment of Metastatic Femoral Fractures: Achieving an Improved Quality of Life for Cancer Patients	ANTICANCER RESEARCH			English	Article						Femur; metastasis; intramedullary nailing; polymethylmethacrylate; physical status; prognosis	LONG GAMMA-NAIL; BONE METASTASES; PROXIMAL FEMUR; ENDOPROSTHETIC REPLACEMENT; SCORING SYSTEM; LESIONS; RECONSTRUCTION; CARCINOMA	Background: The femur is the most common long bone affected by metastatic carcinoma. We report our experience regarding treatment of metastatic femoral fracture using femoral head prosthesis (FHP) or intramedullary nailing (IM nail) with augmentation by polymethylmethacrylate (PMMA). Patients and Methods: Thirty-five complete fractures in 33 patients were treated surgically. Metastatic lesions were present in the femoral head to neck region (n=9), trochanteric to shaft region (n=23) and supracondular region (n=3). Results: Eight out of 9 patients with proximal femoral metastasis reconstructed by FHP were later able to walk outdoors. For the 11 patients with trochanteric metastasis, the short type of gamma nail was used for bony fixation. In two patients the inserted IM nails were broken. All other cases showed excellent clinical outcomes. For the 12 patients with femoral shaft metastasis, the long type of gamma nail was inserted. Nine cases showed excellent clinical outcomes without any serious complications. Conclusion: FHP is indicated for metastases in the femoral head to neck region. IM nailing is best indicated when the lesion is located in the proximal to mid shaft and the patient's life expectancy is <6 month.	[Morishige, Masashi; Muramatsu, Keiichi; Tominaga, Yasuhiro; Hashimoto, Takahiro; Taguchi, Toshihiko] Yamaguchi Univ, Sch Med, Dept Orthoped Surg, Ube, Yamaguchi 7558505, Japan	Muramatsu, K (reprint author), Yamaguchi Univ, Sch Med, Dept Orthoped Surg, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	muramatu@yamaguchi-u.ac.jp					Chandrasekar CR, 2009, J BONE JOINT SURG BR, V91B, P108, DOI 10.1302/0301-620X.91B1.20448; Nilsson J, 2008, INJURY, V39, P404, DOI 10.1016/j.injury.2007.07.006; Wedin R, 2005, J BONE JOINT SURG BR, V87B, P1653, DOI 10.1302/0301-620X.87B12.16629; Katagiri H, 2005, J BONE JOINT SURG BR, V87B, P698, DOI 10.1302/0301-620X.87B5.15185; Edwards SA, 2001, INJURY, V32, P299, DOI 10.1016/S0020-1383(00)00218-7; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Capanna R, 2001, J BONE JOINT SURG BR, V83B, P471, DOI 10.1302/0301-620X.83B4.12202; Giannoudis PV, 1999, ACTA ORTHOP SCAND, V70, P29, DOI 10.3109/17453679909000953; Potter BK, 2009, SURG ONCOL, V18, P343, DOI 10.1016/j.suronc.2008.08.007; Assal M, 2000, J ORTHOP TRAUMA, V14, P394, DOI 10.1097/00005131-200008000-00003; Camnasio F, 2008, ARCH ORTHOP TRAUM SU, V128, P787, DOI 10.1007/s00402-007-0464-y; Hwang N, 2014, EJSO-EUR J SURG ONC, V40, P429, DOI 10.1016/j.ejso.2013.08.001; Leddy LR, 2010, INJURY S2, V41, P48; MIRELS H, 1989, CLIN ORTHOP RELAT R, P256; Moholkar Kirti, 2004, Acta Orthop Belg, V70, P429; Mundy GR, 1998, NEW ENGL J MED, V339, P398, DOI 10.1056/NEJM199808063390609; Ogura K, 2012, INT J CLIN ONCOL, V17, P417, DOI 10.1007/s10147-011-0319-y; Rosa 11 MA, 2002, J ORTHOP TRAUMATOL, V2, P87, DOI 10.1007/s101950200004; Roughage VB, 2000, ORTHOP CLIN N AM, V31, P567; Samsani SR, 2004, EJSO, V30, P993, DOI 10.1016/j.ejso.2004.07.015; Schulte M, 1998, ANTICANCER RES, V18, P2251; Talbot Max, 2005, Clin Orthop Relat Res, V438, P215; van Doorn R, 2000, EUR J SURG, V166, P247	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					427	432				6	Oncology	Oncology	AY7IY	WOS:000347735300056		
J	Hosoda, K; Yamashita, K; Katada, N; Moriya, H; Mieno, H; Sakuramoto, S; Kikuchi, S; Watanabe, M				Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Sakuramoto, Shinichi; Kikuchi, Shiro; Watanabe, Masahiko			Impact of Lower Mediastinal Lymphadenectomy for the Treatment of Esophagogastric Junction Carcinoma	ANTICANCER RESEARCH			English	Article						Esophagogastric junction; lymph node excision; neoplasms; surgery; prognosis	LYMPH-NODE DISSECTION; MINIMALLY INVASIVE ESOPHAGECTOMY; LIMITED TRANSHIATAL RESECTION; RANDOMIZED CONTROLLED-TRIAL; GASTRIC-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; GASTROESOPHAGEAL JUNCTION; SURGICAL COMPLICATIONS; ADENOCARCINOMA	Aim: To define the optimal extent of resection for esophagogastric junction (EGJ) carcinoma. Patients and Methods: We retrospectively reviewed medical records of 193 patients with EGJ adenocarcinoma or squamous cell carcinoma who underwent surgery at the Kitasato University. An index was calculated to evaluate the therapeutic value of lymphadenectomy. Results: The following factors were identified as independent predictors of poor survival: (y)pT3-4, (y)pN3, ly2-3, no performance of splenectomy and R1-2. Although metastases were found in mediastinal lymph-nodes in patients with esophageal invasion of <= 30 mm, the index was 0 for all mediastinal lymph-nodes. By contrast, in patients with esophageal invasion of >30 mm, the index was 13.9 for the No. 110 nodes, which was the second highest after the index for the No. 1 nodes. Conclusion: In EGJ cancer patients with esophageal invasion of >30 mm, aggressive lower mediastinal lymphadenectomy with RO resection is required to obtain the best result.	[Hosoda, Kei; Yamashita, Keishi; Katada, Natsuya; Moriya, Hiromitsu; Mieno, Hiroaki; Sakuramoto, Shinichi; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Hosoda, K (reprint author), Kitasato Univ, Dept Surg, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	k.hosoda@kitasato-u.ac.jp					Altorki N, 2002, ANN SURG, V236, P177, DOI 10.1097/01.SLA.0000021583.51164.F4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Kakeji Y, 2012, SURG TODAY, V42, P351, DOI 10.1007/s00595-011-0114-4; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Butler N, 2011, SURG ENDOSC, V25, P2071, DOI 10.1007/s00464-010-1511-2; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Nagpal K, 2010, SURG ENDOSC, V24, P1621, DOI 10.1007/s00464-009-0822-7; Sgourakis G, 2010, DIGEST DIS SCI, V55, P3031, DOI 10.1007/s10620-010-1153-1; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Yamashita K, 2011, WORLD J GASTROENTERO, V17, P3390, DOI 10.3748/wjg.v17.i29.3390; Altorki NK, 2008, ANN SURG, V248, P221, DOI 10.1097/SLA.0b013e31817bbe59; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Oppedijk V, 2014, J CLIN ONCOL, V32, P385, DOI 10.1200/JCO.2013.51.2186; Ancona E, 2008, ANN SURG ONCOL, V15, P3278, DOI 10.1245/s10434-008-0065-1; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Sepesi B, 2010, J AM COLL SURGEONS, V210, P418, DOI 10.1016/j.jamcollsurg.2010.01.003; Mamidanna R, 2012, ANN SURG, V255, P197, DOI 10.1097/SLA.0b013e31823e39fa; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Hirai Toshihiro, 2005, Ann Thorac Cardiovasc Surg, V11, P4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kauppi J, 2013, ANN SURG ONCOL, V20, P2428, DOI 10.1245/s10434-013-2866-0; Rudiger Siewert J, 2000, ANN SURG, V232, P353; Takeuchi H, 2014, ANN SURG; The Japan Esophageal Society, 2008, JAP CLASS ES CANC; UICC International Union Against Cancer, 2009, TNM CLASSIFICATION M; Weitz J, 2003, J CLIN ONCOL, V21, P4597, DOI 10.1200/JCO.2003.12.136	36	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					445	456				12	Oncology	Oncology	AY7IY	WOS:000347735300059		
J	Takahashi, T; Saikawa, Y; Fukuda, K; Nakamura, R; Wada, N; Kawakubo, H; Takeuchi, H; Takaishi, H; Icitagawa, Y				Takahashi, Tsunehiro; Saikawa, Yoshiro; Fukuda, Kazumasa; Nakamura, Rieko; Wada, Norihito; Kawakubo, Hirofumi; Takeuchi, Hiroya; Takaishi, Hiromasa; Icitagawa, Yuko			Phase I Study of S-1 plus Fractional Cisplatin as Adjuvant Chemotherapy for Advanced Gastric Cancer in an Outpatient Setting (KOGC-03)	ANTICANCER RESEARCH			English	Article						Gastric cancer; adjuvant chemotherapy; outpatient setting; S-1; cisplatin	LOW-DOSE CISPLATIN; COMBINATION CHEMOTHERAPY; 5-FLUOROURACIL; TRIAL; ADENOCARCINOMA; FEASIBILITY; DISSECTION; SURGERY	Aim: The aim of this phase I study was to adjust the dose of cisplatin as adjuvant combination chemotherapy with S-1 in an outpatient setting for gastric cancer. Patients and Methods: The first course was initiated with S-1 monotherapy on days 1-28. From the second to the sixth course, S-1 was administered on days 1-28 and cisplatin was added on days 1, 15, and 29. The dose level of cisplatin was escalated as follows: 20 mg/m(2) (level I); 25 mg/m(2) (level 2); 30 mg/m(2) (level.3). Dose-limiting toxicity was a delay factor of the start of the next course due to incomplete recovery. Results: The maximum tolerated and recommended doses were confirmed as level 3 and level 2, respectively. Conclusion: Although further clinical trials are recommended to evaluate efficacy, this combination of S-1 plus cisplatin regimen is expected to become a standard adjuvant treatment for gastric cancer in the outpatient setting.	[Takahashi, Tsunehiro; Takaishi, Hiromasa] Keio Univ Hosp, Keio Canc Ctr, Shinjuku Ku, Tokyo 1608582, Japan; [Saikawa, Yoshiro; Fukuda, Kazumasa; Nakamura, Rieko; Wada, Norihito; Kawakubo, Hirofumi; Takeuchi, Hiroya; Icitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Takahashi, T (reprint author), Keio Univ Hosp, Keio Canc Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsunehiro-t@a8.keio.jp					Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Takahari D, 2011, CANCER CHEMOTH PHARM, V67, P1423, DOI 10.1007/s00280-010-1432-8; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P456; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Chung YS, 1997, CANCER, V80, P1; DENTINO M, 1978, CANCER, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO;2-F; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim R, 1999, INT J ONCOL, V15, P921; Kondo K, 1996, ONCOLOGY, V53, P64; National Cancer Institute, CANC THER EV PROGR C; RODER JD, 1993, CANCER-AM CANCER SOC, V72, P2089, DOI 10.1002/1097-0142(19931001)72:7<2089::AID-CNCR2820720706>3.0.CO;2-H; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Takahashi T, 2010, ANTICANCER RES, V30, P3759; Takahashi T, 2006, ANTICANCER RES, V26, P1631	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					467	471				5	Oncology	Oncology	AY7IY	WOS:000347735300062		
J	Hayashi, K; Yamada, S; Inatani, H; Okamoto, H; Takeuchi, A; Nishida, H; Yamamoto, N; Tsuchiya, H; Otsuka, T				Hayashi, Katsuhiro; Yamada, Satoshi; Inatani, Hiroyuki; Okamoto, Hideki; Takeuchi, Akihiko; Nishida, Hideji; Yamamoto, Norio; Tsuchiya, Hiroyuki; Otsuka, Takanobu			Salvage Method for Unplanned Excision of Soft Tissue Sarcoma: Long-term Results of Second-look Surgery Following Radio-hyperthermo-chemotherapy	ANTICANCER RESEARCH			English	Article						Soft tissue sarcoma; hyperthermotherapy; unplanned excision; chemotherapy; surgery	PREOPERATIVE CHEMOTHERAPY; COLORECTAL-CANCER; APOPTOSIS; SYSTEM; CELLS	We have established a "second-look operation" protocol that consists of whole biopsy of surgical scar tissue following radio-hyperthermo-chemotherapy (RHC) after unplanned excision of soft tissue sarcoma. Out of 30 patients who underwent RHC for soft tissue sarcoma at our Institution, 6 were enrolled into this study to undergo a second-look operation for unplanned excision. Radiotherapy was given to a total dose of 32 Gy. Hyperthermia was conducted once a week, for a total of five sessions. Chemotherapy was performed at weekly intervals. Surgery was performed to excise the scar tissue that was enhanced on preoperative MRI. In all six cases, no residual tumors were identified in resected scar tissue; thus, no additional wide excision was performed. The average follow-up period was 10.9 years. There were no local recurrences, and all patients were alive at their final follow-up. Long-term follow-up confirmed that RHC can replace additional wide excision for unplanned excision of soft tissue sarcoma.	[Hayashi, Katsuhiro; Yamada, Satoshi; Inatani, Hiroyuki; Okamoto, Hideki; Otsuka, Takanobu] Nagoya City Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 467, Japan; [Hayashi, Katsuhiro; Inatani, Hiroyuki; Takeuchi, Akihiko; Nishida, Hideji; Yamamoto, Norio; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan	Hayashi, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan.	hayashikatsu830@aol.com	hayashi, katsuhiro/C-4685-2015				ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Qureshi YA, 2012, ANN SURG ONCOL, V19, P871, DOI 10.1245/s10434-011-1876-z; Canter RJ, 2013, J SURG ONCOL, V108, P142, DOI 10.1002/jso.23372; Dell' Anna T, 2012, BRIT J CANCER, V107, P785, DOI 10.1038/bjc.2012.336; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; GILBERTSEN VA, 1962, SURG GYNECOL OBSTET, V114, P438; KAWAGUCHI N, 2004, CLIN ORTHOP RELA FEB, P165, DOI DOI 10.1097/01.BLO.0000116308.86761.F5; Matsubara T, 2008, HISTOPATHOLOGY, V52, P706, DOI 10.1111/j.1365-2559.2008.03015.x; Meric F, 2002, CANCER, V95, P1120, DOI 10.1002/cncr.10794; MINTON JP, 1985, CANCER, V55, P1284, DOI 10.1002/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO;2-B; Mochizuki K, 2012, J ORTHOP SCI, V17, P339, DOI 10.1007/s00776-012-0242-8; Otsuka Takanobu, 2001, International Journal of Clinical Oncology, V6, P253, DOI 10.1007/PL00012114; PEZZI CM, 1990, ANN SURG, V211, P476, DOI 10.1097/00000658-199004000-00015; PFLEIDERER A, 1980, MUNCHEN MED WOCHEN, V122, P655; Pisters PWT, 1997, J CLIN ONCOL, V15, P3481; STEELE G, 1980, AM J SURG, V139, P544, DOI 10.1016/0002-9610(80)90335-9; Sugarbaker PH, 2011, INT J SURG ONCOL, V2011; Yonezawa M, 1996, INT J CANCER, V66, P347; Yonezawa Masato, 2002, J Orthop Sci, V7, P117, DOI 10.1007/s776-002-8432-4	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					493	498				6	Oncology	Oncology	AY7IY	WOS:000347735300066		
J	Fujiwara, Y; Shiba, H; Shirai, Y; Iwase, R; Haruki, K; Furukawa, K; Futagawa, Y; Misawa, T; Yanaga, K				Fujiwara, Yuki; Shiba, Hiroaki; Shirai, Yoshihiro; Iwase, Ryota; Haruki, Koichiro; Furukawa, Kenei; Futagawa, Yasuro; Misawa, Takeyuki; Yanaga, Katsuhiko			Perioperative Serum Albumin Correlates with Postoperative Pancreatic Fistula After Pancreaticoduodenectomy	ANTICANCER RESEARCH			English	Article						Postoperative pancreatic fistula; pancreaticoduodenectomy; postoperative serum albumin	PROSPECTIVE-RANDOMIZED-TRIAL; BODY CELL MASS; HEAD RESECTION; INFLAMMATORY RESPONSE; CANCER-PATIENTS; RISK-FACTORS; COMPLICATIONS; DRAINAGE; REMOVAL	Objectives: Despite improvements in surgical techniques, instruments and perioperative management, postoperative pancreatic fistula (POPF) remains a serious complication after pancreaticoduodenectomy. The aim of the present study was to characterize a high-risk group for POPF after pancreaticoduodenectomy using perioperative clinical variables of patients. Patients and Methods: This retrospective study comprised of 247 patients who had undergone pancreaticoduodenectomy between May 2000 and May 2013. Perioperative risk factors pertinent to development of POPF were investigated using univariate and multivariate analyses. Results: POPF developed in 43 out of 247 patients (17.4 %). In univariate analysis, male gender (p=0.005), higher postoperative serum amylase (p=0.025) and lower postoperative serum albumin (p=0.041) were significant risk factors for POPF. In multivariate analysis, male gender (p=0.008) and lower postoperative serum albumin (p=0.010) were found to be independent risk factors. Conclusion: Male gender and postoperative lower serum albumin were associated with the development of POPF after pancreaticoduodenectomy.	[Fujiwara, Yuki; Shiba, Hiroaki; Shirai, Yoshihiro; Iwase, Ryota; Haruki, Koichiro; Furukawa, Kenei; Futagawa, Yasuro; Misawa, Takeyuki; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan	Fujiwara, Y (reprint author), Jikei Univ, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	sheetan@jikei.ac.jp					Aldameh A, 2005, J GASTROINTEST SURG, V9, P667, DOI 10.1016/j.gassur.2004.12.006; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Pratt WB, 2008, WORLD J SURG, V32, P419, DOI 10.1007/s00268-007-9388-5; Winter JM, 2007, J AM COLL SURGEONS, V204, P1029, DOI 10.1016/j.jamcollsurg.2007.01.026; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Bassi C, 2010, ANN SURG, V252, P207, DOI 10.1097/SLA.0b013e3181e61e88; Adam U, 2004, AM J SURG, V187, P201, DOI 10.1016/j.amhsurg.2003.11.004; Kawai M, 2006, ANN SURG, V244, P1, DOI 10.1097/01.sla.0000218077.14035.a6; Poon RTP, 2007, ANN SURG, V246, P425, DOI 10.1097/SLA.0b013e3181492c28; Ryan AM, 2007, J GASTROINTEST SURG, V11, P1355, DOI 10.1007/s11605-007-0223-y; Balcom JH, 2001, ARCH SURG-CHICAGO, V136, P391, DOI 10.1001/archsurg.136.4.391; Biichler MW, 2003, ARCH SURG-CHICAGO, V138, P1310; Conlon KC, 2001, ANN SURG, V234, P487, DOI 10.1097/00000658-200110000-00008; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Harbige Laurence S., 1996, Nutrition and Health (Bicester), V10, P285; Hirschel G, 1914, MUNCHEN MED WOCHEN, V61, P1728; Kausch W., 1912, BEITR KLIN CHIR, V78, P439; McMillan DC, 1998, NUTR CANCER, V31, P101; Sato N, 1998, ARCH SURG-CHICAGO, V133, P1094, DOI 10.1001/archsurg.133.10.1094; Scherbakov VI, 2004, B EXP BIOL MED, V138, P565	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					499	503				5	Oncology	Oncology	AY7IY	WOS:000347735300067		
J	Fukuchi, M; Mochiki, E; Suzuki, O; Ishiguro, T; Sobajima, J; Onozawa, H; Imaizumi, H; Shibata, K; Saito, K; Naitoh, H; Kumagai, Y; Ishibashi, K; Ishida, H				Fukuchi, Minoru; Mochiki, Erito; Suzuki, Okihide; Ishiguro, Toru; Sobajima, Jun; Onozawa, Hisashi; Imaizumi, Hideko; Shibata, Kazue; Saito, Kana; Naitoh, Hiroshi; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki			Factors Predicting Recurrence in Patients with Siewert Type II Carcinoma Treated with Curative Resection	ANTICANCER RESEARCH			English	Article						Esophagogastric junction carcinoma; Siewert type II; recurrence	ESOPHAGOGASTRIC JUNCTION CARCINOMA; GASTRIC-CANCER; ADENOCARCINOMA; LYMPHADENECTOMY; CLASSIFICATION; CHEMOTHERAPY; CARDIA; TRIAL	Aim: To evaluate the recurrence risk for Siewert type II esophagogastric junction carcinoma treated with curative resection. Patients and Methods: We retrospectively analyzed clinicopathological and recurrence-free survival (RFS) data of 52 patients after curative resection for Siewert type II carcinoma focusing on the role of lymph node metastasis around the greater curvature or parapyloric area. Results: Recurrence was observed in 21 (40%) patients; the median time-to-recurrence was 11 months (range=3-33 months). According to multivariate Cox proportional hazard regression analysis, involvement of nodes no. 4sa, 4sb, 4d, 5 and/or 6 (odds ratio (OR)=6.62; 95% confidence interval (CI)=1.27-41.1; p=0.04) and younger age (OR=2.10; 95% CI=1.25-3.82; p<0.01) were significant independent risk factors affecting RFS. Conclusion: Involvement of no. 4-6 nodes appears to predict recurrence of Siewert type II carcinoma treated with curative resection. Patients with this risk factor may benefit from effective use of perioperative chemotherapy.	[Fukuchi, Minoru; Mochiki, Erito; Suzuki, Okihide; Ishiguro, Toru; Sobajima, Jun; Onozawa, Hisashi; Imaizumi, Hideko; Shibata, Kazue; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama 3508550, Japan; [Fukuchi, Minoru; Saito, Kana; Naitoh, Hiroshi] Gunma Chuo Hosp, Dept Surg, Gunma, Japan	Fukuchi, M (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	mfukuchi@saitama-med.ac.jp					Siewert JR, 2005, J SURG ONCOL, V90, P139, DOI 10.1002/jso.20218; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Ogata K, 2009, HEPATO-GASTROENTEROL, V56, P1760; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Oda I, 2011, GASTRIC CANCER, V14, P22, DOI 10.1007/s10120-011-0001-0; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fujitani K, 2013, GASTRIC CANCER, V16, P301, DOI 10.1007/s10120-012-0183-0; Fukuchi M, 2014, ANTICANCER RES, V34, P915; Goto H, 2011, GASTRIC CANCER, V16, P590; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kato H, 2005, ANTICANCER RES, V25, P3461; Siewert JR, 2000, ANN SURG, V232, P353; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Siewert JR, 1996, DIS ESOPHAGUS, V9, P173; Sobin LH, 2009, TNM CLASSIFICATION M	17	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					505	509				5	Oncology	Oncology	AY7IY	WOS:000347735300068		
J	Nakanoko, T; Kakeji, Y; Ando, K; Nakashima, Y; Ohgaki, K; Kimura, Y; Saeki, H; Oki, E; Morita, M; Maehara, Y				Nakanoko, Tomonori; Kakeji, Yoshihiro; Ando, Koji; Nakashima, Yuichiro; Ohgaki, Kippei; Kimura, Yasue; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko			Assessment of Surgical Treatment and Postoperative Nutrition in Gastric Cancer Patients Older than 80 Years	ANTICANCER RESEARCH			English	Article						Gastrectomy; elderly patients; nutrition	QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; METAANALYSIS; IMPACT	Background: A gastrectomy for gastric cancer is sometimes required in patients older than 80 years due to the continuously increasing age of society. However, if a gastrectomy worsens the postoperative quality of life and daily activity in elderly patients because of poor nutrition, the procedure may not always be a useful treatment strategy. Patients and Methods: Clinicopathological data of patients with gastric cancer who underwent a gastrectomy at our Department between 1998 and 2008 (N=471) were collected and analyzed. The results of treatment for patients older than 80 years (N=41) were analyzed and compared against those of patients younger than 80 years (N=430). Results: Patients older than 80 years had a higher frequency of preoperative co-morbidities than patients younger than 80 years. However, there was no statistical difference in postoperative complications regarding nutrition between the two groups. Conclusion: Older age is not a determinant of poor nutrition following gastrectomy. Gastrectomy for gastric cancer is, therefore, a useful treatment strategy, regardless of ageing.	[Nakanoko, Tomonori; Kakeji, Yoshihiro; Ando, Koji; Nakashima, Yuichiro; Ohgaki, Kippei; Kimura, Yasue; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp					Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54; Gillison TL, 2010, ONCOLOGY-NY, V24, P76; MAEHARA Y, 1995, BRIT J SURG, V82, P102, DOI 10.1002/bjs.1800820134; Kahlke V, 2004, WORLD J SURG, V28, P369, DOI 10.1007/s00268-003-7119-0; [Anonymous], 2010, AG SPEC CANC INC RAT; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Jeong O, 2010, ANN SURG ONCOL, V17, P1589, DOI 10.1245/s10434-010-0916-4; [Anonymous], 2010, CURR STAT GASTR CANC; Wolters U, 1996, BRIT J ANAESTH, V77, P217; Malmstrom M, 2013, INT J NURS STUD, V50, P44, DOI 10.1016/j.ijnurstu.2012.08.011; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Marano L, 2013, ANN SURG ONCOL, V20, P3912, DOI 10.1245/s10434-013-3088-1; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; [Anonymous], 2010, ABR LIF TABL JAP 200; Eray F, 2013, INT J CANCER, V132, P1133; Huang KH, 2010, WORLD J SURG, V34, P1015, DOI 10.1007/s00268-010-0467-7; Jackson C, 2009, ANN ONCOL, V20, P34, DOI 10.1093/annonc/mdp122; Laurent M, 2014, ONCOLOGIST, V19, P275, DOI 10.1634/theoncologist.2013-0351; Liu TS, 2008, EJSO-EUR J SURG ONC, V34, P1208, DOI 10.1016/j.ejso.2008.02.002; Martella B, 2005, Acta Biomed, V76 Suppl 1, P49; Repetto Lazzaro, 2003, J Support Oncol, V1, P18; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Shojania KG, 2001, EVID REP TECHNOL ASS, Vi-x, P1; Sobin LH, 2010, TNM CLASSIFICATION M	24	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					511	515				5	Oncology	Oncology	AY7IY	WOS:000347735300069		
J	Bessho, H; Wong, B; Huang, D; Siew, EY; Huang, DC; Tan, J; Ong, CK; Tan, SY; Matsumoto, K; Iwamura, M; Teh, BT				Bessho, Hideharu; Wong, Bernice; Huang, Dan; Siew, Ee Yan; Huang, Dachuan; Tan, Jing; Ong, Choon Kiat; Tan, Soo Yong; Matsumoto, Kazumasa; Iwamura, Masatsugu; Teh, Bin Tean			Inhibition of Placental Growth Factor in Renal Cell Carcinoma	ANTICANCER RESEARCH			English	Article						Placental growth factor (PlGF); antiangiogenic therapy; renal cell carcinoma; sunitinib resistance	TUMOR ANGIOGENESIS; COLORECTAL-CANCER; BREAST-CANCER; RESISTANCE; SUNITINIB; THERAPY; VEGF; BEVACIZUMAB; BIOMARKER; EFFICACY	Background/Aim: Placental growth factor (PlGF) is up-regulated in major malignant diseases or following antiangiogenic therapy, although it is present in low levels under normal physiological conditions. TB403, a monoclonal antibody against PlGF, was investigated in clear cell renal cell carcinoma (ccRCC) xenografts since it has been proposed as a potential target in oncology. Materials and Methods: Human ccRCCs were implanted in athymic nude mice to evaluate the efficacy of TB403 and to excise xenograft tumors for molecular experiments. Results: TB403 did not significantly inhibit tumor growth in treatment-naive or sunitinib-resistant ccRCC xenografts. Gene expression profiling resulted in over-expression of the C1orf38 gene, which induced immunoreactivity in macrophages. Angio genesis PCR arrays showed that VEGFR-1 was not expressed in ccRCC xenografts. Conclusion: PlGF blockade did not have a broad antiangiogenic efficacy; however, it might be effective on-target in VEGFR1-expressing tumors. The inhibition of VEGF pathway may induce the activity of tumor-associated-macrophages for angio genesis escape.	[Bessho, Hideharu; Wong, Bernice; Siew, Ee Yan; Huang, Dachuan; Tan, Jing; Ong, Choon Kiat; Teh, Bin Tean] Natl Canc Ctr Singapore, Lab Canc Epigenome, Singapore 169610, Singapore; [Bessho, Hideharu; Wong, Bernice; Siew, Ee Yan; Huang, Dachuan; Tan, Jing; Ong, Choon Kiat; Teh, Bin Tean] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Bessho, Hideharu; Matsumoto, Kazumasa; Iwamura, Masatsugu] Kitasato Univ, Sch Med, Dept Urol, Minato, Kanagawa, Japan; [Huang, Dan] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	Bessho, H (reprint author), Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore.	hideji56@gmail.com			Roche-SingHealth Translational and Research Hub grant	All funding: This work was supported by the Roche-SingHealth Translational and Research Hub grant entitled, "Role of placenta growth factor in antiangiogenic therapeutic related resistance in RCC".	Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/740; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.022574; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Wei SC, 2009, DIS COLON RECTUM, V52, P1630, DOI 10.1007/DCR.0b013e3181afbdaf; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Bagley RG, 2011, CLIN CANCER RES, V17, P976, DOI 10.1158/1078-0432.CCR-10-2687; Escudero-Esparza A, 2010, ONCOL REP, V23, P537, DOI 10.3892/or_00000667; Fatima N, 2011, CANCER CYTOPATHOL, V119, P127, DOI 10.1002/cncy.20135; Nielsen DL, 2012, EXPERT OPIN BIOL TH, V12, P795, DOI 10.1517/14712598.2012.679655; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472CAN-07-1034; Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; ZHANG L, 2005, ALGORITHMICA, V43, P1, DOI [DOI 10.1007/S00453-005-1154-1, 10.2119/2006-00021.Ro]	30	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					531	541				11	Oncology	Oncology	AY7IY	WOS:000347735300072		
J	Tawada, A; Chiba, T; Ooka, Y; Kanogawa, N; Saito, T; Motoyama, T; Ogasawara, S; Suzuki, E; Kanai, F; Yoshikawa, M; Yokosuka, O				Tawada, Akinobu; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Ogasawara, Sadahisa; Suzuki, Eiichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu			Transarterial Chemoembolization with Miriplatin plus Epirubicin in Patients with Hepatocellular Carcinoma	ANTICANCER RESEARCH			English	Article						Hepatocellular carcinoma; transcatheter arterial chemoembolization; miriplatin; epirubicin; combination therapy	TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CISPLATIN-LIPIODOL SUSPENSION; CHEMOTHERAPY; EFFICACY; EMULSION; TRIALS; CANCER; COHORT	Aim: We aimed to evaluate the therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin plus epirubicin in unresectable hepatocellular carcinoma (HCC). Patients and Methods: The efficacy of TACE was evaluated by dynamic computed tomography (CT) or magnetic resonance imaging (MRI) three months after the procedure according to the Response Evaluation Criteria in Cancer Study Group of Japan. Adverse events (AEs), including clinical symptoms, hematological toxicities and blood chemistry toxicities, were assessed using Common Terminology Criteria Version 4.0. Results: Thirty patients with HCC received TACE with miriplatin (miriplatin group) and 29 patients received TACE with miriplatin plus epirubicin (miriplatin-plus-epirubicin group). AEs, such as anorexia and neutropenia, were observed more frequently in the miriplatin-plus-epirubicin group than in the miriplatin group (p=0.028 and 0.014, respectively). However, there was no significant difference in the incidence of these AEs (grade 314) between groups. The objective response rate (ORR), including the complete response (CR) and partial response (PR), was 76.7% in the miriplatin group and 58.6% in the miriplatin-plus-epirubicin group (p=0.224). The median time to progression (TTP) in the miriplatin group and the miriplatin-plus-epirubicin group was 8.2 and 6.1 months, respectively (p=0.12.3). Conclusion: Although TACE with miriplatin plus epirubicin was safe and tolerable, no additional anti-tumor effects were observed compared to TACE with miriplatin. Further analysis is required to refine the efficacy of TACE using miriplatin plus epirubicin.	[Tawada, Akinobu; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Ogasawara, Sadahisa; Suzuki, Eiichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan	Chiba, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	techiba@faculty.chiba-u.jp			Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan)	Osamu Yokosuka received grant support (Scholarship contribution) from Dainippon Sumitomo Pharma Co, Ltd (Osaka, Japan). The remaining authors disclose no conflicts.	Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ueda T, 2013, HEPATOL RES, V43, P1071, DOI 10.1111/hepr.12212; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; CERSOSIMO RJ, 1986, J CLIN ONCOL, V4, P425; Hashimoto Naoko, 2013, Onco Targets Ther, V6, P1025, DOI 10.2147/OTT.S49443; ICHIDA T, 1992, CANCER CHEMOTH PHARM, V31, pS51, DOI 10.1007/BF00687105; Ikeda M, 2010, J GASTROENTEROL, V45, P60, DOI 10.1007/s00535-009-0109-8; Iwazawa J, 2012, ANTICANCER RES, V32, P5039; Iwazawa Jin, 2012, Cancer Manag Res, V4, P113, DOI 10.2147/CMAR.S30431; Iwazawa J, 2014, HEPATOL RES, V44, P201, DOI 10.1111/hepr.12104; Kamada K, 2001, J VASC INTERV RADIOL, V12, P847, DOI 10.1016/S1051-0443(07)61510-3; Kora S, 2013, HEPATOL RES, V43, P1100, DOI 10.1111/hepr.12050; Miyayama S, 2012, JPN J RADIOL, V30, P263, DOI 10.1007/s11604-011-0043-6; Oguro S, 2012, JPN J RADIOL, V30, P735, DOI 10.1007/s11604-012-0116-1; Okimoto K, 2013, ANTICANCER RES, V33, P5603; Otsuji K, HEPATOL RES IN PRESS; Seko Y, 2013, HEPATOL RES, V43, P942, DOI 10.1111/hepr.12041; Shariff Mohamed I F, 2009, Expert Rev Gastroenterol Hepatol, V3, P353, DOI 10.1586/egh.09.35; Yukisawa S, 2012, EUR J GASTROEN HEPAT, V24, P583, DOI 10.1097/MEG.0b013e3283513488	24	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					549	554				6	Oncology	Oncology	AY7IY	WOS:000347735300074		
J	Takakura, K; Koido, S; Kan, S; Yoshida, K; Mori, M; Hirano, Y; Ito, Z; Kobayashi, H; Takami, S; Matsumoto, Y; Kajihara, M; Misawa, T; Okamoto, M; Sugiyama, H; Homma, S; Ohkusa, T; Tajiri, H				Takakura, Kazuki; Koido, Shigeo; Kan, Shin; Yoshida, Kosaku; Mori, Masako; Hirano, Yuta; Ito, Zensho; Kobayashi, Hiroko; Takami, Shinichiro; Matsumoto, Yoshihiro; Kajihara, Mikio; Misawa, Takeyuki; Okamoto, Masato; Sugiyama, Haruo; Homma, Sadamu; Ohkusa, Toshifumi; Tajiri, Hisao			Prognostic Markers for Patient Outcome Following Vaccination with Multiple MHC Class I/II-restricted WT1 Peptide-pulsed Dendritic Cells Plus Chemotherapy for Pancreatic Cancer	ANTICANCER RESEARCH			English	Article						Cytokine; chemoimmunotherapy; dendritic cell; MHC class II; pancreatic cancer; vaccine; WT1	T-CELLS; IMMUNOTHERAPY; GEMCITABINE; ADENOCARCINOMA; NEUTROPHIL; CARCINOMA; VACCINES; S-1	Background/Aim: Treatment combining dendritic cells (DCs) pulsed with three types of major histocompatibility complex (MHC) class land II (DC/WT1/I/II)-restricted Wilms' tumor I (WT1) peptides with chemotherapy may stabilize disease in pancreatic cancer patients. Materials and Methods: Laboratory data from seven patients with pancreatic cancer who underwent combined DC/WT1-I/II vaccination and chemotherapy were analyzed. The DC phenotypes and plasma cytokine profiles were analyzed via flow cytometry. Results: The post-treatment neutrophil to lymphocyte (NIL) ratio was a treatment-related prognostic factor for better survival. Moreover, the mean fluorescence intensities (MFIs) of human leukocyte antigen (HLA)-DR and cluster of differentiation (CD)83 on DCs were significantly increased after chemoimmunotherapy. Interestingly, interleukin (IL)-6 level in plasma was significantly increased after chemoimmunotherapy in non-super-responders. Conclusion: An increased NIL ratio, as well as HLA-DR and CD83 MFI levels may be prognostic markers of longer survival in patients with advanced pancreatic cancer who undergo chemoimmunotherapy.	[Takakura, Kazuki; Koido, Shigeo; Hirano, Yuta; Ito, Zensho; Kobayashi, Hiroko; Takami, Shinichiro; Matsumoto, Yoshihiro; Kajihara, Mikio; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Inst Clin Med & Res, Tokyo, Japan; [Koido, Shigeo; Kan, Shin; Homma, Sadamu] Jikei Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Misawa, Takeyuki] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan; [Yoshida, Kosaku; Mori, Masako] Tella Inc, Div Res & Dev, Tokyo, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan	Koido, S (reprint author), Jikei Univ, Sch Med, Dept Gastroenterol & Hepatol, 163-1 Kashiwa Shita, Kashiwa, Chiba 2778567, Japan.	shigeo_koido@jikei.ac.jp			Ministry of Education, Cultures, Sports, Science and Technology of Japan; Mitsui Life Social Welfare Foundation	This work was supported in part by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan and the Mitsui Life Social Welfare Foundation.	Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Lee Y, 2012, J CANCER RES CLIN, V138, P2009, DOI 10.1007/s00432-012-1281-4; Kimura Y, 2012, PANCREAS, V41, P195, DOI 10.1097/MPA.0b013e31822398c6; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Koido S, 2014, ANTICANCER RES, V34, P3917; Koido S, 2014, CLIN CANCER RES, V20, P4228, DOI 10.1158/1078-0432.CCR-14-0314; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Rettig L, 2011, INT J CANCER, V129, P832, DOI 10.1002/ijc.25756; An X, 2010, BIOMARKERS, V15, P516, DOI 10.3109/1354750X.2010.491557; Koido S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/267539; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Neves AR, 2005, CANCER IMMUNOL IMMUN, V54, P61, DOI 10.1007/s00262-004-0550-8; Zitvogel L, 2012, ONCOIMMUNOLOGY, V1, P1223, DOI 10.4161/onci.21335; Yanagimoto H, 2005, CLIN IMMUNOL, V114, P52, DOI 10.1016/j.clim.2004.09.007; Kobayashi M, 2014, CANCER IMMUNOL IMMUN, V63, P797, DOI 10.1007/s00262-014-1554-7; Koido S, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-51; Nowak AK, 2003, J IMMUNOL, V170, P4905; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tanaka Y, 2005, J IMMUNOL, V174, P1270	21	3	4	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					555	562				8	Oncology	Oncology	AY7IY	WOS:000347735300075		
J	Toyokawa, T; Tanaka, H; Muguruma, K; Tamura, T; Sakurai, K; Kubo, N; Ohira, M; Hirakawa, K				Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Tamura, Tatsuro; Sakurai, Katsunobu; Kubo, Naoshi; Ohira, Masaichi; Hirakawa, Kosei			Primary Gastric Small Cell Carcinoma: A Series of Seven Cases	ANTICANCER RESEARCH			English	Article						Small cell carcinoma; stomach; chemotherapy; paclitaxel	LUNG-CANCER; WEEKLY PACLITAXEL; PHASE-II; STOMACH; CISPLATIN; STAGE	Aim: To present a series of seven cases of gastric. small cell carcinoma (GSCC) treated surgically and to illustrate the clinicopathological features and clinical course. Patients and Methods: Among 1,832 patients with gastric cancer who underwent gastric resection between 1997 and 2012, we reviewed the clinical records of 7 patients with histopathological diagnoses of GSCC. Results: No patients had preoperative confirmation of GSCC from endoscopic biopsy. Curative resection (RO) was achieved in 5 patients (71.4%). Two out of the 5 patients with curative resection survived more than four years. Two out of 3 patients who received weekly paclitaxel had progression-free survival of more than 10 months. The median survival time for the whole patient group was 14 months and the 3-year survival rate was 25.0%. Conclusion: Curative surgery with adjuvant chemotherapy may be essential to improve the prognosis of GSCC, and weekly paclitaxel chemotherapy may represent a promising chemotherapy for GSCC.	[Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Tamura, Tatsuro; Sakurai, Katsunobu; Kubo, Naoshi; Ohira, Masaichi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan	Toyokawa, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	t-toyokawa@med.osaka-cu.ac.jp					MATSUI K, 1991, AM J GASTROENTEROL, V86, P1167; FRAIRE AE, 1992, HUM PATHOL, V23, P520, DOI 10.1016/0046-8177(92)90129-Q; Ishida M, 2013, AM J SURG PATHOL, V37, P949, DOI 10.1097/PAS.0b013e31828ff59d; Yamamoto N, 2006, ANTICANCER RES, V26, P777; Shimoyama R, 2009, GASTRIC CANCER, V12, P206, DOI 10.1007/s10120-009-0524-9; Brenner B, 2004, J CLIN ONCOL, V22, P2730, DOI 10.1200/JCO.2004.09.075; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Iwamuro M, 2009, ACTA MED OKAYAMA, V63, P293; Chiba Naokazu, 2004, Gastric Cancer, V7, P122; Graziano SL, 2008, J THORAC ONCOL, V3, P158, DOI 10.1097/JTO.0b013e318161225e; Hironaka S, GASTRIC CANC, V9, P14; Huang J, 2012, J SURG ONCOL, V106, P994, DOI 10.1002/jso.23186; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Koide N, 2007, SURG TODAY, V37, P989, DOI 10.1007/s00595-007-3504-x; Kubota T, 2012, GASTRIC CANCER, V15, P323, DOI 10.1007/s10120-011-0122-5; Kusayanagi S, 2003, J GASTROEN HEPATOL, V18, P743, DOI 10.1046/j.1440-1746.2003.02822.x; Li AFY, 2010, J SURG ONCOL, V102, P497, DOI 10.1002/jso.21629; Matsusaka T, 1976, Fukuoka Igaku Zasshi, V67, P65; Nishikura Ken, 2003, Gastric Cancer, V6, P203, DOI 10.1007/s10120-003-0249-0; Okita NT, 2011, GASTRIC CANCER, V14, P161, DOI 10.1007/s10120-011-0025-5; Richards D, 2011, DIGEST DIS SCI, V56, P951, DOI 10.1007/s10620-010-1404-1; Tanemura Hiromi, 2002, Int J Clin Oncol, V7, P128; Peng Chunyan, 2013, Rare Tumors, V5, pe6, DOI 10.4081/rt.2013.e6	23	0	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JAN	2015	35	1					563	567				5	Oncology	Oncology	AY7IY	WOS:000347735300076		
J	Ezzikouri, S; Nishimura, T; Kohara, M; Benjelloun, S; Kino, Y; Inoue, K; Matsumori, A; Tsukiyama-Kohara, K				Ezzikouri, Sayeh; Nishimura, Tomohiro; Kohara, Michinori; Benjelloun, Soumaya; Kino, Yoichiro; Inoue, Kazuaki; Matsumori, Akira; Tsukiyama-Kohara, Kyoko			Inhibitory effects of Pycnogenol (R) on hepatitis C virus replication	ANTIVIRAL RESEARCH			English	Article						Natural product; Resistant; ROS; Antioxidant; Replication	PROCYANIDIN-RICH EXTRACT; FRENCH MARITIME PINE; GENOTYPE 1 INFECTION; NF-KAPPA-B; OXIDATIVE STRESS; VIRAL REPLICATION; ACTIVATES STAT-3; RIBAVIRIN; THERAPY; LIVER	Chronic hepatitis C virus (HCV) infection increases the risk of liver cirrhosis and hepatocellular carcinoma. In the last decade, the current standard HCV treatment, pegylated interferon and ribavirin, have limited efficacy and significant side effects. Novel direct acting antivirals show promise, but escape mutants are expected, along with potential side effects. Pycnogenol (R), a French maritime pine extract, has been reported to have antioxidant and antiviral effects. Here, we evaluated the effect of Pycnogenol (R) on HCV replication. Wild-type and protease inhibitor (VX-950; telaprevir)-resistant HCV replicon cells were treated with Pycnogenol (R), Pycnogenol (R) and interferon-alpha, and ribavirin and telaprevir. Pycnogenol (R) effects on replication were also evaluated in HCV-infected chimeric mice. Pycnogenol (R) treatment showed antiviral effects without cytotoxicity at doses up to 50 mu g/mL. Pycnogenol (R) in combination with interferon-alpha or ribavirin showed synergistic effects. Moreover, Pycnogenol (R) inhibited HCV replication in telaprevir-resistant replicon cells; telaprevir and Pycnogenol (R) acted additively to reduce HCV RNA levels in wild-type HCV replicon cells without significantly increasing cytotoxicity. Pycnogenol (R) antiviral activity was higher than its components procyanidin and taxifolin. Further, treatment of infected chimeric mice with Pycnogenol (R) suppressed HCV replication and showed a synergistic effect with interferon-alpha. In addition, Pycnogenol (R) treatment resulted in dose-dependent reduction of reactive oxygen species in HCV replicon cell lines. Pycnogenol (R) is a natural product that may be used to improve the efficacy of the current standard antiviral agents and even to eliminate resistant HCV mutants. (C) 2014 Elsevier B.V. All rights reserved.	[Ezzikouri, Sayeh] Pasteur Inst Morocco, Virol Unit, Viral Hepatitis Lab, Casablanca, Morocco; [Ezzikouri, Sayeh; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan; [Ezzikouri, Sayeh; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8900065, Japan; [Nishimura, Tomohiro; Kino, Yoichiro] Kikuchi Res Ctr, Chemosero Res Inst, Kumamoto, Japan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Inoue, Kazuaki] Showa Univ, Fujigaoka Hosp, Div Gastroenterol, Kanagawa, Japan; [Matsumori, Akira] Tokyo Med Univ, Tokyo 1608402, Japan	Tsukiyama-Kohara, K (reprint author), Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	sayeh.ezzikouri@pasteur.ma; kkohara@vet.kagoshima-u.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Japan Science and Technology Agency); Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science (JSPS) Fellowship for Foreign Researchers	This research was supported by a grant from the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Japan Science and Technology Agency), grants from the Ministry of Health, Labor, and Welfare, Japan, and the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Sayeh Ezzikouri is supported by a Japan Society for the Promotion of Science (JSPS) Fellowship for Foreign Researchers. The authors thank Drs Yuko Tokunaga and Makoto Ozawa for their support during experiments, Dr Lin Li for combination index calculation and Horphag Research Co., Geneva, Switzerland, for their generous gift of Pycnogenol (R) powder.	American Botanical Council, 2010, SCI CLIN MON PYCN; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Quarato G, 2013, INT J BIOCHEM CELL B, V45, P156, DOI 10.1016/j.biocel.2012.06.008; Lee HH, 2010, PHYTOTHER RES, V24, P1242, DOI 10.1002/ptr.3193; Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251; Khachatoorian R, 2012, VIROLOGY, V433, P346, DOI 10.1016/j.virol.2012.08.029; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Feng WY, 2008, JPN J INFECT DIS, V61, P279; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Ozeki I, 2011, J GASTROENTEROL, V46, P929, DOI 10.1007/s00535-011-0411-0; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Li Shenwei, 2010, Antiviral Chemistry & Chemotherapy, V20, P239, DOI 10.3851/IMP1597; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Choi YH, 2009, PHYTOTHER RES, V23, P1691, DOI 10.1002/ptr.2812; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Serejo F, 2003, CAN J GASTROENTEROL, V17, P644; Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Perz JF, 2006, J HEPATOL, V44, P441, DOI 10.1016/j.hep.2005.12.007; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Zibadi S, 2008, NUTR RES, V28, P315, DOI 10.1016/j.nutres.2008.03.003; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; Cho KJ, 2000, TOXICOL APPL PHARM, V168, P64, DOI 10.1006/taap.2000.9001; Choi SH, 2004, J BIOCHEM MOL BIOL, V37, P735; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Inoue K, 2007, HEPATOLOGY, V45, P921, DOI 10.1002/hep.21587; Katsume A, 2013, GASTROENTEROLOGY, V145, P865, DOI 10.1053/j.gastro.2013.06.012; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Lin YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054466; Matsumori A, 2007, J CARD FAIL, V13, P785, DOI 10.1016/j.cardfail.2007.06.721; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082299; Voss P, 2006, FREE RADICAL RES, V40, P673, DOI 10.1080/10715760500419357; Watanabe T, 2006, GENE THER, V13, P883	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	JAN	2015	113						93	102		10.1016/j.antiviral.2014.10.017		10	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	AY9JL	WOS:000347866200011		
J	Takahashi, M; Watari, E; Takahashi, H				Takahashi, Megumi; Watari, Eiji; Takahashi, Hidemi			Dichloroacetate induces cell cycle arrest in human glioblastoma cells persistently infected with measles virus: A way for controlling viral persistent infection	ANTIVIRAL RESEARCH			English	Article						Measles virus; Persistent infection; Mitochondria; Dichloroacetate	SUBACUTE SCLEROSING-PANENCEPHALITIS; MITOCHONDRIAL; INCREASES	We have previously established a human glioblastoma cell line persistently infected with mutant measles virus (MV), and found increased functions of mitochondria in MV persistently infected cells compared with uninfected or acutely infected cells. Moreover, impairment of mitochondria functions induced a breakdown of persistent infection, which suggested that mitochondria might play an important role in the maintenance of persistent infection and loss or functional alterations of mitochondria might be a candidate for possible intervention in persistent infection. In this study we examined the effect of dichloroacetate (DCA), which is known to increase pyruvate oxidation, on mitochondrial functions in MV persistently infected cells. DCA caused mitochondrial dysfunction and cell cycle arrest in MV persistently infected cells; consequently, the expression level of MV proteins were decreased in a DCA dependent manner. Here, we present a new therapeutic approach for persistent infection targeting mitochondrial respiration. Advantage to targeting mitochondrial respiration is that the impairment of mitochondrial functions by DCA is found in MV persistently infected cells not in uninfected cells, which may offer a promising chemotherapeutic strategy with few adverse effects. (C) 2014 Elsevier B.V. All rights reserved.	[Takahashi, Megumi; Watari, Eiji; Takahashi, Hidemi] Nippon Med Sch, Dept Microbiol & Immunol, Bunkyo Ku, Tokyo 1138602, Japan	Takahashi, M (reprint author), Nippon Med Sch, Dept Microbiol & Immunol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	megumi@nms.ac.jp					Claus C, 2014, ARCH VIROL, V159, P1267, DOI 10.1007/s00705-013-1841-1; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Badr MM, 2014, ONCOTARGETS THER, V7, P193, DOI 10.2147/OTT.S56688; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; CARTER MJ, 1983, NATURE, V305, P153, DOI 10.1038/305153a0; Dai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092962; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Hara T, 2000, J NEUROVIROL, V6, P121, DOI 10.3109/13550280009013155; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Takahashi M, 2013, ANTIVIR RES, V99, P238, DOI 10.1016/j.antiviral.2013.06.016; Wang Q, 2011, CURR MED CHEM, V18, P2025; Zheng MF, 2013, CANCER CHEMOTH PHARM, V72, P1031, DOI 10.1007/s00280-013-2281-z	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	JAN	2015	113						107	110		10.1016/j.antiviral.2014.11.008		4	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	AY9JL	WOS:000347866200013		
J	Chujo, M; Yoshida, S; Ota, A; Murata, K; Kawai, S				Chujo, Moeko; Yoshida, Shiori; Ota, Anri; Murata, Kousaku; Kawai, Shigeyuki			Acquisition of the Ability To Assimilate Mannitol by Saccharomyces cerevisiae through Dysfunction of the General Corepressor Tup1-Cyc8	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							TRANSCRIPTIONAL REPRESSION; ETHANOL-PRODUCTION; YEAST; COMPLEX; TUP1; EXPRESSION; CYC8; DEHYDROGENASE; FLOCCULATION; SSN6-TUP1	Saccharomyces cerevisiae normally cannot assimilate mannitol, a promising brown macroalgal carbon source for bioethanol production. The molecular basis of this inability remains unknown. We found that cells capable of assimilating mannitol arose spontaneously from wild-type S. cerevisiae during prolonged culture in mannitol-containing medium. Based on microarray data, complementation analysis, and cell growth data, we demonstrated that acquisition of mannitol-assimilating ability was due to spontaneous mutations in the genes encoding Tup1 or Cyc8, which constitute a general corepressor complex that regulates many kinds of genes. We also showed that an S. cerevisiae strain carrying a mutant allele of CYC8 exhibited superior salt tolerance relative to other ethanologenic microorganisms; this characteristic would be highly beneficial for the production of bioethanol from marine biomass. Thus, we succeeded in conferring the ability to assimilate mannitol on S. cerevisiae through dysfunction of Tup1-Cyc8, facilitating production of ethanol from mannitol.	[Chujo, Moeko; Yoshida, Shiori; Ota, Anri; Murata, Kousaku; Kawai, Shigeyuki] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan	Kawai, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan.	kawais@kais.kyoto-u.ac.jp			Next-Generation World-Leading Researchers [GS012]; National Bio-Resource Project of MEXT, Japan [pGK426]	The pGK426 plasmid was provided by the National Bio-Resource Project of MEXT, Japan.; This study was supported by the Funding Program for Next-Generation World-Leading Researchers GS012 (to S.K.).	[Anonymous], 1991, METHOD ENZYMOL, DOI DOI 10.1016/0076-6879(91)94013-3; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Sherman F, 2002, METHOD ENZYMOL, V350, P3; John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139; Horn SJ, 2000, J IND MICROBIOL BIOT, V25, P249, DOI 10.1038/sj.jim.7000065; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; QUAIN DE, 1987, J GEN MICROBIOL, V133, P1675; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Yoon JJ, 2010, ADV MAT RES, V93-94, P463, DOI 10.4028/www.scientific.net/AMR.93-94.463; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Horn SJ, 2000, J IND MICROBIOL BIOT, V24, P51, DOI 10.1038/sj.jim.2900771; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; LIPKE PN, 1984, J BACTERIOL, V159, P797; NIEHAUS WG, 1982, J BACTERIOL, V151, P243; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1111/j.1574-6976.1997.tb00346.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Parnell EJ, 2011, GENE DEV, V25, P2429, DOI 10.1101/gad.181768.111; Adams JM, 2009, J APPL PHYCOL, V21, P569, DOI 10.1007/s10811-008-9384-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; TornaiLehoczki J, 1996, ANTON LEEUW INT J G, V69, P229, DOI 10.1007/BF00399611; Kim NJ, 2011, BIORESOURCE TECHNOL, V102, P7466, DOI 10.1016/j.biortech.2011.04.071; Zubia M, 2008, J APPL PHYCOL, V20, P1033, DOI 10.1007/s10811-007-9303-3; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-73; Carrico PM, 1998, GENETICS, V148, P637; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Abramova NE, 2001, GENETICS, V157, P1169; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Huesemann M, 2010, BIOMASS BIOFUELS STR, P165, DOI 10.1002/9780470750025.ch8; Hughes SR, 2010, BIOMASS BIOFUELS STR, P55; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; MCENTEE CM, 1989, ANAL BIOCHEM, V176, P303, DOI 10.1016/0003-2697(89)90313-8; Ota A, 2013, J BIOSCI BIOENG, V116, P327, DOI 10.1016/j.jbiosc.2013.03.018; Perfect JR, 1996, J BACTERIOL, V178, P5257; Soares EV, 2011, J APPL MICROBIOL, V110, P1, DOI 10.1111/j.1365-2672.2010.04897.x; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307	43	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JAN	2015	81	1					9	16		10.1128/AEM.02906-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AY1TZ	WOS:000347376200002		
J	Bae, J; Kuroda, K; Ueda, M				Bae, Jungu; Kuroda, Kouichi; Ueda, Mitsuyoshi			Proximity Effect among Cellulose-Degrading Enzymes Displayed on the Saccharomyces cerevisiae	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							CLOSTRIDIUM-THERMOCELLUM; CELL-SURFACE; SACCHARIFICATION; HYDROLYSIS; COMPONENTS; BIOFUELS; PROTEIN; COMPLEX; ACID	Proximity effect is a form of synergistic effect exhibited when cellulases work within a short distance from each other, and this effect can be a key factor in enhancing saccharification efficiency. In this study, we evaluated the proximity effect between 3 cellulose-degrading enzymes displayed on the Saccharomyces cerevisiae cell surface, that is, endoglucanase, cellobiohydrolase, and beta-glucosidase. We constructed 2 kinds of arming yeasts through genome integration: ALL-yeast, which simultaneously displayed the 3 cellulases (thus, the different cellulases were near each other), and MIX-yeast, a mixture of 3 kinds of single-cellulase-displaying yeasts (the cellulases were far apart). The cellulases were tagged with a fluorescence protein or polypeptide to visualize and quantify their display. To evaluate the proximity effect, we compared the activities of ALL-yeast and MIX-yeast with respect to degrading phosphoric acid-swollen cellulose after adjusting for the cellulase amounts. ALL-yeast exhibited 1.25-fold or 2.22-fold higher activity than MIX-yeast did at a yeast concentration equal to the yeast cell number in 1 ml of yeast suspension with an optical density (OD) at 600 nm of 10 (OD10) or OD0.1. At OD0.1, the distance between the 3 cellulases was greater than that at OD10 in MIX-yeast, but the distance remained the same in ALL-yeast; thus, the difference between the cellulose-degrading activities of ALL-yeast and MIX-yeast increased (to 2.22-fold) at OD0.1, which strongly supports the proximity effect between the displayed cellulases. A proximity effect was also observed for crystalline cellulose (Avicel). We expect the proximity effect to further increase when enzyme display efficiency is enhanced, which would further increase cellulose-degrading activity. This arming yeast technology can also be applied to examine proximity effects in other diverse fields.	[Bae, Jungu; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	Ueda, M (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp					Matsuoka H, 2014, YEAST, V31, P67, DOI 10.1002/yea.2995; Tamaru Y, 2000, J BACTERIOL, V182, P5906, DOI 10.1128/JB.182.20.5906-5910.2000; Fujita Y, 2004, APPL ENVIRON MICROB, V70, P1207, DOI 10.1128/AEM.70.2.1207-1212.2004; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; LAMED R, 1983, J BACTERIOL, V156, P828; SAKAI A, 1990, APPL MICROBIOL BIOT, V33, P302, DOI 10.1007/BF00164526; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Matsui K, 2009, APPL MICROBIOL BIOT, V82, P105, DOI 10.1007/s00253-008-1761-2; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Kotaka A, 2010, J BIOSCI BIOENG, V109, P442, DOI 10.1016/j.jbiosc.2009.11.003; Kuroda K, 2009, APPL MICROBIOL BIOT, V82, P713, DOI 10.1007/s00253-008-1808-4; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Shimoi H, 1998, J BACTERIOL, V180, P3381; Bae J, 2013, J MOL MICROB BIOTECH, V23, P370, DOI 10.1159/000351358; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Krauss J, 2012, APPL ENVIRON MICROB, V78, P4301, DOI 10.1128/AEM.07959-11; Inokuma K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-8; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125; Molinier AL, 2011, J MOL BIOL, V405, P143, DOI 10.1016/j.jmb.2010.10.013; Morais S, 2010, MBIO, V1, DOI 10.1128/mBio.00285-10; Nakanishi A, 2012, RENEW ENERG, V44, P199, DOI 10.1016/j.renene.2012.01.078; Nakatani Y, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-66; Shibasaki S, 2001, APPL MICROBIOL BIOT, V55, P471; Vazana Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-182; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32	27	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JAN	2015	81	1					59	66		10.1128/AEM.02864-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AY1TZ	WOS:000347376200007		
J	Kato, S; Yumoto, I; Kamagata, Y				Kato, Souichiro; Yumoto, Isao; Kamagata, Yoichi			Isolation of Acetogenic Bacteria That Induce Biocorrosion by Utilizing Metallic Iron as the Sole Electron Donor	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							SULFATE-REDUCING BACTERIA; MICROBIOLOGICALLY INFLUENCED CORROSION; MICROBIALLY INFLUENCED CORROSION; SP-NOV.; ANAEROBIC-BACTERIA; OXIDE MINERALS; MICROORGANISMS; HYDROCARBON; HYPOTHESIS; AQUIFER	Corrosion of iron occurring under anoxic conditions, which is termed microbiologically influenced corrosion (MIC) or biocorrosion, is mostly caused by microbial activities. Microbial activity that enhances corrosion via uptake of electrons from metallic iron [Fe(0)] has been regarded as one of the major causative factors. In addition to sulfate-reducing bacteria and methanogenic archaea in marine environments, acetogenic bacteria in freshwater environments have recently been suggested to cause MIC under anoxic conditions. However, no microorganisms that perform acetogenesis-dependent MIC have been isolated or had their MIC-inducing mechanisms characterized. Here, we enriched and isolated acetogenic bacteria that induce iron corrosion by utilizing Fe(0) as the sole electron donor under freshwater, sulfate-free, and anoxic conditions. The enriched communities produced significantly larger amounts of Fe(II) than the abiotic controls and produced acetate coupled with Fe(0) oxidation prior to CH4 production. Microbial community analysis revealed that Sporomusa sp. and Desulfovibrio sp. dominated in the enrichments. Strain GT1, which is closely related to the acetogen Sporomusa sphaeroides, was eventually isolated from the enrichment. Strain GT1 grew acetogenetically with Fe(0) as the sole electron donor and enhanced iron corrosion, which is the first demonstration of MIC mediated by a pure culture of an acetogen. Other well-known acetogenic bacteria, including Sporomusa ovata and Acetobacterium spp., did not grow well on Fe(0). These results indicate that very few species of acetogens have specific mechanisms to efficiently utilize cathodic electrons derived from Fe(0) oxidation and induce iron corrosion.	[Kato, Souichiro; Yumoto, Isao; Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Kato, Souichiro; Kamagata, Yoichi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido, Japan; [Kato, Souichiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	Kato, S (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	s.katou@aist.go.jp					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Usher KM, 2014, INT BIODETER BIODEGR, V93, P84, DOI 10.1016/j.ibiod.2014.05.007; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P1783, DOI 10.1128/AEM.00668-09; Kato S, 2010, ENVIRON MICROBIOL, V12, P3114, DOI 10.1111/j.1462-2920.2010.02284.x; Nakamura R, 2009, ANGEW CHEM INT EDIT, V48, P508, DOI 10.1002/anie.200804750; DANIELS L, 1987, SCIENCE, V237, P509, DOI 10.1126/science.237.4814.509; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; SCHINK B, 1984, ARCH MICROBIOL, V137, P250, DOI 10.1007/BF00414553; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Mand J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00268; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Aulenta F, 2013, CHEMSUSCHEM, V6, P433, DOI 10.1002/cssc.201200748; Nakamura R, 2010, CHEMBIOCHEM, V11, P643, DOI 10.1002/cbic.200900775; Pisciotta JM, 2012, APPL ENVIRON MICROB, V78, P5212, DOI 10.1128/AEM.00480-12; Hamilton WA, 2003, BIOFOULING, V19, P65, DOI 10.1080/0892701021000041078; Coetser SE, 2005, CRIT REV MICROBIOL, V31, P213, DOI 10.1080/10408410500304074; Bergmann F, 2011, ENVIRON MICROBIOL, V13, P1125, DOI 10.1111/j.1462-2920.2010.02391.x; Lohner ST, 2014, ISME J, V8, P1673, DOI 10.1038/ismej.2014.82; Rao TS, 2000, CORROS SCI, V42, P1417, DOI 10.1016/S0010-938X(99)00141-9; Parameswaran P, 2011, BIORESOURCE TECHNOL, V102, P263, DOI 10.1016/j.biortech.2010.03.133; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; KING RA, 1971, NATURE, V233, P491, DOI 10.1038/233491a0; SCHAUDER R, 1989, ARCH MICROBIOL, V151, P84; Basso O, 2005, INT J SYST EVOL MICR, V55, P101, DOI 10.1099/ijs.0.63303-0; Jeremiasse AW, 2010, BIOELECTROCHEMISTRY, V78, P39, DOI 10.1016/j.bioelechem.2009.05.005; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Kato S, 2013, MICROBES ENVIRON, V28, P141, DOI 10.1264/jsme2.ME12161; Lee AK, 2003, APPL MICROBIOL BIOT, V62, P134, DOI 10.1007/s00253-003-1314-7; MOLLER B, 1984, ARCH MICROBIOL, V139, P388, DOI 10.1007/BF00408385; Kato S, 2014, MICROBES ENVIRON, V29, P162, DOI 10.1264/jsme2.ME14021; Mori K, 2010, J BIOSCI BIOENG, V110, P426, DOI 10.1016/j.jbiosc.2010.04.012; Videla HA, 2005, INT MICROBIOL, V8, P169; Enning D, 2012, ENVIRON MICROBIOL, V14, P1772, DOI 10.1111/j.1462-2920.2012.02778.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Rajasekar A, 2010, APPL MICROBIOL BIOT, V85, P1175, DOI 10.1007/s00253-009-2289-9; Beech Iwona B, 2004, Curr Opin Biotechnol, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Enning D, 2014, APPL ENVIRON MICROB, V80, P1226, DOI 10.1128/AEM.02848-13; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; Liu FH, 2011, ISME J, V5, P1526, DOI 10.1038/ismej.2011.17; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; Muthukumar N, 2003, ELECTROCHEM COMMUN, V5, P421, DOI 10.1016/S1388-2481(03)00093-6; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536; Pitonzo BJ, 2004, CORROSION, V60, P64; Sekiguchi Y, 2000, INT J SYST EVOL MICR, V50, P771; Suflita JM, 2008, CORROSION, V64, P854, DOI 10.5006/1.3279919; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Wilde E, 1997, INT J SYST BACTERIOL, V47, P164; Zhu XY, 2003, APPL ENVIRON MICROB, V69, P5354, DOI 10.1128/AEM.69.9.5354-5363.2003	52	7	7	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JAN	2015	81	1					67	73		10.1128/AEM.02767-14		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AY1TZ	WOS:000347376200008		
J	Suzuki, H; Kobayashi, J; Wada, K; Furukawa, M; Doi, K				Suzuki, Hirokazu; Kobayashi, Jyumpei; Wada, Keisuke; Furukawa, Megumi; Doi, Katsumi			Thermoadaptation-Directed Enzyme Evolution in an Error-Prone Thermophile Derived from Geobacillus kaustophilus HTA426	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							HOST-VECTOR SYSTEM; 16S RIBOSOMAL-RNA; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; BACILLUS-SUBTILIS; DEOXYRIBONUCLEIC-ACID; MISMATCH REPAIR; CYTOSINE RESIDUES; SELECTION MARKER; COUPLING FACTOR	Thermostability is an important property of enzymes utilized for practical applications because it allows long-term storage and use as catalysts. In this study, we constructed an error-prone strain of the thermophile Geobacillus kaustophilus HTA426 and investigated thermoadaptation-directed enzyme evolution using the strain. A mutation frequency assay using the antibiotics rifampin and streptomycin revealed that G. kaustophilus had substantially higher mutability than Escherichia coli and Bacillus subtilis. The predominant mutations in G. kaustophiluswere A . T -> G . C and C . G -> T . A transitions, implying that the high mutability of G. kaustophilus was attributable in part to high-temperature-associated DNA damage during growth. Among the genes that may be involved in DNA repair in G. kaustophilus, deletions of the mutSL, mutY, ung, and mfd genes markedly enhanced mutability. These genes were subsequently deleted to construct an error-prone thermophile that showed much higher (700- to 9,000-fold) mutability than the parent strain. The error-prone strain was auxotrophic for uracil owing to the fact that the strain was deficient in the intrinsic pyrF gene. Although the strain harboring Bacillus subtilis pyrF was also essentially auxotrophic, cells became prototrophic after 2 days of culture under uracil starvation, generating B. subtilis PyrF variants with an enhanced half-denaturation temperature of >10 degrees C. These data suggest that this error-prone strain is a promising host for thermoadaptation- directed evolution to generate thermostable variants from thermolabile enzymes.	[Suzuki, Hirokazu; Kobayashi, Jyumpei; Furukawa, Megumi] Kyushu Univ, Fac Agr, Grad Sch, Fukuoka 812, Japan; [Suzuki, Hirokazu; Kobayashi, Jyumpei] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 680, Japan; [Wada, Keisuke] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Doi, Katsumi] Kyushu Univ, Fac Agr, Inst Genet Resources, Microbial Genet Div, Fukuoka 812, Japan	Suzuki, H (reprint author), Kyushu Univ, Fac Agr, Grad Sch, Fukuoka 812, Japan.	hirokap@xpost.plala.or.jp	Kobayashi, Junjiro/J-8547-2015		Programme for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry (BRAIN), Japan; Institute for Fermentation, Osaka, Japan	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry (BRAIN), Japan, and in part by the Institute for Fermentation, Osaka, Japan.	AMARTEY SA, 1991, BIOTECHNOL LETT, V13, P621, DOI 10.1007/BF01086315; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951; Suzuki H, 2013, BIOSCI BIOTECH BIOCH, V77, P2316, DOI 10.1271/bbb.1304921; LIAO H, 1986, P NATL ACAD SCI USA, V83, P576, DOI 10.1073/pnas.83.3.576; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Greener A, 1997, MOL BIOTECHNOL, V7, P189, DOI 10.1007/BF02761755; SMITH KC, 1992, MUTAT RES, V277, P139, DOI 10.1016/0165-1110(92)90002-Q; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Brouns SJJ, 2005, J BIOL CHEM, V280, P11422, DOI 10.1074/jbc.M413623200; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Suzuki H, 2012, APPL ENVIRON MICROB, V78, P7376, DOI 10.1128/AEM.01669-12; Parry TE, 2007, LEUKEMIA RES, V31, P1621, DOI 10.1016/j.leukres.2007.05.002; Bommarius AS, 2006, CURR OPIN BIOTECH, V17, P606, DOI 10.1016/j.copbio.2006.10.001; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Nakamura A, 2005, J BIOSCI BIOENG, V100, P158, DOI 10.1263/jbb.100.158; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Suzuki H, 2012, J MICROBIOL BIOTECHN, V22, P1279, DOI 10.4014/jmb.1203.03023; Suzuki H, 2013, APPL ENVIRON MICROB, V79, P5151, DOI 10.1128/AEM.01506-13; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Chautard H, 2007, NAT METHODS, V4, P919, DOI 10.1038/NMETH1090; Fridjonsson O, 2002, J BACTERIOL, V184, P3385, DOI 10.1128/JB.484.12.3385-3391.2002; IMANAKA T, 1990, ANN NY ACAD SCI, V613, P347, DOI 10.1111/j.1749-6632.1990.tb18176.x; Jacobs KL, 1997, J BACTERIOL, V179, P3298; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; KARRAN P, 1980, BIOCHEMISTRY-US, V19, P6005, DOI 10.1021/bi00567a010; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lopez-Olmos K, 2012, J BACTERIOL, V194, P243, DOI 10.1128/JB.06082-11; MATSUMURA M, 1985, J BIOL CHEM, V260, P5298; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; MONTANDON PE, 1986, EMBO J, V5, P3705; Nakashima N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp498; Nicholson WL, 2002, J BACTERIOL, V184, P4936, DOI 10.1128/JB.184.17.4936-4940.2002; NOGUCHI N, 1993, FEMS MICROBIOL LETT, V114, P47, DOI 10.1111/j.1574-6968.1993.tb06549.x; Sasaki M, 2004, FEMS MICROBIOL LETT, V234, P37, DOI 10.1016/j.femsle.2004.03.004; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; Steffler F, 2013, ENZYME MICROB TECH, V53, P307, DOI 10.1016/j.enzmictec.2013.07.002; Tamakoshi M, 2001, EXTREMOPHILES, V5, P17, DOI 10.1007/s007920000168; TIMMS AR, 1992, MOL GEN GENET, V232, P89, DOI 10.1007/BF00299141; Wanner RM, 2009, J BACTERIOL, V191, P6312, DOI 10.1128/JB.00613-09	47	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JAN	2015	81	1					149	158		10.1128/AEM.02577-14		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AY1TZ	WOS:000347376200018		
J	Uehara, K; Watanabe, J; Akao, T; Watanabe, D; Mogi, Y; Shimoi, H				Uehara, Kenji; Watanabe, Jun; Akao, Takeshi; Watanabe, Daisuke; Mogi, Yoshinobu; Shimoi, Hitoshi			Screening of High-Level 4-Hydroxy-2 (or 5)-Ethyl-5 (or 2)-Methyl-3(2H)-Furanone-Producing Strains from a Collection of Gene Deletion Mutants of Saccharomyces cerevisiae	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							FLAVOR COMPOUND 4-HYDROXY-2,5-DIMETHYL-3(2H)-FURANONE; ZYGOSACCHAROMYCES-ROUXII; HEMIASCOMYCETOUS YEASTS; SUPEROXIDE-DISMUTASE; GENOMIC EXPLORATION; SOY-SAUCE; COMPONENT; IDENTIFICATION; BIOSYNTHESIS; FERMENTATION	4-Hydroxy-2 (or 5)-ethyl-5 (or 2)-methyl-3(2H)-furanone (HEMF) is an important flavor compound that contributes to the sensory properties of many natural products, particularly soy sauce and soybean paste. The compound exhibits a caramel-like aroma and several important physiological activities, such as strong antioxidant activity. HEMF is produced by yeast species in soy sauce manufacturing; however, the enzymes involved in HEMF production remain unknown, hindering efforts to breed yeasts with high-level HEMF production. In this study, we identified high-level HEMF-producing mutants among a Saccharomyces cerevisiae gene deletion mutant collection. Fourteen deletion mutants were screened as high-level HEMF-producing mutants, and the ADH1 gene deletion mutant (adh1 Delta) exhibited the maximum HEMF production capacity. Further investigations of the adh1 Delta mutant implied that acetaldehyde accumulation contributes to HEMF production, agreeing with previous findings. Therefore, acetaldehyde might be a precursor for HEMF. The ADH1 gene deletion mutant of Zygosaccharomyces rouxii, which is the dominant strain of yeast found during soy sauce fermentation, also produces HEMF effectively, suggesting that acetaldehyde accumulation might be a benchmark for breeding industrial yeasts with excellent HEMF production abilities.	[Uehara, Kenji; Watanabe, Jun; Mogi, Yoshinobu] Yamasa Corp, Mfg Div, Choshi, Chiba, Japan; [Akao, Takeshi; Watanabe, Daisuke; Shimoi, Hitoshi] Natl Res Inst Brewing, Fundamental Res Div, Higashihiroshima, Hiroshima, Japan	Uehara, K (reprint author), Yamasa Corp, Mfg Div, Choshi, Chiba, Japan.	uehara@yamasa.com					Epstein CB, 2001, MOL BIOL CELL, V12, P297; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Matsufuji Y, 2013, APPL MICROBIOL BIOT, V97, P297, DOI 10.1007/s00253-012-4147-4; Koga T, 1998, J AGR FOOD CHEM, V46, P946, DOI 10.1021/jf9709109; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Raab T, 2006, PLANT CELL, V18, P1023, DOI 10.1105/tpc.105.039784; Pribylova L, 2007, FEMS YEAST RES, V7, P1285, DOI 10.1111/j.1567-1364.2007.00308.x; Ben-Shitrit T, 2012, NAT METHODS, V9, P373, DOI [10.1038/nmeth.1890, 10.1038/NMETH.1890]; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Blank I, 1996, J AGR FOOD CHEM, V44, P531, DOI 10.1021/jf950439o; BRUCHE G, 1995, Z LEBENSM UNTERS FOR, V201, P249, DOI 10.1007/BF01192997; de Montigny J, 2000, FEBS LETT, V487, P52, DOI 10.1016/S0014-5793(00)02279-1; Fukushima D., 1989, IND INDIGENOUS FERME, P1; Harada NS, 2000, J SOY SAUCE RES TECH, V26, P83; Hayashida Y, 1998, J BREW SOC JAPAN, V93, P730; Hayashida Y, 2000, J OSY SAUCE RES TECH, V26, P123; Hayashida Y, 1999, J SOY SAUCE RES TECH, V25, P237; Hayashida Y, 1997, BIOTECHNOL LETT, V19, P429, DOI 10.1023/A:1018335925239; HUBER U A, 1992, Perfumer and Flavorist, V17, P15; Ito H, 1994, JAPANESE J FOOD MICR, V11, P151; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Monde K, 2009, CHIRALITY, V21, pE110, DOI 10.1002/chir.20788; Nagahara A, CANC RES, V52, P1754; Nunomura N, 2006, J BREW SOC JAPAN, V101, P151; NUNOMURA N, 1976, AGR BIOL CHEM TOKYO, V40, P491; Ohata M, 2007, BIOSCI BIOTECH BIOCH, V71, P407, DOI 10.1271/bbb.60466; Sakuma S, 1996, J AM SOC BREW CHEM, V54, P37; Sambrook J., 2012, MOL CLONING LAB MANU; Sasaki M, 1996, J AGR FOOD CHEM, V44, P3273, DOI 10.1021/jf9506500; Sasaki M, 1996, J AGR FOOD CHEM, V44, P230, DOI 10.1021/jf9406727; SASAKI M, 1991, J AGR FOOD CHEM, V39, P934, DOI 10.1021/jf00005a027; Sasaki T, 1998, BIOSCI BIOTECH BIOCH, V62, P1865, DOI 10.1271/bbb.62.1865; Schiefner A, 2013, J BIOL CHEM, V288, P16815, DOI 10.1074/jbc.M113.453852; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sugawara E, 2007, BIOSCI BIOTECH BIOCH, V71, P1761, DOI 10.1271/bbb.60715; Sugawara E, 1991, NIPPON SHOKUHIN KOGY, V38, P491; Sugawara E, 1999, BIOSCI BIOTECH BIOCH, V63, P749, DOI 10.1271/bbb.63.749; Tauchi H, 1997, EWP CENTRAL MISO RES, V24, P122; TRESSL R, 1978, Z LEBENSM UNTERS FOR, V167, P111, DOI 10.1007/BF01136139; Watanabe J, 2010, BIOSCI BIOTECH BIOCH, V74, P1092, DOI 10.1271/bbb.90865; Yaginuma A, 2002, J BREW SOC JPN, V97, P608; Yokotsuka T., 1997, MICROBIOLOGY FERMENT, P351	48	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JAN	2015	81	1					453	460		10.1128/AEM.02628-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AY1TZ	WOS:000347376200049		
J	Kawahara, K; Narikawa, M				Kawahara, Keiji; Narikawa, Masafumi			The unique achievements of Japanese industries in the super-aged society	APPLIED ERGONOMICS			English	Article						Super-aged society; Universal design; Inclusive design		Unique efforts of the Japanese industries in meeting the needs of the super-aged society are introduced through their association with International Association for Universal Design (IAUD). Considerations are made on how successes were brought about, what can be learned as well as what issues should be addressed in the future. (c) 2014 Published by Elsevier Ltd.	[Kawahara, Keiji] Nagoya Univ Arts & Sci, Int Assoc Universal Design, Nagoya, Aichi, Japan; [Narikawa, Masafumi] Tokyo Elect Power Environm Engn Co Inc, Int Assoc Universal Design, Tokyo, Japan	Kawahara, K (reprint author), Nagoya Univ Arts & Sci, Int Assoc Universal Design, Nagoya, Aichi, Japan.	kawahara@kidstudio.co.jp					[Anonymous], 2001, GUID DEV ADDR NEEDS; [Anonymous], 2009, POP EST; [Anonymous], 2008, IAUD NEWSL, V2; Coleman R., 2009, 2 INT C UN DES KYOT; Coleman R., 2011, 3 INT C UN DES HAM 2; Higgins R., 1980, 7 ENEMY HUMAN FACTOR; Ishihara T., 2005, Matsushita Technical Journal, V51; Misugi K., 2005, INT ASS TRAFFIC SAFE, V29, P40; Publication Committee & Information Exchange Center, 2010, ADV EX UD CHALL DIV; Standardization Study Worldng Group, 2009, IAUD UN DES MATR VER; Szenasy S., 2004, DES 21 CENT 3 INT C; Tsuchimura K., 2009, JAPAN PACKAGING I J, V48, P27	12	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0003-6870	1872-9126		APPL ERGON	Appl. Ergon.	JAN	2015	46		B		SI		258	266		10.1016/j.apergo.2013.03.007		9	Engineering, Industrial; Ergonomics; Psychology, Applied	Engineering; Psychology	AY4ZX	WOS:000347584400004		
J	Ogawa, T; Ohki, K; Kamiya, M				Ogawa, Taku; Ohki, Kaori; Kamiya, Mitsunobu			High heterozygosity and phenotypic variation of zoids in apomictic Ulva prolifera (Ulvophyceae) from brackish environments	AQUATIC BOTANY			English	Article						Apomixis; Ecophysiology; hsp90; Phototaxis; Salinity; Speciation	INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; ENTEROMORPHA-PROLIFERA; CONCERTED EVOLUTION; COMPRESSA CHLOROPHYTA; GENETIC-VARIATION; CLONAL VARIATION; GREEN-ALGAE; YELLOW SEA; INTESTINALIS	Apomictic reproduction without alternation of generations has been reported in Ulva prolifera Muller from some brackish environments, and few genetic and phenotypic variations are expected in such apomictic populations. We collected 534 specimens of U. prolifera throughout the year from brackish lakes and a river and genotyped all the samples using a nuclear-encoded hsp90 gene sequence. In total, 14 genotypes were detected, 12 of which were heterozygous (n = 531), and the genotype composition differed between the lakes and estuaries as well as between the high and low brackish sites. We tried to induce discharge of zoids from the collected thalli, and the phenotypes of zoids were examined in total 309 specimens. The flagellum number of the zoids differed among the eight most frequently encountered genotypes, i.e., six genotypes released only biflagellate zoids, whereas the other two produced quadriflagellate zoids. The ratio of specimens that produced positively phototactic zoids, which varied among the genotypes regardless of the flagellum number, was relatively high in the high-salinity brackish regions. The parthenogenetic thallus had the same genotype, flagellum number, and direction of phototaxis relative to the parental thallus in all the genotypes examined, which suggested clonal apomictic reproduction. Apomixis induction through outcrossing between genetically different entities has been reported in other algae and this may have occurred many times in U. prolifera. (C) 2014 Elsevier B.V. All rights reserved.	[Ogawa, Taku] Fukui Prefectural Univ, Grad Sch Biosci & Biotechnol, Obama, Fukui 9170003, Japan; [Ohki, Kaori; Kamiya, Mitsunobu] Fukui Prefectural Univ, Fac Marine Biosci, Obama, Fukui 9170003, Japan	Kamiya, M (reprint author), Fukui Prefectural Univ, Fac Marine Biosci, 1-1 Gakuen Cho, Obama, Fukui 9170003, Japan.	mkamiya@fpu.ac.jp			Mikimoto Fund for Marine Ecology; JSPS KAKENHI [19570092]	The authors would like to acknowledge the staffs of the Fukui Prefectural Kaihin Shizen Center for supporting sampling. We are grateful to Dr. Kazuyoshi Kuwano for providing an U. prolifera isolate and Dr. Shinya Yoshikawa for valuable discussion. This work was financially supported by the Mikimoto Fund for Marine Ecology and JSPS KAKENHI (19570092).	AMSLER CD, 1980, J PHYCOL, V16, P617, DOI 10.1111/j.0022-3646.1980.00617.x; Andersen R.A., 2005, ALGAL CULTURING TECH; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Blomster J, 1998, J PHYCOL, V34, P319, DOI 10.1046/j.1529-8817.1998.340319.x; Steele PR, 2008, MOL PHYLOGENET EVOL, V48, P1013, DOI 10.1016/j.ympev.2008.05.017; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Lin A, 2008, J INTEGR PLANT BIOL, V50, P622, DOI 10.1111/j.1744-7909.2008.00647.x; Kostamo K, 2008, PHYCOLOGIA, V47, P580, DOI 10.2216/08-16.1; Togashi T, 1999, SEX PLANT REPROD, V12, P158, DOI 10.1007/s004970050187; Hiraoka M, 2003, PHYCOLOGIA, V42, P275, DOI 10.2216/i0031-8884-42-3-275.1; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Zhuang YB, 2012, BIORESOURCE TECHNOL, V116, P133, DOI 10.1016/j.biortech.2012.04.036; Alstrom-Rapaport C, 2010, AQUAT BOT, V93, P244, DOI 10.1016/j.aquabot.2010.08.003; Hayakawa YI, 2012, PHYCOL RES, V60, P86, DOI 10.1111/j.1440-1835.2012.00641.x; REED RH, 1978, BRIT PHYCOL J, V13, P149; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; Zhao J, 2011, J APPL PHYCOL, V23, P227, DOI 10.1007/s10811-010-9563-1; Greer SP, 2004, J PHYCOL, V40, P44, DOI 10.1111/j.0022-3646.2003.03-044.x; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; HOXMARK RC, 1975, BOT MAR, V18, P123, DOI 10.1515/botm.1975.18.2.123; KOEMAN RPT, 1981, BRIT PHYCOL J, V16, P9; NISIZAWA K, 1987, HYDROBIOLOGIA, V151, P5, DOI 10.1007/BF00046102; Ogawa T, 2013, PHYCOLOGIA, V52, P637, DOI 10.2216/13-199.1; TANNER CE, 1986, PHYCOLOGIA, V25, P510, DOI 10.2216/i0031-8884-25-4-510.1; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Roche D, 2001, SEX PLANT REPROD, V13, P217, DOI 10.1007/s004970000060; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Duan WJ, 2012, J APPL PHYCOL, V24, P97, DOI 10.1007/s10811-011-9654-7; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; BLIDING C, 1968, BOT NOTISER, V121, P535; Bliding C.V., 1963, OPERA BOT SOC BOT LU, V8, P1; De Silva M.W.R.N., 1973, J MAR BIOL ASSOC UK, V53, P895; GASTONY GJ, 1986, AM J BOT, V73, P1563, DOI 10.2307/2443923; Goldstein D, 1999, MICROSATELLITES EVOL; Hiraoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019371; Hiraoka Masanori, 2003, Phycological Research, V51, P29; Huh Man Kyu, 2004, Protistology, V3, P243; INNES DJ, 1987, MAR BIOL, V94, P459, DOI 10.1007/BF00428253; Kamiya M, 2011, J PHYCOL, V47, P753, DOI 10.1111/j.1529-8817.2011.01016.x; Kamiya M, 2008, J PHYCOL, V44, P977, DOI 10.1111/j.1529-8817.2008.00551.x; Kato F., 1990, B FUKUI CITY MUSEUM, V37, P59; Kato S, 2011, J PHYCOL, V47, P999, DOI 10.1111/j.1529-8817.2011.01037.x; Kauserud H, 2006, MOL ECOL, V15, P421, DOI 10.1111/j.1365-294X.2005.02768.x; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; KOEMAN R P T, 1982, Cryptogamie Algologie, V3, P37; KOEMAN R P T, 1984, Cryptogamie Algologie, V5, P21; Lee R.E., 2008, PHYCOLOGY; Leskinen E, 2004, MOL ECOL, V13, P2257, DOI 10.1111/j.1365-294X.2004.02219.x; Lin AP, 2011, PHYCOL RES, V59, P295, DOI 10.1111/j.1440-1835.2011.00629.x; Madani M, 2011, EUR J PLANT PATHOL, V130, P271, DOI 10.1007/s10658-011-9752-z; Michels E, 2004, HYDROBIOLOGIA, V522, P221, DOI 10.1023/B:HYDR.0000029988.02195.35; MOURITSEN O. G., 2013, SEAWEEDS EDIBLE AVAI; Park CH, 2003, J PLANT RES, V116, P93, DOI 10.1007/s10265-003-0081-y; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sung MS, 2011, MAR BIOTECHNOL, V13, P684, DOI 10.1007/s10126-010-9330-y; Togashi T, 2008, AQUAT ECOL, V42, P355, DOI 10.1007/s10452-007-9105-3; Tominaga H, 2012, FISHERIES SCI, V78, P415, DOI 10.1007/s12562-011-0451-7; [王建伟 WANG Jianwei], 2007, [海洋通报, Marine Science Bulletin], V26, P60; XiuChen L, 2012, T CSAE, V28, P200; YOUNG AJ, 1987, J EXP BOT, V38, P1298, DOI 10.1093/jxb/38.8.1298	64	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3770	1879-1522		AQUAT BOT	Aquat. Bot.	JAN	2015	120		B				185	192		10.1016/j.aquabot.2014.05.015		8	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	AY7RG	WOS:000347756100005		
J	Ng, WL; Szmidt, AE				Ng, Wei Lun; Szmidt, Alfred E.			Introgressive hybridization in two Indo-West Pacific Rhizophora mangrove species, R. mucronata and R. stylosa	AQUATIC BOTANY			English	Article						Indo-West Pacific Rhizophora; ISSR; Introgressive hybridization; Cryptic hybrid	MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; NATURAL HYBRIDIZATION; PENINSULAR MALAYSIA; MOLECULAR PHYLOGENY; HYBRIDS; SPECIATION; POLYMORPHISM; EVOLUTION; INFERENCE	Natural hybridization is common in plants, including mangroves. Three Rhizophora mangrove species are recognized in the Indo-West Pacific region, namely R. apiculata, R. mucronata, and R. stylosa. So far, R. apiculata has been known to form sterile hybrid offspring with R. mucronata (= R. x annamalayana) and with R. stylosa (= R. x lamarckii). A third hybrid between morphologically similar R. mucronata and R. stylosa was only recently shown to exist, via DNA sequencing. However, it has been suspected that this newly discovered hybrid may be fertile, with potential to interbreed to give rise to advanced-generation hybrids in locations where both parental species occur. In this study, inter-simple sequence repeat (ISSR) markers were used to survey several stands where R. mucronata and R. stylosa co-occur. By screening through 26 ISSR primers, a set of species-specific diagnostic bands for each species were first identified from standard samples before being used to genotype the test samples. A chloroplast DNA locus was also sequenced in the test samples to determine the direction of hybridization. Results showed that hybridization occurred between R. mucronata and R. stylosa in all investigated locations with differing levels of introgression, and that it could happen in any direction. (C) 2014 Elsevier B.V. All rights reserved.	[Ng, Wei Lun; Szmidt, Alfred E.] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Ng, Wei Lun] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Malaysia	Szmidt, AE (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	aszmiscb@kyushu-u.org			Global Environment Research Fund from the Ministry of Environment, Japan [D-0901]; Global COE Program, Ministry of Education, Culture, Sports, Science & Technology, Japan	We are grateful to Dr. Hung Tuck Chan, Dr. Iskandar Z. Siregar, and Prof. Cecep Kusmana for assisting with sample collection in Malaysia and Indonesia. Dr. Hung Tuck Chan and anonymous reviewers provided helpful comments and suggestions to an earlier draft of the manuscript. This study was supported in part by the Global Environment Research Fund (D-0901) from the Ministry of Environment, Japan, and the Global COE Program, Ministry of Education, Culture, Sports, Science & Technology, Japan.	Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Anderson EC, 2002, GENETICS, V160, P1217; Guo MM, 2011, AQUAT BOT, V95, P59, DOI 10.1016/j.aquabot.2011.03.001; Duke NC, 2010, BLUMEA, V55, P171, DOI 10.3767/000651910X527293; Ng WL, 2013, TREE GENET GENOMES, V9, P1151, DOI 10.1007/s11295-013-0619-7; Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ceron-Souza I, 2010, AM J BOT, V97, P945, DOI 10.3732/ajb.0900172; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Inomata N, 2009, GENES GENET SYST, V84, P277; Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Wolfe AD, 1998, MOL ECOL, V7, P1107, DOI 10.1046/j.1365-294x.1998.00425.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Falush D, 2003, GENETICS, V164, P1567; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Chan H. T., 1996, Journal of Tropical Forest Science, V9, P128; Duke NC, 2006, SPECIES PROFILES PAC; Duke NC, 2011, BLUMEA, V56, P36, DOI 10.3767/000651911X572968; Kathiresan K., 1999, Environment and Ecology, V17, P500; Kathiresan K., 1995, ENV ECOL, V13, P240; Nasir HM, 2007, J TROP FOR SCI, V19, P57; Ng WL, 2012, ISME GLOMIS ELECT J, V10, P1; Ng WL, 2012, ISME GLOMIS ELECT J, V10, P4; Pannacciulli FG, 2009, MAR BIOL, V156, P2441, DOI 10.1007/s00227-009-1269-z; Parani M, 1997, AQUAT BOT, V58, P165, DOI 10.1016/S0304-3770(97)00003-X; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Qiu Suo, 2008, Journal of Systematics and Evolution, V46, P391; Ragavan P., 2011, ISME GLOMIS ELECT J, V9, P13; Sun M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019671; Tomlinson P. B., 1986, BOT MANGROVES; Tsai CC, 2012, BIOCHEM SYST ECOL, V43, P178, DOI 10.1016/j.bse.2012.03.009; Tyagi AP, 2002, S PAC J NAT SCI, V20, P1; Weber E, 2000, BIOL INVASIONS, V2, P207, DOI DOI 10.1023/A:1010003603310; Wissemann V, 2007, SYST BIODIVERS, V5, P243, DOI 10.1017/S1477200007002381	42	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3770	1879-1522		AQUAT BOT	Aquat. Bot.	JAN	2015	120		B				222	228		10.1016/j.aquabot.2014.07.006		7	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	AY7RG	WOS:000347756100010		
J	Nagasawa, T; Matsushima-Nishiwaki, R; Yasuda, E; Matsuura, J; Toyoda, H; Kaneoka, Y; Kumada, T; Kozawa, O				Nagasawa, Tomoaki; Matsushima-Nishiwaki, Rie; Yasuda, Eisuke; Matsuura, Junya; Toyoda, Hidenori; Kaneoka, Yuji; Kumada, Takashi; Kozawa, Osamu			Heat shock protein 20 (HSPB6) regulates TNF-alpha-induced intracellular signaling pathway in human hepatocellular carcinoma cells	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						HSP20; TNF-alpha; HCC; IKK-alpha; Cell proliferation	NF-KAPPA-B; TUMOR PROGRESSION; EXPRESSION LEVELS; LIVER-CANCER; IKK-BETA; HSP20; PHOSPHORYLATION; INHIBITION; APOPTOSIS; KINASES	We previously demonstrated that the expression of HSP20, a small heat shock protein, is inversely correlated with the progression of HCC. Inflammation is associated with HCC, and numerous cytokines, including TNF-alpha, act as key mediators in the progression of HCC. In the present study, we investigated whether HSP20 is implicated in the TNF-alpha-stimulated intracellular signaling in HCC using human HCC-derived HuH7 cells in the presence of TNF-alpha. In HSP20-overexpressing HCC cells, the cell growth was retarded compared with that in the control cells under long-term exposure of TNF-alpha. Because NF-kappa B pathway is the main intracellular signaling system activated by TNF-alpha, we investigated the effects of HSP20-overexpression of this pathway. The protein levels of but not IKK-beta, in the HSP20-overexpressing cells were decreased. Short-term exposure to TNF-alpha-induced phosphorylation and degradation of 1 kappa B, and the phosphorylation and transactivational activity of NF-kappa B were suppressed in the HSP20-overexpressing HCC cells. Furthermore, the increase in IKK-alpha levels was accompanied by a decrease in the HSP20 levels in human HCC tissues. These findings strongly suggest that HSP20 might decrease the IKK-alpha protein level and that it down-regulates the TNF-alpha-stimulated intracellular signaling in HCC, thus resulting in the suppression of HCC progression. (C) 2014 Elsevier Inc. All rights reserved.	[Nagasawa, Tomoaki; Matsushima-Nishiwaki, Rie; Matsuura, Junya; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Yasuda, Eisuke; Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu 5038502, Japan; [Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Gifu 5038502, Japan; [Yasuda, Eisuke] Suzuka Univ Med Sci, Dept Radiol Technol, Suzuka 5138670, Japan	Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460989]	We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (25460989 to O.K.) from the Ministry of Education, Science, Sports and Culture of Japan.	Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Jiang RQ, 2010, INT J CANCER, V126, P1263, DOI 10.1002/ijc.24854; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Dreiza CM, 2010, CELL STRESS CHAPERON, V15, P1, DOI 10.1007/s12192-009-0127-8; Wang XH, 2009, J MOL CELL CARDIOL, V47, P382, DOI 10.1016/j.yjmcc.2009.05.016; Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; KATO K, 1994, J BIOL CHEM, V269, P15302; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cui RW, 2006, CIRC RES, V99, P723, DOI 10.1161/01.RES.0000244015.10655.3f; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; Moles A, 2013, HEPATOLOGY, V57, P817, DOI 10.1002/hep.26068; Nagasawa T., 2014, ONCOL REP; Nishimura D, 2006, INT J ONCOL, V29, P713; Noda T, 2007, ONCOL REP, V17, P1309; Yasuda E, 2005, BIOCHEM BIOPH RES CO, V337, P337, DOI 10.1016/j.bbrc.2005.08.273	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	JAN 1	2015	565						1	8		10.1016/j.abb.2014.10.010		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ1OL	WOS:000348008000001		
J	Watanabe-Matsui, M; Matsumoto, T; Matsui, T; Ikeda-Saito, M; Muto, A; Murayama, K; Igarashi, K				Watanabe-Matsui, Miki; Matsumoto, Takashi; Matsui, Toshitaka; Ikeda-Saito, Masao; Muto, Akihiko; Murayama, Kazutaka; Igarashi, Kazuhiko			Heme binds to an intrinsically disordered region of Bach2 and alters its conformation	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Intrinsically disordered protein; Heme binding; Small-angle X-ray scattering; Chemical modification; Conformation change	SMALL-ANGLE SCATTERING; ANTIBODY CLASS SWITCH; REV-ERB-ALPHA; TRANSCRIPTION FACTOR; CIRCULAR-DICHROISM; B-CELLS; X-RAY; REPRESSOR BACH2; PROTEINS; BLIMP-1	The transcriptional repressor Bach2 regulates humoral and cellular immunity, including antibody class switching. It possesses a basic leucine zipper domain that mediates DNA binding. Heme inhibits the DNA-binding activity of Bach2 in vitro and induces the degradation of Bach2 in B cells. However, the structural basis of the heme-Bach2 interaction has not been identified. Spectroscopic analyses revealed that Bach2(331-52) is the heme-binding domain, as it includes three Cys-Pro motifs known to be important for heme binding. Heme-titration experiments demonstrated the presence of 5- and 6-coordinated heme-binding modes. Circular dichroism measurements indicated that Bach2(331-52) exists mostly in a random-coil conformation. However, dynamic light scattering analyses showed that, upon heme binding to Bach2331-520, this region becomes denatured at a lower temperature, as compared with unbound Bach2(331-520). In addition, small-angle X-ray scattering and chemical modification analyses revealed that heme binding induces conformational alterations within the unstructured region. A GAL4-based luciferase assay in 293T cells showed that heme alters the protein interactions mediated by Bach2(331-520). These observations suggested that the unstructured region of Bach2 is important for heme binding, and consequently for its functional regulation. (C) 2014 Elsevier Inc. All rights reserved.	[Watanabe-Matsui, Miki; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan; [Matsumoto, Takashi] Rigaku Corp, Akishima, Tokyo, Japan; [Matsui, Toshitaka; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan; [Murayama, Kazutaka] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 980, Japan; [Murayama, Kazutaka] RIKEN Yokohama Inst, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan; [Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi, Japan	Igarashi, K (reprint author), Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	kmura@bme.tohoku.ac.jp; igarashi@med.tohoku.ac.jp	Matsui, Toshitaka/B-1570-2008		JSPS [24570175, 23790320, 21249014, 24350081]	We thank our technical scientist, Ryogo Akasaka (RIKEN Systems and Structural Biology Center, Systems and Structural Biology Research Team), for assistance with the analytical ultracentrifugation experiments. We acknowledge the support of the Biomedical Research Core of Tohoku University, Graduate School of Medicine, and TAMRIC (Tohoku Advanced Medical Research and Incubation Center). This work was supported by a JSPS Grant-in-Aid for Scientific Research (C) Number 24570175 (K. M.), a Grant-in-Aid for Young Scientists (B) Number 23790320 (M. W.-M.), a Grant-inAid for Scientific Research (A) Number 21249014 (K. I.), a Grantin-Aid for Scientific Research (B) Number 24350081 (M. I.-S.), and a Grant-in-Aid for Scientific Research (C) Number 23550186 (T. M.). M. W.-M. was also supported by the Naito Foundation Subsidy for Female Researchers. This research was also supported by the Network Medicine Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and Takeda Science Foundation (K. M. and K. I.), as well as by Grantsin-Aid for Scientific Research on Innovative Areas, Numbers 23117702 (A. M.), 2412006 (M. I.-S.) and 25109504 (T. M.).	Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Shiba K, 2010, ANAL SCI, V26, P659; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.0241-06; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973; Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c; Schuck P, 2000, BIOPHYS J, V78, P1606; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI DOI 10.1039/C1MB05275F; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229; Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x; Laue T.M., 1992, COMPUTER AIDED INTER, P90; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Roychoudhuri K.H.R., 2013, NATURE, V498, P506; Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Woody R. W., 2010, INSTRUMENTAL ANAL IN, P303	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	JAN 1	2015	565						25	31		10.1016/j.abb.2014.11.005		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ1OL	WOS:000348008000004		
J	Terazawa, S; Nakajima, H; Fukasawa, K; Imokawa, G				Terazawa, Shuko; Nakajima, Hiroaki; Fukasawa, Katsunori; Imokawa, Genji			Withaferin A abolishes the stem cell factor-stimulated pigmentation of human epidermal equivalents by interrupting the auto-phosphorylation of c-KIT in human melanocytes	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						Stem cell factor; Melanocytes; Intracellular signaling; Tyrosinase; Human epidermal equivalents; Anti-pigmentation	KAPPA-B KINASE; INNATE IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; SIGNALING MECHANISMS; WITHANIA-SOMNIFERA; MAP KINASE; TYROSINASE INHIBITORS; WAARDENBURG-SYNDROME; COMPOUND WITHAFERIN; THIOL MODIFICATION	We characterized the mechanism(s) underlying the abrogating effect of withaferin A (WFA) on the stem cell factor (SCF)-stimulated pigmentation of human epidermal equivalents (HEEs). Increased gene and protein expression levels of tyrosinase, tyrosinase-related protein1, dopachrome tautomerase, PMEL17, c-KIT and their targeted transcription factor, microphthalmia-associated transcription factor (MITF) were significantly reversed at days 7 and 10, respectively, by treatment with WFA. In WFA-treated normal human melanocytes (NHMs), there was a marked deficiency in the SCF-stimulated series of phosphorylations of c-KIT, Shc, Raf-1, MEK, ERK, MITF and CREB. Treatment with dithiothreitol (DTT) distinctly abolished the suppressive effect of WFA on the SCF-stimulated phosphorylation of c-KIT in NHMs. On the other hand, even after incubation at 4 A degrees C for 2 h with 5 nM SCF, followed by the removal of unbound SCF by washing and then raising the temperature to 37 A degrees C to start the signaling reaction, c-KIT was distinctly phosphorylated to a similar extent by incubation for 15 min with SCF only or with SCF + WFA. These findings indicate that WFA attenuates the SCF-induced activation of c-KIT in NHMs by interrupting the auto-phosphorylation of c-KIT through DTT-suppressible Michael addition thioalkylation reactions without interrupting the binding of SCF to the c-KIT receptor.	[Terazawa, Shuko; Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 4878501, Japan; [Nakajima, Hiroaki; Fukasawa, Katsunori] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo 1920982, Japan	Imokawa, G (reprint author), Chubu Univ, Res Inst Biol Funct, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.	imokawag@dream.ocn.ne.jp					ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Paine C, 2001, J INVEST DERMATOL, V116, P587, DOI 10.1046/j.1523-1747.2001.01291.x; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Bertolotto C, 1998, MOL CELL BIOL, V18, P694; Ando H, 1999, J LIPID RES, V40, P1312; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996; Salojin KV, 2006, J IMMUNOL, V176, P1899; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Hattori H, 2004, J INVEST DERMATOL, V122, P1256, DOI 10.1111/j.0022-202X.2004.22503.x; Nakajima H, 2012, J NAT MED-TOKYO, V66, P435, DOI 10.1007/s11418-011-0604-0; LAVIE D, 1965, J ORG CHEM, V30, P1774, DOI 10.1021/jo01017a015; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Hehner SP, 1999, J IMMUNOL, V163, P5617; Adams JD, 2002, ALTERN THER HEALTH M, V8, P18; Vasudevan SA, 2005, BIOCHEM BIOPH RES CO, V330, P511, DOI 10.1016/j.bbrc.2005.03.028; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Imokawa G, 1996, BIOCHEM J, V314, P305; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Emami S, 2012, ARCH PHARM, V345, P629, DOI 10.1002/ardp.201200028; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Hachiya A, 2001, J INVEST DERMATOL, V116, P578, DOI 10.1046/j.1523-1747.2001.01290.x; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; An SM, 2010, PHYTOTHER RES, V24, P1175, DOI 10.1002/ptr.3095; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Bernier M, 2006, J BIOL CHEM, V281, P2551, DOI 10.1074/jbc.M511878200; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; Hemesath TJ, 1998, NATURE, V391, P298; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Wan P, 2011, MOL CELL BIOCHEM, V354, P241, DOI 10.1007/s11010-011-0823-4; BLUMEJENSEN P, 1991, EMBO J, V10, P4121; Cha S.-H., 2011, DERMATOLOGY, V38, P354; Chung KW, 2012, BBA-GEN SUBJECTS, V1820, P962, DOI 10.1016/j.bbagen.2012.03.018; Codreanu SG, 2006, BIOCHEMISTRY-US, V45, P10020, DOI 10.1021/bi060551n; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; Foley TD, 2004, BIOCHEM BIOPH RES CO, V315, P568, DOI 10.1016/j.bbrc.2004.01.096; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Liang MC, 2003, MOL PHARMACOL, V64, P123, DOI 10.1124/mol.64.1.123; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; LIU L, 1994, MOL CELL BIOL, V14, P6926; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; Nakajima H, 2011, PHYTOTHER RES, V25, P1398, DOI 10.1002/ptr.3552; Nakajima H, 2011, ARCH DERMATOL RES, V303, P263, DOI 10.1007/s00403-011-1143-y; Nakajima H, 2012, ARCH DERMATOL RES, V304, P803, DOI 10.1007/s00403-012-1248-y; Noh JM, 2007, BIOPOLYMERS, V88, P300, DOI 10.1002/bip.20670; Peyregne VP, 2005, MOL CANCER THER, V4, P595, DOI 10.1158/1535-7163.MCT-04-0274; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Prasanna KS, 2009, CURR TRENDS BIOTECHN, V3, P138; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; ROSAZZA JP, 1978, STEROIDS, V31, P671, DOI 10.1016/S0039-128X(78)80007-5; Samadi AK, 2012, TUMOR BIOL, V33, P1179, DOI 10.1007/s13277-012-0363-x; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Shin HM, 2006, INT IMMUNOPHARMACOL, V6, P916, DOI 10.1016/j.intimp.2006.01.006; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; Ueda K, 2002, FEBS LETT, V525, P48, DOI 10.1016/S0014-5793(02)03065-X; Vontzalidou A, 2012, BIOORG MED CHEM LETT, V22, P5523, DOI 10.1016/j.bmcl.2012.07.029; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YADA Y, 1991, J BIOL CHEM, V266, P18352; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039	73	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	JAN	2015	307	1					73	88		10.1007/s00403-014-1518-y		16	Dermatology	Dermatology	AY0KS	WOS:000347286100008		
J	Maw, AA; Kawabe, K; Shimogiri, T; Rerkamnuaychoke, W; Kawamoto, Y; Masuda, S; Okamoto, S				Maw, A. A.; Kawabe, K.; Shimogiri, T.; Rerkamnuaychoke, W.; Kawamoto, Y.; Masuda, S.; Okamoto, S.			Genetic Diversity and Population Structure in Native Chicken Populations from Myanmar, Thailand and Laos by Using 102 Indels Markers	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Indels Markers; Genetic Admixture; Genetic Diversity; Native Chicken	NATURAL-POPULATIONS; POLYMORPHISMS; HETEROZYGOSITY; CONSTITUTION; INDIVIDUALS; NUMBER	The genetic diversity of native chicken populations from Myanmar, Thailand, and Laos was examined by using 102 insertion and/or deletion (indels) markers. Most of the indels loci were polymorphic (71% to 96%), and the genetic variability was similar in all populations. The average observed heterozygosities (H-0) and expected heterozygosities (HE) ranged from 0.205 to 0.263 and 0.239 to 0.381, respectively. The coefficients of genetic differentiation (Gst) for all cumulated populations was 0.125, and the Thai native chickens showed higher Gst (0.088) than Myanmar (0.041) and Laotian (0.024) populations. The pairwise Fst distances ranged from 0.144 to 0.308 among populations. A neighbor-joining (NJ) tree, using Nei's genetic distance, revealed that Thai and Laotian native chicken populations were genetically close, while Myanmar native chickens were distant from the others. The native chickens from these three countries were thought to be descended from three different origins (K = 3) from STRUCTURE analysis. Genetic admixture was observed in Thai and Laotian native chickens, while admixture was absent in Myanmar native chickens.	[Maw, A. A.] Univ Vet Sci, Yezin 05282, Nay Pyi Taw, Myanmar; [Maw, A. A.; Shimogiri, T.; Okamoto, S.] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Kawabe, K.] Kagoshima Univ, Nat Sci Ctr Res & Educ, Kagoshima 8900065, Japan; [Rerkamnuaychoke, W.] Kasetsart Univ, Fac Vet Med, Bangkok 10900, Thailand; [Kawamoto, Y.] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan; [Masuda, S.] Tokai Univ, Liberal Arts Educ Ctr, Tokyo 8691404, Japan	Kawabe, K (reprint author), Kagoshima Univ, Nat Sci Ctr Res & Educ, Kagoshima 8900065, Japan.	kawabe@gene4.agri.kagoshima-u.ac.jp					Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; NEI M, 1978, GENETICS, V89, P583; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Pritchard JK, 2000, GENETICS, V155, P945; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; LEWONTIN RC, 1966, GENETICS, V54, P595; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Cocks S. W., 1919, SHORT HIST BURMA; Dorji N, 2011, TROP ANIM HEALTH PRO, V43, P779, DOI 10.1007/s11250-010-9763-3; Kawabe K, 2014, ASIAN AUSTRAL J ANIM, V27, P19, DOI 10.5713/ajas.2013.13443; Kinoshita K, 2002, ASIAN AUSTRAL J ANIM, V15, P157; Maw AA, 2012, ASIAN AUSTRAL J ANIM, V25, P927, DOI 10.5713/ajas.2011.11511; Mwacharo J. M., 2006, J ANIM GENET JPN, V34, P63; Natalie S. C. F, 2010, INT J LEGAL MED, V124, P589; Nishida Takao, 2000, Animal Science Journal, V71, P470; Okamoto S, 1999, ASIAN AUSTRAL J ANIM, V12, P1011; Okamoto S., 2004, RES REPORT SOC NATIV, V21, P237; Okumura F, 2006, ANIM SCI J, V77, P188, DOI 10.1111/j.1740-0929.2006.00336.x; Riztyan, 2011, POULTRY SCI, V90, P2471; Riztyan, 2012, J POULT SCI, V49, P68; Sambrook J., 1989, MOL CLONING LAB MANU; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Weir BS, 1996, GENETIC DATA ANAL; Yazawin Hmannan, 1829, TABINSHWEHTIS AYUTTH	28	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	JAN	2015	28	1					14	19		10.5713/ajas.14.0212		6	Agriculture, Dairy & Animal Science	Agriculture	AY9KZ	WOS:000347870000003		
J	Wynn, S; Teramura, M; Sato, T; Hanada, M				Wynn, S.; Teramura, M.; Sato, T.; Hanada, M.			Changes of Serum Calcium Concentration, Frequency of Ruminal Contraction and Feed Intake Soon after Parturition of Dairy Cows Fed Difructose Anhydride Ill	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Dairy Cows; Difructose Anhydride III; Feed Intake; Serum Calcium Concentration; Ruminal Contraction	LARGE INTESTINAL EPITHELIUM; ENHANCE NET CALCIUM; DRY-MATTER INTAKE; TRANSITION PERIOD; PERIPARTURIENT DISEASES; TIGHT JUNCTIONS; EARLY LACTATION; MILK FEVER; RAT SMALL; ABSORPTION	Requirements to control the large decrease in serum calcium (Ca) due to parturition and to increase the feed intake soon after parturition have been well accepted in dairy cows. This study was aimed to investigate the feed intake affected by serum Ca concentration with difructose anhydride (DFA) III supplement in daily cows soon after parturition. Fourteen transition Holstein cows were divided into DFA and control (CONT) groups within 1 to 5 parity variations in each group. Measurement schedule for an individual cow was from 14 d before parturition to 7 d following parturition. The cows in DFA group were supplied 0.2 kg/head/d of DFA III feed containing 40 g of pure DFA III while the cows in CONT group received no DFA III. Other feeding procedures were the same for all cows in both groups. At parturition (d 0), serum Ca concentration sharply declined in both groups (p<0.05). Time interval for recovery from decreased serum Ca to its normal range (>9.0 mg/dL) tended to be faster in DFA group (12 h) than in the CONT group (48 h), but the differences were not significant. Active ruminal contraction was observed in DFA group at following parturition of d 1 (p<0.05), d 3 (p<0.05), and d 5 (p<0.01). Dry matter (DM) intake did not differ between the groups. However, positive correlations were observed between serum Ca concentration and ruminal contraction (p<0.001), and between ruminal contraction and DM intake (p<0.001) during following parturition. According to multiple regression analysis (R-2 = 0.824, p<0.001), the DM intake was positively affected by serum Ca concentration and ruminal contraction. These results suggest that feed intake soon after parturition in dairy cows can be increased by improvement of serum Ca concentration and active ruminal contraction, but DFA III supplementation in this study did not improve the lower serum Ca concentration due to parturition.	[Wynn, S.] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Teramura, M.; Sato, T.] Nippon Beet Sugar Mfg Co Ltd, Res Ctr, Obihiro, Hokkaido 0800831, Japan; [Hanada, M.] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan	Hanada, M (reprint author), Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan.	hanada@obihiro.ac.jp					Coblentz WK, 2010, J DAIRY SCI, V93, P1148, DOI 10.3168/jds.2009-2701; Grummer RR, 2004, VET CLIN N AM-FOOD A, V20, P447, DOI 10.1016/j.cvfa.2004.06.013; GOFF JP, 1993, J DAIRY SCI, V76, P101, DOI 10.3168/jds.S0022-0302(93)77328-2; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053; Kikuchi H, 2009, J BIOSCI BIOENG, V107, P262, DOI 10.1016/j.jbiosc.2008.11.013; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573; Hayirli A, 2002, J DAIRY SCI, V85, P3430, DOI 10.3168/jds.S0022-0302(02)74431-7; Goff JP, 2004, VET CLIN N AM-FOOD A, V20, P471, DOI 10.1016/j.cvfa.2004.06.003; Mineo H, 2002, J NUTR, V132, P3394; BALLARD ST, 1995, ANNU REV NUTR, V15, P35; Sato T, 2012, J DAIRY SCI, V95, P5336, DOI 10.3168/jds.2011-4989; HERDT TH, 1988, VET CLIN N AM-FOOD A, V4, P213; Horst RL, 1997, J DAIRY SCI, V80, P1269; Shigematsu N, 2004, BIOSCI BIOTECH BIOCH, V68, P1011, DOI 10.1271/bbb.68.1011; Drackley JK, 1999, J DAIRY SCI, V82, P2259; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914; Drackley JK, 2005, ITAL J ANIM SCI, V4, P323; Kimura K, 2006, J DAIRY SCI, V89, P2588; Suzuki T, 1998, BIOSCI BIOTECH BIOCH, V62, P837, DOI 10.1271/bbb.62.837; CURTIS CR, 1983, J AM VET MED ASSOC, V183, P559; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; Vandehaar MJ, 1999, J DAIRY SCI, V82, P1282; AOAC, 2003, OFFICIAL METHODS ANA; BORSBERRY S, 1989, VET REC, V124, P217; BRONNER F, 1992, J NUTR, V122, P641; DANIEL RCW, 1983, CAN J COMP MED, V47, P276; Forbes J. M., 1995, VOLUNTARY FOOD INTAK; GOFF JP, 1991, J DAIRY SCI, V74, P4022; Goff JP, 1997, J DAIRY SCI, V80, P1260; GRANT RJ, 1995, J ANIM SCI, V73, P2791; Hayirli A., 1999, J DAIRY SCI S1, V82, P113; HUBER TL, 1981, AM J VET RES, V42, P1488; Johansson B., 1987, J CARDIOVASC PHARM, V10, P9; JONSSON G, 1970, VET REC, V87, P575; JONSSON NN, 1999, ANIMAL SCI, V68, P377; Kamiya Yuko, 2005, Animal Science Journal, V76, P325, DOI 10.1111/j.1740-0929.2005.00271.x; Kume Shin-ichi, 2003, Animal Science Journal, V74, P211, DOI 10.1046/j.1344-3941.2003.00107.x; Mineo H, 2004, DIGEST DIS SCI, V49, P122, DOI 10.1023/B:DDAS.0000011613.11671.c7; NRC, 2001, NUTR REQ DAIR CATTL; RAMBERG CF, 1970, AM J PHYSIOL, V219, P1166; ROMO GA, 1991, J DAIRY SCI, V74, P3068; Sato T., 2007, ANIM SCI J, V78, P37; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583	43	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	JAN	2015	28	1					58	68		10.5713/ajas.14.0418		11	Agriculture, Dairy & Animal Science	Agriculture	AY9KZ	WOS:000347870000008		
J	Shrestha, BB; Karanjit, S; Higashibayashi, S; Amaya, T; Hirao, T; Sakurai, H				Shrestha, Binod Babu; Karanjit, Sangita; Higashibayashi, Shuhei; Amaya, Toru; Hirao, Toshikazu; Sakurai, Hidehiro			Investigation of the Dynamic Behavior of Bisumanenyl	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						bisumanenyl; bowl inversion; conformation analysis; polyaromatic hydrocarbons; sumanene	TO-BOWL INVERSION; SUMANENE DERIVATIVES; ENANTIOSELECTIVE SYNTHESIS; TRIMETHYLSUMANENE; SUBSTITUENT; BUCKYBOWL	The behavior of bisumanenyl is dynamic as a result of inversion of each of its sumanene bowls and rotation between the two bowls. This behavior was fully elucidated by a combination of NMR experiments and density functional theory calculations. The MM (or PP) and MP diastereomers are in thermodynamic equilibrium at room temperature and the MM (PP) diastereomer is 1.4-1.9kcalmol(-1) more stable than MP diastereomer. The calculated energy for inversion between the two forms of the bowl is 19.2kcalmol(-1). The MM (PP) and MP diastereomers have two rotational stable conformers that rapidly interconvert as a result of the low rotational energy barriers, which were calculated to be 3.9 and 8.9kcalmol(-1), respectively.	[Shrestha, Binod Babu; Karanjit, Sangita; Amaya, Toru; Hirao, Toshikazu; Sakurai, Hidehiro] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Higashibayashi, Shuhei] Inst Mol Sci, Res Ctr Integrat Mol Syst, Okazaki, Aichi 4448787, Japan	Higashibayashi, S (reprint author), Inst Mol Sci, Res Ctr Integrat Mol Syst, Okazaki, Aichi 4448787, Japan.	higashi@ims.ac.jp; hirao@chem.eng.osaka-u.ac.jp					Amaya T, 2012, PURE APPL CHEM, V84, P1089, DOI 10.1351/PAC-CON-11-09-09; Amaya T., 2013, ASIAN J ORG CHEM, V2, P642; Amaya T, 2010, PURE APPL CHEM, V82, P969, DOI 10.1351/PAC-CON-09-10-13; BOTT G, 1980, J AM CHEM SOC, V102, P5618, DOI 10.1021/ja00537a036; Sakurai H, 2003, SCIENCE, V301, P1878, DOI 10.1126/science.1088290; SCOTT LT, 1992, J AM CHEM SOC, V114, P1920, DOI 10.1021/ja00031a079; [Anonymous], 2004, ANGEW CHEM, V116, P5593; Seiders TJ, 2001, J AM CHEM SOC, V123, P517, DOI 10.1021/ja0019981; Amaya T, 2008, CHEM COMMUN, P765, DOI 10.1039/b712839h; Higashibayashi S, 2012, B CHEM SOC JPN, V85, P450, DOI 10.1246/bcsj.20110286; Tsuruoka R, 2010, CHEM LETT, V39, P646, DOI 10.1246/cl.2010.646; ANET FAL, 1967, J AM CHEM SOC, V89, P760, DOI 10.1021/ja00980a006; Higashibayashi S, 2008, J AM CHEM SOC, V130, P8592, DOI 10.1021/ja802822k; Mazzanti A, 2006, J ORG CHEM, V71, P5474, DOI 10.1021/jo060205b; Eisenberg D, 2008, J ORG CHEM, V73, P6073, DOI 10.1021/jo800359z; Petrukhina MA, 2004, ANGEW CHEM INT EDIT, V43, P5477, DOI 10.1002/anie.200460855; Shrestha BB, 2014, BEILSTEIN J ORG CHEM, V10, P841, DOI 10.3762/bjoc.10.80; Shrestha BB, 2013, CHEM LETT, V42, P386, DOI 10.1246/cl.121273; Shrestha BB, 2014, PURE APPL CHEM, V86, P747, DOI 10.1515/pac-2013-1212; Tan Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1896	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JAN	2015	4	1					62	68		10.1002/ajoc.201402226		7	Chemistry, Organic	Chemistry	AY8EB	WOS:000347786100009		
J	Oonishi, Y; Saito, A; Sato, Y				Oonishi, Yoshihiro; Saito, Akira; Sato, Yoshihiro			Rhodium(I)-Catalyzed Intermolecular [2+2+2] Cycloaddition of Allenyl Aldehydes with Alkynes and Related Cyclization	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						[2+2+2] cycloaddition; alkynes; allenyl aldehydes; asymmetric synthesis; rhodium	METHYLENE-GAMMA-BUTYROLACTONES; ARYL ETHYNYL ETHERS; CARBONYL-COMPOUNDS; ARYLATIVE CYCLIZATION; AROMATIC-COMPOUNDS; PALLADIUM COMPLEX; RHODIUM-COMPLEX; KETONES; CYCLOCARBONYLATION; CARBOCYCLIZATION	Rhodium(I)-catalyzed cyclization of allenyl aldehydes with various alkynes was investigated. The cyclizations of internal alkynes that have both an electron-rich aromatic ring and an electron-withdrawing group at the terminus afforded [2+2+2] cycloaddition products in good yields with good to high regio- and enantioselectivity, while the reactions of terminal alkynes gave dienyl ketones instead of [2+2+2] cycloaddition products in good yields. These results indicate that the nature of the alkynes greatly influences the reaction course.	[Oonishi, Yoshihiro; Saito, Akira; Sato, Yoshihiro] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Sato, Yoshihiro] ACT C Japan Sci & Technol Agcy JST, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Oonishi, Y (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Nishi 6,Kita 12, Sapporo, Hokkaido 0600812, Japan.	biyo@pharm.hokudai.ac.jp					Agenet N., 2007, ORG REACTIONS, V68, P1; Amarasinghe KKD, 2002, J AM CHEM SOC, V124, P9366, DOI 10.1021/ja027148y; Dominguez G, 2011, CHEM SOC REV, V40, P3430, DOI 10.1039/c1cs15029d; TSUDA T, 1988, J AM CHEM SOC, V110, P8570, DOI 10.1021/ja00233a057; Oonishi Y, 2011, J AM CHEM SOC, V133, P10386, DOI 10.1021/ja203824v; Tanaka K, 2008, ANGEW CHEM INT EDIT, V47, P1312, DOI 10.1002/anie.200704758; Yamaguchi H, 2006, ORG BIOMOL CHEM, V4, P3571, DOI 10.1039/b609242j; Tsukamoto H, 2008, ORG LETT, V10, P1047, DOI 10.1021/ol702966j; Takimoto M, 2011, SYNLETT, P1423, DOI 10.1055/s-0030-1260565; Tanaka K, 2007, ORG LETT, V9, P2203, DOI 10.1021/ol0707721; Wender PA, 2006, ANGEW CHEM INT EDIT, V45, P2459, DOI 10.1002/anie.200600300; Tanaka K, 2002, ORG LETT, V4, P933, DOI 10.1021/ol017308v; Tekavec TN, 2008, J ORG CHEM, V73, P2641, DOI 10.1021/jo702508w; Evans PA, 2005, J AM CHEM SOC, V127, P12466, DOI 10.1021/ja053123y; Tanaka K, 2009, CHEM-ASIAN J, V4, P508, DOI 10.1002/asia.200800378; Oonishi Y, 2012, ANGEW CHEM INT EDIT, V51, P11548, DOI 10.1002/anie.201206508; Li S, 2011, J HETEROCYCLIC CHEM, V48, P517, DOI 10.1002/jhet.555; Miyauchi Y, 2012, ORG LETT, V14, P5856, DOI 10.1021/ol3027158; Perreault S, 2009, CHEM SOC REV, V38, P3149, DOI 10.1039/b816702h; Yu CM, 2005, ORG LETT, V7, P3733, DOI 10.1021/ol0513701; Wender PA, 2001, J AM CHEM SOC, V123, P179, DOI 10.1021/ja0021159; Trost BM, 2014, ANGEW CHEM INT EDIT, V53, P2826, DOI 10.1002/anie.201305972; Shibata T, 2008, ORG BIOMOL CHEM, V6, P1317, DOI 10.1039/b720031e; Inglesby PA, 2010, CHEM SOC REV, V39, P2791, DOI 10.1039/b913110h; Chopade PR, 2006, ADV SYNTH CATAL, V348, P2307, DOI 10.1002/adsc.200600325; Bennacer B, 2005, J AM CHEM SOC, V127, P17756, DOI 10.1021/ja054221m; Yamamoto Y, 2002, J AM CHEM SOC, V124, P6844, DOI 10.1021/ja0264100; Masuda K, 2011, J AM CHEM SOC, V133, P6918, DOI 10.1021/ja201337x; Tanaka R, 2010, J AM CHEM SOC, V132, P1238, DOI 10.1021/ja9104655; Miyauchi Y, 2011, ANGEW CHEM INT EDIT, V50, P10922, DOI 10.1002/anie.201105519; Galan BR, 2009, ANGEW CHEM INT EDIT, V48, P2830, DOI 10.1002/anie.200804651; Oonishi Y, 2013, TETRAHEDRON, V69, P7713, DOI 10.1016/j.tet.2013.04.068; HAYASHI T, 1991, TETRAHEDRON-ASYMMETR, V2, P601, DOI 10.1016/S0957-4166(00)86112-1; FRYZUK MD, 1990, ORGANOMETALLICS, V9, P1359, DOI 10.1021/om00118a088; Galan B. R., 2009, ANGEW CHEM, V121, P2870; GLEITER R, 1989, TETRAHEDRON LETT, V30, P2893, DOI 10.1016/S0040-4039(00)99151-2; Guo XX, 2010, TETRAHEDRON-ASYMMETR, V21, P1730, DOI 10.1016/j.tetasy.2010.04.039; Ha YH, 2002, ORG LETT, V4, P1143, DOI 10.1021/ol025557t; Harvey D. F., 1989, SYNLETT, P15; Hong JT, 2010, ADV SYNTH CATAL, V352, P2949, DOI 10.1002/adsc.201000648; Ishida M, 2011, CHEM-EUR J, V17, P12578, DOI 10.1002/chem.201102418; JOLLY RS, 1990, J AM CHEM SOC, V112, P4965, DOI 10.1021/ja00168a055; Kang SK, 2002, ANGEW CHEM INT EDIT, V41, P343, DOI 10.1002/1521-3773(20020118)41:2<343::AID-ANIE343>3.0.CO;2-1; Kang S.-K., 2002, ANGEW CHEM, V114, P353, DOI 10.1002/1521-3757(20020118)114:2<353::AID-ANGE353>3.0.CO;2-M; Kang SK, 2002, J ORG CHEM, V67, P4376, DOI 10.1021/jo020017v; Kang SK, 2002, ANGEW CHEM INT EDIT, V41, P1584, DOI 10.1002/1521-3773(20020503)41:9<1584::AID-ANIE1584>3.0.CO;2-Y; Kang S.-K., 2002, ANGEW CHEM, V114, P1654, DOI 10.1002/1521-3757(20020503)114:9<1654::AID-ANGE1654>3.0.CO;2-I; Kang SK, 2003, ORG LETT, V5, P2813, DOI 10.1021/ol034787k; Kang SK, 2002, CHEM COMMUN, P2634, DOI 10.1039/b207620a; Ko KJ, 2007, B KOREAN CHEM SOC, V28, P1921; Kong JR, 2006, J AM CHEM SOC, V128, P16040, DOI 10.1021/ja0664786; Miyauchi Y., 2011, ANGEW CHEM, V123, P11114; Montgomery J, 2002, ORG LETT, V4, P4009, DOI 10.1021/ol026670m; Oonishi Y., 2012, ANGEW CHEM, V124, P11716; Otake Y, 2009, EUR J ORG CHEM, P2737, DOI 10.1002/ejoc.200900185; Sakashita K, 2014, CHEM LETT, V43, P1260, DOI 10.1246/c1.140448; Seong W, 2010, B KOREAN CHEM SOC, V31, P559, DOI 10.5012/bkcs.2010.31.03.559; Song M, 2005, TETRAHEDRON, V61, P11440, DOI 10.1016/j.tet.2005.08.066; SUDA T, 2011, EUR J ORG CHEM, V50, P4475; Suda T., 2011, ANGEW CHEM, V123, P4567; Takahashi T, 2002, J AM CHEM SOC, V124, P1144, DOI 10.1021/ja010678u; Tanaka K., 2008, ANGEW CHEM, V120, P1332, DOI 10.1002/ange.200704758; Tanaka K., 2013, TRANSITION METAL MED; Tecavec T. N., 2005, ORG LETT, V7, P4037; Trost B. M., 2014, ANGEW CHEM, V126, P2868; Tsuchikama K, 2007, SYNLETT, P1395, DOI 10.1055/s-2007-980352; Tsukamoto H, 2008, J AM CHEM SOC, V130, P388, DOI 10.1021/ja076080p; Varela JA, 2008, SYNLETT, P2571, DOI 10.1055/s-2008-1078275; Wender P. A., 2006, ANGEW CHEM, V118, P2519, DOI 10.1002/ange.200600300; Yu CM, 2004, J ORG CHEM, V69, P8506, DOI 10.1021/jo049252z; Zhou L, 2008, HETEROCYCLES, V76, P923; Zhou LS, 2010, HETEROCYCLES, V80, P725, DOI 10.3987/REV-09-SR(S)6	72	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	JAN	2015	4	1					81	86		10.1002/ajoc.201402239		6	Chemistry, Organic	Chemistry	AY8EB	WOS:000347786100011		
J	Li, N; Takeyama, T; Jordan, LA; Kohda, M				Li, Ning; Takeyama, Tomohiro; Jordan, Lyndon Alexander; Kohda, Masanori			Female control of paternity by spawning site choice in a cooperatively polyandrous cichlid	BEHAVIOUR			English	Article						cooperative polyandry; spawning site choice; female manipulation of paternity; multiple paternity; external fertilization; cryptic female choice	VARIABLE MATING SYSTEM; JULIDOCHROMIS-ORNATUS; REPRODUCTIVE SKEW; PRUNELLA-MODULARIS; SPERM COMPETITION; PARENTAL-ROLES; SOCIAL-STATUS; TESTIS SIZE; FISH; CARE	Multiple mating of females is widespread, and females often obtain direct and/or indirect benefits by mating with multiple males. However, female control of multiple paternity broods is usually only possible in internally fertilising animals with complex reproductive systems including cryptic female choice. Here we present direct evidence that a cooperative polyandrous cichlid fish with external fertilisation, Julidochromis transcriptus, uses environmental factors to manipulate male access to, and therefore paternity of, their egg clutches. Polyandrous females receive more paternal investment from both of large alpha males and small beta males than monogamous females. We used a 'step nest' design, in which large alpha males and small beta males were restricted to the wide and narrow nest areas respectively, and found that when kept in polyandrous trios, females laid their egg clutches exactly at the borderline between the two regions each male could access. In contrast, females in pairs laid their clutches in either the wide or narrow area depending on the size of their mating partner. Our results demonstrate that polyandrous females carefully choose egg deposition site, increasing the direct benefits they receive from mating partners by using environmental structures to manipulate paternity. In this way, externally fertilising J. transcriptus manipulate male behaviour in a manner similar to cryptic female choice in internally fertilising animals.	[Li, Ning; Takeyama, Tomohiro; Jordan, Lyndon Alexander; Kohda, Masanori] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan; [Takeyama, Tomohiro] Okayama Univ Sci, Fac Biosphere Geosphere Sci, Dept Biosphere Geosphere Sci, Kita Ku, Okayama 7000005, Japan; [Jordan, Lyndon Alexander] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Kohda, M (reprint author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan.	kohda.tangayika@gmail.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS)	We are grateful to members of the Laboratory of Animal Sociology, Osaka City University for their fruitful discussion and two anonymous reviewers for a number of valuable and helpful comments. All experiments were conducted in compliance with the Regulations on Animal Experiments in Osaka City University and the Japan Ethological Society. Financial support by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to M.K.), and by Japan Society for the Promotion of Science (JSPS) (to L.A.J.) is gratefully acknowledged.	Andersson M., 1994, SEXUAL SELECTION; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Cooney R, 2000, P ROY SOC B-BIOL SCI, V267, P801, DOI 10.1098/rspb.2000.1074; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Cockburn A, 2003, J ANIM ECOL, V72, P189, DOI 10.1046/j.1365-2656.2003.00694.x; BURKE T, 1989, NATURE, V338, P249, DOI 10.1038/338249a0; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Gasparini C, 2011, P ROY SOC B-BIOL SCI, V278, P2495, DOI 10.1098/rspb.2010.2369; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Li SH, 2002, BEHAV ECOL, V13, P87, DOI 10.1093/beheco/13.1.87; DAVIES NB, 1985, ANIM BEHAV, V33, P628, DOI 10.1016/S0003-3472(85)80087-7; Davies NB, 1996, ANIM BEHAV, V51, P27, DOI 10.1006/anbe.1996.0003; Arnqvist G, 2005, SEXUAL CONFLICT; Awata S, 2006, BEHAV ECOL, V17, P372, DOI 10.1093/beheco/arj043; Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; Awata S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1701, DOI 10.1007/s00265-008-0598-0; Awata S, 2006, J ETHOL, V24, P125, DOI 10.1007/s10164-005-0171-5; Awata S, 2004, BEHAVIOUR, V141, P1135, DOI 10.1163/1568539042664623; Awata S, 2010, ETHOLOGY, V116, P316, DOI 10.1111/j.1439-0310.2009.01735.x; Bertran J, 2004, ETHOL ECOL EVOL, V16, P181; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; BIRKHEAD TR, 1987, BEHAVIOUR, V101, P101, DOI 10.1163/156853987X00396; Bruintjes R, 2013, FUNCT ECOL, V27, P730, DOI 10.1111/1365-2435.12088; Cant MA, 2002, AM NAT, V160, P602, DOI 10.1086/342820; Clutton-Brock T., 1991, EVOLUTION PARENTAL C; Cockburn Andrew, 2004, P81, DOI 10.1017/CBO9780511606816.006; Davies N. B, 1992, DUNNOCK BEHAV SOCIAL; EASON PK, 1995, ANIM BEHAV, V49, P725; Eberhard W. G., 1996, FEMALE CONTROL SECUA; Harada Y, 1996, AM NAT, V147, P996, DOI 10.1086/285890; Harger R., 2009, REPROD SKEW VERTEBRA; Immler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1219, DOI 10.1007/s00265-009-0744-3; Kohda M, 2009, P R SOC B, V276, P4207, DOI 10.1098/rspb.2009.1175; Snow S. E. L., 2005, P ROY SOC LOND B BIO, V272, P1139; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; Whittingham LA, 1998, ANIM BEHAV, V55, P629, DOI 10.1006/anbe.1997.0751; Williams DA, 2004, BEHAV ECOL SOCIOBIOL, V55, P370, DOI 10.1007/s00265-003-0728-7; Wong BBM, 2004, ANIM BEHAV, V67, P583, DOI 10.1016/j.anbehav.2003.08.015	43	0	0	BRILL ACADEMIC PUBLISHERS	LEIDEN	PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS	0005-7959	1568-539X		BEHAVIOUR	Behaviour		2015	152	2					231	245		10.1163/1568539X-00003242		15	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	AZ1XU	WOS:000348029300007		
J	Nurrohman, H; Nakashima, S; Takagaki, T; Sadr, A; Nikaido, T; Asakawa, Y; Uo, M; Marshall, SJ; Tagami, J				Nurrohman, Hamid; Nakashima, Syozi; Takagaki, Tomohiro; Sadr, Alireza; Nikaido, Toru; Asakawa, Yuya; Uo, Motohiro; Marshall, Sally J.; Tagami, Junji			Immobilization of phosphate monomers on collagen induces biomimetic mineralization	BIO-MEDICAL MATERIALS AND ENGINEERING			English	Article						Functional monomer; chemical structure; steric hindrance; type-I collagen; biomimetic mineralization	ADHESIVE PERFORMANCE; FUNCTIONAL MONOMERS; DENTIN; ACID; REMINERALIZATION; HYDROXYAPATITE; INDUCTION; FLUID	BACKGROUND: Immobilization of phosphoproteins on type-I collagen via covalent binding may induce extra- and intrafibrillar mineralization. OBJECTIVE: This study tested the hypothesis thatmethacrylate phosphate esters immobilized on reconstituted type-I collagen can mimic the nucleating role of phosphoproteins. METHODS: Three functional monomers (MDP, GPDM and Phenyl-P) that differed in chemical structure and steric hindrances around the phosphate moiety were evaluated. Reconstituted type-I collagen was either left untouched (control) or treated by 5% monomer/ethanol for 20 s. All samples were incubated in simulated dentinal fluid as mineralizing medium at 37 degrees C for 7 or 14 days. The extra- and intrafibrillar mineralization were examined by SEM and TEM/SAED crystallography, respectively. RESULTS: FT-IR spectroscopy showed that the phosphate groups were incorporated on reconstituted collagen, irrespective of their chemical structure. MDP immobilization induced dense growth of extrafibrillar mineral over time, while with GPDM- and Phenyl-P-immobilized collagen, mineralization was moderate and sparse, respectively. TEM/SAED evidence disclosed that intrafibrillar minerals exclusively occurred in MDP-immobilized collagen. CONCLUSIONS: Immobilization of MDP, which had the lowest steric hindrance, could induce significant biomimetic extraand intrafibrillar mineralization; resembling the lowest level of hierarchy organization of dentin.	[Nurrohman, Hamid; Nakashima, Syozi; Takagaki, Tomohiro; Sadr, Alireza; Nikaido, Toru; Asakawa, Yuya; Uo, Motohiro; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Tokyo 1138549, Japan; [Nurrohman, Hamid; Marshall, Sally J.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA	Takagaki, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	takagaki.ope@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS); International Research Center for Molecular Science in Tooth and Bone Diseases (GCOE)	This study was supported by the Japan Society for the Promotion of Science (JSPS) and International Research Center for Molecular Science in Tooth and Bone Diseases (GCOE). We thank Shizuko Ichinose for TEM technical assistance and Kathryn Grandfield for SAED analysis.	Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Hayakawa T, 2004, J ORAL REHABIL, V31, P67; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Yoshida Y, 2004, J DENT RES, V83, P454; Fukegawa D, 2006, J DENT RES, V85, P941; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X; Kinney JH, 2003, J DENT RES, V82, P957; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Saito T, 1998, J BONE MINER RES, V13, P265, DOI 10.1359/jbmr.1998.13.2.265; Mai S, 2009, DENT MATER, V25, P1230, DOI 10.1016/j.dental.2009.05.001; Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; Van Landuyt KL, 2008, J DENT RES, V87, P757; Jee SS, 2010, J CRYST GROWTH, V312, P1249, DOI 10.1016/j.jcrysgro.2009.11.010; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Nurrohman H, 2012, DENT MATER, V28, pE89, DOI 10.1016/j.dental.2012.04.025; Odian G., 2004, PRINCIPLES POLYM; Ozok AR, 2004, J DENT RES, V83, P849; de Araujo AFP, 1999, BIOPHYS J, V76, P2319; SHELLIS RP, 1994, CARIES RES, V28, P14	23	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-2989	1878-3619		BIO-MED MATER ENG	Bio-Med. Mater. Eng.		2015	25	1					89	99		10.3233/BME-141243		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AZ1IB	WOS:000347992000008		
J	Itou, J; Tanaka, S; Sato, F; Akiyama, R; Kawakami, Y; Toi, M				Itou, Junji; Tanaka, Sunao; Sato, Fumiaki; Akiyama, Ryutaro; Kawakami, Yasuhiko; Toi, Masakazu			An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Breast cancer; Interleukin-6; Optical labeling; Paracrine effect; Proliferation; The OPA system	GROWTH-FACTOR; CELL-LINES; FLUORESCENT PROTEIN; INTRINSIC SUBTYPES; SIGNALING PATHWAY; EXPRESSION; ESTABLISHMENT; CARCINOMA; CYCLE; IL-6	Proliferation analysis is one of the basic approaches to characterize various cell types. In conventional cell proliferation assays, the same sample cannot be observed overtime, nor can a specific group within a heterogeneous population of cells, for example, cancerous cells, be analyzed separately. To overcome these limitations, we established an optical labeling-based proliferation assay system with the Kaede protein, whose fluorescence can be irreversibly photoconverted from green to red by irradiation. After a single non-toxic photoconversion event, the intensity of red fluorescence in each cell is reduced by cell division. From this, we developed a simple method to quantify cell proliferation by monitoring reduction of red fluorescence over time. This study shows that the optical labeling-based proliferation assay is a viable novel method to analyze cell proliferation, and could enhance our understanding of mechanisms regulating cell proliferation machinery. We used this newly established system to analyze the functions of secreted interleukin-6 (IL-6) in cancer cell proliferation, which had not been fully characterized. Reduction in proliferation was observed following IL-6 knockdown. However, after co-culturing with IL-6-expressing cells, the proliferation of Kaede-labeled IL-6-knockdown cells was restored. These data indicate that in basal-like breast cancer cells, IL-6 exhibits a paracrine effect to positively regulate cell proliferation. Our results thus demonstrate that cancer cells can secrete signaling molecules, such as IL-6, to support the proliferation of other cancer cells. (C) 2014 Elsevier B.V. All rights reserved.	[Itou, Junji; Tanaka, Sunao; Sato, Fumiaki; Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, Kyoto 6068507, Japan; [Akiyama, Ryutaro; Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Akiyama, Ryutaro; Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Kawakami, Yasuhiko] Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA; [Kawakami, Yasuhiko] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA	Itou, J (reprint author), 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	junji-itou@umin.ac.jp			JSPS [25870384]; Taiho Pharmaceutical Cd. Ltd.	We thank Dr Kunio Kitada, Dr Yasuko Miyake, Dr Elham Falchrejahani, Dr Fengling Pu and Ms Kayoko Koishihara for technical assistance. We thank Dr Isao Oishi and Dr Yoshiaki Matsumoto for editorial assistance. We thank the members of the Departments of Breast Surgery, and of Hepato-biliary-pancreatic Surgery and Transplantation for sharing laboratory equipment. Confocal imaging and time-lapse analysis using Leica TCS SP8 were performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study was supported by JSPS Grant-in-Aid for Young Scientists (B) No. 25870384. Financial support was provided by Taiho Pharmaceutical Cd. Ltd.	Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Itou J, 2012, DEVELOPMENT, V139, P4133, DOI 10.1242/dev.079756; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Itou J, 2013, FEBS LETT, V587, P3115, DOI 10.1016/j.febslet.2013.07.049; Kang B, 2012, NANO LETT, V12, P5369, DOI 10.1021/nl3027586; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Adjei AA, 2005, J CLIN ONCOL, V23, P5386, DOI 10.1200/JCO.2005.23.648; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Douglas AM, 1997, ONCOGENE, V14, P661, DOI 10.1038/sj.onc.1200882; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/nmeth.1296, 10.1038/NMETH.1296]; Faraji S, 2014, ANNU REV PHYS CHEM, V65, P275, DOI 10.1146/annurev-physchem-040513-103626; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Trautinger F, 1996, J PHOTOCH PHOTOBIO B, V35, P141, DOI 10.1016/S1011-1344(96)07344-7; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Badache A, 2001, CANCER RES, V61, P383; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Itou J, 2012, DEVELOPMENT, V139, P1620, DOI 10.1242/dev.073056; DANFORTH DN, 1993, CANCER RES, V53, P1538; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Asgeirsson KS, 1998, CYTOKINE, V10, P720, DOI 10.1006/cyto.1998.0349; Chiu JJ, 1996, CLIN CANCER RES, V2, P215; Haapajarvi T, 1999, EXP CELL RES, V248, P272, DOI 10.1006/excr.1999.4403; Hesse M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2089; Jiang XP, 2011, ANTICANCER RES, V31, P2899; JOHNSTON PG, 1992, CANCER RES, V52, P6860; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kojima H., 2013, JAKSTAT, V2; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Miyawaki A, 2004, NAT BIOTECHNOL, V22, P1374, DOI 10.1038/nbt1104-1374; Moon HY, 2013, FISH SHELLFISH IMMUN, V34, P1390, DOI 10.1016/j.fsi.2013.02.021; MORINAGA Y, 1989, J IMMUNOL, V143, P3538; Niepel M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-20; Sottocornola R, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt101; TAMM I, 1989, J EXP MED, V170, P1649, DOI 10.1084/jem.170.5.1649	48	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JAN	2015	1853	1					27	40		10.1016/j.bbamcr.2014.10.004		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY5FJ	WOS:000347598100003		
J	Kawada, D; Kobayashi, H; Tomita, T; Nakata, E; Nagano, M; Siekhaus, DE; Toshima, JY; Toshima, J				Kawada, Daiki; Kobayashi, Hiromu; Tomita, Tsuyoshi; Nakata, Eisuke; Nagano, Makoto; Siekhaus, Dania Elisabeth; Toshima, Junko Y.; Toshima, Jiro			The yeast Arf-GAP Glo3p is required for the endocytic recycling of cell surface proteins	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Arf-GAP; Small GTPase; Vesicular trafficking; Intracellular trafficking; Endocytosis	ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; FACTOR PHEROMONE RECEPTOR; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; COAT COMPLEX; SNARE SNC1P; VESICLE	Small GTP-binding proteins of the Ras superfamily play diverse roles in intracellular trafficking. Among them, the Rab, Arf, and Rho families function in successive steps of vesicle transport, in forming vesicles from donor membranes, directing vesicle trafficking toward target membranes and docking vesicles onto target membranes. These proteins act as molecular switches that are controlled by a cycle of GTP binding and hydrolysis regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). In this study we explored the role of GAPs in the regulation of the endocytic pathway using fluorescently labeled yeast mating pheromone alpha-factor. Among 25 non-essential GAP mutants, we found that deletion of the GLO3 gene, encoding Arf-GAP protein, caused defective internalization of fluorescently labeled alpha-factor. Quantitative analysis revealed that glo3 Delta cells show defective alpha-factor binding to the cell surface. Interestingly, Ste2p, the alpha-factor receptor, was mis-localized from the plasma membrane to the vacuole in glo3 Delta cells. Domain deletion mutants of Glo3p revealed that a GAP-independent function, as well as the GAP activity, of Glo3p is important for both alpha-factor binding and Ste2p localization at the cell surface. Additionally, we found that deletion of the GLO3 gene affects the size and number of Arf1p-residing Golgi compartments and causes a defect in transport from the TGN to the plasma membrane. Furthermore, we demonstrated that glo3 Delta cells were defective in the late endosome-to-TGN transport pathway, but not in the early endosome-to-TGN transport pathway. These findings suggest novel roles for Ad-GAP Glo3p in endocytic recycling of cell surface proteins. (C) 2014 Elsevier B.V. All rights reserved.	[Kawada, Daiki; Kobayashi, Hiromu; Tomita, Tsuyoshi; Nakata, Eisuke; Nagano, Makoto; Toshima, Jiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Nagano, Makoto; Toshima, Junko Y.; Toshima, Jiro] Tokyo Univ Sci, RIST, Res Ctr RNA Sci, Katsushika Ku, Tokyo 1258585, Japan; [Siekhaus, Dania Elisabeth] IST Austria, A-3400 Klosterneuburg, Austria; [Toshima, Junko Y.] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Toshima, JY (reprint author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Wakamatsu Cho 2-2, Tokyo 1628480, Japan.	yama_jun@aoni.waseda.jp; jtosiscb@rs.noda.tus.ac.jp			Japan Society for the Promotion of Science; Novartis Foundation (Japan); Mitsubishi Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Futaba Electronics Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Hamaguchi Foundation for the Advancement of Biochemistry; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation	We thank Dr. Hugh Pelham for kindly providing the GFP Snc1 (en-) plasmid. This work was supported by the Japan Society for the Promotion of Science for J.Y.T., and the Novartis Foundation (Japan), the Mitsubishi Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Futaba Electronics Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Hamaguchi Foundation for the Advancement of Biochemistry, the Takeda Science Foundation, and the Kurata Memorial Hitachi Science and Technology Foundation, to J.T.	Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Tang HY, 1997, MOL CELL BIOL, V17, P4294; Paczkowski JE, 2012, EMBO J, V31, P4191, DOI 10.1038/emboj.2012.268; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kojima A, 2012, BBA-MOL CELL RES, V1823, P534, DOI 10.1016/j.bbamcr.2011.12.004; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Lewis MJ, 2000, MOL BIOL CELL, V11, P23; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Spang A, 2010, FEBS LETT, V584, P2646, DOI 10.1016/j.febslet.2010.04.005; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245; Min MK, 2013, PLANT PHYSIOL, V161, P676, DOI 10.1104/pp.112.209148; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; LEE FJS, 1994, J BIOL CHEM, V269, P20931; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Reggiori F, 2003, J BIOL CHEM, V278, P5009, DOI 10.1074/jbc.M210436200; Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210; Santos B, 1997, MOL CELL BIOL, V17, P2485; Schindler C, 2009, TRAFFIC, V10, P1362, DOI 10.1111/j.1600-0854.2009.00952.x; Smaczynska-de R., 2008, TRAFFIC, V9, P559, DOI 10.1111/j.1600-0854.2008.00708.x; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; STEARNS T, 1990, MOL CELL BIOL, V10, P6690; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Toret CP, 2008, TRAFFIC, V9, P848, DOI 10.1111/j.1600-0854.2008.00726.x; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Toshima JY, 2009, MOL BIOL CELL, V20, P5039, DOI 10.1091/mbc.E09-07-0541; Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007; Yahara N, 2001, MOL BIOL CELL, V12, P221; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792	55	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	JAN	2015	1853	1					144	156		10.1016/j.bbamcr.201410.009		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY5FJ	WOS:000347598100014		
J	Adler, PH; Inci, A; Yildirim, A; Duzlu, O; McCreadie, JW; Kudela, M; Khazeni, A; Bruderova, T; Seitz, G; Takaoka, H; Otsuka, Y; Bass, J				Adler, Peter H.; Inci, Abdullah; Yildirim, Alparslan; Duzlu, Onder; McCreadie, John W.; Kudela, Matus; Khazeni, Atefeh; Bruderova, Tatiana; Seitz, Gunther; Takaoka, Hiroyuki; Otsuka, Yasushi; Bass, Jon			Are black flies of the subgenus Wilhelmia (Diptera: Simuliidae) multiple species or a single geographical generalist? Insights from the macrogenome	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						biodiversity; pests; polytene chromosomes; Simulium lineatum	CYTOLOGICAL DESCRIPTION; COMPLEX DIPTERA; CHROMOSOMES; EVOLUTION; IIIL-1; TURKEY; IS-7	Organisms with vast distributions often represent geographical mosaics of cryptic species. The black fly Simulium (Wilhelmia) lineatum is among the most widely distributed members of the family Simuliidae, ranging from the British Isles to eastern China. Rather than viewing S.lineatum as a possible aggregate of multiple species, taxonomists have suggested a more inclusive taxon with additional synonyms. Accordingly, S.lineatum is an ideal candidate for testing the hypothesis that a wide geographical distribution signals the presence of more than one species. A cytogenetic approach was used to probe the macrogenome of S.lineatum and other taxa proposed by taxonomists as conspecific. The banding patterns in the polytene chromosomes of 480 larvae from 15 countries across the Palearctic Region revealed 128 rearrangements of the complement. All rearrangements were autosomal and 89% were inversions nonrandomly distributed among species and among chromosome arms. The analyses clarify long-standing confusion over previously proposed names and reveal a longitudinal succession of four species sequentially replacing one another from west to east: Simulium lineatum s.s., Simulium balcanicum, Simulium turgaicum, and Simulium takahasii. Thus, S.turgaicum is recalled from synonymy and the other three species are validated. Within the most-represented species, S.balcanicum, the frequency of inversions follows a longitudinal gradient with a north-south bias; as the distance between the sites increases along this north-west-south-east axis, the similarity of inversion frequencies between sites decreases. Validation of the concept that broadly distributed black flies are composites of structurally similar species provides a framework for guiding discovery of additional biodiversity.(c) 2014 The Linnean Society of London, Biological Journal of the Linnean Society, 2014, 114, 163-183.	[Adler, Peter H.] Clemson Univ, Entomol Program, Clemson, SC 29634 USA; [Inci, Abdullah; Yildirim, Alparslan; Duzlu, Onder] Erciyes Univ, Fac Vet Med, Dept Parasitol, Kayseri, Turkey; [McCreadie, John W.] Univ S Alabama, Dept Biol Sci, Mobile, AL 36688 USA; [Kudela, Matus; Bruderova, Tatiana] Comenius Univ, Dept Zool, SK-84215 Bratislava, Slovakia; [Khazeni, Atefeh] Isfahan Univ Med Sci, Dept Parasitol & Mycol, Esfahan 7346181746, Iran; [Seitz, Gunther] Dist Govt Lower Bavaria, D-84028 Landshut, Germany; [Takaoka, Hiroyuki] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Otsuka, Yasushi] Kagoshima Univ, Res Ctr Pacific Isl, Kagoshima 8908580, Japan; [Bass, Jon] Wessex Chalk Stream & Rivers Trust, Kimbridge SO51 0LE, Hants, England	Adler, PH (reprint author), Clemson Univ, Entomol Program, Clemson, SC 29634 USA.	padler@clemson.edu			National Science Foundation [DEB-0841636, DEB-0933218]; Scientific and Technological Research Council of Turkey [111 O 426]; VEGA of the Ministry of Education of the Slovak Republic [1/0561/14]; Slovak Research and Development Agency [APVV-0436-12]; NIFA/USDA [SC-1700433]	We thank C. E. Beard for excellent technical assistance and C. L. Brockhouse and three anonymous reviewers for their insightful comments on the manuscript. This work was funded, in part, by National Science Foundation awards DEB-0841636 (Discovery and Prediction of Hidden Biodiversity in Black Flies (Diptera: Simuliidae)) under the American Recovery and Reinvestment Act of 2009 and DEB-0933218 (MIDGEPEET: A Collaborative Effort to Increase Taxonomic Expertise in Understudied Families of Nematocerous Diptera). Funding also came from The Scientific and Technological Research Council of Turkey Research Project 111 O 426 'The Molecular Classification of Black Fly (Diptera: Simuliidae) Species Which Pose a Problem in Central Kizilirmak Basin and the Investigation of Their Vector Potentials by Real Time PCR', VEGA grant no. 1/0561/14 of the Ministry of Education of the Slovak Republic, and the Slovak Research and Development Agency under contract No. APVV-0436-12. This is Technical Contribution no. 6253 of the Clemson University Experiment Station, and is based on work supported in part by NIFA/USDA under project number SC-1700433.	Adler P. H., 2014, WORLD BLACKFLIES DIP; Adler PH., 2004, BLACK FLIES SIMULIID; Adler Peter H., 2009, P523, DOI 10.1002/9781444308211.ch22; PROCUNIER WS, 1975, CAN J ZOOL, V53, P1638, DOI 10.1139/z75-197; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; ROTHFELS K, 1981, CAN J ZOOL, V59, P1857; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Pandit SN, 2009, ECOLOGY, V90, P2253, DOI 10.1890/08-0851.1; ROTHFELS KH, 1979, ANNU REV ENTOMOL, V24, P507, DOI 10.1146/annurev.en.24.010179.002451; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; ADLER PH, 1984, CAN J ZOOL, V62, P1308; Rohde C, 2006, GENETICA, V126, P77, DOI 10.1007/s10709-005-1433-4; PROCUNIER WS, 1982, CAN J ZOOL, V60, P2852, DOI 10.1139/z82-364; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Bentinck W, 1955, BLACK FLIES JAPAN KO; BROCKHOUSE C, 1985, CAN J ZOOL, V63, P2145; Chubareva L. A., 2008, TSITOLOGICHESKIE KAR; Chubareva L. A., 2007, Entomologicheskoe Obozrenie, V86, P895; CROSSKEY R W, 1972, Entomologist's Gazette, V23, P249; Crosskey RW, 2007, AQUAT INSECT, V29, P21, DOI 10.1080/01650420701213853; Crosskey RW, 1990, NATURAL HIST BLACKFI; Crosskey R.W., 1997, NEW TAXONOMIC GEOGRA; Gallardo-Mayenco A., 2002, Limnetica, V21, P47; GRINCHUK TM, 1974, TSITOLOGIYA+, V16, P1432; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; HIRAI H, 1994, GENOME, V37, P36, DOI 10.1139/g94-006; Huang Li, 2012, Acta Entomologica Sinica, V55, P988; Kamali M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002960; Knoz J, 1976, BIOLOGIA, V5, P91; Kovatschev S., 1979, 21 ARB IAD, P392; Lunneborg C. E, 2000, DATA ANAL RESAMPLING; Mayr E, 1963, ANIMAL SPECIES EVOLU; McCune B., 2002, ANAL ECOLOGICAL COMM, P300; Petrova NA, 2003, RUSS J GENET+, V39, P32, DOI 10.1023/A:1022014725940; Rivosecchi L., 1978, Fauna d'Italia, V13, P1; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1983, CAN J ZOOL, V61, P2612; ROTHFELS K. H., 1953, CANADIAN JOUR ZOOL, V31, P226, DOI 10.1139/z53-020; ROTHFELS K, 1981, CHROMOSOMA, V82, P673, DOI 10.1007/BF00285775; Rubtsov IA, 1956, FAUNA USSR NEW SERIE, V6; Sariozkan Savas, 2014, Turkiye Parazitoloji Dergisi, V38, P116, DOI 10.5152/tpd.2014.3446; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stocker AJ, 2004, GENOME, V47, P1144, DOI 10.1139/G04-078; WEBER EA, 1989, GENOME, V32, P589; Werner D, 2005, ABH BER NATURK, V27, P205; Williams PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032992; Yilmaz A, 2007, ERU U VET FAK DERG, V4, P91	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4066	1095-8312		BIOL J LINN SOC	Biol. J. Linnean Soc.	JAN	2015	114	1					163	183		10.1111/bij.12403		21	Evolutionary Biology	Evolutionary Biology	AY8YG	WOS:000347836000013		
J	Ozawa, T; Yin, W; Fu, CZ; Claremont, M; Smith, L; Reid, DG				Ozawa, Tomowo; Yin, Wei; Fu, Cuizhang; Claremont, Martine; Smith, Lisa; Reid, David G.			Allopatry and overlap in a clade of snails from mangroves and mud flats in the Indo-West Pacific and Mediterranean (Gastropoda: Potamididae: Cerithideopsilla)	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						allopatric speciation; GMYC; marine biogeography; southern China	MOLECULAR PHYLOGENY; HISTORICAL BIOGEOGRAPHY; NORTHWESTERN PACIFIC; SPECIES DELIMITATION; MARINE BIODIVERSITY; GENUS CERITHIDEA; SPECIATION; DISPERSAL; DIVERSITY; TAXONOMY	Cerithideopsilla is a genus of potamidid snails found in high abundance on sedimentary intertidal flats and beneath mangrove trees on continental shores in the tropical and subtropical Indo-West Pacific region and Mediterranean Sea. Taxonomic revisions have recognized four species, but recent molecular studies have hinted at a higher diversity. Here, we analyse 377 individuals sampled from across the known range and use a combination of molecular phylogenetic (mitochondrial COI and 16S rRNA, and nuclear 28S rRNA genes), statistical (generalized mixed Yule-coalescent GMYC method) and morphological (shell form) criteria to delimit 16 species. These form four species groups, corresponding with the traditionally recognized species C.alata, C. djadjariensis' (for which the valid name is C.incisa), C.cingulata and C.conica. Distribution maps were compiled using museum specimens identified by diagnostic shell characters. In combination with the molecular phylogenetic trees, these suggest an allopatric speciation mode, with diversification centred on the East Asian coastline and northern Australia, and a pronounced gap in the eastern Indonesian corridor', an area of low oceanic productivity. There is, however, frequently geographical overlap between sister species and we suggest from several sources of evidence (e.g. presence of C.conica in isolated saline lakes 900 km from the sea) that post-speciation transport by migratory birds has occurred. Nine of the 16 species occur between the Gulf of Tonkin and Hong Kong, so southern China is significant for both the evolution and conservation of Cerithideopsilla species.(c) 2014 The Linnean Society of London, Biological Journal of the Linnean Society, 2014, 114, 212-228.	[Ozawa, Tomowo] Cyber Univ, Dept World Heritage, Nagoya Off, Chikusa Ku, Nagoya, Aichi 4640029, Japan; [Yin, Wei; Fu, Cuizhang] Fudan Univ, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Claremont, Martine; Smith, Lisa] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Reid, DG (reprint author), Nat Hist Museum, Dept Life Sci, London SW7 5BD, England.	d.reid@nhm.ac.uk			National Basic Research Program of China (973 Program) [2013CB430404]; Ministry of Education, Science, Sports and Culture, Japan [13854001]	For provision of specimens for the molecular study we thank: P. Bouchet, B. J. Craig, G. Feulner, H. Fukuda, V. Garilli, M. Glaubrecht, E. Glover, Y. Kano, T. Nakano, M. Spencer-Jones, K-S. Tan, J. D. Taylor, S. Tracey, F. E. Wells, R. C. Willan, K. Yahya and K. Y. Yang. We are grateful to museum curators for access to collections and loan of specimens: J. Goud, V. Heros, I. Loch, A. Miller and E. E. Strong. For assistance in the field DGR thanks: S. Panha, K-S. Tan, S-H. Tan and Z. Yasin. TO thanks S. Hayashi and M. Arao for their technical assistance in operating automated sequencers at Nagoya University. We thank three reviewers for their helpful comments on an earlier version of the text. This study was partly supported by the National Basic Research Program of China (973 Program: no. 2013CB430404) and Grant-in Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (project no. 13854001 to TO). DGR thanks P. S. Rainbow of the Natural History Museum for institutional support that made this project possible. This project was conceived as a collaboration between TO, WY, CF and DGR; sequencing was by TO, WY, CF, MC and LS; analysis by MC; fieldwork by TO, CF and DGR; and writing by DGR.	Ando Miho, 2005, Venus (Tokyo), V63, P145; Williams ST, 2004, EVOLUTION, V58, P2227; Polgar G, 2014, MOL PHYLOGENET EVOL, V73, P161, DOI 10.1016/j.ympev.2014.01.014; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Batenburg SJ, 2011, PALAEOGEOGR PALAEOCL, V306, P75, DOI 10.1016/j.palaeo.2011.03.031; Williams ST, 2006, MOL PHYLOGENET EVOL, V39, P33, DOI 10.1016/j.ympev.2005.12.017; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Ragionieri L, 2009, MOL PHYLOGENET EVOL, V52, P825, DOI 10.1016/j.ympev.2009.04.008; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; Reid DG, 2012, ZOOL SCR, V41, P125, DOI 10.1111/j.1463-6409.2011.00505.x; Reid DG, 2008, MOL PHYLOGENET EVOL, V47, P680, DOI 10.1016/j.ympev.2008.01.003; HOUBRICK RS, 1991, MALACOLOGIA, V33, P289; Ellison AM, 2002, TREES-STRUCT FUNCT, V16, P181, DOI 10.1007/s00468-001-0133-7; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Miura O, 2010, MOL PHYLOGENET EVOL, V56, P40, DOI 10.1016/j.ympev.2010.04.012; Fratini S, 2005, EVOL ECOL RES, V7, P219; Shih HT, 2009, HYDROBIOLOGIA, V635, P373, DOI 10.1007/s10750-009-9930-6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Williams S, 2011, EVOLUTION, V65, P1752, DOI 10.1111/j.1558-5646.2011.01255.x; Kojima S, 2006, MAR BIOL, V149, P525, DOI 10.1007/s00227-005-0183-2; Miura O, 2012, P ROY SOC B-BIOL SCI, V279, P1061, DOI 10.1098/rspb.2011.1599; Paulay G, 2002, INTEGR COMP BIOL, V42, P922, DOI 10.1093/icb/42.5.922; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Claremont M, 2011, J BIOGEOGR, V38, P1016, DOI 10.1111/j.1365-2699.2011.02482.x; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1466-822X.1999.00126.x; [Anonymous], 2013, NORTH TERRIT NAT FEB; Schubart CD, 2006, J ZOOL SYST EVOL RES, V44, P193, DOI 10.1111/j.1439-0469.2006.00354.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ashton EC, 2003, J TROP ECOL, V19, P127, DOI 10.1017/S0266467403003158; Avise JC, 2004, MOL MARKERS NATURAL; Bellwood DR, 2012, BIOTIC EVOLUTION ENV, V82, P216; Boere G.C., 2006, WATERBIRDS WORLD, P40; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; [陈卉 Chen Hui], 2014, [水生生物学报, Acta Hydrobiologica Sinica], V38, P75; Coyne J. A., 2004, SPECIATION; Daru BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066686; Ezard T., 2009, SPLITS SPECIES LIMIT; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Frey MA, 2010, J BIOGEOGR, V37, P1515, DOI 10.1111/j.1365-2699.2010.02283.x; Golding RE, 2012, MOL PHYLOGENET EVOL, V63, P72, DOI 10.1016/j.ympev.2011.12.016; Groombridge B., 2002, WORLD ATLAS BIODIVER; Habe T., 1955, Venus Fukuyama, V18, P204; Hasegawa K., 2000, MARINE MOLLUSKS JAPA, P133; Hellberg ME, 1998, EVOLUTION, V52, P1311, DOI 10.2307/2411301; Hoeksema Bert W., 2007, V29, P117; Hong Jae-Sang, 2010, Plankton & Benthos Research, V5, P255; Itoigawa J, 1982, MONOGRAPH MIZUNAMI B, V3-B, P1; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Kamimura Satomi, 2010, Plankton & Benthos Research, V5, P250; Kaneko K, 1997, ANIMALS INHABITED AN; Kimura T, 2002, VENUS, V61, P114; Kowalke Thorsten, 2001, Freiberger Forschungshefte Reihe C, V492, P27; Lantin-Olaguer I, 2001, INVERTEBR REPROD DEV, V39, P195, DOI 10.1080/07924259.2001.9652484; Lozouet P., 2008, PHILIPPINE MARINE MO, V1, P284; LOZOUET P, 1986, Annales de Paleontologie, V72, P163; Maki Eiko, 2002, Venus (Tokyo), V61, P61; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.2307/2411270; Oyama K., 1959, THE MOLLUSCAN SHELLS, V2; Ozawa T, 2009, ZOOL SCR, V38, P503, DOI 10.1111/j.1463-6409.2009.00390.x; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Plaziat Jean-Claude, 2001, Wetlands Ecology and Management, V9, P161, DOI 10.1023/A:1011118204434; Plaziat J-C, 2005, MODERN ENV MOLLUSCS; Plaziat Jean-Claude, 1993, Journal of Paleolimnology, V8, P163; Plaziat J.-C., 2008, MANGROVE ENV MOLLUSC; R Development Core Team, 2009, R LANG ENV STAT COMP; RAO MB, 1982, MALACOLOGIA, V22, P553; Rees W. J., 1965, Proceedings of the Malacological Society of London, V36, P269; Reid DG, 2010, MOL PHYLOGENET EVOL, V55, P185, DOI 10.1016/j.ympev.2009.09.036; Reid DG, 2014, ZOOTAXA, V 3775, P1, DOI 10.11646/zootaxa.3775.1.1; Reid D.G., 1996, SYSTEMATICS EVOLUTIO; Reid DG, 2013, BIOL J LINN SOC, V110, P564, DOI 10.1111/bij.12151; Reid David G., 2007, Zootaxa, V1420, P1; REID D.G, 1986, LITTORINID MOLLUSCS; Reid DG, 2001, NAUTILUS, V115, P115; Reid DG, 2014, ZOOTAXA, V3779, P61, DOI 10.11646/zootaxa.3779.1.8; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; Shih HT, 2008, ZOOL STUD, V47, P114; Shuto T, 1978, CONTRIBUTIONS GEOLOG, V19, P113; SOUSA WP, 1993, J EXP MAR BIOL ECOL, V166, P19, DOI 10.1016/0022-0981(93)90076-Z; Spalding M.D., 1997, WORLD MANGROVE ATLAS; Tang WX, 2010, ZOOL SCI, V27, P8, DOI 10.2108/zsj.27.8; Altena C. O. van Regteren, 1940, ZOOL MEDEDEEL LEYDEN, V22, P211; VOHRA F C, 1970, Proceedings of the Malacological Society of London, V39, P187; WELLS F E, 1985, P139; Yin W, 2009, ZOOL SCI, V26, P467, DOI 10.2108/zsj.26.467	96	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4066	1095-8312		BIOL J LINN SOC	Biol. J. Linnean Soc.	JAN	2015	114	1					212	228		10.1111/bij.12401		17	Evolutionary Biology	Evolutionary Biology	AY8YG	WOS:000347836000016		
J	Hirano, T; Kameda, Y; Kimura, K; Chiba, S				Hirano, Takahiro; Kameda, Yuichi; Kimura, Kazuki; Chiba, Satoshi			Divergence in the shell morphology of the land snail genus Aegista (Pulmonata: Bradybaenidae) under phylogenetic constraints	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						habitat use; molecular phylogeny; mollusca; shell shape	FUNCTIONAL CONSTRAINTS; TERRESTRIAL GASTROPOD; MOLECULAR PHYLOGENY; EVOLUTION; TAXONOMY; MANDARINA; SHAPE; STYLOMMATOPHORA; INCLINATION; ARCHIPELAGO	The role of natural selection in phenotypic evolution is central to evolutionary biology. Phenotypic evolution is affected by various factors other than adaptation, and recent focus has been placed on the effects of phylogenetic constraints and niche conservatism on phenotypic evolution. Here, we investigate the relationship between the shell morphology and habitat use of bradybaenid land snails of the genus Aegista and clarify the causes of the divergence in shell morphology among phylogenetically related species. The results of ancestral state reconstruction showed that arboreal species have evolved independently from ground-dwelling species at least four times. A significant association was found between shell shape and habitat use, despite the existence of a certain degree of phylogenetic constraint between these traits. A principal component analysis showed that arboreal species tend to have a relatively high-spired shell with a narrow umbilicus. By contrast, ground-dwelling species have a low-spired shell with a wide umbilicus. Although the latitude and elevation of the sampling locations showed no relationship with shell morphology, the geology of the sampling locations affected the shell size of arboreal species. The development of a well-balanced shell shape is one effective method for reducing the cost of locomotion under the force of gravity in each life habitat, resulting in the divergence in shell morphology and the independent evolution of morphologically similar species among different lineages. The present study suggests that ecological divergence is probably the cause of shell morphology divergence in land snails.(c) 2014 The Linnean Society of London, Biological Journal of the Linnean Society, 2014, 114, 229-241.	[Hirano, Takahiro; Kimura, Kazuki; Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9800862, Japan; [Kameda, Yuichi] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan	Hirano, T (reprint author), Tohoku Univ, Grad Sch Life Sci, 41 Kawauchi, Sendai, Miyagi 9800862, Japan.	hirano0223t@yahoo.co.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albers JC., 1850, HELICEEN NACH NATURL; MANTEL N, 1967, CANCER RES, V27, P209; Dunn CP, 2003, TRENDS ECOL EVOL, V18, P270, DOI 10.1016/S0169-5347(03)00094-6; Okajima R, 2011, AM NAT, V178, P801, DOI 10.1086/662674; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Okajima R, 2013, EVOLUTION, V67, P429, DOI 10.1111/j.1558-5646.2012.01772.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Noshita K, 2012, PALEOBIOLOGY, V38, P322, DOI 10.1666/10060.1; Parent CE, 2009, AM NAT, V174, P898, DOI 10.1086/646604; Okajima R, 2009, EVOLUTION, V63, P2877, DOI 10.1111/j.1558-5646.2009.00780.x; Wade CM, 2007, J MOLLUS STUD, V73, P411, DOI 10.1093/mollus/eym030; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Chiba S, 1999, EVOLUTION, V53, P460, DOI 10.2307/2640782; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Barker G.M., 2001, BIOL TERRESTRIAL MOL; BERRILL NJ, 1987, INT J INVER REP DEV, V11, P1; Burnham K. P., 2002, MODEL SELECTION MULT; Chiba S, 1999, BIOL J LINN SOC, V66, P465, DOI 10.1111/j.1095-8312.1999.tb01921.x; Chiba S, 2007, BIOL J LINN SOC, V91, P149, DOI 10.1111/j.1095-8312.2007.00790.x; Davison A, 2005, J ZOOL, V267, P329, DOI 10.1017/S0952836905007648; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Gravel D, 2012, NATURE COMMUNICATION, V3; Gredler V, 1887, MALAKOZOOLOGISCHE BL, V9, P1; Hirano T, 2014, MOL PHYLOGENET EVOL, V70, P171, DOI 10.1016/j.ympev.2013.09.020; Jacobi A, 1898, J COLL SCI IMP U TOK, V12, P1; Johnson MS, 2000, BIOL J LINN SOC, V69, P577, DOI 10.1006/bijl.1999.0386; Kameda YC, 2007, MOL PHYLOGENET EVOL, V45, P519, DOI 10.1016/j.ympev.2007.03.021; LARSEN EW, 1992, TRENDS ECOL EVOL, V7, P414, DOI 10.1016/0169-5347(92)90023-5; Maddison W. P., 2011, MESQUITE MODULAR SYS; Moreno-Rueda G, 2009, EVOL ECOL, V23, P463, DOI 10.1007/s10682-008-9245-5; MURRAY J, 1980, PROC R SOC SER B-BIO, V211, P83, DOI 10.1098/rspb.1980.0159; Pfenninger M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-59; R Development Core Team, 2013, R LANG ENV STAT COMP; Randle HD, 2004, ADAPTIVE SPECIATION, P192; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; Schluter H, 2000, AM NAT             S, V156, pS4; Smits PD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-146; Stankowski S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-2; Vermeij G.J., 1987, EVOLUTION ESCALATION	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4066	1095-8312		BIOL J LINN SOC	Biol. J. Linnean Soc.	JAN	2015	114	1					229	241		10.1111/bij.12407		13	Evolutionary Biology	Evolutionary Biology	AY8YG	WOS:000347836000017		
J	Araki, N; Trencsenyi, G; Krasznai, ZT; Nizsaloczki, E; Sakamoto, A; Kawano, N; Miyado, K; Yoshida, K; Yoshida, M				Araki, Naoya; Trencsenyi, Gyoergy; Krasznai, Zoard T.; Nizsaloczki, Eniko; Sakamoto, Ayako; Kawano, Natsuko; Miyado, Kenji; Yoshida, Kaoru; Yoshida, Manabu			Seminal Vesicle Secretion 2 Acts as a Protectant of Sperm Sterols and Prevents Ectopic Sperm Capacitation in Mice	BIOLOGY OF REPRODUCTION			English	Article						cholesterol efflux; seminal plasma; sperm capacitation; SVS2	PROTEIN-TYROSINE PHOSPHORYLATION; CHOLESTEROL PHOSPHOLIPID RATIO; MEDIATED SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; DECAPACITATION FACTOR; MAMMALIAN SPERM; MOUSE SPERM; EPIDIDYMAL MATURATION; FERTILIZING-CAPACITY; HUMAN-SPERMATOZOA	Seminal vesicle secretion 2 (SVS2) is a protein secreted by the mouse seminal vesicle. We previously demonstrated that SVS2 regulates fertilization in mice; SVS2 is attached to a ganglioside GM1 on the plasma membrane of the sperm head and inhibits sperm capacitation in in vitro fertilization as a decapacitation factor. Furthermore, male mice lacking SVS2 display prominently reduced fertility in vivo, which indicates that SVS2 protects spermatozoa from some spermicidal attack in the uterus. In this study, we tried to investigate the mechanisms by which SVS2 controls in vivo sperm capacitation. SVS2-deficient males that mated with wild-type partners resulted in decreased cholesterol levels on ejaculated sperm in the uterine cavity. SVS2 prevented cholesterol efflux from the sperm plasma membrane and incorporated liberated cholesterol in the sperm plasma membrane, thereby reversibly preventing the induction of sperm capacitation by bovine serum albumin and methyl-beta-cyclodextrin in vitro. SVS2 enters the uterus and the uterotubal junction, arresting sperm capacitation in this area. Therefore, our results show that SVS2 keeps sterols on the sperm plasma membrane and plays a key role in unlocking sperm capacitation in vivo.	[Araki, Naoya; Sakamoto, Ayako; Yoshida, Manabu] Univ Tokyo, Sch Sci, Misaki Marine Biol Stn, Miura, Kanagawa 2380225, Japan; [Trencsenyi, Gyoergy] Univ Debrecen, Dept Nucl Med, H-4012 Debrecen, Hungary; [Krasznai, Zoard T.] Univ Debrecen, Dept Obstet & Gynecol, H-4012 Debrecen, Hungary; [Nizsaloczki, Eniko] Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; [Kawano, Natsuko; Miyado, Kenji] Natl Ctr Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Yoshida, Kaoru] Toin Univ Yokohama, Ctr Biomed Engn, Yokohama, Kanagawa, Japan; [Yoshida, Manabu] Univ Tokyo, Ctr Marine Biol, Miura, Kanagawa 2380225, Japan	Yoshida, M (reprint author), Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, 1024 Koajiro, Miura, Kanagawa 2380225, Japan.	yoshida@mmbs.s.u-tokyo.ac.jp			MEXT; Japan Society for the Promotion of Science (JSPS; KAKENHI); JSPS; Hungarian Academy of Sciences	This work was supported in part by Grants-in-Aid for Scientific Research from MEXT and Japan Society for the Promotion of Science (JSPS; KAKENHI) to K.M. and M.Y., and by JSPS and the Hungarian Academy of Sciences under the Japan-Hungary Research Cooperative Program.	Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; DAVIS BK, 1980, P NATL ACAD SCI-BIOL, V77, P1546, DOI 10.1073/pnas.77.3.1546; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; DAVIS BK, 1979, BIOCHIM BIOPHYS ACTA, V558, P257, DOI 10.1016/0005-2736(79)90260-8; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Lu CH, 2011, BIOL REPROD, V84, P514, DOI 10.1095/biolreprod.110.085100; GO KJ, 1985, BIOL REPROD, V32, P145, DOI 10.1095/biolreprod32.1.145; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Kawano N, 2014, P NATL ACAD SCI USA, V111, P4145, DOI 10.1073/pnas.1320715111; Morales CR, 2012, HISTOL HISTOPATHOL, V27, P317; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; Flesch FM, 2001, J CELL SCI, V114, P3543; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; Ilangumaran S, 1998, BIOCHEM J, V335, P433; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; RANA APS, 1991, BIOCHIM BIOPHYS ACTA, V1061, P185, DOI 10.1016/0005-2736(91)90284-F; BEDFORD JM, 1962, AM J PHYSIOL, V202, P179; BENOFF S, 1993, HUM REPROD, V8, P2155; CHANG MC, 1957, NATURE, V179, P258, DOI 10.1038/179258a0; Cross NL, 1996, BIOL REPROD, V54, P138, DOI 10.1095/biolreprod54.1.138; DAVIS BK, 1974, J REPROD FERTIL, V41, P241; DAVIS BK, 1981, P NATL ACAD SCI-BIOL, V78, P7560, DOI 10.1073/pnas.78.12.7560; Davis BK, 1978, S PHARM EFF LIP, P145; DUKELOW WR, 1966, P SOC EXP BIOL MED, V121, P396; HOSHI K, 1990, HUM REPROD, V5, P71; Huang YH, 1999, BIOCHEM J, V343, P241, DOI 10.1042/0264-6021:3430241; Jakop U, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-49; Jones R, 2010, DEV BIOL, V339, P398, DOI 10.1016/j.ydbio.2009.12.044; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Kawano N, 2007, BIOL REPROD, V76, P353, DOI 10.1095/biolreprod.106.056887; KESSEL RG, 1985, ANAT REC, V212, P358, DOI 10.1002/ar.1092120406; LANGLAIS J, 1988, GAMETE RES, V20, P185, DOI 10.1002/mrd.1120200209; LEGAULT Y, 1979, BIOL REPROD, V20, P1213, DOI 10.1095/biolreprod20.5.1213; O'Rand MG, 2011, J ANDROL, V32, P698, DOI 10.2164/jandrol.110.012781; REYES A, 1975, FERTIL STERIL, V26, P148; SCHROEDE.F, 1971, J ANTIBIOT, V24, P846; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; SUZUKI F, 1988, J ULTRA MOL STRUCT R, V100, P39, DOI 10.1016/0889-1605(88)90057-2; Tseng HC, 2013, J CELL BIOCHEM, V114, P888, DOI 10.1002/jcb.24428; Wang ZJ, 2008, ASIAN J ANDROL, V10, P770, DOI 10.1111/j.1745-7262.2008.00393.x; Yanagimachi R., 1994, P189; Zarintash RJ, 1996, BIOL REPROD, V55, P19, DOI 10.1095/biolreprod55.1.19	52	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	JAN 1	2015	92	1							8	10.1095/biolreprod.114.120642		10	Reproductive Biology	Reproductive Biology	AZ0DI	WOS:000347916100008		
J	Ogiwara, K; Hagiwara, A; Rajapakse, S; Takahashi, T				Ogiwara, Katsueki; Hagiwara, Akane; Rajapakse, Sanath; Takahashi, Takayuki			The Role of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Follicle Rupture During Ovulation in the Teleost Medaka	BIOLOGY OF REPRODUCTION			English	Article						medaka; nonmammalian vertebrate; ovulation; PAI-1; plasmin; uPA	PROGESTERONE-RECEPTORS; ANDROGEN RECEPTOR; MOLECULAR-CLONING; MIFEPRISTONE; GENE; MICE; EXPRESSION; MECHANISM; FISH; RAT	We previously reported that the serine protease plasmin plays a role in follicle rupture during ovulation in the teleost medaka. In this study, we showed that urokinase-type plasminogen activator 1 (Plau1) is a physiological activator of plasminogen. Morphological analyses revealed that in the preovulatory follicle, plau1 mRNA was detected in association with follicle cells, while Plau1 protein was localized in the oocyte egg membrane. Both an inactive precursor and an active form of Plau1 were present at constant levels in the membrane fraction via the latter half of the 24-h spawning cycle. Plasminogen activator inhibitor-1 (Pai1) was detected in the follicle layer of the preovulatory follicle, but the protein level was low at approximately 7 h prior to ovulation. We showed that plasmin hydrolyzed laminin, which is a major component of the basement membrane and is situated between the granulosa and theca cells of the follicle. In vitro ovulation of large follicles was significantly inhibited by anti-Plau1 antibodies and active recombinant Pai1. Levels of Pai1 expression were increased in vivo at approximately 7 h prior to ovulation. Expression of Pai1 was also induced in vitro in the follicle with recombinant medaka luteinizing hormone (Lh). Lh-induced expression of pail mRNA was significantly suppressed by the presence of MDL (an adenylyl cyclase inhibitor), trilostane (a 3beta-hydroxysteroid dehydrogenase inhibitor), and RU486 (a nuclear progestin receptor antagonist). These results support our recent proposal of a sequential two-step ECM protein hydrolysis model for follicle rupture for medaka ovulation.	[Ogiwara, Katsueki; Hagiwara, Akane; Takahashi, Takayuki] Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan; [Rajapakse, Sanath] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka	Takahashi, T (reprint author), Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan.	ttakaha@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24247010]	This work was supported in part by Grants-in-Aid for Scientific Research 24247010 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Ohnishi J, 2005, BBA-PROTEINS PROTEOM, V1751, P95, DOI 10.1016/j.bbapap.2005.05.002; Sathananthan AH, 2006, MICROSC RES TECHNIQ, V69, P396, DOI 10.1002/jemt.20299; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Song LN, 2004, MOL ENDOCRINOL, V18, P70, DOI 10.1210/me.2003-0189; Oka K, 2013, MOL CELL ENDOCRINOL, V365, P153, DOI 10.1016/j.mce.2012.10.014; Abdel-Hafiz HA, 2014, J STEROID BIOCHEM, V140, P80, DOI 10.1016/j.jsbmb.2013.12.008; LOUTRADIS D, 1991, HUM REPROD, V6, P1238; Colgin DC, 1997, ANIM REPROD SCI, V47, P197, DOI 10.1016/S0378-4320(97)00011-0; Curry TE, 2006, SEMIN REPROD MED, V24, P228, DOI 10.1055/s-2006-948552; Ny A, 1999, ENDOCRINOLOGY, V140, P5030, DOI 10.1210/en.140.11.5030; Bager R, 2012, J BIOL CHEM, V287, P27526, DOI 10.1074/jbc.M112.369207; BEERS WH, 1975, CELL, V6, P379, DOI 10.1016/0092-8674(75)90187-7; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bloom W, 1968, TXB HISTOLOGY, P728; Castellino FJ, 2004, HDB PROTEOLYTIC ENZY, V2, P1692; Ellis V, 2004, HDB PROTEOLYTIC ENZY, V2, P1677; Ensembl Database, ENS DAT GEN INF; Espey LL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P425; Fujimori C, 2011, MOL CELL ENDOCRINOL, V332, P67, DOI 10.1016/j.mce.2010.09.015; Hagiwara A, BIOL REPROD, V90, P126; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Iwamatsu T, 1988, ZOOL SCI, V5, P349; Kato Y, 2010, CELL TISSUE RES, V340, P595, DOI 10.1007/s00441-010-0969-5; Leonardsson G, 1995, P NATL ACAD SCI USA, V92, P12446, DOI 10.1073/pnas.92.26.12446; LESLIE ND, 1990, J BIOL CHEM, V265, P1339; NAGAI M, 1985, GENE, V36, P183; Norrevang A., 1968, International Review of Cytology, V23, P113; Ny A, 1997, EUR J BIOCHEM, V244, P487, DOI 10.1111/j.1432-1033.1997.00487.x; ODOR DL, 1960, J BIOPHYS BIOCHEM CY, V7, P567, DOI 10.1083/jcb.7.3.567; Ogiwara K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093880; Ogiwara K, 2007, P NATL ACAD SCI USA, V104, P7021, DOI 10.1073/pnas.0610447104; Ogiwara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054482; PENG XR, 1993, EUR J BIOCHEM, V214, P147, DOI 10.1111/j.1432-1033.1993.tb17907.x; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Ravaglia MA, 2003, TISSUE CELL, V35, P9, DOI 10.1016/S0040-8166(02)00098-8; Robker RL, 2009, NUCL RECEPT SIGNAL, V7, pe01; SANCHEZCRIADO JE, 1990, BIOL REPROD, V42, P877, DOI 10.1095/biolreprod42.6.877; SPITZ IM, 1993, NEW ENGL J MED, V329, P404; TSAFRIRI A, 1989, ENDOCRINOLOGY, V124, P415; VANDERSCHOOT P, 1987, ENDOCRINOLOGY, V121, P1375; WOURMS JP, 1976, DEV BIOL, V50, P338, DOI 10.1016/0012-1606(76)90156-1	43	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	JAN 1	2015	92	1							10	10.1095/biolreprod.114.121442		17	Reproductive Biology	Reproductive Biology	AZ0DI	WOS:000347916100010		
J	Wu, ATH; Aoki, T; Sakoda, M; Ohta, S; Ichimura, S; Ito, T; Ushida, T; Furukawa, KS				Wu, Andy T. H.; Aoki, Teruo; Sakoda, Megumu; Ohta, Seiichi; Ichimura, Shigetoshi; Ito, Taichi; Ushida, Takashi; Furukawa, Katsuko S.			Enhancing Osteogenic Differentiation of MC3T3-E1 Cells by Immobilizing Inorganic Polyphosphate onto Hyaluronic Acid Hydrogel	BIOMACROMOLECULES			English	Article							EPIDERMAL-GROWTH-FACTOR; BONE-GRAFT; STEM-CELLS; IN-VIVO; HYDROXYAPATITE; REGENERATION; INDUCTION; SCAFFOLDS; MODEL; ADHESIONS	In tissue engineering, precise control of cues in the microenvironment is essential to stimulate cells to undergo bioactivities such as proliferation, differentiation, and matrix production. However, current approaches are inefficient in providing nondepleting cues. In this study, we have developed a novel bioactive hydrogel (HAX-PolyP) capable of enhancing tissue growth by conjugating inorganic polyphosphate chains onto hyaluronic acid macromers. The immobilized polyphosphates provided constant osteoconductive stimulation to the embedded murine osteoblast precursor cells, resulting in up-regulation of osteogenic marker genes and enhanced levels of ALP activity. The osteoconductive activity was significantly higher when compared to those stimulated with free-floating polyphosphates. Even at very low concentrations, immobilization of polyphosphates onto the scaffold allowed sufficient signaling leading to more effective osteoconduction. These results demonstrate the potential of our novel material as an injectable bioactive scaffold, which can be clinically useful for developing bone grafts and bone regeneration applications.	[Wu, Andy T. H.; Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Aoki, Teruo; Ito, Taichi] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Ohta, Seiichi; Ito, Taichi; Ushida, Takashi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1138656, Japan; [Ito, Taichi; Furukawa, Katsuko S.] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Sakoda, Megumu; Ichimura, Shigetoshi] Kanagawa Inst Technol, Dept Appl Biosci, Atsugi, Kanagawa 2430292, Japan	Furukawa, KS (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	furukawa@mech.t.u-tokyo.ac.jp		Ohta, Seiichi/0000-0002-4775-8199	program of Next Generation on World-Leading Researchers (NEXT), Japan Society for the Promotion of Science (JSPS); Global COB Program (GCOE), Medical System Innovation on Multidisciplinary Integration, MEXT, Japan	This work was funded by the program of Next Generation on World-Leading Researchers (NEXT), Japan Society for the Promotion of Science (JSPS) and in part by the Global COB Program (GCOE), Medical System Innovation on Multidisciplinary Integration, MEXT, Japan.	Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Boerckel JD, 2012, J ORTHOP RES, V30, P1067, DOI 10.1002/jor.22042; Nakagawa Y, 2015, CARBOHYD POLYM, V117, P43, DOI 10.1016/j.carbpol.2014.09.037; Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050; YONEDA M, 1988, J CELL SCI, V90, P265; Aslan M, 2006, J BIOMATER APPL, V20, P209, DOI 10.1177/0885328206051047; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b; Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021; Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555; Zellin G, 2000, BONE, V26, P161, DOI 10.1016/S8756-3282(99)00252-5; De Kort E, 2009, DAIRY SCI TECHNOL, V89, P283, DOI 10.1051/dst/2009008; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5; Wang SN, 2012, STEM CELL RES, V8, P346, DOI 10.1016/j.scr.2011.12.005; Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba; Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021; Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043; Budiraharjo R, 2013, J BIOMAT SCI-POLYM E, V24, P645, DOI 10.1080/09205063.2012.703949; Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7; Feng Y. F., 2012, PLOS ONE, V7, P1; Huang Y., 2013, J NANOMATER, V2013, P1; Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e; Kang H, 2012, TISSUE ENG PT A, V18, P331, DOI [10.1089/ten.TEA.2011.0074, 10.1089/ten.tea.2011.0074]; Kawazoe Y, 2008, INT J BIOL SCI, V4, P37; Kawazoe Y, 2004, J DENT RES, V83, P613; Morimoto D, 2010, J BONE MINER METAB, V28, P418, DOI 10.1007/s00774-010-0157-4; Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Usui Y, 2010, J DENT RES, V89, P504, DOI 10.1177/0022034510363096; Yoshikawa H, 2009, J R SOC INTERFACE, V6, P341	35	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JAN	2015	16	1					166	173		10.1021/bm501356c		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY9IQ	WOS:000347864200015		
J	Miki, K; Inoue, T; Kobayashi, Y; Nakano, K; Matsuoka, H; Yamauchi, F; Yano, T; Ohe, K				Miki, Koji; Inoue, Tatsuhiro; Kobayashi, Yasuhito; Nakano, Katsuya; Matsuoka, Hideki; Yamauchi, Fumio; Yano, Tetsuya; Ohe, Kouichi			Near-Infrared Dye-Conjugated Amphiphilic Hyaluronic Acid Derivatives as a Dual Contrast Agent for In Vivo Optical and Photoacoustic Tumor Imaging	BIOMACROMOLECULES			English	Article							POLYMERIC NANOPARTICLES; PHOTOTHERMAL THERAPY; CLICK CHEMISTRY; CANCER; COPOLYMERS; CHEMOTHERAPY; DIAGNOSIS; DELIVERY; SYSTEMS; CARRIER	Amphiphilic hyaluronic acid (HA) derivatives bearing hydrophobic indocyanine green dye derivatives and hydrophilic poly(ethylene glycol) were synthesized through the use of condensation and copper-catalyzed click cyclization reactions. The amphiphilic HA derivatives dissolved in water and formed self-assemblies in which the near-infrared dyes were tightly packed and arranged to form dimers or H-aggregates. By irradiating an aqueous solution of HA derivatives with near-infrared light, photoacoustic signals were detected along with fluorescence emission. Self-assemblies consisting of HA derivatives could smoothly accumulate in tumor tissues by passive tumor targeting. By utilizing HA derivatives as a contrast agent, tumor sites were clearly visualized by optical imaging as well as by photoacoustic tomography.	[Miki, Koji; Inoue, Tatsuhiro; Kobayashi, Yasuhito; Nakano, Katsuya; Ohe, Kouichi] Kyoto Univ, Dept Energy & Hydrocarbon Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Matsuoka, Hideki] Kyoto Univ, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Yamauchi, Fumio; Yano, Tetsuya] Canon Inc, Corp R&D Headquarters, Ohta Ku, Tokyo 1468501, Japan	Miki, K (reprint author), Kyoto Univ, Dept Energy & Hydrocarbon Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	kojimiki@scl.kyoto-u.ac.jp; ohe@scl.kyoto-u.ac.jp			Modality Xn program of Kyoto University/Canon joint research project-Innovative Techno-Hub for Integrated Medical Bio-Imaging from MEXT Budget for the Promotion of Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401]	This work is supported by Modality Xn program of Kyoto University/Canon joint research project-Innovative Techno-Hub for Integrated Medical Bio-Imaging from MEXT Budget for the Promotion of Science and Technology, a Grant-in-Aid for Young Scientists (A), and a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (No. 2401)" of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. We acknowledge Professor Teruyuki Kondo and Dr. Yu Kimura in Kyoto University for TEM measurements.	Gann AW, 2014, ORG LETT, V16, P2003, DOI 10.1021/ol500389t; Lee S, 2011, BIOCONJUGATE CHEM, V22, P125, DOI 10.1021/bc1004119; Han HS, 2013, J CONTROL RELEASE, V168, P105, DOI 10.1016/j.jconrel.2013.02.022; Yousefi A, 2013, J CONTROL RELEASE, V170, P209, DOI 10.1016/j.jconrel.2013.05.040; Palumbo FS, 2006, CARBOHYD POLYM, V66, P379, DOI 10.1016/j.carbpol.2006.03.023; Lee DE, 2012, J MATER CHEM, V22, P10444, DOI 10.1039/c2jm31406a; Choi KY, 2011, BIOMATERIALS, V32, P1880, DOI 10.1016/j.biomaterials.2010.11.010; Zha ZB, 2013, CHEM COMMUN, V49, P3455, DOI 10.1039/c3cc40608c; Miki K, 2010, BIOMATERIALS, V31, P934, DOI 10.1016/j.biomaterials.2009.10.005; Levi J, 2010, J AM CHEM SOC, V132, P11264, DOI 10.1021/ja104000a; Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s; Gong H, 2014, ADV FUNCT MATER, V24, P6492, DOI 10.1002/adfm.201401451; Ng KK, 2014, ACS NANO, V8, P8363, DOI 10.1021/nn502858b; Mok H, 2012, CHEM COMMUN, V48, P8628, DOI 10.1039/c2cc33555g; Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Doiron AL, 2009, PHARM RES-DORDR, V26, P674, DOI 10.1007/s11095-008-9786-x; Huang P, 2013, ANGEW CHEM INT EDIT, V52, P13958, DOI 10.1002/anie.201308986; Gong H, 2013, ADV DRUG DELIVER REV, V65, P1951, DOI 10.1016/j.addr.2013.10.002; Petersen AL, 2012, ADV DRUG DELIVER REV, V64, P1417, DOI 10.1016/j.addr.2012.09.003; Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/nnano.2013.302, 10.1038/NNANO.2013.302]; Akers WJ, 2011, ACS NANO, V5, P173, DOI 10.1021/nn102274q; Cho HJ, 2012, J CONTROL RELEASE, V162, P111, DOI 10.1016/j.jconrel.2012.06.011; Oh EJ, 2008, BIOCONJUGATE CHEM, V19, P2401, DOI 10.1021/bc800255y; Jing LJ, 2014, BIOMATERIALS, V35, P5814, DOI 10.1016/j.biomaterials.2014.04.005; Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f; Iha RK, 2009, CHEM REV, V109, P5620, DOI 10.1021/cr900138t; Choi KY, 2010, BIOMATERIALS, V31, P106, DOI 10.1016/j.biomaterials.2009.09.030; Choi KY, 2009, J MATER CHEM, V19, P4102, DOI 10.1039/b900456d; Zackrisson S, 2014, CANCER RES, V74, P979, DOI 10.1158/0008-5472.CAN-13-2387; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; Choi KY, 2012, BIOMATERIALS, V33, P6186, DOI 10.1016/j.biomaterials.2012.05.029; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Vollrath A, 2013, J MATER CHEM B, V1, P1994, DOI 10.1039/c3tb20089b; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Miki K, 2011, ANGEW CHEM INT EDIT, V50, P6567, DOI 10.1002/anie.201101005; Min HS, 2013, ADV FUNCT MATER, V23, P5518, DOI 10.1002/adfm.201301131; Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068; Ding JX, 2011, J POLYM SCI POL CHEM, V49, P2665, DOI 10.1002/pola.24698; Dragulescu-Andrasi A, 2013, J AM CHEM SOC, V135, P11015, DOI 10.1021/ja4010078; Elchinger PH, 2011, POLYMERS-BASEL, V3, P1607, DOI 10.3390/polym3041607; Ghosh A, 2011, LANGMUIR, V27, P9237, DOI 10.1021/la201550a; Kim YJ, 2010, BIOMATERIALS, V31, P9057, DOI 10.1016/j.biomaterials.2010.08.015; Krasia-Christoforou T, 2013, J MATER CHEM B, V1, P3002, DOI 10.1039/c3tb20191k; Miki K, 2012, B CHEM SOC JPN, V85, P1277, DOI 10.1246/bcsj.20120220; Miki K, 2011, SMALL, V7, P3536, DOI 10.1002/smll.201101637; Miki K, 2014, SMALL, V10, P3119, DOI 10.1002/smll.201400358; Mild K., 2009, BIOCONJUGATE CHEM, V20, P511; Takechi K, 2006, J PHYS CHEM B, V110, P16169, DOI 10.1021/jp063651b; Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.TEC.2013.0203, 10.1089/ten.tec.2013.0203]	50	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JAN	2015	16	1					219	227		10.1021/bm501438e		9	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY9IQ	WOS:000347864200021		
J	Wada, S; Kabir, AMR; Kawamura, R; Ito, M; Inoue, D; Sada, K; Kakugo, A				Wada, Shoki; Kabir, Arif Md Rashedul; Kawamura, Ryuzo; Ito, Masald; Inoue, Daisuke; Sada, Kazuki; Kakugo, Akira			Controlling the Bias of Rotational Motion of Ring-Shaped Microtubule Assembly	BIOMACROMOLECULES			English	Article							ACTIVE SELF-ORGANIZATION; BIOMOLECULAR MOTORS; COUNTERCLOCKWISE MOTION; TRANSPORT; MOTILITY; TUBULIN; SURFACE; LENGTH; BUFFER	Biomolecular motor system microtubule (MT)-kinesin is considered a building block for developing artificial microdevices. Recently, an active self-organization method has been established to integrate MT filaments into ring-shaped assembly that can produce rotational motion both in the clockwise and in the counterclockwise directions. In this work, we have investigated the effect of parameters such as MT and kinesin concentration, length, and rigidity of MT and type of kinesin (structure of tail region) on the preferential rotation of the ring-shaped MT assembly produced in an active self-organization. We elucidated that these factors can significantly affect the bias of rotation of the ring-shaped MT assembly, which seems to be related to the fluctuation of leading tip of moving MT filaments. This new finding might be important for designing handedness regulated artificial biomachine using the ring-shaped MT assembly in future.	[Wada, Shoki; Ito, Masald; Inoue, Daisuke; Sada, Kazuki; Kakugo, Akira] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan; [Kabir, Arif Md Rashedul; Sada, Kazuki; Kakugo, Akira] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Kawamura, Ryuzo] Saitama Univ, Dept Chem, Saitama 3388570, Japan	Kakugo, A (reprint author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan.	kakugo@sci.hokudai.ac.jp	Kawamura, Ryuzo/I-6724-2015	Kawamura, Ryuzo/0000-0001-6918-7502	PRESTO (Japan Science and Technology Agency); Ministry of Education, Culture, Sports, Science, and Technology of Japan [24104004]	This research was financially supported by PRESTO (Japan Science and Technology Agency) and Grant-in-Aid for Scientific Research on Innovative Areas named "Molecular robotics" (Grant Number 24104004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kabir AMR, 2011, LANGMUIR, V27, P13659, DOI 10.1021/la202467f; Inoue D, 2013, SOFT MATTER, V9, P7061, DOI 10.1039/c3sm50704a; van den Heuvel MGL, 2006, SCIENCE, V312, P910, DOI 10.1126/science.1124258; Hess H, 2004, CHEM-EUR J, V10, P2110, DOI 10.1002/chem.200305712; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Chan V, 2014, LAB CHIP, V14, P653, DOI 10.1039/c3lc50989c; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kakugo A, 2002, ADV MATER, V14, P1124, DOI 10.1002/1521-4095(20020816)14:16<1124::AID-ADMA1124>3.0.CO;2-M; Peloquin J, 2005, NAT METHODS, V2, P299, DOI 10.1038/nmeth0405-299; Kabir AMR, 2012, POLYM J, V44, P607, DOI 10.1038/pj.2012.26; Hess H, 2011, ANNU REV BIOMED ENG, V13, P429, DOI 10.1146/annurev-bioeng-071910-124644; Hess H, 2002, NANO LETT, V2, P113, DOI 10.1021/nl015647b; Kakugo A, 2011, BIOMACROMOLECULES, V12, P3394, DOI 10.1021/bm200829t; Bachand GD, 2014, WIRES NANOMED NANOBI, V6, P163, DOI 10.1002/wnan.1252; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; GREEN N. M., 1970, Methods in Enzymology, V18A, P418; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Idan O, 2012, NANO LETT, V12, P240, DOI 10.1021/nl203450h; Ito M, 2014, POLYM J, V46, P220, DOI 10.1038/pj.2013.89; Jeune-Smith Y, 2010, SOFT MATTER, V6, P1778, DOI 10.1039/b919488f; Kabir AMR, 2011, MACROMOL BIOSCI, V11, P1314, DOI 10.1002/mabi.201100060; Kabir AMR, 2012, SOFT MATTER, V8, P10863, DOI 10.1039/c2sm26441b; Kawamura K, 2010, NANOTECHNOLOGY, V21; Kawamura R., 2009, LANGMUIR, V26, P533; Kawamura R, 2008, BIOMACROMOLECULES, V9, P2277, DOI 10.1021/bm800639w; Lam AT, 2014, SOFT MATTER, V10, P8731, DOI 10.1039/c4sm01518e; Liu HQ, 2013, CELL MOL BIOENG, V6, P98, DOI 10.1007/s12195-012-0256-5; Liu HQ, 2008, ADV MATER, V20, P4476, DOI 10.1002/adma.200801291; Luria I, 2011, SOFT MATTER, V7, P3108, DOI 10.1039/c0sm00802h; Pampaloni F, 2006, P NATL ACAD SCI USA, V103, P10248, DOI 10.1073/pnas.0603931103; Tamura Y, 2011, SOFT MATTER, V7, P5654, DOI 10.1039/c1sm05413a; Vale R. D., 1994, J BIOL CHEM, V269, P23769	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JAN	2015	16	1					374	378		10.1021/bm501573v		5	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY9IQ	WOS:000347864200038		
J	Araki, J; Kurihara, M				Araki, Jun; Kurihara, Mari			Preparation of Sterically Stabilized Chitin Nanowhisker Dispersions by Grafting of Poly(ethylene glycol) and Evaluation of Their Dispersion Stability	BIOMACROMOLECULES			English	Article							CELLULOSE MICROCRYSTAL SUSPENSION; CRYSTALLINE REGIONS; ELASTIC-MODULUS; RHEOLOGICAL PROPERTIES; MECHANICAL-PROPERTIES; NATIVE CELLULOSE; ALPHA-CHITIN; NANOCRYSTALS; WHISKERS; NANOCOMPOSITES	Sterically stabilized chitin nanowhiskers (ChNWs) were prepared by surface grafting monomethoxy poly(ethylene glycol) (mPEG) via reductive amination of primary amino groups on ChNWs and terminal aldehydes on mPEG. The amount of grafted mPEG was determined to be 0.2-0.3 g/g ChNWs, by conductometric titration, from the decrease in amino groups after grafting. ChNWs with controlled amounts of surface amino groups were obtained by deacetylation; however, this did not cause a drastic change in the amount of grafted mPEG. Grafting was confirmed by Fourier-transform infrared spectroscopy; however, X-ray diffractometry indicated no sign of mPEG. Thermogravimetry indicated a higher amount of mPEG than that from titration, suggesting an overestimation due to the facilitated combustion of grafted samples. In contrast to ungrafted samples, all grafted samples were stable in the presence of electrolytes. However, liquid-crystalline phase separation of grafted ChNWs was not observed, possibly owing to the high viscosity of the concentrated sample.	[Araki, Jun] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan; [Araki, Jun] Shinshu Univ, Inst Fiber Engn IFES, ICCER, Ueda, Nagano 3868567, Japan; [Kurihara, Mari] Shinshu Univ, Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan	Araki, J (reprint author), Shinshu Univ, Fac Text Sci & Technol, Tokida 3-15-1, Ueda, Nagano 3868567, Japan.	jun@shinshu-u.ac.jp	Araki, Jun/A-7023-2015		Japan Society for the Promotion of Science [22750202]	This research was supported by Grants-in-Aid for Scientific Research (Young Scientists (B), no. 22750202), Japan Society for the Promotion of Science. The authors are grateful to Professor Yasuo Gotoh (Shinshu University) for the use of the TG instruments, Prof. Mutsumi Kimura and Sachiko Yoshioka (Shinshu University) for FT-IR measurements, and to the Satellite Venture Business Laboratories of Shinshu University for the use of an electron microscope. The authors are also grateful to Yasuhiro Hida, Yuki Moriguchi, and Yuldko Bessho (Shinshu University) for their help in additional sample preparations and measurements. The authors would like to thank Enago (www.enago.jp) for English language review.	Araki J, 2014, MOL CRYST LIQ CRYST, V592, P99, DOI 10.1080/07315171.2013.840758; Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551; CARLSTROM D, 1957, J BIOPHYS BIOCHEM CY, V3, P669, DOI 10.1083/jcb.3.5.669; Zeng JB, 2012, BIOMACROMOLECULES, V13, P1, DOI 10.1021/bm201564a; BATTISTA OA, 1950, IND ENG CHEM, V42, P502, DOI 10.1021/ie50483a029; Heux L, 2000, LANGMUIR, V16, P8210, DOI 10.1021/la9913957; Hasani M, 2008, SOFT MATTER, V4, P2238, DOI 10.1039/b806789a; BATTISTA OA, 1962, IND ENG CHEM, V54, P20, DOI 10.1021/ie50633a003; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Araki J, 2012, POLYM J, V44, P713, DOI 10.1038/pj.2012.11; Paillet M, 2001, MACROMOLECULES, V34, P6527, DOI 10.1021/ma002049v; Gousse C, 2004, POLYMER, V45, P1569, DOI 10.1016/j.polymer.2003.12.028; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.3.CO;2-8; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; REVOL JF, 1993, INT J BIOL MACROMOL, V15, P329, DOI 10.1016/0141-8130(93)90049-R; Zhou CJ, 2011, BIOMACROMOLECULES, V12, P2617, DOI 10.1021/bm200401p; NISHINO T, 1995, J POLYM SCI POL PHYS, V33, P1647, DOI 10.1002/polb.1995.090331110; MARCHESSAULT RH, 1959, NATURE, V184, P632, DOI 10.1038/184632a0; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Uddin AJ, 2011, COMPOS PART A-APPL S, V42, P741, DOI 10.1016/j.compositesa.2011.02.012; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; Araki J, 2000, LANGMUIR, V16, P2413, DOI 10.1021/1a9911180; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Uddin AJ, 2011, BIOMACROMOLECULES, V12, P617, DOI 10.1021/bm101280f; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Monfardini C, 1998, BIOCONJUGATE CHEM, V9, P418, DOI 10.1021/bc970184f; Kloser E, 2010, LANGMUIR, V26, P13450, DOI 10.1021/la101795s; PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109; Araki J, 2013, SOFT MATTER, V9, P4125, DOI 10.1039/c3sm27514k; Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705; Li J, 1996, J COLLOID INTERF SCI, V183, P365, DOI 10.1006/jcis.1996.0558; Araki J, 2001, LANGMUIR, V17, P21, DOI 10.1021/la001070m; Yi J, 2008, POLYMER, V49, P4406, DOI 10.1016/j.polymer.2008.08.008; Mariano M, 2014, J POLYM SCI POL PHYS, V52, P791, DOI 10.1002/polb.23490; MATSUURA H, 1969, J POLYM SCI A2, V7, P1735, DOI 10.1002/pol.1969.160071009; Araki J, 2014, POLYM ADVAN TECHNOL, V25, P1108, DOI 10.1002/pat.3361; Araki J, 2002, J APPL POLYM SCI, V85, P1349, DOI 10.1002/app.10549; Bhadra D., 2002, PHARMAZIE, V57, P1; BORTEL E, 1979, MAKROMOL CHEM, V180, P2491; DEVOS R, 1986, POLYM BULL, V15, P547; Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p; Elazzouzi-Hafraoui S, 2009, J PHYS CHEM B, V113, P11069, DOI 10.1021/jp900122t; Fan Y, 2008, BIOMACROMOLECULES, V9, P192, DOI 10.1021/bm700966g; Gorochovceva N, 2005, EUR POLYM J, V41, P2653, DOI 10.1016/j.eurpolymj.2005.05.021; Hermans J., 1963, J POLYM SCI C, V2, P145; Hermans J., 1963, J POLYM SCI C, V2, P129; Ifuku S, 2012, CARBOHYD POLYM, V90, P623, DOI 10.1016/j.carbpol.2012.05.087; KONDO T, 1994, MACROMOLECULES, V27, P210, DOI 10.1021/ma00079a031; Li J, 1997, J APPL POLYM SCI, V65, P373; Masson C, 2001, J POLYM SCI POL CHEM, V39, P4022, DOI 10.1002/pola.10049; Michatresh O. A., 2002, MACROMOL CHEM PHYS, V203, P2273; PRESTON RD, 1971, J MICROSC-OXFORD, V93, P7; STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P177, DOI 10.1002/app.1987.070330115; Uddin AJ, 2011, TEXT RES J, V81, P447, DOI 10.1177/0040517511399967; Uddin AJ, 2011, POLYM INT, V60, P1230, DOI 10.1002/pi.3067; Uddin AJ, 2012, POLYM INT, V61, P1010, DOI 10.1002/pi.4174; XU W, 1994, SCANNING MICROSCOPY, V8, P499; HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207; Yang L, 1996, EUR POLYM J, V32, P535, DOI 10.1016/0014-3057(95)00182-4; Yoshifuji A, 2006, BIOMACROMOLECULES, V7, P2878, DOI 10.1021/bm060516w	66	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JAN	2015	16	1					379	388		10.1021/bm5016078		10	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY9IQ	WOS:000347864200039		
J	Wong, YM; Hoshino, Y; Sudesh, K; Miura, Y; Numata, K				Wong, Yoke-Ming; Hoshino, Yu; Sudesh, Kumar; Miura, Yoshiko; Numata, Keiji			Optimization of Poly(N-isopropylacrylamide) as an Artificial Amidase	BIOMACROMOLECULES			English	Article							MOLECULARLY IMPRINTED POLYMERS; IMIDAZOLE-CONTAINING POLYMERS; PANCREATIC RIBONUCLEASE-A; TRANSITION-STATE ANALOGS; P-NITROPHENYL ACETATE; ENZYME-LIKE CATALYSIS; ALPHA-CHYMOTRYPSIN; DISSOCIATION-CONSTANTS; NANOGEL PARTICLES; SERINE PROTEASES	Poly(N-isopropylacrylamide) microgel (NMG) has been developed by adding various functional groups to control surface charges, hydrophobicity, pK(a) and protein adsorption capacity. Here, we developed and optimized NMG anchored with three types of functional groups as a polymeric catalyst to hydrolyze amide bonds under optimized mild conditions. Various optimization strategies were evaluated for efficient hydrolysis activity on a p-nitroaniline-based substrate by using a colorimetric assay. Based on the results, we propose a mechanism to hydrolyze amide bonds and determine the theoretical average distance, using NMG bearing functional group of 1-vinylimidazole as the study model. The hydrolysis of amide bonds was inhibited by a transition-state protease inhibitor, which also confirmed the proposed reaction model for NMG. These results provide an insight into the strategies developed to functionalize hydrogels through an enzyme-mimic approach for future robust bio- and chemical conversions as well as therapeutic utilities.	[Wong, Yoke-Ming; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Enzyme Res Team, Biomass Engn Program, Cooperat Div, Wako, Saitama 3510198, Japan; [Wong, Yoke-Ming; Sudesh, Kumar] Univ Sains Malaysia, Ecobiomat Res Lab, Sch Biol Sci, Minden 11800, Malaysia; [Hoshino, Yu; Miura, Yoshiko] Kyushu Univ, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan	Hoshino, Y (reprint author), Kyushu Univ, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	yhoshino@chem-eng.kyushu-u.ac.jp; keiji.numata@riken.jp	Numata, Keiji/H-9751-2012; 	Sudesh, Kumar/0000-0003-4756-9192	RIKEN Biomass Engineering Program; MEXT [23111716, 25107726]; USM Fellowship; RIKEN International Program	This work was supported by the RIKEN Biomass Engineering Program (K.N.) and MEXT (23111716 and 25107726). Y.-M.W. thanks the USM Fellowship scheme and RIKEN International Program Associate for financial supports.	Smith MH, 2011, MACROMOLECULES, V44, P8154, DOI 10.1021/ma201365p; Kirby AJ, 1996, ANGEW CHEM INT EDIT, V35, P707; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Hoshino Y, 2014, ADV MATER, V26, P3718, DOI 10.1002/adma.201305957; Wulff G, 2002, CHEM REV, V102, P1, DOI 10.1021/cr980039a; BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255; Ramstrom O, 1999, CURR OPIN CHEM BIOL, V3, P759, DOI 10.1016/S1367-5931(99)00037-X; DSOUZA VT, 1987, ACCOUNTS CHEM RES, V20, P146, DOI 10.1021/ar00136a004; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Mujika JI, 2006, CHEM-EUR J, V12, P7215, DOI 10.1002/chem.200600052; Yamazaki T, 2001, ANAL CHIM ACTA, V435, P209, DOI 10.1016/S0003-2670(01)00933-3; Pauling L, 1933, J CHEM PHYS, V1, P362, DOI 10.1063/1.1749304; Shen ZY, 2006, COLLOID POLYM SCI, V284, P1001, DOI 10.1007/s00396-005-1442-y; Gao J, 1997, MACROMOLECULES, V30, P6873, DOI 10.1021/ma9703517; Hoshino Y, 2012, J AM CHEM SOC, V134, P15209, DOI 10.1021/ja306053s; Hoshino Y, 2012, J AM CHEM SOC, V134, P18177, DOI 10.1021/ja3080192; Okhapkin IM, 2004, MACROMOLECULES, V37, P7879, DOI 10.1021/ma0487453; TSUKADA H, 1985, J MOL BIOL, V184, P703, DOI 10.1016/0022-2836(85)90314-6; Buron CC, 2006, COLLOID SURFACE A, V289, P163, DOI 10.1016/j.colsurfa.2006.04.029; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Russo N, 1997, BIOCHEM BIOPH RES CO, V231, P671, DOI 10.1006/bbrc.1997.6167; Hoshino Y, 2010, J AM CHEM SOC, V132, P13648, DOI 10.1021/ja1058982; FEIL H, 1992, MACROMOLECULES, V25, P5528, DOI 10.1021/ma00046a063; DONALDSON TL, 1980, IND ENG CHEM FUND, V19, P260, DOI 10.1021/i160075a005; WLODAWER A, 1983, P NATL ACAD SCI-BIOL, V80, P3628, DOI 10.1073/pnas.80.12.3628; Johansson C, 2010, J COLLOID INTERF SCI, V347, P241, DOI 10.1016/j.jcis.2010.03.072; Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697; DIXON M, 1953, BIOCHEM J, V55, P170; Debord JD, 2003, LANGMUIR, V19, P7662, DOI 10.1021/la0342924; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Yoshimatsu K, 2012, ANGEW CHEM INT EDIT, V51, P2405, DOI 10.1002/anie.201107797; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; OVERBERGER CG, 1963, J AM CHEM SOC, V85, P951, DOI 10.1021/ja00890a026; MCPHEE W, 1993, J COLLOID INTERF SCI, V156, P24, DOI 10.1006/jcis.1993.1075; Ionov L, 2008, ADV FUNCT MATER, V18, P1501, DOI 10.1002/adfm.200800017; PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8; ASCENZI P, 1982, BIOCHEMISTRY-US, V21, P2483, DOI 10.1021/bi00539a030; BLOW DM, 1976, ACCOUNTS CHEM RES, V9, P145, DOI 10.1021/ar50100a004; Bommarius A. S., 2005, BIOCATALYSIS; GOLD AM, 1964, BIOCHEMISTRY-US, V3, P783, DOI 10.1021/bi00894a009; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P537; Hu ZB, 2000, ADV MATER, V12, P1173, DOI 10.1002/1521-4095(200008)12:16<1173::AID-ADMA1173>3.0.CO;2-Z; IRIE M, 1984, J BIOCHEM-TOKYO, V95, P751; Ito S, 1999, LANGMUIR, V15, P4289, DOI 10.1021/la9811867; Jencks W.P., 1969, CATALYSIS CHEM ENZYM; Jozefowicz M, 1997, BIOMATERIALS, V18, P1633, DOI 10.1016/S0142-9612(97)00145-2; Karmalkar RN, 1996, MACROMOLECULES, V29, P1366, DOI 10.1021/ma951263u; Kellum M. G., 2008, POLYM PREPR, V49, P866; Khaligh NG, 2013, RSC ADV, V3, P99, DOI 10.1039/c2ra21295a; Komai T., 1971, J BIOCH, V70, P467; Kunitake T., 1976, ADV POLYM SCI, V20, P159; KUNITAKE T, 1969, J AM CHEM SOC, V91, P2716, DOI 10.1021/ja01038a051; KUNITAKE T, 1976, J AM CHEM SOC, V98, P7793, DOI 10.1021/ja00440a054; LeonLai CH, 1996, CAN J CHEM, V74, P38, DOI 10.1139/v96-005; LINDQUIS.RN, 1973, J AM CHEM SOC, V95, P8762, DOI 10.1021/ja00807a043; MORAWETZ H, 1979, J MACROMOL SCI CHEM, VA13, P311, DOI 10.1080/00222337908068105; OVERBERG.CG, 1969, ACCOUNTS CHEM RES, V2, P217, DOI 10.1021/ar50019a004; SAITO T, 1965, B CHEM SOC JPN, V38, P4, DOI 10.1246/bcsj.38.4; Suh J, 2003, ACCOUNTS CHEM RES, V36, P562, DOI 10.1021/ar020037j; Wang GQ, 2000, P NATL ACAD SCI USA, V97, P9861, DOI 10.1073/pnas.180192597	60	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	JAN	2015	16	1					411	421		10.1021/bm501671		11	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AY9IQ	WOS:000347864200042		
J	Ahn, J; Miura, Y; Yamada, N; Chida, T; Liu, XY; Kim, A; Sato, R; Tsumura, R; Koga, Y; Yasunaga, M; Nishiyama, N; Matsumura, Y; Cabral, H; Kataoka, K				Ahn, Jooyeon; Miura, Yutaka; Yamada, Naoki; Chida, Tsukasa; Liu, Xueying; Kim, Ahram; Sato, Ryuta; Tsumura, Ryo; Koga, Yoshikatsu; Yasunaga, Masahiro; Nishiyama, Nobuhiro; Matsumura, Yasuhiro; Cabral, Horacio; Kataoka, Kazunori			Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer	BIOMATERIALS			English	Article						Drug delivery; Platinum; Micelle; Nanoparticle; Chemotherapy	BLOCK-COPOLYMER MICELLES; TISSUE FACTOR; ANTITUMOR-ACTIVITY; CYTOTOXIC DRUG; DISULFIDE BOND; GENE DELIVERY; BREAST-CANCER; SOLID TUMORS; IN-VIVO; IMMUNOMICELLES	Antibody-mediated therapies including antibody-drug conjugates (ADCs) have shown much potential in cancer treatment by tumor-targeted delivery of cytotoxic drugs. However, there is a limitation of pay-loads that can be delivered by ADCs. Integration of antibodies to drug-loaded nanocarriers broadens the applicability of antibodies to a wide range of therapeutics. Herein, we developed antibody fragment-installed polymeric micelles via maleimide-thiol conjugation for selectively delivering platinum drugs to pancreatic tumors. By tailoring the surface density of maleimide on the micelles, one tissue factor (TF)-targeting Fab' was conjugated to each carrier. Fab'-installed platinum-loaded micelles exhibited more than 15-fold increased cellular binding within 1 h and rapid cellular internalization compared to non-targeted micelles, leading to superior in vitro cytotoxicity. In vivo, Fab'-installed micelles significantly suppressed the growth of pancreatic tumor xenografts for more than 40 days, outperforming non-targeted micelles and free drugs. These results indicate the potential of Fab'-installed polymeric micelles for efficient drug delivery to solid tumors. (C) 2014 Elsevier Ltd. All rights reserved.	[Ahn, Jooyeon; Chida, Tsukasa; Kim, Ahram; Cabral, Horacio; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Miura, Yutaka; Liu, Xueying; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo 1130033, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Yamada, Naoki; Nishiyama, Nobuhiro] Tokyo Inst Technol, Chem Resources Lab, Div Polymer Chem, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Sato, Ryuta; Tsumura, Ryo; Koga, Yoshikatsu; Matsumura, Yasuhiro] Natl Canc Ctr Hosp East, Div Dev Therapeut, Kashiwa, Chiba 2778577, Japan	Kataoka, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kataoka@bmw.t.u-tokyo.ac.jp	Kataoka, Kazunori/K-7108-2012; Nishiyama, Nobuhiro/F-1867-2014	Kataoka, Kazunori/0000-0002-8591-413X; Nishiyama, Nobuhiro/0000-0002-6886-9357	Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Health, Labor, and Welfare (MHLW); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Challenging Exploratory Research [24659584]; Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine; National Cancer Center Research and Development Fund; Health and Labour Sciences Research Grants (Clinical Trial on Development of New Drugs and Medical Devices);  [23700526];  [25750172];  [24689051]	The authors thank R. Shiratori and N. Henzan for helping with synthesis experiments, Y. Mochida for micelle characterization, and K. Date for assistance with animal experiments. The authors also thank M. Naito for FCS analysis. This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS) (KK), Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare (MHLW) (NN, KK), and Center of Innovation Program (COI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KK). This study was partially supported by Grants-in-Aid for Young Scientists (B; No. 23700526 and No. 25750172 to HC; and A; No. 24689051 to YM), Challenging Exploratory Research (No. 24659584 to YM), Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine (KK), the National Cancer Center Research and Development Fund (YM) and the Health and Labour Sciences Research Grants (Clinical Trial on Development of New Drugs and Medical Devices) (YM).	Aliabadi Hamidreza Montazeri, 2006, Expert Opin Drug Deliv, V3, P139, DOI 10.1517/17425247.3.1.139; Breij ECW, 2014, CANCER RES, V74, P1214, DOI 10.1158/0008-5472.CAN-13-2440; Mochida Y, 2014, ACS NANO, V8, P6724, DOI 10.1021/nn500498t; Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Dirisala A, 2014, BIOMATERIALS, V35, P5359, DOI 10.1016/j.biomaterials.2014.03.037; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; THORPE PE, 1987, CANCER RES, V47, P5924; Flygare JA, 2013, CHEM BIOL DRUG DES, V81, P113, DOI 10.1111/cbdd.12085; Li W, 2012, BIOMATERIALS, V33, P5349, DOI 10.1016/j.biomaterials.2012.04.016; Noh T, 2008, J POLYM SCI POL CHEM, V46, P7321, DOI 10.1002/pola.23036; Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006; Song HY, 2009, ORG BIOMOL CHEM, V7, P3400, DOI 10.1039/b904060a; Cabral H, 2007, J CONTROL RELEASE, V121, P146, DOI 10.1016/j.jconrel.2007.05.024; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Nitori N, 2005, CLIN CANCER RES, V11, P2531, DOI 10.1158/1078-0432.CCR-04-0866; Saito Y, 2011, EUR J CANCER, V47, P2230, DOI 10.1016/j.ejca.2011.04.028; Sofuni A, 2005, J GASTROENTEROL, V40, P518, DOI 10.1007/s00535-005-1578-z; Cabral H, 2005, J CONTROL RELEASE, V101, P223, DOI 10.1016/j.jconrel.2004.08.022; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Humphreys DP, 2007, PROTEIN ENG DES SEL, V20, P227, DOI 10.1093/protein/gzm015; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100; Miura Y, 2013, ACS NANO, V7, P8583, DOI 10.1021/nn402662d; Cabral H, 2014, J CONTROL RELEASE, V190, P465, DOI 10.1016/j.jconrel.2014.06.042; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Song H, 2010, BIOMATERIALS, V31, P2302, DOI 10.1016/j.biomaterials.2009.11.067; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Chu TW, 2012, BIOMATERIALS, V33, P7174, DOI 10.1016/j.biomaterials.2012.06.024; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Barginear MF, 2009, OPEN BREAST CANC J, V1, P25, DOI DOI 10.1016/S0169-5347(03)00002-8; Gao Z, 2003, J DRUG TARGET, V11, P87, DOI 10.1080/1061186031000138623; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Lorenzet R, 1998, BLOOD COAGUL FIBRIN, V9, pS49; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385; Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus; Trail P.A., 2013, ANTIBODIES, V2, P113, DOI DOI 10.3390/ANTIB2010113; YOKOYAMA M, 1989, MAKROMOL CHEM, V190, P2041	51	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2015	39						23	30		10.1016/j.biomaterials.2014.10.069		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AY7TB	WOS:000347760600003		
J	Ohta, H				Ohta, Hiroyuki			Reevaluation of McCulloch-Pitts-von Neumann's clock	BIOSYSTEMS			English	Article						Synchronization; Central clock; Constant synaptic delay; von Neumann; Temporal summation	PAIRED-PULSE FACILITATION; SHORT-TERM FACILITATION; V PYRAMIDAL NEURONS; IN-VIVO; INTRINSIC-PROPERTIES; MOTOR INFORMATION; PREFRONTAL CORTEX; SYNAPTIC INPUT; PURKINJE-CELLS; CA1 REGION	In neuroscience research,. a firing pattern expression, called a firing snapshot, defined by firing counts of multiple neurons in discrete time-bin is frequently used. However, the firing pattern expression over multiple neurons requires synchronization commonly known as a "central clock" in computation circuits to externally control or observe multi-neuron firing. Since it is not appropriate to hypothesize the central clock in the brain, we have to reconsider the synchronization assumption. We found the historical origins of central clock synchronization in the works of McCulloch, Pitts and von Neumann and propose an alternative perspective to study neural processing without the central clock. In the "First draft of a report on the EDVAC" known as the first proposal of store-program type computer, von Neumann incorporated McCulloch and Pitts' arbitrary assumption of constant synaptic delay into the logical circuit modeling. He introduced a constant pulse delay stabilized by a central clock to synchronize multiple pulse lines. This constant delay carried over to automaton theory by von Neumann and then theoretical neuroscience as an integral part of distributed representation and firing pattern analysis. Instead, we propose a rethinking of neuronal processing by focusing on a variable synaptic delay. We review neuron-type dependent differences and point out that the maximum inter-stimulus interval which can affect the last stimulus response is longer than the minimum inter-spike interval, indicating the possibility of asynchronous input summation without a firing rate level clock. This fundamental baseline contributes to the investigation of time consuming processes: e.g., the compression of appositional synaptic inputs with duration into a single firing. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3598513, Japan	Ohta, H (reprint author), Natl Def Med Coll, Dept Physiol, Tokorozawa, Saitama 3598513, Japan.	ohta@ndmc.ac.jp			MEXT/JSPS KAKENHI [24700200]; National Defense Medical College; Cooperative Research Project Program of RIEC; Tohoku University; Research Foundation for Opto-Science and Technology, Hamamatsu, Japan	We are grateful to K. Shiotani for advice and D.A. Tyurmin for language assistance and advice. This work was supported by MEXT/JSPS KAKENHI Grant Number 24700200, a grant for Specific Research from National Defense Medical College, the Cooperative Research Project Program of RIEC, Tohoku University and the Research Foundation for Opto-Science and Technology, Hamamatsu, Japan.	Akopian G, 2007, J PHYSIOL-LONDON, V580, P225, DOI 10.1113/jphysiol.2006.115790; Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-07.2007; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; [Anonymous], 1948, EDSAC REPORT CAMBRID; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Piccinini G, 2004, SYNTHESE, V141, P175, DOI 10.1023/B:SYNT.0000043018.52445.3e; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Mahon S, 2003, J PHYSIOL-LONDON, V550, P947, DOI 10.1113/jphysiol.2003.043125; Reyes A, 1999, J NEUROSCI, V19, P3827; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Zhang ZW, 2004, J NEUROPHYSIOL, V91, P1171, DOI 10.1152/jn.00855.2003; GODFREY MD, 1993, IEEE ANN HIST COMPUT, V15, P11, DOI 10.1109/85.194088; Satake S, 2012, J PHYSIOL-LONDON, V590, P5653, DOI 10.1113/jphysiol.2012.234070; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Barto A., 1995, MODELS INFORM PROCES, P215; Burks A.W, 1978, HIST COMPUTING 20 CE, P311, DOI Academic Press; Cohen D, 1981, COMPUTER; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409; Eckert J., 1945, W670ORD4926 MOOR S4; Engbers J.D.T., 2013, FRONT CELL NEUROSCI, V7; Herbert A., 2013, MAKING HIST COMPUTIN, V416, P297, DOI http://dx. doi.org/10.1007/978-3-642-41650-7_27; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Itoh K., 2008, PHILOS HIST SCI STUD, V2, P117; Magee J., 1999, NAT NEUROSCI, V2, P848, DOI 10.1038/12229; Mahon S, 2000, LEARN MEMORY, V7, P357, DOI 10.1101/lm.34800; Mahon S, 2000, J PHYSIOL-LONDON, V527, P345, DOI 10.1111/j.1469-7793.2000.t01-1-00345.x; Markov A., 1954, T MIAN, V42, P3; McClelland J., 1986, PARALLEL DISTRIBUTED; McCulloch W., 1945, B MATH BIOPHYS, V7, P8; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; ONN SP, 1994, SYNAPSE, V16, P195, DOI 10.1002/syn.890160305; RALL W, 1967, J NEUROPHYSIOL, V30, P1138; Rall W., 1964, NEURAL THEORY MODELI, P73; Ranck J B Jr, 1973, Exp Neurol, V41, P461; Sutton R., 1998, REINFORCEMENT LEARNI; von Neumann J., 1956, ANN MATH STUD, V34, P43; von Neumann J., 1966, THEORY SELF REPRODUC; Von Neumann J., 1945, 1 DRAFT REP EDVAC; von Neumann J., 1951, CEREBRAL MECH BEHAV, P1; Warre R, 2011, NEUROBIOL DIS, V41, P591, DOI 10.1016/j.nbd.2010.10.013; Wilkes M.V., 1948, Electronic Engineering, V20; WILKES MV, 1949, NATURE, V164, P341, DOI 10.1038/164341a0; Williams S.R., 2009, SCIENCE, V80, P1907	52	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0303-2647	1872-8324		BIOSYSTEMS	Biosystems	JAN	2015	127						7	13		10.1016/j.biosystems.2014.10.003		7	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	AY9JI	WOS:000347865900002		
J	Mannis, GN; Logan, AC; Leavitt, AD; Yanada, M; Hwang, J; Olin, RL; Damon, LE; Andreadis, C; Ai, WZ; Gaensler, KM; Greene, CC; Gupta, NK; Kaplan, LD; Mahindra, A; Miyazaki, Y; Naoe, T; Ohtake, S; Sayre, PH; Smith, CC; Venstrom, JM; Wolf, JL; Caballero, L; Emi, N; Martin, TG				Mannis, G. N.; Logan, A. C.; Leavitt, A. D.; Yanada, M.; Hwang, J.; Olin, R. L.; Damon, L. E.; Andreadis, C.; Ai, W. Z.; Gaensler, K. M.; Greene, C. C.; Gupta, N. K.; Kaplan, L. D.; Mahindra, A.; Miyazaki, Y.; Naoe, T.; Ohtake, S.; Sayre, P. H.; Smith, C. C.; Venstrom, J. M.; Wolf, J. L.; Caballero, L.; Emi, N.; Martin, T. G.			Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis	BONE MARROW TRANSPLANTATION			English	Article							TRANS-RETINOIC ACID; BONE-MARROW-TRANSPLANTATION; CELL TRANSPLANTATION; COMPLETE REMISSION; CONSOLIDATION; APOPTOSIS; RISK; CHEMOTHERAPY; PETHEMA; AS2O3	A potential link between arsenic (ATO)-based therapy and delayed hematopoietic recovery after autologous hematopoietic SCT (HSCT) for acute promyelocytic leukemia (APL) has previously been reported. We retrospectively reviewed the clinical histories of 58 patients undergoing autologous HSCT for APL at 21 institutions in the United States and Japan. Thirty-three (56%) of the patients received ATO-based therapy prior to stem cell collection. Delayed neutrophil engraftment occurred in 10 patients (17%): 9 of the 10 patients (90%) received prior ATO (representing 27% of all ATO-treated patients), compared with 1 of the 10 patients (10%) not previously treated with ATO (representing 4% of all ATO-naive patients; P < 0.001). Compared with ATO-naive patients, ATO-treated patients experienced significantly longer times to ANC recovery (median 12 days vs 9 days, P < 0.001). In multivariate analysis, the only significant independent predictor of delayed neutrophil engraftment was prior treatment with ATO (hazard ratio 4.87; P < 0.001). Of the available stem cell aliquots from APL patients, the median viable post-thaw CD34+ cell recovery was significantly lower than that of cryopreserved autologous stem cell products from patients with non-APL AML. Our findings suggest that ATO exposure prior to CD34+ cell harvest has deleterious effects on hematopoietic recovery after autologous HSCT.	[Mannis, G. N.; Logan, A. C.; Olin, R. L.; Damon, L. E.; Andreadis, C.; Ai, W. Z.; Gaensler, K. M.; Greene, C. C.; Gupta, N. K.; Kaplan, L. D.; Mahindra, A.; Sayre, P. H.; Smith, C. C.; Venstrom, J. M.; Wolf, J. L.; Martin, T. G.] Univ Calif San Francisco, Div Hematol Malignancies & Blood & Marrow Transpl, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Leavitt, A. D.; Caballero, L.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Yanada, M.; Emi, N.] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 47011, Japan; [Hwang, J.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Miyazaki, Y.] Nagasaki Univ, Dept Hematol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Naoe, T.] Nagoya Univ, Dept Hematol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ohtake, S.] Kanazawa Univ, Dept Clin Lab Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Martin, TG (reprint author), Univ Calif San Francisco, Div Hematol Malignancies & Blood & Marrow Transpl, Dept Med, 400 Parnassus Ave,Room A522, San Francisco, CA 94143 USA.	tmartin@medicine.ucsf.edu			American Society of Hematology Research Training Award; Ministry of Health, Labour and Welfare of Japan [23-004]; National Cancer Center Research and Development Fund [26-A-24]	We would like to thank Jennifer Rasmussen and Katrina De La Cruz of the UCSF Blood and Marrow Transplant Laboratory for their expert technical assistance with the CD34+ cell viability assays, and Nicole Foley and Sara Halvestine of the UCSF Division of Blood and Marrow Transplantation for their assistance with data management. This work was supported in part by an American Society of Hematology Research Training Award for Fellows (GNM), a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (Clinical Cancer Research 23-004); and the National Cancer Center Research and Development Fund (26-A-24).	Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Yamamoto JF, 2008, CANCER CAUSE CONTROL, V19, P379, DOI 10.1007/s10552-007-9097-2; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Ades L, 2013, AM J HEMATOL, V88, P556, DOI 10.1002/ajh.23451; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Fenaux P, 1999, BLOOD, V94, P1192; Yanada M, 2013, BLOOD, V121, P3095, DOI 10.1182/blood-2012-11-466862; Evens AM, 2004, LEUKEMIA RES, V28, P891, DOI 10.1016/j.leukres.2004.01.011; Shen ZX, 1997, BLOOD, V89, P3354; Chen GQ, 1996, BLOOD, V88, P1052; Sanz MA, 2000, BLOOD, V96, P1247; Roboz GJ, 2000, BLOOD, V96, P1525; Sanz MA, 2004, BLOOD, V103, P1237, DOI 10.1182/blood-2003-07-2462; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Jing YK, 1999, BLOOD, V94, P2102; Hayashi T, 2002, MOL CANCER THER, V1, P851; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; de Botton S, 2005, J CLIN ONCOL, V23, P120, DOI 10.1200/JCO.2005.03.127; Linker CA, 2009, BONE MARROW TRANSPL, V44, P353, DOI 10.1038/bmt.2009.36; MANDELLI F, 1994, BONE MARROW TRANSPL, V14, P293; Ottaviani E, 1998, HAEMATOLOGICA, V83, P1051; Ueki T, 2008, PATHOL ONCOL RES, V14, P387, DOI 10.1007/s12253-008-9049-5	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JAN	2015	50	1					40	44		10.1038/bmt.2014.201		5	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AY8MD	WOS:000347806800008		
J	Fuji, S; Mori, T; Khattry, N; Cheng, J; Do, YR; Yakushijin, K; Kohashi, S; Fukuda, T; Kim, SW				Fuji, S.; Mori, T.; Khattry, N.; Cheng, J.; Do, Y. R.; Yakushijin, K.; Kohashi, S.; Fukuda, T.; Kim, S-W		Nutr Support Working Grp Asian	Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality	BONE MARROW TRANSPLANTATION			English	Article							STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; COLORECTAL-CANCER PATIENTS; IMPROVES PATIENT OUTCOMES; VERSUS-HOST-DISEASE; MARROW-TRANSPLANTATION; PARENTERAL-NUTRITION; CONTROLLED-TRIAL; CLINICAL-TRIALS; BODY-MASS	Patients after allogeneic hematopoietic SCT (HSCT) are at risk of malnutrition. To assess the impact of malnutrition after allogeneic HSCT on transplant outcomes, we conducted a retrospective study. Adult patients who received allogeneic HSCT from 2000 to 2009 for standard-risk leukemia and achieved disease-free survival up to 3 months after allogeneic HSCT were included. From participating centers, 145 patients were enrolled. Median age was 46 years (19-68). Patients were classified based on weight loss during 3 months after allogeneic HSCT as follows: normal group (weight loss < 5%, n = 53), mild malnutrition group (5% <= weight loss < 10%, n = 47), severe malnutrition group (10% <= weight loss, n = 45). The cumulative incidences of 2-year nonrelapse mortality (NRM) were 3.8% in the normal group, 8.5% in the mild malnutrition group and 27.3% in the severe malnutrition group. The probabilities of a 2-year OS were 73.2% in the normal group, 74.5% in the mild malnutrition group and 55.3% in the severe malnutrition group. In multivariate analysis, severe malnutrition was associated with an increased risk of NRM and a worse OS. In conclusion, weight loss >= 10% was associated with a worse clinical outcome. Prospective studies that identify patients at risk of malnutrition and intervention by a nutritional support team are warranted.	[Fuji, S.; Fukuda, T.; Kim, S-W] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo 1040045, Japan; [Mori, T.; Kohashi, S.] Keio Univ Hosp, Div Hematol, Tokyo, Japan; [Khattry, N.] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India; [Cheng, J.] St Vincents Hosp, Dept Nutr Serv, Sydney, NSW 2010, Australia; [Do, Y. R.] Keimyung Univ, Div Hematooncol, Dongsan Med Ctr, Taegu, South Korea; [Yakushijin, K.] Kobe Univ, Dept Hematol & Clin Immunol, Kobe, Hyogo 657, Japan	Fuji, S (reprint author), Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sfuji@ncc.go.jp					Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Odelli C, 2005, CLIN ONCOL-UK, V17, P639, DOI 10.1016/j.clon.2005.03.015; Langer CJ, 2001, NUTRITION, V17, pS1, DOI 10.1016/S0899-9007(01)80001-0; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Glover EI, 2010, CURR OPIN CLIN NUTR, V13, P630, DOI 10.1097/MCO.0b013e32833f1ae5; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; White JV, 2012, J ACAD NUTR DIET, V112, P730, DOI 10.1016/j.jand.2012.03.012; WEISDORF SA, 1987, TRANSPLANTATION, V43, P833, DOI 10.1097/00007890-198743060-00012; Urbain P, 2013, BONE MARROW TRANSPL, V48, P446, DOI 10.1038/bmt.2012.158; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; LENSSEN P, 1990, J AM DIET ASSOC, V90, P835; Navarro WH, 2010, BIOL BLOOD MARROW TR, V16, P1442, DOI 10.1016/j.bbmt.2010.04.009; Fuji S, 2009, AM J HEMATOL, V84, P63, DOI 10.1002/ajh.21307; Paddon-Jones D, 2006, J NUTR, V136, P2123; Jacobsohn DA, 2002, BONE MARROW TRANSPL, V29, P231, DOI 10.1038/sj/bmt/1703352; Ravasco P, 2005, J CLIN ONCOL, V23, P1431, DOI 10.1200/JCO.2005.02.054; Johansen N, 2004, CLIN NUTR, V23, P539, DOI 10.1016/j.clnu.2003.10.008; Biolo G, 2007, AM J CLIN NUTR, V86, P366; Middleton MH, 2001, INTERN MED J, V31, P455, DOI 10.1046/j.1445-5994.2001.00109.x; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Ravasco P, 2012, AM J CLIN NUTR, V96, P1346, DOI 10.3945/ajcn.111.018838; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Pressoir M, 2010, BRIT J CANCER, V102, P966, DOI 10.1038/sj.bjc.6605578; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Charuhas PM, 1997, JPEN-PARENTER ENTER, V21, P157, DOI 10.1177/0148607197021003157; Ferrando AA, 1999, J CLIN ENDOCR METAB, V84, P3515, DOI 10.1210/jc.84.10.3515; Fuji S, 2014, BONE MARROW TRANSPL, V49, P1505, DOI 10.1038/bmt.2014.178; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kharfan-Dabaja MA, 2011, BIOL BLOOD MARROW TR, V17, P384, DOI 10.1016/j.bbmt.2010.07.011; Lenssen P, 2009, THOMAS HEMATOPOIETIC, P1551, DOI 10.1002/9781444303537.ch101; LENSSEN P, 1983, EXP HEMATOL, V11, P974; SPENCER GD, 1986, TRANSPLANTATION, V42, P602, DOI 10.1097/00007890-198612000-00006; Wu D, 1998, TRANSPLANTATION, V66, P1319, DOI 10.1097/00007890-199811270-00010	34	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JAN	2015	50	1					100	105		10.1038/bmt.2014.228		6	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AY8MD	WOS:000347806800018		
J	Ikezoe, T; Yang, J; Nishioka, C; Yokoyama, A				Ikezoe, T.; Yang, J.; Nishioka, C.; Yokoyama, A.			Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen	BONE MARROW TRANSPLANTATION			English	Article							HUMAN SOLUBLE THROMBOMODULIN; DISSEMINATED INTRAVASCULAR COAGULATION; VERSUS-HOST-DISEASE; ACTIVATED PROTEIN-C; LECTIN-LIKE DOMAIN; FACTOR-KAPPA-B; RECOMBINANT THROMBOMODULIN; MOLECULE EXPRESSION; TRANSPLANTATION; ENGRAFTMENT	Recombinant human soluble thrombomodulin (rTM), a potent anticoagulant, has been used for the treatment of disseminated intravascular coagulation in Japan since 2008. Interestingly, rTM possesses anti-inflammatory and cytoprotective functions. This study examined whether rTM alleviates GVHD in a murine hematopoietic SCT (HSCT) model. Use of rTM significantly improved the survival of mice on day 28 of transplantation (survival rate 70% in rTM - treated mice vs 35% in control, P < 0.05) in association with a significant decrease in plasma levels of IL-6, IFN-gamma and high-mobility group B1 DNA-binding protein on day 7 of HSCT. Intriguingly, the proportion of regulatory T cells in the spleen was significantly increased in rTM-treated mice on day 7 of transplantation compared with control diluent-treated mice. In addition, elevated plasma levels of TM and fibrin/fibrinogen degradation product were noted in HSCT-recipient mice, suggesting coagulopathy caused by endothelial cell damage in this GVHD model. The use of rTM potently decreased these levels. Importantly, rTM did not hamper the anti-GVL and engraftment of hematopoietic cells. Taken together, the use of rTM may prevent GVHD and serve as a potential therapeutic strategy to improve clinical outcomes in individuals who receive HSCT.	[Ikezoe, T.; Yang, J.; Nishioka, C.; Yokoyama, A.] Kochi Univ, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan	Ikezoe, T (reprint author), Kochi Univ, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan.	ikezoet@kochi-u.ac.jp			JSPS KAKENHI [23591421, 26461406]; Research for Promoting Technological Seeds; Uehara Memorial Foundation; Senshin Medical Research Foundation	This work was supported, in part, by JSPS KAKENHI grant number 23591421 and 26461406, Research for Promoting Technological Seeds, The Uehara Memorial Foundation and The Senshin Medical Research Foundation.	Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; Ikezoe T, 2013, EUR J HAEMATOL, V91, P442, DOI 10.1111/ejh.12188; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Carreras E, 2011, BONE MARROW TRANSPL, V46, P1495, DOI 10.1038/bmt.2011.65; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; Kudo D, 2013, CLIN EXP IMMUNOL, V173, P276, DOI 10.1111/cei.12106; Nagato M, 2009, CRIT CARE MED, V37, P2181, DOI 10.1097/CCM.0b013e3181a55184; Sakai M, 2010, BONE MARROW TRANSPL, V45, P803, DOI 10.1038/bmt.2009.242; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Maruyama I, 1999, THROMB HAEMOSTASIS, V82, P718; Luft T, 2011, BLOOD, V118, P1685, DOI 10.1182/blood-2011-02-334821; Ikezoe T, 2014, INT J HEMATOL, V100, P27, DOI 10.1007/s12185-013-1463-0; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Nomura S, 2011, THROMB HAEMOSTASIS, V105, P1118, DOI 10.1160/TH10-12-0802; Yamakawa K, 2013, INTENS CARE MED, V39, P644, DOI 10.1007/s00134-013-2822-2; Dietrich S, 2014, HAEMATOLOGICA, V99, P541, DOI 10.3324/haematol.2013.090209; Gallez-Hawkins GM, 2009, BIOL BLOOD MARROW TR, V15, P872, DOI 10.1016/j.bbmt.2009.03.022; Gando S, 2005, THROMB RES, V116, P91, DOI 10.1016/j.thromres.2004.09.022; Ikezoe T, 2011, BONE MARROW TRANSPL, V46, P616, DOI 10.1038/bmt.2010.158; Ikezoe T, 2012, ARTERIOSCL THROM VAS, V32, P2259, DOI 10.1161/ATVBAHA.112.251157; Ikezoe T, 2003, MOL PHARMACOL, V64, P1521, DOI 10.1124/mol.64.6.1521; Ikezoe T, 2010, BONE MARROW TRANSPL, V45, P783, DOI 10.1038/bmt.2009.217; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x	27	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	JAN	2015	50	1					113	120		10.1038/bmt.2014.208		8	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AY8MD	WOS:000347806800020		
J	Kawase, H; Okata, Y; Ito, K; Ida, A				Kawase, Hisoshi; Okata, Yoji; Ito, Kimiaki; Ida, Akihiko			Spawning behavior and paternal egg care in a circular structure constructed by pufferfish, Torquigener albomaculosus (Pisces: Tetraodontidae)	BULLETIN OF MARINE SCIENCE			English	Article							SOCIAL-ORGANIZATION; SHARPNOSE PUFFER; MATING SYSTEM; MONACANTHIDAE; TRIGGERFISH; BALISTIDAE; NIPHOBLES; FILEFISH	Males of the pufferfish, Torquigener albomaculosus Matsuura, 2014, are known to construct a nest surrounded by radially aligned peaks and valleys on sandy seabeds, which plays an important role in female mate choice. Here, we report the spawning and parental egg care behavior by the pufferfish based on underwater observations. Pufferfish spawning occurred from spring to summer. Although semi-lunar mating and hatching were observed in the latter period of the spawning season, their periodicity was not consistent throughout the spawning season. Females visited males' nests on the sandy bottom, and males courted them by stirring up sand in the nest and performing a rush and retreat behavior. The females and males mated in pairs, releasing gametes on the nest within approximately 1 s. They mated repeatedly until females left the nest. The males mated with other females on the same day. After matings, males stayed at the nest site and cared for the eggs deposited on the sandy bottom until hatching; males flapped their fins to stir the eggs on the bottom, and drove away fishes that passed close to the nest site. Hatching occurred synchronously with the male flapping behavior around sunset. The reproductive ecology of T albomaculosus is unique in its paternal egg care and mating system of male-territory-visiting polygamy, and this is the first record of this behavior in marine pufferfishes.	[Kawase, Hisoshi] Coastal Branch Nat Hist Museum & Inst Chiba, Chiba 2995242, Japan; [Okata, Yoji] Higashi Komagata, Sumida Ku, Tokyo 1300005, Japan; [Ito, Kimiaki] Marine Stn Amami Yadorihama, Kagoshima 8941523, Japan; [Ida, Akihiko] NHK Enterprises Inc, Shibuya Ku, Tokyo 1500047, Japan	Kawase, H (reprint author), Coastal Branch Nat Hist Museum & Inst Chiba, 123 Yoshio, Chiba 2995242, Japan.	kawase@chiba-muse.or.jp			JSPS [22570032]	We would like to thank H Ida, H Enomoto, T Matsushita, and T Kawasaki of NHK for field observations at Amami-Oshima Island. We also thank H Doi of Osaka Aquarium KAIYUKAN for providing us with information on the spawning ecology of freshwater pufferfishes. W Gladstone, University of Technology Sydney, gave us helpful comments on the manuscript. This study was supported by JSPS KAKENHI Grant No. 22570032.	KAWASE H, 1995, ENVIRON BIOL FISH, V43, P241, DOI 10.1007/BF00005856; Kawase H, 2003, ENVIRON BIOL FISH, V66, P211, DOI 10.1023/A:1023978722744; Kawase H, 1996, ICHTHYOL RES, V43, P315, DOI 10.1007/BF02347603; Beller J, 1958, AQUAR TERRAR Z, V11, P232; Cohn F, 1912, BLATT AQUAR TERRAR, V23, P582; Doi H, 2006, HOW TO KEEP PUFFERS, P102; Feigs G., 1955, Aquarium Philadelphia, V24, P373; Fujita S, 1956, SCI B FAC AGR KYUSHU, V15, P519; Fujita S, 1988, PUFFER FISHES JAPANE; GLADSTONE W, 1987, ENVIRON BIOL FISH, V20, P255; GLADSTONE W, 1987, MAR BIOL, V96, P185, DOI 10.1007/BF00427018; GLADSTONE W, 1994, ENVIRON BIOL FISH, V39, P249, DOI 10.1007/BF00005127; HONMA Y, 1980, JPN J ICHTHYOL, V27, P129; Katayama M, 1964, B FAC ED YAMAGUCHI U, V13, P35; Kawase H, 2002, FISHERIES SCI, V68, P119; Kawase H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02106; KOBAYASHI DR, 1986, ENVIRON BIOL FISH, V15, P141, DOI 10.1007/BF00005429; KUSAKABE DAIJIRO, 1962, JOUR FAC FISH AND ANIMAL HUSBANDRY HIROSHIMA UNIV, V4, P47; Kuwamura T., 1988, PARENTAL CARE SOCIAL; Matsuura K., 2014, ICHTHYOL RES; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakamura K., 1958, AQUACULTURE SCI, V5, P16; Nelson JS, 2006, FISHES WORLD; Nishimura T, 2006, HOW TO KEEP PUFFERS, P98; Randow H, 1934, WOCHENSCHR AQUAR TER, V31, P561; SIKKEL PC, 1990, ENVIRON BIOL FISH, V27, P243, DOI 10.1007/BF00002743; Sugiyama Y, 2006, HOW TO KEEP PUFFERS; Takami T, 1974, STUDIES SEEDING PROD, V1, P1; Thresher RE, 1984, REPROD REEF FISHES; UNO YUTAKA, 1955, JOUR TOKYO UNIV FISH, V41, P169; Yamahira K, 1996, J EXP MAR BIOL ECOL, V198, P291, DOI 10.1016/0022-0981(96)00002-0; YAMAHIRA K, 1994, ENVIRON BIOL FISH, V40, P255, DOI 10.1007/BF00002513	32	0	0	ROSENSTIEL SCH MAR ATMOS SCI	MIAMI	4600 RICKENBACKER CAUSEWAY, MIAMI, FL 33149 USA	0007-4977	1553-6955		B MAR SCI	Bull. Mar. Sci.	JAN	2015	91	1					33	43		10.5343/bms.2014.1055		11	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	AY7TI	WOS:000347761300003		
J	Montano, S; Chou, WH; Chen, CA; Galli, P; Reimer, JD				Montano, Simone; Chou, Wen-Hua; Chen, Chaolun Allen; Galli, Paolo; Reimer, James Davis			First record of the coral-killing sponge Terpios hoshinota in the Maldives and Indian Ocean	BULLETIN OF MARINE SCIENCE			English	Editorial Material									[Montano, Simone; Galli, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Montano, Simone; Galli, Paolo] MaRHE Ctr Marine Res & High Educ Ctr, Magoodhoo Isl, Faalu Atoll, Maldives; [Chou, Wen-Hua; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Reimer, James Davis] Univ Ryukyus, Mol Invertebrate Systemat & Ecol Lab, Fac Sci, Nishihara, Okinawa 9030213, Japan	Reimer, JD (reprint author), Univ Ryukyus, Mol Invertebrate Systemat & Ecol Lab, Fac Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	jreimer@sci.u-ryukyu.ac.jp					Fujii T, 2011, CORAL REEFS, V30, P483, DOI 10.1007/s00338-011-0734-6; Liao MH, 2007, ZOOL STUD, V46, P520; BRYAN P G, 1973, Micronesica, V9, P237; de Voogd NJ, 2013, CORAL REEFS, V32, P755, DOI 10.1007/s00338-013-1030-4; Reimer JD, 2010, ZOOLOGICAL STUDIES, V50, P394; Rutzler Klaus, 1993, Scientia Marina, V57, P395	6	2	2	ROSENSTIEL SCH MAR ATMOS SCI	MIAMI	4600 RICKENBACKER CAUSEWAY, MIAMI, FL 33149 USA	0007-4977	1553-6955		B MAR SCI	Bull. Mar. Sci.	JAN	2015	91	1					97	98		10.5343/bms.2014.1054		2	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	AY7TI	WOS:000347761300009		
J	Takeda, S; Smith, SY; Tamura, T; Saito, H; Takahashi, F; Samadfam, R; Haile, S; Doyle, N; Endo, K				Takeda, Satoshi; Smith, Susan Y.; Tamura, Tatsuya; Saito, Hitoshi; Takahashi, Fumiaki; Samadfam, Rana; Haile, Solomon; Doyle, Nancy; Endo, Koichi			Long-Term Treatment with Eldecalcitol (1 alpha, 25-Dihydroxy-2 beta- (3-hydroxypropyloxy) Vitamin D-3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats	CALCIFIED TISSUE INTERNATIONAL			English	Article						Vitamin D; Eldecalcitol; Bone biomechanical strength; Bone turnover; Bone mineral density; Bone resorption	1-ALPHA,25-DIHYDROXY-2-BETA-(3-HYDROXYPROPOXY)VITAMIN D-3 ED-71; D ANALOG; MICRODAMAGE ACCUMULATION; TRABECULAR BONE; BIOMECHANICAL PROPERTIES; MINERAL DENSITY; CORTICAL BONE; FEMALE RATS; ALENDRONATE; ESTROGEN	The purpose of this study is to estimate the efficacy of eldecalcitol (1 alpha, 25-Dihydroxy-2 beta- (3-hydroxypropyloxy) vitamin D-3; ELD) on bone metabolism after long-term administration. Six-month-old Wistar-Imamichi rats were ovariectomized (OVX) and administered ELD orally at doses of 7.5, 15, or 30 ng/kg daily. Bone mineral density (BMD), urinary excretion of deoxypyridinoline (DPD), a bone resorption marker, and serum total alkaline phosphatase (ALP), a surrogate marker of bone formation, were assessed after 3, 6, and 12 months of treatment. After 12 months of treatment, the biomechanical strength of the L4 lumbar vertebra and femoral shaft was measured, and bone histomorphometry was performed on the L3 lumbar vertebra and the tibia diaphysis. ELD prevented OVX-induced decreases in BMD of the lumbar vertebrae and femur throughout the treatment period. ELD significantly suppressed OVX-induced increases in urinary DPD excretion throughout the treatment period with minimal effects on ALP. OVX resulted in significant decreases in ultimate load and stiffness of the L4 lumbar vertebra and femoral shaft, and ELD significantly prevented the reduction in these biomechanical parameters. Bone histomorphometry at the L3 lumbar vertebra revealed that OVX induced increases in bone resorption parameters (osteoclast surface and osteoclast number) and bone formation parameters (osteoblast surface, osteoid surface, and bone formation rate), and ELD suppressed these parameters after 12 months treatment. Activation frequency, which was elevated in the OVX/vehicle group, was significantly suppressed to baseline levels in ELD-treated groups, indicating that ELD maintained bone turnover at a normal level. ELD also prevented OVX-induced deterioration of microstructure in trabecular and cortical bone. These results indicated that long-term treatment of OVX rats with ELD suppressed bone turnover, and prevented OVX-induced bone loss, deterioration of bone microstructure, and reduction in bone biomechanical strength.	[Takeda, Satoshi; Endo, Koichi] Chugai Pharmaceut Co Ltd, Prod Res Dept, Shizuoka 4128513, Japan; [Smith, Susan Y.; Samadfam, Rana; Doyle, Nancy] Charles River Labs Preclin Serv, Montreal, PQ, Canada; [Tamura, Tatsuya] Chugai Pharmaceut Co Ltd, Discovery Pharmacol Dept 1, Shizuoka, Japan; [Saito, Hitoshi] Chugai Pharmaceut Co Ltd, Dept Med Sci, Tokyo, Japan; [Takahashi, Fumiaki] Chugai Pharmaceut Co Ltd, Primary Lifecycle Management Dept, Tokyo, Japan; [Haile, Solomon] Charles River Labs Preclin Serv, Dept Pathol, Montreal, PQ, Canada	Endo, K (reprint author), Chugai Pharmaceut Co Ltd, Prod Res Dept, 1-135 Komakado, Shizuoka 4128513, Japan.	endokui@chugai-pharm.co.jp					Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Colin EM, 1999, J BONE MINER RES, V14, P57, DOI 10.1359/jbmr.1999.14.1.57; Liel Y, 1999, ENDOCRINOLOGY, V140, P280, DOI 10.1210/en.140.1.280; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; MIYAMOTO K, 1993, CHEM PHARM BULL, V41, P1111; Hatakeyama S, 2007, J STEROID BIOCHEM, V103, P222, DOI 10.1016/j.jsbmb.2006.12.025; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Ito M, 2002, BONE, V31, P351, DOI 10.1016/S8756-3282(02)00830-X; Mashiba T, 2001, BONE, V28, P524, DOI 10.1016/S8756-3282(01)00414-8; Ono Y, 1997, CHEM PHARM BULL, V45, P1626; Allen MR, 2007, J BONE MINER RES, V22, P1759, DOI 10.1359/JBMR.070720; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Chapurlat RD, 2007, J BONE MINER RES, V22, P1502, DOI 10.1359/JBMR.070609; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Schneider JP, 2009, GERIATRICS, V64, P18; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; Brown AJ, 2011, CALCIFIED TISSUE INT, V89, P372, DOI 10.1007/s00223-011-9528-7; Dong XL, 2014, LIFE SCI, V96, P26, DOI 10.1016/j.lfs.2013.12.025; Komatsubara S, 2003, J BONE MINER RES, V18, P512, DOI 10.1359/jbmr.2003.18.3.512; Li M., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P39; Liu XQ, 2008, J BONE MINER METAB, V26, P425, DOI 10.1007/s00774-008-0854-4; Ma YFL, 2003, ENDOCRINOLOGY, V144, P2008, DOI 10.1210/en.2002-221061; Matsumoto T, 2010, J STEROID BIOCHEM, V121, P261, DOI 10.1016/j.jsbmb.2010.03.035; Ono Y, 1998, BIOORGAN MED CHEM, V6, P2517, DOI 10.1016/S0968-0896(98)80025-4; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Shiraishi A, 2000, J BONE MINER RES, V15, P770, DOI 10.1359/jbmr.2000.15.4.770; Stepan JJ, 2007, BONE, V41, P378, DOI 10.1016/j.bone.2007.04.198; Tanaka Y, 1996, J BONE MINER RES, V11, P325; TSURUKAMI H, 1994, CALCIFIED TISSUE INT, V54, P142, DOI 10.1007/BF00296065; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	JAN	2015	96	1					45	55		10.1007/s00223-014-9937-5		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AY6YU	WOS:000347709400006		
J	Fujii, K; Moriwaki, K; Torii, T; Hashimoto, K; Shiroyama, K; Tajima, M; Sanuki, M; Kurita, S				Fujii, Kiyoshi; Moriwaki, Katsuyuki; Torii, Tsuyoshi; Hashimoto, Ken; Shiroyama, Kazuhisa; Tajima, Minoru; Sanuki, Mikako; Kurita, Shigeaki			Urinary retention occurring one week after spinal anesthesia: a case of Elsberg syndrome	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							PATIENT	We describe a case of urinary retention caused by viral sacral myeloradiculitis (Elsberg syndrome) that occurred one week after spinal anesthesia. The differential diagnosis of urinary retention after spinal anesthesia is discussed. A 76-yr-old male patient presented for operative removal of a right testicular hydrocele under spinal anesthesia. Anesthesia and surgery were uneventful, and he was discharged on the fifth postoperative day. Two days after discharge, he developed intermittent anal pain and voiding difficulty and was readmitted to hospital on the tenth postoperative day. He subsequently developed urinary retention, incontinence of feces, and difficulty in defecation. Magnetic resonance imaging showed no epidural hematoma, abscess, or other lesions in the spinal column, cauda equina, or spinal cord. Neurological examination showed dysesthesia in the perineal region and loss of the anal reflex and bulbocavernosus response, which indicated sacral (S4-5) radiculopathy or a lesion of the conus of the spinal cord. A cerebrospinal analysis showed slight elevation of protein without pleocytosis. After neurologic consultation, herpetic sacral myeloradiculitis was suspected and intravenous acyclovir was administered along with large doses of methylprednisolone and immunoglobulin. The symptoms gradually resolved, and the difficulty in voiding resolved 19 days after initiation of the treatment. The patient was discharged 23 days after the start of the treatment without any other complications. This case suggests that Elsberg syndrome is important in the differential diagnosis of urinary retention after spinal anesthesia and should be discriminated from other anesthesia-related complications.	[Fujii, Kiyoshi; Moriwaki, Katsuyuki; Hashimoto, Ken; Shiroyama, Kazuhisa; Tajima, Minoru; Sanuki, Mikako; Kurita, Shigeaki] Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Dept Anesthesiol Crit Care & Pain Med, Kure, Hiroshima 7370023, Japan; [Torii, Tsuyoshi] Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Dept Neurol, Kure, Hiroshima 7370023, Japan	Moriwaki, K (reprint author), Natl Hosp Org, Kure Med Ctr, Chugoku Canc Ctr, Dept Anesthesiol Crit Care & Pain Med, Aoyamacho 3-1, Kure, Hiroshima 7370023, Japan.	moriwaki@kure-nh.go.jp					Agarwal Anil, 2009, Indian J Anaesth, V53, P543; Altorok N, 2011, CLEV CLIN J MED, V78, P151, DOI 10.3949/ccjm.78a.10071; Kato J, 2011, CAN J ANESTH, V58, P638, DOI 10.1007/s12630-011-9505-7; Berger JR, 2008, ARCH NEUROL-CHICAGO, V65, P596, DOI 10.1001/archneur.65.5.596; Eberhardt O, 2004, NEUROLOGY, V63, P758; Sakakibara R, 2006, J NEUROL, V253, P1103, DOI 10.1007/s00415-006-0189-9; Baldini G, 2009, ANESTHESIOLOGY, V110, P1139, DOI 10.1097/ALN.0b013e31819f7aea; Sarifakioglu AB, 2013, AM J PHYS MED REHAB, V92, P179, DOI 10.1097/PHM.0b013e31826edb03; Avidan A, 2002, ANESTHESIOLOGY, V97, P257, DOI 10.1097/00000542-200207000-00032; Choi S, 2012, CAN J ANESTH, V59, P681, DOI 10.1007/s12630-012-9717-5; Horlocker TT, 2006, REGION ANESTH PAIN M, V31, P334, DOI 10.1016/j.rapm.2006.04.002; Yoshida A, 2012, OPEN J OBSTET GYNECO, V2, P202	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JAN	2015	62	1					50	53		10.1007/s12630-014-0241-7		4	Anesthesiology	Anesthesiology	AY6MN	WOS:000347680400009		
J	Sano, H; Suzuki, T; Kaneda, Y				Sano, Hitomi; Suzuki, Takashi; Kaneda, Yuri			Gas leak due to a damaged GE Disposable Multi Absorber Canister used with an EZchange Module following its reinstallation during anesthesia	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Letter									[Sano, Hitomi; Suzuki, Takashi; Kaneda, Yuri] Showa Univ, Koto Toyosu Hosp, Dept Anesthesiol, Tokyo, Japan	Suzuki, T (reprint author), Showa Univ, Koto Toyosu Hosp, Dept Anesthesiol, Tokyo, Japan.	tksuzuki@med.showa-u.ac.jp					FDA - US Food and Drug Administration, CLASS 1 DEV REC MULT; FDA - US Food and Drug Administration, CLASS 2 DEV REC EZCH; Paul C, 2010, ANAESTHESIST, V59, P652, DOI 10.1007/s00101-010-1751-5; Wax D, 2007, ANESTHESIOLOGY, V106, P404, DOI 10.1097/00000542-200702000-00041	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JAN	2015	62	1					96	97		10.1007/s12630-014-0248-0		2	Anesthesiology	Anesthesiology	AY6MN	WOS:000347680400015		
J	Kurashige, J; Mima, K; Sawada, G; Takahashi, Y; Eguchi, H; Sugimachi, K; Mori, M; Yanagihara, K; Yashiro, M; Hirakawa, K; Baba, H; Mimori, K				Kurashige, Junji; Mima, Kosuke; Sawada, Genta; Takahashi, Yusuke; Eguchi, Hidetoshi; Sugimachi, Keishi; Mori, Masaki; Yanagihara, Kazuyoshi; Yashiro, Masakazu; Hirakawa, Kosei; Baba, Hideo; Mimori, Koshi			Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer	CARCINOGENESIS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; TGF-BETA; STROMAL FIBROBLASTS; COLORECTAL-CANCER; BREAST-CANCER; NUDE-MICE; CARCINOMA; PROGRESSION; FAMILY	CAFs induced the hypermethylation of the miR-200b promoter regions and reduced miR-200b expression and there was a negative correlation between miR-200b expression in gastric cancer specimens and alpha-smooth muscle actin expression in the stroma of gastric cancer.Cancer-associated fibroblasts (CAFs) have recently been linked to the invasion and metastasis of gastric cancer. In addition, the microRNA (miR)-200 family plays a central role in the regulation of the epithelial-mesenchymal transition process during cancer metastasis, and aberrant DNA methylation is one of the key mechanisms underlying regulation of the miR-200 family. In this study, we clarified whether epigenetic changes of miR-200b by CAFs stimulate cancer invasion and peritoneal dissemination in gastric cancer. We evaluated the relationship between miR-200b and CAFs using a coculture model. In addition, we established a peritoneal metastasis mouse model and investigated the expression and methylation status of miR-200b. We also investigated the expression and methylation status of miR-200b and CAFs expression in primary gastric cancer samples. CAFs (CAF-37 and CAF-50) contributed to epigenetic changes of miR-200b, reduced miR-200b expression and promoted tumor invasion and migration in NUGC3 and OCUM-2M cells in coculture. In the model mice, epigenetic changes of miR-200b were observed in the inoculated high-frequency peritoneal dissemination cells. In the 173 gastric cancer samples, the low miR-200b expression group demonstrated a significantly poorer prognosis compared with the high miR-200b expression group and was associated with peritoneal metastasis. In addition, downregulation of miR-200b in cancer cells was significantly correlated with alpha-smooth muscle actin expression. Our data provide evidence that CAFs reduce miR-200b expression and promote tumor invasion through epigenetic changes of miR-200b in gastric cancer. Thus, CAFs might be a therapeutic target for inhibition of gastric cancer.	[Kurashige, Junji; Mima, Kosuke; Sawada, Genta; Takahashi, Yusuke; Eguchi, Hidetoshi; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Dept Surg, Beppu Hosp, Beppu, Oita 8740838, Japan; [Kurashige, Junji; Mima, Kosuke; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto 8608556, Japan; [Sawada, Genta; Takahashi, Yusuke; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka 5650871, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba 2778577, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Mimori, K (reprint author), Kyushu Univ, Dept Surg, Beppu Hosp, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp			MEXT [24008081, 25430111, 25461953, 25861199, 25861200, 24592005, 21229015]; Funding Program for Next Generation World Leading Researchers [LS094]; MEXT 'Systems Cancer Research' [4201]; MEXT Strategic Programs on Innovative Research 'Supercomputational Life Science'; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]; Ministry of Health, Labour and Welfare [14524362, 14525288]	Grants-in-Aid for Scientific Research of MEXT (24008081, 25430111, 25461953, 25861199, 25861200, 24592005 and 21229015); Funding Program for Next Generation World Leading Researchers (LS094); Grants-in-Aid for Scientific Research on Innovative Areas of MEXT 'Systems Cancer Research' (4201); The MEXT Strategic Programs on Innovative Research 'Supercomputational Life Science'. This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140230). Computation time was also provided by the Supercomputer System, Human Genome Center, Institute of Medical Science, University of Tokyo and The OITA Cancer Research Foundation 2014. Grant-in-Aid for Scientific Research of Ministry of Health, Labour and Welfare (14524362 and 14525288).	Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Matsumura N, 2011, GENOME RES, V21, P74, DOI 10.1101/gr.108803.110; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Sohn BH, 2010, GASTROENTEROLOGY, V138, P1898, DOI 10.1053/j.gastro.2009.12.044; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Ikeguchi M, 2009, SURG TODAY, V39, P290, DOI 10.1007/s00595-008-3860-1; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Takahashi I, 2000, HEPATO-GASTROENTEROL, V47, P1485; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; YASHIRO M, 1995, BRIT J CANCER, V72, P1200, DOI 10.1038/bjc.1995.486; Yashiro Masakazu, 2010, Cancer Microenviron, V3, P127, DOI 10.1007/s12307-010-0036-5; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zhang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025168	50	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	JAN	2015	36	1					133	141		10.1093/carcin/bgu232		9	Oncology	Oncology	AY9BM	WOS:000347844700018		
J	Galluzzi, L; Bravo-San Pedro, JM; Vitale, I; Aaronson, SA; Abrams, JM; Adam, D; Alnemri, ES; Altucci, L; Andrews, D; Annicchiarico-Petruzzelli, M; Baehrecke, EH; Bazan, NG; Bertrand, MJ; Bianchi, K; Blagosklonny, MV; Blomgren, K; Borner, C; Bredesen, DE; Brenner, C; Campanella, M; Candi, E; Cecconi, F; Chan, FK; Chandel, NS; Cheng, EH; Chipuk, JE; Cidlowski, JA; Ciechanover, A; Dawson, TM; Dawson, VL; De Laurenzi, V; De Maria, R; Debatin, KM; Di Daniele, N; Dixit, VM; Dynlacht, BD; El-Deiry, WS; Fimia, GM; Flavell, RA; Fulda, S; Garrido, C; Gougeon, ML; Green, DR; Gronemeyer, H; Hajnoczky, G; Hardwick, JM; Hengartner, MO; Ichijo, H; Joseph, B; Jost, PJ; Kaufmann, T; Kepp, O; Klionsky, DJ; Knight, RA; Kumar, S; Lemasters, JJ; Levine, B; Linkermann, A; Lipton, SA; Lockshin, RA; Lopez-Otin, C; Lugli, E; Madeo, F; Malorni, W; Marine, JC; Martin, SJ; Martinou, JC; Medema, JP; Meier, P; Melino, S; Mizushima, N; Moll, U; Munoz-Pinedo, C; Nunez, G; Oberst, A; Panaretakis, T; Penninger, JM; Peter, ME; Piacentini, M; Pinton, P; Prehn, JH; Puthalakath, H; Rabinovich, GA; Ravichandran, KS; Rizzuto, R; Rodrigues, CM; Rubinsztein, DC; Rudel, T; Shi, Y; Simon, HU; Stockwell, BR; Szabadkai, G; Tait, SW; Tang, HL; Tavernarakis, N; Tsujimoto, Y; Berghe, TV; Vandenabeele, P; Villunger, A; Wagner, EF; Walczak, H; White, E; Wood, WG; Yuan, J; Zakeri, Z; Zhivotovsky, B; Melino, G; Kroemer, G				Galluzzi, L.; Bravo-San Pedro, J. M.; Vitale, I.; Aaronson, S. A.; Abrams, J. M.; Adam, D.; Alnemri, E. S.; Altucci, L.; Andrews, D.; Annicchiarico-Petruzzelli, M.; Baehrecke, E. H.; Bazan, N. G.; Bertrand, M. J.; Bianchi, K.; Blagosklonny, M. V.; Blomgren, K.; Borner, C.; Bredesen, D. E.; Brenner, C.; Campanella, M.; Candi, E.; Cecconi, F.; Chan, F. K.; Chandel, N. S.; Cheng, E. H.; Chipuk, J. E.; Cidlowski, J. A.; Ciechanover, A.; Dawson, T. M.; Dawson, V. L.; De laurenzi, V.; De Maria, R.; Debatin, K-M; Di Daniele, N.; Dixit, V. M.; Dynlacht, B. D.; El-Deiry, W. S.; Fimia, G. M.; Flavell, R. A.; Fulda, S.; Garrido, C.; Gougeon, M-L; Green, D. R.; Gronemeyer, H.; Hajnoczky, G.; Hardwick, J. M.; Hengartner, M. O.; Ichijo, H.; Joseph, B.; Jost, P. J.; Kaufmann, T.; Kepp, O.; Klionsky, D. J.; Knight, R. A.; Kumar, S.; Lemasters, J. J.; Levine, B.; Linkermann, A.; Lipton, S. A.; Lockshin, R. A.; Lopez-Otin, C.; Lugli, E.; Madeo, F.; Malorni, W.; Marine, J-C; Martin, S. J.; Martinou, J-C; Medema, J. P.; Meier, P.; Melino, S.; Mizushima, N.; Moll, U.; Munoz-Pinedo, C.; Nunez, G.; Oberst, A.; Panaretakis, T.; Penninger, J. M.; Peter, M. E.; Piacentini, M.; Pinton, P.; Prehn, J. H.; Puthalakath, H.; Rabinovich, G. A.; Ravichandran, K. S.; Rizzuto, R.; Rodrigues, C. M.; Rubinsztein, D. C.; Rudel, T.; Shi, Y.; Simon, H-U; Stockwell, B. R.; Szabadkai, G.; Tait, S. W.; Tang, H. L.; Tavernarakis, N.; Tsujimoto, Y.; Berghe, T. Vanden; Vandenabeele, P.; Villunger, A.; Wagner, E. F.; Walczak, H.; White, E.; Wood, W. G.; Yuan, J.; Zakeri, Z.; Zhivotovsky, B.; Melino, G.; Kroemer, G.			Essential versus accessory aspects of cell death: recommendations of the NCCD 2015	CELL DEATH AND DIFFERENTIATION			English	Review							MITOCHONDRIAL PERMEABILITY TRANSITION; TUMOR-NECROSIS-FACTOR; APOPTOSIS-INDUCING FACTOR; MIXED LINEAGE KINASE; CYTOCHROME-C RELEASE; ISCHEMIA-REPERFUSION INJURY; DOMAIN-LIKE PROTEIN; Q-VD-OPH; OUTER-MEMBRANE PERMEABILIZATION; CASPASE INHIBITION SWITCHES	Cells exposed to extreme physicochemical or mechanical stimuli die in an uncontrollable manner, as a result of their immediate structural breakdown. Such an unavoidable variant of cellular demise is generally referred to as 'accidental cell death' (ACD). In most settings, however, cell death is initiated by a genetically encoded apparatus, correlating with the fact that its course can be altered by pharmacologic or genetic interventions. 'Regulated cell death' (RCD) can occur as part of physiologic programs or can be activated once adaptive responses to perturbations of the extracellular or intracellular microenvironment fail. The biochemical phenomena that accompany RCD may be harnessed to classify it into a few subtypes, which often (but not always) exhibit stereotyped morphologic features. Nonetheless, efficiently inhibiting the processes that are commonly thought to cause RCD, such as the activation of executioner caspases in the course of apoptosis, does not exert true cytoprotective effects in the mammalian system, but simply alters the kinetics of cellular demise as it shifts its morphologic and biochemical correlates. Conversely, bona fide cytoprotection can be achieved by inhibiting the transduction of lethal signals in the early phases of the process, when adaptive responses are still operational. Thus, the mechanisms that truly execute RCD may be less understood, less inhibitable and perhaps more homogeneous than previously thought. Here, the Nomenclature Committee on Cell Death formulates a set of recommendations to help scientists and researchers to discriminate between essential and accessory aspects of cell death.	[Galluzzi, L.; Bravo-San Pedro, J. M.] Gustave Roussy Canc Ctr, Villejuif, France; [Galluzzi, L.; Bravo-San Pedro, J. M.; Kepp, O.; Kroemer, G.] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Contre Canc 11, F-75006 Paris, France; [Galluzzi, L.; Kroemer, G.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bravo-San Pedro, J. M.; Kepp, O.; Kroemer, G.] Gustave Roussy, INSERM, U1138, Paris, France; [Vitale, I.; De Maria, R.] Regina Elena Inst Canc Res, Rome, Italy; [Aaronson, S. A.; Chipuk, J. E.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Abrams, J. M.] UT Southwestrn Med Ctr, Dept Cell Biol, Dallas, TX USA; [Adam, D.] Univ Kiel, Inst Immunol, Kiel, Germany; [Alnemri, E. S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Altucci, L.] Seconda Univ Napoli, Dipartimento Biochim Biofis & Patol Gen, Naples, Italy; [Andrews, D.] Univ Toronto, Dept Biochem & Med Biophys, Toronto, ON, Canada; [Annicchiarico-Petruzzelli, M.] IRCCS, IDI, Biochem Lab, Rome, Italy; [Baehrecke, E. H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Bazan, N. G.] Sch Med, Neurosci Ctr Excellence, New Orleans, LA USA; [Bertrand, M. J.; Berghe, T. Vanden; Vandenabeele, P.] VIB, Inflammat Res Ctr, Ghent, Belgium; [Bertrand, M. J.; Berghe, T. Vanden; Vandenabeele, P.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Bianchi, K.] Canc Res UK Ctr Excellence, Barts Canc Inst, London, England; [Bianchi, K.] Queen Mary Univ London, John Vane Sci Ctr, London, England; [Blagosklonny, M. V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Blomgren, K.] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Borner, C.] Univ Freiburg, Inst Mol Med, D-79106 Freiburg, Germany; [Borner, C.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Bredesen, D. E.] Buck Inst Res Aging, Novato, CA USA; [Bredesen, D. E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Brenner, C.] INSERM, UMRS769, Chatenay Malabry, France; [Brenner, C.] LabEx LERMIT, Chatenay Malabry, France; [Brenner, C.] Univ Paris 11, Orsay, France; [Campanella, M.] UCL, Dept Comparat Biomed Sci, London, England; [Campanella, M.] UCL, Consortium Mitochondrial Res, London, England; [Candi, E.; Melino, G.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Cecconi, F.] IRCCS Fdn Santa Lucia, Lab Mol Neuroembryol, Rome, Italy; [Cecconi, F.; Piacentini, M.] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cecconi, F.] Danish Canc Soc Res Ctr, Unit Cell Stress & Survival, Copenhagen, Denmark; [Chan, F. K.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Chandel, N. S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Cheng, E. H.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Cheng, E. H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Cidlowski, J. A.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC USA; [Ciechanover, A.] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, Tumor & Vasc Biol Res Ctr, Haifa, Israel; [Dawson, T. M.; Dawson, V. L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Solomon H Snyder Dept Neurosci,Dept Neurol Pharma, Baltimore, MD USA; [Dawson, T. M.; Dawson, V. L.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [De laurenzi, V.] Gabriele Annunzio Univ, Dept Expt & Clin Sci, Chieti, Italy; [Debatin, K-M] Ulm Univ Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany; [Di Daniele, N.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Dixit, V. M.] Genentech Inc, Dept Physiol Chem, South San Francisco, CA USA; [Dynlacht, B. D.] NYU, Sch Med, Smilow Res Ctr, Dept Pathol, New York, NY USA; [Dynlacht, B. D.] NYU, Sch Med, Smilow Res Ctr, Inst Canc, New York, NY USA; [El-Deiry, W. S.] Penn State Coll Med, Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Lab Translat Oncol & Expt Canc Therapeut, Hershey, PA USA; [Fimia, G. M.] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lecce, Italy; [Fimia, G. M.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy; [Flavell, R. A.] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany; [Garrido, C.] INSERM, U866, Dijon, France; [Garrido, C.] Univ Burgundy, Fac Med, Dijon, France; [Gougeon, M-L] Inst Pasteur, Infect & Epidemiol Dept, Antiviral Immun Biotherapy & Vaccine Unit, Paris, France; [Green, D. R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gronemeyer, H.] IGBMC, Dept Funct Genom & Canc, Illkirch Graffenstaden, France; [Hajnoczky, G.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Hardwick, J. M.; Tang, H. L.] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Hengartner, M. O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Ichijo, H.] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Joseph, B.; Panaretakis, T.] Canc Centrum Karolinska CCK, Dept Oncol Pathol, Stockholm, Sweden; [Jost, P. J.] Tech Univ Munich, Dept Med Hematol, D-80290 Munich, Germany; [Kaufmann, T.] Univ Bern, Fac Med, Inst Pharmacol, Bern, Switzerland; [Knight, R. A.] UCL, Inst Child Hlth, Med Mol Biol Unit, London, England; [Knight, R. A.; Melino, G.] Med Res Council Toxicol Unit, Leicester, Leics, England; [Kumar, S.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia; [Kumar, S.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Kumar, S.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Lemasters, J. J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci & Biochem & Mol, Charleston, SC 29425 USA; [Levine, B.] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Linkermann, A.] Univ Kiel, Div Nephrol & Hypertens, Kiel, Germany; [Lipton, S. A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Lipton, S. A.] Sanford Burnham Ctr Neurosci Aging & Stem Cel Res, La Jolla, CA USA; [Lipton, S. A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Lipton, S. A.] Univ Calif San Diego, San Diego, CA 92103 USA; [Lockshin, R. A.] St Johns Univ, Dept Biol Sci, Queens, NY USA; [Lopez-Otin, C.] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Biochem & Mol Biol, Oviedo, Spain; [Lugli, E.] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy; [Madeo, F.] Graz Univ, Inst Mol Biosci, Graz, Austria; [Malorni, W.] Ist Superiore Sanita, Dept Therapeut Res & Med Evaluat, Rome, Italy; [Malorni, W.] San Raffaele Inst, Sulmona, Italy; [Marine, J-C] Ctr Biol Dis, Lab Mol Canc Biol, Leuven, Belgium; [Marine, J-C] Ctr Human Genet, Lab Mol Canc Biol, Leuven, Belgium; [Martin, S. J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Dublin, Ireland; [Martinou, J-C] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Medema, J. P.] Univ Amsterdam, Acad Med Ctr, Lab Experiments Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Meier, P.] Breakthrough Toby Robins Breast Canc Res Ctr, Inst Canc Res, London, England; [Melino, S.] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Mizushima, N.; Munoz-Pinedo, C.] Univ Tokyo, Fac Med, Cell Death Regulat Grp, Tokyo 113, Japan; [Moll, U.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Munoz-Pinedo, C.] Bellvitge Biomed Res Inst IDIBELL, Cell Death Regulat Grp, Barcelona, Spain; [Nunez, G.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Nunez, G.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Oberst, A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Penninger, J. M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Peter, M. E.] Northwestern Univ, Feinberg Sch Med, Dept Hematol Oncol, Chicago, IL 60611 USA; [Pinton, P.] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, I-44100 Ferrara, Italy; [Pinton, P.] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Prehn, J. H.] Royal Coll Surg, Dept Physiol & Med Phys, Dublin, Ireland; [Puthalakath, H.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Rabinovich, G. A.] Consejo Nacl Invest Cient & Tecn, Inst Biol Med Expt IBYME, Immunopathol Lab, RA-1033 Buenos Aires, DF, Argentina; [Ravichandran, K. S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Rizzuto, R.; Szabadkai, G.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Rodrigues, C. M.] Univ Lisbon, Fac Pharm, Res Inst Med, P-1699 Lisbon, Portugal; [Rubinsztein, D. C.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Rudel, T.] Univ Wurzburg, Dept Microbiol, D-97070 Wurzburg, Germany; [Shi, Y.] Soochow Univ, Soochow Inst Translat Med, Suzhou, Peoples R China; [Simon, H-U] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Stockwell, B. R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, B. R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Szabadkai, G.] UCL, Dept Cell & Dev Biol, London, England; [Szabadkai, G.] UCL, Consortium Mitochondrial Res, London, England; [Tait, S. W.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Tait, S. W.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Tavernarakis, N.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Tavernarakis, N.] Univ Crete, Fac Med, Dept Basic Sci, Iraklion, Crete, Greece; [Tsujimoto, Y.] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Vandenabeele, P.] Univ Ghent, Methusalem Program, B-9000 Ghent, Belgium; [Villunger, A.] Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria; [Wagner, E. F.] Spanish Natl Canc Res Ctr CNIO, Canc Cell Biol Program, Madrid, Spain; [Walczak, H.] UCL, Inst Canc, Ctr Cell Death Canc & Inflammat CCCI, London, England; [White, E.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Wood, W. G.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wood, W. G.] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA; [Yuan, J.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Zakeri, Z.] Queens Coll, Dept Biol, Queens, NY USA; [Zakeri, Z.] CUNY, Grad Ctr, Queens, NY USA; [Zhivotovsky, B.] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; [Zhivotovsky, B.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow, Russia; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France	Galluzzi, L (reprint author), Ctr Rech Cordeliers, Equipe Apoptose Canc & Immun 11, 15 Rue Ecole Med, F-75006 Paris, France.	deadoc@vodafone.it; kroemer@orange.fr	Zhivotovsky, Boris/A-4346-2014; Lopez-Otin, Carlos/C-6657-2013; Linkermann, Andreas/H-3551-2012; Chan, Francis/E-9647-2014; Vandenabeele, Peter/C-8597-2009; Debatin, Klaus-Michael/J-9704-2014; Adam, Dieter/E-9763-2010; Bravo San Pedro, Jose Manuel/F-1680-2015; Penninger, Josef/I-6860-2013; Prehn, Jochen/A-3928-2010; Wagner, Erwin/G-9637-2012; Marine, Jean Christophe/J-2237-2015; Munoz-Pinedo, Cristina/B-6118-2008; Gronemeyer, Hinrich/G-6240-2011	Flavell, Richard/0000-0003-4461-0778; Zhivotovsky, Boris/0000-0002-2238-3482; Dawson, Valina/0000-0002-2915-3970; Panaretakis, Theocharis/0000-0001-5754-6950; Lopez-Otin, Carlos/0000-0001-6964-1904; Linkermann, Andreas/0000-0001-6287-9725; MELINO, SONIA MICHAELA/0000-0001-7694-5279; Blomgren, Klas/0000-0002-0476-7271; Cecconi, Francesco/0000-0002-5614-4359; Kaufmann, Thomas/0000-0001-9906-874X; Chan, Francis/0000-0002-4803-8353; Debatin, Klaus-Michael/0000-0002-8397-1886; Adam, Dieter/0000-0002-5668-5032; Wagner, Erwin/0000-0001-7872-0196; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Gronemeyer, Hinrich/0000-0001-9454-2449			Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Galluzzi L, 2014, NAT CELL BIOL, V16, P728, DOI 10.1038/ncb3005; Hirsch T, 1997, ONCOGENE, V15, P1573, DOI 10.1038/sj.onc.1201324; Grander D, 2009, AUTOPHAGY, V5, P1198; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Dam AD, 2013, BBA-MOL CELL RES, V1833, P3426, DOI 10.1016/j.bbamcr.2013.04.014; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Galluzzi L, 2014, CELL RES, V24, P139, DOI 10.1038/cr.2014.8; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Yin XM, 1999, NATURE, V400, P886; Roach HI, 2000, J BONE JOINT SURG BR, V82B, P601, DOI 10.1302/0301-620X.82B4.9846; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Labi V, 2014, BLOOD, V123, P2652, DOI 10.1182/blood-2013-11-537217; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Miyazaki K, 2001, J BIOCHEM-TOKYO, V129, P963; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; Denton D, 2010, AUTOPHAGY, V6, P163; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Mazzarello P, 1999, NAT CELL BIOL, V1, pE13, DOI 10.1038/8964; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; ZHU HJ, 1995, FEBS LETT, V374, P303, DOI 10.1016/0014-5793(95)01116-V; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Nihira K, 2014, CANCER SCI, V105, P568, DOI 10.1111/cas.12396; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Eguchi Y, 1997, CANCER RES, V57, P1835; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; LASTER SM, 1988, J IMMUNOL, V141, P2629; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Kenis H, 2010, J NUCL MED, V51, P259, DOI 10.2967/jnumed.109.068429; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Lindner AU, 2013, CANCER RES, V73, P519, DOI 10.1158/0008-5472.CAN-12-2269; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Slee EA, 1996, BIOCHEM J, V315, P21; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Gogvadze V, 2009, SEMIN CANCER BIOL, V19, P57, DOI 10.1016/j.semcancer.2008.11.007; Weinlich R, 2011, TRENDS CELL BIOL, V21, P630, DOI 10.1016/j.tcb.2011.09.002; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Han WD, 2012, INT J MOL SCI, V13, P7212, DOI 10.3390/ijms13067212; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI126322; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Li XL, 2010, J NEUROCHEM, V113, P1012, DOI 10.1111/j.1471-4159.2010.06667.x; KISCHKEL FC, 1995, EMBO J, V14, P5579; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj/cdd/4400998; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Irmler M, 1997, NATURE, V388, P190; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Delbridge ARD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008789; Vaux DL, 2002, CELL DEATH DIFFER, V9, P349, DOI 10.1038/sj/onc/4400990; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Criollo A, 2011, EMBO J, V30, P4908, DOI 10.1038/emboj.2011.413; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; Volbracht C, 2001, MOL MED, V7, P36; Vandenabeele P, 2012, CELL DEATH DIFFER, V19, P1093, DOI 10.1038/cdd.2012.65; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI 10.1016/j.chom.2012.01.016; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Basit F, 2013, CELL DEATH DIFFER, V20, P1161, DOI 10.1038/cdd.2013.45; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Oppenheim RW, 2001, J NEUROSCI, V21, P4752; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JC126321; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; La Scola B, 2003, SCIENCE, V299, P2033; Nagasaka A, 2010, CELL DEATH DIFFER, V17, P931, DOI 10.1038/cdd.2009.186; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Enzenmuller S, 2013, CANCER LETT, V329, P27, DOI 10.1016/j.canlet.2012.09.007; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; BELLAMY COC, 1995, SEMIN CANCER BIOL, V6, P3, DOI 10.1006/scbi.1995.0002; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bonora M, 2015, ONCOGENE, V34, P1475, DOI 10.1038/onc.2014.96; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chen WW, 2012, J NEUROCHEM, V120, P70, DOI 10.1111/j.1471-4159.2011.07526.x; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; CHOW SC, 1995, FEBS LETT, V364, P134, DOI 10.1016/0014-5793(95)00370-O; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; del Moral RMG, 2013, SCI WORLD J, DOI 10.1155/2013/486574; Denton D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3916; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Endres Matthias, 1998, Journal of Cerebral Blood Flow and Metabolism, V18, P238; Fiers W., 1995, Journal of Inflammation, V47, P67; Fulda S, 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/214074; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; Grootjans S, 2014, CELL DEATH BIOL DIS, P335, DOI 10.1007/978-1-4614-8220-8_18; Han W, 2014, DEV NEUROSCI-BASEL, V36, P64, DOI 10.1159/000357939; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Hou W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.493; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kehe K, 2008, ARCH TOXICOL, V82, P461, DOI 10.1007/s00204-007-0265-7; Kim SJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.238; Knight KR, 1997, EUR J PHARMACOL, V332, P273, DOI 10.1016/S0014-2999(97)01101-1; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; MacFarlane M, 2009, XENOBIOTICA, V39, P616, DOI 10.1080/00498250903137990; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Mellen MA, 2009, AUTOPHAGY, V5, P964; Michels J, 2013, ONCOGENE, V33, P3894; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Munoz-Pinedo C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.246; Murphy E, 2014, BIOCHEM BIOPH RES CO, V449, P384, DOI 10.1016/j.bbrc.2014.04.144; Nicotera P, 1998, TOXICOL LETT, V103, P139; Noch E, 2009, CANCER BIOL THER, V8, P1791; Okada M, 2004, BLOOD, V103, P2299, DOI 10.1182/blood-2003-05-1605; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Park EJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.202; Pearson H, 2008, NATURE, V454, P677, DOI 10.1038/454677a; Pogrebniak A, 2003, EUR J MED RES, V8, P438; Prabhakaran K, 2004, TOXICOL APPL PHARM, V195, P194, DOI 10.1016/j.taap.2003.11.012; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Renolleau S, 2007, J NEUROCHEM, V100, P1062, DOI 10.1111/j.1471-4159.2006.04269.x; Saikumar P, 2007, FASEB J, V21, pA258; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Scheller C, 2006, J CELL BIOCHEM, V97, P1350, DOI 10.1002/jcb.20670; SCHWEICH.JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; Steinhart L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.320; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tang HL, 2014, J VIS EXP, V2014; Tracy K, 2013, CURR TOP DEV BIOL, V103, P101, DOI 10.1016/B978-0-12-385979-2.00004-6; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj/cdd/4400966; Varma H, 2013, EXP CELL RES, V319, P1759, DOI 10.1016/j.yexcr.2013.03.019; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Verrier F, 2003, ANN NY ACAD SCI, V1010, P126, DOI 10.1196/annals.1299.022; Volbracht C, 1999, MOL MED, V5, P477; Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wolf BB, 1999, BLOOD, V94, P1683; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Zhang WH, 2013, J SURG RES, V185, P851, DOI 10.1016/j.jss.2013.07.049; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118; Zhu DH, 1996, MOL PHARMACOL, V50, P506	336	47	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	JAN	2015	22	1			SI		58	73		10.1038/cdd.2014.137		16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY9AJ	WOS:000347841600008		
J	Noguchi, H; Saitoh, I; Tsugata, T; Kataoka, H; Watanabe, M; Noguchi, Y				Noguchi, H.; Saitoh, I.; Tsugata, T.; Kataoka, H.; Watanabe, M.; Noguchi, Y.			Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection	CELL DEATH AND DIFFERENTIATION			English	Article							HUMAN SOMATIC-CELLS; HUMAN IPS CELLS; EPIGENETIC MEMORY; PROGENITOR CELLS; PANCREATIC-DUCT; DEFINED FACTORS; BETA-CELLS; IN-VIVO; FIBROBLASTS; DIFFERENTIATION	Although induced pluripotent stem (iPS) cells have significant implications for overcoming most of the ethical issues associated with embryonic stem (ES) cells, there are still several unresolved issues related to the use of iPS cells for clinical applications, such as teratoma formation. In this study, we were able to generate tissue-specific stem (induced tissue-specific stem; iTS) cells from the pancreas (iTS-P) or liver (iTS-L) by transient overexpression of reprogramming factors, combined with tissue-specific selection. The generation of iTS cells was easier than that of iPS cells. The iTS-P/iTS-L cells express genetic markers of endoderm and pancreatic/hepatic progenitors and were able to differentiate into insulin-producing cells/hepatocytes more efficiently than ES cells. Subcutaneous transplantation of both types of iTS cells into immunodeficient mice resulted in no teratoma formation. The technology used for the transient overexpression of reprogramming factors and tissue-specific selection may be useful for the generation of other tissue-specific stem cells, and the generation of iTS cells could have important implications for the clinical application of stem cells.	[Noguchi, H.] Natl Hosp Org, Chiba East Natl Hosp, Dept Surg, Chiba 2608712, Japan; [Noguchi, H.] Univ Ryukyus, Grad Sch Med, Dept Regenerat Med, Okinawa, Japan; [Noguchi, H.; Tsugata, T.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan; [Noguchi, H.] Open Univ Japan, Nat & Environm Sci Program, Chiba, Japan; [Saitoh, I.] Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Niigata, Japan; [Kataoka, H.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Primary Care & Med Educ, Okayama, Japan; [Watanabe, M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan; [Noguchi, Y.] Hiroshima Int Univ, Dept Socioenvironm Design, Hiroshima, Japan	Noguchi, H (reprint author), Natl Hosp Org, Chiba East Natl Hosp, Dept Surg, Chuo Ku, 673 Nitona Cho, Chiba 2608712, Japan.	n.hirofumi@cehpnet.com			Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare	This work was supported in part by the Japan Society for the Promotion of Science and the Ministry of Health, Labour and Welfare.	D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; NIWA H, 1991, GENE, V108, P193; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/nature06534; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Noguchi H, 2010, CELL TRANSPLANT, V19, P879, DOI 10.3727/096368910X509004; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Kuise T, 2013, CELL MED, V5, P69; Noguchi H, 2009, CELL TRANSPLANT, V18, P563; Saitoh I, 2012, CELL MED, V3, P97; Yamamoto T, 2006, DIABETOLOGIA, V49, P2359, DOI 10.1007/s00125-006-0372-7	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	JAN	2015	22	1			SI		145	155		10.1038/cdd.2014.132		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AY9AJ	WOS:000347841600015		
J	Jensen, CS; Misonou, H				Jensen, Camilla Stampe; Misonou, Hiroaki			Live-cell Imaging of Post-Golgi Transport Vesicles in Cultured Hippocampal Neurons	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Hippocampal neurons; Ion channels; Live-cell imaging; Post-Golgi vesicles; Intracellular transport; Analysis and quantification	GATED ION CHANNELS; ENDOPLASMIC-RETICULUM; POTASSIUM CHANNELS; MEMBRANE-PROTEINS; FLUORESCENT PROTEIN; LIVING CELLS; K+ CHANNEL; TRAFFICKING; LOCALIZATION; SURFACE	The subcellular localization of neuronal membrane signaling molecules such as receptors and ion channels depends on intracellular trafficking mechanisms. Essentially, vesicular trafficking mechanisms ensure that a large number of membrane proteins are correctly targeted to different subcellular compartments of neurons. In the past two decades, the establishment and advancement of fluorescent protein technology have provided us with opportunities to study how proteins are trafficked in living cells. However, live imaging of trafficking processes in neurons necessitate imaging tools to distinguish the several different routes that neurons use for protein trafficking. Here we provide a novel protocol to selectively visualize post-Golgi transport vesicles carrying fluorescent-labeled ion channel proteins in living neurons. Further, we provide a number of analytical tools we developed to quantify characteristics of different types of transport vesicles. We demonstrate the application of our protocol to investigate whether ion channels are sorted into distinct vesicular populations at the Golgi apparatus. We also demonstrate how these techniques are suitable for pharmacological dissection of the transport mechanisms by which post-Golgi vesicles are trafficked in neurons. Our protocol uniquely combines the classic temperature-block with close monitoring of the transient expression of transfected protein tagged with fluorescent proteins, and provides a quick and easy way to study protein trafficking in living neurons. We believe that the procedures described here are useful for researchers who are interested in studying molecular mechanisms of protein trafficking in neurons.	[Jensen, Camilla Stampe; Misonou, Hiroaki] Univ Maryland, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Jensen, Camilla Stampe] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Misonou, Hiroaki] Doshisha Univ, Grad Sch Brain Sci, Kizugawa, Kyoto 6190225, Japan	Misonou, H (reprint author), Doshisha Univ, Grad Sch Brain Sci, 4-1-1 Kizudawadai, Kizugawa, Kyoto 6190225, Japan.	h_misonou@mac.com		Misono, Hiroaki/0000-0001-5892-1804	Takeda Science Foundation; Naito Foundation; Lundbeck Foundation	We thank Drs. James Trimmer, Stephanie Kaech, Okunola Jeyifous, and Stephen Siegelbaum for generously providing precious reagents. We also thank Dr. Shoji Watanabe for his technical assistance. The work was supported by Takeda Science Foundation (H.M.) and the Naito Foundation (H.M.). C.S.J was supported by the Lundbeck Foundation.	Misonou H, 2005, J NEUROSCI METH, V144, P165, DOI 10.1016/j.neuemth.2004.11.007; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Horton AC, 2003, J NEUROSCI, V23, P6188; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Al-Bassam S, 2012, CELL REPORTS, V2, P89, DOI 10.1016/j.celrep.2012.05.018; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Boncompain G, 2013, METHOD CELL BIOL, V118, P179, DOI 10.1016/B978-0-12-417164-0.00011-2; CIDARREGUI A, 1995, J NEUROSCI, V15, P4259; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Goslin K., 1998, CULTURING NERVE CELL, P339; Jensen CS, 2014, J BIOL CHEM, V289, P10566, DOI 10.1074/jbc.M113.534495; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Menegola M, 2008, NEUROSCIENCE, V154, P953, DOI 10.1016/j.neuroscience.2008.04.022; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Vacher H, 2007, DETERMINANTS VOLTAGE	36	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2015	35	1					123	135		10.1007/s10571-014-0103-4		13	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AY9QC	WOS:000347884500013		
J	Chen, S; Shimada, M; Nakamura, N; Huang, SL; Liu, KX; Chen, JE				Chen Si; Shimada, M.; Nakamura, N.; Huang Sen-Lin; Liu Ke-Xin; Chen Jia-Er			Beam breakup simulation study for a high energy ERL	CHINESE PHYSICS C			English	Article						energy recovery linac; beam breakup; higher order mode		The maximum beam current that can be accelerated in an energy recovery linac (ERL) can be severely limited by the transverse multi-pass beam breakup instability (BBU), especially M. future EEL light sources with multi-GeV high energy beam energy and more than 100 mA average current. In this paper, the multi-pass BBU of such a high energy ERL is studied based on the simulation of a 3-GeV ERL light source that is proposed by KEK. This work is expected to provide a reference for future high energy ERL projects.	[Chen Si; Chen Jia-Er] Univ Chinese Acad Sci, Sch Phys, Beijing 100190, Peoples R China; [Chen Si; Huang Sen-Lin; Liu Ke-Xin; Chen Jia-Er] Peking Univ, Inst Heavy Ion Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Shimada, M.; Nakamura, N.] KEK, Tsukuba, Ibaraki 3050801, Japan	Chen, S (reprint author), Univ Chinese Acad Sci, Sch Phys, Beijing 100190, Peoples R China.	huangsl@pku.edu.cn; kxliu@pku.edu.cn			Major State Basic Research Development Program of China [2011CB808404]	Supported by Major State Basic Research Development Program of China (2011CB808404)	[Anonymous], 2012, EN REC LIN PREL DES; Chen S, 2013, CHINESE PHYS C, V37, DOI 10.1088/1674-1137/37/8/087001; Cui XH, 2013, CHINESE PHYS C, V37, DOI 10.1088/1674-1137/37/7/077005; Hajima R, 2007, P 41 ADV ICFA BEAM D, P133; Liepe M, 2003, P 11 WORKSH RF SUP L, P115; Nakamura N., 2012, P IPAC, P1040; Pozdeyev E, 2005, PHYS REV SPEC TOP-AC, V8, DOI 10.1103/PhysRevSTAB.8.054401; Rosenzweig G, 1994, PHYS REV E, V49, P1599; Sakai H, 2007, P 41 ADV ICFA BEAM D, P56; Shimada M, COMMUNICATION; Valles N., 2012, P IPAC2012 NEW ORL L, P2387; XIAO L, 2007, P PAC07 ALB NEW MEX, P2454	12	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	JAN	2015	39	1							017006	10.1088/1674-1137/39/1/017006		5	Physics, Nuclear; Physics, Particles & Fields	Physics	AY7TQ	WOS:000347762100017		
J	Zhao, DY; Wang, GW; Pan, WM; Sun, Y; Qiu, F; Zhang, J; Mi, ZH; Lin, HY; Sha, P; Wang, QY; Xu, B; Ma, Q				Zhao Dan-Yang; Wang Guang-Wei; Pan Wei-Min; Sun Yi; Qiu Feng; Zhang Juan; Mi Zheng-Hui; Lin Hai-Ying; Sha Peng; Wang Qun-Yao; Xu Bo; Ma Qiang			High accuracy amplitude and phase measurements based on a double heterodyne architecture	CHINESE PHYSICS C			English	Article						amplitude and phase measurements; double heterodyne architecture; wide IF; non-IQ sampling; LLRF		In the digital low level RF (LLRF) system of a circular (particle) accelerator, the RF field signal is usually down converted to a fixed intermediate frequency (IF). The ratio of IF and sampling frequency determines the processing required, and differs in various LLRF systems. It is generally desirable to design a universally compatible architecture for different IFs with no change to the sampling frequency and algorithm. A new RF detection method based on a double heterodyne architecture for wide IF range has been developed, which achieves the high accuracy requirement of modern LLRF. In this paper, the relation of IF and phase error is systematically analyzed for the first time and verified by experiments. The effects of temperature drift for 16 h IF detection are inhibited by the amplitude and phase calibrations.	[Zhao Dan-Yang; Zhang Juan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhao Dan-Yang; Wang Guang-Wei; Pan Wei-Min; Sun Yi; Zhang Juan; Mi Zheng-Hui; Lin Hai-Ying; Sha Peng; Wang Qun-Yao; Xu Bo; Ma Qiang] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China; [Qiu Feng] KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan	Zhao, DY (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	zhaody@mail.ihep.ac.cn					Wang Z, 2012, IEEE T INSTRUM MEAS, V61, P912, DOI 10.1109/TIM.2011.2179334; Brannon Brad, 2000, AN501 AN DEV; Fernandez-Vazquez, 2011, SIGNAL PROCESS, V91, P1143; Kester W., 2004, DATA CONVERSION HDB; Mavric U, 2008, NUCL INSTRUM METH A, V594, P90, DOI 10.1016/j.nima.2008.06.002; Miller, 1991, IEEE T INSTRUM MEAS, V40, P578; Qiu F, 2012, NUCL INSTRUM METH A, V675, P139, DOI 10.1016/j.nima.2012.01.068; References Garoby R, 1997, AIP C P; Ruscak S, 1995, ANALOG DIALOGUE, P29; Simrock S, 2006, P LINAC KNOXV TENN U, P21	10	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	JAN	2015	39	1							017002	10.1088/1674-1137/39/1/017002		6	Physics, Nuclear; Physics, Particles & Fields	Physics	AY7TQ	WOS:000347762100013		
J	Sasaki, W; Doi, T; Richards, KJ; Masumoto, Y				Sasaki, Wataru; Doi, Takeshi; Richards, Kelvin J.; Masumoto, Yukio			The influence of ENSO on the equatorial Atlantic precipitation through the Walker circulation in a CGCM	CLIMATE DYNAMICS			English	Article						ITCZ; ENSO; Equatorial Atlantic; Coupled general circulation model	SEA-SURFACE TEMPERATURE; NINO-SOUTHERN-OSCILLATION; VERTICAL SCALE STRUCTURES; OCEAN-ATMOSPHERE MODEL; TROPICAL ATLANTIC; VARIABILITY; CLIMATE; BIASES; PACIFIC; THERMOCLINE	The link between El Nio/Southern Oscillation (ENSO) and the equatorial Atlantic precipitation during boreal spring (March-April-May) is explored using a coupled general circulation model (CGCM). Interannual variability of the equatorial Atlantic sea surface temperature (SST) in the CGCM is excluded by nudging the modeled SST toward the climatological monthly mean of observed SST in the equatorial Atlantic, but full air-sea coupling is allowed elsewhere. It is found that the equatorial Atlantic precipitation is reduced (increased) during El Nio (La Nia) in the case where the interannual variability of the equatorial Atlantic SST is disabled. The precipitation anomalies in the equatorial Atlantic during ENSO are not strongly associated with the meridional migration of the Atlantic inter-tropical convergence zone. We find the reduced precipitation in the equatorial Atlantic during El Nio is associated with an enhanced Atlantic Walker circulation characterized by strengthened low-level easterlies and anomalous dry, downward winds over the equatorial Atlantic, while the Pacific Walker circulation is weakened. The upper-level anomalous westerlies over the equatorial Atlantic are consistent with a Matsuno-Gill-type response to heating in the eastern equatorial Pacific. Our results of the CGCM experiments suggest that changes to the Walker circulation induced by ENSO contribute significantly to changes in precipitation over the equatorial Atlantic.	[Sasaki, Wataru] Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, Yokohama, Kanagawa, Japan; [Doi, Takeshi; Masumoto, Yukio] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Richards, Kelvin J.] Univ Hawaii Manoa, Int Pacific Res Ctr SOEST, Honolulu, HI 96822 USA; [Masumoto, Yukio] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan	Sasaki, W (reprint author), Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, 3173-25 Kanazawa Ku,Showa Machi, Yokohama, Kanagawa, Japan.	wsasaki@jamstec.go.jp	Doi, Takeshi/C-1989-2013				Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; Richter I, 2008, CLIM DYNAM, V31, P587, DOI 10.1007/s00382-008-0364-z; Masson S, 2012, CLIM DYNAM, V39, P681, DOI 10.1007/s00382-011-1247-2; Richter I, 2014, CLIM DYNAM, V42, P171, DOI 10.1007/s00382-012-1624-5; Munnich M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023900; Ham YG, 2013, NAT GEOSCI, V6, P112, DOI [10.1038/ngeo1686, 10.1038/NGEO1686]; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Doi T, 2012, J CLIMATE, V25, P5494, DOI 10.1175/JCLI-D-11-00360.1; Pezzi LP, 2001, CLIM DYNAM, V17, P205, DOI 10.1007/s003820000104; Huang B, 2004, CLIM DYNAM, V23, P133, DOI 10.1007/s00382-004-0443-8; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Biasutti M, 2006, J CLIMATE, V19, P935, DOI 10.1175/JCLI3673.1; Chiang JCH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000307; Xie SP, 1999, J CLIMATE, V12, P64, DOI 10.1175/1520-0442-12.1.64; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Saravanan R, 2000, J CLIMATE, V13, P2177, DOI 10.1175/1520-0442(2000)013<2177:IBTAVA>2.0.CO;2; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Luo JJ, 2005, J CLIMATE, V18, P2344, DOI 10.1175/JCLI3404.1; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; BLANKE B, 1993, J PHYS OCEANOGR, V23, P1363, DOI 10.1175/1520-0485(1993)023<1363:VOTTAO>2.0.CO;2; XIE SP, 1994, TELLUS A, V46, P340, DOI 10.1034/j.1600-0870.1994.t01-1-00001.x; Giannini A, 2004, CLIM DYNAM, V22, P839, DOI 10.1007/s00382-004-0420-2; Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Ding H, 2012, CLIM DYNAM, V38, P1965, DOI 10.1007/s00382-011-1097-y; Bates SC, 2008, J CLIMATE, V21, P5501, DOI 10.1175/2008JCLI1983.1; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; Huang BH, 2005, J CLIMATE, V18, P1652, DOI 10.1175/JCLI3368.1; Huang BH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014872; Levitus S., 1982, 13 NOAA; Madec G, 2008, NOTE POLE MODELISATI, V27, P1288; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Okumura Y, 2006, J CLIMATE, V19, P5859, DOI 10.1175/JCLI3928.1; Rodriguez-Fonseca B, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040048; Roeckner E, 2003, 349 MAX PLANCK I; Sasaki W, 2013, CLIM DYNAM, V41, P443, DOI 10.1007/s00382-012-1593-8; Sasaki W, 2014, CLIM DYNAM, V43, P2539, DOI 10.1007/s00382-014-2072-1; Sasaki W, 2012, OCEAN MODEL, V57-58, P29, DOI 10.1016/j.ocemod.2012.09.002; Valcke S., 2004, TRCMGC0468 CERFACS; Wang CZ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026324	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	JAN	2015	44	1-2					191	202		10.1007/s00382-014-2133-5		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AY6ZF	WOS:000347710400008		
J	Idoue, A; Hirata, C; Utsumi, M; Miyai, N; Iwahara, A; Hattori, S; Uematsu, Y; Shiba, M; Buyo, M; Arita, M				Idoue, Ayaka; Hirata, Chiaki; Utsumi, Miyoko; Miyai, Nobuyuki; Iwahara, Akihiko; Hattori, Sonomi; Uematsu, Yuji; Shiba, Mitsuru; Buyo, Momoko; Arita, Mikio			Relationship between blood pressure response during step exercise test and atherosclerotic markers	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article						Arteriosclerosis; cardiovascular diseases; exercise blood pressure; intima media thickness; metabolic equivalents; step test	MIDDLE-AGED MEN; DYNAMIC EXERCISE; HYPERTENSION; RISK; SENSITIVITY; MECHANISMS; WAVE	The relationship between blood pressure (BP) response to exercise and atherosclerotic markers were evaluated in a population based sample of 426 normotensive subjects. The subjects with greater increase of SBP during exercise and delayed recovery of SBP after exercise showed higher hs-CRP and SBP2. Multiple regression analysis revealed that the greater BP response and delayed BP recovery were independently associated with SBP2 after adjusting for resting SBP, age, and gender. These results suggest that early atherosclerosis may contribute to greater BP responses to exercise, supporting the concept that exercise BP adds incremental information of cardiovascular risks to resting BP.	[Idoue, Ayaka; Hirata, Chiaki; Utsumi, Miyoko; Miyai, Nobuyuki; Iwahara, Akihiko; Hattori, Sonomi; Uematsu, Yuji; Shiba, Mitsuru; Buyo, Momoko; Arita, Mikio] Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama 6410011, Japan	Arita, M (reprint author), Wakayama Med Univ, Sch Hlth & Nursing Sci, 580 Mikazura, Wakayama 6410011, Japan.	arita-nc@wakayama-med.ac.jp					American College of Sports Medicine, 2013, ACSMS GUID EX TEST P; Singh JP, 1999, CIRCULATION, V99, P1831; Tsioufis C, 2008, AM J MED, V121, P894, DOI [10.1016/j.amjmed.2008.05.035, 10.1053/j.ajkd.2009.11.024]; Kurl S, 2001, STROKE, V32, P2036, DOI 10.1161/hs0901.095395; Jae SY, 2006, J HYPERTENS, V24, P881, DOI 10.1097/01.hjh.0000222758.54111.e2; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Thanassoulis G, 2012, CIRCULATION, V125, P2836, DOI 10.1161/CIRCULATIONAHA.111.063933; Fossum E, 1999, HYPERTENSION, V33, P781; MUNDAL R, 1994, HYPERTENSION, V24, P56; FRANZ IW, 1985, CARDIOLOGY, V72, P147, DOI 10.1159/000173856; Miyai N, 2002, HYPERTENSION, V39, P761, DOI 10.1161/hy0302.105777; Palatini P, 1998, J SPORT MED PHYS FIT, V38, P1; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Williams IL, 2002, INT J OBESITY, V26, P754, DOI 10.1038/sj.ijo.0801995; Laukkanen JA, 2004, HYPERTENSION, V44, P820, DOI 10.1161/01.HYP.0000148460.95060.f2; PESCATELLO LS, 1991, CIRCULATION, V83, P1557; OROURKE MF, 1993, J HYPERTENS, V11, P327, DOI 10.1097/00004872-199304000-00001; Le VV, 2008, PROG CARDIOVASC DIS, V51, P135, DOI 10.1016/j.pcad.2008.07.001; Takamura T, 2008, HYPERTENS RES, V31, P257, DOI 10.1291/hypres.31.257; Brett SE, 2000, CIRCULATION, V101, P611; Funada J, 2010, ATHEROSCLEROSIS, V210, P268, DOI 10.1016/j.atherosclerosis.2009.11.003; JULIUS S, 1994, CARDIOVASC DRUG THER, V8, P11, DOI 10.1007/BF00877080; Lim P, 1999, J HUM HYPERTENS, V13, P520; LIMA EG, 1995, HYPERTENSION, V26, P1121; REN JF, 1985, J AM COLL CARDIOL, V5, P1224; Silva D, 2012, REV PORT CARDIOL, V31, P733, DOI 10.1016/j.repc.2012.02.018; Tzemos N, 2002, QJM-INT J MED, V95, P423, DOI 10.1093/qjmed/95.7.423; World Health Organization International Society of Hypertension Writing Group, 2003, J HYPERTENS, V21, P1983	28	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1963	1525-6006		CLIN EXP HYPERTENS	Clin. Exp. Hypertens.		2015	37	1					19	25		10.3109/10641963.2014.897716		7	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	AZ1EF	WOS:000347982300004		
J	Nishihara, M; Hirooka, Y; Sunagawa, K				Nishihara, Masaaki; Hirooka, Yoshitaka; Sunagawa, Kenji			Combining irbesartan and trichlormethiazide enhances blood pressure reduction via inhibition of sympathetic activity without adverse effects on metabolism in hypertensive rats with metabolic syndrome	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article						Angiotensin II receptor blocker; combination therapy; diuretics; hypertension; metabolic syndrome; sympathetic activity	ROSTRAL VENTROLATERAL MEDULLA; RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; CARDIOVASCULAR REGULATION; RECEPTOR BLOCKADE; NERVE ACTIVITY; BRAIN; OBESITY; ADIPONECTIN; SYMPATHOEXCITATION	Sympathoexcitation and oxidative stress in the brain have pivotal roles in hypertension with metabolic syndrome (MetS). Here, we examined whether oral administration of irbesartan (IRB) and trichlormethiazide (TCM) decreases blood pressure (BP) via inhibiting sympathetic activity through anti-oxidant effects in the brain of spontaneously hypertensive rats (SHR-cp). IRB/TCM treatment decreased BP more profoundly than IRB monotherapy. Urinary norepinephrine excretion and oxidative stress in the brain were decreased in both IRB and IRB/TCM groups without any adverse effect on the metabolic profile. These findings suggest that IRB/TCM profoundly decreases BP in SHR-cp by inhibiting sympathetic activity via anti-oxidant effects in the brain.	[Nishihara, Masaaki; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan	Hirooka, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp			Shionogi Co., Ltd.	This study was supported by a grant from Shionogi & Co., Ltd. The authors alone are responsible for the content and writing of the paper.	Aleixandre de Artinano A, 2009, BR J NUTR, V102, P1246, DOI DOI 10.1017/S0007114509990729; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Kishi T, 2011, CLIN EXP HYPERTENS, V33, P240, DOI 10.3109/10641963.2011.583969; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323; Wray DW, 2010, HYPERTENSION, V55, P1217, DOI 10.1161/HYPERTENSIONAHA.109.147058; Nishihara M, 2012, J HYPERTENS, V30, P97, DOI 10.1097/HJH.0b013e32834e1df4; Grassi G, 1998, J HYPERTENS, V16, P1789, DOI 10.1097/00004872-199816120-00012; Kishi T, 2012, HYPERTENS RES, V35, P940, DOI 10.1038/hr.2012.63; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Grassi G, 2010, AM J HYPERTENS, V23, P1052, DOI 10.1038/ajh.2010.154; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Ishimitsu T, 2009, HYPERTENS RES, V32, P962, DOI 10.1038/hr.2009.133; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Menon DV, 2009, J CLIN ENDOCR METAB, V94, P1361, DOI 10.1210/jc.2008-2660; Clasen R, 2005, HYPERTENSION, V46, P137, DOI 10.1161/01.HYP.0000168046.19884.6a; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; Grassi G, 2003, J HYPERTENS, V21, P1761, DOI 10.1097/01.hjh.0000084718.53355.69; Hirooka Y, 2011, HYPERTENS RES, V34, P407, DOI 10.1038/hr.2011.14; Sica DA, 2011, J CLIN HYPERTENS, V13, P639, DOI 10.1111/j.1751-7176.2011.00512.x; Grassi G, 2006, HYPERTENS RES, V29, P839, DOI 10.1291/hypres.29.839; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Araki S, 2009, HYPERTENS RES, V32, P1091, DOI 10.1038/hr.2009.160; Culman J, 2002, J HUM HYPERTENS, V16, pS64, DOI 10.1038/sj.jhh.1001442; Fasshauer M, 2004, BIOCHIMIE, V86, P779, DOI 10.1016/j.biochi.2004.09.016; Forni Valentina, 2011, Integr Blood Press Control, V4, P17, DOI 10.2147/IBPC.S12211; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hirooka Y, 2010, CIRC J, V74, P827, DOI 10.1253/circj.CJ-10-0153; Kishi T, 2013, INT J HYPERTENS, V2013; Konno S, 2012, J HYPERTENS, V30, P1992, DOI 10.1097/HJH.0b013e328357fa98; Krum H, 2006, AM J PHYSIOL-HEART C, V290, pH1706, DOI 10.1152/ajpheart.00885.2005; Neutel Joel M, 2005, J Clin Hypertens (Greenwich), V7, P578, DOI 10.1111/j.1524-6175.2004.04720.x; Nishihara M, 2012, J HYPERTENS, V30, P1758, DOI 10.1097/HJH.0b013e32835613d7; Nozoe M, 2008, J HYPERTENS, V26, P2176, DOI 10.1097/HJH.0b013e32830dd5d3; Polidori C, 1998, EUR J PHARMACOL, V352, P15, DOI 10.1016/S0014-2999(98)00329-X; Takai S, 2011, J PHARMACOL SCI, V116, P309, DOI 10.1254/jphs.11053FP; UEDA M, 1978, JPN J PHARMACOL, V28, P617, DOI 10.1254/jjp.28.617	38	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1963	1525-6006		CLIN EXP HYPERTENS	Clin. Exp. Hypertens.		2015	37	1					33	38		10.3109/10641963.2014.897719		6	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	AZ1EF	WOS:000347982300006		
J	Makita, S; Tanaka, F; Onoda, T; Ohsawa, M; Tanno, K; Omama, S; Yoshida, Y; Ishibashi, Y; Segawa, T; Takahashi, T; Satoh, K; Itai, K; Sakata, K; Ohta, M; Kuribayashi, T; Ogasawara, K; Ogawa, A; Okayama, A; Nakamura, M				Makita, Shinji; Tanaka, Fumitaka; Onoda, Toshiyuki; Ohsawa, Masaki; Tanno, Kozo; Omama, Shinichi; Yoshida, Yuki; Ishibashi, Yasuhiro; Segawa, Toshie; Takahashi, Tomohiro; Satoh, Kenyu; Itai, Kazuyoshi; Sakata, Kiyomi; Ohta, Mutsuko; Kuribayashi, Toru; Ogasawara, Kuniaki; Ogawa, Akira; Okayama, Akira; Nakamura, Motoyuki			Elevated blood pressure at the first measurement predicts cardiovascular disease independently from the subsequent second reading in men, but not in women	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article						Acute myocardial infarction; blood pressure; cardiovascular event; epidemiology; stroke	ASIA-PACIFIC REGION; MYOCARDIAL-INFARCTION; HEART-DISEASE; RISK-FACTORS; ONE OCCASION; STROKE; COUNTRIES; INDEXES; METAANALYSIS; VARIABILITY	Background and methods: There have been no investigations concerning the association of each blood pressure (BP) reading with future cardiovascular disease (CVD) when multiple measurements are taken on one occasion. This community-based, prospective cohort study (n = 23 344, mean age = 62.4 years) investigated the associations between the BP obtained from the first and second of two consecutive measurements on one occasion and future cardiovascular events in men and women. Results: During the mean follow-up of 5.5 years, 624 CVD events were identified. On the Cox regression analysis of age-and BP-adjusted models, the increased CVD risk of a hypertensive first measurement (systolic BP >= 140 mmHg) was independent from the second measurement in men. Even in subjects without a hypertensive second measurement, the CVD risk of the hypertensive first measurement was increased in men. In women, despite a hypertensive first measurement, subjects with a systolic BP < 130 mmHg on the second measurement showed a significantly reduced risk for CVD compared with subjects who retained a hypertensive level during the two measurements. Conclusions: An elevated BP on the first measurement should not be disregarded for CVD risk estimation in men, even if the second BP moves to the normal range. In women, elevated BP on the first measurement may have relatively less meaning for CVD prediction if the second BP shifts to a normal range.	[Makita, Shinji; Tanaka, Fumitaka; Segawa, Toshie; Takahashi, Tomohiro; Satoh, Kenyu; Nakamura, Motoyuki] Iwate Med Univ, Dept Internal Med, Div Cardioangiol, Morioka, Iwate 0208505, Japan; [Onoda, Toshiyuki; Ohsawa, Masaki; Tanno, Kozo; Itai, Kazuyoshi; Sakata, Kiyomi] Iwate Med Univ, Dept Hyg & Prevent Med, Morioka, Iwate 0208505, Japan; [Omama, Shinichi; Yoshida, Yuki; Ogasawara, Kuniaki; Ogawa, Akira] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan; [Ishibashi, Yasuhiro] Iwate Med Univ, Dept Neurol, Morioka, Iwate 0208505, Japan; [Ohta, Mutsuko] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Kuribayashi, Toru] Iwate Univ, Fac Educ, Dept Hlth & Phys Educ, Morioka, Iwate 020, Japan; [Okayama, Akira] Japan AntiTB Assoc, Inst Hlth Serv 1, Tokyo, Japan	Makita, S (reprint author), Iwate Med Univ, Dept Internal Med, Div Cardioangiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	makitas@seagreen.ocn.ne.jp			Japan Arteriosclerosis Prevention Fund (JAPF); Japan Arteriosclerosis Longitudinal Study (JALS) group; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT/JSPS KAKENHI) [25461089]	This work was supported by grants from the Japan Arteriosclerosis Prevention Fund (JAPF), the Japan Arteriosclerosis Longitudinal Study (JALS) group, the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT/JSPS KAKENHI Grant Number 25461089).	Lewington S, 2002, LANCET, V360, P1903; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Omama S, 2006, J NEUROL NEUROSUR PS, V77, P1345, DOI 10.1136/jnnp.2006.090373; DEGAUDEMARIS R, 1994, J HYPERTENS, V12, P831; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Inoue R, 2006, HYPERTENSION, V48, P877, DOI 10.1161/01.HYP.0000242285.83728.ee; Kawabe H, 2005, CLIN EXP HYPERTENS, V27, P215, DOI 10.1081/CEH-200048854; Kawabe H, 2012, CLIN EXP HYPERTENS, V34, P237, DOI 10.3109/10641963.2012.681079; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Miura K, 2004, HYPERTENSION, V44, P715, DOI 10.1161/01.HYP.0000145108.23948.7b; Myers MG, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d286; Ueshima H, 2003, J HUM HYPERTENS, V17, P851, DOI 10.1038/sj.jhh.1001602; Peters SAE, 2013, STROKE, V44, P2394, DOI 10.1161/STROKEAHA.113.001624; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1963	1525-6006		CLIN EXP HYPERTENS	Clin. Exp. Hypertens.		2015	37	1					39	44		10.3109/10641963.2014.897720		6	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	AZ1EF	WOS:000347982300007		
J	Isegawa, K; Hirooka, Y; Kishi, T; Yasukawa, K; Utsumi, H; Sunagawa, K				Isegawa, Kengo; Hirooka, Yoshitaka; Kishi, Takuya; Yasukawa, Keiji; Utsumi, Hideo; Sunagawa, Kenji			Benefit of azilsartan on blood pressure elevation around rest-to-active phase in spontaneously hypertensive rats	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article						Angiotensin receptor blocker; blood pressure; hypertension; morning surge; sympathetic nervous system	ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC-NERVE ACTIVITY; TYPE-1 RECEPTOR BLOCKER; ANGIOTENSIN-II; OXIDATIVE STRESS; AT(1) RECEPTOR; MORNING SURGE; STROKE; BRAIN; RISK	Abnormal elevation of blood pressure in early morning (rest-to-active phase) is suggested to cause cardiovascular events. We investigated whether azilsartan (AZL), a novel potent angiotensin receptor blocker, suppresses blood pressure elevation from the light-rest to dark-active phase in spontaneously hypertensive rats (SHRs). AZL has a sustained depressor effect around the rest-to-active phase in SHRs to a greater extent than candesartan (CAN), despite their similar depressor effects for over 24 h. AZL did not cause sympathoexcitation. These results suggest that AZL has a more sustained depressor effect than CAN around the rest-to-active phase in SHRs, and might have advantages for early morning hypertension.	[Isegawa, Kengo; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan; [Kishi, Takuya] Kyushu Univ, Grad Sch Med Sci, Dept Adv Therapeut Cardiovasc Dis, Fukuoka 8128582, Japan; [Yasukawa, Keiji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Biofunct Sci, Fukuoka 8128582, Japan; [Yasukawa, Keiji; Utsumi, Hideo] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 8128582, Japan	Hirooka, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [B24390198]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (B24390198).	UTSUMI H, 1990, BIOCHEM BIOPH RES CO, V172, P1342, DOI 10.1016/0006-291X(90)91597-L; Kishi T, 2010, HYPERTENSION, V55, P291, DOI 10.1161/HYPERTENSIONAHA.109.138636; White WB, 2010, HYPERTENSION, V55, P835, DOI 10.1161/HYPERTENSIONAHA.109.148908; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Kario K, 2008, J AM SOC HYPERTENS, V2, P397, DOI 10.1016/j.jash.2008.05.004; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Fang ZW, 1999, J HYPERTENS, V17, P983, DOI 10.1097/00004872-199917070-00015; Ojima M, 2011, J PHARMACOL EXP THER, V336, P801, DOI 10.1124/jpet.110.176636; Kishi T, 2012, HYPERTENS RES, V35, P940, DOI 10.1038/hr.2012.63; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Kajiya T, 2011, J HYPERTENS, V29, P2476, DOI 10.1097/HJH.0b013e32834c46fd; White WB, 2011, HYPERTENSION, V57, P413, DOI 10.1161/HYPERTENSIONAHA.110.163402; Ye SH, 2002, HYPERTENSION, V39, P1101, DOI 10.1161/01.HYP.0000018590.26853.C7; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Kusumoto K, 2011, EUR J PHARMACOL, V669, P84, DOI 10.1016/j.ejphar.2011.07.014; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Kishi T, 2001, HYPERTENSION, V38, P896; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Hirooka Y, 2011, HYPERTENS RES, V34, P407, DOI 10.1038/hr.2011.14; Suzuki J, 2010, HYPERTENS RES, V33, P1060, DOI 10.1038/hr.2010.125; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Nishimura Y, 2000, BRAIN RES, V871, P29, DOI 10.1016/S0006-8993(00)02377-5; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Araki S, 2009, HYPERTENS RES, V32, P1091, DOI 10.1038/hr.2009.160; Basset A, 2004, J HYPERTENS, V22, P727, DOI 10.1097/01.hjh.0000098280.36684.a0; Culman J, 2002, J HUM HYPERTENS, V16, pS64, DOI 10.1038/sj.jhh.1001442; Ito K, 2006, HYPERTENSION, V48, P651, DOI 10.1161/01.HYP.0000238125.21656.9e; Kishi T, 2004, CIRCULATION, V109, P3257; Kishi T, 2009, CLIN EXP HYPERTENS, V31, P698, DOI 10.3109/10641960903407066; Konno S, 2008, J CARDIOVASC PHARM, V52, P555, DOI 10.1097/FJC.0b013e318192690e; Krum H, 2006, AM J PHYSIOL-HEART C, V290, P1706; Kurtz Theodore W, 2012, Vasc Health Risk Manag, V8, P133, DOI 10.2147/VHRM.S22595; PARLOW J, 1995, HYPERTENSION, V25, P1058; Seltzer A, 2004, BRAIN RES, V1028, P9, DOI 10.1016/j.brainres.2004.06.079; Sonta T, 2005, BIOCHEM BIOPH RES CO, V330, P415, DOI 10.1016/j.bbrc.2005.02.174; Sueta D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000035; Takai S, 2013, J PHARMACOL SCI, V123, P371, DOI 10.1254/jphs.13167FP; Volpe Massimo, 2012, Integr Blood Press Control, V5, P19, DOI 10.2147/IBPC.S13784; WADA T, 1994, EUR J PHARMACOL, V253, P27, DOI 10.1016/0014-2999(94)90753-6; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200	43	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1963	1525-6006		CLIN EXP HYPERTENS	Clin. Exp. Hypertens.		2015	37	1					45	50		10.3109/10641963.2014.897721		6	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	AZ1EF	WOS:000347982300008		
J	Yasuda, G; Saka, S; Ando, D; Hirawa, N				Yasuda, Gen; Saka, Sanae; Ando, Daisaku; Hirawa, Nobuhito			Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney disease	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article						alpha(1)-adrenergic antagonists; ambulatory blood pressure monitoring; diabetic nephropathy; orthostatic hypotension; power spectral analysis; sympathetic nervous activity	SPECTRAL-ANALYSIS; THERAPY; SLEEP; TRIAL; HALT; DRUG	We conducted a prospective study to assess the effects of doxazosin, as the third agent, on morning and position-related blood pressure (BP) in 77 diabetic patients with chronic kidney disease, who were allocated randomly to doxazosin and diuretics groups. Doxazosin decreased morning BP but diuretics could not decrease pre-awakening diastolic BP. Only doxazosin improved sympathovagal balance. Doxazosin and diuretics decreased standing and sitting BP but only doxazosin improved sympathovagal balance regardless of body positions. Doxazosin did not decrease absolute BP changes shortly after standing. In diabetic patients, doxazosin decreased morning BP through improving sympathovagal balance without causing significant orthostatic hypotension (ClinicalTrials.gov number, NCT00295555).	[Yasuda, Gen; Saka, Sanae; Ando, Daisaku; Hirawa, Nobuhito] Yokohama City Univ, Ctr Hosp, Div Nephrol & Hypertens, Yokohama, Kanagawa 2320024, Japan	Yasuda, G (reprint author), Yokohama City Univ, Sch Med, Dept Nephrol, Minami Ku, 4-57 Urafune, Yokohama, Kanagawa 2320024, Japan.	y911429@yokohama-cu.ac.jp					Ohkubo T, 2004, HYPERTENS RES, V27, P755, DOI 10.1291/hypres.27.755; Dodt C, 1997, HYPERTENSION, V30, P71; Tochikubo O, 1996, HYPERTENSION, V27, P1318; COWLEY AW, 1973, CIRC RES, V32, P564; FURLAN R, 1990, CIRCULATION, V81, P537; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; IMHOLZ BPM, 1990, CLIN SCI, V79, P73; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Chapman N, 2008, CIRCULATION, V118, P42, DOI 10.1161/CIRCULATIONAHA.107.737957; Davis BR, 2002, ANN INTERN MED, V137, P313; Fotherby Martin, 1997, Blood Pressure, V6, P343, DOI 10.3109/08037059709062093; Graham RM, 1976, BRIT MED J, V27, P1293; Guyton AC, 2000, TXB MED PHYSL; Jacob G, 1998, AM J MED SCI, V315, P95, DOI 10.1097/00000441-199802000-00005; Kario K, 2000, HYPERTENSION, V35, P787; Khurana RK, 1996, CLIN AUTON RES, V6, P335, DOI 10.1007/BF02556304; LUNDJOHANSEN P, 1992, J CARDIOVASC PHARM, V19, pS27, DOI 10.1097/00005344-199219001-00007; Mallion JM, 2000, BLOOD PRESS MONIT, V5, P169; Morgan TO, 2003, AM J HYPERTENS, V16, P46, DOI 10.1016/S0895-7061(02)03081-9; MORIGUCHI A, 1993, AM J HYPERTENS, V6, P198; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; Ohta Y, 2007, HYPERTENS RES, V30, P301, DOI 10.1291/hypres.30.301; Okano Y, 2009, CLIN EXP HYPERTENS, V31, P680, DOI 10.3109/10641960903407041; PICKERING TG, 1994, AM J HYPERTENS, V7, P844; TAKATA Y, 1995, ANGIOLOGY, V46, P11, DOI 10.1177/000331979504600102; Veelken R, 1996, AM J HYPERTENS, V9, pS139, DOI 10.1016/0895-7061(96)00289-0; Yasuda G, 2005, DIABETIC MED, V22, P1394, DOI 10.1111/j.464-5491.2005.01636.x	29	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1963	1525-6006		CLIN EXP HYPERTENS	Clin. Exp. Hypertens.		2015	37	1					75	81		10.3109/10641963.2014.913599		7	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	AZ1EF	WOS:000347982300013		
J	Hiramatsu, T; Kataoka, H; Osaki, M; Hagino, H				Hiramatsu, Tetsuya; Kataoka, Hideyuki; Osaki, Mari; Hagino, Hiroshi			Effect of aging on oral and swallowing function after meal consumption	CLINICAL INTERVENTIONS IN AGING			English	Article						normal adults; dysphagia; fatigue; elderly	SURFACE ELECTROMYOGRAPHY; AGE	Background/purpose: Dysphagia may worsen due to fatigue of the infrahyoid and suprahyoid muscle groups as a result of repetitive swallowing during a meal. We investigated the hypothesis that meal consumption may reduce tongue strength and endurance in older adults (OAs). Methods: Tongue-palate pressure, oral diadochokinesis, repetitive saliva swallowing, and surface electromyography activity before and after a meal were measured in 23 young adults (YAs) and 23 OA volunteers. Results: There was a statistically significant difference in both tongue pressure and the number of voluntary swallows between YAs and OAs. Peak tongue pressure was significantly lower in OAs than YAs both before and after meal consumption. The most notable finding was that the first time interval (the time from test initiation to the beginning of the first swallow) was prolonged after meal consumption only in OAs, whereas the first time interval showed no difference between YAs and OAs before meal consumption with reference to the repetitive saliva swallowing test. The initiation of swallowing was prolonged by both meal consumption and aging; there was a significant interaction between these two factors. The number of repetitions of the monosyllable/pa/was statistically similar between YAs and OAs before meal consumption, but it was significantly lower in OAs after meal consumption. Conclusion: Aging leads to declining tongue pressure and motor function of the lips. It is possible that swallowing function declines in older individuals when meal consumption is prolonged, especially at the end of mealtime, as a result of their efforts in mastication and swallowing.	[Hiramatsu, Tetsuya] Matsue Comed Coll, Dept Speech Pathol & Audiol, Matsue, Shimane 6900265, Japan; [Hiramatsu, Tetsuya] Tottori Univ, Grad Sch Med Sci, Yonago, Tottori, Japan; [Kataoka, Hideyuki; Hagino, Hiroshi] Tottori Univ, Fac Med, Sch Hlth Sci, Yonago, Tottori 683, Japan; [Osaki, Mari; Hagino, Hiroshi] Tottori Univ Hosp, Rehabil Div, Yonago, Tottori, Japan	Hiramatsu, T (reprint author), Matsue Comed Coll, Dept Speech Pathol & Audiol, 2081-4 Kamionocho, Matsue, Shimane 6900265, Japan.	h5706@matsuecc.ac.jp					CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174; Kays SA, 2010, J SPEECH LANG HEAR R, V53, P898, DOI 10.1044/1092-4388(2009/09-0048); Vaiman M, 2004, DYSPHAGIA, V19, P125, DOI 10.1007/s00455-003-0504-x; Tamura F, 2002, DYSPHAGIA, V17, P235, DOI 10.1007/s00455-002-0063-6; Burkhead LM, 2007, DYSPHAGIA, V22, P251, DOI 10.1007/s00455-006-9074-z; Hiiemae KM, 2003, CRIT REV ORAL BIOL M, V14, P413; BROWN WF, 1972, J NEUROL NEUROSUR PS, V35, P845, DOI 10.1136/jnnp.35.6.845; Shaker R, 1997, AM J PHYSIOL-GASTR L, V272, pG1518; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Roos MR, 1997, MUSCLE NERVE, V20, P679; Chodzko-Zajko WI, 1987, J VOICE, V1, P18, DOI 10.1016/S0892-1997(87)80019-X; Fucile S, 1998, DYSPHAGIA, V13, P195, DOI 10.1007/PL00009571; Logemann JA, 1998, EVALUATION TREATMENT; Sheth N, 1988, Dysphagia, V2, P209, DOI 10.1007/BF02414428; STAL P, 1990, ARCH ORAL BIOL, V35, P449, DOI 10.1016/0003-9969(90)90208-R; Vaiman M, 2005, LARYNGOSCOPE, V115, P68, DOI 10.1097/01.mlg.0000150673.53107.20	16	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-1998			CLIN INTERV AGING	Clin. Interv. Aging		2015	10						229	235		10.2147/CIA.S75211		7	Geriatrics & Gerontology	Geriatrics & Gerontology	AY8DR	WOS:000347785200001		
J	Tsuji, S; Mazuka, R; Cristia, A; Fikkert, P				Tsuji, Sho; Mazuka, Reiko; Cristia, Alejandrina; Fikkert, Paula			Even at 4 months, a labial is a good enough coronal, but not vice versa	COGNITION			English	Article						Infant; Language acquisition; Speech perception; Perceptual asymmetry; Cross-linguistic comparison	VOWEL PERCEPTION; INFANTS; RECOGNITION; ACQUISITION; ASYMMETRIES; CONTRASTS; PLACE	Numerous studies have revealed an asymmetry tied to the perception of coronal place of articulation: participants accept a labial mispronunciation of a coronal target, but not vice versa. Whether or not this asymmetry is based on language-general properties or arises from language-specific experience has been a matter of debate. The current study suggests a bias of the first type by documenting an early, cross-linguistic asymmetry related to coronal place of articulation. Japanese and Dutch 4- and 6-month-old infants showed evidence of discrimination if they were habituated to a labial and then tested on a coronal sequence, but not vice versa. This finding has important implications for both phonological theories and infant speech perception research. (C) 2014 Elsevier B.V. All rights reserved.	[Tsuji, Sho; Fikkert, Paula] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Tsuji, Sho] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Mazuka, Reiko] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Mazuka, Reiko] Duke Univ, Durham, NC 27706 USA; [Cristia, Alejandrina] PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist,EHESS,CNRS, Paris, France	Tsuji, S (reprint author), Max Planck Inst Psycholinguist, Wundtlaan 1, NL-6525 XD Nijmegen, Netherlands.	tsujish@gmail.com; mazuka@brain.riken.jp; alecristia@gmail.com; Fikkert@let.ru.nl					Amano S., 2000, NIHONGO NO GOI TOKUS, V7; Anderson JL, 2003, LANG SPEECH, V46, P155; Mitterer H, 2011, J EXP PSYCHOL HUMAN, V37, P496, DOI 10.1037/a0020989; Polka L, 2011, J PHONETICS, V39, P467, DOI 10.1016/j.wocn.2010.08.007; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037//0012-1649.34.6.1289; QUINN PC, 1993, PERCEPTION, V22, P463, DOI 10.1068/p220463; Lahiri A, 2010, J PHONETICS, V38, P44, DOI 10.1016/j.wocn.2010.01.002; GILMORE GC, 1979, PERCEPT PSYCHOPHYS, V25, P425, DOI 10.3758/BF03199852; STEVENS KN, 1978, J ACOUST SOC AM, V64, P1358, DOI 10.1121/1.382102; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Schwartz JL, 2005, SPEECH COMMUN, V45, P425, DOI 10.1016/j.specom.2004.12.001; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Cornell SA, 2013, J EXP PSYCHOL HUMAN, V39, P757, DOI 10.1037/a0030862; Baayen R. H., 1995, CELEX LEXICAL DATABA; Chang Steve S., 2001, ROLE SPEECH PERCEPTI, P79; Chomsky N., 1968, SOUND PATTERN ENGLIS; Cohen L. B., 2004, HABIT X NEW PROGRAM; Dijkstra N., 2011, P BOST U C LANG DEV, V35, P170; Jusczyk P. W., 2002, LANG ACQUIS, V10, P31, DOI 10.1207/S15327817LA1001_3; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; Maddiesson I., 1984, PATTERNS SOUNDS; Narayan CR, 2008, J PHONETICS, V36, P191, DOI 10.1016/j.wocn.2007.10.001; Pons F, 2012, CHILD DEV, V83, P965, DOI 10.1111/j.1467-8624.2012.01740.x; Prunet J.-F., 1991, PHONETICS PHONOLOGY, V2; Tsuji S., 2010, 17 INT C INF STUD BA	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-0277	1873-7838		COGNITION	Cognition	JAN	2015	134						252	256		10.1016/j.cognition.2014.10.009		5	Psychology, Experimental	Psychology	AY5GF	WOS:000347600200024		
J	Giga, Y; Kuroda, H				Giga, Yoshikazu; Kuroda, Hirotoshi			A COUNTEREXAMPLE TO FINITE TIME STOPPING PROPERTY FOR ONE-HARMONIC MAP FLOW	COMMUNICATIONS ON PURE AND APPLIED ANALYSIS			English	Article						One-harmonic map flow; finite time stopping; singular diffusion; extinction; total variation flow	1-HARMONIC FLOW; DIFFUSION; EQUATIONS; VALUES; S-2; D-2	For a very strong diffusion equation like total variation flow it is often observed that the solution stops at a steady state in a finite time. This phenomenon is called a finite time stopping or a finite time extinction if the steady state is zero. Such a phenomenon is also observed in one-harmonic map flow from an interval to a unit circle when initial data is piecewise constant. However, if the target manifold is a unit two-dimensional sphere, the finite time stopping may not occur. An explicit example is given in this paper.	[Giga, Yoshikazu] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Kuroda, Hirotoshi] Osaka Prefecture Univ, Naka Ku, Sakai, Osaka 5998531, Japan	Giga, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	labgiga@ms.u-tokyo.ac.jp; kuroda@sci.hokudai.ac.jp			Japan Society for the Promotion of Science [21224001, 23244015, 25610025]	The first author is partly supported by Grants-in-Aid for Scientific Research No. 21224001 (Kiban S), No. 23244015 (Kiban A) and No. 25610025 (Houga) of Japan Society for the Promotion of Science. The current address of the second author is "Fostering Future Leaders to Open New Frontiers in Materials Science", Program for Leading Graduate Schools Promotion Office, Faculty of Science, Hokkaido University, Kita 10 Nishi 8, Kita-ku, Sapporo, 060-0810, Japan.	Andreu-Vaillo F, 2004, PROGR MATH, V223; Tang B, 2000, INT J COMPUT VISION, V36, P149, DOI 10.1023/A:1008152115986; Tang B, 2001, IEEE T IMAGE PROCESS, V10, P701, DOI 10.1109/83.918563; KOMURA Y, 1967, J MATH SOC JPN, V19, P493; Andreu F, 2002, J FUNCT ANAL, V188, P516, DOI 10.1006/jfan.2001.3829; Barrett JW, 2008, SIAM J MATH ANAL, V40, P1471, DOI 10.1137/070680825; BREZIS H., 1973, OPERATEURS MAXIMAUX; Dal Passo R, 2008, CALC VAR PARTIAL DIF, V32, P533, DOI 10.1007/s00526-007-0153-2; Dibenedetto E., 1993, DEGENERATE PARABOLIC; Feng XB, 2010, CALC VAR PARTIAL DIF, V37, P111, DOI 10.1007/s00526-009-0255-0; Giacomelli L, 2014, ANAL PDE, V7, P627, DOI 10.2140/apde.2014.7.627; Giacomelli L, 2013, SIAM J MATH ANAL, V45, P1723, DOI 10.1137/12088402X; Giacomelli L, 2010, SIAM J MATH ANAL, V42, P2791, DOI 10.1137/090764293; Giga Y, 2011, DISCRETE CONT DYN-A, V30, P509, DOI 10.3934/dcds.2011.30.509; Giga Y, 2007, INT S NUM M, V154, P209; Giga Y., 2004, ABSTR APPL ANAL, V8, P651; Giga Y., 2004, B SOC PARANA MAT, V22, P9; Giga Y., 2003, METHODS APPL ANAL, V10, P253; Giga Y., 2005, INTERDISCIP INFORM S, V11, P199, DOI 10.4036/iis.2005.199; Kobayashi R, 1999, J STAT PHYS, V95, P1187, DOI 10.1023/A:1004570921372	20	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1534-0392	1553-5258		COMMUN PUR APPL ANAL	Commun. Pure Appl. Anal	JAN	2015	14	1					121	125		10.3934/cpaa.2015.14.121		5	Mathematics, Applied; Mathematics	Mathematics	AZ0FA	WOS:000347920400008		
J	Koike, S; Kosugi, T				Koike, Shigeaki; Kosugi, Takahiro			REMARKS ON THE COMPARISON PRINCIPLE FOR QUASILINEAR PDE WITH NO ZEROTH ORDER TERMS	COMMUNICATIONS ON PURE AND APPLIED ANALYSIS			English	Article						Viscosity solution; comparison principle; quasilinear elliptic equation	DEGENERATE ELLIPTIC-EQUATIONS; VISCOSITY SOLUTIONS; MAXIMUM PRINCIPLE; UNIQUENESS; EXISTENCE	A comparison principle for viscosity solutions of second-order quasilinear elliptic partial differential equations with no zeroth order terms is shown. A different transformation from that of Barles and Busca in [3] is adapted to enable us to deal with slightly more general equations.	[Koike, Shigeaki; Kosugi, Takahiro] Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Koike, S (reprint author), Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan.	koike@math.tohoku.ac.jp; sb2m12@math.tohoku.ac.jp			Japan Society for the Promotion of Science [23340028]; Interdepartmental Doctoral Degree Program for Multi-dimensional Materials Science Leaders	The first author is supported by Grant-in-Aid for Scientific Research (No. 23340028) of Japan Society for the Promotion of Science. The second author is supported in part by Interdepartmental Doctoral Degree Program for Multi-dimensional Materials Science Leaders.	Aronsson G, 2004, B AM MATH SOC, V41, P439, DOI 10.1090/S0273-0979-04-01035-3; Bardi M, 1999, ARCH MATH, V73, P276, DOI 10.1007/s000130050399; JENSEN R, 1988, ARCH RATION MECH AN, V101, P1, DOI 10.1007/BF00281780; Juutinen P, 2001, SIAM J MATH ANAL, V33, P699, DOI 10.1137/S0036141000372179; Barles G, 2001, COMMUN PART DIFF EQ, V26, P2323, DOI 10.1081/PDE-100107824; BARLES G, 1999, SYS CON FDN, P209; CHEN YG, 1991, J DIFFER GEOM, V33, P749; Crandall MG, 2008, LECT NOTES MATH, V1927, P75; CRANDALL MG, 1983, T AM MATH SOC, V277, P1, DOI 10.2307/1999343; Crandall M. G., 1992, B AM MATH SOC, V277, P1; Ishii H., 1991, FUNKC EKVACIOJ-SER I, V34, P143; JENSEN R, 1993, ARCH RATION MECH AN, V123, P51, DOI 10.1007/BF00386368; Kawohl B., 2000, FUNKC EKVACIOJ-SER I, V43, P241; Kawohl B, 2007, COMMUN PART DIFF EQ, V32, P1209, DOI 10.1080/03605300601113043; Koike S., 2004, MSJ MEMOIR, V13; Lindqvist P., 2006, U JYVASKYLA DEP MATH; Luo YS, 2005, J MATH ANAL APPL, V307, P736, DOI 10.1016/j.jmaa.2005.01.055; Rockafellar RT, 1970, PRINCETON MATH SERIE, V28; Trudinger N.S., 1988, REV MAT IBEROAM, V4, P453	19	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1534-0392	1553-5258		COMMUN PUR APPL ANAL	Commun. Pure Appl. Anal	JAN	2015	14	1					133	142		10.3934/cpaa.2015.14.133		10	Mathematics, Applied; Mathematics	Mathematics	AZ0FA	WOS:000347920400010		
J	Al-Baali, M; Narushima, Y; Yabe, H				Al-Baali, Mehiddin; Narushima, Yasushi; Yabe, Hiroshi			A family of three-term conjugate gradient methods with sufficient descent property for unconstrained optimization	COMPUTATIONAL OPTIMIZATION AND APPLICATIONS			English	Article						Unconstrained optimization; Three-term conjugate gradient method; Sufficient descent condition; Global convergence	GLOBAL CONVERGENCE; LINE SEARCH; FUNCTION MINIMIZATION; TESTING ENVIRONMENT; GUARANTEED DESCENT; ALGORITHM	Recently, conjugate gradient methods, which usually generate descent search directions, are useful for large-scale optimization. Narushima et al. (SIAM J Optim 21:212-230, 2011) have proposed a three-term conjugate gradient method which satisfies a sufficient descent condition. We extend this method to two parameters family of three-term conjugate gradient methods which can be used to control the magnitude of the directional derivative. We show that these methods converge globally and work well for suitable choices of the parameters. Numerical results are also presented.	[Al-Baali, Mehiddin] Sultan Qaboos Univ, Dept Math & Stat, Muscat 123, Oman; [Narushima, Yasushi] Yokohama Natl Univ, Dept Management Syst Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Yabe, Hiroshi] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, Tokyo 1628601, Japan	Narushima, Y (reprint author), Yokohama Natl Univ, Dept Management Syst Sci, Hodogaya Ku, 79-4 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	albaali@squ.edu.om; narushima@ynu.ac.jp; yabe@rs.kagu.tus.ac.jp			Japan Society for the Promotion of Science [25330030]	The authors would like to thank Prof. William W. Hager, the Editor-in-Chief of the journal, and the anonymous reviewers for valuable comments on a draft of this paper. We would also like to thank Prof. Yu-Hong Dai for providing his program code of conjugate gradient methods. The second and third authors are supported in part by the Grant-in-Aid for Scientific Research (C) 25330030 of Japan Society for the Promotion of Science	Narushima Y, 2011, SIAM J OPTIMIZ, V21, P212, DOI 10.1137/080743573; Gould NIM, 2003, ACM T MATH SOFTWARE, V29, P373, DOI 10.1145/962437.962439; BONGARTZ I, 1995, ACM T MATH SOFTWARE, V21, P123, DOI 10.1145/200979.201043; Dolan ED, 2002, MATH PROGRAM, V91, P201, DOI 10.1007/s101070100263; ALBAALI M, 1985, IMA J NUMER ANAL, V5, P121, DOI 10.1093/imanum/5.1.121; Yu GH, 2008, J IND MANAG OPTIM, V4, P565; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Dai YH, 2013, SIAM J OPTIMIZ, V23, P296, DOI 10.1137/100813026; Zhang L, 2007, OPTIM METHOD SOFTW, V22, P697, DOI 10.1080/10556780701223293; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; Dai YH, 2001, APPL MATH OPT, V43, P87, DOI 10.1007/s002450010019; BARZILAI J, 1988, IMA J NUMER ANAL, V8, P141, DOI 10.1093/imanum/8.1.141; Zhang L, 2006, NUMER MATH, V104, P561, DOI 10.1007/s00211-006-0028-z; Cheng WY, 2007, NUMER FUNC ANAL OPT, V28, P1217, DOI 10.1080/01630560701749524; Zhang L, 2006, IMA J NUMER ANAL, V26, P629, DOI 10.1093/imanum/drl016; Hager WW, 2006, ACM T MATH SOFTWARE, V32, P113, DOI 10.1145/1132973.1132979; LIU Y, 1991, J OPTIMIZ THEORY APP, V69, P129, DOI 10.1007/BF00940464; Sugiki K, 2012, J OPTIMIZ THEORY APP, V153, P733, DOI 10.1007/s10957-011-9960-x; Gilbert JC, 1992, SIAM J OPTIMIZ, V2, P21, DOI 10.1137/0802003; Dai YH, 1999, SIAM J OPTIMIZ, V10, P177, DOI 10.1137/S1052623497318992; Fletcher R, 1987, PRACTICAL METHODS OP; Fletcher R, 2005, APPL OPTIMIZAT, V96, P235; Hager WW, 2013, SIAM J OPTIMIZ, V23, P2150, DOI 10.1137/120898097; Hager W.W., 2005, CG DESCENT VERSION 1; Hager W.W., 2006, PACIFIC J OPTIM, V2, P35; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; SORENSON HW, 1969, J FRANKLIN I, V288, P421, DOI 10.1016/0016-0032(69)90253-1; Zhang L, 2009, J COMPUT APPL MATH, V225, P146, DOI 10.1016/j.cam.2008.07.016; Zoutendijk G., 1970, Integer and nonlinear programming	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0926-6003	1573-2894		COMPUT OPTIM APPL	Comput. Optim. Appl.	JAN	2015	60	1					89	110		10.1007/s10589-014-9662-z		22	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	AY7ER	WOS:000347724700004		
J	Yamanishi, T; Sugihara, K; Ohkuma, K; Uosaki, K				Yamanishi, Teruya; Sugihara, Kazutomi; Ohkuma, Kazumasa; Uosaki, Katsuji			Programming Instruction Using a Micro Robot as a Teaching Tool	COMPUTER APPLICATIONS IN ENGINEERING EDUCATION			English	Article						introductory instruction; computer programming; robotics; information science	LEGO MINDSTORMS; SYSTEMS	This practical report analyzes a programming class using a micro robot (MR), the smallest soccer robot in the RoboCup world competition. This class examined the effect of using the MR as the actual equipment employed in programming. Questionnaire results on this class revealed that these teaching materials evoked a heightened programming interest among students. Moreover, the problems related to programming instruction using an MR were better understood; therefore, a strategy for improving the related problems is discussed here. (c) 2013 Wiley Periodicals, Inc. Comput Appl Eng Educ 23:109-116, 2015; View this article online at ; DOI	[Yamanishi, Teruya; Sugihara, Kazutomi; Ohkuma, Kazumasa; Uosaki, Katsuji] Fukui Univ Technol, Dept Management Informat Sci, Fukui, Japan	Yamanishi, T (reprint author), Fukui Univ Technol, Dept Management Informat Sci, Fukui, Japan.	yamanisi@fukui-ut.ac.jp			Fukui University of Technology;  [21500962];  [24501221]	Contract grant sponsor: Grant-in-Aid for Scientific Research; Contract grant numbers: C-21500962, C-24501221; Contract grant sponsor: Fukui University of Technology.	Inanc T, 2012, COMPUT APPL ENG EDUC, V20, P203, DOI 10.1002/cae.20386; Behrens A, 2010, IEEE T EDUC, V53, P306, DOI 10.1109/TE.2009.2017272; Aliane N, 2011, COMPUT APPL ENG EDUC, V19, P615, DOI 10.1002/cae.20342; Birk A, 2010, IEEE ROBOT AUTOM MAG, V17, P108, DOI 10.1109/MRA.2010.938847; Cuellar MP, 2014, COMPUT APPL ENG EDUC, V22, P153, DOI 10.1002/cae.20541; [Anonymous], 2004, ACM J ED RES COMP, V4, P1; Williams AB, 2003, IEEE T EDUC, V46, P206, DOI 10.1109/TE.2002.808260; Benson B, 2011, IEEE T EDUC, V54, P197, DOI 10.1109/TE.2010.2078819; Burkhard HD, 2002, IEEE ROBOT AUTOM MAG, V9, P31, DOI 10.1109/MRA.2002.1019488; Gomez-de-Gabriel JM, 2011, IEEE T EDUC, V54, P41, DOI 10.1109/TE.2010.2043359; Hernando M, 2011, IEEE T EDUC, V54, P569, DOI 10.1109/TE.2010.2095014; Karp T, 2010, IEEE T EDUC, V53, P80, DOI 10.1109/TE.2009.2024410; Kim SH, 2009, IEEE T EDUC, V52, P99, DOI 10.1109/TE.2008.919809; Lopez D, 2009, IEEE T IND ELECTRON, V56, P4791, DOI 10.1109/TIE.2008.2007007; Martin J. F., 2003, Computer Applications in Engineering Education, V10, DOI 10.1002/cae.10026; Ruiz-del-Solar J, 2010, IEEE T EDUC, V53, P38, DOI 10.1109/TE.2009.2022946; Simoncic S, 2014, COMPUT APPL ENG EDUC, V22, P474, DOI 10.1002/cae.20573; Verner I. M., 2002, J ENG EDUC, V91, P355	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1061-3773	1099-0542		COMPUT APPL ENG EDUC	Comput. Appl. Eng. Educ.	JAN	2015	23	1					109	116		10.1002/cae.21582		8	Computer Science, Interdisciplinary Applications; Education, Scientific Disciplines; Engineering, Multidisciplinary	Computer Science; Education & Educational Research; Engineering	AY7EM	WOS:000347724100009		
J	Caniou, Y; Codognet, P; Richoux, F; Diaz, D; Abreu, S				Caniou, Yves; Codognet, Philippe; Richoux, Florian; Diaz, Daniel; Abreu, Salvador			Large-scale parallelism for constraint-based local search: the costas array case study	CONSTRAINTS			English	Article						CSP; Local search; Metaheuristics; Parallelism; Implementation	META-HEURISTICS; SPECIAL-ISSUE; CONSTRUCTIONS; OPTIMIZATION; ENUMERATION; ALGORITHMS; TIME	We present the parallel implementation of a constraint-based Local Search algorithm and investigate its performance on several hardware platforms with several hundreds or thousands of cores. We chose as the basis for these experiments the Adaptive Search method, an efficient sequential Local Search method for Constraint Satisfaction Problems (CSP). After preliminary experiments on some CSPLib benchmarks, we detail the modeling and solving of a hard combinatorial problem related to radar and sonar applications: the Costas Array Problem. Performance evaluation on some classical CSP benchmarks shows that speedups are very good for a few tens of cores, and good up to a few hundreds of cores. However for a hard combinatorial search problem such as the Costas Array Problem, performance evaluation of the sequential version shows results outperforming previous Local Search implementations, while the parallel version shows nearly linear speedups up to 8,192 cores. The proposed parallel scheme is simple and based on independent multi-walks with no communication between processes during search. We also investigated a cooperative multi-walk scheme where processes share simple information, but this scheme does not seem to improve performance.	[Caniou, Yves] CNRS Univ Tokyo UCBL, JFLI, Lyon, France; [Codognet, Philippe] CNRS Univ Tokyo UPMC, JFLI, Tokyo, Japan; [Richoux, Florian] CNRS Univ Tokyo LINA, JFLI, UNAM, Nantes, France; [Richoux, Florian; Diaz, Daniel] Univ Paris 01, F-75231 Paris 05, France; [Abreu, Salvador] Univ Evora CENTRIA, Evora, Portugal	Richoux, F (reprint author), CNRS Univ Tokyo LINA, JFLI, UNAM, Nantes, France.	yves.caniou@enslyon.fr; codognet@is.s.u-tokyo.ac.jp; florian.richoux@univnantes.fr; daniel.diaz@univ-paris1.fr; spa@di.uevora.pt			CNRS; RENATER	We acknowledge that some results in this paper have been achieved using the PRACE Research Infrastructure resource JUGENE based in Germany at the Julich Supercomputing Centre, while some others were carried out using the Grid'5000 experimental testbed, being developed under the INRIA ALADDIN development action with support from CNRS, RENATER and several Universities as well as other funding bodies.	Aida K, 2005, 2005 SYMPOSIUM ON APPLICATIONS AND THE INTERNET, PROCEEDINGS, P164, DOI 10.1109/SAINT.2005.1; Aiex RM, 2002, J HEURISTICS, V8, P343, DOI 10.1023/A:1015061802659; Alava M., 2007, PNAS, V105, P253; Alba E, 2004, J HEURISTICS, V10, P239, DOI 10.1023/B:HEUR.0000026984.08350.12; Amdahl G., 1967, VALIDITY SINGLE PROC, P483; Bolze R, 2006, INT J HIGH PERFORM C, V20, P481, DOI 10.1177/1094342006070078; MINTON S, 1992, ARTIF INTELL, V58, P161, DOI 10.1016/0004-3702(92)90007-K; Benoist T, 2011, 4OR-Q J OPER RES, V9, P299, DOI 10.1007/s10288-011-0165-9; Crainic TG, 2002, J HEURISTICS, V8, P247, DOI 10.1023/A:1015084116772; COSTAS JP, 1984, P IEEE, V72, P996, DOI 10.1109/PROC.1984.12967; Crainic TG, 2004, J HEURISTICS, V10, P293, DOI 10.1023/B:HEUR.0000026897.40171.1a; Xiang T, 2007, APPL MATH COMPUT, V190, P1637, DOI 10.1016/j.amc.2007.02.103; Hoos HH, 1999, ARTIF INTELL, V112, P213, DOI 10.1016/S0004-3702(99)00048-X; GENDRON B, 1994, OPER RES, V42, P1042, DOI 10.1287/opre.42.6.1042; Martins R, 2012, CONSTRAINTS, V17, P304, DOI 10.1007/s10601-012-9121-3; Boettcher S, 2000, ARTIF INTELL, V119, P275, DOI 10.1016/S0004-3702(00)00007-2; Aiex RM, 2007, OPTIM LETT, V1, P355, DOI 10.1007/s11590-006-0031-4; Arbelaez A., 2011, LNCS, P2011; Arbelaez A., 2013, SEQUENTIAL PARALLEL; Arbelaez A., 2012, MASSIVELY PARALLEL L; Balint A., 2011, SPARROW2011; Beard JK, 2007, IEEE T AERO ELEC SYS, V43, P522, DOI 10.1109/TAES.2007.4285351; Bessiere C., 2006, CONSTRAINT PROPAGATI; Boettcher S., 2003, ARXIVCS0209030; Bordeaux L., 2009, EXPT MASSIVELY PARAL; Caniou Y., 2011, EXPT PARALLEL CONSTR, P6622; Caromel D., 2007, GRID BNB PARALLEL BR; CHANG W, 1987, P IEEE, V75, P522; Chassin de Kergommeaux J., 1994, ACM COMPUT SURV, V26, P295; Chen YW, 2011, PHYSICA A, V390, P4459, DOI 10.1016/j.physa.2011.06.070; Chu G., 2009, CONFIDENCE BASED WOR; Chu G., 2008, PARALLELIZATION MINI; Codognet P., 2003, EFFICIENT LIB SOLVIN; Codognet P., 2001, YET ANOTHER LOCAL SE; Diaz D., 2012, CONSTRAINT BASED LOC, P7219; Diaz D, 2012, CONCURR COMP-PRACT E, V24, P647, DOI 10.1002/cpe.1855; Drakakis K, 2011, ADV MATH COMMUN, V5, P69, DOI 10.3934/amc.2011.5.69; Drakakis K., 2008, DISTANCE VECTORS COS; Drakakis K, 2011, ADV MATH COMMUN, V5, P547, DOI 10.3934/amc.2011.5.547; Drakakis K., 2006, J APPL MATH, V2006, P1; Galinier P., 2000, GEN APPROACH CONSTRA; Gent I.P., 1999, CSPLIB BENCHMARK LIB; GOLOMB SW, 1984, J COMB THEORY A, V37, P13, DOI 10.1016/0097-3165(84)90015-3; GOLOMB SW, 1984, P IEEE, V72, P1143, DOI 10.1109/PROC.1984.12994; Gomes C., 2004, STREAMLINED CONSTRAI; Gonzalez T.F., 2007, HDB APPROXIMATION AL; Hamadi Y., 2009, J SATISFIABILITY BOO, V6, P245; Hoos H., 1998, EVALUATING LAS VEGAS; Hutter F, 2010, ANN MATH ARTIF INTEL, V60, P65, DOI 10.1007/s10472-010-9191-0; Ibaraki T., 2005, METAHEURISTICS; Kadioglu S., 2009, DIALECTIC SEARCH; Kautz H., 2008, INCOMPLETE ALGORITHM; Maneva E, 2008, THEOR COMPUT SCI, V407, P359, DOI 10.1016/j.tcs.2008.06.053; Michel L., 2006, DISTRIBUTED CONSTRAI; Michel L., 2007, PARALLELIZING CONSTR; Michel L, 2009, COMPUT OPER RES, V36, P2357, DOI 10.1016/j.cor.2008.08.014; Moisan T., 2013, PARALLEL DISCREPANCY; Ohmura K., 2009, UEDA K C SAT PARALLE; Orue A., 2010, CORROSION-US, P2345; Pardalos P., 1995, PARALLEL SEARCH COMB; Pedro V., 2012, THESIS U EVORA; Perron L., 1999, SEARCH PROCEDURES PA; Regin J.C., 2013, EMBARRASSINGLY PARAL; Ribeiro CC, 2012, J GLOBAL OPTIM, V54, P405, DOI 10.1007/s10898-011-9769-z; Rickard S., 2006, STOCHASTIC SEARCH CO; Russo J., 2010, CISS, P1; Schubert Tobias, 2009, J SATISFIABILITY BOO, V6, P203; Simonis H., LIMITS PROPAGATION; Truchet C., 2013, PREDICTION PARALLEL; Truchet C., 2004, THESIS U PARIS 7; VAN HENTENRYCK P., 1989, CONSTRAINT SATISFACT; Van Hentenryck Pascal, 2005, CONSTRAINT BASED LOC; Van Luong T., 2010, LOCAL SEARCH ALGORIT; Verhoeven M., 1996, THESIS U EINDHOVEN; Verhoeven M. G. A., 1995, Journal of Heuristics, V1, DOI 10.1007/BF02430365; Xie F., 2010, MASSIVELY PARALLEL C	76	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1383-7133	1572-9354		CONSTRAINTS	Constraints	JAN	2015	20	1					30	56		10.1007/s10601-014-9168-4		27	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Computer Science	AY6QJ	WOS:000347690400002		
J	Sato, S; Ishitani, O				Sato, Shunsuke; Ishitani, Osamu			Photochemical reactions of fac-rhenium(I) tricarbonyl complexes and their application for synthesis	COORDINATION CHEMISTRY REVIEWS			English	Review						Photochemical reaction; Photophysics; Rhenium complex; Multi nuclear complex	LIGAND SUBSTITUTION-REACTIONS; CARBONYL-DIIMINE-COMPLEXES; EXCITED-STATE DYNAMICS; PHOTOCATALYTIC CO2 REDUCTION; RHENIUM(I) COMPLEXES; ELECTRON-TRANSFER; ABSORPTION-SPECTROSCOPY; MULTINUCLEAR COMPLEXES; BIPYRIDINE COMPLEXES; METAL-COMPLEXES	The photochemical ligand substitution and isomerization reactions of fac-[Re'(L-L')(CO)(3)(L '')](n+)-type complexes are reviewed. We especially focus on the mechanistic studies of the these reactions for affording deeper insights into energetically higher excited states of Re(I) complexes, other than the lowest (MLCT)-M-3 excited state. Moreover, application of the photochemical reactions for synthesis of the linear-shaped and ring-shaped Re(I) multinuclear complexes is described. (C) 2014 Elsevier B.V. All rights reserved.	[Sato, Shunsuke] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Sato, Shunsuke] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ishitani, Osamu] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, Tokyo 1528551, Japan	Ishitani, O (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, O okayama 2-12-1,NE 1, Tokyo 1528551, Japan.	ishitani@chem.titech.ac.jp	Ishitani, Osamu/C-4947-2011	Ishitani, Osamu/0000-0001-9557-7854	Japan Society for the Promotion of Science (JSPS) [24107005]; Precursory Research for Embryonic Science and Technology (PRESTO)	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Artificial photosynthesis (AnApple)' (No. 24107005 from the Japan Society for the Promotion of Science (JSPS)) and the Precursory Research for Embryonic Science and Technology (PRESTO).	SLONE RV, 1995, J AM CHEM SOC, V117, P11813, DOI 10.1021/ja00152a027; Takeda H, 2008, J AM CHEM SOC, V130, P2023, DOI 10.1021/ja077752e; Tsubaki H, 2005, J AM CHEM SOC, V127, P15544, DOI 10.1021/ja053814u; CASPAR JV, 1983, J PHYS CHEM-US, V87, P952, DOI 10.1021/j100229a010; Hori H, 1996, J PHOTOCH PHOTOBIO A, V96, P171, DOI 10.1016/1010-6030(95)04298-9; Bredenbeck J, 2004, J AM CHEM SOC, V126, P990, DOI 10.1021/ja0380190; Agarwal J, 2011, J PHYS CHEM A, V115, P2877, DOI [10.1021/jp111342r, 10.1021/jp111347r]; Vlcek A, 2010, TOP ORGANOMETAL CHEM, V29, P73, DOI 10.1007/3418_2009_4; Heydova R, 2012, J PHYS CHEM A, V116, P11319, DOI 10.1021/jp305461z; Slone RV, 1997, INORG CHEM, V36, P5422, DOI 10.1021/ic9703991; Cannizzo A, 2008, J AM CHEM SOC, V130, P8967, DOI 10.1021/ja710763w; Takeda H, 2010, COORDIN CHEM REV, V254, P346, DOI 10.1016/j.ccr.2009.09.030; Ranjan S, 2003, INORG CHEM, V42, P1248, DOI 10.1021/ic0259181; Belanger S, 1999, J AM CHEM SOC, V121, P557, DOI 10.1021/ja9829867; Stufkens DJ, 1998, COORDIN CHEM REV, V177, P127, DOI 10.1016/S0010-8545(98)00132-5; Wong WY, 2009, COORDIN CHEM REV, V253, P1709, DOI 10.1016/j.ccr.2009.01.013; GIORDANO PJ, 1979, J AM CHEM SOC, V101, P2888, DOI 10.1021/ja00505a016; Balzani V, 1996, CHEM REV, V96, P759, DOI 10.1021/cr941154y; Hori H, 1999, J PHOTOCH PHOTOBIO A, V120, P119, DOI 10.1016/S1010-6030(98)00430-4; Agarwal J, 2012, J AM CHEM SOC, V134, P5180, DOI 10.1021/ja2105834; Morimoto T, 2013, J AM CHEM SOC, V135, P13266, DOI 10.1021/ja406144h; Koike K, 2000, INORG CHEM, V39, P2777, DOI 10.1021/ic9911901; Coogan MP, 2009, NEW J CHEM, V33, P1094, DOI 10.1039/b819453j; Sato S, 2012, CHEM-EUR J, V18, P15722, DOI 10.1002/chem.201202734; Zalis S, 2013, INORG CHEM, V52, P5775, DOI 10.1021/ic3025843; Ziessel R, 1998, INORG CHEM, V37, P5061, DOI 10.1021/ic980570o; Casson LA, 2011, DALTON T, V40, P11960, DOI 10.1039/c1dt11233c; Li F, 2003, APPL PHYS LETT, V83, P4716, DOI 10.1063/1.1632545; Li F, 2004, APPL PHYS LETT, V84, P148, DOI 10.1063/1.1638635; Koike K, 2002, J AM CHEM SOC, V124, P11448, DOI 10.1021/ja017032m; Sun SS, 2000, J AM CHEM SOC, V122, P8956, DOI 10.1021/ja001677p; Ko CC, 2010, CHEM-EUR J, V16, P13773, DOI 10.1002/chem.201000793; Koike K, 1997, ORGANOMETALLICS, V16, P5724, DOI 10.1021/om970608p; Dinolfo PH, 2006, J AM CHEM SOC, V128, P12592, DOI 10.1021/ja0623764; Sato S, 2007, INORG CHEM, V46, P3531, DOI 10.1021/ic0621603; Doherty MD, 2010, COORDIN CHEM REV, V254, P2472, DOI 10.1016/j.ccr.2009.12.013; Kumar A, 2010, TOP ORGANOMETAL CHEM, V29, P1, DOI 10.1007/3418_2009_2; WRIGHTON M, 1974, J AM CHEM SOC, V96, P998, DOI 10.1021/ja00811a008; FURUE M, 1991, COORDIN CHEM REV, V111, P221, DOI 10.1016/0010-8545(91)84027-3; Walters KA, 2002, INORG CHEM, V41, P2909, DOI 10.1021/ic011015g; Hayashi Y, 2003, J AM CHEM SOC, V125, P11976, DOI 10.1021/ja035960a; El Nahhas A, 2013, J PHYS CHEM A, V117, P361, DOI 10.1021/jp3106502; Liard DJ, 2004, J PHYS CHEM A, V108, P2363, DOI 10.1021/jp0366320; MEYER TJ, 1985, CHEM REV, V85, P187, DOI 10.1021/cr00067a002; Morimoto T, 2013, J AM CHEM SOC, V135, P16825, DOI 10.1021/ja409271s; Sato S, 2007, INORG CHEM, V46, P9051, DOI 10.1021/ic701458h; HAWECKER J, 1986, HELV CHIM ACTA, V69, P1990, DOI 10.1002/hlca.19860690824; Tamaki Y, 2013, J CATAL, V304, P22, DOI 10.1016/j.jcat.2013.04.002; Bakova R, 2011, COORDIN CHEM REV, V255, P975, DOI 10.1016/j.ccr.2010.12.027; Busby M, 2004, INORG CHEM, V43, P4523, DOI 10.1021/ic049659m; Busby M, 2004, INORG CHEM, V43, P4994, DOI 10.1021/ic035471b; Cheung AWY, 2011, INORG CHEM, V50, P4798, DOI 10.1021/ic102429t; Farrell IR, 2002, INORG CHEM, V41, P4318, DOI 10.1021/ic020218h; Farrell IR, 1999, J AM CHEM SOC, V121, P5296, DOI 10.1021/ja984350l; Hasselmann GM, 1999, Z PHYS CHEM, V212, P39; Ishitani O, 2001, CHEM COMMUN, P1514, DOI 10.1039/b104220n; Kurz P, 2006, EUR J INORG CHEM, P2966, DOI 10.1002/ejic.200600166; Lo L.T.-L., 2013, CHEM COMMUN, P2311; LUONG JC, 1979, J AM CHEM SOC, V101, P1597, DOI 10.1021/ja00500a041; Nahhas A. E., 2011, INORG CHEM, V50, P2932; Nahhas A.E., 2010, J PHYS CHEM A, V114, P6361; Ng CO, 2008, INORG CHEM, V47, P7447, DOI 10.1021/ic800906x; Ortiz TP, 2004, INORG CHEM, V43, P132, DOI 10.1021/ic034560l; Polo AS, 2004, COORDIN CHEM REV, V248, P1343, DOI 10.1016/j.ccr.2004.04.013; Rossenaar BD, 1996, CHEM-EUR J, V2, P228, DOI 10.1002/chem.19960020216; SACKSTEDER L, 1990, INORG CHEM, V29, P4335, DOI 10.1021/ic00346a033; Stufkens D. J., 1992, COMMENTS INORG CHEM, V13, P359, DOI 10.1080/02603599208048467; Takeda H, 2006, ANAL SCI, V22, P545, DOI 10.2116/analsci.22.545; Tsubaki H, 2005, DALTON T, P385, DOI 10.1039/b407947g; Vaughan JG, 2013, DALTON T, V42, P14100, DOI 10.1039/c3dt51614h; VICHOVA J, 1992, J AM CHEM SOC, V114, P10903, DOI 10.1021/ja00053a029; VLCEK A, 1994, COORDIN CHEM REV, V132, P167, DOI 10.1016/0010-8545(94)80037-5; Vlcek A, 2002, COORDIN CHEM REV, V230, P225, DOI 10.1016/S0010-8545(02)00047-4; Walters K.A., 1998, SPECTRUM-J STATE GOV, V11, P1; Worl L. A., 1991, DALTON T, P849; Yam VWW, 2003, EUR J INORG CHEM, P4035, DOI 10.1002/ejic.20030220; Yamamoto Y, 2010, J AM CHEM SOC, V132, P11743, DOI 10.1021/ja104601b; Yamamoto Y, 2008, J AM CHEM SOC, V130, P14659, DOI 10.1021/ja8044579; Zhang M., 2004, J PHYS CHEM B, V108, P13185, DOI 10.1021/jp0489323	79	5	5	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0010-8545	1873-3840		COORDIN CHEM REV	Coord. Chem. Rev.	JAN 1	2015	282				SI		50	59		10.1016/j.ccr.2014.05.009		10	Chemistry, Inorganic & Nuclear	Chemistry	AY4ZQ	WOS:000347583800005		
J	Li, RH; Lockley, MG; Matsukawa, M; Liu, MW				Li, Rihui; Lockley, Martin G.; Matsukawa, Masaki; Liu, Mingwei			Important Dinosaur-dominated footprint assemblages from the Lower Cretaceous Tianjialou Formation at the Houzuoshan Dinosaur Park, Junan County, Shandong Province, China	CRETACEOUS RESEARCH			English	Article						Dinosaur footprints; Cretaceous; Shandong Province; China	BIRD-TRACK; KOREA	Multiple track-bearing levels in Lower Cretaceous fluvial successions at the Houzuoshan Dinosaur Park also known as the "Junan Geological Park of Dinosaurian Relic" in Junan County, Shandong Province, China, have recently become globally famous for the unique vertebrate footprints they yield. These include Shandongornipes, the first zygodactyl bird track reported from the fossil record. Dromaeopodus, the first reported tracicway of a large dromaeosaur, and a new ichnospecies of Minisauripus. However, these important trackways represent only a small part of the vertebrate track record at the Houzuoshan Dinosaur Park site. Herein we describe the entire ichnofaunas representing 12 discrete mapped assemblages (surfaces) at 20 different stratigraphic levels. In total we have recorded more than 360 footprints comprising at least 130 individual tracicways, belonging to eight named ichnogenera of which five (Grallator sensu lato, Asianopodus, Minisauripus, Velociraptorichnus and Dromaeopodus) are attributed to non-avian theropods, one (Omithopodichnus) to an ornithopod and two (Shandongomipes and Koreanaornis) to birds (avian theropods). This remarkable track record allows us to characterize the ichnofaunas as one of the most distinctive and diverse yet reported from the entire Mesozoic. The ichnofauna is heavily theropod-dominated representing almost similar to 90% of the total tracicways, with Asianopodus the most ubiquitous track type occurring at 18 of the 20 (or 90%) of the observed levels and representing -74% of all tracicways. None of the other track types occur at more than 5 levels or represent more than 8.3% of the tracicways. Such theropod-domination is consistent with patterns noted for other Lower Cretaceous ichnofaunas from China. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Rihui] Minist Land & Resources, Key Lab Marine Hydrocarbon Resource & Environm Ge, Qingdao 266071, Peoples R China; [Li, Rihui] Qingdao Inst Marine Geol, Qingdao 266071, Peoples R China; [Lockley, Martin G.] Univ Colorado, Dinosaur Trackers Res Grp, Denver, CO 80217 USA; [Matsukawa, Masaki] Tokyo Gakugei Univ, Dept Environm Sci, Koganei, Tokyo 1848501, Japan; [Liu, Mingwei] Fourth Geol & Mineral Resources Survey Shandong, Weifang 261021, Peoples R China	Lockley, MG (reprint author), Univ Colorado, Dinosaur Trackers Res Grp, Denver, CO 80217 USA.	rihuiliqd@qq.com; Martin.Lockley@UCDenver.edu; matsukaw@u-gakugei.ac.jp			National Natural Science Foundation of China [40972005, 40572011]; China Geological Survey [GZH200800501, 1212011220113]; University of Colorado Denver; Dinosaur Tracks Museum; Dinosaur Trackers Research Group	This study was supported financially by National Natural Science Foundation of China (grant no: 40972005 and 40572011 to R. Li), and partly supported by China Geological Survey (Nos. GZH200800501, 1212011220113). The study was also supported, in part, by the offices of the University of Colorado Denver, Dinosaur Tracks Museum and Dinosaur Trackers Research Group. All specimens with the prefix CU have were transferred, in 2012, to the University of Colorado Museum of Natural History (UCM) and will in future have the replacement prefix UCM, without change to the numbers.	Lockley MG, 2008, CRETACEOUS RES, V29, P115, DOI 10.1016/j.cretres.2007.04.003; OSTROM JH, 1972, PALAEOGEOGR PALAEOCL, V11, P287, DOI 10.1016/0031-0182(72)90049-1; Lim JD, 2012, ICHNOS, V19, P101, DOI 10.1080/10420940.2012.664059; Lockley MG, 2010, BIRDS-EVOL BEHAV ECO, P1; Matsukawa M, 2006, CRETACEOUS RES, V27, P3, DOI 10.1016/j.cretres.2005.10.009; Zhang JP, 2006, CRETACEOUS RES, V27, P44, DOI 10.1016/j.cretres.2005.10.006; Xing LD, 2013, ACTA PALAEONTOL POL, V58, P723, DOI 10.4202/app.2011.0115; Xing Li-Da, 2012, Palaeoworld, V21, P50, DOI 10.1016/j.palwor.2012.02.004; Lockley MG, 2009, GEOL Q, V53, P415; Xing LD, 2013, CRETACEOUS RES, V45, P114, DOI 10.1016/j.cretres.2013.07.009; Lockley MG, 2007, NATURWISSENSCHAFTEN, V94, P657, DOI 10.1007/s00114-007-0239-x; Kim JY, 2008, PALAEOGEOGR PALAEOCL, V262, P72, DOI 10.1016/j.palaeo.2008.02.003; Li RH, 2005, CHINESE SCI BULL, V50, P1149, DOI 10.1360/982004-823; Xing Li-Da, 2011, Palaeoworld, V20, P308, DOI 10.1016/j.palwor.2011.01.001; Tang JF, 2008, ACTA PETROL SIN, V24, P1333; Ling WL, 2007, SCI CHINA SER D, V50, P813, DOI 10.1007/s11430-007-2065-6; Kim JY, 2009, CRETACEOUS RES, V30, P1387, DOI 10.1016/j.cretres.2009.08.003; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; Chen P. J., 2006, CRETACEOUS RES, V27, P21; Hitchcock E., 1858, ICHNOLOGY NEW ENGLAN; KIM B. K., 1969, J GEOLOGICAL SOC KOR, V5, P243; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Li Rihui, 2000, Geological Review (Beijing), V46, P605; [李日辉 Li Rihui], 2002, [地质通报, Geological Bulletin of China], V21, P596; Li R., 2005, J VERTEBR PALEONTOL, V25, p84A; Li RH, 2011, CRETACEOUS RES, V32, P422, DOI 10.1016/j.cretres.2010.10.006; [刘明渭 Liu Minwei], 2003, [地层学杂志, Journal of Stratigraphy], V27, P247; Lockley M. G., 2012, 11 MES TERR EC AUG 1, P311; Lockley M. G., 2012, 11 MES TERR EC S AUG; Lockley M. G., 2012, 11 MES TERR EC AUG 1, P315; Lockley Martin G., 2001, P428; Lockley M. G., 2014, NEW MEXICO MUSEUM NA, V62, P441; Lockley Martin G., 2010, Bulletin of the New Mexico Museum of Natural History and Science, V51, P99; Lockley M. G., 2011, CRETACEOUS RES, V34, P84; Lockley M. G., 1989, AGE DINOSAURS SHORT, P134; Lockley M. G., 2014, NEW MEXICO MUSEUM NA, V62, P287; Lockley MG, 1998, NEW MEXICO MUSEUM NA, V14, P135; Lockley M.G., 2014, NEW MEXICO MUSEUM NA, V62, P279; Lockley M.G., 2014, BIOL J LINN IN PRESS; Lull R. S., 1953, CONNECTICUT STATE GE, V81, P1; Matsukawa Masaki, 2005, Ichnos, V12, P201, DOI 10.1080/10420940591009231; Matsukawa M., 2007, P HAEN UH INT DIN S, P177; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586; [彭楠 Peng Nan], 2013, [古地理学报, Journal of Palaeogeography], V15, P517; Thulborn R.A., 1990, DINOSAUR TRACKS; Wang B., 2013, J PALEOGEOGRAPHY, V15, P489; [Xing Lida 邢立达], 2010, [地质通报, Geological Bulletin of China], V29, P1105; Xing L.D., ICHNOS IN PRESS; [许欢 Xu Huan], 2013, [古地理学报, Journal of Palaeogeography], V15, P467; Yabe H, 1940, P IMPERIAL ACAD JAPA, V16, P560; You Hailu, 1995, P151; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhen Shuonan, 1995, Memoirs of Beijing Natural History Museum, V54, P105	53	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6671	1095-998X		CRETACEOUS RES	Cretac. Res.	JAN	2015	52		A				83	100		10.1016/j.cretres.2014.08.004		18	Geology; Paleontology	Geology; Paleontology	AY6GY	WOS:000347666300006		
J	Naz, I; Saifullah; Palomares-Rius, JE; Khan, SM; Ali, S; Ahmad, M; Ali, A; Khan, A				Naz, Ishrat; Saifullah; Palomares-Rius, J. E.; Khan, S. M.; Ali, S.; Ahmad, M.; Ali, A.; Khan, A.			Control of Southern root knot nematode Meloidogyne incognita (Kofoid and White) Chitwood on tomato using green manure of Fumaria parviflora Lam (Fumariaceae)	CROP PROTECTION			English	Article						Fumaria parviflora; Tomato; Meloidogyne incognita; Integrated Pest Management; Green manure	PLANT-PARASITIC NEMATODES; NEMATOCIDAL ACTIVITY; BIOLOGICAL-CONTROL; BRASSICA-OLERACEA; MANAGEMENT; JAVANICA; POPULATIONS; SUPPRESSION; AMENDMENTS; CULTIVARS	Extracts of the plant Fumaria parviflora have demonstrated nematicidal properties and it is a potential novel control agent against plant parasitic nematodes. In this research, we examined the use of E parviflora, in green house and field experiments, as a green manure against Meloidogyne incognita on tomato. M incognita did not parasitize E parviflora as shown using a host pathogenicity test with a range of different inoculation rates of the nematode. Applications of E parviflora 15 days before transplanting at the highest dose of 30 g fresh chopped whole plant material per kg of soil showed the most promising results. The root portion of F. parviflora showed higher nematicidal activity than the tops of the plant. All plant growth parameters studied were significantly promoted by the application of green manure in addition to the toxic effect on M. incognita. These data suggest that E parviflora could be used alone or as part of an Integrated Pest Management strategy as a novel management tool for M. incognita. (C) 2014 Elsevier Ltd. All rights reserved.	[Naz, Ishrat; Saifullah; Ahmad, M.; Ali, A.] Univ Agr, Dept Plant Pathol, Peshawar, Khyber Pakhtunk, Pakistan; [Palomares-Rius, J. E.] Miyazaki Univ, Dept Parasitol, Fac Med, Miyazaki 8891692, Japan; [Palomares-Rius, J. E.] CSIC, IAS, Cordoba 14080, Spain; [Khan, S. M.; Ali, S.; Khan, A.] Univ Haripur, Dept Agr, Khyber Pakthunkhwa, Pakistan	Naz, I (reprint author), Univ Agr, Dept Plant Pathol, POB 25130, Peshawar, Khyber Pakhtunk, Pakistan.	ishratro@hotmail.com	Palomares-Rius, Juan /K-8004-2015; 	Palomares-Rius, Juan Emilio/0000-0003-1776-8131	Higher Education Commission (Fellowship Program Phase-VI) of Pakistan under the Indigenous scholarship program [HEC5000]	This research, part of PhD study by Ishrat Naz, was supported by the Higher Education Commission (HEC5000 Fellowship Program Phase-VI) of Pakistan under the Indigenous scholarship program. We thank Dr. Juan A. Navas-Cortes (IAS-CSIC, Spain) for his suggestions in the statistical analysis and Dr. John Jones (JHI, Scotland) for technically reviewing the manuscript.	AKHTAR M, 1993, Z PFLANZENK PFLANZEN, V100, P337; SANG JP, 1984, CAN J PLANT SCI, V64, P77; McSorley R, 2011, J NEMATOL, V43, P69; Hooks CRR, 2003, CROP PROT, V22, P223, DOI 10.1016/S0261-2194(02)00172-2; Akhtar M, 2000, BIORESOURCE TECHNOL, V74, P35, DOI 10.1016/S0960-8524(99)00154-6; Potter MJ, 1998, J CHEM ECOL, V24, P67, DOI 10.1023/A:1022336812240; MOJTAHEDI H, 1991, J NEMATOL, V23, P170; MOJTAHEDI H, 1993, J NEMATOL, V25, P303; Cartea ME, 2008, PHYTOCHEMISTRY, V69, P403, DOI 10.1016/j.phytochem.2007.08.014; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Shepherd MA, 2002, SOIL USE MANAGE, V18, P284, DOI 10.1079/SUM2002134; Monfort WS, 2007, CROP PROT, V26, P1359, DOI 10.1016/j.cropro.2006.11.008; Kokalis-Burelle N, 2012, J NEMATOL, V44, P142; Collange B, 2011, CROP PROT, V30, P1251, DOI 10.1016/j.cropro.2011.04.016; Rao Chandana Venkateswara, 2007, Acta Pharmaceutica (Zagreb), V57, P491, DOI 10.2478/v10007-007-0039-z; BENTLEY HR, 1955, J CHEM SOC, P596, DOI 10.1039/jr9550000596; Braddy N., 1999, ELEMENTS NATURE PROP; Bridge J., 1987, Principles and practice of nematode control in crops., P389; Campbell C. L., 1990, INTRO PLANT DIS EPID; Crow WT, 1996, J NEMATOL, V28, P648; Duponnois R, 1995, BIOCONTROL SCI TECHN, V5, P517, DOI 10.1080/09583159550039693; FERRAZ S., 2004, NEMATOLOGY ADV PERSP, P931; Gomez K.A., 1984, STAT PROCEDURES AGR; Javed N, 2007, CROP PROT, V26, P530, DOI 10.1016/j.cropro.2006.05.003; Khan H., 2000, INT J AGRIC BIOL, V2, P360; Khattak B., 2008, THESIS U AGR PESHAWA; Kokalis-Burelle N, 2005, J NEMATOL, V37, P467; Kumari N. Swarna, 2005, Communications in Agricultural and Applied Biological Sciences, V70, P909; Moens Maurice, 2009, P1, DOI 10.1079/9781845934927.0001; Moyes CL, 2000, J CHEM ECOL, V26, P2625, DOI 10.1023/A:1005549115751; Naz I, 2013, J AGR FOOD CHEM, V61, P5689, DOI 10.1021/jf401309r; Naz I, 2013, PLANT PATHOL, V62, P943, DOI 10.1111/j.1365-3059.2012.02682.x; Naz I., 2014, INT J AGR B IN PRESS; Nico AI, 2004, CROP PROT, V23, P581, DOI 10.1016/j.cropro.2003.11.005; Odour-Owino P, 2003, NEMATOLOGIA MEDITERR, V31, P121; Pakeerathan K., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P494; Rakesh Pandey, 2003, Nematode management in plants, P103; Reynolds LB, 2000, AGRON J, V92, P957; Sharon E, 2001, PHYTOPATHOLOGY, V91, P687, DOI 10.1094/PHYTO.2001.91.7.687; Southey J.F., 1986, TECHNICAL B MAFF ADA, P202; TAYLOR A. L., 1978, BIOL IDENTIFICATION; Wang K.H., 2007, PLANT DIS, V35, P1	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0261-2194	1873-6904		CROP PROT	Crop Prot.	JAN	2015	67						121	129		10.1016/j.cropro.2014.10.005		9	Agronomy	Agriculture	AY4WO	WOS:000347576100019		
J	Kawauchi, Y; Takagi, H; Hanafusa, K; Kono, M; Yamatani, M; Kojima, N				Kawauchi, Yoko; Takagi, Hideaki; Hanafusa, Kei; Kono, Mirei; Yamatani, Minami; Kojima, Naoya			SIGNR1-mediated phagocytosis, but not SIGNR1-mediated endocytosis or cell adhesion, suppresses LPS-induced secretion of IL-6 from murine macrophages	CYTOKINE			English	Article						SIGNR1; Phagocytosis; Endocytosis; Cell adhesion; IL-6	C-TYPE LECTINS; OLIGOMANNOSE-COATED LIPOSOMES; TNF-ALPHA PRODUCTION; DC-SIGN; DENDRITIC CELLS; CANDIDA-ALBICANS; RECEPTOR; LIPOPOLYSACCHARIDE; RECOGNITION; ACTIVATION	C-type lectin receptors (CLRs) serve as phagocytosis receptors for pathogens and also function as adhesion molecules and in the recognition and endocytosis of glycosylated self-antigens. In the present study, we demonstrated that phagocytosis mediated by a mouse mannose-binding CLR, SIGNR1 significantly suppressed the LPS-induced secretion of the specific pro-inflammatory cytokines from the resident peritoneal macrophages and the mouse macrophage-like cells that express SIGNR1 (RAW-SIGNR1). LPS-induced secretion of IL-6 from peritoneal macrophages suppressed in response to uptake of oligomannose-coated liposomes (OMLs), and the suppression was partly inhibited by treatment with an anti-SIGNR1 antibody. LPS-induced secretion of IL-6 from RAW-SIGNR1 cells was also clearly inhibited by treatment of the cells with OMLs >0.4 mu m in diameter, but treatment with OMLs <0.4 mu m in diameter did not affect the IL-6 secretion. In contrast, LPS-induced TNF-alpha secretion from the cells was not affected on treatment of the cells with OMLs. Suppression of the IL-6 secretion was not observed following treatment with oligomannose-containing soluble polymers or when cells were bound to an oligomannose-coated solid phase. Phagocytosis of oligomannose-coated liposomes did not interfere with the transcription of IL-6 mRNA, but did affect IL-6 mRNA stability, leading to suppression of IL-6 secretion. Interestingly, treatment of the cells with Ly290042, a PI3 kinase inhibitor, partly blocked the suppression of LPS-induced secretion of IL-6 by OML. Thus, we conclude that SIGNR1-mediated phagocytosis but not SIGNR1-mediated endocytosis and cell adhesion, suppresses the TLR4-mediated production of specific proinflammatory cytokines via PI3 kinase signaling. (C) 2014 Elsevier Ltd. All rights reserved.	[Kawauchi, Yoko; Takagi, Hideaki; Hanafusa, Kei; Kono, Mirei; Yamatani, Minami; Kojima, Naoya] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 2591292, Japan	Kojima, N (reprint author), Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 2591292, Japan.	naoyaki@keyaki.cc.u-tokai.ac.jp					Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Kawai T, 2001, J IMMUNOL, V167, P5887; Numazaki M, 2009, BIOCHEM BIOPH RES CO, V386, P202, DOI 10.1016/j.bbrc.2009.06.011; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chu CL, 2005, J IMMUNOL, V175, P2880; Takagi H, 2009, GLYCOBIOLOGY, V19, P258, DOI 10.1093/glycob/cwn128; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Saunders SP, 2010, J IMMUNOL, V184, P2627, DOI 10.4049/jimmunol.0901970; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Kojima N, 2008, J CONTROL RELEASE, V129, P26, DOI 10.1016/j.jconrel.2008.03.023; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Dunnen Den, 2009, CANCER IMMUNOL IMMUN, V58, P19; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Kawauchi Y, 2014, CELL IMMUNOL, V287, P121, DOI 10.1016/j.cellimm.2014.01.004; Kawauchi Y, 2012, GLYCOCONJUGATE J, V29, P481, DOI 10.1007/s10719-012-9406-1; Kawauchi Y, 2014, INT IMMUNOPHARMACOL, V19, P27, DOI 10.1016/j.intimp.2013.12.030; Takagi H, 2007, CYTOKINE, V40, P241, DOI 10.1016/j.cyto.2007.10.005; Takahara K, 2012, INFECT IMMUN, V80, P1699, DOI 10.1128/IAI.06308-11; Takahara K, 2012, INT IMMUNOL, V24, P89, DOI 10.1093/intimm/dxr103; Takahara K, 2011, EUR J IMMUNOL, V41, P1435, DOI 10.1002/eji.200940188	30	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	JAN	2015	71	1					45	53		10.1016/j.cyto.2014.08.002		9	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	AY4ZZ	WOS:000347584600006		
J	Cheng, MQ; Fu, HL; Jiang, J; Lo, YH; Miao, Y				Cheng, Minquan; Fu, Hung-Lin; Jiang, Jing; Lo, Yuan-Hsun; Miao, Ying			New bounds on (2)over-bar-separable codes of length 2	DESIGNS CODES AND CRYPTOGRAPHY			English	Article						Multimedia fingerprinting; Separable code; 4-Cycle free bipartite graph; Zarankiewicz number; Projective plane	BIPARTITE GRAPHS; FRAMEPROOF CODES; ALGORITHMS; GIRTH	Let be a code of length over an alphabet of letters. The descendant code of is defined to be the set of words such that for all . is a -separable code if for any two distinct such that , , we always have . The study of separable codes is motivated by questions about multimedia fingerprinting for protecting copyrighted multimedia data. Let be the maximal possible size of such a separable code. In this paper, we provide an improved upper bound for by a graph theoretical approach, and a new lower bound for by deleting suitable points and lines from a projective plane, which coincides with the improved upper bound in some places. This corresponds to the bounds of maximum size of bipartite graphs with girth and a construction of such maximal bipartite graphs.	[Cheng, Minquan] Guangxi Normal Univ, Dept Math Sci, Guilin 541004, Peoples R China; [Fu, Hung-Lin] Natl Chiao Tung Univ, Dept Appl Math, Hsinchu 300, Taiwan; [Jiang, Jing] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Lo, Yuan-Hsun] Natl Univ Kaohsiung, Dept Appl Math, Kaohsiung 811, Taiwan; [Miao, Ying] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan	Cheng, MQ (reprint author), Guangxi Normal Univ, Dept Math Sci, Guilin 541004, Peoples R China.	chengqinshi@hotmail.com; hlfu@math.nctu.edu.tw; jjiang2008@hotmail.com; yhlo0830@gmail.com; miao@sk.tsukuba.ac.jp			Guangxi Natural Science Foundation [2013GXNSFCA019001]; general scientific research project of the Education Department of Guangxi Province [2013YB039]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; NSC [100-2115-M-009-005-MY3]; JSPS [24540111]	The interesting paper [8] was drawn to the authors' attention by one of the two anonymous reviewers. The authors express their sincere thanks to the reviewers for their valuable comments and suggestions in revising this paper. Cheng is supported by Guangxi Natural Science Foundation under Grant No. 2013GXNSFCA019001, by the general scientific research project of the Education Department of Guangxi Province (Grant No. 2013YB039), and by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. Fu and Lo are supported by NSC 100-2115-M-009-005-MY3. Miao is supported by JSPS Grant-in-Aid for Scientific Research (C) under Grant No. 24540111.	Boneh D, 1998, IEEE T INFORM THEORY, V44, P1897, DOI 10.1109/18.705568; Staddon JN, 2001, IEEE T INFORM THEORY, V47, P1042, DOI 10.1109/18.915661; Blackburn SR, 2003, SIAM J DISCRETE MATH, V16, P499, DOI 10.1137/S0895480101384633; Cheng MQ, 2011, IEEE T INFORM THEORY, V57, P4843, DOI 10.1109/TIT.2011.2146130; Singer J, 1938, T AM MATH SOC, V43, P377, DOI 10.2307/1990067; Cheng MQ, 2012, IEEE T INFORM THEORY, V58, P1791, DOI 10.1109/TIT.2011.2174614; Stinson DR, 2000, J STAT PLAN INFER, V86, P595, DOI 10.1016/S0378-3758(99)00131-7; Bryant DE, 2002, DISCRETE MATH, V259, P263, DOI 10.1016/S0012-365X(02)00371-0; BENSON CT, 1966, CANADIAN J MATH, V18, P1091, DOI 10.4153/CJM-1966-109-8; Bollobas B., 1978, EXTREMAL GRAPH THEOR; Damasdi G., 2013, ANN U EOTVOS LORAND; deCaen D, 1997, J COMB THEORY A, V77, P268, DOI 10.1006/jcta.1997.2745; ERDOS P, 1995, EUR J COMBIN, V16, P567, DOI 10.1016/0195-6698(95)90039-X; Garcia-Vazquez P., 2006, ELECT NOTES DISCRET, V26, P67, DOI 10.1016/j.endm.2006.08.012; Goddard W, 2000, DISCRETE MATH, V219, P85, DOI 10.1016/S0012-365X(99)00370-2; Gyori E, 1997, DISCRETE MATH, V165, P371, DOI 10.1016/S0012-365X(96)00184-7; Hirschfeld J. W. P., 1998, PROJECTIVE GEOMETRIE; Hollmann HDL, 1998, J COMB THEORY A, V82, P121, DOI 10.1006/jcta.1997.2851; Hoory S, 2002, J COMB THEORY B, V86, P215, DOI 10.1006/jctb.2002.2123; Lam T., 2005, AUSTRALASIAN J COMBI, V32, P163; Lam T, 2001, B AUST MATH SOC, V63, P435; Liu K.J.R., 2005, MULTIMEDIA FINGERPRI; Mehlhorn K., 1984, DATA STRUCTURES ALGO, V1st; Naor A, 2005, COMB PROBAB COMPUT, V14, P845, DOI [10.1017/S0963548305007029, 10.1017/S093548305007029]; Neuwirth S., 2001, ARXIVMATH0102210; WENGER R, 1991, J COMB THEORY B, V52, P113, DOI 10.1016/0095-8956(91)90097-4; Zarankiewicz K., 1951, C MATH, V2, P301	27	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1022	1573-7586		DESIGN CODE CRYPTOGR	Designs Codes Cryptogr.	JAN	2015	74	1					31	40		10.1007/s10623-013-9849-9		10	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	AY6RD	WOS:000347692400003		
J	Minami, H; Inoue, H; Haji, A; Isomoto, H; Urabe, S; Hashiguchi, K; Matsushima, K; Akazawa, Y; Yamaguchi, N; Ohnita, K; Takeshima, F; Nakao, K				Minami, Hitomi; Inoue, Haruhiro; Haji, Amyn; Isomoto, Hajime; Urabe, Shigetoshi; Hashiguchi, Keiichi; Matsushima, Kayoko; Akazawa, Yuko; Yamaguchi, Naoyuki; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko			Per-oral endoscopic myotomy: Emerging indications and evolving techniques	DIGESTIVE ENDOSCOPY			English	Review						diffuse esophageal spasm; esophageal achalasia; indocyanine green (ICG); per-oral endoscopic myotomy (POEM); per-oral endoscopic tumor resection	DIFFUSE ESOPHAGEAL SPASM; HELLER MYOTOMY; BOTULINUM TOXIN; PNEUMATIC DILATION; ACHALASIA; POEM	Esophageal achalasia is a benign esophageal motility disorder resulting from an impaired relaxation of the lower esophageal sphincter. The principles of treatment involve disruption of the sphincter at the esophagogastric junction. Treatment techniques include balloon dilatation, botulinum toxin injection, and surgical myotomy. In 2008, per-oral endoscopic myotomy (POEM) was introduced by Inoue etal. as an endoscopic myotomy with no skin incision. The procedure has been well accepted and widely applied owing to its minimal invasiveness and high cure rates. Moreover, there have been discussions on wider indications for POEM and new technical developments have been reported. The present article reviews the historical background and present status of POEM, as well as future prospects for its application in the treatment of esophageal achalasia.	[Minami, Hitomi; Isomoto, Hajime; Urabe, Shigetoshi; Hashiguchi, Keiichi; Matsushima, Kayoko; Akazawa, Yuko; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki 8528501, Japan; [Yamaguchi, Naoyuki; Ohnita, Ken] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan; [Inoue, Haruhiro] Showa Univ, Koto Toyosu Hosp, Digest Dis Ctr, Tokyo, Japan; [Haji, Amyn] Kings Coll London, Dept Surg, London WC2R 2LS, England	Minami, H (reprint author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	le7novembre@gmail.com					Onimaru M, 2013, J AM COLL SURGEONS, V217, P598, DOI 10.1016/j.jamcollsurg.2013.05.025; Inoue H, 2012, ENDOSCOPY, V44, P225, DOI 10.1055/s-0031-1291659; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Suzuki T, 2010, ENDOSCOPY, V42, P1021, DOI 10.1055/s-0030-1255969; Eckardt VF, 2004, GUT, V53, P629, DOI 10.1136/gut.2003.029298; Sharata A, 2013, J GASTROINTEST SURG, V17, P1188, DOI 10.1007/s11605-013-2193-6; Ling TS, 2014, J GASTROEN HEPATOL, V29, P1609, DOI 10.1111/jgh.12570; Pasricha PJ, 2007, ENDOSCOPY, V39, P761, DOI 10.1055/s-2007-966764; Minami H, 2014, DIGEST ENDOSC, V26, P43, DOI 10.1111/den.12086; Shiwaku H, 2013, GASTROINTEST ENDOSC, V77, P149, DOI 10.1016/j.gie.2012.02.008; Campos GM, 2009, ANN SURG, V249, P45, DOI 10.1097/SLA.0b013e31818e43ab; Ohya TR, 2012, GASTROINTEST ENDOSC, V75, P405, DOI 10.1016/j.gie.2011.09.045; Baldaque-Silva F, 2014, GASTROINTEST ENDOSC, V79, P544, DOI 10.1016/j.gie.2013.10.023; Dunaway P M, 2001, Gastrointest Endosc Clin N Am, V11, P425; Heller E, 1914, MITT GRENZGEB MED CH, V27, P141; Litle VR, 2008, ANN THORAC SURG, V85, pS743, DOI 10.1016/j.athoracsur.2007.12.004; Mikaeli J, 2004, DIS ESOPHAGUS, V17, P213, DOI 10.1111/j.1442-2050.2004.00410.x; Minami H, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-22; Minami H, 2014, ENDOSCOPY, V46, pE79, DOI 10.1055/s-0032-1309922; PASRICHA PJ, 1993, GASTROENTEROLOGY, V105, P1045; PASRICHA PJ, 1993, LANCET, V341, P244, DOI 10.1016/0140-6736(93)90109-T; Petersen RP, 2010, SURG LAPARO ENDO PER, V20, P321, DOI 10.1097/SLE.0b013e3181f39fdb; Rohof WO, 2012, CURR OPIN GASTROEN, V28, P389, DOI 10.1097/MOG.0b013e328353af8f; Sumiyama K, 2009, GASTROINTEST ENDOSC, V69, P1129, DOI 10.1016/j.gie.2008.08.007; Tanaka E, 2013, J ANESTH, V28, P456; Vigneswaran Y, 2014, J GASTROINTEST SURG; Wang L, 2008, WORLD J GASTROENTERO, V14, P7122, DOI 10.3748/wjg.14.7122	27	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		175	181		10.1111/den.12328		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400001		
J	Ohki, T; Yamato, M; Ota, M; Takagi, R; Kondo, M; Kanai, N; Okano, T; Yamamoto, M				Ohki, Takeshi; Yamato, Masayuki; Ota, Masaho; Takagi, Ryo; Kondo, Makoto; Kanai, Nobuo; Okano, Teruo; Yamamoto, Masakazu			Application of regenerative medical technology using tissue-engineered cell sheets for endoscopic submucosal dissection of esophageal neoplasms	DIGESTIVE ENDOSCOPY			English	Review						cell sheet technology; endoscopic submucosal dissection (ESD); esophageal stricture; oral mucosal epithelial cell sheet; regenerative medicine	ALLOGRAFT DERMAL MATRIX; STEROID GEL APPLICATION; EPITHELIAL-CELLS; ORAL PREDNISOLONE; IN-VITRO; STRICTURE; CULTURE; PREVENTION; TRANSPLANTATION; RECONSTRUCTION	We have developed a technique for endoscopic transplantation of cultured autologous oral mucosal epithelial cell sheets to an esophageal ulcer following endoscopic submucosal dissection (ESD). The epithelial cell sheets successfully prevented esophageal stricture after ESD. Key technology is that epithelial cell sheets cultured from oral mucosal tissue and attached proteins can be harvested using cell sheet technology and can be transplanted to a wound site without the use of adhesive material. This regenerative procedure can promote the epithelialization of ulceration safely and effectively. In the near future, the development of advanced endoscopic treatment of regenerative medicine shows promise.	[Ohki, Takeshi; Ota, Masaho; Kanai, Nobuo; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo 1628666, Japan; [Ohki, Takeshi; Yamato, Masayuki; Takagi, Ryo; Kondo, Makoto; Kanai, Nobuo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan	Ohki, T (reprint author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ohki@ige.twmu.ac.jp			High-Tech Research Center Program, Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology Cell Sheet Tissue Engineering Center (CSTEC); Global COE program; Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM); Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	THIS STUDY WAS supported by The High-Tech Research Center Program, Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology Cell Sheet Tissue Engineering Center (CSTEC), the Global COE program, the Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), and by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan.	Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4; WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I; Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022; Mori H, 2013, J GASTROEN HEPATOL, V28, P999, DOI 10.1111/jgh.12154; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Grikscheit T, 2003, J THORAC CARDIOV SUR, V126, P537, DOI 10.1016/S0022-5223(03)00032-1; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Ono S, 2009, ENDOSCOPY, V41, P661, DOI 10.1055/s-0029-1214867; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025; Takagi R, 2012, WORLD J GASTROENTERO, V18, P5145, DOI 10.3748/wjg.v18.i37.5145; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001; Takagi R, 2011, PATHOBIOLOGY, V78, P311, DOI 10.1159/000322575; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sato H, 2013, GASTROINTEST ENDOSC, V78, P250, DOI 10.1016/j.gie.2013.01.008; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007; Kobayashi T, 2013, BIOMATERIALS, V34, P9010, DOI 10.1016/j.biomaterials.2013.07.065; [Anonymous], 2007, NAT CLIN PRACT GASTR, V4, P122; Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005; Egami M, 2013, ARCH PHARM RES, V37, P96; Isomoto H, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-46; Kanai N, 2012, GASTROINTEST ENDOSC, V76, P873, DOI 10.1016/j.gie.2012.06.017; Kanai N, 2013, GASTROINTEST ENDOSC, V77, pAB147; Murakami Daisuke, 2006, J Artif Organs, V9, P185, DOI 10.1007/s10047-006-0342-3; Ohki Takeshi, 2014, Gastrointest Endosc Clin N Am, V24, P273, DOI 10.1016/j.giec.2013.11.003; Ohki T, 2007, GASTROINTEST ENDOSC, V65, pAB272, DOI 10.1016/j.gie.2007.03.655; Ohki T., 2011, TECHNIQUES GASTROINT, V13, P105; Ono S, 2011, CLIN J GASTROENTEROL, V3, P155; Ozeki M, 2006, J BIOMED MATER RES A, V79A, P771, DOI 10.1002/jbm.a.30885; Sasaki R, 2012, J BIOMED MATER RES A, V100A, P2849, DOI 10.1002/jbm.a.34216; Sawa Y, 2011, SURG TODAY, V42, P181; Saxena AK, 2009, J GASTROINTEST SURG, V13, P1037, DOI 10.1007/s11605-009-0836-4; Saxena AK, 2009, J PEDIATR SURG, V44, P896, DOI 10.1016/j.jpedsurg.2009.01.019; Susa M, 2013, GASTROINTEST ENDOSC, V77, pAB549; Takagi R, 2010, J TISSUE ENG REGEN M, V5, pe63; Takahashi H, 2010, ENDOSCOPY, V43, P184; Yamaguchi N, 2011, DIGESTION, V83, P291, DOI 10.1159/000321093; Yamato M, 2007, J ROBOT MECHATRONICS, V19, P500; Yang F, 2013, J GASTROEN HEPATOL, V28, P1795, DOI 10.1111/jgh.12370	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		182	188		10.1111/den.12354		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400002		
J	Hiki, N; Nunobe, S; Matsuda, T; Hirasawa, T; Yamamoto, Y; Yamaguchi, T				Hiki, Naoki; Nunobe, Souya; Matsuda, Tatsuo; Hirasawa, Toshiaki; Yamamoto, Yorimasa; Yamaguchi, Toshiharu			Laparoscopic endoscopic cooperative surgery	DIGESTIVE ENDOSCOPY			English	Review						classical laparoscopic and endoscopic cooperative surgery (LECS); gastrointestinal stromal tumor (GIST); laparoscopic endoscopic cooperating surgery; laparoscopic surgery; gastric submucosal tumor	FULL-THICKNESS RESECTION; GASTRIC SUBMUCOSAL TUMOR; MUCOSAL RESECTION; PORCINE MODEL; DISSECTION; FEASIBILITY; ANASTOMOSIS; CLOSURE; CANCER; WALL	Laparoscopic and endoscopic cooperative surgery (LECS) is a newly developed concept for tumor dissection of the gastrointestinal tract that was first investigated for local resection of gastric gastrointestinal stromal tumors (GIST). The first reported version of LECS for GIST has been named classical LECS' to distinguish it from other modified LECS procedures, such as inverted LECS, a combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique (CLEAN-NET), and non-exposed endoscopic wall-inversion surgery (NEWS). These modified LECS procedures were developed for dissection of malignant tumors which may seed tumor cells into the abdominal cavity. While these LECS-related procedures might prevent tumor seeding, their application is limited by several factors, such as tumor size, location and technical difficulty. Currently, classical LECS is a safe and useful procedure for gastric submucosal tumors without mucosal defects, independent of tumor location, such as proximity to the esophagogastric junction or pyloric ring. For future applications of LECS-related procedures for other malignant diseases with mucosal lesions such as GIST with mucosal defects and gastric cancer, some improvements in the techniques are needed.	[Hiki, Naoki; Nunobe, Souya; Matsuda, Tatsuo; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr, Tokyo, Japan; [Hirasawa, Toshiaki; Yamamoto, Yorimasa] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Endoscopy, Gastroenterol Ctr, Tokyo, Japan	Hiki, N (reprint author), Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	naki@bd.mbn.or.jp					Tsujimoto H, 2012, WORLD J SURG, V36, P327, DOI 10.1007/s00268-011-1387-x; Abe N, 2009, SURG ENDOSC, V23, P1908, DOI 10.1007/s00464-008-0317-y; Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Park PO, 2005, GASTROINTEST ENDOSC, V61, P601, DOI 10.1016/S0016-5107(04)02774-9; Ohgami M, 1999, WORLD J SURG, V23, P187; Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Kawahira H, 2012, HEPATO-GASTROENTEROL, V59, P415, DOI 10.5754/hge11456; Abe N, 2013, DIGEST ENDOSC, V25, P64, DOI 10.1111/j.1443-1661.2012.01387.x; Suzuki H, 2001, ENDOSCOPY, V33, P437, DOI 10.1055/s-2001-14269; Hoteya S, 2014, DIGEST ENDOSC, V26, P538, DOI 10.1111/den.12215; Choi SM, 2007, EJSO-EUR J SURG ONC, V33, P444, DOI 10.1016/j.ejso.2006.11.003; Ludwig K, 2002, SURG ENDOSC, V16, P1561, DOI 10.1007/s00464-001-9224-1; Qiu WQ, 2013, J DIGEST DIS, V14, P469, DOI 10.1111/1751-2980.12076; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Bergstrom M, 2006, GASTROINTEST ENDOSC, V63, P307, DOI 10.1016/j.gie.2005.09.035; Goto O, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0358-y, DOI 10.1007/S10120-014-0358-Y]; Hyung WJ, 2005, J SURG ONCOL, V89, P95, DOI 10.1002/jso.20195; Ikeda K, 2005, GASTROINTEST ENDOSC, V62, P122, DOI 10.1016/S0016-5107(05)00517-1; Ikeda K, 2006, GASTROINTEST ENDOSC, V64, P82, DOI 10.1016/j.gie.2005.12.039; Mitsui T, 2013, SURG LAPARO ENDO PER, V23, pE217, DOI 10.1097/SLE.0b013e31828e3f94; Ridwelski K, 2002, Surg Endosc, V16, P537, DOI 10.1007/s004640042014; Yano Hiroshi, 2005, Gastric Cancer, V8, P186, DOI 10.1007/s10120-005-0333-8	24	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		197	204		10.1111/den.12404		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400004		
J	Hosoe, N; Naganuma, M; Ogata, H				Hosoe, Naoki; Naganuma, Makoto; Ogata, Haruhiko			Current status of capsule endoscopy through a whole digestive tract	DIGESTIVE ENDOSCOPY			English	Review						capsule endoscopy; double-balloon enteroscopy; esophageal capsule endoscopy; gastroesophageal reflux disease; inflammatory bowel disease	IRON-DEFICIENCY ANEMIA; SINGLE-CENTER EXPERIENCE; INFLAMMATORY-BOWEL-DISEASE; PILLCAM COLON CAPSULE; GASTROESOPHAGEAL-REFLUX DISEASE; LOWER GASTROINTESTINAL-TRACT; CONVENTIONAL UPPER ENDOSCOPY; DIAGNOSTIC YIELD; VIDEO CAPSULE; ULCERATIVE-COLITIS	More than a decade has passed since small-bowel capsule endoscopy (CE) was first reported. Small-bowel CE is a non-invasive tool that allows visualization of the entire small-intestinal mucosa and facilitates detection of small-intestinal abnormalities. Several studies have shown benefit of small-bowel CE for certain disorders. Because it is non-invasive, CE has been applied to other organs including the esophagus, stomach, and colon. The main indications for esophageal CE (ECE) are screening for gastroesophageal reflux disease/Barrett's esophagus, and esophageal varices. However, the clinical benefit of ECE is unconfirmed. Magnetically guided CE (MGCE) was developed to visualize the gastric mucosa. MGCE is a new concept with room for improvement of capsule navigation and the preparation protocol. Recently, two new small-bowel CE tools were released. First-generation colon CE (CCE-1) has moderate sensitivity and specificity compared with colonoscopy for colorectal neoplasia surveillance. To obtain higher accuracy, a second-generation CCE (CCE-2) was developed with a high sensitivity for detecting clinically relevant polypoid lesions. A possible application of CCE is for inflammatory bowel disease. In the near future, CE may include diagnostic and therapeutic functions such as magnifying endoscopy systems, targeted biopsy forceps, and drug delivery systems.	[Hosoe, Naoki; Naganuma, Makoto; Ogata, Haruhiko] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo 1608582, Japan	Hosoe, N (reprint author), Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	nhosoe@z5.keio.jp			Given Imaging, Ltd, Yokneam, Israel	NH RECEIVED A research grant from Given Imaging, Ltd, Yokneam, Israel. The other authors declare no conflict of interests for this article.	Adler SN, 2014, SURG ENDOSC, V28, P570, DOI 10.1007/s00464-013-3206-y; Aihara H, 2011, GASTROINTEST ENDOSC, V73, P1274, DOI 10.1016/j.gie.2011.01.073; Alarcon-Fernandez O, 2013, CLIN GASTROENTEROL H, V11, P534, DOI 10.1016/j.cgh.2012.10.016; Albert JG, 2005, GUT, V54, P1721, DOI 10.1136/gut.2005.069427; Albert JG, 2008, EUR J GASTROEN HEPAT, V20, P971, DOI 10.1097/MEG.0b013e3282fb2a53; Annibale B, 2003, DIGEST LIVER DIS, V35, P784, DOI 10.1016/S1590-8658(03)00453-5; Koulaouzidis A, 2012, GASTROINTEST ENDOSC, V76, P983, DOI 10.1016/j.gie.2012.07.035; Keller J, 2011, GASTROINTEST ENDOSC, V73, P22, DOI 10.1016/j.gie.2010.08.053; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Wang A, 2013, GASTROINTEST ENDOSC, V78, P805, DOI 10.1016/j.gie.2013.06.026; Costamagna G, 2002, GASTROENTEROLOGY, V123, P999, DOI 10.1053/gast.2002.35988; Van Gossum A, 2009, NEW ENGL J MED, V361, P264, DOI 10.1056/NEJMoa0806347; Kim HM, 2014, J NEUROGASTROENTEROL, V20, P261, DOI [10.5056/jnm.2014.20.2.261, 10.5056/jnm.20.2.261]; Rey JF, 2012, GASTROINTEST ENDOSC, V75, P373, DOI 10.1016/j.gie.2011.09.030; Pennazio M, 2004, GASTROENTEROLOGY, V126, P643, DOI 10.1053/j.gastro.2003.11.057; Schoofs N, 2006, ENDOSCOPY, V38, P971, DOI 10.1055/s-2006-944835; Morita E, 2010, GASTROINTEST ENDOSC, V72, P836, DOI 10.1016/j.gie.2010.06.016; Zagorowicz ES, 2013, WORLD J GASTROENTERO, V19, P9043, DOI 10.3748/wjg.v19.i47.9043; Lecleire S, 2012, ENDOSCOPY, V44, P337, DOI 10.1055/s-0031-1291614; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1053/S1542-3565(04)00603-2; Imagawa H, 2011, GASTROINTEST ENDOSC, V73, P299, DOI 10.1016/j.gie.2010.10.016; Spada C, 2011, J CLIN GASTROENTEROL, V45, P119, DOI 10.1097/MCG.0b013e3181dac04b; Mehdizadeh S, 2010, GASTROINTEST ENDOSC, V71, P121, DOI 10.1016/j.gie.2009.06.034; Lepileur L, 2012, CLIN GASTROENTEROL H, V10, P1376, DOI 10.1016/j.cgh.2012.05.024; Sacher-Huvelin S, 2010, ALIMENT PHARM THER, V32, P1145, DOI 10.1111/j.1365-2036.2010.04458.x; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Swain P, 2010, GASTROINTEST ENDOSC, V71, P1290, DOI 10.1016/j.gie.2010.01.064; Milano A, 2011, GASTROINTEST ENDOSC, V73, P1002, DOI 10.1016/j.gie.2011.01.006; Lapalus MG, 2009, AM J GASTROENTEROL, V104, P1112, DOI 10.1038/ajg.2009.66; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Sharma P, 2008, AM J GASTROENTEROL, V103, P525, DOI 10.1111/j.1572-0241.2007.01233.x; Bourreille A, 2009, ENDOSCOPY, V41, P618, DOI 10.1055/s-0029-1214790; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Esaki M, 2010, DIGEST DIS SCI, V55, P2294, DOI 10.1007/s10620-009-1036-5; Matsumoto T, 2005, ENDOSCOPY, V37, P827, DOI 10.1055/s-870207; de Franchis R, 2008, HEPATOLOGY, V47, P1595, DOI 10.1002/hep.22227; Ladas SD, 2010, ENDOSCOPY, V42, P220, DOI 10.1055/s-0029-1243968; Muhammad A, 2009, J CLIN GASTROENTEROL, V43, P627, DOI 10.1097/MCG.0b013e318181b442; Laine L, 2010, GASTROENTEROLOGY, V138, P1673, DOI 10.1053/j.gastro.2010.01.047; Meister T, 2013, TECH COLOPROCTOL, V17, P641, DOI 10.1007/s10151-012-0965-8; Hartmann D, 2012, ENDOSCOPY, V44, P482, DOI 10.1055/s-0031-1291611; Rey JF, 2010, ENDOSCOPY, V42, P541, DOI 10.1055/s-0030-1255521; Kornbluth A, 2005, ENDOSCOPY, V37, P1051, DOI 10.1055/s-870315; Robinson CA, 2011, GASTROINTEST ENDOSC, V74, P1061, DOI 10.1016/j.gie.2011.07.019; Postgate A, 2008, GASTROINTEST ENDOSC, V68, P1209, DOI 10.1016/j.gie.2008.06.035; Clarke JO, 2008, GASTROINTEST ENDOSC, V68, P267, DOI 10.1016/j.gie.2007.11.055; Carey EJ, 2007, AM J GASTROENTEROL, V102, P89, DOI 10.1111/j.1572-0241.2006.00941.x; Sung J, 2012, ENDOSCOPY, V44, P754, DOI 10.1055/s-0032-1309819; Lin OS, 2007, GASTROINTEST ENDOSC, V65, P577, DOI 10.1016/j.gie.2006.06.035; Gay G, 2010, AM J GASTROENTEROL, V105, P1076, DOI 10.1038/ajg.2009.624; Saperas E, 2007, AM J GASTROENTEROL, V102, P731, DOI 10.1111/j.1572-0241.2007.01058.x; Eliakim R, 2005, J CLIN GASTROENTEROL, V39, P572, DOI 10.1097/01.mcg.0000170764.29202.24; Galmiche JP, 2008, AM J GASTROENTEROL, V103, P538, DOI 10.1111/j.1572-0241.2007.01731.x; Kameda N, 2008, J GASTROENTEROL, V43, P434, DOI 10.1007/s00535-008-2182-9; Keller J, 2010, GASTROINTEST ENDOSC, V72, P941, DOI 10.1016/j.gie.2010.06.053; Triester SL, 2005, AM J GASTROENTEROL, V100, P2407, DOI 10.1111/j.1572-0241.2005.00274.x; Estevez E, 2006, EUR J GASTROEN HEPAT, V18, P881; Kakugawa Y, 2012, WORLD J GASTROENTERO, V18, P2092, DOI 10.3748/wjg.v18.i17.2092; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; Yamada A, 2012, HEPATO-GASTROENTEROL, V59, P676, DOI 10.5754/hge12180; Pohl J, 2010, ENDOSCOPY, V42, P490, DOI 10.1055/s-0029-1243994; Esaki M, 2014, J GASTROEN HEPATOL, V29, P96, DOI 10.1111/jgh.12411; Arakawa D, 2009, GASTROINTEST ENDOSC, V69, P866, DOI 10.1016/j.gie.2008.06.008; Laurain A, 2014, DIGEST LIVER DIS, V46, P535, DOI 10.1016/j.dld.2014.02.002; van Turenhout ST, 2010, J GASTROINTEST LIVER, V19, P141; Apostolopoulos P, 2006, ENDOSCOPY, V38, P1127, DOI 10.1055/s-2006-944736; Burak KW, 2003, CURR OPIN GASTROEN, V19, P477, DOI 10.1097/00001574-200309000-00008; Cañas-Ventura Alex, 2013, World J Gastrointest Endosc, V5, P551, DOI 10.4253/wjge.v5.i11.551; Caspari R, 2004, ENDOSCOPY, V36, P1054, DOI 10.1055/s-2004-826041; Chavalitdhamrong D, 2012, CLIN GASTROENTEROL H, V10; Denzer UW, 2014, J CLIN GASTROENTEROL; Eisen GM, 2006, ENDOSCOPY, V38, P31, DOI 10.1055/s-2005-921189; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Eliakim R, 2004, ALIMENT PHARM THERAP, V20, P1083, DOI 10.1111/j-1365-2036.2004.02206.x; Enns R, 2004, CAN J GASTROENTEROL, V18, P555; Fireman Z, 2004, EUR J GASTROEN HEPAT, V16, P927, DOI 10.1097/01.meg.0000131039.30983.53; Frenette CT, 2008, WORLD J GASTROENTERO, V14, P4480, DOI 10.3748/wjg.14.4480; Gralnek IM, 2006, ENDOSCOPY, V38, P913, DOI 10.1055/s-2006-944718; Gralnek IM, 2008, ENDOSCOPY, V40, P275, DOI 10.1055/s-2007-995645; Hassan C, 2011, ENDOSCOPY, V43, P780, DOI 10.1055/s-0030-1256409; Hatogai K, 2012, GUT LIVER, V6, P218, DOI 10.5009/gnl.2012.6.2.218; Holleran GE, 2013, EUR J GASTROEN HEPAT, V25, P327, DOI 10.1097/MEG.0b013e32835b7d3a; Hosoe N, 2013, J GASTROEN HEPATOL, V28, P1174, DOI 10.1111/jgh.12203; Kornbluth A, 2004, INFLAMM BOWEL DIS, V10, P278, DOI 10.1097/00054725-200405000-00017; Koslowsky B, 2006, ENDOSCOPY, V38, P27, DOI 10.1055/s-2005-921034; Koulaouzidis A, 2012, SCAND J GASTROENTERO, V47, P1094, DOI 10.3109/00365521.2012.704938; Laine L, 2010, GASTROENTEROLOGY, V138; Lapalus MG, 2006, ENDOSCOPY, V38, P36, DOI 10.1055/s-2006-924975; LEWIS BS, 1991, GUT, V32, P763, DOI 10.1136/gut.32.7.763; Marya N, 2014, GASTROINTEST ENDOSC, V79, P669, DOI 10.1016/j.gie.2013.11.022; Mata A, 2005, GASTROINTEST ENDOSC, V61, P721, DOI 10.1016/S0016-5107(05)00289-0; Naganuma M, 2014, DIGEST ENDOSC, V26, P20, DOI 10.1111/den.12161; Negreanu L, 2014, TECH COLOPROCTOL, V18, P277, DOI 10.1007/s10151-013-1054-3; Negreanu Lucian, 2013, World J Gastrointest Endosc, V5, P559, DOI 10.4253/wjge.v5.i11.559; Ness-Jensen E, 2012, GUT, V61, P1390, DOI 10.1136/gutjnl-2011-300715; Ohmiya N, 2010, GASTROINTEST ENDOSC, V72, P1209, DOI 10.1016/j.gie.2010.08.018; Oliva S, 2014, ENDOSCOPY, V46, P485, DOI 10.1055/s-0034-1365413; Papadakis KA, 2005, ENDOSCOPY, V37, P1018, DOI 10.1055/s-2005-870263; Pena LR, 2008, DIGEST LIVER DIS, V40, P216, DOI 10.1016/j.dld.2007.10.022; Pilz JB, 2010, BMC GASTROENTEROL, V18, P66; Pioche M, 2012, ENDOSCOPY, V44, P911, DOI 10.1055/s-0032-1310008; Rey Jean-Francois, 2013, Keio Journal of Medicine, V62, P41, DOI 10.2302/kjm.2012-0011-RE; Schreibman I, 2011, DIGEST DIS SCI, V56, P220, DOI 10.1007/s10620-010-1272-8; Sethi S, 2014, DIGEST DIS SCI, V59, P2497, DOI 10.1007/s10620-014-3178-3; Sidhu R, 2009, J GASTROINTEST LIVER, V18, P273; Spada C, 2011, DIGEST LIVER DIS, V43, P251, DOI 10.1016/j.dld.2010.10.001; Spada C, 2011, DIGEST LIVER DIS, V43, P300, DOI 10.1016/j.dld.2010.10.005; Suzuki H, 2014, NEUROGASTROENT MOTIL, V26, P764, DOI 10.1111/nmo.12319; Triantafyllou K, 2014, GASTROINTEST ENDOSC, V79, P307, DOI 10.1016/j.gie.2013.07.061; Trifan A, 2010, J GASTROINTEST LIVER, V19, P21; Urgesi R, 2012, TUMORI, V98, P357, DOI 10.1700/1125.12405; Usui S, 2014, DIGEST ENDOSC, V26, P665, DOI 10.1111/den.12269; Yamada A, 2011, HEPATO-GASTROENTEROL, V58, P1240, DOI 10.5754/hge10736; Ye CA, 2013, J DIGEST DIS, V14, P117, DOI 10.1111/1751-2980.12005; Yoshida S, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-15	115	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		205	215		10.1111/den.12380		11	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400005		
J	Tanaka, S; Asayama, N; Shigita, K; Hayashi, N; Oka, S; Chayama, K				Tanaka, Shinji; Asayama, Naoki; Shigita, Kenjiro; Hayashi, Nana; Oka, Shiro; Chayama, Kazuaki			Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: Future perspectives	DIGESTIVE ENDOSCOPY			English	Review						endoscopic submucosal dissection (ESD); lymph node metastasis; recurrence; submucosal colorectal carcinoma; T1 carcinoma	LYMPH-NODE METASTASIS; LASER IMAGING-SYSTEM; LONG-TERM OUTCOMES; RISK-FACTORS; INCOMPLETE RESECTION; MUCOSAL RESECTION; INVASION DEPTH; COLONIC POLYPS; CANCER; MANAGEMENT	According to the Japanese Society for Cancer of the Colon and Rectum Guidelines 2014 for the Treatment of Colorectal Cancer, cases with T1 colorectal carcinoma should be considered for additional colectomy with lymph node dissection when histologically complete en bloc resection is endoscopically carried out and when one of the four risk factors listed below is present. These four risk factors are: (i) submucosal (SM) invasion depth 1000m; (ii) positive vascular invasion; (iii) poorly differentiated adenocarcinoma, signet ring cell carcinoma, or mucinous carcinoma; and (iv) grade 2/3 budding at the deepest part of SM invasion. However, the probability of lymph node metastasis is extremely low if none of these risk factors are present, with the exception of SM invasion depth 1000m. Consequently, it is assumed that there will be an increasing number of cases where no additional surgery is done, or cases of moderate invasive carcinoma in which endoscopic treatment is carried out to achieve an excisional biopsy, for which complete resection is applicable. In these cases, the preoperative diagnosis, resection techniques such as endoscopic submucosal dissection, features of resected specimens, and the accuracy of pathological diagnosis are all extremely important.	[Tanaka, Shinji; Hayashi, Nana; Oka, Shiro] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Asayama, Naoki; Shigita, Kenjiro; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan	Tanaka, S (reprint author), Hiroshima Univ Hosp, Dept Endoscopy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	colon@hiroshima-u.ac.jp					Yoshii S, 2014, CLIN GASTROENTEROL H, V12, P292, DOI 10.1016/j.cgh.2013.08.008; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; Yoda Y, 2013, ENDOSCOPY, V45, P718, DOI 10.1055/s-0033-1344234; Ikematsu H, 2013, GASTROENTEROLOGY, V144, P551, DOI 10.1053/j.gastro.2012.12.003; Yamauchi H, 2008, SURG TODAY, V38, P905, DOI 10.1007/s00595-007-3751-x; Tanaka S, 2006, GASTROINTEST ENDOSC, V64, P604, DOI 10.1016/j.gie.2006.06.007; Kanao H, 2009, GASTROINTEST ENDOSC, V69, P631, DOI 10.1016/j.gie.2008.08.028; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Hayashi N, 2013, GASTROINTEST ENDOSC, V78, P625, DOI 10.1016/j.gie.2013.04.185; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Ozawa S, 2013, INT J COLORECTAL DIS, V28, P1247, DOI 10.1007/s00384-013-1701-1; Bosch SL, 2013, ENDOSCOPY, V45, P827, DOI 10.1055/s-0033-1344238; Yoshida N, 2014, DIGEST ENDOSC, V26, P250, DOI 10.1111/den.12127; MINAMOTO T, 1993, AM J GASTROENTEROL, V88, P1035; Tanaka S, 2013, DIGEST ENDOSC, V25, P107, DOI 10.1111/den.12016; Nakadoi K, 2012, J GASTROEN HEPATOL, V27, P1057, DOI 10.1111/j.1440-1746.2011.07041.x; Hayashi N, 2014, GASTROINTEST ENDOSC, V79, P427, DOI 10.1016/j.gie.2013.09.014; TANAKA S, 1995, J GASTROENTEROL, V30, P710, DOI 10.1007/BF02349636; Caputo D, 2014, INT J SURG, V12, P209, DOI 10.1016/j.ijsu.2013.12.012; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Tanaka S, 2002, ONCOL REP, V9, P1005; Kobayashi H, 2011, J GASTROENTEROL, V46, P203, DOI 10.1007/s00535-010-0341-2; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Barillari P, 1996, DIS COLON RECTUM, V39, P388, DOI 10.1007/BF02054052; CHRISTIE JP, 1988, AM SURGEON, V54, P93; CONTE CC, 1987, J SURG ONCOL, V36, P116, DOI 10.1002/jso.2930360209; Higuchi T, 2006, J JPN SOC COLOPROCTO, V59, P857; Ikematsu H, 2013, DIGEST ENDOSC, V25, P6, DOI 10.1111/den.12114; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Japanese Society for Cancer of the Colon and Rectum (JSCCR), 2014, JSCCR GUID TREATM CO; Japanese Society for Cancer of the Colon and Rectum (JSCCR), 2005, JSCCR GUID TREATM CO; Japanese Society for Cancer of the Colon and Rectum (JSCCR), 1998, JAP CLASS COL CARC; Japanese Society of Gastroenterology (JSGE), 2014, CLIN PRACT GUID COL; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kye BH, 2012, BMC SURG, p[6, 12]; KYZER S, 1992, CANCER, V70, P2044, DOI 10.1002/1097-0142(19921015)70:8<2044::AID-CNCR2820700805>3.0.CO;2-X; Mou S, 2014, SURG ENDOSC, V27, P2692; Nakadoi K, 2014, SURG ENDOSC, V28, P1269, DOI 10.1007/s00464-013-3321-9; Oka S, 2013, DIGEST ENDOSC, V25, P21, DOI 10.1111/den.12089; Read TE, 2002, J AM COLL SURGEONS, V195, P33, DOI 10.1016/S1072-7515(02)01224-3; Saito Yutaka, 2014, Gastrointest Endosc Clin N Am, V24, P245, DOI 10.1016/j.giec.2013.11.005; Sato K, 2014, SURG ENDOSC; SHATNEY CH, 1974, SURG GYNECOL OBSTET, V139, P845; SHINYA H, 1982, SURG CLIN N AM, V62, P861; Tanaka S, 2000, ONCOL REP, V7, P783; TANAKA S, 1995, DIS COLON RECTUM, V38, P959, DOI 10.1007/BF02049732; Tanaka Shinji, 2013, Clin Endosc, V46, P138, DOI 10.5946/ce.2013.46.2.138; Tanaka S, 2014, GASTROENTEROL ENDOSC, V56, P1598; Ueno H, 2013, J GASTROENTEROL; Wada H, 2013, INT J CLIN ONCOL, V18, P1025, DOI 10.1007/s10147-012-0490-9; Whitlow C, 1997, DIS COLON RECTUM, V40, P929, DOI 10.1007/BF02051200; Yoshida N, 2014, J GASTROENTEROL, V49, P73, DOI 10.1007/s00535-013-0772-7	52	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		216	222		10.1111/den.12326		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400006		
J	Neumann, H; Kudo, SE; Kiesslich, R; Neurath, MF				Neumann, Helmut; Kudo, Shin-Ei; Kiesslich, Ralf; Neurath, Markus F.			Advanced colonoscopic imaging using endocytoscopy	DIGESTIVE ENDOSCOPY			English	Review						advanced endoscopic imaging; endocytoscopy; endomicroscopy; endoscopy; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; ABERRANT CRYPT FOCI; IN-VIVO; COLORECTAL NEOPLASMS; DIAGNOSTIC ABILITY; EX-VIVO; CANCER; CHROMOENDOSCOPY; ENDOSCOPY; HISTOLOGY	Optical biopsy techniques were recently introduced to luminal gastrointestinal endoscopy. These include confocal laser endomicroscopy, spectroscopic imaging techniques and endocytoscopy. Optical biopsy techniques allow on demand in vivo histology during ongoing endoscopy, thereby potentially accelerating clinical diagnosis and specific therapy. In the present review, we focus on endocytoscopy as one of the rapidly emerging optical biopsy techniques. We provide technical details of currently available endocytoscopy systems and give tips on their use in clinical practice. We also summarize applications of endocytoscopy for colorectal pathologies.	[Neumann, Helmut; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Neumann, Helmut; Neurath, Markus F.] Univ Hosp Erlangen, Ludwig Demling Endoscopy Ctr Excellence, Erlangen, Germany; [Kiesslich, Ralf] Dr Horst Schmidt Kliniken, Klin Innere Med 2, Wiesbaden, Germany; [Kudo, Shin-Ei] Showa Univ, Northern Yokohama Hosp, Digest Dis Ctr, Yokohama, Kanagawa, Japan	Neumann, H (reprint author), Univ Erlangen Nurnberg, Dept Med 1, Ulmenweg 18, D-91054 Erlangen, Germany.	helmut.neumann@uk-erlangen.de					Sasajima K, 2006, GASTROINTEST ENDOSC, V63, P1010, DOI 10.1016/j.gie.2006.01.021; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Neumann H, 2013, INFLAMM BOWEL DIS, V19, P356, DOI 10.1002/ibd.23025; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; Kwon RS, 2009, GASTROINTEST ENDOSC, V70, P610, DOI 10.1016/j.gie.2009.06.030; Tontini GE, 2013, ALIMENT PHARM THER, V38, P1198, DOI 10.1111/apt.12508; Neumann H, 2011, WORLD J GASTROENTERO, V17, P3184, DOI 10.3748/wjg.v17.i27.3184; Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; Kudo S, 2014, J GASTROEN HEPATOL, V29, P83, DOI 10.1111/jgh.12374; Rotondano G, 2010, INT J COLORECTAL DIS, V25, P1111, DOI 10.1007/s00384-010-0969-7; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Kessler WR, 2011, ENDOSCOPY, V43, P683, DOI 10.1055/s-0030-1256381; Tontini GE, 2014, EXPERT REV GASTROENT, V8, P543, DOI 10.1586/17474124.2014.899899; Bessho R, 2011, J GASTROENTEROL, V46, P1197, DOI 10.1007/s00535-011-0439-1; Mori Y, 2013, ENDOSCOPY, V45, P98, DOI 10.1055/s-0032-1325932; Kodashima S, 2006, ENDOSCOPY, V38, P1115, DOI 10.1055/s-2006-944915; Ichimasa K, 2014, DIGEST ENDOSC, V26, P403, DOI 10.1111/den.12164; Cipolletta L, 2009, ENDOSCOPY, V41, P129, DOI 10.1055/s-0028-1103452; Takayama T, 2001, GASTROENTEROLOGY, V121, P599, DOI 10.1053/gast.2001.27203; Eberl T, 2007, ENDOSCOPY, V39, P497, DOI 10.1055/s-2007-966446; Fasoli A, 2009, ENDOSCOPY, V41, P41; Haque Tanvir, 2014, Curr Gastroenterol Rep, V16, P380, DOI 10.1007/s11894-014-0380-6; Hosoe N, 2010, GASTROINTEST ENDOSC, V72, P643, DOI 10.1016/j.gie.2010.04.031; Kimura S, 2006, BIOMED RES-TOKYO, V27, P255, DOI 10.2220/biomedres.27.255; Kutsukawa M, 2014, GASTROINTEST ENDOSC, V79, P648, DOI 10.1016/j.gie.2013.08.029; Mamula P, 2011, GASTROINTEST ENDOSC, V73, P1092, DOI 10.1016/j.gie.2011.01.062; Meroni E, 2007, ENDOSCOPY, V39, P369, DOI 10.1055/s-2007-966098; Monkemuller K, 2009, CLIN GASTROENTEROL H, V7, P641, DOI 10.1016/j.cgh.2009.02.032; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Neumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058753; Neumann Helmut, 2013, Gastrointest Endosc Clin N Am, V23, P695, DOI 10.1016/j.giec.2013.03.006; Neumann H, 2011, CLIN GASTROENTEROL H, V9, P13; Neurath MF, 2010, ENDOSCOPY, V42, P314; Rastogi Amit, 2013, Clin Endosc, V46, P120, DOI 10.5946/ce.2013.46.2.120; Takayama T, 2005, CLIN GASTROENTEROL H, V3, P42; Vieth M, 2012, PATHOLOGE, V33, P215, DOI 10.1007/s00292-012-1642-4	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		232	238		10.1111/den.12395		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400008		
J	Kanno, A; Masamune, A; Shimosegawa, T				Kanno, Atsushi; Masamune, Atsushi; Shimosegawa, Tooru			Endoscopic approaches for the diagnosis of autoimmune pancreatitis	DIGESTIVE ENDOSCOPY			English	Review						endoscopic retrograde cholangiopancreatography (ERCP); endoscopic ultrasonography (EUS); EUS-guided fine-needle aspiration (EUS-FNA); immunoglobulin (Ig)G4-related disease; IgG4-related sclerosing cholangitis	PRIMARY SCLEROSING CHOLANGITIS; FINE-NEEDLE-ASPIRATION; INTERNATIONAL CONSENSUS; INTRADUCTAL ULTRASONOGRAPHY; EUS ELASTOGRAPHY; CRITERIA; FEATURES; BIOPSY; ULTRASOUND; PROPOSAL	Autoimmune pancreatitis (AIP) is characterized by diffuse pancreatic enlargement and irregular narrowing of the main pancreatic duct (MPD). Immunoglobulin (Ig)G4-related sclerosing cholangitis (IgG4-SC) associated with AIP frequently appears as a bile duct stricture. Therefore, it is important to differentiate AIP and IgG4-SC from pancreatic cancer and cholangiocarcinoma or primary sclerosing cholangitis, respectively. Endoscopy plays a central role in the diagnosis of AIP and IgG4-SC because it provides imaging of the MPD and bile duct strictures as well as the ability to obtain tissue samples for histological evaluations. Diffuse irregular narrowing of MPD on endoscopic retrograde cholangiopancreatography (ERCP) is rather specific to AIP, but localized narrowing of the MPD is often difficult to differentiate from MPD stenosis caused by pancreatic cancer. A long stricture (>1/3 the length of the MPD) and lack of upstream dilatation from the stricture (<5mm) might be key features of AIP on ERCP. Some cholangiographic features, such as segmental strictures, stric tures of the lower bile duct, and long strictures with prestenotic dilatation, are more common in IgG4-SC than in cholangiocarcinoma. Endoscopic ultrasonography (EUS) reveals diffuse hypoechoic pancreatic enlargement, sometimes with hypoechoic inclusions, in patients with AIP. In addition, EUS-elastography and contrast-enhanced harmonic EUS have been developed with promising results. The usefulness of EUS-guided fine-needle aspiration has been increasingly recognized for obtaining adequate tissue samples for the histological diagnosis of AIP. Further improvement of endoscopic procedures and devices will contribute to more accurate diagnosis of AIP and IgG4-SC.	[Kanno, Atsushi; Masamune, Atsushi; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Kanno, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	atsushih@med.tohoku.ac.jp			Japan Society for the Promotion of Science [25461020]; Research Committee of Intractable Pancreatic Disease by the Ministry of Health, Labour and Welfare of Japan	THIS WORK WAS supported in part by a Grant-in-Aid from Japan Society for the Promotion of Science (#25461020 to A. Kanno), the Research Committee of Intractable Pancreatic Disease (Principal investigators: Tooru Shimosegawa and Yoshifumi Takeyama) provided by the Ministry of Health, Labour and Welfare of Japan.	Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Kloppel G, 2003, PANCREAS, V27, P14, DOI 10.1097/00006676-200307000-00002; Fusaroli P, 2011, GASTROINTEST ENDOSC, V74, P645, DOI 10.1016/j.gie.2011.03.1246; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Okazaki K, 2014, J GASTROENTEROL, V49, P567, DOI 10.1007/s00535-014-0942-2; Sugumar A, 2009, AM J GASTROENTEROL, V104, P2308, DOI 10.1038/ajg.2009.336; Kamisawa T, 2008, GASTROINTEST ENDOSC, V68, P358, DOI 10.1016/j.gie.2008.02.018; Domagk D, 2002, GUT, V51, P240, DOI 10.1136/gut.51.2.240; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Ohara H, 2013, J GASTROEN HEPATOL, V28, P1247, DOI 10.1111/jgh.12248; Imazu H, 2012, SCAND J GASTROENTERO, V47, P853, DOI 10.3109/00365521.2012.679686; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Vosskuhl K, 2012, ENDOSCOPY, V44, P48, DOI 10.1055/s-0030-1256872; Dietrich CF, 2009, ENDOSCOPY, V41, P718, DOI 10.1055/s-0029-1214866; Mei M, 2013, GASTROINTEST ENDOSC, V77, P578, DOI 10.1016/j.gie.2012.09.035; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Wakabayashi T, 2003, AM J GASTROENTEROL, V98, P2679, DOI 10.1016/j.amjgastroenterol.2003.07.004; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Iwashita T, 2012, CLIN GASTROENTEROL H, V10, P316, DOI 10.1016/j.cgh.2011.09.032; Moon SH, 2010, GASTROINTEST ENDOSC, V71, P960, DOI 10.1016/j.gie.2009.12.004; Janssen J, 2007, GASTROINTEST ENDOSC, V65, P971, DOI 10.1016/j.gie.2006.12.057; Hocke M, 2006, WORLD J GASTROENTERO, V12, P246; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Hoki N, 2009, J GASTROENTEROL, V44, P154, DOI 10.1007/s00535-008-2294-2; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Zhang LZ, 2010, AM J SURG PATHOL, V34, P88, DOI 10.1097/PAS.0b013e3181c6c09a; Pearson RK, 2003, PANCREAS, V27, P1, DOI 10.1097/00006676-200307000-00001; Varadarajulu S, 2004, ENDOSCOPY, V36, P397, DOI 10.1055/s-2004-814316; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Nakazawa T, 2004, GASTROINTEST ENDOSC, V60, P937, DOI 10.1016/S0016-5107(04)02229-1; Naitoh I, 2009, J GASTROENTEROL, V44, P1147, DOI 10.1007/s00535-009-0108-9; Sugumar A, 2011, GUT, V60, P666, DOI 10.1136/gut.2010.207951; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Farrell JJ, 2004, GASTROINTEST ENDOSC, V60, P927, DOI 10.1016/S0016-5107(04)02230-8; Awadallah NS, 2006, AM J GASTROENTEROL, V101, P284, DOI 10.1111/j.1572-0241.2006.00383.x; Hocke M, 2011, ENDOSCOPY, V43, P163, DOI 10.1055/s-0030-1256022; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3883, DOI 10.3748/wjg.v18.i29.3883; Itoi T, 2013, J GASTROENTEROL, V48, P504, DOI 10.1007/s00535-012-0652-6; Kim KP, 2006, WORLD J GASTROENTERO, V12, P2487; Kubota K, 2014, GASTROINTEST ENDOS S, V79, pAB348; Kubota K, 2008, GASTROINTEST ENDOSC, V68, P1204, DOI 10.1016/j.gie.2008.08.013; Levy MJ, 2005, GASTROINTEST ENDOSC, V61, P467, DOI 10.1016/S0016-5107(04)02802-0; Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society, 2002, SUIZOU, V17, P585; Moon SH, 2012, GASTROINTEST ENDOSC, V76, P645, DOI 10.1016/j.gie.2012.04.458; Nakazawa T, 2006, PANCREAS, V32, P229, DOI 10.1097/01.mpa.0000202941.85955.07; Schneider A, 2009, INTERNIST, V50, P318, DOI 10.1007/s00108-008-2262-1; Sepehr A, 2008, AM J SURG PATHOL, V32, P1770, DOI 10.1097/PAS.0b013e318185490a; Okazaki K, 2012, PANCREAS, V41, P1341; Takuma K, 2011, WORLD J GASTROENTERO, V17, P2332, DOI 10.3748/wjg.v17.i18.2332; Tamada K, 2002, GUT, V50, P326, DOI 10.1136/gut.50.3.326; The Japan Pancreas Society the Ministry of Health and Welfare Investigation Research Team for Intractable Pancreatic Disease, 2012, SUIZO, V27, P17; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	57	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		250	258		10.1111/den.12343		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400010		
J	Isayama, H; Hamada, T; Yasuda, I; Itoi, T; Ryozawa, S; Nakai, Y; Kogure, H; Koike, K				Isayama, Hiroyuki; Hamada, Tsuyoshi; Yasuda, Ichiro; Itoi, Takao; Ryozawa, Shomei; Nakai, Yousuke; Kogure, Hirofumi; Koike, Kazuhiko			TOKYO criteria 2014 for transpapillary biliary stenting	DIGESTIVE ENDOSCOPY			English	Review						biliary drainage; biliary stent; biliary stricture; metallic stent; obstructive jaundice	EXPANDABLE METAL STENTS; MALIGNANT OBSTRUCTIVE-JAUNDICE; RANDOMIZED-TRIAL; COVERED WALLSTENT; BILE-DUCT; PALLIATION; MANAGEMENT; ENDOPROSTHESIS; COMPLICATIONS; METAANALYSIS	It is difficult to carry out meta-analyses or to compare the results of different studies of biliary stents because there is no uniform evaluation method. Therefore, a standardized reporting system is required. We propose a new standardized system for reporting on biliary stents, the TOKYO criteria 2014', based on a consensus among Japanese pancreatobiliary endoscopists. Instead of stent occlusion, we use recurrent biliary obstruction, which includes occlusion and migration. The time to recurrent biliary obstruction was estimated using Kaplan-Meier analysis with the log-rank test. We can evaluate both plastic and self-expandable metallic stents (uncovered and covered). We also propose specification of the cause of recurrent biliary obstruction, identification of complications other than recurrent biliary obstruction, indication of severity, measures of technical and clinical success, and a standard for clinical care. Most importantly, the TOKYO criteria 2014 allow comparison of biliary stent quality across studies. Because blocked stents can be drained not only using transpapillary techniques but also by an endoscopic ultrasonography-guided transmural procedure, we should devise an evaluation method that includes transmural stenting in the near future.	[Isayama, Hiroyuki; Hamada, Tsuyoshi; Nakai, Yousuke; Kogure, Hirofumi; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Yasuda, Ichiro] Teikyo Univ, Dept Gastroenterol, Mizonokuchi Hosp, Kawasaki, Kanagawa, Japan; [Ryozawa, Shomei] Saitama Med Univ, Dept Gastroenterol, Int Med Ctr, Hidaka, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp					Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Telford JJ, 2010, GASTROINTEST ENDOSC, V72, P907, DOI 10.1016/j.gie.2010.08.021; Isayama H, 2011, DIGEST ENDOSC, V23, P310, DOI 10.1111/j.1443-1661.2011.01124.x; Isayama H, 2009, GASTROINTEST ENDOSC, V70, P37, DOI 10.1016/j.gie.2008.09.032; Krokidis M, 2010, CARDIOVASC INTER RAD, V33, P97, DOI 10.1007/s00270-009-9604-9; Krokidis M, 2011, CARDIOVASC INTER RAD, V34, P352, DOI 10.1007/s00270-010-9880-4; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; Kullman E, 2010, GASTROINTEST ENDOSC, V72, P915, DOI 10.1016/j.gie.2010.07.036; Kahaleh M, 2005, GASTROINTEST ENDOSC, V61, P528, DOI 10.1016/S0016-5107(04)02593-3; ANDERSEN JR, 1989, GUT, V30, P1132, DOI 10.1136/gut.30.8.1132; SMITH AC, 1994, LANCET, V344, P1655, DOI 10.1016/S0140-6736(94)90455-3; Isayama H, 2004, GUT, V53, P729, DOI 10.1136/gut.2003.018945; SHEPHERD HA, 1988, BRIT J SURG, V75, P1166, DOI 10.1002/bjs.1800751207; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; SPEER AG, 1987, LANCET, V2, P57; Almadi MA, 2013, CLIN GASTROENTEROL H, V11, P27, DOI 10.1016/j.cgh.2012.10.019; Hausegger KA, 1997, CARDIOVASC INTER RAD, V20, P191, DOI 10.1007/s002709900135; Isayama H, 2002, GASTROINTEST ENDOSC, V55, P366, DOI 10.1067/mge.2002.121876; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mukai T, 2011, J HEPATO-BIL-PAN SCI, V18, P646, DOI 10.1007/s00534-011-0406-5; Nakai Y, 2005, GASTROINTEST ENDOSC, V62, P742, DOI 10.1016/j.gie.2005.06.030; Saleem A, 2011, GASTROINTEST ENDOSC, V74, P321, DOI 10.1016/j.gie.2011.03.1249; Ung KA, 2013, SCAND J GASTROENTERO, V48, P459, DOI 10.3109/00365521.2012.758766	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	JAN	2015	27	2			SI		259	264		10.1111/den.12379		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AY8NL	WOS:000347810400011		
J	Xue, L; Furusawa, Y; Okayasu, R; Miura, M; Cui, X; Liu, CH; Hirayama, R; Matsumoto, Y; Yajima, H; Yu, D				Xue, Lian; Furusawa, Yoshiya; Okayasu, Ryuichi; Miura, Masahiko; Cui, Xing; Liu, Cuihua; Hirayama, Ryoichi; Matsumoto, Yoshitaka; Yajima, Hirohiko; Yu, Dong			The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function	DNA REPAIR			English	Article						DNA double strand breaks; Complex DNA damage structure; Early G2/M checkpoint; ATR; ATM; DNA end resection	AFFECTING CELL RADIOSENSITIVITY; REPAIR PATHWAY; DAMAGE RESPONSE; IONIZING-RADIATION; G(2) CHECKPOINT; END-RESECTION; HEAVY-IONS; CHK1; ARREST; PHOSPHORYLATION	DNA double strand break (DSB) repair pathway choice following ionizing radiation (IR) is currently an appealing research topic, which is still largely unclear. Our recent paper indicated that the complexity of DSBs is a critical factor that enhances DNA end resection. It has been well accepted that the RPA-coated single strand DNA produced by resection is a signaling structure for ATR activation. Therefore, taking advantage of high linear energy transfer (LET) radiation to effectively produce complex DSBs, we investigated how the complexity of DSB influences the function of ATR pathway on the G2/M checkpoint regulation. Human skin fibroblast cells with or without ATM were irradiated with X rays or heavy ion particles, and dual-parameter flow cytometry was used to quantitatively assess the mitotic entry at early period post radiation by detecting the cells positive for phosphor histone H3. In ATM-deficient cells, ATR pathway played a pivotal role and functioned in a dose- and LET-dependent way to regulate the early G2/M arrest even as low as 0.2 Gy for heavy ion radiation, which indicated that ATR pathway could be rapidly activated and functioned in an ATM-independent, but DSB complexity-dependent manner following exposure to IR. Furthermore, ATR pathway also functioned more efficiently in ATM-proficient cells to block G2 to M transition at early period of particle radiation exposure. Accordingly, in contrast to ATM inhibitor, ATR inhibitor had a more effective radiosensitizing effect on survival fraction following heavy ion beams as compared with X ray radiation. Taken together, our results reveal that the complexity of DSBs is a crucial factor for the activation of ATR pathway for G2/M checkpoint regulation, and ATM-dependent end resection is not essential for the activation. (C) 2014 Elsevier B.V. All rights reserved.	[Xue, Lian] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China; [Xue, Lian] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China; [Furusawa, Yoshiya; Cui, Xing; Liu, Cuihua; Hirayama, Ryoichi; Matsumoto, Yoshitaka; Yajima, Hirohiko] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan; [Okayasu, Ryuichi] Natl Inst Radiol Sci, Int Open Lab, Chiba 2638555, Japan; [Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Restitut, Tokyo, Japan; [Yu, Dong] Soochow Univ, Coll Med, Sch Radiol Med & Protect, Suzhou, Peoples R China	Yajima, H (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	hyajima@nirs.go.jp; yudong@suda.edu.cn			National Natural Science Foundation of China [81102076, 11475125]; Universities Natural Science Foundation of Jiangsu Province [BK20131165]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Scientific Research Foundation for Returned Scholars, Soochow University [Q412600711]; JSPS KAKENHI [24249067]	We thank Dr. Bing Wang, Dr. Yasuharu Ninomiya, Dr. Akira Fujimori, Dr. Masao Suzuki, Dr. Hiroshi Fujisawa, Dr. Ayako Kariya and Dr. Huizi Li for technical help. This work was supported by 'National Natural Science Foundation of China (No. 81102076)', 'National Natural Science Foundation of China (No. 11475125)', 'Universities Natural Science Foundation of Jiangsu Province (No. BK20131165)', 'Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)', 'Scientific Research Foundation for Returned Scholars, Soochow University (No. Q412600711)' and JSPS KAKENHI no. 24249067.	Van C, 2010, J CELL BIOL, V189, P233, DOI 10.1083/jcb.200909105; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Krempler A, 2007, CELL CYCLE, V6, P1682; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Xue L, 2009, MUTAT RES-FUND MOL M, V670, P15, DOI 10.1016/j.mrfmmm.2009.06.016; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Xue L, 2009, INT J RADIAT ONCOL, V75, P235, DOI 10.1016/j.ijrobp.2009.04.088; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Okayasu R, 2012, INT J CANCER, V130, P991, DOI 10.1002/ijc.26445; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Sarkaria JN, 1999, CANCER RES, V59, P4375; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; den Elzen N, 2004, CELL CYCLE, V3, P529; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Gupta A., 2013, RADIAT RES, V181, P1; Kobayashi M, 2013, GENES CELLS, V18, P238, DOI 10.1111/gtc.12031; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Li S, 2000, NATURE, V406, P210; Lobrich M, 2011, CURR CANCER RES, P53, DOI 10.1007/978-1-4419-8044-1_3; Saha J, 2013, DNA REPAIR, V12, P1143, DOI 10.1016/j.dnarep.2013.10.004; Wang HY, 2005, CELL CYCLE, V4, P300; Wang HY, 2008, CELL CYCLE, V7, P2444; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986	49	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	JAN	2015	25						72	83		10.1016/j.dnarep.2014.11.004		12	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AY9KA	WOS:000347867600008		
J	Hossain, A; Yamaguchi, F; Hirose, K; Matsunaga, T; Sui, L; Hirata, Y; Noguchi, C; Katagi, A; Kamitori, K; Dong, Y; Tsukamoto, I; Tokuda, M				Hossain, Akram; Yamaguchi, Fuminori; Hirose, Kayoko; Matsunaga, Toru; Sui, Li; Hirata, Yuko; Noguchi, Chisato; Katagi, Ayako; Kamitori, Kazuyo; Dong, Youyi; Tsukamoto, Ikuko; Tokuda, Masaaki			Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						rare sugar D-psicose; OLETF rats; type 2 diabetes mellitus; insulin resistance; adiposity; beta-islet preservation	FASTING PLASMA-GLUCOSE; PANCREATIC BETA-CELL; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; OLETF; HYPERGLYCEMIA; INTERLEUKIN-6; DYSLIPIDEMIA	Background: The fundamental cause of overweight and obesity is consumption of calorie-dense foods. We have introduced a zero-calorie sweet sugar, D-psicose (D-allulose), a rare sugar that has been proven to have strong antihyperglycemic and antihyperlipidemic effects, and could be used as a replacement of natural sugar for the obese and diabetic subjects. Aim: Above mentioned efficacy of D-psicose (D-allulose) has been confirmed in our previous studies on type 2 diabetes mellitus (T2DM) model Otsuka Long-Evans Tokushima Fatty (OLETF) rats with short-term treatment. In this study we investigated the long-term effect of D-psicose in preventing the commencement and progression of T2DM with the mechanism of preservation of pancreatic beta-cells in OLETF rats. Methods: Treated OLETF rats were fed 5% D-psicose dissolved in water and control rats only water. Nondiabetic control rats, Long-Evans Tokushima Otsuka (LETO), were taken as healthy control and fed water. To follow the progression of diabetes, periodic measurements of blood glucose, plasma insulin, and body weight changes were continued till sacrifice at 60 weeks. Periodic in vivo body fat mass was measured. On sacrifice, pancreas, liver, and abdominal adipose tissues were collected for various staining tests. Results: D-Psicose prevented the commencement and progression of T2DM till 60 weeks through the maintenance of blood glucose levels, decrease in body weight gain, and the control of postprandial hyperglycemia, with decreased levels of HbA(1c) in comparison to nontreated control rats. This improvement in glycemic control was accompanied by the maintenance of plasma insulin levels and the preservation of pancreatic beta-cells with the significant reduction in inflammatory markers. Body fat accumulation was significantly lower in the treatment group, with decreased infiltration of macrophages in the abdominal adipose tissue. Conclusion: Our findings suggest that the rare sugar D-psicose could be beneficial for the prevention and control of obesity and hyperglycemia with the preservation of beta-cells in the progression of T2DM.	[Hossain, Akram; Yamaguchi, Fuminori; Hirose, Kayoko; Sui, Li; Hirata, Yuko; Noguchi, Chisato; Katagi, Ayako; Kamitori, Kazuyo; Dong, Youyi; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Hossain, Akram] Matsutani Chem Ind Co Ltd, Res & Dev, Itami, Hyogo, Japan; [Matsunaga, Toru] Kagawa Univ, Fac Med, Div Hosp Pathol, Miki, Kagawa 7610793, Japan; [Tsukamoto, Ikuko] Kagawa Univ, Fac Med, Dept Pharmacobioinformat, Miki, Kagawa 7610793, Japan	Hossain, A (reprint author), Kagawa Univ, Fac Med, Dept Cell Physiol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hossain@med.kagawa-u.ac.jp					Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Lee E, 2011, BIOCHEM BIOPH RES CO, V414, P397, DOI 10.1016/j.bbrc.2011.09.087; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Aksoy N, 2003, CELL BIOCHEM FUNCT, V21, P121, DOI 10.1002/cbf.1006; Murao K, 2007, LIFE SCI, V81, P592, DOI 10.1016/j.lfs.2007.06.019; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Hossain MA, 2011, BIOCHEM BIOPH RES CO, V405, P7, DOI 10.1016/j.bbrc.2010.12.091; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Baek SH, 2010, J FOOD SCI, V75, pH49, DOI 10.1111/j.1750-3841.2009.01434.x; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77; Matsuo T, 2001, ASIA PAC J CLIN NUTR, V10, P233, DOI 10.1046/j.1440-6047.2001.00246.x; Bavarva JH, 2008, PHYTOTHER RES, V22, P620, DOI 10.1002/ptr.2302; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Izumori K, 2006, J BIOTECHNOL, V124, P717, DOI 10.1016/j.jbiotec.2006.04.016; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Hossain A, 2012, BIOCHEM BIOPH RES CO, V425, P717, DOI 10.1016/j.bbrc.2012.07.135; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Shin A, 2009, J AM DIET ASSOC, V109, P633, DOI 10.1016/j.jada.2008.12.015; Toyoda Y, 2000, ARCH HISTOL CYTOL, V63, P243, DOI 10.1679/aohc.63.243; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Murata A, 2003, J BIOSCI BIOENG, V96, P89, DOI 10.1016/S1389-1723(03)90104-6; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Moon JR, 2009, CLIN NUTR, V28, P516, DOI 10.1016/j.clnu.2009.04.025; Avignon A, 1997, DIABETES CARE, V20, P1822, DOI 10.2337/diacare.20.12.1822; Hishiike T, 2013, J AGR FOOD CHEM, V61, P7381, DOI 10.1021/jf401449m; Bell SJ, 2002, CRIT REV FOOD SCI, V42, P163, DOI 10.1080/10408690290825501; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Du H, 2009, AM J CLIN NUTR, V91, P329; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; LARSSON B, 1984, BRIT MED J, V288, P1401; Matsuo T., 2006, Technical Bulletin of the Faculty of Agriculture, Kagawa University, V58, P27; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Ohkita M, 2011, J PHARMACOL SCI, V115, P461, DOI 10.1254/jphs.10R37FM; Otani M, 2010, BRIT J PHARMACOL, V159, P462, DOI 10.1111/j.1476-5381.2009.00548.x; Suna S, 2007, TOXICOL LETT, V173, P107, DOI 10.1016/j.toxlet.2007.06.015; Woo V, 2008, INT J CLIN PRACT, V62, P1935, DOI 10.1111/j.1742-1241.2008.01941.x	47	2	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2015	9						525	535		10.2147/DDDT.S71289		11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ0BC	WOS:000347910500001		
J	Mizokami, F; Mizuno, T				Mizokami, Fumihiro; Mizuno, Tomohiro			Acute Kidney Injury Induced by Antimicrobial Agents in the Elderly: Awareness and Mitigation Strategies	DRUGS & AGING			English	Article							ACUTE INTERSTITIAL NEPHRITIS; ACUTE-RENAL-FAILURE; VANCOMYCIN-INDUCED NEPHROTOXICITY; GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; INFECTIOUS-DISEASES-SOCIETY; AMINOGLYCOSIDE-ASSOCIATED NEPHROTOXICITY; STAPHYLOCOCCUS-AUREUS BACTEREMIA; CLINICAL-PRACTICE GUIDELINES; INVASIVE FUNGAL-INFECTIONS	The use of antimicrobial agents has increased in recent years as treatments have diversified and resistant bacteria have appeared. With increased use of antimicrobial agents, elderly patients are prone to adverse drug reactions (ADRs) as a result of factors such as drug-drug interactions, polypharmacy, long-term use, and over- or under-dosage. In particular, elderly patients using antimicrobials are at increased risk to develop drug-induced acute kidney injury (AKI), which is the most common severe ADR in such patients. AKI is a serious problem that is associated with mortality amongst hospitalized patients. Antimicrobial-induced AKI can be classified into three different types: acute tubular necrosis (ATN), acute interstitial nephritis (AIN), and renal tubule lumen obstruction. AKI can generally be prevented by proper maintenance of fluid balance. To design dosage regimens that ensure efficient drug excretion via the kidney, it is necessary to accurately estimate renal function; however, the kidney undergoes age-dependent structural and functional alterations over time. Therefore, proper management of antimicrobial agents by an antimicrobial stewardship team may lead to decreased incidence of AKI. This article reviews antimicrobial-induced AKI and discusses potential strategies for increasing awareness of AKI and mitigating its clinical effects.	[Mizokami, Fumihiro] Natl Ctr Geriatr & Gerontol, Dept Pharm, Obu, Aichi 4748511, Japan; [Mizuno, Tomohiro] Meijo Univ, Grad Sch Pharm, Nagoya, Aichi, Japan	Mizokami, F (reprint author), Natl Ctr Geriatr & Gerontol, Dept Pharm, 430 Morioka Cho, Obu, Aichi 4748511, Japan.	mizokami@ncgg.go.jp					ALLON M, 1990, ARCH INTERN MED, V150, P2187, DOI 10.1001/archinte.150.10.2187; America SfHEo America IDSo, 2012, POLICY STATEMENT, V33, P322; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Elyasi S, 2013, EUR J CLIN PHARMACOL, V69, P747, DOI 10.1007/s00228-012-1406-3; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Michail S, 1998, SCAND J RHEUMATOL, V27, P233; Fogazzi GB, 1996, NEPHROL DIAL TRANSPL, V11, P379; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; BUTLER WT, 1964, ANN INTERN MED, V61, P175; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278; Lombardi R, 2003, RENAL FAILURE, V25, P775, DOI 10.1081/JDI-120024293; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; WALKER RJ, 1988, ANNU REV PHARMACOL, V28, P331; SCHAFERKORTING M, 1993, CLIN PHARMACOKINET, V25, P329; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P1330, DOI 10.1128/AAC.01602-07; Obialo CI, 2002, J NATL MED ASSOC, V94, P127; Boyd CM, 2008, AGING CLIN EXP RES, V20, P181; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Singh N P, 2003, J Assoc Physicians India, V51, P970; Vandecasteele SJ, 2010, KIDNEY INT, V77, P760, DOI 10.1038/ki.2010.35; Finfer S, 2004, NEW ENGL J MED, V350, P2247; LINDEMAN RD, 1986, EXP GERONTOL, V21, P379, DOI 10.1016/0531-5565(86)90044-6; Nigwekar SU, 2009, CLIN J AM SOC NEPHRO, V4, P261, DOI 10.2215/CJN.03780808; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Lodise TP, 2009, CLIN INFECT DIS, V49, P507, DOI 10.1086/600884; CARLSON MA, 1994, J AM COLL SURGEONS, V179, P361; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; ROWE JW, 1976, J GERONTOL, V31, P155; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650; Mizokami F, 2013, CLIN INTERV AGING, V8, P1015, DOI 10.2147/CIA.S50238; Prakash J, 2001, J Assoc Physicians India, V49, P877; Kubin CJ, 2012, J INFECTION, V65, P80, DOI 10.1016/j.jinf.2012.01.015; Perazella MA, 2003, AM J MED SCI, V325, P349, DOI 10.1097/00000441-200306000-00006; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Beck LH, 1998, CLIN GERIATR MED, V14, P199; TULKENS PM, 1989, TOXICOL LETT, V46, P107, DOI 10.1016/0378-4274(89)90121-5; Jeffres MN, 2007, CLIN THER, V29, P1107, DOI 10.1016/j.clinthera.2007.06.014; Toyoguchi T, 1997, ANTIMICROB AGENTS CH, V41, P1985; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; HO PWL, 1979, ANN INTERN MED, V91, P227; Cetin H, 2007, CLIN EXP PHARMACOL P, V34, P1181, DOI 10.1111/j.1440-1681.2007.04695.x; Baciewicz AM, 2003, ANN PHARMACOTHER, V37, P182; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; van Hal SJ, 2013, ANTIMICROB AGENTS CH, V57, P734, DOI 10.1128/AAC.01568-12; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Shen WC, 2011, NEPHROLOGY, V16, P697, DOI 10.1111/j.1440-1797.2011.01488.x; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Celik I, 2005, BASIC CLIN PHARMACOL, V97, P325, DOI 10.1111/j.1742-7843.2005.pto_153.x; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945; ECK P, 1991, NEW ENGL J MED, V325, P1178; Zappitelli M, 2011, NEPHROL DIAL TRANSPL, V26, P144, DOI 10.1093/ndt/gfq375; Girois SB, 2006, EUR J CLIN MICROBIOL, V25, P138, DOI 10.1007/s10096-005-0080-0; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Qiao X, 2005, J GERONTOL A-BIOL, V60, P830; Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI 10.1093/cid/ciq257; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003; Cantarovich F, 2004, AM J KIDNEY DIS, V44, P402, DOI 10.1053/j.ajkd.2004.05.021; Nakamura T, 2009, SHOCK, V31, P454, DOI 10.1097/SHK.0b013e3181891131; Pathak A, 1998, CLIN INFECT DIS, V26, P334, DOI 10.1086/516321; Oktem F, 2005, TOXICOLOGY, V215, P227, DOI 10.1016/j.tox.2005.07.009; SALTISSI D, 1979, BRIT MED J, V2, P50; Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Dupont B, 2002, J ANTIMICROB CHEMOTH, V49, P31; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Slaughter RL, 1998, PHARMACOECONOMICS, V14, P385, DOI 10.2165/00019053-199814040-00005; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Horey A, 2012, ANN PHARMACOTHER, V46, P1477, DOI 10.1345/aph.1R158; Millan X, 2014, CANCER TREAT RES, V161, P413, DOI 10.1007/978-3-319-04220-6_14; Traunmuller F, 2011, PHARMACOLOGY, V88, P213, DOI 10.1159/000331860; Barreto R, 2014, J HEPATOL, V61, P35, DOI 10.1016/j.jhep.2014.02.023; MCCORMACK JP, 1992, CLIN INFECT DIS, V14, P320; Linden P, 2000, CLIN TRANSPLANT, V14, P329, DOI 10.1034/j.1399-0012.2000.140409.x; Boswell GW, 1998, J CLIN PHARMACOL, V38, P583; XU XO, 1995, ENDOCRINOLOGY, V136, P4551, DOI 10.1210/en.136.10.4551; Minejima E, 2011, ANTIMICROB AGENTS CH, V55, P3278, DOI 10.1128/AAC.00173-11; Kelly AM, 2008, ANN INTERN MED, V148, P284; MOORE RD, 1984, ANN INTERN MED, V100, P352; Friedrich JO, 2005, ANN INTERN MED, V142, P510; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Wheeler DS, 2008, CRIT CARE MED, V36, P1297, DOI 10.1097/CCM.0b013e318169245a; VERBRUGGE LM, 1989, MILBANK Q, V67, P450, DOI 10.2307/3350223; Covic A, 1998, NEPHROL DIAL TRANSPL, V13, P924, DOI 10.1093/ndt/13.4.924; Wong-Beringer A, 2011, INT J ANTIMICROB AG, V37, P95, DOI 10.1016/j.ijantimicag.2010.10.013; Portilla D, 2003, SEMIN NEPHROL, V23, P432, DOI 10.1016/S0270-9295(03)00088-3; SMITH EJ, 1980, JAMA-J AM MED ASSOC, V244, P360, DOI 10.1001/jama.244.4.360; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI 10.1007/s00134-012-2769-8; Chen SCA, 2007, MED J AUSTRALIA, V187, P404; Dresser GK, 2000, CLIN PHARMACOKINET, V38, P41, DOI 10.2165/00003088-200038010-00003; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; RECKELHOFF JF, 1993, AM J PHYSIOL, V265, pR1126; SIMONSEN O, 1985, SCAND J CLIN LAB INV, V45, P97, DOI 10.3109/00365518509160980; TAUCHI H, 1971, GERONTOLOGY, V17, P87; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bagshaw Sean M, 2007, Crit Care Resusc, V9, P60; BAILEY JR, 1992, AM J NEPHROL, V12, P271, DOI 10.1159/000168458; Barza M, 1996, BRIT MED J, V312, P338; BEAN B, 1985, J INFECT DIS, V151, P362; Borthwick E, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3365; Boyer A, 2013, DRUG SAFETY, V36, P217, DOI 10.1007/s40264-013-0031-0; Cappelletty D, 2013, AM J HEALTH-SYST PH, V70, P1065, DOI 10.2146/ajhp120482; Chou JS, 1997, ANN CLIN LAB SCI, V27, P116; CODDING CE, 1989, AM J KIDNEY DIS, V14, P512; DARMADY EM, 1973, J PATHOL, V109, P195, DOI 10.1002/path.1711090304; De Vriese AS, 1998, AM J KIDNEY DIS, V31, P108, DOI 10.1053/ajkd.1998.v31.pm9428460; DOUGLAS JB, 1969, AM J MED, V46, P154, DOI 10.1016/0002-9343(69)90067-9; EPSTEIN M, 1979, FED PROC, V38, P168; Feely J, 1990, Clin Geriatr Med, V6, P269; GOURTSOYIANNIS N, 1990, AM J ROENTGENOL, V155, P541; Haase M, 2008, CRIT CARE, V12, DOI 10.1186/cc6972; Hatala R, 1996, ANN INTERN MED, V124, P717; Hazlewood KA, 2010, AM J MED, V123; Hodoshima Naoko, 2004, Drug Metab Pharmacokinet, V19, P68, DOI 10.2133/dmpk.19.68; HOLLENBE.NK, 1974, CIRC RES, V34, P309; Hung CC, 2006, NEPHROL DIAL TRANSPL, V21, P237, DOI 10.1093/ndt/gfi178; Ingram PR, 2008, J ANTIMICROB CHEMOTH, V62, P168, DOI 10.1093/jac/dkn080; Khalili Hossein, 2013, Acta Med Iran, V51, P871; Kleinknecht D, 1977, CONTRIB NEPHROL, V10, P42; Lim S, 2003, RENAL FAILURE, V25, P647, DOI 10.1081/JDI-120022557; LINDEMAN RD, 1992, DRUG AGING, V2, P423; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; LINTON AL, 1980, ANN INTERN MED, V93, P735; Lipsky BA, 2012, CLIN INFECT DIS, V54; Liu C, 2011, CLIN INFECT DIS; Martin Jennifer H, 2010, Clin Biochem Rev, V31, P21; Meaney CJ, 2014, PHARMACOTHERAPY; MEYER BR, 1989, J AM GERIATR SOC, V37, P791; Mizokami F, 2012, AM J GERIATR PHARMAC, V10, P123, DOI 10.1016/j.amjopharm.2012.02.003; Mylotte JM, 1999, AM J INFECT CONTROL, V27, P10, DOI 10.1016/S0196-6553(99)70069-6; Nicolle LE, 1996, CLIN MICROBIOL REV, V9, P1; Nielsen Erik Waage, 2004, Tidsskr Nor Laegeforen, V124, P2907; Okamoto G, 2007, CLIN BIOCHEM, V40, P485, DOI 10.1016/j.clinbiochem.2007.01.008; PATTERSO.RM, 1971, ARCH INTERN MED, V127, P241, DOI 10.1001/archinte.127.2.241; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Pereira Jose M, 2013, Curr Clin Pharmacol, V8, P25; Pestotnik SL, 1996, ANN INTERN MED, V124, P884; Plakogiannis R, 2007, PHARMACOTHERAPY, V27, P1456, DOI 10.1592/phco.27.10.1456; POOLE G, 1971, Postgraduate Medical Journal, V47, P742; Prowle JR, 2010, NAT REV NEPHROL, V6, P521, DOI 10.1038/nrneph.2010.100; Reece RJ, 1996, NEPHROL DIAL TRANSPL, V11, P393; Rosenberg IH, 1997, J NUTR, V127, pS990; ROWE JW, 1976, NEPHRON, V17, P270, DOI 10.1159/000180731; SAWYER MH, 1988, AM J MED, V84, P1067, DOI 10.1016/0002-9343(88)90313-0; SCHENTAG JJ, 1981, ANTIMICROB AGENTS CH, V19, P859; Sierra P, 1997, Rev Esp Anestesiol Reanim, V44, P383; Stavreva G., 2008, Trakia Journal of Sciences, V6, P7; Stewart J, 2009, ADDING INSULT INJURY; Strausbaugh L J, 2000, J Am Med Dir Assoc, V1, P62; Streetman D S, 2000, Crit Care Nurs Q, V22, P1; Streetman DS, 2001, PHARMACOTHERAPY, V21, P443, DOI 10.1592/phco.21.5.443.34490; Tanaka A, 2007, THER DRUG MONIT, V29, P261, DOI 10.1097/FTD.0b013e31803bcfd2; Tran KT, 2003, EXP CELL RES, V289, P359, DOI 10.1016/S0014-4827(03)00287-8; Wai AO, 1998, ANN PHARMACOTHER, V32, P1160, DOI 10.1345/aph.17448	168	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1170-229X	1179-1969		DRUG AGING	Drugs Aging	JAN	2015	32	1					1	12		10.1007/s40266-014-0232-y		12	Geriatrics & Gerontology; Pharmacology & Pharmacy	Geriatrics & Gerontology; Pharmacology & Pharmacy	AY8NN	WOS:000347810600001		
J	Iizuka, T; Yamaguchi, A; Haba, MK; Amelin, Y; Holden, P; Zink, S; Huyskens, MH; Ireland, TR				Iizuka, Tsuyoshi; Yamaguchi, Akira; Haba, Makiko K.; Amelin, Yuri; Holden, Peter; Zink, Sonja; Huyskens, Magdalena H.; Ireland, Trevor R.			Timing of global crustal metamorphism on Vesta as revealed by high-precision U-Pb dating and trace element chemistry of eucrite zircon	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						HED meteorites; meteorite zircon; U-Pb dating; oxygen fugacity; Ti-thermometry	TI-IN-ZIRCON; EARLY SOLAR-SYSTEM; HIGH-TEMPERATURE METAMORPHISM; IVREA-VERBANO ZONE; PARENT BODY; BASALTIC EUCRITES; AGE-DETERMINATION; THERMAL HISTORY; MN-53-CR-53 SYSTEMATICS; MASS-SPECTROMETRY	Non-cumulate eucrites represent basaltic crust that experienced a complex thermal history involving multistage metamorphism and metasomatism, probably on asteroid Vesta. To better constrain the thermal history of these rocks and their parent body, we have integrated high-precision U-Pb age and trace element data for zircon grains with sizes up to 80 jam in the eucrite Agoult. All analyzed zircon grains yielded concordant U-Pb dates that correspond to the precise Pb-207/Pb-206 age of 4554.5 +/- 2.0 Ma. The Ti contents in these zircon grains indicate their crystallization at subsolidus temperatures of ca. 900 degrees C, which are similar to the inferred conditions of pyroxene exsolution in most basaltic eucrites that occurred during protracted thermal metamorphism. The zircon crystallization temperatures, together with the presence of baddeleyite needles and variable Zr concentration in Agoult ilmenite grains, indicate metamorphic origin of the Agoult zircon through Zr release from ilmenite followed by reaction with silica. We therefore consider the zircon Pb-207/Pb-206 age as the timing of the widespread thermal metamorphism in Vesta's crust. The metamorphic age is coincident with the oldest Mn-Cr date for cumulate eucrites, supporting the view that the thermal metamorphism is a result of burial of basaltic crust and subsequent heating from the hot interior rather than collision of asteroids. The zircon rare earth element patterns with restricted Ce positive anomalies suggest that the metamorphism occurred at an oxygen fugacity below the iron-wastite buffer, implying the absence of oxidizing agents such as aqueous fluid within the crust at that time. (C) 2014 Elsevier B.V. All rights reserved.	[Iizuka, Tsuyoshi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Iizuka, Tsuyoshi; Amelin, Yuri; Holden, Peter; Zink, Sonja; Huyskens, Magdalena H.; Ireland, Trevor R.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Yamaguchi, Akira; Haba, Makiko K.] Natl Inst Polar Res, Tokyo, Japan; [Yamaguchi, Akira] Grad Univ Adv Sci, Sch Multidisciplinary Sci, Dept Polar Sci, Tokyo, Japan	Iizuka, T (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Hongo 7-3-1,Bunkyo, Tokyo 1130033, Japan.	iizuka@eps.s.u-tokyo.ac.jp	Iizuka, Tsuyoshi/E-5332-2010; Ireland, Trevor/A-4993-2008	Ireland, Trevor/0000-0001-7617-3889	Australian Research Council [DP109514]; Japan Society for the Promotion of Science [23840013]; Overseas Internship Program for Outstanding Young Earth and Planetary Researchers from the University of Tokyo	We are grateful to J. Avila, H. Yoshida and A. Okubo for analytical support and I. Williams and D. Rubatto for assistance with sample preparation. This work is financed by the Australian Research Council (Discovery Grant and Australian Postdoctoral Fellowship DP109514) and the Japan Society for the Promotion of Science (Grant #23840013). T.I. acknowledges supports by Overseas Internship Program for Outstanding Young Earth and Planetary Researchers from the University of Tokyo.	Amelin Y, 2008, GEOCHIM COSMOCHIM AC, V72, P221, DOI 10.1016/j.gca.2007.09.034; CLAYTON RN, 1976, EARTH PLANET SC LETT, V30, P10, DOI 10.1016/0012-821X(76)90003-0; METZLER K, 1995, PLANET SPACE SCI, V43, P499, DOI 10.1016/0032-0633(94)00219-H; Cherniak DJ, 2003, REV MINERAL GEOCHEM, V53, P113, DOI 10.2113/0530113; Kleine T, 2005, EARTH PLANET SC LETT, V231, P41, DOI 10.1016/j.epsl.2004.12.016; Grange ML, 2011, GEOCHIM COSMOCHIM AC, V75, P2213, DOI 10.1016/j.gca.2011.01.036; Hiess J, 2008, CHEM GEOL, V247, P323, DOI 10.1016/j.chemgeo.2007.10.012; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Taylor DJ, 2009, EARTH PLANET SC LETT, V279, P157, DOI 10.1016/j.epsl.2008.12.030; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Hirata T, 2001, CHEM GEOL, V176, P323, DOI 10.1016/S0009-2541(00)00370-3; NYQUIST LE, 1986, J GEOPHYS RES-SOLID, V91, P8137, DOI 10.1029/JB091iB08p08137; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; Srinivasan G, 2007, SCIENCE, V317, P345, DOI 10.1126/science.1140264; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Shearer CK, 2012, GEOCHIM COSMOCHIM AC, V83, P138, DOI 10.1016/j.gca.2011.11.031; Trail D, 2012, GEOCHIM COSMOCHIM AC, V97, P70, DOI 10.1016/j.gca.2012.08.032; Yamaguchi A, 2001, GEOCHIM COSMOCHIM AC, V65, P3577, DOI 10.1016/S0016-7037(01)00681-0; Zhou Q, 2013, GEOCHIM COSMOCHIM AC, V110, P152, DOI 10.1016/j.gca.2013.02.016; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Boyet M, 2010, EARTH PLANET SC LETT, V291, P172, DOI 10.1016/j.epsl.2010.01.010; Hayden LA, 2007, EARTH PLANET SC LETT, V258, P561, DOI 10.1016/j.epsl.2007.04.020; Valley JW, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-013-0956-4; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5; Glavin DP, 2004, METEORIT PLANET SCI, V39, P693; Kleine T, 2012, GEOCHIM COSMOCHIM AC, V84, P186, DOI 10.1016/j.gca.2012.01.032; Righter K, 1997, METEORIT PLANET SCI, V32, P929; Fu B, 2009, CHEM GEOL, V259, P131, DOI 10.1016/j.chemgeo.2008.10.035; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; JUREWICZ AJG, 1993, GEOCHIM COSMOCHIM AC, V57, P2123, DOI 10.1016/0016-7037(93)90098-H; DUKE MB, 1967, GEOCHIM COSMOCHIM AC, V31, P1637, DOI 10.1016/0016-7037(67)90112-3; Ickert RB, 2011, CONTRIB MINERAL PETR, V162, P447, DOI 10.1007/s00410-010-0605-0; Iizuka T, 2014, GEOCHIM COSMOCHIM AC, V132, P259, DOI 10.1016/j.gca.2014.02.017; Wiedenbeck M, 2004, GEOSTAND GEOANAL RES, V28, P9, DOI 10.1111/j.1751-908X.2004.tb01041.x; Burnham AD, 2012, GEOCHIM COSMOCHIM AC, V95, P196, DOI 10.1016/j.gca.2012.07.034; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Barrat JA, 2011, GEOCHIM COSMOCHIM AC, V75, P3839, DOI 10.1016/j.gca.2011.04.013; Bogard DD, 2003, METEORIT PLANET SCI, V38, P669; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Tera F, 1997, GEOCHIM COSMOCHIM AC, V61, P1713, DOI 10.1016/S0016-7037(97)00018-5; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; GHENT ED, 1984, CONTRIB MINERAL PETR, V86, P248, DOI 10.1007/BF00373670; Drake MJ, 2001, METEORIT PLANET SCI, V36, P501; Yamaguchi A, 1996, ICARUS, V124, P97, DOI 10.1006/icar.1996.0192; Yamaguchi A, 2013, EARTH PLANET SC LETT, V368, P101, DOI 10.1016/j.epsl.2013.02.036; Hoskin PWO, 2000, GEOLOGY, V28, P627, DOI 10.1130/0091-7613(2000)28<627:REECOZ>2.0.CO;2; McSween HY, 2013, METEORIT PLANET SCI, V48, P2090, DOI 10.1111/maps.12108; Bouvier A, 2011, GEOCHIM COSMOCHIM AC, V75, P5310, DOI 10.1016/j.gca.2011.06.033; Baldwin JA, 2008, J METAMORPH GEOL, V26, P213, DOI 10.1111/j.1525-1314.2007.00759.x; Brennecka GA, 2012, P NATL ACAD SCI USA, V109, P9299, DOI 10.1073/pnas.1114043109; Bingen B, 2001, J PETROL, V42, P355, DOI 10.1093/petrology/42.2.355; Cavosie AJ, 2006, GEOCHIM COSMOCHIM AC, V70, P5601, DOI 10.1016/j.gca.2006.08.011; Fu B, 2008, CONTRIB MINERAL PETR, V156, P197, DOI 10.1007/s00410-008-0281-5; Misawa K, 2005, GEOCHIM COSMOCHIM AC, V69, P5847, DOI 10.1016/j.gca.2005.08.009; Connelly JN, 2012, SCIENCE, V338, P651, DOI 10.1126/science.1226919; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; Nemchin A, 2009, NAT GEOSCI, V2, P133, DOI 10.1038/NGEO417; Yamaguchi A, 2009, GEOCHIM COSMOCHIM AC, V73, P7162, DOI 10.1016/j.gca.2009.07.037; Cassata WS, 2009, GEOCHIM COSMOCHIM AC, V73, P6600, DOI 10.1016/j.gca.2009.07.017; Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825; Watson EB, 2005, SCIENCE, V308, P841, DOI 10.1126/science.1110873; Barrat JA, 2003, GEOCHIM COSMOCHIM AC, V67, P3959, DOI 10.1016/S0016-7037(00)00092-9; Ferriss EDA, 2008, EUR J MINERAL, V20, P745, DOI 10.1127/0935-1221/2008/0020-1860; Clenet H, 2014, NATURE, V511, P303, DOI 10.1038/nature13499; TAKEDA H, 1985, J GEOPHYS RES, V90, pC636; Burbine TH, 2001, METEORIT PLANET SCI, V36, P761; Charlier B, 2007, CONTRIB MINERAL PETR, V154, P119, DOI 10.1007/s00410-007-0186-8; Claoue-Long J.C., 1995, GEOCHRONOLOGY TIME S, V54, P3; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; El Goresy A., 1975, P LUN SCI C, V6, P729; Ewing TA, 2013, CONTRIB MINERAL PETR, V165, P757, DOI 10.1007/s00410-012-0834-5; Harlov DE, 2002, J PETROL, V43, P769, DOI 10.1093/petrology/43.5.769; Haba MK, 2014, EARTH PLANET SC LETT, V387, P10, DOI 10.1016/j.epsl.2013.11.006; Huyskens MH, 2012, J ANAL ATOM SPECTROM, V27, P1439, DOI 10.1039/c2ja30083d; Iizuka T., 2013, 44 LUN PLAN SCI C; Ireland T.R., 2003, GEOCHIM COSMOCHIM AC, V132, P259; Ireland T.R., 1992, METEORITICS, V27, P273; Kaltenbach A., 2013, THESIS U OTAGO; KUNZ J, 1995, PLANET SPACE SCI, V43, P527, DOI 10.1016/0032-0633(94)00137-G; Larson H.P., 1975, ICARUS, V20, P213; MANHES G, 1984, GEOCHIM COSMOCHIM AC, V48, P2247, DOI 10.1016/0016-7037(84)90221-7; MCSWEEN HY, 1993, GEOCHIM COSMOCHIM AC, V57, P1105, DOI 10.1016/0016-7037(93)90044-W; MIYAMOTO M, 1977, GEOCHEM J, V11, P161; MIYAMOTO M, 1994, EARTH PLANET SC LETT, V122, P343, DOI 10.1016/0012-821X(94)90007-8; Morisset CE, 2008, CAN MINERAL, V46, P289, DOI 10.3749/canmin.46.2.289; NASLUND HR, 1987, CAN MINERAL, V25, P91; Nyquist L, 1997, GEOCHIM COSMOCHIM AC, V61, P2119, DOI 10.1016/S0016-7037(97)00059-8; PALME H, 1988, METEORITICS, V23, P49; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Roszjar J, 2011, METEORIT PLANET SCI, V46, P1754, DOI 10.1111/j.1945-5100.2011.01265.x; Roszjar J, 2014, CHEM ERDE-GEOCHEM, V74, P453, DOI 10.1016/j.chemer.2014.05.002; Roszjar J., 2012, 43 LUN PLAN SCI C; Schiller M, 2010, GEOCHIM COSMOCHIM AC, V74, P4844, DOI 10.1016/j.gca.2010.05.011; Schwartz JM, 2005, AM MINERAL, V90, P1871, DOI 10.2138/am.2005.1733; Shukolyukov A, 1996, GEOCHIM COSMOCHIM AC, V60, P2453, DOI 10.1016/0016-7037(96)00085-3; Soderlund P, 2004, TECTONICS, V23, DOI 10.1029/2003TC001498; Srinivasan G., 2004, 35 LUN PLAN SCI C; STOLPER E, 1977, GEOCHIM COSMOCHIM AC, V41, P587, DOI 10.1016/0016-7037(77)90300-3; TAKEDA H, 1991, METEORITICS, V26, P129; Treiman AH, 2004, EARTH PLANET SC LETT, V219, P189, DOI 10.1016/S0012-821X(04)00004-4; Wanke H., 1973, GEOCHIM COSM SUPPL, V2, P1461; Warren PH, 2014, GEOCHIM COSMOCHIM AC, V141, P199, DOI 10.1016/j.gca.2014.06.008; WARREN PH, 1985, GEOCHIM COSMOCHIM AC, V49, P577, DOI 10.1016/0016-7037(85)90049-3	107	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	JAN 1	2015	409						182	192		10.1016/j.epsl.2014.10.055		11	Geochemistry & Geophysics	Geochemistry & Geophysics	AY7UF	WOS:000347763500018		
J	Islam, MS; Ahmed, MK; Raknuzzaman, M; Habibullah-Al-Mamun, M; Islam, MK				Islam, Md Saiful; Ahmed, Md Kawser; Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md; Islam, Muhammad Kamrul			Heavy metal pollution in surface water and sediment: A preliminary assessment of an urban river in a developing country	ECOLOGICAL INDICATORS			English	Article						Heavy metal; River; Water; Sediment; Chemical fractionation	PRINCIPAL COMPONENT ANALYSIS; POTENTIAL ECOLOGICAL RISK; SMALL MEDITERRANEAN RIVER; SEQUENTIAL EXTRACTION; SPATIAL-DISTRIBUTION; COASTAL SEDIMENTS; MARINE-SEDIMENTS; TRACE-METALS; WASTE-WATER; CONTAMINATION	The concentration and chemical fractionation of globally alarming six heavy metals (Cr, Ni, Cu, As, Cd and Pb) were measured in surface water and sediment of an urban river in Bangladesh. The decreasing trend of metals were observed in water as Cr>Cu>As>Ni>Pb>Cd and in sediment as Cr>Ni>Cu>Pb>As>Cd. The level of studied metals exceeded the safe limits of drinking water, indicated that water from this river is not safe for drinking and/or cooking purposes. However, the investigated metals showed low mobility except for Cd and Pb which could pose a severe threat to the aquatic environment. Contamination factor (CF) and geoaccumulation index (I-geo) demonstrated that most of the sediment samples were moderately to heavily contaminated by Cr, As, Cd and Pb. The pollution load index (PLI) values were above one (>1) indicates progressive deterioration of the sediment quality. The extent of pollution by heavy metals in the river Korotoa implies that the condition is much frightening to the biota and inhabitants in the vicinity of the river as well. (C) 2014 Elsevier Ltd. All rights reserved.	[Islam, Md Saiful] Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh; [Islam, Md Saiful; Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 240, Japan; [Ahmed, Md Kawser] Univ Dhaka, Dept Oceanog, Dhaka 1000, Bangladesh; [Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh; [Islam, Muhammad Kamrul] Gyeongsang Natl Univ, Dept Hort, Jinju, South Korea	Islam, MS (reprint author), Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh.	msaifulpstu@yahoo.com					Alves J.P.H., 2007, J BRAZIL CHEM SOC, V18, P758; Franco-Uria A, 2009, J HAZARD MATER, V165, P1008, DOI 10.1016/j.jhazmat.2008.10.118; Birch GF, 2008, ICES J MAR SCI, V65, P1407, DOI 10.1093/icesjms/fsn139; Yuan CG, 2004, ENVIRON INT, V30, P769, DOI 10.1016/j.envint.2004.01.001; Nouri J, 2011, ENVIRON EARTH SCI, V62, P639, DOI 10.1007/s12665-010-0553-z; Yuan GL, 2011, J HAZARD MATER, V185, P336, DOI 10.1016/j.jhazmat.2010.09.039; Selvaraj K, 2004, MAR POLLUT BULL, V49, P174, DOI 10.1016/j.matpolbul.2004.02.006; Suresh G, 2011, APPL RADIAT ISOTOPES, V69, P1466, DOI 10.1016/j.apradiso.2011.05.020; Cenci RM, 2004, SCI TOTAL ENVIRON, V332, P167, DOI 10.1016/j.scitotenv.2004.01.018; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Abdel-Ghani NT, 2007, INT J ENVIRON SCI TE, V4, P451, DOI 10.1007/BF03325980; Mohiuddin KM, 2012, ENVIRON MONIT ASSESS, V184, P265, DOI 10.1007/s10661-011-1966-1; Bhuiyan MAH, 2011, ENVIRON MONIT ASSESS, V175, P633, DOI 10.1007/s10661-010-1557-6; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Datta DK, 1998, ENVIRON GEOL, V36, P93; Baeyens W, 2007, SCI TOTAL ENVIRON, V384, P409, DOI 10.1016/j.scitotenv.2007.05.044; Yu GB, 2011, CHEMOSPHERE, V85, P1080, DOI 10.1016/j.chemosphere.2011.07.039; Ahmad MK, 2010, INT J ENVIRON RES, V4, P321; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Liu CB, 2009, B ENVIRON CONTAM TOX, V82, P26, DOI 10.1007/s00128-008-9563-x; PARDO R, 1990, WATER RES, V24, P373, DOI 10.1016/0043-1354(90)90016-Y; Loska K, 1997, WATER AIR SOIL POLL, V93, P347, DOI 10.1023/A:1022121615949; [Anonymous], 2004, GUID DRINK WAT QUAL; Caeiro S, 2005, ECOL INDIC, V5, P151, DOI 10.1016/j.ecolind.2005.02.001; Morillo J, 2004, CHEMOSPHERE, V55, P431, DOI 10.1016/j.chemosphere.2003.10.047; Koukal B, 2004, ENVIRON POLLUT, V131, P163, DOI 10.1016/j.envpol.2004.01.014; Kabala C, 2001, J ENVIRON QUAL, V30, P485; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; Jain CK, 2004, WATER RES, V38, P569, DOI 10.1016/j.watres.2003.10.042; Dassenakis M, 1998, APPL GEOCHEM, V13, P197, DOI 10.1016/S0883-2927(97)00065-6; Karbassi AR, 2008, ENVIRON MONIT ASSESS, V147, P107, DOI 10.1007/s10661-007-0102-8; Zhang J, 2002, ESTUAR COAST SHELF S, V54, P1051, DOI 10.1006/ecss.2001.0879; Bermejo JCS, 2003, ENVIRON INT, V29, P69; Armitage PD, 2007, RIVER RES APPL, V23, P997, DOI 10.1002/rra.1022; Srebotnjak T, 2012, ECOL INDIC, V17, P108, DOI 10.1016/j.ecolind.2011.04.023; Maiz I, 2000, ENVIRON POLLUT, V110, P3, DOI 10.1016/S0269-7491(99)00287-0; Nicolau R, 2006, CHEMOSPHERE, V63, P469, DOI 10.1016/j.chemosphere.2005.08.025; Sin SN, 2001, ENVIRON INT, V26, P297, DOI 10.1016/S0160-4120(01)00003-4; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Fu J, 2014, J HAZARD MATER, V270, P102, DOI [10.1016/j.jhazmat.2014.01.044, 10.1010/j.jhazmat.2014.01.044]; Asaduzzaman A. T. M., 2002, ATLAS URBAN GEOLOGY, V14, P415; Environment Canada and Ministere de l'Environnement du Quebec, 1992, METH GUID CHAR SED; Facetti J, 1998, SCI TOTAL ENVIRON, V209, P79, DOI 10.1016/S0048-9697(97)00299-4; Gupta A, 2009, ENVIRON MONIT ASSESS, V157, P449, DOI 10.1007/s10661-008-0547-4; HAMILTON RS, 1984, SCI TOTAL ENVIRON, V33, P59, DOI 10.1016/0048-9697(84)90381-4; Islam M. S., 2014, Journal of Water and Environment Technology, V12, P109, DOI 10.2965/jwet.2014.109; Khadse GK, 2008, ENVIRON MONIT ASSESS, V147, P83, DOI 10.1007/s10661-007-0100-x; Kwon YT, 2001, MICROCHEM J, V68, P135, DOI 10.1016/S0026-265X(00)00140-5; Mitamura M, 2008, J GEOL, V116, P288, DOI 10.1086/587789; MUKAI H, 1994, J GEOPHYS RES-ATMOS, V99, P3717, DOI 10.1029/93JD02917; Nwuche CO, 2010, INT J ENVIRON SCI TE, V7, P697; Olivares-Rieumont S, 2005, WATER RES, V39, P3945, DOI 10.1016/j.watres.2005.07.011; Persuad D., 1993, GUIDELINES PROTECTIO; Pravin U.S., 2012, AM J CHEM, V2, P171; Pueyo M, 2003, J ENVIRON QUAL, V32, P2054; Rahman MA, 2012, ENVIRON MONIT ASSESS, V184, P5755, DOI 10.1007/s10661-011-2379-x; Rahman MS, 2014, ENVIRON EARTH SCI, V71, P2293, DOI 10.1007/s12665-013-2631-5; Raphael E.C., 2011, ENV RES J, V5, P6; Renner R, 2004, ENVIRON SCI TECHNOL, V38, p382A, DOI 10.1021/es040642c; Rudnick RL, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Schottler SP, 2006, J PALEOLIMNOL, V36, P19, DOI 10.1007/s10933-006-0007-5; Shikazono N, 2012, ENVIRON GEOCHEM HLTH, V34, P13, DOI 10.1007/s10653-011-9409-z; Singh KP, 2005, WATER AIR SOIL POLL, V166, P321, DOI 10.1007/s11270-005-5268-5; Tomilson D. C., 1980, HELGOL MEERESUNLTERS, V33, P566; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; USEPA, 2001, EPA823B01002 USEPA O; USEPA, 1999, 530D99001C USEPA, V3; Venugopal T, 2009, B ENVIRON CONTAM TOX, V82, P211, DOI 10.1007/s00128-008-9533-3; Wu YF, 2008, B ENVIRON CONTAM TOX, V80, P465, DOI 10.1007/s00128-008-9397-6; Xiangdong L., 2000, CHEM SPEC BIOAVAILAB, V12, P17	71	8	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	JAN	2015	48						282	291		10.1016/j.ecolind.2014.08.016		10	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AY3PK	WOS:000347495100028		
J	Iijima, H; Nagaike, T				Iijima, Hayato; Nagaike, Takuo			Appropriate vegetation indices for measuring the impacts of deer on forest ecosystems	ECOLOGICAL INDICATORS			English	Article						Absolute deer density; Browsing; Cervus nippon; Coverage and height of understory; vegetation; Debarking	WHITE-TAILED DEER; BARK STRIPPING DAMAGE; SIKA-DEER; RED DEER; LARGE HERBIVORES; CERVUS-ELAPHUS; CENTRAL JAPAN; ODOCOILEUS-VIRGINIANUS; POPULATION-DYNAMICS; ECOLOGICAL IMPACTS	Increasing deer density can cause serious degradation of forests in the Americas, Europe, and Asia. To manage deer impacts, evaluating their current impacts on forest ecosystems is necessary, usually via vegetation indices. However, the relationship between vegetation indices and absolute deer density, while taking into account tree size, snow depth, light condition, and the type of understory vegetation, has never been investigated. We examined the relationship between various vegetation indices and absolute deer density in 344 study plots in the deciduous broad-leaved forest of Yamanashi Prefecture, central Japan. In each plot, debarking and browsing, along with the coverage and maximum height of understory vegetation, were surveyed. Estimated deer densities for 82 5 x 5-km mesh units ranged from 0.8 deer/km(2) to 32.7 deer/km(2). The percentages of debarked trees within a plot ranged from 0 to 84%. Debarking was promoted by high deer density, small tree size, and thick snow. The effect of tree size on debarking was stronger than that of deer density. Occurrence of browsing on understory vegetation was higher at higher deer densities, and where understory vegetation was dominated by evergreen dwarf bamboo. Coverage and maximum height of understory vegetation were unaffected by deer density but increased with canopy openness and the dominance of dwarf bamboo in the understory. Overall, we predict that debarking of small trees living in heavy snow areas should occur even at low deer densities (<10 deer/km(2)). Browsing on dwarf bamboo should occur at intermediate deer densities (10-30 deer/km(2)), while debarking of thick trees living in low snow areas should occur only at high deer densities (>= 30 deer/km(2)). Our study shows that debarking and browsing on understory vegetation are appropriate indices for evaluating deer impacts on forest ecosystems, but that tree size, snow depth, and the type of understory vegetation should also be considered. (C) 2014 Elsevier Ltd. All rights reserved.	[Iijima, Hayato; Nagaike, Takuo] Yamanashi Forest Res Inst, Fujikawa, Yamanashi 4000502, Japan	Iijima, H (reprint author), Yamanashi Forest Res Inst, 2290-1 Saishoji, Fujikawa, Yamanashi 4000502, Japan.	hayato.iijima@gmail.com		Iijima, Hayato/0000-0003-1064-9420	employment promotion project of the Ministry of Health, Labor and Welfare, Japan	We thank Takeshi Honda and Chiaki Ootsu for comments on the manuscript. We are also grateful for the editor and two anonymous reviewers for improving our manuscript. This study was partly funded by the employment promotion project of the Ministry of Health, Labor and Welfare, Japan.	Akashi N, 2011, J FOREST RES-JPN, V16, P500, DOI 10.1007/s10310-010-0245-2; Ando Masaki, 2004, Mammal Study, V29, P73, DOI 10.3106/mammalstudy.29.73; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Nagaike T, 2012, ECOL RES, V27, P467, DOI 10.1007/s11284-011-0917-1; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Gelman A, 2006, BAYESIAN ANAL, V1, P515; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Kaji K, 2004, J WILDLIFE MANAGE, V68, P889, DOI 10.2193/0022-541X(2004)068[0889:IOACSD]2.0.CO;2; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; Forsyth DM, 2007, J WILDLIFE MANAGE, V71, P964, DOI 10.2193/2005-695; Kiffner C, 2008, SILVA FENN, V42, P125, DOI 10.14214/sf.269; Gill RMA, 2010, FORESTRY, V83, P53, DOI 10.1093/forestry/cpp031; Nuttle T, 2014, J ECOL, V102, P221, DOI 10.1111/1365-2745.12175; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Yamamura K, 2008, POPUL ECOL, V50, P131, DOI 10.1007/s10144-007-0069-x; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Morecroft MD, 2001, FORESTRY, V74, P251, DOI 10.1093/forestry/74.3.251; Akashi N, 1999, FOREST ECOL MANAG, V113, P75, DOI 10.1016/S0378-1127(98)00415-0; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Suzuki M, 2013, OIKOS, V122, P104, DOI 10.1111/j.1600-0706.2012.20431.x; Takeuchi T, 2011, FOREST ECOL MANAG, V261, P2089, DOI 10.1016/j.foreco.2011.03.002; Beguin J, 2011, ECOL APPL, V21, P439, DOI 10.1890/09-2100.1; Borkowski J., 1996, J FOR RES, V1, P9, DOI 10.1007/BF02348332; Borkowski J, 2012, FOREST ECOL MANAG, V263, P17, DOI 10.1016/j.foreco.2011.09.029; Cornett MW, 2000, BIOL CONSERV, V93, P359, DOI 10.1016/S0006-3207(99)00129-9; Faraway J.J., 2005, EXTENDING LINEAR MOD; Filazzola A, 2014, FOREST ECOL MANAG, V313, P10, DOI 10.1016/j.foreco.2013.10.040; Heuze R, 2005, ANN FOREST SCI, V62, P175; Honda T, 2008, LANDSC ECOL ENG, V4, P97, DOI 10.1007/s11355-008-0047-2; Ito H, 2005, ECOL RES, V20, P121, DOI 10.1007/s11284-004-0023-8; Janos P., 2006, J VEG SCI, V17, P113; Japan Meteorological Agency, 2002, MESH CLIM DAT JAP JA; Jiang, 2005, J FOR RES, V10, P359; Kraft LS, 2004, FOREST ECOL MANAG, V199, P219, DOI 10.1016/j.foreco.2004.05.044; Kumar S, 2006, J FOREST RES-JPN, V11, P337, DOI 10.1007/s10310-006-0216-9; Masse A, 2012, FOREST ECOL MANAG, V285, P67, DOI 10.1016/j.foreco.2012.07.039; McLaren BE, 2000, FOREST ECOL MANAG, V133, P179, DOI 10.1016/S0378-1127(99)00223-6; Morellet N, 2001, WILDLIFE SOC B, V29, P1243; Nagaike T, 2003, FOREST ECOL MANAG, V175, P563, DOI 10.1016/S0378-1127(02)00221-9; Nagaike T., 2014, JAPANINT SCHOLAR RES; Plummer M, 2003, P 3 INT WORKSH DISTR, P20; Putman R, 2011, MAMMAL REV, V41, P197, DOI 10.1111/j.1365-2907.2010.00172.x; Quantum GIS Development Team, 2014, QGIS GEOGR INF SYST; R Core Team, 2013, R LANG ENV STAT COMP; Randall JA, 2011, FOREST ECOL MANAG, V261, P408, DOI 10.1016/j.foreco.2010.10.026; STEWART GH, 1989, BIOL CONSERV, V49, P275, DOI 10.1016/0006-3207(89)90048-7; TAKATSUKI S, 1989, Ecological Research, V4, P287, DOI 10.1007/BF02348449; Tanentzap AJ, 2012, FOREST ECOL MANAG, V264, P159, DOI 10.1016/j.foreco.2011.10.005; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x; Vospernik S, 2006, SILVA FENN, V40, P589, DOI 10.14214/sf.316; Waller DM, 1997, WILDLIFE SOC B, V25, P217	55	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	JAN	2015	48						457	463		10.1016/j.ecolind.2014.09.009		7	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AY3PK	WOS:000347495100049		
J	Yamanaka, S; Akasaka, T; Yamaura, Y; Kaneko, M; Nakamura, F				Yamanaka, Satoshi; Akasaka, Takumi; Yamaura, Yuichi; Kaneko, Masami; Nakamura, Futoshi			Time-lagged responses of indicator taxa to temporal landscape changes in agricultural landscapes	ECOLOGICAL INDICATORS			English	Article						Bats; Biological indicator; Carabid beetles; Ecological traits; Historical land change	GROUND BEETLES COLEOPTERA; EXTINCTION DEBT; BODY-SIZE; BIODIVERSITY CONSERVATION; HABITAT FRAGMENTATION; FOREST FRAGMENTS; CARABID BEETLES; TROPICAL FOREST; BATS; BIOINDICATORS	Biological indicator methods represent one of the most effective and widely used strategies for understanding the influences of environmental degradation on biodiversity in various landscapes. Researchers and land managers generally assume that the present distributions of biological indicator species are influenced by the current environment. However, recent studies have suggested the importance of past environments to species distributions (i.e., a time lag between changes in species distribution and habitat alterations). Therefore, it is necessary to understand the effects of past environments on the distributions of indicator species. We conducted a survey on the Tokachi Plain in Hokkaido, Japan. We targeted two taxa that have been widely used as indicator species (carabid beetles and bats) and investigated whether past landscape environments influenced their present distributions. We showed that past landscape environments (5 decades prior to the present) influenced the distributions of some ecological trait groups in each taxon (large body size for carabid beetles and a 25 kHz peak echolocation frequency for bats) and that these effects varied among groups. Our results suggest the need to consider the dynamics of land-use changes and the effects of past environments on the distributions of indicator taxa, otherwise we may misunderstand the effects of environmental degradation on biodiversity. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamanaka, Satoshi; Nakamura, Futoshi] Hokkaido Univ, Grad Sch Agr, Dept Forest Sci, Sapporo, Hokkaido 0608589, Japan; [Akasaka, Takumi] Obihiro Univ Agr & Vet Med, Lab Conservat Ecol, Obihiro, Hokkaido 0808555, Japan; [Yamaura, Yuichi] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 3058687, Japan; [Kaneko, Masami] Rakuno Gakuen Univ, Dept Biosphere & Environm Sci, Ebetsu, Hokkaido 0690836, Japan	Akasaka, T (reprint author), Obihiro Univ Agr & Vet Med, Lab Conservat Ecol, Nishi 2 Sen 11, Obihiro, Hokkaido 0808555, Japan.	syama@for.agr.hokudai.ac.jp; mail2taq@gmail.com	Yamaura, Yuichi/A-3638-2012; Nakamura, Futoshi/A-6696-2012	Yamaura, Yuichi/0000-0001-9355-4413; 	Zoshinkai Fund for Protection of Endangered Animals from the Ministry of Education, Science, and Culture, Japan [23248021]; Grant of the Environment Research and Technology Development Fund from the Ministry of the Environment of Japan [4D-1201]; Ministry of Land, Infrastructure, Transport, and Tourism of Japan	We are grateful to H. taki and two anonymous reviewers for helpful advice that improved the manuscript. We also thank the members of the Laboratory of Forest Ecosystem Management of Hokkaido University for their assistance in our field survey. This study was funded by the Zoshinkai Fund for Protection of Endangered Animals, Grants in Aid for Scientific Research (No. 23248021) from the Ministry of Education, Science, and Culture, Japan; a Grant of the Environment Research and Technology Development Fund (4D-1201) from the Ministry of the Environment of Japan, and the research fund for the Tokachi River provided by the Ministry of Land, Infrastructure, Transport, and Tourism of Japan.	Aguirre LF, 2002, J MAMMAL, V83, P775, DOI 10.1644/1545-1542(2002)083<0775:SOANSB>2.0.CO;2; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Magura T, 2002, EUR J SOIL BIOL, V38, P291, DOI 10.1016/S1164-5563(02)01162-7; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Niemela J, 2007, J INSECT CONSERV, V11, P5, DOI 10.1007/s10841-006-9014-0; Akasaka T, 2010, LANDSC ECOL ENG, V6, P247, DOI 10.1007/s11355-010-0105-4; Rykken JJ, 1997, CONSERV BIOL, V11, P522, DOI 10.1046/j.1523-1739.1997.95336.x; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Fahy O, 1998, FOREST ECOL MANAG, V110, P263, DOI 10.1016/S0378-1127(98)00285-0; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Maisonhaute JE, 2010, AGR ECOSYST ENVIRON, V139, P500, DOI 10.1016/j.agee.2010.09.008; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Podlutsky AJ, 2005, J GERONTOL A-BIOL, V60, P1366; [Anonymous], 2014, IUCN RED LIST THREAT; Sang A, 2010, BIOL CONSERV, V143, P1405, DOI 10.1016/j.biocon.2010.03.015; Perner J, 2003, AGR ECOSYST ENVIRON, V98, P169, DOI 10.1016/S0167-8809(03)00079-3; Peck SL, 1998, ENVIRON ENTOMOL, V27, P1102; Hanski I, 2013, ANIM CONSERV, V16, P12, DOI 10.1111/acv.12024; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Kusch J, 2004, FOLIA ZOOL, V53, P113; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Kerth G, 2001, BEHAV ECOL SOCIOBIOL, V50, P283, DOI 10.1007/s002650100352; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; Hillen J, 2009, BIOL CONSERV, V142, P817, DOI 10.1016/j.biocon.2008.12.017; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Magura T, 2006, BASIC APPL ECOL, V7, P472, DOI 10.1016/j.baae.2005.08.005; Woodcock BA, 2010, AGR ECOSYST ENVIRON, V139, P181, DOI 10.1016/j.agee.2010.07.018; Lindenmayer DB, 1999, FOREST ECOL MANAG, V115, P277, DOI 10.1016/S0378-1127(98)00406-X; Cousins SAO, 2011, BIOL CONSERV, V144, P782, DOI 10.1016/j.biocon.2010.11.009; Januschke K, 2014, ECOL INDIC, V38, P243, DOI 10.1016/j.ecolind.2013.10.031; Cole LJ, 2002, AGR ECOSYST ENVIRON, V93, P323, DOI 10.1016/S0167-8809(01)00333-4; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Akasaka T, 2012, BIOL CONSERV, V145, P15, DOI 10.1016/j.biocon.2011.08.017; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Barton K, 2011, MUMIN MULTIMODEL INF; Bates Douglas, 2011, LME4 LINEAR MIXED EF; Burnham K. P., 2002, MODEL SELECTION MULT; Crawley MJ, 2002, STAT COMPUTING INTRO; Fukui D, 2011, FOREST ECOL MANAG, V261, P1546, DOI 10.1016/j.foreco.2011.02.001; Griffin Donald R., 2004, P6; KREMEN C, 1994, CONSERV BIOL, V8, P388, DOI 10.1046/j.1523-1739.1994.08020388.x; Lesinski G, 2007, FOLIA ZOOL, V56, P153; Magura T, 2001, J BIOGEOGR, V28, P129, DOI 10.1046/j.1365-2699.2001.00534.x; New TR, 2005, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9780511542114; Ohdachi S. D., 2009, WILD MAMMALS JAPAN; Pacha MJ, 2008, AGR ECOSYST ENVIRON, V123, P81, DOI 10.1016/j.agee.2007.05.002; Petit S, 1998, AGR ECOSYST ENVIRON, V69, P243, DOI 10.1016/S0167-8809(98)00111-X; R Core Team, 2013, R LANG ENV STAT COMP; Soga M, 2013, J INSECT CONSERV, V17, P421, DOI 10.1007/s10841-012-9524-x; Solari S, 2002, ENVIRON MONIT ASSESS, V76, P89, DOI 10.1023/A:1015272905263; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Ueno S., 1985, COLEOPTERA JAPAN COL; Yajima T., 2002, CHANGE PRESENT CONDI	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1470-160X	1872-7034		ECOL INDIC	Ecol. Indic.	JAN	2015	48						593	598		10.1016/j.ecolind.2014.08.024		6	Biodiversity Conservation; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AY3PK	WOS:000347495100063		
J	Nakamura, Y				Nakamura, Yasuhiko			Price versus quantity in a mixed duopoly: The case of relative profit maximization	ECONOMIC MODELLING			English	Article						Quantity competition; Price competition; Mixed markets; Differentiated products; Relative profit maximization	DIFFERENTIATED DUOPOLY; COMPETITION; UNCERTAINTY; OLIGOPOLY; EVOLUTION; BEHAVIOR	This paper examines the endogenous choice problem of each firm's price or quantity contract in a mixed duopoly composed of one social welfare maximizing public firm and one relative profit-maximizing private firm. In this paper, we show that unless the degree of product differentiation and the degree of importance of the private firm's relative performance are low, the quantity competition can analytically become the unique equilibrium market structure on the basis of the dominant strategies of the public firm and the private firm when the degree of importance of firm l's relative performance is sufficiently high. This result contrasts strikingly with that obtained in a standard mixed duopoly composed of one social welfare-maximizing public firm and one absolute profit maximizing private firm. In addition, even in the area wherein both the degree of product differentiation and the degree of the private firm's relative performance are sufficiently low, through numerical simulations, the quantity competition tends to become the unique equilibrium market structure when the degree of importance of the private firm's relative performance is sufficiently high, whereas the price competition tends to become the unique equilibrium market structure when the degree of importance of the private firm's relative performance is sufficiently low. (C) 2014 Elsevier B.V. All rights reserved.	[Nakamura, Yasuhiko] Nihon Univ, Coll Econ, Tokyo 1018360, Japan	Nakamura, Y (reprint author), Nihon Univ, Coll Econ, Chiyoda Ku, 1-3-2 Misaki Cho, Tokyo 1018360, Japan.	yasuhiko.r.nakamura@gmail.com					SINGH N, 1984, RAND J ECON, V15, P546, DOI 10.2307/2555525; Alchian AA, 1950, J POLIT ECON, V58, P211, DOI 10.1086/256940; Matsumura T, 2012, ECON LETT, V116, P174, DOI 10.1016/j.econlet.2012.02.012; Matsumura T, 2012, B ECON RES, V64, ps22, DOI 10.1111/j.1467-8586.2012.00439.x; VegaRedondo F, 1997, ECONOMETRICA, V65, P375, DOI 10.2307/2171898; Coats JC, 2005, ECON INQ, V43, P614, DOI 10.1093/ei/cbi042; KLEMPERER P, 1986, RAND J ECON, V17, P618, DOI 10.2307/2555486; Matsumura T., 2010, COMPETITION PRIVATIZ; Nakamura Y., 2013, THEORETICAL ECONOMIC, V3, P124; Tanaka Y, 2001, J MATH ECON, V35, P409, DOI 10.1016/S0304-4068(00)00072-0; TANAKA Y, 2001, ECON THEOR, V17, P639; Tasnadi A, 2006, INT J IND ORGAN, V24, P541, DOI 10.1016/j.ijindorg.2005.07.009; Wang Y. C., 2010, INT J EC BUS, V17, P207; Wang YC, 2009, S AFR J ECON, V77, P577	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	JAN	2015	44						37	43		10.1016/j.econmod.2014.09.019		7	Economics	Business & Economics	AY7LL	WOS:000347741600005		
